PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Erbe, C; Williams, R; Sandilands, D; Ashe, E				Erbe, Christine; Williams, Rob; Sandilands, Doug; Ashe, Erin			Identifying Modeled Ship Noise Hotspots for Marine Mammals of Canada's Pacific Region	PLOS ONE			English	Article							PORPOISE PHOCOENA-PHOCOENA; CUMULATIVE SOUND EXPOSURE; ORCINUS-ORCA; UNDERWATER NOISE; TONAL SIGNALS; DELPHINAPTERUS-LEUCAS; BEHAVIORAL-RESPONSES; DETECTION THRESHOLDS; HEARING SENSITIVITY; OCEAN MEASUREMENTS	The inshore, continental shelf waters of British Columbia (BC), Canada are busy with ship traffic. South coast waters are heavily trafficked by ships using the ports of Vancouver and Seattle. North coast waters are less busy, but expected to get busier based on proposals for container port and liquefied natural gas development and expansion. Abundance estimates and density surface maps are available for 10 commonly seen marine mammals, including northern resident killer whales, fin whales, humpback whales, and other species with at-risk status under Canadian legislation. Ship noise is the dominant anthropogenic contributor to the marine soundscape of BC, and it is chronic. Underwater noise is now being considered in habitat quality assessments in some countries and in marine spatial planning. We modeled the propagation of underwater noise from ships and weighted the received levels by species-specific audiograms. We overlaid the audiogram-weighted maps of ship audibility with animal density maps. The result is a series of so-called "hotspot'' maps of ship noise for all 10 marine mammal species, based on cumulative ship noise energy and average distribution in the boreal summer. South coast waters (Juan de Fuca and Haro Straits) are hotspots for all species that use the area, irrespective of their hearing sensitivity, simply due to ubiquitous ship traffic. Secondary hotspots were found on the central and north coasts (Johnstone Strait and the region around Prince Rupert). These maps can identify where anthropogenic noise is predicted to have above-average impact on species-specific habitat, and where mitigation measures may be most effective. This approach can guide effective mitigation without requiring fleet-wide modification in sites where no animals are present or where the area is used by species that are relatively insensitive to ship noise.	[Erbe, Christine] Curtin Univ, Ctr Marine Sci & Technol, Perth, WA 6845, Australia; [Williams, Rob; Ashe, Erin] Univ St Andrews, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Sandilands, Doug] Provincetown Ctr Coastal Studies, Provincetown, MA USA	Curtin University; University of St Andrews	Erbe, C (corresponding author), Curtin Univ, Ctr Marine Sci & Technol, Perth, WA 6845, Australia.	Christine.Erbe@curtin.edu.au	Erbe, Christine/AAA-3801-2021; Erbe, Christine/H-4777-2012; Williams, Rob/C-5882-2011	Erbe, Christine/0000-0002-7884-9907; Williams, Rob/0000-0001-7496-453X; Ashe, Erin/0000-0001-9918-1419	Marie Curie International Incoming Fellowship within the 7th European Community [PIIF-GA-2009-253407]; Marisla Foundation	Marie Curie International Incoming Fellowship within the 7th European Community; Marisla Foundation	RW was supported by a Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme (Project CONCEAL, FP7, PIIF-GA-2009-253407). These analyses were funded by a grant to RW and EA from Marisla Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardy T, 2003, AQUAT CONSERV, V13, P353, DOI 10.1002/aqc.583; American National Standards Institute, 1986, S1271986 ANSI AC SOC; Andre Michel, 2007, Aquatic Mammals, V33, P1, DOI 10.1578/AM.33.1.2007.1; AU D, 1982, FISH B-NOAA, V80, P371; Au Whitlow W. L., 2007, Aquatic Mammals, V33, P76, DOI 10.1578/AM.33.1.2007.76; Borja A, 2010, MAR POLLUT BULL, V60, P2175, DOI 10.1016/j.marpolbul.2010.09.026; Boyd IL, 2011, OCEANOGRAPHY, V24, P174, DOI 10.5670/oceanog.2011.37; Brill RL, 2001, J ACOUST SOC AM, V109, P1717, DOI 10.1121/1.1356704; Clark CW, 2009, MAR ECOL PROG SER, V395, P201, DOI 10.3354/meps08402; Clark CW., 2004, ECHOLOCATION BATS DO; Ellison WT, 2012, CONSERV BIOL, V26, P21, DOI 10.1111/j.1523-1739.2011.01803.x; Erbe C, 1998, DEEP-SEA RES PT II, V45, P1373, DOI 10.1016/S0967-0645(98)00027-7; Erbe C, 2000, J ACOUST SOC AM, V108, P1332, DOI 10.1121/1.1288938; Erbe C, 2002, MAR MAMMAL SCI, V18, P394, DOI 10.1111/j.1748-7692.2002.tb01045.x; Erbe C, 2008, J ACOUST SOC AM, V124, P2216, DOI 10.1121/1.2970094; Erbe C, 2013, ACOUST AUST, V41, P12; Erbe C, 2013, J ACOUST SOC AM, V133, pEL326, DOI 10.1121/1.4795220; Erbe C, 2012, J ACOUST SOC AM, V132, pEL423, DOI 10.1121/1.4758779; Erbe C, 2012, ADV EXP MED BIOL, V730, P477, DOI 10.1007/978-1-4419-7311-5_108; Erbe C, 2012, ADV EXP MED BIOL, V730, P17, DOI 10.1007/978-1-4419-7311-5_3; Erbe C, 2009, J ACOUST SOC AM, V125, P2443, DOI 10.1121/1.3089588; FRANCOIS RE, 1982, J ACOUST SOC AM, V72, P896, DOI 10.1121/1.388170; FRANCOIS RE, 1982, J ACOUST SOC AM, V72, P1879, DOI 10.1121/1.388673; Groison AL, 2011, ENVIRON BIOL FISH, V91, P7, DOI 10.1007/s10641-010-9753-3; HALL JD, 1972, J ACOUST SOC AM, V51, P515, DOI 10.1121/1.1912871; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hatch L, 2008, ENVIRON MANAGE, V42, P735, DOI 10.1007/s00267-008-9169-4; Hatch LT, 2012, CONSERV BIOL, V26, P983, DOI 10.1111/j.1523-1739.2012.01908.x; Hatch LT, 2009, MAR ECOL PROG SER, V395, P223, DOI 10.3354/meps07945; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Holt DE, 2011, ENVIRON BIOL FISH, V91, P121, DOI 10.1007/s10641-010-9756-0; Houser DS, 2008, MAR MAMMAL SCI, V24, P28, DOI 10.1111/j.1748-7692.2007.00148.x; Houser DS, 2006, J ACOUST SOC AM, V120, P4090, DOI 10.1121/1.2357993; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; Kastak D, 1998, J ACOUST SOC AM, V103, P2216, DOI 10.1121/1.421367; Kastak D, 2000, CAN J ZOOL, V77, P1751; Kastelein RA, 2005, J ACOUST SOC AM, V118, P1820, DOI 10.1121/1.1992650; Kastelein RA, 2002, J ACOUST SOC AM, V112, P334, DOI 10.1121/1.1480835; Kastelein RA, 2010, J ACOUST SOC AM, V128, P3211, DOI 10.1121/1.3493435; Kastelein RA, 2010, J ACOUST SOC AM, V127, P1135, DOI 10.1121/1.3283019; Kastelein RA, 2009, J ACOUST SOC AM, V125, P1222, DOI 10.1121/1.3050283; Leeney RH, 2011, AQUAT MAMM, V37, P151, DOI 10.1578/AM.37.2.2011.151; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marmo B., 2013, MODELLING NOISE EFFE; Matthiopoulos J, 2008, MAMMAL REV, V38, P167, DOI 10.1111/j.1365-2907.2008.00123.x; Meager JJ, 2011, J FISH BIOL, V78, P1437, DOI 10.1111/j.1095-8649.2011.02951.x; Merchant ND, 2014, MAR POLLUT BULL, V78, P85, DOI 10.1016/j.marpolbul.2013.10.058; Miller PJO, 2012, AQUAT MAMM, V38, P362, DOI 10.1578/AM.38.4.2012.362; MOHL B, 1968, Journal of Auditory Research, V8, P27; National Research Council, 2000, MAR MAMM LOW FREQ SO; National Research Council, 2003, OC NOIS MAR MAMM; Nowacek DP, 2007, MAMMAL REV, V37, P81, DOI 10.1111/j.1365-2907.2007.00104.x; Popov Vladimir V., 2007, Aquatic Mammals, V33, P24, DOI 10.1578/AM.33.1.2007.24; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Ross D., 1976, MECH UNDERWATER NOIS; Scheidat Meike, 2004, Journal of Cetacean Research and Management, V6, P63; Southall Brandon L., 2007, Aquatic Mammals, V33, pI; Szymanski MD, 1999, J ACOUST SOC AM, V106, P1134, DOI 10.1121/1.427121; TERHUNE JM, 1988, CAN J ZOOL, V66, P1578, DOI 10.1139/z88-230; Tremel Donald P., 1998, Aquatic Mammals, V24, P63; Tyack PL, 2000, SPR HDB AUD, V12, P156; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Wade PR, 1998, MAR MAMMAL SCI, V14, P1, DOI 10.1111/j.1748-7692.1998.tb00688.x; WENZ GM, 1962, J ACOUST SOC AM, V34, P1936, DOI 10.1121/1.1909155; Williams R, 2014, ANIM CONSERV, V17, P174, DOI 10.1111/acv.12076; Williams R, 2006, BIOL CONSERV, V133, P301, DOI 10.1016/j.biocon.2006.06.010; Woodbury PB, 2003, ENVIRON TOXICOL CHEM, V22, P977, DOI 10.1002/etc.5620220504; Zacharias MA, 2005, CONSERV BIOL, V19, P86, DOI 10.1111/j.1523-1739.2005.00148.x	68	55	55	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89820	10.1371/journal.pone.0089820	http://dx.doi.org/10.1371/journal.pone.0089820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598866	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400029
J	Gage-Bouchard, EA; Devine, KA				Gage-Bouchard, Elizabeth A.; Devine, Katie A.			Examining Parents' Assessments of Objective and Subjective Social Status in Families of Children with Cancer	PLOS ONE			English	Article							SELF-RATED HEALTH; SOCIOECONOMIC-STATUS; AFRICAN-AMERICANS; RISK	Introduction: Understanding the social determinants of child health is a prominent area of research. This paper examines the measurement of socioeconomic position in a sample of families of children with cancer. Socioeconomic position is difficult to measure in pediatric health research due to sensitivity of asking about finances when research is conducted in health care delivery settings, financial volatility associated with periods of pediatric illness, and difficulty recruiting fathers to research. Methods: Caregivers of children with cancer (n = 76) completed a questionnaire that included the MacArthur Scale of Subjective Social Status (SSS). SSS was measured using two 10-rung ladders with differing referent groups: the US and respondents' communities. Respondents placed themselves on each ladder by placing an X on the rung that represented their social position in relation to the two referent groups. Individuals' SSS ratings and discrepancies in SSS ratings within couples were examined, and associations with objective social status measures were evaluated using Pearson correlations or t-tests. Results: Parents' placement on the US and community ladders was positively associated with their income, education, wealth, household savings, and household savings minus debt. On average, respondents placed themselves higher on the US ladder compared to the community ladder. There was an average intra-couple discrepancy of 1.25 rungs in partner's placements on the US ladder and a 1.56 rung difference for the community ladder. This intra-couple discrepancy was not associated with gender. Discussion: Results offer insight into the use of subjective social status measures to capture a more holistic assessment of socioeconomic position and the measurement of socioeconomic position in two-parent families.	[Gage-Bouchard, Elizabeth A.] SUNY Buffalo, Sch Publ Hlth, Dept Community Hlth & Hlth Behav, Buffalo, NY 14260 USA; [Devine, Katie A.] Rutgers State Univ, Div Populat Sci, Rutgers Canc Inst New Jersey, Dept Med, New Brunswick, NJ 08903 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Gage-Bouchard, EA (corresponding author), SUNY Buffalo, Sch Publ Hlth, Dept Community Hlth & Hlth Behav, Buffalo, NY 14260 USA.	eagage@buffalo.edu	Devine, Katie/K-1298-2019	Devine, Katie/0000-0002-1003-8905	National Institutes of Health [R21CA141165, R25CA114101, R25CA10618, P30CA072720]; NATIONAL CANCER INSTITUTE [P30CA072720, R21CA141165, R25CA114101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Institutes of Health, grants R21CA141165, R25CA114101, R25CA10618 and P30CA072720. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler N., 2007, MACARTHUR SCALE SUBJ; Adler N, 2008, SOC SCI MED, V66, P1034, DOI 10.1016/j.socscimed.2007.11.031; Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Duncan GJ, 2001, SOC SCI RES, V30, P248, DOI 10.1006/ssre.2000.0696; Gage E, 2010, CANCER NURS, V33, pE1, DOI 10.1097/NCC.0b013e3181c29583; Galobardes B, 2003, SOZ PRAVENTIV MED, V48, P70, DOI 10.1007/s000380300008; Ghaed SG, 2007, HEALTH PSYCHOL, V26, P668, DOI 10.1037/0278-6133.26.6.668; Goldman N, 2006, J CROSS-CULT GERONTO, V21, P71, DOI 10.1007/s10823-006-9020-4; Hu PF, 2005, J AM GERIATR SOC, V53, P483, DOI 10.1111/j.1532-5415.2005.53169.x; Iida H, 2013, AM J PUBLIC HEALTH, V103, P480, DOI 10.2105/AJPH.2012.300845; JACKMAN MR, 1979, PUBLIC OPIN QUART, V43, P443, DOI 10.1086/268543; JACKMAN MR, 1973, AM SOCIOL REV, V38, P569, DOI 10.2307/2094408; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Lareau Annette, 2000, QUAL SOCIOL, V23, P407, DOI DOI 10.1023/A:1005574724760; Mehta NK, 2013, SOC SCI MED, V95, P6, DOI 10.1016/j.socscimed.2012.09.011; Mitchell SJ, 2007, APPL DEV SCI, V11, P239, DOI 10.1080/10888690701762159; Ostrove JM, 2000, HEALTH PSYCHOL, V19, P613, DOI 10.1037/0278-6133.19.6.613; Singh-Manoux A, 2005, PSYCHOSOM MED, V67, P855, DOI 10.1097/01.psy.0000188434.52941.a0; Singh-Manoux A, 2003, SOC SCI MED, V56, P1321, DOI 10.1016/S0277-9536(02)00131-4; Subramanyam MA, 2012, SOC SCI MED, V74, P1146, DOI 10.1016/j.socscimed.2011.12.042; Thompson AL, 2013, SOC SCI MED, V97, P288, DOI 10.1016/j.socscimed.2012.12.007; Wolff LS, 2010, SOC SCI MED, V70, P2019, DOI 10.1016/j.socscimed.2010.02.033; Wolff LS, 2010, J HEALTH PSYCHOL, V15, P560, DOI 10.1177/1359105309354345	24	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89842	10.1371/journal.pone.0089842	http://dx.doi.org/10.1371/journal.pone.0089842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24599006	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400031
J	Lee, J; Sohn, I; Do, IG; Kim, KM; Park, SH; Park, JO; Park, YS; Lim, HY; Sohn, TS; Bae, JM; Choi, MG; Lim, DH; Min, BH; Lee, JH; Rhee, PL; Kim, JJ; Choi, DI; Choi, DI; Das, K; Tan, P; Jung, SH; Kang, WK; Kim, S				Lee, Jeeyun; Sohn, Insuk; Do, In-Gu; Kim, Kyoung-Mee; Park, Se Hoon; Park, Joon Oh; Park, Young Suk; Lim, Ho Yeong; Sohn, Tae Sung; Bae, Jae Moon; Choi, Min Gew; Lim, Do Hoon; Min, Byung Hoon; Lee, Joon Haeng; Rhee, Poong Lyul; Kim, Jae J.; Choi, Dong Il; Tan, Iain Beehuat; Das, Kakoli; Tan, Patrick; Jung, Sin Ho; Kang, Won Ki; Kim, Sung			Nanostring-Based Multigene Assay to Predict Recurrence for Gastric Cancer Patients after Surgery	PLOS ONE			English	Article							GENE-EXPRESSION; COLON-CANCER; ADENOCARCINOMA; CAPECITABINE; ASSOCIATION; DISSECTION; TISSUES; TFDP1	Despite the benefits from adjuvant chemotherapy or chemoradiotherapy, approximately one-third of stage II gastric cancer (GC) patients developed recurrences. The aim of this study was to develop and validate a prognostic algorithm for gastric cancer (GCPS) that can robustly identify high-risk group for recurrence among stage II patients. A multi-step gene expression profiling study was conducted. First, a microarray gene expression profiling of archived paraffin-embedded tumor blocks was used to identify candidate prognostic genes (N = 432). Second, a focused gene expression assay including prognostic genes was used to develop a robust clinical assay (GCPS) in stage II patients from the same cohort (N = 186). Third, a predefined cut off for the GCPS was validated using an independent stage II cohort (N = 216). The GCPS was validated in another set with stage II GC who underwent surgery without adjuvant treatment (N = 300). GCPS was developed by summing the product of Cox regression coefficients and normalized expression levels of 8 genes (LAMP5, CDC25B, CDK1, CLIP4, LTB4R2, MATN3, NOX4, TFDP1). A prospectively defined cut-point for GCPS classified 22.7% of validation cohort treated with chemoradiotherapy (N = 216) as high-risk group with 5-year recurrence rate of 58.6% compared to 85.4% in the low risk group (hazard ratio for recurrence = 3.16, p = 0.00004). GCPS also identified high-risk group among stage II patients treated with surgery only (hazard ratio = 1.77, p = 0.0053).	[Lee, Jeeyun; Park, Se Hoon; Park, Joon Oh; Park, Young Suk; Lim, Ho Yeong; Kang, Won Ki] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea; [Sohn, Insuk; Do, In-Gu; Jung, Sin Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Canc Res Inst, Seoul, South Korea; [Do, In-Gu; Kim, Kyoung-Mee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Sohn, Tae Sung; Bae, Jae Moon; Choi, Min Gew; Kim, Sung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; [Lim, Do Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Min, Byung Hoon; Lee, Joon Haeng; Rhee, Poong Lyul; Kim, Jae J.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Gastroenterol, Seoul, South Korea; [Choi, Dong Il] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Tan, Iain Beehuat; Tan, Patrick] Duke NUS Grad Med Sch Singapore, Singapore, Singapore; [Das, Kakoli; Tan, Patrick] Genome Inst Singapore, Singapore, Singapore; [Tan, Patrick] Canc Sci Inst Singapore, Singapore, Singapore	Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Kang, WK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea.	wkkang@skku.edu; sungkimm@skku.edu	Lee, Jee Yun/C-9646-2011; Lee, Jeeyun/I-7171-2015; Park, Se Hoon/GMX-1199-2022; Kim, Sung/G-4114-2014	Park, Se Hoon/0000-0001-5084-9326; Tan, Iain/0000-0003-4951-0354; Das, Kakoli/0000-0002-0990-276X; Rhee, Poong-Lyul/0000-0003-0495-5296	Samsung Medical Center	Samsung Medical Center(Samsung)	This study was supported by an Intramural grant from the Samsung Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2003, J CLIN ONCOL, V21, P241, DOI 10.1200/JCO.2003.05.044; Bang Y, 2011, J CLIN ONCOL, V29; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; Clark-Langone KM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-279; Fan JB, 2004, GENOME RES, V14, P878, DOI 10.1101/gr.2167504; Folli S, 2001, JPN J CLIN ONCOL, V31, P495, DOI 10.1093/jjco/hye107; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Kim S, 2005, INT J RADIAT ONCOL, V63, P1279, DOI 10.1016/j.ijrobp.2005.05.005; Lee J, 2012, J CLIN ONCOL, V30, P268, DOI 10.1200/JCO.2011.39.1953; Lee K, 2004, PROTEOMICS, V4, P3343, DOI 10.1002/pmic.200400960; Levi F, 2004, ANN ONCOL, V15, P338, DOI 10.1093/annonc/mdh057; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Nigro JJ, 1999, ANN SURG, V230, P433, DOI 10.1097/00000658-199909000-00015; Sohn I, 2009, BIOINFORMATICS, V25, P1775, DOI 10.1093/bioinformatics/btp322; Tan IB, 2011, GASTROENTEROLOGY, V141, P476, DOI 10.1053/j.gastro.2011.04.042; Yasui K, 2003, J HUM GENET, V48, P609, DOI 10.1007/s10038-003-0086-3; Yasui K, 2002, HEPATOLOGY, V35, P1476, DOI 10.1053/jhep.2002.33683	21	87	87	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90133	10.1371/journal.pone.0090133	http://dx.doi.org/10.1371/journal.pone.0090133			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598828	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400047
J	Amin, MT; Nawaz, M; Amin, MN; Han, M				Amin, Muhammad T.; Nawaz, Mohsin; Amin, Muhammad N.; Han, Mooyoung			Solar Disinfection of Pseudomonas aeruginosa in Harvested Rainwater: A Step towards Potability of Rainwater	PLOS ONE			English	Article							DRINKING-WATER; PLASTIC BOTTLES; INACTIVATION; SODIS; QUALITY; SIMULATION; PATHOGENS; RADIATION; MATTER; COLI	Efficiency of solar based disinfection of Pseudomonas aeruginosa (P. aeruginosa) in rooftop harvested rainwater was evaluated aiming the potability of rainwater. The rainwater samples were exposed to direct sunlight for about 8-9 hours and the effects of water temperature (degrees C), sunlight irradiance (W/m(2)), different rear surfaces of polyethylene terephthalate bottles, variable microbial concentrations, pH and turbidity were observed on P. aeruginosa inactivation at different weathers. In simple solar disinfection (SODIS), the complete inactivation of P. aeruginosa was obtained only under sunny weather conditions (>50 degrees C and >700 W/m(2)) with absorptive rear surface. Solar collector disinfection (SOCODIS) system, used to improve the efficiency of simple SODIS under mild and weak weather, completely inactivated the P. aeruginosa by enhancing the disinfection efficiency of about 20% only at mild weather. Both SODIS and SOCODIS systems, however, were found inefficient at weak weather. Different initial concentrations of P. aeruginosa and/or Escherichia coli had little effects on the disinfection efficiency except for the SODIS with highest initial concentrations. The inactivation of P. aeruginosa increased by about 10-15% by lowering the initial pH values from 10 to 3. A high initial turbidity, adjusted by adding kaolin, adversely affected the efficiency of both systems and a decrease, about 15-25%; in inactivation of P. aeruginosa was observed. The kinetics of this study was investigated by Geeraerd Model for highlighting the best disinfection system based on reaction rate constant. The unique detailed investigation of P. aeruginosa disinfection with sunlight based disinfection systems under different weather conditions and variable parameters will help researchers to understand and further improve the newly invented SOCODIS system.	[Amin, Muhammad T.; Nawaz, Mohsin] King Saud Univ, Alamoudi Water Res Chair, Riyadh, Saudi Arabia; [Amin, Muhammad N.] King Faisal Univ, Coll Engn, Dept Civil & Environm Engn, Al Hofuf Al Ahsa, Saudi Arabia; [Han, Mooyoung] Seoul Natl Univ, Civil & Environm Engn Dept, Seoul, South Korea	King Saud University; Seoul National University (SNU)	Amin, MT (corresponding author), King Saud Univ, Alamoudi Water Res Chair, Riyadh, Saudi Arabia.	mtamin@ksu.edu.sa	Amin, Muhammad Tahir/G-1525-2011; Amin, Muhammad Nasir/D-2089-2014	Amin, Muhammad Tahir/0000-0001-8283-9958; Amin, Muhammad Nasir/0000-0001-6524-4389	National Plan of Science and Technology (NPST) at King Saud University [11-WAT1875-02]	National Plan of Science and Technology (NPST) at King Saud University	Authors would like to thank and extend their sincere appreciation to the National Plan of Science and Technology (NPST) at King Saud University for the financial support through Project # 11-WAT1875-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acra A, 1984, UNICEF GUIDELINES HO; Albrechtsen HJ, 2002, WATER SCI TECHNOL, V46, P311, DOI 10.2166/wst.2002.0694; American Public Health Association, 2012, INDIAN J ENV SCI, V22nd ed.; Amin MT, 2011, DESALINATION, V276, P416, DOI 10.1016/j.desal.2011.03.076; Amin M. T., 2007, Water Science and Technology: Water Supply, V7, P185, DOI 10.2166/ws.2007.109; Amin MT, 2009, WATER RES, V43, P5225, DOI 10.1016/j.watres.2009.08.041; Amin MT, 2009, WATER SCI TECHNOL, V60, P419, DOI 10.2166/wst.2009.347; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bosshard F, 2010, ENVIRON MICROBIOL, V12, P2931, DOI 10.1111/j.1462-2920.2010.02268.x; Conroy RM, 1996, LANCET, V348, P1695, DOI 10.1016/S0140-6736(96)02309-4; Dayem AMA, 2011, DESALIN WATER TREAT, V36, P119, DOI 10.5004/dwt.2011.2227; El Ghetany HH, 2010, DESALIN WATER TREAT, V20, P11, DOI 10.5004/dwt.2010.1207; Fennema, 1996, FOOD CHEM, P879; Fisher MB, 2008, J WATER HEALTH, V6, P35, DOI 10.2166/wh.2007.005; Geeraerd AH, 2000, INT J FOOD MICROBIOL, V59, P185, DOI 10.1016/S0168-1605(00)00362-7; Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038; Gomez-Couso H, 2010, AM J TROP MED HYG, V82, P35, DOI 10.4269/ajtmh.2010.09-0284; Han MY, 2007, WATER SCI TECHNOL, V56, P73, DOI 10.2166/wst.2007.778; Hobbins M, 2003, J WATER SUPPLY RES T, V56, P245; Joyce TM, 1996, APPL ENVIRON MICROB, V62, P399, DOI 10.1128/AEM.62.2.399-402.1996; Kaushik R, 2012, APPL ENVIRON MICROB, V78, P2813, DOI 10.1128/AEM.07695-11; Kaushik R, 2012, ATMOS ENVIRON, V46, P131, DOI 10.1016/j.atmosenv.2011.10.013; Kehoe SC, 2001, WATER RES, V35, P1061, DOI 10.1016/S0043-1354(00)00353-5; Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI 10.1016/j.jhin.2009.04.020; Lilya D, 2001, THESIS U IDAHO MOSCO; Lonnen J, 2005, WATER RES, V39, P877, DOI 10.1016/j.watres.2004.11.023; McGuigan KG, 1998, J APPL MICROBIOL, V84, P1138, DOI 10.1046/j.1365-2672.1998.00455.x; Miguntanna NS, 2010, DESALIN WATER TREAT, V19, P205, DOI 10.5004/dwt.2010.1886; Morais PV, 1997, APPL ENVIRON MICROB, V63, P851, DOI 10.1128/AEM.63.3.851-856.1997; National Health and Medical Reasearch Council, 2018, AUSTR COD RESP COND; Nawaz M, 2012, SCI TOTAL ENVIRON, V431, P20, DOI 10.1016/j.scitotenv.2012.05.022; Oates PM, 2003, WATER RES, V37, P47, DOI 10.1016/S0043-1354(02)00241-5; Read RH, 1997, LETT APPL MICROBIOL, V24, P276, DOI 10.1046/j.1472-765X.1997.00130.x; Rijal GK, 2001, WATER SCI TECHNOL, V43, P155, DOI 10.2166/wst.2001.0728; Rincon AG, 2004, APPL CATAL B-ENVIRON, V51, P283, DOI 10.1016/j.apcatb.2004.03.007; Schmid P, 2008, WATER RES, V42, P5054, DOI 10.1016/j.watres.2008.09.025; Sommer B, 1997, J WATER SUPPLY RES T, V46, P127; Uba BN, 2000, J WATER SUPPLY RES T, V49, P281, DOI 10.2166/aqua.2000.0024; Ubomba-Jaswa E, 2009, PHOTOCH PHOTOBIO SCI, V8, P587, DOI 10.1039/b816593a; Vialle C, 2012, WATER RESOUR MANAG, V26, P2233, DOI 10.1007/s11269-012-0012-6; Wegelin M, 2001, J WATER SUPPLY RES T, V50, P125, DOI 10.2166/aqua.2001.0012; Wegelin M., 1994, J WATER SRT AQUA, V43, P154; WHO/UNICEF Joint Monitoring Programme, 2012, PROGR DRINK WAT SAN	43	9	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90743	10.1371/journal.pone.0090743	http://dx.doi.org/10.1371/journal.pone.0090743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595188	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900143
J	Herbert, C; Shadie, AM; Bunting, MM; Tedla, N; Garthwaite, L; Freeman, A; Yoo, H; Park, SH; Kumar, RK				Herbert, Cristan; Shadie, Alexander M.; Bunting, Melissa M.; Tedla, Nicodemus; Garthwaite, Linda; Freeman, Araluen; Yoo, Hyouna; Park, Sang-Ho; Kumar, Rakesh K.			Anti-Inflammatory and Anti-Remodelling Effects of ISU201, a Modified Form of the Extracellular Domain of Human BST2, in Experimental Models of Asthma: Association with Inhibition of Histone Acetylation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC ALLERGEN CHALLENGE; STROMAL CELL ANTIGEN-2; MURINE CHRONIC ASTHMA; FACTOR-KAPPA-B; AIRWAY INFLAMMATION; MOUSE; EXACERBATION; CYTOKINE; HYPERREACTIVITY	There are few alternatives to glucocorticosteroids for treatment of asthma. We assessed the activity of a novel protein drug designated ISU201, the extracellular domain of the human cell surface protein BST2, stabilised by fusion with the Fc region of IgG, in mouse models of mild chronic asthma and an acute exacerbation of asthma. The ability of ISU201 to suppress airway inflammation and remodelling was compared with that of dexamethasone. Female BALB/c mice were systemically sensitised with ovalbumin, then received controlled low-level challenge with aerosolised ovalbumin for 6 weeks, which induced lesions of mild chronic asthma, and were treated with drugs during the final 2 weeks. Alternatively, sensitised mice received 4 weeks of chronic low-level challenge and were treated 24 and 2 hours before a final single moderate-level challenge, which triggered acute airway inflammation simulating an asthmatic exacerbation. Inflammation and remodelling were quantified, as was the expression of pro-inflammatory cytokines in bronchoalveolar lavage fluid and tissues. To identify cellular targets of ISU201, we assessed the effects of the drug on activated lymphocytes, macrophages and airway epithelial cells. In the model of mild chronic asthma, ISU201 was as effective as dexamethasone in suppressing airway inflammation and most changes of remodelling. In the model of an allergen-induced acute exacerbation of chronic asthma, ISU201 was also an effective anti-inflammatory agent, although it was less active than dexamethasone. The drug acted on multiple cellular targets, suppressing production of pro-inflammatory cytokines by lymphocytes and macrophages. ISU201 significantly reduced acetylation of histone H4 in airway epithelial cells, suggesting at least one potential mechanism of action. We conclude that in these models of asthma, ISU201 is a broad-spectrum inhibitor of both airway inflammation and remodelling. Thus, unlike drugs which target specific mediators, it could potentially be an alternative or an adjunct to glucocorticoids for the treatment of asthma.	[Herbert, Cristan; Shadie, Alexander M.; Bunting, Melissa M.; Tedla, Nicodemus; Garthwaite, Linda; Freeman, Araluen; Kumar, Rakesh K.] Univ New S Wales, Inflammat & Infect Res Ctr, Sch Med Sci, Sydney, NSW, Australia; [Yoo, Hyouna; Park, Sang-Ho] Isu Abxis Co Ltd, Seoul, South Korea	University of New South Wales Sydney	Kumar, RK (corresponding author), Univ New S Wales, Inflammat & Infect Res Ctr, Sch Med Sci, Sydney, NSW, Australia.	R.Kumar@unsw.edu.au	Kumar, Rakesh/ABD-1065-2020; Kumar, Rakesh K/J-6124-2012	Kumar, Rakesh/0000-0001-7664-0803; Kumar, Rakesh K/0000-0002-9531-8411	Australian Research Council [LP110200170]; Isu Abxis Co., Ltd.	Australian Research Council(Australian Research Council); Isu Abxis Co., Ltd.	This work was supported by an Australian Research Council Linkage Project grant (LP110200170) with Isu Abxis Co., Ltd. as the commercial partner. The Australian Research Council had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Isu Abxis Co., Ltd. supplied ISU201 as a gift to the laboratory, advised about appropriate dosage and delivery of the drug, and provided access to unpublished data. Two of the authors are employees of Isu Abxis Co., Ltd. These authors contributed to study design, decision to publish, and preparation of the manuscript.	Barnes PJ, 2010, TRENDS PHARMACOL SCI, V31, P335, DOI 10.1016/j.tips.2010.04.009; Barnes Peter J, 2009, Proc Am Thorac Soc, V6, P693, DOI 10.1513/pats.200907-071DP; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Bunting MM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/250938; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Dougherty RH, 2009, CLIN EXP ALLERGY, V39, P193, DOI 10.1111/j.1365-2222.2008.03157.x; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Foster PS, 2000, LAB INVEST, V80, P655, DOI 10.1038/labinvest.3780068; Fulkerson PC, 2005, CLIN EXP ALLERGY, V35, P1251, DOI 10.1111/j.1365-2222.2005.02354.x; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Hart LA, 1998, AM J RESP CRIT CARE, V158, P1585, DOI 10.1164/ajrccm.158.5.9706116; Herbert C, 2008, CLIN EXP ALLERGY, V38, P847, DOI 10.1111/j.1365-2222.2008.02950.x; Herbert C, 2013, DIS MODEL MECH, V6, P479, DOI 10.1242/dmm.010728; Herbert C, 2010, AM J PATHOL, V177, P1657, DOI 10.2353/ajpath.2010.100019; Holt PG, 2010, J ALLERGY CLIN IMMUN, V125, P963, DOI 10.1016/j.jaci.2010.02.011; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Korsgren M, 1997, J EXP MED, V185, P885, DOI 10.1084/jem.185.5.885; Kumar RK, 1997, EXP LUNG RES, V23, P427, DOI 10.3109/01902149709039236; Kumar RK, 2003, J PHARMACOL EXP THER, V307, P349, DOI 10.1124/jpet.103.053819; Kumar RK, 2013, MIDDLETONS ALLERGY, P986; Marks G. B., 2011, ASTHMA AUSTR 2011; MBAWUIKE IN, 1989, J LEUKOCYTE BIOL, V46, P119, DOI 10.1002/jlb.46.2.119; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Poynter ME, 2002, AM J PATHOL, V160, P1325, DOI 10.1016/S0002-9440(10)62559-X; Schneider T, 1996, J IMMUNOL METHODS, V198, P1, DOI 10.1016/0022-1759(96)00143-3; Shifren Adrian, 2012, J Allergy (Cairo), V2012, P316049, DOI 10.1155/2012/316049; Shore SA, 2003, AM J RESP CRIT CARE, V168, P910, DOI 10.1164/rccm.2307006; Siegle JS, 2006, AM J RESP CELL MOL, V35, P565, DOI 10.1165/rcmb.2006-0135OC; Swiecki M, 2012, J IMMUNOL, V188, P2488, DOI 10.4049/jimmunol.1103145; Tavano B, 2013, J IMMUNOL, V190, P2622, DOI 10.4049/jimmunol.1202391; Temelkovski J, 1998, THORAX, V53, P849, DOI 10.1136/thx.53.10.849; Tsaprouni LG, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-1; Wang W, 2010, CURR DRUG TARGETS, V11, P957, DOI 10.2174/138945010791591412; Ward C, 2002, THORAX, V57, P309, DOI 10.1136/thorax.57.4.309; Webb DC, 2000, J IMMUNOL, V165, P108, DOI 10.4049/jimmunol.165.1.108; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Yoo H, 2011, CELL IMMUNOL, V267, P23, DOI 10.1016/j.cellimm.2010.10.011	39	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90436	10.1371/journal.pone.0090436	http://dx.doi.org/10.1371/journal.pone.0090436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594933	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900110
J	Sui, HS; Yi, YL; Yao, JR; Liang, B; Sun, XS; Hu, SM; Uc, A; Nelson, DJ; Ode, KL; Philipson, LH; Engelhardt, JF; Norris, AW				Sui, Hongshu; Yi, Yaling; Yao, Jianrong; Liang, Bo; Sun, Xingshen; Hu, Shanming; Uc, Aliye; Nelson, Deborah J.; Ode, Katie Larson; Philipson, Louis H.; Engelhardt, John F.; Norris, Andrew W.			Quantifying Insulin Sensitivity and Entero-Insular Responsiveness to Hyper- and Hypoglycemia in Ferrets	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; BETA-CELL FUNCTION; HYPERGLYCEMIC CLAMP; GLUCOSE-METABOLISM; DIABETES-MELLITUS; SKELETAL-MUSCLE; HUMAN OBESITY; ORAL GLUCOSE; FATTY-ACIDS; RESISTANCE	Ferrets are an important emerging model of cystic fibrosis related diabetes. However, there is little documented experience in the use of advanced techniques to quantify aspects of diabetes pathophysiology in the ferret. Glycemic clamps are the gold standard technique to assess both insulin sensitivity and insulin secretion in humans and animal models of diabetes. We therefore sought to develop techniques for glycemic clamps in ferrets. To assess insulin sensitivity, we performed euglycemic hyperinsulinemic clamps in 5-6 week old ferrets in the anesthetized and conscious states. To assess insulin secretion, we performed hyperglycemic clamps in conscious ferrets. To evaluate responsiveness of ferret islet and entero-insular hormones to low glucose, a portion of the hyperglycemic clamps were followed by a hypoglycemic clamp. The euglycemic hyperinsulinemic clamps demonstrated insulin responsiveness in ferrets similar to that previously observed in humans and rats. The anesthetic isoflurane induced marked insulin resistance, whereas lipid emulsion induced mild insulin resistance. In conscious ferrets, glucose appearance was largely suppressed at 4 mU/kg/min insulin infusion, whereas glucose disposal was progressively increased at 4 and 20 mU/kg/min insulin. Hyperglycemic clamp induced first phase insulin secretion. Hypoglycemia induced a rapid diminishment of insulin, as well as a rise in glucagon and pancreatic polypeptide levels. The incretins GLP-1 and GIP were affected minimally by hyperglycemic and hypoglycemic clamp. These techniques will prove useful in better defining the pathophysiology in ferrets with cystic fibrosis related diabetes.	[Sui, Hongshu; Yi, Yaling; Liang, Bo; Sun, Xingshen; Engelhardt, John F.] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Yao, Jianrong; Hu, Shanming; Uc, Aliye; Ode, Katie Larson; Norris, Andrew W.] Univ Iowa, Carver Coll Med, Dept Pediat, Iowa City, IA USA; [Sui, Hongshu] Taishan Med Univ, Dept Histol & Embryol, Tai An, Shandong, Peoples R China; [Nelson, Deborah J.] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; [Philipson, Louis H.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Engelhardt, John F.; Norris, Andrew W.] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA USA	University of Iowa; University of Iowa; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Chicago; University of Chicago; University of Iowa	Engelhardt, JF (corresponding author), Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA.	john-engelhardt@uiowa.edu; andrew-norris@uiowa.edu	Norris, Andrew W/O-5499-2018	Norris, Andrew W/0000-0001-8396-9543; Larson Ode, Katie/0000-0002-1086-9135; Engelhardt, John/0000-0003-2389-9277; Uc, Aliye/0000-0003-2004-5743	National Institutes of Health [R24 DK096518, R01 DK097820]; Fraternal Order of Eagles Diabetes Research Center; University of Iowa Center for Gene Therapy [DK54759]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL123482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595, P30DK054759, R01DK097820, R24DK096518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fraternal Order of Eagles Diabetes Research Center; University of Iowa Center for Gene Therapy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R24 DK096518 (to J.F.E., A.W.N., D.J.N.), R01 DK097820 (to A.U. & A.W.N.), a Fraternal Order of Eagles Diabetes Research Center grant (to A.W.N.), and the University of Iowa Center for Gene Therapy (DK54759). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN A, 1994, J CLIN ENDOCR METAB, V79, P80, DOI 10.1210/jc.79.1.80; Ball RS, 2006, ILAR J, V47, P348, DOI 10.1093/ilar.47.4.348; Battezzati A, 2007, EUR J ENDOCRINOL, V156, P369, DOI 10.1530/eje.1.02344; Bell J A, 1999, Vet Clin North Am Exot Anim Pract, V2, P169; Bell JA, 1999, VET CLIN N AM EXOT A, V2, pviii; Boari A, 2010, VET RES COMMUN, V34, pS107, DOI 10.1007/s11259-010-9369-2; BODEN G, 1995, J CLIN INVEST, V96, P1261, DOI 10.1172/JCI118160; BONORA E, 1990, ACTA DIABETOL LAT, V27, P309, DOI 10.1007/BF02580935; Chen Sue, 2008, Vet Clin North Am Exot Anim Pract, V11, P107, DOI 10.1016/j.cvex.2007.09.001; Davis SN, 2000, DIABETES, V49, P1897, DOI 10.2337/diabetes.49.11.1897; DEFRONZO RA, 1978, J CLIN INVEST, V62, P204, DOI 10.1172/JCI109108; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DEFRONZO RA, 1977, DIABETES, V26, P445, DOI 10.2337/diabetes.26.5.445; Hardin DS, 2008, J INVEST MED, V56, P567, DOI 10.2310/JIM.0b013e3181671788; Hardin DS, 1999, DIABETES, V48, P1082, DOI 10.2337/diabetes.48.5.1082; Hardin DS, 2001, AM J PHYSIOL-ENDOC M, V281, pE1022, DOI 10.1152/ajpendo.2001.281.5.E1022; HASEGAWA S, 1992, J VET MED SCI, V54, P583, DOI 10.1292/jvms.54.583; Hillman M, 2012, J CYST FIBROS, V11, P144, DOI 10.1016/j.jcf.2011.11.001; HOLL RW, 1995, EUR J PEDIATR, V154, P356, DOI 10.1007/s004310050303; HORBER FF, 1990, ANESTHESIOLOGY, V73, P82, DOI 10.1097/00000542-199007000-00013; Hu SM, 2012, MOL ENDOCRINOL, V26, P977, DOI 10.1210/me.2011-1253; Kim JK, 1996, DIABETES, V45, P446, DOI 10.2337/diabetes.45.4.446; KOLTERMAN OG, 1980, J CLIN INVEST, V65, P1272, DOI 10.1172/JCI109790; Kuo P, 2011, J CLIN ENDOCR METAB, V96, pE851, DOI 10.1210/jc.2010-2460; LAAGER R, 1993, J CLIN INVEST, V92, P1903, DOI 10.1172/JCI116783; LAM WF, 1993, DIGESTION, V54, P48, DOI 10.1159/000201011; LANNG S, 1993, ACTA ENDOCRINOL-COP, V128, P207, DOI 10.1530/acta.0.1280207; MORAN A, 1994, DIABETES, V43, P1020, DOI 10.2337/diabetes.43.8.1020; Olivier AK, 2012, J CLIN INVEST, V122, P3755, DOI 10.1172/JCI60610; Otis CR, 2003, COMPARATIVE MED, V53, P53; Phair KA, 2011, J AM ASSOC LAB ANIM, V50, P531; Poulsen PL, 2000, METABOLISM, V49, P1598, DOI 10.1053/meta.2000.18558; Quon BS, 2012, PAEDIATR RESPIR REV, V13, P206, DOI 10.1016/j.prrv.2012.03.005; Radike Kerstin, 2011, Diabetes Care, V34, pe43, DOI 10.2337/dc10-2286; RAKOTOAMBININA B, 1994, PEDIATR RES, V36, P667, DOI 10.1203/00006450-199411000-00024; REDMOND AOB, 1977, ACTA PAEDIATR SCAND, V66, P199, DOI 10.1111/j.1651-2227.1977.tb07833.x; ROSENTHAL KL, 1993, AM J VET RES, V54, P29; Slingerland LI, 2007, HORM METAB RES, V39, P341, DOI 10.1055/s-2007-976541; SMITH D, 1987, METABOLISM, V36, P1167, DOI 10.1016/0026-0495(87)90244-7; STATEN M, 1984, METABOLISM, V33, P132, DOI 10.1016/0026-0495(84)90125-2; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; Sun X, 2008, J CLIN INVEST, V118, P1578, DOI 10.1172/JCI34599; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; VERDONK CA, 1980, J CLIN INVEST, V65, P1119, DOI 10.1172/JCI109765; Woerle HJ, 2012, DIABETES, V61, P2349, DOI 10.2337/db11-1701; Wyre Nicole R, 2013, Vet Clin North Am Exot Anim Pract, V16, P469, DOI 10.1016/j.cvex.2013.02.003	46	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90519	10.1371/journal.pone.0090519	http://dx.doi.org/10.1371/journal.pone.0090519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594704	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900115
J	Thakur, N; Upadhyay, SK; Verma, PC; Chandrashekar, K; Tuli, R; Singh, PK				Thakur, Nidhi; Upadhyay, Santosh Kumar; Verma, Praveen C.; Chandrashekar, Krishnappa; Tuli, Rakesh; Singh, Pradhyumna K.			Enhanced Whitefly Resistance in Transgenic Tobacco Plants Expressing Double Stranded RNA of v-ATPase A Gene	PLOS ONE			English	Article							BEMISIA-TABACI; MULTIPLE CROPS; COTTON; APHID; INTERFERENCE; ALEYRODIDAE; SUPPRESSION; HOMOPTERA; HONEYDEW; BOLLWORM	Background: Expression of double strand RNA (dsRNA) designed against important insect genes in transgenic plants have been shown to give protection against pests through RNA interference (RNAi), thus opening the way for a new generation of insect-resistant crops. We have earlier compared the efficacy of dsRNAs/siRNAs, against a number of target genes, for interference in growth of whitefly (Bemisia tabaci) upon oral feeding. The v-ATPase subunit A (v-ATPaseA) coding gene was identified as a crucial target. We now report the effectiveness of transgenic tobacco plants expressing siRNA to silence v-ATPaseA gene expression for the control of whitefly infestation. Methodology/Principal Findings: Transgenic tobacco lines were developed for the expression of long dsRNA precursor to make siRNA and knock down the v-ATPaseA mRNA in whitefly. Molecular analysis and insecticidal properties of the transgenic plants established the formation of siRNA targeting the whitefly v-ATPaseA, in the leaves. The transcript level of v-ATPaseA in whiteflies was reduced up to 62% after feeding on the transgenic plants. Heavy infestation of whiteflies on the control plants caused significant loss of sugar content which led to the drooping of leaves. The transgenic plants did not show drooping effect. Conclusions/Significance: Host plant derived pest resistance was achieved against whiteflies by genetic transformation of tobacco which generated siRNA against the whitefly v-ATPaseA gene. Transgenic tobacco lines expressing dsRNA of v-ATPaseA, delivered sufficient siRNA to whiteflies feeding on them, mounting a significant silencing response, leading to their mortality. The transcript level of the target gene was reduced in whiteflies feeding on transgenic plants. The strategy can be taken up for genetic engineering of plants to control whiteflies in field crops.	[Thakur, Nidhi; Upadhyay, Santosh Kumar; Verma, Praveen C.; Chandrashekar, Krishnappa; Singh, Pradhyumna K.] Natl Bot Res Inst, Plant Mol Biol Lab, Lucknow 226001, Uttar Pradesh, India; [Thakur, Nidhi; Verma, Praveen C.; Singh, Pradhyumna K.] Acad Sci & Innovat Res, New Delhi, India; [Upadhyay, Santosh Kumar; Tuli, Rakesh] Natl Agri Food Biotechnol Inst, Dept Biotechnol, Mohali, Punjab, India; [Chandrashekar, Krishnappa] Indian Agr Res Inst, Reg Stn, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Academy of Scientific & Innovative Research (AcSIR); Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Singh, PK (corresponding author), Natl Bot Res Inst, Plant Mol Biol Lab, Lucknow 226001, Uttar Pradesh, India.	pksingh@nbri.res.in	Verma, Praveen C/F-9709-2010; TULI, RAKESH/AAD-3047-2021; Chadrashekar, K/AAX-4996-2021; Upadhyay, Santosh/ABD-2302-2020	Verma, Praveen C/0000-0002-3732-0564; Upadhyay, Santosh/0000-0001-6991-0502	DST	DST(Department of Science & Technology (India))	The authors are thankful to CSIR for providing the research facilities. We are thankful to Dr. Manjusha Srivastava (NBRI) for her kind help in performing sugar estimation. NT is thankful to CSIR for SRF support. RT is thankful to DST for JC Bose Fellowship.	Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; CANGELOSI GA, 1989, J BACTERIOL, V171, P1609, DOI 10.1128/jb.171.3.1609-1615.1989; Chassy BM, 2010, ISB NEWS REPORT; Christou P, 2006, TRENDS PLANT SCI, V11, P302, DOI 10.1016/j.tplants.2006.04.001; De Barro PJ, 2000, MOL PHYLOGENET EVOL, V16, P29, DOI 10.1006/mpev.1999.0768; Dhaliwal G. S., 2010, Indian Journal of Ecology, V37, P1; Dubey NK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-241; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FLEMING R, 1985, J ECON ENTOMOL, V78, P1179, DOI 10.1093/jee/78.6.1179; Geley S, 2004, EXP GERONTOL, V39, P985, DOI 10.1016/j.exger.2004.03.040; Ghanim M, 2007, INSECT BIOCHEM MOLEC, V37, P732, DOI 10.1016/j.ibmb.2007.04.006; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Henneberry TJ, 2000, SOUTHWEST ENTOMOL, V25, P161; Henneberry TJ, 2000, SOUTHWEST ENTOMOL, V25, P1; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jin SX, 2012, PLANT BIOTECHNOL J, V10, P313, DOI 10.1111/j.1467-7652.2011.00663.x; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Karatolos N, 2010, PEST MANAG SCI, V66, P1304, DOI 10.1002/ps.2014; Kos M, 2009, TRENDS BIOTECHNOL, V27, P621, DOI 10.1016/j.tibtech.2009.08.002; Li SJ, 2011, INSECT SCI, V18, P101, DOI 10.1111/j.1744-7917.2010.01395.x; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mlotshwa S, 2002, PLANT CELL, V14, pS289, DOI 10.1105/tpc.001677; Naimov S, 2003, PLANT BIOTECHNOL J, V1, P51, DOI 10.1046/j.1467-7652.2003.00005.x; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Porcar M, 2009, APPL ENVIRON MICROB, V75, P4897, DOI 10.1128/AEM.00686-09; Raccah B., 2009, ENCY LIFE SCI ELS, DOI 10.1002/9780470015902.A0021525.a0000760.pub2.; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Virla EG, 2010, CROP PROT, V29, P635, DOI 10.1016/j.cropro.2009.12.019; Wieczorek H, 2000, J EXP; Wieczorek H, 2009, J EXP BIOL, V212, P1611, DOI 10.1242/jeb.030007; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; YANG NS, 1990, DEV GENET, V11, P289, DOI 10.1002/dvg.1020110407; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhang HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017241	38	118	129	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e87235	10.1371/journal.pone.0087235	http://dx.doi.org/10.1371/journal.pone.0087235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595215	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900002
J	Wang, ZW; Chen, Y; Wang, YN; Xue, HD; Jin, ZY; Kong, LY; Cao, J; Li, S				Wang, Zhiwei; Chen, Yu; Wang, Yining; Xue, Huadan; Jin, Zhengyu; Kong, Lingyan; Cao, Jian; Li, Shuo			Feasibility of Low-Dose Contrast Medium High Pitch CT Angiography for the Combined Evaluation of Coronary, Head and Neck Arteries	PLOS ONE			English	Article							DUAL-SOURCE CT; COMPUTED-TOMOGRAPHY ANGIOGRAPHY; IMAGE QUALITY; DIAGNOSTIC PERFORMANCE; RADIATION-EXPOSURE; CAROTID ARTERIES; ACCURACY; PREVALENCE; STENOSIS; ATHEROSCLEROSIS	Purpose: To evaluate the image quality and radiation dose of combined heart, head, and neck CT angiography (CTA) using prospectively electrocardiography (ECG)-triggered high-pitch spiral scan protocol, compared with single coronary CTA. Materials and Methods: 151 consecutive patients were prospectively included and randomly divided into three groups. Group 1 (n = 47) underwent combined heart, neck, and head CTA using prospectively ECG-triggered high-pitch spiral (Flash) scan protocol with a single-phase intravenous injection of iodinated contrast and saline flush; Group 2 (n = 51) underwent single coronary CTA with Flash scan protocol; and Group 3 (n = 53) underwent single coronary CTA with prospective sequence scan protocol. All patients were examined on a dual source CT (Definition FLASH). The image quality was determined for each CT study. Results: Patients of scanning protocol Group 1, 2, and 3 showed no significant differences in age, sex, heart rates, and BMI. Evaluation of coronary artery image quality showed comparable results in the three scanning protocol groups on a per patient-based analysis. In group 1, image quality was found to be sufficient to be diagnostic in all arterial segments of carotid arteries. The mean dose-length product (DLP) for group 1 was 256.3 +/- 24.5 mGyxcm and was significantly higher in comparison with group 2 (93.4 +/- 19.9 mGyxcm; p<0.001). However, there was no significant difference of DLP between group 1 and group 3 (254.1 +/- 69.9 mGyxcm). Conclusions: The combined heart, neck, and head arteries scan using prospectively electrocardiography (ECG)-triggered high-pitch spiral scan protocol in 1 single examination resulted in an excellent opacification of the aorta, the carotid arteries, and the coronary arteries and provided a good image quality with low radiation dose.	[Wang, Zhiwei; Chen, Yu; Wang, Yining; Xue, Huadan; Jin, Zhengyu; Kong, Lingyan; Cao, Jian; Li, Shuo] Peking Union Med Coll Hosp, Dept Radiol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Wang, YN (corresponding author), Peking Union Med Coll Hosp, Dept Radiol, Beijing, Peoples R China.	wangyining@pumch.cn		Jin, Zhengyu/0000-0002-6179-9632	National Natural Science Fundation of China [81000629]; Beijing Nova of Science and Technology [Z121107002512072]	National Natural Science Fundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova of Science and Technology	This work was supported by the National Natural Science Fundation of China (Grant number: 81000629) and Beijing Nova of Science and Technology (Grant number: Z121107002512072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach S, 2011, JACC-CARDIOVASC IMAG, V4, P328, DOI 10.1016/j.jcmg.2011.01.012; Achenbach S, 2010, EUR HEART J, V31, P340, DOI 10.1093/eurheartj/ehp470; Alkadhi H, 2010, HEART, V96, P933, DOI 10.1136/hrt.2009.189100; Arca M, 2011, INTERN EMERG MED, V6, P571, DOI 10.1007/s11739-011-0550-6; Austen W G, 1975, Circulation, V51, P5; Bartlett ES, 2008, AM J NEURORADIOL, V29, P1677, DOI 10.3174/ajnr.A1210; Beitzke D, 2011, EUR RADIOL, V21, P2434, DOI 10.1007/s00330-011-2188-1; Bjerrum IS, 2013, INT J CARDIOVAS IMAG, V29, P301, DOI 10.1007/s10554-012-0091-8; Calvet D, 2010, CIRCULATION, V121, P1623, DOI 10.1161/CIRCULATIONAHA.109.906958; Coskun U, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-59; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Ertel D, 2009, EUR RADIOL, V19, P2357, DOI 10.1007/s00330-009-1503-6; Ferencik M, 2006, EUR J RADIOL, V57, P373, DOI 10.1016/j.ejrad.2005.12.023; Fujikawa A, 2010, NEURORADIOLOGY, V52, P291, DOI 10.1007/s00234-009-0611-y; Furtado AD, 2010, AM J NEURORADIOL, V31, P1290, DOI 10.3174/ajnr.A2075; Gaziano JM, 2001, HEART DIS TXB CARDIO, P1; Johnson KM, 2009, AM J ROENTGENOL, V192, P235, DOI 10.2214/AJR.08.1056; Johnson TRC, 2007, INVEST RADIOL, V42, P684, DOI 10.1097/RLI.0b013e31806907d0; Johnson TRC, 2007, J COMPUT ASSIST TOMO, V31, P265, DOI 10.1097/01.rct.0000236421.35761.7a; Kim JJ, 2010, AM J NEURORADIOL, V31, P91, DOI 10.3174/ajnr.A1768; Leschka S, 2009, EUR RADIOL, V19, P2896, DOI 10.1007/s00330-009-1618-9; Li AH, 2007, HEART VESSELS, V22, P297, DOI 10.1007/s00380-006-0971-8; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Moon JH, 2011, KOREAN J RADIOL, V12, P308, DOI 10.3348/kjr.2011.12.3.308; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nair SB, 2012, POSTGRAD MED J, V88, P694, DOI 10.1136/postgradmedj-2011-130214; Napoli A, 2009, EUR RADIOL, V19, P1704, DOI 10.1007/s00330-009-1342-5; Neefjes LA, 2011, RADIOLOGY, V261, P779, DOI 10.1148/radiol.11110606; Puchner S, 2009, J ENDOVASC THER, V16, P336, DOI 10.1583/08-2636.1; Sanaei-Ardekani M, 2005, CARDIOVASC REVASCULA, V6, P82, DOI 10.1016/j.carrev.2005.07.004; Scheffel H, 2006, EUR RADIOL, V16, P2739, DOI 10.1007/s00330-006-0474-0; Shuman WP, 2008, RADIOLOGY, V248, P431, DOI 10.1148/radiol.2482072192; Sommer WH, 2010, AM J ROENTGENOL, V195, P1306, DOI 10.2214/AJR.10.4416; Steinvil A, 2011, J AM COLL CARDIOL, V57, P779, DOI 10.1016/j.jacc.2010.09.047; Tublin ME, 1998, AM J ROENTGENOL, V171, P933, DOI 10.2214/ajr.171.4.9762972; Vanhoenacker PK, 2007, RADIOLOGY, V244, P419, DOI 10.1148/radiol.2442061218; Weustink AC, 2007, J AM COLL CARDIOL, V50, P786, DOI 10.1016/j.jacc.2007.04.068	37	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90268	10.1371/journal.pone.0090268	http://dx.doi.org/10.1371/journal.pone.0090268			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595301	Green Submitted, gold, Green Published			2022-12-27	WOS:000332468900087
J	Yang, M; Jiang, LX; Huang, HP; Zeng, SB; Qiu, F; Yu, M; Li, XR; Wei, S				Yang, Mei; Jiang, Lixin; Huang, Huiping; Zeng, Shengbo; Qiu, Fen; Yu, Miao; Li, Xiaorong; Wei, Sheng			Dietary Exposure to Aluminium and Health Risk Assessment in the Residents of Shenzhen, China	PLOS ONE			English	Article							UK TOTAL DIET; ALZHEIMERS-DISEASE; PARENTERAL-NUTRITION; PRETERM INFANTS; TRACE-ELEMENTS; BIOAVAILABILITY; METALS; WATER; AREA; TOXICOKINETICS	Although there are great changes of dietary in the past few decades in China, few are known about the aluminium exposure in Chinese diet. The aim of this study is to systematically evaluate the dietary aluminium intake level in residents of Shenzhen, China. A total of 853 persons from 244 household were investigated their diet by three days food records. Finally, 149 kinds of foods in 17 food groups were selected to be the most consumed foods. From them, 1399 food samples were collected from market to test aluminium concentration. High aluminium levels were found in jellyfish (median, 527.5 mg/kg), fried twisted cruller (median, 466.0 mg/kg), shell (median, 107.1 mg/kg). The Shenzhen residents' average dietary aluminium exposure was estimated at 1.263 mg/kg bw/week which is lower than the PTWI (provisional tolerable weekly intake). But 0-2 and 3-13 age groups have the highest aluminium intake exceeding the PTWI (3.356 mg/kg bw/week and 3.248 mg/kg bw/week) than other age groups. And the main dietary aluminium exposure sources are fried twisted cruller, leaf vegetables and bean products. Our study suggested that even three decades rapid economy development, children in Shenzhen still have high dietary aluminium exposure risk. How to control high dietary aluminium exposure still is a great public health challenge in Shenzhen, China.	[Yang, Mei; Jiang, Lixin; Huang, Huiping] Futian Dist Ctr Dis Control & Prevent Shenzhen, Dept Hlth Surveillance & Management, Shenzhen, Guangdong, Peoples R China; [Yang, Mei; Zeng, Shengbo; Qiu, Fen] Futian Dist Ctr Dis Control & Prevent Shenzhen, Dept Lab, Shenzhen, Guangdong, Peoples R China; [Yu, Miao; Li, Xiaorong; Wei, Sheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Wei, S (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China.	ws2008cn@gmail.com			Medical Scientific Research Foundation of Guangdong Province, China [A2012591]	Medical Scientific Research Foundation of Guangdong Province, China	This work was supported by Medical Scientific Research Foundation of Guangdong Province, China (A2012591). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnich N, 2012, FOOD CHEM TOXICOL, V50, P2432, DOI 10.1016/j.fct.2012.04.016; Aung NN, 2006, FOOD ADDIT CONTAM A, V23, P883, DOI 10.1080/02652030600699643; Bishop NJ, 1997, NEW ENGL J MED, V336, P1557, DOI 10.1056/NEJM199705293362203; Campbell A, 2002, NEPHROL DIAL TRANSPL, V17, P17, DOI 10.1093/ndt/17.suppl_2.17; China MoHo, 2009, GBT233742009 CHIN MO; Fewtrell MS, 2011, P NUTR SOC, V70, P299, DOI 10.1017/S0029665111000498; FRENCH P, 1989, FOOD CHEM TOXICOL, V27, P495, DOI 10.1016/0278-6915(89)90040-9; Gonzalez-Weller D, 2010, J AGR FOOD CHEM, V58, P10452, DOI 10.1021/jf102779t; Gupta VB, 2005, CELL MOL LIFE SCI, V62, P143, DOI 10.1007/s00018-004-4317-3; Hernandez-Sanchez A, 2013, EUR J CLIN NUTR, V67, P230, DOI 10.1038/ejcn.2012.219; Krewski D, 2007, J TOXICOL ENV HEAL B, V10, P1, DOI 10.1080/10937400701597766; Liu SQ, 2011, PREV CHRONIC DIS, V8; Nayak P, 2001, FOOD CHEM TOXICOL, V39, P587, DOI 10.1016/S0278-6915(00)00173-3; Ohno K, 2010, WATER SCI TECHNOL, V62, P2694, DOI 10.2166/wst.2010.392; Priest ND, 2004, J ENVIRON MONITOR, V6, P375, DOI 10.1039/b314329p; Rose M, 2010, FOOD ADDIT CONTAM A, V27, P1380, DOI 10.1080/19440049.2010.496794; Saiyed SM, 2005, FOOD ADDIT CONTAM A, V22, P234, DOI 10.1080/02652030500073584; Varma P P, 1999, J Assoc Physicians India, V47, P690; Wang YC, 2012, J ENVIRON SCI, V24, P690, DOI 10.1016/S1001-0742(11)60833-4; Wong WWK, 2010, FOOD ADDIT CONTAM A, V27, P457, DOI 10.1080/19440040903490112; Xu DC, 2013, ECOTOX ENVIRON SAFE, V90, P103, DOI 10.1016/j.ecoenv.2012.12.018; Yokel RA, 2006, J TOXICOL ENV HEAL B, V9, P63, DOI 10.1080/15287390500196230; Yokel RA, 2001, PHARMACOL TOXICOL, V88, P159, DOI 10.1034/j.1600-0773.2001.d01-98.x; Yokel RA, 2000, NEUROTOXICOLOGY, V21, P813; Yokel RA, 2006, TOXICOLOGY, V227, P86, DOI 10.1016/j.tox.2006.07.014; Ysart G, 1999, FOOD ADDIT CONTAM, V16, P391, DOI 10.1080/026520399283876	26	20	24	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89715	10.1371/journal.pone.0089715	http://dx.doi.org/10.1371/journal.pone.0089715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594670	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900031
J	Bae, Y; Ito, T; Iida, T; Uchida, K; Sekine, M; Nakajima, Y; Kumagai, J; Yokoyama, T; Kawachi, H; Akashi, T; Eishi, Y				Bae, Yuan; Ito, Takashi; Iida, Tadatsune; Uchida, Keisuke; Sekine, Masaki; Nakajima, Yutaka; Kumagai, Jiro; Yokoyama, Tetsuji; Kawachi, Hiroshi; Akashi, Takumi; Eishi, Yoshinobu			Intracellular Propionibacterium acnes Infection in Glandular Epithelium and Stromal Macrophages of the Prostate with or without Cancer	PLOS ONE			English	Article							NF-KAPPA-B; ETIOLOGIC LINK; INFLAMMATION; SARCOIDOSIS; TISSUE; MEN; TRANSCRIPTION; SPECIMENS; DNA	Background: Recent reports on Propionibacterium acnes (P. acnes) suggest that this bacterium is prevalent in the prostate, is associated with acute and chronic prostatic inflammation, and might have a role in prostate carcinogenesis. Methods: To evaluate the pathogenic role of this indigenous bacterium, we screened for the bacterium in radical prostatectomy specimens using enzyme immunohistochemistry with a novel P. acnes-specific monoclonal antibody (PAL antibody), together with an anti-nuclear factor-kappa B (NF-kappa B) antibody. We examined formalin-fixed and paraffin-embedded tissue sections of radical prostatectomy specimens from 28 patients with prostate cancer and 18 age-matched control patients with bladder cancer, but without prostate cancer. Results: Immunohistochemistry with the PAL antibody revealed small round bodies within some non-cancerous glandular epithelium and stromal macrophages in most prostate samples. Prostate cancer samples had higher frequencies of either cytoplasmic P. acnes or nuclear NF-kappa B expression of glandular epithelium and higher numbers of stromal macrophages with P. acnes than control samples. These parameters were also higher in the peripheral zone than in the transitional zone of the prostate, especially in prostate cancer samples. Nuclear NF-kappa B expression was more frequent in glands with P. acnes than in glands without P. acnes. The number of stromal macrophages with the bacterium correlated with the grade of chronic inflammation in both the PZ and TZ areas and with the grade of acute inflammation in the TZ area. Conclusions: Immunohistochemical analysis with a novel monoclonal antibody for detecting P. acnes in the prostate suggested that intraepithelial P. acnes infection in non-cancerous prostate glands and inflammation caused by the bacterium may contribute to the development of prostate cancer.	[Bae, Yuan; Ito, Takashi; Iida, Tadatsune; Kawachi, Hiroshi; Eishi, Yoshinobu] Tokyo Med & Dent Univ, Grad Sch, Dept Human Pathol, Bunkyo Ku, Tokyo, Japan; [Uchida, Keisuke; Sekine, Masaki; Nakajima, Yutaka; Akashi, Takumi; Eishi, Yoshinobu] Tokyo Med & Dent Univ, Grad Sch, Div Surg Pathol, Bunkyo Ku, Tokyo, Japan; [Nakajima, Yutaka] Yokohama City Minato Red Cross Hosp, Dept Pathol, Yokohama, Kanagawa, Japan; [Yokoyama, Tetsuji] Natl Inst Publ Hlth, Dept Hlth Promot, Wako, Saitama 3510197, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); National Institute of Public Health - Japan	Eishi, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Human Pathol, Bunkyo Ku, Tokyo, Japan.	eishi.path@tmd.ac.jp	Eishi, Yoshinobu/N-3602-2017	Eishi, Yoshinobu/0000-0002-0521-1670	Japan Society for the Promotion of Science [24659402]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research 24659402 (YE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev O, 2006, CANCER CAUSE CONTROL, V17, P1127, DOI 10.1007/s10552-006-0054-2; Alexeyev O, 2009, UROLOGY, V73, P220, DOI 10.1016/j.urology.2008.02.052; Alexeyev OA, 2007, J CLIN MICROBIOL, V45, P3721, DOI 10.1128/JCM.01543-07; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Berger RE, 1997, J UROLOGY, V157, P863, DOI 10.1016/S0022-5347(01)65066-3; Bezbradica JS, 2009, NAT IMMUNOL, V10, P333, DOI 10.1038/ni.1713; Burkhart CG, 1999, POSTGRAD MED J, V75, P328, DOI 10.1136/pgmj.75.884.328; Cohen RJ, 2005, J UROLOGY, V173, P1969, DOI 10.1097/01.ju.0000158161.15277.78; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; Eady E. A., 1994, Reviews in Medical Microbiology, V5, P163; Eishi Y, 2013, RESPIR INVESTIG, V51, P56, DOI 10.1016/j.resinv.2013.01.001; Fehri LF, 2011, INT J MED MICROBIOL, V301, P69, DOI 10.1016/j.ijmm.2010.08.014; Funke G, 1997, CLIN MICROBIOL REV, V10, P125, DOI 10.1128/CMR.10.1.125; Furukawa A, 2009, MICROB PATHOGENESIS, V46, P80, DOI 10.1016/j.micpath.2008.10.013; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Harlow E, 1988, ANTIBODIES LAB MANUA, P139; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Ishige I, 1999, LANCET, V354, P120, DOI 10.1016/S0140-6736(98)12310-3; Ito T, 2008, LAB INVEST, V88, P664, DOI 10.1038/labinvest.2008.33; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kruglov AA, 2008, CYTOKINE GROWTH F R, V19, P231, DOI 10.1016/j.cytogfr.2008.04.010; Lee JC, 2003, J UROLOGY, V169, P584, DOI 10.1016/S0022-5347(05)63958-4; Lindert KA, 2000, J UROLOGY, V164, P76, DOI 10.1016/S0022-5347(05)67453-8; Negi M, 2012, MODERN PATHOL, V25, P1284, DOI 10.1038/modpathol.2012.80; Nickel JC, 1999, BJU INT, V84, P976; Perry A, 2011, EXPERT REV ANTI-INFE, V9, P1149, DOI [10.1586/ERI.11.137, 10.1586/eri.11.137]; Sfanos KS, 2008, PROSTATE, V68, P306, DOI 10.1002/pros.20680; Shannon BA, 2006, BJU INT, V98, P388, DOI 10.1111/j.1464-410X.2006.06273.x; SHIINA H, 1992, UROL INT, V48, P187, DOI 10.1159/000282328; Shinohara DB, 2013, PROSTATE, V73, P1007, DOI 10.1002/pros.22648; Talwalkar SS, 2006, MODERN PATHOL, V19, P1402, DOI 10.1038/modpathol.3800668; Tanabe T, 2006, BBA-MOL BASIS DIS, V1762, P794, DOI 10.1016/j.bbadis.2006.07.006; Vasto S, 2008, FUTURE ONCOL, V4, P637, DOI 10.2217/14796694.4.5.637; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995	38	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90324	10.1371/journal.pone.0090324	http://dx.doi.org/10.1371/journal.pone.0090324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587325	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200171
J	Nguyen, C; Ranque, B; Baubet, T; Berezne, A; Mestre-Stanislas, C; Rannou, F; Papelard, A; Morell-Dubois, S; Revel, M; Moro, MR; Guillevin, L; Poiraudeau, S; Mouthon, L				Christelle Nguyen; Ranque, Brigitte; Baubet, Thierry; Berezne, Alice; Mestre-Stanislas, Caroline; Rannou, Francois; Papelard, Agathe; Morell-Dubois, Sandrine; Revel, Michel; Moro, Marie-Rose; Guillevin, Loic; Poiraudeau, Serge; Mouthon, Luc		Grp Francais Rech Sclerodermie	Clinical, Functional and Health-Related Quality of Life Correlates of Clinically Significant Symptoms of Anxiety and Depression in Patients with Systemic Sclerosis: A Cross-Sectional Survey	PLOS ONE			English	Article							PREFERENCE DISABILITY QUESTIONNAIRE; HAND FUNCTION SCALE; PULMONARY ARTERIAL-HYPERTENSION; HOSPITAL ANXIETY; DISEASE-ACTIVITY; MOUTH HANDICAP; SCLERODERMA; VALIDATION; PREVALENCE; TRIALS	Objectives: To identify clinical, functional and health-related quality of life (HRQoL) correlates of clinically significant symptoms of anxiety and depression in patients with systemic sclerosis (SSc). Methods: Three-hundred-and-eighty-one patients fulfilling the American College of Rheumatology and/or the Leroy and Medsger criteria for SSc were assessed for visceral involvement, disability and HRQoL (assessed by SF-36). Clinically significant symptoms of anxiety and depression were evaluated with the Hospital Anxiety Depression Scale (HAD) (defined cut-off >= 8). Results: 9.2% the patients had limited SSc, 50.5% limited cutaneous SSc (lcSSc), and 40.3% diffuse cutaneous SSc (dcSSc). Overall, 40.4% and 58.8% of the patients had clinically significant symptoms of depression and anxiety, respectively. Compared to patients without clinically significant symptoms of depression, patients with clinically significant symptoms of depression had poorer health status, HRQoL mental and physical component, and greater global disability, hand disability and aesthetic impairment. Compared to patients without clinically significant symptoms of anxiety, patients with clinically significant symptoms of anxiety had poorer SF-36 mental and physical component scores. On multivariable analysis, excluding mental component score of SF-36, variables independently associated with clinically significant symptoms of depression and anxiety were global disability and physical component of SF-36, plus female gender for clinically significant symptoms of anxiety only. Remarkably, patients with and without clinically significant psychiatric symptoms were comparable for all disease-related clinical features assessed. Conclusion: High levels of clinically significant symptoms of anxiety and depression are observed among SSc patients. Clinically significant psychiatric symptoms are rather associated with increased disability and altered HRQoL, than with disease-specific organ manifestations.	[Christelle Nguyen; Berezne, Alice; Mestre-Stanislas, Caroline; Guillevin, Loic; Mouthon, Luc] Univ Paris 05, Ctr Reference Vasc Necrosantes & Sclerodemie Syst, Fac Med Paris Descartes, Hop Cochin,Pole Med Interne, Paris, France; [Christelle Nguyen; Ranque, Brigitte; Baubet, Thierry; Berezne, Alice; Mestre-Stanislas, Caroline; Guillevin, Loic; Mouthon, Luc] Assistance Publ Hop Paris, Paris, France; [Ranque, Brigitte] Univ Paris 05, Hop Europe Georges Pompidou, Fac Med Paris Descartes, Serv Med Interne, Paris, France; [Baubet, Thierry] Univ Paris 13, Hop Avicenne, Serv Psychopathol, EA 3413, Bobigny, France; [Christelle Nguyen; Rannou, Francois; Papelard, Agathe; Revel, Michel; Poiraudeau, Serge] Univ Paris 05, Serv Med Phys & Readaptat, Fac Med Paris Descartes, Hop Cochin, Paris, France; [Christelle Nguyen; Rannou, Francois; Papelard, Agathe; Revel, Michel; Poiraudeau, Serge] Inst Federatif Rech Handicap, INSERM, AP HP, Paris, France; [Morell-Dubois, Sandrine] Univ Lille 2, Hop Claude Huriez, Ctr Reference Sclerodermie Syst, Serv Med Interne, Lille, France; [Moro, Marie-Rose] Univ Paris 05, Serv Psychopathol Adolescent, Fac Med Paris Descartes, Hop Cochin, Paris, France; [Moro, Marie-Rose] Assistance Publ Hop Paris, INSERM, U669, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Mouthon, L (corresponding author), Univ Paris 05, Ctr Reference Vasc Necrosantes & Sclerodemie Syst, Fac Med Paris Descartes, Hop Cochin,Pole Med Interne, Paris, France.	luc.mouthon@cch.aphp.fr	POIRAUDEAU, SERGE/P-5301-2016; ranque, brigitte/B-7298-2014	ranque, brigitte/0000-0001-8549-2275; Poiraudeau, Serge/0000-0002-1988-9124; Baubet, Thierry/0000-0002-4112-1592; Nguyen, MD, PhD, Christelle/0000-0001-7141-3230				Akpek G, 2001, BLOOD, V97, P1219, DOI 10.1182/blood.V97.5.1219; Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Angelopoulos NV, 2001, PSYCHOTHER PSYCHOSOM, V70, P145, DOI 10.1159/000056240; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Baubet Thierry, 2011, Presse Med, V40, pe111, DOI 10.1016/j.lpm.2010.09.019; Benrud-Larson LM, 2002, PAIN, V95, P267, DOI 10.1016/S0304-3959(01)00409-2; Beretta L, 2006, REUMATISMO, V58, P219, DOI 10.4081/reumatismo.2006.219; Berezne A, 2011, ARTHRIT CARE RES, V63, P277, DOI 10.1002/acr.20342; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bongi SM, 2012, RHEUMATOL INT, V32, P2785, DOI 10.1007/s00296-011-2049-x; Bouvard M, 1996, PROTOCOLES ECHELLES; Cosco TD, 2012, J PSYCHOSOM RES, V72, P180, DOI 10.1016/j.jpsychores.2011.06.008; Danieli E, 2005, CLIN RHEUMATOL, V24, P48, DOI 10.1007/s10067-004-0970-z; Duruoz MT, 1996, J RHEUMATOL, V23, P1167; EVANS C, 1985, LANCET, V1, P1204; Georges C, 2005, CLIN RHEUMATOL, V24, P3, DOI 10.1007/s10067-004-0942-3; Hachulla E, 2005, ARTHRITIS RHEUM-US, V52, P3792, DOI 10.1002/art.21433; Haythornthwaite JA, 2003, RHEUM DIS CLIN N AM, V29, P427, DOI 10.1016/S0889-857X(03)00020-6; Heinberg LJ, 2007, BODY IMAGE, V4, P79, DOI 10.1016/j.bodyim.2006.11.002; Hesselstrand R, 2013, SCAND J RHEUMATOL, V42, P317, DOI 10.3109/03009742.2012.756928; Honarmand K, 2009, MULT SCLER J, V15, P1518, DOI 10.1177/1352458509347150; Hudson M, 2008, ARTHRIT RHEUM-ARTHR, V59, P279, DOI 10.1002/art.23344; Hyphantis TN, 2007, J PSYCHOSOM RES, V62, P47, DOI 10.1016/j.jpsychores.2006.07.028; Imaizumi T, 2003, STROKE, V34, P1693, DOI 10.1161/01.STR.0000075771.88719.CE; Jewett LR, 2013, RHEUMATOLOGY, V52, P669, DOI 10.1093/rheumatology/kes347; Johnson SR, 2005, ARTHRIT RHEUM-ARTHR, V53, P256, DOI 10.1002/art.21084; Lamberg L, 1996, JAMA-J AM MED ASSOC, V276, P857, DOI 10.1001/jama.276.11.857; Legendre U, 2005, JOINT BONE SPINE, V72, P408, DOI 10.1016/j.jbspin.2003.11.008; LEPINE JP, 1989, SOC PSYCH PSYCH EPID, V24, P301, DOI 10.1007/BF01788033; Lepine JP, 2005, ENCEPHALE, V31, P182; LeRoy EC, 2001, J RHEUMATOL, V28, P1573; Matsuura E, 2003, J RHEUMATOL, V30, P1782; Merkel PA, 2002, ARTHRITIS RHEUM-US, V46, P2410, DOI 10.1002/art.10486; Mestre-Stanislas Caroline, 2010, Presse Med, V39, pe205, DOI 10.1016/j.lpm.2010.02.038; Mouthon L, 2007, ANN RHEUM DIS, V66, P1651, DOI 10.1136/ard.2007.070532; Mouthon L, 2008, ARTHRIT RHEUM-ARTHR, V59, P968, DOI 10.1002/art.23819; Mozzetta A, 2008, J EUR ACAD DERMATOL, V22, P336, DOI 10.1111/j.1468-3083.2007.02426.x; Mukerjee D, 2003, ANN RHEUM DIS, V62, P1088, DOI 10.1136/ard.62.11.1088; Mura G, 2012, Clin Pract Epidemiol Ment Health, V8, P30, DOI 10.2174/1745017901208010030; Nguyen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017551; Nguyen C, 2010, RHEUMATOLOGY, V49, P982, DOI 10.1093/rheumatology/kep400; Nguyen C, 2010, J RHEUMATOL, V37, P359, DOI 10.3899/jrheum.090632; Nietert PJ, 2005, J RHEUMATOL, V32, P51; Ostojic P, 2010, MOD RHEUMATOL; Poole J L, 1991, Arthritis Care Res, V4, P27, DOI 10.1002/art.1790040106; Poole JL, 2011, ARTHRIT CARE RES, V63, pS189, DOI 10.1002/acr.20631; POOLE JL, 1994, AM J OCCUP THER, V48, P46, DOI 10.5014/ajot.48.1.46; Pope J, 2011, ARTHRIT CARE RES, V63, pS98, DOI 10.1002/acr.20598; Rannou F, 2007, ARTHRIT RHEUM-ARTHR, V57, P94, DOI 10.1002/art.22468; Richards H., 2004, PSYCHOL HEALTH MED, V9, P29, DOI [10.1080/13548500310001637733, DOI 10.1080/13548500310001637733]; Richards HL, 2003, ARTHRIT RHEUM-ARTHR, V49, P689, DOI 10.1002/art.11385; Ritchie K, 2004, BRIT J PSYCHIAT, V184, P147, DOI 10.1192/bjp.184.2.147; Roca RP, 1996, ARTHRITIS RHEUM, V39, P1035, DOI 10.1002/art.1780390623; Rouchell A, 1996, DEPRESSION TXB CONSU; Sandqvist G, 2009, SCAND J RHEUMATOL, V18, P1; Schouffoer AA, 2013, CLIN RHEUMATOL, V32, P1649, DOI 10.1007/s10067-013-2321-4; Steen VD, 2000, ARTHRITIS RHEUM-US, V43, P2437, DOI 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U; Straat JH, 2013, J PSYCHOSOM RES, V74, P116, DOI 10.1016/j.jpsychores.2012.11.012; Straszecka J, 1996, CLIN RHEUMATOL, V15, P621, DOI 10.1007/BF02238557; Tamby MC, 2003, AUTOIMMUN REV, V2, P152, DOI 10.1016/S1568-9972(03)00004-1; Thombs BD, 2007, ARTHRIT RHEUM-ARTHR, V57, P1089, DOI 10.1002/art.22910; TUGWELL P, 1987, J RHEUMATOL, V14, P446; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	64	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90484	10.1371/journal.pone.0090484	http://dx.doi.org/10.1371/journal.pone.0090484			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24587375	gold, Green Submitted, Green Published			2022-12-27	WOS:000332396200209
J	Kepp, KP; Dasmeh, P				Kepp, Kasper P.; Dasmeh, Pouria			A Model of Proteostatic Energy Cost and Its Use in Analysis of Proteome Trends and Sequence Evolution	PLOS ONE			English	Article							AMINO-ACID USAGE; MESSENGER-RNA; CODON-USAGE; COMPENSATORY EXPRESSION; ESCHERICHIA-COLI; QUALITY-CONTROL; PROTEINS; EVOLVE; GENES; YEAST	A model of proteome-associated chemical energetic costs of cells is derived from protein-turnover kinetics and protein folding. Minimization of the proteostatic maintenance cost can explain a range of trends of proteomes and combines both protein function, stability, size, proteostatic cost, temperature, resource availability, and turnover rates in one simple framework. We then explore the ansatz that the chemical energy remaining after proteostatic maintenance is available for reproduction (or cell division) and thus, proportional to organism fitness. Selection for lower proteostatic costs is then shown to be significant vs. typical effective population sizes of yeast. The model explains and quantifies evolutionary conservation of highly abundant proteins as arising both from functional mutations and from changes in other properties such as stability, cost, or turnover rates. We show that typical hypomorphic mutations can be selected against due to increased cost of compensatory protein expression (both in the mutated gene and in related genes, i.e. epistasis) rather than compromised function itself, although this compensation depends on the protein's importance. Such mutations exhibit larger selective disadvantage in abundant, large, synthetically costly, and/or short-lived proteins. Selection against increased turnover costs of less stable proteins rather than misfolding toxicity per se can explain equilibrium protein stability distributions, in agreement with recent findings in E. coli. The proteostatic selection pressure is stronger at low metabolic rates (i.e. scarce environments) and in hot habitats, explaining proteome adaptations towards rough environments as a question of energy. The model may also explain several trade-offs observed in protein evolution and suggests how protein properties can coevolve to maintain low proteostatic cost.	[Kepp, Kasper P.; Dasmeh, Pouria] Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark	Technical University of Denmark	Kepp, KP (corresponding author), Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark.	kpj@kemi.dtu.dk	Kepp, Kasper P./AAA-4626-2021; Kepp, Kasper Planeta/G-1748-2013	Kepp, Kasper P./0000-0002-6754-7348; Kepp, Kasper Planeta/0000-0002-6754-7348; Dasmeh, Pouria/0000-0002-4527-5302	Danish Center for Scientific Computing [2012-02-23]	Danish Center for Scientific Computing	The authors wish to thank the Danish Center for Scientific Computing (grant # 2012-02-23) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; BADALOO A, 1989, CLIN SCI, V77, P93, DOI 10.1042/cs0770093; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Bershtein S, 2013, MOL CELL, V49, P133, DOI 10.1016/j.molcel.2012.11.004; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Bloom JD, 2006, MOL BIOL EVOL, V23, P1751, DOI 10.1093/molbev/msl040; Branden C., 1999, INTRO PROTEIN STRUCT; Cai L, 2012, ANNU REV CELL DEV BI, V28, P59, DOI 10.1146/annurev-cellbio-092910-154010; Charoenlap N, 2005, FEMS MICROBIOL LETT, V249, P73, DOI 10.1016/j.femsle.2005.06.002; Chen PQ, 2010, BIOPHYS J, V98, P1109, DOI 10.1016/j.bpj.2009.11.048; Chen YW, 2008, MOL BIOL EVOL, V25, P1530, DOI 10.1093/molbev/msn122; Coghlan A, 2000, YEAST, V16, P1131, DOI 10.1002/1097-0061(20000915)16:12<1131::AID-YEA609>3.0.CO;2-F; Dasmeh P, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002929; De Sancho D, 2011, PHYS CHEM CHEM PHYS, V13, P17030, DOI 10.1039/c1cp20402e; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Destro T, 2011, J EXP BOT, V62, P805, DOI 10.1093/jxb/erq316; DEVISSER R, 1992, MOLECULAR, BIOCHEMICAL AND PHYSIOLOGICAL ASPECTS OF PLANT RESPIRATION, P493; Dill KA, 2011, P NATL ACAD SCI USA, V108, P17876, DOI 10.1073/pnas.1114477108; Dokholyan NV, 2001, J MOL BIOL, V312, P289, DOI 10.1006/jmbi.2001.4949; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Echols N, 2002, NUCLEIC ACIDS RES, V30, P2515, DOI 10.1093/nar/30.11.2515; FENCHEL T, 1983, MICROBIAL ECOL, V9, P99, DOI 10.1007/BF02015125; Fraser KPP, 2007, ADV MAR BIOL, V52, P267, DOI 10.1016/S0065-2881(06)52003-6; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Garat B, 2000, BIOCHEM BIOPH RES CO, V279, P996, DOI 10.1006/bbrc.2000.4051; Geiler-Samerotte KA, 2011, P NATL ACAD SCI USA, V108, P680, DOI 10.1073/pnas.1017570108; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghosh K, 2010, BIOPHYS J, V99, P3996, DOI 10.1016/j.bpj.2010.10.036; Ghosh K, 2009, P NATL ACAD SCI USA, V106, P10649, DOI 10.1073/pnas.0903995106; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Goldstein RA, 2008, CURR OPIN STRUC BIOL, V18, P170, DOI 10.1016/j.sbi.2008.01.006; Goldstein RA, 2011, PROTEINS, V79, P1396, DOI 10.1002/prot.22964; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; Harold F. M., 1986, VITAL FORCE STUDY BI; Harrison PM, 2003, NUCLEIC ACIDS RES, V31, P1033, DOI 10.1093/nar/gkg169; Heizer EM, 2006, MOL BIOL EVOL, V23, P1670, DOI 10.1093/molbev/msl029; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Kepp KP, 2012, CHEM REV, V112, P5193, DOI 10.1021/cr300009x; Khan Z, 2013, SCIENCE, V342, P1100, DOI 10.1126/science.1242379; KIMURA M, 1962, GENETICS, V47, P713; Linden R, 2012, CELL MOL LIFE SCI, V69, P1105, DOI 10.1007/s00018-011-0847-7; Lobkovsky AE, 2010, P NATL ACAD SCI USA, V107, P2983, DOI 10.1073/pnas.0910445107; Makela T, 2010, PHYS LIFE REV, V7, P477, DOI 10.1016/j.plrev.2010.10.001; McCarthy ID, 2011, J EXP BIOL, V214, P1821, DOI 10.1242/jeb.052753; MULLER H. J., 1932, Proceedings. 6th Int. Congr. Genet., V1, P213; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Pal C, 2001, GENETICS, V158, P927; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; Plata G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r98; POWARS DR, 1984, BLOOD, V63, P921, DOI 10.1182/blood.V63.4.921.921; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; Quigg A, 2003, PLANT CELL ENVIRON, V26, P693, DOI 10.1046/j.1365-3040.2003.01004.x; Raiford DW, 2008, J MOL EVOL, V67, P621, DOI 10.1007/s00239-008-9162-9; Reeds P. J., 1985, SUBSTRATE ENERGY MET, P46; ROBINSON M, 1984, NUCLEIC ACIDS RES, V12, P6663, DOI 10.1093/nar/12.17.6663; Sawle L, 2011, BIOPHYS J, V101, P217, DOI 10.1016/j.bpj.2011.05.059; Scheurwater I, 2000, J EXP BOT, V51, P1089, DOI 10.1093/jexbot/51.347.1089; SCHNEIDER ED, 1994, MATH COMPUT MODEL, V19, P25, DOI 10.1016/0895-7177(94)90188-0; Schrodinger E, 1948, WHAT IS LIFE PHYS AS; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Seligmann H, 2003, J MOL EVOL, V56, P151, DOI 10.1007/s00239-002-2388-z; Serohijos AWR, 2013, BIOPHYS J, V104, pL1, DOI 10.1016/j.bpj.2012.11.3838; Serohijos AWR, 2012, CELL REP, V2, P249, DOI 10.1016/j.celrep.2012.06.022; SHARP PM, 1991, J MOL EVOL, V33, P23, DOI 10.1007/BF02100192; SMITH RW, 1995, J COMP PHYSIOL B, V165, P93, DOI 10.1007/BF00301473; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; Stefanis L, 2012, CSH PERSPECT BIOL, V4; Swire J, 2007, J MOL EVOL, V64, P558, DOI 10.1007/s00239-006-0206-8; Taverna DM, 2002, J MOL BIOL, V315, P479, DOI 10.1006/jmbi.2001.5226; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tsai IJ, 2008, P NATL ACAD SCI USA, V105, P4957, DOI 10.1073/pnas.0707314105; Vilaprinyo E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000674; Wagner A, 2005, MOL BIOL EVOL, V22, P1365, DOI 10.1093/molbev/msi126; Wang E, 2005, TRENDS GENET, V21, P492, DOI 10.1016/j.tig.2005.06.013; WATERLOW JC, 1995, ANNU REV NUTR, V15, P57, DOI 10.1146/annurev.nu.15.070195.000421; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Zeldovich KB, 2007, P NATL ACAD SCI USA, V104, P16152, DOI 10.1073/pnas.0705366104; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010	84	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90504	10.1371/journal.pone.0090504	http://dx.doi.org/10.1371/journal.pone.0090504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587382	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200216
J	Lock, JG; Mamaghani, MJ; Shafqat-Abbasi, H; Gong, XW; Tyrcha, J; Stromblad, S				Lock, John G.; Mamaghani, Mehrdad Jafari; Shafqat-Abbasi, Hamdah; Gong, Xiaowei; Tyrcha, Joanna; Stromblad, Staffan			Plasticity in the Macromolecular-Scale Causal Networks of Cell Migration	PLOS ONE			English	Article							GTP-BINDING PROTEIN; ACTIN STRESS FIBERS; FOCAL ADHESIONS; RHO GTPASES; GROWTH; ROCK; DYNAMICS; KINASE; ORGANIZATION; RECRUITMENT	Heterogeneous and dynamic single cell migration behaviours arise from a complex multi-scale signalling network comprising both molecular components and macromolecular modules, among which cell-matrix adhesions and F-actin directly mediate migration. To date, the global wiring architecture characterizing this network remains poorly defined. It is also unclear whether such a wiring pattern may be stable and generalizable to different conditions, or plastic and context dependent. Here, synchronous imaging-based quantification of migration system organization, represented by 87 morphological and dynamic macromolecular module features, and migration system behaviour, i.e., migration speed, facilitated Granger causality analysis. We thereby leveraged natural cellular heterogeneity to begin mapping the directionally specific causal wiring between organizational and behavioural features of the cell migration system. This represents an important advance on commonly used correlative analyses that do not resolve causal directionality. We identified organizational features such as adhesion stability and adhesion F-actin content that, as anticipated, causally influenced cell migration speed. Strikingly, we also found that cell speed can exert causal influence over organizational features, including cell shape and adhesion complex location, thus revealing causality in directions contradictory to previous expectations. Importantly, by comparing unperturbed and signalling-modulated cells, we provide proof-of-principle that causal interaction patterns are in fact plastic and context dependent, rather than stable and generalizable.	[Lock, John G.; Mamaghani, Mehrdad Jafari; Shafqat-Abbasi, Hamdah; Gong, Xiaowei; Stromblad, Staffan] Karolinska Inst, Dept Biosci & Nutr, Ctr Biosci, Huddinge, Sweden; [Mamaghani, Mehrdad Jafari; Tyrcha, Joanna] Stockholm Univ, Dept Math, Div Math Stat, S-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm University	Lock, JG (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Ctr Biosci, Huddinge, Sweden.	john.lock@ki.se; staffan.stromblad@ki.se	Abbasi, Hamdah Shafqat/Z-3514-2019	Lock, John/0000-0002-3880-4106; Gong, Xiaowei/0000-0002-5120-8587; Stromblad, Staffan/0000-0002-1236-6339	EU-FP7-Systems Microscopy NoE [HEALTH-F4-2010-258068]; Centre for Biosciences at KI; Swedish Research Council; Swedish Cancer Society; Knut and Alice Wallenberg Foundation	EU-FP7-Systems Microscopy NoE; Centre for Biosciences at KI; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by grants to SS from the EU-FP7-Systems Microscopy NoE (Grant No. HEALTH-F4-2010-258068), the Centre for Biosciences at KI, the Swedish Research Council and the Swedish Cancer Society. Imaging occurred at the live cell-imaging unit at the Department of Biosciences and Nutrition at KI, supported by grants from the Knut and Alice Wallenberg Foundation, the Swedish Research Council and the Centre for Biosciences at KI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; [Anonymous], [No title captured]; Bar-Yam Y, 2004, COMPLEXITY, V9, P15, DOI 10.1002/cplx.20029; Barnhart EL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001059; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Byron A, 2011, SCI SIGNAL 2, V4; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Colo GP, 2012, J CELL SCI, V125, P5338, DOI 10.1242/jcs.105270; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Geiger T, 2012, CURR OPIN CELL BIOL, V24, P562, DOI 10.1016/j.ceb.2012.05.004; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Horwitz R, 2003, CURR BIOL, V13, pR756, DOI 10.1016/j.cub.2003.09.014; Hou Y, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-8; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; Ku CJ, 2012, CELL, V149, P1073, DOI 10.1016/j.cell.2012.03.044; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lazebnik Y, 2002, CANCER CELL, V2, P179, DOI 10.1016/S1535-6108(02)00133-2; Li ZL, 2010, MOL BIOL CELL, V21, P3317, DOI 10.1091/mbc.E10-03-0245; Lock JG, 2008, SEMIN CANCER BIOL, V18, P65, DOI 10.1016/j.semcancer.2007.10.001; Lock JG, 2010, EXP CELL RES, V316, P1438, DOI 10.1016/j.yexcr.2010.04.001; Maree AFM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002402; Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Oltvai ZN, 2002, SCIENCE, V298, P763, DOI 10.1126/science.1078563; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Pe'er Dana, 2005, Sci STKE, V2005, ppl4, DOI 10.1126/stke.2812005pl4; RAO CR, 1948, J ROY STAT SOC B, V10, P159; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; Ridley AJ, 2001, J CELL SCI, V114, P2713; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; SMILENOV L, 1992, FEBS LETT, V302, P227, DOI 10.1016/0014-5793(92)80447-O; Strohman RC, 1997, NAT BIOTECHNOL, V15, P194, DOI 10.1038/nbt0397-194; Struckhoff AP, 2010, J CELL SCI, V123, P401, DOI 10.1242/jcs.052167; TAKAISHI K, 1994, ONCOGENE, V9, P273; Tkach V, 2005, CELL MOTIL CYTOSKEL, V61, P21, DOI 10.1002/cm.20062; Tkachenko E, 2011, NAT CELL BIOL, V13, P660, DOI 10.1038/ncb2231; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Tsuji T, 2002, J CELL BIOL, V157, P819, DOI 10.1083/jcb.200112107; Vilela M, 2011, NAT CELL BIOL, V13, P1011, DOI 10.1038/ncb2325; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Welf ES, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-15; Welf ES, 2011, WIRES SYST BIOL MED, V3, P231, DOI 10.1002/wsbm.110; Wiener N., 1956, MODERN MATH ENG, P165; Winograd-Katz SE, 2009, J CELL BIOL, V186, P423, DOI 10.1083/jcb.200901105; Wolfenson H, 2011, J CELL SCI, V124, P1425, DOI 10.1242/jcs.077388; Yam PT, 2007, J CELL BIOL, V178, P1207, DOI 10.1083/jcb.200706012; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Zamir E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001901; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	73	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90593	10.1371/journal.pone.0090593	http://dx.doi.org/10.1371/journal.pone.0090593			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587399	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200233
J	Willis, TA; Hollingsworth, KG; Coombs, A; Sveen, ML; Andersen, S; Stojkovic, T; Eagle, M; Mayhew, A; de Sousa, PL; Dewar, L; Morrow, JM; Sinclair, CDJ; Thornton, JS; Bushby, K; Lochmuller, H; Hanna, MG; Hogrel, JY; Carlier, PG; Vissing, J; Straub, V				Willis, Tracey A.; Hollingsworth, Kieren G.; Coombs, Anna; Sveen, Marie-Louise; Andersen, Soren; Stojkovic, Tanya; Eagle, Michelle; Mayhew, Anna; de Sousa, Paulo Loureiro; Dewar, Liz; Morrow, Jasper M.; Sinclair, Christopher D. J.; Thornton, John S.; Bushby, Kate; Lochmuller, Hanns; Hanna, Michael G.; Hogrel, Jean-Yves; Carlier, Pierre G.; Vissing, John; Straub, Volker			Quantitative Magnetic Resonance Imaging in Limb-Girdle Muscular Dystrophy 2I: A Multinational Cross-Sectional Study	PLOS ONE			English	Article							MUSCLE MRI; DIXON TECHNIQUE; DECOMPOSITION	We conducted a prospective multinational study of muscle pathology using magnetic resonance imaging (MRI) in patients with limb-girdle muscular dystrophy 2I (LGMD2I). Thirty eight adult ambulant LGMD2I patients (19 male; 19 female) with genetically identical mutations (c.826C>A) in the fukutin-related protein (FKRP) gene were recruited. In each patient, T1-weighted (T(1)w) imaging was assessed by qualitative grading for 15 individual lower limb muscles and quantitative Dixon imaging was analysed on 14 individual lower limb muscles by region of interest analysis. We described the pattern and appearance of muscle pathology and gender differences, not previously reported for LGMD2I. Diffuse fat infiltration of the gastrocnemii muscles was demonstrated in females, whereas in males fat infiltration was more prominent in the medial than the lateral gastrocnemius (p = 0.05). In the anterior thigh of males, in contrast to females, median fat infiltration in the vastus medialis muscle (45.7%) exceeded that in the vastus lateralis muscle (11.2%) (p < 0.005). MRI is non-invasive, objective and does not rely on patient effort compared to clinical and physical measures that are currently employed. We demonstrated (i) that the quantitative Dixon technique is an objective quantitative marker of disease and (ii) new observations of gender specific patterns of muscle involvement in LGMD2I.	[Willis, Tracey A.; Eagle, Michelle; Mayhew, Anna; Bushby, Kate; Lochmuller, Hanns; Straub, Volker] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Willis, Tracey A.] Robert Jones & Agnes Hunt Orthopaed Hosp, Oswestry SY10 7AG, Shrops, England; [Hollingsworth, Kieren G.; Coombs, Anna] Newcastle Univ, Inst Cellular Med, Newcastle Magnet Resonance Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Sveen, Marie-Louise; Andersen, Soren; Vissing, John] Univ Copenhagen, Rigshosp, Dept Neurol, Neuromuscular Res Unit, DK-2100 Copenhagen, Denmark; [Stojkovic, Tanya] Grp Hosp Pitie Salpetriere, Inst Myol, Ctr Reference Malad Neuromusculaires Paris Est, F-75634 Paris, France; [de Sousa, Paulo Loureiro; Hogrel, Jean-Yves; Carlier, Pierre G.] Grp Hosp Pitie Salpetriere, Inst Myol, F-75634 Paris, France; [Dewar, Liz; Morrow, Jasper M.; Sinclair, Christopher D. J.; Thornton, John S.; Hanna, Michael G.] UCL Inst Neurol, Dept Mol Neurosci, MRC Ctr Neuromuscular Dis, London, England	Newcastle University - UK; Keele University; Newcastle University - UK; Rigshospitalet; University of Copenhagen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of London; University College London	Hollingsworth, KG (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Magnet Resonance Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	kieren.hollingsworth@ncl.ac.uk	STOJKOVIC, Tanya/AAA-3967-2021	Hanna, Michael/0000-0003-0825-4075; Straub, Volker/0000-0001-9046-3540; Hogrel, Jean-Yves/0000-0003-0045-7505; Thornton, John/0000-0003-3248-8437; Lochmuller, Hanns/0000-0003-2324-8001	MRC Centre for Neuromuscular Disease; Muscular Dystrophy Campaign, UK; UK Medical Research Council [G1100160]; UCL/UCLH NIHR Comprehensive Biomedical Research Centre; Sara and Ludvig Elsass Foundation, Denmark; Association Francaise contre Les Myopathies; EU [036825]; MRC [G1100160, MR/K000608/1] Funding Source: UKRI; Medical Research Council [G1100160, MR/K000608/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10036] Funding Source: researchfish	MRC Centre for Neuromuscular Disease(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Muscular Dystrophy Campaign, UK(Muscular Dystrophy Association); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCL/UCLH NIHR Comprehensive Biomedical Research Centre; Sara and Ludvig Elsass Foundation, Denmark; Association Francaise contre Les Myopathies(Association Francaise contre les Myopathies); EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The project was mainly funded through the MRC Centre for Neuromuscular Disease (http://www.cnmd.ac.uk/). Diagnostic facilities at the Newcastle Muscle Centre are supported by the National Commissioning Group (NCG) for rare neuromuscular disorders. TW is funded by the Muscular Dystrophy Campaign, UK. KGH is supported by the UK Medical Research Council (G1100160). The authors would like to acknowledge the financial support of the UCL/UCLH NIHR Comprehensive Biomedical Research Centre for the research staff in London, UK. The authors gratefully acknowledge the help of Valerie Decostre and Gwenn Ollivier and the Sara and Ludvig Elsass Foundation, Denmark, and the Association Francaise contre Les Myopathies for the MRI funding. The collaboration between the centres was facilitated by the TREAT-NMD network of excellence (http://www.treat-nmd.eu/), which has been funded by the EU via FP6 contract number 036825. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Bushby K M D, 2003, Neuromuscul Disord, V13, P80, DOI 10.1016/S0960-8966(02)00183-9; BUSHBY KMD, 1995, NEUROMUSCULAR DISORD, V5, P71, DOI 10.1016/0960-8966(93)E0006-G; Coombs BD, 1997, MAGNET RESON MED, V38, P884, DOI 10.1002/mrm.1910380606; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; Fischer D, 2005, J NEUROL, V252, P538, DOI 10.1007/s00415-005-0684-4; GLOVER GH, 1991, MAGNET RESON MED, V18, P371, DOI 10.1002/mrm.1910180211; Hicks D, 2011, BRAIN, V134, P171, DOI 10.1093/brain/awq294; Lodi R, 1997, NEUROMUSCULAR DISORD, V7, P505, DOI 10.1016/S0960-8966(97)00108-9; Mercuri E, 2005, CURR OPIN NEUROL, V18, P526, DOI 10.1097/01.wco.0000183947.01362.fe; Mercuri E, 2005, NEUROMUSCULAR DISORD, V15, P303, DOI 10.1016/j.nmd.2005.01.004; Mercuri E, 2005, NEUROMUSCULAR DISORD, V15, P164, DOI 10.1016/j.nmd.2004.10.008; Mercuri E, 2002, NEUROMUSCULAR DISORD, V12, P631, DOI 10.1016/S0960-8966(02)00023-8; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; Mercuri Eugenio, 2002, Eur J Paediatr Neurol, V6, P305; Poppe M, 2003, NEUROLOGY, V60, P1246, DOI 10.1212/01.WNL.0000058902.88181.3D; Sookhoo S, 2007, CLIN RADIOL, V62, P160, DOI 10.1016/j.crad.2006.08.012; Walter MC, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013953; Wattjes MP, 2010, EUR RADIOL, V20, P2447, DOI 10.1007/s00330-010-1799-2; Wicklund MP, 2003, NEUROLOGY, V60, P1230, DOI 10.1212/WNL.60.8.1230; YOUNKIN DP, 1987, NEUROLOGY, V37, P165, DOI 10.1212/WNL.37.1.165	22	63	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90377	10.1371/journal.pone.0090377	http://dx.doi.org/10.1371/journal.pone.0090377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587344	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200183
J	Fahrenbach, JP; Andrade, J; McNally, EM				Fahrenbach, John P.; Andrade, Jorge; McNally, Elizabeth M.			The CO-Regulation Database (CORD): A Tool to Identify Coordinately Expressed Genes	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; CANCER; PROTEIN; FAMILY; P16; TRANSCRIPTOMEBROWSER; COEXPRESSION; MICROARRAY; POWERFUL; INVASION	Background: Meta-analysis of gene expression array databases has the potential to reveal information about gene function. The identification of gene-gene interactions may be inferred from gene expression information but such meta-analysis is often limited to a single microarray platform. To address this limitation, we developed a gene-centered approach to analyze differential expression across thousands of gene expression experiments and created the CO-Regulation Database (CORD) to determine which genes are correlated with a queried gene. Results: Using the GEO and ArrayExpress database, we analyzed over 120,000 group by group experiments from gene microarrays to determine the correlating genes for over 30,000 different genes or hypothesized genes. CORD output data is presented for sample queries with focus on genes with well-known interaction networks including p16 (CDKN2A), vimentin (VIM), MyoD (MYOD1). CDKN2A, VIM, and MYOD1 all displayed gene correlations consistent with known interacting genes. Conclusions: We developed a facile, web-enabled program to determine gene-gene correlations across different gene expression microarray platforms. Using well-characterized genes, we illustrate how CORD's identification of co-expressed genes contributes to a better understanding a gene's potential function. The website is found at http://cord-db.org.	[Fahrenbach, John P.; McNally, Elizabeth M.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Andrade, Jorge] Univ Chicago, Ctr Res Informat, Chicago, IL 60637 USA; [McNally, Elizabeth M.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Fahrenbach, JP (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jfahrenbach@uchicago.edu	Andrade, Jorge/H-3104-2019; McNally, Elizabeth/W-4909-2019	Andrade, Jorge/0000-0003-3210-2186; fahrenbach, john/0000-0001-6785-9707; McNally, Elizabeth/0000-0002-1221-719X	National Institutes of Health [F31 HL097587, AR052646, NS072027, HL61322]; Doris Duke Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL097587, R01HL061322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS072027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health F31 HL097587 (to JF), AR052646, NS072027, HL61322 and the Doris Duke Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r139; [Anonymous], GENES DEV, V3, P1086; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Chen R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-548; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; EBRALIDZE A, 1989, GENE DEV, V3, P1086, DOI 10.1101/gad.3.7.1086; Eckes B, 1998, J CELL SCI, V111, P1897; Engreitz JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-603; Fischer CA, 2010, ANN ONCOL, V21, P1961, DOI 10.1093/annonc/mdq210; Francetic T, 2011, TRANSCR-AUSTIN, V2, P109, DOI 10.4161/trns.2.3.15829; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Guweidhi A, 2005, ANN SURG, V242, P224, DOI 10.1097/01.sla.0000171866.45848.68; Hellman NE, 2008, J BIOL CHEM, V283, P4272, DOI 10.1074/jbc.M708027200; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Ivaska Johanna, 2011, Small GTPases, V2, P51; Kapushesky M, 2012, NUCLEIC ACIDS RES, V40, pD1077, DOI 10.1093/nar/gkr913; Komatsu K, 2000, CLIN CANCER RES, V6, P172; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Lepoivre C, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-19; Li LW, 2009, INT J CANCER, V125, P1505, DOI 10.1002/ijc.24513; Lopez F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004001; Maschler S, 2010, EMBO MOL MED, V2, P401, DOI 10.1002/emmm.201000095; Mattila H, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-327; Moinova H, 2012, CANCER EPIDEM BIOMAR, V21, P594, DOI 10.1158/1055-9965.EPI-11-1060; Obayashi T, 2013, NUCLEIC ACIDS RES, V41, pD1014, DOI 10.1093/nar/gks1014; OLSON EN, 1993, CIRC RES, V72, P1, DOI 10.1161/01.RES.72.1.1; Powell EL, 2005, AM J SURG PATHOL, V29, P1497, DOI 10.1097/01.pas.0000170349.47680.e8; Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Rung J, 2013, NAT REV GENET, V14, P89, DOI 10.1038/nrg3394; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Schneider-Stock R, 2005, CLIN CANCER RES, V11, P638; Surowiak P, 2008, HISTOL HISTOPATHOL, V23, P531, DOI 10.14670/HH-23.531; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Tinguely M, 2008, CANCER SCI, V99, P720, DOI 10.1111/j.1349-7006.2008.00738.x; Umezu T, 2010, P NATL ACAD SCI USA, V107, P4601, DOI 10.1073/pnas.0909501107; van den Abbeele A, 2007, CANCER LETT, V255, P57, DOI 10.1016/j.canlet.2007.03.023; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509	44	9	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90408	10.1371/journal.pone.0090408	http://dx.doi.org/10.1371/journal.pone.0090408			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599084	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400071
J	Gonzalez-Gomez, PL; Madrid-Lopez, N; Salazar, JE; Suarez, R; Razeto-Barry, P; Mpodozis, J; Bozinovic, F; Vasquez, RA				Gonzalez-Gomez, Paulina L.; Madrid-Lopez, Natalia; Salazar, Juan E.; Suarez, Rodrigo; Razeto-Barry, Pablo; Mpodozis, Jorge; Bozinovic, Francisco; Vasquez, Rodrigo A.			Cognitive Ecology in Hummingbirds: The Role of Sexual Dimorphism and Its Anatomical Correlates on Memory	PLOS ONE			English	Article							BLACK-CAPPED CHICKADEES; FOOD-STORING BIRDS; SPATIAL MEMORY; MARSH TITS; ADAPTIVE SPECIALIZATION; HIPPOCAMPAL-FORMATION; SEASONAL-CHANGES; NEURON NUMBERS; STORED FOOD; ABILITY	In scatter-hoarding species, several behavioral and neuroanatomical adaptations allow them to store and retrieve thousands of food items per year. Nectarivorous animals face a similar scenario having to remember quality, location and replenishment schedules of several nectar sources. In the green-backed firecrown hummingbird (Sephanoides sephanoides), males are territorial and have the ability to accurately keep track of nectar characteristics of their defended food sources. In contrast, females display an opportunistic strategy, performing rapid intrusions into males territories. In response, males behave aggressively during the non-reproductive season. In addition, females have higher energetic demands due to higher thermoregulatory costs and travel times. The natural scenario of this species led us to compared cognitive abilities and hippocampal size between males and females. Males were able to remember nectar location and renewal rates significantly better than females. However, the hippocampal formation was significantly larger in females than males. We discuss these findings in terms of sexually dimorphic use of spatial resources and variable patterns of brain dimorphisms in birds.	[Gonzalez-Gomez, Paulina L.; Vasquez, Rodrigo A.] Univ Chile, Fac Ciencias, Inst Ecol & Biodiversidad, Santiago, Chile; [Razeto-Barry, Pablo] Univ Diego Portales, Vicerrectoria Acad, Santiago, Chile; [Gonzalez-Gomez, Paulina L.; Razeto-Barry, Pablo] Inst Filosofia & Ciencias Complejidad, Santiago, Chile; [Madrid-Lopez, Natalia; Salazar, Juan E.; Suarez, Rodrigo; Mpodozis, Jorge] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; [Bozinovic, Francisco] Pontificia Univ Catolica Chile, Ctr Estudios Avanzados Ecol & Biodiversidad, MIII & LINCGlobal, Dept Ecol, Santiago, Chile	Universidad de Chile; University Diego Portales; Universidad de Chile; Pontificia Universidad Catolica de Chile	Gonzalez-Gomez, PL (corresponding author), Univ Chile, Fac Ciencias, Inst Ecol & Biodiversidad, Santiago, Chile.	plgonzalezgomez@gmail.com	Suarez, Rodrigo/J-1529-2014; Suarez, Rodrigo/N-9437-2016; , Paulina/ABA-6634-2021	Suarez, Rodrigo/0000-0001-5153-5652; Suarez, Rodrigo/0000-0001-5153-5652; , Paulina/0000-0002-1219-8881; Salazar, Juan Esteban/0000-0003-1480-6761	CONICYT; FONDECYT [1130015, 1090794, 1060186];  [PFB-23-CONICYT];  [ICM-P05-002]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ; 	This work received funding from CONICYT (PGG and RS), FONDECYT 1130015 (FB) and FONDECYT 1090794, 1060186; ICM-P05-002; and PFB-23-CONICYT (RAV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astie Andrea Alejandra, 1998, Animal Cognition, V1, P77, DOI 10.1007/s100710050011; Baker HG, 1998, BIOTROPICA, V30, P559, DOI 10.1111/j.1744-7429.1998.tb00097.x; Boogert NJ, 2011, BEHAV ECOL, V22, P447, DOI 10.1093/beheco/arq173; Brown GE, 2013, BEHAV ECOL SOCIOBIOL, V67, P43, DOI 10.1007/s00265-012-1422-4; Burger DK, 2013, BEHAV BRAIN RES, V236, P131, DOI 10.1016/j.bbr.2012.08.044; Chalcoff VR, 2006, ANN BOT-LONDON, V97, P413, DOI 10.1093/aob/mcj043; Clayton NS, 1997, BEHAV PROCESS, V41, P237, DOI 10.1016/S0376-6357(97)00050-8; Costa SS, 2011, BRAIN BEHAV EVOLUT, V77, P55, DOI 10.1159/000323668; Day LB, 2011, BRAIN BEHAV EVOLUT, V77, P206, DOI 10.1159/000327046; Dunlap AS, 2006, ANIM BEHAV, V72, P401, DOI 10.1016/j.anbehav.2006.01.015; Galea LAM, 1996, J EXP BIOL, V199, P195; GAULIN SJC, 1986, AM NAT, V127, P74, DOI 10.1086/284468; Gonzalez-Gomez PL, 2011, BEHAV ECOL SOCIOBIOL, V65, P2141, DOI 10.1007/s00265-011-1222-2; Gonzalez-Gomez PL, 2011, ANIM BEHAV, V81, P1257, DOI 10.1016/j.anbehav.2011.03.014; Gonzalez-Gomez PL, 2011, AUK, V128, P36, DOI 10.1525/auk.2011.10024; Gonzalez-Gomez PL, 2009, J ORNITHOL, V150, P351, DOI 10.1007/s10336-008-0356-0; HAFTORN S, 1954, KONGELIGE NORSKE VID, V4, P1; Healy SD, 2009, BEHAV PROCESS, V80, P288, DOI 10.1016/j.beproc.2008.10.002; Healy SD, 2004, BRAIN BEHAV EVOLUT, V63, P211, DOI 10.1159/000076782; Healy SD, 1996, BEHAV BRAIN RES, V81, P61, DOI 10.1016/S0166-4328(96)00044-7; Henderson J, 2006, CURR BIOL, V16, P512, DOI 10.1016/j.cub.2006.01.054; Irwin RE, 2000, OIKOS, V91, P499, DOI 10.1034/j.1600-0706.2000.910311.x; Jones CM, 2003, BEHAV NEUROSCI, V117, P403, DOI 10.1037/0735-7044.117.3.403; KREBS JR, 1989, P NATL ACAD SCI USA, V86, P1388, DOI 10.1073/pnas.86.4.1388; Krushinskaya N.L., 1966, ZH EVOL BIOCH FISIOL, V11, P563; McKechnie AE, 2006, P ROY SOC B-BIOL SCI, V273, P931, DOI 10.1098/rspb.2005.3415; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pravosudov VV, 2013, ANNU REV ECOL EVOL S, V44, P173, DOI 10.1146/annurev-ecolsys-110512-135904; Pravosudov VV, 2010, PHILOS T R SOC B, V365, P859, DOI 10.1098/rstb.2009.0216; PRAVOSUDOV VV, 1985, ZOOL ZH, V64, P1036; Pravosudov VV, 2002, BEHAV NEUROSCI, V116, P515, DOI 10.1037//0735-7044.116.4.515; Reboreda JC, 1996, NEUROREPORT, V7, P505, DOI 10.1097/00001756-199601310-00031; Roth TC, 2010, PHILOS T R SOC B, V365, P915, DOI 10.1098/rstb.2009.0208; Roth TC, 2009, P R SOC B, V276, P401, DOI 10.1098/rspb.2008.1184; SHERRY D, 1982, Z TIERPSYCHOL, V58, P153; SHERRY DF, 1981, ANIM BEHAV, V29, P1260, DOI 10.1016/S0003-3472(81)80078-4; SHERRY DF, 1989, BEHAV NEUROSCI, V103, P308, DOI 10.1037/0735-7044.103.2.308; SHERRY DF, 1989, BRAIN BEHAV EVOLUT, V34, P308, DOI 10.1159/000116516; SHERRY DF, 1992, TRENDS NEUROSCI, V15, P298, DOI 10.1016/0166-2236(92)90080-R; Sherry DF, 1993, P NATL ACAD SCI USA, V90, P7893; SHETTLEWORTH SJ, 1982, J EXP PSYCHOL ANIM B, V8, P354, DOI 10.1037/0097-7403.8.4.354; SHETTLEWORTH SJ, 1995, BEHAV BRAIN RES NATU, P159; Smulders TV, 2010, PHILOS T R SOC B, V365, P883, DOI 10.1098/rstb.2009.0211; Smulders TV, 2000, J NEUROBIOL, V44, P414, DOI 10.1002/1097-4695(20000915)44:4<414::AID-NEU4>3.0.CO;2-I; Sokal RR, 1995, BIOMETRY; Temeles EJ, 2005, AUK, V122, P187, DOI 10.1642/0004-8038(2005)122[0187:FATEOS]2.0.CO;2; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; Ward BJ, 2012, BIOL LETTERS, V8, P657, DOI 10.1098/rsbl.2011.1180; [No title captured]	49	16	16	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90165	10.1371/journal.pone.0090165	http://dx.doi.org/10.1371/journal.pone.0090165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599049	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400052
J	Hartcher-O'Brien, J; Di Luca, M; Ernst, MO				Hartcher-O'Brien, Jess; Di Luca, Massimiliano; Ernst, Marc O.			The Duration of Uncertain Times: Audiovisual Information about Intervals Is Integrated in a Statistically Optimal Fashion	PLOS ONE			English	Article							TEMPORAL DISCRIMINATION; NEURAL MECHANISMS; PERCEPTION; CHANNELS; VISION; TICK	Often multisensory information is integrated in a statistically optimal fashion where each sensory source is weighted according to its precision. This integration scheme isstatistically optimal because it theoretically results in unbiased perceptual estimates with the highest precisionpossible. There is a current lack of consensus about how the nervous system processes multiple sensory cues to elapsed time. In order to shed light upon this, we adopt a computational approach to pinpoint the integration strategy underlying duration estimationof audio/visual stimuli. One of the assumptions of our computational approach is that the multisensory signals redundantly specify the same stimulus property. Our results clearly show that despite claims to the contrary, perceived duration is the result of an optimal weighting process, similar to that adopted for estimates of space. That is, participants weight the audio and visual information to arrive at the most precise, single duration estimate possible. The work also disentangles how different integration strategies - i.e. consideringthe time of onset/offset ofsignals - might alter the final estimate. As such we provide the first concrete evidence of an optimal integration strategy in human duration estimates.	[Hartcher-O'Brien, Jess; Di Luca, Massimiliano; Ernst, Marc O.] Max Planck Inst Biol Cybernet, Multisensory Percept & Act Grp, D-72076 Tubingen, Germany; [Hartcher-O'Brien, Jess; Ernst, Marc O.] Univ Bielefeld, Cognit Neurosci Dept, D-33615 Bielefeld, Germany; [Hartcher-O'Brien, Jess; Ernst, Marc O.] Univ Bielefeld, Cognit Interact Technol Ctr Excellence, D-33615 Bielefeld, Germany; [Di Luca, Massimiliano] Univ Birmingham, Ctr Computat Neurosci & Cognit Robot, Birmingham, W Midlands, England; [Di Luca, Massimiliano] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Ernst, Marc O.] Bernstein Ctr Computat Neurosci, Tubingen, Germany	Max Planck Society; University of Bielefeld; University of Bielefeld; University of Birmingham; University of Birmingham	Hartcher-O'Brien, J (corresponding author), Max Planck Inst Biol Cybernet, Multisensory Percept & Act Grp, Spemannstr 38, D-72076 Tubingen, Germany.	hartcher@limsi.fr	Di Luca, Massimiliano/A-7850-2012	Di Luca, Massimiliano/0000-0003-3085-7251; Ernst, Marc/0000-0003-4197-8569	Max Planck Institute for biological cybernetics	Max Planck Institute for biological cybernetics	JHO was supported by a stipend from the Max Planck Institute for biological cybernetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN LG, 1974, PERCEPT PSYCHOPHYS, V16, P26, DOI 10.3758/BF03203244; Angrilli A, 1997, PERCEPT PSYCHOPHYS, V59, P972, DOI 10.3758/BF03205512; Ayhan I, 2011, J VISION, V11, DOI 10.1167/11.7.22; Balci F, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00056; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; Burr D, 2007, NAT NEUROSCI, V10, P423, DOI 10.1038/nn1874; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Cass J, 2006, VISION RES, V46, P2859, DOI 10.1016/j.visres.2006.02.015; CHURCH RM, 1984, ANN NY ACAD SCI, V423, P566, DOI 10.1111/j.1749-6632.1984.tb23459.x; Cicchini GM, 2012, J NEUROSCI, V32, P1056, DOI 10.1523/JNEUROSCI.3411-11.2012; Clark J.J., 1990, DATA FUSION SENSORY; Di Luca M, 2009, J VISION, V9, DOI 10.1167/9.12.7; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Gallistel CR, 2009, PSYCHOL REV, V116, P439, DOI 10.1037/a0015251; Gamache PL, 2010, EUR J NEUROSCI, V31, P1908, DOI 10.1111/j.1460-9568.2010.07197.x; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Gorea A, 2011, J PHYSIOL-PARIS, V105, P153, DOI 10.1016/j.jphysparis.2011.09.008; Grondin S, 2001, PSYCHOL BULL, V127, P22, DOI 10.1037//0033-2909.127.1.22; Hartcher-O'Brien J, 2011, J EXP PSYCHOL HUMAN, V37, P1383, DOI 10.1037/a0024234; Heron J, 2012, P ROY SOC B-BIOL SCI, V279, P690, DOI 10.1098/rspb.2011.1131; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Klink PC, 2011, ATTEN PERCEPT PSYCHO, V73, P219, DOI 10.3758/s13414-010-0010-9; LEGGE GE, 1980, J OPT SOC AM, V70, P1458, DOI 10.1364/JOSA.70.001458; Ley I, 2009, J EXP PSYCHOL HUMAN, V35, P1005, DOI 10.1037/a0015021; Maij F, 2009, J NEUROPHYSIOL, V102, P490, DOI 10.1152/jn.91253.2008; Matell MS, 2000, BIOESSAYS, V22, P94, DOI 10.1002/(SICI)1521-1878(200001)22:1<94::AID-BIES14>3.0.CO;2-E; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; Oruc I, 2003, VISION RES, V43, P2451, DOI 10.1016/S0042-6989(03)00435-8; Park J, 2003, EXP BRAIN RES, V149, P527, DOI 10.1007/s00221-003-1376-x; STROMEYER CF, 1974, VISION RES, V14, P1409, DOI 10.1016/0042-6989(74)90016-9; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Ulrich R, 2006, PERCEPT PSYCHOPHYS, V68, P1140, DOI 10.3758/BF03193716; Wiener M, 2011, FRONTIERS INTEGRATIV, V5, P1, DOI DOI 10.3389/FNINT2011.00031/ABSTRACT; Xuan B, 2007, J VISION, V7, DOI 10.1167/7.10.2; Yarrow K, 2001, NATURE, V414, P302, DOI 10.1038/35104551	37	37	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89339	10.1371/journal.pone.0089339	http://dx.doi.org/10.1371/journal.pone.0089339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594578	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500013
J	Kim, WC; Ma, CA; Li, WM; Chohan, M; Wilson, DM; Lee, CH				Kim, Wan Cheol; Ma, Conan; Li, Wai-Ming; Chohan, Manbir; Wilson, David M., III; Lee, Chow H.			Altered Endoribonuclease Activity of Apurinic/Apyrimidinic Endonuclease 1 Variants Identified in the Human Population	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; EXCISION-REPAIR PATHWAY; DNA-REPAIR; GENETIC POLYMORPHISMS; CANCER-RISK; BREAST-CANCER; MESSENGER-RNA; APE1; APE1/REF-1; SITE	Apurinic/apyrimidinic endonuclease 1 (APE1) is the major mammalian enzyme in the DNA base excision repair pathway and cleaves the DNA phosphodiester backbone immediately 5' to abasic sites. APE1 also has 3'-5' DNA exonuclease and 3' DNA phosphodiesterase activities, and regulates transcription factor DNA binding through its redox regulatory function. The human APE1 has recently been shown to endonucleolytically cleave single-stranded regions of RNA. Towards understanding the biological significance of the endoribonuclease activity of APE1, we examined eight different amino acid substitution variants of APE1 previously identified in the human population. Our study shows that six APE1 variants, D148E, Q51H, I64V, G241R, R237A, and G306A, exhibit a 76-85% reduction in endoribonuclease activity against a specific coding region of the c-myc RNA, yet fully retain the ability to cleave apurinic/apyrimidinic DNA. We found that two APE1 variants, L104R and E126D, exhibit a unique RNase inhibitor-resistant endoribonuclease activity, where the proteins cleave c-myc RNA 3' of specific single-stranded guanosine residues. Expression of L104R and E126D APE1 variants in bacterial Origami cells leads to a 60-80% reduction in colony formation and a 1.5-fold increase in cell doubling time, whereas the other variants, which exhibit diminished endoribonuclease activity, had no effect. These data indicate that two human APE1 variants exhibit a unique endoribonuclease activity, which correlates with their ability to induce cytotoxicity or slow down growth in bacterial cells and supports the notion of their biological functionality.	[Kim, Wan Cheol; Ma, Conan; Li, Wai-Ming; Chohan, Manbir; Lee, Chow H.] Univ British Columbia, Chem Program, Prince George, BC, Canada; [Wilson, David M., III] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA	University of British Columbia; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Lee, CH (corresponding author), Univ British Columbia, Chem Program, Prince George, BC, Canada.	chow.lee@unbc.ca	Wilson, David M/AAK-5409-2021	Wilson, David M/0000-0002-8945-0395; Kim, Wan/0000-0002-6788-8986	Natural Sciences & Engineering Research Council [227158]; Intramural Research Program at the NIH, National Institute on Aging	Natural Sciences & Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Intramural Research Program at the NIH, National Institute on Aging	This research was supported by a Discovery Grant (#227158) from Natural Sciences & Engineering Research Council to CHL, and in part by the Intramural Research Program at the NIH, National Institute on Aging to DMWIII. The funders had no role in study design, decision to publish, or preparation of the manuscript.	Barnes T, 2009, NUCLEIC ACIDS RES, V37, P3946, DOI 10.1093/nar/gkp275; Berquist BR, 2008, J MOL BIOL, V379, P17, DOI 10.1016/j.jmb.2008.03.053; Chang JS, 2009, CARCINOGENESIS, V30, P78, DOI 10.1093/carcin/bgn261; Gu DY, 2009, MUTAGENESIS, V24, P507, DOI 10.1093/mutage/gep036; Hadi MZ, 2000, NUCLEIC ACIDS RES, V28, P3871, DOI 10.1093/nar/28.20.3871; Hayward C, 1999, NEUROLOGY, V52, P1899, DOI 10.1212/WNL.52.9.1899; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Illuzzi J. L., 2013, PLOS ONE, DOI [10.1371/journal.pone.0065922, DOI 10.1371/J0URNAL.P0NE.0065922]; Kim WC, 2011, J MOL BIOL, V411, P960, DOI 10.1016/j.jmb.2011.06.050; Kim Wan-Cheol, 2010, Int J Biochem Mol Biol, V1, P12; Li MX, 2014, ANTIOXID REDOX SIGN, V20, P678, DOI 10.1089/ars.2013.5492; Li WM, 2010, FEBS J, V277, P627, DOI 10.1111/j.1742-4658.2009.07488.x; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Olkowski ZL, 1998, NEUROREPORT, V9, P239, DOI 10.1097/00001756-199801260-00012; Smith BD, 2006, J MOL BIOL, V362, P459, DOI 10.1016/j.jmb.2006.07.020; Smith TR, 2008, CARCINOGENESIS, V29, P2132, DOI 10.1093/carcin/bgn193; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Tomkins A, 2000, NEUROREPORT, V11, P1695, DOI 10.1097/00001756-200006050-00020; Vascotto C, 2009, MOL CELL BIOL, V29, P1834, DOI 10.1128/MCB.01337-08; Wang ML, 2010, DNA CELL BIOL, V29, P303, DOI 10.1089/dna.2009.0969; Wilson DM, 2011, MUTAT RES-FUND MOL M, V711, P100, DOI 10.1016/j.mrfmmm.2010.12.004; Zhang YW, 2006, CANCER EPIDEM BIOMAR, V15, P353, DOI 10.1158/1055-9965.EPI-05-0653	22	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90837	10.1371/journal.pone.0090837	http://dx.doi.org/10.1371/journal.pone.0090837			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595156	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500104
J	Lagranha, VL; Matte, U; de Carvalho, TG; Seminotti, B; Pereira, CC; Koeller, DM; Woontner, M; Goodman, SI; de Souza, DOG; Wajner, M				Lagranha, Valeska Lizzi; Matte, Ursula; de Carvalho, Talita Giacomet; Seminotti, Bianca; Pereira, Carolina Coffi; Koeller, David M.; Woontner, Michael; Goodman, Stephen I.; Gomes de Souza, Diogo Onofre; Wajner, Moacir			Increased Glutamate Receptor and Transporter Expression in the Cerebral Cortex and Striatum of Gcdh(-/-) Mice: Possible Implications for the Neuropathology of Glutaric Acidemia Type I	PLOS ONE			English	Article							METHYL-D-ASPARTATE; ACIDURIA TYPE-I; DEHYDROGENASE DEFICIENT MICE; MESSENGER-RNA EXPRESSION; EXCITATORY AMINO-ACIDS; 3-HYDROXYGLUTARIC ACID; OXIDATIVE STRESS; PLASMA-MEMBRANES; NMDA RECEPTORS; RAT-BRAIN	We determined mRNA expression of the ionotropic glutamate receptors NMDA (NR1, NR2A and NR2B subunits), AMPA (GluR2 subunit) and kainate (GluR6 subunit), as well as of the glutamate transporters GLAST and GLT1 in cerebral cortex and striatum of wild type (WT) and glutaryl-CoA dehydrogenase deficient (Gchh(-/-)) mice aged 7, 30 and 60 days. The protein expression levels of some of these membrane proteins were also measured. Overexpression of NR2A and NR2B in striatum and of GluR2 and GluR6 in cerebral cortex was observed in 7-day-old Gcdh(-/-). There was also an increase of mRNA expression of all NMDA subunits in cerebral cortex and of NR2A and NR2B in striatum of 30-day-old Gcdh(-/-) mice. At 60 days of life, all ionotropic receptors were overexpressed in cerebral cortex and striatum of Gcdh(-/-) mice. Higher expression of GLAST and GLT1 transporters was also verified in cerebral cortex and striatum of Gcdh(-/-) mice aged 30 and 60 days, whereas at 7 days of life GLAST was overexpressed only in striatum from this mutant mice. Furthermore, high lysine intake induced mRNA overexpression of NR2A, NR2B and GLAST transcripts in striatum, as well as of GluR2 and GluR6 in both striatum and cerebral cortex of Gcdh(-/-) mice. Finally, we found that the protein expression of NR2A, NR2B, GLT1 and GLAST were significantly greater in cerebral cortex of Gcdh(-/-) mice, whereas NR2B and GLT1 was similarly enhanced in striatum, implying that these transcripts were translated into their products. These results provide evidence that glutamate receptor and transporter expression is higher in Gcdh(-/-) mice and that these alterations may be involved in the pathophysiology of GA I and possibly explain, at least in part, the vulnerability of striatum and cerebral cortex to injury in patients affected by GA I.	[Lagranha, Valeska Lizzi; Seminotti, Bianca; Pereira, Carolina Coffi; Gomes de Souza, Diogo Onofre; Wajner, Moacir] Univ Fed Rio Grande do Sul, Dept Bioquim, Inst Ciencias Basicas Saude, Porto Alegre, RS, Brazil; [Matte, Ursula; de Carvalho, Talita Giacomet] Hosp Clin Porto Alegre, Ctr Terapia Genica, Ctr Pesquisas Expt, Porto Alegre, RS, Brazil; [Koeller, David M.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Koeller, David M.] Oregon Hlth & Sci Univ, Dept Mol Genet, Portland, OR 97201 USA; [Koeller, David M.] Oregon Hlth & Sci Univ, Dept Med Genet, Portland, OR 97201 USA; [Woontner, Michael; Goodman, Stephen I.] Univ Colorado Denver, Sch Med, Aurora, CO USA; [Wajner, Moacir] Hosp Clin Porto Alegre, Serv Genet Med, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Wajner, M (corresponding author), Univ Fed Rio Grande do Sul, Dept Bioquim, Inst Ciencias Basicas Saude, Porto Alegre, RS, Brazil.	mwajner@ufrgs.br	Matte, Ursula/J-4589-2012; Souza, Diogo O/J-8894-2014; Wajner, Moacir/K-8763-2015; Da Silveira Matte umatte, Ursula/U-3912-2019; Seminotti, Bianca/U-2869-2019	Souza, Diogo O/0000-0002-4322-0404; Wajner, Moacir/0000-0001-6372-1807; Da Silveira Matte umatte, Ursula/0000-0003-4977-6662; Seminotti, Bianca/0000-0002-9803-7746	CNPq; PRONEX II; FIPE-HCPA; FAPERGS; PROPESQ/UFRGS; FINEP research grant Rede Instituto Brasileiro deNeurociencia (IBN-Net) [01.06.0842-00]; Instituto Nacional de Ciencia eTecnologia - Excitotoxicidade e Neuroprotecao (INCT-EN)	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PRONEX II; FIPE-HCPA; FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); PROPESQ/UFRGS; FINEP research grant Rede Instituto Brasileiro deNeurociencia (IBN-Net); Instituto Nacional de Ciencia eTecnologia - Excitotoxicidade e Neuroprotecao (INCT-EN)	This work was supported by grants from CNPq, PRONEX II, FIPE-HCPA, FAPERGS, PROPESQ/UFRGS and FINEP research grant Rede Instituto Brasileiro deNeurociencia (IBN-Net) # 01.06.0842-00, and Instituto Nacional de Ciencia eTecnologia - Excitotoxicidade e Neuroprotecao (INCT-EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Aida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036853; AKAZAWA C, 1994, J COMP NEUROL, V347, P150, DOI 10.1002/cne.903470112; Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; Amaral AU, 2012, MOL GENET METAB, V107, P375, DOI 10.1016/j.ymgme.2012.08.016; Amaral AU, 2012, MOL GENET METAB, V107, P81, DOI 10.1016/j.ymgme.2012.04.015; Arzberger T, 1997, J NEUROPATH EXP NEUR, V56, P440, DOI 10.1097/00005072-199704000-00013; Barbon A, 2011, BIOCHEMISTRY-MOSCOW+, V76, P882, DOI 10.1134/S0006297911080037; Bjugstad KB, 2001, J INHERIT METAB DIS, V24, P631, DOI 10.1023/A:1012706908779; Blanke ML, 2009, FRONT NEUROSCI, P283; Bodamer OA, 2004, J INHERIT METAB DIS, V27, P877, DOI 10.1023/B:BOLI.0000045772.09776.e0; Clinton SM, 2006, J NEUROCHEM, V98, P1114, DOI 10.1111/j.1471-4159.2006.03954.x; Colwell CS, 1998, DEV NEUROSCI-BASEL, V20, P154, DOI 10.1159/000017310; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dalcin KB, 2007, CELL MOL NEUROBIOL, V27, P805, DOI 10.1007/s10571-007-9197-2; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Das AM, 2003, MOL GENET METAB, V78, P108, DOI 10.1016/S1096-7192(02)00227-5; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Duan SM, 1999, J NEUROSCI, V19, P10193; ERECINSKA M, 1994, PROG NEUROBIOL, V43, P37, DOI 10.1016/0301-0082(94)90015-9; Erecinska M, 2004, PROG NEUROBIOL, V73, P397, DOI 10.1016/j.pneurobio.2004.06.003; FAROOQUI AA, 1994, J NEUROSCI RES, V38, P6, DOI 10.1002/jnr.490380103; Ferreira GD, 2005, INT J DEV NEUROSCI, V23, P687, DOI 10.1016/j.ijdevneu.2005.08.003; Fighera MR, 2006, NEUROBIOL DIS, V22, P611, DOI 10.1016/j.nbd.2006.01.002; FlottRahmel B, 1997, J INHERIT METAB DIS, V20, P387, DOI 10.1023/A:1005342331229; Forstner R, 1999, PEDIATR RADIOL, V29, P138, DOI 10.1007/s002470050558; Freudenberg F, 2004, NEUROBIOL DIS, V16, P581, DOI 10.1016/j.nbd.2004.05.001; Frizzo MES, 2004, NEUROCHEM INT, V44, P345, DOI 10.1016/S0197-0186(03)00169-4; Funk CBR, 2005, BRAIN, V128, P711, DOI 10.1093/brain/awh401; Furuta A, 1997, J NEUROSCI, V17, P8363; GOODMAN SI, 1977, J PEDIATR-US, V90, P746, DOI 10.1016/S0022-3476(77)81240-7; Goodman SI, 2001, METABOLIC MOL BASIS, P1971; Haberny KA, 2002, TOXICOL SCI, V68, P9, DOI 10.1093/toxsci/68.1.9; Harting I, 2009, BRAIN, V132, P1764, DOI 10.1093/brain/awp112; Hedlund GL, 2006, AM J MED GENET C, V142C, P86, DOI 10.1002/ajmg.c.30088; Henson MA, 2008, CEREB CORTEX, V18, P2560, DOI 10.1093/cercor/bhn017; Hoffmann GF, 1999, J INHERIT METAB DIS, V22, P381, DOI 10.1023/A:1005543904484; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; INSEL TR, 1990, NEUROSCIENCE, V35, P31, DOI 10.1016/0306-4522(90)90117-M; Jafari P, 2011, MOL GENET METAB, V104, P425, DOI 10.1016/j.ymgme.2011.08.027; Jensen FE, 2002, INT J DEV NEUROSCI, V20, P339, DOI 10.1016/S0736-5748(02)00012-6; Koeller DM, 2002, HUM MOL GENET, V11, P347, DOI 10.1093/hmg/11.4.347; Kolker S, 2000, J INHERIT METAB DIS, V23, P359, DOI 10.1023/A:1005683314525; Kolker S, 2004, J INHERIT METAB DIS, V27, P805, DOI 10.1023/B:BOLI.0000045762.37248.28; Kolker S, 1999, J INHERIT METAB DIS, V22, P259; Kolker S, 2000, PEDIATR RES, V47, P495; Kolker S, 2002, PEDIATR RES, V52, DOI 10.1203/01.PDR.0000023176.89966.45; Kolker S, 2000, AMINO ACIDS, V18, P31, DOI 10.1007/s007260050003; Kolker S, 2002, J NEUROSCI RES, V68, P424, DOI 10.1002/jnr.10187; Latini A, 2005, J INHERIT METAB DIS, V28, P57, DOI 10.1007/s10545-005-3677-7; Latini A, 2002, BRAIN RES, V956, P367, DOI 10.1016/S0006-8993(02)03573-4; Latini A, 2007, CELL MOL NEUROBIOL, V27, P423, DOI 10.1007/s10571-006-9134-9; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lima TTF, 1998, BRAIN RES, V802, P55, DOI 10.1016/S0006-8993(98)00563-0; Lindner M, 2004, J INHERIT METAB DIS, V27, P851, DOI 10.1023/B:BOLI.0000045769.96657.af; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lund TM, 2004, J NEUROSCI RES, V77, P143, DOI 10.1002/jnr.20136; Maragakis NJ, 2001, ARCH NEUROL-CHICAGO, V58, P365, DOI 10.1001/archneur.58.3.365; Marques FD, 2003, BRAIN RES, V964, P153, DOI 10.1016/S0006-8993(02)04118-5; Matsuda K, 2003, J NEUROSCI, V23, P10064; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; Miyamoto K, 2001, BRAIN RES, V901, P252, DOI 10.1016/S0006-8993(01)02281-8; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MORTON DH, 1991, AM J MED GENET, V41, P89, DOI 10.1002/ajmg.1320410122; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Nansen EA, 2000, DEV NEUROSCI-BASEL, V22, P329, DOI 10.1159/000017457; Neumaier-Probst E, 2004, J INHERIT METAB DIS, V27, P869, DOI 10.1023/B:BOLI.0000045771.66300.2a; NOVELLI A, 1988, BRAIN RES, V451, P205, DOI 10.1016/0006-8993(88)90765-2; OLNEY JW, 1969, J NEUROPATH EXP NEUR, V28, P455, DOI 10.1097/00005072-196907000-00007; Ozawa S, 1998, Tanpakushitsu Kakusan Koso, V43, P1589; Pei DS, 2006, BRAIN, V129, P465, DOI 10.1093/brain/awh700; Perez-Duenas B, 2009, EUR J PAEDIATR NEURO, V13, P534, DOI 10.1016/j.ejpn.2008.12.002; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Porciuncula LO, 2000, J NEUROL SCI, V173, P93, DOI 10.1016/S0022-510X(99)00307-X; Porciuncula LO, 2004, NEUROCHEM INT, V45, P1075, DOI 10.1016/j.neuint.2004.05.002; Rosa RB, 2004, NEUROCHEM INT, V45, P1087, DOI 10.1016/j.neuint.2004.05.001; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; SATOH E, 1992, J NEUROCHEM, V58, P1038, DOI 10.1111/j.1471-4159.1992.tb09359.x; Sauer SW, 2006, J NEUROCHEM, V97, P899, DOI 10.1111/j.1471-4159.2006.03813.x; Seminotti B, 2013, MOL GENET METAB, V108, P30, DOI 10.1016/j.ymgme.2012.11.001; Seminotti B, 2012, MOL GENET METAB, V106, P31, DOI 10.1016/j.ymgme.2012.03.002; Spalloni A, 2013, BBA-MOL BASIS DIS, V1832, P312, DOI 10.1016/j.bbadis.2012.11.013; Strauss KA, 2003, AM J MED GENET C, V121C, P38, DOI 10.1002/ajmg.c.20007; Strauss KA, 2003, AM J MED GENET C, V121C, P53, DOI 10.1002/ajmg.c.20008; Swanson RA, 1997, J NEUROSCI, V17, P932; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Ullensvang K, 1997, EUR J NEUROSCI, V9, P1646, DOI 10.1111/j.1460-9568.1997.tb01522.x; Ullrich K, 1999, J INHERIT METAB DIS, V22, P392, DOI 10.1023/A:1005595921323; Wajner M, 2004, J INHERIT METAB DIS, V27, P825, DOI 10.1023/B:BOLI.0000045765.37043.fb; Wajner M, 2004, J INHERIT METAB DIS, V27, P427, DOI 10.1023/B:BOLI.0000037353.13085.e2; Wajner M, 2011, J BIOENERG BIOMEMBR, V43, P31, DOI 10.1007/s10863-011-9324-0; Wang Y, 2010, APOPTOSIS, V15, P1382, DOI 10.1007/s10495-010-0481-0; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N; Wroge CM, 2012, J NEUROSCI, V32, P6732, DOI 10.1523/JNEUROSCI.6371-11.2012; Zinnanti WJ, 2007, J CLIN INVEST, V117, P3258, DOI 10.1172/JCI31617; Zinnanti WJ, 2006, BRAIN, V129, P899, DOI 10.1093/brain/awl009	99	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90477	10.1371/journal.pone.0090477	http://dx.doi.org/10.1371/journal.pone.0090477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594605	Green Submitted, Green Published, gold			2022-12-27	WOS:000332475500057
J	O'Neill, DG; Church, DB; McGreevy, PD; Thomson, PC; Brodbelt, DC				O'Neill, Dan G.; Church, David B.; McGreevy, Paul D.; Thomson, Peter C.; Brodbelt, Dave C.			Prevalence of Disorders Recorded in Dogs Attending Primary-Care Veterinary Practices in England	PLOS ONE			English	Article							INHERITED DISORDERS; PUREBRED DOGS; PEDIGREE DOGS; DISEASE SURVEILLANCE; COMPANION ANIMALS; ATOPIC-DERMATITIS; SELECTION BIAS; INSURANCE DATA; REFERRAL BIAS; INSURED DOGS	Purebred dog health is thought to be compromised by an increasing occurence of inherited diseases but inadequate prevalence data on common disorders have hampered efforts to prioritise health reforms. Analysis of primary veterinary practice clinical data has been proposed for reliable estimation of disorder prevalence in dogs. Electronic patient record (EPR) data were collected on 148,741 dogs attending 93 clinics across central and south-eastern England. Analysis in detail of a random sample of EPRs relating to 3,884 dogs from 89 clinics identified the most frequently recorded disorders as otitis externa (prevalence 10.2%, 95% CI: 9.1-11.3), periodontal disease (9.3%, 95% CI: 8.3-10.3) and anal sac impaction (7.1%, 95% CI: 6.1-8.1). Using syndromic classification, the most prevalent body location affected was the head-and-neck (32.8%, 95% CI: 30.7-34.9), the most prevalent organ system affected was the integument (36.3%, 95% CI: 33.9-38.6) and the most prevalent pathophysiologic process diagnosed was inflammation (32.1%, 95% CI: 29.8-34.3). Among the twenty most-frequently recorded disorders, purebred dogs had a significantly higher prevalence compared with crossbreds for three: otitis externa (P = 0.001), obesity (P = 0.006) and skin mass lesion (P = 0.033), and popular breeds differed significantly from each other in their prevalence for five: periodontal disease (P = 0.002), overgrown nails (P = 0.004), degenerative joint disease (P = 0.005), obesity (P = 0.001) and lipoma (P = 0.003). These results fill a crucial data gap in disorder prevalence information and assist with disorder prioritisation. The results suggest that, for maximal impact, breeding reforms should target commonly-diagnosed complex disorders that are amenable to genetic improvement and should place special focus on at-risk breeds. Future studies evaluating disorder severity and duration will augment the usefulness of the disorder prevalence information reported herein.	[O'Neill, Dan G.; Brodbelt, Dave C.] Univ London Royal Vet Coll, London, England; [Church, David B.] Univ London Royal Vet Coll, Small Anim Med & Surg Grp, London, England; [McGreevy, Paul D.; Thomson, Peter C.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of Sydney	O'Neill, DG (corresponding author), Univ London Royal Vet Coll, London, England.	doneill@rvc.ac.uk	Brodbelt, David C/C-6005-2009; Thomson, Peter/V-7290-2019; O'Neill, Dan Gerard/H-8351-2019	Brodbelt, David C/0000-0001-5628-4194; Thomson, Peter/0000-0003-4428-444X; O'Neill, Dan Gerard/0000-0003-1115-2723; McGreevy, Paul/0000-0001-7220-8378	RSPCA	RSPCA	This study was part of a Ph.D. study that was financially supported by the RSPCA (http://www.rspca.org.uk/sciencegroup/companionanimals). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VJ, 2010, J SMALL ANIM PRACT, V51, P512, DOI 10.1111/j.1748-5827.2010.00974.x; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Albuquerque C, 2012, VET J, V191, P299, DOI 10.1016/j.tvjl.2011.08.017; [Anonymous], 2009, VET REC, V164, P481; [Anonymous], 2013, VET REC, V172, P277; APGAW, 2009, HLTH FUT PED DOGS; Aragon CL, 2005, VET SURG, V34, P93, DOI 10.1111/j.1532-950X.2005.00016.x; Asher L, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-74; Asher L, 2009, VET J, V182, P402, DOI 10.1016/j.tvjl.2009.08.033; Bartlett PC, 2010, PREV VET MED, V94, P264, DOI 10.1016/j.prevetmed.2010.01.007; Bateson P., 2010, INDEPENDENT INQUIRY; BATT RM, 1989, J SMALL ANIM PRACT, V30, P3, DOI 10.1111/j.1748-5827.1989.tb01451.x; BBC, 2008, PED DOGS EXP; Bell J, 2012, CLIN TRUTHS PURE BRE, P22; Bellumori TP, 2013, JAVMA-J AM VET MED A, V242, P1549, DOI 10.2460/javma.242.11.1549; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bonnett BN, 2005, ACTA VET SCAND, V46, P105, DOI 10.1186/1751-0147-46-105; Brady S, 2012, VET J, V193, P522, DOI 10.1016/j.tvjl.2012.01.025; BVA/KC, 2013, HIP DYSPL SCHEM; BVA/KC, 2013, ELB SCHEM; BVA/KC, 2013, CHIAR MALF SYRING SC; BVA/KC/ISS, 2013, EYE SCHEM; Calboli FCF, 2008, GENETICS, V179, P593, DOI 10.1534/genetics.107.084954; CAWC, 2006, BREED WELF COMP AN W; Chodick G, 2007, ANN EPIDEMIOL, V17, P106, DOI 10.1016/j.annepidem.2006.06.004; Collins LM, 2010, ANIM WELFARE, V19, P67; Collins LM, 2011, VET J, V189, P147, DOI 10.1016/j.tvjl.2011.06.012; Crispin S, 2011, VET REC, V168, P53, DOI 10.1136/vr.c4949; Dank G, 2012, J SMALL ANIM PRACT, V53, P679, DOI 10.1111/j.1748-5827.2012.01296.x; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; Edney ATB., 1997, OBSERVATIONAL STUDY; Egenvall A, 1998, PREV VET MED, V36, P51, DOI 10.1016/S0167-5877(98)00073-7; Egenvall A, 2000, VET REC, V146, P519, DOI 10.1136/vr.146.18.519; Egenvall A, 2000, VET REC, V146, P551, DOI 10.1136/vr.146.19.551; Egenvall A, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-42; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Fleming JM, 2011, J VET INTERN MED, V25, P187, DOI 10.1111/j.1939-1676.2011.0695.x; Friedmann E, 2009, VET CLIN N AM-SMALL, V39, P293, DOI 10.1016/j.cvsm.2008.10.015; FROOM P, 1992, THEOR MED, V13, P255, DOI 10.1007/BF00489202; German AJ, 2003, J VET INTERN MED, V17, P8, DOI 10.1111/j.1939-1676.2003.tb01318.x; German AJ, 2006, J NUTR, V136, p1940S, DOI 10.1093/jn/136.7.1940S; Glickman L, 2012, NATL COMPANION ANIMA; Gobar GM, 1998, J AM VET MED ASSOC, V213, P251; Gough A., 2010, BREED PREDISPOSITION; Greenland S, 2008, INT J EPIDEMIOL, V37, P430, DOI 10.1093/ije/dyn064; Group TVC, 2013, VENOM VET NOM; HEIN H. E., 1963, Journal of Small Animal Practice, V4, P457, DOI 10.1111/j.1748-5827.1963.tb01302.x; Hillier A, 2001, VET IMMUNOL IMMUNOP, V81, P147, DOI 10.1016/S0165-2427(01)00296-3; HODGMAN S. F. J., 1963, Journal of Small Animal Practice, V4, P447, DOI 10.1111/j.1748-5827.1963.tb01301.x; Houlton JEF, 2008, VET COMP ORTHOPAED, V21, P231; Hudson JI, 2005, EPIDEMIOLOGY, V16, P355, DOI 10.1097/01.ede.0000158224.50593.e3; Indrebo A, 2007, ACTA VET SCANDIN SS6, V50, pS6; Irion DN, 2003, J HERED, V94, P81, DOI 10.1093/jhered/esg004; John U, 1999, ALCOHOL ALCOHOLISM, V34, P786, DOI 10.1093/alcalc/34.5.786; Kathrani A, 2011, VET REC, V169, P635, DOI 10.1136/vr.d5380; KC, 2013, DNA SCREEN SCHEM RES; Kearsley-Fleet L, 2013, VET REC, V172, DOI 10.1136/vr.101133; Kirkwood BR, 2003, ESSENTIAL MED STAT; KNIGHT G. C., 1963, Journal of Small Animal Practice, V4, P463, DOI 10.1111/j.1748-5827.1963.tb01303.x; Leroy G, 2011, VET J, V189, P177, DOI 10.1016/j.tvjl.2011.06.016; Lewis TW, 2010, ANIM WELFARE, V19, P93; Lewis T. W., 2010, PLOS ONE, V5; Lewis TW, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-16; Lewis T, 2011, VET J, V188, P73, DOI 10.1016/j.tvjl.2010.02.016; Lober WB, 2002, J AM MED INFORM ASSN, V9, P105, DOI 10.1197/jamia.M1052; Lourenco-Martins AM, 2011, VET OPHTHALMOL, V14, P248, DOI 10.1111/j.1463-5224.2011.00874.x; Lund EM, 1999, J AM VET MED ASSOC, V214, P1336; Lund EM, 1997, DEV EVALUATION MODEL; Mandl KD, 2004, J AM MED INFORM ASSN, V11, P141, DOI 10.1197/jamia.M1356; Marsella R, 2009, J INVEST DERMATOL, V129, P2351, DOI 10.1038/jid.2009.98; McGreevy PD, 2007, ANIM WELFARE, V16, P125; McGreevy PD, 1999, ANIM WELFARE, V8, P329; McMillan FD, 2001, J AM VET MED ASSOC, V219, P1204, DOI 10.2460/javma.2001.219.1204; Medivet, 2014, MED VET PARTN; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Mellersh C, 2012, MAMM GENOME, V23, P109, DOI 10.1007/s00335-011-9365-z; Mellersh CS, 1997, ADV VET MED-ACAD PR, V40, P191; Mountziaris PM, 2011, TISSUE ENG PART B-RE, V17, P393, DOI [10.1089/ten.teb.2011.0182, 10.1089/ten.TEB.2011.0182]; Murray JK, 2010, VET REC, V166, P163, DOI 10.1136/vr.b4712; Neff MW, 2006, CELL, V124, P229, DOI 10.1016/j.cell.2006.01.008; Nelson R.W., 2004, SMALL ANIMAL CLIN DI, V4th, P165; Neuber A., 2009, UK Vet: Companion Animal, V14, P56, DOI 10.1111/j.2044-3862.2009.tb00386.x; NOAH, 2013, FACTS FIG UK AN MED; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Packer RMA, 2012, ANIM WELFARE, V21, P81, DOI 10.7120/096272812X13345905673809; Page GP, 2003, AM J HUM GENET, V73, P711, DOI 10.1086/378900; Pearce N, 2007, OCCUP ENVIRON MED, V64, P562, DOI 10.1136/oem.2006.026690; Pedersen HD, 2000, CARDIOVASC RES, V47, P234, DOI 10.1016/S0008-6363(00)00113-9; Platt S, 2006, J VET INTERN MED, V20, P1355, DOI 10.1892/0891-6640(2006)20[1355:POUABD]2.0.CO;2; Powers MY, 2010, JAVMA-J AM VET MED A, V237, P532, DOI 10.2460/javma.237.5.532; Rand JS, 2004, J NUTR, V134, p2072S, DOI 10.1093/jn/134.8.2072S; Rooney N, 2008, PEDIGREE DOG BREEDIN; Rooney NJ, 2010, ANIM WELFARE, V19, P133; Rooney NJ, 2009, J VET BEHAV, V4, P180, DOI 10.1016/j.jveb.2009.06.002; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Rust MK, 2005, TRENDS PARASITOL, V21, P232, DOI 10.1016/j.pt.2005.03.010; Scott DW., 2001, MULLER KIRKS SMALL A, P996; SLATER MR, 1992, PREV VET MED, V13, P77, DOI 10.1016/0167-5877(92)90092-T; SLEATOR DD, 1983, J COMPUT SYST SCI, V26, P362, DOI 10.1016/0022-0000(83)90006-5; Smith FJD, 2003, AM J CLIN DERMATOL, V4, P347, DOI 10.2165/00128071-200304050-00005; Soll-Johanning H, 2004, DAN MED BULL, V51, P207; Starkey Mike P., 2005, Briefings in Functional Genomics & Proteomics, V4, P112; Stone AB, 2008, ZOONOSES PUBLIC HLTH, V55, P378, DOI 10.1111/j.1863-2378.2008.01129.x; Summers JF, 2010, VET J, V183, P39, DOI 10.1016/j.tvjl.2009.11.002; VetCompass, 2013, VETCOMPASS HLTH SURV; Vilson A, 2013, VET REC, V173, P116, DOI 10.1136/vr.101577; Virues-Ortega JV, 2006, J NERV MENT DIS, V194, P52, DOI 10.1097/01.nmd.0000195354.03653.63; Walsh F, 2009, FAM PROCESS, V48, P462, DOI 10.1111/j.1545-5300.2009.01296.x; Wayne RK, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P279; WILLIS M. B., 1963, Journal of Small Animal Practice, V4, P469, DOI 10.1111/j.1748-5827.1963.tb01305.x; Wilson B, 2011, VET J, V189, P160, DOI 10.1016/j.tvjl.2011.06.014; Wood JLN, 2002, PREV VET MED, V55, P95, DOI 10.1016/S0167-5877(02)00090-9	113	152	155	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90501	10.1371/journal.pone.0090501	http://dx.doi.org/10.1371/journal.pone.0090501			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594665	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500058
J	Tang, D; Zhang, JQ; Yuan, ZX; Gao, J; Wang, S; Ye, NY; Li, P; Gao, SJ; Miao, Y; Wang, DR; Jiang, KR				Tang, Dong; Zhang, Jingqiu; Yuan, Zhongxu; Gao, Jun; Wang, Sen; Ye, Nianyuan; Li, Ping; Gao, Sujun; Miao, Yi; Wang, Daorong; Jiang, Kuirong			Pancreatic Satellite Cells Derived Galectin-1 Increase the Progression and Less Survival of Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							STELLATE CELLS; CANCER CELLS; EXPRESSION; MICROENVIRONMENT; PROLIFERATION; ACTIVATION; PROTEIN; MATRIX; INVASIVENESS; METASTASIS	Background: Galectin-1, a member of carbohydrate-binding proteins with a polyvalent function on tumor progression, was found strongly expressed in pancreatic satellite cells (PSCs), which partner in crime with cancer cells and promote the development of pancreatic ductal adenocarcinoma (PDAC). We evaluated the effects of PSCs derived Galectin-1 on the progression of PDAC, as well as the tumor establishment and development in mouse xenografts. Methods: The relationship between immunohistochemistry staining intensity of Galectin-1 and clinicopathologic variables were assessed in 66 PDAC tissues, 18 chronic pancreatitis tissues and 10 normal controls. The roles of PSCs isolated from PDAC and normal pancreas on the proliferative activity, MMP2 and MMP9 expression, and the invasion of CFPAC-1 in the co-cultured system, as well as on the tumor establishment and development in mouse xenografts by mixed implanting with CFPAC-1 subcutaneously were evaluated. Results: Galectin-1 expression was gradually increased from normal pancreas (negative), chronic pancreatitis (weak) to PDAC (strong), in which Galectin-1 expression was also increased from well, moderately to poorly differentiated PDAC. Galectin-1 staining intensity of pancreatic cancer tissue was associated with increase in tumor size, lymph node metastasis, perineural invasion and differentiation and UICC stage, and served as the independent prognostic indicator of poor survival of pancreatic cancer. In vitro and in vivo experiments indicated that TGF-beta 1 upregulated Galectin-1 expression in PSCs, which could further promotes the proliferative activity, MMP2 and MMP9 expression, and invasion of pancreatic cancer cells, as well as the tumor establishment and growth. Conclusion: Galectin-1 expression in stromal cells of pancreatic cancer suggests that this protein plays a role in the promotion of cancer cells invasion and metastasis and provides a therapeutic target for the treatment of pancreatic cancer.	[Tang, Dong; Gao, Jun; Ye, Nianyuan; Li, Ping; Wang, Daorong] Yang Zhou Univ, Dept Gen Surg, Subei Peoples Hosp Jiangsu Prov, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China; [Zhang, Jingqiu; Gao, Sujun] Yang Zhou Univ, Dept Digest Syst, Subei Peoples Hosp Jiangsu Prov, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China; [Yuan, Zhongxu] Anhui 2 Prov Peoples Hosp, Dept Gen Surg, Hefei, Anhui, Peoples R China; [Wang, Sen] Nanjing Med Univ, Coll Clin Med, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Miao, Yi; Jiang, Kuirong] Nanjing Med Univ, Dept Gen Surg, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; Nanjing Medical University; Nanjing Medical University	Wang, DR (corresponding author), Yang Zhou Univ, Dept Gen Surg, Subei Peoples Hosp Jiangsu Prov, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China.	daorong666@sina.com; jiangkuirong@163.com		Wang, Sen/0000-0001-7179-626X	Postdoctoral Science Foundation of China [2013M530243]; Social Development of Science and Technology Research Projects of Yangzhou City [2012123]	Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Social Development of Science and Technology Research Projects of Yangzhou City	This work is supported by Postdoctoral Science Foundation of China (No. 2013M530243) and Social Development of Science and Technology Research Projects of Yangzhou City (No. 2012123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, LANCET ONCOL, V11, P1107, DOI 10.1016/S1470-2045(10)70281-3; Ansari D, 2010, SCAND J GASTROENTERO, V45, P1022, DOI 10.3109/00365521003734174; Apte MV, 2006, J GASTROEN HEPATOL, V21, pS97, DOI 10.1111/j.1440-1746.2006.04587.x; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bektas S, 2010, PATHOL ONCOL RES, V16, P569, DOI 10.1007/s12253-010-9248-8; Berberat PO, 2001, J HISTOCHEM CYTOCHEM, V49, P539, DOI 10.1177/002215540104900414; Camby I, 2002, J NEUROPATH EXP NEUR, V61, P585, DOI 10.1093/jnen/61.7.585; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Chen R, 2012, CANCER BIOL THER, V13, P899, DOI 10.4161/cbt.20842; Chung JC, 2008, ANZ J SURG, V78, P245, DOI 10.1111/j.1445-2197.2008.04429.x; Daroqui CM, 2007, CANCER IMMUNOL IMMUN, V56, P491, DOI 10.1007/s00262-006-0208-9; Dings RPM, 2010, BIOCONJUGATE CHEM, V21, P20, DOI 10.1021/bc900287y; Fitzner B, 2005, CELL SIGNAL, V17, P1240, DOI 10.1016/j.cellsig.2004.12.012; Gerloff A, 2010, INT J ENV RES PUB HE, V7, P1093, DOI 10.3390/ijerph7031093; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; He JL, 2006, METHOD ENZYMOL, V417, P247, DOI 10.1016/S0076-6879(06)17017-2; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang XH, 2009, PANCREATOLOGY, V9, P165, DOI 10.1159/000178888; Jung EJ, 2007, INT J CANCER, V120, P2331, DOI 10.1002/ijc.22434; Juszczynski P, 2007, P NATL ACAD SCI USA, V104, P13134, DOI 10.1073/pnas.0706017104; Kikuta K, 2010, BIOCHEM BIOPH RES CO, V403, P380, DOI 10.1016/j.bbrc.2010.11.040; Kovacs-Solyom F, 2010, IMMUNOL LETT, V127, P108, DOI 10.1016/j.imlet.2009.10.003; Kuroda T, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-134; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Luo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099016; Masamune A, 2006, AM J PHYSIOL-GASTR L, V290, pG729, DOI 10.1152/ajpgi.00511.2005; Masamune A, 2005, BIOCHEM PHARMACOL, V70, P869, DOI 10.1016/j.bcp.2005.06.008; Masamune A, 2009, GUT, V58, P550, DOI 10.1136/gut.2008.154401; Masamune A, 2008, J GASTROENTEROL, V43, P352, DOI 10.1007/s00535-008-2162-0; Masamune A, 2009, CLIN GASTROENTEROL H, V7, pS48, DOI 10.1016/j.cgh.2009.07.038; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Qiu J, 2008, J CELL BIOCHEM, V104, P1054, DOI 10.1002/jcb.21691; Rabinovich GA, 2005, BRIT J CANCER, V92, P1188, DOI 10.1038/sj.bjc.6602493; Roda O, 2009, GASTROENTEROLOGY, V136, P1379, DOI 10.1053/j.gastro.2008.12.039; Satelli A, 2011, CANCER LETT, V301, P38, DOI 10.1016/j.canlet.2010.10.027; Shen JJ, 2004, CANCER RES, V64, P9018, DOI 10.1158/0008-5472.CAN-04-3262; Sioud M, 2011, SCAND J IMMUNOL, V73, P79, DOI 10.1111/j.1365-3083.2010.02491.x; Spano D, 2010, MOL MED, V16, P102, DOI 10.2119/molmed.2009.00119; Spector I, 2010, PANCREAS, V39, P1008, DOI 10.1097/MPA.0b013e3181da8aa3; Tang D, 2013, INT J CANCER, V132, P993, DOI 10.1002/ijc.27715; Tang D, 2012, INT J CANCER, V130, P2337, DOI 10.1002/ijc.26290; Thijssen VL, 2010, CANCER RES, V70, P6216, DOI 10.1158/0008-5472.CAN-09-4150; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Tripathi P, 2009, INDIAN J HEMATOL BLO, V25, P10, DOI 10.1007/s12288-009-0003-9; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Wang L, 2000, LAB INVEST, V80, P1233, DOI 10.1038/labinvest.3780131; Wu MH, 2009, MOL CANCER RES, V7, P311, DOI 10.1158/1541-7786.MCR-08-0297; Xu ZH, 2010, AM J PATHOL, V177, P2585, DOI 10.2353/ajpath.2010.090899; Xue XF, 2011, PANCREAS, V40, P832, DOI 10.1097/MPA.0b013e318217945e	55	38	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90476	10.1371/journal.pone.0090476	http://dx.doi.org/10.1371/journal.pone.0090476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595374	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500056
J	Torrado, M; Franco, D; Hernandez-Torres, F; Crespo-Leiro, MG; Iglesias-Gil, C; Castro-Beiras, A; Mikhailov, AT				Torrado, Mario; Franco, Diego; Hernandez-Torres, Francisco; Crespo-Leiro, Maria G.; Iglesias-Gil, Carmen; Castro-Beiras, Alfonso; Mikhailov, Alexander T.			Pitx2c Is Reactivated in the Failing Myocardium and Stimulates Myf5 Expression in Cultured Cardiomyocytes	PLOS ONE			English	Article							HEART-FAILURE; MUSCLE DIFFERENTIATION; CELL-PROLIFERATION; EJECTION FRACTION; INTRON RETENTION; PROGENITOR CELLS; GENE-EXPRESSION; RIEGER-SYNDROME; ATRIAL; MYOGENESIS	Background: Pitx2 (paired-like homeodomain 2 transcription factor) is crucial for heart development, but its role in heart failure (HF) remains uncertain. The present study lays the groundwork implicating Pitx2 signalling in different modalities of HF. Methodology/Principal Findings: A variety of molecular, cell-based, biochemical, and immunochemical assays were used to evaluate: (1) Pitx2c expression in the porcine model of diastolic HF (DHF) and in patients with systolic HF (SHF) due to dilated and ischemic cardiomyopathy, and (2) molecular consequences of Pitx2c expression manipulation in cardiomyocytes in vitro. In pigs, the expression of Pitx2c, physiologically downregulated in the postnatal heart, is significantly re-activated in left ventricular (LV) failing myocardium which, in turn, is associated with increased expression of a restrictive set of Pitx2 target genes. Among these, Myf5 was identified as the top upregulated gene. In vitro, forced expression of Pitx2c in cardiomyocytes, but not in skeletal myoblasts, activates Myf5 in dose-dependent manner. In addition, we demonstrate that the level of Pitx2c is upregulated in the LV-myocardium of SHF patients. Conclusions/Significance: The results provide previously unrecognized evidence that Pitx2c is similarly reactivated in postnatal/adult heart at distinct HF phenotypes and suggest that Pitx2c is involved, directly or indirectly, in the regulation of Myf5 expression in cardiomyocytes.	[Torrado, Mario; Castro-Beiras, Alfonso; Mikhailov, Alexander T.] Univ A Coruna, Inst Hlth Sci, La Coruna, Spain; [Franco, Diego; Hernandez-Torres, Francisco] Univ Jaen, Dept Expt Biol, Jaen, Spain; [Crespo-Leiro, Maria G.; Iglesias-Gil, Carmen; Castro-Beiras, Alfonso] Univ Hosp Ctr La Coruna, La Coruna, Spain	Universidade da Coruna; Universidad de Jaen; Complejo Hospitalario Universitario A Coruna	Mikhailov, AT (corresponding author), Univ A Coruna, Inst Hlth Sci, La Coruna, Spain.	a.mikhailov@udc.es	Hernandez-Torres, Francisco/P-1558-2018; IGLESIAS, CARMEN/R-4932-2016	Hernandez-Torres, Francisco/0000-0003-1343-8274; Franco, Diego/0000-0002-5669-7164; Crespo-Leiro, Maria Generosa/0000-0002-3085-167X; Mikhailov, Alexander/0000-0002-1146-4113; Torrado, Mario/0000-0001-9762-7018; IGLESIAS, CARMEN/0000-0002-3131-1181	Institute of Health Sciences; Autonomic Government of Galicia, Spain [GRC 2013/061]; Excellence Project of the Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia [CTS1416]; CNIC-T translactional grant [CNIC-T 2009/08]	Institute of Health Sciences; Autonomic Government of Galicia, Spain; Excellence Project of the Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia; CNIC-T translactional grant	ATM, MT and AC-B were supported by funds from the Institute of Health Sciences and by a grant (GRC 2013/061) from the Autonomic Government of Galicia, Spain. DF and FH-T were supported by Excellence Project of the Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia (grant # CTS1416) and a CNIC-T translactional grant (CNIC-T 2009/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammirabile G, 2012, CARDIOVASC RES, V93, P291, DOI 10.1093/cvr/cvr314; [Anonymous], EUR J HEART FAIL S; Bajard L, 2006, GENE DEV, V20, P2450, DOI 10.1101/gad.382806; BEINLICH CJ, 1995, J MOL CELL CARDIOL, V27, P273, DOI 10.1016/S0022-2828(08)80026-0; Bergmann MW, 2010, CIRC RES, V107, P1198, DOI 10.1161/CIRCRESAHA.110.223768; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Borlaug BA, 2011, CIRCULATION, V123, P2006, DOI 10.1161/CIRCULATIONAHA.110.954388; Campbell AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035822; Chinchilla A, 2011, CIRC-CARDIOVASC GENE, V4, P269, DOI 10.1161/CIRCGENETICS.110.958116; Christoffels VM, 2010, CIRC RES, V106, P240, DOI 10.1161/CIRCRESAHA.109.205419; Clause KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040725; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Crippa S, 2011, J CELL BIOL, V193, P1197, DOI 10.1083/jcb.201011099; De Keulenaer GW, 2011, CIRCULATION, V123, P1996, DOI 10.1161/CIRCULATIONAHA.110.981431; Diehl AG, 2006, INVEST OPHTH VIS SCI, V47, P1785, DOI 10.1167/iovs.05-1424; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Doetschman T, 2012, CELL TISSUE RES, V347, P203, DOI 10.1007/s00441-011-1241-3; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; Edwards JG, 1996, CIRC RES, V78, P379, DOI 10.1161/01.RES.78.3.379; Francetic T, 2011, TRANSCR-AUSTIN, V2, P109, DOI 10.4161/trns.2.3.15829; Franco D, 2003, TRENDS CARDIOVAS MED, V13, P157, DOI 10.1016/S1050-1738(03)00039-2; Franco D, 2014, TRENDS CARDIOVAS MED, V24, P23, DOI 10.1016/j.tcm.2013.06.001; Franco D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00206; Franco D, 2011, CARDIOVASC RES, V91, P223, DOI 10.1093/cvr/cvr078; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Ganga M, 2003, J BIOL CHEM, V278, P22437, DOI 10.1074/jbc.M210163200; George I, 2010, EUR J HEART FAIL, V12, P444, DOI 10.1093/eurjhf/hfq039; Hernandez-Torres F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-199; Hjalt Tord A., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010082; Hsu J, 2012, CIRC-CARDIOVASC GENE, V5, P327, DOI 10.1161/CIRCGENETICS.111.961631; Huang Y, 2009, FEBS LETT, V583, P638, DOI 10.1016/j.febslet.2009.01.028; Iwata J, 2012, J BIOL CHEM, V287, P2353, DOI 10.1074/jbc.M111.280974; Kahr PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026389; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kirchhof P, 2011, CIRC-CARDIOVASC GENE, V4, P123, DOI 10.1161/CIRCGENETICS.110.958058; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Knopp P, 2013, DEV BIOL, V377, P293, DOI 10.1016/j.ydbio.2013.02.011; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lozano-Velasco E, 2011, DEV BIOL, V357, P165, DOI 10.1016/j.ydbio.2011.06.039; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Martinez-Fernandez S, 2006, DEV DYNAM, V235, P2930, DOI 10.1002/dvdy.20924; Mikhailov AT, 2008, INT J DEV BIOL, V52, P811, DOI 10.1387/ijdb.082655am; MINER JH, 1992, DEVELOPMENT, V114, P853; Mok GF, 2011, REPRODUCTION, V141, P301, DOI 10.1530/REP-10-0394; Murry CE, 1996, J CLIN INVEST, V98, P2209, DOI 10.1172/JCI119030; Oikonomopoulos A, 2011, CIRC RES, V109, P1363, DOI 10.1161/CIRCRESAHA.111.250282; Paylakhi SH, 2011, MOL VIS, V17, P1209; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Rios R, 2002, AM J PHYSIOL-CELL PH, V282, pC993, DOI 10.1152/ajpcell.00372.2001; Rossi A, 2006, INT J CARDIOL, V110, P386, DOI 10.1016/j.ijcard.2005.08.049; SANTERRE RF, 1993, MOL CELL BIOL, V13, P6044, DOI 10.1128/MCB.13.10.6044; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Su DM, 2013, BBA-MOL BASIS DIS, V1832, P2145, DOI 10.1016/j.bbadis.2013.07.013; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Sweetman D., 2012, SKELETAL MUSCLE MYOG, P31; Tao Y, 2014, CIRC-CARDIOVASC GENE, DOI [10.1161/CIRCGENETICS.1113.000259, DOI 10.1161/CIRCGENETICS.1113.000259]; Teo SG, 2010, EUR J ECHOCARDIOGR, V11, P38, DOI 10.1093/ejechocard/jep153; Tessari A, 2008, CIRC RES, V102, P813, DOI 10.1161/CIRCRESAHA.107.163188; Torrado M, 2004, EUR J HEART FAIL, V6, P161, DOI 10.1016/j.ejheart.2003.11.004; Torrado M, 2003, J MOL MED, V81, P566, DOI 10.1007/s00109-003-0470-7; Torrado M, 2006, FEBS LETT, V580, P4182, DOI 10.1016/j.febslet.2006.06.073; Torrado M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026392; Torrado M, 2010, EXP BIOL MED, V235, P941, DOI 10.1258/ebm.2010.010078; Torrado M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/603159; Torrado M, 2009, GENE, V440, P28, DOI 10.1016/j.gene.2009.03.017; Tumer Z, 2009, EUR J HUM GENET, V17, P1527, DOI 10.1038/ejhg.2009.93; Van der Heiden K, 2011, INT REV CEL MOL BIO, V290, P87, DOI 10.1016/B978-0-12-386037-8.00004-1; Venugopalan SR, 2008, HUM MOL GENET, V17, P3643, DOI 10.1093/hmg/ddn258; Wang J, 2010, P NATL ACAD SCI USA, V107, P9753, DOI 10.1073/pnas.0912585107; Yang CF, 2008, J CHIN MED ASSOC, V71, P79, DOI 10.1016/S1726-4901(08)70079-0; Zacharias AL, 2011, DEV BIOL, V349, P395, DOI 10.1016/j.ydbio.2010.10.028; Zakeri R, 2013, CIRCULATION, V128, P1085, DOI 10.1161/CIRCULATIONAHA.113.001475; Zhou YM, 2013, INT J MOL MED, V32, P827, DOI 10.3892/ijmm.2013.1463; Zu LY, 2010, J MOL CELL CARDIOL, V49, P5, DOI 10.1016/j.yjmcc.2010.02.007	74	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90561	10.1371/journal.pone.0090561	http://dx.doi.org/10.1371/journal.pone.0090561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595098	Green Submitted, Green Published, gold			2022-12-27	WOS:000332475500067
J	Zhang, ZC; Peng, XC; Li, ST; Zhang, N; Wang, Y; Wei, H				Zhang, Zhichao; Peng, Xichun; Li, Shaoting; Zhang, Ning; Wang, Yong; Wei, Hua			Isolation and Identification of Quercetin Degrading Bacteria from Human Fecal Microbes	PLOS ONE			English	Article							SP-NOV; FLAVONOIDS; METABOLISM; BIOAVAILABILITY; SURVIVAL	Quercetin has a wide range of biological properties. The gut microflora can often modulate its biological activity and their potential health effects. There still is a lack of information about gut bacteria involving in this process. The strains of gut microbes from human feces that can transform quercetin were isolated and identified by in vitro fermentation. The results showed that Escherichia coli, Stretococcus lutetiensis, Lactobacillus acidophilus, Weissella confusa, Enterococcus gilvus, Clostridium perfringens and Bacteroides fragilis have the various ability of degrading quercetin. Among them, C. perfringens and B. fragilis were discovered to have the strongest ability of degrading quercetin. Additionally, quercetin can't inhibit the growth of C. perfringens. In conclusion, many species of gut microbiota can degrade quercetin, but their ability are different.	[Zhang, Zhichao; Peng, Xichun; Li, Shaoting; Zhang, Ning; Wang, Yong] Jinan Univ, Dept Food Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Wei, Hua] Nanchang Univ, State Key Lab Food Sci & Technol, Nanchang, Peoples R China	Jinan University; Nanchang University	Peng, XC (corresponding author), Jinan Univ, Dept Food Sci & Engn, Guangzhou, Guangdong, Peoples R China.	tpxchun@jnu.edu.cn; weihua114@live.cn	WANG, YONG/K-5715-2019; Li, Shaoting/GMX-0413-2022	WEI, HUA/0000-0003-4341-8290	National Natural Science Funds [31271849]; National Innovation Experiment Program for University Students [101055902]; State Key Laboratory of Food Science and Technology, Nanchang University [SKLF-KF-201212]	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); National Innovation Experiment Program for University Students; State Key Laboratory of Food Science and Technology, Nanchang University	The program was supported by the funds of the National Natural Science Funds (No. 31271849), National Innovation Experiment Program for University Students (No. 101055902) and the Open Project Program of State Key Laboratory of Food Science and Technology, Nanchang University (No. SKLF-KF-201212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma K, 2010, FOOD CHEM TOXICOL, V48, P1117, DOI 10.1016/j.fct.2010.02.005; Braune A, 2001, APPL ENVIRON MICROB, V67, P5558, DOI 10.1128/AEM.67.12.5558-5567.2001; Chang YZ, 2012, FOOD CHEM, V133, P445, DOI 10.1016/j.foodchem.2012.01.060; GIBSON LF, 1986, LETT APPL MICROBIOL, V3, P127, DOI 10.1111/j.1472-765X.1986.tb01565.x; Hoefel D, 2005, J APPL MICROBIOL, V99, P175, DOI 10.1111/j.1365-2672.2005.02573.x; Ishizawa K, 2011, J PHARMACOL SCI, V115, P466, DOI 10.1254/jphs.10R38FM; Jacobs DM, 2009, CURR DRUG METAB, V10, P41, DOI 10.2174/138920009787048383; KRUMHOLZ LR, 1986, ARCH MICROBIOL, V144, P8, DOI 10.1007/BF00454948; Lotito SB, 2011, FREE RADICAL BIO MED, V51, P454, DOI 10.1016/j.freeradbiomed.2011.04.032; Lu LL, 2013, BIOMED CHROMATOGR, V27, P509, DOI 10.1002/bmc.2820; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Maniatis T., 1982, MOL CLONING; Rasmussen SE, 2005, MOL NUTR FOOD RES, V49, P159, DOI 10.1002/mnfr.200400082; Rastmanesh R, 2011, CHEM-BIOL INTERACT, V189, P1, DOI 10.1016/j.cbi.2010.10.002; Schneider H, 1999, ARCH MICROBIOL, V171, P81, DOI 10.1007/s002030050682; Serra A, 2012, FOOD CHEM, V130, P383, DOI 10.1016/j.foodchem.2011.07.055; Setchell KDR, 2002, J NUTR, V132, P3577, DOI 10.1093/jn/132.12.3577; Tannock GW, 2012, INFLAMM BOWEL DIS, V18, P925, DOI 10.1002/ibd.21936; Tannock GW, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/954051; Walle T, 2004, FREE RADICAL BIO MED, V36, P829, DOI 10.1016/j.freeradbiomed.2004.01.002; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; WINTER J, 1989, APPL ENVIRON MICROB, V55, P1203, DOI 10.1128/AEM.55.5.1203-1208.1989; WINTER J, 1991, INT J SYST BACTERIOL, V41, P355, DOI 10.1099/00207713-41-3-355; XU X, 1995, J NUTR, V125, P2307, DOI 10.1093/jn/125.9.2307; Yoshino S, 2011, NUTRITION, V27, P847, DOI 10.1016/j.nut.2010.09.002; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	27	42	44	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90531	10.1371/journal.pone.0090531	http://dx.doi.org/10.1371/journal.pone.0090531			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594786	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500060
J	Ferraretto, X; Estellat, C; Damond, F; Longuet, P; Epelboin, S; Demailly, P; Yazbeck, C; Llabador, MA; Pasquet, B; Yazdanpanah, Y; Matheron, S; Patrat, C				Ferraretto, Xavier; Estellat, Candice; Damond, Florence; Longuet, Pascale; Epelboin, Sylvie; Demailly, Pauline; Yazbeck, Chadi; Llabador, Marie-Astrid; Pasquet, Blandine; Yazdanpanah, Yazdan; Matheron, Sophie; Patrat, Catherine			Timing of Intermittent Seminal HIV-1 RNA Shedding in Patients with Undetectable Plasma Viral Load under Combination Antiretroviral Therapy	PLOS ONE			English	Article							TREATED PATIENTS; SEMEN; INFECTION; BLOOD; COUPLES; SAMPLES; MEN	It was demonstrated that combination antiretroviral therapy (cART) reduces the HIV-1 viral load (VL) in the blood and the seminal compartment. Some studies have reported that the seminal HIV-1 VL is undetectable in individuals with an undetectable blood plasma viral load (bpVL) under cART. However, some recent studies have demonstrated that seminal HIV-1 RNA may still be detected, and potentially infectious, even in the case of an undetectable bpVL. The aim of this retrospective study was to determine the detection rate of a seminal VL and whether shedding could be intermittent over a very short time. From January 2006 to December 2011, 88 HIV-1 infected men, enrolled in an Assisted Reproduction program, provided 306 semen samples, corresponding to 177 frozen sperm samples (two samples delivered at a one-hour interval (n = 129) or one sample (n = 48)). All enrolled men were under cART, with an undetectable bpVL for more than 6 months. HIV-1 RNA was quantified in seminal plasma using a Roche COBAS Ampliprep COBAS TaqMan HIV-1 test. Seminal HIV-1 RNA was detected in 23 samples (7.5%) from 17 patients (19.3%). This detection rate was stable over years. With regards to the freezing of two samples delivered at a one-hour interval, the proportion of discordance between the first and second samples was 9.3% (12/129). Our results confirm the intermittent shedding of HIV-1 in semen. While this finding has been shown by studies examining longer time intervals, to our knowledge, this has never been demonstrated over such a short time interval.	[Ferraretto, Xavier; Demailly, Pauline; Llabador, Marie-Astrid; Patrat, Catherine] Grp Hosp Bichat Claude Bernard, Lab Biol Reprod, Paris, France; [Estellat, Candice; Pasquet, Blandine] Grp Hosp Bichat Claude Bernard, Dept Epidemiol & Rech Clin, Paris, France; [Estellat, Candice; Pasquet, Blandine] INSERM, Ctr Invest Clin Epidemiol Clin CIE 801, Paris, France; [Damond, Florence] Grp Hosp Bichat Claude Bernard, Lab Virol, Paris, France; [Damond, Florence; Demailly, Pauline; Llabador, Marie-Astrid; Yazdanpanah, Yazdan; Matheron, Sophie; Patrat, Catherine] Univ Paris 07, Paris, France; [Longuet, Pascale; Yazdanpanah, Yazdan; Matheron, Sophie] Grp Hosp Bichat Claude Bernard, Serv Malad Infect & Trop, Paris, France; [Epelboin, Sylvie; Yazbeck, Chadi] Grp Hosp Bichat Claude Bernard, Serv Gynecol Obstet, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Ferraretto, X (corresponding author), Grp Hosp Bichat Claude Bernard, Lab Biol Reprod, Paris, France.	xavier.ferraretto@gmail.com	Matheron, Sophie/D-7420-2017	Matheron, Sophie/0000-0001-7879-6553; epelboin, sylvie/0000-0001-7972-1609				Bachelot- Narquin R, 2010, J OFFICIEL REPUBLIQU; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Bujan L, 2004, AIDS, V18, P757, DOI 10.1097/00002030-200403260-00006; Bujan L, 2007, AIDS, V21, P1909, DOI 10.1097/QAD.0b013e3282703879; CAZEIN F, 2012, B EPIDEMIOLOGIQUE HE, V46, P529; Chakraborty H, 2001, AIDS, V15, P621, DOI 10.1097/00002030-200103300-00012; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dulioust E, 2010, AIDS, V24, P1595, DOI 10.1097/QAD.0b013e32833b47fc; Gupta P, 2000, J INFECT DIS, V182, P79, DOI 10.1086/315644; Halfon P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010569; Lambert-Niclot S, 2012, AIDS, V26, P971, DOI 10.1097/QAD.0b013e328352ae09; Leruez-Ville M, 2002, AIDS, V16, P486, DOI 10.1097/00002030-200202150-00023; Loutfy MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055747; Marcelin AG, 2008, AIDS, V22, P1677, DOI 10.1097/QAD.0b013e32830abdc8; Pasquier C, 2006, J MED VIROL, V78, P877, DOI 10.1002/jmv.20636; Pasquier C, 2009, J CLIN MICROBIOL, V47, P2883, DOI 10.1128/JCM.02131-08; SEMPRINI AE, 1992, LANCET, V340, P1317, DOI 10.1016/0140-6736(92)92495-2; Sheth PM, 2009, AIDS, V23, P2050, DOI 10.1097/QAD.0b013e3283303e04; Taylor S, 2001, SEX TRANSM INFECT, V77, P4, DOI 10.1136/sti.77.1.4; Vernazza P, 2008, B MED SUISSES, V89, P165; Vernazza PL, 2011, AIDS, V25, P2005, DOI 10.1097/QAD.0b013e32834a36d0; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006	22	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e88922	10.1371/journal.pone.0088922	http://dx.doi.org/10.1371/journal.pone.0088922			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594873	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900010
J	Tateishi-Karimata, H; Isono, N; Sugimoto, N				Tateishi-Karimata, Hisae; Isono, Noburu; Sugimoto, Naoki			New Insights into Transcription Fidelity: Thermal Stability of Non-Canonical Structures in Template DNA Regulates Transcriptional Arrest, Pause, and Slippage	PLOS ONE			English	Article							RNA-POLYMERASE-II; G-QUADRUPLEX STRUCTURES; CROWDING CONDITIONS; FORMING SEQUENCE; ION MOVEMENT; LOGIC GATES; ELONGATION; SITE; TERMINATION; HYDRATION	The thermal stability and topology of non-canonical structures of G-quadruplexes and hairpins in template DNA were investigated, and the effect of non-canonical structures on transcription fidelity was evaluated quantitatively. We designed ten template DNAs: A linear sequence that does not have significant higher-order structure, three sequences that form hairpin structures, and six sequences that form G-quadruplex structures with different stabilities. Templates with non-canonical structures induced the production of an arrested, a slipped, and a full-length transcript, whereas the linear sequence produced only a full-length transcript. The efficiency of production for run-off transcripts (full-length and slipped transcripts) from templates that formed the non-canonical structures was lower than that from the linear. G-quadruplex structures were more effective inhibitors of full-length product formation than were hairpin structure even when the stability of the G-quadruplex in an aqueous solution was the same as that of the hairpin. We considered that intra-polymerase conditions may differentially affect the stability of non-canonical structures. The values of transcription efficiencies of run-off or arrest transcripts were correlated with stabilities of non-canonical structures in the intra-polymerase condition mimicked by 20 wt% polyethylene glycol (PEG). Transcriptional arrest was induced when the stability of the G-quadruplex structure (-Delta G degrees(37)) in the presence of 20 wt% PEG was more than 8.2 kcal mol(-1). Thus, values of stability in the presence of 20 wt% PEG are an important indicator of transcription perturbation. Our results further our understanding of the impact of template structure on the transcription process and may guide logical design of transcription-regulating drugs.	[Tateishi-Karimata, Hisae; Isono, Noburu; Sugimoto, Naoki] Konan Univ, Frontier Inst Biomol Engn Res FIBER, Kobe, Hyogo, Japan; [Sugimoto, Naoki] Konan Univ, Fac Frontiers Innovat Res Sci & Technol FIRST, Kobe, Hyogo, Japan	Konan University; Konan University	Sugimoto, N (corresponding author), Konan Univ, Frontier Inst Biomol Engn Res FIBER, Kobe, Hyogo, Japan.	sugimoto@konan-u.ac.jp	Tateishi-Karimata, Hisae/AAH-2992-2020	Tateishi-Karimata, Hisae/0000-0001-6161-9817	Ministry of Education, Culture, Sports, Science and Technology (MEXT) Program for the Strategic Research Foundation at Private Universities, Japan; Nagase Science and Technology Foundation; Hirao Taro Foundation of the Konan University Association for Academic Research; Grants-in-Aid for Scientific Research [24750168, 26620138] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) Program for the Strategic Research Foundation at Private Universities, Japan; Nagase Science and Technology Foundation; Hirao Taro Foundation of the Konan University Association for Academic Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by the Grants-in-Aid for Scientific Research, the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Program for the Strategic Research Foundation at Private Universities (2009-2014), Japan, the Nagase Science and Technology Foundation, and the Hirao Taro Foundation of the Konan University Association for Academic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand VS, 2006, J BIOL CHEM, V281, P35677, DOI 10.1074/jbc.M608180200; Bandwar RP, 2002, J MOL BIOL, V324, P63, DOI 10.1016/S0022-2836(02)01034-3; Bassi GS, 2003, BIOCHEMISTRY-US, V42, P9980, DOI 10.1021/bi0346906; Belotserkovskii BP, 2007, J BIOL CHEM, V282, P32433, DOI 10.1074/jbc.M704618200; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Brinson RG, 2009, BIOCHEMISTRY-US, V48, P6988, DOI 10.1021/bi900357j; Broxson C, 2011, BIOCHEMISTRY-US, V50, P4162, DOI 10.1021/bi2002136; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; Chen YW, 2012, J AM CHEM SOC, V134, P13220, DOI 10.1021/ja305764d; Ditlevson JV, 2008, NUCLEIC ACIDS RES, V36, P3163, DOI 10.1093/nar/gkn136; EBBINGHAUS SW, 1993, J CLIN INVEST, V92, P2433, DOI 10.1172/JCI116850; Endoh T, 2013, ANGEW CHEM INT EDIT, V52, P5522, DOI 10.1002/anie.201300058; FUKUNAGA Y, 1982, J BIOCHEM-TOKYO, V92, P143, DOI 10.1093/oxfordjournals.jbchem.a133911; Hawryluk PJ, 2004, NUCLEIC ACIDS RES, V32, P1904, DOI 10.1093/nar/gkh505; Howe KJ, 2003, RNA, V9, P993, DOI 10.1261/rna.5390803; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; KASSAVETIS GA, 1981, J BIOL CHEM, V256, P2777; KING GC, 1986, BIOCHEMISTRY-US, V25, P36, DOI 10.1021/bi00349a006; Kobayashi K, 2011, CHEM LETT, V40, P855, DOI 10.1246/cl.2011.855; Kuzmine I, 2001, NUCLEIC ACIDS RES, V29, P2601, DOI 10.1093/nar/29.12.2601; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Li T, 2010, ANAL CHEM, V82, P7576, DOI 10.1021/ac1019446; Liu XQ, 2009, J BIOL CHEM, V284, P36262, DOI 10.1074/jbc.M109.056820; Ma Y, 2009, BIOORG MED CHEM LETT, V19, P3414, DOI 10.1016/j.bmcl.2009.05.030; MACDONALD LE, 1993, J MOL BIOL, V232, P1030, DOI 10.1006/jmbi.1993.1458; McLuckie KIE, 2011, J AM CHEM SOC, V133, P2658, DOI 10.1021/ja109474c; Miller MC, 2010, J AM CHEM SOC, V132, P17105, DOI 10.1021/ja105259m; Miyoshi D, 2003, NUCLEOS NUCLEOT NUCL, V22, P203, DOI 10.1081/NCN-120019528; Miyoshi D, 2006, J AM CHEM SOC, V128, P7957, DOI 10.1021/ja061267m; Miyoshi D, 2006, ANGEW CHEM INT EDIT, V45, P7716, DOI 10.1002/anie.200602404; Nakano S, 2004, J AM CHEM SOC, V126, P14330, DOI 10.1021/ja0463029; Nakano S, 2009, J AM CHEM SOC, V131, P16881, DOI 10.1021/ja9066628; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Podbevsek P, 2008, J AM CHEM SOC, V130, P14287, DOI 10.1021/ja8048282; Rodriguez R, 2007, ANGEW CHEM INT EDIT, V46, P5405, DOI 10.1002/anie.200605075; Rudd MD, 1996, J BIOL CHEM, V271, P21549, DOI 10.1074/jbc.271.35.21549; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sket P, 2004, ORG BIOMOL CHEM, V2, P1970, DOI 10.1039/b406815g; Smargiasso N, 2008, J AM CHEM SOC, V130, P10208, DOI 10.1021/ja801535e; Spink CH, 1999, BIOCHEMISTRY-US, V38, P496, DOI 10.1021/bi9820154; Strathern J, 2013, J BIOL CHEM, V288, P2689, DOI 10.1074/jbc.M112.429506; Tateishi-Karimata H., 2013, CURR PROTOC NUCL ACI; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Tornaletti S, 2006, CHEM RES TOXICOL, V19, P1215, DOI 10.1021/tx060103g; Torres AG, 2011, RNA, V17, P933, DOI 10.1261/rna.2533811; Toulme F, 2005, J MOL BIOL, V351, P39, DOI 10.1016/j.jmb.2005.05.052; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Tse MT, 2012, NAT REV DRUG DISCOV, V11, P674, DOI 10.1038/nrd3825; Tsuji A, 2010, J AM CHEM SOC, V132, P12464, DOI 10.1021/ja105154k; Van Horn WD, 2009, J AM CHEM SOC, V131, P8030, DOI 10.1021/ja901871n; WAGNER LA, 1990, NUCLEIC ACIDS RES, V18, P3529, DOI 10.1093/nar/18.12.3529; Wang GL, 2006, P NATL ACAD SCI USA, V103, P2677, DOI 10.1073/pnas.0511084103; Yaku H, 2013, METHODS; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	58	39	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90580	10.1371/journal.pone.0090580	http://dx.doi.org/10.1371/journal.pone.0090580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594642	gold, Green Published, Green Submitted			2022-12-27	WOS:000332468900119
J	Wang, Y; Tian, RM; Gao, ZM; Bougouffa, S; Qian, PY				Wang, Yong; Tian, Ren Mao; Gao, Zhao Ming; Bougouffa, Salim; Qian, Pei-Yuan			Optimal Eukaryotic 18S and Universal 16S/18S Ribosomal RNA Primers and Their Application in a Study of Symbiosis	PLOS ONE			English	Article							DEEP-SEA; BACTERIAL COMMUNITIES; MICROBIAL EUKARYOTES; WATER COLUMNS; COPY NUMBER; GENOME SIZE; DIVERSITY; SUBUNIT; GENES; LIFE	Eukaryotic 18S ribosomal RNA (rRNA) gene primers that feature a wide coverage are critical in detecting the composition of eukaryotic microscopic organisms in ecosystems. Here, we predicted 18S rRNA primers based on consecutive conserved sites and evaluated their coverage efficiency and scope of application to different eukaryotic groups. After evaluation, eight of them were considered as qualified 18S primers based on coverage rate. Next, we examined common conserved regions in prokaryotic 16S and eukaryotic 18S rRNA sequences to design 16S/18S universal primers. Three 16S/18S candidate primers, U515, U1390 and U1492, were then considered to be suitable for simultaneous amplification of the rRNA sequences in three domains. Eukaryotic 18S and prokaryotic 16S rRNA genes in a sponge were amplified simultaneously using universal primers U515 and U1390, and the subsequent sorting of pyrosequenced reads revealed some distinctive communities in different parts of the sample. The real difference in biodiversity between prokaryotic and eukaryotic symbionts could be discerned as the dissimilarity between OTUs was increased from 0.005 to 0.1. A network of the communities in external and internal parts of the sponge illustrated the co-variation of some unique microbes in certain parts of the sponge, suggesting that the universal primers are useful in simultaneous detection of prokaryotic and eukaryotic microbial communities.	[Wang, Yong; Tian, Ren Mao; Gao, Zhao Ming; Bougouffa, Salim; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, Yong] Chinese Acad Sci, Sanya Inst Deep Sea Sci & Engn, San Ya, Hai Nan, Peoples R China	Hong Kong University of Science & Technology; Chinese Academy of Sciences; Institute of Deep-Sea Science & Engineering, CAS	Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	boqianpy@ust.hk	Bougouffa, Salim/AAG-8976-2020	Bougouffa, Salim/0000-0001-9218-6452; wang, yong/0000-0003-3595-3867; Tian, Renmao/0000-0003-2151-4417; Qian, Pei-Yuan/0000-0003-4074-9078	Chinese Academy of Sciences (CAS) [XDB06010100, XDB06010200]; National Basic Research Program of China (973 Program) [2012CB417304]; Nature Science Foundation of China [U1301232]; Sanya Institute of Deep Sea Science and Engineering, CAS [SIDSSE-201206, SIDSSE-201305, SIDSSE-BR-201303]; King Abdullah University of Science and Technology [SA-C0040/UK-C0016]	Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sanya Institute of Deep Sea Science and Engineering, CAS; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	Funding: This study was supported by the "Strategic Priority Research Program" of the Chinese Academy of Sciences (CAS) (No. XDB06010100 and XDB06010200), National Basic Research Program of China (973 Program, No. 2012CB417304), the Nature Science Foundation of China (U1301232) and awards from the Sanya Institute of Deep Sea Science and Engineering, CAS (SIDSSE-201206, SIDSSE-201305) and SIDSSE-BR-201303) and from King Abdullah University of Science and Technology (SA-C0040/UK-C0016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Behnke A, 2006, APPL ENVIRON MICROB, V72, P3626, DOI 10.1128/AEM.72.5.3626-3636.2006; Biddle JF, 2012, ISME J, V6, P1018, DOI 10.1038/ismej.2011.164; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Birnstiel M L, 1971, Prog Nucleic Acid Res Mol Biol, V11, P351, DOI 10.1016/S0079-6603(08)60332-3; Blifernez-Klassen O, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2210; Bougouffa S, 2013, APPL ENVIRON MICROB, V79, P3425, DOI 10.1128/AEM.00254-13; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dawson SC, 2002, P NATL ACAD SCI USA, V99, P8324, DOI 10.1073/pnas.062169599; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; Edgcomb VP, 2002, P NATL ACAD SCI USA, V99, P7658, DOI 10.1073/pnas.062186399; ELWOOD HJ, 1985, MOL BIOL EVOL, V2, P399; Ferrer M, 2012, ENVIRON MICROBIOL, V14, P268, DOI 10.1111/j.1462-2920.2011.02634.x; Gadd GM, 2010, MICROBIOL-SGM, V156, P609, DOI 10.1099/mic.0.037143-0; Giovanonni LE, 1988, J BACTERIOL, V170, P720; Huang Y, 2009, BIOINFORMATICS, V25, P1338, DOI 10.1093/bioinformatics/btp161; Huws SA, 2007, J MICROBIOL METH, V70, P565, DOI 10.1016/j.mimet.2007.06.013; Jeffery NW, 2013, GENOME, V56, P451, DOI 10.1139/gen-2012-0122; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Kittelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047879; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee OO, 2009, APPL ENVIRON MICROB, V75, P3513, DOI 10.1128/AEM.00002-09; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Nonnenmann MW, 2012, J ENVIRON MONITOR, V14, P2038, DOI 10.1039/c2em30229b; Orsi W, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00341; Orsi W, 2012, ISME J, V6, P1586, DOI 10.1038/ismej.2012.7; Parfrey LW, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00153; Pawlowski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018169; Pillet L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032373; Prokopowich CD, 2003, GENOME, V46, P48, DOI 10.1139/G02-103; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Ragon M, MOL ECOL, V21, P3852; Roussel EG, 2011, FEMS MICROBIOL ECOL, V77, P647, DOI 10.1111/j.1574-6941.2011.01161.x; Sharp KH, 2012, ISME J, V6, P790, DOI 10.1038/ismej.2011.144; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stoeck T, 2006, PROTIST, V157, P31, DOI 10.1016/j.protis.2005.10.004; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088	49	59	59	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90053	10.1371/journal.pone.0090053	http://dx.doi.org/10.1371/journal.pone.0090053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594623	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900059
J	Xie, DZ; Chen, F; Lin, SY; Wang, SQ; You, CH; Monroig, O; Tocher, DR; Li, YY				Xie, Dizhi; Chen, Fang; Lin, Siyuan; Wang, Shuqi; You, Cuihong; Monroig, Oscar; Tocher, Douglas R.; Li, Yuanyou			Cloning, Functional Characterization and Nutritional Regulation of Delta 6 Fatty Acyl Desaturase in the Herbivorous Euryhaline Teleost Scatophagus Argus	PLOS ONE			English	Article							SALMON SALMO-SALAR; ACID-COMPOSITION; MARINE TELEOST; FRESH-WATER; FISH-OIL; GROWTH-PERFORMANCE; SEA BASS; EXPRESSION; ELONGASE; N-3	Marine fish are generally unable or have low ability for the biosynthesis of long-chain polyunsaturated fatty acids (LC-PUFA) from C18 PUFA precursors, with some notable exceptions including the herbivorous marine teleost Siganus canaliculatus in which such a capability was recently demonstrated. To determine whether this is a unique feature of S. canaliculatus or whether it is common to the herbivorous marine teleosts, LC-PUFA biosynthetic pathways were investigated in the herbivorous euryhaline Scatophagus argus. A putative desaturase gene was cloned and functionally characterized, and tissue expression and nutritional regulation were investigated. The full-length cDNA was 1972 bp, containing a 1338 bp open-reading frame encoding a polypeptide of 445 amino acids, which possessed all the characteristic features of fatty acyl desaturase (Fad). Functional characterization by heterologous expression in yeast showed the protein product of the cDNA efficiently converted 18:3n-3 and 18:2n-6 to 18:4n-3 and 18:3n-6, respectively, indicating Delta 6 desaturation activity. Quantitative real-time PCR showed that highest Delta 6 fad mRNA expression was detected in liver followed by brain, with lower expression in other tissues including intestine, eye, muscle, adipose, heart kidney and gill, and lowest expression in stomach and spleen. The expression of Delta 6 fad was significantly affected by dietary lipid and, especially, fatty acid composition, with highest expression of mRNA in liver of fish fed a diet with a ratio of 18: 3n-3/18:2n-6 of 1.72:1. The results indicated that S. argus may have a different LC-PUFA biosynthetic system from S. canaliculatus despite possessing similar habitats and feeding habits suggesting that LC-PUFA biosynthesis may not be common to all marine herbivorous teleosts.	[Xie, Dizhi; Chen, Fang; Lin, Siyuan; Wang, Shuqi; You, Cuihong; Li, Yuanyou] Shantou Univ, Inst Marine Biol, Shantou, Guangdong, Peoples R China; [Xie, Dizhi; Chen, Fang; Lin, Siyuan; Wang, Shuqi; You, Cuihong; Li, Yuanyou] Guangdong Prov Key Lab Marine Biotechnol, Shantou, Guangdong, Peoples R China; [Monroig, Oscar; Tocher, Douglas R.] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland	Shantou University; University of Stirling	Li, YY (corresponding author), Shantou Univ, Inst Marine Biol, Shantou, Guangdong, Peoples R China.	yyli@stu.edu.cn	Monroig, Oscar/K-9117-2014; Xie, Dizhi/AAG-9519-2019; Tocher, Douglas R/C-5652-2011	Monroig, Oscar/0000-0001-8712-0440; Tocher, Douglas R/0000-0002-8603-9410	National Natural Science Foundation of China (NSFC) [31110103913]; NSFC [41276179, 31202011, 31202012]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Major International Joint Research Project from National Natural Science Foundation of China (NSFC) (31110103913), NSFC General Projects (No. 41276179) and Youth Projects (No. 31202011, 31202012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimuddin, 2005, TRANSGENIC RES, V14, P159, DOI 10.1007/s11248-004-7435-7; Awada M, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-23; Barry Terence P., 1992, Asian Fisheries Science, V5, P163; Bell JG, 2002, J NUTR, V132, P222, DOI 10.1093/jn/132.2.222; Bell JG, 1997, LIPIDS, V32, P515, DOI 10.1007/s11745-997-0066-4; BELL JG, 1993, PROSTAG LEUKOTR ESS, V49, P665, DOI 10.1016/0952-3278(93)90075-8; Bell JG, 2001, J NUTR, V131, P1535, DOI 10.1093/jn/131.5.1535; Bell MV, 2001, LIPIDS, V36, P1153, DOI 10.1007/s11745-001-0826-1; Berry S., 2004, NUTR BULL, V29, P72, DOI DOI 10.1111/J.1467-3010.2003.00361.X; Blanchard G, 2008, AQUACULTURE, V284, P144, DOI 10.1016/j.aquaculture.2008.07.011; BRENNER R R, 1981, Progress in Lipid Research, V20, P315, DOI 10.1016/0163-7827(81)90063-1; Brouwer IA, 2006, PROG LIPID RES, V45, P357, DOI 10.1016/j.plipres.2006.02.004; Castro LFC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031950; Eilander A, 2007, PROSTAG LEUKOTR ESS, V76, P189, DOI 10.1016/j.plefa.2007.01.003; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fonseca-Madrigal J, 2006, FISH PHYSIOL BIOCHEM, V32, P317, DOI 10.1007/s10695-006-9109-2; Francis DS, 2007, J AGR FOOD CHEM, V55, P1582, DOI 10.1021/jf062153x; Gandhi V., 2002, Journal of the Marine Biological Association of India, V44, P115; Gonzalez-Rovira A, 2009, AQUACULTURE, V298, P90, DOI 10.1016/j.aquaculture.2009.10.012; Hastings N, 2004, MAR BIOTECHNOL, V6, P463, DOI 10.1007/s10126-004-3002-8; Hastings N, 2001, P NATL ACAD SCI USA, V98, P14304, DOI 10.1073/pnas.251516598; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; Izquierdo MS, 2008, FISH PHYSIOL BIOCHEM, V34, P117, DOI 10.1007/s10695-007-9152-7; Jaya-Ram A, 2011, COMP BIOCHEM PHYS A, V158, P415, DOI 10.1016/j.cbpa.2010.11.018; Kennedy SR, 2006, LIPIDS, V41, P423, DOI 10.1007/s11745-006-5116-4; Kim SH, 2011, BIOTECHNOL LETT, V33, P1185, DOI 10.1007/s10529-011-0555-2; Li YY, 2008, COMP BIOCHEM PHYS B, V151, P183, DOI 10.1016/j.cbpb.2008.06.013; Li YY, 2010, P NATL ACAD SCI USA, V107, P16840, DOI 10.1073/pnas.1008429107; Monroig O., 2011, AVANCES NUTR ACUICOL; Monroig O, 2013, AQUACULTURE, V412, P14, DOI 10.1016/j.aquaculture.2013.06.032; Monroig O, 2012, AQUACULTURE, V350, P63, DOI 10.1016/j.aquaculture.2012.04.017; Montes R, 2013, EUR J CLIN NUTR, V67, P658, DOI 10.1038/ejcn.2013.68; Morais S, 2011, AQUACULTURE, V313, P129, DOI 10.1016/j.aquaculture.2011.01.031; Muhlhausler BS, 2013, CURR OPIN ENDOCRINOL, V20, P56, DOI 10.1097/MED.0b013e32835c1ba7; Ren HT, 2013, GENE, V525, P11, DOI 10.1016/j.gene.2013.04.073; Ren HT, 2012, COMP BIOCHEM PHYS B, V163, P184, DOI 10.1016/j.cbpb.2012.05.016; Ruyter B, 2000, FISH PHYSIOL BIOCHEM, V23, P151, DOI 10.1023/A:1007893317923; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santigosa E, 2011, MAR BIOTECHNOL, V13, P22, DOI 10.1007/s10126-010-9264-4; Sargent John R., 2002, P181; Seiliez I, 2003, COMP BIOCHEM PHYS B, V135, P449, DOI 10.1016/S1096-4959(03)00111-8; Tanomman S, 2013, COMP BIOCHEM PHYS B, V166, P148, DOI 10.1016/j.cbpb.2013.07.011; Tocher DR, 2006, LIPIDS, V41, P1003, DOI 10.1007/s11745-006-5051-4; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Tocher DR, 2001, COMP BIOCHEM PHYS B, V130, P257, DOI 10.1016/S1096-4959(01)00429-8; Tocher DR, 2003, LIPIDS, V38, P723, DOI 10.1007/s11745-003-1120-y; Torrejon C, 2007, PROSTAG LEUKOTR ESS, V77, P319, DOI 10.1016/j.plefa.2007.10.014; Torstensen B.E., 2010, FISH OIL REPLACEMENT, P405, DOI 10.1201/9781439808634-c13; Vagner M, 2009, BRIT J NUTR, V101, P1452, DOI 10.1017/S0007114508088053; van der Merwe LF, 2013, AM J CLIN NUTR, V97, P45, DOI 10.3945/ajcn.112.042267; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Xu SD, 2012, AQUAC RES, V43, P1276, DOI 10.1111/j.1365-2109.2011.02931.x; Yamamoto Y, 2010, FISHERIES SCI, V76, P463, DOI 10.1007/s12562-010-0227-5; Yoshimura K., 2003, MER, V41, P82; Zheng X, 2004, COMP BIOCHEM PHYS B, V139, P269, DOI 10.1016/j.cbpc.2004.08.003; Zheng XZ, 2009, AQUACULTURE, V290, P122, DOI 10.1016/j.aquaculture.2009.02.010; Zheng XZ, 2005, BBA-MOL CELL BIOL L, V1734, P13, DOI 10.1016/j.bbalip.2005.01.006; Zheng XZ, 2005, LIPIDS, V40, P13, DOI 10.1007/s11745-005-1355-7	61	40	44	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90200	10.1371/journal.pone.0090200	http://dx.doi.org/10.1371/journal.pone.0090200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594899	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900079
J	Dugas, M; Dugas-Breit, S				Dugas, Martin; Dugas-Breit, Susanne			Integrated Data Management for Clinical Studies: Automatic Transformation of Data Models with Semantic Annotations for Principal Investigators, Data Managers and Statisticians	PLOS ONE			English	Article							INTEROPERABILITY	Design, execution and analysis of clinical studies involves several stakeholders with different professional backgrounds. Typically, principle investigators are familiar with standard office tools, data managers apply electronic data capture (EDC) systems and statisticians work with statistics software. Case report forms (CRFs) specify the data model of study subjects, evolve over time and consist of hundreds to thousands of data items per study. To avoid erroneous manual transformation work, a converting tool for different representations of study data models was designed. It can convert between office format, EDC and statistics format. In addition, it supports semantic annotations, which enable precise definitions for data items. A reference implementation is available as open source package ODMconverter at http://cran.r-project.org.	[Dugas, Martin] Univ Munster, Inst Med Informat, D-48149 Munster, Germany; [Dugas-Breit, Susanne] Univ Munich, Klin & Poliklin Dermatol & Allergol, Munich, Germany	University of Munster; University of Munich	Dugas, M (corresponding author), Univ Munster, Inst Med Informat, D-48149 Munster, Germany.	dugas@uni-muenster.de			Deutsche Forschungsgemeinschaft; University of Muenster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Muenster	The authors acknowledge financial support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Breil B, 2012, APPL CLIN INFORM, V3, P276, DOI 10.4338/ACI-2012-03-RA-0011; Bruland P, 2012, STUD HEALTH TECHNOL, V180, P564, DOI 10.3233/978-1-61499-101-4-564; Dugas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067883; Getz K., 2008, RAJ PHARM, V5, P315; Hearn J, 2007, EUR J CANCER, V43, P8, DOI 10.1016/j.ejca.2006.09.016; R Core Team, 2021, R LANGUAGE ENV STAT; Stewart DJ, 2010, J CLIN ONCOL, V28, P2925, DOI 10.1200/JCO.2009.27.5404	7	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90492	10.1371/journal.pone.0090492	http://dx.doi.org/10.1371/journal.pone.0090492			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587378	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200212
J	Melli, V; Riginella, E; Nalon, M; Mazzoldi, C				Melli, Valentina; Riginella, Emilio; Nalon, Marco; Mazzoldi, Carlotta			From Trap to Nursery. Mitigating the Impact of an Artisanal Fishery on Cuttlefish Offspring	PLOS ONE			English	Article							NORTHERN ADRIATIC SEA; SEPIA-OFFICINALIS L.; EGGS; CEPHALOPODA; TRENDS	Background: Overexploitation and the impact of several types of human activities have caused declines of marine resources. The direct and active involvement of fishermen in the management of marine resources is effective not only for resource conservation, but also for changing fishermen's attitudes. In this study, we proposed and tested the efficacy and suitability of a measure for mitigating the impact of a trap fishery on cuttlefish eggs in the North Adriatic Sea. This measure directly involves fishermen in promoting the conservation of the early, and more vulnerable, stages of the cuttlefish life cycle. Methodology/Principal findings: Through surveys on fishing boats and interviews with fishermen, we found that traps placed in coastal areas during the cuttlefish breeding season have a high impact on cuttlefish eggs, with over 3 million eggs likely being destroyed by 3750 traps of 15 fishermen in less than 3 miles of coast. The use of removable ropes attached inside traps as an additional substrate for egg deposition allowed the recovery of 23.7% of the eggs deposited on the traps on average, without affecting the catch rate of adults. Experiments examining hatching success in the field highlighted the need for a careful choice of hatching sites to maximise the efficacy of the mitigation measure. Conclusions/Significance: The proposed mitigation measure reduced the impact of fishing on cuttlefish eggs, with no significant effect on the commercial catch. Fishermen showed a positive attitude towards the application of this measure, which is inexpensive and easy to employ. The direct involvement of fishermen in the management of this resource and the maintenance of traditional fishing methods are a novel aspect of the proposed measure and represent the basis for its success.	[Melli, Valentina; Riginella, Emilio; Nalon, Marco; Mazzoldi, Carlotta] Univ Padua, Dept Biol, Padua, Italy	University of Padua	Mazzoldi, C (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	carlotta.mazzoldi@unipd.it	Riginella, Emilio/Q-2987-2019; Melli, Valentina/AAB-1980-2019; Mazzoldi, Carlotta/AAU-8628-2020	Riginella, Emilio/0000-0002-1442-8310; Melli, Valentina/0000-0002-4778-9331; MAZZOLDI, CARLOTTA/0000-0002-2798-3030	project CLODIA; Veneto Region (Italy) (DGR) [4069]	project CLODIA; Veneto Region (Italy) (DGR)	This work was supported by the project CLODIA funded by the Veneto Region (Italy) Law 15/2007 (DGR n. 4069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Anderson M.J., 2008, GUIDE SOFTWARE STAT; Barausse A, 2011, J FISH BIOL, V79, P1453, DOI 10.1111/j.1095-8649.2011.03139.x; Barausse A, 2009, ESTUAR COAST SHELF S, V83, P577, DOI 10.1016/j.ecss.2009.05.003; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Belcari P, 2002, B MAR SCI, V71, P187; Blanc A, 1998, FISH RES, V38, P225, DOI 10.1016/S0165-7836(98)00164-7; Boal JG, 2010, J CHEM ECOL, V36, P834, DOI 10.1007/s10886-010-9816-0; CADDY JF, 1995, OCEAN COAST MANAGE, V26, P1, DOI 10.1016/0964-5691(95)00015-T; Caddy JF, 2005, PHILOS T R SOC B, V360, P59, DOI 10.1098/rstb.2004.1567; Castilla JC, 2001, REV FISH BIOL FISHER, V11, P1, DOI 10.1023/A:1014235924952; Clark R. C., 2006, FGE430FIN SUSS SEA F; Clodia database, 2012, CLODIA DATABASE DATA; Colloca F, 2004, FISH RES, V69, P359, DOI 10.1016/j.fishres.2004.06.014; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cox TA, 2007, CONSERV BIOL, V21, P1155, DOI 10.1111/j.1523-1739.2007.00772.x; Cronin ER, 2000, MAR BIOL, V136, P863, DOI 10.1007/s002270000274; Curiel D, 2006, ATLANTE LAGUNA VENEZ, P130; Domingues PM, 2002, AQUACULT INT, V10, P207, DOI 10.1023/A:1022148802078; Duarte CM, 2002, ENVIRON CONSERV, V29, P192, DOI 10.1017/S0376892902000127; Erisman B, 2010, FISH RES, V106, P279, DOI 10.1016/j.fishres.2010.08.007; Food and Agriculture Organization (FAO), 2012, STAT WORLD FISH AQ 2; Guidetti P, 2010, CONSERV BIOL, V24, P312, DOI 10.1111/j.1523-1739.2009.01358.x; Gutowska MA, 2009, MAR BIOL, V156, P515, DOI 10.1007/s00227-008-1096-7; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Heck KL, 2003, MAR ECOL PROG SER, V253, P123, DOI 10.3354/meps253123; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Kelleher K., 2005, 470 FAO; LEGOFF R, 1991, B MAR SCI, V49, P341; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Onsoy B, 2005, TURK J VET ANIM SCI, V29, P613; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Perez-Ramirez M, 2012, OCEAN COAST MANAGE, V63, P24, DOI 10.1016/j.ocecoaman.2012.03.009; Royer J, 2006, FISH RES, V78, P96, DOI 10.1016/j.fishres.2005.12.004; Russo A, 1996, SCI MAR, V60, P33; Sfriso A, 2007, HYDROBIOLOGIA, V577, P71, DOI 10.1007/s10750-006-0418-3; Tzanatos E, 2005, FISH RES, V73, P147, DOI 10.1016/j.fishres.2004.12.006; Tzanatos E, 2013, ICES J MAR SCI, V70, P78, DOI 10.1093/icesjms/fss161; VOLLENWEIDER RA, 1992, SCIENCE OF THE TOTAL ENVIRONMENT, SUPPLEMENT 1992, P63; Watanuki N., 1999, SOUTH PAC STUD, V19, P31	41	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90542	10.1371/journal.pone.0090542	http://dx.doi.org/10.1371/journal.pone.0090542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587390	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200224
J	Saha, D; Pal, A; Biswas, A; Panigrahi, R; Sarkar, N; Das, D; Sarkar, J; Guha, SK; Saha, B; Chakrabarti, S; Chakravarty, R				Saha, Debraj; Pal, Ananya; Biswas, Avik; Panigrahi, Rajesh; Sarkar, Neelakshi; Das, Dipanwita; Sarkar, Jayeeta; Guha, Subhasish Kamal; Saha, Bibhuti; Chakrabarti, Sekhar; Chakravarty, Runu			Molecular Characterization of HBV Strains Circulating among the Treatment-Naive HIV/HBV Co-Infected Patients of Eastern India	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; PRECORE/CORE DELETION MUTANT; HEPATOCELLULAR-CARCINOMA; GENOTYPE-A; CLINICAL-SIGNIFICANCE; DIFFERENTIAL PATTERN; EVOLUTIONARY RATES; LIVER-DISEASE; MUTATIONS; PROMOTER	Previously we reported that the exposure to hepatitis B virus (HBV) infection serves as a major threat among the treatment naive HIV infected population of eastern India. Hence, molecular characterization of these strains is of utmost importance in order to identify clinically significant HBV mutations. A total of 85 treatment naive HIV/HBV co-infected participants were included of whom the complete basal core promoter/precore region, the core and the whole envelope gene could be successfully sequenced for 59, 57 and 39 isolates respectively. Following phylogenetic analysis, it was found that HBV/D was the predominant genotype with HBV/D2 (38.5%) being the most prevalent subgenotype followed by HBV/A1. The major mutations affecting HBeAg expression includes the A1762T/G1764A (13.6%), G1896A (22%) and G1862T mutation (33.9%) which was predominantly associated with HBV/A1. Moreover, the prevalence of G1896A was considerably high among the HBeAg negative HIV/HBV co-infected subjects compared to HBV mono-infection. The main amino acid substitutions within the MHC class II restricted T-cell epitope of HBcAg includes the T12S (15.8%) and T67N (12.3%) mutation and the V27I (10.5%) mutation in the MHC class I restricted T-cell epitope. PreS1/S2 deletion was detected in 3 isolates with all harboring the BCP double mutation. Furthermore, the frequently occurring mutations in the major hydrophilic loop of the S gene include the T125M, A128V and M133I/L. Therefore, this study is the first from India to report useful information on the molecular heterogeneity of the HBV strains circulating among the treatment naive HIV/HBV co-infected population and is thus clinically relevant.	[Saha, Debraj; Pal, Ananya; Biswas, Avik; Sarkar, Neelakshi; Das, Dipanwita; Chakravarty, Runu] ICMR Virus Unit, Kolkata, W Bengal, India; [Sarkar, Jayeeta; Guha, Subhasish Kamal; Saha, Bibhuti] Calcutta Sch Trop Med, Kolkata, W Bengal, India; [Panigrahi, Rajesh] Tulane Univ, Sch Med, Dept Pathol & Lab Med, New Orleans, LA 70112 USA; [Chakrabarti, Sekhar] Natl Inst Cholera & Enter Dis, Kolkata, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); ICMR - Virus Unit, Kolkata; Calcutta School of Tropical Medicine (CSTM); Tulane University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Chakravarty, R (corresponding author), ICMR Virus Unit, ID & BG Hosp Campus, Kolkata, W Bengal, India.	runugc@gmail.com		Panigrahi, Rajesh/0000-0002-6704-0029	Department of Biotechnology (DBT), Government of India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	This work is supported by research grant from Department of Biotechnology (DBT), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2003, GASTROENTEROLOGY, V125, P1370, DOI 10.1016/j.gastro.2003.07.016; Audsley J, 2010, VIROLOGY, V405, P539, DOI 10.1016/j.virol.2010.06.038; Banerjee A, 2005, INTERVIROLOGY, V48, P389, DOI 10.1159/000086066; Biswas A, 2009, HEPATOL RES, V39, P53, DOI 10.1111/j.1872-034X.2008.00403.x; Biswas A, 2012, INFECT GENET EVOL, V12, P384, DOI 10.1016/j.meegid.2012.01.007; Biswas A, 2011, J MED VIROL, V83, P253, DOI 10.1002/jmv.21979; Bock CT, 1997, GASTROENTEROLOGY, V113, P1976, DOI 10.1016/S0016-5085(97)70018-0; Bozdayi AM, 1999, INFECTION, V27, P357, DOI 10.1007/s150100050043; Cabuang LM, 2012, J MED VIROL, V84, P1166, DOI 10.1002/jmv.23328; Chan HLY, 2004, GUT, V53, P1494, DOI 10.1136/gut.2003.033324; Chandra PK, 2009, J VIRAL HEPATITIS, V16, P749, DOI 10.1111/j.1365-2893.2009.01129.x; Chandra PK, 2007, INTERVIROLOGY, V50, P173, DOI 10.1159/000098960; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Datta S, 2008, INTERVIROLOGY, V51, P275, DOI 10.1159/000170902; Fares MA, 2002, J MOL EVOL, V54, P807, DOI 10.1007/s00239-001-0084-z; Fukushima K, 2008, HEPATOL RES, V38, P842, DOI 10.1111/j.1872-034X.2008.00332.x; Gandhe SS, 2003, J VIRAL HEPATITIS, V10, P367, DOI 10.1046/j.1365-2893.2003.00445.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hou JL, 2002, J GEN VIROL, V83, P2291, DOI 10.1099/0022-1317-83-9-2291; Hsieh YH, 2004, CARCINOGENESIS, V25, P2023, DOI 10.1093/carcin/bgh207; Hur GM, 1996, J MED VIROL, V48, P38, DOI 10.1002/(SICI)1096-9071(199601)48:1<38::AID-JMV6>3.3.CO;2-Y; Kao JH, 2003, GASTROENTEROLOGY, V124, P327, DOI 10.1053/gast.2003.50053; Kew MC, 2005, J MED VIROL, V75, P513, DOI 10.1002/jmv.20311; Kim DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047372; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kitab B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042891; Kramvis A, 1999, J VIRAL HEPATITIS, V6, P415, DOI 10.1046/j.1365-2893.1999.00189.x; Kumar Ashish, 2005, Indian J Gastroenterol, V24, P19; Laras A, 1998, J VIRAL HEPATITIS, V5, P241, DOI 10.1046/j.1365-2893.1998.00109.x; Lee SA, 2012, J HEPATOL, V56, P63, DOI 10.1016/j.jhep.2011.06.028; Liu SJ, 2009, JNCI-J NATL CANCER I, V101, P1066, DOI 10.1093/jnci/djp180; Marschenz S, 2006, GASTROENTEROLOGY, V131, P765, DOI 10.1053/j.gastro.2006.07.008; Mathews Gail, 2003, J HIV Ther, V8, P77; Mayaphi SH, 2013, J MED VIROL, V85, P1883, DOI 10.1002/jmv.23695; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Pal A, 2013, VIROLOGY, V436, P134, DOI 10.1016/j.virol.2012.11.003; Qu LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059583; Revill PA, 2007, AIDS, V21, P1701, DOI 10.1097/QAD.0b013e32826fb305; Saha D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073613; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Sellier P, 2010, J CLIN VIROL, V47, P13, DOI 10.1016/j.jcv.2009.10.010; Soriano V, 2007, J INFECT DIS, V195, P1181, DOI 10.1086/512679; Soussan P, 2001, J GEN VIROL, V82, P367, DOI 10.1099/0022-1317-82-2-367; Sugauchi F, 2003, J MED VIROL, V70, P537, DOI 10.1002/jmv.10428; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka Y, 2004, HEPATOLOGY, V40, P747, DOI 10.1002/hep.20365; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Tong MJ, 2007, LIVER INT, V27, P1356, DOI 10.1111/j.1478-3231.2007.01585.x; Zehender G, 2008, VIROLOGY, V380, P84, DOI 10.1016/j.virol.2008.07.009; Zehender G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037198	54	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90432	10.1371/journal.pone.0090432	http://dx.doi.org/10.1371/journal.pone.0090432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587360	gold, Green Submitted, Green Published			2022-12-27	WOS:000332396200195
J	Pouchieu, C; Chajes, V; Laporte, F; Kesse-Guyot, E; Galan, P; Hercberg, S; Latino-Martel, P; Touvier, M				Pouchieu, Camille; Chajes, Veronique; Laporte, Francois; Kesse-Guyot, Emmanuelle; Galan, Pilar; Hercberg, Serge; Latino-Martel, Paule; Touvier, Mathilde			Prospective Associations between Plasma Saturated, Monounsaturated and Polyunsaturated Fatty Acids and Overall and Breast Cancer Risk - Modulation by Antioxidants: A Nested Case-Control Study	PLOS ONE			English	Article							PROSTATE-CANCER; DIETARY-FAT; 5,8,11-EICOSATRIENOIC ACID; SERUM PHOSPHOLIPIDS; BETA-CAROTENE; RETINOL; PREVENTION; VITAMINS; ALPHA; CARCINOGENESIS	Background: Mechanistic data suggest that different types of fatty acids play a role in carcinogenesis and that antioxidants may modulate this relationship but epidemiologic evidence is lacking. Our aim was to investigate the association between plasma saturated, monounsaturated and polyunsaturated fatty acids (SFAs, MUFAs and PUFAs) and overall and breast cancer risk and to evaluate the potential modulatory effect of an antioxidant supplementation on these relationships. Methods: A nested case-control study included all first incident cancer cases diagnosed in the SU.VI.MAX study between 1994 and 2002 (n = 250 cases, one matched control/case). Participants to the SU.VI.MAX randomized controlled trial received either vitamin/mineral antioxidants or placebo during this intervention period. Baseline fatty acid composition of plasma total lipids was measured by gas chromatography. Conditional logistic regression was performed overall and stratified by intervention group. Results: Dihomo-gamma-linolenic acid (P-trend = 0.002), the dihomo-gamma-linolenic/linoleic acids ratio (P-trend = 0.001), mead acid (P-trend = 0.0004), and palmitoleic acid (P-trend = 0.02) were inversely associated with overall cancer risk. The arachidonic/dihomo-gamma-linolenic acids ratio (P-trend = 0.02) and linoleic acid (P-trend = 0.02) were directly associated with overall cancer risk. Similar results were observed for breast cancer specifically. In stratified analyses, associations were only observed in the placebo group. Notably, total PUFAs were directly associated with overall (P-trend = 0.02) and breast cancer risk in the placebo group only. Conclusion: Specific SFAs, MUFAs and PUFAs were prospectively differentially associated with cancer risk. In addition, this study suggests that antioxidants may modulate these associations by counteracting the potential effects of these fatty acids on carcinogenesis.	[Pouchieu, Camille; Kesse-Guyot, Emmanuelle; Galan, Pilar; Hercberg, Serge; Latino-Martel, Paule; Touvier, Mathilde] Univ Paris 07, Univ Paris 05, Univ Paris 13, Inra U1125,INSERM 81153,Epidemiol & Biostat Ctr, Bobigny, France; [Chajes, Veronique] Int Agcy Res Canc, Lyon, France; [Laporte, Francois] Univ Hosp Grenoble, Dept Integrated Biol, Grenoble, France; [Hercberg, Serge] Avicenne Hosp, Dept Publ Hlth, Bobigny, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; World Health Organization; International Agency for Research on Cancer (IARC); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP	Pouchieu, C (corresponding author), Univ Paris 07, Univ Paris 05, Univ Paris 13, Inra U1125,INSERM 81153,Epidemiol & Biostat Ctr, Bobigny, France.	c.pouchieu@uren.smbh.univ-paris13.fr	Pilar, Galan/F-2908-2017; Latino-Martel, Paule/F-2706-2017; Kesse-Guyot, Emmanuelle/F-2692-2017; Touvier, Mathilde/E-8817-2017; Kesse-Guyot, Emmanuelle/ABH-7347-2020; Latino-Martel, Paule/O-1549-2019; Serge, Hercberg/F-3038-2017; HERCBERG, Serge/B-4429-2008; Kesse-Guyot, Emmanuelle/K-4689-2012; Latino-Martel, Paule/W-1437-2017	Pilar, Galan/0000-0003-1706-3107; Latino-Martel, Paule/0000-0003-4581-852X; Kesse-Guyot, Emmanuelle/0000-0002-9715-3534; Touvier, Mathilde/0000-0002-8322-8857; Latino-Martel, Paule/0000-0003-4581-852X; Serge, Hercberg/0000-0002-3168-1350; HERCBERG, Serge/0000-0002-3168-1350; Latino-Martel, Paule/0000-0003-4581-852X; Chajes, Veronique/0000-0003-1297-3064	French Ministry of Health	French Ministry of Health	This study was funded by the French Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arab L, 2003, J NUTR, V133, p925S, DOI 10.1093/jn/133.3.925S; Bassett JK, 2013, INT J CANCER, V133, P1882, DOI 10.1002/ijc.28203; Bingham SA, 2003, LANCET, V362, P212, DOI 10.1016/S0140-6736(03)13913-X; Brasky TM, 2011, AM J EPIDEMIOL, V173, P1429, DOI 10.1093/aje/kwr027; Byers T, 1997, AM J CLIN NUTR, V66, P1541; Chajes V, 1999, INT J CANCER, V83, P585, DOI 10.1002/(SICI)1097-0215(19991126)83:5&lt;585::AID-IJC2&gt;3.0.CO;2-Z; Chajes V, 2008, AM J EPIDEMIOL, V167, P1312, DOI 10.1093/aje/kwn069; Chajes V, 2011, AM J CLIN NUTR, V94, P1304, DOI 10.3945/ajcn.110.005892; Chajes V, 2011, CURR OPIN LIPIDOL, V22, P6, DOI 10.1097/MOL.0b013e3283404552; Chavarro JE, 2007, CANCER EPIDEM BIOMAR, V16, P1364, DOI 10.1158/1055-9965.EPI-06-1033; Cheng TYD, 2013, AM J EPIDEMIOL, V177, P1106, DOI 10.1093/aje/kws356; Colas S, 2005, NUTR CANCER, V51, P178, DOI 10.1207/s15327914nc5102_8; Colas S, 2006, CLIN CANCER RES, V12, P5879, DOI 10.1158/1078-0432.CCR-06-0386; Comba A, 2011, CANCER METAST REV, V30, P325, DOI 10.1007/s10555-011-9308-x; Crowe FL, 2008, AM J CLIN NUTR, V88, P1353, DOI 10.3945/ajcn.2008.26369; Food and Agriculture Organization of the United Nations Food and Nutrition, 2010, 91 UN FAO FOOD NUTR; GANN PH, 1994, J NATL CANCER I, V86, P281, DOI 10.1093/jnci/86.4.281; HAMMARSTROM S, 1981, J BIOL CHEM, V256, P2275; Harvei S, 1997, INT J CANCER, V71, P545, DOI 10.1002/(SICI)1097-0215(19970516)71:4<545::AID-IJC7>3.0.CO;2-U; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; JAKSCHIK BA, 1983, J BIOL CHEM, V258, P2797; King IB, 2005, CANCER EPIDEM BIOMAR, V14, P988, DOI 10.1158/1055-9965.EPI-04-0517; Kojima M, 2005, AM J EPIDEMIOL, V161, P462, DOI 10.1093/aje/kwi066; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; Mannisto S, 2003, CANCER EPIDEM BIOMAR, V12, P1422; Marino M, 2008, STEROIDS, V73, P853, DOI 10.1016/j.steroids.2007.12.003; Menendez JA, 2004, INT J ONCOL, V24, P1369; Michels KB, 2001, INT J CANCER, V91, P563, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1079&gt;3.0.CO;2-9; Nkondjock A, 2003, BREAST, V12, P128, DOI 10.1016/S0960-9776(02)00284-9; Nohl H, 2005, ANTICANCER RES, V25, P2793; Pala V, 2001, J NATL CANCER I, V93, P1088, DOI 10.1093/jnci/93.14.1088; Park SY, 2009, CANCER CAUSE CONTROL, V20, P211, DOI 10.1007/s10552-008-9236-4; Pauwels EKJ, 2008, DRUG NEWS PERSPECT, V21, P504, DOI 10.1358/dnp.2008.21.9.1290819; Rissanen H, 2003, NUTR CANCER, V45, P168, DOI 10.1207/S15327914NC4502_05; Rose DP, 1997, AM J CLIN NUTR, V66, P1513; Saadatian-Elahi M, 2004, INT J CANCER, V111, P584, DOI 10.1002/ijc.20284; Saadatian-Elahi M, 2002, IARC Sci Publ, V156, P227; Serini S, 2011, CHEM RES TOXICOL, V24, P2093, DOI 10.1021/tx200314p; Simonsen NR, 1998, AM J CLIN NUTR, V68, P134, DOI 10.1093/ajcn/68.1.134; Takata Y, 2009, CANCER CAUSE CONTROL, V20, P497, DOI 10.1007/s10552-009-9314-2; Thiebaut ACM, 2009, INT J CANCER, V124, P924, DOI 10.1002/ijc.23980; Verhoeven DTH, 1997, BRIT J CANCER, V75, P149, DOI 10.1038/bjc.1997.25; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Wang XP, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-25; WELSCH CW, 1987, AM J CLIN NUTR, V45, P192, DOI 10.1093/ajcn/45.1.192; WELSCH CW, 1995, FREE RADICAL BIO MED, V18, P757, DOI 10.1016/0891-5849(94)00187-O; Wirfalt E, 2004, EUR J CLIN NUTR, V58, P761, DOI 10.1038/sj.ejcn.1601874; World Health Organization, 1993, ICD 10 INT CLASS DIS; Zock PL, 1997, AM J EPIDEMIOL, V145, P1114, DOI 10.1093/oxfordjournals.aje.a009074	49	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90442	10.1371/journal.pone.0090442	http://dx.doi.org/10.1371/journal.pone.0090442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587366	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800109
J	Chalfant, M; Bernd, KK				Chalfant, Madeleine; Bernd, Karen K.			17 beta-Estradiol Alters Rat Type-II Alveolar Cell Recovery from High Levels of Ozone	PLOS ONE			English	Article							NF-KAPPA-B; ARYL-HYDROCARBON RECEPTOR; GENE-EXPRESSION; OXIDATIVE STRESS; OXIDIZED TRYPTOPHAN; GENDER-DIFFERENCE; DOWN-REGULATION; ESTROGEN; EXPOSURE; MICE	Respiratory health is negatively impacted by exposure to ozone or to estrogens. Increasingly, individuals have simultaneous environmental exposure to both compounds. Characterizing the cellular responses stimulated by the combination of ozone and estrogens, therefore, is crucial to our complete understanding of the compounds' environmental health impacts. Our work introduces an alveolar cell culture model with defined media that provides evidence of ozone damage and determines sex hormones alter the cells' susceptibility to oxidative damage. Specifically, we investigated the individual and combined effects of environmentally relevant levels of ozone and 17 beta-estradiol on non-cancerous rat, type-II alveolar cells by examining biomarkers of cellular health and redox balance. The data reveal a complex role for 17 beta-estradiol in cellular recovery from 1 hr exposure to high ozone levels. At 0.5 hr post-ozone necrosis and inflammation markers show 17 beta-estradiol augments the detrimental effects of 350 ppb ozone, but after 24 hr of recovery, steroid treatment alters glutathione redox ratio and allows cellular proliferation.	[Chalfant, Madeleine; Bernd, Karen K.] Davidson Coll, Dept Biol, Davidson, NC 28036 USA	Davidson College	Bernd, KK (corresponding author), Davidson Coll, Dept Biol, Davidson, NC 28036 USA.	kabernd@davidson.edu	Bernd, Karen K/K-2774-2012	Bernd, Karen K/0000-0002-0743-2848	Merck Foundation; Davidson Research Initiative Grant	Merck Foundation(Merck & Company); Davidson Research Initiative Grant	This work was funded by a Merck Foundation Undergraduate Research in Biochemistry Grant (to KB) and a Davidson Research Initiative Grant (to MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, FREE RADICAL BIO MED, V39, P213, DOI 10.1016/j.freeradbiomed.2005.03.009; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Carey MA, 2007, AM J PHYSIOL-LUNG C, V293, pL272, DOI 10.1152/ajplung.00174.2007; Chang LW, 2007, CARCINOGENESIS; Cook MB, 2011, CANCER EPIDEM BIOMAR, V20, P1629, DOI 10.1158/1055-9965.EPI-11-0246; De Marinis E, 2010, NEUROSIGNALS, V18, P223, DOI 10.1159/000323906; de Torres JP, 2009, EUR RESPIR J, V33, P528, DOI 10.1183/09031936.00096108; Dhondt S, 2012, ENVIRON IMPACT ASSES, V36, P42, DOI 10.1016/j.eiar.2012.03.004; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Dougherty SM, 2006, ENDOCR-RELAT CANCER, V13, P113, DOI 10.1677/erc.1.01118; Dransfield MT, 2007, CHEST, V132, P464, DOI 10.1378/chest.07-0863; Fucic A, 2010, TOXICOL PATHOL, V38, P849, DOI 10.1177/0192623310378136; Funabashi H, 2004, TOXICOLOGY, V204, P75, DOI 10.1016/j.tox.2004.06.047; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Hamilton KL, 2004, ARTERIOSCL THROM VAS, V24, P1628, DOI 10.1161/01.ATV.0000137188.76195.fb; Ho CC, 2008, TOXICOL SCI, V104, P294, DOI 10.1093/toxsci/kfn096; Kafoury RM, 2007, ENVIRON TOXICOL, V22, P159, DOI 10.1002/tox.20246; Karlsson C, 2012, APMIS, V120, P451, DOI 10.1111/j.1600-0463.2011.02850.x; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Kosmider B, 2010, FREE RADICAL BIO MED, V48, P1513, DOI 10.1016/j.freeradbiomed.2010.02.032; Last JA, 2005, TOXICOL APPL PHARM, V208, P117, DOI 10.1016/j.taap.2005.02.001; Lin PP, 2004, TOXICOL APPL PHARM, V195, P83, DOI 10.1016/j.taap.2003.11.001; LU SC, 1991, J CLIN INVEST, V88, P260, DOI 10.1172/JCI115286; Maher TM, 2010, AM J RESP CRIT CARE, V182, P73, DOI 10.1164/rccm.200905-0674OC; Massaro D, 2007, AM J PHYSIOL-LUNG C, V293, pL222, DOI 10.1152/ajplung.00384.2006; Medina-Ramon M, 2006, AM J EPIDEMIOL, V163, P579, DOI 10.1093/aje/kwj078; Miyaguchi Chosei, 2004, Physiological Chemistry and Physics and Medical NMR, V36, P21; Nadadur SS, 2005, ENVIRON HEALTH PERSP, V113, P1717, DOI 10.1289/ehp.7413; Park GY, 2006, AM J PHYSIOL-LUNG C, V290, pL797, DOI 10.1152/ajplung.00513.2005; Porter W, 2001, J MOL ENDOCRINOL, V26, P31, DOI 10.1677/jme.0.0260031; Prokhorova S, 1998, AM J PHYSIOL-LUNG C, V275, pL1200, DOI 10.1152/ajplung.1998.275.6.L1200; Rahman I, 1999, ANTIOXID REDOX SIGN, V1, P425, DOI 10.1089/ars.1999.1.4-425; Roy D, 2007, J TOXICOL ENV HEAL B, V10, P235, DOI 10.1080/15287390600974924; Si ML, 2001, ENDOCRINE, V15, P255, DOI 10.1385/ENDO:15:3:255; Sindhu RK, 2000, J PHARMACOL EXP THER, V292, P1008; Sindhu RK, 1999, IN VITRO MOL TOXICOL, V12, P149; Singhal R, 2008, CARCINOGENESIS, V29, P227, DOI 10.1093/carcin/bgm288; Urata Y, 2006, J BIOL CHEM, V281, P13092, DOI 10.1074/jbc.M601984200; van de Wetering JK, 2004, EUR J BIOCHEM, V271, P1229, DOI 10.1111/j.1432-1033.2004.04040.x; Verma MK, 2011, J STEROID BIOCHEM, V127, P216, DOI 10.1016/j.jsbmb.2011.07.013; Wang GR, 2002, ENVIRON HEALTH PERSP, V110, P79, DOI 10.1289/ehp.0211079; Wang JR, 2006, FREE RADICAL BIO MED, V40, P1914, DOI 10.1016/j.freeradbiomed.2006.01.017; WELSHONS WV, 1988, MOL CELL ENDOCRINOL, V57, P169, DOI 10.1016/0303-7207(88)90072-X; Zhang Y, 2004, J NEUROSCI, V24, P5315, DOI 10.1523/JNEUROSCI.0913-04.2004	44	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90530	10.1371/journal.pone.0090530	http://dx.doi.org/10.1371/journal.pone.0090530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599035	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400089
J	Pang, F; Zha, RP; Zhao, YJ; Wang, QF; Chen, D; Zhang, ZF; Chen, TY; Yao, M; Gu, JR; He, XH				Pang, Fei; Zha, Ruopeng; Zhao, Yingjun; Wang, Qifeng; Chen, Di; Zhang, Zhenfeng; Chen, Taoyang; Yao, Ming; Gu, Jianren; He, Xianghuo			MiR-525-3p Enhances the Migration and Invasion of Liver Cancer Cells by Downregulating ZNF395	PLOS ONE			English	Article							PAPILLOMAVIRUS BINDING-FACTOR; HEPATOCELLULAR-CARCINOMA; TUMOR-CELLS; METASTASIS; MICRORNAS; OSTEOSARCOMA; TARGETS; GENES; CARCINOGENESIS; EXPRESSION	Liver cancer is one of leading causes of cancer-related deaths. A deeper mechanistic understanding of liver cancer could lead to the development of more effective therapeutic strategies. In our previous work, we screened 646 miRNAs and identified 11 that regulate liver cancer cell migration. The current study shows that miR-525-3p is frequently up-regulated in liver cancer tissues, and enhanced expression of miR-525-3p can promote liver cancer cell migration and invasion. Zinc finger protein 395 (ZNF395) is the direct functional target gene for miR-525-3p, and it is frequently down-regulated in liver cancer tissues. High expression of ZNF395 can significantly inhibit while knockdown of ZNF395 expression can markedly enhance the migration and invasion of liver cancer cells, suggesting that ZNF395 suppresses metastasis in liver cancer. Down-regulation of ZNF395 can mediate miR-525-3p induced liver cancer cell migration and invasion. In conclusion, miR-525-3p promotes liver cancer cell migration and invasion by directly targeting ZNF395, and the fact that miR-525-3p and ZNF395 both play important roles in liver cancer progression makes them potential therapeutic targets.	[Pang, Fei; Zha, Ruopeng] Fudan Univ, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Pang, Fei; Zha, Ruopeng; Zhao, Yingjun; Chen, Di; Zhang, Zhenfeng; Gu, Jianren; He, Xianghuo] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China; [Wang, Qifeng] Fudan Univ, Shanghai Canc Hosp, Shanghai 200433, Peoples R China; [Chen, Taoyang] Qi Dong Liver Canc Inst, Qi Dong, Peoples R China; [Yao, Ming] Shanghai Jiao Tong Univ, Dept Expt Pathol, Shanghai Canc Inst, Sch Med, Shanghai 200030, Peoples R China	Fudan University; Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University	He, XH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China.	xhhe@shsci.org	He, Xianghuo/I-1497-2014	He, Xianghuo/0000-0001-8872-668X	National 973 Key Basic Research Program [2013CB910504]; Shanghai Health Bureau [XYQ2011047, XBR2011039]; State Key Project for Liver Cancer [2012ZX10002-009013]	National 973 Key Basic Research Program(National Basic Research Program of China); Shanghai Health Bureau; State Key Project for Liver Cancer	This work was partially supported by grants from The National 973 Key Basic Research Program (2013CB910504), Shanghai Health Bureau (XYQ2011047, XBR2011039) and The State Key Project for Liver Cancer (2012ZX10002-009013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Boeckle S, 2002, VIROLOGY, V293, P103, DOI 10.1006/viro.2001.1231; BREEDIS C, 1954, AM J PATHOL, V30, P969; Brooks SA, 2010, ACTA HISTOCHEM, V112, P3, DOI 10.1016/j.acthis.2008.11.022; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Ding J, 2013, HEPATOLOGY, V58, P654, DOI 10.1002/hep.26378; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fatima S, 2012, ONCOGENE, V31, P4233, DOI 10.1038/onc.2011.580; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Inamura K, 2007, HUM PATHOL, V38, P702, DOI 10.1016/j.humpath.2006.11.019; Jia D, 2013, CELL RES; Jia DS, 2011, HEPATOLOGY, V54, P1227, DOI 10.1002/hep.24495; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li S, 2009, HEPATOLOGY, V49, P1194, DOI 10.1002/hep.22757; Liu ZZ, 2006, BIOORG MED CHEM LETT, V16, P1282, DOI 10.1016/j.bmcl.2005.11.069; MAREEL MM, 1993, CRIT REV ONCOGENESIS, V4, P559; MILLER FR, 1983, INVAS METAST, V3, P234; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Port M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-52; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Seo M, 2009, BIOCHEM BIOPH RES CO, V381, P153, DOI 10.1016/j.bbrc.2009.01.188; Sichtig N, 2007, ARCH BIOCHEM BIOPHYS, V464, P90, DOI 10.1016/j.abb.2007.04.017; Tsukahara T, 2008, CANCER SCI, V99, P368, DOI 10.1111/j.1349-7006.2008.00695.x; Tsukahara T, 2009, CANCER SCI, V100, P47, DOI 10.1111/j.1349-7006.2008.00991.x; Velazquez RF, 2003, HEPATOLOGY, V37, P520, DOI 10.1053/jhep.2003.50093; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang W, 2012, CARCINOGENESIS, V33, P1113, DOI 10.1093/carcin/bgs113; Wong QWL, 2010, CLIN CANCER RES, V16, P867, DOI 10.1158/1078-0432.CCR-09-1840; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Ying Q, 2011, HEPATOLOGY, V54, P2064, DOI 10.1002/hep.24614; Zha RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087665	39	34	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90867	10.1371/journal.pone.0090867	http://dx.doi.org/10.1371/journal.pone.0090867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599008	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400142
J	Tang, WF; Qiu, H; Jiang, HP; Wang, LX; Sun, B; Gu, HY				Tang, Weifeng; Qiu, Hao; Jiang, Heping; Wang, Lixin; Sun, Bin; Gu, Haiyong			Aurora-A V57I (rs1047972) Polymorphism and Cancer Susceptibility: A Meta-Analysis Involving 27,269 Subjects	PLOS ONE			English	Article							PATHWAY CONFER SUSCEPTIBILITY; CHROMOSOMAL INSTABILITY; KINASE POLYMORPHISMS; GENETIC-VARIANTS; RISK; ASSOCIATION; EXPRESSION; OVEREXPRESSION; MITOSIS; AURKA	Background: The association between Aurora-A V57I (rs1047972, G>A) polymorphism and cancer susceptibility has been widely studied. However, the results are inconsistent. Methodology/Principal Findings: To obtain a more precise evaluation of the relationship, we performed a meta-analysis of 14 case-control studies involving a total of 11,245 cancer cases and 16,024 controls. Our results demonstrated that there was a borderline evidence of an association between the Aurora-A V57I polymorphism and the decreased risk of overall cancer in two genetic models: AA vs. GA+GG and AA vs. GG. In a stratified analysis by cancer type, significant association between Aurora-A V57I polymorphism and the decreased risk of breast cancer was identified in one genetic model: AA vs. GG. In a stratified analysis by ethnicity, in three genetic models, significant decreased cancer risk was observed among Caucasians (AA vs. GA+GG; AA vs. GG and A vs. G) instead of Asians. Furthermore, a stratified analysis by ethnicity in breast cancer subgroup, five genetic models (AA+GA vs. GG; AA vs. GA+GG; AA vs. GG; AA vs. GA and A vs. G), significant decreased cancer risk was observed among Caucasians, but not among Asians. A slight publication bias was observed in our meta-analysis, thus nonparametric "trim-and-fill'' method was utilized to detect the stability of our results. The adjusted odds ratios and confidence intervals showed that Aurora-A V57I polymorphism might be a protective factor for cancer risk, suggesting the reliability of our findings. Conclusion: In summary, this meta-analysis suggests that Aurora-A V57I polymorphism may be a protective factor for cancer risk.	[Tang, Weifeng; Sun, Bin; Gu, Haiyong] Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Jiangsu, Peoples R China; [Qiu, Hao; Wang, Lixin] Southeast Univ, Sch Med, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Jiang, Heping] Jiangsu Univ, Affiliated Jintan Peoples Hosp, Emergency Dept, Jintan, Jiangsu, Peoples R China	Jiangsu University; Southeast University - China; Jiangsu University	Sun, B (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Jiangsu, Peoples R China.	xwk88915080@126.com; haiyong_gu@hotmail.com	Qiu, Hao/HGU-4490-2022		Jiangsu University Clinical Medicine Science and Technology Development Fund [JLY20120004]; Affiliated People's Hospital of Jiangsu University Fund [Y200913]; National Natural Science Foundation of China [81370001, 81101889, 81000028]; Jiangsu Province Natural Science Foundation [BK2010333, BK2011481]	Jiangsu University Clinical Medicine Science and Technology Development Fund; Affiliated People's Hospital of Jiangsu University Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This study was supported by Jiangsu University Clinical Medicine Science and Technology Development Fund (JLY20120004), Affiliated People's Hospital of Jiangsu University Fund (Y200913) and National Natural Science Foundation of China (81370001, 81101889, 81000028) and Jiangsu Province Natural Science Foundation (BK2010333, BK2011481). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2010, BREAST CANCER RES TR, V120, P727, DOI 10.1007/s10549-009-0489-8; Baba Y, 2009, NEOPLASIA, V11, P418, DOI 10.1593/neo.09154; Chen JY, 2007, CLIN CANCER RES, V13, P3100, DOI 10.1158/1078-0432.CCR-06-2319; Chen JY, 2007, MOL CARCINOGEN, V46, P249, DOI 10.1002/mc.20283; Chen L, 2005, GENETIC POLYMORPHISM; Cox DG, 2006, CANCER CAUSE CONTROL, V17, P81, DOI 10.1007/s10552-005-0429-9; Dai Q, 2004, CANCER EPIDEM BIOMAR, V13, P2065; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DiCioccio RA, 2004, CANCER EPIDEM BIOMAR, V13, P1589; Dogan I, 2008, DNA CELL BIOL, V27, P443, DOI 10.1089/dna.2007.0719; Du J, 2008, BIOCHEM BIOPH RES CO, V370, P213, DOI 10.1016/j.bbrc.2008.03.072; Egan KM, 2004, CARCINOGENESIS, V25, P2149, DOI 10.1093/carcin/bgh231; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Gast A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024370; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Ju H, 2006, CANCER LETT, V242, P273, DOI 10.1016/j.canlet.2005.11.015; Kimura MT, 2005, CANCER RES, V65, P3548, DOI 10.1158/0008-5472.CAN-04-2149; Lassmann S, 2007, CLIN CANCER RES, V13, P4083, DOI 10.1158/1078-0432.CCR-06-2775; Lentini L, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-212; Lo YL, 2005, INT J CANCER, V115, P276, DOI 10.1002/ijc.20855; MANTEL N, 1959, J NATL CANCER I, V22, P719; Milam MR, 2007, GYNECOL ONCOL, V107, P71, DOI 10.1016/j.ygyno.2007.05.025; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Pan JY, 2012, CANCER-AM CANCER SOC, V118, P4346, DOI 10.1002/cncr.26581; Perricone C, 2013, IMMUNOGENETICS; Ruan Y, 2011, J PATHOL, V225, P535, DOI 10.1002/path.2902; Tatsuka M, 2005, ONCOGENE, V24, P1122, DOI 10.1038/sj.onc.1208293; Wang W, 2007, CLIN CANCER RES, V13, P5974, DOI 10.1158/1078-0432.CCR-07-0113; Ye S, 2000, MATRIX BIOL, V19, P623, DOI 10.1016/S0945-053X(00)00102-5; Ye YQ, 2008, CANCER-AM CANCER SOC, V112, P2467, DOI 10.1002/cncr.23472	32	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90328	10.1371/journal.pone.0090328	http://dx.doi.org/10.1371/journal.pone.0090328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598702	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400064
J	Rey-Santano, C; Mielgo, V; Valls-i-Soler, A; Encinas, E; Lukas, JC; Vozmediano, V; Suarez, E				Rey-Santano, Carmen; Mielgo, Victoria; Valls-i-Soler, Adolfo; Encinas, Esther; Lukas, John C.; Vozmediano, Valvanera; Suarez, Elena			Evaluation of Fentanyl Disposition and Effects in Newborn Piglets as an Experimental Model for Human Neonates	PLOS ONE			English	Article							CHEST-WALL RIGIDITY; CONTINUOUS-INFUSION FENTANYL; PATENT DUCTUS-ARTERIOSUS; PRETERM INFANTS; DOSE FENTANYL; JUVENILE PIGS; ANESTHESIA; PHARMACOKINETICS; ANALGESIA; RESPONSES	Background: Fentanyl is widely used off-label in NICU. Our aim was to investigate its cerebral, cardiovascular and pulmonary effects as well as pharmacokinetics in an experimental model for neonates. Methods: Fentanyl (5 mu g/kg bolus immediately followed by a 90 minute infusion of 3 mu g/kg/h) was administered to six mechanically ventilated newborn piglets. Cardiovascular, ventilation, pulmonary and oxygenation indexes as well as brain activity were monitored from T = 0 up to the end of experiments (T = 225-300 min). Also plasma samples for quantification of fentanyl were drawn. Results: A "reliable degree of sedation" was observed up to T = 210-240 min, consistent with the selected dosing regimen and the observed fentanyl plasma levels. Unlike cardiovascular parameters, which were unmodified except for an increasing trend in heart rate, some of the ventilation and oxygenation indexes as well as brain activity were significantly altered. The pulmonary and brain effects of fentanyl were mostly recovered from T = 210 min to the end of experiment. Conclusion: The newborn piglet was shown to be a suitable experimental model for studying fentanyl disposition as well as respiratory and cardiovascular effects in human neonates. Therefore, it could be extremely useful for further investigating the drug behaviour under pathophysiological conditions.	[Rey-Santano, Carmen; Mielgo, Victoria; Valls-i-Soler, Adolfo] Cruces Univ Hosp, Expt Neonatal Physiol Unit, BioCruces Hlth Res Inst, Baracaldo, Bizkaia, Spain; [Encinas, Esther; Lukas, John C.; Suarez, Elena] Univ Basque Country, UPV EHU, Dept Pharmacol, Fac Med, Leioa, Bizkaia, Spain; [Lukas, John C.; Vozmediano, Valvanera] Dynakin SL, Drug Modeling & Consulting, Derio, Bizkaia, Spain	Hospital Universitario Cruces; University of Basque Country	Rey-Santano, C (corresponding author), Cruces Univ Hosp, Expt Neonatal Physiol Unit, BioCruces Hlth Res Inst, Baracaldo, Bizkaia, Spain.	macarmen.reysantano@osakidetza.net		Suarez, Elena/0000-0002-6683-4847	Spanish Carlos III Health Institute [FIS 10/943, RD12/0026/0001]; Basque Country Government; INNPACTO project of the Spanish Ministry of Science and Innovation - MICINN [ITP-09000-2010-002]; European Regional Development Fund (FEDER)	Spanish Carlos III Health Institute; Basque Country Government(Basque Government); INNPACTO project of the Spanish Ministry of Science and Innovation - MICINN; European Regional Development Fund (FEDER)(European Commission)	This study was partially supported by grants from the Spanish Carlos III Health Institute: FIS 10/943 and RD12/0026/0001 (Red SAMID: Maternal, Child Health and Development Research Network, within the framework of the VI Spanish National Plan for R+D+i 2008-2012). It was also supported by a predoctoral grant to one of the authors (EE) from the Research Staff Training Program (Basque Country Government) and by an INNPACTO project of the Spanish Ministry of Science and Innovation - MICINN (ITP-09000-2010-002), which is financed by the European Regional Development Fund (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2008, PEDIATR RES, V64, P653, DOI 10.1203/PDR.0b013e318186e5dd; ANAND KJS, 1987, LANCET, V1, P62; Anzenbacher P, 1998, DRUG METAB DISPOS, V26, P56; Aranda JV, 2005, CLIN THER, V27, P877, DOI 10.1016/j.clinthera.2005.06.019; Bernet V, 2010, PEDIATR RES, V67, P650, DOI 10.1203/PDR.0b013e3181da44ba; Calvo R, 2006, CURR PHARM DESIGN, V12, P977, DOI 10.2174/138161206776055967; COLLINS C, 1985, ANESTH ANALG, V64, P1078; da Silva O, 1999, J Perinatol, V19, P120, DOI 10.1038/sj.jp.7200145; Dewhirst E, 2012, PEDIATR EMERG CARE, V28, P465, DOI 10.1097/PEC.0b013e3182535a2a; Encinas E, 2013, PEDIATR DRUGS, V15, P10; Fahnenstich H, 2000, CRIT CARE MED, V28, P836, DOI 10.1097/00003246-200003000-00037; FRIESEN RH, 1986, ANESTHESIOLOGY, V64, P238, DOI 10.1097/00000542-198602000-00018; Fritz HG, 2005, ANESTH ANALG, V100, P996, DOI 10.1213/01.ANE.0000146517.17910.54; Guinsburg R, 1996, J PEDIAT, V132, P954; HICKEY PR, 1985, ANESTH ANALG, V64, P483; Hsu Benson, 2009, WMJ, V108, P343; IRAZUZTA J, 1993, CRIT CARE MED, V21, P1001, DOI 10.1097/00003246-199307000-00013; ITOH H, 1993, CAN J VET RES, V57, P74; Kuroha M, 2001, J VET PHARMACOL THER, V24, P423, DOI 10.1046/j.1365-2885.2001.00367.x; Labroo RB, 1997, DRUG METAB DISPOS, V25, P1072; McNamara PJ, 2002, AAPS PHARMSCI, V4; Modanlou HCD, 1996, J INVEST MED, V44, P362; Norman E, 2013, PEDIATR RES, V73, P87, DOI 10.1038/pr.2012.153; Prakash Smita, 2010, J Anaesthesiol Clin Pharmacol, V26, P567; Rajan V, 1998, BIOL NEONATE, V74, P39, DOI 10.1159/000014009; ROBINSON S, 1981, ANESTH ANALG, V60, P331; ROSOW CE, 1982, ANESTHESIOLOGY, V56, P93, DOI 10.1097/00000542-198202000-00003; Roth WJ, 2013, AAPS J, V15, P763, DOI 10.1208/s12248-013-9482-6; SCHIEBER RA, 1985, ANESTHESIOLOGY, V63, P166, DOI 10.1097/00000542-198508000-00009; SCOTT JC, 1985, ANESTHESIOLOGY, V62, P234, DOI 10.1097/00000542-198503000-00005; Sen S, 2004, INTENS CARE MED, V30, P496, DOI 10.1007/s00134-003-2141-0; Smith RP, 2004, AM J OBSTET GYNECOL, V190, P836, DOI 10.1016/j.ajog.2003.09.064; Tsuji M, 1998, PEDIATR RES, V44, P591, DOI 10.1203/00006450-199810000-00020; WELLS S, 1994, HEART LUNG, V23, P196; YASTER M, 1987, ANESTHESIOLOGY, V66, P524, DOI 10.1097/00000542-198704000-00013; YASTER M, 1987, ANESTHESIOLOGY, V66, P433, DOI 10.1097/00000542-198703000-00035	36	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90728	10.1371/journal.pone.0090728	http://dx.doi.org/10.1371/journal.pone.0090728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595018	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500092
J	Brodersen, J; Chapman, BB; Nilsson, PA; Skov, C; Hansson, LA; Bronmark, C				Brodersen, Jakob; Chapman, Ben B.; Nilsson, P. Anders; Skov, Christian; Hansson, Lars-Anders; Bronmark, Christer			Fixed and Flexible: Coexistence of Obligate and Facultative Migratory Strategies in a Freshwater Fish	PLOS ONE			English	Article							PREDATION; EVOLUTION; RISK	Migration is an important event in many animal life histories, but the degree to which individual animals participate in seasonal migrations often varies within populations. The powerful ecological and evolutionary consequences of such partial migration are now well documented, but the underlying mechanisms are still heavily debated. One potential mechanism of partial migration is between-individual variation in body condition, where animals in poor condition cannot pay the costs of migration and hence adopt a resident strategy. However, underlying intrinsic traits may overrule such environmental influence, dictating individual consistency in migratory patterns. Unfortunately, field tests of individual consistency compared to the importance of individual condition on migratory propensity are rare. Here we analyse 6 years of field data on roach migration, gathered by tagging almost 3000 individual fish and monitoring their seasonal migrations over extended periods of time. Our aims were to provide a field test of the role of condition in wild fish for migratory decisions, and also to assess individual consistency in migratory tendency. Our analyses reveal that (1) migratory strategy, in terms of migration/residency, is highly consistent within individuals over time and (2) there is a positive relationship between condition and the probability of migration, but only in individuals that adopt a migratory strategy at some point during their lives. However, life-long residents do not differ in condition to migrants, hence body condition is only a good predictor of migratory tendency in fish with migratory phenotypes and not a more general determinant of migratory tendency for the population. As resident individuals can achieve very high body condition and still remain resident, we suggest that our data provides some of the first field evidence to show that both facultative and obligate strategies can co-exist within populations of migratory animals.	[Brodersen, Jakob; Chapman, Ben B.; Nilsson, P. Anders; Hansson, Lars-Anders; Bronmark, Christer] Lund Univ, Dept Biol, Lund, Sweden; [Brodersen, Jakob] EAWAG Swiss Fed Inst Aquat Sci & Technol, Ctr Ecol Evolut & Biogeochem, Dept Fish Ecol & Evolut, Kastanienbaum, Switzerland; [Skov, Christian] Tech Univ Denmark DTU, Natl Inst Aquat Resources, Silkeborg, Denmark	Lund University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Technical University of Denmark	Brodersen, J (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	jakob.brodersen@eawag.ch	Hansson, Lars-Anders/HCI-2735-2022; Skov, Christian/X-6511-2019; Nilsson, Anders/H-6836-2014	Skov, Christian/0000-0002-8547-6520; Nilsson, Anders/0000-0002-3541-9835; Hansson, Lars-Anders/0000-0002-3035-1317	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); Swedish Research Council (VR); Danish Angling License Funds; FP7 Marie Curie Intra-European fellowship	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Swedish Research Council (VR)(Swedish Research Council); Danish Angling License Funds; FP7 Marie Curie Intra-European fellowship	The work was supported by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), the Swedish Research Council (VR), and the Danish Angling License Funds. BBC was funded by an FP7 Marie Curie Intra-European fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTHOLD P, 1991, TRENDS ECOL EVOL, V6, P254, DOI 10.1016/0169-5347(91)90072-6; BERTHOLD P, 1994, P ROY SOC B-BIOL SCI, V257, P311, DOI 10.1098/rspb.1994.0131; BOHL E, 1980, OECOLOGIA, V44, P368, DOI 10.1007/BF00545241; Brodersen J, 2008, ECOLOGY, V89, P1195, DOI 10.1890/07-1318.1; Brodersen J, 2011, OIKOS, V120, P1838, DOI 10.1111/j.1600-0706.2011.19433.x; Brodersen J, 2012, BIOL LETTERS, V8, P21, DOI 10.1098/rsbl.2011.0634; Bronmark C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001957; Chapman BB, 2012, J FISH BIOL, V81, P456, DOI 10.1111/j.1095-8649.2012.03342.x; Chapman BB, 2012, J FISH BIOL, V81, P479, DOI 10.1111/j.1095-8649.2012.03349.x; Chapman BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061223; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Chapman BB, 2011, ECOL LETT, V14, P871, DOI 10.1111/j.1461-0248.2011.01648.x; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; GODIN JGJ, 1994, BEHAV ECOL SOCIOBIOL, V34, P359, DOI 10.1007/BF00197006; GOTCEITAS V, 1991, BEHAV ECOL SOCIOBIOL, V29, P255, DOI 10.1007/BF00163982; Kinnerback A, 2013, NATL REGISTER SURVEY; LUNDBERG P, 1987, J THEOR BIOL, V125, P351, DOI 10.1016/S0022-5193(87)80067-X; LUNDBERG P, 1988, TRENDS ECOL EVOL, V3, P172, DOI 10.1016/0169-5347(88)90035-3; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; McNamara JM, 1998, J AVIAN BIOL, V29, P416, DOI 10.2307/3677160; Olsson IC, 2006, ECOL LETT, V9, P645, DOI 10.1111/j.1461-0248.2006.00909.x; Pulido F, 1996, P NATL ACAD SCI USA, V93, P14642, DOI 10.1073/pnas.93.25.14642; Pulido F, 2011, OIKOS, V120, P1776, DOI 10.1111/j.1600-0706.2011.19844.x; Rolshausen G, 2009, CURR BIOL, V19, P2097, DOI 10.1016/j.cub.2009.10.061; Skov C, 2005, J FISH BIOL, V67, P1195, DOI 10.1111/j.1095-8649.2005.00814.x; Skov C, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1178; Swingland IR, 1984, ECOLOGY ANIMAL MIGRA; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Wood CC, 1996, EVOLUTION, V50, P1265, DOI [10.1111/j.1558-5646.1996.tb02367.x, 10.2307/2410667]	30	38	38	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90294	10.1371/journal.pone.0090294	http://dx.doi.org/10.1371/journal.pone.0090294			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594698	Green Submitted, gold, Green Published			2022-12-27	WOS:000332468900091
J	Cheng, NC; van Zandwijk, N; Reid, G				Cheng, Ngan Ching; van Zandwijk, Nico; Reid, Glen			Cilengitide Inhibits Attachment and Invasion of Malignant Pleural Mesothelioma Cells through Antagonism of Integrins alpha v beta 3 and alpha v beta 5	PLOS ONE			English	Article							PHASE-I; GLIOMA-CELLS; APOPTOSIS; ASBESTOS; CANCER; ALPHA(V)BETA(3); ANGIOGENESIS; TEMOZOLOMIDE; METASTASIS; DISTINCT	Malignant pleural mesothelioma (MPM) is an almost invariably fatal, asbestos-related malignancy arising from the mesothelial membrane lining the thoracic cavities. Despite some improvements in treatment, therapy is not considered curative and median survival following diagnosis is less than 1 year. Although still classed as a rare cancer, the incidence of MPM is increasing, and the limited progress in treating the disease makes the identification of new therapies a priority. As there is evidence for expression of the integrins alpha v beta 3 and alpha v beta 5 in MPM, there is a rationale for investigating the effects on MPM of cilengitide, a synthetic peptide inhibitor of integrin alpha v heterodimer with high specificity for alpha v beta 3 and alpha v beta 5. In mesothelial cells (MC) and 7 MPM cell lines, growth inhibition by cilengitide was associated with the expression level of its target integrins. Furthermore, cilengitide caused cell detachment and subsequent death of anoikis-sensitive cells. It also suppressed invasion of MPM cells in monolayer and three-dimensional cultures. Gene knockdown experiments indicated that these effects of cilengitide were, at least partly, due to antagonism of alpha v beta 3 and alpha v beta 5.	[Cheng, Ngan Ching; van Zandwijk, Nico; Reid, Glen] Univ Sydney, Asbestos Dis Res Inst, Concord, NSW, Australia	University of Sydney	Cheng, NC (corresponding author), Univ Sydney, Asbestos Dis Res Inst, Concord, NSW, Australia.	ngan.cheng@sydney.edu.au	van Zandwijk, Nico/E-4177-2012	van Zandwijk, Nico/0000-0002-8405-9688; Reid, Glen/0000-0001-6465-5223	Cancer Institute NSW [11/TPG/3-06]; Merck [4501161930]	Cancer Institute NSW; Merck(Merck & Company)	This study was funded by a Cancer Institute NSW grant (11/TPG/3-06) to NvZ and GR, and an investigator initiated study grant (4501161930) from Merck to GR and NvZ. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alghisi GC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004449; Barth TFE, 1997, INT J CANCER, V72, P77, DOI 10.1002/(SICI)1097-0215(19970703)72:1<77::AID-IJC12>3.0.CO;2-7; BOYLAN AM, 1995, J CLIN INVEST, V96, P1987, DOI 10.1172/JCI118246; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Byzova TV, 1998, THROMB HAEMOSTASIS, V80, P726; Cristaudo A, 2011, J THORAC ONCOL, V6, P1587, DOI 10.1097/JTO.0b013e31821e1c08; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Flores RM, 2007, J THORAC ONCOL, V2, P957, DOI 10.1097/JTO.0b013e31815608d9; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Goodman SL, 2012, BIOL OPEN, V1, P329, DOI 10.1242/bio.2012364; Hammes HP, 1996, NAT MED, V2, P529, DOI 10.1038/nm0596-529; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim YH, 2013, INT J CANC; Klominek J, 1997, INT J CANCER, V72, P1034, DOI 10.1002/(SICI)1097-0215(19970917)72:6<1034::AID-IJC19>3.0.CO;2-4; Koukoulis GK, 1997, HUM PATHOL, V28, P84, DOI 10.1016/S0046-8177(97)90284-7; Leblond P, 2013, ANTICANCER DRUGS; LECHNER JF, 1985, P NATL ACAD SCI USA, V82, P3884, DOI 10.1073/pnas.82.11.3884; MacDonald TJ, 2001, NEUROSURGERY, V48, P151, DOI 10.1097/00006123-200101000-00026; Marshall JF, 1996, SEMIN CANCER BIOL, V7, P129, DOI 10.1006/scbi.1996.0018; Maurer GD, 2009, NEURO-ONCOLOGY, V11, P747, DOI 10.1215/15228517-2009-012; Mikkelsen T, 2009, INT J CANCER, V124, P2719, DOI 10.1002/ijc.24240; Nabors LB, 2007, J CLIN ONCOL, V25, P1651, DOI 10.1200/JCO.2006.06.6514; Nisato Riccardo E., 2003, Angiogenesis, V6, P105, DOI 10.1023/B:AGEN.0000011801.98187.f2; O'Donnell PH, 2012, INVEST NEW DRUG, V30, P604, DOI 10.1007/s10637-010-9537-9; Oliveira-Ferrer L, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-86; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Reardon David A, 2011, Genes Cancer, V2, P1159, DOI 10.1177/1947601912450586; Relan V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058132; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Sigstad E, 2005, DIAGN CYTOPATHOL, V33, P325, DOI 10.1002/dc.20282; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; SMYTHE WR, 1994, ANN THORAC SURG, V57, P1395, DOI 10.1016/0003-4975(94)90090-6; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; Tentori L, 2008, ONCOL REP, V19, P1039; Tsao AS, 2009, J CLIN ONCOL, V27, P2081, DOI 10.1200/JCO.2008.19.8523; Vermorken JB, 2011, BRIT J CANCER, V104, P1691, DOI 10.1038/bjc.2011.152; Wiggins HL, 2010, BIOTECHNIQUES, V48, P120, DOI 10.2144/000113353; Zervos MD, 2008, CURR OPIN PULM MED, V14, P303, DOI 10.1097/MCP.0b013e328302851d	41	25	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90374	10.1371/journal.pone.0090374	http://dx.doi.org/10.1371/journal.pone.0090374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595274	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900101
J	Jeff, JM; Armstrong, LL; Ritchie, MD; Denny, JC; Kho, AN; Basford, MA; Wolf, WA; Pacheco, JA; Li, RL; Chisholm, RL; Roden, DM; Hayes, MG; Crawford, DC				Jeff, Janina M.; Armstrong, Loren L.; Ritchie, Marylyn D.; Denny, Joshua C.; Kho, Abel N.; Basford, Melissa A.; Wolf, Wendy A.; Pacheco, Jennifer A.; Li, Rongling; Chisholm, Rex L.; Roden, Dan M.; Hayes, M. Geoffrey; Crawford, Dana C.			Admixture Mapping and Subsequent Fine-Mapping Suggests a Biologically Relevant and Novel Association on Chromosome 11 for Type 2 Diabetes in African Americans	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ELECTRONIC MEDICAL-RECORDS; EMERGE NETWORK; RISK LOCI; VARIANT; VISUALIZATION; ANCESTRY; GENETICS; REVEALS; DISEASE	Type 2 diabetes (T2D) is a complex metabolic disease that disproportionately affects African Americans. Genome-wide association studies (GWAS) have identified several loci that contribute to T2D in European Americans, but few studies have been performed in admixed populations. We first performed a GWAS of 1,563 African Americans from the Vanderbilt Genome-Electronic Records Project and Northwestern University NUgene Project as part of the electronic Medical Records and Genomics (eMERGE) network. We successfully replicate an association in TCF7L2, previously identified by GWAS in this African American dataset. We were unable to identify novel associations at p<5.0x10(-8) by GWAS. Using admixture mapping as an alternative method for discovery, we performed a genome-wide admixture scan that suggests multiple candidate genes associated with T2D. One finding, TCIRG1, is a T-cell immune regulator expressed in the pancreas and liver that has not been previously implicated for T2D. We performed subsequent fine-mapping to further assess the association between TCIRG1 and T2D in >5,000 African Americans. We identified 13 independent associations between TCIRG1, CHKA, and ALDH3B1 genes on chromosome 11 and T2D. Our results suggest a novel region on chromosome 11 identified by admixture mapping is associated with T2D in African Americans.	[Jeff, Janina M.] Vanderbilt Univ, Charles Bronfman Inst Personalized Med, Icahn Sch Med Mt Sinai, Nashville, TN 37235 USA; [Crawford, Dana C.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [Denny, Joshua C.; Roden, Dan M.] Vanderbilt Univ, Dept Med, Div Clin Pharmacol, Nashville, TN 37235 USA; [Denny, Joshua C.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37235 USA; [Basford, Melissa A.; Roden, Dan M.] Vanderbilt Univ, Off Personalized Med, Nashville, TN 37235 USA; [Roden, Dan M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA; [Kho, Abel N.] Northwestern Univ, Div Gen Internal Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Armstrong, Loren L.; Hayes, M. Geoffrey] Northwestern Univ, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Pacheco, Jennifer A.; Chisholm, Rex L.; Hayes, M. Geoffrey] Northwestern Univ, Ctr Genet Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Wolf, Wendy A.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Li, Rongling] NHGRI, Off Populat Genom, Bethesda, MD 20892 USA; [Ritchie, Marylyn D.] Penn State Univ, Dept Biochem & Mol Biol, Ctr Syst Genom, University Pk, PA 16802 USA	Icahn School of Medicine at Mount Sinai; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Crawford, DC (corresponding author), Vanderbilt Univ, Ctr Human Genet Res, 221 Kirkland Hall, Nashville, TN 37235 USA.	crawford@chgr.mc.vanderbilt.edu	Crawford, Dana/O-5578-2019; Roden, Dan/ABD-5412-2021; Denny, Josh/AAL-3359-2021; Chisholm, Rex/B-3418-2009	Crawford, Dana/0000-0002-6437-6248; Denny, Josh/0000-0002-3049-7332; Hayes, M Geoffrey/0000-0002-4617-3981; Pacheco, Jennifer/0000-0001-8021-5818; Chisholm, Rex/0000-0002-5638-3990	NIH/NHGRI [U01HG004609, U01HG04603]; NCATS/NIH [UL1 TR000445]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007824] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004609, U01HG006378, U01HG006388, U01HG004603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178, R25GM062459] Funding Source: NIH RePORTER	NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH/NHGRI U01HG004609 (Northwestern University as part of eMERGE) and U01HG04603 (Vanderbilt University as part of eMERGE, also serving as the Administrative Coordinating Center). A portion of the dataset(s) used for the analyses described were obtained from Vanderbilt University Medical Center's BioVU which is supported by institutional funding and by the Vanderbilt CTSA grant UL1 TR000445 from NCATS/NIH. As part of the cooperative agreement, NHGRI participated in the study design, data collection and analysis, and preparation of the manuscript.	ADA, 2011, DIAB STAT; Ahlqvist E, 2011, CLIN CHEM, V57, P241, DOI 10.1373/clinchem.2010.157016; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bielinski SJ, 2011, MAYO CLIN PROC, V86, P606, DOI 10.4065/mcp.2011.0178; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Cheng CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032840; Cheng CY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000490; Crosslin DR, 2011, HUMGENET; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Denny JC, 2010, CIRCULATION, V122, P2016, DOI 10.1161/CIRCULATIONAHA.110.948828; Ding KY, 2012, MAYO CLIN PROC, V87, P461, DOI 10.1016/j.mayocp.2012.01.016; Disease NIoDaK, 2007, NAT DIAB INF PRED WH; Dumitrescu L, 2010, GENETMED; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gallego-Ortega D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007819; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gower BA, 2002, J CLIN ENDOCR METAB, V87, P2218, DOI 10.1210/jc.87.5.2218; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Herder C, 2011, EUR J CLIN INVEST, V41, P679, DOI 10.1111/j.1365-2362.2010.02454.x; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kho AN, 2012, J AM MED INFORM ASSN, V19, P212, DOI 10.1136/amiajnl-2011-000439; Kullo IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013011; Long JR, 2012, AM J EPIDEMIOL, V176, P995, DOI 10.1093/aje/kws176; Maskarinec G, 2009, ETHNIC DIS, V19, P49; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; Mozaffarian D, 2009, ARCH INTERN MED, V169, P798, DOI 10.1001/archinternmed.2009.21; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pendergrass SA, 2010, BIODATA MIN, V3, DOI 10.1186/1756-0381-3-10; Pulley J, 2010, CTS-CLIN TRANSL SCI, V3, P42, DOI 10.1111/j.1752-8062.2010.00175.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramirez de Molina A, 2008, INT J BIOCHEM CELL B, V40, P1753, DOI 10.1016/j.biocel.2008.01.013; Rasmussen-Torvik LJ, 2012, CTS-CLIN TRANSL SCI, V5, P394, DOI 10.1111/j.1752-8062.2012.00446.x; Reich D, 2009, PLOSGENET, V5; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Tandon A, 2011, GENET EPIDEMIOL, V35, P80, DOI 10.1002/gepi.20550; Tong Y, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-15; Turner SD, 2011, PLOS ONE, V6; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Yaeger R, 2008, CANCER EPIDEM BIOMAR, V17, P1329, DOI 10.1158/1055-9965.EPI-07-2505; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zuvich RL, 2011, GENET EPIDEMIOL, V35, P887, DOI 10.1002/gepi.20639	54	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e86931	10.1371/journal.pone.0086931	http://dx.doi.org/10.1371/journal.pone.0086931			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595071	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900001
J	Theodore, CM; Stamps, BW; King, JB; Price, LSL; Powell, DR; Stevenson, BS; Cichewicz, RH				Theodore, Christine M.; Stamps, Blake W.; King, Jarrod B.; Price, Lauren S. L.; Powell, Douglas R.; Stevenson, Bradley S.; Cichewicz, Robert H.			Genomic and Metabolomic Insights into the Natural Product Biosynthetic Diversity of a Feral-Hog-Associated Brevibacillus laterosporus Strain	PLOS ONE			English	Article							HUMAN MICROBIOME; EVOLUTION; ACID	Bacteria associated with mammals are a rich source of microbial biodiversity; however, little is known concerning the abilities of these microbes to generate secondary metabolites. This report focuses on a bacterium isolated from the ear of a feral hog from southwestern Oklahoma, USA. The bacterium was identified as a new strain (PE36) of Brevibacillus latersporus, which was shown via genomic analysis to contain a large number of gene clusters presumably involved in secondary metabolite biosynthesis. A scale-up culture of B. latersporus PE36 yielded three bioactive compounds that inhibited the growth of methicillin-resistant Staphylococcus aureus (basiliskamides A and B and 12-methyltetradecanoic acid). Further studies of the isolate's secondary metabolome provided both new (auripyrazine) and previously-described pyrazine-containing compounds. In addition, a new peptidic natural product (auriporcine) was purified that was determined to be composed of a polyketide unit, two L-proline residues, two D-leucine residues, one L-leucine residue, and a reduced L-phenylalanine (L-phenylalanol). An examination of the genome revealed two gene clusters that are likely responsible for generating the basiliskamides and auriporcine. These combined genomic and chemical studies confirm that new and unusual secondary metabolites can be obtained from the bacterial associates of wild mammals.	[Theodore, Christine M.; King, Jarrod B.; Price, Lauren S. L.; Powell, Douglas R.; Cichewicz, Robert H.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Theodore, Christine M.; King, Jarrod B.; Price, Lauren S. L.; Stevenson, Bradley S.; Cichewicz, Robert H.] Univ Oklahoma, Inst Nat Prod Applicat & Res Technol, Nat Prod Discovery Grp, Norman, OK 73019 USA; [Stamps, Blake W.; Stevenson, Bradley S.] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Cichewicz, RH (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.	rhcichewicz@ou.edu	Stevenson, Bradley Scott/A-2786-2011; Stamps, Blake Warren/H-9781-2019; Cichewicz, Robert H/H-5233-2012	Stevenson, Bradley Scott/0000-0001-9432-9744; Stamps, Blake Warren/0000-0001-9713-9014; Cichewicz, Robert/0000-0003-0744-4117	National Institutes of Health [5R21AI101487]; Office of the Vice President for Research, University of Oklahoma, Norman Campus; Shimadzu Equipment Grant Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Vice President for Research, University of Oklahoma, Norman Campus; Shimadzu Equipment Grant Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this project was provided in part by an award from the National Institutes of Health (5R21AI101487), a Challenge Grant from the Office of the Vice President for Research, University of Oklahoma, Norman Campus, and an award through the Shimadzu Equipment Grant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASENSIO C, 1976, BIOCHEM BIOPH RES CO, V69, P7, DOI 10.1016/S0006-291X(76)80264-1; Barsby T, 2002, J NAT PROD, V65, P1447, DOI 10.1021/np0201321; Bhushan R, 2004, AMINO ACIDS, V27, P231, DOI 10.1007/s00726-004-0118-0; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Bythell BJ, 2010, J AM CHEM SOC, V132, P14766, DOI 10.1021/ja101556g; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; Cragg GM, 2002, TRENDS PHARMACOL SCI, V23, P404, DOI 10.1016/S0165-6147(02)02099-0; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jensen K, 2012, CHEM BIOL, V19, P329, DOI 10.1016/j.chembiol.2012.01.005; Jessup DA, 2003, ILAR J, V44, P277, DOI 10.1093/ilar.44.4.277; Joyner PM, 2010, ORG BIOMOL CHEM, V8, P5486, DOI 10.1039/c0ob00579g; Kelly MTS, 2005, Patent application, Patent No. [US 20050277779, 20050277779]; KITAHARA T, 1995, BIOSCI BIOTECH BIOCH, V59, P78, DOI 10.1271/bbb.59.78; Kochhar S, 2002, PROTEIN PROTOCOLS HD, P995; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032118; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Piel J, 2004, NAT PROD REP, V21, P519, DOI 10.1039/b310175b; Piel J, 2009, NAT PROD REP, V26, P338, DOI 10.1039/b703499g; Piel J, 2010, NAT PROD REP, V27, P996, DOI 10.1039/b816430b; Ruas-Madiedo P, 2010, J APPL MICROBIOL, V109, P2079, DOI 10.1111/j.1365-2672.2010.04839.x; Shaaban M, 2002, J NAT PROD, V65, P1660, DOI 10.1021/np020019a; Wang XR, 2012, ORG BIOMOL CHEM, V10, P2044, DOI 10.1039/c2ob06856g; Wei MQ, 2008, CANCER LETT, V259, P16, DOI 10.1016/j.canlet.2007.10.034; Yang JY, 2011, CURR OPIN CHEM BIOL, V15, P79, DOI 10.1016/j.cbpa.2010.10.025; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	29	19	20	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90124	10.1371/journal.pone.0090124	http://dx.doi.org/10.1371/journal.pone.0090124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595070	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900070
J	Wan, XB; Jiang, R; Xie, FY; Qi, ZY; Li, AJ; Ye, WJ; Hua, YJ; Zhu, YL; Zou, X; Guo, L; Mai, HQ; Guo, X; Hong, MH; Chen, MY				Wan, Xiang-Bo; Jiang, Rou; Xie, Fang-Yun; Qi, Zhen-Yu; Li, Ai-Ju; Ye, Wei-Jun; Hua, Yi-Jun; Zhu, Yu-Liang; Zou, Xiong; Guo, Ling; Mai, Hai-Qiang; Guo, Xiang; Hong, Ming-Huang; Chen, Ming-Yuan			Endoscope-Guided Interstitial Intensity-Modulated Brachytherapy and Intracavitary Brachytherapy as Boost Radiation for Primary Early T Stage Nasopharyngeal Carcinoma	PLOS ONE			English	Article							EXTERNAL-BEAM RADIATION; CANCER PATIENTS; LOCAL-CONTROL; RECURRENT; SALVAGE; REIRRADIATION; THERAPY	Background: Intracavitary brachytherapy (ICBT) is usually applied as boost radiotherapy for superficial residual of nasopharyngeal carcinoma (NPC) after primary extern-beam radiptherapy (ERT). Here, we evaluated the outcome of endoscope-guided interstitial intensity-modulated brachytherapy (IMBT) boost radiation for deep-seated residual NPC. Methodology/Principal Findings: Two hundred and thirteen patients with residual NPC who were salvaged with brachytherapy boost radiation during 2005-2009 were analyzed retrospectively. Among these patients, 171 patients had superficial residual NPC (<= 1 cm below the nasopharyngeal epithelium) were treated with ICBT boost radiation, and interstitial IMBT boost radiation was delivered to 42 patients with deep-seated residual NPC (>1 cm below the nasopharyngeal epithelium). We found that IMBT boost subgroup had a higher ratio of T2b (81.0% VS 34.5%, P<0.001) and stage II (90.5% VS 61.4%, P = 0.001) than that of ICBT boost subgroup. The dosage of external-beam radiotherapy in the nasopharyngeal (63.06 +/- 3.8 VS 62.6 +/- 64.3 Gray (Gy), P = 0.67) and regional lymph nodes (55.8 +/- 5.0 VS 57.5 +/- 5.7 Gy, P = 0.11) was comparable in both groups. For brachytherapy, IMBT subgroup had a lower boost radiation dosage than ICBT subgroup (11.0 +/- 62.9 VS 14.8 +/- 3.2 Gy, P<0.01). Though the IMBT group had deeper residual tumors and received lower boost radiation dosages, both subgroups had the similar 5-year actuarial overall survival rate (IMBT VS ICBT group: 96.8% VS 93.6%, P = 0.87), progression-free survival rate (92.4% VS 86.5%, P = 0.41) and distant metastasis-free survival rate (94.9% VS 92.7%, P = 0.64). Moreover, IMBT boost radiation subgroup had a similar local (97.4% VS 94.4%, P = 0.57) and regional (95.0% VS 97.2%, P = 0.34) control to ICBT subgroup. The acute and late toxicities rates were comparable between the both subgroups. Conclusions/Significance: IMBT boost radiation may be a promising therapeutic selection for deep-seated residual NPC.	[Wan, Xiang-Bo; Jiang, Rou; Hua, Yi-Jun; Zhu, Yu-Liang; Zou, Xiong; Guo, Ling; Mai, Hai-Qiang; Guo, Xiang; Hong, Ming-Huang; Chen, Ming-Yuan] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China; [Wan, Xiang-Bo; Jiang, Rou; Xie, Fang-Yun; Li, Ai-Ju; Ye, Wei-Jun; Hua, Yi-Jun; Zhu, Yu-Liang; Zou, Xiong; Guo, Ling; Mai, Hai-Qiang; Guo, Xiang; Hong, Ming-Huang; Chen, Ming-Yuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Wan, Xiang-Bo] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Xie, Fang-Yun; Qi, Zhen-Yu; Li, Ai-Ju; Ye, Wei-Jun] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Wan, Xiang-Bo; Jiang, Rou; Xie, Fang-Yun; Qi, Zhen-Yu; Li, Ai-Ju; Ye, Wei-Jun; Hua, Yi-Jun; Zhu, Yu-Liang; Zou, Xiong; Guo, Ling; Mai, Hai-Qiang; Guo, Xiang; Hong, Ming-Huang; Chen, Ming-Yuan] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Chen, MY (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China.	chmingy@mail.sysu.edu.cn	Chen, Ming/GVU-8412-2022		Program for Training Programme Foundation for the Talents by Sun Yat-sen University Cancer Center; New Century Excellent Talents in University [NCET-12-0562]; Sun Yat-Sen University Clinical Research 5010 Program [201310]; National Natural Science Foundation of China [81071890, 81000934, 81370060]; Guangdong Provincial Natural Science Foundation of China [S2013020012726]; Foundation for Distinguished Young Scholars of Sun Yat-sen University [13ykzd20]; Foundation for Pearl River Science & Technology Young Scholars of Guangzhou [2013J2200043]; Foundation for Outstanding Doctoral Thesis of Guangdong Province [sybzzxm201207]; National High Technology Research and Development Program of China (863 Program) [2012AA02A501]	Program for Training Programme Foundation for the Talents by Sun Yat-sen University Cancer Center; New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Sun Yat-Sen University Clinical Research 5010 Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); Foundation for Distinguished Young Scholars of Sun Yat-sen University; Foundation for Pearl River Science & Technology Young Scholars of Guangzhou; Foundation for Outstanding Doctoral Thesis of Guangdong Province; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the Program for Training Programme Foundation for the Talents by Sun Yat-sen University Cancer Center (MY Chen, 2009), New Century Excellent Talents in University (NCET-12-0562), Sun Yat-Sen University Clinical Research 5010 Program (201310), National Natural Science Foundation of China (Grants No. 81071890, No. 81000934 and No. 81370060), Guangdong Provincial Natural Science Foundation of China (S2013020012726), Foundation for Distinguished Young Scholars of Sun Yat-sen University (No. 13ykzd20), Foundation for Pearl River Science & Technology Young Scholars of Guangzhou (No. 2013J2200043), Foundation for Outstanding Doctoral Thesis of Guangdong Province (No. sybzzxm201207), and National High Technology Research and Development Program of China (863 Program, No. 2012AA02A501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan ATC, 2011, EUR J CANCER, V47, pS302, DOI 10.1016/S0959-8049(11)70179-4; Chan ATC, 2005, J CLIN ONCOL, V23, P3568, DOI 10.1200/JCO.2005.02.147; Chen Ming-Yuan, 2007, Ai Zheng, V26, P513; Chua DTT, 1998, INT J RADIAT ONCOL, V41, P379, DOI 10.1016/S0360-3016(98)00063-7; Das RK, 2004, INT J RADIAT ONCOL, V59, P1224, DOI 10.1016/j.ijrobp.2004.03.030; Greene FL PD, 2002, AJCC CANC STAGING HD, P73; Huang EY, 2013, INT J RADIAT ONCOL, V85, P123, DOI 10.1016/j.ijrobp.2012.03.045; Kovacs G, 2007, BRACHYTHERAPY, V6, P142, DOI 10.1016/j.brachy.2007.02.062; Lee AWM, 2012, ORAL ONCOL, V48, P768, DOI 10.1016/j.oraloncology.2012.02.017; Lee AWM, 1997, INT J RADIAT ONCOL, V38, P43, DOI 10.1016/S0360-3016(97)00244-7; Leung TW, 2008, INT J RADIAT ONCOL, V70, P361, DOI 10.1016/j.ijrobp.2007.06.078; Leung TW, 2000, INT J RADIAT ONCOL, V48, P1331, DOI 10.1016/S0360-3016(00)00776-8; Leung TW, 2005, CANCER, V104, P1648, DOI 10.1002/cncr.21371; Nomden CN, 2013, RADIOTHER ONCOL, V107, P69, DOI 10.1016/j.radonc.2013.04.006; Palmer AL, 2013, MED PHYS, V40, DOI 10.1118/1.4805100; Ren YF, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-165; Ren YF, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-113; Schinagl DAX, 2010, INT J RADIAT ONCOL, V78, P689, DOI 10.1016/j.ijrobp.2009.08.072; Shi CY, 2010, MED PHYS, V37, P3725, DOI 10.1118/1.3456598; Stoker SD, 2013, CURR TREAT OPTION ON, V14, P475, DOI 10.1007/s11864-013-0261-5; Sultanem K, 2000, INT J RADIAT ONCOL, V48, P711, DOI 10.1016/S0360-3016(00)00702-1; Teo PML, 2000, INT J RADIAT ONCOL, V46, P445, DOI 10.1016/S0360-3016(99)00326-0; Teo PML, 1998, INT J RADIAT ONCOL, V40, P897, DOI 10.1016/S0360-3016(97)00854-7; WANG CC, 1991, AM J CLIN ONCOL-CANC, V14, P5, DOI 10.1097/00000421-199102000-00002; Wu JX, 2013, BRACHYTHERAPY, V12, P479, DOI 10.1016/j.brachy.2012.10.004	25	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90048	10.1371/journal.pone.0090048	http://dx.doi.org/10.1371/journal.pone.0090048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595299	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900057
J	Yabusaki, K; Faits, T; McMullen, E; Figueiredo, JL; Aikawa, M; Aikawa, E				Yabusaki, Katsumi; Faits, Tyler; McMullen, Eri; Figueiredo, Jose Luiz; Aikawa, Masanori; Aikawa, Elena			A Novel Quantitative Approach for Eliminating Sample-To-Sample Variation Using a Hue Saturation Value Analysis Program	PLOS ONE			English	Article							THICKNESS; CRYOSTAT	Objectives: As computing technology and image analysis techniques have advanced, the practice of histology has grown from a purely qualitative method to one that is highly quantified. Current image analysis software is imprecise and prone to wide variation due to common artifacts and histological limitations. In order to minimize the impact of these artifacts, a more robust method for quantitative image analysis is required. Methods and Results: Here we present a novel image analysis software, based on the hue saturation value color space, to be applied to a wide variety of histological stains and tissue types. By using hue, saturation, and value variables instead of the more common red, green, and blue variables, our software offers some distinct advantages over other commercially available programs. We tested the program by analyzing several common histological stains, performed on tissue sections that ranged from 4 mm to 10 mm in thickness, using both a red green blue color space and a hue saturation value color space. Conclusion: We demonstrated that our new software is a simple method for quantitative analysis of histological sections, which is highly robust to variations in section thickness, sectioning artifacts, and stain quality, eliminating sample-to-sample variation.	[Yabusaki, Katsumi; Faits, Tyler; McMullen, Eri; Figueiredo, Jose Luiz; Aikawa, Masanori; Aikawa, Elena] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Interdisciplinary Cardiovasc Sci,Div Cardiova, Boston, MA 02115 USA; [Aikawa, Masanori; Aikawa, Elena] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Excellence Vasc Biol,Div Cardiovasc Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Aikawa, E (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Interdisciplinary Cardiovasc Sci,Div Cardiova, Boston, MA 02115 USA.	eaikawa@partners.org	Aikawa, Elena/L-6173-2019	Aikawa, Masanori/0000-0002-9275-2079; Aikawa, Elena/0000-0001-7835-2135; Faits, Tyler/0000-0002-7524-6166	Kowa Company, Ltd. (Tokyo, Japan); National Institutes of Health [R01HL114805, R01HL109506, R01HL107550]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107550, R01HL114805, R01HL109506] Funding Source: NIH RePORTER	Kowa Company, Ltd. (Tokyo, Japan); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by a research grant from Kowa Company, Ltd. (Tokyo, Japan, to M. A.) and the National Institutes of Health grants (R01HL114805; R01HL109506 to E. A.; R01HL107550 to M. A.). The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY A, 1984, HISTOCHEM J, V16, P61, DOI 10.1007/BF01003436; Csordas A, 2007, LIFE SCI, V80, P633, DOI 10.1016/j.lfs.2006.10.009; Hamer PCD, 2006, MICROSC RES TECHNIQ, V69, P835, DOI 10.1002/jemt.20354; New SEP, 2013, CIRC RES, V113, P72, DOI 10.1161/CIRCRESAHA.113.301036; Poynton C, 2003, DIGITAL VIDEO HDTV A; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; Taylor CR, 2006, HISTOPATHOLOGY, V49, P411, DOI 10.1111/j.1365-2559.2006.02513.x	7	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89627	10.1371/journal.pone.0089627	http://dx.doi.org/10.1371/journal.pone.0089627			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595280	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900027
J	Heid, H; Rickelt, S; Zimbelmann, R; Winter, S; Schumacher, H; Dorflinger, Y; Kuhn, C; Franke, WW				Heid, Hans; Rickelt, Steffen; Zimbelmann, Ralf; Winter, Stefanie; Schumacher, Heiderose; Doerflinger, Yvette; Kuhn, Caecilia; Franke, Werner W.			On the Formation of Lipid Droplets in Human Adipocytes: The Organization of the Perilipin-Vimentin Cortex	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; ELECTRON-MICROSCOPY; ADIPOSE CONVERSION; SURFACE-LAYER; PAT-FAMILY; CELLS; CHOLESTEROL; PROTEINS; CAVEOLIN; EXPRESSION	We report on the heterogeneity and diversity of lipid droplets (LDs) in early stages of adipogenesis by elucidating the cell and molecular biology of amphiphilic and cytoskeletal proteins regulating and stabilizing the generation of LDs in human adipose cells. A plethora of distinct and differently sized LDs was detected by a brief application of adipocyte differentiation medium and additional short treatment with oleic acid. Using these cells and highly specific antibodies for LD-binding proteins of the perilipin (PLIN) family, we could distinguish between endogenously derived LDs (endogenous LDs) positive for perilipin from exogenously induced LDs (exogenous LDs) positive for adipophilin, TIP47 and S3-12. Having optimized these stimulation conditions, we used early adipogenic differentiation stages to investigate small-sized LDs and concentrated on LD-protein associations with the intermediate-sized filament (IF) vimentin. This IF protein was described earlier to surround lipid globules, showing spherical, cage-like structures. Consequently - by biochemical methods, by immunofluorescence microscopy and by electron- and immunoelectron microscopy - various stages of emerging lipid globules were revealed with perilipin as linking protein between LDs and vimentin. For this LD-PLIN-Vimentin connection, a model is now proposed, suggesting an interaction of proteins via opposed charged amino acid domains respectively. In addition, multiple sheaths of smooth endoplasmic reticulum cisternae surrounding concentrically nascent LDs are shown. Based on our comprehensive localization studies we present and discuss a novel pathway for the LD formation.	[Heid, Hans; Rickelt, Steffen; Zimbelmann, Ralf; Winter, Stefanie; Schumacher, Heiderose; Doerflinger, Yvette; Franke, Werner W.] German Canc Res Ctr, Helmholtz Grp Cell Biol, Heidelberg, Germany; [Kuhn, Caecilia; Franke, Werner W.] Progen Biotech, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Heid, H (corresponding author), German Canc Res Ctr, Helmholtz Grp Cell Biol, Heidelberg, Germany.	h.heid@dkfz.de		Rickelt, Steffen/0000-0002-5224-7764; Franke, Werner W./0000-0002-4873-8448	Helmholtz Group for Cell Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany	Helmholtz Group for Cell Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany	This was funded by the Helmholtz Group for Cell Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2010, MOL BIOL CELL; ALMAHBOBI G, 1995, CELL TISSUE RES, V281, P387, DOI 10.1007/s004410050436; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Brasaemle DL, 2012, J BIOL CHEM, V287, P2273, DOI 10.1074/jbc.R111.309088; Brasaemle DL, 2006, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB0315S29; Clifford GM, 1998, FEBS LETT, V435, P125, DOI 10.1016/S0014-5793(98)01052-7; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Ewers H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004721; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fawcett D, 1981, CELL ATLAS FINE STRU; FRANKE WW, 1987, CELL, V49, P131, DOI 10.1016/0092-8674(87)90763-X; FRANKE WW, 1969, HISTOCHEMISTRY, V19, P162, DOI 10.1007/BF00281096; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Fujimoto T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004838; Gandotra S, 2011, NEW ENGL J MED, V364, P740, DOI 10.1056/NEJMoa1007487; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Hall PF, 1997, MICROSC RES TECHNIQ, V36, P463, DOI 10.1002/(SICI)1097-0029(19970315)36:6<463::AID-JEMT4>3.0.CO;2-J; Heid H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063061; Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021; Holwell TA, 1999, J LIPID RES, V40, P1440; Hsieh K, 2012, J CELL SCI, V125, P4067, DOI 10.1242/jcs.104943; Ingelmo-Torres M, 2009, TRAFFIC, V10, P1785, DOI 10.1111/j.1600-0854.2009.00994.x; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Lieber JG, 1996, J CELL SCI, V109, P3047; Loo LH, 2009, J CELL BIOL, V187, P375, DOI 10.1083/jcb.200904140; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; NOVIKOFF AB, 1980, J CELL BIOL, V87, P180, DOI 10.1083/jcb.87.1.180; Ohsaki Y, 2008, J CELL SCI, V121, P2415, DOI 10.1242/jcs.025452; Ohsaki Y, 2009, BBA-MOL CELL BIOL L, V1791, P399, DOI 10.1016/j.bbalip.2008.10.002; Ostermeyer AG, 2004, J CELL BIOL, V164, P69, DOI 10.1083/jcb.200303037; Pol A, 2005, MOL BIOL CELL, V16, P2091, DOI 10.1091/mbc.E04-08-0737; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Prattes S, 2000, J CELL SCI, V113, P2977; Saka HA, 2012, ANNU REV CELL DEV BI, V28, P411, DOI 10.1146/annurev-cellbio-092910-153958; Shen WJ, 2012, ENDOCRINOLOGY, V153, P3249, DOI 10.1210/en.2012-1048; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Straub BK, 2010, MODERN PATHOL, V23, P480, DOI 10.1038/modpathol.2009.191; Straub BK, 2008, HEPATOLOGY, V47, P1936, DOI 10.1002/hep.22268; Straub BK, 2013, HISTOPATHOLOGY, V62, P617, DOI 10.1111/his.12038; Suzuki M, 2011, J ELECTRON MICROSC, V60, pS101, DOI 10.1093/jmicro/dfr016; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; van Meer G, 2001, J CELL BIOL, V152, pF29, DOI 10.1083/jcb.152.5.F29; Vassilopoulos S, 2009, SCIENCE, V324, P1192, DOI 10.1126/science.1171529; Vatier C, 2013, CURR DIAB REP; Vogt DA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003302; Walter M, 2009, BIOL CELL, V101, P141, DOI 10.1042/BC20070171; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; WOOD EM, 1967, ANAT REC, V157, P437, DOI 10.1002/ar.1091570304	55	45	45	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90386	10.1371/journal.pone.0090386	http://dx.doi.org/10.1371/journal.pone.0090386			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587346	Green Published, gold			2022-12-27	WOS:000332396200185
J	Li, JF; Lu, JW; Li, XK; Ren, T; Cong, RH; Zhou, L				Li, Jifu; Lu, Jianwei; Li, Xiaokun; Ren, Tao; Cong, Rihuan; Zhou, Li			Dynamics of Potassium Release and Adsorption on Rice Straw Residue	PLOS ONE			English	Article							NUTRIENT BALANCES; CROP RESIDUE; SOIL; DECOMPOSITION; MANAGEMENT; FERTILIZER; TILLAGE; SYSTEMS; MANURE; MAIZE	Straw application can not only increase crop yields, improve soil structure and enrich soil fertility, but can also enhance water and nutrient retention. The aim of this study was to ascertain the relationships between straw decomposition and the release-adsorption processes of K+. This study increases the understanding of the roles played by agricultural crop residues in the soil environment, informs more effective straw recycling and provides a method for reducing potassium loss. The influence of straw decomposition on the K+ release rate in paddy soil under flooded condition was studied using incubation experiments, which indicated the decomposition process of rice straw could be divided into two main stages: (a) a rapid decomposition stage from 0 to 60 d and (b) a slow decomposition stage from 60 to 110 d. However, the characteristics of the straw potassium release were different from those of the overall straw decomposition, as 90% of total K was released by the third day of the study. The batches of the K sorption experiments showed that crop residues could adsorb K+ from the ambient environment, which was subject to decomposition periods and extra K+ concentration. In addition, a number of materials or binding sites were observed on straw residues using IR analysis, indicating possible coupling sites for K+ ions. The aqueous solution experiments indicated that raw straw could absorb water at 3.88 g g(-1), and this rate rose to its maximum 15 d after incubation. All of the experiments demonstrated that crop residues could absorb large amount of aqueous solution to preserve K+ indirectly during the initial decomposition period. These crop residues could also directly adsorb K+ via physical and chemical adsorption in the later period, allowing part of this K+ to be absorbed by plants for the next growing season.	[Li, Jifu; Lu, Jianwei; Li, Xiaokun; Ren, Tao; Cong, Rihuan; Zhou, Li] Huazhong Agr Univ, Coll Resources & Environm, Wuhan, Peoples R China; [Li, Jifu; Lu, Jianwei; Li, Xiaokun; Ren, Tao; Cong, Rihuan; Zhou, Li] Minist Agr, Key Lab Arable Land Conservat Middle & Lower Reac, Wuhan, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Lu, JW (corresponding author), Huazhong Agr Univ, Coll Resources & Environm, Wuhan, Peoples R China.	lunm@mail.hzau.edu.cn	Ren, Tao/P-1434-2014	Ren, Tao/0000-0003-1986-7985; Ren, Tao/0000-0002-7147-3775	Non-profit Research Foundation for Agriculture [201103039]; National Natural Science Foundation of China [41301319]; Fundamental Research Funds for the Central Universities [2012BQ059]; International Potash Institute Co-operation Program	Non-profit Research Foundation for Agriculture; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); International Potash Institute Co-operation Program	This work was supported by Non-profit Research Foundation for Agriculture (201103039), National Natural Science Foundation of China (41301319), Fundamental Research Funds for the Central Universities (2012BQ059) and International Potash Institute Co-operation Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandratos N., 2012, 1203 ESA FAO UN AGR, DOI [10.22004/ag.econ.288998, DOI 10.22004/AG.ECON.288998]; Cakmak I, 2002, PLANT SOIL, V247, P3, DOI 10.1023/A:1021194511492; Cao W, 2013, ENVIRON TECHNOL, V34, P7, DOI 10.1080/09593330.2012.679626; Chen XL, 2011, CARBOHYD POLYM, V85, P245, DOI 10.1016/j.carbpol.2011.02.022; Daudu CK, 2009, AGR ECOSYST ENVIRON, V134, P153, DOI 10.1016/j.agee.2009.06.012; Ding Y, 2012, BIORESOURCE TECHNOL, V114, P20, DOI 10.1016/j.biortech.2012.01.110; Duong TTT, 2013, GEODERMA, V195, P42, DOI 10.1016/j.geoderma.2012.11.010; Evenett SJ, 2012, TRADE COMPETITION PR; Honary S, 2013, TROP J PHARM RES, V12, P255, DOI 10.4314/tjpr.v12i2.19; Iqbal A, 2013, PLANT SOIL, V367, P285, DOI 10.1007/s11104-012-1460-8; Jordan C. F., 1985, Nutrient cycling in tropical forest ecosystems.; Karami A, 2012, AGR ECOSYST ENVIRON, V148, P22, DOI 10.1016/j.agee.2011.10.021; Kaur N, 2006, INDIAN J CROP SCI, V1, P161; Ke X, 2009, J SHENZHEN U SCI ENG, V26, P72; Kozak JA, 2007, HYDROL PROCESS, V21, P229, DOI 10.1002/hyp.6235; Lai GY, 2006, SCI CHINA SER D, V49, P135, DOI 10.1007/s11430-006-8113-9; Lal R, 2005, ENVIRON INT, V31, P575, DOI 10.1016/j.envint.2004.09.005; Li XK, 2009, PLANT SOIL, V320, P141, DOI 10.1007/s11104-008-9879-7; Liao LB, 2010, MINERAL MAT MODERN T; Liao YL, 2013, J INTEGR AGR, V12, P694, DOI 10.1016/S2095-3119(13)60288-9; Lin ChaoWen, 2011, Scientia Agricultura Sinica, V44, P1847; Liu Y, 2013, SOIL TILL RES, V130, P7, DOI 10.1016/j.still.2013.01.012; Lu P, 2012, POWDER TECHNOL, V225, P149, DOI 10.1016/j.powtec.2012.04.002; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; PAL D, 1975, SOIL SCI SOC AM J, V39, P59, DOI 10.2136/sssaj1975.03615995003900010018x; Panaullah GM, 2006, J PLANT NUTR, V29, P173, DOI 10.1080/01904160500416554; Pathak H, 2010, NUTR CYCL AGROECOSYS, V86, P287, DOI 10.1007/s10705-009-9292-5; Peter L, 2011, INFRARED RAMAN SPECT; Rawls WJ, 2003, GEODERMA, V116, P61, DOI 10.1016/S0016-7061(03)00094-6; Regmi AP, 2002, BIOL FERT SOILS, V36, P240, DOI 10.1007/s00374-002-0525-x; Rocha CG, 2009, J HAZARD MATER, V166, P383, DOI 10.1016/j.jhazmat.2008.11.074; Rodriguez-Lizana A, 2010, NUTR CYCL AGROECOSYS, V87, P199, DOI 10.1007/s10705-009-9328-x; Sheldrick WF, 2003, AGR ECOSYST ENVIRON, V94, P341, DOI 10.1016/S0167-8809(02)00038-5; Sims JT, 1999, WATER SCI TECHNOL, V39, P291, DOI 10.1016/S0273-1223(99)00346-7; Singh B, 2008, ADV AGRON, V98, P117, DOI 10.1016/S0065-2113(08)00203-4; Stewart WM, 2005, AGRON J, V97, P1, DOI 10.2134/agronj2005.0001; Tejada M, 2009, SOIL TILL RES, V102, P109, DOI 10.1016/j.still.2008.08.004; Thomas MB, 1998, COMB P INT PLANT PRO, V48, P66; Tong XJ, 2011, CHEM ENG J, V172, P828, DOI 10.1016/j.cej.2011.06.069; United Nations DoEaSA Population Division, 2013, ESAPWP228 UN DOEASA; Van Reeuwijk L.P., 1986, PROCEDURES SOIL ANAL; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; WALKLEY A, 1947, SOIL SCI, V63, P251, DOI 10.1097/00010694-194704000-00001; Wang XB, 2007, NUTR CYCL AGROECOSYS, V79, P17, DOI 10.1007/s10705-006-9070-6; Wang XY, 2012, ENVIRON SCI TECHNOL, V46, P7159, DOI 10.1021/es300522x; Yang SM, 2007, J PLANT NUTR SOIL SC, V170, P234, DOI 10.1002/jpln.200622012; Yu G, 2010, APPL BIOCHEM BIOTECH, V160, P539, DOI 10.1007/s12010-008-8420-z; Zhu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062073	48	46	65	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90440	10.1371/journal.pone.0090440	http://dx.doi.org/10.1371/journal.pone.0090440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587364	Green Submitted, gold, Green Published			2022-12-27	WOS:000332396200199
J	Healey, GD; Lockridge, JA; Zinnen, S; Hopkin, JM; Richards, I; Walker, W				Healey, Gareth D.; Lockridge, Jennifer A.; Zinnen, Shawn; Hopkin, Julian M.; Richards, Ivan; Walker, William			Development of Pre-Clinical Models for Evaluating the Therapeutic Potential of Candidate siRNA Targeting STAT6	PLOS ONE			English	Article							SHORT INTERFERING RNA; INHALED CORTICOSTEROIDS; AIRWAY HYPERREACTIVITY; ALLERGIC RHINITIS; ASTHMA; DELIVERY; INTERLEUKIN-13; INFLAMMATION; EPITHELIUM; BARRIERS	Developing siRNA therapeutics poses technical challenges including appropriate molecular design and testing in suitable pre-clinical models. We previously detailed sequence-selection and modification strategies for siRNA candidates targeting STAT6. Here, we describe methodology that evaluates the suitability of candidate siRNA for respiratory administration. Chemically-modified siRNA exhibited similar inhibitory activity (IC50) against STAT6 in vitro compared to unmodified siRNA and apical exposure testing with Caco-2 cell monolayers showed modification was not associated with cellular toxicity. Use of a modified RNA extraction protocol improved the sensitivity of a PCR-based bio-analytical assay (lower limit of siRNA strand quantification = 0.01 pg/mu l) which was used to demonstrate that lung distribution profiles for both siRNAs were similar following intra-tracheal administration. However, after 6 hours, modified siRNA was detected in lung tissue at concentrations >1000-fold higher than unmodified siRNA. Evaluation in a rat model of allergic inflammation confirmed the persistence of modified siRNA in vivo, which was detectable in broncho-alveolar lavage (BAL) fluid, BAL cells and lung tissue samples, 72 hours after dosing. Based upon the concept of respiratory allergy as a single airway disease, we considered nasal delivery as a route for respiratory targeting, evaluating an intra-nasal exposure model that involved simple dosing followed by fine dissection of the nasal cavity. Notably, endogenous STAT6 expression was invariant throughout the nasal cavities and modified siRNA persisted for at least 3 days after administration. Coupled with our previous findings showing upregulated expression of inflammatory markers in nasal samples from asthmatics, these findings support the potential of intranasal siRNA delivery. In summary, we demonstrate the successful chemical modification of STAT6 targeting siRNA, which enhanced bio-availability without cellular toxicity or reduced efficacy. We have established a robust, sensitive method for determining siRNA bio-distribution in vivo, and developed a nasal model to aid evaluation. Further work is warranted.	[Healey, Gareth D.; Hopkin, Julian M.; Walker, William] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Healey, Gareth D.] Swansea Univ, Allerna Therapeut Ltd, Swansea, W Glam, Wales; [Lockridge, Jennifer A.] Lockridge Pharmaceut Consulting LLC, Westminster, CO USA; [Zinnen, Shawn] Zincyte Consulting, Denver, CO USA; [Richards, Ivan] Sunapten Therapeut, Kalamazoo, MI USA	Swansea University; Swansea University	Healey, GD (corresponding author), Swansea Univ, Coll Med, Swansea, W Glam, Wales.	g.d.healey@swansea.ac.uk	Healey, Gareth/T-5948-2019	Healey, Gareth/0000-0001-9531-1220	Allerna Therapeutics Ltd.	Allerna Therapeutics Ltd.	Funding for this study was provided by Allerna Therapeutics Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NP, 2006, RESP MED, V100, P1297, DOI 10.1016/j.rmed.2006.04.015; Akimoto T, 1998, J EXP MED, V187, P1537, DOI 10.1084/jem.187.9.1537; Bakhtiyari S, 2013, THER DELIV, V4, P45, DOI [10.4155/TDE.12.136, 10.4155/tde.12.136]; Bourdin A, 2009, THORAX, V64, P999, DOI 10.1136/thx.2008.112862; Bousquet J, 2003, ALLERGY, V58, P691, DOI 10.1034/j.1398-9995.2003.00105.x; Braunstahl Gert-Jan, 2009, Proc Am Thorac Soc, V6, P652, DOI 10.1513/pats.200906-052DP; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Clark KL, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2012.57; Czimmerer Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055168; Darcan-Nicolaisen Y, 2009, J IMMUNOL, V182, P7501, DOI 10.4049/jimmunol.0713433; DeVincenzo J, 2008, ANTIVIR RES, V77, P225, DOI 10.1016/j.antiviral.2007.11.009; Dolovich MB, 2011, LANCET, V377, P1032, DOI 10.1016/S0140-6736(10)60926-9; Finkelman FD, 2008, J ALLERGY CLIN IMMUN, V121, P603, DOI 10.1016/j.jaci.2008.01.008; Frois C, 2009, CLIN THER, V31, P2779, DOI 10.1016/j.clinthera.2009.12.021; Grimm D, 2009, ADV DRUG DELIVER REV, V61, P672, DOI 10.1016/j.addr.2009.05.002; Harkema JR, 2006, TOXICOL PATHOL, V34, P252, DOI 10.1080/01926230600713475; Healey GD, 2013, J CELL MOL MED, V17, P356, DOI 10.1111/jcmm.12014; Healey Gareth D, 2010, J RNAi Gene Silencing, V6, P401; HILGERS AR, 1990, PHARMACEUT RES, V7, P902, DOI 10.1023/A:1015937605100; Holgate ST, 2007, TRENDS IMMUNOL, V28, P248, DOI 10.1016/j.it.2007.04.007; Holmes AM, 2011, DRUG DISCOV TODAY, V16, P659, DOI 10.1016/j.drudis.2011.05.014; Izuhara K, 2006, CURR MED CHEM, V13, P2291, DOI 10.2174/092986706777935140; Izuhara K, 1999, INT J MOL MED, V3, P3; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Kuperman DA, 2008, CURR MOL MED, V8, P384, DOI 10.2174/156652408785161032; Lively TN, 2008, J ALLERGY CLIN IMMUN, V121, P88, DOI 10.1016/j.jaci.2007.08.029; McCaskill J, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.22; Merkel OM, 2012, ACCOUNTS CHEM RES, V45, P961, DOI 10.1021/ar200110p; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Moschos SA, 2011, MOL THER, V19, P2163, DOI 10.1038/mt.2011.206; Murugan A, 2009, CURR OPIN PULM MED, V15, P12, DOI 10.1097/MCP.0b013e32831de235; Musacchio T, 2013, FRONT BIOSCI-LANDMRK, V18, P58, DOI 10.2741/4087; Nerurkar MM, 1996, PHARMACEUT RES, V13, P528, DOI 10.1023/A:1016033702220; Oh CK, 2010, EUR RESP REV, V115; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Scaggiante B, 2011, CURR DRUG METAB, V12, P11, DOI 10.2174/138920011794520017; Takahashi Y, 2009, ADV DRUG DELIVER REV, V61, P760, DOI 10.1016/j.addr.2009.04.006; Togias A, 2003, J ALLERGY CLIN IMMUN, V111, P1171, DOI 10.1067/mai.2003.1592; Volpe DA, 2011, FUTURE MED CHEM, V3, P2063, DOI [10.4155/FMC.11.149, 10.4155/fmc.11.149]; Walker W, 2009, IMMUNOLOGY, V127, P256, DOI 10.1111/j.1365-2567.2008.02951.x; Wang J, 2010, AAPS J, V12, P492, DOI 10.1208/s12248-010-9210-4; Wenzel S, 2006, AM J RESP CRIT CARE, V174, P1173, DOI 10.1164/rccm.2609002; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x	47	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90338	10.1371/journal.pone.0090338	http://dx.doi.org/10.1371/journal.pone.0090338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587331	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800102
J	Bessaud, M; Razafindratsimandresy, R; Nougairede, A; Joffret, ML; Deshpande, JM; Dubot-Peres, A; Heraud, JM; de Lamballerie, X; Delpeyroux, F; Bailly, JL				Bessaud, Mael; Razafindratsimandresy, Richter; Nougairede, Antoine; Joffret, Marie-Line; Deshpande, Jagadish M.; Dubot-Peres, Audrey; Heraud, Jean-Michel; de Lamballerie, Xavier; Delpeyroux, Francis; Bailly, Jean-Luc			Molecular Comparison and Evolutionary Analyses of VP1 Nucleotide Sequences of New African Human Enterovirus 71 Isolates Reveal a Wide Genetic Diversity	PLOS ONE			English	Article							ACUTE FLACCID PARALYSIS; POPULATION-DYNAMICS; SPECIES C; RECOMBINATION; INDIA; EPIDEMIOLOGY; CIRCULATION; EMERGENCE; COXSACKIE; FREQUENCY	Most circulating strains of Human enterovirus 71 (EV-A71) have been classified primarily into three genogroups (A to C) on the basis of genetic divergence between the 1D gene, which encodes the VP1 capsid protein. The aim of the present study was to provide further insights into the diversity of the EV-A71 genogroups following the recent description of highly divergent isolates, in particular those from African countries, including Madagascar. We classified recent EV-A71 isolates by a large comparison of 3,346 VP1 nucleotidic sequences collected from GenBank. Analysis of genetic distances and phylogenetic investigations indicated that some recently-reported isolates did not fall into the genogroups A-C and clustered into three additional genogroups, including one Indian genogroup (genogroup D) and 2 African ones (E and F). Our Bayesian phylogenetic analysis provided consistent data showing that the genogroup D isolates share a recent common ancestor with the members of genogroup E, while the isolates of genogroup F evolved from a recent common ancestor shared with the members of the genogroup B. Our results reveal the wide diversity that exists among EV-A71 isolates and suggest that the number of circulating genogroups is probably underestimated, particularly in developing countries where EV-A71 epidemiology has been poorly studied.	[Bessaud, Mael; Nougairede, Antoine; Dubot-Peres, Audrey; de Lamballerie, Xavier] Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth, UMR D Emergence Pathol Virales 190, Marseille, France; [Razafindratsimandresy, Richter; Heraud, Jean-Michel] Inst Pasteur Madagascar, Unite Virol, Antananarivo, Madagascar; [Joffret, Marie-Line; Delpeyroux, Francis] Inst Pasteur, Unite Biol Virus Enter, Paris, France; [Joffret, Marie-Line] INSERM, U994, Paris, France; [Deshpande, Jagadish M.] Enterovirus Res Ctr, Bombay, Maharashtra, India; [Dubot-Peres, Audrey] Mahosot Hosp, Wellcome Trust Res Unit, Lao Oxford Mahosot Hosp, Viangchan, Laos; [Dubot-Peres, Audrey] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Bailly, Jean-Luc] Univ Auvergne, Clermont Univ, EPIE EA4843, Clermont Ferrand, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); ICMR - Enterovirus Research Centre; University of Oxford; Universite Clermont Auvergne (UCA)	Bessaud, M (corresponding author), Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth, UMR D Emergence Pathol Virales 190, Marseille, France.	bessaud@laposte.net	Heraud, Jean-Michel/O-1464-2013; Delpeyroux, Francis/H-8838-2016; Razafindratsimandresy, Richter/H-9881-2014; DELPEYROUX, Francis/ABA-5429-2021; Bailly, Jean-Luc/ABE-9210-2020; Bessaud, Maël/J-3961-2019	Heraud, Jean-Michel/0000-0003-1107-0859; Delpeyroux, Francis/0000-0002-4895-823X; DELPEYROUX, Francis/0000-0002-4895-823X; Bessaud, Maël/0000-0001-6758-9591; JOFFRET, Marie-Line/0000-0002-5244-5429; Bailly, Jean-Luc/0000-0002-9770-6450; Deshpande, Jagadish/0000-0001-5194-0375	Agence Interetablissements de Recherche pour le Developpement in Madagascar; Agence Nationale de la Recherche [ANR-09-MIEN-019]; Fondation pour la Recherche Medicale in France [DMI20091117313]	Agence Interetablissements de Recherche pour le Developpement in Madagascar; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale in France(Institut National du Cancer (INCA) France)	Financial support for this project was provided by the Agence Interetablissements de Recherche pour le Developpement in Madagascar and by the Agence Nationale de la Recherche (ANR-09-MIEN-019) and the Fondation pour la Recherche Medicale (DMI20091117313) in France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzug M. J., 2009, Southern African Journal of Epidemiology & Infection, V24, P5; Bessaud M, 2012, J CLIN MICROBIOL, V50, P1650, DOI 10.1128/JCM.06657-11; Bessaud M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024823; Bouslama L, 2007, J VIROL, V81, P8944, DOI 10.1128/JVI.00180-07; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Combelas N, 2011, VIRUSES-BASEL, V3, P1460, DOI 10.3390/v3081460; Deshpande JM, 2003, CURR SCI INDIA, V84, P1350; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kottaridi C, 2005, DIAGN MICR INFEC DIS, V53, P113, DOI 10.1016/j.diagmicrobio.2005.06.016; Li YP, 2013, J INFECT DIS; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lukashev AN, 2010, REV MED VIROL, V20, P327, DOI 10.1002/rmv.660; Lukashev AN, 2005, J GEN VIROL, V86, P3281, DOI 10.1099/vir.0.81264-0; McMinn PC, 2012, CURR OPIN VIROL, V2, P199, DOI 10.1016/j.coviro.2012.02.009; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Mirand A, 2012, CLIN MICROBIOL INFEC, V18, pE110, DOI 10.1111/j.1469-0691.2012.03789.x; Mirand A, 2010, J GEN VIROL, V91, P2263, DOI 10.1099/vir.0.021741-0; Oberste MS, 2004, J VIROL, V78, P2948, DOI 10.1128/JVI.78.6.2948-2955.2004; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Rao CD, 2012, EMERG INFECT DIS, V18, P1833, DOI 10.3201/eid1811.111457; Sadeuh-Mba SA, 2013, J CLIN MICROBIOL, V51, P759, DOI 10.1128/JCM.02119-12; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Shih SR, 2000, VIRUS RES, V68, P127, DOI 10.1016/S0168-1702(00)00162-3; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; van der Sanden S, 2010, J GEN VIROL, V91, P1949, DOI 10.1099/vir.0.019695-0; Yip CCY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-222; Yu HY, 2010, VIRUS GENES, V41, P1, DOI 10.1007/s11262-010-0472-9; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1; Zhu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056318	38	95	104	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90624	10.1371/journal.pone.0090624	http://dx.doi.org/10.1371/journal.pone.0090624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598878	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400104
J	Lobner, M; Luppa, M; Konnopka, A; Meisel, HJ; Gunther, L; Meixensberger, J; Stengler, K; Angermeyer, MC; Konig, HH; Riedel-Heller, SG				Loebner, Margrit; Luppa, Melanie; Konnopka, Alexander; Meisel, Hans J.; Guenther, Lutz; Meixensberger, Juergen; Stengler, Katarina; Angermeyer, Matthias C.; Koenig, Hans-Helmut; Riedel-Heller, Steffi G.			Inpatient or Outpatient Rehabilitation after Herniated Disc Surgery? - Setting-Specific Preferences, Participation and Outcome of Rehabilitation	PLOS ONE			English	Article							HOSPITAL ANXIETY; DEPRESSION; HEALTH; PAIN	Objective: To examine rehabilitation preferences, participation and determinants for the choice of a certain rehabilitation setting (inpatient vs. outpatient) and setting-specific rehabilitation outcomes. Methods: The longitudinal observational study referred to 534 consecutive disc surgery patients (18-55 years). Face-to-face baseline interviews took place about 3.6 days after disc surgery during acute hospital stay. 486 patients also participated in a follow-up interview via telephone three months later (dropout-rate: 9%). The following instruments were used: depression and anxiety (Hospital Anxiety and Depression Scale), pain intensity (numeric analog scale), health-related quality of life (Short Form 36 Health Survey), subjective prognosis of gainful employment (SPE-scale) as well as questions on rehabilitation attendance, return to work, and amount of sick leave days. Results: The vast majority of patients undergoing surgery for a herniated disc attended a post-hospital rehabilitation treatment program (93%). Thereby two-thirds of these patients took part in an inpatient rehabilitation program (67.9%). Physical, psychological, vocational and health-related quality of life characteristics differed widely before as well as after rehabilitation depending on the setting. Inpatient rehabilitees were significantly older, reported more pain, worse physical quality of life, more anxiety and depression and a worse subjective prognosis of gainful employment before rehabilitation. Pre-rehabilitation differences remained significant after rehabilitation. More than half of the outpatient rehabilitees (56%) compared to only one third of the inpatient rehabilitees (33%) returned to work three months after disc surgery (p<.001). Conclusion: The results suggest a "pre-selection" of patients with better health status in outpatient rehabilitation. Gaining better knowledge about setting-specific selection processes may help optimizing rehabilitation allocation procedures and improve rehabilitation effects such as return to work.	[Loebner, Margrit; Luppa, Melanie; Riedel-Heller, Steffi G.] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany; [Konnopka, Alexander; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany; [Meisel, Hans J.] Berufsgenossenschaftliche Kliniken Bergmannstrost, Dept Neurosurg, Halle, Saale, Germany; [Guenther, Lutz] Klinikum St Georg gGmbH, Dept Neurosurg, Leipzig, Germany; [Meixensberger, Juergen] Univ Leipzig, Dept Neurosurg, D-04109 Leipzig, Germany; [Stengler, Katarina] Univ Leipzig, Dept Psychiat & Psychotherapy, D-04109 Leipzig, Germany; [Angermeyer, Matthias C.] Ctr Publ Mental Hlth, Gosing Am Wagram, Austria; [Angermeyer, Matthias C.] Univ Cagliary, Dept Publ Hlth, Cagliari, Italy	Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Leipzig University; Leipzig University; University of Cagliari	Lobner, M (corresponding author), Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany.	Margrit.Loebner@medizin.uni-leipzig.de	König, Hans-Helmut/P-1211-2018; Löbner, Margrit/AAD-7309-2022; Riedel-Heller, Steffi/ABG-1537-2021; Luppa, Melanie/AAQ-7338-2021	König, Hans-Helmut/0000-0001-5711-6862; Löbner, Margrit/0000-0001-5984-8127; 	Deutsche Rentenversicherung Bund [8011-106-31/31.81]	Deutsche Rentenversicherung Bund	This study was funded by the Deutsche Rentenversicherung Bund (Project: Psychiatric comorbidity and early retirement in patients with somatic diseases. Reference Number: 8011-106-31/31.81). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bergmann S, 2004, PAIN, V108, P115, DOI 10.1016/j.pain.2003.12.013; Bullinger M, 1998, SF 36 FRAGEBOGEN ZUM; Bullinger M., 2000, BUNDESGESUNDHEITSBLA, V43, P190, DOI DOI 10.1007/S001030050034; Burger W, 2002, Rehabilitation (Stuttg), V41, P92; Burger W, 2000, GRUNDLAGEN REHABILIT, P139; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davidson M, 2002, PHYS THER, V82, P8, DOI 10.1093/ptj/82.1.8; Deutsche Rentenversicherung Bund, 2010, REH BER 2010 MED BER; Herrmann C., 1995, HADS D HOSP ANXIETY; Hinz A, 2001, PSYCHOTHER PSYCH MED, V51, P193, DOI 10.1055/s-2001-13279; IBM Corporation, 2011, IBM SPSS STAT 20 0; Junge A, 2004, ORTHOPADE, V33, P545, DOI 10.1007/s00132-003-0613-0; Kramer J, 2001, ORTHOPADE, V30, P121, DOI 10.1007/s001320050583; Kramer J, 1994, INTERVERTEBRAL DISK; Lobner M, 2012, J PSYCHOSOM RES, V72, P185, DOI 10.1016/j.jpsychores.2011.10.007; Merkesdal S, 1999, Rehabilitation (Stuttg), V38 Suppl 1, pS37; Mittag O, 2003, Rehabilitation (Stuttg), V42, P169; Mittag O, 2003, SOZ PRAVENTIV MED, V48, P361, DOI 10.1007/s00038-003-2037-3; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Morfeld M, 2002, GESUNDHEITSPSYCHOLOG, P443; Richter M, 2011, PSYCHIAT PRAX, V38, P237, DOI 10.1055/s-0030-1266068; Riedel-Heller S, 2012, PSYCHIAT PRAX, V39, P103, DOI 10.1055/s-0032-1304894; StataCorp, 2011, STAT STAT SOFTW REL; Theodoridis T, 2006, ORTHOPADIE UNFALLCHI, V1, P495; Watzke S, 2006, GESUNDHEITSPSYCHOLOG, P265; Wittchen HU, 1997, INSTRUCTION MANUAL E; Woischneck D, 2000, Rehabilitation (Stuttg), V39, P88; Wolf N, 1999, Rehabilitation (Stuttg), V38 Suppl 1, pS44; World Health Organization, 1991, INT CLASS DIS ICD 10; Zieger M, 2011, J OCCUP REHABIL, V21, P54, DOI 10.1007/s10926-010-9257-1; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	33	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89200	10.1371/journal.pone.0089200	http://dx.doi.org/10.1371/journal.pone.0089200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24598904	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400011
J	Fonner, VA; Armstrong, KS; Kennedy, CE; O'Reilly, KR; Sweat, MD				Fonner, Virginia A.; Armstrong, Kevin S.; Kennedy, Caitlin E.; O'Reilly, Kevin R.; Sweat, Michael D.			School Based Sex Education and HIV Prevention in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							ADOLESCENT REPRODUCTIVE HEALTH; HUMAN-IMMUNODEFICIENCY-VIRUS; MEDIUM-SIZED CITY; RISK-REDUCTION; AIDS EDUCATION; HIV/AIDS PREVENTION; PEER EDUCATION; YOUNG-PEOPLE; SOUTH-AFRICA; PROGRAM	Objectives: School-based sex education is a cornerstone of HIV prevention for adolescents who continue to bear a disproportionally high HIV burden globally. We systematically reviewed and meta-analyzed the existing evidence for school-based sex education interventions in low-and middle-income countries to determine the efficacy of these interventions in changing HIV-related knowledge and risk behaviors. Methods: We searched five electronic databases, PubMed, Embase, PsycInfo, CINAHL, and Sociological Abstracts, for eligible articles. We also conducted hand-searching of key journals and secondary reference searching of included articles to identify potential studies. Intervention effects were synthesized through random effects meta-analysis for five outcomes: HIV knowledge, self-efficacy, sexual debut, condom use, and number of sexual partners. Results: Of 6191 unique citations initially identified, 64 studies in 63 articles were included in the review. Nine interventions either focused exclusively on abstinence (abstinence-only) or emphasized abstinence (abstinence-plus), whereas the remaining 55 interventions provided comprehensive sex education. Thirty-three studies were able to be meta-analyzed across five HIV-related outcomes. Results from meta-analysis demonstrate that school-based sex education is an effective strategy for reducing HIV-related risk. Students who received school-based sex education interventions had significantly greater HIV knowledge (Hedges g = 0.63, 95% Confidence Interval (CI): 0.49-0.78, p<0.001), self-efficacy related to refusing sex or condom use (Hedges g = 0.25, 95% CI: 0.14-0.36, p<0.001), condom use (OR = 1.34, 95% CI: 1.18-1.52, p<0.001), fewer sexual partners (OR = 0.75, 95% CI: 0.67-0.84, p<0.001) and less initiation of first sex during follow-up (OR = 0.66, 95% CI: 0.54-0.83, p<0.001). Conclusions: The paucity of abstinence-only or abstinence-plus interventions identified during the review made comparisons between the predominant comprehensive and less common abstinence-focused programs difficult. Comprehensive school-based sex education interventions adapted from effective programs and those involving a range of school-based and community-based components had the largest impact on changing HIV-related behaviors.	[Fonner, Virginia A.; Kennedy, Caitlin E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Armstrong, Kevin S.; O'Reilly, Kevin R.; Sweat, Michael D.] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Medical University of South Carolina	Fonner, VA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	vtedrow@jhsph.edu		Fonner, Virginia/0000-0002-9005-3549	US National Institute of Mental Health [R01 MH090173, RC1 MH088950]; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088950, R01MH090173] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the US National Institute of Mental Health, Grants R01 MH090173 and RC1 MH088950. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha S, 2004, J ADOLESCENT HEALTH, V34, P441, DOI [10.1016/j.jadohealth.2003.07.016, 10.1016/S1054-139X(03)00331-8]; Agha S, 2002, AIDS EDUC PREV, V14, P269, DOI 10.1521/aeap.14.5.269.23875; Antunes MC, 1997, AIDS, V11, pS121; APLASCA MRA, 1995, AIDS, V9, pS7; Bertrand JT, 2006, HEALTH EDUC RES, V21, P567, DOI 10.1093/her/cyl036; Borenstein M., 2009, INTRO METAANALYSIS; CACERES CF, 1994, J ADOLESCENT HEALTH, V15, P582, DOI 10.1016/1054-139X(94)90143-Q; Cai Y, 2008, INT J STD AIDS, V19, P848, DOI 10.1258/ijsa.2008.008129; Cartagena RG, 2006, J ADOLESC HLTH, V39; Cheng Y, 2008, J ADOLESCENT HEALTH, V42, P184, DOI 10.1016/j.jadohealth.2007.07.016; Chhabra R, 2008, ETHN DIS, V18; Chin HB, 2012, AM J PREV MED, V42, P272, DOI 10.1016/j.amepre.2011.11.006; Cuijpers P, 2010, J AFFECT DISORDERS, V126, P349, DOI 10.1016/j.jad.2010.01.001; Daboer J C, 2008, Niger J Med, V17, P324; Dalrymple L., 1993, EDUC PSYCHOL-UK, V13, P147; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Díaz Margarita, 2005, Cad. Saúde Pública, V21, P589, DOI 10.1590/S0102-311X2005000200026; Doyle AM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000287; Enah C, 2010, J ASS NURSES AIDS CA; Fawole IO, 1999, HEALTH EDUC RES, V14, P675, DOI 10.1093/her/14.5.675; Fiscian VS, 2009, AIDS EDUC PREV, V21, P67, DOI 10.1521/aeap.2009.21.1.67; Fitzgerald AM, 1999, J ADOLESCENT HEALTH, V25, P52, DOI 10.1016/S1054-139X(98)00120-7; Fonner VA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001224.pub4; Gallant M, 2004, SOC SCI MED, V58, P1337, DOI 10.1016/S0277-9536(03)00331-9; Gallegos EC, 2008, SALUD PUBLICA MEXICO, V50, P59, DOI 10.1590/S0036-36342008000100012; Gao Y, 2001, REPROD FERT DEVELOP, V13, P729, DOI 10.1071/RD01082; Givaudan Martha, 2008, Psychol Health Med, V13, P98, DOI 10.1080/13548500701295256; Gotzsche PC, 2007, JAMA-J AM MED ASSOC, V298, P430, DOI 10.1001/jama.298.4.430; Halpern CT, 2008, SOC SCI MED, V67, P628, DOI 10.1016/j.socscimed.2008.05.001; Harvey B, 2000, INT J STD AIDS, V11, P105, DOI 10.1258/0956462001915453; HASSELBLAD V, 1995, PSYCHOL BULL, V117, P167, DOI 10.1037/0033-2909.117.1.167; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOGAN DR, 2005, BRIT MED J, V331, P1431, DOI DOI 10.1136/BMJ.38643.368692.68; Huang H, 2008, INT J STD AIDS, V19, P342, DOI 10.1258/ijsa.2007.007208; Iurcovich M., 1998, Journal of HIV/AIDS Prevention and Education for Adolescents and Children, V2, P91; James S, 2006, AIDS EDUC PREV, V18, P281, DOI 10.1521/aeap.2006.18.4.281; Karnell AP, 2006, AIDS EDUC PREV, V18, P295, DOI 10.1521/aeap.2006.18.4.295; Kennedy C, 2007, AIDS CARE, V19, P707, DOI 10.1080/09540120701203261; Kennedy CE, 2010, B WORLD HEALTH ORGAN, V88, P615, DOI 10.2471/BLT.09.068213; Kennedy CE, 2012, AIDS BEHAV; Kinsler J, 2004, HEALTH EDUC RES, V19, P730, DOI 10.1093/her/cyg091; Kinsman J, 2001, HEALTH EDUC RES, V16, P85, DOI 10.1093/her/16.1.85; Kirby D, 1997, CHILD YOUTH SERV REV, V19, P415, DOI 10.1016/S0190-7409(97)00025-X; KIRBY D, 1992, J SCHOOL HEALTH, V62, P280, DOI 10.1111/j.1746-1561.1992.tb01244.x; Kirby DB, 2007, J ADOLESCENT HEALTH, V40, P206, DOI 10.1016/j.jadohealth.2006.11.143; KLEPP KI, 1994, AIDS, V8, P1157, DOI 10.1097/00002030-199408000-00019; Klepp KI, 1997, AM J PUBLIC HEALTH, V87, P1931, DOI 10.2105/AJPH.87.12.1931; KUHN L, 1994, AIDS CARE, V6, P161, DOI 10.1080/09540129408258627; Kyrychenko P, 2006, J ADOLESCENT HEALTH, V39, P900, DOI 10.1016/j.jadohealth.2006.06.006; Li S, 2010, INT J STD AIDS, V21, P82, DOI 10.1258/ijsa.2009.008514; Li XM, 2008, AIDS EDUC PREV, V20, P1, DOI 10.1521/aeap.2008.20.1.1; Lou CH, 2006, J ADOLESCENT HEALTH, V39, P720, DOI 10.1016/j.jadohealth.2006.04.003; Lou Chao-hua, 2005, Fudan Xuebao (Yixuekexueban), V32, P289; Low W Y, 2004, Med J Malaysia, V59, P443; Magnani R, 2005, J ADOLESCENT HEALTH, V36, P289, DOI 10.1016/j.jadohealth.2004.02.025; Magnussen Lesley, 2004, Int J Adolesc Med Health, V16, P303; Martinez-Donate AP, 2004, J SEX RES, V41, P267, DOI 10.1080/00224490409552234; Martiniuk ALC, 2003, INT J EPIDEMIOL, V32, P131, DOI 10.1093/ije/dyg014; Maticka-Tyndale E., 2010, SEX EDUC-SEX SOC LEA, V10, P113, DOI DOI 10.1080/14681811003666481; Medley A, 2009, AIDS EDUC PREV, V21, P181, DOI 10.1521/aeap.2009.21.3.181; Milleliri Jean-Marie, 2003, Sante, V13, P253; Miller AN, 2008, J HEALTH COMMUN, V13, P345, DOI 10.1080/10810730802063470; Mmari K, 2009, GLOB PUBLIC HEALTH, V4, P350, DOI 10.1080/17441690701664418; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; MUNODAWAFA D, 1995, INT J NURS STUD, V32, P27, DOI 10.1016/0020-7489(94)00029-J; Norr KF, 2007, AJAR-AFR J AIDS RES, V6, P239, DOI 10.2989/16085900709490420; Okonofua Friday E., 2003, International Journal of Infectious Diseases, V7, P61, DOI 10.1016/S1201-9712(03)90044-0; Orwin R.G., 1994, HDB RES SYNTHESIS; Ott MA, 2007, CURR OPIN OBSTET GYN, V19, P446, DOI 10.1097/GCO.0b013e3282efdc0b; Paul-Ebhohimhen VA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-4; Perez F, 2003, AIDS CARE, V15, P77, DOI 10.1080/0954012021000039789; Pick S, 2007, AIDS EDUC PREV, V19, P408, DOI 10.1521/aeap.2007.19.5.408; Pierce CA, 2008, ORGAN RES METHODS, V11, P188, DOI 10.1177/1094428106296641; Ross DA, 2007, AIDS, V21, P1943, DOI 10.1097/QAD.0b013e3282ed3cf5; Rusakaniko S, 1997, Cent Afr J Med, V43, P1; Saksena Sangeeta, 2003, Indian Journal of Pediatrics, V70, P203, DOI 10.1007/BF02725582; Santelli JS, 2013, GLOB PUBLIC HEALTH, V8, P1, DOI 10.1080/17441692.2012.759609; Shen LX, 2008, INT J STD AIDS, V19, P761, DOI 10.1258/ijsa.2008.008053; Shuey DA, 1999, HEALTH EDUC RES, V14, P411, DOI 10.1093/her/14.3.411; Singh S, 2003, AIDS CARE, V15, P71, DOI 10.1080/095401202100039770; Singh S., 2005, SEX ED, V5, P307, DOI [DOI 10.1080/14681810500278089, 10.1080/14681810500278089]; Smith E, 2008, PREV SCI, V9, P311, DOI 10.1007/s11121-008-0103-z; Speizer IS, 2003, J ADOLESCENT HEALTH, V33, P324, DOI 10.1016/S1054-139X(02)00535-9; Srisuphun W, 2002, THAI J NURSING RES, V6, P11; Stanger-Hall KF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024658; Stanton BF, 1998, AIDS, V12, P2473, DOI 10.1097/00002030-199818000-00017; Sweat M, 2007, AIDS, V21, P1070, DOI 10.1097/QAD.0b013e3280f774da; Sweat MD, 2012, B WORLD HEALTH ORGAN, V90, P613, DOI 10.2471/BLT.11.094268; Thakor Hitendra G., 2000, Indian Journal of Pediatrics, V67, P551, DOI 10.1007/BF02758475; Thato R, 2008, J ADV NURS, V62, P457, DOI 10.1111/j.1365-2648.2008.04609.x; Torabi MR, 2000, J SCHOOL HEALTH, V70, P229, DOI 10.1111/j.1746-1561.2000.tb07422.x; UN Human Rights Council, 2010, AHRC1425ADD1 UN HUM; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Visser M, 1996, S AFR J PSYCHOL, V26, P103, DOI 10.1177/008124639602600206; Visser Maretha J, 2005, SAHARA J, V2, P203; Visser Maretha J, 2007, SAHARA J, V4, P678; Wagman J, 2009, J INTERPERS VIOLENCE, V24, P2073, DOI 10.1177/0886260508327707; Walker D, 2006, BMJ-BRIT MED J, V332, P1189, DOI 10.1136/bmj.38796.457407.80; Wang LY, 2000, ARCH PEDIAT ADOL MED, V154, P1017, DOI 10.1001/archpedi.154.10.1017; Ye XX, 2009, INT J STD AIDS, V20, P549, DOI 10.1258/ijsa.2008.008471; Zheng Yu-huang, 2002, Hunan Yike Daxue Xuebao, V27, P515	102	151	153	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89692	10.1371/journal.pone.0089692	http://dx.doi.org/10.1371/journal.pone.0089692			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4FD	24594648	gold, Green Published, Green Submitted			2022-12-27	WOS:000332475500020
J	Surma, M; Handy, C; Chang, J; Kapur, R; Wei, L; Shi, JJ				Surma, Michelle; Handy, Caitlin; Chang, Jiang; Kapur, Reuben; Wei, Lei; Shi, Jianjian			ROCK1 Deficiency Enhances Protective Effects of Antioxidants against Apoptosis and Cell Detachment	PLOS ONE			English	Article							RHO-ASSOCIATED KINASE; DOXORUBICIN-INDUCED CARDIOMYOPATHY; BINDING PROTEIN RHO; NADPH OXIDASE; N-ACETYLCYSTEINE; MOLECULAR-MECHANISMS; REACTIVE OXYGEN; CANCER-THERAPY; LIM-KINASE; IN-VIVO	We have recently reported that the homologous Rho kinases, ROCK1 and ROCK2, play different roles in regulating stress-induced stress fiber disassembly and cell detachment, and the ROCK1 deficiency in mouse embryonic fibroblasts (MEF) has remarkable anti-apoptotic, anti-detachment and pro-survival effects against doxorubicin, a chemotherapeutic drug. This study investigated the roles of ROCK isoforms in doxorubicin-induced reactive oxygen species (ROS) generation which is believed to be the major mechanism underlying its cytotoxicity to normal cells, and especially to cardiomyocytes. Different antioxidants have been shown to provide a protective role reported in numerous experimental studies, but clinical trials of antioxidant therapy showed insufficient benefit against the cardiac side effect. We found that both ROCK1(-/-) and ROCK2(-/-) MEFs exhibited reduced ROS production in response to doxorubicin treatment. Interestingly, only ROCK1 deficiency, but not ROCK2 deficiency, significantly enhanced the protective effects of antioxidants against doxorubicin-induced cytotoxicity. First, ROCK1 deficiency and N-acetylcysteine (an anti-oxidant) treatment synergistically reduced ROS levels, caspase activation and cell detachment. In addition, the reduction of ROS generation in ROCK1(-/-) MEFs in response to doxorubicin treatment was in part through inhibiting NADPH oxidase activity. Furthermore, ROCK1 deficiency enhanced the inhibitory effects of diphenyleneiodonium (an inhibitor of NADPH oxidase) on ROS generation and caspase 3 activation induced by doxorubicin. Finally, ROCK1 deficiency had greater protective effects than antioxidant treatment, especially on reducing actin cytoskeleton remodeling. ROCK1 deficiency not only reduced actomyosin contraction but also preserved central stress fiber stability, whereas antioxidant treatment only reduced actomyosin contraction without preserving central stress fibers. These results reveal a novel strategy to enhance the protective effect of antioxidant therapy by targeting the ROCK1 pathway to stabilize the actin cytoskeleton and boost the inhibitory effects on ROS production, apoptosis and cell detachment.	[Surma, Michelle; Handy, Caitlin; Wei, Lei; Shi, Jianjian] Indiana Univ, Sch Med, Riley Heart Res Ctr, Indianapolis, IN 46202 USA; [Surma, Michelle; Handy, Caitlin; Kapur, Reuben; Wei, Lei; Shi, Jianjian] Indiana Univ, Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Chang, Jiang] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Wei, L (corresponding author), Indiana Univ, Sch Med, Riley Heart Res Ctr, Indianapolis, IN 46202 USA.	lewei@iupui.edu; jishi@iupui.edu		Chang, Jiang/0000-0003-3707-7557	National Institutes of Health [HL107537]; American Heart Association, Midwest Affiliate [12GRNT12060525]; Riley Children's Foundation; NATIONAL CANCER INSTITUTE [R01CA173852] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077177, R01HL123953, R01HL107537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, Midwest Affiliate(American Heart Association); Riley Children's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants (HL107537), a Grant-in-Aid award from American Heart Association, Midwest Affiliate (12GRNT12060525), and by the Riley Children's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2007, J BIOL CHEM, V282, P35373, DOI 10.1074/jbc.M702175200; Aghajanian A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008045; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Brandes RP, 2005, CARDIOVASC RES, V65, P16, DOI 10.1016/j.cardiores.2004.08.007; Chang J, 2006, P NATL ACAD SCI USA, V103, P14495, DOI 10.1073/pnas.0601911103; Childs AC, 2002, CANCER RES, V62, P4592; COLOMBO R, 1990, CANCER BIOCHEM BIOPH, V11, P217; Deng SW, 2007, FREE RADICAL BIO MED, V42, P466, DOI 10.1016/j.freeradbiomed.2006.11.013; DOROSHOW JH, 1986, J BIOL CHEM, V261, P3068; DOROSHOW JH, 1981, J CLIN INVEST, V68, P1053, DOI 10.1172/JCI110328; Feng ZQ, 2010, COLLOID SURFACE B, V75, P67, DOI 10.1016/j.colsurfb.2009.08.010; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Hahmann C, 2010, CELL MOL LIFE SCI, V67, P171, DOI 10.1007/s00018-009-0189-x; Higashi M, 2003, CIRC RES, V93, P767, DOI 10.1161/01.RES.0000096650.91688.28; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kotamraju S, 2000, J BIOL CHEM, V275, P33585, DOI 10.1074/jbc.M003890200; Lemarie A, 2008, J IMMUNOL, V180, P6010, DOI 10.4049/jimmunol.180.9.6010; Leung T, 1996, MOL CELL BIOL, V16, P5313; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mali RS, 2011, CANCER CELL, V20, P357, DOI 10.1016/j.ccr.2011.07.016; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Millea PJ, 2009, AM FAM PHYSICIAN, V80, P265; Moon C, 2010, AM J RESP CRIT CARE, V181, P374, DOI 10.1164/rccm.200907-1061OC; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nisimoto Y, 1997, J BIOL CHEM, V272, P18834, DOI 10.1074/jbc.272.30.18834; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; RAJAGOPALAN S, 1988, CANCER RES, V48, P4766; Rath N, 2012, EMBO REP, V13, P900, DOI 10.1038/embor.2012.127; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Sawyer DB, 2010, PROG CARDIOVASC DIS, V53, P105, DOI 10.1016/j.pcad.2010.06.007; Shi JJ, 2013, J CARDIOVASC PHARM, V62, P341, DOI 10.1097/FJC.0b013e3182a3718f; Shi JJ, 2013, CELL CYCLE, V12, P1492, DOI 10.4161/cc.24699; Shi JJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.10; Shi J, 2011, CURR PEDIATR REV, V7, P329, DOI 10.2174/157339611796892265; Shi JJ, 2012, AM J PHYSIOL-HEART C, V302, pH1603, DOI 10.1152/ajpheart.00844.2011; Shi JJ, 2010, J MOL CELL CARDIOL, V49, P819, DOI 10.1016/j.yjmcc.2010.08.008; Shiotani S, 2007, GENE THER, V14, P1425, DOI 10.1038/sj.gt.3303000; Simunek T, 2009, PHARMACOL REP, V61, P154; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Surma M, 2011, FUTUR CARDIOL, V7, P657, DOI [10.2217/fca.11.51, 10.2217/FCA.11.51]; Tacar O, 2013, J PHARM PHARMACOL, V65, P157, DOI 10.1111/j.2042-7158.2012.01567.x; van Dalen EC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003917.pub4; Wang N, 2011, FOOD CHEM TOXICOL, V49, P2975, DOI 10.1016/j.fct.2011.06.080; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050; Zhang YW, 2009, ARCH IMMUNOL THER EX, V57, P435, DOI 10.1007/s00005-009-0051-8; Zhang YM, 2006, FASEB J, V20, P916, DOI 10.1096/fj.05-5129com; Zhao YY, 2010, CANCER RES, V70, P9287, DOI 10.1158/0008-5472.CAN-10-2664	51	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90758	10.1371/journal.pone.0090758	http://dx.doi.org/10.1371/journal.pone.0090758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595357	gold, Green Published, Green Submitted			2022-12-27	WOS:000332475500098
J	Venkatesh, GH; Manjunath, VB; Mumbrekar, KD; Negi, H; Fernandes, DJ; Sharan, K; Banerjee, S; Sadashiva, SRB				Venkatesh, Goutham Hassan; Manjunath, Vadhiraja Bejadi; Mumbrekar, Kamalesh Dattaram; Negi, Hitendra; Fernandes, Donald Jerard; Sharan, Krishna; Banerjee, Sourjya; Sadashiva, Satish Rao Bola			Polymorphisms in Radio-Responsive Genes and Its Association with Acute Toxicity among Head and Neck Cancer Patients	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; NORMAL TISSUE-REACTIONS; DNA-REPAIR GENES; BREAST-CANCER; RADIATION-THERAPY; CELLULAR RADIOSENSITIVITY; IONIZING-RADIATION; PROSTATE-CANCER; LUNG-CANCER; RADIOTHERAPY	Cellular and molecular approaches are being explored to find a biomarker which can predict the development of radiation induced acute toxicity prior to radiation therapy. SNPs in radiation responsive genes may be considered as an approach to develop tools for finding the inherited basis of clinical radiosensitivity. The current study attempts to screen single nucleotide polymorphisms/deletions in DNA damage response, DNA repair, profibrotic cytokine as well as antioxidant response genes and its predictive potential with the normal tissue adverse reactions from 183 head and neck cancer patients undergoing platinum based chemoradiotherapy or radiotherapy alone. We analysed 22 polymorphisms in 17 genes having functional relevance to radiation response. Radiation therapy induced oral mucositis and skin erythema was considered as end point for clinical radiosensitivity. Direct correlation of heterozygous and mutant alleles with acute reactions as well as haplotype correlation revealed NBN variants to be of predictive significance in analysing oral mucositis prior to radiotherapy. In addition, genetic linkage disequilibrium existed in XRCC1 polymorphisms for >grade 2 oral mucositis and skin reaction indicating the complex inheritance pattern. The current study indicates an association for polymorphism in NBN with normal tissue radiosensitivity and further warrants the replication of such studies in a large set of samples.	[Venkatesh, Goutham Hassan; Mumbrekar, Kamalesh Dattaram; Sadashiva, Satish Rao Bola] Manipal Univ, Sch Life Sci, Div Radiobiol & Toxicol, Manipal, Karnataka, India; [Negi, Hitendra] Manipal Univ, Sch Life Sci, Div Biotechnol, Manipal, Karnataka, India; [Manjunath, Vadhiraja Bejadi] Manipal Hosp, Bangalore, Karnataka, India; [Banerjee, Sourjya] Kasturba Med Coll & Hosp, Dept Radiotherapy & Oncol, Mangalore, Karnataka, India; [Fernandes, Donald Jerard; Sharan, Krishna] Kasturba Med Coll & Hosp, Shiridi SaiBaba Canc Hosp & Res Ctr, Dept Radiotherapy & Oncol, Manipal, Karnataka, India	Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal	Sadashiva, SRB (corresponding author), Manipal Univ, Sch Life Sci, Div Radiobiol & Toxicol, Manipal, Karnataka, India.	satishraomlsc@gmail.com	MUMBREKAR, KAMALESH/H-3388-2015; MUMBREKAR, KAMALESH/AAD-5791-2019	MUMBREKAR, KAMALESH/0000-0003-1888-6252; MUMBREKAR, KAMALESH/0000-0003-1888-6252; Hassan Venkatesh, Goutham/0000-0002-6520-435X; Banerjee, Sourjya/0000-0003-4710-2701; Rao Bola Sadashiva, Satish/0000-0002-9631-9731	Department of Biotechnology, Government of India [BT/01/COE/06/02/07]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Funded by Department of Biotechnology, Government of India, grant number BT/01/COE/06/02/07 (http://dbtindia.nic.in/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosone CB, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1526; Andreassen CN, 2012, RADIOTHER ONCOL, V105, P283, DOI 10.1016/j.radonc.2012.11.003; Andreassen CN, 2009, RADIOTHER ONCOL, V92, P299, DOI 10.1016/j.radonc.2009.06.015; Barnett GC, 2012, LANCET ONCOL, V13, P65, DOI 10.1016/S1470-2045(11)70302-3; Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Chang-Claude J, 2009, BRIT J CANCER, V100, P1680, DOI 10.1038/sj.bjc.6605036; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; Damaraju S, 2006, CLIN CANCER RES, V12, P2545, DOI 10.1158/1078-0432.CCR-05-2703; Giotopoulos G, 2007, BRIT J CANCER, V96, P1001, DOI 10.1038/sj.bjc.6603637; Goutham HV, 2012, INT J RADIAT ONCOL, V84, pE607, DOI 10.1016/j.ijrobp.2012.06.041; Ishikawa A, 2011, INT J RADIAT ONCOL, V81, P1144, DOI 10.1016/j.ijrobp.2010.09.012; Isomura M, 2008, CLIN CANCER RES, V14, P6683, DOI 10.1158/1078-0432.CCR-07-4389; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Guerra JLL, 2012, RADIOTHER ONCOL, V105, P299, DOI 10.1016/j.radonc.2012.08.014; Millikan RC, 2005, CANCER EPIDEM BIOMAR, V14, P2326, DOI 10.1158/1055-9965.EPI-05-0186; Parliament MB, 2010, SEMIN RADIAT ONCOL, V20, P232, DOI 10.1016/j.semradonc.2010.05.003; Popanda O, 2006, CANCER EPIDEM BIOMAR, V15, P1048, DOI 10.1158/1055-9965.EPI-06-0046; Popanda O, 2009, MUTAT RES-FUND MOL M, V667, P58, DOI 10.1016/j.mrfmmm.2008.10.014; Pratesi N, 2011, RADIOTHER ONCOL, V99, P356, DOI 10.1016/j.radonc.2011.05.062; Reuther S, 2013, INT J RADIAT ONCOL, V85, P460, DOI 10.1016/j.ijrobp.2012.01.090; Safwat A, 2002, INT J RADIAT ONCOL, V52, P198, DOI 10.1016/S0360-3016(01)02690-6; Schirmer MA, 2011, INT J RADIAT ONCOL, V79, P866, DOI 10.1016/j.ijrobp.2010.08.040; Silva J, 2012, DNA CELL BIOL, V31, P1182, DOI 10.1089/dna.2011.1562; Suga T, 2007, INT J RADIAT ONCOL, V69, P685, DOI 10.1016/j.ijrobp.2007.06.021; Trotti A, 2000, INT J RADIAT ONCOL, V47, P1, DOI 10.1016/S0360-3016(99)00558-1; Voets AM, 2012, RADIOTHER ONCOL, V105, P296, DOI 10.1016/j.radonc.2012.09.016; Werbrouck J, 2009, INT J RADIAT ONCOL, V73, P1187, DOI 10.1016/j.ijrobp.2008.08.073; West CM, 2012, GENOME MED, V3, pe52; Zackrisson B, 2003, ACTA ONCOL, V42, P443, DOI 10.1080/02841860310014886; Zschenker O, 2010, RADIOTHER ONCOL, V97, P26, DOI 10.1016/j.radonc.2010.01.016	31	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89079	10.1371/journal.pone.0089079	http://dx.doi.org/10.1371/journal.pone.0089079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594932	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500009
J	Chen, D; Huang, JF; Liu, K; Zhang, LQ; Yang, Z; Chuai, ZR; Wang, YX; Shi, DC; Huang, Q; Fu, WL				Chen, Dong; Huang, Jun-Fu; Liu, Kai; Zhang, Li-Qun; Yang, Zhao; Chuai, Zheng-Ran; Wang, Yun-Xia; Shi, Da-Chuan; Huang, Qing; Fu, Wei-Ling			BRAF(V600E) Mutation and Its Association with Clinicopathological Features of Colorectal Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ISLAND METHYLATOR PHENOTYPE; BRAF V600E MUTATION; COLON-CANCER; MICROSATELLITE INSTABILITY; POOR SURVIVAL; PROGNOSTIC-FACTOR; STAGE-II; KRAS; SMOKING; POPULATION	Background: Colorectal cancer (CRC) is a heterogeneous disease with multiple underlying causative genetic mutations. The B-type Raf proto-oncogene (BRAF) plays an important role in the mitogen-activated protein kinase (MAPK) signaling cascade during CRC. The presence of BRAF(V600E) mutation can determine the response of a tumor to chemotherapy. However, the association between the BRAF(V600E) mutation and the clinicopathological features of CRC remains controversial. We performed a systematic review and meta-analysis to estimate the effect of BRAF(V600E) mutation on the clinicopathological characteristics of CRC. Methods: We identified studies that examined the effect of BRAF(V600E) mutation on CRC within the PubMed, ISI Science Citation Index, and Embase databases. The effect of BRAF(V600E) on outcome parameters was estimated by odds ratios (ORs) with 95% confidence intervals (CIs) for each study using a fixed effects or random effects model. Results: 25 studies with a total of 11,955 CRC patients met inclusion criteria. The rate of BRAF(V600) was 10.8% (1288/11955). The BRAF(V600E) mutation in CRC was associated with advanced TNM stage, poor differentiation, mucinous histology, microsatellite instability (MSI), CpG island methylator phenotype (CIMP). This mutation was also associated with female gender, older age, proximal colon, and mutL homolog 1 (MLH1) methylation. Conclusions: This meta-analysis demonstrated that BRAF(V600E) mutation was significantly correlated with adverse pathological features of CRC and distinct clinical characteristics. These data suggest that BRAF(V600E) mutation could be used to supplement standard clinical and pathological staging for the better management of individual CRC patients, and could be considered as a poor prognostic marker for CRC.	[Chen, Dong; Huang, Jun-Fu; Zhang, Li-Qun; Yang, Zhao; Chuai, Zheng-Ran; Wang, Yun-Xia; Shi, Da-Chuan; Huang, Qing; Fu, Wei-Ling] Third Mil Med Univ, Southwest Hosp, Dept Lab Med, Chongqing, Peoples R China; [Liu, Kai] Third Mil Med Univ, Res Ctr Nutr & Food Safety, Inst Mil Prevent Med, Chongqing, Peoples R China	Army Medical University; Army Medical University	Huang, Q (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Lab Med, Chongqing, Peoples R China.	Dr.Q.Huang@gmail.com; weilingfu@yahoo.com	Zhang, Li/GWM-7501-2022; fu, weiling/AAX-3286-2021; Huang, Qing/E-1872-2017	fu, weiling/0000-0002-5768-6563; Huang, Qing/0000-0002-0140-8978	National High Technology Research and Development Program of China (National 863 Program) [2011AA02A121, 2013AA020204]; Preferential Foundation of Science and Technology Activities for Students Studying Abroad of Chongqing [YuLiuZhu201201]; Scientific Research Foundation for Returned Overseas Chinese Scholars of the State Education Ministry	National High Technology Research and Development Program of China (National 863 Program)(National High Technology Research and Development Program of China); Preferential Foundation of Science and Technology Activities for Students Studying Abroad of Chongqing; Scientific Research Foundation for Returned Overseas Chinese Scholars of the State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported in part by grants from the National High Technology Research and Development Program of China (National 863 Program, No. 2011AA02A121 and 2013AA020204) the Preferential Foundation of Science and Technology Activities for Students Studying Abroad of Chongqing (No. YuLiuZhu201201), the Project Sponsored by the Scientific Research Foundation for Returned Overseas Chinese Scholars of the State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang PW, 2009, CANCER LETT, V273, P221, DOI 10.1016/j.canlet.2008.08.001; Artale S, 2008, J CLIN ONCOL, V26, P4217, DOI 10.1200/JCO.2008.18.7286; Bagadi SB, 2012, INT J BIOL MARKER, V27, P27, DOI 10.5301/JBM.2012.9108; Barault L, 2008, INT J CANCER, V122, P2255, DOI 10.1002/ijc.23388; Bozzao C, 2012, INT J BIOL MARKER, V27, pE366, DOI 10.5301/JBM.2012.9765; Curtin K, 2009, INT J CANCER, V125, P158, DOI 10.1002/ijc.24338; English DR, 2008, CANCER EPIDEM BIOMAR, V17, P1774, DOI 10.1158/1055-9965.EPI-08-0091; Farina-Sarasqueta A, 2010, ANN ONCOL, V21, P2396, DOI 10.1093/annonc/mdq258; French AJ, 2008, CLIN CANCER RES, V14, P3408, DOI 10.1158/1078-0432.CCR-07-1489; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Kadiyska TK, 2007, CANCER DETECT PREV, V31, P254, DOI 10.1016/j.cdp.2007.04.001; Krol LC, 2012, EUR J CANCER, V48, P1108, DOI 10.1016/j.ejca.2012.02.054; Li HT, 2011, ONCOL REP, V25, P1691, DOI 10.3892/or.2011.1217; Li WQ, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-2; Mao C, 2013, CANCER-AM CANCER SOC, V119, P714, DOI 10.1002/cncr.27804; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Marzouk Ola, 2011, Cancers (Basel), V3, P2767, DOI 10.3390/cancers3022767; Naguib A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-99; Ogino S, 2012, CLIN CANCER RES, V18, P890, DOI 10.1158/1078-0432.CCR-11-2246; Ottawa Hospital Research Institute, NEWCASTLE OTTAWA SCA; Pai RK, 2012, AM J SURG PATHOL, V36, P744, DOI 10.1097/PAS.0b013e31824430d7; Phipps AI, 2012, CANCER EPIDEM BIOMAR, V21, P1792, DOI 10.1158/1055-9965.EPI-12-0674; Price TJ, 2011, J CLIN ONCOL, V29, P2675, DOI 10.1200/JCO.2010.34.5520; Rako I, 2012, NEOPLASMA, V59, P376, DOI 10.4149/neo_2012_049; Rose JS, 2012, CANCER-AM CANCER SOC, V118, P6243, DOI 10.1002/cncr.27666; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Rozek LS, 2010, CANCER EPIDEM BIOMAR, V19, P838, DOI 10.1158/1055-9965.EPI-09-1112; Samowitz WS, 2006, J NATL CANCER I, V98, P1731, DOI 10.1093/jnci/djj468; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Sclafani F, 2013, CRIT REV ONCOL HEMAT, V87, P55, DOI 10.1016/j.critrevonc.2012.11.003; Shaukat A, 2010, DIGEST DIS SCI, V55, P2352, DOI 10.1007/s10620-010-1182-9; Tejpar S, 2010, ONCOLOGIST, V15, P390, DOI 10.1634/theoncologist.2009-0233; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Tie J, 2011, INT J CANCER, V128, P2075, DOI 10.1002/ijc.25555; Tran B, 2011, CANCER-AM CANCER SOC, V117, P4623, DOI 10.1002/cncr.26086; Vilkin A, 2009, CANCER-AM CANCER SOC, V115, P760, DOI 10.1002/cncr.24019; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wang L, 2003, CANCER RES, V63, P5209; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Yokota T, 2011, BRIT J CANCER, V104, P856, DOI 10.1038/bjc.2011.19; Zlobec I, 2010, INT J CANCER, V127, P367, DOI 10.1002/ijc.25042	41	106	112	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90607	10.1371/journal.pone.0090607	http://dx.doi.org/10.1371/journal.pone.0090607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594804	gold, Green Published, Green Submitted			2022-12-27	WOS:000332468900124
J	Zweytick, D; Japelj, B; Mileykovskaya, E; Zorko, M; Dowhan, W; Blondelle, SE; Riedl, S; Jerala, R; Lohner, K				Zweytick, Dagmar; Japelj, Bostjan; Mileykovskaya, Eugenia; Zorko, Mateja; Dowhan, William; Blondelle, Sylvie E.; Riedl, Sabrina; Jerala, Roman; Lohner, Karl			N-acylated Peptides Derived from Human Lactoferricin Perturb Organization of Cardiolipin and Phosphatidylethanolamine in Cell Membranes and Induce Defects in Escherichia coli Cell Division	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; ANTIMICROBIAL PEPTIDES; OUTER-MEMBRANE; PHOSPHOLIPID-COMPOSITION; BOVINE LACTOFERRICIN; AQUEOUS-SOLUTION; ACTIVE PEPTIDES; ACRIDINE-ORANGE; ANTIBIOTICS	Two types of recently described antibacterial peptides derived from human lactoferricin, either nonacylated or N-acylated, were studied for their different interaction with membranes of Escherichia coli in vivo and in model systems. Electron microscopy revealed striking effects on the bacterial membrane as both peptide types induced formation of large membrane blebs. Electron and fluorescence microscopy, however demonstrated that only the N-acylated peptides partially induced the generation of oversized cells, which might reflect defects in cell-division. Further a different distribution of cardiolipin domains on the E. coli membrane was shown only in the presence of the N-acylated peptides. The lipid was distributed over the whole bacterial cell surface, whereas cardiolipin in untreated and nonacylated peptide-treated cells was mainly located at the septum and poles. Studies with bacterial membrane mimics, such as cardiolipin or phosphatidylethanolamine revealed that both types of peptides interacted with the negatively charged lipid cardiolipin. The nonacylated peptides however induced segregation of cardiolipin into peptide-enriched and peptide-poor lipid domains, while the N-acylated peptides promoted formation of many small heterogeneous domains. Only N-acylated peptides caused additional severe effects on the main phase transition of liposomes composed of pure phosphatidylethanolamine, while both peptide types inhibited the lamellar to hexagonal phase transition. Lipid mixtures of phosphatidylethanolamine and cardiolipin revealed anionic clustering by all peptide types. However additional strong perturbation of the neutral lipids was only seen with the N-acylated peptides. Nuclear magnetic resonance demonstrated different conformational arrangement of the N-acylated peptide in anionic and zwitterionic micelles revealing possible mechanistic differences in their action on different membrane lipids. We hypothesized that both peptides kill bacteria by interacting with bacterial membrane lipids but only N-acylated peptides interact with both charged cardiolipin and zwitterionic phosphatidylethanolamine resulting in remodeling of the natural phospholipid domains in the E. coli membrane that leads to defects in cell division.	[Zweytick, Dagmar; Riedl, Sabrina; Lohner, Karl] Graz Univ, Div Biophys, Inst Mol Biosci, Graz, Austria; [Japelj, Bostjan; Zorko, Mateja; Jerala, Roman] Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia; [Mileykovskaya, Eugenia; Dowhan, William] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX USA; [Blondelle, Sylvie E.] Torrey Pines Inst Mol Studies, Dept Biochem, San Diego, CA USA; [Jerala, Roman] Ctr Excellence EN FIST, Ljubljana, Slovenia	University of Graz; National Institute of Chemistry - Slovenia; University of Texas System; University of Texas Health Science Center Houston; Torrey Pines Institute for Molecular Studies, California	Zweytick, D (corresponding author), Graz Univ, Div Biophys, Inst Mol Biosci, Graz, Austria.	dagmar.zweytick@uni-graz.at	; Jerala, Roman/H-9850-2015	Mileykovskaya, Eugenia/0000-0002-8775-4467; Zweytick, Dagmar/0000-0002-4766-7713; Jerala, Roman/0000-0002-6337-5251	EC-specific RTD Program [QLK2-CT-2002-01001]; Slovenian Research Agency; European structural funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020478, R01GM020478] Funding Source: NIH RePORTER	EC-specific RTD Program; Slovenian Research Agency(Slovenian Research Agency - Slovenia); European structural funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was mainly supported by the EC-specific RTD Program Grant QLK2-CT-2002-01001. RJ, BJ and MZ were supported by the program and projects from the Slovenian Research Agency and in part by the European structural funds to the Centre of Excellence EN-FIST. The funders had no role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Blondelle SE, 2004, PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, P877; Brunecky R, 2005, BIOCHEMISTRY-US, V44, P16064, DOI 10.1021/bi051127+; COSTERTON JW, 1974, BACTERIOL REV, V38, P87, DOI 10.1128/MMBR.38.1.87-110.1974; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; DEVOE IW, 1973, J EXP MED, V138, P1156, DOI 10.1084/jem.138.5.1156; Epand RM, 2011, J PEPT SCI, V17, P298, DOI 10.1002/psc.1319; Epand RM, 2010, BBA-BIOMEMBRANES, V1798, P1272, DOI 10.1016/j.bbamem.2010.03.012; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Hancock REW, 1997, TRENDS MICROBIOL, V5, P37, DOI 10.1016/S0966-842X(97)81773-8; Haukland HH, 2001, FEBS LETT, V508, P389, DOI 10.1016/S0014-5793(01)03100-3; HAWROT E, 1978, J BIOL CHEM, V253, P8213; HENNESSEY JP, 1981, BIOCHEMISTRY-US, V20, P1085, DOI 10.1021/bi00508a007; Hickel A, 2008, BBA-BIOMEMBRANES, V1778, P2325, DOI 10.1016/j.bbamem.2008.05.014; HOEKSTRA D, 1976, BIOCHIM BIOPHYS ACTA, V455, P889, DOI 10.1016/0005-2736(76)90058-4; Hunter HN, 2005, ANTIMICROB AGENTS CH, V49, P3387, DOI 10.1128/AAC.49.8.3387-3395.2005; Kadurugamuwa JL, 1997, J ANTIMICROB CHEMOTH, V40, P615, DOI 10.1093/jac/40.5.615; KATSUI N, 1982, J BACTERIOL, V151, P1523, DOI 10.1128/JB.151.3.1523-1531.1982; KNOX KW, 1966, J BACTERIOL, V92, P1206, DOI 10.1128/JB.92.4.1206-1217.1966; Koppelman CM, 2004, MOL MICROBIOL, V51, P645, DOI 10.1046/j.1365-2958.2003.03876.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lewis RNAH, 2007, BIOPHYS J, V92, P3166, DOI 10.1529/biophysj.106.094003; LIPPENS G, 1995, J BIOMOL NMR, V5, P327, DOI 10.1007/BF00211762; Lohner K, 2005, COMB CHEM HIGH T SCR, V8, P241, DOI 10.2174/1386207053764576; Lohner K, 2009, GEN PHYSIOL BIOPHYS, V28, P105, DOI 10.4149/gpb_2009_02_105; Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621; MACKERELL AD, 1995, J PHYS CHEM-US, V99, P1846, DOI 10.1021/j100007a011; Matsuzaki K, 1996, BIOCHEMISTRY-US, V35, P11361, DOI 10.1021/bi960016v; MAYRAND D, 1989, CAN J MICROBIOL, V35, P607, DOI 10.1139/m89-097; Mileykovskaya E, 2005, CURR OPIN MICROBIOL, V8, P135, DOI 10.1016/j.mib.2005.02.012; Mileykovskaya E, 1998, J BACTERIOL, V180, P4252, DOI 10.1128/JB.180.16.4252-4257.1998; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Mileykovskaya E., 2012, ESCHERICHIA COLI BAC, P149; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Nguyen LT, 2005, J PEPT SCI, V11, P379, DOI 10.1002/psc.629; NORRIS V, 1992, J THEOR BIOL, V154, P91, DOI 10.1016/S0022-5193(05)80190-0; PETIT JM, 1992, EUR J BIOCHEM, V209, P267, DOI 10.1111/j.1432-1033.1992.tb17285.x; Pristovsek P, 2002, J COMPUT CHEM, V23, P335, DOI 10.1002/jcc.10011; Prossnigg F, 2010, BIOPHYS CHEM, V150, P129, DOI 10.1016/j.bpc.2010.04.004; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; RIETVELD AG, 1993, J BIOL CHEM, V268, P12427; Schibli DJ, 1999, FEBS LETT, V446, P213, DOI 10.1016/S0014-5793(99)00214-8; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Shai Y, 2001, PEPTIDES, V22, P1629, DOI 10.1016/S0196-9781(01)00498-3; Smallcombe SH, 1995, J MAGN RESON SER A, V117, P295, DOI 10.1006/jmra.1995.0759; SOMEYA A, 1979, ANTIMICROB AGENTS CH, V16, P87, DOI 10.1128/AAC.16.1.87; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Tieleman DP, 2000, J PHYS CHEM B, V104, P6380, DOI 10.1021/jp001268f; Ulvatne H, 2004, FEMS MICROBIOL LETT, V237, P377, DOI 10.1016/j.femsle.2004.07.001; Vogel HJ, 2002, BIOCHEM CELL BIOL, V80, P49, DOI 10.1139/o01-213; Wadhwani P, 2012, BIOPHYS J, V103, P265, DOI 10.1016/j.bpj.2012.06.004; Wilkinson S.G., 1988, MICROBIAL LIPIDS, V1, P299; Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0; Zorko M, 2009, BBA-BIOMEMBRANES, V1788, P314, DOI 10.1016/j.bbamem.2008.10.015; Zweytick D, 2006, BBA-BIOMEMBRANES, V1758, P1426, DOI 10.1016/j.bbamem.2006.02.032; Zweytick D, 2011, J BIOL CHEM, V286, P21266, DOI 10.1074/jbc.M110.195412	62	31	31	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90228	10.1371/journal.pone.0090228	http://dx.doi.org/10.1371/journal.pone.0090228			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595074	gold, Green Published, Green Submitted			2022-12-27	WOS:000332468900084
J	Fukumoto, R; Burns, TM; Kiang, JG				Fukumoto, Risaku; Burns, True M.; Kiang, Juliann G.			Ciprofloxacin Enhances Stress Erythropoiesis in Spleen and Increases Survival after Whole-Body Irradiation Combined with Skin-Wound Trauma	PLOS ONE			English	Article							DOUBLE-BLIND; ANEMIA; MACROPHAGES; HOMEOSTASIS; HEMATOPOIESIS; ACTIVATION; THERAPY; DISEASE	Severe hematopoietic loss is one of the major therapeutic targets after radiation-combined injury (CI), a kind of injury resulting from radiation exposure combined with other traumas. In this study, we tested the use of ciprofloxacin (CIP) as a treatment, because of recently reported immunomodulatory effects against CI that may improve hematopoiesis. The CIP regimen was a daily, oral dose for 3 weeks, with the first dose 2 h after CI. CIP treatment improved 30-day survival in mice at 80% compared to 35% for untreated controls. Study of early changes in hematological parameters identified CI-induced progressive anemia by 10 days that CIP significantly ameliorated. CI induced erythropoietin (EPO) mRNA in kidney and protein in kidney and serum; CIP stimulated EPO mRNA expression. In spleens of CI mice, CIP induced bone morphogenetic protein 4 (BMP4) in macrophages with EPO receptors. Splenocytes from CIP-treated CI mice formed CD71(+) colony-forming unit-erythroid significantly better than those from controls. Thus, CIP-mediated BMP4-dependent stress erythropoiesis may play a role in improving survival after CI.	[Fukumoto, Risaku; Burns, True M.; Kiang, Juliann G.] Armed Forces Radiobiol Res Inst, Radiat Combined Injury Program, Bethesda, MD 20889 USA; [Kiang, Juliann G.] Uniformed Serv Univ Hlth Sci, Dept Radiat Biol, Bethesda, MD 20814 USA; [Kiang, Juliann G.] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA	United States Department of Defense; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Kiang, JG (corresponding author), Armed Forces Radiobiol Res Inst, Radiat Combined Injury Program, Bethesda, MD 20889 USA.	juliann.kiang@usuhs.edu			NIAID [R21/33AI080553]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080553] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID R21/33AI080553. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; [Anonymous], 2013, M CUR RAD 1903 NOB P; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; Bratosin D, 1998, BIOCHIMIE, V80, P173, DOI 10.1016/S0300-9084(98)80024-2; BREBAN M, 1992, J RHEUMATOL, V19, P216; Canton R, 2011, FEMS MICROBIOL REV, V35, P977, DOI 10.1111/j.1574-6976.2011.00295.x; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Dalhoff A, 2003, LANCET INFECT DIS, V3, P359, DOI 10.1016/S1473-3099(03)00658-3; DAVIS AK, 1954, ANN SURG, V140, P726, DOI 10.1097/00000658-195411000-00012; De Pauw B E, 1989, J Chemother, V1, P606; FRASER JK, 1988, EXP HEMATOL, V16, P836; Freifeld A, 1999, NEW ENGL J MED, V341, P305, DOI 10.1056/NEJM199907293410501; Fukumoto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058389; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Ibuki Y, 2004, CELL MOL BIOL, V50, P617, DOI 10.1170/75; Kiang JG, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-20; Kiang JG, 2010, RADIAT RES, V173, P319, DOI 10.1667/RR1892.1; KLETTER Y, 1994, EXP HEMATOL, V22, P360; KRANTZ SB, 1991, BLOOD, V77, P419; Lahat G, 2007, INFLAMM BOWEL DIS, V13, P557, DOI 10.1002/ibd.20077; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; Lang KS, 2002, CELL PHYSIOL BIOCHEM, V12, P365, DOI 10.1159/000067907; Millot S, 2010, BLOOD, V116, P6072, DOI 10.1182/blood-2010-04-281840; Rubin P., 1968, CLIN RAD PATHOLOGY; Shalit I, 1997, EUR J HAEMATOL, V58, P92; Singbrant S, 2011, BLOOD, V117, P5631, DOI 10.1182/blood-2010-11-320564; Theurl I, 2009, BLOOD, V113, P5277, DOI 10.1182/blood-2008-12-195651; Thia KT, 2009, INFLAMM BOWEL DIS, V15, P17, DOI 10.1002/ibd.20608	29	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90448	10.1371/journal.pone.0090448	http://dx.doi.org/10.1371/journal.pone.0090448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587369	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200203
J	Whited, MC; Schneider, KL; Appelhans, BM; Ma, YS; Waring, ME; DeBiasse, MA; Busch, AM; Oleski, JL; Merriam, PA; Olendzki, BC; Crawford, SL; Ockene, IS; Lemon, SC; Pagoto, SL				Whited, Matthew C.; Schneider, Kristin L.; Appelhans, Bradley M.; Ma, Yunsheng; Waring, Molly E.; DeBiasse, Michele A.; Busch, Andrew M.; Oleski, Jessica L.; Merriam, Philip A.; Olendzki, Barbara C.; Crawford, Sybil L.; Ockene, Ira S.; Lemon, Stephenie C.; Pagoto, Sherry L.			Severity of Depressive Symptoms and Accuracy of Dietary Reporting among Obese Women with Major Depressive Disorder Seeking Weight Loss Treatment	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ENERGY-INTAKE; SOCIAL DESIRABILITY; COMORBID OBESITY; HOPELESSNESS; POPULATION; ANXIETY	An elevation in symptoms of depression has previously been associated with greater accuracy of reported dietary intake, however this association has not been investigated among individuals with a diagnosis of major depressive disorder. The purpose of this study was to investigate reporting accuracy of dietary intake among a group of women with major depressive disorder in order to determine if reporting accuracy is similarly associated with depressive symptoms among depressed women. Reporting accuracy of dietary intake was calculated based on three 24-hour phone-delivered dietary recalls from the baseline phase of a randomized trial of weight loss treatment for 161 obese women with major depressive disorder. Regression models indicated that higher severity of depressive symptoms was associated with greater reporting accuracy, even when controlling for other factors traditionally associated with reporting accuracy (coefficient = 0.01 95% CI = 0.01 - 0.02). Seventeen percent of the sample was classified as low energy reporters. Reporting accuracy of dietary intake increases along with depressive symptoms, even among individuals with major depressive disorder. These results suggest that any study investigating associations between diet quality and depression should also include an index of reporting accuracy of dietary intake as accuracy varies with the severity of depressive symptoms.	[Whited, Matthew C.] E Carolina Univ, Dept Psychol, Greenville, NC 27858 USA; [Schneider, Kristin L.] Rosalind Franklin Univ, Dept Psychol, Chicago, IL USA; [Appelhans, Bradley M.; Lemon, Stephenie C.; Pagoto, Sherry L.] Rush Univ, Med Ctr, Dept Prevent Med, Chicago, IL 60612 USA; [Appelhans, Bradley M.; Lemon, Stephenie C.; Pagoto, Sherry L.] Rush Univ, Med Ctr, Dept Behav Sci, Chicago, IL 60612 USA; [Ma, Yunsheng; Oleski, Jessica L.; Merriam, Philip A.; Olendzki, Barbara C.; Crawford, Sybil L.] Univ Massachusetts, Sch Med, Dept Med, Div Prevent & Behav Med, Worcester, MA USA; [Waring, Molly E.] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Div Epidemiol Chron Dis & Vulnerable Populat, Worcester, MA USA; [DeBiasse, Michele A.] Boston Univ, Coll Hlth & Rehabil Sci, Sargent Dept Hlth Sci Boston, Boston, MA 02215 USA; [Busch, Andrew M.] Brown Univ, Miriam Hosp, Ctr Behav Med, Providence, RI USA; [Busch, Andrew M.] Brown Univ, Miriam Hosp, Ctr Prevent Med, Providence, RI USA; [Busch, Andrew M.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Ockene, Ira S.] Univ Massachusetts, Sch Med, Dept Med, Div Cardiovasc Med, Worcester, MA USA	University of North Carolina; East Carolina University; Rosalind Franklin University Medical & Science; Rush University; Rush University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Boston University; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Brown University; University of Massachusetts System; University of Massachusetts Worcester	Whited, MC (corresponding author), E Carolina Univ, Dept Psychol, Greenville, NC 27858 USA.	whitedm@ecu.edu	Whited, Matthew/AAF-6979-2020; Olendzki, Barbara/K-1067-2019; Olendzki, Barbara/AAQ-9077-2020; Ma, Yunsheng/D-9665-2016	Olendzki, Barbara/0000-0003-4307-5187; Ma, Yunsheng/0000-0003-2317-3716; Busch, Andrew/0000-0002-3577-5960; Waring, Molly E./0000-0002-9884-9824; /0000-0001-8502-6290	United States National Institute of Health [R01 MH078012-02, U48 DP001933]; National Institutes of Health [1U01HL105268, KL2TR000160, 5R01HL094575-04, K23HL109620, K23HL107391]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000160] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP001933] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL107391, R01HL094575, K23HL109620, U01HL105268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078012] Funding Source: NIH RePORTER	United States National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by United States National Institute of Health grants: R01 MH078012-02 and U48 DP001933. Salary or partial salary support for individual authors was provided by the National Institutes of Health grants 1U01HL105268 (MEW), KL2TR000160 (MEW), 5R01HL094575-04 (YM), K23HL109620 (MCW), or K23HL107391(AMB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript after choosing to fund the parent study from which these data originate.	Adams SJ, 1998, J HUM NUTR DIET, V11, P295, DOI 10.1046/j.1365-277X.1998.00110.x; Akbaraly TN, 2009, BRIT J PSYCHIAT, V195, P408, DOI 10.1192/bjp.bp.108.058925; ALLOY LB, 1990, CONTEMPORARY PSYCHOLOGICAL APPROACHES TO DEPRESSION, P71; ALLOY LB, 1979, J EXP PSYCHOL GEN, V108, P441, DOI 10.1037/0096-3445.108.4.441; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Archer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076632; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Blanton CA, 2006, J NUTR, V136, P2594, DOI 10.1093/jn/136.10.2594; Briefel RR, 1997, AM J CLIN NUTR, V65, P1203; Burke LE, 2011, J AM DIET ASSOC, V111, P92, DOI 10.1016/j.jada.2010.10.008; COLE DA, 1988, J CONSULT CLIN PSYCH, V56, P131; de Wit L, 2010, PSYCHIAT RES, V178, P230, DOI 10.1016/j.psychres.2009.04.015; DOBSON K, 1989, CAN J BEHAV SCI, V21, P418, DOI 10.1037/h0079839; First MB, 2002, STRUCTURED CLIN INTE; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hill RJ, 2001, BRIT J NUTR, V85, P415, DOI 10.1079/BJN2000281; Jacka FN, 2010, AM J PSYCHIAT, V167, P305, DOI 10.1176/appi.ajp.2009.09060881; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kretsch MJ, 1999, J AM DIET ASSOC, V99, P300, DOI 10.1016/S0002-8223(99)00078-4; Linde JA, 2011, ANN BEHAV MED, V41, P119, DOI 10.1007/s12160-010-9232-2; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Ma YS, 2009, ANN EPIDEMIOL, V19, P553, DOI 10.1016/j.annepidem.2009.04.010; Mendez MA, 2011, AM J EPIDEMIOL, V173, P448, DOI 10.1093/aje/kwq380; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Olendzki BC, 2008, J AM DIET ASSOC, V108, P1003, DOI 10.1016/j.jada.2008.03.006; Pagoto S, 2013, INT J OBESITY, V37, P1427, DOI 10.1038/ijo.2013.25; Pagoto S, 2011, PSYCHOLOGICAL CO-MORBIDITIES OF PHYSICAL ILLNESS: A BEHAVIORAL MEDICINE PERSPECTIVE, P1, DOI 10.1007/978-1-4419-0029-6_1; Rohde P, 2013, CLIN PSYCHOL SCI, V1, P41, DOI 10.1177/2167702612457599; Schneider KL, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-77; STROSAHL KD, 1984, J CONSULT CLIN PSYCH, V52, P449, DOI 10.1037/0022-006X.52.3.449; TANAKAMATSUMI J, 1986, J CONSULT CLIN PSYCH, V54, P328, DOI 10.1037/0022-006X.54.3.328; Tooze JA, 2012, EUR J CLIN NUTR, V66, P569, DOI 10.1038/ejcn.2011.198; Yannakoulia M, 2007, J AM COLL NUTR, V26, P327, DOI 10.1080/07315724.2007.10719619; Yannakoulia M, 2011, MATURITAS, V69, P63, DOI 10.1016/j.maturitas.2011.01.016	34	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90361	10.1371/journal.pone.0090361	http://dx.doi.org/10.1371/journal.pone.0090361			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24587338	Green Published, gold			2022-12-27	WOS:000332396200179
J	Shikuma, CM; Chow, DC; Gangcuangco, LMA; Zhang, GX; Keating, SM; Norris, PJ; Seto, TB; Parikh, N; Kallianpur, KJ; Nakamoto, BK; Nagamine, LS; Ndhlovu, LC; Barbour, JD				Shikuma, Cecilia M.; Chow, Dominic C.; Gangcuangco, Louie Mar A.; Zhang, Guangxiang; Keating, Sheila M.; Norris, Philip J.; Seto, Todd B.; Parikh, Nisha; Kallianpur, Kalpana J.; Nakamoto, Beau K.; Nagamine, Lorna S.; Ndhlovu, Lishomwa C.; Barbour, Jason D.			Monocytes Expand with Immune Dysregulation and Is Associated with Insulin Resistance in Older Individuals with Chronic HIV	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; INFECTED PATIENTS; DISEASE PROGRESSION; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; INFLAMMATORY CYTOKINES; PLASMINOGEN-ACTIVATOR; METABOLIC SYNDROME; DENDRITIC CELLS; PLASMA-LEVELS	Background: Rates of insulin resistance are increased in HIV-infected patients on stable antiretroviral therapy (ART). Such increase may partially be due to HIV-induced immune dysregulation involving monocytes (MO) and its subsets. Materials and Methods: Cross-sectional analysis of 141 HIV-infected subjects age >= 40 years on stable ART. Homeostatic model assessment-insulin resistance (HOMA-IR) and rates of metabolic syndrome were calculated. Subjects were classified by fasting glucose and oral glucose tolerance test (OGTT) into clinical diabetes categories. Multi-parametric flow cytometry was used to determine MO subset percentages: [classical (CD14(++)CD16(-)), intermediate (CD14(++)D16(+)), non-classical (CD14(low/+)CD16(++)), and a recently identified fourth (CD14(low/+)CD16(-)) 'transitional' MO subset] and percentage of activated (CD38(+)HLA-DR+) CD8 T cells. Absolute levels of cells were calculated using clinical CBC and T cell subset data. Multiple plasma soluble biomarkers were assessed by Luminex technology. Results: Median age 50 years, CD4 count (percent) 505 cells/mL (29%), and 89% male. Total MO (r = -0.23, p = 0.006) and classical and non-classical MO subsets correlated negatively with CD4 percent. No correlations were seen with CD4 count as absolute values. Log-total MO and log-classical MO predicted HOMA-IR independently of HIV immuno-virologic and diabetes risk factors (beta = 0.42, p = 0.02 and beta = 0.35, p = 0.02, respectively) and were increased in subjects with metabolic syndrome (p = 0.03 and p = 0.05 respectively). Total and/or subset MO levels correlated with multiple soluble plasma biomarkers including CRP, IL-6, MMP-9, MPO, SAA, SAP and tPAI-1, with tPAI-1 independently predicting HOMA-IR (beta = 0.74, p < 0.001). Conclusions: MO levels increase with worsening HIV immune dysregulation as assessed by CD4 percent. CD4 percent may provide additional information about MO and metabolic risk in this population beyond absolute values. MO, and specifically classical MO, may contribute to insulin resistance and metabolic syndrome during chronic HIV infection. Multiple soluble plasma biomarkers including tPAI-1 increase with increase in MO. Levels of tPAI-1 independently predict the development of insulin resistance.	[Shikuma, Cecilia M.; Chow, Dominic C.; Gangcuangco, Louie Mar A.; Zhang, Guangxiang; Seto, Todd B.; Parikh, Nisha; Kallianpur, Kalpana J.; Nakamoto, Beau K.; Nagamine, Lorna S.; Ndhlovu, Lishomwa C.; Barbour, Jason D.] Univ Hawaii, Hawaii Ctr AIDS, Honolulu, HI 96822 USA; [Keating, Sheila M.; Norris, Philip J.] Blood Syst Res Inst, San Francisco, CA USA; [Norris, Philip J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Seto, Todd B.; Parikh, Nisha] Queens Med Ctr, Honolulu, HI USA; [Nakamoto, Beau K.] Straub Clin & Hosp, Honolulu, HI USA	University of Hawaii System; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; The Queen's Medical Center	Shikuma, CM (corresponding author), Univ Hawaii, Hawaii Ctr AIDS, Honolulu, HI 96822 USA.	shikuma@hawaii.edu	n, l/AAX-3992-2020; Gangcuangco, Louie Mar/P-9579-2019	Gangcuangco, Louie Mar/0000-0002-6714-9294; Ndhlovu, Lishomwa/0000-0001-5427-4187; Keating, Sheila/0000-0002-8324-3694; Chow, Dominic/0000-0001-7395-038X	 [R01HL095135];  [U54RR026136];  [U54MD007584];  [G12MD007601]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026136] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007601, U54MD007584] Funding Source: NIH RePORTER	; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by grants R01HL095135, U54RR026136, U54MD007584, and G12MD007601. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armah KA, 2012, CLIN INFECT DIS, V55, P126, DOI 10.1093/cid/cis406; Barbour JD, 2014, ATHEROSCLEROSIS, V232, P52, DOI 10.1016/j.atherosclerosis.2013.10.021; Boufassa F, 2012, ANTIVIR THER, V17, P91, DOI 10.3851/IMP1916; Brown TT, 2010, DIABETES CARE, V33, P2244, DOI 10.2337/dc10-0633; De Larranaga G, 2004, J THROMB HAEMOST, V2, P532, DOI 10.1111/j.1538-7836.2004.00602.x; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; El-Sadr W, 2005, HIV MED, V6, P114, DOI 10.1111/j.1468-1293.2005.00273.x; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Erzen B, 2013, HEART VESSELS, V28, P570, DOI 10.1007/s00380-012-0287-9; Fernandez-Real JM, 2003, ENDOCR REV, V24, P278, DOI 10.1210/er.2002-0010; Funderburg NT, 2012, BLOOD, V120, P4599, DOI 10.1182/blood-2012-05-433946; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Gutierrez AD, 2012, ENDOCRINE, V41, P1, DOI 10.1007/s12020-011-9565-z; Guzman-Fulgencio M, 2011, J INFECTION, V63, P382, DOI 10.1016/j.jinf.2011.08.006; Haas L, 2013, DIABETES CARE, V36, pS100, DOI [10.2337/dc13-S100, 10.2337/dc13-S004]; HAMSTEN A, 1985, NEW ENGL J MED, V313, P1557, DOI 10.1056/NEJM198512193132501; Han JY, 2009, JAIDS-J ACQ IMM DEF, V52, P553, DOI 10.1097/QAI.0b013e3181c1d4fe; Hulgan T, 2005, J INFECT DIS, V192, P950, DOI 10.1086/432955; Hulgan T, 2007, J INFECT DIS, V195, P425, DOI 10.1086/510536; Jaksic VP, 2013, CLIN INVEST MED, V36, pE24; Jalbert E CT, 2013, PLOS ONE IN PRESS; Jalbert E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075500; Corrales JJ, 2007, J DIABETES COMPLICAT, V21, P41, DOI 10.1016/j.jdiacomp.2005.09.006; Koppel K, 2002, J ACQ IMMUN DEF SYND, V29, P441, DOI 10.1097/00042560-200204150-00003; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Kusao I, 2012, J NEUROPSYCH CLIN N, V24, P71, DOI 10.1176/appi.neuropsych.11050109; Limone P, 2003, J INFECTION, V47, P52, DOI 10.1016/S0163-4453(03)00055-0; Min D, 2012, MEDIAT INFLAMM, V2012, DOI DOI 10.1155/2012/649083; Moore DM, 2006, HIV MED, V7, P383, DOI 10.1111/j.1468-1293.2006.00397.x; Petoumenos K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17426; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Scarpellini E, 2012, DIGEST DIS, V30, P148, DOI 10.1159/000336664; Seidler S, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-30; Skalicky J, 2008, CLIN CHEM LAB MED, V46, P499, DOI 10.1515/CCLM.2008.096; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; van Vonderen MGA, 2009, J INFECT DIS, V199, P1186, DOI 10.1086/597475; Yang MX, 2012, INFLAMMATION, V35, P388, DOI 10.1007/s10753-011-9374-9; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	42	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90330	10.1371/journal.pone.0090330	http://dx.doi.org/10.1371/journal.pone.0090330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587328	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800100
J	Cordero, RR; Damiani, A; Ferrer, J; Jorquera, J; Tobar, M; Labbe, F; Carrasco, J; Laroze, D				Cordero, Raul R.; Damiani, Alessandro; Ferrer, Jorge; Jorquera, Jose; Tobar, Mario; Labbe, Fernando; Carrasco, Jorge; Laroze, David			UV Irradiance and Albedo at Union Glacier Camp (Antarctica): A Case Study	PLOS ONE			English	Article							GROUND-BASED MEASUREMENTS; SINGLE SCATTERING ALBEDO; SURFACE ALBEDO; TOTAL OZONE; ULTRAVIOLET IRRADIANCE; SPECTRAL IRRADIANCE; SNOW ALBEDO; OMI; CLIMATOLOGY; UNCERTAINTY	We report on the first spectral measurements of ultraviolet (UV) irradiance and the albedo at a Camp located in the southern Ellsworth Mountains on the broad expanse of Union Glacier (700 m altitude, 79 degrees 46' S; 82 degrees 52'W); about 1,000 km from the South Pole. The measurements were carried out by using a double monochromator-based spectroradiometer during a campaign (in December 2012) meant to weight up the effect of the local albedo on the UV irradiance. We found that the albedo measured at noon was about 0.95 in the UV and the visible part of the spectrum. This high surface reflectivity led to enhancements in the UV index under cloudless conditions of about 50% in comparison with snow free surfaces. Spectral measurements carried out elsewhere as well as estimates retrieved from the Ozone Monitoring Instrument (OMI) were used for further comparisons.	[Cordero, Raul R.; Damiani, Alessandro; Ferrer, Jorge; Jorquera, Jose; Tobar, Mario] Univ Santiago Chile, Dept Fis, Santiago, Chile; [Jorquera, Jose] Escuela Super Politecn Litoral, Guayaquil, Ecuador; [Labbe, Fernando] Univ Tecn Federico Santa Maria, Dept Ingn Mecan, Valparaiso, Chile; [Carrasco, Jorge] Direcc Meteorol Chile, Santiago, Chile; [Laroze, David] Univ Tarapaca, Inst Alta Invest, Arica, Chile	Universidad de Santiago de Chile; Escuela Superior Politecnica del Litoral; Universidad Tecnica Federico Santa Maria; Universidad de Tarapaca	Cordero, RR (corresponding author), Univ Santiago Chile, Dept Fis, Santiago, Chile.	raul.cordero@usach.cl	Carrasco, Jorge/ACG-6766-2022; Carrasco, Jorge/AAC-4799-2021; Damiani, Alessandro/X-4677-2019; Laroze, David/E-9134-2011; Cordero, Raul R/M-7979-2017; Laroze, David/Z-2852-2019; Carrasco, Jorge F/K-2949-2014	Carrasco, Jorge/0000-0003-2154-5483; Carrasco, Jorge/0000-0003-2154-5483; Damiani, Alessandro/0000-0003-3014-6193; Laroze, David/0000-0002-6487-8096; Laroze, David/0000-0002-6487-8096; Carrasco, Jorge F/0000-0003-2154-5483; Cordero, Raul R./0000-0001-7607-7993	Escuela Superior Politecnica del Litoral (Guayaquil, ECUADOR); CONICYT-REDES [Preis 130047]; CONICYT-BMBF; FONDEF [IT13I10034]; FONDECYT [Preis 1120639, 1140239, Preis 1120764]; Millennium Scientific Initiative [P10-061-F]; CEDENNA; UTA-Project [8750-12]; USACH-DICYT ASOCIATIVO; UTFSM-DGIP	Escuela Superior Politecnica del Litoral (Guayaquil, ECUADOR); CONICYT-REDES; CONICYT-BMBF(Federal Ministry of Education & Research (BMBF)); FONDEF; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Scientific Initiative; CEDENNA; UTA-Project; USACH-DICYT ASOCIATIVO; UTFSM-DGIP	Although the support of the Escuela Superior Politecnica del Litoral (Guayaquil, ECUADOR), CONICYT-REDES (Preis 130047), CONICYT-BMBF, FONDEF (IT13I10034), FONDECYT (Preis 1120639, 1140239 and Preis 1120764), Millennium Scientific Initiative (P10-061-F), CEDENNA, UTA-Project 8750-12, USACH-DICYT ASOCIATIVO, and UTFSM-DGIP, is gratefully acknowledged, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton M, 2011, ATMOS RES, V100, P83, DOI 10.1016/j.atmosres.2010.12.029; Anton M, 2010, ATMOS CHEM PHYS, V10, P5979, DOI 10.5194/acp-10-5979-2010; Aoki T, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015507; Badosa J, 2007, ATMOS CHEM PHYS, V7, P2817, DOI 10.5194/acp-7-2817-2007; Bais AF, 2005, ATMOS ENVIRON, V39, P1093, DOI 10.1016/j.atmosenv.2004.09.080; Bais AF, 2001, J GEOPHYS RES-ATMOS, V106, P12509, DOI 10.1029/2000JD900561; Balis D, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008796; Bernhard G, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004937; Bernhard G, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003450; Bernhard G, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD005857; Bernhard G, 2005, P SOC PHOTO-OPT INS, V5886, P51; Bernhard G, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007865; Bernhard G, 2010, UV RADIATION IN GLOBAL CLIMATE CHANGE, P48, DOI 10.1007/978-3-642-03313-1_3; Blumthaler M, 2009, MOCA JOINT ASS MONTR; Brandt RE, 2005, J CLIMATE, V18, P3606, DOI 10.1175/JCLI3489.1; Bromwich DH, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000363; Buchard V, 2008, ATMOS CHEM PHYS, V8, P4517, DOI 10.5194/acp-8-4517-2008; Buchard V, 2011, ATMOS MEAS TECH, V4, P1, DOI 10.5194/amt-4-1-2011; Cabrera S, 2012, J PHOTOCH PHOTOBIO B, V115, P73, DOI 10.1016/j.jphotobiol.2012.06.013; Cede A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006585; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Cordero RR, 2013, PHOTOCH PHOTOBIO SCI, V12, P1193, DOI 10.1039/c3pp25440b; Cordero RR, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/4/045104; Cordero RR, 2008, METROLOGIA, V45, P1, DOI 10.1088/0026-1394/45/1/001; Cordero RR, 2007, OPT COMMUN, V276, P44, DOI 10.1016/j.optcom.2007.04.008; Cordero RR, 2013, METROLOGIA, V50, pL1, DOI 10.1088/0026-1394/50/5/L1; Cordero RR, 2013, ANTARCT SCI, V25, P791, DOI 10.1017/S0954102013000175; Cordero RR, 2013, APPL OPTICS, V52, P6287, DOI 10.1364/AO.52.006287; Cordero RR, 2009, METROLOGIA, V46, P19, DOI 10.1088/0026-1394/46/1/003; DAHLBACK A, 1991, PLANET SPACE SCI, V39, P671, DOI 10.1016/0032-0633(91)90061-E; Damiani A, 2013, INT J REMOTE SENS, V34, P5812, DOI 10.1080/01431161.2013.796101; Damiani A, 2012, REMOTE SENS ENVIRON, V127, P162, DOI 10.1016/j.rse.2012.08.023; Douglass A, 2011, 52 GLOB OZ RES MON P; Flemming J, 2011, ATMOS CHEM PHYS, V11, P1961, DOI 10.5194/acp-11-1961-2011; Grenfell TC, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001866; GRENFELL TC, 1994, J GEOPHYS RES-ATMOS, V99, P18669, DOI 10.1029/94JD01484; Grobner J, 2000, J GEOPHYS RES-ATMOS, V105, P26991, DOI 10.1029/2000JD900395; Grobner J., 2007, REPORT PMOD WRC COST; Grobner J, 2006, METROLOGIA, V43, pS66, DOI 10.1088/0026-1394/43/2/S14; Grooss JU, 2011, ATMOS CHEM PHYS, V11, P12217, DOI 10.5194/acp-11-12217-2011; Gueymard CA, 2004, SOL ENERGY, V76, P423, DOI 10.1016/j.solener.2003.08.039; Hall A, 2004, J CLIMATE, V17, P1550, DOI 10.1175/1520-0442(2004)017&lt;1550:TROSAF&gt;2.0.CO;2; Ialongo I, 2008, ATMOS CHEM PHYS, V8, P3283, DOI 10.5194/acp-8-3283-2008; Ialongo I., 2009, ATMOS CHEM PHYS DISC, V9, P19009, DOI DOI 10.5194/acpd-9-19009-2009; Kazadzis S, 2009, ATMOS CHEM PHYS, V9, P4593, DOI 10.5194/acp-9-4593-2009; Kazadzis S, 2009, ATMOS CHEM PHYS, V9, P585, DOI 10.5194/acp-9-585-2009; Kleipool QL, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010290; Kylling A, 2000, J GEOPHYS RES-ATMOS, V105, P4949, DOI 10.1029/1999JD900304; Lenoble J, 1998, APPL OPTICS, V37, P2441, DOI 10.1364/AO.37.002441; Li SS, 2003, APPL OPTICS, V42, P5427, DOI 10.1364/AO.42.005427; Mayer B, 2005, ATMOS CHEM PHYS, V5, P1855, DOI 10.5194/acp-5-1855-2005; McKinlay AF., 1987, CIE J, P83; McPeters R, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008802; Meinander O, 2008, ATMOS CHEM PHYS, V8, P6551, DOI 10.5194/acp-8-6551-2008; Meinander O, 2013, ATMOS CHEM PHYS, V13, P3793, DOI 10.5194/acp-13-3793-2013; Meinander O., 2009, GEOPHYSICS, V45, P183; O'Byrne G, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013079; PARISH TR, 1987, NATURE, V328, P51, DOI 10.1038/328051a0; Pedersen CA, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010440; Pirazzini R, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004617; Satheesh SK, 2006, ATMOS ENVIRON, V40, P3008, DOI 10.1016/j.atmosenv.2006.01.031; Seckmeyer G., 2001, 125 WMOGAW; Smolskaia I, 2003, APPL OPTICS, V42, P1583, DOI 10.1364/AO.42.001583; STAMNES K, 1991, APPL OPTICS, V30, P4418, DOI 10.1364/AO.30.004418; Tanskanen A, 2007, ATMOS CHEM PHYS, V7, P2759, DOI 10.5194/acp-7-2759-2007; Tanskanen A, 2006, IEEE T GEOSCI REMOTE, V44, P1267, DOI 10.1109/TGRS.2005.862203; Tanskanen A, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008830; Van den Broeke MR, 2004, J GLACIOL, V50, P565, DOI 10.3189/172756504781829756; Vaughan DG, 2001, SCIENCE, V293, P1777, DOI 10.1126/science.1065116; Weihs P, 2008, ATMOS CHEM PHYS, V8, P5615, DOI 10.5194/acp-8-5615-2008; Weller R, 2013, ATMOS CHEM PHYS, V13, P1579, DOI 10.5194/acp-13-1579-2013; Winton M, 2006, J CLIMATE, V19, P359, DOI 10.1175/JCLI3624.1; Wuttke S, 2006, ANN GEOPHYS-GERMANY, V24, P7, DOI 10.5194/angeo-24-7-2006; Wuttke S, 2006, J ATMOS OCEAN TECH, V23, P241, DOI 10.1175/JTECH1826.1	74	14	17	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90705	10.1371/journal.pone.0090705	http://dx.doi.org/10.1371/journal.pone.0090705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598906	gold, Green Submitted, Green Published			2022-12-27	WOS:000332479400122
J	Lin, TY; Chu, YY; Yang, YC; Hsu, SW; Liu, ST; Chang, LK				Lin, Ting-Yu; Chu, Ya-Yun; Yang, Ya-Chun; Hsu, Shih-Wei; Liu, Shih-Tung; Chang, Li-Kwan			MCAF1 and Rta-Activated BZLF1 Transcription in Epstein-Barr Virus	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; IMMEDIATE-EARLY PROTEIN; SWITCH GENE BZLF1; LYTIC CYCLE; EPITHELIAL-CELLS; BMLF1 PROMOTER; BRLF1; EBV; BINDING; TRANSACTIVATORS	Epstein-Barr virus (EBV) expresses two transcription factors, Rta and Zta, which are involved in the transcriptional activation of EBV lytic genes. This study sought to elucidate the mechanism by which Rta activates transcription of the Zta-encoding gene, BZLF1, through the ZII element in the gene promoter. In a DNA affinity precipitation assay, ATF2 was found to associate with an Rta-interacting protein, MCAF1, at the ZII element. The interaction between Rta, MCAF1, and ATF2 at the same site in the ZII region was further verified in vivo by chromatin immunoprecipitation assay. The complex appears to be crucial for the activation of BZLF1 transcription, as the overexpression of two ATF2-dominant negative mutants, or the introduction of MCAF1 siRNA into 293T cells, were both found to substantially reduce Rta-mediated transcription levels of BZLF1. Moreover, this study also found that the Rta-MCAF1-ATF2 complex binds to a typical AP-1 binding sequence on the promoter of BMRF2, a key viral gene for EBV infection. Mutation of this sequence decreased Rta-mediated promoter activity significantly. Taken together, these results indicate a critical role for MCAF1 in AP-1-dependent Rta activation of BZLF1 transcription.	[Lin, Ting-Yu; Chu, Ya-Yun; Yang, Ya-Chun; Chang, Li-Kwan] Natl Taiwan Univ, Dept Biochem Sci & Technol, Coll Life Sci, Taipei 10764, Taiwan; [Hsu, Shih-Wei; Liu, Shih-Tung] Chang Gung Univ, Dept Microbiol & Immunol, Mol Genet Lab, Tao Yuan, Taiwan	National Taiwan University; Chang Gung University	Chang, LK (corresponding author), Natl Taiwan Univ, Dept Biochem Sci & Technol, Coll Life Sci, Taipei 10764, Taiwan.	changlk@ntu.edu.tw	Hsiao, Wei-Hung/B-9931-2013		National Health Research Institute [NHRI-EX102-10030BI]	National Health Research Institute(National Health Research Institutes - Taiwan)	This work was supported by National Health Research Institute (Grant NHRI-EX102-10030BI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AL, 2000, J VIROL, V74, P1224, DOI 10.1128/JVI.74.3.1224-1233.2000; Bergbauer M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001114; Bhende PM, 2004, NAT GENET, V36, P1099, DOI 10.1038/ng1424; Chang LK, 2008, J MOL BIOL, V379, P231, DOI 10.1016/j.jmb.2008.04.011; Chang LK, 2010, NUCLEIC ACIDS RES, V38, P4687, DOI 10.1093/nar/gkq243; Chang LK, 2005, NUCLEIC ACIDS RES, V33, P6528, DOI 10.1093/nar/gki956; Chang LK, 2000, NUCLEIC ACIDS RES, V28, P3918, DOI 10.1093/nar/28.20.3918; Chang LK, 2004, J BIOL CHEM, V279, P38803, DOI 10.1074/jbc.M405470200; Chang PJ, 1998, J VIROL, V72, P5128, DOI 10.1128/JVI.72.6.5128-5136.1998; CHEVALLIERGRECO A, 1986, EMBO J, V5, P3243, DOI 10.1002/j.1460-2075.1986.tb04635.x; DAVIES AH, 1991, J VIROL, V65, P6838, DOI 10.1128/JVI.65.12.6838-6844.1991; De Graeve F, 2000, ONCOGENE, V19, P1807, DOI 10.1038/sj.onc.1203492; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; FIXMAN ED, 1992, J VIROL, V66, P5030, DOI 10.1128/JVI.66.8.5030-5039.1992; FLEMINGTON E, 1990, J VIROL, V64, P1217, DOI 10.1128/JVI.64.3.1217-1226.1990; FLEMINGTON E, 1990, J VIROL, V64, P1227, DOI 10.1128/JVI.64.3.1227-1232.1990; Fujita N, 2003, MOL CELL BIOL, V23, P2834, DOI 10.1128/MCB.23.8.2834-2843.2003; GRUFFAT H, 1990, NUCLEIC ACIDS RES, V18, P6835, DOI 10.1093/nar/18.23.6835; GRUFFAT H, 1992, J VIROL, V66, P46, DOI 10.1128/JVI.66.1.46-52.1992; Hinuma Y, 1967, J Virol, V1, P1045; HOLLEYGUTHRIE EA, 1990, J VIROL, V64, P3753, DOI 10.1128/JVI.64.8.3753-3759.1990; Huang J, 2006, J VIROL, V80, P1098, DOI 10.1128/JVI.80.3.1098-1109.2006; Karlsson QH, 2008, BIOCHEM SOC T, V36, P637, DOI 10.1042/BST0360637; KENNEY S, 1989, J VIROL, V63, P3878, DOI 10.1128/JVI.63.9.3878-3883.1989; Lee YH, 2008, J GEN VIROL, V89, P2437, DOI 10.1099/vir.0.2008/003897-0; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; Liu CN, 1996, J VIROL, V70, P2545, DOI 10.1128/JVI.70.4.2545-2555.1996; Lu CC, 2006, VIROLOGY, V345, P358, DOI 10.1016/j.virol.2005.09.064; LUKA J, 1979, VIROLOGY, V94, P228, DOI 10.1016/0042-6822(79)90455-0; QUINLIVAN EB, 1993, NUCLEIC ACIDS RES, V21, P1999, DOI 10.1093/nar/21.8.1999; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; RUF IK, 1995, J VIROL, V69, P7648, DOI 10.1128/JVI.69.12.7648-7657.1995; SCHEPERS A, 1993, EMBO J, V12, P3921, DOI 10.1002/j.1460-2075.1993.tb06070.x; Speck SH, 1997, TRENDS MICROBIOL, V5, P399, DOI 10.1016/S0966-842X(97)01129-3; Sun CC, 2007, J VIROL, V81, P13566, DOI 10.1128/JVI.01055-07; Uchimura Y, 2006, J BIOL CHEM, V281, P23180, DOI 10.1074/jbc.M602280200; Wang YCJ, 1997, VIROLOGY, V227, P323, DOI 10.1006/viro.1996.8326; Xiao JQ, 2008, VIROLOGY, V370, P430, DOI 10.1016/j.virol.2007.09.012; Yang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054075	39	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90698	10.1371/journal.pone.0090698	http://dx.doi.org/10.1371/journal.pone.0090698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598729	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400119
J	Jackson, A; Li, KL; Zhu, XP				Jackson, Alan; Li, Ka-Loh; Zhu, Xiaoping			Semi-Quantitative Parameter Analysis of DCE-MRI Revisited: Monte-Carlo Simulation, Clinical Comparisons, and Clinical Validation of Measurement Errors in Patients with Type 2 Neurofibromatosis	PLOS ONE			English	Article							CONTRAST-ENHANCED MRI; NORMAL PERIPHERAL ZONE; MAGNETIC-RESONANCE; BREAST-CANCER; PROSTATE-CANCER; GD-DTPA; NEOADJUVANT CHEMOTHERAPY; ANTIVASCULAR THERAPIES; IMAGING MEASUREMENTS; MICROVESSEL DENSITY	Purpose: To compare semi-quantitative (SQ) and pharmacokinetic (PK) parameters for analysis of dynamic contrast enhanced MR data (DCE-MRI) and investigate error-propagation in SQ parameters. Methods: Clinical data was collected from five patients with type 2-neurofibromatosis (NF2) receiving anti-angiogenic therapy for rapidly growing vestibular schwannoma (VS). There were 7 VS and 5 meningiomas. Patients were scanned prior to therapy and at days 3 and 90 of treatment. Data was collected using a dual injection technique to permit direct comparison of SQ and PK parameters. Monte Carlo modeling was performed to assess potential measurement errors in SQ parameters in persistent, washout, and weakly enhancing tissues. The simulation predictions for five semi-quantitative parameters were tested using the clinical DCE-MRI data. Results: In VS, SQ parameters and K-trans showed close correlation and demonstrated similar therapy induced reductions. In meningioma, only the denoised Signal Enhancement Ratio (R-se1/se2(DN)) showed a significant therapy induced reduction (p<0.05). Simulation demonstrated: 1) Precision of SQ metrics normalized to the pre-contrast-baseline values (MSErel and Sigma MSErel) is improved by use of an averaged value from multiple baseline scans; 2) signal enhancement ratio R-mse1/mse2 shows considerable susceptibility to noise; 3) removal of outlier values to produce a new parameter, R-mse1/mse2(DN), improves precision and sensitivity to therapy induced changes. Direct comparison of in-vivo analysis with Monte Carlo simulation supported the simulation predicted error distributions of semi-quantitative metrics. Conclusion: PK and SQ parameters showed similar sensitivity to anti-angiogenic therapy induced changes in VS. Modeling studies confirmed the benefits of averaging baseline signal from multiple images for normalized SQ metrics and demonstrated poor noise tolerance in the widely used signal enhancement ratio, which is corrected by removal of outlier values.	[Jackson, Alan; Li, Ka-Loh; Zhu, Xiaoping] Univ Manchester, Wolfson Mol Imaging Ctr, Manchester, Lancs, England	University of Manchester	Jackson, A (corresponding author), Univ Manchester, Wolfson Mol Imaging Ctr, Manchester, Lancs, England.	alan.jackson@manchester.ac.uk	Zhu, Xiaoping/AAO-2711-2021	Zhu, Xiaoping/0000-0002-4351-121X; JACKSON, ALAN/0000-0002-1623-0383	Manchester Cancer Research Centre; Cancer Research UK [16465, 18097] Funding Source: researchfish	Manchester Cancer Research Centre; Cancer Research UK(Cancer Research UK)	This study was locally funded by the Manchester Cancer Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akisik MF, 2010, RADIOLOGY, V256, P441, DOI 10.1148/radiol.10091733; Arasu VA, 2011, ACAD RADIOL, V18, P716, DOI 10.1016/j.acra.2011.02.008; Asselin MC, 2012, EUR J CANCER, V48, P447, DOI 10.1016/j.ejca.2011.12.025; Balvay D, 2005, MAGNET RESON MED, V54, P868, DOI 10.1002/mrm.20650; Bolouri MS, 2013, RADIOLOGY, V269, P353, DOI 10.1148/radiol.13130058; Bone B, 2003, ACTA RADIOL, V44, P373, DOI 10.1034/j.1600-0455.2003.00080.x; Brown J, 2000, MAGN RESON IMAGING, V18, P765, DOI 10.1016/S0730-725X(00)00167-3; Buadu LD, 1996, RADIOLOGY, V200, P639, DOI 10.1148/radiology.200.3.8756909; Buckler AJ, 2011, RADIOLOGY, V259, P875, DOI 10.1148/radiol.10100800; Buckley DL, 2002, MAGN RESON MED, V47, P601, DOI 10.1002/mrm.10080; De Lussanet QG, 2005, INT J RADIAT ONCOL, V63, P1309, DOI 10.1016/j.ijrobp.2005.04.052; Dyke JP, 2003, RADIOLOGY, V228, P271, DOI 10.1148/radiol.2281011651; El Khouli RH, 2009, AM J ROENTGENOL, V193, pW295, DOI 10.2214/AJR.09.2483; Engelbrecht MR, 2003, RADIOLOGY, V229, P248, DOI 10.1148/radiol.2291020200; Esserman Laura, 1999, Breast J, V5, P13, DOI 10.1046/j.1524-4741.1999.005001013.x; Evelhoch J, 2005, CANCER RES, V65, P7041, DOI 10.1158/0008-5472.CAN-05-0674; Evelhoch JL, 1999, JMRI-J MAGN RESON IM, V10, P254, DOI 10.1002/(SICI)1522-2586(199909)10:3<254::AID-JMRI5>3.0.CO;2-9; Evelhoch JL, 2000, ISMRM 8 SCI M DENV, P1439; Ferl GZ, 2010, MAGN RESON MED, V63, P1366, DOI 10.1002/mrm.22335; FLICKINGER FW, 1993, MAGN RESON IMAGING, V11, P617, DOI 10.1016/0730-725X(93)90002-U; Flickinger FW, 1990, RADIOLOGY, V174, P491; Florie J, 2006, AM J ROENTGENOL, V186, P1384, DOI 10.2214/AJR.04.1454; Fritz-Hansen T, 1998, MAGNET RESON MED, V40, P922, DOI 10.1002/mrm.1910400619; Furman-Haran E, 2002, J COMPUT ASSIST TOMO, V26, P376, DOI 10.1097/00004728-200205000-00012; Galbraith SM, 2002, NMR BIOMED, V15, P132, DOI 10.1002/nbm.731; GRIBBESTAD IS, 1994, JMRI-J MAGN RESON IM, V4, P477, DOI 10.1002/jmri.1880040339; Hattangadi J, 2008, AM J ROENTGENOL, V190, P1630, DOI 10.2214/AJR.07.2533; Ikeda O, 1999, ACTA RADIOL, V40, P585, DOI 10.3109/02841859909175592; Jansen SA, 2007, RADIOLOGY, V245, P684, DOI 10.1148/radiol.2453062061; Jansen SA, 2011, J MAGN RESON IMAGING, V33, P1382, DOI 10.1002/jmri.22567; KAISER WA, 1989, RADIOLOGY, V170, P681, DOI 10.1148/radiology.170.3.2916021; Karahaliou A, BR J RADIOL, V83, P296; Koh TS, 2011, MAGN RESON MED, V65, P250, DOI 10.1002/mrm.22596; Kuhl CK, 1999, RADIOLOGY, V211, P101, DOI 10.1148/radiology.211.1.r99ap38101; Kuhl CK, 2000, J MAGN RESON IMAGING, V12, P965, DOI 10.1002/1522-2586(200012)12:6<965::AID-JMRI23>3.0.CO;2-1; Lavini C, 2011, J MAGN RESON IMAGING, V34, P1303, DOI 10.1002/jmri.22742; Lavini C, 2009, MAGN RESON IMAGING, V27, P62, DOI 10.1016/j.mri.2008.05.012; Leach MO, 2012, EUR RADIOL, V22, P1451, DOI 10.1007/s00330-012-2446-x; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; Leach MO, 2003, BRIT J RADIOL, V76, pS87, DOI 10.1259/bjr/15917261; Levman J, 2008, IEEE T MED IMAGING, V27, P688, DOI 10.1109/TMI.2008.916959; Li KL, 2008, RADIOLOGY, V248, P79, DOI 10.1148/radiol.2481070846; Li KL, 2007, MAGN RESON MED, V58, P572, DOI 10.1002/mrm.21361; Li KL, 2012, MAGN RESON MED, V68, P452, DOI 10.1002/mrm.23252; Li KL, 2003, MAGNET RESON MED, V50, P1286, DOI 10.1002/mrm.10652; MILLARD S.P., 2000, ENV STAT S PLUS; Narang J, 2011, NEURO-ONCOLOGY, V13, P1037, DOI 10.1093/neuonc/nor075; O'Connor JPB, 2011, BRIT J RADIOL, V84, pS112, DOI 10.1259/bjr/55166688; O'Connor JPB, 2012, NAT REV CLIN ONCOL, V9, P167, DOI 10.1038/nrclinonc.2012.2; Padhani AR, 2000, CLIN RADIOL, V55, P99, DOI 10.1053/crad.1999.0327; Partridge SC, 2010, J MAGN RESON IMAGING, V32, P1124, DOI 10.1002/jmri.22362; Rouviere O, 2003, EUR RADIOL, V13, P931, DOI 10.1007/s00330-002-1617-6; Schabel MC, 2008, PHYS MED BIOL, V53, P2345, DOI 10.1088/0031-9155/53/9/010; Sourbron SP, 2011, MAGN RESON MED, V66, P735, DOI 10.1002/mrm.22861; Su MY, 2003, J MAGN RESON IMAGING, V18, P467, DOI 10.1002/jmri.10380; Tofts PS, 2011, BRIT J RADIOL, V84, pS213, DOI 10.1259/bjr/74316620; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Tuncbilek N, 2004, ABDOM IMAGING, V29, P166, DOI 10.1007/s00261-003-0090-2; Vokurka EA, 2002, AM J NEURORADIOL, V23, P459; Warren R, 2006, MAGN RESON IMAGING, V24, P917, DOI 10.1016/j.mri.2006.03.004; Waterton JC, 2012, EUR J CANCER, V48, P409, DOI 10.1016/j.ejca.2011.11.037; Williams TC, 2007, RADIOLOGY, V244, P94, DOI 10.1148/radiol.2441060634; Zahra MA, 2009, INT J RADIAT ONCOL, V74, P766, DOI 10.1016/j.ijrobp.2008.08.023; Zelhof B, 2009, BJU INT, V104, P621, DOI 10.1111/j.1464-410X.2009.08457.x; Zhang XM, 2008, J MAGN RESON IMAGING, V27, P1309, DOI 10.1002/jmri.21378; Zhu XP, 2000, J MAGN RESON IMAGING, V11, P575, DOI 10.1002/1522-2586(200006)11:6<575::AID-JMRI2>3.0.CO;2-1	66	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90300	10.1371/journal.pone.0090300	http://dx.doi.org/10.1371/journal.pone.0090300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594707	Green Submitted, Green Published, gold			2022-12-27	WOS:000332475500041
J	Robson, K; Alizart, M; Martin, J; Nagel, R				Robson, Kathryn; Alizart, Michelle; Martin, Jarad; Nagel, Robyn			Coeliac Patients Are Undiagnosed at Routine Upper Endoscopy	PLOS ONE			English	Article							DUODENAL BIOPSY; DISEASE; DIAGNOSIS; PREVALENCE; SCREEN	Background and Aims: Two out of three patients with Coeliac Disease (CD) in Australia are undiagnosed. This prospective clinical audit aimed to determine how many CD patients would be undiagnosed if duodenal biopsy had only been performed if the mucosa looked abnormal or the patient presented with typical CD symptoms. Methods: All eligible patients presenting for upper gastrointestinal endoscopy (OGD) in a regional center from 2004-2009 underwent prospective analysis of presenting symptoms and duodenal biopsy. Clinical presentations were defined as either Major (diarrhea, weight loss, iron deficiency, CD family history or positive celiac antibodies-Ab) or Minor Clinical Indicators (CI) to duodenal biopsy (atypical symptoms). Newly diagnosed CD patients had follow up celiac antibody testing. Results: Thirty-five (1.4%) new cases of CD were identified in the 2,559 patients biopsied at upper endoscopy. Almost a quarter (23%) of cases presented with atypical symptoms. There was an inverse relationship between presentation with Major CI's and increasing age (<16, 16-59 and >60: 100%, 81% and 50% respectively, p = 0.03); 28% of newly diagnosed CD patients were aged over 60 years. Endoscopic appearance was a useful diagnostic tool in only 51% (18/35) of CD patients. Coeliac antibodies were positive in 34/35 CD patients (sensitivity 97%). Conclusions: Almost one quarter of new cases of CD presented with atypical symptoms and half of the new cases had unremarkable duodenal mucosa. At least 10% of new cases of celiac disease are likely to be undiagnosed at routine upper endoscopy, particularly patients over 60 years who more commonly present atypically. All new CD patients could be identified in this study by performing pre-operative celiac antibody testing on all patients presenting for OGD and proceeding to biopsy only positive antibody patients and those presenting with either Major CI or abnormal duodenal mucosa for an estimated cost of AUS$4,629 and AUS$3,710 respectively.	[Robson, Kathryn; Alizart, Michelle; Nagel, Robyn] Medici Med Ctr, Toowoomba Gastroenterol Clin, Toowoomba, Qld, Australia; [Martin, Jarad] St Andrews Hosp, Radiat Oncol Queensland, Toowoomba, Qld, Australia; [Nagel, Robyn] Univ Queensland, Rural Sch Med, Toowoomba, Qld, Australia	University of Queensland	Nagel, R (corresponding author), Medici Med Ctr, Toowoomba Gastroenterol Clin, Toowoomba, Qld, Australia.	robynnagel@tgclinic.com.au	; nagel, robyn/J-7991-2014	Martin, Jarad/0000-0002-4929-0278; nagel, robyn/0000-0001-8389-2718				Abdulkarim AS, 2003, ALIMENT PHARM THER, V17, P987, DOI 10.1046/j.1365-2036.2003.01442.x; Anderson RP, 2008, INTERN MED J, V38, P790, DOI 10.1111/j.1445-5994.2008.01741.x; Bassen MS, 2009, J GASTROENTEROL H S2, V24, pA228; Burgell KR, 2008, J GASTROENTEROL H S4, V23, pA176; Burger JPW, 2013, NETH J MED, V71, P308; Collin P, 2005, GASTROENTEROLOGY, V128, pS104, DOI 10.1053/j.gastro.2005.02.021; Duggan JM, 2004, MED J AUSTRALIA, V180, P524, DOI 10.5694/j.1326-5377.2004.tb06058.x; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; Fasano A, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3592; HANKEY GL, 1994, GUT, V35, P65, DOI 10.1136/gut.35.1.65; Hopper AD, 2007, BMJ-BRIT MED J, V334, P729, DOI 10.1136/bmj.39133.668681.BE; Hovell CJ, 2001, MED J AUSTRALIA, V175, P247, DOI 10.5694/j.1326-5377.2001.tb143555.x; Johnson MW, 2008, NAT CLIN PRACT GASTR, V5, P697, DOI 10.1038/ncpgasthep1281; Jones S, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-24; Leeds JS, 2008, BRIT MED BULL, V88, P157, DOI 10.1093/bmb/ldn044; Lohi S, 2009, ANN MED, V41, P508, DOI 10.1080/07853890903036199; Olds G, 2002, GASTROINTEST ENDOSC, V56, P407, DOI 10.1067/mge.2002.127412; Pais WP, 2008, GASTROINTEST ENDOSC, V67, P1082, DOI 10.1016/j.gie.2007.10.015; Rashtak S, 2009, GASTROENTEROL CLIN N, V38, P433, DOI 10.1016/j.gtc.2009.06.005; Shamir R, 2007, J GASTROEN HEPATOL, V22, P532, DOI 10.1111/j.1440-1746.2006.04728.x; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119	22	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90552	10.1371/journal.pone.0090552	http://dx.doi.org/10.1371/journal.pone.0090552			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595045	gold, Green Published			2022-12-27	WOS:000332475500066
J	Bonomo, LDF; Silva, DN; Boasquivis, PF; Paiva, FA; Guerra, JFD; Martins, TAF; Torres, AGD; de Paula, ITBR; Caneschi, WL; Jacolot, P; Grossin, N; Tessier, FJ; Boulanger, E; Silva, ME; Pedrosa, ML; Oliveira, RD				Bonomo, Larissa de Freitas; Silva, David Nunes; Boasquivis, Patricia Ferreira; Paiva, Franciny Aparecida; da Costa Guerra, Joyce Ferreira; Faria Martins, Talita Alves; de Jesus Torres, Alvaro Gustavo; Borges Raposo de Paula, Igor Thadeu; Caneschi, Washington Luiz; Jacolot, Philippe; Grossin, Nicolas; Tessier, Frederic J.; Boulanger, Eric; Silva, Marcelo Eustaquio; Pedrosa, Maria Lucia; Oliveira, Riva de Paula			Acai (Euterpe oleracea Mart.) Modulates Oxidative Stress Resistance in Caenorhabditis elegans by Direct and Indirect Mechanisms	PLOS ONE			English	Article							AMAZONIAN PALM BERRY; LIFE-SPAN EXTENSION; ANTIOXIDANT PROPERTIES; FACTOR SKN-1; RICH FRUIT; IN-VITRO; PULP; FLAVONOIDS; ACRYLAMIDE; EXTRACT	Acai (Euterpe oleracea Mart.) has recently emerged as a promising source of natural antioxidants. Despite its claimed pharmacological and nutraceutical value, studies regarding the effects of acai in vivo are limited. In this study, we use the Caenorhabditis elegans model to evaluate the in vivo antioxidant properties of acai on an organismal level and to examine its mechanism of action. Supplementation with acai aqueous extract (AAE) increased both oxidative and osmotic stress resistance independently of any effect on reproduction and development. AAE suppressed bacterial growth, but this antimicrobial property did not influence stress resistance. AAE-increased stress resistance was correlated with reduced ROS production, the prevention of sulfhydryl (SH) level reduction and gcs-1 activation under oxidative stress conditions. Our mechanistic studies indicated that AAE promotes oxidative stress resistance by acting through DAF-16 and the osmotic stress response pathway OSR-1/UNC-43/SEK-1. Finally, AAE increased polyglutamine protein aggregation and decreased proteasome activity. Our findings suggest that natural compounds available in AAE can improve the antioxidant status of a whole organism under certain conditions by direct and indirect mechanisms.	[Bonomo, Larissa de Freitas; Silva, David Nunes; Boasquivis, Patricia Ferreira; Paiva, Franciny Aparecida; da Costa Guerra, Joyce Ferreira; Borges Raposo de Paula, Igor Thadeu; Caneschi, Washington Luiz; Silva, Marcelo Eustaquio; Pedrosa, Maria Lucia; Oliveira, Riva de Paula] Univ Fed Ouro Preto, Nucl Pesquisa Ciencias Biol, Ouro Preto, Brazil; [Pedrosa, Maria Lucia] Univ Fed Ouro Preto, Dept Ciencias Biol, Ouro Preto, Brazil; [Faria Martins, Talita Alves; de Jesus Torres, Alvaro Gustavo; Oliveira, Riva de Paula] Univ Fed Ouro Preto, Dept Biodiversidade Evolucao & Meio Ambiente, Ouro Preto, Brazil; [Jacolot, Philippe; Tessier, Frederic J.] Inst Polytech LaSalle Beauvais, Beauvais, France; [Grossin, Nicolas; Boulanger, Eric] Univ Lille 2, Fac Med Pole Rech, Lille, France; [Silva, Marcelo Eustaquio] Univ Fed Ouro Preto, Dept Alimentos, Ouro Preto, Brazil	Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; UniLaSalle; Universite de Lille - ISITE; Universite de Lille; Universidade Federal de Ouro Preto	Oliveira, RD (corresponding author), Univ Fed Ouro Preto, Nucl Pesquisa Ciencias Biol, Ouro Preto, Brazil.	rivaoliveira@nupeb.ufop.br	Tessier, Frederic J/G-3729-2018	Tessier, Frederic J/0000-0001-8096-5715; Paiva, Franciny Aparecida/0000-0002-2052-1079; de Paula Oliveira, Riva/0000-0002-6092-6142; BOULANGER, Eric/0000-0002-5204-2849; Ferreira Boasquivis, Patricia/0000-0002-6811-9978; Magalhaes, Talita/0000-0003-2818-369X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [473015/2008 0]; Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) [CBBAPQ- 01153-08, CBB-PPM-00491-10]; Universidade Federal de Ouro Preto (UFOP); CAPES; CNPq; FAPEMIG; UFOP	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Universidade Federal de Ouro Preto (UFOP); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); UFOP	This work received financial support from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Process 473015/2008 0), Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG Process CBBAPQ- 01153-08 and CBB-PPM-00491-10) and Universidade Federal de Ouro Preto (UFOP). Research fellowships were sponsored by CAPES (Bonomo, L. F.; Boasquivis, P. F.; de Paula, I. T. B. R; Guerra, J.F.C.), CNPq (Oliveira, R. P., Pedrosa, M. L., Silva, M. E.), FAPEMIG (Paiva, F. A.; Silva, D.N.) and UFOP (Caneschi, W. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Boulanger E, 2007, KIDNEY INT, V71, P126, DOI 10.1038/sj.ki.5002016; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; BRENNER S, 1974, GENETICS, V77, P71; Buchter C, 2013, INT J MOL SCI, V14, P11895, DOI 10.3390/ijms140611895; Choe KP, 2007, FEBS J, V274, P5782, DOI 10.1111/j.1742-4658.2007.06098.x; Guerra JFD, 2011, J CLIN BIOCHEM NUTR, V49, P188, DOI 10.3164/jcbn.11-02; Del Pozo-Insfran D, 2004, J AGR FOOD CHEM, V52, P1539, DOI 10.1021/jf035189n; Garigan D, 2002, GENETICS, V161, P1101; Gems D, 2000, J GERONTOL A-BIOL, V55, pB215, DOI 10.1093/gerona/55.5.B215; Girones-Vilaplana A, 2012, J AGR FOOD CHEM, V60, P6571, DOI 10.1021/jf300873k; Giusti MM, 2001, CURRENT PROTOCOLS FO; Gonzalez-Manzano S, 2012, J AGR FOOD CHEM, V60, P8911, DOI 10.1021/jf3004256; Gordon A, 2012, FOOD CHEM, V133, P256, DOI 10.1016/j.foodchem.2011.11.150; Grunz G, 2012, MECH AGEING DEV, V133, P1, DOI 10.1016/j.mad.2011.11.005; Guha S, 2013, AGE, V35, P1559, DOI 10.1007/s11357-012-9459-x; Hasegawa K, 2004, TOXICOL LETT, V152, P183, DOI 10.1016/j.toxlet.2004.04.037; Hasegawa K, 2008, TOXICOL SCI, V101, P215, DOI 10.1093/toxsci/kfm276; Hasegawa K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011194; Heinrich M, 2011, PHYTOCHEM LETT, V4, P10, DOI 10.1016/j.phytol.2010.11.005; Hogan S, 2010, FOOD CHEM, V118, P208, DOI 10.1016/j.foodchem.2009.04.099; Honzel D, 2008, J AGR FOOD CHEM, V56, P8319, DOI 10.1021/jf800401d; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Ishikado A, 2012, FREE RADIC BIOL MED; Jensen GS, 2008, J AGR FOOD CHEM, V56, P8326, DOI 10.1021/jf8016157; Jensen GS, 2011, J MED FOOD, V14, P702, DOI 10.1089/jmf.2010.0150; Kampkotter A, 2007, PHARMACOL RES, V55, P139, DOI 10.1016/j.phrs.2006.11.006; Kampkotter A, 2008, COMP BIOCHEM PHYS B, V149, P314, DOI 10.1016/j.cbpb.2007.10.004; Kampkotter A, 2007, TOXICOLOGY, V234, P113, DOI 10.1016/j.tox.2007.02.006; Kang J, 2011, FOOD CHEM, V128, P152, DOI 10.1016/j.foodchem.2011.03.011; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Lamitina T, 2006, P NATL ACAD SCI USA, V103, P12173, DOI 10.1073/pnas.0602987103; Liedo P, 2012, EXP GERONTOL, V47, P536, DOI 10.1016/j.exger.2012.05.001; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Montiel-Davalos A, 2010, TOXICOL IN VITRO, V24, P135, DOI 10.1016/j.tiv.2009.08.004; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; MunizMiret N, 1996, FOREST ECOL MANAG, V87, P163, DOI 10.1016/S0378-1127(96)03825-X; Murphy CT, 2006, EXP GERONTOL, V41, P910, DOI 10.1016/j.exger.2006.06.040; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Noratto GD, 2011, J AGR FOOD CHEM, V59, P7999, DOI 10.1021/jf201056x; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Pietsch K, 2009, BIOGERONTOLOGY, V10, P565, DOI 10.1007/s10522-008-9199-6; Reisner K, 2011, J BIOCHEM MOL TOXIC, V25, P269, DOI 10.1002/jbt.20386; Rufino MDM, 2011, FOOD RES INT, V44, P2100, DOI 10.1016/j.foodres.2010.09.011; Schauss AG, 2006, J AGR FOOD CHEM, V54, P8604, DOI 10.1021/jf0609779; Schauss AG, 2006, J AGR FOOD CHEM, V54, P8598, DOI 10.1021/jf060976g; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Shi YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039515; Solomon A, 2004, GENETICS, V167, P161, DOI 10.1534/genetics.167.1.161; Song J, 2013, FOOD CHEM TOXICOL, V58, P306, DOI 10.1016/j.fct.2013.05.003; Spada PDS, 2009, J MED FOOD, V12, P1084, DOI 10.1089/jmf.2008.0236; Sun XP, 2010, EXP GERONTOL, V45, P243, DOI 10.1016/j.exger.2010.01.008; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Udani JK, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-45; Wheeler JM, 2006, GENETICS, V174, P1327, DOI 10.1534/genetics.106.059089; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; Wu ZX, 2002, CELL MOL BIOL, V48, P725; Xue YL, 2011, J AGR FOOD CHEM, V59, P5927, DOI 10.1021/jf104798n; Yu YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009339	61	34	37	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89933	10.1371/journal.pone.0089933	http://dx.doi.org/10.1371/journal.pone.0089933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594796	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900048
J	Janssen, PKC; Olivier, B; Zwinderman, AH; Waldinger, MD				Janssen, Paddy K. C.; Olivier, Berend; Zwinderman, Aeilko H.; Waldinger, Marcel D.			Measurement Errors in Polymerase Chain Reaction Are a Confounding Factor for a Correct Interpretation of 5-HTTLPR Polymorphism Effects on Lifelong Premature Ejaculation: A Critical Analysis of a Previously Published Meta-Analysis of Six Studies	PLOS ONE			English	Article							HARDY-WEINBERG EQUILIBRIUM; DRUG-TREATMENT; EXACT TESTS; DISEQUILIBRIUM; POPULATION; SOCIETY; GENE; LAW	Objective: To analyze a recently published meta-analysis of six studies on 5-HTTLPR polymorphism and lifelong premature ejaculation (PE). Methods: Calculation of fraction observed and expected genotype frequencies and Hardy Weinberg equilibrium (HWE) of cases and controls. LL, SL and SS genotype frequencies of patients were subtracted from genotype frequencies of an ideal population (LL25%, SL50%, SS25%, p = 1 for HWE). Analysis of PCRs of six studies and re-analysis of the analysis and Odds ratios (ORs) reported in the recently published meta-analysis. Results: Three studies deviated from HWE in patients and one study deviated from HWE in controls. In three studies in-HWE the mean deviation of genotype frequencies from a theoretical population not-deviating from HWE was small: LL(1.7%), SL(22.3%), SS(0.6%). In three studies not-in-HWE the mean deviation of genotype frequencies was high: LL(23.3%), SL(218.5%) and SS(21.8%) with very low percentage SL genotype concurrent with very high percentage SS genotype. The most serious PCR deviations were reported in the three not-in-HWE studies. The three in-HWE studies had normal OR. In contrast, the three not-in-HWE studies had a low OR. Conclusions: In three studies not-in-HWE and with very low OR, inadequate PCR analysis and/or inadequate interpretation of its gel electrophoresis resulted in very low SL and a resulting shift to very high SS genotype frequency outcome. Consequently, PCRs of these three studies are not reliable. Failure to note the inadequacy of PCR tests makes such PCRs a confounding factor in clinical interpretation of genetic studies. Currently, a meta-analysis can only be performed on three studies-in-HWE. However, based on the three studies-in-HWE with OR of about 1 there is not any indication that in men with lifelong PE the frequency of LL, SL and SS genotype deviates from the general male population and/or that the SL or SS genotype is in any way associated with lifelong PE.	[Janssen, Paddy K. C.; Olivier, Berend; Waldinger, Marcel D.] Univ Utrecht, Dept Pharmaceut Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands; [Janssen, Paddy K. C.] Viecuri Hosp Venlo, Dept Cent Hosp Pharm, Venlo, Netherlands; [Olivier, Berend] Yale Univ, Sch Med, Deptartment Psychiat, New Haven, CT USA; [Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Dept Med Stat Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands; [Waldinger, Marcel D.] HagaZiekenhuis, Outpatient Dept Neurosexol, The Hague, Netherlands	Utrecht University; VieCuri Medical Center; Yale University; University of Amsterdam; Academic Medical Center Amsterdam; Haga Hospital	Waldinger, MD (corresponding author), Univ Utrecht, Dept Pharmaceut Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands.	md@waldinger.demon.nl	Olivier, Berend/AAX-4412-2021	Janssen, Paddy/0000-0002-3050-2728; Janssen, Paddy/0000-0002-4935-7663				Chiao JY, 2010, P ROY SOC B-BIOL SCI, V277, P529, DOI 10.1098/rspb.2009.1650; Edwards AWF, 2008, GENETICS, V179, P1143, DOI 10.1534/genetics.104.92940; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; Janssen PKC, 2009, J SEX MED, V6, P276, DOI 10.1111/j.1743-6109.2008.01033.x; Jern P, 2013, ARCH SEX BEHAV, V42, P45, DOI 10.1007/s10508-012-9991-x; LI CC, 1988, GENETICS, V119, P731; Luo Shun-wen, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P514; Mayo O, 2008, TWIN RES HUM GENET, V11, P249, DOI 10.1375/twin.11.3.249; McMahon CG, 2008, J SEX MED, V5, P1590, DOI 10.1111/j.1743-6109.2008.00901.x; MULLIS KB, 1990, SCI AM, V262, P56, DOI 10.1038/scientificamerican0490-56; Ozbek E, 2009, ASIAN J ANDROL, V11, P351, DOI 10.1038/aja.2008.3; Safarinejad MR, 2009, J UROLOGY, V181, P2656, DOI 10.1016/j.juro.2009.01.105; Sambrook J., 2001, MOL CLONING LAB MANU; Schaid DJ, 2006, AM J HUM GENET, V79, P1071, DOI 10.1086/510257; Serefoglu EC, 2011, J SEX MED, V8, P540, DOI 10.1111/j.1743-6109.2010.02095.x; Serefoglu EC, 2010, J SEX MED, V7, P810, DOI 10.1111/j.1743-6109.2009.01570.x; Stark AE, 2006, GENETICS, V174, P1695, DOI 10.1534/genetics.106.057042; Waldinger M D, 1998, Int J Psychiatry Clin Pract, V2, P287, DOI 10.3109/13651509809115376; Waldinger MD, 2011, KOREAN J UROL, V52, P1, DOI 10.4111/kju.2011.52.1.1; Waldinger MD, 2009, J UROLOGY, V182, P2983, DOI 10.1016/j.juro.2009.08.069; Waldinger MD, 2009, ASIAN J ANDROL, V11, P524, DOI 10.1038/aja.2009.32; Waldinger MD, 2004, INT J IMPOT RES, V16, P369, DOI 10.1038/sj.ijir.3901172; Waldinger MD, 1998, PSYCHIATR GENET, V8, P37, DOI 10.1097/00041444-199800810-00007; Waldinger MD, 1998, BEHAV BRAIN RES, V92, P111, DOI 10.1016/S0166-4328(97)00183-6; Waldinger MD, 2003, INT J IMPOT RES, V15, P309, DOI 10.1038/sj.ijir.3901023; Weinberg W., 1908, JAHRESH VER VATERL N, V64, P369; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Yonan AL, 2006, PSYCHIAT GENET, V16, P31, DOI 10.1097/01.ypg.0000174393.79883.05; Zhang X, 2013, J SEX MED; Zhu LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054994; Zuccarello D, 2012, J SEX MED, V9, P1659, DOI 10.1111/j.1743-6109.2012.02715.x	31	19	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e88031	10.1371/journal.pone.0088031	http://dx.doi.org/10.1371/journal.pone.0088031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595335	gold, Green Published, Green Submitted			2022-12-27	WOS:000332468900004
J	Kong, XY; Xu, XF; Yan, YH; Guo, FF; Li, J; Hu, YL; Zhou, HJ; Xun, QY				Kong, Xiangyi; Xu, XiaoFeng; Yan, Yuhua; Guo, Feifei; Li, Jian; Hu, Yali; Zhou, Huaijun; Xun, Qingying			Estrogen Regulates the Tumour Suppressor MiRNA-30c and Its Target Gene, MTA-1, in Endometrial Cancer	PLOS ONE			English	Article							GROWTH-FACTOR; MICRORNA EXPRESSION; MESSENGER-RNAS; RECEPTOR; CELLS; ADENOCARCINOMA; PROLIFERATION; CARCINOMA; BETA	MicroRNA-30c (miR-30c) has been reported to be a tumour suppressor in endometrial cancer (EC). We demonstrate that miR-30c is down-regulated in EC tissue and is highly expressed in estrogen receptor (ER)-negative HEC-1-B cells. MiR-30c directly inhibits MTA-1 expression and functions as a tumour suppressor via the miR-30c-MTA-1 signalling pathway. Furthermore, miR-30c is decreased upon E-2 treatment in both ER-positive Ishikawa and ER-negative HEC-1-B cells. Taken together, our results suggest that miR-30c is an important deregulated miRNA in EC and might serve as a potential biomarker and novel therapeutic target for EC.	[Kong, Xiangyi; Xu, XiaoFeng; Yan, Yuhua; Guo, Feifei; Li, Jian; Hu, Yali; Zhou, Huaijun] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Gynecol & Obstet, Nanjing 210008, Jiangsu, Peoples R China; [Xun, Qingying] Southeast Univ, Coll Med, Dept Physiol, Nanjing, Jiangsu, Peoples R China; [Hu, Yali] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Reprod Med Ctr, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Southeast University - China; Nanjing University	Zhou, HJ (corresponding author), Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Gynecol & Obstet, Nanjing 210008, Jiangsu, Peoples R China.	zhouhj2007@126.com; xqyzhou@126.com			Six Talent Summit Project of Jiangsu Province Personnel bureau [WSW-021]	Six Talent Summit Project of Jiangsu Province Personnel bureau	This work was supported by Six Talent Summit Project of Jiangsu Province Personnel bureau (WSW-021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Balasenthil S, 2006, HUM PATHOL, V37, P656, DOI 10.1016/j.humpath.2006.01.024; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Bockhorn J, 2013, BREAST CANCER RES TR, V137, P373, DOI 10.1007/s10549-012-2346-4; Boren T, 2008, GYNECOL ONCOL, V110, P206, DOI 10.1016/j.ygyno.2008.03.023; Bridge G, 2012, BLOOD, V120, P5063, DOI 10.1182/blood-2012-04-423004; Busacca S, 2010, AM J RESP CELL MOL, V42, P312, DOI 10.1165/rcmb.2009-0060OC; CHARNOCKJONES DS, 1993, BIOL REPROD, V48, P1120, DOI 10.1095/biolreprod48.5.1120; Chen XY, 2012, CANCER LETT, V314, P41, DOI 10.1016/j.canlet.2011.09.014; Da Sacco L, 2013, INT J MOL SCI, V14, P480, DOI 10.3390/ijms14010480; Du B, 2011, WORLD J GASTROENTERO, V17, P1219, DOI 10.3748/wjg.v17.i9.1219; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Eitan R, 2009, GYNECOL ONCOL, V114, P253, DOI 10.1016/j.ygyno.2009.04.024; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Goparaju CM, 2011, ONCOGENE, V30, P2767, DOI 10.1038/onc.2010.643; Guo Jigang, 2010, Cancer Biol Ther, V9, P446, DOI 10.4161/cbt.9.6.10894; He YQ, 2012, EXP MOL MED, V44, P723, DOI 10.3858/emm.2012.44.12.079; Heinzelmann J, 2011, WORLD J UROL, V29, P367, DOI 10.1007/s00345-010-0633-4; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Jia W, 2011, MOL CANCER RES, V9, P1732, DOI 10.1158/1541-7786.MCR-11-0245; Joglekar MV, 2009, ISLETS, V1, P137, DOI 10.4161/isl.1.2.9578; Karas RH, 2001, CIRC RES, V89, P534, DOI 10.1161/hh1801.097239; Klinge CM, 2012, TRENDS ENDOCRIN MET, V23, P223, DOI 10.1016/j.tem.2012.03.002; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lee H, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-174; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Li S, 2012, BREAST CANCER RES TR, V136, P77, DOI 10.1007/s10549-012-2166-6; Li XB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029350, 10.1371/journal.pone.0051199]; Masuda M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-S1-S2; Nothnick WB, 2010, REPROD SCI, V17, P987, DOI 10.1177/1933719110377472; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Patel N, 2011, BIOCHEM J, V434, P473, DOI 10.1042/BJ20101585; Rodriguez-Gonzalez FG, 2011, BREAST CANCER RES TR, V127, P43, DOI 10.1007/s10549-010-0940-x; Sorbe Bengt, 2012, ISRN Obstet Gynecol, V2012, P325790, DOI 10.5402/2012/325790; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Tanic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038847; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Wang G, 2010, INT UROL NEPHROL, V42, P95, DOI 10.1007/s11255-009-9584-3; Wang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046888; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; Wu YJ, 2011, CANCER-AM CANCER SOC, V117, P3989, DOI 10.1002/cncr.25944; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017; Zhang R, 2012, CANCER LETT, V314, P155, DOI 10.1016/j.canlet.2011.09.027; Zhang YS, 2012, J BIOL CHEM, V287, P41514, DOI 10.1074/jbc.M112.404871; Zhao J, 2013, ARTERIOSCL THROM VAS, V33, P257, DOI 10.1161/ATVBAHA.112.300200; Zhou HJ, 2012, ONCOL REP, V27, P807, DOI 10.3892/or.2011.1574	47	50	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90810	10.1371/journal.pone.0090810	http://dx.doi.org/10.1371/journal.pone.0090810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595016	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900148
J	Purkey, MT; Li, J; Mentch, F; Grant, SFA; Desrosiers, M; Hakonarson, H; Toskala, E				Purkey, Michael T.; Li, Jin; Mentch, Frank; Grant, Struan F. A.; Desrosiers, Martin; Hakonarson, Hakon; Toskala, Elina			Genetic Variation in Genes Encoding Airway Epithelial Potassium Channels Is Associated with Chronic Rhinosinusitis in a Pediatric Population	PLOS ONE			English	Article							BASOLATERAL K+ CHANNELS; CYSTIC-FIBROSIS; LARGE-CONDUCTANCE; CL-SECRETION; INCREASED PREVALENCE; MOLECULAR DIVERSITY; CFTR POTENTIATOR; ANION SECRETION; G-PROTEIN; EXPRESSION	Background: Apical potassium channels regulate ion transport in airway epithelial cells and influence air surface liquid (ASL) hydration and mucociliary clearance (MCC). We sought to identify whether genetic variation within genes encoding airway potassium channels is associated with chronic rhinosinusitis (CRS). Methods: Single nucleotide polymorphism (SNP) genotypes for selected potassium channels were derived from data generated on the Illumnia HumanHap550 BeadChip or Illumina Human610-Quad BeadChip for 828 unrelated individuals diagnosed with CRS and 5,083 unrelated healthy controls from the Children's Hospital of Philadelphia (CHOP). Statistical analysis was performed with set-based tests using PLINK, and corrected for multiple testing. Results: Set-based case control analysis revealed the gene KCNMA1 was associated with CRS in our Caucasian subset of the cohort (598 CRS cases and 3,489 controls; p = 0.022, based on 10,000 permutations). In addition there was borderline evidence that the gene KCNQ5 (p = 0.0704) was associated with the trait in our African American subset of the cohort (230 CRS cases and 1,594 controls). In addition to the top significant SNPs rs2917454 and rs6907229, imputation analysis uncovered additional genetic variants in KCNMA1 and in KCNQ5 that were associated with CRS. Conclusions: We have implicated two airway epithelial potassium channels as novel susceptibility loci in contributing to the pathogenesis of CRS.	[Purkey, Michael T.] Hosp Univ Penn, Dept Otorhinolaryngol, Philadelphia, PA 19104 USA; [Li, Jin; Mentch, Frank; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Desrosiers, Martin] McGill Univ, Montreal Gen Hosp, Dept Otolaryngol, Montreal, PQ H3G 1A4, Canada; [Hakonarson, Hakon] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Toskala, Elina] Temple Univ, Dept Otolaryngol, Philadelphia, PA 19122 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; McGill University; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	Hakonarson@email.chop.edu; Elina.Toskala@tuhs.temple.edu			Institute Development Funds	Institute Development Funds	This work was supported by the Institute Development Funds to The Center for Applied Genomics and an Adele S. and Daniel S. Kubert Estate gift to the Center for Applied Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Bardou O, 2009, AM J PHYSIOL-LUNG C, V296, pL145, DOI 10.1152/ajplung.90525.2008; Bernard K, 2003, J MEMBRANE BIOL, V196, P15, DOI 10.1007/s00232-003-0621-3; Chadwick LH, 2012, EPIGENOMICS-UK, V4, P317, DOI [10.2217/epi.12.18, 10.2217/EPI.12.18]; Chorev Michal, 2012, Frontiers in Genetics, V3, P55, DOI 10.3389/fgene.2012.00055; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Cohen NA, 2006, OTOLARYNG HEAD NECK, V134, P601, DOI 10.1016/j.otohns.2005.11.042; COOK DI, 1989, J MEMBRANE BIOL, V110, P139, DOI 10.1007/BF01869469; Cowley EA, 2002, J PHYSIOL-LONDON, V538, P747, DOI 10.1113/jphysiol.2001.013300; Delagranda A, 2008, RHINOLOGY, V46, P125; Derendorf H, 2008, ALLERGY, V63, P1292, DOI 10.1111/j.1398-9995.2008.01750.x; Deshane J, 2010, J BIOL CHEM, V285, P16476, DOI 10.1074/jbc.M109.058586; Doring F, 1998, J NEUROSCI, V18, P8625; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Greisner WA, 1996, ALLERGY ASTHMA PROC, V17, P283, DOI 10.2500/108854196778662192; Harvey PR, 2011, AM J RESP CELL MOL, V45, P592, DOI 10.1165/rcmb.2010-0484OC; Hollenhorst MI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/174306; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hsu J, 2013, J ALLERGY CLIN IMMUN, V131, P977, DOI 10.1016/j.jaci.2013.01.028; Inglis SK, 2007, AM J PHYSIOL-LUNG C, V292, pL1304, DOI 10.1152/ajplung.00424.2006; Jovanovic S, 2003, AM J RESP CELL MOL, V28, P363, DOI 10.1165/rcmb.2002-0101OC; Kennedy DW, 2012, INT FORUM ALLERGY RH, V2, P93, DOI 10.1002/alr.21043; Kennedy DW, 2004, ANN OTO RHINOL LARYN, V113, P6, DOI 10.1177/00034894041130S503; Leroy C, 2006, AM J PHYSIOL-LUNG C, V291, pL1207, DOI 10.1152/ajplung.00376.2005; LOCKEY RF, 1973, ANN INTERN MED, V78, P57, DOI 10.7326/0003-4819-78-1-57; Lusk RP, 1997, OTOLARYNG HEAD NECK, V117, pS53, DOI 10.1016/S0194-5998(97)70008-1; Mall M, 2003, PEDIATR RES, V53, P608, DOI 10.1203/01.PDR.0000057204.51420.DC; Mall M, 2000, AM J RESP CELL MOL, V23, P283, DOI 10.1165/ajrcmb.23.3.4060; Manzanares D, 2011, J BIOL CHEM, V286, P19830, DOI 10.1074/jbc.M110.185074; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Monaghan AS, 1997, PFLUG ARCH EUR J PHY, V433, P294; Moser SL, 2008, J MEMBRANE BIOL, V221, P153, DOI 10.1007/s00232-008-9093-9; O'Grady SM, 2003, AM J PHYSIOL-LUNG C, V284, pL689, DOI 10.1152/ajplung.00256.2002; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; Ooi EH, 2010, OTOLARYNG CLIN N AM, V43, P473, DOI 10.1016/j.otc.2010.02.020; Oomen Karin P Q, 2012, Int J Otolaryngol, V2012, P789572, DOI 10.1155/2012/789572; Ott CJ, 2009, J CELL MOL MED, V13, P680, DOI 10.1111/j.1582-4934.2008.00621.x; Plummer HK, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-104; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raman V, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.1.e13; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ridge FPG, 1997, BBA-BIOMEMBRANES, V1327, P249, DOI 10.1016/S0005-2736(97)00073-4; RIORDAN JR, 1989, SCIENCE, V245, P1066; SAKAKURA Y, 1985, CLIN OTOLARYNGOL, V10, P79, DOI 10.1111/j.1365-2273.1985.tb01171.x; Sakuma T, 1998, PHARMACOL TOXICOL, V83, P16, DOI 10.1111/j.1600-0773.1998.tb01436.x; Sayegh R, 1999, J BIOL CHEM, V274, P12431, DOI 10.1074/jbc.274.18.12431; Scohy S, 2000, NUCLEIC ACIDS RES, V28, P3743, DOI 10.1093/nar/28.19.3743; Soler ZM, 2009, OTOLARYNG HEAD NECK, V141, P454, DOI 10.1016/j.otohns.2009.06.085; Tan BK, 2010, CURR OPIN OTOLARYNGO, V18, P21, DOI 10.1097/MOO.0b013e3283350053; Teng SY, 2003, BIOCHEM BIOPH RES CO, V303, P808, DOI 10.1016/S0006-291X(03)00433-9; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Verschuren JJW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056262; Verschuren JJW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042401; Wang XJ, 2005, ARCH OTOLARYNGOL, V131, P237, DOI 10.1001/archotol.131.3.237; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhao KQ, 2012, AM J PHYSIOL-LUNG C, V302, pL4, DOI 10.1152/ajplung.00102.2011	58	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89329	10.1371/journal.pone.0089329	http://dx.doi.org/10.1371/journal.pone.0089329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595210	gold, Green Submitted, Green Published			2022-12-27	WOS:000332468900015
J	Wang, MH; Wang, WP; Zhang, P; Xiao, JJ; Wang, JG; Huang, CQ				Wang, Minghua; Wang, Weiping; Zhang, Ping; Xiao, Juanjuan; Wang, Jianguo; Huang, Chaoqun			Discrimination of the Expression of Paralogous microRNA Precursors That Share the Same Major Mature Form	PLOS ONE			English	Article							HOST GENES; MIR-17-92 CLUSTER; MIRNA; IDENTIFICATION; PROLIFERATION; TRANSCRIPTION; DIFFERENTIATION; COEXPRESSION; HNF-1-ALPHA; DROSOPHILA	Background: MicroRNAs (miRNAs) are a class of small non-coding RNAs generated from endogenous transcripts that form hairpin structures. The hairpin precursor is processed into two mature miRNAs that form major/minor duplexes. Mature miRNAs regulate gene expression by cleaving mRNA or repressing protein translation. Numerous miRNAs have been discovered via deep sequencing. Many miRNAs are produced from multiple genome sites. These miRNAs are grouped into paralogous families of miRNAs that generate the same major mature form within organisms. Currently, no method of distinguishing the expression of these miRNAs is available. Results: In the present study, strategies were developed to discriminate and quantify the expression of paralogous miRNA precursors. First, paralogous miRNA precursors that were differentially expressed in tissues were identified through analysis of the coexpression scores of their major and minor forms based on deep sequencing data. Then the precursors were identified by monitoring the expression of their host gene or minor form using real-time PCR. Finally, precursors were identified by assessing the expression of clusters of miRNA members. These approaches were used to distinguish miR-128-1 and miR-128-2 as well as miR-194-1 and miR-194-2. The mechanism of transcription related to the differential expression of miR-194-1 and miR-194-2 was also investigated. Conclusion: This is the first report to distinguish paralogous miRNA copies by analyzing the expression of major-minor pairs, the host gene, and miRNA clusters. Discriminating paralogous precursors can provide useful information for investigating the mechanisms that regulate miRNA gene expression under different physiological and pathological conditions.	[Wang, Minghua; Wang, Weiping; Zhang, Ping; Xiao, Juanjuan; Wang, Jianguo] Soochow Univ, Coll Med, Dept Biochem & Mol Biol, Suzhou, Jiangsu, Peoples R China; [Huang, Chaoqun] Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA	Soochow University - China; Oklahoma State University System; Oklahoma State University - Stillwater	Wang, MH (corresponding author), Soochow Univ, Coll Med, Dept Biochem & Mol Biol, Suzhou, Jiangsu, Peoples R China.	mhwang@suda.edu.cn; chaoqunhuang89@yahoo.com			National Natural Science Foundation of China [81071957]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grant from the National Natural Science Foundation of China (Grant 81071957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Biasiolo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023854; Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Castellano L, 2013, NUCLEIC ACIDS RES, V41, P3339, DOI 10.1093/nar/gks1474; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Furlotte NA, 2011, BIOINFORMATICS, V27, pI288, DOI 10.1093/bioinformatics/btr221; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Griffiths-Jones S, 2011, EMBO REP, V12, P172, DOI 10.1038/embor.2010.191; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; He CJ, 2012, NUCLEIC ACIDS RES, V40, P4002, DOI 10.1093/nar/gkr1312; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Hu HY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-413; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kuchenbauer F, 2011, BLOOD, V118, P3350, DOI 10.1182/blood-2010-10-312454; Kuehn H, 2008, CURR PROTOC BIOINFOR, P12, DOI [10.1002/0471250953.bi0712-22, DOI 10.1002/0471250953.BI0712-22]; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li SC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S13; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Liang S, 2006, PHYSIOL GENOMICS, V26, P158, DOI 10.1152/physiolgenomics.00313.2005; Makova KD, 2003, GENOME RES, V13, P1638, DOI 10.1101/gr.1133803; Marco A, 2012, RNA BIOL, V9, P242, DOI 10.4161/rna.19160; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Pan JB, 2012, BIOINFORMATICS, V28, P1544, DOI 10.1093/bioinformatics/bts169; Pereira V, 2009, GENETICS, V183, P1597, DOI 10.1534/genetics.109.110247; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ryazansky SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-371; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Shomron N, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/594678; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; WU GD, 1994, J BIOL CHEM, V269, P17080; Xiang R, 2012, BRAZ J MED BIOL RES, V45, P131, DOI 10.1590/S0100-879X2012007500007; Yu G, 2012, J SURG ONCOL, V106, P232, DOI 10.1002/jso.22138; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595; Yu XP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-79; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034688	38	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90591	10.1371/journal.pone.0090591	http://dx.doi.org/10.1371/journal.pone.0090591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594692	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900121
J	Whitesell, TR; Kennedy, RM; Carter, AD; Rollins, EL; Georgijevic, S; Santoro, MM; Childs, SJ				Whitesell, Thomas R.; Kennedy, Regan M.; Carter, Alyson D.; Rollins, Evvi-Lynn; Georgijevic, Sonja; Santoro, Massimo M.; Childs, Sarah J.			An alpha-Smooth Muscle Actin (acta2/alpha sma) Zebrafish Transgenic Line Marking Vascular Mural Cells and Visceral Smooth Muscle Cells	PLOS ONE			English	Article							SONIC HEDGEHOG; TIE2 RECEPTOR; IN-VIVO; PDGF-B; PERICYTES; EXPRESSION; ANGIOGENESIS; MATURATION; STABILITY; CADHERIN	Mural cells of the vascular system include vascular smooth muscle cells (SMCs) and pericytes whose role is to stabilize and/or provide contractility to blood vessels. One of the earliest markers of mural cell development in vertebrates is alpha smooth muscle actin (acta2; alpha sma), which is expressed by pericytes and SMCs. In vivo models of vascular mural cell development in zebrafish are currently lacking, therefore we developed two transgenic zebrafish lines driving expression of GFP or mCherry in acta2-expressing cells. These transgenic fish were used to trace the live development of mural cells in embryonic and larval transgenic zebrafish. acta2:EGFP transgenic animals show expression that largely mirrors native acta2 expression, with early pan-muscle expression starting at 24 hpf in the heart muscle, followed by skeletal and visceral muscle. At 3.5 dpf, expression in the bulbus arteriosus and ventral aorta marks the first expression in vascular smooth muscle. Over the next 10 days of development, the number of acta2:EGFP positive cells and the number of types of blood vessels associated with mural cells increases. Interestingly, the mural cells are not motile and remain in the same position once they express the acta2:EGFP transgene. Taken together, our data suggests that zebrafish mural cells develop relatively late, and have little mobility once they associate with vessels.	[Whitesell, Thomas R.; Kennedy, Regan M.; Carter, Alyson D.; Rollins, Evvi-Lynn; Georgijevic, Sonja; Childs, Sarah J.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Whitesell, Thomas R.; Kennedy, Regan M.; Carter, Alyson D.; Rollins, Evvi-Lynn; Georgijevic, Sonja; Childs, Sarah J.] Univ Calgary, Smooth Muscle Res Grp, Calgary, AB, Canada; [Santoro, Massimo M.] Univ Leuven KU Leuven, VIB Vesalius Res Ctr, Louvain, Belgium	University of Calgary; University of Calgary; Flanders Institute for Biotechnology (VIB); KU Leuven	Childs, SJ (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	schilds@ucalgary.ca	Childs, Sarah/AAG-5111-2021	Childs, Sarah/0000-0003-2261-580X; SANTORO, Massimo Mattia/0000-0003-4605-5085	National Science and Engineering Research Council [RGPIN/312496-2009]; Heart and Stroke Foundation of Alberta, Nunavut and NWT [M06092]; Alberta Innovates [201400188] Funding Source: researchfish	National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Alberta, Nunavut and NWT; Alberta Innovates	This work was supported by grants to SJC from the National Science and Engineering Research Council (RGPIN/312496-2009) and the Heart and Stroke Foundation of Alberta, Nunavut and NWT (M06092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JJ, 2010, GENESIS, V48, P457, DOI 10.1002/dvg.20638; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Crump JG, 2004, DEVELOPMENT, V131, P5703, DOI 10.1242/dev.01444; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Georgijevic S, 2007, DEV DYNAM, V236, P1623, DOI 10.1002/dvdy.21165; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Gittenberger-de Groot AC, 1999, ARTERIOSCL THROM VAS, V19, P1589; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Grimes AC, 2006, DEV BIOL, V290, P265, DOI 10.1016/j.ydbio.2005.11.042; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hu N, 2000, ANAT REC, V260, P148, DOI 10.1002/1097-0185(20001001)260:2<148::AID-AR50>3.0.CO;2-X; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Huang JB, 2010, CIRC RES, V106, P583, DOI 10.1161/CIRCRESAHA.109.207852; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Killian ECO, 2009, DEV BIOL, V333, P161, DOI 10.1016/j.ydbio.2009.06.031; Kim J, 2010, P NATL ACAD SCI USA, V107, P17206, DOI 10.1073/pnas.0915016107; Korn J, 2002, J COMP NEUROL, V442, P78, DOI 10.1002/cne.1423; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lamont RE, 2010, MECH DEVELOP, V127, P159, DOI 10.1016/j.mod.2010.02.001; Lauter G, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-10; Lavine KJ, 2008, J CLIN INVEST, V118, P2404, DOI 10.1172/JCI34561; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Le V. P., 2012, J VIS EXP; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu J, 2007, P NATL ACAD SCI USA, V104, P13990, DOI 10.1073/pnas.0700825104; Liu J, 2012, DEV BIOL, V363, P95, DOI 10.1016/j.ydbio.2011.12.022; Mack CP, 1999, CIRC RES, V84, P852; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Miano JM, 2006, ZEBRAFISH, V3, P455, DOI 10.1089/zeb.2006.3.455; Mundell NA, 2011, DEVELOPMENT, V138, P641, DOI 10.1242/dev.054718; Nielsen CM, 2010, DEV BIOL, V340, P430, DOI 10.1016/j.ydbio.2010.01.032; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Passman JN, 2008, P NATL ACAD SCI USA, V105, P9349, DOI 10.1073/pnas.0711382105; Patan S, 1998, MICROVASC RES, V56, P1, DOI 10.1006/mvre.1998.2081; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Proulx K, 2010, DEV BIOL, V348, P34, DOI 10.1016/j.ydbio.2010.08.036; Renard M, 2010, EUR J HUM GENET, V18, P895, DOI 10.1038/ejhg.2010.45; Roman BL, 2002, DEVELOPMENT, V129, P3009; Santoro MM, 2009, MECH DEVELOP, V126, P638, DOI 10.1016/j.mod.2009.06.1080; Seiler C, 2010, DEV DYNAM, V239, P2806, DOI 10.1002/dvdy.22420; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; von Tell D, 2006, EXP CELL RES, V312, P623, DOI 10.1016/j.yexcr.2005.10.019; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Wang WD, 2011, DEV BIOL, V360, P173, DOI 10.1016/j.ydbio.2011.09.019; Wasteson P, 2008, DEVELOPMENT, V135, P1823, DOI 10.1242/dev.020958; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Zeng L, 2009, P NATL ACAD SCI USA, V106, P17793, DOI 10.1073/pnas.0903693106	55	60	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90590	10.1371/journal.pone.0090590	http://dx.doi.org/10.1371/journal.pone.0090590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594685	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900120
J	Zhang, LX; Hu, QH; Zhang, F				Zhang, Lixiao; Hu, Qiuhong; Zhang, Fan			Input-Output Modeling for Urban Energy Consumption in Beijing: Dynamics and Comparison	PLOS ONE			English	Article							CO2 EMISSIONS; INTERNATIONAL-TRADE; EMBODIED ENERGY; RESOURCES USE; REQUIREMENTS; CHINA; INVENTORY	Input-output analysis has been proven to be a powerful instrument for estimating embodied (direct plus indirect) energy usage through economic sectors. Using 9 economic input-output tables of years 1987, 1990, 1992, 1995, 1997, 2000, 2002, 2005, and 2007, this paper analyzes energy flows for the entire city of Beijing and its 30 economic sectors, respectively. Results show that the embodied energy consumption of Beijing increased from 38.85 million tonnes of coal equivalent (Mtce) to 206.2 Mtce over the past twenty years of rapid urbanization; the share of indirect energy consumption in total energy consumption increased from 48% to 76%, suggesting the transition of Beijing from a production-based and manufacturing-dominated economy to a consumption-based and service-dominated economy. Real estate development has shown to be a major driving factor of the growth in indirect energy consumption. The boom and bust of construction activities have been strongly correlated with the increase and decrease of system-side indirect energy consumption. Traditional heavy industries remain the most energy-intensive sectors in the economy. However, the transportation and service sectors have contributed most to the rapid increase in overall energy consumption. The analyses in this paper demonstrate that a system-wide approach such as that based on input-output model can be a useful tool for robust energy policy making.	[Zhang, Lixiao; Hu, Qiuhong] Beijing Normal Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100875, Peoples R China; [Zhang, Fan] World Bank, Washington, DC 20433 USA	Beijing Normal University; The World Bank	Zhang, LX (corresponding author), Beijing Normal Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100875, Peoples R China.	zhanglixiao@bnu.edu.cn	Zhang, Lixiao/G-1462-2014		National Natural Science Foundation of China [41371521]; National Science Foundation for Innovative Research Group [51121003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Innovative Research Group	This work was supported by the National Natural Science Foundation of China (Grant No. 41371521) and National Science Foundation for Innovative Research Group (Grant No. 51121003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara V, 2003, ENERG POLICY, V31, P1673, DOI 10.1016/S0301-4215(02)00233-1; Baynes T, 2011, ENERG POLICY, V39, P7298, DOI 10.1016/j.enpol.2011.08.053; Beijing Statistics Bureau, 1999, BEIJ INP OUTP TABL 1; Beijing Statistics Bureau, 1998, BEIJ STAT YB; Beijing Statistics Bureau, 2001, BEIJ INP OUTP TABL 1; Beijing Statistics Bureau, 2006, BEIJ INP OUTP TABL 1; Beijing Statistics Bureau, 2008, BEIJ STAT YB; Beijing Statistics Bureau, 1995, BEIJ INP OUTP TABL 1; Beijing Statistics Bureau, 2003, BEIJ STAT YB; Beijing Statistics Bureau, 2004, BEIJ INP OUTP TABL 1; Beijing Statistics Bureau, 1996, BEIJ STAT YB; Beijing Statistics Bureau, 1991, BEIJ INP OUTP TABL 1; Beijing Statistics Bureau, 1993, BEIJ STAT YB; Beijing Statistics Bureau, 1991, BEIJ STAT YB; Beijing Statistics Bureau, 1988, BEIJ STAT YB; Beijing Statistics Bureau, 1990, BEIJ INP OUTP TABL 1; Beijing Statistics Bureau, 2009, BEIJ INP OUTP TABL 1; Beijing Statistics Bureau, 1996, BEIJ INP OUTP TABL 1; Beule F D, 2000, BACKWARD LINKAGES FO; Bin S, 2005, ENERG POLICY, V33, P197, DOI 10.1016/S0301-4215(03)00210-6; Brown MT, 1996, ECOL ECON, V19, P219, DOI 10.1016/S0921-8009(96)00046-8; Bullard C.W., 1978, RESOUR ENERGY, V1, P267, DOI DOI 10.1016/0165-0572(78)90008-7; BULLARD CW, 1975, ENERG POLICY, V3, P268, DOI 10.1016/0301-4215(75)90035-X; Chen GQ, 2013, COMMUN NONLINEAR SCI, V18, P2493, DOI 10.1016/j.cnsns.2012.12.029; Chen GQ, 2010, COMMUN NONLINEAR SCI, V15, P3647, DOI 10.1016/j.cnsns.2009.12.024; Chen ZM, 2010, COMMUN NONLINEAR SCI, V15, P1942, DOI 10.1016/j.cnsns.2009.08.001; Chung WS, 2009, APPL ENERG, V86, P1902, DOI 10.1016/j.apenergy.2009.02.001; COSTANZA R, 1980, SCIENCE, V210, P1219, DOI 10.1126/science.210.4475.1219; Dhakal S, 2009, ENERG POLICY, V37, P4208, DOI 10.1016/j.enpol.2009.05.020; Fan Y, 2007, ENVIRON MODELL SOFTW, V22, P378, DOI 10.1016/j.envsoft.2005.12.007; Feng KS, 2013, P NATL ACAD SCI USA, V110, P11654, DOI 10.1073/pnas.1219918110; Feng YY, 2013, ECOL MODEL, V252, P44, DOI 10.1016/j.ecolmodel.2012.09.008; Fridley D, 2010, EMBODIED ENERGY ALTE; Fung PLK, 2013, NEW PUSH REFORM SIGN; HAN XL, 1994, ENERGY J, V15, P165; Kaneko S., 2003, P INT WORKSH POL INT; Labandeira X, 2002, ENERG POLICY, V30, P597, DOI 10.1016/S0301-4215(01)00124-0; Lenzen M, 2004, ECOL ECON, V49, P375, DOI 10.1016/j.ecolecon.2004.01.019; Lenzen M, 1998, ENERG POLICY, V26, P495, DOI 10.1016/S0301-4215(98)00012-3; Lenzen M, 2008, URBAN ENERGY TRANSITION: FROM FOSSIL FUELS TO RENEWABLE POWER, P91, DOI 10.1016/B978-0-08-045341-5.00004-9; LEONTIEF W, 1970, REV ECON STAT, V52, P262, DOI 10.2307/1926294; Liang QM, 2007, ENERG POLICY, V35, P1685, DOI 10.1016/j.enpol.2006.04.018; Liang S, 2010, ECOL ECON, V69, P1805, DOI 10.1016/j.ecolecon.2010.04.019; Lindner S, 2012, ECON SYST RES, V24, P329, DOI 10.1080/09535314.2012.689954; Liu HT, 2009, ENERG POLICY, V37, P3194, DOI 10.1016/j.enpol.2009.04.016; Liu HT, 2010, ENERG POLICY, V38, P3957, DOI 10.1016/j.enpol.2010.03.019; Liu QY, 2002, EC MANAGEMENT METALL, V6, P12; Liu Z, 2012, ENERG POLICY, V49, P751, DOI 10.1016/j.enpol.2012.07.016; Machado G, 2001, ECOL ECON, V39, P409, DOI 10.1016/S0921-8009(01)00230-0; Miller R., 2009, INPUT OUTPUT ANAL FD; Mindali O, 2004, TRANSPORT RES A-POL, V38, P143, DOI 10.1016/j.tra.2003.10.004; Park HC, 2007, ENERG POLICY, V35, P2839, DOI 10.1016/j.enpol.2006.10.002; Peters GP, 2008, ENVIRON SCI TECHNOL, V42, P1401, DOI 10.1021/es072023k; Peters GP, 2007, ENVIRON SCI TECHNOL, V41, P5939, DOI 10.1021/es070108f; Phdungsilp A., 2003, ENETT2550003; Rasmussen PN, 1956, STUDIES INTERSECTORA, P58; Rosado L., 2009, CONACCOUNT 2008 URBA, P159; Tiwari P, 2000, ENERG POLICY; Yabe N, 2004, ENERG POLICY, V32, P595, DOI 10.1016/S0301-4215(02)00312-9; Zhang B, 2010, ENERG POLICY, V38, P4304, DOI 10.1016/j.enpol.2010.03.059; Zhang LX, 2011, ENERGIES, V4, P2295, DOI 10.3390/en4122295; Zhang LX, 2011, ENERGIES, V4, P26, DOI 10.3390/en4010026; Zhou SY, 2010, COMMUN NONLINEAR SCI, V15, P3201, DOI 10.1016/j.cnsns.2009.11.026	63	24	26	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89850	10.1371/journal.pone.0089850	http://dx.doi.org/10.1371/journal.pone.0089850			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4CT	24595199	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900040
J	Bachand, M; Pellerin, S; Moretti, M; Aubin, I; Tremblay, JP; Cote, SD; Poulin, M				Bachand, Marianne; Pellerin, Stephanie; Moretti, Marco; Aubin, Isabelle; Tremblay, Jean-Pierre; Cote, Steeve D.; Poulin, Monique			Functional Responses and Resilience of Boreal Forest Ecosystem after Reduction of Deer Density	PLOS ONE			English	Article							WHITE-TAILED DEER; BIRD POPULATIONS; BALSAM FIR; PLANT; TRAITS; COMMUNITIES; BEETLE; REGENERATION; ABUNDANCE; DISTURBANCE	The functional trait-based approach is increasingly used to predict responses of ecological communities to disturbances, but most studies target a single taxonomic group. Here, we assessed the resilience of a forest ecosystem to an overabundant herbivore population by assessing changes in 19 functional traits for plant, 13 traits for ground beetle and 16 traits for songbird communities after six years of controlled browsing on Anticosti Island (Quebec, Canada). Our results indicated that plants were more responsive to 6 years of reduced browsing pressure than ground beetles and songbirds. However, co-inertia analysis revealed that ground beetle communities responded in a similar way than plant communities with stronger relationships between plant and ground beetle traits at reduced deer density, a pattern not detected between plant and songbird. High deer density favored plants species that reproduce vegetatively and with abiotic pollination and seed dispersal, traits implying little interaction with animal. On the other hand, traits found at reduced deer density mostly involved trophic interaction. For example, plants in this treatment had fleshy fruits and large seeds dispersed by birds or other animals whereas ground beetle species were carnivorous. Overall, our results suggest that plant communities recovered some functional components to overabundant herbivore populations, since most traits associated with undisturbed forests were reestablished after six years of deer reduction. The re-establishment of functional plant communities with traits involving trophic interaction induces changes in the ground-beetle trait community, but forest structure remains likely insufficiently heterogeneous to shift the songbird trait community within six years.	[Bachand, Marianne; Pellerin, Stephanie; Tremblay, Jean-Pierre; Cote, Steeve D.; Poulin, Monique] Univ Laval, Dept Biol, Chaire Rech Ind CRSNG Prod Forestiers Anticosti, Quebec City, PQ G1K 7P4, Canada; [Bachand, Marianne; Tremblay, Jean-Pierre; Cote, Steeve D.; Poulin, Monique] Univ Laval, Ctr Etud Nord, Quebec City, PQ, Canada; [Bachand, Marianne; Pellerin, Stephanie; Poulin, Monique] McGill Univ, Quebec Ctr Biodivers Sci, Montreal, PQ, Canada; [Pellerin, Stephanie] Jardin Bot Montreal, Inst Rech Biol Vegetale, Montreal, PQ, Canada; [Moretti, Marco] Swiss Fed Res Inst WSL, Bellinzona, Switzerland; [Aubin, Isabelle] Canadian Forest Serv, Great Lake Forestry Ctr, Sault Ste Marie, ON, Canada	Laval University; Laval University; McGill University; Universite de Montreal; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Natural Resources Canada; Canadian Forest Service; Great Lakes Forestry Centre	Poulin, M (corresponding author), Univ Laval, Dept Biol, Chaire Rech Ind CRSNG Prod Forestiers Anticosti, Quebec City, PQ G1K 7P4, Canada.	monique.poulin@fsaa.ulaval.ca		Pellerin, Stephanie/0000-0002-5148-1065; Moretti, Marco/0000-0002-5845-3198; Tremblay, Jean-Pierre/0000-0003-0978-529X	Natural Sciences and Engineering Research Council of Canada (NSERC)-Produits Forestiers Anticosti Industrial Chair; Quebec Ministry of Natural Resources and Wildlife; NSERC; Quebec Centre for Biodiversity Science (QCBS)	Natural Sciences and Engineering Research Council of Canada (NSERC)-Produits Forestiers Anticosti Industrial Chair(Natural Sciences and Engineering Research Council of Canada (NSERC)); Quebec Ministry of Natural Resources and Wildlife; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Quebec Centre for Biodiversity Science (QCBS)	Funding for this research was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC)-Produits Forestiers Anticosti Industrial Chair (SDC), the Quebec Ministry of Natural Resources and Wildlife, NSERC discovery grants (MP, SP), as well as NSERC and Quebec Centre for Biodiversity Science (QCBS) scholarships (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allombert S, 2005, BIOL CONSERV, V126, P1, DOI 10.1016/j.biocon.2005.04.001; [Anonymous], 1975, COMMUNITIES ECOSYSTE; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; BAKER HG, 1972, ECOLOGY, V53, P997, DOI 10.2307/1935413; Barbaro L, 2009, ECOGRAPHY, V32, P321, DOI 10.1111/j.1600-0587.2008.05546.x; Barton PS, 2011, J APPL ECOL, V48, P943, DOI 10.1111/j.1365-2664.2011.01994.x; Beaupre P., 2005, NAT CAN, V129, P110; Beguin J, 2009, CAN J FOREST RES, V39, P596, DOI 10.1139/X08-196; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Brousseau PM, 2013, BIODIVERS CONSERV, V22, P77, DOI 10.1007/s10531-012-0400-5; Cardinal E, 2012, CAN J ZOOL, V90, P704, DOI [10.1139/Z2012-037, 10.1139/z2012-037]; Cardinal E, 2012, ECOSCIENCE, V19, P38, DOI 10.2980/19-1-3441; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; De Bello F, 2005, J APPL ECOL, V42, P824, DOI 10.1111/j.1365-2664.2005.01079.x; de Bello F, 2007, COMMUNITY ECOL, V8, P163, DOI 10.1556/ComEc.8.2007.2.3; de Bello F, 2010, BIOL CONSERV, V143, P9, DOI 10.1016/j.biocon.2009.04.022; De Caceres M, 2010, OIKOS, V119, P1674, DOI 10.1111/j.1600-0706.2010.18334.x; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; Demars BOL, 2012, ECOL INDIC, V23, P301, DOI 10.1016/j.ecolind.2012.04.011; Desrochers A, 1998, CAN J ZOOL, V76, P989, DOI 10.1139/cjz-76-6-989; Diaz S, 2007, GLOBAL CHANGE BIOL, V13, P313, DOI 10.1111/j.1365-2486.2006.01288.x; DOLEDEC S, 1994, FRESHWATER BIOL, V31, P277, DOI 10.1111/j.1365-2427.1994.tb01741.x; Dufresne M, 2011, ECOSCIENCE, V18, P363, DOI 10.2980/18-4-3366; Gardner SM, 1997, BIOL CONSERV, V81, P275, DOI 10.1016/S0006-3207(96)00148-6; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Grime J. P., 2001, PLANT STRATEGIES VEG; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Hebert C, 2000, J INSECT CONSERV, V4, P191, DOI 10.1023/A:1009611501133; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hidding B, 2012, FOREST ECOL MANAG, V276, P96, DOI 10.1016/j.foreco.2012.03.023; Husheer SW, 2003, FOREST ECOL MANAG, V181, P99, DOI 10.1016/S0378-1127(03)00120-8; Jansen A, 2005, RESTOR ECOL, V13, P275, DOI 10.1111/j.1526-100X.2005.00035.x; Jobin LJ, 1992, 26 LFC, V26; KEVAN PG, 1983, ANNU REV ENTOMOL, V28, P407, DOI 10.1146/annurev.en.28.010183.002203; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Lavoral S, 1999, J VEG SCI, V10, P661, DOI 10.2307/3237081; Lavorel S, 1997, TRENDS ECOL EVOL, V12, P474, DOI 10.1016/S0169-5347(97)01219-6; Lavorel S, 2013, J VEG SCI, V24, P942, DOI 10.1111/jvs.12083; Legendre P., 2012, NUMERICAL ECOLOGY; Luck GW, 2012, J ANIM ECOL, V81, P1065, DOI 10.1111/j.1365-2656.2012.01974.x; Malhi Y, 1999, PLANT CELL ENVIRON, V22, P715, DOI 10.1046/j.1365-3040.1999.00453.x; MCINNES PF, 1992, ECOLOGY, V73, P2059, DOI 10.2307/1941455; McShea WJ, 2000, CONSERV BIOL, V14, P1161, DOI 10.1046/j.1523-1739.2000.99210.x; Moretti M, 2010, ECOGRAPHY, V33, P760, DOI 10.1111/j.1600-0587.2009.06172.x; Moretti M, 2009, ECOGRAPHY, V32, P299, DOI 10.1111/j.1600-0587.2008.05524.x; Mulder Christa P.H., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P29, DOI 10.1078/1433-8319-00064; Pakeman RJ, 2011, ECOLOGY, V92, P1353, DOI 10.1890/10-1728.1; Perrins CM, 2001, FORESTRY, V74, P299, DOI 10.1093/forestry/74.3.299; Pimlott D. H., 1963, INT UN GAM BIOL C, V6, P106; Potvin F, 2003, ECOSCIENCE, V10, P487, DOI 10.1080/11956860.2003.11682796; Sera B, 2004, FOLIA GEOBOT, V39, P27, DOI 10.1007/BF02803262; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Tremblay JP, 2007, J APPL ECOL, V44, P552, DOI 10.1111/j.1365-2664.2007.01290.x; Tremblay JP, 2006, OECOLOGIA, V150, P78, DOI 10.1007/s00442-006-0504-2; Van der Wal R, 2004, FUNCT ECOL, V18, P77, DOI 10.1111/j.1365-2435.2004.00820.x; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Wiegmann SM, 2006, BIOL CONSERV, V129, P109, DOI 10.1016/j.biocon.2005.10.027	57	9	9	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90437	10.1371/journal.pone.0090437	http://dx.doi.org/10.1371/journal.pone.0090437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587362	Green Published, gold			2022-12-27	WOS:000332396200197
J	Rogers, NK; Clements, D; Dongre, A; Harrison, TW; Shaw, D; Johnson, SR				Rogers, Natasha K.; Clements, Debbie; Dongre, Arundhati; Harrison, Tim W.; Shaw, Dominic; Johnson, Simon R.			Extra-Cellular Matrix Proteins Induce Matrix Metalloproteinase-1 (MMP-1) Activity and Increase Airway Smooth Muscle Contraction in Asthma	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TENASCIN-C; CELL PROLIFERATION; GENE-EXPRESSION; COLLAGEN; ELASTASE; SURVIVAL; INTERLEUKIN-13; TRANSCRIPTION; FIBRONECTIN	Airway remodelling describes the histopathological changes leading to fixed airway obstruction in patients with asthma and includes extra-cellular matrix (ECM) deposition. Matrix metalloproteinase-1 (MMP-1) is present in remodelled airways but its relationship with ECM proteins and the resulting functional consequences are unknown. We used airway smooth muscle cells (ASM) and bronchial biopsies from control donors and patients with asthma to examine the regulation of MMP-1 by ECM in ASM cells and the effect of MMP-1 on ASM contraction. Collagen-I and tenascin-C induced MMP-1 protein expression, which for tenascin-C, was greater in asthma derived ASM cells. Tenascin-C induced MMP-1 expression was dependent on ERK1/2, JNK and p38 MAPK activation and attenuated by function blocking antibodies against the beta 1 and beta 3 integrin subunits. Tenascin-C and MMP-1 were not expressed in normal airways but co-localised in the ASM bundles and reticular basement membrane of patients with asthma. Further, ECM from asthma derived ASM cells stimulated MMP-1 expression to a greater degree than ECM from normal ASM. Bradykinin induced contraction of ASM cells seeded in 3D collagen gels was reduced by the MMP inhibitor ilomastat and by siRNA knockdown of MMP-1. In summary, the induction of MMP-1 in ASM cells by tenascin-C occurs in part via integrin mediated MAPK signalling. MMP-1 and tenascin-C are co-localised in the smooth muscle bundles of patients with asthma where this interaction may contribute to enhanced airway contraction. Our findings suggest that ECM changes in airway remodelling via MMP-1 could contribute to an environment promoting greater airway narrowing in response to broncho-constrictor stimuli and worsening asthma symptoms.	[Johnson, Simon R.] Univ Nottingham, Div Resp Med, Nottingham NG7 2RD, England; Univ Nottingham, Resp Res Unit, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Johnson, SR (corresponding author), Univ Nottingham, Div Resp Med, Nottingham NG7 2RD, England.	simon.johnson@nottingham.ac.uk	shaw, dominick/N-1293-2014	shaw, dominick/0000-0003-4106-8469; Johnson, Simon/0000-0002-9837-2763	Medical Research Council [G1100163]; University of Nottingham; Asthma UK [11/031] Funding Source: researchfish; MRC [G1100163] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Nottingham; Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by Medical Research Council (grant G1100163) and a University of Nottingham PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altraja A, 1996, AM J RESP CELL MOL, V15, P482, DOI 10.1165/ajrcmb.15.4.8879182; Araujo BB, 2008, EUR RESPIR J, V32, P61, DOI 10.1183/09031936.00147807; Aysola RS, 2008, CHEST, V134, P1183, DOI 10.1378/chest.07-2779; Barton R, 2008, THORAX, V63, P1, DOI 10.1136/thx.2007.086215; Bendeck MP, 2000, ARTERIOSCL THROM VAS, V20, P1467, DOI 10.1161/01.ATV.20.6.1467; BRAMLEY AM, 1995, AM J RESP CRIT CARE, V152, P1513, DOI 10.1164/ajrccm.152.5.7582286; Carragher NO, 1999, J CELL BIOL, V147, P619, DOI 10.1083/jcb.147.3.619; Castellon R, 2002, INVEST OPHTH VIS SCI, V43, P2758; Cataldo DD, 2004, LAB INVEST, V84, P418, DOI 10.1038/labinvest.3700063; Clements D, 2010, J IMMUNOL, V185, P1812, DOI 10.4049/jimmunol.0902149; Dolhnikoff M, 2009, J ALLERGY CLIN IMMUN, V123, P1090, DOI 10.1016/j.jaci.2009.02.032; Elshaw SR, 2004, BRIT J PHARMACOL, V142, P1318, DOI 10.1038/sj.bjp.0705883; Fera E, 2004, J BIOL CHEM, V279, P35573, DOI 10.1074/jbc.M400711200; Freyer AM, 2004, AM J RESP CELL MOL, V31, P440, DOI 10.1165/rcmb.2003-0241OC; Freyer AM, 2001, AM J RESP CELL MOL, V25, P569, DOI 10.1165/ajrcmb.25.5.4605; Galoian KA, 2007, EXP BIOL MED, V232, P515; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI 10.1146/annurev.cellbio.042308.113318; Hasaneen NA, 2005, FASEB J, V19, P1507, DOI 10.1096/fj.04-3350fje; Henderson N, 2007, AM J PHYSIOL-LUNG C, V292, pL1030, DOI 10.1152/ajplung.00317.2006; Hirst SJ, 2000, AM J RESP CELL MOL, V23, P335, DOI 10.1165/ajrcmb.23.3.3990; Imai K, 2001, AM J RESP CRIT CARE, V163, P786, DOI 10.1164/ajrccm.163.3.2001073; Ito I, 2009, CLIN EXP ALLERGY, V39, P1370, DOI 10.1111/j.1365-2222.2009.03293.x; Jarai G, 2004, EUR J PHARMACOL, V497, P255, DOI 10.1016/j.ejphar.2004.06.055; Johnson PRA, 2004, J ALLERGY CLIN IMMUN, V113, P690, DOI 10.1016/j.jaci.2003.12.312; Jones PL, 1997, J CELL BIOL, V139, P279, DOI 10.1083/jcb.139.1.279; KARLINSKY JB, 1976, AM REV RESPIR DIS, V113, P769; Khan MA, 2010, AM J PHYSIOL-LUNG C, V299, pL98, DOI 10.1152/ajplung.00011.2010; Laitinen A, 1997, AM J RESP CRIT CARE, V156, P951, DOI 10.1164/ajrccm.156.3.9610084; Lee JH, 2001, AM J RESP CELL MOL, V25, P474, DOI 10.1165/ajrcmb.25.4.4522; Leufgen H, 2005, J CELL PHYSIOL, V204, P146, DOI 10.1002/jcp.20289; Lim M, 1998, FEBS LETT, V441, P88, DOI 10.1016/S0014-5793(98)01474-4; Lydolph MC, 2009, EXP CELL RES, V315, P3312, DOI 10.1016/j.yexcr.2009.09.022; Margulis A, 2009, J IMMUNOL, V183, P1739, DOI 10.4049/jimmunol.0803951; Markwick L, 2011, CLIN EXPT A IN PRESS; Matsumoto H, 2007, THORAX, V62, P848, DOI 10.1136/thx.2006.070474; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; NAGAI H, 1991, INFLAMMATION, V15, P317, DOI 10.1007/BF00917316; Nakahara H, 2006, EUR J IMMUNOL, V36, P3334, DOI 10.1002/eji.200636271; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; Ohta Y, 2008, J IMMUNOL, V180, P4191, DOI 10.4049/jimmunol.180.6.4191; Pang YG, 2009, BIOMATERIALS, V30, P2023, DOI 10.1016/j.biomaterials.2008.12.064; Pini L, 2007, EUR RESPIR J, V29, P71, DOI 10.1183/09031936.00047905; PRIETO AL, 1992, J CELL BIOL, V119, P663, DOI 10.1083/jcb.119.3.663; Qin Z, 2013, J BIOL CHEM; Rajah R, 1996, AM J PHYSIOL-LUNG C, V271, pL1014, DOI 10.1152/ajplung.1996.271.6.L1014; Rajah R, 1999, AM J RESP CELL MOL, V20, P199, DOI 10.1165/ajrcmb.20.2.3148; Roberts ME, 2011, EUR RESPIR J, V37, P1482, DOI 10.1183/09031936.00039710; ROCHE WR, 1989, LANCET, V1, P520; Schuliga M, 2010, AM J PHYSIOL-LUNG C, V298, pL584, DOI 10.1152/ajplung.00312.2009; Schuliga MJ, 2009, AM J RESP CELL MOL, V41, P731, DOI 10.1165/rcmb.2008-0361OC; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Shrestha P, 1996, ORAL ONCOL, V32B, P106, DOI 10.1016/0964-1955(95)00074-7; Silverman ES, 2002, AM J RESP CELL MOL, V27, P697, DOI 10.1165/rcmb.2002-0011OC; SRIRAMARAO P, 1993, J CELL SCI, V105, P1001; Tanaka R, 2009, J BIOL CHEM, V284, P19817, DOI 10.1074/jbc.M109.009860; TREMBLE P, 1994, MOL BIOL CELL, V5, P439, DOI 10.1091/mbc.5.4.439; Wadsworth SJ, 2004, AM J PHYSIOL-LUNG C, V286, pL596, DOI 10.1152/ajplung.00217.2003; Yokoyama K, 2000, J BIOL CHEM, V275, P16891, DOI 10.1074/jbc.M000610200; Zhu YK, 2001, AM J PHYSIOL-LUNG C, V281, pL868, DOI 10.1152/ajplung.2001.281.4.L868; Zhu YK, 2001, AM J RESP CELL MOL, V25, P620, DOI 10.1165/ajrcmb.25.5.4495	60	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90565	10.1371/journal.pone.0090565	http://dx.doi.org/10.1371/journal.pone.0090565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587395	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200229
J	Kruis, AL; Stallberg, B; Jones, RCM; Tsiligianni, IG; Lisspers, K; van der Molen, T; Kocks, JWH; Chavannes, NH				Kruis, Annemarije L.; Stallberg, Bjorn; Jones, Rupert C. M.; Tsiligianni, Ioanna G.; Lisspers, Karin; van der Molen, Thys; Kocks, Jan Willem H.; Chavannes, Niels H.			Primary Care COPD Patients Compared with Large Pharmaceutically-Sponsored COPD Studies: An UNLOCK Validation Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FLUTICASONE PROPIONATE; EXTERNAL VALIDITY; CONTROLLED-TRIALS; HEALTH-STATUS; EXACERBATIONS; SALMETEROL; MORTALITY; TORCH; QUESTIONNAIRE	Background: Guideline recommendations for chronic obstructive pulmonary disease (COPD) are based on the results of large pharmaceutically-sponsored COPD studies (LPCS). There is a paucity of data on disease characteristics at the primary care level, while the majority of COPD patients are treated in primary care. Objective: We aimed to evaluate the external validity of six LPCS (ISOLDE, TRISTAN, TORCH, UPLIFT, ECLIPSE, POET-COPD) on which current guidelines are based, in relation to primary care COPD patients, in order to inform future clinical practice guidelines and trials. Methods: Baseline data of seven primary care databases (n = 3508) from Europe were compared to baseline data of the LPCS. In addition, we examined the proportion of primary care patients eligible to participate in the LPCS, based on inclusion criteria. Results: Overall, patients included in the LPCS were younger (mean difference (MD)-2.4; p = 0.03), predominantly male (MD 12.4; p = 0.1) with worse lung function (FEV1% MD -16.4; p < 0.01) and worse quality of life scores (SGRQ MD 15.8; p = 0.01). There were large differences in GOLD stage distribution compared to primary care patients. Mean exacerbation rates were higher in LPCS, with an overrepresentation of patients with >= 1 and >= 2 exacerbations, although results were not statistically significant. Our findings add to the literature, as we revealed hitherto unknown GOLD I exacerbation characteristics, showing 34% of mild patients had >= 1 exacerbations per year and 12% had >= 2 exacerbations per year. The proportion of primary care patients eligible for inclusion in LPCS ranged from 17% (TRISTAN) to 42% (ECLIPSE, UPLIFT). Conclusion: Primary care COPD patients stand out from patients enrolled in LPCS in terms of gender, lung function, quality of life and exacerbations. More research is needed to determine the effect of pharmacological treatment in mild to moderate patients. We encourage future guideline makers to involve primary care populations in their recommendations.	[Kruis, Annemarije L.; Chavannes, Niels H.] Leiden Univ, Dept Publ Hlth & Primary Care, Med Ctr, Leiden, Netherlands; [Stallberg, Bjorn; Lisspers, Karin] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Jones, Rupert C. M.] Univ Plymouth, Peninsula Med Sch, Plymouth PL4 8AA, Devon, England; [Tsiligianni, Ioanna G.; van der Molen, Thys; Kocks, Jan Willem H.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands; [Tsiligianni, Ioanna G.; van der Molen, Thys; Kocks, Jan Willem H.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands; [Tsiligianni, Ioanna G.] Agia Barbara Hlth Care Ctr, Iraklion, Crete, Greece	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Uppsala University; University of Plymouth; University of Groningen; University of Groningen	Kruis, AL (corresponding author), Leiden Univ, Dept Publ Hlth & Primary Care, Med Ctr, Leiden, Netherlands.	a.l.kruis@lumc.nl	Chavannes, Niels/F-1148-2011	Chavannes, Niels/0000-0002-8607-9199	International Primary Care Respiratory Group (IPCRG) through Novartis AG, Basel, Switzerland	International Primary Care Respiratory Group (IPCRG) through Novartis AG, Basel, Switzerland	The International Primary Care Respiratory Group (IPCRG) provided funding for this research project, through an unrestricted grant by Novartis AG, Basel, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Aisanov Z, 2012, INT J CHRONIC OBSTR, V7, P271, DOI 10.2147/COPD.S28059; [Anonymous], 2013, DUTCH CCMO GUIDELINE; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Bourbeau J, 2008, CAN RESPIR J, V15, P13, DOI 10.1155/2008/173904; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley P, 2004, EUR RESPIR J, V24, P206; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Celli B, 2011, AM J RESP CRIT CARE, V183, P317, DOI 10.1164/rccm.201004-0665OC; Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; Chavannes N, 2010, PRIM CARE RESP J, V19, P408, DOI 10.4104/pcrj.2010.00084; Chavannes Niels H, 2009, Prim Care Respir J, V18, P171, DOI 10.3132/pcrj.2009.00003; de Miguel-Diez J, 2011, LUNG, V189, P199, DOI 10.1007/s00408-011-9289-0; Decramer M, 2009, LANCET, V374, P1171, DOI 10.1016/S0140-6736(09)61298-8; Glaab Thomas, 2006, COPD, V3, P141, DOI 10.1080/15412550600829299; Global Initiative for Chronic Obstructive Lung Disease, 2013, GLOB STRAT DIAGN MAN; Herland K, 2005, RESP MED, V99, P11, DOI 10.1016/j.rmed.2004.03.026; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jenkins CR, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-59; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; Jones PW, 2003, EUR RESPIR J, V21, P68, DOI 10.1183/09031936.03.00013303; Jones RCM, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-62; Kim AM, 2010, NATURE, V465, P688, DOI 10.1038/465688a; Kocks J, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-41; Kruis AL, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-17; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Miravitlles M, 2007, RESP MED, V101, P1753, DOI 10.1016/j.rmed.2007.02.019; Pierson DJ, 2006, RESP CARE, V51, P277; Rabe KF, 2011, LANCET, V378, P1038, DOI 10.1016/S0140-6736(11)61295-6; Rothwell PM, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010009; Salinas GD, 2011, INT J CHRONIC OBSTR, V6, P171, DOI 10.2147/COPD.S16396; Spencer S, 2004, EUR RESPIR J, V23, P698, DOI 10.1183/09031936.04.00121404; Sundh J, 2012, INT J CHRONIC OBSTR, V7, P833, DOI 10.2147/COPD.S38119; Sundh J, 2012, PRIM CARE RESP J, V21, P295, DOI 10.4104/pcrj.2012.00054; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Travers J, 2007, RESP MED, V101, P1313, DOI 10.1016/j.rmed.2006.10.011; Tsiligianni IG, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-20; van der Molen Thys, 2003, Health Qual Life Outcomes, V1, P13, DOI 10.1186/1477-7525-1-13; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Vogelmeier C, 2011, NEW ENGL J MED, V364, P1093, DOI 10.1056/NEJMoa1008378; White P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075221	43	68	68	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90145	10.1371/journal.pone.0090145	http://dx.doi.org/10.1371/journal.pone.0090145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598945	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400050
J	Vighi, M; Borrell, A; Crespo, EA; Oliveira, LR; Simoes-Lopes, PC; Flores, PAC; Garcia, NA; Aguilar, A				Vighi, Morgana; Borrell, Asuncion; Crespo, Enrique A.; Oliveira, Larissa R.; Simoes-Lopes, Paulo C.; Flores, Paulo A. C.; Garcia, Nestor A.; Aguilar, Alejandro			Stable Isotopes Indicate Population Structuring in the Southwest Atlantic Population of Right Whales (Eubalaena australis)	PLOS ONE			English	Article							PENINSULA VALDES; FOOD-WEB; MOVEMENTS; FRACTIONATION; ECOLOGY; TISSUES	From the early 17th century to the 1970s southern right whales, Eubalaena australis, were subject to intense exploitation along the Atlantic coast of South America. Catches along this coast recorded by whalers originally formed a continuum from Brazil to Tierra del Fuego. Nevertheless, the recovery of the population has apparently occurred fragmentarily, and with two main areas of concentration, one off southern Brazil (Santa Catarina) and another off central Argentina (Peninsula Valdes). This pattern suggests some level of heterogeneity amongst the population, which is apparently contradicted by records that traced individuals moving throughout the whole geographical extension covered by the species in the Southwest Atlantic. To test the hypothesis of the potential occurrence of discrete subpopulations exploiting specific habitats, we investigated N, C and O isotopic values in 125 bone samples obtained from whaling factories operating in the early 1970s in southern Brazil (n = 72) and from contemporary and more recent strandings occurring in central Argentina (n = 53). Results indicated significant differences between the two sampling areas, being delta C-13 and delta O-18 values significantly higher in samples from southern Brazil than in those from central Argentina. This variation was consistent with isotopic baselines from the two areas, indicating the occurrence of some level of structure in the Southwest Atlantic right whale population and equally that whales more likely feed in areas commonly thought to exclusively serve as nursing grounds. Results aim at reconsidering of the units currently used in the management of the southern right whale in the Southwest Atlantic Ocean. In the context of the current die-off affecting the species in Peninsula Valdes, these results also highlight the necessity to better understand movements of individuals and precisely identify their feeding areas.	[Vighi, Morgana; Borrell, Asuncion; Aguilar, Alejandro] Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain; [Vighi, Morgana; Borrell, Asuncion; Aguilar, Alejandro] Univ Barcelona, Fac Biol, IRBio, Barcelona, Spain; [Crespo, Enrique A.; Garcia, Nestor A.] Natl Univ Patagonia, Lab Marine Mammals, Ctr Nacl Patagon CENPAT CONICET, Puerto Madryn, Argentina; [Oliveira, Larissa R.] Univ Vale Rio Sinos UNISINOS, Sao Leopoldo, Brazil; [Simoes-Lopes, Paulo C.] Univ Fed Santa Catarina, Ctr Biol Sci, Dept Ecol & Zool, BR-88010970 Florianopolis, SC, Brazil; [Flores, Paulo A. C.] MMA, ICMBio, CMA, Ctr Nacl Pesquisa & Conservacao Mamiferos Aquat, BR-88053700 Jurere Florianopolis, MG, Brazil; [Flores, Paulo A. C.] Study Grp Aquat Mammals Rio Grande Sul GEMARS, Imbe, Brazil	University of Barcelona; University of Barcelona; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade do Vale do Rio dos Sinos (Unisinos); Universidade Federal de Santa Catarina (UFSC)	Vighi, M (corresponding author), Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain.	morgana.vighi@gmail.com	Simões-Lopes, P. C./AAC-8562-2020; Vighi, Morgana/B-7982-2015; Borrell, Asunción/B-8257-2009; Simões-Lopes, P. C./I-9501-2012; Aguilar, Alex/L-1283-2014	Simões-Lopes, P. C./0000-0002-7338-3669; Borrell, Asunción/0000-0002-6714-0724; Simões-Lopes, P. C./0000-0002-7338-3669; Aguilar, Alex/0000-0002-5751-2512; Oliveira, Larissa/0000-0002-5735-3697	Fundacion BBVA [BIOCON08-194/09]; Agencia de Gestio d'Ajuts Universitaris I de Recerca (AGAUR) of the Catalunya Government	Fundacion BBVA; Agencia de Gestio d'Ajuts Universitaris I de Recerca (AGAUR) of the Catalunya Government	Fundacion BBVA funded this research as part of the project "Efectos de la explotacion humana sobre depredadores apicales y la estructura de la red trofica del Mar Argentino durante los ultimos 6000 anos" (BIOCON08-194/09 2009-2011). Funding of MV's PhD project was granted by a FI scholarship of the Agencia de Gestio d'Ajuts Universitaris I de Recerca (AGAUR) of the Catalunya Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2001, Journal of Cetacean Research and Management Special Issue, V2, P1; Berzin AA, 2008, MAR FISH REV, V70, P1; Best PB, 1996, MAR BIOL, V124, P483, DOI 10.1007/BF00351030; BEST PB, 1993, MAR MAMMAL SCI, V9, P227, DOI 10.1111/j.1748-7692.1993.tb00451.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Born EW, 2003, J MARINE SYST, V43, P1, DOI 10.1016/S0924-7963(03)00085-X; Borrell A, 2012, RAPID COMMUN MASS SP, V26, P1596, DOI 10.1002/rcm.6267; Bowen GJ, 2010, ANNU REV EARTH PL SC, V38, P161, DOI 10.1146/annurev-earth-040809-152429; Carroll E, 2011, MAR ECOL PROG SER, V432, P257, DOI 10.3354/meps09145; Clapham PJ, 2008, MAR MAMMAL SCI, V24, P183, DOI 10.1111/j.1748-7692.2007.00175.x; Clementz MT, 2001, OECOLOGIA, V129, P461, DOI 10.1007/s004420100745; Cooke J. G., 2001, Journal of Cetacean Research and Management Special Issue, P125; Crawford K, 2008, MAMMAL REV, V38, P87, DOI 10.1111/j.1365-2907.2008.00120.x; de Oliveira Santos Marcos Cesar, 2001, Journal of Cetacean Research and Management Special Issue, V2, P153; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; Ellis M, 1969, BALEIA BRASIL COLONI; FRY B, 1988, LIMNOL OCEANOGR, V33, P1182, DOI 10.4319/lo.1988.33.5.1182; Gimenez J, 2013, RAPID COMMUN MASS SP, V27, P1801, DOI 10.1002/rcm.6633; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Greig Antonio B., 2001, Journal of Cetacean Research and Management Special Issue, V2, P157; Groch Karina R., 2005, Latin American Journal of Aquatic Mammals, V4, P41; Hart AB, 2006, WHALING FALKLAND ISL; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; Hoffmeyer MS, 2010, REV BIOL MAR OCEANOG, V45, P131; International Council for Coaching Excellence, 2013, INT SPORT COACH FRAM, P1; International Union for Conservation of Nature, 2012, IUCN RED LIST THREAT; International Whaling Commission, 2011, J CETACEAN RES MAN S, V12, P367; International Whaling Commission, 2011, WORKSH SO RIGHT WHAL; International Whaling Commission, 2013, WORKSH SO RIGHT WHAL; International Whaling Commission, 2012, J CETACEAN RES MAN S, V13, P154; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jacob U, 2005, MAR ECOL PROG SER, V287, P251, DOI 10.3354/meps287251; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; KENNEY RD, 1995, CONT SHELF RES, V15, P385, DOI 10.1016/0278-4343(94)00053-P; KNOWLTON AR, 1992, MAR MAMMAL SCI, V8, P397, DOI 10.1111/j.1748-7692.1992.tb00054.x; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Leaper R, 2006, BIOL LETTERS, V2, P289, DOI 10.1098/rsbl.2005.0431; MATTHEWS L. HARRISON, 1932, DISCOVERY REPTS [GOVERNMENT DEPENDENCIES FALKLAND ISLS], V5, P467; MATTHEWS L. HARRISON, 1938, DISCOVERY REPTS [GOVT DEPENDENCIES FALKLAND ISLANDS], V17, P169; McMahon KW, 2013, LIMNOL OCEANOGR, V58, P697, DOI 10.4319/lo.2013.58.2.0697; Mermoz J.F., 1980, International Whaling Commission Report of the Commission, P183; Mermoz JF, 1980, NATURAL HIST WHALES, V30, P183; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Patenaude NJ, 2007, J HERED, V98, P147, DOI 10.1093/jhered/esm005; Payne R., 1990, REPORT INT WHALING C, P271; Pontalti Monica, 2011, Biotemas, V24, P109, DOI 10.5007/2175-7925.2011v24n2p109; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Richards R, 2009, NEW ZEAL J ZOOL, V36, P447, DOI 10.1080/03014223.2009.9651477; Riofrio-Lazo M, 2013, RAPID COMMUN MASS SP, V27, P1076, DOI 10.1002/rcm.6556; Rowntree Victoria J., 2001, Journal of Cetacean Research and Management Special Issue, V2, P133; Rowntree VJ, 1998, MAR MAMMAL SCI, V14, P99, DOI 10.1111/j.1748-7692.1998.tb00693.x; Simoes-Lopes P. C., 1992, P 3 REUN TRAB EXP MA, P62; Sironi M., 2009, SC61BRG19 INT WHAL C; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Tonnessen JN., 1982, HIST MODERN WHALING; Tormosov DD, 1998, BIOL CONSERV, V86, P185, DOI 10.1016/S0006-3207(98)00008-1; TOWNSEND CHARLES HASKINS, 1935, ZOOLOGICA [NEW YORK], V19, P1; Valenzuela LO, 2009, MOL ECOL, V18, P782, DOI 10.1111/j.1365-294X.2008.04069.x; WHITEHEAD H, 1982, CAN J ZOOL, V60, P2203, DOI 10.1139/z82-282; Whitehead H., 1981, NEW TECHNIQUES ASSES, P189; YOSHIDA N, 1991, J GEOPHYS RES-OCEANS, V96, P815, DOI 10.1029/90JC01580	63	18	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90489	10.1371/journal.pone.0090489	http://dx.doi.org/10.1371/journal.pone.0090489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598539	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400081
J	Dagar, S; Nagar, S; Goel, M; Cherukuri, P; Dhingra, NK				Dagar, Sushma; Nagar, Saumya; Goel, Manvi; Cherukuri, Pitchaiah; Dhingra, Narender K.			Loss of Photoreceptors Results in Upregulation of Synaptic Proteins in Bipolar Cells and Amacrine Cells	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; RD10 MOUSE MODEL; HETEROGENEOUS DISTRIBUTION; DEVELOPMENTAL EXPRESSION; ECTOPIC SYNAPTOGENESIS; VESICLE PROTEINS; VISUAL FUNCTION; ROYAL-COLLEGE; MUTANT MOUSE; DEGENERATION	Deafferentation is known to cause significant changes in the postsynaptic neurons in the central nervous system. Loss of photoreceptors, for instance, results in remarkable morphological and physiological changes in bipolar cells and horizontal cells. Retinal ganglion cells (RGCs), which send visual information to the brain, are relatively preserved, but show aberrant firing patterns, including spontaneous bursts of spikes in the absence of photoreceptors. To understand how loss of photoreceptors affects the circuitry presynaptic to the ganglion cells, we measured specific synaptic proteins in two mouse models of retinal degeneration. We found that despite the nearly total loss of photoreceptors, the synaptophysin protein and mRNA levels in retina were largely unaltered. Interestingly, the levels of synaptophysin in the inner plexiform layer (IPL) were higher, implying that photoreceptor loss results in increased synaptophysin in bipolar and/or amacrine cells. The levels of SV2B, a synaptic protein expressed by photoreceptors and bipolar cells, were reduced in whole retina, but increased in the IPL of rd1 mouse. Similarly, the levels of syntaxin-I and synapsin-I, synaptic proteins expressed selectively by amacrine cells, were higher after loss of photoreceptors. The upregulation of syntaxin-I was evident as early as one day after the onset of photoreceptor loss, suggesting that it did not require any massive or structural remodeling, and therefore is possibly reversible. Together, these data show that loss of photoreceptors results in increased synaptic protein levels in bipolar and amacrine cells. Combined with previous reports of increased excitatory and inhibitory synaptic currents in RGCs, these results provide clues to understand the mechanism underlying the aberrant spiking in RGCs.	[Dagar, Sushma; Nagar, Saumya; Goel, Manvi; Cherukuri, Pitchaiah; Dhingra, Narender K.] Natl Brain Res Ctr, Gurgaon, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Dhingra, NK (corresponding author), Natl Brain Res Ctr, Gurgaon, Haryana, India.	naren@nbrc.ac.in	Goel, Manvi/T-3148-2019	Goel, Manvi/0000-0003-2049-5605; Nagar, Saumya/0000-0002-9111-477X	National Brain Research Centre; Department of Biotechnology, Government of India [BT/PR6410/Med/14/801/2005, BT/PR6615/Med/14/857/2005]; Council of Scientific and Industrial Research, Government of India [09/821(0035)/2011-EMR-I]	National Brain Research Centre; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by National Brain Research Centre and Grants BT/PR6410/Med/14/801/2005 and BT/PR6615/Med/14/857/2005 to NKD from the Department of Biotechnology, Government of India. SD was supported by a research fellowship (09/821(0035)/2011-EMR-I) from the Council of Scientific and Industrial Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaratnasingam C, 2009, INVEST OPHTH VIS SCI, V50, P2824, DOI 10.1167/iovs.08-3206; Barhoum R, 2008, NEUROSCIENCE, V155, P698, DOI 10.1016/j.neuroscience.2008.06.042; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; Brandstatter JH, 1996, J COMP NEUROL, V370, P1, DOI 10.1002/(SICI)1096-9861(19960617)370:1<1::AID-CNE1>3.0.CO;2-7; Chow AY, 2001, IEEE T NEUR SYS REH, V9, P86, DOI 10.1109/7333.918281; Chua J, 2009, J COMP NEUROL, V514, P473, DOI 10.1002/cne.22029; Claes E, 2004, INVEST OPHTH VIS SCI, V45, P2039, DOI 10.1167/iovs.03-0741; Cuenca N, 2005, EUR J NEUROSCI, V22, P1057, DOI 10.1111/j.1460-9568.2005.04300.x; DEITCH JS, 1984, J COMP NEUROL, V229, P66, DOI 10.1002/cne.902290106; Dhingra A, 2012, J NEUROSCI, V32, P11343, DOI 10.1523/JNEUROSCI.1436-12.2012; Dhingra NK, 1997, DEV BRAIN RES, V102, P267, DOI 10.1016/S0165-3806(97)00085-0; DRAGER UC, 1978, J COMP NEUROL, V180, P85, DOI 10.1002/cne.901800107; Freed MA, 2003, NEURON, V38, P89, DOI 10.1016/S0896-6273(03)00166-1; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Goel M, 2012, NEUROSCIENCE, V225, P152, DOI 10.1016/j.neuroscience.2012.08.066; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HERROLD KM, 1967, ARCH OPHTHALMOL-CHIC, V78, P650, DOI 10.1001/archopht.1967.00980030652017; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Horch HW, 2009, INSECT MOL BIOL, V18, P483, DOI 10.1111/j.1365-2583.2009.00891.x; Humayun MS, 2003, VISION RES, V43, P2573, DOI 10.1016/S0042-6989(03)00457-7; Jain V, 2012, J COMP NEUROL, V520, P742, DOI 10.1002/cne.22765; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; Kihara AH, 2008, NEUROSCIENCE, V151, P995, DOI 10.1016/j.neuroscience.2007.09.088; Kim HY, 2007, AM J PHYSIOL-RENAL, V293, pF1238, DOI 10.1152/ajprenal.00151.2007; Kirkeby S, 2005, J IMMUNOL METHODS, V301, P102, DOI 10.1016/j.jim.2005.04.006; KITZES LM, 1995, J COMP NEUROL, V353, P341, DOI 10.1002/cne.903530303; Kurpius D, 2006, GLIA, V54, P58, DOI 10.1002/glia.20355; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Lazzell DR, 2004, J BIOL CHEM, V279, P52124, DOI 10.1074/jbc.M407502200; Lo FS, 2002, J NEUROPHYSIOL, V88, P794, DOI 10.1152/jn.2002.88.2.794; Machida S, 2008, INVEST OPHTH VIS SCI, V49, P442, DOI 10.1167/iovs.07-0291; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; MANDELL JW, 1990, NEURON, V5, P19, DOI 10.1016/0896-6273(90)90030-J; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Marchena M, 2011, EXP EYE RES, V93, P607, DOI 10.1016/j.exer.2011.07.010; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; Margolis DJ, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/507037; Mazzoni F, 2008, J NEUROSCI, V28, P14282, DOI 10.1523/JNEUROSCI.4968-08.2008; Menzler J, 2011, J NEUROSCI, V31, P2280, DOI 10.1523/JNEUROSCI.4238-10.2011; Morgans CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005230; MURASHIMA YL, 1990, J NEUROCHEM, V54, P893, DOI 10.1111/j.1471-4159.1990.tb02335.x; Nagar S, 2009, NEUROSCIENCE, V160, P517, DOI 10.1016/j.neuroscience.2009.02.056; Nambu H, 1997, PATHOL INT, V46, P874; Park SJ, 2004, CELL TISSUE RES, V315, P407, DOI 10.1007/s00441-003-0844-8; Peng YW, 2003, NEUROSCIENCE, V119, P813, DOI 10.1016/S0306-4522(03)00153-2; Peng YW, 2000, NAT NEUROSCI, V3, P1121, DOI 10.1038/80639; Phillips MJ, 2010, J COMP NEUROL, V518, P2071, DOI 10.1002/cne.22322; Pu ML, 2006, INVEST OPHTH VIS SCI, V47, P3579, DOI 10.1167/iovs.05-1450; Puthussery T, 2009, EUR J NEUROSCI, V29, P1533, DOI 10.1111/j.1460-9568.2009.06728.x; Sakai T, 2009, INVEST OPHTH VIS SCI, V50, P4402, DOI 10.1167/iovs.09-3458; Sherry DM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-54; Specht D, 2007, EUR J NEUROSCI, V26, P2506, DOI 10.1111/j.1460-9568.2007.05886.x; Stasheff SF, 2008, J NEUROPHYSIOL, V99, P1408, DOI 10.1152/jn.00144.2007; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; Strettoi E, 2003, VISION RES, V43, P867, DOI 10.1016/S0042-6989(02)00594-1; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Trenholm S, 2012, J PHYSL; Varela C, 2003, VISION RES, V43, P879, DOI 10.1016/S0042-6989(02)00493-5; von Kriegstein K, 1999, EUR J NEUROSCI, V11, P1335, DOI 10.1046/j.1460-9568.1999.00542.x; Wan QF, 2010, NEURON, V66, P884, DOI 10.1016/j.neuron.2010.05.010; Wang MM, 2003, J COMP NEUROL, V460, P106, DOI 10.1002/cne.10636; WESTENBROEK RE, 1988, J COMP NEUROL, V274, P334, DOI 10.1002/cne.902740304; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Yazulla S, 1997, VISION RES, V37, P3471, DOI 10.1016/S0042-6989(96)00223-4	66	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90250	10.1371/journal.pone.0090250	http://dx.doi.org/10.1371/journal.pone.0090250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595229	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500039
J	Liu, WJ; Ji, JL; Chen, H; Ye, CY				Liu, Wenjuan; Ji, Jianlin; Chen, Hua; Ye, Chenyu			Optimal Color Design of Psychological Counseling Room by Design of Experiments and Response Surface Methodology	PLOS ONE			English	Article							AFFECTIVE APPRAISALS; RESIDENTIAL AREAS; VISUAL PROPERTIES; SEX-DIFFERENCES; INTERIOR COLOR; ENVIRONMENT; PREFERENCES; ASSOCIATIONS; EMOTIONS; OFFICE	Color is one of the most powerful aspects of a psychological counseling environment. Little scientific research has been conducted on color design and much of the existing literature is based on observational studies. Using design of experiments and response surface methodology, this paper proposes an optimal color design approach for transforming patients' perception into color elements. Six indices, pleasant-unpleasant, interesting-uninteresting, exciting-boring, relaxing-distressing, safe-fearful, and active-inactive, were used to assess patients' impression. A total of 75 patients participated, including 42 for Experiment 1 and 33 for Experiment 2. 27 representative color samples were designed in Experiment 1, and the color sample (L = 75, a = 0, b = -60) was the most preferred one. In Experiment 2, this color sample was set as the 'central point', and three color attributes were optimized to maximize the patients' satisfaction. The experimental results show that the proposed method can get the optimal solution for color design of a counseling room.	[Liu, Wenjuan; Ji, Jianlin; Chen, Hua; Ye, Chenyu] Fudan Univ, Dept Psychol Med, Zhongshan Hosp, Shanghai 200433, Peoples R China	Fudan University	Liu, WJ (corresponding author), Fudan Univ, Dept Psychol Med, Zhongshan Hosp, Shanghai 200433, Peoples R China.	wenjuanliuzs@gmail.com			Youth Foundation of Zhongshan Hospital [2012 ZSQN-25]; Youth Foundation of Shanghai Municipal Health Bureau [z0124y170]	Youth Foundation of Zhongshan Hospital; Youth Foundation of Shanghai Municipal Health Bureau	The work was supported by Youth Foundation of Zhongshan Hospital (No. 2012 ZSQN-25) and Youth Foundation of Shanghai Municipal Health Bureau (No.z0124y170). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KH, 2002, HDB ENV PSYCHOL, P129; Boman E, 2004, ENVIRON BEHAV, V36, P207, DOI 10.1177/0013916503256644; BOX GEP, 1951, J R STAT SOC B, V13, P1, DOI 10.1111/j.2517-6161.1951.tb00067.x; BOYATZIS CJ, 1994, J GENET PSYCHOL, V155, P77, DOI 10.1080/00221325.1994.9914760; CHILD IL, 1968, CHILD DEV, V39, P237, DOI 10.2307/1127374; Ching Francis, 1996, ARCHITECTURE FORM SP; Danger WP, 1987, COLOR HDB; DERRINGER G, 1980, J QUAL TECHNOL, V12, P214, DOI 10.1080/00224065.1980.11980968; Fehrman K. R., 2004, COLOR SECRET INFLUEN, V2nd; Gross R, 1998, GEN HOSP PSYCHIAT, V20, P108, DOI 10.1016/S0163-8343(98)00007-3; Hanyu K, 1997, J ENVIRON PSYCHOL, V17, P301, DOI 10.1006/jevp.1997.0067; Hanyu K, 2000, J ENVIRON PSYCHOL, V20, P273, DOI 10.1006/jevp.1999.0163; Hemphill M, 1996, J GENET PSYCHOL, V157, P275, DOI 10.1080/00221325.1996.9914865; JACOBS KW, 1974, PERCEPT MOTOR SKILL, V38, P763, DOI 10.2466/pms.1974.38.3.763; Korzh Nina N., 1993, J RUSSIAN E EUROPEAN, V31, P22; KWALLEK N, 1988, PERCEPT MOTOR SKILL, V66, P123, DOI 10.2466/pms.1988.66.1.123; KWALLEK N, 1990, APPL ERGON, V21, P275, DOI 10.1016/0003-6870(90)90197-6; Kwallek N, 1997, COLOR RES APPL, V22, P121, DOI 10.1002/(SICI)1520-6378(199704)22:2<121::AID-COL7>3.0.CO;2-V; LUNDEEN EJ, 1989, PSYCHOL REP, V64, P715, DOI 10.2466/pr0.1989.64.3.715; Miwa Y, 2006, ENVIRON BEHAV, V38, P484, DOI 10.1177/0013916505280084; Montgomery D., 2001, DESIGN ANAL EXPT, V5th; Nourse EW, 1971, PERCEPT MOTOR SKILL, V32, P403; Pressly PK, 2001, J COUNS DEV, V79, P148, DOI 10.1002/j.1556-6676.2001.tb01954.x; Rubin H. R., 1998, STATUS REPORT INVEST; Sherman SA., 2005, CHILDREN YOUTH ENV, V15, P186; SILVER NC, 1995, PERCEPT MOTOR SKILL, V80, P920, DOI 10.2466/pms.1995.80.3.920; Sommer B., 1997, PRACTICAL GUIDE BEHA, V4th; TERWOGT MM, 1995, J GEN PSYCHOL, V122, P5, DOI 10.1080/00221309.1995.9921217; Thurber CA, 1999, ENVIRON BEHAV, V31, P487, DOI 10.1177/00139169921972209; Venolia C., 1988, HEALING ENV; Ward G., 1995, SUPERVISION, V56, P3; WELLER L, 1988, J GEN PSYCHOL, V115, P433, DOI 10.1080/00221309.1988.9710580; Whitehouse S, 2001, J ENVIRON PSYCHOL, V21, P301, DOI 10.1006/jevp.2001.0224; WILSON GD, 1966, PERCEPT MOTOR SKILL, V23, P947, DOI 10.2466/pms.1966.23.3.947; Wyszecki G, 1982, COLOR SCI, Vsecond; Zeisel J., 2002, INQUIRY DESIGN TOOLS, P3	36	13	13	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90646	10.1371/journal.pone.0090646	http://dx.doi.org/10.1371/journal.pone.0090646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4FD	24594683	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500081
J	Reid, JL; Mendenhall, CD; Rosales, JA; Zahawi, RA; Holl, KD				Reid, J. Leighton; Mendenhall, Chase D.; Abel Rosales, J.; Zahawi, Rakan A.; Holl, Karen D.			Landscape Context Mediates Avian Habitat Choice in Tropical Forest Restoration	PLOS ONE			English	Article							SEED DISPERSAL; RAIN-FOREST; ECOLOGICAL RESTORATION; ECOSYSTEM SERVICES; FRUGIVOROUS BIRDS; DEGRADED LANDS; TREE ISLANDS; PATCH SIZE; BIODIVERSITY; CONSERVATION	Birds both promote and prosper from forest restoration. The ecosystem functions birds perform can increase the pace of forest regeneration and, correspondingly, increase the available habitat for birds and other forest-dependent species. The aim of this study was to learn how tropical forest restoration treatments interact with landscape tree cover to affect the structure and composition of a diverse bird assemblage. We sampled bird communities over two years in 13 restoration sites and two old-growth forests in southern Costa Rica. Restoration sites were established on degraded farmlands in a variety of landscape contexts, and each included a 0.25-ha plantation, island treatment (trees planted in patches), and unplanted control. We analyzed four attributes of bird communities including frugivore abundance, nectarivore abundance, migrant insectivore richness, and compositional similarity of bird communities in restoration plots to bird communities in old-growth forests. All four bird community variables were greater in plantations and/or islands than in control treatments. Frugivore and nectarivore abundance decreased with increasing tree cover in the landscape surrounding restoration plots, whereas compositional similarity to old-growth forests was greatest in plantations embedded in landscapes with high tree cover. Migrant insectivore richness was unaffected by landscape tree cover. Our results agree with previous studies showing that increasing levels of investment in active restoration are positively related to bird richness and abundance, but differences in the effects of landscape tree cover on foraging guilds and community composition suggest that trade-offs between biodiversity conservation and bird-mediated ecosystem functioning may be important for prioritizing restoration sites.	[Reid, J. Leighton; Holl, Karen D.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA; [Mendenhall, Chase D.] Stanford Univ, Ctr Conservat Biol, Dept Biol, Stanford, CA 94305 USA; [Abel Rosales, J.; Zahawi, Rakan A.] Org Trop Studies, San Vito De Coto Brus, Costa Rica	University of California System; University of California Santa Cruz; Stanford University	Reid, JL (corresponding author), Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA.	j.leighton.reid@gmail.com	Zahawi, Rakan/N-1028-2014	Zahawi, Rakan/0000-0002-5678-2967	US National Science Foundation [NSF-DEB 0918112]; University of California Santa Cruz Open Access Fund	US National Science Foundation(National Science Foundation (NSF)); University of California Santa Cruz Open Access Fund	Financial support was provided by the US National Science Foundation (NSF-DEB 0918112 and graduate fellowships to J.L.R. and C.D.M.), Peter and Helen Bing, Ralph and Louise Haberfield, the Moore Family Foundation, the Koret Foundation, the Mertz Gilmore Foundation, and the Winslow Foundation. Funding for Open Access provided by the University of California Santa Cruz Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aide TM, 1994, RESTOR ECOL, V2, P219, DOI [10.1111/j.1526-100X.1994.tb00054.x, DOI 10.1111/J.1526-100X.1994.TB00054.X]; American Ornithologists Union, 1998, CHECK LIST N AM BIRD, V7th; Arriagada RA, 2012, LAND ECON, V88, P382, DOI 10.3368/le.88.2.382; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Blake JG, 2001, AUK, V118, P304, DOI 10.1642/0004-8038(2001)118[0304:BAISGA]2.0.CO;2; Brancalion PHS., 2012, UNASYLVA, V63, P41, DOI DOI 10.1007/S13398-014-0173-7.2; Burnham K. P., 1998, MODEL SELECTION INFE; Catterall CP, 2012, BIOL CONSERV, V146, P53, DOI 10.1016/j.biocon.2011.10.033; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Cole RJ, 2010, ECOL APPL, V20, P1255, DOI 10.1890/09-0714.1; Cole RJ, 2009, BIOTROPICA, V41, P319, DOI 10.1111/j.1744-7429.2009.00490.x; DaSilva JMC, 1996, CONSERV BIOL, V10, P491, DOI 10.1046/j.1523-1739.1996.10020491.x; de la Pena-Domene M, 2013, ECOL APPL, V23, P1124, DOI 10.1890/12-1728.1; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Dixon KW, 2009, SCIENCE, V325, P571, DOI 10.1126/science.1176295; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Duncan RS, 1999, ECOL APPL, V9, P998, DOI 10.1890/1051-0761(1999)009[0998:SDAPFS]2.0.CO;2; Edwards DP, 2010, CONSERV LETT, V3, P313, DOI 10.1111/j.1755-263X.2010.00143.x; Fink RD, 2009, RESTOR ECOL, V17, P479, DOI 10.1111/j.1526-100X.2008.00383.x; Freeman AND, 2009, EMU, V109, P331, DOI 10.1071/MU09089; Galindo-Gonzalez J, 2000, CONSERV BIOL, V14, P1693, DOI [10.1046/j.1523-1739.2000.99072.x, 10.1111/j.1523-1739.2000.99072.x]; Garcia D, 2012, P ROY SOC B-BIOL SCI, V279, P3106, DOI 10.1098/rspb.2012.0175; Gardner TA, 2012, BIOL CONSERV, V154, P61, DOI 10.1016/j.biocon.2011.11.018; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Graham LLB, 2012, RESTOR ECOL, V20, P631, DOI 10.1111/j.1526-100X.2011.00805.x; Grainger MJ, 2011, RESTOR ECOL, V19, P111, DOI 10.1111/j.1526-100X.2009.00630.x; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; GUEVARA S, 1993, VEGETATIO, V108, P319; Harvey CA, 2010, CONSERV LETT, V3, P53, DOI 10.1111/j.1755-263X.2009.00086.x; Hill JK, 2004, J APPL ECOL, V41, P744, DOI 10.1111/j.0021-8901.2004.00926.x; Holdridge L. R., 1971, Forest environments in tropical life zones: a pilot study.; Holl KD, 1999, BIOTROPICA, V31, P229, DOI 10.1111/j.1744-7429.1999.tb00135.x; Holl KD, 1998, RESTOR ECOL, V6, P253, DOI 10.1046/j.1526-100X.1998.00638.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hutto R.L., 1985, P455; Huxel GR, 1999, RESTOR ECOL, V7, P309, DOI 10.1046/j.1526-100X.1999.72024.x; Ibarra-Macias A, 2011, BIOL CONSERV, V144, P703, DOI 10.1016/j.biocon.2010.08.006; Ingle NR, 2003, OECOLOGIA, V134, P251, DOI 10.1007/s00442-002-1081-7; Jansen A, 2005, RESTOR ECOL, V13, P275, DOI 10.1111/j.1526-100X.2005.00035.x; Karp DS, 2013, ECOL LETT, V16, P1339, DOI 10.1111/ele.12173; Karp DS, 2011, P NATL ACAD SCI USA, V108, P21134, DOI 10.1073/pnas.1118276108; Lindell CA, 2013, RESTOR ECOL, V21, P515, DOI 10.1111/j.1526-100X.2012.00905.x; Lindell CA, 2013, SUSTAINABILITY-BASEL, V5, P1177, DOI 10.3390/su5031177; Lindell CA, 2012, BIRD CONSERV INT, V22, P94, DOI 10.1017/S0959270911000177; Lindenmayer DB, 2010, BIOL CONSERV, V143, P289, DOI 10.1016/j.biocon.2009.10.010; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; Maechler M., 2011, LME4 LINEAR MIXED EF; MARRA PP, 1993, AUK, V110, P565, DOI 10.2307/4088420; Mason NWH, 2012, BIOL CONSERV, V155, P157, DOI 10.1016/j.biocon.2012.05.019; Mendenhall CD, 2013, CONSERV LETT, V6, P125, DOI 10.1111/j.1755-263X.2012.00302.x; Mendenhall CD, 2012, BIOL CONSERV, V151, P32, DOI 10.1016/j.biocon.2012.01.069; Mendenhall CD, 2011, P NATL ACAD SCI USA, V108, P16313, DOI 10.1073/pnas.1111687108; Montague-Drake RM, 2009, BIOL CONSERV, V142, P2896, DOI 10.1016/j.biocon.2009.07.009; Moore RP, 2008, ECOL LETT, V11, P960, DOI 10.1111/j.1461-0248.2008.01196.x; Moran C, 2004, OECOLOGIA, V141, P584, DOI 10.1007/s00442-004-1685-1; Morrison EB, 2012, ECOL APPL, V22, P1526, DOI 10.1890/11-1118.1; Morrison EB, 2010, J APPL ECOL, V47, P130, DOI 10.1111/j.1365-2664.2009.01743.x; Munro Nicola T., 2007, Ecological Management & Restoration, V8, P199, DOI 10.1111/j.1442-8903.2007.00368.x; Munro NT, 2011, RESTOR ECOL, V19, P223, DOI 10.1111/j.1526-100X.2010.00703.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; O'Dea N, 2007, BIODIVERS CONSERV, V16, P1131, DOI 10.1007/s10531-006-9095-9; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Ortega-Alvarez Ruben, 2012, Ecological Restoration, V30, P116, DOI 10.3368/er.30.2.116; Parrotta JA, 1997, FOREST ECOL MANAG, V99, P21, DOI 10.1016/S0378-1127(97)00192-8; Pearman PB, 2002, ECOL MONOGR, V72, P19, DOI 10.1890/0012-9615(2002)072[0019:TSOCSH]2.0.CO;2; Pejchar L, 2008, BIOL CONSERV, V141, P536, DOI 10.1016/j.biocon.2007.11.008; Phelps J, 2012, BIOL CONSERV, V154, P53, DOI 10.1016/j.biocon.2011.12.031; R Core Team, 2021, R LANGUAGE ENV STAT; Redo DJ, 2012, P NATL ACAD SCI USA, V109, P8839, DOI 10.1073/pnas.1201664109; Reid JL, 2013, RESTOR ECOL, V21, P153, DOI 10.1111/j.1526-100X.2012.00922.x; Reid JL, 2012, BIOTROPICA, V44, P350, DOI 10.1111/j.1744-7429.2011.00814.x; Reid JL, 2008, J TROP ECOL, V24, P685, DOI 10.1017/S0266467408005415; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Rickert E., 2005, THESIS EVERGREEN STA; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Robinson W. D., 2010, Open Environmental Sciences, V4, P21, DOI 10.2174/1876325101004010021; Ruiz-Gutierrez V, 2010, J APPL ECOL, V47, P621, DOI 10.1111/j.1365-2664.2010.01811.x; Ruiz-Jaen MC, 2005, RESTOR ECOL, V13, P569, DOI 10.1111/j.1526-100X.2005.00072.x; Schwartz MW, 2000, OECOLOGIA, V122, P297, DOI 10.1007/s004420050035; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Seligson M, 1980, PEASANTS COSTA RICA; SER, 2022, US; Shiels AB, 2003, RESTOR ECOL, V11, P457, DOI 10.1046/j.1526-100X.2003.rec0269.x; Sodhi NS, 2007, J ORNITHOL, V148, pS305, DOI 10.1007/s10336-007-0180-y; Stiles F.G., 1989, GUIDE BIRDS COSTA RI; Stouffer PC, 2009, DIVERS DISTRIB, V15, P88, DOI 10.1111/j.1472-4642.2008.00497.x; Tambosi LR, 2014, RESTOR ECOL, V22, P169, DOI 10.1111/rec.12049; Traveset Anna, 2002, P339, DOI 10.1079/9780851995250.0339; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Van Bael SA, 2008, ECOLOGY, V89, P928, DOI 10.1890/06-1976.1; Vellend M, 2003, ECOLOGY, V84, P1158, DOI 10.1890/0012-9658(2003)084[1158:HLIROP]2.0.CO;2; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; Webb TJ, 2006, P ROY SOC B-BIOL SCI, V273, P757, DOI 10.1098/rspb.2005.3364; WHITTAKER RJ, 1994, J BIOGEOGR, V21, P245, DOI 10.2307/2845528; Wunderle JM, 1997, FOREST ECOL MANAG, V99, P223, DOI 10.1016/S0378-1127(97)00208-9; Young TP, 2000, BIOL CONSERV, V92, P73, DOI 10.1016/S0006-3207(99)00057-9; Zahawi RA, 2006, ECOL APPL, V16, P464, DOI 10.1890/1051-0761(2006)016[0464:TFRTIA]2.0.CO;2; Zobel M, 1997, TRENDS ECOL EVOL, V12, P266, DOI 10.1016/S0169-5347(97)01096-3	102	37	38	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90573	10.1371/journal.pone.0090573	http://dx.doi.org/10.1371/journal.pone.0090573			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595233	gold, Green Submitted, Green Published			2022-12-27	WOS:000332475500069
J	Li, B; Li, R; Zhang, C; Bian, HJ; Wang, F; Xiao, J; Liu, SW; Yi, W; Zhang, MX; Wang, SX; Zhang, Y; Su, GH; Ji, XP				Li, Bin; Li, Rui; Zhang, Chun; Bian, Hong-jun; Wang, Fu; Xiao, Jie; Liu, Shan-wen; Yi, Wei; Zhang, Ming-xiang; Wang, Shuang-xi; Zhang, Yun; Su, Guo-hai; Ji, Xiao-ping			MicroRNA-7a/b Protects against Cardiac Myocyte Injury in Ischemia/Reperfusion by Targeting Poly(ADP-Ribose) Polymerase	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; INDUCED APOPTOSIS; DOWN-REGULATION; H9C2 CELLS; GROWTH; CARDIOMYOCYTES; CANCER; RECEPTOR; HEART; INHIBITORS	Objectives: MicroRNA-7 (miR-7) is highly connected to cancerous cell proliferation and metastasis. It is also involved in myocardial ischemia-reperfusion (I/R) injury and is upregulated in cardiomyocyte under simulated I/R (SI/R). We aimed to investigate the role of miR-7 during myocardial I/R injury in vitro and in vivo and a possible gene target. Methods and Results: Real-time PCR revealed that miR-7a/b expression was upregulated in H9c2 cells after SI/R. Flow cytometry showed SI/R-induced cell apoptosis was decreased with miR-7a/b mimic transfection but increased with miR-7a/b inhibitor in H9c2 cells. In a rat cardiac I/R injury model, infarct size determination and TUNEL assay revealed that miR-7a/b mimic decreased but miR-7a/b inhibitor increased cardiac infarct size and cardiomyocyte apoptosis as compared with controls. We previously identified an important gene connected with cell apoptosis -- poly(ADP-ribose) polymerase (PARP) -- as a candidate target for miR-7a/b and verified the target by luciferase reporter activity assay and western blot analysis. Conclusions: miR-7a/b is sensitive to I/R injury and protects myocardial cells against I/R-induced apoptosis by negatively regulating PARP expression in vivo and in vitro. miR-7a/b may provide a new therapeutic approach for treatment of myocardial I/R injury. Poly(ADP-ribose) polymerase.	[Li, Bin; Li, Rui; Wang, Fu; Xiao, Jie; Liu, Shan-wen; Zhang, Ming-xiang; Wang, Shuang-xi; Zhang, Yun; Ji, Xiao-ping] Shandong Univ, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China; [Li, Bin; Li, Rui; Wang, Fu; Xiao, Jie; Liu, Shan-wen; Zhang, Ming-xiang; Wang, Shuang-xi; Zhang, Yun; Ji, Xiao-ping] Shandong Univ, Chinese Minist Hlth, Dept Cardiol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Li, Bin; Su, Guo-hai] Shandong Univ, Jinan Cent Hosp, Dept Hlth care, Jinan 250100, Shandong, Peoples R China; [Zhang, Chun] Laizhou Peoples Hosp, Dept Cardiol, Laizhou, Shandong, Peoples R China; [Bian, Hong-jun] Shandong Univ, Shandong Prov Hosp, Dept Emergency, Jinan 250100, Shandong, Peoples R China; [Liu, Shan-wen] Linyi Peoples Hosp, Dept Emergency, Linyi, Shandong, Peoples R China; [Yi, Wei] Shandong Univ, Sch Mech Engn, Jinan 250100, Shandong, Peoples R China; [Yi, Wei] Shandong Univ, Engn Training Ctr, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Shandong University	Su, GH (corresponding author), Shandong Univ, Jinan Cent Hosp, Dept Hlth care, Jinan 250100, Shandong, Peoples R China.	guohaisu@medmail.com.cn; jixiaoping1964@hotmail.com	Yi, Weiming/ABD-7435-2020		National Natural Science Foundation of China [81070087]; National 973 Basic Research Program of China [2012CB722406]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China)	This work was supported by the the National Natural Science Foundation of China [81070087], and the National 973 Basic Research Program of China [2012CB722406]. the URL of any funder's website:http://isisn.nsfc.gov.cn/egrantweb/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Callis TE, 2008, TRENDS MOL MED, V14, P254, DOI 10.1016/j.molmed.2008.03.006; Chakrabarti M, 2012, BRAIN RES, V1454, P1, DOI 10.1016/j.brainres.2012.03.017; Choi JY, 2007, BIOCHEM BIOPH RES CO, V352, P366, DOI 10.1016/j.bbrc.2006.11.036; Duan HJ, 1996, J BIOL CHEM, V271, P16720, DOI 10.1074/jbc.271.28.16720; Duex JE, 2011, J BIOL CHEM, V286, P25377, DOI 10.1074/jbc.M111.222760; Ekhterae D, 1999, CIRC RES, V85, pE70; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fleury S, 2003, CIRCULATION, V107, P2375, DOI 10.1161/01.CIR.0000065598.46411.EF; Ji ES, 2004, ACTA PHARMACOL SIN, V25, P306; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Latronico MVG, 2007, CIRC RES, V101, P1225, DOI 10.1161/CIRCRESAHA.107.163147; Liu JH, 2008, AM J PHYSIOL-HEART C, V295, pH1956, DOI 10.1152/ajpheart.00407.2008; Mohanty Ipseeta, 2006, BMC Complement Altern Med, V6, P3, DOI 10.1186/1472-6882-6-3; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Qi JN, 2012, FEBS LETT, V586, P1201, DOI 10.1016/j.febslet.2012.03.011; Qin YJ, 2012, INT J MED SCI, V9, P413, DOI 10.7150/ijms.4514; Rai K, 2011, MOL CANCER THER, V10, P1720, DOI 10.1158/1535-7163.MCT-11-0220; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Tang YH, 2009, INT HEART J, V50, P377, DOI 10.1536/ihj.50.377; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Villa P, 1997, TRENDS BIOCHEM SCI, V22, P388, DOI 10.1016/S0968-0004(97)01107-9; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang JX, 2011, NAT MED, V17, P71, DOI 10.1038/nm.2282; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Xiao J, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-35; Xiong SD, 2011, INT J BIOL SCI, V7, P805, DOI 10.7150/ijbs.7.805; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Ye YM, 2010, CARDIOVASC RES, V87, P535, DOI 10.1093/cvr/cvq053; Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007; Zhao YJ, 2009, CHINESE MED J-PEKING, V122, P1322, DOI 10.3760/cma.j.issn.0366-6999.2009.11.016; Zhou HZ, 2006, AM J PHYSIOL-HEART C, V291, pH714, DOI 10.1152/ajpheart.00823.2005	40	49	63	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90096	10.1371/journal.pone.0090096	http://dx.doi.org/10.1371/journal.pone.0090096			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594984	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900067
J	Pinz, S; Unser, S; Brueggemann, S; Besl, E; Al-Rifai, N; Petkes, H; Amslinger, S; Rascle, A				Pinz, Sophia; Unser, Samy; Brueggemann, Susanne; Besl, Elisabeth; Al-Rifai, Nafisah; Petkes, Hermina; Amslinger, Sabine; Rascle, Anne			The Synthetic alpha-Bromo-2 ',3,4,4 '-Tetramethoxychalcone (alpha-Br-TMC) Inhibits the JAK/STAT Signaling Pathway	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; DNA-BINDING ACTIVITY; NF-KAPPA-B; TRANSACTIVATION DOMAIN; LEUKEMIA-CELLS; CONSTITUTIVE ACTIVATION; SERINE PHOSPHORYLATION; HEMATOPOIETIC-CELLS; STAT5 ACTIVATION; GENE-EXPRESSION	Signal transducer and activator of transcription STAT5 and its upstream activating kinase JAK2 are essential mediators of cytokine signaling. Their activity is normally tightly regulated and transient. However, constitutive activation of STAT5 is found in numerous cancers and a driving force for malignant transformation. We describe here the identification of the synthetic chalcone alpha-Br-2',3,4,4'-tetramethoxychalcone (alpha-Br-TMC) as a novel JAK/STAT inhibitor. Using the non-transformed IL-3-dependent B cell line Ba/F3 and its oncogenic derivative Ba/F3-1*6 expressing constitutively activated STAT5, we show that alpha-Br-TMC targets the JAK/STAT pathway at multiple levels, inhibiting both JAK2 and STAT5 phosphorylation. Moreover, alpha-Br-TMC alters the mobility of STAT5A/B proteins in SDS-PAGE, indicating a change in their post-translational modification state. These alterations correlate with a decreased association of STAT5 and RNA polymerase II with STAT5 target genes in chromatin immunoprecipitation assays. Interestingly, expression of STAT5 target genes such as Cis and c-Myc was differentially regulated by alpha-Br-TMC in normal and cancer cells. While both genes were inhibited in IL-3-stimulated Ba/F3 cells, expression of the oncogene c-Myc was down-regulated and that of the tumor suppressor gene Cis was up-regulated in transformed Ba/F3-1* 6 cells. The synthetic chalcone alpha-Br-TMC might therefore represent a promising novel anticancer agent for therapeutic intervention in STAT5-associated malignancies.	[Pinz, Sophia; Unser, Samy; Brueggemann, Susanne; Besl, Elisabeth; Rascle, Anne] Univ Regensburg, Inst Immunol, Signaling Res Grp Stat5, D-93053 Regensburg, Germany; [Al-Rifai, Nafisah; Petkes, Hermina; Amslinger, Sabine] Univ Regensburg, Inst Organ Chem, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg	Amslinger, S (corresponding author), Univ Regensburg, Inst Organ Chem, D-93053 Regensburg, Germany.	sabine.amslinger@chemie.uni-regensburg.de; anne.rascle@klinik.uni-regensburg.de	Al-Rifai, Nafisah/AAW-8832-2021; Rascle, Anne/AAC-1904-2019; Amslinger, Sabine/H-9072-2015	Al-Rifai, Nafisah/0000-0003-3128-052X; Rascle, Anne/0000-0001-7464-8545; Amslinger, Sabine/0000-0001-6588-3658; /0000-0001-8613-0655	Deutsche Forschungsgemeinschaft [RA 2010/2-1]; Deutsche Krebshilfe [109750]; Fonds der Chemischen Industrie; DAAD	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the Deutsche Forschungsgemeinschaft (Grant No. RA 2010/2-1 to AR), the Deutsche Krebshilfe (Grant No. 109750 to AR), institutional research funds (Foerderlinie C to AR), the Fonds der Chemischen Industrie (Liebig scholarship to SA) and the DAAD (Doctoral scholarship to NA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rifai N, 2013, CHEM-EUR J, V19, P15384, DOI 10.1002/chem.201302117; Amslinger S, 2013, ORG BIOMOL CHEM, V11, P549, DOI 10.1039/c2ob27163j; Amslinger S, 2010, CHEMMEDCHEM, V5, P351, DOI 10.1002/cmdc.200900499; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Batovska DI, 2010, CURR CLIN PHARMACOL, V5, P1, DOI 10.2174/157488410790410579; Beuvink I, 2000, J BIOL CHEM, V275, P10247, DOI 10.1074/jbc.275.14.10247; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Butturini E, 2013, FREE RADIC BIOL MED; Butturini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020174; Chim CS, 2004, BLOOD, V103, P4630, DOI 10.1182/blood-2003-06-2007; de Groot RP, 1999, BLOOD, V94, P1108, DOI 10.1182/blood.V94.3.1108.415k07_1108_1112; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Elliott J, 2008, BIOCHEM SOC T, V36, P464, DOI 10.1042/BST0360464; Evrot E, 2013, CLIN CANCER RES, V19, P6230, DOI 10.1158/1078-0432.CCR-13-0905; Fujihara M, 1998, J IMMUNOL, V161, P3659; Funakoshi-Tago M, 2008, BIOCHEM PHARMACOL, V76, P1681, DOI 10.1016/j.bcp.2008.09.012; Garcon L, 2006, BLOOD, V108, P1551, DOI 10.1182/blood-2005-10-009514; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Gryder BE, 2012, FUTURE MED CHEM, V4, P505, DOI [10.4155/FMC.12.3, 10.4155/fmc.12.3]; Guerini V, 2008, LEUKEMIA, V22, P740, DOI 10.1038/sj.leu.2405049; Hanan EJ, 2012, J MED CHEM, V55, P10090, DOI 10.1021/jm3012239; Hayakawa F, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.63; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; Ioannidis S, 2011, J MED CHEM, V54, P262, DOI 10.1021/jm1011319; Jatiani Shashidhar S, 2010, Genes Cancer, V1, P331, DOI 10.1177/1947601910371337; John S, 1999, MOL CELL BIOL, V19, P1910; Kim BH, 2013, BIOCHEM PHARMACOL, V86, P950, DOI 10.1016/j.bcp.2013.08.009; Kraus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037207; Levitzki A, 2006, ANNU REV BIOCHEM, V75, P93, DOI 10.1146/annurev.biochem.75.103004.142657; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Litterst CM, 2003, J BIOL CHEM, V278, P45340, DOI 10.1074/jbc.M303644200; Liu CB, 1999, J BIOL CHEM, V274, P6342, DOI 10.1074/jbc.274.10.6342; Liu YC, 2007, LIFE SCI, V80, P1420, DOI 10.1016/j.lfs.2006.12.040; Liu Yongbo, 2012, J Exp Ther Oncol, V10, P1; Lord JD, 2000, J IMMUNOL, V164, P2533, DOI 10.4049/jimmunol.164.5.2533; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Luo C, 2004, DRUG DISCOV TODAY, V9, P268, DOI 10.1016/S1359-6446(03)03014-9; Ma L, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.6; Ma L, 2010, P NATL ACAD SCI USA, V107, P19314, DOI 10.1073/pnas.1010253107; Mamoon NM, 2007, BIOCHEMISTRY-US, V46, P14810, DOI 10.1021/bi701118u; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Muller J, 2008, CHEMBIOCHEM, V9, P723, DOI 10.1002/cbic.200700701; Muller J, 2008, ANAL BIOCHEM, V375, P249, DOI 10.1016/j.ab.2008.01.017; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; Nelson Erik A, 2012, Genes Cancer, V3, P503, DOI 10.1177/1947601912466555; Nelson EA, 2011, ONCOTARGET, V2, P518; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; Nieborowska-Skorska M, 1999, J EXP MED, V189, P1229, DOI 10.1084/jem.189.8.1229; Niwa Y, 2005, ONCOGENE, V24, P6406, DOI 10.1038/sj.onc.1208788; Nosaka T, 2002, EXP HEMATOL, V30, P697, DOI 10.1016/S0301-472X(02)00808-1; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Pandey MK, 2009, MOL PHARMACOL, V75, P525, DOI 10.1124/mol.108.052548; Paukku K, 2004, CYTOKINE GROWTH F R, V15, P435, DOI 10.1016/j.cytogfr.2004.09.001; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; Pietschmann K, 2012, MOL CANCER THER, V11, P2373, DOI 10.1158/1535-7163.MCT-12-0129; Quintas-Cardama A, 2013, CLIN CANCER RES, V19, P1933, DOI 10.1158/1078-0432.CCR-12-0284; Rascle A, 2003, NUCLEIC ACIDS RES, V31, P6882, DOI 10.1093/nar/gkg907; Rascle A, 2003, MOL CELL BIOL, V23, P4162, DOI 10.1128/MCB.23.12.4162-4173.2003; Rascle A, 2009, EXP CELL RES, V315, P76, DOI 10.1016/j.yexcr.2008.10.012; Roskoski R, 2003, BIOCHEM BIOPH RES CO, V309, P709, DOI 10.1016/j.bbrc.2003.08.055; Santos FPS, 2011, BLOOD REV, V25, P53, DOI 10.1016/j.blre.2010.10.004; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Simmler C, 2013, J AGR FOOD CHEM, V61, P2146, DOI 10.1021/jf304445p; Nguyen TV, 2012, MOL CELL, V45, P210, DOI 10.1016/j.molcel.2011.12.026; Townsend DM, 2008, CANCER RES, V68, P2870, DOI 10.1158/0008-5472.CAN-07-5957; Nguyen T, 2011, CLIN CANCER RES, V17, P3219, DOI 10.1158/1078-0432.CCR-11-0234; Valentino L, 2006, BIOCHEM PHARMACOL, V71, P713, DOI 10.1016/j.bcp.2005.12.017; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; Wang YC, 2009, BLOOD, V114, P5024, DOI 10.1182/blood-2009-05-222133; Ward AC, 2000, BLOOD, V95, P19; Warsch W, 2013, BLOOD, V122, P2167, DOI 10.1182/blood-2013-02-485573; Weber A, 2005, ONCOGENE, V24, P6699, DOI 10.1038/sj.onc.1208818; Weber A, 2013, PHARMACEUTICALS, V6, P960, DOI 10.3390/ph6080960; Wieczorek M, 2012, CYTOKINE GROWTH F R, V23, P293, DOI 10.1016/j.cytogfr.2012.06.005; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Yamashita H, 1998, J BIOL CHEM, V273, P30218, DOI 10.1074/jbc.273.46.30218; Yang J, 2010, MOL CANCER THER, V9, P3386, DOI 10.1158/1535-7163.MCT-10-0416; Zhang Q, 2005, P NATL ACAD SCI USA, V102, P6948, DOI 10.1073/pnas.0501959102	86	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90275	10.1371/journal.pone.0090275	http://dx.doi.org/10.1371/journal.pone.0090275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595334	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900088
J	Sarker, AH; Chatterjee, A; Williams, M; Lin, S; Havel, C; Jacob, P; Boldogh, I; Hazra, TK; Talbot, P; Hang, B				Sarker, Altaf H.; Chatterjee, Arpita; Williams, Monique; Lin, Sabrina; Havel, Christopher; Jacob, Peyton, III; Boldogh, Istvan; Hazra, Tapas K.; Talbot, Prudence; Hang, Bo			NEIL2 Protects against Oxidative DNA Damage Induced by Sidestream Smoke in Human Cells	PLOS ONE			English	Article							CILIARY BEAT FREQUENCY; TOBACCO-SMOKE; LUNG-CANCER; CIGARETTE-SMOKE; IN-VITRO; REPAIR; GLYCOSYLASE; RISK; EXPOSURE; IDENTIFICATION	Secondhand smoke (SHS) is a confirmed lung carcinogen that introduces thousands of toxic chemicals into the lungs. SHS contains chemicals that have been implicated in causing oxidative DNA damage in the airway epithelium. Although DNA repair is considered a key defensive mechanism against various environmental attacks, such as cigarette smoking, the associations of individual repair enzymes with susceptibility to lung cancer are largely unknown. This study investigated the role of NEIL2, a DNA glycosylase excising oxidative base lesions, in human lung cells treated with sidestream smoke (SSS), the main component of SHS. To do so, we generated NEIL2 knockdown cells using siRNA-technology and exposed them to SSS-laden medium. Representative SSS chemical compounds in the medium were analyzed by mass spectrometry. An increased production of reactive oxygen species (ROS) in SSS-exposed cells was detected through the fluorescent detection and the induction of HIF-1 alpha. The long amplicon-quantitative PCR (LA-QPCR) assay detected significant dose-dependent increases of oxidative DNA damage in the HPRT gene of cultured human pulmonary fibroblasts (hPF) and BEAS-2B epithelial cells exposed to SSS for 24 h. These data suggest that SSS exposure increased oxidative stress, which could contribute to SSS-mediated toxicity. siRNA knockdown of NEIL2 in hPF and HEK 293 cells exposed to SSS for 24 h resulted in significantly more oxidative DNA damage in HPRT and POLB than in cells with control siRNA. Taken together, our data strongly suggest that decreased repair of oxidative DNA base lesions due to an impaired NEIL2 expression in non-smokers exposed to SSS would lead to accumulation of mutations in genomic DNA of lung cells over time, thus contributing to the onset of SSS-induced lung cancer.	[Sarker, Altaf H.; Hang, Bo] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Dept Canc & DNA Damage Responses, Berkeley, CA 94720 USA; [Chatterjee, Arpita; Boldogh, Istvan; Hazra, Tapas K.] Univ Texas Med Branch, Div Pulm & Crit Care Med, Galveston, TX 77555 USA; [Williams, Monique; Lin, Sabrina; Talbot, Prudence] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Havel, Christopher; Jacob, Peyton, III] Univ Calif San Francisco, Med Ctr, Dept Med, San Francisco Gen Hosp, San Francisco, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California Riverside; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Sarker, AH (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Dept Canc & DNA Damage Responses, Berkeley, CA 94720 USA.	AHSarker@lbl.gov; Bo_Hang@lbl.gov	Classen, Scott/AAY-8176-2020; Talbot, Prue/AAY-3896-2021; Chatterjee, Arpita/GPS-9141-2022		California Tobacco-Related Disease Research Program (TRDRP), under the U.S. Department of Energy [19XT-0070, DE-AC02-05CH11231]; National Institutes of Health [CA63503, CA092584, S10 RR026437, P30 DA012393]; TRDRP Consortium on Thirdhand Smoke [20PT-0184]; Flight Attendant Medical Research Institute Bland Lane Center of Excellence on Secondhand Smoke; NATIONAL CANCER INSTITUTE [R01CA063503, P01CA092584] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA012393] Funding Source: NIH RePORTER	California Tobacco-Related Disease Research Program (TRDRP), under the U.S. Department of Energy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TRDRP Consortium on Thirdhand Smoke; Flight Attendant Medical Research Institute Bland Lane Center of Excellence on Secondhand Smoke; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Dr. Bo Hang was supported by the Grant 19XT-0070 (to B. H.) from the California Tobacco-Related Disease Research Program (TRDRP), under the U.S. Department of Energy Contract no. DE-AC02-05CH11231. Dr. Altaf Sarker was supported by National Institutes of Health Grants CA63503 and CA092584 (Dr. Priscilla K. Cooper. PI). Instrumentation and analytical chemistry at UCSF were supported by the TRDRP Consortium on Thirdhand Smoke, 20PT-0184 (Dr. Neal L. Benowitz, PI), the Flight Attendant Medical Research Institute Bland Lane Center of Excellence on Secondhand Smoke (Dr. Rita F. Redberg, PI), and the National Institutes of Health, S10 RR026437 (to Dr. P.J.) and P30 DA012393 (Dr. Reese T. Jones, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhakat KK, 2006, MOL CELL BIOL, V26, P1654, DOI 10.1128/MCB.26.5.1654-1665.2006; Delaney S, 2012, FREE RADICAL RES, V46, P420, DOI 10.3109/10715762.2011.653968; Dey S, 2012, DNA REPAIR, V11, P570, DOI 10.1016/j.dnarep.2012.03.005; Dizdaroglu M, 2012, CANCER LETT, V327, P26, DOI 10.1016/j.canlet.2012.01.016; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Feng Z, 2006, JNCI-J NATL CANCER I, V94, P1527; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Hang B, 2006, DNA REPAIR GENETIC I, P23; Hang B, 2013, MUTAGENESIS, V28, P381, DOI 10.1093/mutage/get013; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Howard DJ, 1998, ARCH BIOCHEM BIOPHYS, V352, P293, DOI 10.1006/abbi.1998.0605; Husgafvel-Pursiainen K, 2004, MUTAT RES-REV MUTAT, V567, P427, DOI 10.1016/j.mrrev.2004.06.004; Izzotti A, 1999, CARCINOGENESIS, V20, P1499, DOI 10.1093/carcin/20.8.1499; Jacob P, 2013, CHEM RES TOXICOL, V26, P1615, DOI 10.1021/tx400094y; Janik J, 2011, MUTAT RES-FUND MOL M, V709-10, P21, DOI 10.1016/j.mrfmmm.2011.02.009; Jung SN, 2008, CARCINOGENESIS, V29, P713, DOI 10.1093/carcin/bgn032; Kaufmann R. B., 2010, Morbidity and Mortality Weekly Report, V59, P1141; Knoll M, 1998, REPROD TOXICOL, V12, P57, DOI 10.1016/S0890-6238(97)00100-7; KNOLL M, 1995, BIOL REPROD, V53, P29, DOI 10.1095/biolreprod53.1.29; Lin CH, 2012, J EPIDEMIOL, V22, P537, DOI 10.2188/jea.JE20120048; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; Matt GE, 2011, ENVIRON HEALTH PERSP, V119, P1218, DOI 10.1289/ehp.1103500; National Cancer Institute, 2004, CANC PROGR REP 2003; Paz-Elizur T, 2003, J NATL CANCER I, V95, P1312, DOI 10.1093/jnci/djg033; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Roszkowski K, 2011, MED SCI MONITOR, V17, pCR329, DOI 10.12659/MSM.881805; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Sarker AH, 1998, J MOL BIOL, V282, P761, DOI 10.1006/jmbi.1998.2042; Smith CJ, 2003, FOOD CHEM TOXICOL, V41, P807, DOI 10.1016/S0278-6915(03)00021-8; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; U.S. Department of Health and Human Services, 2010, REP SURG GEN TOB SMO; US Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; Wei W, 2012, MOL BIOL REP, V39, P11249, DOI 10.1007/s11033-012-2035-8; Zhai XD, 2008, CLIN CANCER RES, V14, P4345, DOI 10.1158/1078-0432.CCR-07-5282; Zhong DY, 2012, GENET MOL RES, V11, P3490, DOI 10.4238/2012.September.26.4	37	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90261	10.1371/journal.pone.0090261	http://dx.doi.org/10.1371/journal.pone.0090261			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595271	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900086
J	Yoneoka, D; Hisashige, A; Ota, E; Miyamoto, K; Nomura, S; Segawa, M; Gilmour, S; Shibuya, K				Yoneoka, Daisuke; Hisashige, Akinori; Ota, Erika; Miyamoto, Karin; Nomura, Shuhei; Segawa, Miwako; Gilmour, Stuart; Shibuya, Kenji			Are Japanese Randomized Controlled Trials Up to the Task? A Systematic Review	PLOS ONE			English	Review							QUALITY; INTERVENTIONS; TRENDS; BIAS	Objectives: Despite increasing numbers of RCTs done in Japan, existing international databases fail to capture them, and detailed information on the quality of Japanese RCTs is still missing. This study assessed the characteristics and quality of Japanese RCTs and analyzed factors related to their quality. Methods: All RCTs conducted in Japan, and published as original articles that assessed the effect of healthcare interventions on humans in 2010, were included. We excluded study protocols, conference abstracts, and comments. In addition, quasi-RCTs were excluded. Data were independently abstracted and assessed by two of the authors and disagreements were resolved by consensus. The quality of Japanese RCTs randomly sampled was assessed using the method guidelines for systematic reviews from the Cochrane Back Review Group. The factors affecting RCT quality were analyzed using a logistic regression model. Results: A total of 1013 RCTs conducted in Japan were published in 2010. The majority was small-scale (55% of RCTs with sample size less than 50). Eighty percent of RCTs had no information on the funding source and only 8% had been registered before their implementation. RCTs not indexed in international databases were a moderate number (118 RCTs: 37.7% of non-indexed RCTs were of high quality). Surgical intervention studies for external causes of morbidity and mortality with a large sample size, trial registration and a large number of arms were most likely to be of higher quality. Conclusion: Despite a considerable number of RCTs conducted in Japan, their quality is not satisfactory in some domains. On the other hand, there are high-quality, non-indexed RCTs. The full disclosure of trial information and quality control of clinical trials are urgently needed in Japan.	[Yoneoka, Daisuke; Hisashige, Akinori; Ota, Erika; Miyamoto, Karin; Nomura, Shuhei; Segawa, Miwako; Gilmour, Stuart; Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, Tokyo, Japan; [Hisashige, Akinori] Inst Healthcare Technol Assessment, Tokushima, Japan	University of Tokyo	Yoneoka, D (corresponding author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.	blue.sky.sea.dy@gmail.com	Yoneoka, Daisuke/A-9336-2016; Nomura, Shuhei/HCH-5356-2022	Yoneoka, Daisuke/0000-0002-3525-5092; Ota, Erika/0000-0002-3945-7441; Shibuya, Kenji/0000-0003-2528-7530; Nomura, Shuhei/0000-0002-2963-7297				[Anonymous], 2013, GLOB BURD DIS COUNTR; Chalmers I, 2003, BRIT MED J, V327, P1017, DOI 10.1136/bmj.327.7422.1017; Falagas ME, 2009, J CLIN EPIDEMIOL, V62, P227, DOI 10.1016/j.jclinepi.2008.07.012; Flanagin A, 2002, JAMA-J AM MED ASSOC, V288, P3166, DOI 10.1001/jama.288.24.3166; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; GBD 2001 Country Collaboration, 2013, LANCET, V381, P965, DOI 10.1016/S0140-6736(13)60283-4; Glasziou PP, 2009, MED J AUSTRALIA, V191, P52, DOI 10.5694/j.1326-5377.2009.tb02686.x; Gluud C, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-7; Higgins JPT, 2008, COCHRANE HDB SYSTEMA, Vxxi, DOI DOI 10.1002/9780470712184; Iglehart JK, 2009, NEW ENGL J MED, V361, P325, DOI 10.1056/NEJMp0904133; Joseph L, 2004, STAT METHODS RATES P; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Lozano R, 2013, LANCET, V381, P628; Moher D., 1999, HEALTH TECHNOL ASSES, V3, pi, DOI [DOI 10.3310/HTA3120, 10.3310/hta3120]; Moher D, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-98; Nallamothu BK, 2008, CIRCULATION, V118, P1294, DOI 10.1161/CIRCULATIONAHA.107.703579; Olivo SA, 2008, PHYS THER, V88, P156, DOI 10.2522/ptj.20070147; Ota E, 2012, COCHRANE DB SYST REV, P9; Ota E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006045.pub3; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Prioritization IoMCoCER Medicine To, 2009, IN NAT PRIOR COMP EF; Sawada T, 2013, EUR HEART J, V34, P1023, DOI 10.1093/eurheartj/eht030; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; Scott IA, 2012, MED J AUSTRALIA, V196, P304, DOI 10.5694/mja11.10364; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Straus SE, 2005, EVIDENCE BASED MED P; Strippoli GFM, 2004, J AM SOC NEPHROL, V15, P411, DOI 10.1097/01.ASN.0000100125.21491.46; Tanimoto T, 2013, LANCET, V382, P940, DOI 10.1016/S0140-6736(13)61933-9; Thiers FA, 2008, NAT REV DRUG DISCOV, V7, P13, DOI 10.1038/nrd2441; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Yank V, 1999, ANN INTERN MED, V130, P661, DOI 10.7326/0003-4819-130-8-199904200-00013; Yui Y, 2012, LANCET, V379, pE48, DOI 10.1016/S0140-6736(12)60599-6	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90127	10.1371/journal.pone.0090127	http://dx.doi.org/10.1371/journal.pone.0090127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595104	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900071
J	Campbell, J; Sharma, A				Campbell, Julia; Sharma, Anu			Cross-Modal Re-Organization in Adults with Early Stage Hearing Loss	PLOS ONE			English	Article							AUDITORY-EVOKED POTENTIALS; HUMAN FACE PERCEPTION; SPEECH-PERCEPTION; CORTICAL REORGANIZATION; EARLY-BLIND; NOISE TEST; COCHLEAR; PLASTICITY; CORTEX; BRAIN	Cortical cross-modal re-organization, or recruitment of auditory cortical areas for visual processing, has been well-documented in deafness. However, the degree of sensory deprivation necessary to induce such cortical plasticity remains unclear. We recorded visual evoked potentials (VEP) using high-density electroencephalography in nine persons with adult-onset mild-moderate hearing loss and eight normal hearing control subjects. Behavioral auditory performance was quantified using a clinical measure of speech perception-in-noise. Relative to normal hearing controls, adults with hearing loss showed significantly larger P1, N1, and P2 VEP amplitudes, decreased N1 latency, and a novel positive component (P2') following the P2 VEP. Current source density reconstruction of VEPs revealed a shift toward ventral stream processing including activation of auditory temporal cortex in hearing-impaired adults. The hearing loss group showed worse than normal speech perception performance in noise, which was strongly correlated with a decrease in the N1 VEP latency. Overall, our findings provide the first evidence that visual cross-modal re-organization not only begins in the early stages of hearing impairment, but may also be an important factor in determining behavioral outcomes for listeners with hearing loss, a finding which demands further investigation.	[Campbell, Julia; Sharma, Anu] Univ Colorado, Dept Speech Language & Hearing Sci, Boulder, CO 80309 USA; [Sharma, Anu] Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Sharma, A (corresponding author), Univ Colorado, Dept Speech Language & Hearing Sci, Boulder, CO 80309 USA.	anu.sharma@colorado.edu	Campbell, Julia/N-8425-2019	SHARMA, ANU/0000-0001-8568-1420; Campbell, Julia/0000-0003-3985-6204	National Institutes of Health [RO106257, F31DC011970]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006257, F31DC011970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health (RO106257 to A. S., F31DC011970 to J.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Anderson S, 2010, J AM ACAD AUDIOL, V21, P575, DOI 10.3766/jaaa.21.9.3; Andics A, 2010, NEUROIMAGE, V52, P1528, DOI 10.1016/j.neuroimage.2010.05.048; Armstrong BA, 2002, COGNITIVE BRAIN RES, V14, P422, DOI 10.1016/S0926-6410(02)00211-2; Bavelier D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-17-j0001.2000; Bavelier D, 2010, NAT NEUROSCI, V13, P1309, DOI 10.1038/nn1110-1309; Bertrand JA, 2012, EXP BRAIN RES, V216, P145, DOI 10.1007/s00221-011-2920-8; Bosworth RG, 2002, BRAIN COGNITION, V49, P152, DOI 10.1006/brcg.2001.1497; Buckley KA, 2011, EAR HEARING, V32, P2, DOI 10.1097/AUD.0b013e3181fa41bb; Campbell J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00071; Collignon O, 2007, CEREB CORTEX, V17, P457, DOI 10.1093/cercor/bhj162; Collignon O, 2011, P NATL ACAD SCI USA, V108, P4435, DOI 10.1073/pnas.1013928108; Debener S, 2008, PSYCHOPHYSIOLOGY, V45, P20, DOI 10.1111/j.1469-8986.2007.00610.x; Debener S, 2006, TRENDS COGN SCI, V10, P558, DOI 10.1016/j.tics.2006.09.010; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030135; Doucet ME, 2006, BRAIN, V129, P3376, DOI 10.1093/brain/awl264; Doucet ME, 2005, NEUROREPORT, V16, P1753, DOI 10.1097/01.wnr.0000185011.91197.58; DUBNO JR, 1984, J ACOUST SOC AM, V76, P87, DOI 10.1121/1.391011; Dupont P, 2003, EUR J NEUROSCI, V17, P1509, DOI 10.1046/j.1460-9568.2003.02571.x; Finney EM, 2003, NEUROREPORT, V14, P1425, DOI 10.1097/00001756-200308060-00004; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; George EM, 2011, NEUROPSYCHOLOGIA, V49, P1083, DOI 10.1016/j.neuropsychologia.2011.02.001; Gifford RH, 2010, J AM ACAD AUDIOL, V21, P441, DOI 10.3766/jaaa.21.7.3; Gilley PM, 2008, BRAIN RES, V1239, P56, DOI 10.1016/j.brainres.2008.08.026; Giraud AL, 2007, RESTOR NEUROL NEUROS, V25, P381; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; Hine J, 2007, CLIN NEUROPHYSIOL, V118, P1274, DOI 10.1016/j.clinph.2007.03.012; Hornsby BWY, 2011, EAR HEARING, V32, P543, DOI 10.1097/AUD.0b013e31820e5028; Joos K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040544; Kellermann T, 2012, J NEUROSCI, V32, P11453, DOI 10.1523/JNEUROSCI.0678-12.2012; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; Kral A, 2013, NEUROSCIENCE, V247, P117, DOI 10.1016/j.neuroscience.2013.05.021; Kral A, 2012, TRENDS NEUROSCI, V35, P111, DOI 10.1016/j.tins.2011.09.004; Kujala T, 2000, TRENDS NEUROSCI, V23, P115, DOI 10.1016/S0166-2236(99)01504-0; Kupers R, 2013, NEUROSCI BIOBEHAV R; Lazard DS, 2010, NEUROIMAGE, V49, P3443, DOI 10.1016/j.neuroimage.2009.11.013; Lazard DS, 2014, HEARING RES, V307, P136, DOI 10.1016/j.heares.2013.08.006; Lazard DS, 2013, HUM BRAIN MAPP, V34, P1208, DOI 10.1002/hbm.21504; Lazard DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048739; Lee HJ, 2007, CEREB CORTEX, V17, P909, DOI 10.1093/cercor/bhl001; Letourneau SM, 2011, PERCEPTION, V40, P563, DOI 10.1068/p6858; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; Makeig S, 2004, PLOS BIOL, V2, P747, DOI 10.1371/journal.pbio.0020176; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; McCullough S, 2005, COGNITIVE BRAIN RES, V22, P193, DOI 10.1016/j.cogbrainres.2004.08.012; Meredith MA, 2012, NEUROSCIENCE, V214, P136, DOI 10.1016/j.neuroscience.2012.04.001; Meredith MA, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/601591; Meredith MA, 2011, P NATL ACAD SCI USA, V108, P8856, DOI 10.1073/pnas.1018519108; Moore BCJ, 1996, EAR HEARING, V17, P133, DOI 10.1097/00003446-199604000-00007; Nasr S, 2012, NEUROIMAGE, V63, P1743, DOI 10.1016/j.neuroimage.2012.08.031; NEVILLE HJ, 1987, BRAIN RES, V405, P268, DOI 10.1016/0006-8993(87)90296-4; NEVILLE HJ, 1983, BRAIN RES, V266, P127, DOI 10.1016/0006-8993(83)91314-8; Neville HJ, 2001, CLIN NEUROSCI RES, V1, P248, DOI 10.1016/S1566-2772(01)00011-1; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pasley BN, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001251; Puce A, 1999, CEREB CORTEX, V9, P445, DOI 10.1093/cercor/9.5.445; Rauschecker Josef P, 2012, Front Evol Neurosci, V4, P7, DOI 10.3389/fnevo.2012.00007; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; Rouger J, 2012, HUM BRAIN MAPP, V33, P1929, DOI 10.1002/hbm.21331; Sadato N, 2005, CEREB CORTEX, V15, P1113, DOI 10.1093/cercor/bhh210; Sandmann P, 2012, BRAIN, V135, P555, DOI 10.1093/brain/awr329; Schirmer A, 2012, NEUROIMAGE, V63, P137, DOI 10.1016/j.neuroimage.2012.06.025; Sharma A, 2005, HEARING RES, V203, P134, DOI 10.1016/j.heares.2004.12.010; Sharma A, 2007, INT J AUDIOL, V46, P494, DOI 10.1080/14992020701524836; Sharma A, 2013, SPRINGER HANDB AUDIT, V47, P189, DOI 10.1007/2506_2013_7; Sharma A, 2011, SPRINGER HANDB AUDIT, V39, P233, DOI 10.1007/978-1-4419-9434-9_10; Sharma A, 2009, J COMMUN DISORD, V42, P272, DOI 10.1016/j.jcomdis.2009.03.003; Souza PE, 2007, J AM ACAD AUDIOL, V18, P54, DOI 10.3766/jaaa.18.1.5; Strelnikov K, 2013, BRAIN, V136, P3682, DOI 10.1093/brain/awt274; Tong YX, 2009, BRAIN RES, V1297, P80, DOI 10.1016/j.brainres.2009.07.089; Vachon P, 2013, NEUROSCIENCE, V245, P50, DOI 10.1016/j.neuroscience.2013.04.004; Vermiglio AJ, 2012, J AM ACAD AUDIOL, V23, P779, DOI 10.3766/jaaa.23.10.4; Voss P, 2006, NEUROREPORT, V17, P383, DOI 10.1097/01.wnr.0000204983.21748.2d; Voss P, 2008, NEUROIMAGE, V40, P746, DOI 10.1016/j.neuroimage.2007.12.020; Watkins KE, 2013, J NEUROSCI, V33, P18242, DOI 10.1523/JNEUROSCI.2546-13.2013; Wilkinson F, 2000, CURR BIOL, V10, P1455, DOI 10.1016/S0960-9822(00)00800-9; Wilson RH, 2007, J SPEECH LANG HEAR R, V50, P844, DOI 10.1044/1092-4388(2007/059); Woodhouse L, 2009, INT J LANG COMM DIS, V44, P253, DOI 10.1080/13682820802090281	80	92	100	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90594	10.1371/journal.pone.0090594	http://dx.doi.org/10.1371/journal.pone.0090594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587400	gold, Green Submitted, Green Published			2022-12-27	WOS:000332396200234
J	Gao, YM; Yu, XY; Xue, BB; Zhou, F; Wang, XH; Yang, DR; Liu, NL; Xu, L; Fang, XH; Zhu, HZ				Gao, Yimin; Yu, Xiaoyan; Xue, Binbin; Zhou, Fei; Wang, Xiaohong; Yang, Darong; Liu, Nianli; Xu, Li; Fang, Xiaohong; Zhu, Haizhen			Inhibition of Hepatitis C Virus Infection by DNA Aptamer against NS2 Protein	PLOS ONE			English	Article							RNA APTAMER; CULTURE; MUTATIONS; BIND; P7	NS2 protein is essential for hepatitis C virus (HCV) replication. NS2 protein was expressed and purified. Aptamers against NS2 protein were raised and antiviral effects of the aptamers were examined. The molecular mechanism through which the aptamers exert their anti-HCV activity was investigated. The data showed that aptamer NS2-3 inhibited HCV RNA replication in replicon cell line and infectious HCV cell culture system. NS2-3 and another aptamer NS2-2 were demonstrated to inhibit infectious virus production without cytotoxicity in vitro. They did not affect hepatitis B virus replication. Interferon beta (IFN-beta) and interferon-stimulated genes (ISGs) were not induced by the aptamers in HCV-infected hepatocytes. Furthermore, our study showed that N-terminal region of NS2 protein is involved in the inhibition of HCV infection by NS2-2. I861T within NS2 is the major resistance mutation identified. Aptamer NS2-2 disrupts the interaction of NS2 with NS5A protein. The data suggest that NS2-2 aptamer against NS2 protein exerts its antiviral effects through binding to the N-terminal of NS2 and disrupting the interaction of NS2 with NS5A protein. NS2-specific aptamer is the first NS2 inhibitor and can be used to understand the mechanisms of virus replication and assembly. It may be served as attractive candidates for inclusion in the future HCV direct-acting antiviral combination therapies.	[Gao, Yimin; Yu, Xiaoyan; Xue, Binbin; Zhou, Fei; Wang, Xiaohong; Yang, Darong; Liu, Nianli; Zhu, Haizhen] Hunan Univ, Dept Mol Med, State Key Lab Chemo Biosensing & Chemometr, Changsha 410082, Hunan, Peoples R China; [Yang, Darong; Liu, Nianli; Zhu, Haizhen] Cent South Univ, Xiangya Med Sch, Res Ctr Canc Prevent & Treatment & Translat Med, Res Ctr Liver Canc,Hunan Prov Tumor Hosp,Affiliat, Changsha, Hunan, Peoples R China; [Xu, Li; Fang, Xiaohong] Chinese Acad Sci, Inst Chem, Key Lab Mol Nanostruct & Nanotechnol, Beijing 100080, Peoples R China	Hunan University; Central South University; Chinese Academy of Sciences; Institute of Chemistry, CAS	Zhu, HZ (corresponding author), Hunan Univ, Dept Mol Med, State Key Lab Chemo Biosensing & Chemometr, Changsha 410082, Hunan, Peoples R China.	zhuhaizhen69@yahoo.com	Gao, Yu/HGE-1937-2022; Yang, Darong/HHZ-5465-2022; gao, yi/HCI-8298-2022; wang, xiao/HGB-7081-2022; Gao, Y./GWZ-3665-2022	wang, xiao/0000-0002-4088-3341; Yang, Darong/0000-0002-5343-9047	National Science and Technology Major Project of the Ministry of Science and Technology of China [2009ZX10004-312]; National Natural Science Foundation of China [81271885]; Program for New Century Excellent Talents in University [NCET-09-0339]	National Science and Technology Major Project of the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Science and Technology Major Project of the Ministry of Science and Technology of China (2009ZX10004-312), National Natural Science Foundation of China (81271885), and Program for New Century Excellent Talents in University (NCET-09-0339) to HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentham M, 2012, J VIROL, V86, P2371, DOI 10.1128/JVI.05696-11; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; de la Fuente C, 2013, J VIROL, V87, P4130, DOI 10.1128/JVI.03174-12; Ditzler MA, 2011, NUCLEIC ACIDS RES, V39, P8237, DOI 10.1093/nar/gkr381; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Hwang SY, 2012, NUCLEIC ACIDS RES, V40, P2724, DOI 10.1093/nar/gkr1098; Jiang JY, 2012, J VIROL, V86, P8987, DOI 10.1128/JVI.00004-12; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lorenz IC, 2006, NATURE, V442, P831, DOI 10.1038/nature04975; Lorenz IC, 2010, VIRUSES-BASEL, V2, P1635, DOI 10.3390/v2081635; Ma YH, 2011, J VIROL, V85, P86, DOI 10.1128/JVI.01070-10; Monto A, 2010, AM J GASTROENTEROL, V105, P989, DOI 10.1038/ajg.2009.726; Moore MD, 2011, J BIOL CHEM, V286, P2526, DOI 10.1074/jbc.M110.178426; Pawlotsky JM, 2007, GASTROENTEROLOGY, V132, P1979, DOI 10.1053/j.gastro.2007.03.116; Pawlotsky Jean-Michel, 2012, F1000 Biol Rep, V4, P5, DOI 10.3410/B4-5; Ramalingam D, 2011, J VIROL, V85, P305, DOI 10.1128/JVI.02626-09; Tan WH, 2011, TRENDS BIOTECHNOL, V29, P634, DOI 10.1016/j.tibtech.2011.06.009; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Van Melckebeke H, 2008, P NATL ACAD SCI USA, V105, P9210, DOI 10.1073/pnas.0712121105; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wheeler LA, 2011, J CLIN INVEST, V121, P2401, DOI 10.1172/JCI45876; Yang DR, 2013, ANTIMICROB AGENTS CH, V57, P4937, DOI 10.1128/AAC.00897-13; Yang DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027552; Yang DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059020, 10.1371/journal.pone.0054495, 10.1371/journal.pone.0062329]; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Yi MK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000403; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhu HZ, 2003, HEPATOLOGY, V37, P1180, DOI 10.1053/jhep.2003.50184	34	25	26	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90333	10.1371/journal.pone.0090333	http://dx.doi.org/10.1371/journal.pone.0090333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587329	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200173
J	Fuentes, E; Caballero, J; Alarcon, M; Rojas, A; Palomo, I				Fuentes, Eduardo; Caballero, Julio; Alarcon, Marcelo; Rojas, Armando; Palomo, Ivan			Chlorogenic Acid Inhibits Human Platelet Activation and Thrombus Formation	PLOS ONE			English	Article							P-SELECTIN EXPRESSION; PROTEIN-KINASE-A; ADENOSINE RECEPTOR; INCREASES; THERAPY; ASPIRIN; DOCKING; BINDING; COFFEE	Background: Chlorogenic acid is a potent phenolic antioxidant. However, its effect on platelet aggregation, a critical factor in arterial thrombosis, remains unclear. Consequently, chlorogenic acid-action mechanisms in preventing platelet activation and thrombus formation were examined. Methods and Results: Chlorogenic acid in a dose-dependent manner (0.1 to 1 mmol/L) inhibited platelet secretion and aggregation induced by ADP, collagen, arachidonic acid and TRAP-6, and diminished platelet firm adhesion/aggregation and platelet-leukocyte interactions under flow conditions. At these concentrations chlorogenic acid significantly decreased platelet inflammatory mediators (sP-selectin, sCD40L, CCL5 and IL-1 beta) and increased intraplatelet cAMP levels/PKA activation. Interestingly, SQ22536 (an adenylate cyclase inhibitor) and ZM241385 (a potent A(2A) receptor antagonist) attenuated the antiplatelet effect of chlorogenic acid. Chlorogenic acid is compatible to the active site of the adenosine A(2A) receptor as revealed through molecular modeling. In addition, chlorogenic acid had a significantly lower effect on mouse bleeding time when compared to the same dose of aspirin. Conclusions: Antiplatelet and antithrombotic effects of chlorogenic acid are associated with the A(2A) receptor/adenylate cyclase/cAMP/PKA signaling pathway.	[Fuentes, Eduardo; Alarcon, Marcelo; Palomo, Ivan] Univ Talca, Dept Clin Biochem & Immunohematol, Interdisciplinary Excellence Res Program Hlth Agi, Fac Hlth Sci, Talca, Chile; [Fuentes, Eduardo; Alarcon, Marcelo; Palomo, Ivan] CONICYT Reg, CEAP, Gore Maule, Talca, Chile; [Caballero, Julio] Univ Talca, Fac Engn Bioinformat, Ctr Bioinformat & Mol Simulat, Talca, Chile; [Rojas, Armando] Catholic Univ Maule, Fac Med, Biomed Res Labs, Talca, Chile	Universidad de Talca; Universidad de Talca; Universidad Catolica del Maule	Fuentes, E (corresponding author), Univ Talca, Dept Clin Biochem & Immunohematol, Interdisciplinary Excellence Res Program Hlth Agi, Fac Hlth Sci, Talca, Chile.	edfuentes@utalca.cl; ipalomo@utalca.cl	Rojas, Armando/D-2647-2014; Palomo, Iván/I-4321-2018; Caballero, Julio/G-3654-2014; Alarcon, Marcelo A/I-5016-2018	Caballero, Julio/0000-0003-0182-1444; Alarcon, Marcelo A/0000-0001-7596-5382; Rojas, Armando/0000-0001-9911-7142; Fuentes Quinteros, Eduardo/0000-0003-0099-4108; Palomo, Ivan/0000-0002-9618-8778	CONICYT [REGIONAL/GORE MAULE/CEAP/R09I2001]; Interdisciplinary Excellence Research Program on Healthy Aging (PIEIES); Fondecyt, Chile [1130216]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Interdisciplinary Excellence Research Program on Healthy Aging (PIEIES); Fondecyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was funded by the CONICYT REGIONAL/GORE MAULE/CEAP/R09I2001, Interdisciplinary Excellence Research Program on Healthy Aging (PIEIES), and supported by grant no. 1130216 (I. P., M. G., R. M., M. A., J.C.) from Fondecyt, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CW, 2001, CHEST, V119, p300S, DOI 10.1378/chest.119.1_suppl.300S; Albers GW, 2001, STROKE, V32, P2948, DOI 10.1161/hs1201.100829; Amin RP, 2013, J COMPLEMENT INTEGR, V10, P1; [Anonymous], 2003, INT CARD DIS STAT; Appeldoorn CCM, 2005, CIRCULATION, V111, P106, DOI 10.1161/01.CIR.0000151307.10576.02; Aukrust P, 1999, CIRCULATION, V100, P614, DOI 10.1161/01.CIR.100.6.614; Badimon L, 2012, EUR HEART J-ACUTE CA, V1, P60, DOI 10.1177/2048872612441582; Barrett NE, 2008, BRIT J PHARMACOL, V154, P918, DOI 10.1038/bjp.2008.151; Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444; Bijak M, 2013, PHYTOTHER RES, V27, P71, DOI 10.1002/ptr.4682; Conant Carolyn G, 2009, J Vis Exp, DOI 10.3791/1644; DECLERCK F, 1976, THROMB RES, V8, P179, DOI 10.1016/0049-3848(76)90261-9; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Enomoto Y, 2011, INT J MOL MED, V27, P695, DOI 10.3892/ijmm.2011.637; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; FROJMOVIC M, 1991, BIOPHYS J, V59, P815, DOI 10.1016/S0006-3495(91)82294-9; Fuentes Eduardo, 2013, Evid Based Complement Alternat Med, V2013, P609714, DOI 10.1155/2013/609714; Fuentes E, 2013, MOLECULES, V18, P11526, DOI 10.3390/molecules180911526; Hwang SJ, 2013, INFLAMM RES, V2013, P1; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jensen BO, 2004, BLOOD, V104, P2775, DOI 10.1182/blood-2004-03-1058; Ji XB, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-44; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Karunanidhi A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/392058; LARANJINHA JAN, 1994, BIOCHEM PHARMACOL, V48, P487, DOI 10.1016/0006-2952(94)90278-X; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Libersan D, 2003, THROMB HAEMOSTASIS, V89, P310, DOI 10.1055/s-0037-1613448; Loyau S, 2012, ARTERIOSCL THROM VAS, V32, P778, DOI 10.1161/ATVBAHA.111.241067; MARKS DC, 1992, LEUKEMIA RES, V16, P1165, DOI 10.1016/0145-2126(92)90114-M; Martins PAD, 2006, J LEUKOCYTE BIOL, V79, P499, DOI 10.1189/jlb.0605318; Martins PD, 2004, ARTERIOSCL THROM VAS, V24, P193, DOI 10.1161/01.ATV.0000106320.40933.E5; Massberg Steffen, 2003, Semin Vasc Med, V3, P147; Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]; Merten M, 2000, CIRCULATION, V102, P1931, DOI 10.1161/01.CIR.102.16.1931; Munoz C, 2012, J MOL GRAPH MODEL, V32, P39, DOI 10.1016/j.jmgm.2011.10.005; NARDINI M, 1995, FREE RADICAL BIO MED, V19, P541, DOI 10.1016/0891-5849(95)00052-Y; Nurden AT, 2011, THROMB HAEMOSTASIS, V105, pS13, DOI 10.1160/THS10-11-0720; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Olthof MR, 2001, AM J CLIN NUTR, V73, P532; Onate B, 2012, FASEB J, V26, P4327, DOI 10.1096/fj.12-207217; Plaza M, 2008, TRENDS FOOD SCI TECH, V19, P31, DOI 10.1016/j.tifs.2007.07.012; Przyklenk K, 2007, LASER MED SCI, V22, P42, DOI 10.1007/s10103-006-0410-1; Raju NC, 2012, CURR OPIN CARDIOL, V27, P499, DOI 10.1097/HCO.0b013e328356ae95; Serebruany VL, 2004, AM J HEMATOL, V75, P40, DOI 10.1002/ajh.10451; WALTER U, 1993, ADV EXP MED BIOL, V344, P237; Wang YL, 2014, MULTIMED TOOLS APPL, V73, P7, DOI 10.1007/s11042-012-1267-x; Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655; World Health Organization, 2004, WHO PUBL DEF ATL GLO; Yang D, 2010, J THROMB HAEMOST, V8, P817, DOI 10.1111/j.1538-7836.2010.03769.x	49	66	72	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90699	10.1371/journal.pone.0090699	http://dx.doi.org/10.1371/journal.pone.0090699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598787	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400120
J	Wu, W; Yu, LH; Ma, B; Xu, MJ				Wu, Wei; Yu, Li-hua; Ma, Bei; Xu, Ming-juan			The Inhibitory Effect of Doxycycline on Cisplatin-Sensitive and -Resistant Epithelial Ovarian Cancer	PLOS ONE			English	Article							CELL; CARCINOMA; APOPTOSIS; CHEMOKINE; PROLIFERATION; RECEPTOR	Background: Detecting a new effective and hypotoxic anticancer drug is an emerging new strategy for cancer chemotherapy. Doxycycline (DC) is a kind of antibiotics but also inhibits tumorigenesis. Methods: MTT and cell invasion assay, flow cytometry, western-blot analysis and nude mice were used to investigate the effects and underlying mechanisms of doxycycline on epithelial ovarian cancer cells. Results: Doxycycline inhibited the proliferation and invasion of SKOV3 and SKOV3/DDP; induced moderate apoptosis of SKOV3/DDP. CXCR4 expression at both mRNA and protein levels was downregulated in both cell lines when treated with doxycycline. Akt and ERK1/2 were involved in doxycycline effect on cell proliferation of SKOV3 but not of SKOV3/DDP. Akt and EKR1/2 phosphorylation were activated by SDF-1 alpha, which was then inhibited by doxycycline in SKOV3. Pro-caspase-3 expression was significantly higher in SKOV3 than that in SKOV3/DDP which was upregulated when treated with doxycycline. In vivo, doxycycline inhibited peritoneal tumor xenograft and decreased malignant ascites. Conclusion: Doxycycline not only has an inhibitory effect on ovarian cancer, but also can increase sensitivity to cisplatin. SDF-1 alpha/CXCR4-regulated Akt and ERK 1/2 activations are probably involved in the antitumor effect of doxycycline on SKOV3 cells, while upregulation of pro-caspase-3 may be the main mechanism involved in SKOV3/DDP cells.	[Wu, Wei; Xu, Ming-juan] Second Mil Med Univ, Changhai Hosp, Dept Gynecol & Obstet, Shanghai, Peoples R China; [Wu, Wei; Yu, Li-hua; Ma, Bei] Second Mil Med Univ, Dept Physiol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Ma, B (corresponding author), Second Mil Med Univ, Dept Physiol, Shanghai, Peoples R China.	mabei08@yahoo.com.cn; 13636373419@163.com			Science and Technology Commission of Shanghai Municipality [10411960100]; Changhai Hospital [CH125510105]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Changhai Hospital	This work was supported by Science and Technology Commission of Shanghai Municipality (No. 10411960100) and Changhai Hospital (No. CH125510105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Barbieri F, 2010, J ONCOL, V2010, DOI 10.1155/2010/426956; Bottone MG, 2008, CELL PROLIFERAT, V41, P506, DOI 10.1111/j.1365-2184.2008.00530.x; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Gubbels JAA, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-8; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lai PBS, 2007, APOPTOSIS, V12, P387, DOI 10.1007/s10495-006-0571-1; Li HJ, 2011, MOL CELL ENDOCRINOL, V338, P28, DOI 10.1016/j.mce.2011.02.014; Marsh S, 2009, INT J GYNECOL CANCER, V19, pS30, DOI 10.1111/IGC.0b013e3181c10513; Miyanishi N, 2010, BIOCHEM BIOPH RES CO, V403, P154, DOI 10.1016/j.bbrc.2010.11.007; Mouratidis PXE, 2007, INT J CANCER, V120, P743, DOI 10.1002/ijc.22303; Nonaka M, 2012, INT J GYNECOL CANCER, V22, P922, DOI 10.1097/IGC.0b013e31824f0b13; Onoda T, 2006, INT J CANCER, V118, P1309, DOI 10.1002/ijc.21447; Sato N, 2005, CANCER BIOL THER, V4, P70, DOI 10.4161/cbt.4.1.1378; Scotton CJ, 2001, CANCER RES, V61, P4961; Shen LC, 2010, ORAL ONCOL, V46, P178, DOI 10.1016/j.oraloncology.2009.11.013; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Suh DH, 2012, J GYNECOL ONCOL, V23, P53, DOI 10.3802/jgo.2012.23.1.53; Sun Bao-cun, 2006, Zhonghua Bing Li Xue Za Zhi, V35, P677; Sun T, 2009, CANCER LETT, V285, P141, DOI 10.1016/j.canlet.2009.05.004; Tang H, 2013, GENE THER, V20, P770, DOI 10.1038/gt.2012.96; Ueda Y, 2006, CANCER RES, V66, P5665, DOI 10.1158/0008-5472.CAN-05-3579; Wendt MK, 2006, ONCOGENE, V25, P4986, DOI 10.1038/sj.onc.1209505; Yang XK, 2004, J CANCER RES CLIN, V130, P423, DOI 10.1007/s00432-004-0556-9; Yoon H, 2011, BIOCHEM BIOPH RES CO, V405, P333, DOI 10.1016/j.bbrc.2010.11.130	29	19	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89841	10.1371/journal.pone.0089841	http://dx.doi.org/10.1371/journal.pone.0089841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598933	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400030
J	Robertson, ER; Hadi, M; Morgan, LJ; Pickering, SP; Collins, G; New, S; Griffin, D; McCulloch, P; Catchpole, KC				Robertson, Eleanor R.; Hadi, Mohammed; Morgan, Lauren J.; Pickering, Sharon P.; Collins, Gary; New, Steve; Griffin, Damien; McCulloch, Peter; Catchpole, Ken C.			Oxford NOTECHS II: A Modified Theatre Team Non-Technical Skills Scoring System	PLOS ONE			English	Article							OPERATING-ROOM; COMMUNICATION; RELIABILITY; BEHAVIOR; TOOL; TRAINEES; PATTERNS; AVIATION; SCALE; ERROR	Background: We previously developed and validated the Oxford NOTECHS rating system for evaluating the non-technical skills of an entire operating theatre team. Experience with the scale identified the need for greater discrimination between levels of performance within the normal range. We report here the development of a modified scale (Oxford NOTECHS II) to facilitate this. The new measure uses an eight-point instead of a four point scale to measure each dimension of nontechnical skills, and begins with a default rating of 6 for each element. We evaluated this new scale in 297 operations at five NHS sites in four surgical specialities. Measures of theatre process reliability (glitch count) and compliance with the WHO surgical safety checklist were scored contemporaneously, and relationships with NOTECHS II scores explored. Results: Mean team Oxford NOTECHS II scores was 73.39 (range 37-92). The means for surgical, anaesthetic and nursing sub-teams were 24.61 (IQR 23, 27); 24.22 (IQR 23, 26) and 24.55 (IQR 23, 26). Oxford NOTECHS II showed good inter-rater reliability between human factors and clinical observers in each of the four domains. Teams with high WHO compliance had higher mean Oxford NOTECHS II scores (74.5) than those with low compliance (71.1) (p = 0.010). We observed only a weak correlation between Oxford NOTECHS II scores and glitch count; r = -0.26 (95% CI -0.36 to -0.15). Oxford NOTECHS II scores did not vary significantly between 5 different hospital sites, but a significant difference was seen between specialities (p = 0.001). Conclusions: Oxford NOTECHS II provides good discrimination between teams while retaining reliability and correlation with other measures of teamwork performance, and is not confounded by technical performance. It is therefore suitable for combined use with a technical performance scale to provide a global description of operating theatre team performance.	[Robertson, Eleanor R.; Morgan, Lauren J.; McCulloch, Peter] Univ Oxford, Nuffield Dept Surg Sci, Qual Reliabil Safety & Teamwork Unit, Oxford, England; [Hadi, Mohammed; Pickering, Sharon P.; Griffin, Damien] Univ Warwick, Warwick Med Sch, Warwick Orthopaed, Coventry CV4 7AL, W Midlands, England; [Collins, Gary] Univ Oxford, Ctr Stat Med, Oxford, England; [New, Steve] Univ Oxford, Said Business Sch, Oxford, England; [Catchpole, Ken C.] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA	University of Oxford; University of Warwick; University of Oxford; University of Oxford; Cedars Sinai Medical Center	McCulloch, P (corresponding author), Univ Oxford, Nuffield Dept Surg Sci, Qual Reliabil Safety & Teamwork Unit, Oxford, England.	Peter.McCulloch@nds.ox.ac.uk	Collins, Gary Stephen/A-2258-2014; Catchpole, Ken/A-6149-2008	Collins, Gary Stephen/0000-0002-2772-2316; Catchpole, Ken/0000-0003-4073-3025; McCulloch, Peter/0000-0002-3210-8273; Morgan, Lauren/0000-0001-8395-9492; New, Steve/0000-0002-0350-7902	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research programme [RP-PG-0108-10020]	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research programme(National Institute for Health Research (NIHR))	This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research programme (Reference Number RP-PG-0108-10020). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. http://www.ccf.nihr.ac.uk/Pages/Home.aspx. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catchpole K, 2009, SAFER SURG ANAL BEHA, pxxvi; Catchpole Ken R, 2010, J Patient Saf, V6, P180, DOI 10.1097/PTS.0b013e3181f100ea; Chalwin RP, 2013, INTERN MED J, V43, P962, DOI 10.1111/imj.12172; Christian CK, 2006, SURGERY, V139, P159, DOI 10.1016/j.surg.2005.07.037; Dekker Sidney, 2012, JUST CULTURE BALANCI; Fletcher G, 2003, BRIT J ANAESTH, V90, P580, DOI 10.1093/bja/aeg112; Flin R., 2005, CONT ISSUES HUMAN FA, P133; Flin R, 2011, BEST PRACT RES-CLIN, V25, P215, DOI 10.1016/j.bpa.2011.02.005; Greenberg CC, 2007, J AM COLL SURGEONS, V204, P533, DOI 10.1016/j.jamcollsurg.2007.01.010; Hadi M, 2011, INT J SURG, V9, P538; Healey AN, 2006, ERGONOMICS, V49, P589, DOI 10.1080/00140130600568899; Hollnagel E., 2007, RESILIENCE ENG CONCE; Hull L, 2011, J AM COLL SURGEONS, V212, P234, DOI 10.1016/j.jamcollsurg.2010.11.001; Kemper PF, 2013, BMJ QUAL SAF, V22, P586, DOI 10.1136/bmjqs-2012-001451; Kennedy TJT, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b128; Leonard M, 2004, QUAL SAF HEALTH CARE, V13, pI85, DOI 10.1136/qshc.2004.010033; Lingard L, 2004, QUAL SAF HEALTH CARE, V13, P330, DOI 10.1136/qshc.2003.008425; Lingard L, 2002, ACAD MED, V77, P232, DOI 10.1097/00001888-200203000-00013; McCulloch P, 2009, QUAL SAF HEALTH CARE, V18, P109, DOI 10.1136/qshc.2008.032045; Mishra A, 2009, QUAL SAF HEALTH CARE, V18, P104, DOI 10.1136/qshc.2007.024760; Mitchell L, 2011, P HUMAN FACTORS ERGO, V55, P690; Mitchell L, 2012, INT J NURS STUD, V49, P201, DOI 10.1016/j.ijnurstu.2011.08.012; Morgan L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003519; Niitsu H, 2013, SURG TODAY, V43, P271, DOI 10.1007/s00595-012-0313-7; Pickering SP, 2013, BRIT J SURG, V100, P1664, DOI 10.1002/bjs.9305; Reason J, 1995, Qual Health Care, V4, P80, DOI 10.1136/qshc.4.2.80; Robertson E, 2011, INT J SURG, V9, P549; Rosenstein AH, 2006, J AM COLL SURGEONS, V203, P96, DOI 10.1016/j.jamcollsurg.2006.03.027; Sevdalis N, 2008, AM J SURG, V196, P184, DOI 10.1016/j.amjsurg.2007.08.070; Sexton JB, 2000, BMJ-BRIT MED J, V320, P745, DOI 10.1136/bmj.320.7237.745; Sharma B, 2011, SURG ONCOL, V20, P169, DOI 10.1016/j.suronc.2010.10.001; Yule S, 2008, WORLD J SURG, V32, P548, DOI 10.1007/s00268-007-9320-z	33	73	76	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90320	10.1371/journal.pone.0090320	http://dx.doi.org/10.1371/journal.pone.0090320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594911	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500043
J	Shi, Y; Liu, C; Liu, X; Tang, DG; Wang, JC				Shi, Yang; Liu, Can; Liu, Xin; Tang, Dean G.; Wang, Junchen			The microRNA miR-34a Inhibits Non-Small Cell Lung Cancer (NSCLC) Growth and the CD44(hi) Stem-Like NSCLC Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; SIDE POPULATION; EXPRESSION; METASTASIS; APOPTOSIS; MIRNAS; LINES; CYCLE	Lung cancer is among the most lethal malignancies with a high metastasis and recurrence rate, which is probably due to the existence of lung cancer stem cells (CSCs). CSCs in many tumors including non-small cell lung cancer (NSCLC) have been identified using adhesion molecular CD44, either individually or in combination with other marker(s). MicroRNAs (miRNAs) regulate both normal stem cells and CSCs and dysregulation of miRNAs has been implicated in tumorigenesis. Recently, miR-34a was found to be downregulated in NSCLC cells but the biological functions of miR-34a in regulating NSCLC cell behavior have not been extensively studied. Here we show that transfection of synthetic miR-34a, but not the negative control (NC) miRNA oligonucleotides (oligos) in three NSCLC cell lines, i.e., A549, H460, and H1299, inhibited their holoclone formation, clonogenic expansion, and tumor regeneration in vivo. Furthermore, the lentiviral vector-mediated overexpression of miR-34a in purified CD44(hi) H460 cells also inhibited tumor outgrowth. In contrast, expression of miR-34a antagomirs (i.e., antisense oligos) in the CD44(lo) H460 cells promoted tumor development. Our study shows that miR-34a is a negative regulator of the tumorigenic properties of NSCLC cells and CD44(hi) lung CSCs, and establishes a strong rationale for developing miR-34a as a novel therapeutic agent against NSCLC.	[Shi, Yang; Wang, Junchen] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Pathol, Shanghai 200092, Peoples R China; [Shi, Yang; Liu, Can; Liu, Xin; Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Shi, Yang; Tang, Dean G.; Wang, Junchen] Tongji Univ, Sch Med, Shanghai East Hosp, Canc Stem Cell Inst,Res Ctr Translat Med, Shanghai 200092, Peoples R China	Tongji University; University of Texas System; UTMD Anderson Cancer Center; Tongji University	Wang, JC (corresponding author), Tongji Univ, Sch Med, Shanghai East Hosp, Dept Pathol, Shanghai 200092, Peoples R China.	jeancwangdfyy@gmail.com	Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174	National Natural Science Foundation of China [81141096, 81372512]; Key Project Fund of Shanghai Science and Technology association, China [05119554]; NIH [R01-CA155693]; Department of Defense [PC120817]; CPRIT [RP120380]; MDACC Center for Cancer Epigenetics; RNA Center-Laura & John Arnold Foundation; DOD [PC121553]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project Fund of Shanghai Science and Technology association, China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); CPRIT; MDACC Center for Cancer Epigenetics; RNA Center-Laura & John Arnold Foundation; DOD(United States Department of Defense)	This study was supported by the National Natural Science Foundation of China(Grant No. 81141096 and Grant No. 81372512) and the Key Project Fund of Shanghai Science and Technology association, China (Grant No. 05119554) to J. Wang, and NIH (R01-CA155693), Department of Defense (PC120817), CPRIT (RP120380), and the MDACC Center for Cancer Epigenetics and RNA Center-Laura & John Arnold Foundation grants to DG. Tang. C. Liu was supported, in part, by a DOD post-doctoral fellowship (PC121553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandi N, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-55; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Chen F, 2012, J BIOCHEM MOL TOXIC, V26, P79, DOI 10.1002/jbt.20412; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Das B, 2008, STEM CELLS, V26, P1818, DOI 10.1634/stemcells.2007-0724; Di Martino MT, 2012, CLIN CANCER RES, V18, P6260, DOI 10.1158/1078-0432.CCR-12-1708; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Duan WM, 2013, J RADIAT RES, V54, P611, DOI 10.1093/jrr/rrs136; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Garofalo M, 2011, ANNU REV PHARMACOL, V51, P25, DOI 10.1146/annurev-pharmtox-010510-100517; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kumar B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037601; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Li LS, 2013, CLIN EXP MED, V13, P109, DOI 10.1007/s10238-012-0186-5; Liu C, 2012, CANCER RES, V72, P3393, DOI 10.1158/0008-5472.CAN-11-3864; Liu C, 2011, CANCER RES, V71, P5950, DOI 10.1158/0008-5472.CAN-11-1035; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Pang RTK, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-25; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Sell S, 2010, AM J PATHOL, V176, P2584, DOI 10.2353/ajpath.2010.091064; Shi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033358; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Tang DG, 2012, CELL RES, V22, P457, DOI 10.1038/cr.2012.13; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang X, 2013, CANCER BIOTHER RADIO, V28, P45, DOI 10.1089/cbr.2012.1218; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Yan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033778; Yang S, 2013, ONCOGENE, V32, P4294, DOI 10.1038/onc.2012.432; Zhao HE, 2013, ONCOL REP, V29, P1027, DOI 10.3892/or.2013.2234	34	97	104	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90022	10.1371/journal.pone.0090022	http://dx.doi.org/10.1371/journal.pone.0090022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595209	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500030
J	Tian, FM; Greplova, M; Frebort, I; Dale, N; Napier, R				Tian, Faming; Greplova, Marta; Frebort, Ivo; Dale, Nicholas; Napier, Richard			A Highly Selective Biosensor with Nanomolar Sensitivity Based on Cytokinin Dehydrogenase	PLOS ONE			English	Article							GLASSY-CARBON ELECTRODE; FLOW-INJECTION ANALYSIS; ZEATIN-TYPE CYTOKININS; MICROELECTRODE BIOSENSOR; SENSOR; NADH; 2,6-DICHLOROPHENOLINDOPHENOL; BIOSYNTHESIS; LOCALIZATION; PERFORMANCE	We have developed a N-6-dimethylallyladenine (cytokinin) dehydrogenase-based microbiosensor for real-time determination of the family of hormones known as cytokinins. Cytokinin dehydrogenase from Zea mays (ZmCKX1) was immobilised concurrently with electrodeposition of a silica gel film on the surface of a Pt microelectrode, which was further functionalized by free electron mediator 2,6-dichlorophenolindophenol (DCPIP) in supporting electrolyte to give a bioactive film capable of selective oxidative cleavage of the N-6- side chain of cytokinins. The rapid electron shuffling between freely diffusible DCPIP and the FAD redox group in ZmCKX1 endowed the microbiosensor with a fast response time of less than 10 s. The immobilised ZmCKX1 retained a high affinity for its preferred substrate N-6-(Delta(2)-isopentenyl) adenine (iP), and gave the miniaturized biosensor a large linear dynamic range from 10 nM to 10 mu M, a detection limit of 3.9 nM and a high sensitivity to iP of 603.3 mu AmM(-1)cm(-2) (n = 4, R-2 = 0.9999). Excellent selectivity was displayed for several other aliphatic cytokinins and their ribosides, including N-6-(Delta(2)-isopentenyl) adenine, N-6-(Delta(2)-isopentenyl) adenosine, cis-zeatin, trans-zeatin and trans-zeatin riboside. Aromatic cytokinins and metabolites such as cytokinin glucosides were generally poor substrates. The microbiosensors exhibited excellent stability in terms of pH and long-term storage and have been used successfully to determine low nanomolar cytokinin concentrations in tomato xylem sap exudates.	[Tian, Faming; Dale, Nicholas; Napier, Richard] Univ Warwick, Warwick Biosensor Grp, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Greplova, Marta; Frebort, Ivo] Palacky Univ, Dept Mol Biol, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic	University of Warwick; Palacky University Olomouc	Dale, N (corresponding author), Univ Warwick, Warwick Biosensor Grp, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	n.e.dale@warwick.ac.uk; Richard.Napier@warwick.ac.uk	Frébort, Ivo/G-6382-2018; Dale, Nicholas/C-7772-2011	Frébort, Ivo/0000-0002-4032-4961; Dale, Nicholas/0000-0003-2196-2949	BBSRC fund [BB/I023933/1]; Operational Program Education for Competitiveness - European Social Fund [CZ.1.07/2.3.00/20.0165]; BBSRC [BB/I023933/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I023933/1] Funding Source: researchfish	BBSRC fund(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Operational Program Education for Competitiveness - European Social Fund(European Social Fund (ESF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the BBSRC fund (award ref. BB/I023933/1) and the Operational Program Education for Competitiveness - European Social Fund (project CZ.1.07/2.3.00/20.0165 to I.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alferov SV, 2006, RUSS J ELECTROCHEM+, V42, P403, DOI 10.1134/S1023193506040185; Bilyeu KD, 2001, PLANT PHYSIOL, V125, P378, DOI 10.1104/pp.125.1.378; Brunoud G, 2012, NATURE, V482, P103, DOI 10.1038/nature10791; Chikkaveeraiah BV, 2009, ELECTROCHEM COMMUN, V11, P819, DOI 10.1016/j.elecom.2009.02.002; Dale N, 2012, PURINERG SIGNAL, V8, pS27, DOI 10.1007/s11302-011-9273-4; DAVIS GC, 1985, ANAL CHEM, V57, pA638, DOI 10.1021/ac00283a001; Dicu D, 2003, ANAL LETT, V36, P1755, DOI 10.1081/AL-120023613; Florou AB, 2000, ANAL CHIM ACTA, V409, P113, DOI 10.1016/S0003-2670(00)00709-1; Florou AB, 1998, ELECTROANAL, V10, P1261, DOI 10.1002/(SICI)1521-4109(199812)10:18<1261::AID-ELAN1261>3.0.CO;2-M; Frebortova J, 2007, BIOL PLANTARUM, V51, P673, DOI 10.1007/s10535-007-0141-6; Frebortova J, 2004, BIOCHEM J, V380, P121, DOI 10.1042/BJ20031813; Gajdosova S, 2011, J EXP BOT, V62, P2827, DOI 10.1093/jxb/erq457; Galuszka P, 2005, PLANT CELL PHYSIOL, V46, P716, DOI 10.1093/pcp/pci074; Hassan RYA, 2011, ANAL BIOCHEM, V419, P26, DOI 10.1016/j.ab.2011.07.025; HERNANDEZ L, 1995, ANAL CHIM ACTA, V315, P33, DOI 10.1016/0003-2670(95)00290-G; Hernandez P, 1997, ELECTROANAL, V9, P235, DOI 10.1002/elan.1140090309; Hirose N, 2008, J EXP BOT, V59, P75, DOI 10.1093/jxb/erm157; Hwang I, 2006, PHYSIOL PLANTARUM, V126, P528, DOI 10.1111/j.1399-3054.2006.00665.x; Kim HJ, 2006, SENSOR ACTUAT B-CHEM, V119, P143, DOI 10.1016/j.snb.2005.12.013; Kopecny D, 2008, J MOL BIOL, V380, P886, DOI 10.1016/j.jmb.2008.05.044; Kowalska M, 2011, ANAL CHIM ACTA, V701, P218, DOI 10.1016/j.aca.2011.06.018; Kudoyarova GR, 2007, J EXP BOT, V58, P161, DOI 10.1093/jxb/erl116; Li J, 2003, ANAL BIOCHEM, V321, P89, DOI 10.1016/S0003-2697(03)00427-5; Llaudet E, 2005, ANAL CHEM, V77, P3267, DOI 10.1021/ac048106q; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Munteanu FD, 2001, J ELECTROANAL CHEM, V509, P2, DOI 10.1016/S0022-0728(01)00376-X; Novak O, 2003, ANAL CHIM ACTA, V480, P207, DOI 10.1016/S0003-2670(03)00025-4; Novak O, 2008, PHYTOCHEMISTRY, V69, P2214, DOI 10.1016/j.phytochem.2008.04.022; Perez FG, 1998, ANAL CHEM, V70, P2380, DOI 10.1021/ac970715t; Popelkova H, 2006, BIOCHEM J, V398, P113, DOI 10.1042/BJ20060280; Smehilova M, 2009, J EXP BOT, V60, P2701, DOI 10.1093/jxb/erp126; Svacinova J, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-17; TANG HT, 1991, ANAL BIOCHEM, V192, P243, DOI 10.1016/0003-2697(91)90215-F; Tian F, 2007, ANAL CHEM, V79, P6760, DOI 10.1021/ac070822f; Tian FM, 2009, ANAL CHIM ACTA, V645, P86, DOI 10.1016/j.aca.2009.04.048; Vlasakova V, 1998, J PHARMACEUT BIOMED, V17, P39, DOI 10.1016/S0731-7085(97)00151-9; Voss U, 2013, INT J DEV BIOL, V57, P525, DOI 10.1387/ijdb.130208dw; Wall M, 2010, PURINERG SIGNAL, V6, P339, DOI 10.1007/s11302-010-9185-8; Witters E, 1999, PHYTOCHEM ANALYSIS, V10, P143, DOI 10.1002/(SICI)1099-1565(199905/06)10:3&lt;143::AID-PCA441&gt;3.0.CO;2-G; Zurcher E, 2013, PLANT PHYSIOL, V161, P1066, DOI 10.1104/pp.112.211763	40	1	2	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90877	10.1371/journal.pone.0090877	http://dx.doi.org/10.1371/journal.pone.0090877			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595403	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500108
J	van Diepen, M; Schroijen, MA; Dekkers, OM; Rotmans, JI; Krediet, RT; Boeschoten, EW; Dekker, FW				van Diepen, Merel; Schroijen, Marielle A.; Dekkers, Olaf M.; Rotmans, Joris I.; Krediet, Raymond T.; Boeschoten, Elisabeth W.; Dekker, Friedo W.			Predicting Mortality in Patients with Diabetes Starting Dialysis	PLOS ONE			English	Article							STAGE RENAL-DISEASE; MULTIPLE IMPUTATION; PERITONEAL-DIALYSIS; PROGNOSTIC MODELS; HEMODIALYSIS; RISK; SURVIVAL; ADEQUACY; OUTCOMES; IMPACT	Background: While some prediction models have been developed for diabetic populations, prediction rules for mortality in diabetic dialysis patients are still lacking. Therefore, the objective of this study was to identify predictors for 1-year mortality in diabetic dialysis patients and use these results to develop a prediction model. Methods: Data were used from the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD), a multicenter, prospective cohort study in which incident patients with end stage renal disease (ESRD) were monitored until transplantation or death. For the present analysis, patients with DM at baseline were included. A prediction algorithm for 1-year all-cause mortality was developed through multivariate logistic regression. Candidate predictors were selected based on literature and clinical expertise. The final model was constructed through backward selection. The model's predictive performance, measured by calibration and discrimination, was assessed and internally validated through bootstrapping. Results: A total of 394 patients were available for statistical analysis; 82 (21%) patients died within one year after baseline (3 months after starting dialysis therapy). The final prediction model contained seven predictors; age, smoking, history of macrovascular complications, duration of diabetes mellitus, Karnofsky scale, serum albumin and hemoglobin level. Predictive performance was good, as shown by the c-statistic of 0.810. Internal validation showed a slightly lower, but still adequate performance. Sensitivity analyses showed stability of results. Conclusions: A prediction model containing seven predictors has been identified in order to predict 1-year mortality for diabetic incident dialysis patients. Predictive performance of the model was good. Before implementing the model in clinical practice, for example for counseling patients regarding their prognosis, external validation is necessary.	[van Diepen, Merel; Schroijen, Marielle A.; Dekkers, Olaf M.; Dekker, Friedo W.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Schroijen, Marielle A.; Dekkers, Olaf M.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands; [Rotmans, Joris I.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Krediet, Raymond T.] Univ Amsterdam, Acad Med Ctr, Dept Nephrol, NL-1105 AZ Amsterdam, Netherlands; [Boeschoten, Elisabeth W.] Hans Mak Inst, Naarden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	Schroijen, MA (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands.	m.a.schroijen@lumc.nl	Krediet, Raymond/AAP-3291-2021; Rotmans, Joris I./G-8866-2014; Dekker, Friedo W/B-6452-2011; Krediet, Raymond/GLT-2390-2022	Rotmans, Joris I./0000-0001-9682-6234; Dekker, Friedo W/0000-0002-2433-2494; Krediet, Raymond/0000-0002-9851-8507; Dekkers, Olaf/0000-0002-1333-7580	CTMM, the Center for Translational Molecular Medicine, project PREDICCt [01C-104]; Dutch Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation [E.018]; Dutch National Health Insurance Board [OG97/005]	CTMM, the Center for Translational Molecular Medicine, project PREDICCt; Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Dutch National Health Insurance Board	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project PREDICCt (grant 01C-104), and supported by the Dutch Heart Foundation, Dutch Diabetes Research Foundation and Dutch Kidney Foundation. This study was supported by grants from the Dutch Kidney Foundation (E.018) and the Dutch National Health Insurance Board (OG97/005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Bazeley J, 2011, CLIN J AM SOC NEPHRO, V6, P2452, DOI 10.2215/CJN.00710111; Berhane AM, 2011, CLIN J AM SOC NEPHRO, V6, P2444, DOI 10.2215/CJN.00580111; Bos WJW, 2010, J HYPERTENS, V28, P439, DOI 10.1097/HJH.0b013e3283349a3c; Brotman DJ, 2005, ARCH INTERN MED, V165, P138, DOI 10.1001/archinte.165.2.138; COX DR, 1958, BIOMETRIKA, V45, P562, DOI 10.1093/biomet/45.3-4.562; de Goeij MCM, 2013, NEPHROL DIAL TRANSPL, V28, P2415, DOI 10.1093/ndt/gft221; Desai AS, 2011, AM J KIDNEY DIS, V58, P717, DOI 10.1053/j.ajkd.2011.05.020; Efron B., 1994, INTRO BOOTSTRAP; Forsblom C, 2011, J AM SOC NEPHROL, V22, P537, DOI 10.1681/ASN.2010020194; Goodkin DA, 2004, AM J KIDNEY DIS, V44, pS16, DOI 10.1053/j.akjd.2004.08.006; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HARRELL FE, 2009, DESIGN PACKAGE R PAC; Hill CJ, 2014, AM J KIDNEY DIS, V63, P84, DOI 10.1053/j.ajkd.2013.06.020; Holme I, 2012, J INTERN MED, V271, P463, DOI 10.1111/j.1365-2796.2011.02435.x; Keane WF, 2006, CLIN J AM SOC NEPHRO, V1, P761, DOI 10.2215/CJN.01381005; Kenward MG, 2007, STAT METHODS MED RES, V16, P199, DOI 10.1177/0962280206075304; Liem YS, 2007, KIDNEY INT, V71, P153, DOI 10.1038/sj.ki.5002014; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; R Core Team, 2020, R LANG ENV STAT COMP; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Rubin DB, 2004, MULTIPLE IMPUTATION; Sarnak MJ, 2003, AM J KIDNEY DIS, V41, pS11, DOI 10.1016/S0272-6386(03)00372-X; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Stel VS, 2011, CLIN KIDNEY J, V4, P1, DOI 10.1093/ndtplus/sfq191; Steyerberg E., 2012, CLIN PREDICTION MODE; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Termorshuizen F, 2003, J AM SOC NEPHROL, V14, P2851, DOI 10.1097/01.ASN.0000091585.45723.9E; Tripepi G, 2008, KIDNEY INT, V74, P1512, DOI 10.1038/ki.2008.416; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Van Dijk PCW, 2005, KIDNEY INT, V67, P1489, DOI 10.1111/j.1523-1755.2005.00227.x; van Manen JG, 2002, AM J KIDNEY DIS, V40, P82, DOI 10.1053/ajkd.2002.33916; Villar E, 2007, DIABETES CARE, V30, P3070, DOI 10.2337/dc07-0895; Vonesh EF, 2004, KIDNEY INT, V66, P2389, DOI 10.1111/j.1523-1755.2004.66028.x; Vupputuri S, 2011, DIABETES RES CLIN PR, V91, P246, DOI 10.1016/j.diabres.2010.11.022; Wagner M, 2011, AM J KIDNEY DIS, V57, P894, DOI 10.1053/j.ajkd.2010.12.023	37	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89744	10.1371/journal.pone.0089744	http://dx.doi.org/10.1371/journal.pone.0089744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594735	Green Submitted, gold, Green Published			2022-12-27	WOS:000332475500021
J	Al-Ansari, MM; Aboussekhra, A				Al-Ansari, Mysoon M.; Aboussekhra, Abdelilah			Caffeine Mediates Sustained Inactivation of Breast Cancer-Associated Myofibroblasts via Up-Regulation of Tumor Suppressor Genes	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CELL MOTILITY; FIBROBLASTS; EXPRESSION; PROTEIN; PTEN; ANGIOGENESIS; COFFEE; TEA	Background: Active cancer-associated fibroblasts (CAFs) or myofibroblasts play important roles not only in the development and progression of breast carcinomas, but also in their prognosis and treatment. Therefore, targeting these cells through suppressing their supportive procarcinogenic paracrine effects is mandatory for improving the current therapies that are mainly targeting tumor cells. To this end, we investigated the effect of the natural and pharmacologically safe molecule, caffeine, on CAF cells and their various procarcinogenic effects. Methodology/Principal Findings: We have shown here that caffeine up-regulates the tumor suppressor proteins p16, p21, p53 and Cav-1, and reduces the expression/secretion of various cytokines (IL-6, TGF-beta, SDF-1 and MMP-2), and down-regulates alpha-SMA. Furthermore, caffeine suppressed the migratory/invasiveness abilities of CAF cells through PTEN-dependent Akt/Erk1/2 inactivation. Moreover, caffeine reduced the paracrine pro-invasion/-migration effects of CAF cells on breast cancer cells. These results indicate that caffeine can inactivate breast stromal myofibroblasts. This has been confirmed by showing that caffeine also suppresses the paracrine pro-angiogenic effect of CAF cells through down-regulating HIF-1 alpha and its downstream effector VEGF-A. Interestingly, these effects were sustained in absence of caffeine. Conclusion/Significance: The present findings provide a proof of principle that breast cancer myofibroblasts can be inactivated, and thereby caffeine may provide a safe and effective prevention against breast tumor growth/recurrence through inhibition of the procarcinogenic effects of active stromal fibroblasts.	[Al-Ansari, Mysoon M.] King Saud Univ, Fac Sci & Med Studies, Dept Microbiol, Riyadh, Saudi Arabia; [Aboussekhra, Abdelilah] King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, Riyadh 11211, Saudi Arabia	King Saud University; King Faisal Specialist Hospital & Research Center	Aboussekhra, A (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, Riyadh 11211, Saudi Arabia.	aboussekhra@kfshrc.edu.sa	Al-Ansari, Mysoon M/X-3875-2018; Al-Ansari, Mysoon/K-1915-2013	Al-Ansari, Mysoon M/0000-0002-2501-691X; Al-Ansari, Mysoon/0000-0002-2501-691X	KFSH&RC (King Faisal Specialist Hospital & Research Center)	KFSH&RC (King Faisal Specialist Hospital & Research Center)	This work was supported by KFSH&RC (King Faisal Specialist Hospital & Research Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel EL, 2007, EUR J CANCER PREV, V16, P446, DOI 10.1097/01.cej.0000243850.59362.73; Aboussekhra A, 2011, INT J DEV BIOL, V55, P841, DOI 10.1387/ijdb.113362aa; Al-Ansari MM, 2013, ONCOGENE, V32, P2356, DOI 10.1038/onc.2012.270; Al-Ansari MM, 2012, NEOPLASIA, V14, P1269, DOI 10.1593/neo.121632; Al-Mohanna MA, 2007, NUCLEIC ACIDS RES, V35, P223, DOI 10.1093/nar/gkl1075; Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Berra E, 2000, CANCER METAST REV, V19, P139, DOI 10.1023/A:1026506011458; BLANCHARD J, 1983, EUR J CLIN PHARMACOL, V24, P93, DOI 10.1007/BF00613933; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Bode AM, 2007, CANCER LETT, V247, P26, DOI 10.1016/j.canlet.2006.03.032; Conney AH, 2007, TOXICOL APPL PHARM, V224, P209, DOI 10.1016/j.taap.2006.11.001; D'Anello L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-300; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Farhang Ghahremani M, 2013, CELL DEATH DIFFER, V20, P888, DOI 10.1038/cdd.2013.12; Foukas LC, 2002, J BIOL CHEM, V277, P37124, DOI 10.1074/jbc.M202101200; Franco OE, 2010, SEMIN CELL DEV BIOL, V21, P33, DOI 10.1016/j.semcdb.2009.10.010; Ganmaa D, 2008, INT J CANCER, V122, P2071, DOI 10.1002/ijc.23336; Hashimoto T, 2004, CANCER RES, V64, P3344, DOI 10.1158/0008-5472.CAN-03-3453; Hawsawi NM, 2008, CANCER RES, V68, P2717, DOI 10.1158/0008-5472.CAN-08-0192; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Ku BM, 2011, MOL CELLS, V31, P275, DOI 10.1007/s10059-011-0027-5; LELO A, 1986, CLIN PHARMACOL THER, V39, P54, DOI 10.1038/clpt.1986.10; Li H, 2013, ANAT CELL BIOL, V46, P57, DOI 10.5115/acb.2013.46.1.57; Lou YR, 1999, NUTR CANCER, V33, P146, DOI 10.1207/S15327914NC330205; Merdzhanova G, 2010, ONCOGENE, V29, P5392, DOI 10.1038/onc.2010.281; Merighi S, 2007, MOL PHARMACOL, V72, P395, DOI 10.1124/mol.106.032920; Milanini J, 1998, J BIOL CHEM, V273, P18165, DOI 10.1074/jbc.273.29.18165; Miwa S, 2011, INT J ONCOL, V39, P465, DOI 10.3892/ijo.2011.1051; Moskovits N, 2006, CANCER RES, V66, P10671, DOI 10.1158/0008-5472.CAN-06-2323; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Okano JI, 2008, BASIC CLIN PHARMACOL, V102, P543, DOI 10.1111/j.1742-7843.2008.00231.x; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pinto MP, 2010, CANCER RES, V70, P2655, DOI 10.1158/0008-5472.CAN-09-4373; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; Saiki S, 2011, AUTOPHAGY, V7, P176, DOI 10.4161/auto.7.2.14074; Shimoda M, 2010, SEMIN CELL DEV BIOL, V21, P19, DOI 10.1016/j.semcdb.2009.10.002; Skinner HD, 2004, J BIOL CHEM, V279, P45643, DOI 10.1074/jbc.M404097200; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Wang FS, 2004, J BIOL CHEM, V279, P10331, DOI 10.1074/jbc.M308013200; Weng LP, 2001, HUM MOL GENET, V10, P605, DOI 10.1093/hmg/10.6.605; WOLFROM DM, 1991, BREAST CANCER RES TR, V19, P269, DOI 10.1007/BF01961163; Xin H, 2012, MOL CANCER RES, V10, P108, DOI 10.1158/1541-7786.MCR-11-0435; Yang HY, 2004, CLIN EXP METASTAS, V21, P719, DOI 10.1007/s10585-004-8251-4; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033	46	26	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90907	10.1371/journal.pone.0090907	http://dx.doi.org/10.1371/journal.pone.0090907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595168	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900157
J	Kluver, N; Ortmann, J; Paschke, H; Renner, P; Ritter, AP; Scholz, S				Kluever, Nils; Ortmann, Julia; Paschke, Heidrun; Renner, Patrick; Ritter, Axel P.; Scholz, Stefan			Transient Overexpression of adh8a Increases Allyl Alcohol Toxicity in Zebrafish Embryos	PLOS ONE			English	Article							DEVELOPMENTAL TOXICITY; ALTERNATIVE METHOD; LIFE STAGES; ASSAY; METABOLISM; ACTIVATION; PREDICTION; RERIO; TERM	Fish embryos are widely used as an alternative model to study toxicity in vertebrates. Due to their complexity, embryos are believed to more resemble an adult organism than in vitro cellular models. However, concerns have been raised with respect to the embryo's metabolic capacity. We recently identified allyl alcohol, an industrial chemical, to be several orders of magnitude less toxic to zebrafish embryo than to adult zebrafish (embryo LC50 = 478 mg/L vs. fish LC50 = 0.28 mg/L). Reports on mammals have indicated that allyl alcohol requires activation by alcohol dehydrogenases (Adh) to form the highly reactive and toxic metabolite acrolein, which shows similar toxicity in zebrafish embryos and adults. To identify if a limited metabolic capacity of embryos indeed can explain the low allyl alcohol sensitivity of zebrafish embryos, we compared the mRNA expression levels of Adh isoenzymes (adh5, adh8a, adh8b and adhfe1) during embryo development to that in adult fish. The greatest difference between embryo and adult fish was found for adh8a and adh8b expression. Therefore, we hypothesized that these genes might be required for allyl alcohol activation. Microinjection of adh8a, but not adh8b mRNA led to a significant increase of allyl alcohol toxicity in embryos similar to levels reported for adults (LC50 = 0.42 mg/L in adh8a mRNA-injected embryos). Furthermore, GC/MS analysis of adh8a-injected embryos indicated a significant decline of internal allyl alcohol concentrations from 0.23-58 ng/embryo to levels below the limit of detection (<4.6 mu g/L). Injection of neither adh8b nor gfp mRNA had an impact on internal allyl alcohol levels supporting that the increased allyl alcohol toxicity was mediated by an increase in its metabolization. These results underline the necessity to critically consider metabolic activation in the zebrafish embryo. As demonstrated here, mRNA injection is one useful approach to study the role of candidate enzymes involved in metabolization.	[Kluever, Nils; Ortmann, Julia; Renner, Patrick; Scholz, Stefan] UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Leipzig, Germany; [Paschke, Heidrun; Ritter, Axel P.] UFZ Helmholtz Ctr Environm Res, Dept Analyt Chem, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Kluver, N (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Leipzig, Germany.	nils.kluever@ufz.de	Scholz, Stefan/B-7776-2014; Klüver, Nils/D-8678-2015	Scholz, Stefan/0000-0002-6990-4716; 	CEFIC-LRI/DEFRA-UK (European Chemical Industry Council Long-range Research Initiative/ Department for Environment, Food and Rural Affairs); Federal Ministry of Education and Research (BMBF) GenDarT2 [PTJ-BIO/0315190]	CEFIC-LRI/DEFRA-UK (European Chemical Industry Council Long-range Research Initiative/ Department for Environment, Food and Rural Affairs); Federal Ministry of Education and Research (BMBF) GenDarT2(Federal Ministry of Education & Research (BMBF))	This work was partially supported by a CEFIC-LRI/DEFRA-UK (European Chemical Industry Council Long-range Research Initiative/ Department for Environment, Food and Rural Affairs) research grant and by the Federal Ministry of Education and Research (BMBF) GenDarT2 [PTJ-BIO/0315190]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton W, 2010, XENOBIOTICA, V40, P547, DOI 10.3109/00498254.2010.493960; Ali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021076; [Anonymous], 2006, ISO15088; ATZORI L, 1989, Drug Metabolism and Drug Interactions, V7, P295; Auerbach SS, 2008, TOXICOLOGY, V253, P79, DOI 10.1016/j.tox.2008.08.014; BORENFREUND E, 1987, CANCER LETT, V34, P243, DOI 10.1016/0304-3835(87)90173-X; Brannen KC, 2010, BIRTH DEFECTS RES B, V89, P66, DOI 10.1002/bdrb.20223; Busquet F, 2008, TOXICOL SCI, V104, P177, DOI 10.1093/toxsci/kfn065; Cai J, 2009, CHEM RES TOXICOL, V22, P708, DOI 10.1021/tx800465m; Clements R.G., 1994, EPA748R93002 OFF POL, V7403; Cowan-Ellsberry CE, 2008, CHEMOSPHERE, V70, P1804, DOI 10.1016/j.chemosphere.2007.08.030; Embry MR, 2010, AQUAT TOXICOL, V97, P79, DOI 10.1016/j.aquatox.2009.12.008; Escher BI, 2011, CHEM RES TOXICOL, V24, P1134, DOI 10.1021/tx200114y; FLOURIOT G, 1993, J CELL SCI, V105, P407; Geiger DLB L. T., 1990, ACUTE TOXICITIES ORG; GOLDSTEIN JA, 1993, ENVIRON HEALTH PERSP, V100, P169, DOI 10.2307/3431523; Gustafson AL, 2012, REPROD TOXI IN PRESS; Henn K, 2011, COMP BIOCHEM PHYS C, V153, P91, DOI 10.1016/j.cbpc.2010.09.003; Hoke RA, 2005, ENVIRON TOXICOL CHEM, V24, P2677, DOI 10.1897/04-506R.1; Knobel M, 2012, ENVIRON SCI TECHNOL, V46, P9690, DOI 10.1021/es301729q; Kramer NI, 2009, TOXICOL IN VITRO, V23, P1372, DOI 10.1016/j.tiv.2009.07.029; Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006; Madden JC, 2006, EXPERT OPIN DRUG MET, V2, P545, DOI 10.1517/17425255.2.4.545; NAGEL R, 1991, ECOTOX ENVIRON SAFE, V21, P157, DOI 10.1016/0147-6513(91)90017-J; Padilla S, 2012, REPROD TOXI IN PRESS; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reimers MJ, 2006, NEUROTOXICOL TERATOL, V28, P497, DOI 10.1016/j.ntt.2006.05.007; Reimers MJ, 2004, J BIOL CHEM, V279, P38303, DOI 10.1074/jbc.M401165200; Reimers MJ, 2004, NEUROTOXICOL TERATOL, V26, P769, DOI 10.1016/j.ntt.2004.06.012; Russom CL, 1997, ENVIRON TOXICOL CHEM, V16, P948, DOI 10.1002/etc.5620160514; Schirmer K, 2008, AQUAT TOXICOL, V90, P128, DOI 10.1016/j.aquatox.2008.08.005; Selderslaghs IWT, 2012, REPROD TOXICOL, V33, P142, DOI 10.1016/j.reprotox.2011.08.003; Selderslaghs IWT, 2009, REPROD TOXICOL, V28, P308, DOI 10.1016/j.reprotox.2009.05.004; Spielmann H, 2006, ATLA-ALTERN LAB ANIM, V34, P527, DOI 10.1177/026119290603400504; Strahle U, 2012, REPROD TOXICOL, V33, P128, DOI 10.1016/j.reprotox.2011.06.121; Tanneberger K, 2013, ENVIRON SCI TECHNOL, V47, P1110, DOI 10.1021/es303505z; Tao T, 2009, J GENET GENOMICS, V36, P325, DOI 10.1016/S1673-8527(08)60121-6; Weigt S, 2011, TOXICOLOGY, V281, P25, DOI 10.1016/j.tox.2011.01.004	38	17	17	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90619	10.1371/journal.pone.0090619	http://dx.doi.org/10.1371/journal.pone.0090619			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594943	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900125
J	Maeda, R; Suzuki, H; Tanaka, Y; Tamura, T				Maeda, Ryo; Suzuki, Hidefumi; Tanaka, Yuta; Tamura, Taka-aki			Interaction between Transactivation Domain of p53 and Middle Part of TBP-Like Protein (TLP) Is Involved in TLP-Stimulated and p53-Activated Transcription from the p21 Upstream Promoter	PLOS ONE			English	Article							TATA-BINDING PROTEIN; DNA-DAMAGE; ACTIVATION DOMAIN; TUMOR SUPPRESSION; CELL-CYCLE; IN-VIVO; GENE; DIFFERENTIATION; TLP/TRF2/TLF; EXPRESSION	TBP-like protein (TLP) is involved in transcriptional activation of an upstream promoter of the human p21 gene. TLP binds to p53 and facilitates p53-activated transcription from the upstream promoter. In this study, we clarified that in vitro affinity between TLP and p53 is about one-third of that between TBP and p53. Extensive mutation analyses revealed that the TLP-stimulated function resides in transcription activating domain 1 (TAD1) in the N-terminus of p53. Among the mutants, #22.23, which has two amino acid substitutions in TAD1, exhibited a typical mutant phenotype. Moreover, #22.23 exhibited the strongest mutant phenotype for TLP-binding ability. It is thus thought that TLP-stimulated and p53-dependent transcriptional activation is involved in TAD1 binding of TLP. #22.23 had a decreased transcriptional activation function, especially for the upstream promoter of the endogenous p21 gene, compared with wild-type p53. This mutant did not facilitate p53-dependent growth repression and etoposide-mediated cell-death as wild-type p53 does. Moreover, mutation analysis revealed that middle part of TLP, which is requited for p53 binding, is involved in TLP-stimulated and p53-dependent promoter activation and cell growth repression. These results suggest that activation of the p21 upstream promoter is mediated by interaction between specific regions of TLP and p53.	[Maeda, Ryo; Suzuki, Hidefumi; Tanaka, Yuta; Tamura, Taka-aki] Chiba Univ, Dept Biol, Grad Sch Sci, Chiba, Japan	Chiba University	Tamura, T (corresponding author), Chiba Univ, Dept Biol, Grad Sch Sci, Chiba, Japan.	ttamura@faculty.chiba-u.jp	Suzuki, Hidefumi/GRR-9474-2022		JSPS KAKENHI [24570193]; Grants-in-Aid for Scientific Research [24570193] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant Number 24570193. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Berk AJ, 2000, CELL, V103, P5, DOI 10.1016/S0092-8674(00)00098-2; Bryant GO, 1996, GENE DEV, V10, P2491, DOI 10.1101/gad.10.19.2491; Chong JA, 2005, MOL CELL BIOL, V25, P2632, DOI 10.1128/MCB.25.7.2632-2643.2005; D'Alessio JA, 2009, MOL CELL, V36, P924, DOI 10.1016/j.molcel.2009.12.011; David WM, 1999, ONCOGENE, V18, P7666; Davidson I, 2003, TRENDS BIOCHEM SCI, V28, P391, DOI 10.1016/S0968-0004(03)00117-8; Deato MDE, 2008, MOL CELL, V32, P96, DOI 10.1016/j.molcel.2008.09.009; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hochheimer A, 2002, NATURE, V420, P439, DOI 10.1038/nature01167; HORIKOSHI N, 1995, MOL CELL BIOL, V15, P227, DOI 10.1128/MCB.15.1.227; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Li AG, 2007, MOL CELL, V28, P408, DOI 10.1016/j.molcel.2007.09.006; LIU X, 1993, MOL CELL BIOL, V13, P3291, DOI 10.1128/MCB.13.6.3291; McLure KG, 1998, EMBO J, V17, P3342, DOI 10.1093/emboj/17.12.3342; Muller M, 2006, DRUG RESIST UPDATE, V9, P288, DOI 10.1016/j.drup.2007.01.001; Nakadai T, 2004, J BIOL CHEM, V279, P7447, DOI 10.1074/jbc.M305412200; Ohbayashi T, 2001, BIOCHEM BIOPH RES CO, V285, P616, DOI 10.1006/bbrc.2001.5217; Ohbayashi T, 2003, NUCLEIC ACIDS RES, V31, P2127, DOI 10.1093/nar/gkg315; Ohbayashi T, 1999, NUCLEIC ACIDS RES, V27, P750, DOI 10.1093/nar/27.3.750; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Persengiev SP, 2003, P NATL ACAD SCI USA, V100, P14887, DOI 10.1073/pnas.2036440100; Radhakrishnan SK, 2006, ONCOGENE, V25, P1812, DOI 10.1038/sj.onc.1209195; Reina JH, 2007, GENE DEV, V21, P2855, DOI 10.1101/gad.1623207; SETO E, 1992, P NATL ACAD SCI USA, V89, P12028, DOI 10.1073/pnas.89.24.12028; Shimada M, 2003, MOL CELL BIOL, V23, P4107, DOI 10.1128/MCB.23.12.4107-4120.2003; Shiraishi S, 2007, J BIOL CHEM, V282, P9017, DOI 10.1074/jbc.M611513200; Shiraishi S, 2009, GENE, V436, P115, DOI 10.1016/j.gene.2009.01.016; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Suenaga Y, 2009, J BIOL CHEM, V284, P35433, DOI 10.1074/jbc.M109.050047; Suzuki H, 2012, J BIOL CHEM, V287, P19792, DOI 10.1074/jbc.M112.369629; Tanaka Y, 2007, BIOCHEM BIOPH RES CO, V352, P21, DOI 10.1016/j.bbrc.2006.10.175; Teichmann M, 1999, P NATL ACAD SCI USA, V96, P13720, DOI 10.1073/pnas.96.24.13720; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; TRUANT R, 1993, J BIOL CHEM, V268, P2284; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145	47	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90190	10.1371/journal.pone.0090190	http://dx.doi.org/10.1371/journal.pone.0090190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594805	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900078
J	Merida, S; Sancho-Tello, M; Navea, A; Almansa, I; Muriach, M; Bosch-Morell, F				Merida, Salvador; Sancho-Tello, Maria; Navea, Amparo; Almansa, Inmaculada; Muriach, Maria; Bosch-Morell, Francisco			An Anti-Interleukin-2 Receptor Drug Attenuates T-Helper 1 Lymphocytes-Mediated Inflammation in an Acute Model of Endotoxin-Induced Uveitis	PLOS ONE			English	Article							REGULATORY T-CELLS; ANTIBODY DACLIZUMAB; AQUEOUS-HUMOR; NITRIC-OXIDE; IFN-GAMMA; EXPRESSION; CYTOKINES; INDUCTION; MACROPHAGES; GLUTATHIONE	The aim of the present study was to evaluate the anti-inflammatory efficacy of Daclizumab, an anti-interleukin-2 receptor drug, in an experimental uveitis model upon a subcutaneous injection of lipopolysaccharide into Lewis rats, a valuable model for ocular acute inflammatory processes. The integrity of the blood-aqueous barrier was assessed 24 h after endotoxin-induced uveitis by evaluating two parameters: cell count and protein concentration in aqueous humors. The histopathology of all the ocular structures (cornea, lens, sclera, choroid, retina, uvea, and anterior and posterior chambers) was also considered. Enzyme-linked immunosorbent assays of the aqueous humor samples were performed to quantify the levels of the different chemokine and cytokine proteins. Similarly, a biochemical analysis of oxidative stress-related markers was also assessed. The inflammation observed in the anterior chamber of the eyes when Daclizumab was administered with endotoxin was largely prevented since the aqueous humor protein concentration substantially lowered concomitantly with a significant reduction in the uveal and vitreous histopathological grading. Th1 lymphocytes-related cytokines, such as Interleukin-2 and Interferon-gamma, also significantly reduced with related anti-oxidant systems recovery. Daclizumab treatment in endotoxin-induced uveitis reduced Th1 lymphocytes-related cytokines, such as Interleukin-2 and Interferon gamma, by about 60-70% and presented a preventive role in endotoxin-induced oxidative stress. This antioxidant protective effect of Daclizumab may be related to several of the observed Daclizumab effects in our study, including IL-6 cytokine regulatory properties and a substantial concomitant drop in INF gamma. Concurrently, Daclizumab treatment triggered a significant reduction in both the uveal histopathological grading and protein concentration in aqueous humors, but not in cellular infiltration.	[Merida, Salvador; Almansa, Inmaculada; Bosch-Morell, Francisco] Univ CEU Cardenal Herrera, Inst Ciencias Biomed, Valencia, Spain; [Sancho-Tello, Maria] Univ Valencia, Dept Patol, Valencia, Spain; [Navea, Amparo; Bosch-Morell, Francisco] Fdn Fomento Invest Sanitaria & Biomed Comunitat V, Valencia, Spain; [Muriach, Maria] Univ Jaume 1, Unidad Predept Med, Castellon De La Plana, Spain	Universidad CEU Cardenal Herrera; University of Valencia; Universitat Jaume I	Bosch-Morell, F (corresponding author), Univ CEU Cardenal Herrera, Inst Ciencias Biomed, Valencia, Spain.	fbosch@uch.ceu.es	Sancho-Tello, Maria/F-8566-2016; Sancho-Tello, Maria/AAA-1304-2019; Morell, Francisco Bosch/AAA-8355-2019; Almansa, Inma/K-8869-2014; Navea, Amparo/D-4577-2009; Muriach, María/AAB-2003-2019; Almansa, Inmaculada/F-4183-2016	Sancho-Tello, Maria/0000-0002-7080-2979; Sancho-Tello, Maria/0000-0002-7080-2979; Morell, Francisco Bosch/0000-0002-8681-9230; Almansa, Inma/0000-0001-8085-3377; Navea, Amparo/0000-0002-9856-5370; Almansa, Inmaculada/0000-0001-8085-3377; Muriach, Maria/0000-0002-6525-0073	Fundacion San Pablo [PRUCHB06/09, PRCEU-UCH 13/07]; Copernicus Santander Programme of the Universidad CEU Cardenal Herrera; Mutua Madrilena Institution	Fundacion San Pablo; Copernicus Santander Programme of the Universidad CEU Cardenal Herrera; Mutua Madrilena Institution	The work was supported in part by Grant no. PRUCHB06/09 and PRCEU-UCH 13/07 from the Fundacion San Pablo to FBM and the Copernicus Santander Programme of the Universidad CEU Cardenal Herrera. The last corrections of the work (revision process) have been supported by Mutua Madrilena Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bosch-Morell F, 2002, FREE RADICAL BIO MED, V33, P669, DOI 10.1016/S0891-5849(02)00954-1; Bosch-Morell F, 1999, FREE RADICAL BIO MED, V26, P1383, DOI 10.1016/S0891-5849(98)00335-9; Bousquet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049036; Busse D, 2010, P NATL ACAD SCI USA, V107, P3058, DOI 10.1073/pnas.0812851107; Cano M, 2010, VISION RES, V50, P652, DOI 10.1016/j.visres.2009.08.018; Caspi R. R., 2006, DRUG DISCOV TODAY, V3, P3; Chang JH, 2005, SURV OPHTHALMOL, V50, P364, DOI 10.1016/j.survophthal.2005.04.003; Chen W, 2009, MOL VIS, V15, P619; DEVOS AF, 1994, INVEST OPHTH VIS SCI, V35, P3873; Field MG, 2011, EXP EYE RES, V93, P548, DOI 10.1016/j.exer.2011.06.023; Foxman EF, 2002, J IMMUNOL, V168, P2483, DOI 10.4049/jimmunol.168.5.2483; Garcia-Bermudez M, 2012, PLOS ONE, V7; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Heiligenhaus A, 2010, GRAEF ARCH CLIN EXP, V248, P1531, DOI 10.1007/s00417-010-1485-8; HERBORT CP, 1988, GRAEF ARCH CLIN EXP, V226, P553, DOI 10.1007/BF02169204; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Ilieva I, 2004, EXP EYE RES, V79, P181, DOI 10.1016/j.exer.2004.03.009; Kaplanski G, 2003, TRENDS IMMUNOL, V24, P25, DOI 10.1016/S1471-4906(02)00013-3; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McDyer JF, 2002, J IMMUNOL, V169, P2736, DOI 10.4049/jimmunol.169.5.2736; Merida S, 2013, FREE RADICAL RES, V47, P593, DOI 10.3109/10715762.2013.805882; Mullen JC, 2007, J HEART LUNG TRANSPL, V26, P504, DOI 10.1016/j.healun.2007.01.032; Nussenblatt RB, 2005, OPHTHALMOLOGY, V112, P764, DOI 10.1016/j.ophtha.2004.12.034; Nussenblatt RB, 1999, P NATL ACAD SCI USA, V96, P7462, DOI 10.1073/pnas.96.13.7462; Omari KM, 2009, AM J PATHOL, V174, P164, DOI 10.2353/ajpath.2009.080350; Ooi KGJ, 2006, CLIN MED RES, V4, P294, DOI 10.3121/cmr.4.4.294; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Rao NA, 2000, PROG RETIN EYE RES, V19, P41, DOI 10.1016/S1350-9462(99)00003-8; Rech AJ, 2009, ANN NY ACAD SCI, V1174, P99, DOI 10.1111/j.1749-6632.2009.04939.x; REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9; REEM GH, 1984, SCIENCE, V225, P429, DOI 10.1126/science.6429853; RICHARD MJ, 1992, J CHROMATOGR-BIOMED, V577, P9, DOI 10.1016/0378-4347(92)80593-F; Romero MJ, 1998, FREE RADICAL BIO MED, V25, P993, DOI 10.1016/S0891-5849(98)00118-X; ROSENBAUM JT, 1980, NATURE, V286, P611, DOI 10.1038/286611a0; Sasaki M, 2009, INVEST OPHTH VIS SCI, V50, P1433, DOI 10.1167/iovs.08-2493; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Sen HN, 2009, AM J OPHTHALMOL, V148, P696, DOI 10.1016/j.ajo.2009.06.003; Sijssens KM, 2007, EXP EYE RES, V85, P443, DOI 10.1016/j.exer.2007.06.011; Smith JR, 1998, IMMUNOL CELL BIOL, V76, P497, DOI 10.1046/j.1440-1711.1998.00783.x; Snyder JT, 2007, BLOOD, V109, P5399, DOI 10.1182/blood-2006-12-062943; Steinke JW, 2006, J ALLERGY CLIN IMMUN, V117, pS441, DOI 10.1016/j.jaci.2005.07.001; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Sutherland DER, 2001, ANN SURG, V233, P463, DOI 10.1097/00000658-200104000-00003; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Totemeyer S, 2006, J IMMUNOL, V176, P4804, DOI 10.4049/jimmunol.176.8.4804; Trinh L, 2008, MOL VIS, V14, P2428; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vincenti F, 1998, NEW ENGL J MED, V338, P161, DOI 10.1056/NEJM199801153380304; Wruck CJ, 2011, J BIOL CHEM, V286, P4493, DOI 10.1074/jbc.M110.162008; Wuest SC, 2011, NAT MED, V17, P604, DOI 10.1038/nm.2365; Xu YZ, 2010, MOL VIS, V16, P1689; Yeh S, 2008, J AUTOIMMUN, V31, P91, DOI 10.1016/j.jaut.2008.05.001; Zhang WJ, 2007, P NATL ACAD SCI USA, V104, P4077, DOI 10.1073/pnas.0700305104	62	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90216	10.1371/journal.pone.0090216	http://dx.doi.org/10.1371/journal.pone.0090216			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595020	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900082
J	Thessen, AE; Parr, CS				Thessen, Anne E.; Parr, Cynthia Sims			Knowledge Extraction and Semantic Annotation of Text from the Encyclopedia of Life	PLOS ONE			English	Article								Numerous digitization and ontological initiatives have focused on translating biological knowledge from narrative text to machine-readable formats. In this paper, we describe two workflows for knowledge extraction and semantic annotation of text data objects featured in an online biodiversity aggregator, the Encyclopedia of Life. One workflow tags text with DBpedia URIs based on keywords. Another workflow finds taxon names in text using GNRD for the purpose of building a species association network. Both workflows work well: the annotation workflow has an F1 Score of 0.941 and the association algorithm has an F1 Score of 0.885. Existing text annotators such as Terminizer and DBpedia Spotlight performed well, but require some optimization to be useful in the ecology and evolution domain. Important future work includes scaling up and improving accuracy through the use of distributional semantics.	[Thessen, Anne E.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85283 USA; [Parr, Cynthia Sims] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA	Arizona State University; Arizona State University-Tempe; Smithsonian Institution; Smithsonian National Museum of Natural History	Thessen, AE (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85283 USA.	annethessen@gmail.com	Parr, Cynthia/E-8013-2010	Parr, Cynthia/0000-0002-8870-7099; Thessen, Anne/0000-0002-2908-3327	Encyclopedia of Life; John D. and Catherine T. MacArthur Foundation; Alfred P. Sloan Foundation	Encyclopedia of Life; John D. and Catherine T. MacArthur Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	Funding for CSP and AET came from the Encyclopedia of Life. Funding for the Encyclopedia of Life comes from the John D. and Catherine T. MacArthur Foundation, the Alfred P. Sloan Foundation, the participating institutions in the Encyclopedia of Life consortium, and individual donations from users around the world. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti Donat, 2009, BMC Res Notes, V2, P53, DOI 10.1186/1756-0500-2-53; Akella LM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-211; Ananiadou S, 2006, TRENDS BIOTECHNOL, V24, P571, DOI 10.1016/j.tibtech.2006.10.002; Bizer C, 2009, INT J SEMANT WEB INF, V5, P1, DOI 10.4018/jswis.2009081901; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Chang JT, 2006, TEXT MINING BIOL BIO, P99; Chen LF, 2005, BIOINFORMATICS, V21, P248, DOI 10.1093/bioinformatics/bth496; Clark T, 2004, BRIEF BIOINFORM; Cui H, 2012, J AM SOC INF SCI TEC, V63, P738, DOI 10.1002/asi.22618; Deans AR, 2008, ZOOTAXA, P28, DOI 10.11646/zootaxa.1787.1.2; Deans AR, 2012, TRENDS ECOL EVOL, V27, P78, DOI 10.1016/j.tree.2011.11.007; Hancock D, 2009, TERMINIZER ASSISTING; Heath T., 2011, LINKED DATA EVOLVING; IISE, 2011, STAT OBS SPEC; Jackson P., 2007, NATURAL LANGUAGE PRO; Krallinger M, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s8, 10.1186/gb-2008-9-S2-S8]; Leary PR, 2007, BIOINFORMATICS, V23, P1434, DOI 10.1093/bioinformatics/btm109; Madin J, 2007, ECOL INFORM, V2, P279, DOI 10.1016/j.ecoinf.2007.05.004; Mendes P.N., 2011, P 7 INT C SEMANTIC S, P1, DOI [10.1145/2063518.2063519, DOI 10.1145/2063518.2063519]; Michener WK, 2012, TRENDS ECOL EVOL, V27, P85, DOI 10.1016/j.tree.2011.11.016; Miller J, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-87; Milne D., 2008, P CIKM, DOI 10.1145/1458082.1458150; Mungall CJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r5; Page RDM, 2008, BRIEF BIOINFORM, V9, P345, DOI 10.1093/bib/bbn022; Page Roderic D.M., 2006, Biodiversity Informatics, V3, P1; Parr C., 2006, ETHAN EVOLUTIONARY T; Parr CS, 2012, TRENDS ECOL EVOL, V27, P94, DOI 10.1016/j.tree.2011.11.001; Patterson DJ, 2008, ZOOTAXA, P153, DOI 10.11646/zootaxa.1950.1.12; Patterson David J., 2010, P117; Penev L, 2010, ZOOKEYS, P1, DOI 10.3897/zookeys.50.538; Poelen J, 2013, MAR BIOL M MEX CIT M; Rizzo G, 2012, LINKED DATA WEB LDOW; Rotman D, 2012, J AM SOC INF SCI TEC, V63, P1092, DOI 10.1002/asi.22633; Sanchez-Graillet O, 2007, BIOINFORMATICS, V23, pI424, DOI 10.1093/bioinformatics/btm184; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Tan P.-N., 2019, INTRO DATA MINING, V2nd ed.; Thessen Anne E., 2012, Advances in Bioinformatics, V2012, P391574, DOI 10.1155/2012/391574; Washington NL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000247; Webb C, 2011, TDWG ANN C NEW ORL L; Wieczorek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029715; Williams RJ, 2006, J WEB SEMANT, V4, P237, DOI 10.1016/j.websem.2006.06.002; Yu H, 2007, J BIOMED INFORM, V40, P150, DOI 10.1016/j.jbi.2006.06.001	43	15	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89550	10.1371/journal.pone.0089550	http://dx.doi.org/10.1371/journal.pone.0089550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594988	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900023
J	Huang, W; Seo, J; Willingham, SB; Czyzewski, AM; Gonzalgo, ML; Weissman, IL; Barron, AE				Huang, Wei; Seo, Jiwon; Willingham, Stephen B.; Czyzewski, Ann M.; Gonzalgo, Mark L.; Weissman, Irving L.; Barron, Annelise E.			Learning from Host-Defense Peptides: Cationic, Amphipathic Peptoids with Potent Anticancer Activity	PLOS ONE			English	Article							HELICAL ANTIMICROBIAL PEPTIDES; CANCER-CELLS; LYTIC PEPTIDES; TUMOR-GROWTH; SIDE-CHAINS; BUFORIN II; MEMBRANE; MICE; OLIGOMERS; MECHANISM	Cationic, amphipathic host defense peptides represent a promising group of agents to be developed for anticancer applications. Poly-N-substituted glycines, or peptoids, are a class of biostable, peptidomimetic scaffold that can display a great diversity of side chains in highly tunable sequences via facile solid-phase synthesis. Herein, we present a library of anti-proliferative peptoids that mimics the cationic, amphipathic structural feature of the host defense peptides and explore the relationships between the structure, anticancer activity and selectivity of these peptoids. Several peptoids are found to be potent against a broad range of cancer cell lines at low-micromolar concentrations including cancer cells with multidrug resistance (MDR), causing cytotoxicity in a concentration-dependent manner. They can penetrate into cells, but their cytotoxicity primarily involves plasma membrane perturbations. Furthermore, peptoid 1, the most potent peptoid synthesized, significantly inhibited tumor growth in a human breast cancer xenotransplantation model without any noticeable acute adverse effects in mice. Taken together, our work provided important structural information for designing host defense peptides or their mimics for anticancer applications. Several cationic, amphipathic peptoids are very attractive for further development due to their high solubility, stability against protease degradation, their broad, potent cytotoxicity against cancer cells and their ability to overcome multidrug resistance.	[Huang, Wei; Barron, Annelise E.] Stanford Univ, Dept Bioengn, Palo Alto, CA 94304 USA; [Willingham, Stephen B.; Weissman, Irving L.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94304 USA; [Gonzalgo, Mark L.] Stanford Univ, Dept Urol, Palo Alto, CA 94304 USA; [Weissman, Irving L.] Stanford Univ, Dept Pathol, Palo Alto, CA 94304 USA; [Seo, Jiwon] Gwangju Inst Sci & Technol, Div Liberal Arts & Sci, Kwangju, South Korea; [Seo, Jiwon] Gwangju Inst Sci & Technol, Dept Chem, Kwangju, South Korea; [Czyzewski, Ann M.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA	Stanford University; Stanford University; Stanford University; Stanford University; Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Northwestern University	Barron, AE (corresponding author), Stanford Univ, Dept Bioengn, Palo Alto, CA 94304 USA.	aebarron@stanford.edu	Czyzewski, Ann/R-3421-2019	Seo, Jiwon/0000-0002-5433-5071; Barron, Annelise/0000-0002-0735-6873	National Institutes of Health [5 R01 AI072666-04]; National Research Foundation of Korea [2011-0014890]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (5 R01 AI072666-04 to A.E.B.) and the National Research Foundation of Korea (2011-0014890 to J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER MA, 1993, CANCER RES, V53, P3052; Barlow PG, 2010, AM J RESP CELL MOL, V43, P692, DOI 10.1165/rcmb.2009-0250OC; Bhutia SK, 2008, TRENDS BIOTECHNOL, V26, P210, DOI 10.1016/j.tibtech.2008.01.002; Boudreault PL, 2008, CHEM COMMUN, P2118, DOI 10.1039/b800528a; Buchau AS, 2010, J IMMUNOL, V184, P369, DOI 10.4049/jimmunol.0902110; Burkoth TS, 2003, J AM CHEM SOC, V125, P8841, DOI 10.1021/ja0352101; Chongsiriwatana NP, 2008, P NATL ACAD SCI USA, V105, P2794, DOI 10.1073/pnas.0708254105; Cragg GM, 2009, CHEM REV, V109, P3012, DOI 10.1021/cr900019j; Czyzewski AM, J ANTIMICRO IN PRESS; Czyzewski AM, 2008, AICHE J, V54, P2, DOI 10.1002/aic.11402; DeFeo-Jones D, 2000, NAT MED, V6, P1248, DOI 10.1038/81351; Dennison SR, 2006, CURR PROTEIN PEPT SC, V7, P487, DOI 10.2174/138920306779025611; Dharap SS, 2005, P NATL ACAD SCI USA, V102, P12962, DOI 10.1073/pnas.0504274102; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Fischer R, 2004, J BIOL CHEM, V279, P12625, DOI 10.1074/jbc.M311461200; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Gottler LM, 2009, BBA-BIOMEMBRANES, V1788, P1680, DOI 10.1016/j.bbamem.2008.10.009; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Kirshenbaum K, 1998, P NATL ACAD SCI USA, V95, P4303, DOI 10.1073/pnas.95.8.4303; Leuschner C, 2004, CURR PHARM DESIGN, V10, P2299, DOI 10.2174/1381612043383971; Makovitzki A, 2009, CANCER RES, V69, P3458, DOI 10.1158/0008-5472.CAN-08-3021; McPhee JB, 2005, J PEPT SCI, V11, P677, DOI 10.1002/psc.704; Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095; Oren Z, 1998, BIOPOLYMERS, V47, P451; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Papo N, 2004, CANCER RES, V64, P5779, DOI 10.1158/0008-5472.CAN-04-1438; Papo N, 2003, BIOCHEMISTRY-US, V42, P9346, DOI 10.1021/bi027212o; Papo N, 2003, J BIOL CHEM, V278, P21018, DOI 10.1074/jbc.M211204200; Park CB, 2000, P NATL ACAD SCI USA, V97, P8245, DOI 10.1073/pnas.150518097; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Patch JA, 2003, J AM CHEM SOC, V125, P12092, DOI 10.1021/ja037320d; Rege K, 2007, CANCER RES, V67, P6368, DOI 10.1158/0008-5472.CAN-06-3658; Rothbard JB, 2004, J AM CHEM SOC, V126, P9506, DOI 10.1021/ja0482536; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Sok M, 1999, CANCER LETT, V139, P215, DOI 10.1016/S0304-3835(99)00044-0; Soman NR, 2009, J CLIN INVEST, V119, P2830, DOI 10.1172/JCI38842; Spicakova T, 2010, MOL CANCER THER, V9, P2970, DOI 10.1158/1535-7163.MCT-10-0780; Tolley DA, 1996, J UROLOGY, V155, P1238; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wu CW, 2003, J AM CHEM SOC, V125, P13525, DOI 10.1021/ja037540r; Wu CW, 2001, J AM CHEM SOC, V123, P6778, DOI 10.1021/ja003154n; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216; ZUCKERMANN RN, 1992, P NATL ACAD SCI USA, V89, P4505, DOI 10.1073/pnas.89.10.4505	44	51	52	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90397	10.1371/journal.pone.0090397	http://dx.doi.org/10.1371/journal.pone.0090397			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587350	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200189
J	Ibanez-Gimeno, P; Galtes, I; Jordana, X; Malgosa, A; Manyosa, J				Ibanez-Gimeno, Pere; Galtes, Ignasi; Jordana, Xavier; Malgosa, Assumpcio; Manyosa, Joan			Biomechanics of Forearm Rotation: Force and Efficiency of Pronator Teres	PLOS ONE			English	Article							MOMENT ARMS; FUNCTIONAL IMPLICATIONS; ISOMETRIC PRONATION; ELBOW; SUPINATORS; MOTION	Biomechanical models are useful to assess the effect of muscular forces on bone structure. Using skeletal remains, we analyze pronator teres rotational efficiency and its force components throughout the entire flexion-extension and pronation-supination ranges by means of a new biomechanical model and 3D imaging techniques, and we explore the relationship between these parameters and skeletal structure. The results show that maximal efficiency is the highest in full elbow flexion and is close to forearm neutral position for each elbow angle. The vertical component of pronator teres force is the highest among all components and is greater in pronation and elbow extension. The radial component becomes negative in pronation and reaches lower values as the elbow flexes. Both components could enhance radial curvature, especially in pronation. The model also enables to calculate efficiency and force components simulating changes in osteometric parameters. An increase of radial curvature improves efficiency and displaces the position where the radial component becomes negative towards the end of pronation. A more proximal location of pronator teres radial enthesis and a larger humeral medial epicondyle increase efficiency and displace the position where this component becomes negative towards forearm neutral position, which enhances radial curvature. Efficiency is also affected by medial epicondylar orientation and carrying angle. Moreover, reaching an object and bringing it close to the face in a close-to-neutral position improve efficiency and entail an equilibrium between the forces affecting the elbow joint stability. When the upper-limb skeleton is used in positions of low efficiency, implying unbalanced force components, it undergoes plastic changes, which improve these parameters. These findings are useful for studies on ergonomics and orthopaedics, and the model could also be applied to fossil primates in order to infer their locomotor form. Moreover, activity patterns in human ancient populations could be deduced from parameters reported here.	[Ibanez-Gimeno, Pere; Malgosa, Assumpcio] Univ Autonoma Barcelona, Dept Biol Anim Biol Vegetal & Ecol, Unitat Antropol Biol, E-08193 Barcelona, Catalonia, Spain; [Galtes, Ignasi] Inst Med Legal Catalunya Montcada & Reixach, Ctr Patol Forense Collserola, Barcelona, Catalonia, Spain; [Galtes, Ignasi] Univ Autonoma Barcelona, Dept Psiquiatria & Med Legal, Unitat Med Legal & Forense, E-08193 Barcelona, Catalonia, Spain; [Jordana, Xavier] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont ICP, Dept Paleobiol, E-08193 Barcelona, Catalonia, Spain; [Manyosa, Joan] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Unitat Biofis, E-08193 Barcelona, Catalonia, Spain; [Manyosa, Joan] Univ Autonoma Barcelona, Ctr Estudis Biofis, E-08193 Barcelona, Catalonia, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); Autonomous University of Barcelona; Autonomous University of Barcelona	Manyosa, J (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Unitat Biofis, E-08193 Barcelona, Catalonia, Spain.	joan.manyosa@uab.cat	Ibáñez-Gimeno, Pere/F-8973-2014; Malgosa, Assumpció/K-2406-2014; Jordana, Xavier/L-9301-2014; Galtés, Ignasi/K-3053-2014; Jordana, Xavier/G-7537-2017	Ibáñez-Gimeno, Pere/0000-0001-6724-2926; Malgosa, Assumpció/0000-0003-1723-3671; Jordana, Xavier/0000-0001-8990-4388; Galtés, Ignasi/0000-0002-5758-2668; Jordana, Xavier/0000-0002-6016-6630	Ministerio de Ciencia e Innovacion [CGL2008-00800/BOS]; Generalitat de Catalunya [2009 SGR 566]; Programa de Formacion de Profesorado Universitario, Ministerio de Educacion, Cultura y Deporte [AP2009-5102]; Programa Juan de la Cierva, Ministerio de Economia y Competitividad [JCI-2010-08157]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Programa de Formacion de Profesorado Universitario, Ministerio de Educacion, Cultura y Deporte; Programa Juan de la Cierva, Ministerio de Economia y Competitividad	This work is supported by grants from the Ministerio de Ciencia e Innovacion (grant no. CGL2008-00800/BOS), the Generalitat de Catalunya (grant no. 2009 SGR 566), the Programa de Formacion de Profesorado Universitario, Ministerio de Educacion, Cultura y Deporte (grant no. AP2009-5102) awarded to Pere Ibanez-Gimeno and the Programa Juan de la Cierva, Ministerio de Economia y Competitividad (grant no. JCI-2010-08157) awarded to Xavier Jordana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello L, 1990, INTRO HUMAN EVOLUTIO; [Anonymous], 2006, SOFTW WIND; [Anonymous], 1995, ANATOMA HUMANA; [Anonymous], 2007, ED ED WIND; BASMAJIAN JV, 1957, J BONE JOINT SURG AM, V39, P1106, DOI 10.2106/00004623-195739050-00011; Bremer AK, 2006, CLIN BIOMECH, V21, P683, DOI 10.1016/j.clinbiomech.2006.03.002; Ciochon Russell L., 2004, P249; Galtes I, 2008, AM J PHYS ANTHROPOL, V135, P293, DOI 10.1002/ajpa.20743; Galtes I, 2009, AM J PHYS ANTHROPOL, V140, P589, DOI 10.1002/ajpa.21144; Galtes I, 2009, AM J PHYS ANTHROPOL, V138, P286, DOI 10.1002/ajpa.20926; Gordon KD, 2004, J ORTHOPAED RES, V22, P208, DOI 10.1016/S0736-0266(03)00115-3; Goto A, 2004, J SHOULDER ELB SURG, V13, P441, DOI 10.1016/j.jse.2004.01.022; Hale R, 2011, J BIOMECH, V44, P650, DOI 10.1016/j.jbiomech.2010.11.009; Haugstvedt JR, 2001, ACTA ORTHOP SCAND, V72, P629, DOI 10.1080/000164701317269076; Ibanez-Gimeno P, 2013, INT J OSTEOARCHAEOL, V23, P211, DOI 10.1002/oa.2299; Ibanez-Gimeno P, 2012, ANAT REC, V295, P1092, DOI 10.1002/ar.22483; Jablonski NG, 2002, J HUM EVOL, V43, P887, DOI 10.1006/jhev.2002.0607; Kapandji A. I., 2002, FISIOLOGIA ARTICULAR; KNUSSMANN R, 1967, BIBL PRIMATOL, P1; Lan N, 2004, P ANN INT IEEE EMBS, V26, P4661; MacPhee RDE, 2006, AM MUS NOVIT, P3; Marzke MW, 1997, AM J PHYS ANTHROPOL, V102, P91; MORREY BF, 1988, J BONE JOINT SURG AM, V70A, P250, DOI 10.2106/00004623-198870020-00014; MORREY BF, 1976, J BONE JOINT SURG AM, V58, P501, DOI 10.2106/00004623-197658040-00013; Mukhopadhyay P, 2007, INT J IND ERGONOM, V37, P313, DOI 10.1016/j.ergon.2006.11.007; Murray WM, 2002, J BIOMECH, V35, P19, DOI 10.1016/S0021-9290(01)00173-7; MURRAY WM, 1995, J BIOMECH, V28, P513, DOI 10.1016/0021-9290(94)00114-J; NAITO A, 1991, Okajimas Folia Anatomica Japonica, V68, P283; O'Sullivan LW, 2002, J ELECTROMYOGR KINES, V12, P275, DOI 10.1016/S1050-6411(02)00014-7; O'Sullivan LW, 2001, CONT ERGONOMICS 2001, P79; Richards RR, 1996, J BONE JOINT SURG AM, V78A, P916, DOI 10.2106/00004623-199606000-00017; Rose Michael D., 1993, P70; Rouviere H, 1988, ANATOMIA HUMANA DESC; Seiffert ER, 2000, P NATL ACAD SCI USA, V97, P10062, DOI 10.1073/pnas.97.18.10062; SHIBA R, 1988, J ORTHOPAED RES, V6, P897, DOI 10.1002/jor.1100060614; TRINKAUS E, 1988, AM J PHYS ANTHROPOL, V75, P15, DOI 10.1002/ajpa.1330750103; Tsaopoulos DE, 2007, J BIOMECH, V40, P645, DOI 10.1016/j.jbiomech.2006.01.022; TUTTLE RH, 1992, AM J PHYS ANTHROPOL, V87, P215, DOI 10.1002/ajpa.1330870208	38	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90319	10.1371/journal.pone.0090319	http://dx.doi.org/10.1371/journal.pone.0090319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587322	Green Published, gold			2022-12-27	WOS:000332396200168
J	Kong, QS; Yuan, JX; Gao, LY; Zhao, S; Jiang, W; Huang, Y; Bie, ZL				Kong, Qiusheng; Yuan, Jingxian; Gao, Lingyun; Zhao, Shuang; Jiang, Wei; Huang, Yuan; Bie, Zhilong			Identification of Suitable Reference Genes for Gene Expression Normalization in qRT-PCR Analysis in Watermelon	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; RT-PCR; SYSTEMATIC VALIDATION; ARABIDOPSIS; SELECTION; FRUIT; PUBLICATION; SEQUENCE; GENOME	Watermelon is one of the major Cucurbitaceae crops and the recent availability of genome sequence greatly facilitates the fundamental researches on it. Quantitative real-time reverse transcriptase PCR (qRT-PCR) is the preferred method for gene expression analyses, and using validated reference genes for normalization is crucial to ensure the accuracy of this method. However, a systematic validation of reference genes has not been conducted on watermelon. In this study, transcripts of 15 candidate reference genes were quantified in watermelon using qRT-PCR, and the stability of these genes was compared using geNorm and NormFinder. geNorm identified ClTUA and ClACT, ClEF1 alpha and ClACT, and ClCAC and ClTUA as the best pairs of reference genes in watermelon organs and tissues under normal growth conditions, abiotic stress, and biotic stress, respectively. NormFinder identified ClYLS8, ClUBCP, and ClCAC as the best single reference genes under the above experimental conditions, respectively. ClYLS8 and ClPP2A were identified as the best reference genes across all samples. Two to nine reference genes were required for more reliable normalization depending on the experimental conditions. The widely used watermelon reference gene 18SrRNA was less stable than the other reference genes under the experimental conditions. Catalase family genes were identified in watermelon genome, and used to validate the reliability of the identified reference genes. ClCAT1 and ClCAT2 were induced and upregulated in the first 24 h, whereas ClCAT3 was downregulated in the leaves under low temperature stress. However, the expression levels of these genes were significantly overestimated and misinterpreted when 18SrRNA was used as a reference gene. These results provide a good starting point for reference gene selection in qRT-PCR analyses involving watermelon.	[Kong, Qiusheng; Yuan, Jingxian; Gao, Lingyun; Zhao, Shuang; Jiang, Wei; Huang, Yuan; Bie, Zhilong] Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Coll Hort & Forestry, Wuhan, Peoples R China	Huazhong Agricultural University	Bie, ZL (corresponding author), Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Coll Hort & Forestry, Wuhan, Peoples R China.	biezhilong@hotmail.com	Kong, Qiusheng/F-7710-2012	Kong, Qiusheng/0000-0003-0939-4424	earmarked fund for Modern Agro-industry Technology Research System [CARS-26-16]; National Science & Technology Pillar Program [2012BAD02B03-16]; Special Fund for Agro-scientific Research in the Public Interest [201003066-6]	earmarked fund for Modern Agro-industry Technology Research System; National Science & Technology Pillar Program; Special Fund for Agro-scientific Research in the Public Interest	This work was founded by the earmarked fund for Modern Agro-industry Technology Research System (CARS-26-16), the National Science & Technology Pillar Program during the 12th Five-year Plan Period (2012BAD02B03-16), and Special Fund for Agro-scientific Research in the Public Interest (201003066-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2011, PLANTA, V233, P947, DOI 10.1007/s00425-010-1341-4; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carvalho FCQ, 2013, EUPHYTICA, V190, P169, DOI 10.1007/s10681-012-0766-1; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Die JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073354; Du YY, 2008, J INTEGR PLANT BIOL, V50, P1318, DOI 10.1111/j.1744-7909.2008.00741.x; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fredslund J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-369; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Guo SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-454; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Lu GY, 2011, EUR J PLANT PATHOL, V131, P585, DOI 10.1007/s10658-011-9833-z; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Marum L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035113; Mhamdi A, 2012, ARCH BIOCHEM BIOPHYS, V525, P181, DOI 10.1016/j.abb.2012.04.015; Mhamdi A, 2010, J EXP BOT, V61, P4197, DOI 10.1093/jxb/erq282; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; Obrero A, 2011, J AGR FOOD CHEM, V59, P5402, DOI 10.1021/jf200689r; Park SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051502; Reddy DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078555; Sestili S, 2013, J PLANT BIOCHEM BIOT, V3, P1; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041659; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Warzybok A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072887; Wechter WP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-275; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	39	120	133	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90612	10.1371/journal.pone.0090612	http://dx.doi.org/10.1371/journal.pone.0090612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587403	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200237
J	Veerappa, AM; Murthy, NM; Vishweswaraiah, S; Lingaiah, K; Suresh, RV; Nachappa, SA; Prashali, N; Yadav, SN; Srikanta, MA; Manjegowda, DS; Seshachalam, KB; Ramachandra, NB				Veerappa, Avinash M.; Murthy, Megha N.; Vishweswaraiah, Sangeetha; Lingaiah, Kusuma; Suresh, Raviraj V.; Nachappa, Somanna Ajjamada; Prashali, Nelchi; Yadav, Sangeetha Nuggehalli; Srikanta, Manjula Arsikere; Manjegowda, Dinesh S.; Seshachalam, Keshava B.; Ramachandra, Nallur B.			Copy Number Variations Burden on miRNA Genes Reveals Layers of Complexities Involved in the Regulation of Pathways and Phenotypic Expression	PLOS ONE			English	Article							MICRORNA EXPRESSION; DOWN-REGULATION; DE-NOVO; POLYMORPHISM; DISEASE; SUSCEPTIBILITY; PREDISPOSES; MIR-675; MIR-126; FAMILY	MicroRNAs are involved in post-transcriptional down-regulation of gene expression. Variations in miRNA genes can severely affect downstream-regulated genes and their pathways. However, population-specific burden of CNVs on miRNA genes and the complexities created towards the phenotype is not known. From a total of 44109 CNVs investigated from 1715 individuals across 12 populations using high-throughput arrays, 4007 miRNA-CNVs (similar to 9%) consisting 6542 (similar to 5%) miRNA genes with a total of 333 (similar to 5%) singleton miRNA genes were identified. We found miRNA-CNVs across the genomes of individuals showing multiple hits in many targets, co-regulated under the same pathway. This study proposes four mechanisms unraveling the many complexities in miRNA genes, targets and co-regulated miRNA genes towards establishment of phenotypic diversity.	[Veerappa, Avinash M.; Murthy, Megha N.; Vishweswaraiah, Sangeetha; Lingaiah, Kusuma; Suresh, Raviraj V.; Nachappa, Somanna Ajjamada; Prashali, Nelchi; Yadav, Sangeetha Nuggehalli; Srikanta, Manjula Arsikere; Ramachandra, Nallur B.] Univ Mysore, Dept Studies Zool, Genet & Genom Lab, Mysore, Karnataka, India; [Manjegowda, Dinesh S.] Yenepoya Univ, Yenepoya Med Coll, Dept Anat, Mangalore, Karnataka, India; [Seshachalam, Keshava B.] JSS Hosp, Dept Neurol, Mysore, Karnataka, India; [Manjegowda, Dinesh S.] Nitte Univ, KS Hegde Med Acad, Ctr Sci Educ & Res, Mangalore, Karnataka, India	University of Mysore; Yenepoya (Deemed to be University); JSS Academy of Higher Education & Research; NITTE (Deemed to be University); K.S. Hegde Medical Academy; Nitte University Center for Science Education & Research (NUCSER)	Ramachandra, NB (corresponding author), Univ Mysore, Dept Studies Zool, Genet & Genom Lab, Mysore, Karnataka, India.	nallurbr@gmail.com		Ajjamada, Somanna/0000-0002-9359-9803	Department of Science and Technology-Health Science, Government of India, New Delhi [SR/SO/HS-103/2007]; Yenepoya University Seed grant (YU/Seed Grant), Mangalore [2011-011]	Department of Science and Technology-Health Science, Government of India, New Delhi; Yenepoya University Seed grant (YU/Seed Grant), Mangalore	This work received funding from the following sources: Department of Science and Technology-Health Science (SR/SO/HS-103/2007), Government of India, New Delhi; Yenepoya University Seed grant (YU/Seed Grant/2011-011), Mangalore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix Inc, 2008, US MAN GEN CONS SOFT; Affymetrix Inc, 2005, TECHN NOT GUID PROB; Affymetrix Inc, 2009, DAT SHEET GEN WID HU; Affymetrix Inc, 2007, WHIT PAP BRLMM P GEN; Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anglicheau D, 2009, P NATL ACAD SCI USA, V106, P5330, DOI 10.1073/pnas.0813121106; [Anonymous], SNP VAR SUIT VERS 7; [Anonymous], 2008, ANN ICRP, V38, P1; Arias M, 2006, NEUROMUSCULAR DISORD, V16, P498, DOI 10.1016/j.nmd.2006.05.011; Bottoni A, 2005, J CELL PHYSIOL, V204, P280, DOI 10.1002/jcp.20282; Butler JL, 2013, BIOINFORMATICS, V29, P262, DOI 10.1093/bioinformatics/bts650; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Duan SW, 2009, RNA BIOL, V6, P412, DOI 10.4161/rna.6.4.8830; Dudek KA, 2010, J BIOL CHEM, V285, P24381, DOI 10.1074/jbc.M110.111328; Ehli EA, 2012, EUR J HUM GENET, V20, P1037, DOI 10.1038/ejhg.2012.49; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Feng L, 2011, BIOCHEM BIOPH RES CO, V406, P534, DOI 10.1016/j.bbrc.2011.02.081; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fu WQ, 2010, AM J HUM GENET, V87, P494, DOI 10.1016/j.ajhg.2010.09.006; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Girirajan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002334; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Greco S, 2012, DIABETES, V61, P1633, DOI 10.2337/db11-0952; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Hartmann S, 2008, HAEMATOL-HEMATOL J, V93, P1318, DOI 10.3324/haematol.12875; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hsu PWC, 2006, NUCLEIC ACIDS RES, V34, pD135, DOI 10.1093/nar/gkj135; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ju XL, 2009, PEDIATR HEMAT ONCOL, V26, P1, DOI 10.1080/08880010802378338; Keller A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007440; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lacaria M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002713; Lee C, 2007, NAT GENET, V39, pS48, DOI 10.1038/ng2092; Lekkerkerker C., 1962, FUND MATH, V51, P45, DOI DOI 10.4064/FM-51-1-45-64; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lian J, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-13; Marcinkowska M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-183; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mraz M, 2012, BLOOD, V119, P2110, DOI 10.1182/blood-2011-11-394874; Park J, 2006, CANCER EPIDEM BIOMAR, V15, P1473, DOI 10.1158/1055-9965.EPI-06-0141; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rossi S, 2008, MAMM GENOME, V19, P526, DOI 10.1007/s00335-008-9119-8; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shadravan Farideh, 2013, Frontiers in Genetics, V4, P32, DOI 10.3389/fgene.2013.00032; Shen WF, 2008, MOL CELL BIOL, V28, P4609, DOI 10.1128/MCB.01652-07; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tsang WP, 2010, CARCINOGENESIS, V31, P350, DOI 10.1093/carcin/bgp181; Vaishnavi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056781; VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wu XD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-707; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Yi ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043184; Zeng LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059685; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007826	63	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90391	10.1371/journal.pone.0090391	http://dx.doi.org/10.1371/journal.pone.0090391			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587348	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000332396200187
J	Pizzi, C; Cole, TJ; Richiardi, L; dos-Santos-Silva, I; Corvalan, C; De Stavola, B				Pizzi, Costanza; Cole, Tim J.; Richiardi, Lorenzo; dos-Santos-Silva, Isabel; Corvalan, Camila; De Stavola, Bianca			Prenatal Influences on Size, Velocity and Tempo of Infant Growth: Findings from Three Contemporary Cohorts	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; CATCH-UP GROWTH; BIRTH COHORT; WEIGHT-GAIN; CHILDHOOD GROWTH; SYSTEMATIC REVIEWS; EARLY DETERMINANTS; POSTNATAL-GROWTH; LATER LIFE; OBESITY	Background: Studying prenatal influences of early life growth is relevant to life-course epidemiology as some of its features have been linked to the onset of later diseases. Methods: We studied the association between prenatal maternal characteristics (height, age, parity, education, pre-pregnancy body mass index (BMI), smoking, gestational diabetes and hypertension) and offspring weight trajectories in infancy using SuperImposition by Translation And Rotation (SITAR) models, which parameterize growth in terms of three biologically interpretable parameters: size, velocity and tempo. We used data from three contemporary cohorts based in Portugal (GXXI, n = 738), Italy (NINFEA, n = 2,925), and Chile (GOCS, n = 959). Results: Estimates were generally consistent across the cohorts for maternal height, age, parity and pre-pregnancy overweight/obesity. Some exposures only affected one growth parameter (e. g. maternal height (per cm): 0.4% increase in size (95% confidence interval (CI): 0.3; 0.5)), others were either found to affect size and velocity (e. g. pre-pregnancy underweight vs normal weight: smaller size (-4.9%, 95% CI: -6.5; -3.3), greater velocity (5.9%, 95% CI: 1.9; 10.0)), or to additionally influence tempo (e. g. pre-pregnancy overweight/obesity vs normal weight: increased size (7.9%, 95% CI: 4.9; 10.8), delayed tempo (0.26 months, 95% CI: 0.11; 0.41), decreased velocity (24.9%, 95% CI: -10.8; 0.9)). Conclusions: By disentangling the growth parameters of size, velocity and tempo, we found that prenatal maternal characteristics, especially maternal smoking, pre-pregnancy overweight and underweight, parity and gestational hypertension, are associated with different aspects of infant weight growth. These results may offer insights into the mechanisms governing infant growth.	[Pizzi, Costanza; Richiardi, Lorenzo] Univ Turin, Dept Med Sci, Canc Epidemiol Unit, Turin, Italy; [Pizzi, Costanza; Richiardi, Lorenzo] CPO Piemonte, Turin, Italy; [Pizzi, Costanza; De Stavola, Bianca] Univ London London Sch Hyg & Trop Med, Ctr Stat Methodol, London WC1E 7HT, England; [Cole, Tim J.] UCL Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England; [dos-Santos-Silva, Isabel] Univ London London Sch Hyg & Trop Med, Noncommunicable Dis Epidemiol Dept, London WC1E 7HT, England; [Corvalan, Camila] Univ Chile, Inst Nutr & Food Technol, Santiago, Chile	University of Turin; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Universidad de Chile	Pizzi, C (corresponding author), Univ Turin, Dept Med Sci, Canc Epidemiol Unit, Turin, Italy.	costanza.pizzi@unito.it	Cole, Tim J/B-7883-2008; Corvalan, Camila/B-2914-2011; richiardi, lorenzo/J-3480-2018	Cole, Tim J/0000-0001-5711-8200; Corvalan, Camila/0000-0003-3766-7709; richiardi, lorenzo/0000-0003-0316-9402; dos Santos Silva, Isabel/0000-0002-6596-8798; De Stavola, Bianca Lucia/0000-0001-7853-0528	Compagnia San-Paolo Foundation; Piedmont Region; Italian Ministry of University and Research; Programa Operacional de Sade - Saude XXI, Quadro Comunitario de Apoio III; Administracao Regional de Saude Norte; Fondecyt [1060785, 1090252, 1120326]; Medical Research Council [MR/J004839/1]; MRC [MR/J004839/1] Funding Source: UKRI	Compagnia San-Paolo Foundation(Compagnia di San Paolo); Piedmont Region(Regione Piemonte); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Programa Operacional de Sade - Saude XXI, Quadro Comunitario de Apoio III; Administracao Regional de Saude Norte; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	NINFEA cohort was partially funded by Compagnia San-Paolo Foundation, Piedmont Region and Italian Ministry of University and Research. GXXI cohort was funded by Programa Operacional de Sade - Saude XXI, Quadro Comunitario de Apoio III and by Administracao Regional de Saude Norte. GOCS cohort was funded by Fondecyt projects 1060785, 1090252 and 1120326. TJC is funded by Medical Research Council grant MR/J004839/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Barker DJP, 1998, MOTHERS BABIES HLTH; Beath KJ, 2007, STAT MED, V26, P2547, DOI 10.1002/sim.2718; Bulk-Bunschoten AMW, 2002, PAEDIATR PERINAT EP, V16, P361, DOI 10.1046/j.1365-3016.2002.00440.x; Cole TJ, 2010, INT J EPIDEMIOL, V39, P1558, DOI 10.1093/ije/dyq115; Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F; Corvalan C, 2009, AM J CLIN NUTR, V90, P547, DOI 10.3945/ajcn.2008.27318; De Stavola BL, 2004, AM J EPIDEMIOL, V159, P671, DOI 10.1093/aje/kwh097; Dietz PM, 2006, EPIDEMIOLOGY, V17, P170, DOI 10.1097/01.ede.0000198470.26932.9a; Dubois L, 2006, INT J OBESITY, V30, P610, DOI 10.1038/sj.ijo.0803141; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Fall CHD, 2011, ANN HUM BIOL, V38, P410, DOI 10.3109/03014460.2011.592513; Gamborg M, 2009, AM J EPIDEMIOL, V169, P1167, DOI 10.1093/aje/kwp047; Harville EW, 2012, AM J EPIDEMIOL, V176, pS150, DOI 10.1093/aje/kws231; Hindmarsh PC, 2008, PEDIATR RES, V63, P99, DOI 10.1203/PDR.0b013e31815b8e8f; Howe LD, 2011, INT J PEDIATR OBES, V6, pE144, DOI 10.3109/17477166.2010.500387; Hui LL, 2010, ANN EPIDEMIOL, V20, P827, DOI 10.1016/j.annepidem.2010.07.001; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Johnson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019918; Larsen PS, 2013, PAEDIATR PERINAT EP, V27, P393, DOI 10.1111/ppe.12060; Martin RM, 2004, EPIDEMIOLOGY, V15, P308, DOI 10.1097/01.ede.0000120042.16363.e3; Mihrshahi S, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-99; Monasta L, 2010, OBES REV, V11, P695, DOI 10.1111/j.1467-789X.2010.00735.x; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Ong KK, 2010, ENDOCR DEV, V19, P53, DOI 10.1159/000316897; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Pizzi C, 2014, J R STAT SOC A STAT, V177, P371, DOI 10.1111/rssa.12020; Pizzi C, 2012, J EPIDEMIOL COMMUN H, V66, P976, DOI 10.1136/jech-2011-200065; Prentice A, 2012, AM J CLIN NUTR, V96, P1042, DOI 10.3945/ajcn.112.037481; Raikkonen K, 2009, AM J EPIDEMIOL, V170, P447, DOI 10.1093/aje/kwp132; Regnault N, 2010, AM J CLIN NUTR, V92, P594, DOI 10.3945/ajcn.2010.29292; Richiardi L, 2007, EUR J EPIDEMIOL, V22, P831, DOI 10.1007/s10654-007-9194-2; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Skrondal A., 2004, GEN LATENT VARIABLE; Touwslager RN, 2011, J PEDIAT, V158; Tzoulaki I, 2010, AM J EPIDEMIOL, V171, P989, DOI 10.1093/aje/kwq027; Vansteelandt S, 2012, CAUSALITY STAT PERSP; Vohr BR, 1999, DIABETES CARE, V22, P1284, DOI 10.2337/diacare.22.8.1284; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886	42	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90291	10.1371/journal.pone.0090291	http://dx.doi.org/10.1371/journal.pone.0090291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587314	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000332390800099
J	Tarazon, E; Rosello-Lleti, E; Rivera, M; Ortega, A; Molina-Navarro, MM; Trivino, JC; Lago, F; Gonzalez-Juanatey, JR; Orosa, P; Montero, JA; Salvador, A; Portoles, M				Tarazon, Estefania; Rosello-Lleti, Esther; Rivera, Miguel; Ortega, Ana; Micaela Molina-Navarro, Maria; Carlos Trivino, Juan; Lago, Francisca; Ramon Gonzalez-Juanatey, Jose; Orosa, Placido; Anastasio Montero, Jose; Salvador, Antonio; Portoles, Manuel			RNA Sequencing Analysis and Atrial Natriuretic Peptide Production in Patients with Dilated and Ischemic Cardiomyopathy	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; CHRONIC HEART-FAILURE; B-TYPE; GUIDELINE UPDATE; GENE-EXPRESSION; ESC GUIDELINES; PLASMA; CORIN; DIAGNOSIS; VENTRICLES	Background: The atrium is the major site of ANP synthesis, which has been said to increase in heart failure as a result of increased production in the left ventricular (LV) myocardium. This is a key issue related to its diagnostic and prognostic capabilities. We aimed to evaluate protein levels of proANP and ANP and the enzymes that cleave the natriuretic peptides, corin and furin, in the LV tissue of heart transplant patients with dilated (DCM) and ischemic (ICM) cardiomyopathy compared with control donors (CNT). We also evaluate mRNA levels of ANP gene (NPPA) by RNA sequencing in the same tissue. Methods and Results: Seventy-three human LV tissue samples from ICM (n = 30) and DCM (n = 33) patients and CNT (n = 10) were analyzed by Western blot and RNA sequencing. Comparing protein levels according to etiology, neither DCM nor ICM showed levels of proANP or ANP different from those of CNT. However, NPPA was increased in both groups compared to CNT (DCM 32 fold, p<0.0001; ICM 10 fold, p<0.0001). Corin (but not furin) was elevated in the ICM group compared to CNT (112 +/- 24 vs. 100 +/- 7, p<0.05), and its level was inversely related with LV ejection fraction (LVEF) (r = -0.399, p<0.05). Conclusions: Patients present with elevated levels of NPPA but not of proANP or ANP proteins in LV tissue, which may be due to posttranscripcional regulation of NPPA or different pathways for ANP secretion between the atrium and ventricle. Moreover, there are differences between DCM and ICM in corin levels, indicating that a different molecular mechanism may exist that converge in this syndrome. Further, LV concentration of corin is inversely related to LVEF in ICM.	[Tarazon, Estefania; Rosello-Lleti, Esther; Rivera, Miguel; Ortega, Ana; Micaela Molina-Navarro, Maria; Portoles, Manuel] Inst Invest Sanitaria Hosp Univ La Fe, Cardiocirculatory Unit, Valencia, Spain; [Carlos Trivino, Juan] Sistemas Genom, Valencia, Spain; [Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp, Dept Cardiol, Cellular & Mol Cardiol Res Unit, Santiago De Compostela, Spain; [Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp, Inst Biomed Res, Santiago De Compostela, Spain; [Orosa, Placido] Hosp San Francesc de Borja, Cardiol Unit, Gandia, Spain; [Anastasio Montero, Jose] Hosp Univ La Fe, Serv Cirugia Cardiovasc, Valencia, Spain; [Salvador, Antonio] Hosp Univ La Fe, Dept Cardiol, Heart Failure & Transplantat Unit, Valencia, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe	Portoles, M (corresponding author), Inst Invest Sanitaria Hosp Univ La Fe, Cardiocirculatory Unit, Valencia, Spain.	portoles_man@gva.es	Tarazón, Estefanía/D-6950-2017; PORTOLES, MANUEL/B-4789-2009; Ortega, Ana AO/D-3027-2017; Roselló Lletí, Esther/ABG-8503-2020; Ortega, Ana/AAG-5941-2020; Roselló-Lletí, Esther/B-2695-2017	Tarazón, Estefanía/0000-0003-3466-2558; PORTOLES, MANUEL/0000-0002-4415-7160; Ortega, Ana AO/0000-0002-9763-0505; Roselló Lletí, Esther/0000-0003-2627-6104; Ortega, Ana/0000-0002-9763-0505; Roselló-Lletí, Esther/0000-0003-2627-6104; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388; , Micaela/0000-0002-2103-0351	National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III'' [RETICS 12/0042/0003, PI10/00275]	National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III''	This work was supported by grants from the National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III'' [RETICS 12/0042/0003, Project PI10/00275]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arora P, 2013, J CLIN INVEST, V123, P3378, DOI 10.1172/JCI67383; BLOCH KD, 1986, CELL, V47, P695, DOI 10.1016/0092-8674(86)90512-X; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Cortes R, 2007, HEART, V93, P957, DOI 10.1136/hrt.2006.096891; Cortes R, 2006, EUR J HEART FAIL, V8, P621, DOI 10.1016/j.ejheart.2005.11.011; Cortes R, 2012, INT J CARDIOL, V158, P199, DOI 10.1016/j.ijcard.2011.01.014; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Dickstein K, 2010, EUR J HEART FAIL, V12, P1143, DOI [10.1093/eurjhf/hfq192, 10.1093/europace/euq392]; Dong NZ, 2010, CIRC-HEART FAIL, V3, P207, DOI 10.1161/CIRCHEARTFAILURE.109.903849; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Ibebuogu UN, 2011, CIRC-HEART FAIL, V4, P114, DOI 10.1161/CIRCHEARTFAILURE.109.895581; Ichiki T, 2013, AM J PHYSIOL-REG I, V304, pR102, DOI 10.1152/ajpregu.00233.2012; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu P, 2003, CAN J CARDIOL, V19, P347; Macrae Duncan J, 2007, Proc Am Thorac Soc, V4, P176, DOI 10.1513/pats.200701-011GC; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008847; Mooney M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061088; NELESEN RA, 1992, CIRCULATION, V86, P463, DOI 10.1161/01.CIR.86.2.463; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; Rivera M, 2005, EUR J HEART FAIL, V7, P1168, DOI 10.1016/j.ejheart.2005.04.003; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosello-Lleti E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031189; Ruskoaho H, 2003, ENDOCR REV, V24, P341, DOI 10.1210/er.2003-0006; SAITO Y, 1987, BIOCHEM BIOPH RES CO, V148, P211, DOI 10.1016/0006-291X(87)91097-7; Semenov AG, 2010, CLIN CHEM, V56, P1166, DOI 10.1373/clinchem.2010.143883; Seronde MF, 2013, INT J CARDIOL, V168, P3404, DOI 10.1016/j.ijcard.2013.04.164; TAKAHASHI T, 1992, CIRC RES, V71, P9, DOI 10.1161/01.RES.71.1.9; Tarazon E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048957; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; TSUCHIMOCHI H, 1988, CIRCULATION, V78, P920, DOI 10.1161/01.CIR.78.4.920; Waldo SW, 2008, J AM COLL CARDIOL, V51, P1874, DOI 10.1016/j.jacc.2007.12.051; Winters AL, 2005, ANAL BIOCHEM, V346, P43, DOI 10.1016/j.ab.2005.07.041; Wu QY, 2009, KIDNEY INT, V75, P142, DOI 10.1038/ki.2008.418; Zolty R, 2008, CLIN BIOCHEM, V41, P1255, DOI 10.1016/j.clinbiochem.2008.05.008	36	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90157	10.1371/journal.pone.0090157	http://dx.doi.org/10.1371/journal.pone.0090157			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599027	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400051
J	Vasquez-Limeta, A; Wagstaff, KM; Ortega, A; Crouch, DH; Jans, DA; Cisneros, B				Vasquez-Limeta, Alejandra; Wagstaff, Kylie M.; Ortega, Arturo; Crouch, Dorothy H.; Jans, David A.; Cisneros, Bulmaro			Nuclear Import of beta-Dystroglycan Is Facilitated by Ezrin-Mediated Cytoskeleton Reorganization	PLOS ONE			English	Article							ACTIN CYTOSKELETON; ERM PROTEINS; LOCALIZATION; DYSTROPHIN; CELLS; TRANSLOCATION; TRANSPORT; MUSCLE; AJUBA; ORGANIZATION	The beta-dystroglycan (beta-DG) protein has the ability to target to multiple sites in eukaryotic cells, being a member of diverse protein assemblies including the transmembranal dystrophin-associated complex, and a nuclear envelope-localised complex that contains emerin and lamins A/C and B1. We noted that the importin alpha 2/beta 1-recognised nuclear localization signal (NLS) of beta-DG is also a binding site for the cytoskeletal-interacting protein ezrin, and set out to determine whether ezrin binding might modulate beta-DG nuclear translocation for the first time. Unexpectedly, we found that ezrin enhances rather than inhibits beta-DG nuclear translocation in C2C12 myoblasts. Both overexpression of a phosphomimetic activated ezrin variant (Ez-T567D) and activation of endogenous ezrin through stimulation of the Rho pathway resulted in both formation of actin-rich surface protrusions and significantly increased nuclear translocation of beta-DG as shown by quantitative microscopy and subcellular fractionation/Western analysis. In contrast, overexpression of a nonphosphorylatable inactive ezrin variant (Ez-T567A) or inhibition of Rho signaling, decreased nuclear translocation of beta-DG concomitant with a lack of cell surface protrusions. Further, a role for the actin cytoskeleton in ezrin enhancement of beta-DG nuclear translocation was implicated by the observation that an ezrin variant lacking its actin-binding domain failed to enhance nuclear translocation of beta-DG, while disruption of the actin cytoskeleton led to a reduction in beta-DG nuclear localization. Finally, we show that ezrin-mediated cytoskeletal reorganization enhances nuclear translocation of the cytoplasmic but not the transmembranal fraction of beta-DG. This is the first study showing that cytoskeleton reorganization can modulate nuclear translocation of beta-DG, with the implication that b-DG can respond to cytoskeleton-driven changes in cell morphology by translocating from the cytoplasm to the nucleus to orchestrate nuclear processes in response to the functional requirements of the cell.	[Vasquez-Limeta, Alejandra; Ortega, Arturo; Cisneros, Bulmaro] Inst Politecn Nacl CINVESTAV IPN, Ctr Invest & Estudios Avanzados, Dept Genet & Biol Mol, Mexico City, DF, Mexico; [Wagstaff, Kylie M.; Jans, David A.] Monash Univ, Nucl Signalling Lab, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Crouch, Dorothy H.] Univ Dundee, Sch Dent, Dundee, Scotland	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Monash University; University of Dundee	Jans, DA (corresponding author), Monash Univ, Nucl Signalling Lab, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	david.jans@monash.edu; bcisnero@cinvestav.mx	Ortega, Arturo/A-2282-2008; Vásquez Limeta, Alejandra/AIE-1291-2022	Ortega, Arturo/0000-0002-9594-8114; Vásquez Limeta, Alejandra/0000-0002-2504-6270; Wagstaff, Kylie/0000-0003-4791-1410; Jans, David/0000-0001-5115-4745	CONACyT (Mexico) [128418]; National Health and Medical Research Council (Australia) [APP1002486];  [203589]	CONACyT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); 	This work was supported by: CONACyT (Mexico); Contract grant number 128418 to BC, and scholarship for PhD studies, Contract number 203589 was granted to AVL; and the National Health and Medical Research Council (Australia); Contract grant number APP1002486 to DAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyanathan K, 2007, CANCER RES, V67, P9097, DOI 10.1158/0008-5472.CAN-07-2987; Baliga BC, 2003, J BIOL CHEM, V278, P4899, DOI 10.1074/jbc.M211512200; Batchelor CL, 2004, EXP CELL RES, V296, P208, DOI 10.1016/j.yexcr.2004.02.010; Batchelor CL, 2007, CELL CYCLE, V6, P353, DOI 10.4161/cc.6.3.3819; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Fazal F, 2007, J BIOL CHEM, V282, P3940, DOI 10.1074/jbc.M608074200; Fuentes-Mera L, 2006, EXP CELL RES, V312, P3023, DOI 10.1016/j.yexcr.2006.06.002; Gonzalez-Ramirez R, 2008, J CELL BIOCHEM, V105, P735, DOI 10.1002/jcb.21870; Henry MD, 1996, CURR OPIN CELL BIOL, V8, P625, DOI 10.1016/S0955-0674(96)80103-7; Higginson JR, 2008, INT J BIOCHEM CELL B, V40, P892, DOI 10.1016/j.biocel.2007.10.019; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; Ilsley JL, 2001, CELL SIGNAL, V13, P625, DOI 10.1016/S0898-6568(01)00188-7; Kanungo J, 2000, MOL BIOL CELL, V11, P3299, DOI 10.1091/mbc.11.10.3299; Kim JH, 2010, J BIOL CHEM, V285, P9995, DOI 10.1074/jbc.M109.061671; Kumeta Masahiro, 2012, Int J Cell Biol, V2012, P494902, DOI 10.1155/2012/494902; Lara-Chacon B, 2010, J CELL BIOCHEM, V110, P706, DOI 10.1002/jcb.22581; Martinez-Vieyra IA, 2013, BBA-MOL CELL RES, V1833, P698, DOI 10.1016/j.bbamcr.2012.11.019; Mathew G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02792; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Montoya-Durango DE, 2008, J BIOL CHEM, V283, P32056, DOI 10.1074/jbc.M802320200; Moore CJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-3; Oppizzi ML, 2008, TRAFFIC, V9, P2063, DOI 10.1111/j.1600-0854.2008.00822.x; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Pouton CW, 2007, ADV DRUG DELIVER REV, V59, P698, DOI 10.1016/j.addr.2007.06.010; Rivier F, 1999, J MUSCLE RES CELL M, V20, P305, DOI 10.1023/A:1005426920070; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Sotgia F, 2003, BIOCHEMISTRY-US, V42, P7110, DOI 10.1021/bi0271289; Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140; Spence HJ, 2004, HUM MOL GENET, V13, P1657, DOI 10.1093/hmg/ddh170; Thompson O, 2010, J CELL SCI, V123, P118, DOI 10.1242/jcs.047902; Villarreal-Silva M, 2009, NEUROCHEMICAL RES; Wagstaff KM, 2006, ANAL BIOCHEM, V348, P49, DOI 10.1016/j.ab.2005.10.029; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Wang YN, 2010, J BIOL CHEM, V285, P38720, DOI 10.1074/jbc.M110.158659; Xiao CY, 1996, J BIOL CHEM, V271, P6451, DOI 10.1074/jbc.271.11.6451; Zh LX, 2007, AM J PHYSIOL-CELL PH, V293, pC874, DOI 10.1152/ajpcell.00111.2007	36	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90629	10.1371/journal.pone.0090629	http://dx.doi.org/10.1371/journal.pone.0090629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599031	Green Submitted, gold, Green Published			2022-12-27	WOS:000332479400106
J	Zimmermann, M; Armeanu-Ebinger, S; Bossow, S; Lampe, J; Smirnow, I; Schenk, A; Lange, S; Weiss, TS; Neubert, W; Lauer, UM; Bitzer, M				Zimmermann, Martina; Armeanu-Ebinger, Sorin; Bossow, Sascha; Lampe, Johanna; Smirnow, Irina; Schenk, Andrea; Lange, Sebastian; Weiss, Thomas S.; Neubert, Wolfgang; Lauer, Ulrich M.; Bitzer, Michael			Attenuated and Protease-Profile Modified Sendai Virus Vectors as a New Tool for Virotherapy of Solid Tumors	PLOS ONE			English	Article							TARGETED ONCOLYTIC POXVIRUS; C-PROTEINS; HOST-CELL; CANCER; ACTIVATION; DEFECTS; THERAPY; FUSION; GENERATION; INHIBITION	Multiple types of oncolytic viruses are currently under investigation in clinical trials. To optimize therapeutic outcomes it is believed that the plethora of different tumor types will require a diversity of different virus types. Sendai virus (SeV), a murine parainfluenza virus, displays a broad host range, enters cells within minutes and already has been applied safely as a gene transfer vector in gene therapy patients. However, SeV spreading naturally is abrogated in human cells due to a lack of virus activating proteases. To enable oncolytic applications of SeV we here engineered a set of novel recombinant vectors by a two-step approach: (i) introduction of an ubiquitously recognized cleavage-motive into SeV fusion protein now enabling continuous spreading in human tissues, and (ii) profound attenuation of these rSeV by the knockout of viral immune modulating accessory proteins. When employing human hepatoma cell lines, newly generated SeV variants now reached high titers and induced a profound tumor cell lysis. In contrast, virus release from untransformed human fibroblasts or primary human hepatocytes was found to be reduced by about three log steps in a time course experiment which enables the cumulation of kinetic differences of the distinct phases of viral replication such as primary target cell infection, target cell replication, and progeny virus particle release. In a hepatoma xenograft animal model we found a tumor-specific spreading of our novel recombinant SeV vectors without evidence of biodistribution into non-malignant tissues. In conclusion, we successfully developed novel tumor-selective oncolytic rSeV vectors, constituting a new tool for virotherapy of solid tumors being ready for further preclinical and clinical development to address distinct tumor types.	[Zimmermann, Martina; Smirnow, Irina; Schenk, Andrea; Lauer, Ulrich M.; Bitzer, Michael] Med Univ Hosp, Dept Internal Med 1, Tubingen, Germany; [Armeanu-Ebinger, Sorin] Univ Childrens Hosp, Tubingen, Germany; [Bossow, Sascha] Natl Ctr Tumor Dis, Dept Translat Oncol, Heidelberg, Germany; [Lampe, Johanna] Inst Mol Med Finland FIMM, Helsinki, Finland; [Lange, Sebastian] Tech Univ Munich, Med Klin, Klinikum Rechts Isar, D-80290 Munich, Germany; [Weiss, Thomas S.] Univ Regensburg Hosp, Ctr Liver Cell Res, Dept Pediat & Adolescent Med, Regensburg, Germany; [Neubert, Wolfgang] Max Planck Inst Biochem, Dept Mol Virol, D-82152 Martinsried, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Technical University of Munich; University of Regensburg; Max Planck Society	Bitzer, M (corresponding author), Med Univ Hosp, Dept Internal Med 1, Tubingen, Germany.	michael.bitzer@uni-tuebingen.de	Lange, Sebastian/S-4635-2019; Weiss, Thomas S./G-3989-2012	Lange, Sebastian/0000-0003-0406-1401; Weiss, Thomas S./0000-0003-0336-0581	Deutsche Forschungsgemeinschaft [SFB 773, BI 669/3-6]; Federal Ministry for Education and Research of Germany [BMBF 01GU0506, 01GU0806]; Deutsche Forschungsgemeinschaft; Tuebingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry for Education and Research of Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University	This work was supported by grants from the Deutsche Forschungsgemeinschaft SFB 773 (B3) and BI 669/3-6, and from the Federal Ministry for Education and Research of Germany (BMBF 01GU0506 & 01GU0806). The authors acknowledge additional support by the "Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armeanu S, 2008, CLIN CANCER RES, V14, P3520, DOI 10.1158/1078-0432.CCR-07-4744; Berchtold S, 2013, J VIROL, V87, P3484, DOI 10.1128/JVI.02106-12; Bitzer M, 2003, Z GASTROENTEROL, V41, P667; Bitzer M, 2003, J GENE MED, V5, P543, DOI 10.1002/jgm.426; Bitzer M, 2003, MOL THER, V7, P210, DOI 10.1016/S1525-0016(02)00052-7; Bitzer M, 1999, J VIROL, V73, P702, DOI 10.1128/JVI.73.1.702-708.1999; Blechacz B, 2006, HEPATOLOGY, V44, P1465, DOI 10.1002/hep.21437; Bourke MG, 2011, CANCER TREAT REV, V37, P618, DOI 10.1016/j.ctrv.2010.12.003; Breitbach CJ, 2011, NATURE, V477, P99, DOI 10.1038/nature10358; Cattaneo R, 2008, NAT REV MICROBIOL, V6, P529, DOI 10.1038/nrmicro1927; Chen NG, 2012, ADV VIROL, V2012, DOI 10.1155/2012/320206; Fontana JM, 2008, IMMUNOL REV, V225, P46, DOI 10.1111/j.1600-065X.2008.00669.x; Galanis E, 2010, CANC RES; Garcin D, 1999, J VIROL, V73, P6559, DOI 10.1128/JVI.73.8.6559-6565.1999; Gotoh B, 1999, FEBS LETT, V459, P205, DOI 10.1016/S0014-5793(99)01241-7; Haddad D, 2012, J NUCL MED, V53, P1933, DOI 10.2967/jnumed.112.105056; Hasegawa Y, 2010, MOL THER, V18, P1778, DOI 10.1038/mt.2010.138; Hawkins LK, 2002, LANCET ONCOL, V3, P17, DOI 10.1016/S1470-2045(01)00618-0; Kato A, 2004, J VIROL, V78, P7443, DOI 10.1128/JVI.78.14.7443-7454.2004; Kelly E, 2007, MOL THER, V15, P651, DOI 10.1038/sj.mt.6300108; Keskinen P, 1999, VIROLOGY, V263, P364, DOI 10.1006/viro.1999.9983; KIDO H, 1992, J BIOL CHEM, V267, P13573; Kinoh H, 2004, GENE THER, V11, P1137, DOI 10.1038/sj.gt.3302272; Kinoh H, 2009, GENE THER, V16, P392, DOI 10.1038/gt.2008.167; Komatsu T, 2004, VIROLOGY, V325, P137, DOI 10.1016/j.virol.2004.04.025; Koyama S, 2008, CYTOKINE, V43, P336, DOI 10.1016/j.cyto.2008.07.009; Kurotani A, 1998, GENES CELLS, V3, P111, DOI 10.1046/j.1365-2443.1998.00170.x; Latorre P, 1998, J VIROL, V72, P5984, DOI 10.1128/JVI.72.7.5984-5993.1998; Laurie SA, 2006, CLIN CANCER RES, V12, P2555, DOI 10.1158/1078-0432.CCR-05-2038; Lech PJ, 2010, EXPERT REV VACCINES, V9, P1275, DOI 10.1586/ERV.10.124; Lemken ML, 2007, INT J ONCOL, V30, P1153; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; LINGE C, 1995, CANCER RES, V55, P4099; Markwell M A, 1984, Adv Exp Med Biol, V174, P369; MARKWELL MAK, 1980, P NATL ACAD SCI-BIOL, V77, P5693, DOI 10.1073/pnas.77.10.5693; MARKWELL MAK, 1981, P NATL ACAD SCI-BIOL, V78, P5406, DOI 10.1073/pnas.78.9.5406; Marozin S, 2008, MOL THER, V16, P1789, DOI 10.1038/mt.2008.201; Naik S, 2009, EXPERT OPIN BIOL TH, V9, P1163, DOI 10.1517/14712590903170653; Park BH, 2008, LANCET ONCOL, V9, P533, DOI 10.1016/S1470-2045(08)70107-4; Patel MR, 2013, TRANSL RES, V161, P355, DOI 10.1016/j.trsl.2012.12.010; Persano L, 2009, CARCINOGENESIS, V30, P851, DOI 10.1093/carcin/bgp052; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Slobod KS, 2004, VACCINE, V22, P3182, DOI 10.1016/j.vaccine.2004.01.053; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Straehle L, 2007, J VIROL, V81, P12227, DOI 10.1128/JVI.01300-07; Stritzker J, 2013, P NATL ACAD SCI USA, V110, P3316, DOI 10.1073/pnas.1216916110; Takeuchi K, 2001, GENES CELLS, V6, P545, DOI 10.1046/j.1365-2443.2001.00442.x; Villar E, 2006, GLYCOCONJUGATE J, V23, P5, DOI 10.1007/s10719-006-5433-0; Wiegand MA, 2007, J VIROL, V81, P13835, DOI 10.1128/JVI.00914-07; Yonemitsu Y, 2013, MOL THER, V21, P707, DOI 10.1038/mt.2012.279; Yoshida A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049968	52	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90508	10.1371/journal.pone.0090508	http://dx.doi.org/10.1371/journal.pone.0090508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598703	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400083
J	Pan, CQ; Trinh, H; Yao, A; Bae, H; Lou, L; Chan, S				Pan, Calvin Q.; Huy Trinh; Yao, Alan; Bae, Ho; Lou, Lillian; Chan, Sing		Study 123 Grp	Efficacy and Safety of Tenofovir Disoproxil Fumarate in Asian-Americans with Chronic Hepatitis B in Community Settings	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA INCIDENCE; LONG-TERM THERAPY; ADEFOVIR DIPIVOXIL; VIRAL SUPPRESSION; HBV DNA; REGRESSION; FIBROTEST; TDF; EMTRICITABINE; PROGRESSION	Background and aims: Chronic hepatitis B (CHB) disproportionately affects the Asian-American population in the USA. Tenofovir disoproxil fumarate (TDF) has demonstrated potent antiviral activity in clinical trials, but data in Asian-Americans from community studies are lacking. Methods: Adult Asian-American patients with CHB from private medical and community-based practices were prospectively enrolled and treated with open-label TDF 300 mg once daily in a single-arm study for 48 weeks. After Week 48, patients had the option to transition to commercially available CHB therapy. The primary efficacy endpoint was hepatitis B virus (HBV) DNA <400 copies/mL at Week 48. Secondary endpoints were safety and tolerability, serologic and biochemical responses, liver fibrosis by FibroTest, and the development of drug-resistant mutations. Results: Of the 90 patients enrolled, 53 (58%) were hepatitis B e antigen (HBeAg)-positive at baseline. At Week 48, 74 patients (82% overall; 70% HBeAg-positive and 100% HBeAg-negative) had HBV DNA <400 copies/mL. Six (12%) HBeAg-positive patients achieved HBeAg loss/seroconversion. The percentage of patients with alanine aminotransferase in the normal range increased from 26% at baseline to 66% at Week 48. The percentage of patients with F0 (no or minimal) fibrosis by FibroTest increased from 48% to 51%, and those with F4 (severe) fibrosis decreased from 4% to 1%. No resistance to TDF developed. Treatment was well tolerated. Most adverse events were mild in severity and considered unrelated to study drug. Conclusions: TDF is effective and well tolerated in Asian-American CHB patients in community clinic-based settings, consistent with larger registration trials. Improvement in liver fibrosis was seen in a proportion of patients. No resistance to TDF developed through 48 weeks of treatment.	[Pan, Calvin Q.] NYU, Sch Med, Dept Med, Div Gastroenterol,Langone Med Ctr, New York, NY USA; [Huy Trinh] San Jose Gastroenterol, San Jose, CA USA; [Yao, Alan] AE & LY Med Associates, Flushing, NY USA; [Bae, Ho] St Vincents Med Ctr, Asian Pacific Liver Ctr, Los Angeles, CA USA; [Lou, Lillian] Nexus Dev, Palo Alto, CA USA; [Chan, Sing] Sing Chan Endoscopy, Flushing, NY 11355 USA	New York University; NYU Langone Medical Center	Chan, S (corresponding author), Sing Chan Endoscopy, Flushing, NY 11355 USA.	singchang@gi-chan.com			Gilead, Foster City, USA	Gilead, Foster City, USA	The study was sponsored by Gilead, Foster City, USA. The funders participated in the study design, data collection and analysis of the data. The funders had no role in the decision to publish the manuscript. Editorial support for the development of the manuscript was funded by the sponsor and provided by Carol Lovegrove, Elements Communications, Westerham, Kent, UK.	Baranova A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-91; Berg T, 2010, GASTROENTEROLOGY, V139, P1207, DOI 10.1053/j.gastro.2010.06.053; Chao SD, 2009, ASIAN PAC J CANCER P, V10, P507; Chu CJ, 2002, HEPATOLOGY, V36, P1408, DOI 10.1053/jhep.2002.36949; Corsa AC, 2012, HEPATOLOGY, V56, p382A; Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024; Fung S, 2012, HEPATOLOGY S, V56, p[S14, 200A]; Gane EJ, 2011, HEPATOLOGY, V54, p1038A; Gish RG, 2010, J VIRAL HEPATITIS, V17, P16, DOI 10.1111/j.1365-2893.2009.01146.x; Halfon P, 2008, GASTROEN CLIN BIOL, V32, P22, DOI 10.1016/S0399-8320(08)73991-5; Hosaka T, 2013, HEPATOLOGY, V58, P98, DOI 10.1002/hep.26180; Ikeda F, 2012, J MED VIROL, V84, P1562, DOI 10.1002/jmv.23371; Kim BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035825; Lai CL, 2013, HEPATOLOGY, V57, P399, DOI 10.1002/hep.25937; Lampertico P, 2012, HEPATOLOGY, V56, p389A; Lee SS, 2008, HEPATOLOGY, V48, p746A; Liaw YF, 2006, ANTIVIR THER, V11, P669; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; Lin SY, 2007, HEPATOLOGY, V46, P1034, DOI 10.1002/hep.21784; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Lok ASF, 2013, NAT REV GASTRO HEPAT, V10, P199, DOI 10.1038/nrgastro.2013.13; MARCELLIN P, 2012, J HEPATOL S2, V56, pS210; Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Pan CQ, 2013, ANTIVIR THER, V18, P841, DOI 10.3851/IMP2481; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; PETERSEN J, 2012, J HEPATOL S2, V56, pS212; Pollack H., 2006, Morbidity and Mortality Weekly Report, V55, P505; Poynard T, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-40; Poynard T, 2012, J HEPATOL, V57, P541, DOI 10.1016/j.jhep.2012.04.025; Quang YN, 2010, J AM COLL HEALTH, V59, P37, DOI 10.1080/07448481.2010.486811; Ribeiro RM, 2010, J INFECT DIS, V202, P1309, DOI 10.1086/656528; Rijckborst V, 2011, ALIMENT PHARM THER, V33, P501, DOI 10.1111/j.1365-2036.2010.04555.x; Robotin MC, 2011, WORLD J HEPATOL, V3, P31, DOI 10.4254/wjh.v3.i2.31; Snow-Lampart A, 2011, HEPATOLOGY, V53, P763, DOI 10.1002/hep.24078; Tong MJ, 2011, DIGEST DIS SCI, V56, P3143, DOI 10.1007/s10620-011-1841-5; van Bommel F, 2012, J HEPATOL S2, V57, pS544; Wong R, 2008, AM J MED, V121, P525, DOI 10.1016/j.amjmed.2008.03.005	39	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89789	10.1371/journal.pone.0089789	http://dx.doi.org/10.1371/journal.pone.0089789			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594870	gold, Green Published, Green Submitted			2022-12-27	WOS:000332475500022
J	Reddy, PS; Kishor, PBK; Seiler, C; Kuhlmann, M; Eschen-Lippold, L; Lee, J; Reddy, MK; Sreenivasulu, N				Reddy, Palakolanu Sudhakar; Kishor, Polavarapu B. Kavi; Seiler, Christiane; Kuhlmann, Markus; Eschen-Lippold, Lennart; Lee, Justin; Reddy, Malireddy K.; Sreenivasulu, Nese			Unraveling Regulation of the Small Heat Shock Proteins by the Heat Shock Factor HvHsfB2c in Barley: Its Implications in Drought Stress Response and Seed Development	PLOS ONE			English	Article							ALPHA-CRYSTALLIN DOMAIN; ORYZA-SATIVA L.; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; SUBCELLULAR-LOCALIZATION; MOLECULAR CHAPERONES; EXPRESSION ANALYSIS; ABIOTIC STRESS; I-TASSER; GENE	The rapid increase in heat shock proteins upon exposure to damaging stresses and during plant development related to desiccation events reveal their dual importance in plant development and stress tolerance. Genome-wide sequence survey identified 20 non-redundant small heat shock proteins (sHsp) and 22 heat shock factor (Hsf) genes in barley. While all three major classes (A, B, C) of Hsfs are localized in nucleus, the 20 sHsp gene family members are localized in different cell organelles like cytoplasm, mitochondria, plastid and peroxisomes. Hsf and sHsp members are differentially regulated during drought and at different seed developmental stages suggesting the importance of chaperone role under drought as well as seed development. In silico cis-regulatory motif analysis of Hsf promoters showed an enrichment with abscisic acid responsive cis-elements (ABRE), implying regulatory role of ABA in mediating transcriptional response of HvsHsf genes. Gene regulatory network analysis identified HvHsfB2c as potential central regulator of the seed-specific expression of several HvsHsps including 17.5CI sHsp. These results indicate that HvHsfB2c is co-expressed in the central hub of small Hsps and therefore it may be regulating the expression of several HvsHsp subclasses HvHsp16.88-CI, HvHsp17.5-CI and HvHsp17.7-CI. The in vivo relevance of binding specificity of HvHsfB2C transcription factor to HSE-element present in the promoter of HvSHP17.5-CI under heat stress exposure is confirmed by gel shift and LUC-reporter assays. Further, we isolated 477 bp cDNA from barley encoding a 17.5 sHsp polypeptide, which was predominantly upregulated under drought stress treatments and also preferentially expressed in developing seeds. Recombinant HvsHsp17.5-CI protein was expressed in E. coli and purified to homogeneity, which displayed in vitro chaperone activity. The predicted structural model of HvsHsp17.5-CI protein suggests that the alpha-crystallin domain is evolutionarily highly conserved.	[Reddy, Palakolanu Sudhakar; Kishor, Polavarapu B. Kavi; Seiler, Christiane; Kuhlmann, Markus; Sreenivasulu, Nese] Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany; [Kishor, Polavarapu B. Kavi] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India; [Kuhlmann, Markus; Sreenivasulu, Nese] Interdisciplinary Ctr Crop Plant Res, Res Grp Abiot Stress Genom, Halle, Germany; [Eschen-Lippold, Lennart; Lee, Justin] Leibniz Inst Plant Biochem IPB, Halle, Germany; [Reddy, Malireddy K.] Int Ctr Genet Engn & Biotechnol, New Delhi, India	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Osmania University; Leibniz Institut fur Pflanzenbiochemie; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Sreenivasulu, N (corresponding author), Int Rice Res Inst, Grain Qual & Nutr Ctr, Manila, Philippines.	srinivas@ipk-gatersleben.de	Lee, Justin/B-6096-2012; Sreenivasulu, Nese/E-8600-2011; Eschen-Lippold, Lennart/I-5098-2016	Lee, Justin/0000-0001-8269-7494; Sreenivasulu, Nese/0000-0002-3998-038X; Eschen-Lippold, Lennart/0000-0001-8907-6922; Kavi Kishor, Polavarapu/0000-0002-9587-7547; Kuhlmann, Markus/0000-0003-3104-0825	IB-BMBF [IND 09/526]; Ministry of Education, SaxonyAnhalt; Germany Academic Exchange programme (DAAD) [A/11/94309]	IB-BMBF; Ministry of Education, SaxonyAnhalt; Germany Academic Exchange programme (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The authors work in the NS laboratory has been supported by grants from the IB-BMBF (IND 09/526) and from the Ministry of Education, SaxonyAnhalt. PSR acknowledges the Leibniz-DAAD post doctoral fellowship award (Number: A/11/94309) from Germany Academic Exchange programme (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almoguera C, 2002, J BIOL CHEM, V277, P43866, DOI 10.1074/jbc.M207330200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Basha E, 2010, J BIOL CHEM, V285, P11489, DOI 10.1074/jbc.M109.074088; Begum T, 2013, MECH DEVELOP, V130, P54, DOI 10.1016/j.mod.2012.05.008; Busch W, 2005, PLANT J, V41, P1, DOI 10.1111/j.1365-313X.2004.02272.x; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Chauhan H, 2012, PLANT CELL ENVIRON, V35, P1912, DOI 10.1111/j.1365-3040.2012.02525.x; Chauhan H, 2011, MOL GENET GENOMICS, V286, P171, DOI 10.1007/s00438-011-0638-8; Close TJ, 2004, PLANT PHYSIOL, V134, P960, DOI 10.1104/pp.103.034462; De Bodt S, 2012, NEW PHYTOL, V195, P707, DOI 10.1111/j.1469-8137.2012.04184.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hong SW, 2001, PLANT J, V27, P25, DOI 10.1046/j.1365-313x.2001.01066.x; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Ikeda M, 2011, PLANT PHYSIOL, V157, P1243, DOI 10.1104/pp.111.179036; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kotak S, 2004, PLANT J, V39, P98, DOI 10.1111/j.1365-313X.2004.02111.x; Kotak S, 2007, PLANT CELL, V19, P182, DOI 10.1105/tpc.106.048165; Kuhlmann M, 2003, J BIOL CHEM, V278, P8786, DOI 10.1074/jbc.M210292200; LEE GJ, 1995, J BIOL CHEM, V270, P10432, DOI 10.1074/jbc.270.18.10432; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lin YX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-76; Lohmann C, 2004, MOL GENET GENOMICS, V271, P11, DOI 10.1007/s00438-003-0954-8; Long TA, 2008, ANNU REV CELL DEV BI, V24, P81, DOI 10.1146/annurev.cellbio.24.110707.175408; Low D, 2000, PLANTA, V211, P575, DOI 10.1007/s004250000315; Ma SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r49; Matsumoto T, 2011, PLANT PHYSIOL, V156, P20, DOI 10.1104/pp.110.171579; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Mittal D, 2009, PLANT PHYSIOL BIOCH, V47, P785, DOI 10.1016/j.plaphy.2009.05.003; Morrow G, 2000, J BIOL CHEM, V275, P31204, DOI 10.1074/jbc.M002960200; Mutwil M, 2011, PLANT CELL, V23, P895, DOI 10.1105/tpc.111.083667; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nover L, 2001, CELL STRESS CHAPERON, V6, P177, DOI 10.1379/1466-1268(2001)006<0177:AATHST>2.0.CO;2; Prandl R, 1996, PLANT MOL BIOL, V31, P157, DOI 10.1007/BF00020615; Puigderrajols P, 2002, J EXP BOT, V53, P1445, DOI 10.1093/jexbot/53.373.1445; Rana RM, 2012, J EXP BOT, V63, P6003, DOI 10.1093/jxb/ers245; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; Reddy PS, 2012, MOL BIOL REP, V39, P7163, DOI 10.1007/s11033-012-1548-5; Reddy PS, 2011, GENE, V474, P29, DOI 10.1016/j.gene.2010.12.004; Ren YJ, 2012, PLANT CELL ENVIRON, V35, P770, DOI 10.1111/j.1365-3040.2011.02450.x; Rojas A, 1999, PLANT J, V20, P601, DOI 10.1046/j.1365-313X.1999.00635.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sarkar NK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-393; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; Siddique M, 2003, CELL STRESS CHAPERON, V8, P381, DOI 10.1379/1466-1268(2003)008<0381:THSPHR>2.0.CO;2; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Sreenivasulu N, 2008, PLANT PHYSIOL, V146, P1738, DOI 10.1104/pp.107.111781; Sreenivasulu N, 2006, PLANT J, V47, P310, DOI 10.1111/j.1365-313X.2006.02789.x; Sreenivasulu N, 2013, ANNU REV PLANT BIOL, V64, P189, DOI 10.1146/annurev-arplant-050312-120215; Sreenivasulu N, 2012, GENE, V506, P265, DOI 10.1016/j.gene.2012.06.076; Stamler R, 2005, J MOL BIOL, V353, P68, DOI 10.1016/j.jmb.2005.08.025; STRAUB PF, 1994, PLANT MOL BIOL, V26, P617, DOI 10.1007/BF00013748; Sun CW, 1997, PLANT J, V11, P1017, DOI 10.1046/j.1365-313X.1997.11051017.x; Sun WN, 2001, PLANT J, V27, P407, DOI 10.1046/j.1365-313X.2001.01107.x; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; von Koskull-Doring P, 2007, TRENDS PLANT SCI, V12, P452, DOI 10.1016/j.tplants.2007.08.014; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Waters ER, 2008, CELL STRESS CHAPERON, V13, P127, DOI 10.1007/s12192-008-0023-7; Waters ER, 2013, J EXP BOT, V64, P391, DOI 10.1093/jxb/ers355; Wehmeyer N, 2000, PLANT PHYSIOL, V122, P1099, DOI 10.1104/pp.122.4.1099; Wehmeyer N, 1996, PLANT PHYSIOL, V112, P747, DOI 10.1104/pp.112.2.747; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	64	44	48	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89125	10.1371/journal.pone.0089125	http://dx.doi.org/10.1371/journal.pone.0089125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594978	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000332475500010
J	Sikulu, MT; Majambere, S; Khatib, BO; Ali, AS; Hugo, LE; Dowell, FE				Sikulu, Maggy T.; Majambere, Silas; Khatib, Bakar O.; Ali, Abdullah S.; Hugo, Leon E.; Dowell, Floyd E.			Using a Near-Infrared Spectrometer to Estimate the Age of Anopheles Mosquitoes Exposed to Pyrethroids	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; CUTICULAR HYDROCARBONS; GAMBIAE COMPLEX; MALARIA; IDENTIFICATION; CULICIDAE; SPECTROSCOPY; POPULATIONS; RESISTANCE; NETS	We report on the accuracy of using near-infrared spectroscopy (NIRS) to predict the age of Anopheles mosquitoes reared from wild larvae and a mixed age-wild adult population collected from pit traps after exposure to pyrethroids. The mosquitoes reared from wild larvae were estimated as <7 or >= 7 d old with an overall accuracy of 79%. The age categories of Anopheles mosquitoes that were not exposed to the insecticide papers were predicted with 78% accuracy whereas the age categories of resistant, susceptible and mosquitoes exposed to control papers were predicted with 82%, 78% and 79% accuracy, respectively. The ages of 85% of the wild-collected mixed-age Anopheles were predicted by NIRS as <= 8 d for both susceptible and resistant groups. The age structure of wild-collected mosquitoes was not significantly different for the pyrethroid-susceptible and pyrethroid-resistant mosquitoes (P = 0.210). Based on these findings, NIRS chronological age estimation technique for Anopheles mosquitoes may be independent of insecticide exposure and the environmental conditions to which the mosquitoes are exposed.	[Sikulu, Maggy T.; Hugo, Leon E.] QIMR Berghofer Med Res Inst, Mosquito Control Lab, Brisbane, Qld, Australia; [Sikulu, Maggy T.] Griffith Univ, Environm Futures Ctr, Brisbane, Qld 4111, Australia; [Sikulu, Maggy T.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania; [Majambere, Silas] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [Majambere, Silas; Khatib, Bakar O.; Ali, Abdullah S.] Minist Hlth & Social Welf, Zanzibar Malaria Control Programme, Zanzibar, Tanzania; [Dowell, Floyd E.] ARS, Engn & Wind Eros Res Unit, USDA, Ctr Grain & Anim Hlth Res, Manhattan, KS USA	QIMR Berghofer Medical Research Institute; Griffith University; Ifakara Health Institute; Liverpool School of Tropical Medicine; University of Liverpool; United States Department of Agriculture (USDA)	Sikulu, MT (corresponding author), QIMR Berghofer Med Res Inst, Mosquito Control Lab, Brisbane, Qld, Australia.	maggy.sikulu@qimrberghofer.edu.au	Hugo, R. Leon E/O-3013-2018; Sikulu-Lord, Maggy/L-8158-2017	Hugo, R. Leon E/0000-0002-6767-9850; Sikulu-Lord, Maggy/0000-0002-9346-2970	CDC	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by a CDC cooperative agreement grant awarded to Ifakara Health Institute to support the NIRS work. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beier JC, 1998, ANNU REV ENTOMOL, V43, P519, DOI 10.1146/annurev.ento.43.1.519; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Caputo B, 2005, J MASS SPECTROM, V40, P1595, DOI 10.1002/jms.961; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Cook PE, 2010, INSECT MOL BIOL, V19, P745, DOI 10.1111/j.1365-2583.2010.01034.x; Desena ML, 1999, J MED ENTOMOL, V36, P811, DOI 10.1093/jmedent/36.6.811; Desena ML, 1999, J MED ENTOMOL, V36, P824, DOI 10.1093/jmedent/36.6.824; DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13; Dowell FE, 2011, AM J TROP MED HYG, V85, P1093, DOI 10.4269/ajtmh.2011.11-0438; GILLIES MT, 1965, B ENTOMOL RES, V56, P237, DOI 10.1017/S0007485300056339; Glunt KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024968; Haji KA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-82; Hugo LE, 2006, AM J TROP MED HYG, V74, P462, DOI 10.4269/ajtmh.2006.74.462; Hugo LE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000608; Jones CM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-24; LINES JD, 1991, MED VET ENTOMOL, V5, P261, DOI 10.1111/j.1365-2915.1991.tb00550.x; MAGESA SM, 1991, ACTA TROP, V49, P97, DOI 10.1016/0001-706X(91)90057-Q; Mayagaya VS, 2009, AM J TROP MED HYG, V81, P622, DOI 10.4269/ajtmh.2009.09-0192; MNZAVA AEP, 1986, ACTA TROP, V43, P277; Ntamatungiro AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-298; Polovodova V., 1949, MED PARASITOL, V28, P352; Rajatileka S, 2011, T ROY SOC TROP MED H, V105, P247, DOI 10.1016/j.trstmh.2011.01.009; ROBERT V, 1991, B WORLD HEALTH ORGAN, V69, P735; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Sikulu M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-186; Sikulu M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-49; Wang MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069439; Wang MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013359; WHO, 1998, B WHO	29	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90657	10.1371/journal.pone.0090657	http://dx.doi.org/10.1371/journal.pone.0090657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594705	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000332475500084
J	Vaessen, MJ; Jansen, JFA; Braakman, HMH; Hofman, PAM; De Louw, A; Aldenkamp, AP; Backes, WH				Vaessen, Maarten J.; Jansen, Jacobus F. A.; Braakman, Hilde M. H.; Hofman, Paul A. M.; De Louw, Anton; Aldenkamp, Albert P.; Backes, Walter H.			Functional and Structural Network Impairment in Childhood Frontal Lobe Epilepsy	PLOS ONE			English	Article							BRAIN NETWORKS; MODULAR ORGANIZATION; COMMUNITY STRUCTURE; COGNITIVE DECLINE; CONNECTIVITY; DIFFUSION; CHILDREN; ABNORMALITIES; EFFICIENCY	In childhood frontal lobe epilepsy (FLE), cognitive impairment and educational underachievement are serious, well-known co-morbidities. The broad scale of affected cognitive domains suggests wide-spread network disturbances that not only involves, but also extends beyond the frontal lobe. In this study we have investigated whole brain connectional properties of children with FLE in relation to their cognitive impairment and compared them with healthy controls. Functional connectivity (FC) of the networks was derived from dynamic fluctuations of resting state fMRI and structural connectivity (SC) was obtained from fiber tractograms of diffusion weighted MRI. The whole brain network was characterized with graph theoretical metrics and decomposed into modules. Subsequently, the graph metrics and the connectivity within and between modules were related to cognitive performance. Functional network disturbances in FLE were related to increased clustering, increased path length, and stronger modularity compared to healthy controls, which was accompanied by stronger within- and weaker between-module functional connectivity. Although structural path length and clustering appeared normal in children with FLE, structural modularity increased with stronger cognitive impairment. It is concluded that decreased coupling between large-scale functional network modules is a hallmark for impaired cognition in childhood FLE.	[Vaessen, Maarten J.; Jansen, Jacobus F. A.; Hofman, Paul A. M.; Backes, Walter H.] Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands; [Vaessen, Maarten J.; Braakman, Hilde M. H.; Hofman, Paul A. M.; De Louw, Anton; Aldenkamp, Albert P.] Epilepsy Ctr Kempenhaeghe, Dept Res & Dev, Heeze, Netherlands; [Vaessen, Maarten J.; Jansen, Jacobus F. A.; Braakman, Hilde M. H.; Hofman, Paul A. M.; Aldenkamp, Albert P.; Backes, Walter H.] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Braakman, Hilde M. H.; Aldenkamp, Albert P.] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Vaessen, MJ (corresponding author), Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands.	m.vaessen@gmail.com	Jansen, Jacobus F.A./C-4098-2009	Jansen, Jacobus F.A./0000-0002-5271-8060	Dutch National Epilepsy Foundation (NEF)	Dutch National Epilepsy Foundation (NEF)	This work was supported by the Dutch National Epilepsy Foundation (NEF, http://www.epilepsiefonds.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Aldenkamp AP, 2004, CHILD NEUROPSYCHOL, V10, P297, DOI 10.1080/09297040490909341; Alexander-Bloch A, 2012, NEUROIMAGE, V59, P3889, DOI 10.1016/j.neuroimage.2011.11.035; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; Bonilha L, 2012, J NEUROL NEUROSUR PS, V83, P903, DOI 10.1136/jnnp-2012-302476; Braakman HMH, 2012, EUR J PAEDIATR NEURO, V16, P707, DOI 10.1016/j.ejpn.2012.05.003; Braakman HMH, 2011, EPILEPSIA, V52, P849, DOI 10.1111/j.1528-1167.2011.03057.x; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Ethofer T, 2011, NEUROIMAGE, V55, P411, DOI 10.1016/j.neuroimage.2010.11.033; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Ghosh SS, 2010, NEUROIMAGE, V53, P85, DOI 10.1016/j.neuroimage.2010.05.075; Ginestet CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021570; Gratton C, 2012, J COGNITIVE NEUROSCI, V24, P1275, DOI 10.1162/jocn_a_00222; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johansen-Berg H, 2011, NEUROIMAGE; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Lancichinetti A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00336; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; MANFORD M, 1992, NEUROLOGY, V42, P1911; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Pereira FRS, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-66; Powell HWR, 2007, NEUROIMAGE, V36, P209, DOI 10.1016/j.neuroimage.2007.02.028; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Pravata E, 2011, AM J NEURORADIOL, V32, P532, DOI 10.3174/ajnr.A2311; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Stadlbauer A, 2008, RADIOLOGY, V247, P179, DOI 10.1148/radiol.2471070707; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Telesford Qawi K, 2010, Front Neuroinform, V4, P117, DOI 10.3389/fninf.2010.00117; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011; Vaessen M, 2011, EPILEPSIA, V52, P166; Vaessen MJ, 2013, CEREB CORTEX, V23, P1997, DOI 10.1093/cercor/bhs186; Vaessen MJ, 2012, CEREB CORTEX, V22, P2139, DOI 10.1093/cercor/bhr298; Vaessen MJ, 2011, ABNORMAL MODUL UNPUB; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vlooswijk MCG, 2011, NEUROLOGY, V77, P938, DOI 10.1212/WNL.0b013e31822cfc2f; Vlooswijk MCG, 2010, NEUROLOGY, V75, P395, DOI 10.1212/WNL.0b013e3181ebdd3e; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Widjaja E, 2013, AM J NEURORADIOL, V34, P2386, DOI 10.3174/ajnr.A3608; Xue KQ, 2014, EPILEPSY RES, V108, P125, DOI 10.1016/j.eplepsyres.2013.10.002; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	60	40	41	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90068	10.1371/journal.pone.0090068	http://dx.doi.org/10.1371/journal.pone.0090068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594874	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500033
J	Zambelli, VO; Fernandes, ACD; Gutierrez, VP; Ferreira, JCB; Parada, CA; Mochly-Rosen, D; Cury, Y				Zambelli, Vanessa Olzon; de Oliveira Fernandes, Ana Carolina; Gutierrez, Vanessa Pacciari; Batista Ferreira, Julio Cesar; Parada, Carlos Amilcar; Mochly-Rosen, Daria; Cury, Yara			Peripheral Sensitization Increases Opioid Receptor Expression and Activation by Crotalphine in Rats	PLOS ONE			English	Article							PROTEIN-KINASE-C; TERRIFICUS SNAKE-VENOM; DORSAL-ROOT GANGLIA; PRIMARY AFFERENT; SPINAL-CORD; UP-REGULATION; KAPPA; INFLAMMATION; DELTA; ANTINOCICEPTION	Inflammation enhances the peripheral analgesic efficacy of opioid drugs, but the mechanisms involved in this phenomenon have not been fully elucidated. Crotalphine (CRP), a peptide that was first isolated from South American rattlesnake C.d. terrificus venom, induces a potent and long-lasting anti-nociceptive effect that is mediated by the activation of peripheral opioid receptors. Because the high efficacy of CRP is only observed in the presence of inflammation, we aimed to elucidate the mechanisms involved in the CRP anti-nociceptive effect induced by inflammation. Using real-time RT-PCR, western blot analysis and ELISA assays, we demonstrate that the intraplantar injection of prostaglandin E2 (PGE(2)) increases the mRNA and protein levels of the mu-and kappa-opioid receptors in the dorsal root ganglia (DRG) and paw tissue of rats within 3 h of the injection. Using conformation state-sensitive antibodies that recognize activated opioid receptors, we show that PGE(2), alone does not increase the activation of these opioid receptors but that in the presence of PGE(2), the activation of specific opioid receptors by CRP and selective mu-and kappa-opioid receptor agonists (positive controls) increases. Furthermore, PGE2 down-regulated the expression and activation of the delta-opioid receptor. CRP increased the level of activated mitogen-activated protein kinases in cultured DRG neurons, and this increase was dependent on the activation of protein kinase C zeta. This CRP effect was much more prominent when the cells were pretreated with PGE(2). These results indicate that the expression and activation of peripheral opioid receptors by opioid-like drugs can be up- or down-regulated in the presence of an acute injury and that acute tissue injury enhances the efficacy of peripheral opioids.	[Zambelli, Vanessa Olzon; de Oliveira Fernandes, Ana Carolina; Gutierrez, Vanessa Pacciari; Cury, Yara] Inst Butantan, Lab Especial Dor & Sinalizacao, Sao Paulo, Brazil; [Batista Ferreira, Julio Cesar] Univ Sao Paulo, Inst Ciencias Biomed, Dept Anat, BR-05508 Sao Paulo, Brazil; [Parada, Carlos Amilcar] Inst Biociencias UNICAMP, Dept Fisiol & Biofis, Campinas, SP, Brazil; [Mochly-Rosen, Daria] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA	Instituto Butantan; Universidade de Sao Paulo; Stanford University	Cury, Y (corresponding author), Inst Butantan, Lab Especial Dor & Sinalizacao, Sao Paulo, Brazil.	yara.cury@butantan.gov.br	Ferreira, Julio Cesar Batista/I-3177-2012; Ferreira, Julio Cesar Batista/AEU-0494-2022; Parada, Carlos Amilcar/C-3974-2012; Ferreira, Julio/L-4687-2019; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Zambelli, Vanessa O/C-2716-2013	Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Amilcar Parada, Carlos/0000-0001-5209-8853; Zambelli, Vanessa/0000-0003-0890-9561; Mochly-Rosen, Daria/0000-0002-6691-8733	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP) [07/03404-4, 07/00135-2]; Instituto Nacional de Ciencia e Tecnologia em Toxinologia (INCTTOX PROGRAM) of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [573790/2008-6]; FAPESP [2008/57898-0]; CAPES/CNPq [301508/2008-9, 305345/2011-7]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA011147] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Nacional de Ciencia e Tecnologia em Toxinologia (INCTTOX PROGRAM) of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by funds from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP, grant numbers 07/03404-4, 07/00135-2), Instituto Nacional de Ciencia e Tecnologia em Toxinologia (INCTTOX PROGRAM) of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant number 573790/2008-6)/FAPESP (grant number 2008/57898-0) and CAPES/CNPq, grant numbers 301508/2008-9 and 305345/2011-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarante LH, 2002, EUR J PHARMACOL, V454, P19, DOI 10.1016/S0014-2999(02)02275-6; ANTONIJEVIC I, 1995, J NEUROSCI, V15, P165; Belcheva MM, 1998, J NEUROCHEM, V70, P635; Belcheva MM, 2005, J BIOL CHEM, V280, P27662, DOI 10.1074/jbc.M502593200; BERRA E, 1993, CELL, V74, P555, DOI 10.1016/0092-8674(93)80056-K; Bohn LM, 2000, J NEUROCHEM, V74, P564, DOI 10.1046/j.1471-4159.2000.740564.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruchas MR, 2008, NEUROREPORT, V19, P1417, DOI 10.1097/WNR.0b013e32830dd655; Bruchas MR, 2007, J BIOL CHEM, V282, P29803, DOI 10.1074/jbc.M705540200; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Bruchas MR, PSYCHOPHARMACOLOGY B, V210, P137; Cahill CM, 2003, PAIN, V101, P199, DOI 10.1016/S0304-3959(02)00333-0; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Connor M, 1999, CLIN EXP PHARMACOL P, V26, P493, DOI 10.1046/j.1440-1681.1999.03049.x; Cunha TM, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-10; Cunha TM, 2010, P NATL ACAD SCI USA, V107, P4442, DOI 10.1073/pnas.0914733107; Decaillot FM, 2003, NAT STRUCT BIOL, V10, P629, DOI 10.1038/nsb950; FERREIRA SH, 1981, PROSTAGLANDINS, V21, P789, DOI 10.1016/0090-6980(81)90235-5; Furst S, 2005, J PHARMACOL EXP THER, V312, P609, DOI 10.1124/jpet.104.075176; Gendron L, 2007, NEUROSCIENCE, V150, P807, DOI 10.1016/j.neuroscience.2007.09.060; Granados-Soto V, 1997, EUR J PHARMACOL, V340, P177, DOI 10.1016/S0014-2999(97)01399-X; Gupta A, 2006, J BIOL CHEM; Gutierrez VP, 2008, EUR J PHARMACOL, V594, P84, DOI 10.1016/j.ejphar.2008.07.053; Gutierrez VP, BEHAV PHARM, V23, P14; HASSAN AHS, 1993, NEUROSCIENCE, V55, P185, DOI 10.1016/0306-4522(93)90465-R; Ji YP, 2007, J PAIN, V8, P494, DOI 10.1016/j.jpain.2007.01.006; Konno K, 2008, PEPTIDES; Kreibich AS, 2004, J NEUROSCI, V24, P6686, DOI 10.1523/JNEUROSCI.1706-04.2004; Kwong K, 2005, J PHYSIOL-LONDON, V564, P437, DOI 10.1113/jphysiol.2004.078725; Law BK, 2000, J BIOL CHEM, V275, P38261, DOI 10.1074/jbc.M005545200; Lecat S, 2002, J BIOL CHEM, V277, P42034, DOI 10.1074/jbc.M203606200; Lomas LM, 2007, PSYCHOPHARMACOLOGY, V191, P273, DOI 10.1007/s00213-006-0663-1; Maekawa K, 1996, PAIN, V64, P365, DOI 10.1016/0304-3959(95)00132-8; Melief EJ, 2010, P NATL ACAD SCI USA, V107, P11608, DOI 10.1073/pnas.1000751107; Mousa SA, 2001, J NEUROIMMUNOL, V115, P71, DOI 10.1016/S0165-5728(01)00271-5; Mousa SA, 2002, J NEUROIMMUNOL, V126, P5, DOI 10.1016/S0165-5728(02)00049-8; Nunez S, 2007, NEUROSCIENCE, V146, P1346, DOI 10.1016/j.neuroscience.2007.02.024; Obara I, 2009, PAIN, V141, P283, DOI 10.1016/j.pain.2008.12.006; Pacheco DF, 2005, LIFE SCI, V78, P54, DOI 10.1016/j.lfs.2005.04.032; Picolo G, 2004, LIFE SCI, V75, P559, DOI [10.1016/S0024-3205(04)00292-9, 10.1016/j.lfs.2003.12.024]; Picolo G, 1998, TOXICON, V36, P223, DOI 10.1016/S0041-0101(97)00048-2; Picolo G, 2000, EUR J PHARMACOL, V391, P55, DOI 10.1016/S0014-2999(99)00934-6; Puehler W, 2004, NEUROSCIENCE, V129, P473, DOI 10.1016/j.neuroscience.2004.06.086; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P209; Sachs D, 2004, P NATL ACAD SCI USA, V101, P3680, DOI 10.1073/pnas.0308382101; SCHAFER M, 1995, EUR J PHARMACOL, V279, P165, DOI 10.1016/0014-2999(95)00150-J; SELLEY DE, 1993, MOL PHARMACOL, V44, P731; Shaqura MA, 2004, J PHARMACOL EXP THER, V308, P712, DOI 10.1124/jpet.103.057257; Southall MD, 2001, J BIOL CHEM, V276, P16083, DOI 10.1074/jbc.M011408200; STEIN C, 1993, ANESTH ANALG, V76, P182; STEIN C, 1989, J PHARMACOL EXP THER, V248, P1269; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Velazquez KT, 2007, PHARMACOL RES, V55, P578, DOI 10.1016/j.phrs.2007.04.006; von Banchet GS, 2003, BRIT J PHARMACOL, V139, P672, DOI 10.1038/sj.bjp.0705278; Zhou L, 1998, J PHARMACOL EXP THER, V286, P1000; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zollner C, 2003, MOL PHARMACOL, V64, P202, DOI 10.1124/mol.64.2.202	58	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90576	10.1371/journal.pone.0090576	http://dx.doi.org/10.1371/journal.pone.0090576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594607	gold, Green Published, Green Submitted			2022-12-27	WOS:000332475500070
J	Calil, IL; Zarpelon, AC; Guerrero, ATG; Alves, JC; Ferreira, SH; Cunha, FQ; Cunha, TM; Verri, WA				Calil, Igor L.; Zarpelon, Ana C.; Guerrero, Ana T. G.; Alves-Filho, Jose C.; Ferreira, Sergio H.; Cunha, Fernando Q.; Cunha, Thiago M.; Verri, Waldiceu A., Jr.			Lipopolysaccharide Induces Inflammatory Hyperalgesia Triggering a TLR4/MyD88-Dependent Cytokine Cascade in the Mice Paw	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; MOUSE MACROPHAGES; IMMUNE-RESPONSE; KAPPA-B; HYPERNOCICEPTION; EXPRESSION; INNATE; CELLS	Inflammatory pain can be triggered by different stimuli, such as trauma, radiation, antigen and infection. In a model of inflammatory pain caused by infection, injection in the mice paw of lipopolysaccharide (LPS), a Toll-like receptor 4 (TLR4) agonist, produces mechanical hyperalgesia. We identify here the TLR4 linked signaling pathways that elicit this response. Firstly, LPS paw injection in wild type (WT) mice produced mechanical hyperalgesia that was not altered in TRIF-/- mice. On the other hand, this response was absent in TLR4 mutant and MyD88 null mice and reduced in TNFR1 null mice. Either an IL-1 receptor antagonist, anti-KC/CXCL1 antibody, indomethacin or guanethidine injection also lessened this response. Moreover, LPS-induced time dependent increases in TNF-alpha, KC/CXCL1 and IL-1 beta expression in the mice paw, which were absent in TLR4 mutant and MyD88 null mice. Furthermore, in TNFR1 deficient mice, the LPS-induced rises in KC/CXCL1 and IL-1 beta release were less than in their wild type counterpart. LPS also induced increase of myeloperoxidase activity in the paw skin, which was inhibited in TLR4 mutant and MyD88 null mice, and not altered in TRIF-/- mice. These results suggest that LPS-induced inflammatory pain in mice is solely dependent on the TLR4/MyD88 rather than the TLR4/TRIF signaling pathway. This pathway triggers pronociceptive cytokine TNF-alpha release that in turn mediates rises in KC/CXCL1 and IL-1 beta expression. Finally, these cytokines might be involved in stimulating production of directly-acting hyperalgesic mediators such as prostaglandins and sympathomimetic amine.	[Calil, Igor L.; Alves-Filho, Jose C.; Ferreira, Sergio H.; Cunha, Fernando Q.; Cunha, Thiago M.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Sao Paulo, Brazil; [Zarpelon, Ana C.; Verri, Waldiceu A., Jr.] Univ Estadual Londrina, Ctr Ciencias Biol, Dept Patol, Londrina, Parana, Brazil; [Guerrero, Ana T. G.] FIOCRUZ Mato Grosso Sul, Campo Grande, MS, Brazil	Universidade de Sao Paulo; Universidade Estadual de Londrina; Fundacao Oswaldo Cruz	Cunha, TM (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Sao Paulo, Brazil.	thicunha@usp.br; waldiceujr@yahoo.com.br	Alves-Filho, Jose Carlos/B-5814-2008; Cunha, Thiago M/B-7729-2012; Cunha, Fernando Q/M-3090-2014; WA, Verri/I-1330-2013	Alves-Filho, Jose Carlos/0000-0002-9918-8714; Cunha, Thiago M/0000-0003-1084-0065; WA, Verri/0000-0003-2756-9283; Cunha, Fernando Queiroz/0000-0003-4755-1670	Sao Paulo Research Foundation (FAPESP) [2011/19670-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Ministerio da Ciencia, Tecnologia e Inovacao (MCTI); SETI/Fundacao Araucaria; Parana State Government	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio da Ciencia, Tecnologia e Inovacao (MCTI); SETI/Fundacao Araucaria; Parana State Government	This work was supported by Grants 2011/19670-0 from Sao Paulo Research Foundation (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Ministerio da Ciencia, Tecnologia e Inovacao (MCTI), SETI/Fundacao Araucaria and Parana State Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, CR BIOL, V327, P581, DOI 10.1016/j.crvi.2004.04.002; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Beutler B, 2004, NAT REV IMMUNOL, V4, P498, DOI 10.1038/nri1401; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Casagrande R, 2006, J PHOTOCH PHOTOBIO B, V84, P21, DOI 10.1016/j.jphotobiol.2006.01.006; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; CUNHA FQ, 1992, BRIT J PHARMACOL, V107, P660, DOI 10.1111/j.1476-5381.1992.tb14503.x; Cunha TM, 2008, EUR J PHARMACOL, V590, P127, DOI 10.1016/j.ejphar.2008.05.048; Cunha TM, 2008, J LEUKOCYTE BIOL, V83, P824, DOI 10.1189/jlb.0907654; Cunha TM, 2007, EUR J PHARMACOL, V573, P221, DOI 10.1016/j.ejphar.2007.07.007; Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018; Cunha TM, 2005, P NATL ACAD SCI USA, V102, P1755, DOI 10.1073/pnas.0409225102; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Endale M, 2013, IMMUNOBIOLOGY, V218, P1452, DOI 10.1016/j.imbio.2013.04.019; FERREIRA SH, 1988, NATURE, V334, P698, DOI 10.1038/334698a0; Ferreira SH, 1997, BRIT J PHARMACOL, V121, P883, DOI 10.1038/sj.bjp.0701211; Gais P, 2010, J IMMUNOL, V184, P5842, DOI 10.4049/jimmunol.0902456; Gandhapudi SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056855; Guerrero ATG, 2008, J LEUKOCYTE BIOL, V83, P122, DOI 10.1189/jlb.0207123; HANDWERKER HO, 1976, PFLUG ARCH EUR J PHY, V365, P221, DOI 10.1007/BF01067022; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Keck S, 2011, J IMMUNOL, V186, P5478, DOI 10.4049/jimmunol.1000458; Loiarro M, 2013, CL LYMPH MYELOM LEUK, V13, P222, DOI 10.1016/j.clml.2013.02.003; Lorenzetti BB, 2002, EUR CYTOKINE NETW, V13, P456; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; MELLER ST, 1994, NEUROPHARMACOLOGY, V33, P1471, DOI 10.1016/0028-3908(94)90051-5; Motta EM, 2009, PEPTIDES, V30, P918, DOI 10.1016/j.peptides.2009.01.011; Needham BD, 2013, P NATL ACAD SCI USA, V110, P1464, DOI 10.1073/pnas.1218080110; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Perl E R, 1976, Prog Brain Res, V43, P263; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Shen H, 2003, J IMMUNOL, V170, P1443, DOI 10.4049/jimmunol.170.3.1443; Shinya K, 2012, J VIROL, V86, P6055, DOI 10.1128/JVI.00365-12; Sugama S, 2009, J NEUROIMMUNOL, V207, P24, DOI 10.1016/j.jneuroim.2008.11.007; Valerio DA, 2009, BRIT J PHARMACOL, V158, P558, DOI 10.1111/j.1476-5381.2009.00325.x; Verri WA, 2008, P NATL ACAD SCI USA, V105, P2723, DOI 10.1073/pnas.0712116105; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001	38	73	77	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90013	10.1371/journal.pone.0090013	http://dx.doi.org/10.1371/journal.pone.0090013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595131	gold, Green Published, Green Submitted			2022-12-27	WOS:000332468900055
J	Peterson, DS; Pickett, KA; Duncan, R; Perlmutter, J; Earhart, GM				Peterson, Daniel S.; Pickett, Kristen A.; Duncan, Ryan; Perlmutter, Joel; Earhart, Gammon M.			Gait-Related Brain Activity in People with Parkinson Disease with Freezing of Gait	PLOS ONE			English	Article							SUPRASPINAL LOCOMOTOR CONTROL; MOTOR IMAGERY; PEDUNCULOPONTINE NUCLEUS; BILATERAL COORDINATION; CLINICAL-ASSESSMENT; MENTAL-IMAGERY; WALKING; PATHOPHYSIOLOGY; CONNECTIVITY; ACTIVATION	Approximately 50% of people with Parkinson disease experience freezing of gait, described as a transient inability to produce effective stepping. Complex gait tasks such as turning typically elicit freezing more commonly than simple gait tasks, such as forward walking. Despite the frequency of this debilitating and dangerous symptom, the brain mechanisms underlying freezing remain unclear. Gait imagery during functional magnetic resonance imaging permits investigation of brain activity associated with locomotion. We used this approach to better understand neural function during gait-like tasks in people with Parkinson disease who experience freezing-"FoG+" and people who do not experience freezing-"FoG-". Nine FoG+ and nine FoG- imagined complex gait tasks (turning, backward walking), simple gait tasks (forward walking), and quiet standing during measurements of blood oxygen level dependent (BOLD) signal. Changes in BOLD signal (i.e. beta weights) during imagined walking and imagined standing were analyzed across FoG+ and FoG- groups in locomotor brain regions including supplementary motor area, globus pallidus, putamen, mesencephalic locomotor region, and cerebellar locomotor region. Beta weights in locomotor regions did not differ for complex tasks compared to simple tasks in either group. Across imagined gait tasks, FoG+ demonstrated significantly lower beta weights in the right globus pallidus with respect to FoG-. FoG+ also showed trends toward lower beta weights in other right-hemisphere locomotor regions (supplementary motor area, mesencephalic locomotor region). Finally, during imagined stand, FoG+ exhibited lower beta weights in the cerebellar locomotor region with respect to FoG-. These data support previous results suggesting FoG+ exhibit dysfunction in a number of cortical and subcortical regions, possibly with asymmetric dysfunction towards the right hemisphere.	[Peterson, Daniel S.; Pickett, Kristen A.; Duncan, Ryan; Perlmutter, Joel; Earhart, Gammon M.] Washington Univ, Program Phys Therapy, St Louis, MO 63130 USA; [Pickett, Kristen A.; Perlmutter, Joel; Earhart, Gammon M.] Washington Univ, Dept Neurol, St Louis, MO USA; [Perlmutter, Joel; Earhart, Gammon M.] Washington Univ, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Earhart, GM (corresponding author), Washington Univ, Program Phys Therapy, St Louis, MO 63130 USA.	earhartg@wusm.wustl.edu		Pickett, Kristen/0000-0002-4889-6817; Peterson, Daniel/0000-0002-4639-6544	National Institutes of Health [R01 NS077959, UL1 TR000448, TL1 TR000449, NS41509, NS075321, 2T32 HD007434-18]; American Parkinson Disease Association (APDA); APDA Center for Advanced PD Research at Washington University; Greater St. Louis APDA; Parkinson Study Group; Parkinson's Disease Foundation's Advancing Parkinson's Treatments Innovations Grant; Barnes Jewish Hospital Foundation Elliot Stein Endowment and Parkinson Disease research fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007434] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000449, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077959, R01NS075321, R01NS041509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Parkinson Disease Association (APDA); APDA Center for Advanced PD Research at Washington University; Greater St. Louis APDA; Parkinson Study Group; Parkinson's Disease Foundation's Advancing Parkinson's Treatments Innovations Grant; Barnes Jewish Hospital Foundation Elliot Stein Endowment and Parkinson Disease research fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health [R01 NS077959 to GE; UL1 TR000448, sub-award TL1 TR000449 to DP; NS41509, NS075321, and UL1 TR000448 to JP; and 2T32 HD007434-18 to KP]; the American Parkinson Disease Association (APDA) [to JP], the APDA Center for Advanced PD Research at Washington University [to JP and GE], the Greater St. Louis APDA [to GE and JP], the Parkinson Study Group [to KP], the Parkinson's Disease Foundation's Advancing Parkinson's Treatments Innovations Grant [to KP], and the Barnes Jewish Hospital Foundation Elliot Stein Endowment and Parkinson Disease research fund [to JP]. Funding agencies had no involvement in the study design; collection, analysis or interpretation of data; writing of the report; and the decision to submit the article for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amboni M, 2008, MOVEMENT DISORD, V23, P395, DOI 10.1002/mds.21850; Amboni M, 2010, MOVEMENT DISORD, V25, P800, DOI 10.1002/mds.23033; Bakker M, 2008, NEUROIMAGE, V41, P998, DOI 10.1016/j.neuroimage.2008.03.020; Bartels AL, 2003, J CLIN NEUROSCI, V10, P584, DOI 10.1016/S0967-5868(03)00192-9; Bartels AL, 2008, MOVEMENT DISORD, V23, pS461, DOI 10.1002/mds.21912; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Bruck A, 2006, MOVEMENT DISORD, V21, P958, DOI 10.1002/mds.20855; Courtine G, 2003, EUR J NEUROSCI, V18, P191, DOI 10.1046/j.1460-9568.2003.02737.x; Cremers J, 2012, MOVEMENT DISORD, V27, P1498, DOI 10.1002/mds.25139; Cremers J, 2012, HUM BRAIN MAPP, V33, P873, DOI 10.1002/hbm.21255; de Lange FP, 2005, J COGNITIVE NEUROSCI, V17, P97, DOI 10.1162/0898929052880039; DeArmond SJ, 1989, STRUCTURE HUMAN BRAI; Deiber MP, 1998, NEUROIMAGE, V7, P73, DOI 10.1006/nimg.1997.0314; Fling BW, 2013, BRAIN; Giladi N, 2001, NEUROLOGY, V56, P1712, DOI 10.1212/WNL.56.12.1712; Giladi N, 2008, MOVEMENT DISORD, V23, pS423, DOI 10.1002/mds.21927; Godde B, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00139; Gray P, 2000, J Neurosci Nurs, V32, P222; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; Hanakawa T, 1999, BRAIN, V122, P1271, DOI 10.1093/brain/122.7.1271; Hashimoto T, 2006, PARKINSONISM RELAT D, V12, pS55, DOI 10.1016/j.parkreldis.2006.05.017; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Immisch I, 2001, NEUROIMAGE, V14, P674, DOI 10.1006/nimg.2001.0856; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; Jahn K, 2010, RESTOR NEUROL NEUROS, V28, P105, DOI 10.3233/RNN-2010-0506; Jahn K, 2008, PROG BRAIN RES, V171, P353, DOI 10.1016/S0079-6123(08)00652-3; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; Jenkinson N, 2009, MOVEMENT DISORD, V24, P319, DOI 10.1002/mds.22189; Karachi C, 2010, J CLIN INVEST, V120, P2745, DOI 10.1172/JCI42642; Karimi M, 2008, BRAIN, V131, P2710, DOI 10.1093/brain/awn179; Kerr GK, 2010, NEUROLOGY, V75, P116, DOI 10.1212/WNL.0b013e3181e7b688; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; la Fougere C, 2010, NEUROIMAGE, V50, P1589, DOI 10.1016/j.neuroimage.2009.12.060; Lewis SJG, 2009, PARKINSONISM RELAT D, V15, P333, DOI 10.1016/j.parkreldis.2008.08.006; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Malouin Francine, 2007, J Neurol Phys Ther, V31, P20; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Moore O, 2007, MOVEMENT DISORD, V22, P2192, DOI 10.1002/mds.21659; Mori S, 1999, J NEUROPHYSIOL, V82, P290, DOI 10.1152/jn.1999.82.1.290; Mori S, 2004, PROG BRAIN RES, V143, P341, DOI 10.1016/S0079-6123(03)43033-1; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; Morris ME, 2006, PHYS THER, V86, P1426, DOI 10.2522/ptj.20050277; Nieuwboer A, 2009, GAIT POSTURE, V30, P459, DOI 10.1016/j.gaitpost.2009.07.108; Pahapill PA, 2000, BRAIN, V123, P1767, DOI 10.1093/brain/123.9.1767; Peterson DS, 2012, PARKINSONISM RELAT D, V18, P1022, DOI 10.1016/j.parkreldis.2012.05.019; Pickett KA, 2012, J PARKINSON DIS, V2, P19, DOI 10.3233/JPD-2012-11045; Plotnik M, 2008, MOVEMENT DISORD, V23, pS444, DOI 10.1002/mds.21984; Plotnik M, 2008, EUR J NEUROSCI, V27, P1999, DOI 10.1111/j.1460-9568.2008.06167.x; Porro CA, 1996, J NEUROSCI, V16, P7688; Prodoehl J, 2010, MOVEMENT DISORD, V25, P2035, DOI 10.1002/mds.23360; Racette BA, 1999, AM J MED GENET, V88, P539, DOI 10.1002/(SICI)1096-8628(19991015)88:5<539::AID-AJMG19>3.3.CO;2-J; Schaafsma JD, 2003, EUR J NEUROL, V10, P391, DOI 10.1046/j.1468-1331.2003.00611.x; Schweder PM, 2010, NEUROREPORT, V21, P914, DOI 10.1097/WNR.0b013e32833ce5f1; Shine JM, 2013, BRAIN, V136, P1204, DOI 10.1093/brain/awt049; Snijders AH, 2012, PARKINSONISM RELAT D, V18, P149, DOI 10.1016/j.parkreldis.2011.09.006; Snijders AH, 2011, BRAIN, V134, P59, DOI 10.1093/brain/awq324; Spildooren J, 2010, MOVEMENT DISORD, V25, P2563, DOI 10.1002/mds.23327; Spraker MB, 2010, HUM BRAIN MAPP, V31, P1928, DOI 10.1002/hbm.20987; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Talairach J., 1998, COPLANAR STEREOTAXIC; Tessitore A, 2012, PARKINSONISM RELAT D, V18, P781, DOI 10.1016/j.parkreldis.2012.03.018; Thevathasan W, 2012, BRAIN, V135, P1446, DOI 10.1093/brain/aws039; Vereeck L, 2008, INT J AUDIOL, V47, P67, DOI 10.1080/14992020701689688; Wagner J, 2008, EXP BRAIN RES, V191, P247, DOI 10.1007/s00221-008-1520-8; Wai YY, 2012, PARKINSONISM RELAT D, V18, P537, DOI 10.1016/j.parkreldis.2012.02.004; Wang CH, 2008, J NEURAL TRANSM, V115, P1149, DOI 10.1007/s00702-008-0058-z; Woosley T, 2008, BRAIN ATLAS VISUAL G; Wu T, 2013, BRAIN, V136, P696, DOI 10.1093/brain/aws360; Zrinzo L, 2008, Br J Neurosurg, V22 Suppl 1, pS19, DOI 10.1080/02688690802448426; Zrinzo L, 2011, J NEURAL TRANSM, V118, P1487, DOI 10.1007/s00702-011-0639-0; Zwergal A, 2012, NEUROBIOL AGING, V33, P1073, DOI 10.1016/j.neurobiolaging.2010.09.022	73	75	78	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90634	10.1371/journal.pone.0090634	http://dx.doi.org/10.1371/journal.pone.0090634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595265	gold, Green Submitted, Green Published			2022-12-27	WOS:000332468900127
J	Vistnes, M; Aronsen, JM; Lunde, IG; Sjaastad, I; Carlson, CR; Christensen, G				Vistnes, Maria; Aronsen, Jan Magnus; Lunde, Ida G.; Sjaastad, Ivar; Carlson, Cathrine R.; Christensen, Geir			Pentosan Polysulfate Decreases Myocardial Expression of the Extracellular Matrix Enzyme ADAMTS4 and Improves Cardiac Function In Vivo in Rats Subjected to Pressure Overload by Aortic Banding	PLOS ONE			English	Article							HEART-FAILURE; ENDOTHELIAL GLYCOCALYX; INTERSTITIAL EDEMA; HEPARAN-SULFATE; KEY ROLES; VERSICAN; ATHEROSCLEROSIS; AGGRECANASE-1; METALLOPROTEINASES; INFLAMMATION	Background: We hypothesized that cleavage of the extracellular matrix (ECM) proteoglycans versican and aggrecan by ADAMTS (a disintegrin and metalloprotease with thrombospondin motifs) proteases, which contributes to stress-induced ECM-reorganization in atherogenesis and osteoarthritis, also play a role in heart failure development. Objectives: The primary objective was to identify alterations in expression of ADAMTS versicanases and aggrecanases during development of heart failure, while evaluation of the effects of in vivo modulation of relevant changes in ADAMTS activity constituted the secondary objective. Methods: Myocardial levels of versican, aggrecan, and their ADAMTS cleaving proteases were examined in Wistar rats six weeks after aortic banding (AB), and versican and selected ADAMTS versicanases were further analyzed in neonatal cardiomyocytes (NCM) and cardiac fibroblasts (NFB) after stimulation by inflammatory mediators. Based on the initial findings, ADAMTS4 was selected the most promising therapeutic target. Thus, rats with AB were treated with pentosan polysulfate (PPS), a polysaccharide with known ADAMTS4-inhibitory properties, and effects on versican fragmentation, left ventricular function and geometry were evaluated. Results: We discovered that myocardial mRNA and protein levels of ADAMTS1 and -4, and mRNA levels of versican, aggrecan, and ADAMTS8 increased after AB, and TNF-alpha and IL-1 beta synergistically increased mRNA of versican and ADAMTS4 in NCM and NFB and secretion of ADAMTS4 from NCM. Furthermore, PPS-treatment improved systolic function, demonstrated by an improved fractional shortening (vehicle 48 +/- 3% versus PPS 60 +/- 1%, p<0.01) after AB. Following PPS-treatment, we observed an similar to 80% reduction in myocardial ADAMTS4 mRNA (p = 0.03), and similar to 50% reduction in the extracellular amount of the p150 versican fragments (p = 0.05), suggesting reduced versicanase activity. Conclusions: Our findings suggest that AB induces an increase in myocardial ADAMTS4 versicanase activity, and that PPS-treatment improved systolic function in the pressure-overloaded heart, holding promise as a novel therapeutic agent in heart failure.	[Vistnes, Maria; Aronsen, Jan Magnus; Lunde, Ida G.; Sjaastad, Ivar; Carlson, Cathrine R.; Christensen, Geir] Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway; [Vistnes, Maria; Aronsen, Jan Magnus; Lunde, Ida G.; Sjaastad, Ivar; Carlson, Cathrine R.; Christensen, Geir] Univ Oslo, Oslo, Norway; [Vistnes, Maria; Aronsen, Jan Magnus; Lunde, Ida G.; Sjaastad, Ivar; Carlson, Cathrine R.; Christensen, Geir] Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Vistnes, Maria; Aronsen, Jan Magnus; Lunde, Ida G.; Sjaastad, Ivar; Carlson, Cathrine R.; Christensen, Geir] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Aronsen, Jan Magnus] Bjorknes Coll, Oslo, Norway; [Lunde, Ida G.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Harvard University; Harvard Medical School	Vistnes, M (corresponding author), Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway.	r.m.vistnes@medisin.uio.no	Lunde, Ida Gjervold/ABN-5567-2022	Lunde, Ida Gjervold/0000-0001-9502-6841; Vistnes, Maria/0000-0002-6243-0626	University of Oslo; Anders Jahre's Fund for the Promotion of Science; Kristian Gerhard Jebsen foundation; South-Eastern Norway Regional Health Authority; Research Council of Norway, Norway; Simon Fougner Hartmanns Family Fund, Denmark	University of Oslo; Anders Jahre's Fund for the Promotion of Science; Kristian Gerhard Jebsen foundation; South-Eastern Norway Regional Health Authority; Research Council of Norway, Norway(Research Council of Norway); Simon Fougner Hartmanns Family Fund, Denmark	This work was supported by University of Oslo, Anders Jahre's Fund for the Promotion of Science (www.unifor.no/Fund.aspx?site = 1&fund = 290), the Kristian Gerhard Jebsen foundation (www.stiftkgj.no), the South-Eastern Norway Regional Health Authority (www.helse-sorost.no), the Research Council of Norway (www.forskningsradet.no), Norway, and the Simon Fougner Hartmanns Family Fund, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Boyle A, 2007, J CARD FAIL, V13, P133, DOI 10.1016/j.cardfail.2006.10.015; Brooks WW, 2010, GENOMICS, V95, P84, DOI 10.1016/j.ygeno.2009.12.002; Cattaruzza S, 2002, J BIOL CHEM, V277, P47626, DOI 10.1074/jbc.M206521200; Chan CK, 2010, J CELL BIOCHEM, V111, P585, DOI 10.1002/jcb.22744; Didangelos A, 2012, J BIOL CHEM, V287, P19341, DOI 10.1074/jbc.C112.350785; Dongaonkar RM, 2010, CARDIOVASC RES, V87, P331, DOI 10.1093/cvr/cvq145; Dorman Gyorgy, 2007, Recent Pat Cardiovasc Drug Discov, V2, P186, DOI 10.2174/157489007782418964; Fomovsky GM, 2010, J MOL CELL CARDIOL, V48, P490, DOI 10.1016/j.yjmcc.2009.08.003; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Hashimoto G, 2001, FEBS LETT, V494, P192, DOI 10.1016/S0014-5793(01)02323-7; Hudson MP, 2006, J AM COLL CARDIOL, V48, P15, DOI 10.1016/j.jacc.2006.02.055; Kenagy RD, 2005, J HISTOCHEM CYTOCHEM, V53, P131, DOI 10.1369/jhc.4A6493.2005; Lockhart M, 2011, BIRTH DEFECTS RES A, V91, P535, DOI 10.1002/bdra.20810; Lunde IG, 2012, PHYSIOL GENOMICS, V44, P162, DOI 10.1152/physiolgenomics.00016.2011; Miserocchi G, 2001, NEWS PHYSIOL SCI, V16, P66; Miyata N, 2010, CLIN EXP HYPERTENS, V32, P511, DOI 10.3109/10641963.2010.496511; Nickel JC, 2005, UROLOGY, V65, P654, DOI 10.1016/j.urology.2004.10.071; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Rodriguez-Manzaneque JC, 2000, J BIOL CHEM, V275, P33471, DOI 10.1074/jbc.M002599200; RUBBOLI A, 1994, AM J PHYSIOL, V267, pH1054, DOI 10.1152/ajpheart.1994.267.3.H1054; Salter RC, 2010, J MOL MED, V88, P1203, DOI 10.1007/s00109-010-0654-x; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Schuchman EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054459; Shioi T, 1997, CIRC RES, V81, P664; Shiomi T, 2010, PATHOL INT, V60, P477, DOI 10.1111/j.1440-1827.2010.02547.x; Sjaastad I, 2000, J APPL PHYSIOL, V89, P1445, DOI 10.1152/jappl.2000.89.4.1445; Spinale FG, 2013, CIRC RES, V112, P195, DOI 10.1161/CIRCRESAHA.112.266882; Strand ME, 2013, FEBS J, V280, P2228, DOI 10.1111/febs.12161; Takizawa M, 2008, FEBS LETT, V582, P2945, DOI 10.1016/j.febslet.2008.07.036; Tanhehco EJ, 1999, J CARDIOVASC PHARM, V34, P153, DOI 10.1097/00005344-199907000-00024; TorreAmione G, 1996, CIRCULATION, V93, P704, DOI 10.1161/01.CIR.93.4.704; Troeberg L, 2008, FASEB J, V22, P3515, DOI 10.1096/fj.08-112680; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; Verma P, 2011, J CELL BIOCHEM, V112, P3507, DOI 10.1002/jcb.23298; Waehre A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018668; Wagsater D, 2008, ATHEROSCLEROSIS, V196, P514, DOI 10.1016/j.atherosclerosis.2007.05.018; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; Wu J, 2011, LAB INVEST, V91, P1459, DOI 10.1038/labinvest.2011.93; Zanin MKB, 1999, ANAT RECORD, V256, P366; Zha YP, 2010, BIOMED PHARMACOTHER, V64, P160, DOI 10.1016/j.biopha.2009.09.012	41	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89621	10.1371/journal.pone.0089621	http://dx.doi.org/10.1371/journal.pone.0089621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595230	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900026
J	Wang, YF; Cui, Q; Liu, F; Huo, YJ; Lu, FM; Chen, H; Chen, HF				Wang, Yi-Feng; Cui, Qian; Liu, Feng; Huo, Ya-Jun; Lu, Feng-Mei; Chen, Heng; Chen, Hua-Fu			A New Method for Computing Attention Network Scores and Relationships between Attention Networks	PLOS ONE			English	Article							HUMAN BRAIN; INHIBITION; COMPONENTS; DEFICITS; SYSTEM; INDEPENDENCE; ISOLABILITY; ROBUSTNESS; STABILITY; GENOTYPE	The attention network test (ANT) is a reliable tool to detect the efficiency of alerting, orienting, and executive control networks. However, studies using the ANT obtained inconsistent relationships between attention networks due to two reasons: on the one hand, the inter-network relationships of attention subsystems were far from clear; on the other hand, ANT scores in previous studies were disturbed by possible inter-network interactions. Here we proposed a new computing method by dissecting cue-target conditions to estimate ANT scores and relationships between attention networks as pure as possible. The method was tested in 36 participants. Comparing to the original method, the new method showed a larger alerting score and a smaller executive control score, and revealed interactions between alerting and executive control and between orienting and executive control. More interestingly, the new method revealed unidirectional influences from alerting to executive control and from executive control to orienting. These findings provided useful information for better understanding attention networks and their relationships in the ANT. Finally, the relationships of attention networks should be considered with more experimental paradigms and techniques.	[Wang, Yi-Feng; Liu, Feng; Huo, Ya-Jun; Lu, Feng-Mei; Chen, Heng; Chen, Hua-Fu] Univ Elect Sci & Technol China, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Sichuan, Peoples R China; [Wang, Yi-Feng; Liu, Feng; Huo, Ya-Jun; Lu, Feng-Mei; Chen, Heng; Chen, Hua-Fu] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Sichuan, Peoples R China; [Cui, Qian] Univ Elect Sci & Technol China, Sch Polit Sci & Publ Adm, Chengdu 610054, Sichuan, Peoples R China	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China; University of Electronic Science & Technology of China	Chen, HF (corresponding author), Univ Elect Sci & Technol China, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Sichuan, Peoples R China.	chenhf@uestc.edu.cn	Liu, Feng/W-7572-2019	Liu, Feng/0000-0002-3570-4222	973 project [2012CB517901]; Natural Science Foundation of China [61035006, 61125304]; Specialized Research Fund for the Doctoral Program of Higher education of China [20120185110028]; Scholarship Award for Excellent Doctoral Student; Ministry of Education [A03003023901010]	973 project(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Scholarship Award for Excellent Doctoral Student; Ministry of Education	HF. Chen was supported by the 973 project [2012CB517901], Natural Science Foundation of China [61035006, 61125304] and the Specialized Research Fund for the Doctoral Program of Higher education of China [20120185110028]. F Liu was supported by the Scholarship Award for Excellent Doctoral Student granted by Ministry of Education (A03003023901010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsdottir S, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-9; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Bush G, 2010, NEUROPSYCHOPHARMACOL, V35, P278, DOI 10.1038/npp.2009.120; Callejas A, 2005, EXP BRAIN RES, V167, P27, DOI 10.1007/s00221-005-2365-z; Callejas A, 2004, BRAIN COGNITION, V54, P225, DOI 10.1016/j.bandc.2004.02.012; Chang CF, 2013, HUM BRAIN MAPP, V34, P869, DOI 10.1002/hbm.21476; Chica AB, 2012, CORTEX, V48, P654, DOI 10.1016/j.cortex.2011.01.009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Diamond A, 2004, AM J PSYCHIAT, V161, P125, DOI 10.1176/appi.ajp.161.1.125; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fan J, 2003, P NATL ACAD SCI USA, V100, P7406, DOI 10.1073/pnas.0732088100; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fan J, 2007, J NEUROSCI, V27, P6197, DOI 10.1523/JNEUROSCI.1833-07.2007; Fan J, 2012, BRAIN BEHAV, V2, P647, DOI 10.1002/brb3.90; Fan J, 2009, BRAIN COGNITION, V70, P209, DOI 10.1016/j.bandc.2009.02.002; Fossella J, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-14; Fuentes LJ, 2008, EXP BRAIN RES, V185, P667, DOI 10.1007/s00221-007-1193-8; Greene DJ, 2008, BRAIN COGNITION, V66, P21, DOI 10.1016/j.bandc.2007.05.003; Greenwood PM, 2000, P NATL ACAD SCI USA, V97, P11661, DOI 10.1073/pnas.97.21.11661; Heyder K, 2004, ACTA PSYCHOL, V115, P271, DOI 10.1016/j.actpsy.2003.12.010; Ishigami Y, 2013, J NEUROSCI METH, V216, P1, DOI 10.1016/j.jneumeth.2013.02.013; Ishigami Y, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00017; Ishigami Y, 2010, J NEUROSCI METH, V190, P117, DOI 10.1016/j.jneumeth.2010.04.019; Ishigami Y, 2009, J INDIVID DIF, V30, P220, DOI 10.1027/1614-0001.30.4.220; Keehn B, 2013, NEUROSCI BIOBEHAV R, V37, P164, DOI 10.1016/j.neubiorev.2012.11.014; Kellermann T, 2011, BRAIN RES, V1386, P127, DOI 10.1016/j.brainres.2011.02.023; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Konrad K, 2005, NEUROIMAGE, V28, P429, DOI 10.1016/j.neuroimage.2005.06.065; Liu K, 2013, BEHAV BRAIN RES, V243, P220, DOI 10.1016/j.bbr.2013.01.013; MacLeod JW, 2010, NEUROPSYCHOLOGY, V24, P637, DOI 10.1037/a0019803; McConnell MM, 2011, ATTEN PERCEPT PSYCHO, V73, P1096, DOI 10.3758/s13414-010-0085-3; Neuhaus AH, 2010, INT J PSYCHOPHYSIOL, V76, P72, DOI 10.1016/j.ijpsycho.2010.02.005; Parasuraman R, 2005, PSYCHOL SCI, V16, P200, DOI 10.1111/j.0956-7976.2005.00804.x; Pelisson D, 2003, CEREBELLUM, V2, P71, DOI 10.1080/14734220310015629; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Posner M. I., 2004, TOPICS INTEGRATIVE N, p[J, 31]; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1994, P NATL ACAD SCI USA, V91, P7398, DOI 10.1073/pnas.91.16.7398; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Posner MI, 2008, ANN NY ACAD SCI, V1129, P193, DOI 10.1196/annals.1417.011; Posner MI, 2007, DEVELOPMENTAL SCI, V10, P24, DOI 10.1111/j.1467-7687.2007.00559.x; Posner MI, 2012, NEUROIMAGE, V61, P450, DOI 10.1016/j.neuroimage.2011.12.040; Prime DJ, 2006, PERCEPT PSYCHOPHYS, V68, P1310, DOI 10.3758/BF03193730; Roberts KL, 2006, J INT NEUROPSYCH SOC, V12, P485, DOI 10.1017/S1355617706060620; Rueda MR, 2004, NEUROPSYCHOLOGIA, V42, P1029, DOI 10.1016/j.neuropsychologia.2003.12.012; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sturm W, 1999, NEUROPSYCHOLOGIA, V37, P797, DOI 10.1016/S0028-3932(98)00141-9; Wager TD, 2004, NEUROIMAGE, V22, P1679, DOI 10.1016/j.neuroimage.2004.03.052; Weinbach N, 2013, ATTEN PERCEPT PSYCHO, V38, P1530; Westlye LT, 2011, CEREB CORTEX, V21, P345, DOI 10.1093/cercor/bhq101; Wolk DA, 2010, P NATL ACAD SCI USA, V107, P10256, DOI 10.1073/pnas.1001412107	55	13	14	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89733	10.1371/journal.pone.0089733	http://dx.doi.org/10.1371/journal.pone.0089733			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594693	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900033
J	Anastasopoulou, P; Tubic, M; Schmidt, S; Neumann, R; Woll, A; Hartel, S				Anastasopoulou, Panagiota; Tubic, Mirnes; Schmidt, Steffen; Neumann, Rainer; Woll, Alexander; Haertel, Sascha			Validation and Comparison of Two Methods to Assess Human Energy Expenditure during Free-Living Activities	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; 2-REGRESSION MODEL; ACTIVITY MONITORS; ACTIGRAPH; ACCELEROMETERS; ASSOCIATION; EXERCISE; CHILDREN; WALKING; HEALTH	Background: The measurement of activity energy expenditure (AEE) via accelerometry is the most commonly used objective method for assessing human daily physical activity and has gained increasing importance in the medical, sports and psychological science research in recent years. Objective: The purpose of this study was to determine which of the following procedures is more accurate to determine the energy cost during the most common everyday life activities; a single regression or an activity based approach. For this we used a device that utilizes single regression models (GT3X, ActiGraph Manufacturing Technology Inc., FL., USA) and a device using activity-dependent calculation models (move II, movisens GmbH, Karlsruhe, Germany). Material and Methods: Nineteen adults (11 male, 8 female; 30.4 +/- 9.0 years) wore the activity monitors attached to the waist and a portable indirect calorimeter (IC) as reference measure for AEE while performing several typical daily activities. The accuracy of the two devices for estimating AEE was assessed as the mean differences between their output and the reference and evaluated using Bland-Altman analysis. Results: The GT3X overestimated the AEE of walking (GT3X minus reference, 1.26 kcal/min), walking fast (1.72 kcal/min), walking up2/downhill (1.45 kcal/min) and walking upstairs (1.92 kcal/min) and underestimated the AEE of jogging (-1.30 kcal/min) and walking upstairs (-2.46 kcal/min). The errors for move II were smaller than those for GT3X for all activities. The move II overestimated AEE of walking (move II minus reference, 0.21 kcal/min), walking up-/downhill (0.06 kcal/min) and stair walking (upstairs: 0.13 kcal/min; downstairs: 0.29 kcal/min) and underestimated AEE of walking fast (-0.11 kcal/min) and jogging (-0.93 kcal/min). Conclusions: Our data suggest that the activity monitor using activity-dependent calculation models is more appropriate for predicting AEE in daily life than the activity monitor using a single regression model.	[Anastasopoulou, Panagiota] Karlsruhe Inst Technol, D-76021 Karlsruhe, Germany; [Tubic, Mirnes; Schmidt, Steffen; Neumann, Rainer; Woll, Alexander; Haertel, Sascha] Karlsruhe Inst Technol, Dept Sport & Sports Sci, D-76021 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Anastasopoulou, P (corresponding author), Karlsruhe Inst Technol, House Competence Hiper Campus, D-76021 Karlsruhe, Germany.	panagiota.anastasopoulou@kit.edu			Deutsche Forschungsgemeinschaft; Karlsruhe Institute of Technology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Karlsruhe Institute of Technology(Helmholtz Association)	We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology.	Berntsen S, 2010, BRIT J SPORT MED, V44, P657, DOI 10.1136/bjsm.2008.048868; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonato Paolo, 2005, J Neuroeng Rehabil, V2, P2, DOI 10.1186/1743-0003-2-2; Bonomi AG, 2009, J APPL PHYSIOL, V107, P655, DOI 10.1152/japplphysiol.00150.2009; Bussmann JBJ, 2009, EUR PSYCHOL, V14, P142, DOI 10.1027/1016-9040.14.2.142; Butte NF, 2012, MED SCI SPORT EXER, V44, pS5, DOI 10.1249/MSS.0b013e3182399c0e; Campbell KL, 2002, MED SCI SPORT EXER, V34, P1667, DOI 10.1097/00005768-200210000-00020; Crouter SE, 2006, EUR J APPL PHYSIOL, V98, P601, DOI 10.1007/s00421-006-0307-5; Crouter SE, 2012, MED SCI SPORT EXER, V44, P1177, DOI 10.1249/MSS.0b013e3182447825; Crouter SE, 2010, MED SCI SPORT EXER, V42, P1029, DOI 10.1249/MSS.0b013e3181c37458; Laich AG, 2011, J EXP MAR BIOL ECOL, V399, P151, DOI 10.1016/j.jembe.2011.01.008; Graham JE, 2008, J EVAL CLIN PRACT, V14, P552, DOI 10.1111/j.1365-2753.2007.00917.x; Grams L, 2011, DEUT Z SPORTMED, V62, P160; Hartel S, 2011, EUR REV AGING PHYS A, V8, P109, DOI 10.1007/s11556-010-0074-5; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Haugen HA, 2007, NUTR CLIN PRACT, V22, P377, DOI 10.1177/0115426507022004377; King GA, 2004, MED SCI SPORT EXER, V36, P1244, DOI 10.1249/01.MSS.0000132379.09364.F8; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Macfarlane DJ, 2012, EUR J APPL PHYSIOL, V112, P2539, DOI 10.1007/s00421-011-2230-7; Maffeis C, 2007, NUTR METAB CARDIOVAS, V17, P394, DOI 10.1016/j.numecd.2006.08.006; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; SCHOELLER DA, 1982, J APPL PHYSIOL, V53, P955, DOI 10.1152/jappl.1982.53.4.955; Terrier P, 2001, ERGONOMICS, V44, P48, DOI 10.1080/00140130118289; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Van Remoortel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039198; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; Welk GJ, 2007, OBESITY, V15, P918, DOI 10.1038/oby.2007.624	28	42	42	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90606	10.1371/journal.pone.0090606	http://dx.doi.org/10.1371/journal.pone.0090606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587401	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200235
J	Madduppa, HH; Timm, J; Kochzius, M				Madduppa, Hawis H.; Timm, Janne; Kochzius, Marc			Interspecific, Spatial and Temporal Variability of Self-Recruitment in Anemonefishes	PLOS ONE			English	Article							SUPPLY-SIDE ECOLOGY; CORAL-REEF FISHES; MARINE POPULATIONS; PARENTAGE ANALYSIS; LARVAL DISPERSAL; MICROSATELLITE LOCI; GENETIC-MARKERS; CONNECTIVITY; CONSERVATION; SOFTWARE	Polymorphic microsatellite DNA parentage analysis was used to investigate the spatio-temporal variability of self-recruitment in populations of two anemonefishes: Amphiprion ocellaris and A. perideraion. Tissue samples of A. ocellaris (n = 364) and A. perideraion (n = 105) were collected from fringing reefs around two small islands (Barrang Lompo and Samalona) in Spermonde Archipelago, Indonesia. Specimens were genotyped based on seven microsatellite loci for A. ocellaris and five microsatellite loci for A. perideraion, and parentage assignment as well as site fidelity were calculated. Both species showed high levels of self-recruitment: 65.2% of juvenile A. ocellaris in Samalona were the progeny of parents from the same island, while on Barrang Lompo 47.4% of A. ocellaris and 46.9% of A. perideraion juveniles had parents from that island. Self-recruitment of A. ocellaris in Barrang Lompo varied from 44% to 52% between the two sampling periods. The site fidelity of A. ocellaris juveniles that returned to their reef site in Barang Lompo was up to 44%, while for A. perideraion up to 19%. In Samalona, the percentage of juveniles that returned to their natal reef site ranged from 8% to 11%. Exchange of progeny between the two study islands, located 7.5 km apart, was also detected via parentage assignments. The larger Samalona adult population of A. ocellaris was identified as the parents of 21% of Barrang Lompo juveniles, while the smaller adult population on Barrang Lompo were the parents of only 4% of Samalona juveniles. High self-recruitment and recruitment to nearby island reefs have important implications for management and conservation of anemonefishes. Small MPAs, preferably on every island/reef, should ensure that a part of the population is protected to enable replenishment by the highly localised recruitment behaviour observed in these species.	[Madduppa, Hawis H.] Bogor Agr Univ IPB, Fac Fisheries & Marine Sci, Bogor, Indonesia; [Timm, Janne] Univ Bremen, D-28359 Bremen, Germany; [Kochzius, Marc] Vrije Univ Brussel, Brussels, Belgium	Bogor Agricultural University; University of Bremen; Vrije Universiteit Brussel	Madduppa, HH (corresponding author), Bogor Agr Univ IPB, Fac Fisheries & Marine Sci, Bogor, Indonesia.	hawis@ipb.ac.id	Madduppa, Hawis/ABD-7468-2021; Kochzius, Marc/AAN-3799-2021	Arafat, Dondy/0000-0002-0100-9213; Madduppa, Hawis/0000-0003-4260-5625; Kochzius, Marc/0000-0001-8953-4719	The German Federal Ministry of Education and Research (BMBF) [03F0472B]	The German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The German Federal Ministry of Education and Research (BMBF http://www.bmbf.de/en/index.php, grant no. 03F0472B) funded this study in the framework of the SPICE II project (Science for the Protection of Indonesian Coastal Marine Ecosystems). The SPICE project was conducted and permitted under the governmental agreement between the German Federal Ministry of Education and Research (BMBF) and the Indonesian Ministry for Research and Technology (RISTEK), Indonesian Institute of Sciences (LIPI), Indonesian Ministry of Maritime Affairs and Fisheries (KKP), and Indonesian Agency for the Assessment and Application of Technology (BPPT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARDY MT, 1994, TRENDS ECOL EVOL, V9, P267, DOI 10.1016/0169-5347(94)90297-6; Allen G.R., 1994, ANEMONEFISHES THEIR; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Arvedlund M, 1996, ETHOLOGY, V102, P197; Atema J, 2002, MAR ECOL PROG SER, V241, P151, DOI 10.3354/meps241151; Birkeland C, 2005, TRENDS ECOL EVOL, V20, P356, DOI 10.1016/j.tree.2005.03.015; Bohnsack JA, 1998, AUST J ECOL, V23, P298, DOI 10.1111/j.1442-9993.1998.tb00734.x; Botsford LW, 2003, ECOL APPL, V13, pS25; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brown C. L., 2001, AQUAR SCI CONSERV, V3, P151; BRUFORD MW, 1993, CURR OPIN GENET DEV, V3, P939, DOI 10.1016/0959-437X(93)90017-J; Buston PM, 2007, MOL ECOL, V16, P3671, DOI 10.1111/j.1365-294X.2007.03421.x; Buston PM, 2009, MOL ECOL, V18, P4707, DOI 10.1111/j.1365-294X.2009.04383.x; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Carreras-Carbonell J, 2007, MAR BIOL, V151, P719, DOI 10.1007/s00227-006-0513-z; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Chozin M., 2008, ILLEGAL COMMON LIFE; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Daly-Engel TS, 2007, CAN J FISH AQUAT SCI, V64, P198, DOI 10.1139/F07-005; DANILOWICZ BS, 1992, AQUACULTURE, V106, P141, DOI 10.1016/0044-8486(92)90198-T; Edinger EN, 1998, MAR POLLUT BULL, V36, P617, DOI 10.1016/S0025-326X(98)00047-2; Edinger EN, 2000, BIOL CONSERV, V92, P1, DOI 10.1016/S0006-3207(99)00067-1; Erdmann M, 1995, NAGA ICLARM Q, P426; FAIRWEATHER PG, 1991, TRENDS ECOL EVOL, V6, P60, DOI 10.1016/0169-5347(91)90125-H; Ferguson A, 1995, J FISH BIOL, V47, P103, DOI 10.1111/j.1095-8649.1995.tb06048.x; Fisher R, 2000, MAR ECOL PROG SER, V202, P163, DOI 10.3354/meps202163; FRICKE H, 1977, NATURE, V266, P830, DOI 10.1038/266830a0; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Gerber S, 2003, MOL ECOL NOTES, V3, P479, DOI 10.1046/j.1471-8286.2003.00439.x; Gerber S, 2000, MOL ECOL, V9, P1037, DOI 10.1046/j.1365-294x.2000.00961.x; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; James MK, 2002, P ROY SOC B-BIOL SCI, V269, P2079, DOI 10.1098/rspb.2002.2128; Jamieson A, 1997, ANIM GENET, V28, P397, DOI 10.1111/j.1365-2052.1997.00186.x; Johnston G, 2003, J APPL ICHTHYOL, V19, P40, DOI 10.1046/j.1439-0426.2003.00351.x; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Kingsford MJ, 2002, B MAR SCI, V70, P309; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Leis JM, 2007, MAR BIOL, V153, P103, DOI 10.1007/s00227-007-0794-x; Leis JM, 1996, MAR FRESHWATER RES, V47, P401, DOI 10.1071/MF9960401; Lester SE, 2005, P ROY SOC B-BIOL SCI, V272, P585, DOI 10.1098/rspb.2004.2985; Liu SYV, 2007, MOL ECOL NOTES, V7, P1169, DOI 10.1111/j.1471-8286.2007.01818.x; Madduppa HH, 2012, THESIS U BREMEN GERM; Madhu K., 2006, Indian Council of Agricultural Research Marine Fisheries Information Service Technical and Extension Series, V188, P1; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MEAGHER TR, 1986, AM NAT, V128, P199, DOI 10.1086/284554; MEAGHER TR, 1986, THEOR POPUL BIOL, V29, P87, DOI 10.1016/0040-5809(86)90006-7; Miller JA, 2004, CAN J FISH AQUAT SCI, V61, P1723, DOI 10.1139/F04-111; Mora C, 2002, TRENDS ECOL EVOL, V17, P422, DOI 10.1016/S0169-5347(02)02584-3; MOYER JT, 1978, JPN J ICHTHYOL, V25, P101; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Quenouille B, 2004, MOL ECOL NOTES, V4, P291, DOI 10.1111/j.1471-8286.2004.00646.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saenz-Agudelo P, 2009, MOL ECOL, V18, P1765, DOI 10.1111/j.1365-294X.2009.04109.x; Saenz-Agudelo P, 2011, P ROY SOC B-BIOL SCI, V278, P2954, DOI 10.1098/rspb.2010.2780; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; Salas E, 2010, MAR BIOL, V157, P437, DOI 10.1007/s00227-009-1330-y; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; SAS Institute, 2012, SAS 9 3; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sponaugle S, 2002, B MAR SCI, V70, P341; Steneck RS, 2006, SCIENCE, V311, P480, DOI 10.1126/science.1123541; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Swearer SE, 2002, B MAR SCI, V70, P251; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297; Timm J, 2008, MOL ECOL, V17, P3999, DOI 10.1111/j.1365-294X.2008.03881.x; TOMASCIK T, 1997, ECOLOGY INDONESIAN S; Tucker Craig S., 2000, Reviews in Fisheries Science, V8, P45, DOI 10.1080/10641260091129170; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wabnitz C., 2003, OCEAN AQUARIUM GLOBA; Wang L, 2012, INT J MOL SCI, V13, P5584, DOI 10.3390/ijms13055584; Ward AJW, 2003, FISH FISH, V4, P348, DOI 10.1046/j.1467-2979.2003.00135.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WELLINGTON GM, 1989, MAR BIOL, V101, P557, DOI 10.1007/BF00541659; Wilson DT, 2001, MAR ECOL PROG SER, V222, P197, DOI 10.3354/meps222197; WRIGHT JM, 1994, REV FISH BIOL FISHER, V4, P384, DOI 10.1007/BF00042912; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; WYRTKI K, 1961, PHYS OCEANOGRAPHY SE	94	15	15	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90648	10.1371/journal.pone.0090648	http://dx.doi.org/10.1371/journal.pone.0090648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587406	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200240
J	Ruiz-Sola, MA; Arbona, V; Gomez-Cadenas, A; Rodriguez-Concepcion, M; Rodriguez-Villalon, A				Aguila Ruiz-Sola, M.; Arbona, Vicent; Gomez-Cadenas, Aurelio; Rodriguez-Concepcion, Manuel; Rodriguez-Villalon, Antia			A Root Specific Induction of Carotenoid Biosynthesis Contributes to ABA Production upon Salt Stress in Arabidopsis	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; SYNTHASE GENE FAMILY; ABIOTIC STRESS; ACCUMULATION; PATHWAYS; CAROTENOGENESIS; EXPRESSION; THALIANA; SIGNAL; AAO3	Abscisic acid (ABA) is a hormone that plays a vital role in mediating abiotic stress responses in plants. Salt exposure induces the synthesis of ABA through the cleavage of carotenoid precursors (xanthophylls), which are found at very low levels in roots. Here we show that de novo ABA biosynthesis in salt-treated Arabidopsis thaliana roots involves an organ-specific induction of the carotenoid biosynthetic pathway. Upregulation of the genes encoding phytoene synthase (PSY) and other enzymes of the pathway producing ABA precursors was observed in roots but not in shoots after salt exposure. A pharmacological block of the carotenoid pathway substantially reduced ABA levels in stressed roots, confirming that an increase in carotenoid accumulation contributes to fuel hormone production after salt exposure. Treatment with exogenous ABA was also found to upregulate PSY expression only in roots, suggesting an organ-specific feedback regulation of the carotenoid pathway by ABA. Taken together, our results show that the presence of high concentrations of salt in the growth medium rapidly triggers a root-specific activation of the carotenoid pathway, probably to ensure a proper supply of ABA precursors required for a sustained production of the hormone.	[Aguila Ruiz-Sola, M.; Rodriguez-Concepcion, Manuel; Rodriguez-Villalon, Antia] CSIC IRTA UAB UB, CRAG, Barcelona, Spain; [Arbona, Vicent; Gomez-Cadenas, Aurelio] Univ Jaume 1, Dept Ciencies Agr & Med Nat, Castellon de La Plana, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; Universitat Jaume I	Rodriguez-Concepcion, M (corresponding author), CSIC IRTA UAB UB, CRAG, Barcelona, Spain.	manuel.rodriguez@cragenomica.es; antia.rodriguezvillalon@unil.ch	Rodriguez-Concepcion, Manuel/I-7229-2015; Arbona, Vicent/K-1748-2015; Ruiz-Sola, M. Aguila/B-4889-2019; Gomez-Cadenas, Aurelio/K-6084-2012	Rodriguez-Concepcion, Manuel/0000-0002-1280-2305; Arbona, Vicent/0000-0003-2232-106X; Ruiz-Sola, M. Aguila/0000-0002-2281-6700; Gomez-Cadenas, Aurelio/0000-0002-4598-2664; Rodriguez-Villalon, Antia/0000-0001-8962-1353	Spanish Direccion General de Investigacion (DGI) [BIO2008-00432, BIO2011-23680]; DGI [AGL2010-22195-C03-01]; Consolider program [CSD2007-00036]; FPI fellowship; EC FP7 project TiMet; Generalitat de Catalunya [2009SGR-26]	Spanish Direccion General de Investigacion (DGI)(Spanish Government); DGI; Consolider program(Spanish Government); FPI fellowship(Spanish Government); EC FP7 project TiMet; Generalitat de Catalunya(Generalitat de Catalunya)	The work was mainly funded by research grants BIO2008-00432 and BIO2011-23680 from the Spanish Direccion General de Investigacion (DGI) to MRC. DGI also provided funding through research grant AGL2010-22195-C03-01 to AGC, the Consolider program (CSD2007-00036), and a FPI fellowship to ARS. Additional funding was provided by EC FP7 project TiMet. The Generalitat de Catalunya provided a FI fellowship to ARV and support grants (2009SGR-26 and XRB program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango J, 2010, PLANTA, V232, P1251, DOI 10.1007/s00425-010-1250-6; Barrero JM, 2006, PLANT CELL ENVIRON, V29, P2000, DOI 10.1111/j.1365-3040.2006.01576.x; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Durgbanshi A, 2005, J AGR FOOD CHEM, V53, P8437, DOI 10.1021/jf050884b; Endo A, 2008, PLANT PHYSIOL, V147, P1984, DOI 10.1104/pp.108.116632; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Gonzalez-Garcia MP, 2011, DEVELOPMENT, V138, P849, DOI 10.1242/dev.057331; Hirschberg J, 2001, CURR OPIN PLANT BIOL, V4, P210, DOI 10.1016/S1369-5266(00)00163-1; Howitt CA, 2006, PLANT CELL ENVIRON, V29, P435, DOI 10.1111/j.1365-3040.2005.01492.x; Jia WS, 2002, J EXP BOT, V53, P2201, DOI 10.1093/jxb/erf079; Jiang F, 2008, J EXP BOT, V59, P37, DOI 10.1093/jxb/erm127; Koiwai H, 2004, PLANT PHYSIOL, V134, P1697, DOI 10.1104/pp.103.036970; LeonKloosterziel KM, 1996, PLANT J, V10, P655, DOI 10.1046/j.1365-313X.1996.10040655.x; Li FQ, 2008, PLANT PHYSIOL, V147, P1334, DOI 10.1104/pp.108.122119; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Li FQ, 2009, PLANT SIGNAL BEHAV, V4, P208, DOI 10.4161/psb.4.3.7798; Lindgren LO, 2003, PLANT PHYSIOL, V132, P779, DOI 10.1104/pp.102.017053; Maass D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006373; Meier S, 2011, BMC SYSTBIOL, V5, P77; Nambara E, 1998, PLANT CELL PHYSIOL, V39, P853, DOI 10.1093/oxfordjournals.pcp.a029444; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Rodriguez-Concepcion M, 2004, PLANT CELL, V16, P144, DOI 10.1105/tpc.016204; Rodriguez-Villalon A, 2009, PLANT J, V60, P424, DOI 10.1111/j.1365-313X.2009.03966.x; Ruiz-Sola M Aguila, 2012, Arabidopsis Book, V10, pe0158, DOI 10.1199/tab.0158; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; Toledo-Ortiz G, 2010, P NATL ACAD SCI USA, V107, P11626, DOI 10.1073/pnas.0914428107; Van Norman JM, 2007, PLANT J, V49, P619, DOI 10.1111/j.1365-313X.2006.02982.x; Welsch R, 2003, PLANTA, V216, P523, DOI 10.1007/s00425-002-0885-3; Welsch R, 2008, PLANT PHYSIOL, V147, P367, DOI 10.1104/pp.108.117028; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453	37	71	72	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90765	10.1371/journal.pone.0090765	http://dx.doi.org/10.1371/journal.pone.0090765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595399	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500099
J	Chen, XL; Chen, TW; Zhang, XM; Li, ZL; Zeng, NL; Li, T; Wang, D; Li, J; Fang, ZJ; Li, H; Chen, J; Liu, J; Xu, GH; Ren, J; Wu, JL; Li, CP				Chen, Xiao-li; Chen, Tian-wu; Zhang, Xiao-ming; Li, Zhen-lin; Zeng, Nan-lin; Li, Ting; Wang, Dan; Li, Jie; Fang, Zhi-jia; Li, Hang; Chen, Jia; Liu, Jun; Xu, Guo-hui; Ren, Jing; Wu, Jian-lin; Li, Chun-ping			Quantitative Assessment of the Presence and Severity of Cirrhosis in Patients with Hepatitis B Using Right Liver Lobe Volume and Spleen Size Measured at Magnetic Resonance Imaging	PLOS ONE			English	Article							PORTAL HEMODYNAMICS; COMPUTED-TOMOGRAPHY; PROGNOSIS; FIBROSIS; HYPERSPLENISM; MRI	Objective: To determine whether right liver lobe volume (RV) and spleen size measured utilizing magnetic resonance (MR) imaging could identify the presence and severity of cirrhosis in patients with hepatitis B. Methods: Two hundred and five consecutive patients with clinically confirmed diagnosis of cirrhosis due to hepatitis B and 40 healthy control individuals were enrolled in this study and underwent abdominal triphasic enhanced scans using MR imaging. Spleen maximal width (W), thickness (T) and length (L), together with RV and spleen volume (SV), were measured utilizing MR imaging. Spleen multidimensional index (SI) was obtained by multiplying previously acquired parameters WxTxL. Then statistical assessment was performed to evaluate the ability of these parameters, including RV, SV, RV/SV and SI, to identify the presence of cirrhosis and define Child-Pugh class of this disease. Results: SV and SI tended to increase (r = 0.557 and 0.622, respectively; all P<0.001), and RV and RV/SV tended to decrease (r = -0.749 and -0.699, respectively; all P<0.001) with increasing Child-Pugh class of cirrhosis. All the parameters, including RV, SV, RV/SV and SI, might be the indicators used to discriminate the patients with liver cirrhosis from the control group, and to distinguish these patients between Child-Pugh class A and B, between B and C, and between A and C (area under receiver operating characteristic curve [AUC] = 0.609-0.975, all P<0.05). Among these parameters, RV/SV was the best noninvasive factor for the discrimination of liver cirrhosis between Child-Pugh class A and B (AUC = 0.725), between A and C (AUC = 0.975), and between B and C (AUC = 0.876), while SI was the best variable to distinguish the cirrhosis patients from the control group (AUC = 0.960, P<0.05). Conclusion: RV/SV should be used to identify the severity of cirrhosis, while SI can be recommended to determine the presence of this disease.	[Chen, Xiao-li; Chen, Tian-wu; Zhang, Xiao-ming; Zeng, Nan-lin; Li, Ting; Wang, Dan; Li, Jie; Li, Hang; Li, Chun-ping] North Sichuan Med Coll, Affiliated Hosp, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China; [Chen, Xiao-li; Chen, Tian-wu; Zhang, Xiao-ming; Zeng, Nan-lin; Li, Ting; Wang, Dan; Li, Jie; Li, Hang; Li, Chun-ping] North Sichuan Med Coll, Affiliated Hosp, Dept Radiol, Nanchong, Sichuan, Peoples R China; [Chen, Xiao-li; Xu, Guo-hui; Ren, Jing] Sichuan Canc Hosp & Inst, Dept Radiol, Chengdu, Sichuan, Peoples R China; [Chen, Xiao-li; Xu, Guo-hui; Ren, Jing] Second Peoples Hosp Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Li, Zhen-lin; Fang, Zhi-jia] Sichuan Univ, West China Hosp, Dept Radiol, Chengdu, Sichuan, Peoples R China; [Chen, Jia] Sichuan Acad Med Sci, Dept Ultrasonog, Chengdu, Sichuan, Peoples R China; [Chen, Jia] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Liu, Jun] Cent S Univ, Xiangya Hosp 2, Dept Radiol, Changsha, Hunan, Peoples R China; [Wu, Jian-lin] Dalian Univ, Affiliated Zhongshan Hosp, Dept Radiol, Dalian 116012, Liaoning, Peoples R China	North Sichuan Medical University; North Sichuan Medical University; Sichuan University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Central South University; Dalian University	Chen, TW (corresponding author), North Sichuan Med Coll, Affiliated Hosp, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China.	chentw@aliyun.com; cjr.wujianlin@vip.163.com	Zhang, Xiao Ming/H-7104-2019	Zhang, Xiao Ming/0000-0001-5327-8506	National Natural Science Foundation of China [81050033]; Key Projects in the Sichuan Province Science and Technology Pillar Program [2011SZ0237]; Science Foundation for Distinguished Young Scholars of Sichuan Province in China [2010JQ0039]; Key Science and Technology Project of Chinese Ministry of Public Health [2014114]; Natural Science Key Project of North Sichuan Medical College [CBY12-A-ZD03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the Sichuan Province Science and Technology Pillar Program; Science Foundation for Distinguished Young Scholars of Sichuan Province in China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Key Science and Technology Project of Chinese Ministry of Public Health; Natural Science Key Project of North Sichuan Medical College	This study was supported by the National Natural Science Foundation of China (Grant No. 81050033), the Key Projects in the Sichuan Province Science and Technology Pillar Program (Grant No. 2011SZ0237), the Science Foundation for Distinguished Young Scholars of Sichuan Province in China (Grant No. 2010JQ0039), the Key Science and Technology Project of Chinese Ministry of Public Health (Grant No. 2014114), and the Natural Science Key Project of North Sichuan Medical College (Grant No. CBY12-A-ZD03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JJ, 1997, RADIOLOGY, V202, P1; Chen XL, 2013, J MAGN RESON IMAGING, V38, P540, DOI 10.1002/jmri.24007; Durand F, 2005, J HEPATOL, V42, pS100, DOI 10.1016/j.jhep.2004.11.015; FISHER MR, 1985, J CLIN GASTROENTEROL, V7, P173, DOI 10.1097/00004836-198504000-00012; HOEFS JC, 1995, HEPATOLOGY, V22, P1113, DOI 10.1016/0270-9139(95)90617-7; Ito K, 1999, AM J ROENTGENOL, V173, P591, DOI 10.2214/ajr.173.3.10470885; Li H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079681; Liu P, 2009, WORLD J GASTROENTERO, V15, P3298, DOI 10.3748/wjg.15.3298; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Mazonakis M, 2002, J MAGN RESON IMAGING, V15, P557, DOI 10.1002/jmri.10109; Murata Y, 2008, J GASTROENTEROL, V43, P632, DOI 10.1007/s00535-008-2202-9; Nagula S, 2006, J HEPATOL, V44, P111, DOI 10.1016/j.jhep.2005.07.036; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Rezai P, 2011, AM J ROENTGENOL, V196, P367, DOI 10.2214/AJR.10.4453; Rustogi R, 2012, J MAGN RESON IMAGING, V35, P1356, DOI 10.1002/jmri.23585; Suarez MS, 2008, TRANSPL P, V40, P2965, DOI 10.1016/j.transproceed.2008.08.110; Saygili OB, 2005, EUR J RADIOL, V54, P400, DOI 10.1016/j.ejrad.2004.08.001; Shah SHA, 1996, AM J GASTROENTEROL, V91, P2580; Shi BM, 2005, WORLD J GASTROENTERO, V11, P708, DOI 10.3748/wjg.v11.i5.708; Talwalkar JA, 2008, HEPATOLOGY, V47, P332, DOI 10.1002/hep.21972; Tan KC, 2008, RADIOLOGY, V248, P317, DOI 10.1148/radiol.2481051024; Taouli B, 2009, AM J ROENTGENOL, V193, P14, DOI 10.2214/AJR.09.2601; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; Wehler M, 2001, HEPATOLOGY, V34, P255, DOI 10.1053/jhep.2001.26522; WITTE CL, 1974, GASTROENTEROLOGY, V67, P498; Zhou L, 2014, J MAGN RESON IMAGING, V39, P872, DOI 10.1002/jmri.24248; Zhou L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083697; Zhou XP, 2007, AM J ROENTGENOL, V189, pW153, DOI 10.2214/AJR.07.2181	28	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89973	10.1371/journal.pone.0089973	http://dx.doi.org/10.1371/journal.pone.0089973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594920	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500028
J	Garcia, D; Al Nima, A; Rappe, C; Ricciardi, MR; Archer, T				Garcia, Danilo; Al Nima, Ali; Rappe, Catrin; Ricciardi, Max Rapp; Archer, Trevor			The Relationship between the JobMatchTalent Test and the NEO PI-R: Construct Validation of an Instrument Designed for Recruitment of Personnel	PLOS ONE			English	Article							CLONINGERS PSYCHOBIOLOGICAL MODEL; PERSONALITY DIMENSIONS; JOB-PERFORMANCE; TEMPERAMENT; EMPLOYMENT; VALIDITY; ABILITY	Background: Personality measures in recruitment situations need to (1) cover the Big-Five model of personality and (2) focus on interpersonal requirements of jobs. We investigated the relationship between the JobMatchTalent test and the NEO Personality Inventory-Revised (NEO PI-R). The JobMatchTalent consists of three areas (i.e., Stability Patterns, Action Patterns, and Relation Patterns) divided in 10 main scales providing a deeper picture of the employee (e. g., Work Structure, Tolerance). Method: The participants (N = 390) were recruited from the professional network LinkedIn and completed online versions of both instruments. We used correlation analysis to investigate the construct validity of the JobMatchTalent test by identifying significant correlation coefficients no lower than +/-.30 (i.e., convergent validity) and those with nonsignificant correlations (i.e., discriminant validity). Regression analyses were used to investigate the variance of the NEO PI-R dimensions that was explained by the JobMatchTalent test. Results: Four of the NEO PI-R dimensions showed considerable overlap with the following JobMatchTalent main scales: (1) Work structure and Decision Characteristics, which both are measures of thoughtfulness, planning, and order (i.e., Conscientiousness); (2) Inner drive, Activity, Drive, Acting, and Communication, which represent different aspects of being outgoing and extrovert (i.e., Extraversion); (3) Tolerance and Social interest, which measure a person's interest and ability to create social relations (i.e., Agreeableness); and (4) Stress Index, a measure of emotional stability (i.e., the opposite of Neuroticism). All 5 NEO PI-R dimensions overlapped with the JobMatchTalent sub-scales. Conclusions: The study suggests that 4 of the NEO PI-R dimensions are logically categorized along the JobMatchTalent main scales: (1) Order and Thoughtfulness, (2) Energy and Extraversion, (3) Social Adaptation and Interest, and (4) Emotion Control. Hence, it suggests substantial overlap between the instruments, but also that the two instruments cannot be considered as equivalent to assess individual differences in recruitment situations.	[Garcia, Danilo; Al Nima, Ali; Rappe, Catrin; Ricciardi, Max Rapp; Archer, Trevor] Univ Gothenburg, Network Empowerment & Well Being, Gothenburg, Sweden; [Garcia, Danilo] Univ Gothenburg, Ctr Eth Law & Mental Hlth CELAM, Gothenburg, Sweden; [Al Nima, Ali; Rappe, Catrin; Ricciardi, Max Rapp; Archer, Trevor] Univ Gothenburg, Dept Psychol, S-40020 Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Garcia, D (corresponding author), Univ Gothenburg, Network Empowerment & Well Being, Gothenburg, Sweden.	danilo.garcia@euromail.se	Garcia, Danilo/AAD-3779-2019	Garcia, Danilo/0000-0003-3356-4454				BARRICK MR, 1991, PERS PSYCHOL, V44, P1, DOI 10.1111/j.1744-6570.1991.tb00688.x; Barrick MR, 2001, INT J SELECT ASSESS, V9, P9, DOI 10.1111/1468-2389.00160; Bendersky C, 2013, ACAD MANAGE J, V56, P387, DOI 10.5465/amj.2011.0316; Cattell H, 2008, SAGE HDB PERSONALITY, P135, DOI DOI 10.4135/9781849200479.N7; Cellar DF, 1996, J APPL PSYCHOL, V81, P694, DOI 10.1037/0021-9010.81.6.694; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Cloninger CR, 2004, FEELING GOOD SCI WEL; Cohen J.E., 1988, STAT POWER ANAL BEHA; COSTA PT, 1984, J APPL PSYCHOL, V69, P390, DOI 10.1037/0021-9010.69.3.390; Costa PT, 2007, REVISED NEO PERSONAL; Coyne JC, 1996, J PERS, V64, P959, DOI 10.1111/j.1467-6494.1996.tb00950.x; Davis L.L., 1992, APPL NURS RES, V5, P194, DOI [10.1016/S0897-1897(05)80008-4, DOI 10.1016/S0897-1897(05)80008-4]; De Fruyt F, 1999, PERS PSYCHOL, V52, P701; De Fruyt F, 2000, PERS INDIV DIFFER, V29, P441, DOI 10.1016/S0191-8869(99)00204-4; DeYoung CG, 2007, J PERS SOC PSYCHOL, V93, P880, DOI 10.1037/0022-3514.93.5.880; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Furnham A, 1998, PERS INDIV DIFFER, V24, P187, DOI 10.1016/S0191-8869(97)00169-4; Garcia D, 2012, J HAPPINESS STUD, V13, P999, DOI 10.1007/s10902-011-9303-5; Garcia D, 2011, J HAPPINESS STUD, V12, P1023, DOI 10.1007/s10902-010-9242-6; Grant AM, 2011, ACAD MANAGE J, V54, P528, DOI 10.5465/AMJ.2011.61968043; Hathaway SR, 1943, MANUAL MINNESTA MULT; Higgins DM, 2007, J PERS SOC PSYCHOL, V93, P298, DOI 10.1037/0022-3514.93.2.298; Hogan R, 1996, AM PSYCHOL, V51, P469, DOI 10.1037/0003-066X.51.5.469; Hoyle rh, 2009, HDB INDIVIDUAL DIFFE, P257, DOI DOI 10.1007/S00018-010-0311-0; Klehe UC, 2012, HUM PERFORM, V25, P273, DOI 10.1080/08959285.2012.703733; MacKinnon D.W., 1944, PERSONALITY BEHAV DI, V1, P3; McCrae RR, 1997, AM PSYCHOL, V52, P509, DOI 10.1037/0003-066X.52.5.509; Moradi S, 2014, FRONT PSYCH IN PRESS; Myers LB, 1985, MANUAL GUIDE DEV USE; Nicholson N, 2005, J RISK RES, V8, P157, DOI 10.1080/1366987032000123856; Olsen K, 2013, JOBMATCHTALENT TECHN; Pauls CA, 2005, PERS INDIV DIFFER, V39, P297, DOI 10.1016/j.paid.2005.01.003; Salgado JF, 1997, J APPL PSYCHOL, V82, P30, DOI 10.1037/0021-9010.82.1.30; Schaefer PS, 2004, J RES PERS, V38, P473, DOI 10.1016/j.jrp.2003.09.010; Tokar DM, 1997, J VOCAT BEHAV, V50, P482, DOI 10.1006/jvbe.1996.1546; Zickar MJ, 1999, J APPL PSYCHOL, V84, P551, DOI 10.1037/0021-9010.84.4.551; Zuckerman M, 2002, BIG FIVE ASSESSMENT, P377	37	3	3	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90309	10.1371/journal.pone.0090309	http://dx.doi.org/10.1371/journal.pone.0090309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4FD	24594872	Green Submitted, Green Published, gold			2022-12-27	WOS:000332475500042
J	Fu, XH; Duan, YM; Liu, YT; Cai, C; Meng, FL; Zhou, JQ				Fu, Xiao-Hong; Duan, Yi-Min; Liu, Yu-Ting; Cai, Chen; Meng, Fei-Long; Zhou, Jin-Qiu			Telomere Recombination Preferentially Occurs at Short Telomeres in Telomerase-Null Type II Survivors	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST TELOMERES; REPLICATION; DNA; ELONGATION; SENESCENCE; MAINTENANCE; PROTEIN; TEL1P; POLYMERASES	In telomerase negative yeast cells, Rad52-dependent recombination is activated to maintain telomeres. This recombination-mediated telomere elongation usually involves two independent pathways, type I and type II, and leads to generation of type I and type II survivors. It remains elusive whether the recombination-mediated telomere elongation prefers to take place on shorter or longer telomeres. In this study, we exploited the de novo telomere addition system to examine the telomere recombination event in telomerase negative cells. We show that recombination preferentially occurs on shorter rather than longer telomeres in both pre-survivors and established type II survivors. In type II survivors, the short VII-L telomeres could invade either terminal TG(1-3) sequence or short tracts of TG(1-3) sequence in subtelomeric Y'-X and Y'-Y' junction to initiate recombination. Unexpectedly, short VII-L telomere recombination still takes place in type II survivors lacking either Rad50 or Rad59, which are required for type II survivor generation in senescing telomerase-null cells. Our results support the notion that Rad50 and Rad59 are not essential for the maintenance of type II survivors once established.	[Fu, Xiao-Hong; Duan, Yi-Min; Liu, Yu-Ting; Meng, Fei-Long; Zhou, Jin-Qiu] Chinese Acad Sci, Shanghai Inst Biol Sci, Univ Chinese Acad Sci, State Key Lab Mol Biol,Shanghai Inst Biochem & Ce, Shanghai, Peoples R China; [Cai, Chen] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University	Zhou, JQ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Univ Chinese Acad Sci, State Key Lab Mol Biol,Shanghai Inst Biochem & Ce, Shanghai, Peoples R China.	jqzhou@sibcb.ac.cn		Meng, Feilong/0000-0003-0333-6872	National Natural Science Foundation of China [31230040, 31221001]; Ministry of Science and Technology of China [2013CB910403, 2011CB966301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from National Natural Science Foundation of China (31230040 and 31221001) and Ministry of Science and Technology of China (2013CB910403 and 2011CB966301) to J-QZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneric M, 2007, EMBO REP, V8, P1080, DOI 10.1038/sj.embor.7401082; Bianchi A, 2007, CELL, V128, P1051, DOI 10.1016/j.cell.2007.01.041; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; CHAN CSM, 1983, CELL, V33, P563, DOI 10.1016/0092-8674(83)90437-3; Chang M, 2011, NAT STRUCT MOL BIOL, V18, P451, DOI 10.1038/nsmb.2034; Chen QJ, 2001, MOL CELL BIOL, V21, P1819, DOI 10.1128/MCB.21.5.1819-1827.2001; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Forstemann K, 2000, NUCLEIC ACIDS RES, V28, P2690, DOI 10.1093/nar/28.14.2690; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hector RE, 2007, MOL CELL, V27, P851, DOI 10.1016/j.molcel.2007.08.007; Hu Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003208; Hughes TR, 2000, CURR BIOL, V10, P809, DOI 10.1016/S0960-9822(00)00562-5; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; Kozak ML, 2010, EMBO J, V29, P158, DOI 10.1038/emboj.2009.314; Le S, 1999, GENETICS, V152, P143; Lendvay TS, 1996, GENETICS, V144, P1399; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; McEachern MJ, 2001, MOL CELL, V7, P695, DOI 10.1016/S1097-2765(01)00215-5; Meng FL, 2009, EMBO J, V28, P1466, DOI 10.1038/emboj.2009.92; Natarajan S, 2002, MOL CELL BIOL, V22, P4512, DOI 10.1128/MCB.22.13.4512-4521.2002; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; Reddel RR, 2001, RADIAT RES, V155, P194, DOI 10.1667/0033-7587(2001)155[0194:ALOTIH]2.0.CO;2; Sabourin M, 2007, MOL CELL, V27, P550, DOI 10.1016/j.molcel.2007.07.016; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Steiner BR, 1996, P NATL ACAD SCI USA, V93, P2817, DOI 10.1073/pnas.93.7.2817; Straatman KR, 2007, CHROMOSOME RES, V15, P1033, DOI 10.1007/s10577-007-1178-2; Teng SC, 2000, MOL CELL, V6, P947, DOI 10.1016/S1097-2765(00)00092-7; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Topcu Z, 2005, P NATL ACAD SCI USA, V102, P3348, DOI 10.1073/pnas.0408770102; Tsai YL, 2002, MOL CELL BIOL, V22, P5679, DOI 10.1128/MCB.22.16.5679-5687.2002; Wellinger RJ, 2010, FEBS LETT, V584, P3734, DOI 10.1016/j.febslet.2010.06.031; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; ZAKIAN VA, 1988, MOL CELL BIOL, V8, P2257, DOI 10.1128/MCB.8.5.2257; Zakian VA, 1996, ANNU REV GENET, V30, P141, DOI 10.1146/annurev.genet.30.1.141	40	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90644	10.1371/journal.pone.0090644	http://dx.doi.org/10.1371/journal.pone.0090644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594632	gold, Green Published, Green Submitted			2022-12-27	WOS:000332468900128
J	Huang, SH; Ke, SC; Lin, TH; Huang, HB; Chen, YC				Huang, Shu-Hsiang; Ke, Shyue-Chu; Lin, Ta-Hsin; Huang, Hsin-Bin; Chen, Yi-Cheng			Effect of C-Terminal Residues of A beta on Copper Binding Affinity, Structural Conversion and Aggregation	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PROTEIN; PEPTIDE; ZINC; COORDINATION; CU(II); ACCUMULATION; GENERATE; FIBRILS; INSIGHT	Many properties of A beta such as toxicity, aggregation and ROS formation are modulated by Cu2+. Previously, the coordination configuration and interaction of Cu2+ with the A beta N-terminus has been extensively studied. However, the effect of A beta C-terminal residues on related properties is still unclear. In the present study, several C-terminus-truncated A beta peptides, including A beta 1-40, A beta 1-35, A beta 1-29, A beta 1-24 and A beta 1-16, were synthesized to characterize the effect of A beta C-terminal residues on Cu2+ binding affinity, structure, aggregation ability and ROS formation. Results show that the A beta C-terminal residues have effect on Cu2+ binding affinity, aggregation ability and inhibitory ability of ROS formation. Compared to the key residues responsible for A beta aggregation and structure in the absence of Cu2+, it is more likely that residues 36-40, rather than residues 17-21 and 30-35, play a key role on the related properties of A beta in the presence of Cu2+.	[Huang, Shu-Hsiang; Chen, Yi-Cheng] MacKay Med Coll, Dept Med, New Taipei City, Taiwan; [Ke, Shyue-Chu] Natl Dong Hwa Univ, Dept Phys, Hualien, Taiwan; [Lin, Ta-Hsin] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Lin, Ta-Hsin] Natl Yang Ming Univ, Inst Biochem, Taipei 112, Taiwan; [Huang, Hsin-Bin] Natl Chung Cheng Univ, Inst Mol Biol, Chiayi, Taiwan	Mackay Medical College; National Dong Hwa University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Chung Cheng University	Chen, YC (corresponding author), MacKay Med Coll, Dept Med, New Taipei City, Taiwan.	chen15@mmc.edu.tw			National Science Council of Taiwan, ROC [NSC101-2627-M-715-001, NSC102-2627-M-715-002]; MacKay Medical College, Taiwan [B1011B05]	National Science Council of Taiwan, ROC(Ministry of Science and Technology, Taiwan); MacKay Medical College, Taiwan	This work was supported by grants from National Science Council of Taiwan, ROC (NSC101-2627-M-715-001 and NSC102-2627-M-715-002 to YCC) and MacKay Medical College, Taiwan (B1011B05 to YCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alies B, 2013, ANAL CHEM, V85, P1501, DOI 10.1021/ac302629u; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Bolognin S, 2011, INT J BIOCHEM CELL B, V43, P877, DOI 10.1016/j.biocel.2011.02.009; Bush AI, 2002, NEUROBIOL AGING, V23, P1031, DOI 10.1016/S0197-4580(02)00120-3; Chen Y, 1996, BIOPHYS J, V71, P163, DOI 10.1016/S0006-3495(96)79213-5; [陈颖 Chen Ying], 2013, [广东农业科学, Guangdong Agricultural Sciences], V40, P8; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Curtain CC, 2001, J BIOL CHEM, V276, P20466, DOI 10.1074/jbc.M100175200; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Faller P, 2009, CHEMBIOCHEM, V10, P2837, DOI 10.1002/cbic.200900321; Fang CL, 2010, REGUL PEPTIDES, V163, P1, DOI 10.1016/j.regpep.2010.05.001; GarzonRodriguez W, 1997, J BIOL CHEM, V272, P21037, DOI 10.1074/jbc.272.34.21037; HAASS C, 1993, J BIOL CHEM, V268, P3021; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Karr JW, 2004, J AM CHEM SOC, V126, P13534, DOI 10.1021/ja0488028; Lee EK, 2005, PROTEIN EXPRES PURIF, V40, P183, DOI 10.1016/j.pep.2004.12.014; Liao MQ, 2007, FEBS LETT, V581, P1161, DOI 10.1016/j.febslet.2007.02.026; Liu RT, 2004, J NEUROSCI RES, V75, P162, DOI 10.1002/jnr.10859; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Morgan DM, 2002, J AM CHEM SOC, V124, P12644, DOI 10.1021/ja0273086; Nadal RC, 2008, BIOCHEMISTRY-US, V47, P11653, DOI 10.1021/bi8011093; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Parthasarathy S, 2011, J AM CHEM SOC, V133, P3390, DOI 10.1021/ja1072178; Rozga M, 2010, CHEM RES TOXICOL, V23, P336, DOI 10.1021/tx900344n; Sarell CJ, 2009, BIOCHEMISTRY-US, V48, P4388, DOI 10.1021/bi900254n; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Shearer J, 2008, J AM CHEM SOC, V130, P17826, DOI 10.1021/ja805940m; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; TANZI RE, 1987, SCIENCE, V238, P666, DOI 10.1126/science.2890207; Wang CC, 2012, J BIOMOL STRUCT DYN, V30, P160, DOI 10.1080/07391102.2012.677767; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Zou K, 2002, J NEUROSCI, V22, P4833, DOI 10.1523/JNEUROSCI.22-12-04833.2002	38	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90385	10.1371/journal.pone.0090385	http://dx.doi.org/10.1371/journal.pone.0090385			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594588	gold, Green Submitted, Green Published			2022-12-27	WOS:000332468900103
J	Kaur, S; Harjai, K; Chhibber, S				Kaur, Sandeep; Harjai, Kusum; Chhibber, Sanjay			Bacteriophage Mediated Killing of Staphylococcus aureus In Vitro on Orthopaedic K Wires in Presence of Linezolid Prevents Implant Colonization	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; SUBINHIBITORY CONCENTRATIONS; FUSIDIC ACID; DRUG-RELEASE; INFECTION; VANCOMYCIN; PENETRATION; PNEUMONIAE; GENTAMICIN; BONE	Background: Infections of bone and joint tissues following arthroplasty surgeries remain a major challenge in orthopaedic settings. Methicillin resistant Staphylococcus aureus (MRSA) is recognised as an established pathogen in such infections. Combination therapy using linezolid and bacteriophage impregnated in biopolymer was investigated in the present study as an alternative strategy to prevent MRSA colonisation on the orthopaedic implant surface. Methodology: Coating of stainless steel orthopaedic grade K-wires was achieved using hydroxypropylmethlycellulose (HPMC) mixed with phage alone, linezolid alone and phage and linezolid together. The potential of these agents to inhibit adhesion of S. aureus (MRSA) 43300 on K-wires was assessed. Coated and naked wires were analysed by scanning electron microscopy (SEM) and fluorescent staining. Result: Significant reduction in bacterial adhesion was achieved on phage/linezolid wires in comparison to naked as well as HPMC coated wires. However, maximum reduction in bacterial adherence (similar to 4 log cycles) was observed on the wires coated with phage-linezolid combination. The frequency of emergence of resistant mutants was also negligible in presence of both the agents. Conclusion: This study provides evidence to confirm that local delivery system employing linezolid (a potent protein synthesis inhibitor) along with a broad spectrum lytic bacteriophage (capable of self-multiplication) is able to attack the adhered as well as surrounding bacteria present near the implant site. Unlike other antibiotic based therapies, this combination has the potential to significantly restrict the emergence of resistant mutants, thus paving the way for effective treatment of MRSA associated infection of medical implants.	[Kaur, Sandeep; Harjai, Kusum; Chhibber, Sanjay] Panjab Univ, Dept Microbiol, Chandigarh 160014, India	Panjab University	Chhibber, S (corresponding author), Panjab Univ, Dept Microbiol, Chandigarh 160014, India.	sanjaychhibber8@gmail.com	Kaur, Sandeep/T-1863-2019	Kaur, Sandeep/0000-0003-3146-1611				Abedon ST, 2010, CURR PHARM BIOTECHNO, V11, P28, DOI 10.2174/138920110790725410; ALDERMAN D A, 1984, International Journal of Pharmaceutical Technology and Product Manufacture, V5, P1; Alfadhel M, 2011, INT J PHARMACEUT, V416, P280, DOI 10.1016/j.ijpharm.2011.07.006; Ambrose CG, 2004, CLIN ORTHOP RELAT R, P293, DOI 10.1097/01.blo.0000126303.41711.a2; Azeredo J, 2008, CURR PHARM BIOTECHNO, V9, P261, DOI 10.2174/138920108785161604; Bedi MS, 2009, WORLD J MICROB BIOT, V25, P1145, DOI 10.1007/s11274-009-9991-8; Bernardo K, 2004, ANTIMICROB AGENTS CH, V48, P546, DOI 10.1128/AAC.48.2.546-555.2004; Billon A, 2005, J MICROENCAPSUL, V22, P841, DOI 10.1080/02652040500162790; Calhoun JH, 1997, CLIN ORTHOP RELAT R, P206; Carlton Richard M., 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P267; Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062, DOI 10.1177/039139880502801103; Cowsar DR, 1974, ADV EXP MED BIOL, V47, P1; Dhand Abhay, 2012, F1000 Med Rep, V4, P4, DOI 10.3410/M4-4; Djurkovic S, 2005, ANTIMICROB AGENTS CH, V49, P1225, DOI 10.1128/AAC.49.3.1225-1228.2005; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Duckworth DH, 2002, BIODRUGS, V16, P57, DOI 10.2165/00063030-200216010-00006; Fines M, 2000, J ANTIMICROB CHEMOTH, V45, P797, DOI 10.1093/jac/45.6.797; FORD JL, 1987, INT J PHARM, V40, P223, DOI 10.1016/0378-5173(87)90172-4; Gemmell CG, 2002, J ANTIMICROB CHEMOTH, V50, P665, DOI 10.1093/jac/dkf192; Gollwitzer H, 2003, J ANTIMICROB CHEMOTH, V51, P585, DOI 10.1093/jac/dkg105; Goodman SB, 2013, BIOMATERIALS, V34, P3174, DOI 10.1016/j.biomaterials.2013.01.074; Grohs P, 2003, ANTIMICROB AGENTS CH, V47, P418, DOI 10.1128/AAC.47.1.418-420.2003; Herrmann DJ, 2008, EXPERT REV ANTI-INFE, V6, P825, DOI 10.1586/14787210.6.6.825; Hickok NJ, 2012, ADV DRUG DELIVER REV, V64, P1165, DOI 10.1016/j.addr.2012.03.015; Kalicke T, 2006, J ORTHOP RES, V24, P1622, DOI 10.1002/jor.20193; Kaur S, 2012, APPL ENVIRON MICROB, V78, P8227, DOI 10.1128/AEM.02371-12; Kumari S, 2011, J MED MICROBIOL, V60, P205, DOI 10.1099/jmm.0.018580-0; Kutateladze M, 2010, TRENDS BIOTECHNOL, V28, P591, DOI 10.1016/j.tibtech.2010.08.001; Kutscha-Lissberg F, 2003, ANTIMICROB AGENTS CH, V47, P3964, DOI 10.1128/AAC.47.12.3964-3966.2003; Langley R, 2003, J MED MICROBIOL, V52, P483, DOI 10.1099/jmm.0.05099-0; Lee BJ, 1999, INT J PHARM, V188, P71, DOI 10.1016/S0378-5173(99)00204-5; Loc-Carrillo Catherine, 2011, Bacteriophage, V1, P111; Lovering AM, 2002, J ANTIMICROB CHEMOTH, V50, P73, DOI 10.1093/jac/dkf066; McMillan D.J., 2011, J BIOMED SCI ENG, V4, P535, DOI [10.4236/jbise.2011.48069, DOI 10.4236/JBISE.2011.48069]; Moellering RC, 2003, ANN INTERN MED, V138, P135, DOI 10.7326/0003-4819-138-2-200301210-00015; Neut D, 2001, J ANTIMICROB CHEMOTH, V47, P885, DOI 10.1093/jac/47.6.885; O'Neill AJ, 2001, J ANTIMICROB CHEMOTH, V47, P647, DOI 10.1093/jac/47.5.647; Partridge SR, 2011, FEMS MICROBIOL REV, V35, P820, DOI 10.1111/j.1574-6976.2011.00277.x; Patel SA, 2012, INT J PHARM RES, V4; PHAM AT, 1994, PHARMACEUT RES, V11, P1379, DOI 10.1023/A:1018975318805; Pradhan R, 2008, MUSET, V1, P55; Puapermpoonsiri U, 2010, INT J PHARMACEUT, V389, P168, DOI 10.1016/j.ijpharm.2010.01.034; Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4; Rana B, 2002, J ANTIMICROB CHEMOTH, V50, P747, DOI 10.1093/jac/dkf207; Raschke MJ, 2004, UNFALLCHIRURG, V107, P653, DOI 10.1007/s00113-004-0828-5; Sakoulas G, 2008, CLIN INFECT DIS, V46, pS360, DOI 10.1086/533592; Salgado CD, 2007, CLIN ORTHOP RELAT R, P48, DOI 10.1097/BLO.0b013e3181123d4e; Skurnik M, 2006, INT J MED MICROBIOL, V296, P5, DOI 10.1016/j.ijmm.2005.09.002; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Sulakvelidze A, 2001, ANN MED, V33, P507, DOI 10.3109/07853890108995959; Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001; Tenover FC, 2007, CLIN INFECT DIS, V44, P1208, DOI 10.1086/513203; Trampuz A, 2006, CURR OPIN INFECT DIS, V19, P349, DOI 10.1097/01.qco.0000235161.85925.e8; Tweden KS, 1997, J HEART VALVE DIS, V6, P553; Verheust C., 2010, APPL BIOSAF, V15, P32, DOI [10.1177/153567601001500106, DOI 10.1177/153567601001500106]; Walls RJ, 2008, J BONE JOINT SURG BR, V90B, P292, DOI 10.1302/0301-620X.90B3.20155; WAN AT, 1991, CLIN CHEM, V37, P1683; Wayne PA, 2006, M7A7 CLIN LAB STAND; Widmer AF, 2001, CLIN INFECT DIS, V33, pS94, DOI 10.1086/321863; Wiederhold NP, 2005, J ANTIMICROB CHEMOTH, V55, P792, DOI 10.1093/jac/dki106	61	41	41	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90411	10.1371/journal.pone.0090411	http://dx.doi.org/10.1371/journal.pone.0090411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594764	gold, Green Submitted, Green Published			2022-12-27	WOS:000332468900106
J	Saia, S; Amato, G; Frenda, AS; Giambalvo, D; Ruisi, P				Saia, Sergio; Amato, Gaetano; Frenda, Alfonso Salvatore; Giambalvo, Dario; Ruisi, Paolo			Influence of Arbuscular Mycorrhizae on Biomass Production and Nitrogen Fixation of Berseem Clover Plants Subjected to Water Stress	PLOS ONE			English	Article							MEDICAGO-SATIVA; FUNGI; DROUGHT; ACCUMULATION; INOCULATION; RHIZOBIUM; FREQUENCY; REGROWTH; ALFALFA; GROWTH	Several studies, performed mainly in pots, have shown that arbuscular mycorrhizal symbiosis can mitigate the negative effects of water stress on plant growth. No information is available about the effects of arbuscular mycorrhizal symbiosis on berseem clover growth and nitrogen (N) fixation under conditions of water shortage. A field experiment was conducted in a hilly area of inner Sicily, Italy, to determine whether symbiosis with AM fungi can mitigate the detrimental effects of drought stress (which in the Mediterranean often occurs during the late period of the growing season) on forage yield and symbiotic N-2 fixation of berseem clover. Soil was either left under water stress (i.e., rain-fed conditions) or the crop was well-watered. Mycorrhization treatments consisted of inoculation of berseem clover seeds with arbuscular mycorrhizal spores or suppression of arbuscular mycorrhizal symbiosis by means of fungicide treatments. Nitrogen biological fixation was assessed using the N-15-isotope dilution technique. Arbuscular mycorrhizal symbiosis was able to mitigate the negative effect of water stress on berseem clover grown in a typical semiarid Mediterranean environment. In fact, under water stress conditions, arbuscular mycorrhizal symbiosis resulted in increases in total biomass, N content, and N fixation, whereas no effect of crop mycorrhization was observed in the well-watered treatment.	[Saia, Sergio; Amato, Gaetano; Frenda, Alfonso Salvatore; Giambalvo, Dario; Ruisi, Paolo] Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy	University of Palermo	Ruisi, P (corresponding author), Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy.	paolo.ruisi@unipa.it	Amato, Gaetano/E-1105-2011; Saia, Sergio/K-7535-2012; Amato, Gaetano/AAT-2213-2020; Frenda, Alfonso Salvatore/AAP-4426-2020; Ruisi, Paolo/L-9337-2015	Amato, Gaetano/0000-0003-0660-7594; Saia, Sergio/0000-0001-5465-8500; Amato, Gaetano/0000-0003-0660-7594; Frenda, Alfonso Salvatore/0000-0002-2393-4936; Giambalvo, Dario/0000-0003-0267-698X; Ruisi, Paolo/0000-0002-5807-6986	Regione Siciliana (Italy) Project SI.CO.BIO.S.	Regione Siciliana (Italy) Project SI.CO.BIO.S.	This study was funded by Regione Siciliana (Italy) Project SI.CO.BIO.S. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato G, 2013, AGRON J, V105, P1222, DOI 10.2134/agronj2013.0038; Antunes PM, 2006, SOIL BIOL BIOCHEM, V38, P1234, DOI 10.1016/j.soilbio.2005.09.016; Auge RM, 2001, MYCORRHIZA, V11, P3, DOI 10.1007/s005720100097; Avice JC, 1997, PLANT SOIL, V188, P189, DOI 10.1023/A:1004291801023; Azcon R, 2001, CAN J BOT, V79, P1175, DOI 10.1139/cjb-79-10-1175; AZCON R, 1988, BIOL FERT SOILS, V7, P28, DOI 10.1007/BF00260728; Barea JM, 2005, NITROGEN FIXATION IN AGRICULTURE, FORESTRY, ECOLOGY, AND THE ENVIRONMENT, P199, DOI 10.1007/1-4020-3544-6_10; Barea Jose-Miguel, 2008, V7, P143; Chalk PM, 2006, SOIL BIOL BIOCHEM, V38, P2944, DOI 10.1016/j.soilbio.2006.05.005; FRIED M, 1977, PLANT SOIL, V47, P713, DOI 10.1007/BF00011042; GAHOONIA TS, 1994, PLANT SOIL, V159, P213, DOI 10.1007/BF00009283; GANRY F, 1982, PLANT SOIL, V68, P321, DOI 10.1007/BF02197937; GERDEMANN J. W., 1963, TRANS BRIT MYCOL SOC, V46, P235; Giambalvo D, 2011, CROP SCI, V51, P1808, DOI 10.2135/cropsci2010.05.0271; Giambalvo D, 2011, PLANT SOIL, V342, P379, DOI 10.1007/s11104-010-0703-9; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Goicoechea N, 1998, J PLANT PHYSIOL, V153, P706, DOI 10.1016/S0176-1617(98)80224-1; HASAN N, 1987, Indian Journal of Nematology, V17, P184; Jayne B, 2013, MYCORRHIZA IN PRESS, DOI [10.1007/s00572-013-0515-x, DOI 10.1007/S00572-013-0515-X.PUBLISHED]; Jung SC, 2012, J CHEM ECOL, V38, P651, DOI 10.1007/s10886-012-0134-6; Kubikova E, 2001, J PLANT PHYSIOL, V158, P1227, DOI 10.1078/0176-1617-00441; Lambers H, 2008, TRENDS ECOL EVOL, V23, P95, DOI 10.1016/j.tree.2007.10.008; Lekberg Y, 2005, NEW PHYTOL, V168, P189, DOI 10.1111/j.1469-8137.2005.01490.x; Marulanda A, 2003, PHYSIOL PLANTARUM, V119, P526, DOI 10.1046/j.1399-3054.2003.00196.x; Meuriot F, 2004, ANN BOT-LONDON, V94, P311, DOI 10.1093/aob/mch144; Miller MH, 2000, CAN J PLANT SCI, V80, P47, DOI 10.4141/P98-130; Olesniewicz KS, 1999, NEW PHYTOL, V142, P133, DOI 10.1046/j.1469-8137.1999.00372.x; PATTERSON NA, 1990, SYMBIOSIS, V8, P9; Pellegrino E, 2011, SOIL BIOL BIOCHEM, V43, P367, DOI 10.1016/j.soilbio.2010.11.002; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Porcel R, 2004, J EXP BOT, V55, P1743, DOI 10.1093/jxb/erh188; RuizLozano JM, 1995, PHYSIOL PLANTARUM, V95, P472, DOI 10.1111/j.1399-3054.1995.tb00865.x; Saia S, 2014, J AGR SCI-CAMBRIDGE, V152, P370, DOI 10.1017/S002185961300004X; SAS Institute, 2008, SAS STAT 9 2 US GUID; Schweiger PF, 2001, SOIL BIOL BIOCHEM, V33, P1231, DOI 10.1016/S0038-0717(01)00028-1; Shokri S., 2009, Journal of Agronomy, V8, P79; Smith SE, 2010, PLANT SOIL, V326, P3, DOI 10.1007/s11104-009-9981-5; UDAIYAN K, 1995, BIOL FERT SOILS, V20, P275, DOI 10.1007/BF00336090; Vietz FG., 1972, WATER DEFICITS PLANT, VIll, P217, DOI DOI 10.1139/CGJ-2014-0090	39	42	44	4	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90738	10.1371/journal.pone.0090738	http://dx.doi.org/10.1371/journal.pone.0090738			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595111	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900142
J	Saitou, K; Lees, JN; Tordoff, MG				Saitou, Katsuyoshi; Lees, John N.; Tordoff, Michael G.			Taste Hedonics Influence the Disposition of Fat by Modulating Gastric Emptying in Rats	PLOS ONE			English	Article							CEPHALIC PHASE RESPONSES; CARDIOVASCULAR-DISEASE; ORAL-STIMULATION; BITTER TASTE; HUMANS; SECRETION; GUSTDUCIN; GLUCOSE; TRIGLYCERIDES; METABOLISM	We investigated how preferred and nonpreferred tastes influence the disposition of fat. Adult male Sprague Dawley rats were infused with 5 ml of 20% intralipid through an intragastric catheter and with 0.3 ml of a taste solution through an intraoral catheter. At 120 min postinfusion, plasma concentrations of fat fuels (triglycerides and non-esterified fatty acids) were either unchanged or slightly higher after rats tasted a preferred sweet taste solution (0.125% saccharin +3% glucose) than after they tasted water. They were markedly lower after rats tasted a non-preferred solution-either a bitter solution (0.15% quinine hydrochloride) or a sweet solution that had previously been the conditioned stimulus for lithium-induced taste aversion. The distribution of C-14-triolein mixed with the gastric load was determined at 4 h postinfusion. Rats that received a non-preferred bitter taste had significantly more C-14 remaining in the stomach than did those that received a preferred sweet taste. These results suggest that taste hedonics-either unconditioned or conditioned aversive tastes-influence fat disposition by altering gastric emptying.	[Saitou, Katsuyoshi; Lees, John N.; Tordoff, Michael G.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Saitou, Katsuyoshi] Kao Corp, Hlth Care Food Res Labs, Tokyo, Japan	Monell Chemical Senses Center; KAO Corporation	Saitou, K (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	saitou.katsuyoshi@kao.co.jp		Tordoff, Michael/0000-0003-1977-9520	Kao Corporation (Tokyo, Japan)	Kao Corporation (Tokyo, Japan)	Financial support for this study was provided by Kao Corporation (Tokyo, Japan; http://www.kao.com/jp/en/corp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah L, 1997, AM J CLIN NUTR, V65, P737, DOI 10.1093/ajcn/65.3.737; Alipour A, 2008, ATHEROSCLEROSIS SUPP, V9, P39, DOI 10.1016/j.atherosclerosissup.2008.05.007; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Bartoshuk LM, 1977, DRINKING BEHAVIOR, P317; Chan DC, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0309-9; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Chavez-Jauregui RN, 2010, GASTROENTEROLOGY, V139, P1538, DOI 10.1053/j.gastro.2010.05.002; FLYNN FW, 1991, BEHAV NEUROSCI, V105, P933, DOI 10.1037/0735-7044.105.6.933; Garcia-Bailo B, 2009, OMICS, V13, P69, DOI 10.1089/omi.2008.0031; Glendinning JI, 2008, PHYSIOL BEHAV, V93, P757, DOI 10.1016/j.physbeh.2007.11.029; Inui-Yamamoto C, 2009, PHYSIOL BEHAV, V96, P717, DOI 10.1016/j.physbeh.2009.01.013; Iwatsuki K, 2012, J PHARMACOL SCI, V118, P123, DOI 10.1254/jphs.11R08CP; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Mattes RD, 2002, J NUTR, V132, P3656, DOI 10.1093/jn/132.12.3656; Mattes RD, 2011, PHYSIOL BEHAV, V105, P27, DOI 10.1016/j.physbeh.2011.02.016; Mattes RD, 2009, CHEMOSENS PERCEPT, V2, P180, DOI 10.1007/s12078-009-9062-4; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Mora S, 2008, CIRCULATION, V118, P993, DOI 10.1161/CIRCULATIONAHA.108.777334; NAIM M, 1978, PHYSIOL BEHAV, V20, P563, DOI 10.1016/0031-9384(78)90248-2; POWLEY TL, 1985, AM J CLIN NUTR, V42, P991, DOI 10.1093/ajcn/42.5.991; RAMIREZ I, 1985, AM J PHYSIOL, V248, pR459, DOI 10.1152/ajpregu.1985.248.4.R459; Robertson MD, 2002, AM J CLIN NUTR, V75, P505, DOI 10.1093/ajcn/75.3.505; Robertson MD, 2003, GUT, V52, P834, DOI 10.1136/gut.52.6.834; Robertson MD, 2002, AM J CLIN NUTR, V76, P71, DOI 10.1093/ajcn/76.1.71; ROSENSTEIN D, 1988, CHILD DEV, V59, P1555, DOI 10.1111/j.1467-8624.1988.tb03683.x; Smeets PAM, 2010, NUTR REV, V68, P643, DOI 10.1111/j.1753-4887.2010.00334.x; Spector AC, 2009, CURR OPIN NEUROBIOL, V19, P370, DOI 10.1016/j.conb.2009.07.014; Steiner JE, 2001, NEUROSCI BIOBEHAV R, V25, P53, DOI 10.1016/S0149-7634(00)00051-8; Teff KL, 2011, PHYSIOL BEHAV, V103, P44, DOI 10.1016/j.physbeh.2011.01.012; Tittelbach TJ, 2001, J AM COLL NUTR, V20, P485, DOI 10.1080/07315724.2001.10719057; Tonosaki K, 2007, BIOMED RES-TOKYO, V28, P79, DOI 10.2220/biomedres.28.79; VALENSTEIN ES, 1967, SCIENCE, V157, P552, DOI 10.1126/science.157.3788.552; Wicks D, 2005, EUR J GASTROEN HEPAT, V17, P961, DOI 10.1097/00042737-200509000-00012	35	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90717	10.1371/journal.pone.0090717	http://dx.doi.org/10.1371/journal.pone.0090717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595359	gold, Green Published, Green Submitted			2022-12-27	WOS:000332468900136
J	Tian, XL; Zhang, Y; Gu, SY; Fan, YC; Sun, Q; Zhang, B; Yan, SH; Xu, WB; Ma, XE; Wang, WR				Tian, Xiaoling; Zhang, Yong; Gu, Suyi; Fan, Yaochun; Sun, Qiang; Zhang, Bo; Yan, Shaohong; Xu, Wenbo; Ma, Xueen; Wang, Wenrui			New Coxsackievirus B4 Genotype Circulating in Inner Mongolia Autonomous Region, China	PLOS ONE			English	Article							HUMAN-ENTEROVIRUS-B; VACCINE-DERIVED POLIOVIRUS; MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; FREQUENT RECOMBINATION; SHANDONG PROVINCE; HAND; FOOT; EVOLUTION; OUTBREAK	Hand, foot, and mouth disease (HFMD) surveillance was initiated in the Inner Mongolia Autonomous Region of China in 2007, a crucial scrutiny for monitoring the prevalence of enterovirus serotypes associated with HFMD patients. However, this surveillance mostly focused on enterovirus 71 (EV-A71) and coxsackievirus A16; therefore, information on other enterovirus serotypes is limited. To identify the other circulating enterovirus serotypes in the HFMD outbreaks in Inner Mongolia in 2010, clinical samples from HFMD patients were investigated. Six coxsackievirus B4 (CVB4) strains were isolated and phylogenetic analyses of VP1 sequences were performed. Full-length genome sequences of two representative CVB4 isolates were acquired and similarity plot and bootscanning analyses were performed. The phylogenetic dendrogram indicated that all CVB4 strains could be divided into 5 genotypes (Genotypes I-V) with high bootstrap support (90-100%). The CVB4 prototype strain (JVB) was the sole member of genotype I. CVB4 strains belonging to genotype II, which were once common in Europe and the Americas, seemingly disappeared and gave way to genotype III and IV strains, which appear to be the dominant circulating strains in the world. All Chinese CVB4 strains belonged to Genotype V, a newly identified genotype supported by a high bootstrap value (100%), and are circulating only in mainland of China. Intertypic recombination occurred in the Chinese CVB4 strains with novel unknown serotype EV-B donor sequences. Two Chinese CVB4 strains had a virulent residue at position 129 of VP1, and one strain also had a virulent residue at position 16 of VP4. Increased surveillance is needed to monitor the emergence of new genetic lineages of enteroviruses in areas that are often associated with large-scale outbreaks. In addition, continued monitoring of enteroviruses by clinical surveillance and genetic characterization should be enhanced.	[Tian, Xiaoling; Gu, Suyi; Fan, Yaochun; Yan, Shaohong; Ma, Xueen; Wang, Wenrui] Inner Mongolia Ctr Dis Control & Prevent, Hohhot City, Inner Mongolia, Peoples R China; [Zhang, Yong; Sun, Qiang; Zhang, Bo; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China; [Zhang, Yong; Sun, Qiang; Zhang, Bo; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Minist Hlth Key Lab Med Virol, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Wang, WR (corresponding author), Inner Mongolia Ctr Dis Control & Prevent, Hohhot City, Inner Mongolia, Peoples R China.	wr821@163.com		Zhang, Yong/0000-0002-2692-5437	Inner Mongolia Autonomous Region science and technology department [20120404]; Inner Mongolia Autonomous Region medical and health research project [2010016]	Inner Mongolia Autonomous Region science and technology department; Inner Mongolia Autonomous Region medical and health research project	The authors received support through the following grants: 1. Inner Mongolia Autonomous Region science and technology department project (grant no. 20120404); 2. Inner Mongolia Autonomous Region medical and health research project (grant no. 2010016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apisarnthanarak A, 2005, CLIN INFECT DIS, V41, P1361, DOI 10.1086/497076; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; CAGGANA M, 1993, J VIROL, V67, P4797, DOI 10.1128/JVI.67.8.4797-4803.1993; Chen P, 2013, J MED VIROL, V85, P483, DOI 10.1002/jmv.23478; Chu PY, 2009, J CLIN VIROL, V45, P16, DOI 10.1016/j.jcv.2009.02.012; Gu R, 2012, VIROLOGY, V427, P135, DOI 10.1016/j.virol.2012.02.009; He YQ, 2013, J CLIN MICROBIOL, V51, P3560, DOI 10.1128/JCM.01231-13; Hu YF, 2012, J VIROL, V86, P10901, DOI 10.1128/JVI.01808-12; Hu YF, 2012, J INFECTION, V65, P189, DOI 10.1016/j.jinf.2012.03.021; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Lindberg AM, 2003, J GEN VIROL, V84, P1223, DOI 10.1099/vir.0.18971-0; Lu QB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052073; Lukashev AN, 2005, J GEN VIROL, V86, P3281, DOI 10.1099/vir.0.81264-0; MINOR PD, 1990, CURR TOP MICROBIOL, V161, P121; Mirand A, 2012, CLIN MICROBIOL INFEC, V18, pE110, DOI 10.1111/j.1469-0691.2012.03789.x; Mulders MN, 2000, J GEN VIROL, V81, P803, DOI 10.1099/0022-1317-81-3-803; Oberste AS, 2007, VIRUS RES, V128, P34, DOI 10.1016/j.virusres.2007.04.001; Oberste MS, 2004, J VIROL, V78, P855, DOI 10.1128/JVI.78.2.855-867.2004; RAMSINGH AI, 1995, J VIROL, V69, P7278, DOI 10.1128/JVI.69.11.7278-7281.1995; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Sun Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055480; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084233; Wang JT, 2012, ARCH VIROL, V157, P1593, DOI 10.1007/s00705-012-1332-9; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Zhang J, 2011, BIOMED ENVIRON SCI, V24, P214, DOI 10.3967/0895-3988.2011.03.002; Zhang Y, 2013, BIOMED ENVIRON SCI, V26, P875, DOI 10.3967/bes2013.015; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2010, J INFECT DIS, V202, P1780, DOI 10.1086/657410; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037206; Zhu Z, 2007, BIOMED ENVIRON SCI, V20, P321	33	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90379	10.1371/journal.pone.0090379	http://dx.doi.org/10.1371/journal.pone.0090379			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595311	Green Submitted, gold, Green Published			2022-12-27	WOS:000332468900102
J	Walls, RL; Deck, J; Guralnick, R; Baskauf, S; Beaman, R; Blum, S; Bowers, S; Buttigieg, PL; Davies, N; Endresen, D; Gandolfo, MA; Hanner, R; Janning, A; Krishtalka, L; Matsunaga, A; Midford, P; Morrison, N; Tuama, EO; Schildhauer, M; Smith, B; Stucky, BJ; Thomer, A; Wieczorek, J; Whitacre, J; Wooley, J				Walls, Ramona L.; Deck, John; Guralnick, Robert; Baskauf, Steve; Beaman, Reed; Blum, Stanley; Bowers, Shawn; Buttigieg, Pier Luigi; Davies, Neil; Endresen, Dag; Gandolfo, Maria Alejandra; Hanner, Robert; Janning, Alyssa; Krishtalka, Leonard; Matsunaga, Andrea; Midford, Peter; Morrison, Norman; Tuama, Eamonn O.; Schildhauer, Mark; Smith, Barry; Stucky, Brian J.; Thomer, Andrea; Wieczorek, John; Whitacre, Jamie; Wooley, John			Semantics in Support of Biodiversity Knowledge Discovery: An Introduction to the Biological Collections Ontology and Related Ontologies	PLOS ONE			English	Article							INTEGRATION; ANNOTATION; LANGUAGE; NETWORK	The study of biodiversity spans many disciplines and includes data pertaining to species distributions and abundances, genetic sequences, traitmeasurements, and ecological niches, complemented by information on collection and measurement protocols. A review of the current landscape of metadata standards and ontologies in biodiversity science suggests that existing standards such as the Darwin Core terminology are inadequate for describing biodiversity data in a semantically meaningful and computationally useful way. Existing ontologies, such as the Gene Ontology and others in the Open Biological and Biomedical Ontologies (OBO) Foundry library, provide a semantic structure but lack many of the necessary terms to describe biodiversity data in all its dimensions. In this paper, we describe the motivation for and ongoing development of a new Biological Collections Ontology, the Environment Ontology, and the Population and Community Ontology. These ontologies share the aim of improving data aggregation and integration across the biodiversity domain and can be used to describe physical samples and sampling processes (for example, collection, extraction, and preservation techniques), as well as biodiversity observations that involve no physical sampling. Together they encompass studies of: 1) individual organisms, including voucher specimens from ecological studies and museum specimens, 2) bulk or environmental samples (e.g., gut contents, soil, water) that include DNA, other molecules, and potentially many organisms, especially microbes, and 3) survey-based ecological observations. We discuss how these ontologies can be applied to biodiversity use cases that span genetic, organismal, and ecosystem levels of organization. We argue that if adopted as a standard and rigorously applied and enriched by the biodiversity community, these ontologies would significantly reduce barriers to data discovery, integration, and exchange among biodiversity resources and researchers.	[Walls, Ramona L.] Univ Arizona, iPlant Collaborat, Tucson, AZ 85721 USA; [Deck, John] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Guralnick, Robert; Stucky, Brian J.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Guralnick, Robert] Univ Colorado, CU Museum Nat Hist, Boulder, CO 80309 USA; [Baskauf, Steve] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Beaman, Reed] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Blum, Stanley] Calif Acad Sci, San Francisco, CA 94118 USA; [Bowers, Shawn] Gonzaga Univ, Spokane, WA 99258 USA; [Buttigieg, Pier Luigi] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Davies, Neil] Univ Calif Berkeley, Gump South Pacific Res Stn, Moorea, France; [Endresen, Dag] Univ Oslo, Nat Hist Museum, GBIF Norway, Oslo, Norway; [Gandolfo, Maria Alejandra] Cornell Univ, Dept Plant Biol, LH Bailey Hortorium, Ithaca, NY USA; [Hanner, Robert] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Janning, Alyssa] Univ Arizona, Sch Informat Resources & Lib Sci, Tucson, AZ USA; [Krishtalka, Leonard] Univ Kansas, Biodivers Inst & Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Matsunaga, Andrea] Univ Florida, Gainesville, FL USA; [Midford, Peter] Univ Kansas, Lawrence, KS 66045 USA; [Morrison, Norman] Univ Manchester, Sch Comp Sci, BioVeL Project, Manchester, Lancs, England; [Tuama, Eamonn O.] GBIF Secretariat, Copenhagen, Denmark; [Schildhauer, Mark] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA; [Smith, Barry] SUNY Buffalo, Dept Philosophy, Buffalo, NY 14260 USA; [Thomer, Andrea] Univ Illinois, Grad Sch Lib & Informat Sci, Urbana, IL USA; [Wieczorek, John] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Whitacre, Jamie] Smithsonian Inst, Informat Branch, Informat Technol Off, Natl Museum Nat Hist, Washington, DC 20560 USA; [Wooley, John] Univ Calif San Diego, La Jolla, CA 92093 USA	University of Arizona; University of California System; University of California Berkeley; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Vanderbilt University; State University System of Florida; University of Florida; California Academy of Sciences; Gonzaga University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Oslo; Cornell University; University of Guelph; University of Arizona; University of Kansas; State University System of Florida; University of Florida; University of Kansas; University of Manchester; National Center for Ecological Analysis & Synthesis; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Berkeley; Smithsonian Institution; Smithsonian National Museum of Natural History; University of California System; University of California San Diego	Walls, RL (corresponding author), Univ Arizona, iPlant Collaborat, Tucson, AZ 85721 USA.	rwalls@iplantcollaborative.org	Smith, Barry/A-9525-2011; Midford, Peter E./B-5946-2008; Baskauf, Steven J/V-2630-2018; Davies, Neil/E-5863-2012; Endresen, Dag/G-1284-2010	Smith, Barry/0000-0003-1384-116X; Midford, Peter E./0000-0001-6512-3296; Baskauf, Steven J/0000-0003-4365-3135; Davies, Neil/0000-0001-8085-5014; Endresen, Dag/0000-0002-2352-5497; Thomer, Andrea/0000-0001-6238-3498; Morrison, Norman/0000-0003-1604-1512; Deck, John/0000-0002-5905-1617; Matsunaga, Andrea/0000-0001-9036-5895; Buttigieg, Pier Luigi/0000-0002-4366-3088; Schildhauer, Mark/0000-0003-0632-7576	US National Science Foundation (NSF) [DBI-0840989, IIS-1255035, DBI: 0956371, 0956350, 0956426, DBI-0851313]; National Institutes of Health (NIH) [U54 HG004028]; European Commission [287589, 283359];  [DBI-0735191]; Direct For Biological Sciences [1062148, 1115210, 1062193, 0956426] Funding Source: National Science Foundation; Division Of Environmental Biology [0956350] Funding Source: National Science Foundation; Div Of Biological Infrastructure [0840989, 1062271, 1062200] Funding Source: National Science Foundation; Div Of Information & Intelligent Systems [1255035] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004028] Funding Source: NIH RePORTER	US National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); ; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We gratefully acknowledge the support from the US National Science Foundation (NSF - http://www.nsf.gov/) through the following grants: Research Coordination Network for Genomic Standards Consortium (DBI-0840989), EAGER: An Interoperable Information Infrastructure for Biodiversity Research (IIS-1255035), Collaborative Research: BiSciCol Tracker: Towards a tagging and tracking infrastructure for biodiversity science collections (DBI: 0956371, 0956350, 0956426), Collaborative Research: Data Integration for Repository Services in Biodiversity Informatics (DBI-0851313), and the National Institutes of Health (NIH - http://www.nih.gov/) through a grant to the National Center for Biomedical Ontology (U54 HG004028). RW is supported by DBI-0735191 (The iPlant Collaborative). PLB is supported by the European Commission under Grant Agreement no 287589 (MicroB3). NM is supported by the European Commission 7th Framework Programme (FP7) as part of its e-Infrastructures activity (Grant no. 283359, BioVeL). Any opinions, findings, conclusions, or recommendations expressed in this report are those of the participants and do not necessarily represent the official views, opinions, or policy of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arp R., 2008, NATURE P, V2, P1, DOI [10101/npre.2008.1941.1, DOI 10.1038/NPRE.2008.1941.1]; Ashburner M, 2001, GENOME RES, V11, P1425; Bada M, 2012, KR MED SERIES; BASKAUF S. J., 2010, BIODIVERSITY INFORM, V7, P17; Beach J, 2010, STRATEGIC PLAN ESTAB; BEACH JH, 1993, ADVANCES IN COMPUTER METHODS FOR SYSTEMATIC BIOLOGY, P241; BERENDSOHN WG, 1995, TAXON, V44, P207, DOI 10.2307/1222443; BIEN project team, 2009, CYB INT BOT INF NETW; Bizer C, 2009, INT J SEMANT WEB INF, V5, P1, DOI 10.4018/jswis.2009081901; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Brinkman Ryan R, 2010, J Biomed Semantics, V1 Suppl 1, pS7, DOI 10.1186/2041-1480-1-S1-S7; Buttigieg PL, J BIOMEDICA IN PRESS; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Catapano T, 2011, RECOMMENDATIONS USE; Ceusters W, 2007, INT J MED INFORM, V76, pS326, DOI 10.1016/j.ijmedinf.2007.02.003; Check E, 2006, NATURE, V439, P378, DOI 10.1038/439378a; Cowell LG, 2010, INFECTIOUS DISEASE INFORMATICS, P373, DOI 10.1007/978-1-4419-1327-2_19; Davies N, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-5; Davies N, 2012, NATURE, V481, P145, DOI 10.1038/481145a; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Deans AR, 2012, TRENDS ECOL EVOL, V27, P78, DOI 10.1016/j.tree.2011.11.007; Deck J, 2013, STAND GENOMIC SCI, V8, P352, DOI 10.4056/sigs.3907833; Eilbeck K, 2004, COMP FUNCT GENOM, V5, P642, DOI 10.1002/cfg.446; Field D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001088; Fisher BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001787; Franz NM, 2009, SYST BIODIVERS, V7, P5, DOI 10.1017/S147720000800282X; Franz Nico M., 2010, Biodiversity Informatics, V7, P45; GEOFFROY M, 2003, SCHRIFTENREIHE VEGET, V39, P5; Gkoutos GV, 2012, INT REV NEUROBIOL, V103, P69, DOI 10.1016/B978-0-12-388408-4.00004-6; Grenon P, 2004, SPAT COGN COMPUT, V4, P69, DOI [10.1207/s15427633scc0401_5, DOI 10.1207/S15427633SCC0401_5]; HAENDEL MA, 2008, COMPUT BIOL SER, V6, P327; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Hardisty A, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-16; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holetschek J, 2012, PLANT BIOSYST, V146, P771, DOI 10.1080/11263504.2012.740085; Horridge M, 2006, P 2006 OWL EXP DIR W; Hrebicek, 2009, P EUR C ENV OPP SEIS, P606; Imam Fahim T., 2012, Frontiers in Genetics, V3, P111, DOI 10.3389/fgene.2012.00111; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kelling S, 2009, BIOSCIENCE, V59, P613, DOI 10.1525/bio.2009.59.7.12; Kennedy J, 2005, TAXONOMIC CONCEPT TR; Kennedy J, 2006, P TAX DAT WORK GROUP; Kottmann R, 2008, OMICS, V12, P115, DOI 10.1089/omi.2008.0A10; Lapp Hilmar, 2011, Bulletin of the American Society for Information Science and Technology, V37, P38, DOI 10.1002/bult.2011.1720370411; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Madin JS, 2008, TRENDS ECOL EVOL, V23, P159, DOI 10.1016/j.tree.2007.11.007; MicroB3, 2012, DEL 4 2 BEST PRACT E; Parr CS, 2012, TRENDS ECOL EVOL, V27, P94, DOI 10.1016/j.tree.2011.11.001; Patterson DJ, 2010, TRENDS ECOL EVOL, V25, P686, DOI 10.1016/j.tree.2010.09.004; Penev L, 2010, ZOOKEYS, P1, DOI 10.3897/zookeys.50.538; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Pyle RL, 2008, ZOOTAXA, P3, DOI 10.11646/zootaxa.1671.1.2; Robbins RJ, 2012, STAND GENOMIC SCI, V7, P159, DOI 10.4056/sigs.3156511; Scholes RJ, 2012, CURR OPIN ENV SUST, V4, P139, DOI 10.1016/j.cosust.2011.12.005; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Stoltzfus Arlin, 2012, BMC Res Notes, V5, P574, DOI 10.1186/1756-0500-5-574; Tiffin N, 2005, NUCLEIC ACIDS RES, V33, P1544, DOI 10.1093/nar/gki296; Tuama EO, 2012, STAND GENOMIC SCI, V7, P166, DOI 10.4056/sigs.3166513; United Nations, 1992, CONV BIOL DIV OP SIG; Vasilevsky N, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar067; Webb C, 2011, P TAX DAT WORK GROUP; Wieczorek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029715; Wooley JC, 2009, STAND GENOMIC SCI, V1, P87, DOI 10.4056/sigs.26218; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823	66	80	82	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89606	10.1371/journal.pone.0089606	http://dx.doi.org/10.1371/journal.pone.0089606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595056	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900024
J	Anthony, NR; Berland, KM				Anthony, Neil R.; Berland, Keith M.			tau FCS: Multi-Method Global Analysis Enhances Resolution and Sensitivity in Fluorescence Fluctuation Measurements	PLOS ONE			English	Article							INTENSITY DISTRIBUTION ANALYSIS; CROSS-CORRELATION SPECTROSCOPY; SINGLE-MOLECULE DETECTION; MULTIPHOTON EXCITATION; 2-PHOTON EXCITATION; CUMULANT ANALYSIS; SATURATION; MICROSCOPY; IDENTIFICATION; PHOTODYNAMICS	Fluorescence fluctuation methods have become invaluable research tools for characterizing the molecular-level physical and chemical properties of complex systems, such as molecular concentrations, dynamics, and the stoichiometry of molecular interactions. However, information recovery via curve fitting analysis of fluctuation data is complicated by limited resolution and challenges associated with identifying accurate fit models. We introduce a new approach to fluorescence fluctuation spectroscopy that couples multi-modal fluorescence measurements with multi-modal global curve fitting analysis. This approach yields dramatically enhanced resolution and fitting model discrimination capabilities in fluctuation measurements. The resolution enhancement allows the concentration of a secondary species to be accurately measured even when it constitutes only a few percent of the molecules within a sample mixture, an important new capability that will allow accurate measurements of molecular concentrations and interaction stoichiometry of minor sample species that can be functionally important but difficult to measure experimentally. We demonstrate this capability using tau FCS, a new fluctuation method which uses simultaneous global analysis of fluorescence correlation spectroscopy and fluorescence lifetime data, and show that tau FCS can accurately recover the concentrations, diffusion coefficients, lifetimes, and molecular brightness values for a two component mixture over a wide range of relative concentrations.	[Anthony, Neil R.; Berland, Keith M.] Emory Univ, Dept Phys, Atlanta, GA 30322 USA	Emory University	Berland, KM (corresponding author), Emory Univ, Dept Phys, Atlanta, GA 30322 USA.	kberlan@emory.edu			National Science Foundation [MCB0817966, DMR0907435]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grants MCB0817966 and DMR0907435. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Becker W, 2005, ADV TIME CORRELATED; BEECHEM JM, 1992, METHOD ENZYMOL, V210, P37; Berland K, 2003, APPL OPTICS, V42, P5566, DOI 10.1364/AO.42.005566; Berland KM, 1996, BIOPHYS J, V71, P410, DOI 10.1016/S0006-3495(96)79242-1; Berland KM, 2004, J BIOTECHNOL, V108, P127, DOI 10.1016/j.jbiotec.2003.11.006; Bohmer M, 2002, CHEM PHYS LETT, V353, P439, DOI 10.1016/S0009-2614(02)00044-1; Brand L, 1997, J PHYS CHEM A, V101, P4313, DOI 10.1021/jp963729w; Chen Y, 1999, METHODS, V19, P234, DOI 10.1006/meth.1999.0854; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; CHEN Y, 2001, NEW TRENDS FLUORESCE; Cianci GC, 2004, MICROSC RES TECHNIQ, V64, P135, DOI 10.1002/jemt.20071; Dehmelt L, 2010, NAT REV MOL CELL BIO, V11, P440, DOI 10.1038/nrm2903; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Elson EL, 2011, BIOPHYS J, V101, P2855, DOI 10.1016/j.bpj.2011.11.012; Kapusta P, 2007, J FLUORESC, V17, P43, DOI 10.1007/s10895-006-0145-1; Kask P, 1999, P NATL ACAD SCI USA, V96, P13756, DOI 10.1073/pnas.96.24.13756; Kask P, 2000, BIOPHYS J, V78, P1703, DOI 10.1016/S0006-3495(00)76722-1; Kim SA, 2007, NAT METHODS, V4, P963, DOI 10.1038/NMETH1104; KNUTSON JR, 1983, CHEM PHYS LETT, V102, P501, DOI 10.1016/0009-2614(83)87454-5; Korlach J, 1999, P NATL ACAD SCI USA, V96, P8461, DOI 10.1073/pnas.96.15.8461; Krichevsky O, 2002, REP PROG PHYS, V65, P251, DOI 10.1088/0034-4885/65/2/203; Kuhnemuth R, 2001, SINGLE MOL, V2, P251, DOI 10.1002/1438-5171(200112)2:4<251::AID-SIMO251>3.0.CO;2-T; Laptenok SP, 2010, PHYS CHEM CHEM PHYS, V12, P7593, DOI 10.1039/b919700a; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; MARCHAND P, 1983, REV SCI INSTRUM, V54, P1034, DOI 10.1063/1.1137498; Mertz J, 1995, OPT LETT, V20, P2532, DOI 10.1364/OL.20.002532; Mertz J, 1998, EUR PHYS J D, V3, P53, DOI 10.1007/s100530050148; Meseth U, 1999, BIOPHYS J, V76, P1619, DOI 10.1016/S0006-3495(99)77321-2; Mukhtar E, 2002, J FLUORESC, V12, P481, DOI 10.1023/A:1021378313407; Muller JD, 2004, BIOPHYS J, V86, P3981, DOI 10.1529/biophysj.103.037887; Muller JD, 2000, BIOPHYS J, V78, P474, DOI 10.1016/S0006-3495(00)76610-0; Nagy A, 2004, BIOPHYS J, V86, p320A; Nagy A, 2005, BIOPHYS J, V89, P2077, DOI 10.1529/biophysj.104.052779; Nguyen TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038209; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Previte MJR, 2008, ANAL CHEM, V80, P3277, DOI 10.1021/ac702474u; Rahim Nur Aida Adbul, 2012, J Biomed Opt, V17, P026013, DOI 10.1117/1.JBO.17.2.026013; Rigler R., 2001, FLUORESCENCE CORRELA; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Skakun VV, 2005, EUR BIOPHYS J BIOPHY, V34, P323, DOI 10.1007/s00249-004-0453-9; So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399; Starchev K, 2001, J COLLOID INTERF SCI, V233, P50, DOI 10.1006/jcis.2000.7229; Thompson NL, 1991, TOPICS FLUORESCENCE, P337; Tsien RY, 2003, NAT REV MOL CELL BIO, pSS16, DOI 10.1038/nrm1196; Verveer PJ, 2000, BIOPHYS J, V78, P2127, DOI 10.1016/S0006-3495(00)76759-2; Webb WW, 2001, APPL OPTICS, V40, P3969, DOI 10.1364/AO.40.003969; Weidtkamp-Peters S, 2009, PHOTOCH PHOTOBIO SCI, V8, P470, DOI 10.1039/b903245m; Widengren J, 2006, ANAL CHEM, V78, P2039, DOI 10.1021/ac0522759; Wu B, 2005, BIOPHYS J, V89, P2721, DOI 10.1529/biophysj.105.063685; Wu B, 2006, BIOPHYS J, V91, P2687, DOI 10.1529/biophysj.106.086181; Wu J, 2007, MICROSC RES TECHNIQ, V70, P682, DOI 10.1002/jemt.20454; Xu, 2002, T FLUOR SP, P471	57	3	3	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90456	10.1371/journal.pone.0090456	http://dx.doi.org/10.1371/journal.pone.0090456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587370	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200204
J	Fraser, EJ; Shah, NM				Fraser, Eleanor J.; Shah, Nirao M.			Complex Chemosensory Control of Female Reproductive Behaviors	PLOS ONE			English	Article							MAIN OLFACTORY EPITHELIUM; TYPE-3 ADENYLYL-CYCLASE; VOMERONASAL ORGAN; SEXUAL-BEHAVIOR; MICE DEFICIENT; MUTANT MICE; PHEROMONE; MOUSE; AGGRESSION; CHANNEL	Olfaction exerts a profound influence on reproductive physiology and behavior in many animals, including rodents. Odors are recognized by sensory neurons residing in the main olfactory epithelium (MOE) and the vomeronasal organ (VNO) in mice and many other vertebrates. The relative contributions of the MOE and VNO in the display of female behaviors are not well understood. Mice null for Cnga2 or Trpc2 essentially lack odor-evoked activity in the MOE and VNO, respectively. Using females mutant for one or both of Cnga2 and Trpc2, we find that maternal care is differentially regulated by the MOE and VNO: retrieval of wandering pups requires the MOE and is regulated redundantly by the VNO whereas maternal aggression requires both sensory epithelia to be functional. Female sexual receptivity appears to be regulated by both the MOE and VNO. Trpc2 null females have previously been shown to display male-type mounting towards other males. Remarkably, we find that females double mutant for Cnga2 and Trpc2 continue to mount other males, indicating that the disinhibition of male-type sexual displays observed in Trpc2 null females does not require chemosensory input from a functional MOE. Taken together, our findings reveal a previously unappreciated complexity in the chemosensory control of reproductive behaviors in the female mouse.	[Fraser, Eleanor J.; Shah, Nirao M.] Univ Calif San Francisco, Dept Anat, Genet Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Shah, NM (corresponding author), Univ Calif San Francisco, Dept Anat, Genet Program, San Francisco, CA 94143 USA.	nms@ucsf.edu			National Institutes of Health (NIH) [R01-NS049488]; Ellison Medical Foundation; National Science Foundation (NSF) [782000-21128]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049488] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the National Institutes of Health (NIH) grant R01-NS049488, the Ellison Medical Foundation, and by a Graduate Research Fellowship (fund number 782000-21128) from the National Science Foundation (NSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAN NJ, 1989, PHYSIOL BEHAV, V45, P875, DOI 10.1016/0031-9384(89)90209-6; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Berghard A, 1996, P NATL ACAD SCI USA, V93, P2365, DOI 10.1073/pnas.93.6.2365; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; CHAMPLIN AK, 1971, J REPROD FERTIL, V27, P233, DOI 10.1530/jrf.0.0270233; Dorries KM, 1997, BRAIN BEHAV EVOLUT, V49, P53, DOI 10.1159/000112981; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; EDWARDS DA, 1973, PHYSIOL BEHAV, V11, P867, DOI 10.1016/0031-9384(73)90282-5; GANDELMAN R, 1972, HORM BEHAV, V3, P23, DOI 10.1016/0018-506X(72)90003-7; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Hasen NS, 2009, GENES BRAIN BEHAV, V8, P639, DOI 10.1111/j.1601-183X.2009.00511.x; Hasen NS, 2011, BEHAV BRAIN RES, V217, P347, DOI 10.1016/j.bbr.2010.11.002; Jyotika J, 2007, DEV NEUROBIOL, V67, P1511, DOI 10.1002/dneu.20525; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Keller M, 2006, CHEM SENSES, V31, P315, DOI 10.1093/chemse/bjj035; Keller M, 2006, EUR J NEUROSCI, V23, P521, DOI 10.1111/j.1460-9568.2005.04589.x; Kelliher KR, 2006, EUR J NEUROSCI, V23, P3385, DOI 10.1111/j.1460-9568.2006.04866.x; Kim S, 2012, NAT NEUROSCI, V15, P1236, DOI 10.1038/nn.3173; Kimchi T, 2007, NATURE, V448, P1009, DOI 10.1038/nature06089; Kingston PA, 1999, SYNAPSE, V32, P1, DOI 10.1002/(SICI)1098-2396(199904)32:1<1::AID-SYN1>3.0.CO;2-M; Leinders-Zufall T, 2007, P NATL ACAD SCI USA, V104, P14507, DOI 10.1073/pnas.0704965104; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Lin WH, 2004, J NEUROSCI, V24, P3703, DOI 10.1523/JNEUROSCI.0188-04.2004; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; McGILL THOMAS E., 1962, BEHAVIOUR, V19, P341, DOI 10.1163/156853962X00087; Ring JR, 1944, ENDOCRINOLOGY, V34, P269, DOI 10.1210/endo-34-4-269; Spors H, 2007, NEURON, V55, P689, DOI 10.1016/j.neuron.2007.08.016; Stowers L, 2005, NEURON, V46, P699, DOI 10.1016/j.neuron.2005.04.032; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Wang ZS, 2006, J NEUROSCI, V26, P7375, DOI 10.1523/JNEUROSCI.1967-06.2006; Wang ZS, 2011, NEUROPSYCHOPHARMACOL, V36, P772, DOI 10.1038/npp.2010.211; Wang ZS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006979; Wu MV, 2009, CELL, V139, P61, DOI 10.1016/j.cell.2009.07.036; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039	38	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90368	10.1371/journal.pone.0090368	http://dx.doi.org/10.1371/journal.pone.0090368			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587340	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200180
J	Fu, CY; Xia, RL; Zhang, TF; Lu, Y; Zhang, SF; Yu, ZQ; Jin, T; Mou, XZ				Fu, Cai-Yun; Xia, Rui-Long; Zhang, Teng-Fei; Lu, Yan; Zhang, Shi-Fu; Yu, Zhi-Qiang; Jin, Tao; Mou, Xiao-Zhou			Hemokinin-1(4-11)-Induced Analgesia Selectively Up-Regulates delta-Opioid Receptor Expression in Mice	PLOS ONE			English	Article							MAMMALIAN TACHYKININ PEPTIDE; IN-SITU HYBRIDIZATION; RAT/MOUSE HEMOKININ-1; MESSENGER-RNA; CARDIOVASCULAR-RESPONSES; PHARMACOLOGICAL PROFILE; FUNCTIONAL EXPRESSION; PERIAQUEDUCTAL GRAY; SUPRASPINAL LEVEL; ANESTHETIZED RATS	Our previous studies have shown that an active fragment of human tachykinins (hHK-1(4-11)) produced an opioid-independent analgesia after intracerebroventricular (i.c.v.) injection in mice, which has been markedly enhanced by a delta OR antagonist, naltrindole hydrochloride (NTI). In this study, we have further characterized the in vivo analgesia after i.c.v. injection of hHK-1(4-11) in mouse model. Our qRT-PCR results showed that the mRNA levels of several ligands and receptors (e. g. PPT-A, PPT-C, KOR, PDYN and PENK) have not changed significantly. Furthermore, neither transcription nor expression of NK1 receptor, MOR and POMC have changed noticeably. In contrast, both mRNA and protein levels of DOR have been up-regulated significantly, indicating that the enhanced expression of delta opioid receptor negatively modulates the analgesia induced by i.c.v. injection of hHK-1(4-11). Additionally, the combinatorial data from our previous and present experiments strongly suggest that the discriminable distribution sites in the central nervous system between hHK-1(4-11) and r/mHK-1 may be attributed to their discriminable analgesic effects. Altogether, our findings will not only contribute to the understanding of the complicated mechanisms regarding the nociceptive modulation of hemokinin-1 as well as its active fragments at supraspinal level, but may also lead to novel pharmacological interventions.	[Fu, Cai-Yun; Xia, Rui-Long; Zhang, Teng-Fei; Lu, Yan; Zhang, Shi-Fu] Zhejiang Sci Tech Univ, Coll Life Sci, Lab Prote & Mol Enzymol, Hangzhou, Zhejiang, Peoples R China; [Jin, Tao; Mou, Xiao-Zhou] Zhejiang Prov Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Fu, Cai-Yun; Mou, Xiao-Zhou] Inst Cell Based Drug Dev Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Yu, Zhi-Qiang] Arizona State Univ, Biodesign Inst, Ctr BioEnerget, Tempe, AZ USA; [Yu, Zhi-Qiang] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA	Zhejiang Sci-Tech University; Zhejiang Provincial People's Hospital; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Fu, CY (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Lab Prote & Mol Enzymol, Hangzhou, Zhejiang, Peoples R China.	fucy03@126.com; zhiqiang.yu.1@asu.edu; mouxiaozhou@gmail.com		Fu, Caiyun/0000-0003-4090-885X	National Natural Science Foundation of China [31000496, 81201783]; 521 Talent Foundation of Zhejiang Sci-Tech University, Key Technologies R&D Program of Zhejiang Province [2012C13015-2]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 521 Talent Foundation of Zhejiang Sci-Tech University, Key Technologies R&D Program of Zhejiang Province	This work was supported by grants from the National Natural Science Foundation of China (No. 31000496, No. 81201783), the 521 Talent Foundation of Zhejiang Sci-Tech University, Key Technologies R&D Program of Zhejiang Province (No. 2012C13015-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellucci F, 2002, BRIT J PHARMACOL, V135, P266, DOI 10.1038/sj.bjp.0704443; Camarda V, 2002, LIFE SCI, V71, P363, DOI 10.1016/S0024-3205(02)01682-X; CHEN Y, 1993, MOL PHARMACOL, V44, P8; DELFS JM, 1994, J COMP NEUROL, V345, P46, DOI 10.1002/cne.903450104; DOUGLASS J, 1984, ANNU REV BIOCHEM, V53, P665; Endo D, 2006, NEUROSCI LETT, V392, P114, DOI 10.1016/j.neulet.2005.09.005; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Fu CY, 2008, BRAIN BEHAV IMMUN, V22, P850, DOI 10.1016/j.bbi.2007.12.010; Fu CY, 2007, BEHAV BRAIN RES, V184, P39, DOI 10.1016/j.bbr.2007.06.019; Fu CY, 2007, EUR J PHARMACOL, V572, P175, DOI 10.1016/j.ejphar.2007.06.014; Fu CY, 2006, BEHAV BRAIN RES, V170, P293, DOI 10.1016/j.bbr.2006.03.007; Fu CY, 2005, BRAIN RES, V1056, P51, DOI 10.1016/j.brainres.2005.07.020; Fueloep L, 2001, PEPT SCI, V7, P397; HALEY TJ, 1957, BRIT J PHARM CHEMOTH, V12, P12, DOI 10.1111/j.1476-5381.1957.tb01354.x; JENSEN TS, 1986, BRAIN RES, V372, P301, DOI 10.1016/0006-8993(86)91138-8; KAKIDANI H, 1982, NATURE, V298, P245, DOI 10.1038/298245a0; Kalyuzhny AE, 1996, J NEUROSCI, V16, P6490; Klassert TE, 2008, J NEUROIMMUNOL, V196, P27, DOI 10.1016/j.jneuroim.2008.02.010; Kong ZQ, 2008, EUR J PHARMACOL, V590, P310, DOI 10.1016/j.ejphar.2008.05.049; Kong ZQ, 2010, NEUROPEPTIDES, V44, P437, DOI 10.1016/j.npep.2010.04.006; KOTANI H, 1986, P NATL ACAD SCI USA, V83, P7074, DOI 10.1073/pnas.83.18.7074; Kurtz MM, 2002, GENE, V296, P205, DOI 10.1016/S0378-1119(02)00861-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long Y, 2007, EUR J PHARMACOL, V569, P119, DOI 10.1016/j.ejphar.2007.04.049; MANSOUR A, 1994, J COMP NEUROL, V350, P412, DOI 10.1002/cne.903500307; Matsumura T, 2008, BRIT J PHARMACOL, V155, P767, DOI 10.1038/bjp.2008.301; MINAMI M, 1993, FEBS LETT, V329, P291, DOI 10.1016/0014-5793(93)80240-U; NAWA H, 1983, NATURE, V306, P32, DOI 10.1038/306032a0; NODA M, 1982, NATURE, V295, P202, DOI 10.1038/295202a0; Page NM, 2004, CELL MOL LIFE SCI, V61, P1652, DOI 10.1007/s00018-004-4035-x; Pennefather JN, 2004, LIFE SCI, V74, P1445, DOI 10.1016/j.lfs.2003.09.039; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; URBAN MO, 1994, BRAIN RES, V652, P9, DOI 10.1016/0006-8993(94)90311-5; Walsh DA, 2006, CURR DRUG TARGETS, V7, P1031, DOI 10.2174/138945006778019291; Xia RL, 2013, PEPTIDES, V43, P113, DOI 10.1016/j.peptides.2013.02.020; Zhang Y, 2000, NAT IMMUNOL, V1, P392, DOI 10.1038/80826	37	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90446	10.1371/journal.pone.0090446	http://dx.doi.org/10.1371/journal.pone.0090446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587368	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200202
J	Pettee, KM; Dvorak, KM; Nestor-Kalinoski, AL; Eisenmann, KM				Pettee, Krista M.; Dvorak, Kaitlyn M.; Nestor-Kalinoski, Andrea L.; Eisenmann, Kathryn M.			An mDia2/ROCK Signaling Axis Regulates Invasive Egress from Epithelial Ovarian Cancer Spheroids	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; ADHERENS JUNCTIONS; CELL-CELL; FORMIN FHOD1; ACTIN; RHOA; ACTIVATION; MDIA1; ROCK; ADHESION	Multi-cellular spheroids are enriched in ascites of epithelial ovarian cancer (OvCa) patients. They represent an invasive and chemoresistant cellular population fundamental to metastatic dissemination. The molecular mechanisms triggering single cell invasive egress from spheroids remain enigmatic. mDia formins are Rho GTPase effectors that are key regulators of F-actin cytoskeletal dynamics. We hypothesized that mDia2-driven F-actin dynamics promote single cell invasive transitions in clinically relevant three-dimensional (3D) OvCa spheroids. The current study is a dissection of the contribution of the F-actin assembly factor mDia2 formin in invasive transitions and using a clinically relevant ovarian cancer spheroid model. We show that RhoA-directed mDia2 activity is required for tight spheroid organization, and enrichment of mDia2 in the invasive cellular protrusions of collagen-embedded OVCA429 spheroids. Depleting mDia2 in ES-2 spheroids enhanced invasive dissemination of single amoeboid-shaped cells. This contrasts with spheroids treated with control siRNA, where a mesenchymal invasion program predominated. Inhibition of another RhoA effector, ROCK, had no impact on ES-2 spheroid formation but dramatically inhibited spheroid invasion through induction of a highly elongated morphology. Concurrent inhibition of ROCK and mDia2 blocked single cell invasion from ES-2 spheroids more effectively than inhibition of either protein alone, indicating that invasive egress of amoeboid cells from mDia2-depleted spheroids is ROCK-dependent. Our findings indicate that multiple GTPase effectors must be suppressed in order to fully block invasive egress from ovarian cancer spheroids. Furthermore, tightly regulated interplay between ROCK and mDia2 signaling pathways dictates the invasive capacities and the type of invasion program utilized by motile spheroid-derived ovarian cancer cells. As loss of the gene encoding mDia2, DRF3, has been linked to cancer progression and metastasis, our results set the stage for understanding molecular mechanisms involved in mDia2-dependent egress of invasive cells from primary epithelial tumors.	[Pettee, Krista M.; Dvorak, Kaitlyn M.; Eisenmann, Kathryn M.] Univ Toledo, Dept Biochem & Canc Biol, Toledo, OH USA; [Nestor-Kalinoski, Andrea L.] Univ Toledo, Dept Surg, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Eisenmann, KM (corresponding author), Univ Toledo, Dept Biochem & Canc Biol, Hlth Sci Campus, Toledo, OH USA.	Kathryn.Eisenmann@utoledo.edu		Eisenmann, Kathryn/0000-0002-5337-5928	University of Toledo Foundation; Department of Defense [OC073269]; DeArce Memorial Endowment Fund in Support for Medical Research and Development; National Cancer Institute [R01CA151632]; NATIONAL CANCER INSTITUTE [R01CA151632] Funding Source: NIH RePORTER	University of Toledo Foundation; Department of Defense(United States Department of Defense); DeArce Memorial Endowment Fund in Support for Medical Research and Development; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the University of Toledo Foundation (KME, ALNK), the Department of Defense Ovarian Cancer Concept Award (KME, OC073269), the DeArce Memorial Endowment Fund in Support for Medical Research and Development (KME), and the National Cancer Institute (KME, ALNK R01CA151632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; Barbolina MV, 2011, BIOCHEM J, V437, P1, DOI 10.1042/BJ20110112; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Bijman MNA, 2008, BIOCHEM PHARMACOL, V76, P707, DOI 10.1016/j.bcp.2008.06.014; Bione S, 1998, AM J HUM GENET, V62, P533, DOI 10.1086/301761; Blumenstein L, 2004, J BIOL CHEM, V279, P53419, DOI 10.1074/jbc.M409551200; Burleson KM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-6; Burleson KM, 2004, CLIN EXP METASTAS, V21, P685, DOI 10.1007/s10585-004-5768-5; Burleson KM, 2004, GYNECOL ONCOL, V93, P170, DOI 10.1016/j.ygyno.2003.12.034; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Copeland JW, 2004, J BIOL CHEM, V279, P50250, DOI 10.1074/jbc.M404429200; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Creekmore AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017676; de Toledo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048344; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dettenhofer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002497; Di Vizio D, 2009, CANCER RES, V69, P5601, DOI 10.1158/0008-5472.CAN-08-3860; Dohda T, 2004, J BIOCHEM, V135, P631, DOI 10.1093/jb/mvh076; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Eisenmann KM, 2007, CURR BIOL, V17, P579, DOI 10.1016/j.cub.2007.03.024; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Frankel A, 1997, CANCER RES, V57, P2388; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Gupton SL, 2007, J CELL SCI, V120, P3475, DOI 10.1242/jcs.006049; Hager MH, 2012, EMBO MOL MED, V4, P743, DOI 10.1002/emmm.201200242; Han YY, 2009, J BIOL CHEM, V284, P33409, DOI 10.1074/jbc.M109.060699; Han ZQ, 2005, CELL COMMUN ADHES, V12, P59, DOI 10.1080/15419060500383168; Hannemann S, 2008, J BIOL CHEM, V283, P27891, DOI 10.1074/jbc.M801800200; Herzog D, 2011, J NEUROSCI, V31, P5120, DOI 10.1523/JNEUROSCI.4807-10.2011; Homem CCF, 2008, DEVELOPMENT, V135, P1005, DOI 10.1242/dev.016337; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Iwanicki MP, 2008, J CELL SCI, V121, P895, DOI 10.1242/jcs.020941; Iwanicki MP, 2011, CANCER DISCOV, V1, P2; Jiang YP, 2006, GYNECOL ONCOL, V103, P226, DOI 10.1016/j.ygyno.2006.02.036; Kajiyama H, 2008, INT J CANCER, V122, P91, DOI 10.1002/ijc.23083; Ketene AN, 2012, NANOMED-NANOTECHNOL, V8, P93, DOI 10.1016/j.nano.2011.05.012; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Lee LF, 2000, J IMMUNOL, V164, P2769, DOI 10.4049/jimmunol.164.5.2769; Leinster DA, 2012, J PATHOL, V227, P136, DOI 10.1002/path.4002; Liang L, 2013, GASTROENTEROLOGY, V144, P624, DOI 10.1053/j.gastro.2012.11.033; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Paluch E, 2006, TRENDS CELL BIOL, V16, P5, DOI 10.1016/j.tcb.2005.11.003; Patel IS, 2003, INT J CANCER, V106, P172, DOI 10.1002/ijc.11086; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Peng J, 2007, CANCER RES, V67, P7565, DOI 10.1158/0008-5472.CAN-07-1467; Popple A, 2012, BRIT J CANCER, V106, P1306, DOI 10.1038/bjc.2012.49; Press JZ, 2012, INT J GYNECOL CANCER, V22, P546, DOI 10.1097/IGC.0b013e318241d9b9; Rath N, 2012, EMBO REP, V13, P900, DOI 10.1038/embor.2012.127; Righi E, 2011, CANCER RES, V71, P5522, DOI 10.1158/0008-5472.CAN-10-3143; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Ryu JR, 2009, MOL CELL BIOL, V29, P1735, DOI 10.1128/MCB.01483-08; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Shi YQ, 2009, BIOCHEM CELL BIOL, V87, P207, DOI 10.1139/O08-130; Shi YQ, 2009, J IMMUNOL, V182, P3837, DOI 10.4049/jimmunol.0803838; Sodek KL, 2012, CANCER METAST REV, V31, P397, DOI 10.1007/s10555-012-9351-2; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Takeya R, 2008, EMBO J, V27, P618, DOI 10.1038/emboj.2008.7; Terry SJ, 2011, NAT CELL BIOL, V13, P159, DOI 10.1038/ncb2156; Theriault BL, 2007, CARCINOGENESIS, V28, P1153, DOI 10.1093/carcin/bgm015; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thumkeo D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025465; Vergara D, 2010, CANCER LETT, V291, P59, DOI 10.1016/j.canlet.2009.09.017; Wallar BJ, 2007, EXP CELL RES, V313, P560, DOI 10.1016/j.yexcr.2006.10.033; Wells Claire M., 2004, V294, P31; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Wyse MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045085; Xing H, 2007, ONCOL REP, V17, P117; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; ZICHA D, 1991, J CELL SCI, V99, P769; Zietarska M, 2007, MOL CARCINOGEN, V46, P872, DOI 10.1002/mc.20315	86	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90371	10.1371/journal.pone.0090371	http://dx.doi.org/10.1371/journal.pone.0090371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587343	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200182
J	Bernardo, BC; Gao, XM; Tham, YK; Kiriazis, H; Winbanks, CE; Ooi, JYY; Boey, EJH; Obad, S; Kauppinen, S; Gregorevic, P; Du, XJ; Lin, RCY; McMullen, JR				Bernardo, Bianca C.; Gao, Xiao-Ming; Tham, Yow Keat; Kiriazis, Helen; Winbanks, Catherine E.; Ooi, Jenny Y. Y.; Boey, Esther J. H.; Obad, Susanna; Kauppinen, Sakari; Gregorevic, Paul; Du, Xiao-Jun; Lin, Ruby C. Y.; McMullen, Julie R.			Silencing of miR-34a Attenuates Cardiac Dysfunction in a Setting of Moderate, but Not Severe, Hypertrophic Cardiomyopathy	PLOS ONE			English	Article							THERAPEUTIC INHIBITION; SARCOPLASMIC-RETICULUM; HEART; MICRORNAS; PROTECTS; FAMILY; ATPASE; RNAS	Therapeutic inhibition of the miR-34 family (miR-34a,-b,-c), or miR-34a alone, have emerged as promising strategies for the treatment of cardiac pathology. However, before advancing these approaches further for potential entry into the clinic, a more comprehensive assessment of the therapeutic potential of inhibiting miR-34a is required for two key reasons. First, miR-34a has similar to 40% fewer predicted targets than the miR-34 family. Hence, in cardiac stress settings in which inhibition of miR-34a provides adequate protection, this approach is likely to result in less potential off-target effects. Secondly, silencing of miR-34a alone may be insufficient in settings of established cardiac pathology. We recently demonstrated that inhibition of the miR-34 family, but not miR-34a alone, provided benefit in a chronic model of myocardial infarction. Inhibition of miR-34 also attenuated cardiac remodeling and improved heart function following pressure overload, however, silencing of miR-34a alone was not examined. The aim of this study was to assess whether inhibition of miR-34a could attenuate cardiac remodeling in a mouse model with pre-existing pathological hypertrophy. Mice were subjected to pressure overload via constriction of the transverse aorta for four weeks and echocardiography was performed to confirm left ventricular hypertrophy and systolic dysfunction. After four weeks of pressure overload (before treatment), two distinct groups of animals became apparent: (1) mice with moderate pathology (fractional shortening decreased similar to 20%) and (2) mice with severe pathology (fractional shortening decreased similar to 37%). Mice were administered locked nucleic acid (LNA)-antimiR-34a or LNA-control with an eight week follow-up. Inhibition of miR-34a in mice with moderate cardiac pathology attenuated atrial enlargement and maintained cardiac function, but had no significant effect on fetal gene expression or cardiac fibrosis. Inhibition of miR-34a in mice with severe pathology provided no therapeutic benefit. Thus, therapies that inhibit miR-34a alone may have limited potential in settings of established cardiac pathology.	[Bernardo, Bianca C.; Gao, Xiao-Ming; Tham, Yow Keat; Kiriazis, Helen; Winbanks, Catherine E.; Ooi, Jenny Y. Y.; Boey, Esther J. H.; Gregorevic, Paul; Du, Xiao-Jun; McMullen, Julie R.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Obad, Susanna] Santaris Pharma, Horsholm, Denmark; [Kauppinen, Sakari] Aalborg Univ Hosp, Dept Haematol, Copenhagen, Denmark; [Lin, Ruby C. Y.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Ramaciotti Ctr Genom, Sydney, NSW, Australia; [McMullen, Julie R.] Monash Univ, Dept Med, Clayton, Vic, Australia; [McMullen, Julie R.] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia	Baker Heart and Diabetes Institute; Aalborg University; University of New South Wales Sydney; Monash University; Monash University	Bernardo, BC (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	bianca.bernardo@bakeridi.edu.au; julie.mcmullen@bakeridi.edu.au	Tham, Yow Keat/ABC-8856-2021; Lin, Ruby CY/A-1636-2009; Gregorevic, Paul/AAH-6040-2021	Tham, Yow Keat/0000-0002-9790-1926; Lin, Ruby CY/0000-0003-4163-511X; Gregorevic, Paul/0000-0002-7418-8945; Ooi, Jenny/0000-0002-4800-6124; Bernardo, Bianca Christine/0000-0002-4534-0549	National Health and Medical Research Council [586603]; Victorian Government; Australian Research Council [FT0001657]; University of New South Wales Vice Chancellor Research Fellowship; Pfizer Australia Senior Research Fellowship; Lundbeck Foundation [R151-2013-14476] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0006395, NNF14SA0011351] Funding Source: researchfish	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government; Australian Research Council(Australian Research Council); University of New South Wales Vice Chancellor Research Fellowship; Pfizer Australia Senior Research Fellowship(PfizerPfizer Australia); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was funded by National Health and Medical Research Council Project Grant 586603 (to J.R.M and R.C.Y.L), and also supported in part by the Victorian Government's Operational Infrastructure Support Program. X.J.D. and J.R.M are National Health and Medical Research Council Senior Research Fellows (APP1043026 and 586604). J.R.M, R.C.Y.L., and P. G. are supported by an Australian Research Council Future Fellowship (FT0001657), a University of New South Wales Vice Chancellor Research Fellowship, and a Pfizer Australia Senior Research Fellowship, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120; Bernardo BC, 2012, P NATL ACAD SCI USA, V109, P17615, DOI 10.1073/pnas.1206432109; Bernardo BC, 2012, HEART LUNG CIRC, V21, P131, DOI 10.1016/j.hlc.2011.11.002; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Concepcion CP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002797; Dangwal S, 2014, ANNU REV PHARMACOL, V54, P185, DOI 10.1146/annurev-pharmtox-011613-135957; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Eisner D, 2013, CIRC RES, V113, P958, DOI 10.1161/CIRCRESAHA.113.302187; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Emanueli C, 2013, CELL RES, V23, P866, DOI 10.1038/cr.2013.57; Gao XM, 2005, AM J PHYSIOL-HEART C, V288, pH2702, DOI 10.1152/ajpheart.00836.2004; Greco S, 2012, DIABETES, V61, P1633, DOI 10.2337/db11-0952; Hsu CP, 2008, BIOL CHEM, V389, P221, DOI 10.1515/BC.2008.032; Hullinger TG, 2012, CIRC RES, V110, P71, DOI 10.1161/CIRCRESAHA.111.244442; Hydbring Per, 2013, F1000Res, V2, P136, DOI 10.12688/f1000research.2-136.v1; Inesi G, 2008, BIOCHEM BIOPH RES CO, V369, P182, DOI 10.1016/j.bbrc.2007.11.161; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Kumarswamy R, 2013, CIRC RES, V113, P676, DOI 10.1161/CIRCRESAHA.113.300226; Latronico MVG, 2011, EXP BIOL MED, V236, P125, DOI 10.1258/ebm.2010.010269; Latronico MVG, 2009, NAT REV CARDIOL, V6, P418, DOI 10.1038/nrcardio.2009.56; Leite-Moreira AM, 2013, DRUG DISCOV TODAY, DOI [10.1016/j.drudis.2013.1007.1025, DOI 10.1016/J.DRUDIS.2013.1007.1025]; Lin RCY, 2010, ARTERIOSCL THROM VAS, V30, P724, DOI 10.1161/ATVBAHA.109.201988; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu N, 2012, NATURE, V482, P519, DOI 10.1038/nature10810; Loffredo FS, 2013, CIRC RES, V113, P97, DOI 10.1161/CIRCRESAHA.113.301933; Lou K, 2012, SCIBX, P5, DOI [10.1038/scibx.2012.1084, DOI 10.1038/SCIBX.2012.1084]; Martins PAD, 2010, NAT CELL BIOL, V12, P1220, DOI 10.1038/ncb2126; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Murphy BL, 2013, CANCER RES, DOI [10.1158/0008-5472.CAN-1113-0927., DOI 10.1158/0008-5472.CAN-1113-0927]; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Pecot CV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3427; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porrello ER, 2013, P NATL ACAD SCI USA, V110, P187, DOI 10.1073/pnas.1208863110; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Silber J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033844; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Trang P, 2011, MOL THER, V19, P1116, DOI 10.1038/mt.2011.48; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Weeks KL, 2012, CIRC-HEART FAIL, V5, P523, DOI 10.1161/CIRCHEARTFAILURE.112.966622; Wei JW, 2012, J CELL BIOL, V197, P509, DOI 10.1083/jcb.201201057; Winbanks CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073589; Wong MYW, 2011, INT J ONCOL, V38, P1189, DOI 10.3892/ijo.2011.970; Xu Q, 2008, ENDOCRINOLOGY, V149, P476, DOI 10.1210/en.2007-1220; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569	49	66	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90337	10.1371/journal.pone.0090337	http://dx.doi.org/10.1371/journal.pone.0090337			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587330	Green Published, gold			2022-12-27	WOS:000332390800101
J	Weafer, J; Gallo, DA; de Wit, H				Weafer, Jessica; Gallo, David A.; de Wit, Harriet			Amphetamine Fails to Alter Cued Recollection of Emotional Images: Study of Encoding, Retrieval, and State-Dependency	PLOS ONE			English	Article							HYPERACTIVE-CHILDREN; FALSE RECOLLECTION; NEURAL MECHANISMS; RECOGNITION MEMORY; EPISODIC MEMORY; ABUSE LIABILITY; INDUCED MOOD; ADDICTION; HUMANS; REWARD	Stimulant drugs facilitate both encoding and retrieval of salient information in laboratory animals, but less is known about their effects on memory for emotionally salient visual images in humans. The current study investigated dextroamphetamine (AMP) effects on memory for emotional pictures in healthy humans, by administering the drug only at encoding, only at retrieval, or at both encoding and retrieval. During the encoding session, all participants viewed standardized positive, neutral, and negative pictures from the International Affective Picture System (IAPS). 48 hours later they attended a retrieval session testing their cued recollection of these stimuli. Participants were randomly assigned to one of four conditions (N = 20 each): condition AP (20 mg AMP at encoding and placebo (PL) at retrieval); condition PA (PL at encoding and AMP at retrieval); condition AA (AMP at encoding and retrieval); or condition PP (PL at encoding and retrieval). Amphetamine produced its expected effects on physiological and subjective measures, and negative pictures were recollected more frequently than neutral pictures. However, contrary to hypotheses, AMP did not affect recollection for positive, negative, or neutral stimuli, whether it was administered at encoding, retrieval, or at both encoding and retrieval. Moreover, recollection accuracy was not state-dependent. Considered in light of other recent drug studies in humans, this study highlights the sensitivity of drug effects to memory testing conditions and suggests future strategies for translating preclinical findings to human behavioral laboratories.	[Weafer, Jessica; de Wit, Harriet] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Gallo, David A.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	de Wit, H (corresponding author), Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA.	hdew@uchicago.edu	Weafer, Jessica/GON-8302-2022	de Wit, Harriet/0000-0002-7211-8994	National Institute on Drug Abuse [DA031796, DA002812, DA033756]; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA033756, R21DA031796, R01DA002812] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by National Institute on Drug Abuse Grants DA031796, DA002812, and DA033756. NIDA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAN MG, 1974, J NERV MENT DIS, V158, P268, DOI 10.1097/00005053-197404000-00005; Ballard ME, J CLIN PSYC IN PRESS; Ballard ME, 2013, PSYCHOPHARMACOLOGY, V226, P515, DOI 10.1007/s00213-012-2924-5; BLANEY PH, 1986, PSYCHOL BULL, V99, P229, DOI 10.1037/0033-2909.99.2.229; Buchanan TW, 2007, PSYCHOL BULL, V133, P761, DOI 10.1037/0033-2909.133.5.761; BUSTAMANTE JA, 1970, PHYSIOL BEHAV, V5, P793, DOI 10.1016/0031-9384(70)90281-7; Carter BL, 1999, ADDICTION, V94, P327, DOI 10.1046/j.1360-0443.1999.9433273.x; Danckert SL, 2011, MEM COGNITION, V39, P1374, DOI 10.3758/s13421-011-0117-9; de Wit H, 2012, NEUROSCI BIOBEHAV R, V36, P1565, DOI 10.1016/j.neubiorev.2012.04.005; Duka T, 2001, PSYCHOPHARMACOLOGY, V153, P295, DOI 10.1007/s002130000564; EICH E, 1995, PSYCHOL SCI, V6, P67, DOI 10.1111/j.1467-9280.1995.tb00309.x; EICH JE, 1975, J VERB LEARN VERB BE, V14, P408, DOI 10.1016/S0022-5371(75)80020-X; EICH JE, 1980, MEM COGNITION, V8, P157, DOI 10.3758/BF03213419; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum H, 2005, J EXP ANAL BEHAV, V84, P619, DOI 10.1901/jeab.2005.80-04; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; FISCHMAN MW, 1991, BRIT J ADDICT, V86, P1563; Gallo D.A., 2013, OXFORD HDB COGNITIVE, P189; Gallo DA, 2013, CURR DIR PSYCHOL SCI, V22, P316, DOI 10.1177/0963721413481472; Gallo DA, 2010, NEUROPSYCHOLOGIA, V48, P3614, DOI 10.1016/j.neuropsychologia.2010.08.011; Gallo DA, 2009, PSYCHOL AGING, V24, P981, DOI 10.1037/a0017545; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jacoby LL, 2005, PSYCHON B REV, V12, P852, DOI 10.3758/BF03196776; JASINSKI DR, 1991, BRIT J ADDICT, V86, P1559; Kensinger E.A., 2009, EMOTIONAL MEMORY ADU; Lang P. J., 1999, INT AFFECTIVE PICTUR; LOWE G, 1983, Substance and Alcohol Actions-Misuse, V4, P273; McNair D., 1971, MANUAL PROFILE MOOD; MILLER ME, 1978, J EXP PSYCHOL-HUM L, V4, P246, DOI 10.1037/0278-7393.4.3.246; Mitchell KJ, 2009, PSYCHOL BULL, V135, P638, DOI 10.1037/a0015849; Muller CP, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00034; O'Brien CP, 1998, J PSYCHOPHARMACOL, V12, P15, DOI 10.1177/026988119801200103; Olausson P, 2003, NEUROPSYCHOPHARMACOL, V28, P1264, DOI 10.1038/sj.npp.1300173; OVERTON DA, 1991, BEHAV PHARMACOL, V2, P253; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; SHEA VT, 1982, PSYCHOPHARMACOLOGY, V78, P266, DOI 10.1007/BF00428163; STEINHAUSEN HC, 1981, PSYCHOPHARMACOLOGY, V74, P389, DOI 10.1007/BF00432754; SWANSON JM, 1976, SCIENCE, V192, P1354, DOI 10.1126/science.1273596; Taylor JR, 1999, PSYCHOPHARMACOLOGY, V142, P31, DOI 10.1007/s002130050859; TEASDALE JD, 1979, J ABNORM PSYCHOL, V88, P248, DOI 10.1037/0021-843X.88.3.248; TEASDALE JD, 1983, BRIT J CLIN PSYCHOL, V22, P163, DOI 10.1111/j.2044-8260.1983.tb00597.x; Torregrossa MM, 2011, NEUROBIOL LEARN MEM, V96, P609, DOI 10.1016/j.nlm.2011.02.014; WEINGARTNER H, 1982, PSYCHIAT RES, V6, P21, DOI 10.1016/0165-1781(82)90034-8; White TL, 2002, PHARMACOL BIOCHEM BE, V73, P729, DOI 10.1016/S0091-3057(02)00818-3; Wyvell CL, 2001, J NEUROSCI, V21, P7831, DOI 10.1523/JNEUROSCI.21-19-07831.2001; Yonelinas AP, 2002, PSYCHON B REV, V9, P575, DOI 10.3758/BF03196315	46	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90423	10.1371/journal.pone.0090423	http://dx.doi.org/10.1371/journal.pone.0090423			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587355	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800107
J	Sauve, CC; Van de Walle, J; Hammill, MO; Arnould, JPY; Beauplet, G				Sauve, Caroline C.; Van de Walle, Joanie; Hammill, Mike O.; Arnould, John P. Y.; Beauplet, Gwenael			Stomach Temperature Records Reveal Nursing Behaviour and Transition to Solid Food Consumption in an Unweaned Mammal, the Harbour Seal Pup (Phoca vitulina)	PLOS ONE			English	Article							MILK INTAKE; SEAWATER DRINKING; BODY-COMPOSITION; HARP SEALS; TELEMETRY REVEALS; FORAGING SUCCESS; PREY CONSUMPTION; DIVING BEHAVIOR; FEEDING EVENTS; ELEPHANT SEAL	Knowledge of milk transfer from mother to offspring and early solid food ingestions in mammals allows for a greater understanding of the factors affecting transition to nutritional independence and pre-weaning growth and survival. Yet studies monitoring suckling behaviour have often relied on visual observations, which might not accurately represent milk intake. We assessed the use of stomach temperature telemetry to monitor suckling and foraging behaviour in free-ranging harbour seal (Phoca vitulina) pups during lactation. Stomach temperature declines were analysed using principal component and cluster analyses, as well as trials using simulated stomachs resulting in a precise classification of stomach temperature drops into milk, seawater and solid food ingestions. Seawater and solid food ingestions represented on average 15.3+/-1.6% [0-40.0%] and 0.7+/-0.2% [0-13.0%], respectively, of individual ingestions. Overall, 63.7% of milk ingestions occurred while the pups were in the water, of which 13.9% were preceded by seawater ingestion. The average time between subsequent ingestions was significantly less for seawater than for milk ingestions. These results suggest that seawater ingestion might represent collateral ingestion during aquatic suckling attempts. Alternatively, as solid food ingestions (n = 19) were observed among 7 pups, seawater ingestion could result from missed prey capture attempts. This study shows that some harbour seals start ingesting prey while still being nursed, indicating that weaning occurs more gradually than previously thought in this species. Stomach temperature telemetry represents a promising method to study suckling behaviour in wild mammals and transition to nutritional independence in various endotherm species.	[Sauve, Caroline C.; Van de Walle, Joanie; Beauplet, Gwenael] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Sauve, Caroline C.; Van de Walle, Joanie; Hammill, Mike O.; Beauplet, Gwenael] Quebec Ocean, Quebec City, PQ, Canada; [Hammill, Mike O.] Fisheries & Oceans Canada, Maurice Lamontagne Inst, Mont Joli, PQ, Canada; [Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia	Laval University; Fisheries & Oceans Canada; Deakin University	Sauve, CC (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada.	caroline.sauve.3@ulaval.ca		Van de Walle, Joanie/0000-0002-5137-1851	Natural Sciences and Engineering Research Council of Canada [355536-2008, 358856-2008, 390930-2010, 431802-2012]; Fonds de recherche Nature et Technologies du Quebec [2010-NC-132906]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de recherche Nature et Technologies du Quebec	This work was supported by Natural Sciences and Engineering Research Council of Canada (URL: http://www.nserc-crsng.gc.ca/index_fra.asp; grants number 355536-2008, 358856-2008, 390930-2010 to GB and 431802-2012 to CCS); and Fonds de recherche Nature et Technologies du Quebec (URL: http://www.fqrnt.gouv.qc.ca/; grant number 2010-NC-132906 to GB). Quebec-Ocean (URL: http://www.quebec-ocean.ulaval.ca/) and the Canadian Department of Fisheries and Oceans (URL: http://www.dfo-mpo.gc.ca/index-eng.htm) provided scientific and logistical support throughout this project. Fisheries and Oceans Canada contributed to data collection and manuscript preparation via the expertise of MO Hammill, P Carter, J-F Gosselin and S Turgeon. Beyond that, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alton AL, 1937, J MAMMAL, V18, P127; Andrews RD, 1999, THESIS U BRIT COLUMB, P1; Arnould JPY, 2002, J ZOOL, V256, P351, DOI 10.1017/S0952836902000389; Austin D, 2006, J ANIM ECOL, V75, P408, DOI 10.1111/j.1365-2656.2006.01057.x; Beauplet G, 2005, J ANIM ECOL, V74, P1160, DOI 10.1111/j.1365-2656.2005.01016.x; Berta A, 2012, MAMMAL REV, V42, P207, DOI 10.1111/j.1365-2907.2011.00193.x; Bigg M.A., 1981, HDB MARINE MAMMALS, V2, P1; BONESS DJ, 1994, BEHAV ECOL SOCIOBIOL, V34, P95; Boness DJ, 1996, BIOSCIENCE, V46, P645, DOI 10.2307/1312894; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Boulva J, 1979, B FISHERIES RES BOAR, pVIII; Bowen W.D., 1991, P66; Bowen WD, 1999, CAN J ZOOL, V77, P978, DOI 10.1139/cjz-77-6-978; Burns JM, 2007, J COMP PHYSIOL B, V177, P687, DOI 10.1007/s00360-007-0167-2; Burns Jennifer M., 1997, P328; Burns R., 2008, BUSINESS RES METHODS; BUSS DH, 1971, J NUTR, V101, P901; Cameron EZ, 1998, ANIM BEHAV, V56, P521, DOI 10.1006/anbe.1998.0793; Catry P, 2004, MAR ECOL PROG SER, V280, P261, DOI 10.3354/meps280261; CLUTTONBROCK TH, 1991, J ANIM ECOL, V60, P593, DOI 10.2307/5300; COSTA DP, 1988, PHYSIOL ZOOL, V61, P160, DOI 10.1086/physzool.61.2.30156147; Cottrell PE, 2002, MAR MAMMAL SCI, V18, P721, DOI 10.1111/j.1748-7692.2002.tb01069.x; Coulson T, 1997, ECOLOGY, V78, P852, DOI 10.1890/0012-9658(1997)078[0852:PSLDAC]2.0.CO;2; DOVE H, 1979, AUST J AGR RES, V30, P725, DOI 10.1071/AR9790725; Dube Y, 2003, CAN J ZOOL, V81, P188, DOI 10.1139/Z02-231; Eisert R, 2009, SMITHSONIAN AT THE POLES: CONTRIBUTIONS TO INTERNATIONAL POLAR YEAR SCIENCE, P335, DOI 10.5479/si.097884601X.25; Fox J, 2011, CA R COMPANION APPL; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; GALES R, 1993, J WILDLIFE MANAGE, V57, P514, DOI 10.2307/3809275; Gentry R.L., 1986, FUR SEALS MATERNAL S; GENTRY RL, 1981, COMP BIOCHEM PHYS A, V68, P81, DOI 10.1016/0300-9629(81)90321-2; Greaves DK, 2004, MAR MAMMAL SCI, V20, P861, DOI 10.1111/j.1748-7692.2004.tb01197.x; Gruebler MU, 2008, ECOLOGY, V89, P2736, DOI 10.1890/07-0786.1; Hair F., 1995, MULTIVARIATE DATA AN, V4th; HAMMILL MO, 1991, CAN J FISH AQUAT SCI, V48, P2471, DOI 10.1139/f91-288; HEDD A, 1995, POLAR BIOL, V15, P155, DOI 10.1007/BF00239055; Hedd A, 1996, POLAR BIOL, V16, P261, DOI 10.1007/s003000050053; HIGGINS LV, 1988, MAR MAMMAL SCI, V4, P44, DOI 10.1111/j.1748-7692.1988.tb00181.x; Horsburgh JM, 2008, MAR MAMMAL SCI, V24, P207, DOI 10.1111/j.1748-7692.2007.00156.x; How OJ, 2007, J COMP PHYSIOL B, V177, P535, DOI 10.1007/s00360-007-0152-9; Jorgensen C, 2001, J EXP BIOL, V204, P3993; KASTELEIN R A, 1988, Aquatic Mammals, V14, P33; Kovacs KM, 1986, THESIS U GUELPH GUEL; Kuhn CE, 2006, J EXP BIOL, V209, P4524, DOI 10.1242/jeb.02530; Lapierre JL, 2004, J EXP BIOL, V207, P3891, DOI 10.1242/jeb.01222; Lea MA, 2002, COMP BIOCHEM PHYS A, V132, P321, DOI 10.1016/S1095-6433(02)00030-2; Lesage V, 1999, CAN J ZOOL, V77, P74, DOI 10.1139/cjz-77-1-74; LYDERSEN C, 1993, ANIM BEHAV, V46, P1213, DOI 10.1006/anbe.1993.1312; Lydersen C, 1999, MAR ECOL PROG SER, V187, P265, DOI 10.3354/meps187265; LYDERSEN C, 1993, J COMP PHYSIOL B, V163, P433; LYDERSEN C, 1992, J ZOOL, V228, P361, DOI 10.1111/j.1469-7998.1992.tb04441.x; MARTIN P, 1984, ANIM BEHAV, V32, P1257, DOI 10.1016/S0003-3472(84)80245-6; Mazerolle M, 2013, I ESTIMES PARAMETRES; McDonald BI, 2012, PHYSIOL BIOCHEM ZOOL, V85, P134, DOI 10.1086/664948; McMahon CR, 2000, ANTARCT SCI, V12, P149, DOI 10.1017/S0954102000000195; MENDL M, 1989, ANIM BEHAV, V37, P513, DOI 10.1016/0003-3472(89)90100-0; Muelbert MMC, 2003, PHYSIOL BIOCHEM ZOOL, V76, P418, DOI 10.1086/375427; MUELBERT MMC, 1993, CAN J ZOOL, V71, P1405, DOI 10.1139/z93-194; Munks SA, 1997, PHYSIOL ZOOL, V70, P691, DOI 10.1086/515871; Oftedal O.T., 1981, THESIS CORNELL U ITH; Plair BL, 2012, ZOO BIOL, V31, P546, DOI 10.1002/zoo.20419; Ponganis PJ, 2007, DEEP-SEA RES PT II, V54, P183, DOI 10.1016/j.dsr2.2006.11.009; R Development Core Team, 2011, R LANG ENV STAT COMP; REITER J, 1978, BEHAV ECOL SOCIOBIOL, V3, P337, DOI 10.1007/BF00303199; Revelle W., 2012, PSYCH PROCEDURES PER; Schreer JF, 2010, AQUAT MAMM, V36, P270, DOI 10.1578/AM.36.3.2010.270; Singer FJ, 1997, J WILDLIFE MANAGE, V61, P12, DOI 10.2307/3802410; Skalstad I, 2000, J COMP PHYSIOL B, V170, P395, DOI 10.1007/s003600000116; Storeheier PV, 2001, COMP BIOCHEM PHYS A, V128, P307, DOI 10.1016/S1095-6433(00)00311-1; Sunde P, 2008, J AVIAN BIOL, V39, P242, DOI 10.1111/j.2008.0908-8857.04194.x; THOMPSON PM, 1994, J ANIM ECOL, V63, P24, DOI 10.2307/5579; Van de Walle J, 2013, THESIS U LAVAL QUEBE; Venables WN, 2002, MASS MODERN APPL STA; Verrier D, 2011, FUNCT ECOL, V25, P818, DOI 10.1111/j.1365-2435.2011.01846.x; Wheatley KE, 2008, OECOLOGIA, V155, P11, DOI 10.1007/s00442-007-0888-7; Wilson R, 1998, MAR BIOL, V130, P559, DOI 10.1007/s002270050277; WILSON RP, 1992, J EXP BIOL, V167, P267; WILSON RP, 1995, J EXP BIOL, V198, P1115; Wilson RP, 1991, COMP BIOCH PHYSL A, V100, P51	79	8	8	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90329	10.1371/journal.pone.0090329	http://dx.doi.org/10.1371/journal.pone.0090329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587327	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000149
J	Al Faraj, A; Shaik, AS; Pureza, MA; Alnafea, M; Halwani, R				Al Faraj, Achraf; Shaik, Asma Sultana; Pureza, Mary Angeline; Alnafea, Mohammad; Halwani, Rabih			Preferential Macrophage Recruitment and Polarization in LPS-Induced Animal Model for COPD: Noninvasive Tracking Using MRI	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; IN-VITRO; DENDRITIC CELLS; CHEMOKINE MDC; INFLAMMATION; MONOCYTES; EXPRESSION; PLASTICITY; RESOLUTION; INFECTION	Noninvasive imaging of macrophages activity has raised increasing interest for diagnosis of chronic obstructive respiratory diseases (COPD), which make them attractive vehicles to deliver contrast agents for diagnostic or drugs for therapeutic purposes. This study was designed to monitor and evaluate the migration of differently polarized M1 and M2 iron labeled macrophage subsets to the lung of a LPS-induced COPD animal model and to assess their polarization state once they have reached the inflammatory sites in the lung after intravenous injection. Ex vivo polarized bone marrow derived M1 or M2 macrophages were first efficiently and safely labeled with amine-modified PEGylated dextran-coated SPIO nanoparticles and without altering their polarization profile. Their biodistribution in abdominal organs and their homing to the site of inflammation in the lung was tracked for the first time using a free-breathing non-invasive MR imaging protocol on a 4.7T magnet after their intravenous administration. This imaging protocol was optimized to allow both detection of iron labeled macrophages and visualization of inflammation in the lung. M1 and M2 macrophages were successfully detected in the lung starting from 2 hours post injection with no variation in their migration profile. Quantification of cytokines release, analysis of surface membrane expression using flow cytometry and immunohistochemistry investigations confirmed the successful recruitment of injected iron labeled macrophages in the lung of COPD mice and revealed that even with a continuum switch in the polarization profile of M1 and M2 macrophages during the time course of inflammation a balanced number of macrophage subsets predominate.	[Al Faraj, Achraf; Shaik, Asma Sultana; Alnafea, Mohammad] King Saud Univ, Dept Radiol Sci, Coll Appl Med Sci, Mol & Cellular Imaging Lab, Riyadh, Saudi Arabia; [Pureza, Mary Angeline; Halwani, Rabih] King Saud Univ, Coll Med, Asthma Res Chair, Riyadh 11461, Saudi Arabia; [Pureza, Mary Angeline; Halwani, Rabih] King Saud Univ, Coll Med, Prince Naif Ctr Immunol Res, Riyadh 11461, Saudi Arabia	King Saud University; King Saud University; King Saud University	Al Faraj, A (corresponding author), King Saud Univ, Dept Radiol Sci, Coll Appl Med Sci, Mol & Cellular Imaging Lab, Riyadh, Saudi Arabia.	aalfaraj@ksu.edu.sa	Al Faraj, Achraf/B-1351-2012; Halwani, Rabih/AAN-1568-2021; shaik, Asma Sultana/E-1284-2016; Faraj, Achraf Al/M-9476-2019	Al Faraj, Achraf/0000-0002-8943-1354; Halwani, Rabih/0000-0002-6516-7771; Faraj, Achraf Al/0000-0002-8943-1354	NPST Program, King Saud University [11-MED1773]	NPST Program, King Saud University(King Saud University)	This work was supported by the NPST Program, King Saud University, Project Number 11-MED1773. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Faraj A, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1797-9; Al Faraj A, 2013, CONTRAST MEDIA MOL I, V8, P193, DOI 10.1002/cmmi.1516; Bamrungsap S, 2012, NANOMEDICINE-UK, V7, P1253, DOI [10.2217/NNM.12.87, 10.2217/nnm.12.87]; Barnes Peter J, 2004, COPD, V1, P59, DOI 10.1081/COPD-120028701; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Boorsma CE, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/769214; Cai QY, 2012, NANOMED-NANOTECHNOL, V8, P365, DOI 10.1016/j.nano.2011.06.019; Cecilio CA, 2011, BRAZ J MED BIOL RES, V44, P671, DOI [10.1590/S0100-879X2011007500067, 10.1590/S0100-879X2011000700010]; Chen ZP, 2009, NANOSCALE RES LETT, V4, P204, DOI 10.1007/s11671-008-9226-1; Ebner B, 2010, CIRC-CARDIOVASC IMAG, V3, P202, DOI 10.1161/CIRCIMAGING.109.902312; Engberink RDO, 2007, RADIOLOGY, V243, P467, DOI 10.1148/radiol.2432060120; Frankenberger M, 2011, MOL MED, V17, P762, DOI 10.2119/molmed.2010.00202; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Global Initiative for Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Godiska R, 1997, J EXP MED, V185, P1595, DOI 10.1084/jem.185.9.1595; Hardison SE, 2010, AM J PATHOL, V176, P774, DOI 10.2353/ajpath.2010.090634; Hauger O, 2007, EUR RADIOL, V17, P2898, DOI 10.1007/s00330-007-0660-8; Herold S, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00065; Lee JS, 2006, RADIOLOGY, V241, P142, DOI 10.1148/radiol.2403051156; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Lum H, 2001, AM J PHYSIOL-CELL PH, V280, pC719; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Redente EF, 2010, J LEUKOCYTE BIOL, V88, P159, DOI 10.1189/jlb.0609378; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Saito S, 2012, INT J NANOMED, V7, P5415, DOI 10.2147/IJN.S33709; Schweiger C, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-28; Singh N, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5358; Soenen SJ, 2012, METHOD ENZYMOL, V509, P195, DOI 10.1016/B978-0-12-391858-1.00011-3; Soenen SJH, 2010, NANOMEDICINE-UK, V5, P1261, DOI 10.2217/NNM.10.106; Strobel K, 2012, MAGN RESON MED, V68, P1924, DOI 10.1002/mrm.24180; Tang KS, 2011, MAGN RESON MED, V65, P1564, DOI 10.1002/mrm.22843; Tyler DJ, 2007, J MAGN RESON IMAGING, V25, P279, DOI 10.1002/jmri.20851; Vazquez-Tello A, 2012, INT ARCH ALLERGY IMM, V157, P406, DOI 10.1159/000329527; Vulcano M, 2001, EUR J IMMUNOL, V31, P812, DOI 10.1002/1521-4141(200103)31:3<812::AID-IMMU812>3.0.CO;2-L; Wang YXJ, 2011, QUANT IMAGING MED SU, V1, P35, DOI 10.3978/j.issn.2223-4292.2011.08.03; Wouters Emiel F M, 2009, Proc Am Thorac Soc, V6, P638, DOI 10.1513/pats.200907-073DP; Yamashita U, 2002, CRIT REV IMMUNOL, V22, P105; Ying S, 2008, J IMMUNOL, V181, P2790, DOI 10.4049/jimmunol.181.4.2790; Yu SS, 2012, INT J NANOMED, V7, P799, DOI 10.2147/IJN.S28531; Zheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063967; Zhu XM, 2012, INT J NANOMED, V7, P953, DOI 10.2147/IJN.S28316	42	27	27	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90829	10.1371/journal.pone.0090829	http://dx.doi.org/10.1371/journal.pone.0090829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598763	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400138
J	Jonsdottir, K; Assmus, J; Slewa, A; Gudlaugsson, E; Skaland, I; Baak, JPA; Janssen, EAM				Jonsdottir, Kristin; Assmus, Joerg; Slewa, Aida; Gudlaugsson, Einar; Skaland, Ivar; Baak, Jan P. A.; Janssen, Emiel A. M.			Prognostic Value of Gene Signatures and Proliferation in Lymph-Node-Negative Breast Cancer	PLOS ONE			English	Article							21-GENE RECURRENCE SCORE; ESTROGEN-RECEPTOR; PROSPECTIVE MULTICENTER; EXPRESSION; CHEMOTHERAPY; VALIDATION; INDEX; MICROARRAY; PREDICTOR; MARKERS	Introduction: The overall survival rate is good for lymph-node-negative breast cancer patients, but they still suffer from serious over-and some undertreatments. Prognostic and predictive gene signatures for node-negative breast cancer have a high number of genes related to proliferation. The prognostic value of gene sets from commercial gene-expression assays were compared with proliferation markers. Methods: Illumina WG6 mRNA microarray analysis was used to examine 94 fresh-frozen tumour samples from node-negative breast cancer patients. The patients were divided into low-and high-risk groups for distant metastasis based on the MammaPrint-related genes, and into low-, intermediate-and high-risk groups based on the recurrence score algorithm with genes included in Oncotype DX. These data were then compared to proliferation status, as measured by the mitotic activity index, the expressions of phosphohistone H3 (PPH3), and Ki67. Results: Kaplan-Meier survival analysis for distant-metastasis-free survival revealed that patients with weak and strong PPH3 expressions had 14-year survival rates of 87% (n = 45), and 65% (n = 49, p = 0.014), respectively. Analysis of the MammaPrint classification resulted in 14-year survival rates of 80% (n = 45) and 71% (n = 49, p = 0.287) for patients with low and high risks of recurrence, respectively. The Oncotype DX categorization yielded 14-year survival rates of 83% (n = 18), 79% (n = 42) and 68% (n = 34) for those in the low-, intermediate-and high-risk groups, respectively (p = 0.52). Supervised hierarchical cluster analysis for distant-metastasis-free survival in the subgroup of patients with strong PPH3 expression revealed that the genes involved in Notch signalling and cell adhesion were expressed at higher levels in those patients with distant metastasis. Conclusion: This pilot study indicates that proliferation has greater prognostic value than the expressions of either MammaPrint- or Oncotype-DX-related genes. Furthermore, in the subgroup of patients with high proliferation, Notch signalling pathway genes appear to be expressed at higher levels in patients who develop distant metastasis.	[Jonsdottir, Kristin; Slewa, Aida; Gudlaugsson, Einar; Skaland, Ivar; Baak, Jan P. A.; Janssen, Emiel A. M.] Stavanger Univ Hosp, Dept Pathol, Stavanger, Norway; [Assmus, Joerg] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway; [Baak, Jan P. A.] Free Univ Amsterdam, Amsterdam, Netherlands	Stavanger University Hospital; University of Bergen; Haukeland University Hospital; Vrije Universiteit Amsterdam	Janssen, EAM (corresponding author), Stavanger Univ Hosp, Dept Pathol, Stavanger, Norway.	emiel.janssen@sus.no	Janssen, Emiel A.M./AAM-2357-2020		Helse Vest, Norway [911450]; Folke Hermansen Foundation; Stavanger University Hospital research department	Helse Vest, Norway; Folke Hermansen Foundation; Stavanger University Hospital research department	Kristin Jonsdottir has a grant from Helse Vest (no: 911450) (http://www.helse-vest.no/english/Sider/side.aspx), Norway and the study received financial support from the Folke Hermansen Foundation (2010) (http://www.folke-fondet.org/index.html) and the Stavanger University Hospital research department (2009-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2005, J CLIN ONCOL, V23, P2996, DOI 10.1200/JCO.2005.08.046; [Anonymous], 2003, WHO CLASSIFICATION T; Baak JPA, 2006, J CLIN PATHOL, V59, P1017, DOI 10.1136/jcp.2005.027839; Baak JPA, 2007, EUR J CANCER, V43, P527, DOI 10.1016/j.ejca.2006.10.001; Baak JPA, 2009, BREAST CANCER RES TR, V115, P241, DOI 10.1007/s10549-008-0126-y; Baak JPA, 2005, J CLIN ONCOL, V23, P5993, DOI 10.1200/JCO.2005.05.511; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Desmedt C, 2006, CELL CYCLE, V5, P2198, DOI 10.4161/cc.5.19.3254; Dontu G, 2004, TRENDS ENDOCRIN MET, V15, P193, DOI 10.1016/j.tem.2004.05.011; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elloumi F, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-54; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Git A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2109; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gudlaugsson E, 2012, HISTOPATHOLOGY; Habel LA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1412; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Haughian JM, 2012, P NATL ACAD SCI USA, V109, P2742, DOI 10.1073/pnas.1106509108; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Janssen EAM, 2009, CELL ONCOL, V31, P335, DOI 10.3233/CLO-2009-0479; Kelly CM, 2010, CANCER-AM CANCER SOC, V116, P5161, DOI 10.1002/cncr.25269; Knauer M, 2010, BREAST CANCER RES TR, V120, P655, DOI 10.1007/s10549-010-0814-2; Lo SS, 2010, J CLIN ONCOL, V28, P1671, DOI 10.1200/JCO.2008.20.2119; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; NICHOLSON RI, 1991, EUR J CANCER, V27, P908, DOI 10.1016/0277-5379(91)90145-4; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Niikura N, 2012, CANCER SCI, V103, P1508, DOI 10.1111/j.1349-7006.2012.02319.x; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Sahebjam S, 2011, BRIT J CANCER, V105, P1342, DOI 10.1038/bjc.2011.402; Sanchez-Navarro I, 2010, BIOTECHNIQUES, V48, P389, DOI 10.2144/000113388; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Simmons MJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3321; Skaland I, 2007, MODERN PATHOL, V20, P1307, DOI 10.1038/modpathol.3800972; Skaland I, 2009, BREAST CANCER RES TR, V114, P39, DOI 10.1007/s10549-008-9980-x; Starmans MHW, 2008, BRIT J CANCER, V99, P1884, DOI 10.1038/sj.bjc.6604746; Sun B, 2011, BREAST J, V17, P172, DOI 10.1111/j.1524-4741.2010.01049.x; Tian S, 2010, BIOMARK INSIGHTS, V5, P129, DOI 10.4137/BMI.S6184; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5; Williams DJ, 2011, APPL IMMUNOHISTO M M, V19, P431, DOI 10.1097/PAI.0b013e318206d23d; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Wolf I, 2008, CANCER-AM CANCER SOC, V112, P731, DOI 10.1002/cncr.23225; Yao K, 2011, INT J SURG PATHOL, V19, P607, DOI 10.1177/1066896910362080	56	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90642	10.1371/journal.pone.0090642	http://dx.doi.org/10.1371/journal.pone.0090642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599057	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400107
J	Wang, LJ; Wang, DB; Fei, XC; Ruan, M; Chai, WM; Xu, L; Li, XX				Wang, Lijun; Wang, Dengbin; Fei, Xiaochun; Ruan, Mei; Chai, Weimin; Xu, Lin; Li, Xiaoxiao			A Rim-Enhanced Mass with Central Cystic Changes on MR Imaging: How to Distinguish Breast Cancer from Inflammatory Breast Diseases?	PLOS ONE			English	Article							ADJACENT VESSEL SIGN; DUCTAL CARCINOMA; FEATURES; ANGIOGENESIS; MASTITIS; LESIONS; BENIGN; TISSUE	Objective: To evaluate the capacity of magnetic resonance imaging (MRI) to distinguish breast cancer from inflammatory breast diseases manifesting as a rim-enhanced mass with central cystic changes. Materials and Methods: Forty cases of breast cancer and 52 of inflammatory breast diseases showing a rim-enhanced mass with central cystic changes were retrospectively reviewed. All cases underwent dynamic contrast-enhanced MRI and 31 of them underwent diffusion-weighted imaging (DWI). Morphological features, dynamic parameters and apparent diffusion coefficient (ADC) values were comparatively analyzed using univariate analysis and binary logistic regression analysis. Results: Breast cancer had a significantly thicker wall than the inflammatory breast diseases (P<0.001) while internal enhancing septa were more common in inflammatory breast diseases (P = 0.003). On DWI, 86.7% of breast cancers demonstrate a peripheral hyperintensity whereas 93.8% of inflammatory breast diseases had a central hyperintensity (P<0.001). Compared to the inflammatory breast diseases, breast cancers had a lower ADC value for the wall (1.09x10(-3) mm(2)/s vs 1.42x10(-3) mm(2)/s, P<0.001) and a higher ADC value for the central part (1.94x10(-3) mm(2)/s vs 1.05x10(-3) mm(2)/s, P<0.001). Conclusions: Both breast cancer and inflammatory breast diseases could present as a rim-enhanced mass with central cystic changes on MRI. Integrated analysis of the MR findings can allow for an accurate differential diagnosis.	[Wang, Lijun; Wang, Dengbin; Ruan, Mei; Xu, Lin; Li, Xiaoxiao] Shanghai Jiao Tong Univ Sch Med, Xinhua Hosp, Dept Radiol, Shanghai, Peoples R China; [Fei, Xiaochun] Shanghai Jiao Tong Univ Sch Med, Ruijin Hosp, Dept Pathol, Shanghai, Peoples R China; [Chai, Weimin] Shanghai Jiao Tong Univ Sch Med, Ruijin Hosp, Dept Radiol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, DB (corresponding author), Shanghai Jiao Tong Univ Sch Med, Xinhua Hosp, Dept Radiol, Shanghai, Peoples R China.	dbwang8@aliyun.com			National Natural Science Foundation of China; Program of Shanghai Municipal Health Outstanding Discipline Leader [NSFC 81171389, NSFC 81371621, XBR 2013110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Municipal Health Outstanding Discipline Leader	This study was funded by the National Natural Science Foundation of China and the Program of Shanghai Municipal Health Outstanding Discipline Leader (NSFC 81171389, NSFC 81371621, and XBR 2013110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MS, 2012, JCPSP-J COLL PHYSICI, V22, P428, DOI 07.2012/JCPSP.428431; American College of Radiology, 2003, ACR BREAST IM REP DA; Bian XW, 2004, INT IMMUNOPHARMACOL, V4, P1537, DOI 10.1016/j.intimp.2004.07.017; Buadu LD, 1997, J COMPUT ASSIST TOMO, V21, P421, DOI 10.1097/00004728-199705000-00016; Dietzel M, 2010, KOREAN J RADIOL, V11, P178, DOI 10.3348/kjr.2010.11.2.178; Dursun M, 2012, RADIOL MED, V117, P529, DOI 10.1007/s11547-011-0733-2; Ferron S, 2012, J RADIOL DIAGN INTER, V93, P93, DOI 10.1016/j.jradio.2011.11.002; Gupta C, 2006, PATHOL RES PRACT, V202, P465, DOI 10.1016/j.prp.2006.01.006; Han M, 2012, AM J ROENTGENOL, V199, P921, DOI 10.2214/AJR.11.7895; Kurz KD, 2010, EUR J RADIOL, V76, P195, DOI 10.1016/j.ejrad.2009.07.036; Liu HQ, 2011, J MAGN RESON IMAGING, V33, P1369, DOI 10.1002/jmri.22464; Luciani A, 2004, AM J ROENTGENOL, V182, P1059, DOI 10.2214/ajr.182.4.1821059; Mansour SM, 2012, EGYPT J RADIOL NUC M, V43, P487, DOI 10.1016/j.ejrnm.2012.04.004; Orguc S, 2012, SINGAP MED J, V53, P737; Renz DM, 2008, EUR RADIOL, V18, P2370, DOI 10.1007/s00330-008-1029-3; Uematsu T, 2013, BREAST CANC IN PRESS; Uematsu T, 2012, BREAST CANCER-TOKYO, V19, P289, DOI 10.1007/s12282-012-0346-1; Uematsu T, 2011, JPN J RADIOL, V29, P609, DOI 10.1007/s11604-011-0612-8; Unal O, 2011, EUR J RADIOL, V77, P490, DOI 10.1016/j.ejrad.2009.08.025; Velasco M, 2005, AM J ROENTGENOL, V184, P1274, DOI 10.2214/ajr.184.4.01841274; Yamaguchi R, 2008, PATHOL INT, V58, P26, DOI 10.1111/j.1440-1827.2007.02184.x; Yoshihara E, 2013, BREAST, V22, P357, DOI 10.1016/j.breast.2012.09.003; Youk JH, 2012, EUR RADIOL, V22, P1724, DOI 10.1007/s00330-012-2425-2	23	9	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90355	10.1371/journal.pone.0090355	http://dx.doi.org/10.1371/journal.pone.0090355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598845	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400067
J	Cai, BX; Zhang, T; Zhong, R; Zou, L; Zhu, BB; Chen, W; Shen, N; Ke, JT; Lou, J; Wang, ZL; Sun, Y; Liu, LF; Song, RR				Cai, Bingxi; Zhang, Ti; Zhong, Rong; Zou, Li; Zhu, Beibei; Chen, Wei; Shen, Na; Ke, Juntao; Lou, Jiao; Wang, Zhenling; Sun, Yu; Liu, Lifeng; Song, Ranran			Genetic Variant in MTRR, but Not MTR, Is Associated with Risk of Congenital Heart Disease: An Integrated Meta-Analysis	PLOS ONE			English	Article							METHIONINE SYNTHASE REDUCTASE; GENOME-WIDE ASSOCIATION; DEFECTS; POLYMORPHISMS; DISEQUILIBRIUM; SUSCEPTIBILITY; HOMOCYSTEINE; METABOLISM; CHILDREN	Background: Congenital heart disease (CHD) is one of the most common birth defects and the leading cause of deaths among individuals with congenital structural abnormalities worldwide. Both Methionine synthase reductase (MTRR) and Methionine synthase (MTR) are key enzymes involved in the metabolic pathway of homocysteine, which are significant in the earlier period embryogenesis, particularly in the cardiac development. Evidence is mounting for the association between MTRR A66G (rs1801394)/MTR A2756G (rs1805087) and the CHD risk, but results are controversial. Therefore, we conducted a meta-analysis integrating case-control and transmitted disequilibrium test (TDT) studies to obtain more precise estimate of the associations of these two variants with the CHD risk. Methods: To combine case-control and TDT studies, we used the Catmap package of R software to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Results: A total of 9 reports were included in the final meta-analysis. Eight of them comprised of 914 cases, 964 controls, and 441 families that were germane to MTRR A66G polymorphism; and 4 reports comprised of 250 cases, 205 controls, and 53 families that were relevant to MTR A2756G polymorphism. The pooled OR for the MTRR 66 G allele versus A allele was 1.35 (95% CI = 1.14-1.59, P<0.001, P-heterogeneity = 0.073). For MTR A2756G, the G allele conferred a pooled OR of 1.10 (95% CI = 0.78-1.57, P = 0.597, P-heterogeneity = 0.173) compared with the A allele. Sensitivity analyses were carried out to asses the effects of each individual study on the pooled OR, indicating the stability of the outcome. Moreover, positive results were also obtained in all subgroups stratified by study type and ethnicity except the subgroup of TDT studies in MTRR A66G variant. Conclusions: This meta-analysis demonstrated a suggestive result that the A66G variant in MTRR, but not the A2756G in MTR, may be associated with the increase of CHD risks.	[Cai, Bingxi; Zhang, Ti; Zhong, Rong; Zou, Li; Zhu, Beibei; Chen, Wei; Shen, Na; Ke, Juntao; Lou, Jiao; Wang, Zhenling; Sun, Yu; Liu, Lifeng] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Peoples R China; [Cai, Bingxi; Zhang, Ti; Zhong, Rong; Zou, Li; Zhu, Beibei; Chen, Wei; Shen, Na; Ke, Juntao; Lou, Jiao; Wang, Zhenling; Sun, Yu; Liu, Lifeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth,Minist Environm Protect,Key Lab Env, State Key Lab Environm Hlth Incubation,MOE,Key La, Wuhan 430074, Peoples R China; [Song, Ranran] Huazhong Univ Sci & Technol, Dept Maternal & Child Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Song, RR (corresponding author), Huazhong Univ Sci & Technol, Dept Maternal & Child Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China.	ranransong@gmail.com	Zhong, Rong/Q-1813-2019; Song, Ranran/Z-3997-2019	Song, Ranran/0000-0002-8354-7698				Aguilar B, 2004, J THROMB THROMBOLYS, V18, P75, DOI 10.1007/s11239-004-0204-x; [Anonymous], 2012, CHINA BIRTH DEFECTS; Bailey LB, 2005, AM J CLIN NUTR, V81, p1213S; Blue GM, 2012, MED J AUSTRALIA, V197, P155, DOI 10.5694/mja12.10811; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Chen W, 2012, BREAST CANCER RES TR, V136, P847, DOI 10.1007/s10549-012-2309-9; Christensen KE, 2012, CARDIOL YOUNG, P1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elmore CL, 2007, MOL GENET METAB, V91, P85, DOI 10.1016/j.ymgme.2007.02.001; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Galdieri LC, 2007, ARCH MED RES, V38, P212, DOI 10.1016/j.arcmed.2006.09.012; Garcia-Barcelo MM, 2010, HUM MOL GENET, V19, P2917, DOI 10.1093/hmg/ddq196; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gong Ting, 2010, Acta Academiae Medicinae Militaris Tertiae, V32, P127; Gulati S, 1997, J BIOL CHEM, V272, P19171, DOI 10.1074/jbc.272.31.19171; Herberg U, 2012, Z GEBURTSH NEONATOL, V216, P132, DOI 10.1055/s-0032-1312670; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Li Y, 2004, YING YANG JIAN KANG, V25, P5; Liu YS, 2007, CHIN J CARDIOVASC RE, V5, P210; Locke AE, 2010, GENET EPIDEMIOL, V34, P613, DOI 10.1002/gepi.20518; Monteiro FPM, 2012, REV LAT-AM ENFERM, V20, P1024, DOI 10.1590/S0104-11692012000600003; Nicodemus KK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-130; NORA JJ, 1968, CIRCULATION, V38, P604, DOI 10.1161/01.CIR.38.3.604; Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200; Pishva SR, 2013, INT J MOL SCI, V14, P2739, DOI 10.3390/ijms14022739; Shaw GM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-49; Song QB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033318; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Thiene G, 2010, CARDIOVASC PATHOL, V19, P259, DOI 10.1016/j.carpath.2010.02.006; Tobias A., 1999, STATA TECHNICAL B, V8, P15; van Beynum IM, 2006, CLIN CHEM LAB MED, V44, P1317, DOI 10.1515/CCLM.2006.254; Verkleij-Hagoort AC, 2006, BJOG-INT J OBSTET GY, V113, P1412, DOI 10.1111/j.1471-0528.2006.01109.x; Verkleij-Hagoort AC, 2008, MOL GENET METAB, V94, P112, DOI 10.1016/j.ymgme.2007.12.002; Verldeij-Hagoort A, 2007, AM J MED GENET A, V143A, P952, DOI 10.1002/ajmg.a.31684; Wang L, 2005, CLIN GASTROENTEROL H, V3, P743, DOI 10.1016/S1542-3565(05)00156-4; Wu C, 2012, NAT GENET, V44, P62, DOI 10.1038/ng.1020; Yamada K, 2006, P NATL ACAD SCI USA, V103, P9476, DOI 10.1073/pnas.0603694103; Zeng W, 2011, GENET MOL RES, V10, P2597, DOI 10.4238/2011.October.25.7; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059570; Zhao JY, 2012, CIRCULATION, V125, P482, DOI 10.1161/CIRCULATIONAHA.111.050245	41	20	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89609	10.1371/journal.pone.0089609	http://dx.doi.org/10.1371/journal.pone.0089609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595101	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500019
J	Calvo-Polanco, M; Sanchez-Romera, B; Aroca, R				Calvo-Polanco, Monica; Sanchez-Romera, Beatriz; Aroca, Ricardo			Mild Salt Stress Conditions Induce Different Responses in Root Hydraulic Conductivity of Phaseolus vulgaris Over-Time	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL SYMBIOSIS; WATER TRANSPORT; GENE-EXPRESSION; AQUAPORIN EXPRESSION; SALINITY STRESS; COLLECTING DUCT; OSMOTIC-STRESS; ABSCISIC-ACID; MEMBRANE; MECHANISMS	Plants respond to salinity by altering their physiological parameters in order to maintain their water balance. The reduction in root hydraulic conductivity is one of the first responses of plants to the presence of salt in order to minimize water stress. Although its regulation has been commonly attributed to aquaporins activity, osmotic adjustment and the toxic effect of Na+ and Cl- have also a main role in the whole process. We studied the effects of 30 mM NaCl on Phaseolus vulgaris plants after 9 days and found different responses in root hydraulic conductivity over-time. An initial and final reduction of root hydraulic conductivity, stomatal conductance, and leaf water potential in response to NaCl was attributed to an initial osmotic shock after 1 day of treatment, and to the initial symptoms of salt accumulation within the plant tissues after 9 days of treatment. After 6 days of NaCl treatment, the increase in root hydraulic conductivity to the levels of control plants was accompanied by an increase in root fructose content, and with the intracellular localization of root plasma membrane aquaporins (PIP) to cortex cells close to the epidermis and to cells surrounding xylem vessels. Thus, the different responses of bean plants to mild salt stress over time may be connected with root fructose accumulation, and intracellular localization of PIP aquaporins.	[Calvo-Polanco, Monica; Sanchez-Romera, Beatriz; Aroca, Ricardo] CSIC, Estn Expt Zaidin, Dept Soil Microbiol & Symbiot Syst, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Calvo-Polanco, M (corresponding author), CSIC, Estn Expt Zaidin, Dept Soil Microbiol & Symbiot Syst, Granada, Spain.	monica.calvo@eez.csic.es	Calvo-Polanco, Monica/AAN-9952-2020; Aroca, Ricardo/K-5268-2014; Sánchez, Beatriz/AAH-9291-2019	Calvo-Polanco, Monica/0000-0002-0813-0921; Aroca, Ricardo/0000-0003-2402-2063; Sanchez Romera, Beatriz/0000-0002-0204-2330	Ministry of Economy and Competitiveness of Spain [AGL2011-25403]; Junta de Andalucia [P10-CVI-5920]	Ministry of Economy and Competitiveness of Spain(Spanish Government); Junta de Andalucia(Junta de Andalucia)	We would like to thank the Ministry of Economy and Competitiveness of Spain(Juan de la Cierva Program and AGL2011-25403 project) and Junta de Andalucia (P10-CVI-5920 project) for research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRE P, 1993, AM J PHYSIOL, V265, pF461, DOI 10.1152/ajprenal.1993.265.3.F461; Aroca R, 2005, PLANT PHYSIOL, V137, P341, DOI 10.1104/pp.104.051045; Aroca R, 2001, PLANT PHYSIOL BIOCH, V39, P1067, DOI 10.1016/S0981-9428(01)01335-3; Aroca R, 2007, NEW PHYTOL, V173, P808, DOI 10.1111/j.1469-8137.2006.01961.x; Aroca R, 2006, ANN BOT-LONDON, V98, P1301, DOI 10.1093/aob/mcl219; Aroca R, 2012, J EXP BOT, V63, P43, DOI 10.1093/jxb/err266; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Benabdellah K, 2009, PLANT MOL BIOL, V70, P647, DOI 10.1007/s11103-009-9497-7; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Boursiac Y, 2008, PLANT J, V56, P207, DOI 10.1111/j.1365-313X.2008.03594.x; Bramley H, 2009, PLANT PHYSIOL, V150, P348, DOI 10.1104/pp.108.134098; Chen T, 2011, PLANT SIGNAL BEHAV, V6, P10; Cho YH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001263; Cho YH, 2007, PLANT SIGNAL BEHAV, V2, P123, DOI 10.4161/psb.2.2.3894; COLMER TD, 1995, PLANT PHYSIOL, V108, P1715, DOI 10.1104/pp.108.4.1715; Diatloff E, 2001, J PLANT NUTR, V24, P75, DOI 10.1081/PLN-100000313; ECHEVARRIA M, 1994, P NATL ACAD SCI USA, V91, P10997, DOI 10.1073/pnas.91.23.10997; Evelin H, 2009, ANN BOT-LONDON, V104, P1263, DOI 10.1093/aob/mcp251; FLOWERS TJ, 1986, AUST J PLANT PHYSIOL, V13, P75, DOI 10.1071/PP9860075; Gambetta GA, 2013, PLANT PHYSIOL, V163, P1254, DOI 10.1104/pp.113.221283; Gao YX, 2010, PLANT SOIL, V331, P193, DOI 10.1007/s11104-009-0245-1; Guo L, 2006, CELL RES, V16, P277, DOI 10.1038/sj.cr.7310035; Hachez C, 2006, PLANT MOL BIOL, V62, P305, DOI 10.1007/s11103-006-9022-1; Henzler T, 1999, PLANTA, V210, P50, DOI 10.1007/s004250050653; Hewitt EJ, 1952, COMMONW AGR BUR; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Horie T, 2011, PLANT CELL PHYSIOL, V52, P663, DOI 10.1093/pcp/pcr027; ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269; Javot H, 2003, PLANT CELL, V15, P509, DOI 10.1105/tpc.008888; JESCHKE WD, 1985, J PLANT PHYSIOL, V121, P211, DOI 10.1016/S0176-1617(85)80055-9; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; KAY R, 1987, SCIENCE, V236, P1299, DOI 10.1126/science.236.4806.1299; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Lee SH, 2010, PLANT CELL ENVIRON, V33, P769, DOI 10.1111/j.1365-3040.2009.02103.x; Liu T, 2001, PLANT GROWTH REGUL, V33, P13, DOI 10.1023/A:1010687711334; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ruiz-Lozano JM, 2012, J EXP BOT, V63, P4033, DOI 10.1093/jxb/ers126; Martinez-Ballesta MDC, 2006, PLANT BIOLOGY, V8, P535, DOI 10.1055/s-2006-924172; Marulanda A, 2010, PLANTA, V232, P533, DOI 10.1007/s00425-010-1196-8; Montero E, 1998, PLANT CELL ENVIRON, V21, P54, DOI 10.1046/j.1365-3040.1998.00249.x; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; MUNNS R, 1984, AUST J PLANT PHYSIOL, V11, P497, DOI 10.1071/PP9840497; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Muries B, 2011, MOL BIOSYST, V7, P1322, DOI 10.1039/c0mb00285b; Park W, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-142; Peterson RL, 2009, TEACHING PLANT ANATO; Postaire O, 2010, PLANT PHYSIOL, V152, P1418, DOI 10.1104/pp.109.145326; Quintero JM, 2001, J EXP BOT, V52, P99, DOI 10.1093/jexbot/52.354.99; Rahnama A, 2010, FUNCT PLANT BIOL, V37, P255, DOI 10.1071/FP09148; Rook F, 1998, PLANT J, V15, P253, DOI 10.1046/j.1365-313X.1998.00205.x; Ruiz-Lozano JM, 2001, NEW PHYTOL, V151, P493, DOI 10.1046/j.0028-646x.2001.00196.x; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Schachtman DP, 2008, TRENDS PLANT SCI, V13, P281, DOI 10.1016/j.tplants.2008.04.003; Shavrukov Y, 2013, J EXP BOT, V64, P119, DOI 10.1093/jxb/ers316; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Steudle E, 1998, J EXP BOT, V49, P775, DOI 10.1093/jexbot/49.322.775; Sutka M, 2011, PLANT PHYSIOL, V155, P1264, DOI 10.1104/pp.110.163113; Thompson AJ, 2007, PLANT PHYSIOL, V143, P1905, DOI 10.1104/pp.106.093559; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P525, DOI 10.4161/psb.3.8.6186; Wan XC, 2010, ACTA BIOCH BIOPH SIN, V42, P351, DOI 10.1093/abbs/gmq029; Wen K, 2005, PHYTOPATHOLOGY, V95, P345, DOI 10.1094/PHYTO-95-0345; Yang HM, 2005, J INTEGR PLANT BIOL, V47, P1159, DOI 10.1111/j.1744-7909.2005.00146.x; Zhou Y, 2007, PLANT CELL ENVIRON, V30, P1566, DOI 10.1111/j.1365-3040.2007.01732.x	66	32	35	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90631	10.1371/journal.pone.0090631	http://dx.doi.org/10.1371/journal.pone.0090631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595059	Green Submitted, gold, Green Published			2022-12-27	WOS:000332475500077
J	Chong, YP; Park, KH; Kim, ES; Kim, MN; Kim, SH; Lee, SO; Choi, SH; Jeong, JY; Woo, JH; Kim, YS				Chong, Yong Pil; Park, Ki-Ho; Kim, Eun Sil; Kim, Mi-Na; Kim, Sung-Han; Lee, Sang-Oh; Choi, Sang-Ho; Jeong, Jin-Yong; Woo, Jun Hee; Kim, Yang Soo			Association of Mannose-Binding Lectin 2 Gene Polymorphisms with Persistent Staphylococcus aureus Bacteremia	PLOS ONE			English	Article							RISK-FACTORS; INFECTION; DEFICIENCY; OUTCOMES; PROTEIN; RESISTANCE; GENOTYPE; PROMOTER; IMMUNITY; LEVEL	Objectives: Mannose-binding lectin (MBL) is an important component of innate immunity. Structural and promoter polymorphisms in the MBL2 gene that are responsible for low MBL levels are associated with susceptibility to infectious diseases. The objective of this study was to investigate the association of serum MBL levels and MBL2 polymorphisms with persistent Staphylococcus aureus bacteremia (SAB) in adult Korean patients. Methods: We conducted a case-control study nested in a prospective cohort of patients with SAB. The study compared 41 patients with persistent bacteremia (>= 7 days) and 46 patients with resolving bacteremia (<3 days). In each subject, we genotyped six single-nucleotide polymorphisms in the promoter region (alleles H/L, X/Y, and P/Q) and exon 1 (alleles A/B, A/C, and A/D) of the MBL2 gene and measured serum MBL concentrations. We also compared MBL2 genotypes between SAB patients and healthy people. Results: Patients with persistent bacteremia were significantly more likely to have low/deficient MBL-producing genotypes and resultant low serum MBL levels, than were patients with resolving bacteremia (P = 0.019 and P = 0.012, respectively). Independent risk factors for persistent bacteremia were metastatic infection (adjusted odds ratio [aOR], 34.7; 95% confidence interval [CI], 12.83-196.37; P = 0.003), methicillin resistance (aOR, 4.10; 95% CI, 3.19-29.57; P = 0.025), and low/deficient MBL-producing genotypes (aOR, 7.64; 95% CI, 4.12-63.39; P = 0.003). Such genotypes were significantly more common in patients with persistent bacteremia than in healthy people (OR, 2.09; 95% CI, 1.03-4.26; P = 0.040). Conclusions: This is the first demonstration of an association of low MBL levels and MBL2 polymorphisms responsible for low or deficient MBL levels with persistent SAB. A combination of factors, including clinical and microbiological characteristics and host defense factors such as MBL levels, may together contribute to the development of persistent SAB.	[Chong, Yong Pil; Kim, Sung-Han; Lee, Sang-Oh; Choi, Sang-Ho; Woo, Jun Hee; Kim, Yang Soo] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea; [Kim, Mi-Na] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul, South Korea; [Park, Ki-Ho] Kyung Hee Univ, Sch Med, Kyung Hee Univ Hosp, Div Infect Dis,Dept Internal Med, Seoul, South Korea; [Chong, Yong Pil; Kim, Eun Sil; Jeong, Jin-Yong; Kim, Yang Soo] Univ Ulsan, Coll Med, Ctr Antimicrobial Resistance & Microbial Genet, Seoul, South Korea; [Jeong, Jin-Yong] Univ Ulsan, Coll Med, Asan Inst Life Sci, Asan Med Ctr, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Kyung Hee University; Kyung Hee University Hospital; University of Ulsan; University of Ulsan	Kim, YS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea.	yskim@amc.seoul.kr	Lee, Sang-Oh/AGV-5413-2022; Chong, Yong Pil/AAB-2623-2021	Lee, Sang-Oh/0000-0003-1381-8787; Choi, Sang-Ho/0000-0002-4972-4531	Korea Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea [A120964]	Korea Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea	This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea (grant number: A120964). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouwman LH, 2006, HUM IMMUNOL, V67, P247, DOI 10.1016/j.humimm.2006.02.030; Casanova JL, 2004, J EXP MED, V199, P1295, DOI 10.1084/jem.20040537; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chong YP, 2013, MEDICINE, V92, P98, DOI 10.1097/MD.0b013e318289ff1e; CHOW JW, 1991, ANN INTERN MED, V115, P585, DOI 10.7326/0003-4819-115-8-585; Fowler VG, 2004, J INFECT DIS, V190, P1140, DOI 10.1086/423145; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Gomi K, 2004, CHEST, V126, P95, DOI 10.1378/chest.126.1.95; Hawkins C, 2007, ARCH INTERN MED, V167, P1861, DOI 10.1001/archinte.167.17.1861; Huh JW, 2009, CRIT CARE, V13, DOI 10.1186/cc8157; Im CH, 2012, RHEUMATOL INT, V32, P2251, DOI 10.1007/s00296-011-1939-2; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Kars M, 2005, EUR J CLIN INVEST, V35, P531, DOI 10.1111/j.1365-2362.2005.01521.x; Khatib R, 2006, SCAND J INFECT DIS, V38, P7, DOI 10.1080/00365540500372846; Khatib R, 2009, SCAND J INFECT DIS, V41, P4, DOI 10.1080/00365540802441711; Kim J, 2009, CLIN EXP RHEUMATOL, V27, pS13; Kullar R, 2011, CLIN INFECT DIS, V52, P975, DOI 10.1093/cid/cir124; Lee SG, 2005, MOL IMMUNOL, V42, P969, DOI 10.1016/j.molimm.2004.09.036; Lin SH, 2010, J ANTIMICROB CHEMOTH, V65, P1792, DOI 10.1093/jac/dkq188; Lozano F, 2005, TISSUE ANTIGENS, V66, P131, DOI 10.1111/j.1399-0039.2005.00436.x; MADSEN HO, 1995, J IMMUNOL, V155, P3013; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Neth O, 2002, J IMMUNOL, V169, P4430, DOI 10.4049/jimmunol.169.8.4430; Ou XT, 2011, J INFECT DIS, V203, P1686, DOI 10.1093/infdis/jir152; Park SY, 2013, INFECTION, V41, P111, DOI 10.1007/s15010-012-0348-0; Seidl K, 2011, ANTIMICROB AGENTS CH, V55, P575, DOI 10.1128/AAC.01028-10; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; Smithson A, 2007, CLIN VACCINE IMMUNOL, V14, P256, DOI 10.1128/CVI.00400-06; Steffensen R, 2000, J IMMUNOL METHODS, V241, P33, DOI 10.1016/S0022-1759(00)00198-8; Takahashi K, 2005, CLIN INFECT DIS, V41, pS440, DOI 10.1086/431987; Takahashi K, 2005, INFECT IMMUN, V73, P8188, DOI 10.1128/IAI.73.12.8188-8193.2005; Ziegler C, 2011, EMBO MOL MED, V3, P652, DOI 10.1002/emmm.201100173	33	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89139	10.1371/journal.pone.0089139	http://dx.doi.org/10.1371/journal.pone.0089139			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595015	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500011
J	Fan, QH; Yu, R; Huang, WX; Cui, XX; Luo, BH; Zhang, LY				Fan, Qiu-Hong; Yu, Rong; Huang, Wei-Xian; Cui, Xi-Xi; Luo, Bing-Hui; Zhang, Li-Yuan			The has-miR-526b Binding-Site rs8506G > A Polymorphism in the lincRNA-NR_024015 Exon Identified by GWASs Predispose to Non-Cardia Gastric Cancer Risk	PLOS ONE			English	Article							LONG NONCODING RNAS; BREAST-CANCER; GENE; EPIDEMIOLOGY; ASSOCIATION; TRANSCRIPTS; METASTASIS; CARCINOMA; LINCRNAS; REVEALS	Gastric cancer including the cardia and non-cardia types is the second frequent cause of cancer-related deaths worldwide. A subset of non-cardia gastric cancer genetic susceptibility loci have been addressed among Asian through genome-wide association studies (GWASs). This study was to evaluate the effects of single nucleotide polymorphisms (SNPs) of long intergenic non-coding RNAs (lincRNAs) on non-cardia gastric cancer susceptibility in Chinese populations. We selected long intergenic noncoding RNAs (lincRNAs) located in non-cardia gastric cancer risk-related loci and identified 10 SNPs located within lincRNA exonic regions. We examined whether genetic polymorphisms in lincRNAs exons are associated with non-cardia gastric cancer risk in 438 non-cardia gastric cancer patients and 727 control subjects in Chinese populations using logistic regression. Functional relevance was further examined by biochemical assays. We found that lincRNA-NR_024015 rs8506AA carrier was significantly associated with risk of non-cardia gastric cancer (adjusted odds ratio [OR] = 1.56, 95% CI = 1.03-2.39, compared with the rs8506 AG or GG genotype. Further stratification analysis showed that the risk effect was more pronounced in subgroups of smokers (P = 0.001). Biochemical analysis demonstrated that the G to A base change at rs8506G>A disrupts the binding site for has-miR-526b, thereby influencing the transcriptional activity of lincRNA-NR_024015 and affecting cell proliferation. Our present study established a robust association between the rs8506G>A polymorphism in the lincRNA-NR_024015 exon and the risk of non-cardia gastric cancer.	[Fan, Qiu-Hong; Cui, Xi-Xi; Luo, Bing-Hui; Zhang, Li-Yuan] Soochow Univ, Affiliated Hosp 2, Dept Radiotherapy & Oncol, Suzhou, Peoples R China; [Yu, Rong] Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou Municipal Hosp, Dept Oncol, Suzhou, Peoples R China; [Huang, Wei-Xian] Wu Jiang First Peoples Hosp, Dept Gastrointestinal Surg, Suzhou, Peoples R China	Soochow University - China; Nanjing Medical University	Zhang, LY (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Radiotherapy & Oncol, Suzhou, Peoples R China.	zhangliyuan126@126.com		Zhang, Liyuan/0000-0002-7469-1743	Suzhou Social Development Fund Project, Jiangsu Province's Key Medical Department [SS08047]	Suzhou Social Development Fund Project, Jiangsu Province's Key Medical Department	This study was supported by the Suzhou Social Development Fund Project (SS08047), Jiangsu Province's Key Medical Department in 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung CC, 2011, HUM GENET, V130, P59, DOI 10.1007/s00439-011-1030-9; de Martel C, 2013, GASTROENTEROL CLIN N, V42, P219, DOI 10.1016/j.gtc.2013.01.003; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Jiang L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3225; Jiang L, 2011, BREAST CANCER RES TR, V126, P487, DOI 10.1007/s10549-010-1094-6; Jin GF, 2011, CARCINOGENESIS, V32, P1655, DOI 10.1093/carcin/bgr187; Kelley JR, 2003, J CLIN EPIDEMIOL, V56, P1, DOI 10.1016/S0895-4356(02)00534-6; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luo JH, 2006, HEPATOLOGY, V44, P1012, DOI 10.1002/hep.21328; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Milne AN, 2009, HUM GENET, V126, P615, DOI 10.1007/s00439-009-0722-x; Morrison LE, 2007, GENE CHROMOSOME CANC, V46, P397, DOI 10.1002/gcc.20419; Nupponen NN, 2001, CANCER METAST REV, V20, P155, DOI 10.1023/A:1015557308033; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Smedley D, 2000, GENE CHROMOSOME CANC, V28, P121, DOI 10.1002/(SICI)1098-2264(200005)28:1<121::AID-GCC14>3.0.CO;2-O; Song X, 2002, P NATL ACAD SCI USA, V99, P6269, DOI 10.1073/pnas.092112199; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Valenti V, 2011, J SURG ONCOL, V104, P124, DOI 10.1002/jso.21947; Wang F, 2008, FEBS LETT, V582, P1919, DOI 10.1016/j.febslet.2008.05.012; Wu H, 2013, CARCINOGENESIS; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zheng J, 2012, CARCINOGENESIS, V33, P2409, DOI 10.1093/carcin/bgs307; Zheng J, 2012, INT J CANCER, V130, P1981, DOI 10.1002/ijc.26253	39	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90008	10.1371/journal.pone.0090008	http://dx.doi.org/10.1371/journal.pone.0090008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595048	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500029
J	Hirayama, T; Asano, Y; Iida, H; Watanabe, T; Nakamura, T; Goitsuka, R				Hirayama, Takehiro; Asano, Yusuke; Iida, Hajime; Watanabe, Takeshi; Nakamura, Takuro; Goitsuka, Ryo			Meis1 Is Required for the Maintenance of Postnatal Thymic Epithelial Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; THYMOCYTE DEVELOPMENT; TRANSCRIPTION FACTORS; PROGENITOR CELLS; EXPRESSION; MOUSE; DIFFERENTIATION; PROLIFERATION; PROTEIN	Most epithelial tissues retain stem/progenitor cells to maintain homeostasis of the adult tissues; however, the existence of a thymic epithelial cell (TEC) progenitor capable of maintaining homeostasis of the postnatal thymus remains unclear. Here, we show that a cell population expressing high levels of Meis1, a homeodomain transcription factor, is enriched in TECs with an immature cellular phenotype. These TECs selectively express genes involved in embryonic thymic organogenesis and epithelial stem cell maintenance, and also have the potential to proliferate and differentiate into mature TEC populations. Furthermore, postnatal inactivation of Meis1 in TECs caused disorganization of the thymic architecture, which ultimately leads to premature disappearance of the thymus. There was an age-associated reduction in the proportion of the TEC population expressing high levels of Meis1, which may also be related to thymic involution. These findings indicate that Meis1 is potentially involved in the maintenance of postnatal TECs with progenitor activity that is required for homeostasis of the postnatal thymus.	[Hirayama, Takehiro; Asano, Yusuke; Iida, Hajime; Goitsuka, Ryo] Tokyo Univ Sci, Res Inst Biomed Sci, Div Dev & Aging, Chiba, Japan; [Watanabe, Takeshi] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan; [Nakamura, Takuro] Japanese Fdn Canc Res, Inst Canc, Dept Carcinogenesis, Tokyo 170, Japan	Tokyo University of Science; Kyoto University; Japanese Foundation for Cancer Research	Goitsuka, R (corresponding author), Tokyo Univ Sci, Res Inst Biomed Sci, Div Dev & Aging, Chiba, Japan.	ryogoi@rs.noda.tus.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [21380183, 23658246, 25111513]; Grants-in-Aid for Scientific Research [24111009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work has been supported by Grant-in-Aid for Scientific Research (21380183, 23658246, 25111513 to R. G.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson G, 2009, EUR J IMMUNOL, V39, P1694, DOI 10.1002/eji.200939379; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Baik S, 2013, EUR J IMMUNOL, V43, P589, DOI 10.1002/eji.201243209; Bessa J, 2008, DEVELOPMENT, V135, P799, DOI 10.1242/dev.011932; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Burnley P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.460; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Candi E, 2007, P NATL ACAD SCI USA, V104, P11999, DOI 10.1073/pnas.0703458104; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Griffith AV, 2009, IMMUNITY, V31, P999, DOI 10.1016/j.immuni.2009.09.024; Gui JG, 2007, INT IMMUNOL, V19, P1201, DOI 10.1093/intimm/dxm095; Heine P, 2008, DEVELOPMENT, V135, P805, DOI 10.1242/dev.012088; Heng TSP, 2005, J IMMUNOL, V175, P2982, DOI 10.4049/jimmunol.175.5.2982; Hetzer-Egger C, 2002, EUR J IMMUNOL, V32, P1175, DOI 10.1002/1521-4141(200204)32:4<1175::AID-IMMU1175>3.0.CO;2-U; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Hollander G, 2006, IMMUNOL REV, V209, P28, DOI 10.1111/j.0105-2896.2006.00357.x; Indra AK, 2000, HORM RES, V54, P296, DOI 10.1159/000053275; Janas ML, 2010, J EXP MED, V207, P247, DOI 10.1084/jem.20091430; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Liu B, 2013, DEVELOPMENT, V140, P780, DOI 10.1242/dev.085035; Maeda R, 2001, ONCOGENE, V20, P1329, DOI 10.1038/sj.onc.1204250; Manley NR, 2004, DEV BIOL, V276, P301, DOI 10.1016/j.ydbio.2004.08.030; Manley NR, 1998, DEV BIOL, V195, P1, DOI 10.1006/dbio.1997.8827; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Noro B, 2006, GENE DEV, V20, P1636, DOI 10.1101/gad.1412606; Nowell Craig S, 2007, Methods Mol Biol, V380, P125; Ohigashi I, 2013, P NATL ACAD SCI USA, V110, P9885, DOI 10.1073/pnas.1301799110; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Peterson P, 2013, EUR J IMMUNOL, V43, P580, DOI 10.1002/eji.201343323; Popa I, 2007, INT IMMUNOL, V19, P1249, DOI 10.1093/intimm/dxm092; Rossi SW, 2007, BLOOD, V109, P3803, DOI 10.1182/blood-2006-10-049767; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shitara S, 2013, J IMMUNOL, V190, P6173, DOI 10.4049/jimmunol.1202573; Suematsu S, 2004, NAT BIOTECHNOL, V22, P1539, DOI 10.1038/nbt1039; Swann JB, 2007, EUR J IMMUNOL, V37, P2364, DOI 10.1002/eji.200737709; Taub DD, 2005, IMMUNOL REV, V205, P72, DOI 10.1111/j.0105-2896.2005.00275.x; Torii MA, 1999, DEVELOPMENT, V126, P443; Tucker ES, 2010, DEVELOPMENT, V137, P2471, DOI 10.1242/dev.049718; Wallin J, 1996, DEVELOPMENT, V122, P23; Xu PX, 2002, DEVELOPMENT, V129, P3033; Yang SJ, 2006, INT IMMUNOL, V18, P729, DOI 10.1093/intimm/dxl010	49	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89885	10.1371/journal.pone.0089885	http://dx.doi.org/10.1371/journal.pone.0089885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594519	Green Submitted, Green Published, gold			2022-12-27	WOS:000332475500026
J	Ji, H; Gu, Q; Chen, LL; Xu, K; Ling, X; Bao, CJ; Tang, FY; Qi, X; Wu, YQ; Ai, J; Shen, GY; Dong, DJ; Yu, HY; Huang, M; Cao, Q; Xu, Y; Zhao, W; Xu, YT; Xia, Y; Chen, SH; Yang, GL; Gu, CL; Xie, GX; Zhu, YF; Zhu, FC; Zhou, MH				Ji, Hong; Gu, Qin; Chen, Li-ling; Xu, Ke; Ling, Xia; Bao, Chang-jun; Tang, Fen-yang; Qi, Xian; Wu, Ying-qiu; Ai, Jing; Shen, Gu-yu; Dong, Dan-jiang; Yu, Hui-yan; Huang, Mao; Cao, Quan; Xu, Ying; Zhao, Wei; Xu, Yang-ting; Xia, Yu; Chen, Shan-hui; Yang, Gen-lin; Gu, Cai-ling; Xie, Guo-xiang; Zhu, Ye-fei; Zhu, Feng-cai; Zhou, Ming-hao			Epidemiological and Clinical Characteristics and Risk Factors for Death of Patients with Avian Influenza A H7N9 Virus Infection from Jiangsu Province, Eastern China	PLOS ONE			English	Article							H5N1; HUMANS; IMMUNITY; ILLNESS	Background: A novel avian influenza A (H7N9) virus has caused great morbidity as well as mortality since its emergence in Eastern China in February 2013. However, the possible risk factors for death are not yet fully known. Methods and Findings: Patients with H7N9 virus infection between March 1 and August 14, 2013 in Jiangsu province were enrolled. Data were collected with a standard form. Mean or percentage was used to describe the features, and Fisher's exact test or t-test test was used to compare the differences between fatal and nonfatal cases with H7N9 virus infection. A total of 28 patients with H7N9 virus infection were identified among whom, nine (32.1%) died. The median age of fatal cases was significant higher than nonfatal cases (P<0.05). Patients with older age were more strongly associated with increased odds of death (OR = 30.0; 95% CI, 2.85-315.62). Co-morbidity with chronic lung disease and hypertension were risk factors for mortality (OR = 14.40; 95% CI, 1.30-159.52, OR = 6.67; 95% CI, 1.09-40.43, respectively). Moreover, the presence of either bilateral lung inflammation or pulmonary consolidation on chest imaging on admission was related with fatal outcome (OR = 7.00; 95% CI, 1.10-44.61). Finally, dynamic monitoring showed that lymphopenia was more significant in fatal group than in nonfatal group from day 11 to week five (P<0.05). The decrease in oxygenation indexes were observed in most cases and more significantly in fatal cases after week three (P<0.05), and the value of nearly all fatal cases were below 200 mmHg during our evaluation period. Conclusions: Among cases with H7N9 virus infection, increased age accompanied by co-morbidities was the risk of death. The severity of lung infection at admission, the persistence of lymphocytopenia, and the extended duration of lower oxygenation index all contributed to worsened outcomes of patients with H7N9 virus infection.	[Ji, Hong; Xu, Ke; Bao, Chang-jun; Tang, Fen-yang; Qi, Xian; Ai, Jing; Yu, Hui-yan; Zhu, Ye-fei] Jiangsu Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Gu, Qin; Dong, Dan-jiang] Nanjing Drum Tower Hosp, Dept Crit Care Med, Nanjing, Jiangsu, Peoples R China; [Chen, Li-ling; Xia, Yu] Suzhou Municipal Ctr Dis Control & Prevent, Suzhou, Jiangsu, Peoples R China; [Ling, Xia; Chen, Shan-hui] Wuxi Municipal Ctr Dis Control & Prevent, Wuxi, Jiangsu, Peoples R China; [Wu, Ying-qiu; Xu, Ying; Gu, Cai-ling] Soochow Univ, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China; [Shen, Gu-yu; Yang, Gen-lin] Nanjing Med Univ, Wuxi Peoples Hosp, Wuxi, Jiangsu, Peoples R China; [Huang, Mao; Cao, Quan] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Zhao, Wei] Second Hosp Nanjing, Nanjing, Jiangsu, Peoples R China; [Xu, Yang-ting; Xie, Guo-xiang] Nanjing Municipal Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Zhu, Feng-cai; Zhou, Ming-hao] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; Nanjing University; Soochow University - China; Jiangnan University; Nanjing Medical University; Nanjing Medical University; Jiangsu Provincial Center for Disease Control & Prevention	Bao, CJ (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.	bao2000_cn@163.com; zmh@jscdc.cn	zhou, minghao/GZA-7244-2022; Xie, Guoxiang/F-3022-2016	Xie, Guoxiang/0000-0002-0951-4150	Jiangsu Province Health Development Project with Science and Education [ZX201109, RC2011085]; Natural Science Foundation of China [81373055]; Jiangsu Province Science and Technology Support Program [BE2012769]; National Ministry of Science and Technology [KJYJ-2013-01-02]; 10th Summit of Six Top Talents of Jiangsu Province	Jiangsu Province Health Development Project with Science and Education; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Science and Technology Support Program; National Ministry of Science and Technology; 10th Summit of Six Top Talents of Jiangsu Province	This study was funded by Jiangsu Province Health Development Project with Science and Education (ZX201109 and RC2011085); Natural Science Foundation of China (No. 81373055); Jiangsu Province Science and Technology Support Program (social development: BE2012769); National Ministry of Science and Technology Emergency Research Project on human infection with avian influenza H7N9 virus (No. KJYJ-2013-01-02). M. H. Zhou and Y.F. Zhu are partly supported by Jiangsu Province Health Development Project with Science and Education (ZX201109 and RC2011085). C.J. Bao is partly supported by Natural Science Foundation of China (No. 81373055), Jiangsu Province Science and Technology Support Program (social development: BE2012769), and the 10th Summit of Six Top Talents of Jiangsu Province. F.Y. Tang is supported by National Ministry of Science and Technology Emergency Research Project on human infection with avian influenza H7N9 virus (No. KJYJ-2013-01-02). The contents of this article are solely the responsibility of the authors and do not necessarily represent the views of the Jiangsu Provincial Centers for Disease Control and Prevention or other organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Adisasmito W, 2010, J INFECT DIS, V202, P1154, DOI 10.1086/656316; Bermejo-Martin JF, 2013, J INFECT DEV COUNTR, V7, P497, DOI 10.3855/jidc.3810; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Commission CNHaFP, DIAGN TREATM PROT HU; Cowling BJ, 2013, EUROSURVEILLANCE, V18, P2; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guan Y, 2013, J INFECT DEV COUNTR, V7, P302, DOI 10.3855/jidc.3675; Hien ND, 2009, EMERG INFECT DIS, V15, P19, DOI 10.3201/eid1501.080073; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V309, P2086, DOI 10.1001/jama.2013.6086; Lee EH, 2010, CLIN INFECT DIS, V50, P1498, DOI 10.1086/652446; Liu S, 2013, J INFECT, DOI 10.1016; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Lu S, 2013, EMERG INFECT DIS, V19; Mei Z, 2013, EMERG INFECT DIS, V19, P1179, DOI 10.3201/eid1907.130523; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Nicoll A., 2008, EURO SURVEILL, V13; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Shinde V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014809; Smallman-Raynor M, 2007, EMERG INFECT DIS, V13, P510, DOI 10.3201/eid1303.060849; WHO/GIP, 2003, CUM NUMB CONF HUM CA; Wong SSY, 2006, CHEST, V129, P156, DOI 10.1378/chest.129.1.156; Wongsurakiat P, 2004, CHEST, V125, P2011, DOI 10.1378/chest.125.6.2011; World Health Organization, FREQ ASK QUEST HUM I; Wu H, 2013, N ENGL J MED; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985	32	30	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89581	10.1371/journal.pone.0089581	http://dx.doi.org/10.1371/journal.pone.0089581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595034	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500018
J	Poissonnier, L; Villain, G; Soncin, F; Mattot, V				Poissonnier, Loic; Villain, Gaelle; Soncin, Fabrice; Mattot, Virginie			Egfl7 Is Differentially Expressed in Arteries and Veins during Retinal Vascular Development	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; MICRORNA MIR-126; ANGIOGENESIS; INTEGRITY; MIGRATION; DEATH; GENE; VEGF; MICE; CNS	The vasculature of the central nervous system (CNS) is composed of vascular endothelial and mural cells which interact closely with glial cells and neurons. The development of the CNS vascularisation is a unique process which requires the contribution of specific regulators in addition to the classical angiogenic factors. The egfl7 gene is mainly detected in endothelial cells during physiological and pathological angiogenesis. Egfl7 codes for a secreted protein which predominantly accumulates into the extracellular space where it controls vascular elastin deposition or the Notch pathway. Egfl7 is the host gene of the microRNA miR126 which is also expressed in endothelial cells and which plays major functions during blood vessel development. While the expression of egfl7 and that of miR126 were well described in endothelial cells during development, their pattern of expression during the establishment of the CNS vasculature is still unknown. By analysing the expression of egfl7 and miR126 during mouse retina vascularisation, we observed that while expression of miR126 is detected in all endothelia, egfl7 is initially expressed in all endothelial cells and then is progressively restricted to veins and to their neighbouring capillaries. The recruitment of mural cells around retina arteries coincides with the down-regulation of egfl7 in the arterial endothelial cells, suggesting that this recruitment could be involved in the loss of egfl7 expression in arteries. However, the expression pattern of egfl7 is similar when mural cell recruitment is prevented by the injection of a PDGFR beta blocking antibody, suggesting that vessel maturation is not responsible for egfl7 down-regulation in retinal arteries.	[Poissonnier, Loic; Villain, Gaelle; Soncin, Fabrice; Mattot, Virginie] Univ Lille Nord France, CNRS, Inst Biol Lille, UMR8161, Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Mattot, V (corresponding author), Univ Lille Nord France, CNRS, Inst Biol Lille, UMR8161, Lille, France.	virginie.mattot@ibl.fr	SONCIN, Fabrice/A-1475-2009	SONCIN, Fabrice/0000-0001-6312-0673	Fondation pour la Recherche Medicale (FRM Regionale Comite Nord-Pas de Calais); Association pour la Recherche sur le Cancer (ARC) [5071]; Comite du Nord de la ligue Nationale contre le Cancer; Canceropole Nord-Ouest; ARC PhD student fellowship	Fondation pour la Recherche Medicale (FRM Regionale Comite Nord-Pas de Calais); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Comite du Nord de la ligue Nationale contre le Cancer; Canceropole Nord-Ouest; ARC PhD student fellowship	This work was supported by Fondation pour la Recherche Medicale (FRM Regionale Comite Nord-Pas de Calais 2009; VM), Association pour la Recherche sur le Cancer (ARC #5071; VM), Comite du Nord de la ligue Nationale contre le Cancer (VM) and Canceropole Nord-Ouest (VM). LP is supported by ARC PhD student fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiwala MV, 2010, CIRCULATION, V122, pS156, DOI 10.1161/CIRCULATIONAHA.109.927715; Bell ML, 2010, MOL CELL BIOL, V30, P1937, DOI 10.1128/MCB.01370-09; Claxton S, 2005, DEV DYNAM, V233, P822, DOI 10.1002/dvdy.20407; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Eichmann A, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006551; Fantin A, 2013, NAT PROTOC, V8, P418, DOI 10.1038/nprot.2013.015; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fitch MJ, 2004, DEV DYNAM, V230, P316, DOI 10.1002/dvdy.20063; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lelievre E, 2008, EMBO J, V27, P1658, DOI 10.1038/emboj.2008.103; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Nichol D, 2010, BLOOD, V116, P6133, DOI 10.1182/blood-2010-03-274860; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Ruhrberg C, 2013, CELL MOL LIFE SCI, V70, P1675, DOI 10.1007/s00018-013-1277-5; Schmidt M, 2007, DEVELOPMENT, V134, P2913, DOI 10.1242/dev.002576; Schmidt MHH, 2009, NAT CELL BIOL, V11, P873, DOI 10.1038/ncb1896; Soncin F, 2003, EMBO J, V22, P5700, DOI 10.1093/emboj/cdg549; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Tam SJ, 2012, DEV CELL, V22, P403, DOI 10.1016/j.devcel.2011.11.018; Uemura A, 2002, J CLIN INVEST, V110, P1619, DOI 10.1172/JCI200215621; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wong Andrew D, 2013, Front Neuroeng, V6, P7, DOI 10.3389/fneng.2013.00007; Xu D, 2008, AM J PHYSIOL-LUNG C, V294, pL17, DOI 10.1152/ajplung.00178.2007	29	8	8	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90455	10.1371/journal.pone.0090455	http://dx.doi.org/10.1371/journal.pone.0090455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595089	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500052
J	Wang, CH; Chang, RW; Ko, YH; Tsai, PR; Wang, SS; Chen, YS; Ko, WJ; Chang, CY; Young, TH; Chang, KC				Wang, Chih-Hsien; Chang, Ru-Wen; Ko, Ya-Hui; Tsai, Pi-Ru; Wang, Shoei-Shen; Chen, Yih-Sharng; Ko, Wen-Je; Chang, Chun-Yi; Young, Tai-Horng; Chang, Kuo-Chu			Prevention of Arterial Stiffening by Using Low-Dose Atorvastatin in Diabetes Is Associated with Decreased Malondialdehyde	PLOS ONE			English	Article							LIPID-DERIVED MALONDIALDEHYDE; PLACEBO-CONTROLLED TRIAL; OXIDATIVE STRESS; VASCULAR COMPLICATIONS; END-PRODUCTS; NITRIC-OXIDE; FATTY-ACIDS; TIME DOMAIN; MELLITUS; SYSTEM	Introduction: Without affecting the lipid profile, a low-dose treatment with atorvastatin contributes to the reduction of oxidative stress, inflammation, and adverse cardiovascular events in diabetes. In this study, we investigated whether low-dose atorvastatin exerts any beneficial effect on vascular dynamics in streptozotocin (STZ)-induced diabetes in male Wistar rats. Methods: Diabetes was induced using a single tail-vein injection of STZ at 55 mg kg(-1). The diabetic rats were treated daily with atorvastatin (10 mg kg(-1) by oral gavage) for 6 weeks. They were also compared with untreated age-matched diabetic controls. Arterial wave reflection was derived using the impulse response function of the filtered aortic input impedance spectra. A thiobarbituric acid reactive substances measurement was used to estimate the malondialdehyde content. Results: The high plasma level of total cholesterol in the diabetic rats did not change in response to this low-dose treatment with atorvastatin. Atorvastatin resulted in a significant increase of 15.4% in wave transit time and a decrease of 33.5% in wave reflection factor, suggesting that atorvastatin may attenuate the diabetes-induced deterioration in systolic loads imposed on the heart. This was in parallel with its lowering of malondialdehyde content in plasma and aortic walls in diabetes. Atorvastatin therapy also prevented the diabetes-related cardiac hypertrophy, as evidenced by the diminished ratio of left ventricular weight to body weight. Conclusion: These findings indicate that low-dose atorvastatin might protect diabetic vasculature against diabetes-associated deterioration in aorta stiffness and cardiac hypertrophy, possibly through its decrease of lipid oxidation-derived malondialdehyde.	[Wang, Chih-Hsien; Wang, Shoei-Shen; Chen, Yih-Sharng] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Wang, Chih-Hsien] Natl Taiwan Univ Hosp, Dept Surg, Hsin Chu Branch, Hsinchu, Taiwan; [Chang, Ru-Wen; Tsai, Pi-Ru; Ko, Wen-Je] Natl Taiwan Univ Hosp, Dept Surg & Traumatol, Taipei, Taiwan; [Wang, Chih-Hsien; Ko, Ya-Hui; Chang, Kuo-Chu] Natl Taiwan Univ, Dept Physiol, Coll Med, Taipei 10764, Taiwan; [Chang, Chun-Yi] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Young, Tai-Horng] Natl Taiwan Univ, Inst Biomed Engn, Coll Med & Engn, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chang, KC (corresponding author), Natl Taiwan Univ, Dept Physiol, Coll Med, Taipei 10764, Taiwan.	kcchang1008@ntu.edu.tw		WANG, CHIH-HSIEN/0000-0003-3214-6867; CHANG, KUO-CHU/0000-0002-4421-5711; Chen, Yih-Sharng/0000-0003-3846-8162; Wang, Shoei-Shen/0000-0003-3201-4143	National Science Council of Taiwan [NSC 101-2320-B-002-021-MY2]; National Taiwan University Hospital, Hsin-Chu Branch [HCH-101-19]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital, Hsin-Chu Branch	This study was supported by grants from the National Science Council of Taiwan (NSC 101-2320-B-002-021-MY2) and National Taiwan University Hospital, Hsin-Chu Branch (HCH-101-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 2003, J HYPERTENS, V21, P3, DOI 10.1097/00004872-200301000-00002; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; BEUGE JA, 1978, METHOD ENZYMOL, V52, P302; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chang KC, 2003, EXP BIOL MED, V228, P70, DOI 10.1177/153537020322800110; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2003, LANCET, V361, P2005; COX RH, 1974, J APPL PHYSIOL, V36, P381, DOI 10.1152/jappl.1974.36.3.381; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Guyton AC, 1992, HUMAN PHYSL MECH DIS, P115; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; JAUHIAINEN M, 1986, J BIOL CHEM, V261, P7032; Jinnouchi Y, 2006, CLIN EXP MED, V6, P191, DOI 10.1007/s10238-006-0115-6; Laufs U, 2003, EUR J CLIN PHARMACOL, V58, P719, DOI 10.1007/s00228-002-0556-0; LAXMINARAYAN S, 1978, IEEE T BIO-MED ENG, V25, P177, DOI 10.1109/TBME.1978.326244; Liu A, 1986, AM J PHYSIOL, V251, pH588; Lykkesfeldt J, 2007, CLIN CHIM ACTA, V380, P50, DOI 10.1016/j.cca.2007.01.028; Milnor W.R., 1989, HEMODYNAMICS, V2nd Edn; MITCHELL GF, 1994, AM J PHYSIOL-HEART C, V267, pH1907, DOI 10.1152/ajpheart.1994.267.5.H1907; Nichols W., 2005, MCDONALDS BLOOD FLOW, V5th; OKABE H, 1980, CLIN CHEM, V26, P1540; Oram JF, 2004, FRONT BIOSCI-LANDMRK, V9, P1240, DOI 10.2741/1300; Pieper GM, 1999, DIABETOLOGIA, V42, P204, DOI 10.1007/s001250051140; Riad A, 2007, EUR J PHARMACOL, V569, P204, DOI 10.1016/j.ejphar.2007.04.065; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Shanmugam N, 2008, DIABETES, V57, P879, DOI 10.2337/db07-1204; SIPKEMA P, 1980, CARDIOVASC RES, V14, P270, DOI 10.1093/cvr/14.5.270; Slatter DA, 1999, J BIOL CHEM, V274, P19661, DOI 10.1074/jbc.274.28.19661; Slatter DA, 2000, DIABETOLOGIA, V43, P550, DOI 10.1007/s001250051342; TOMLINSON KC, 1992, PHARMACOL REV, V44, P103; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; WESTERHOF N, 1972, CARDIOVASC RES, V6, P648, DOI 10.1093/cvr/6.6.648; Williamson JR, 1989, DIABETES MELLITUS PA, P142; Yamagishi S, 2006, CURR PHARM DESIGN, V12, P1549, DOI 10.2174/138161206776389796; ZATZ R, 1986, AM J MED, V80, P443, DOI 10.1016/0002-9343(86)90719-9	38	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90471	10.1371/journal.pone.0090471	http://dx.doi.org/10.1371/journal.pone.0090471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595201	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500054
J	Deetman, PE; Bakker, SJL; Kwakernaak, AJ; Navis, G; Dullaart, RPF				Deetman, Petronella E.; Bakker, Stephan J. L.; Kwakernaak, Arjan J.; Navis, Gerjan; Dullaart, Robin P. F.		PREVEND Study Grp	The Relationship of the Anti-Oxidant Bilirubin with Free Thyroxine Is Modified by Insulin Resistance in Euthyroid Subjects	PLOS ONE			English	Article							SERUM BILIRUBIN; METABOLIC SYNDROME; THYROID-HORMONE; HEPATIC TRANSPORT; HEME OXYGENASE-1; RISK; ASSOCIATION; FAILURE; PATHWAY; GLUCOSE	Background: The strong anti-oxidative properties of bilirubin largely explain its cardioprotective effects. Insulin resistance is featured by low circulating bilirubin. Thyroid hormone affects both bilirubin generation and its biliary transport, but it is unknown whether circulating bilirubin is associated with thyroid function in euthyroid subjects. Aim is to determine relationships of bilirubin with TSH, free T-4 and free T-3 in euthyroid subjects without type 2 diabetes mellitus (T2DM), and to assess whether such a relationship would be modified by the degree of insulin resistance. Methods: Total bilirubin, TSH, free T-4, free T-3, glucose, insulin, lipids and transaminases were measured in 1854 fasting euthyroid subjects without T2DM, recruited from the general population (PREVEND cohort). Insulin resistance was assessed by homeostasis model assessment. Results: Bilirubin was positively related to free T-4 (beta = 0.116, P<0.001) and free T-3 (beta = 0.078, P = 0.001), but bilirubin was unrelated to TSH. The relationship of bilirubin with free T-4 was modified by insulin resistance with a larger effect in more insulin resistant individuals (adjusted for age and sex: beta = 0.043, P = 0.056 for interaction; additionally adjusted for smoking, alcohol intake, transaminases and total cholesterol (beta = 0.044, P = 0.044 for interaction). The association of bilirubin with free T-4 was also modified by high density lipoprotein cholesterol (age- and sex-adjusted: beta = 0.040, P = 0.072). Conclusions: Low bilirubin relates to low free T-4 in euthyroid non-diabetic subjects. Low normal free T-4 may particularly confer low bilirubin in more insulin resistant individuals.	[Deetman, Petronella E.; Bakker, Stephan J. L.; Kwakernaak, Arjan J.; Navis, Gerjan; Dullaart, Robin P. F.; PREVEND Study Grp] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9700 AB Groningen, Netherlands	University of Groningen	Deetman, PE (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9700 AB Groningen, Netherlands.	p.e.deetman@umcg.nl	de Zeeuw, Dick/E-9080-2014; Bakker, Stephan J. L./J-4023-2015	de Zeeuw, Dick/0000-0003-3434-7777; Bakker, Stephan J. L./0000-0003-3356-6791; Stolk, Ronald/0000-0002-0518-1205; Wolffenbuttel, Bruce H.R./0000-0001-9262-6921	Dutch Kidney Foundation [E.033]; Dade Behring; Ausam; Roche; Abbott; Dutch Heart Foundation [2001-005]	Dutch Kidney Foundation; Dade Behring; Ausam; Roche(Roche Holding); Abbott(Abbott Laboratories); Dutch Heart Foundation(Netherlands Heart Foundation)	The Dutch Kidney Foundation supported the infrastructure of the PREVEND program from 1997 to 2003 (Grant E.033). The University Medical Center Groningen supported the infrastructure from 2003 to 2006. Dade Behring, Ausam, Roche, and Abbott financed laboratory equipment and reagents by which various laboratory determinations could be performed. The Dutch Heart Foundation supported studies on lipid metabolism (Grant 2001-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggeli IK, 2011, ENDOCRINOLOGY, V152, P1274, DOI 10.1210/en.2010-1319; Ajja R, 2011, AM J CARDIOL, V108, P1438, DOI 10.1016/j.amjcard.2011.06.067; Bao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012371; Chan KH, 2013, DIABETOLOGIA, V56, P724, DOI 10.1007/s00125-012-2818-4; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Deetman PE, 2013, THYROID IN PRESS; Deetman PE, 2012, TRANSPL INT, V25, P876, DOI 10.1111/j.1432-2277.2012.01515.x; Dullaart RPF, 2012, CLIN CHIM ACTA, V414, P161, DOI 10.1016/j.cca.2012.08.029; Duntas LH, 2002, THYROID, V12, P287, DOI 10.1089/10507250252949405; Ferder L, 2006, CURR HYPERTENS REP, V8, P191, DOI 10.1007/s11906-006-0050-7; GARTNER LM, 1972, AM J PHYSIOL, V222, P1091, DOI 10.1152/ajplegacy.1972.222.5.1091; Harrison EM, 2006, FEBS J, V273, P2345, DOI 10.1111/j.1742-4658.2006.05224.x; Heima NE, 2013, EUR J ENDOCRINOL, V168, P59, DOI 10.1530/EJE-12-0375; Hillege HL, 2001, J INTERN MED, V249, P519, DOI 10.1046/j.1365-2796.2001.00833.x; Katsiki N, 2013, DIABETOLOGIA, V56, P683, DOI 10.1007/s00125-013-2840-1; Kraemer HC, 2004, INT J METH PSYCH RES, V13, P141, DOI 10.1002/mpr.170; Li F, 2011, MOL CELL ENDOCRINOL, V339, P54, DOI 10.1016/j.mce.2011.03.019; Lu M, 2005, J NEUROSCI METH, V143, P209, DOI 10.1016/j.jneumeth.2004.10.002; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Muscogiuri G, 2008, CURR VASC PHARMACOL, V6, P301, DOI 10.2174/157016108785909715; Novotny L, 2003, EXP BIOL MED, V228, P568, DOI 10.1177/15353702-0322805-29; Oda E, 2013, ACTA DIABETOL, V50, P417, DOI 10.1007/s00592-012-0447-5; Ong KL, 2011, ATHEROSCLEROSIS, V219, P728, DOI 10.1016/j.atherosclerosis.2011.07.094; Pinto-Sietsma SJ, 2000, J AM SOC NEPHROL, V11, P1882, DOI 10.1681/ASN.V11101882; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Roos A, 2007, J CLIN ENDOCR METAB, V92, P491, DOI 10.1210/jc.2006-1718; Selvin S., 1996, STAT ANAL EPIDEMIOLO; Shieh G, 2011, BRIT J MATH STAT PSY, V64, P462, DOI 10.1111/j.2044-8317.2010.02002.x; SMITH TJ, 1991, BIOCHIM BIOPHYS ACTA, V1075, P119, DOI 10.1016/0304-4165(91)90240-H; TISDALE WA, 1959, AM J MED, V26, P214, DOI 10.1016/0002-9343(59)90310-9; Triolo M, 2013, CLIN ENDOCRINOL, V79, P416, DOI 10.1111/cen.12138; TUNON MJ, 1991, J HEPATOL, V13, P71, DOI 10.1016/0168-8278(91)90866-A; VANSTEENBERGEN W, 1989, HEPATOLOGY, V9, P314, DOI 10.1002/hep.1840090225; Varin R, 2000, CIRCULATION, V102, P351; Vitek L, 2007, ADV CLIN CHEM, V43, P1, DOI 10.1016/S0065-2423(06)43001-8; Vitek L, 2006, CEREBROVASC DIS, V21, P408, DOI 10.1159/000091966; Vitek L, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00055; Wassen FWJS, 2000, J ENDOCRINOL, V165, P599, DOI 10.1677/joe.0.1650599; Zelle DM, 2011, KIDNEY INT, V79, P686, DOI 10.1038/ki.2010.503	41	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90886	10.1371/journal.pone.0090886	http://dx.doi.org/10.1371/journal.pone.0090886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595410	gold, Green Published, Green Submitted			2022-12-27	WOS:000332468900154
J	Hashimoto, DT; Senhorini, JA; Foresti, F; Martinez, P; Porto-Foresti, F				Hashimoto, Diogo Teruo; Senhorini, Jose Augusto; Foresti, Fausto; Martinez, Paulino; Porto-Foresti, Fabio			Genetic Identification of F1 and Post-F1 Serrasalmid Juvenile Hybrids in Brazilian Aquaculture	PLOS ONE			English	Article							LEPORINUS-MACROCEPHALUS; CLARIAS-MACROCEPHALUS; FISH HYBRIDS; DIPLOID EGGS; CUTTHROAT; MARKERS; HYBRIDIZATION; MANAGEMENT; CATFISH; INTROGRESSION	Juvenile fish trade monitoring is an important task on Brazilian fish farms. However, the identification of juvenile fish through morphological analysis is not feasible, particularly between interspecific hybrids and pure species individuals, making the monitoring of these individuals difficult. Hybrids can be erroneously identified as pure species in breeding facilities, which might reduce production on farms and negatively affect native populations due to escapes or stocking practices. In the present study, we used a multi-approach analysis (molecular and cytogenetic markers) to identify juveniles of three serrasalmid species (Colossoma macropomum, Piaractus mesopotamicus and Piaractus brachypomus) and their hybrids in different stocks purchased from three seed producers in Brazil. The main findings of this study were the detection of intergenus backcrossing between the hybrid female patinga (P. mesopotamicus x P. brachypomus) x C. macropomum and the occurrence of one hybrid triploid individual. This atypical specimen might result from automixis, a mechanism that produces unreduced gametes in some organisms. Moreover, molecular identification indicated that hybrid individuals are traded as pure species or other types of interspecific hybrids, particularly post-F1 individuals. These results show that serrasalmid fish genomes exhibit high genetic heterogeneity, and multi-approach methods and regulators could improve the surveillance of the production and trade of fish species and their hybrids, thereby facilitating the sustainable development of fish farming.	[Hashimoto, Diogo Teruo] Univ Estadual Paulista, UNESP, Ctr Aquicultura, Jaboticabal, SP, Brazil; [Senhorini, Jose Augusto] Inst Chico Mendes Conservacao Biodiversidade, Ctr Pesquisa & Gestao Recursos Pesqueiros Contine, Pirassununga, SP, Brazil; [Foresti, Fausto] Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Morfol, Botucatu, SP, Brazil; [Martinez, Paulino] Univ Santiago de Compostela, Fac Vet, Dept Genet, Lugo, Spain; [Porto-Foresti, Fabio] Univ Estadual Paulista, UNESP, Fac Ciencias, Dept Ciencias Biol, Bauru, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Santiago de Compostela; Universidade Estadual Paulista	Hashimoto, DT (corresponding author), Univ Estadual Paulista, UNESP, Ctr Aquicultura, Campus Jaboticabal, Jaboticabal, SP, Brazil.	diogo@caunesp.unesp.br	Hashimoto, Diogo Teruo/A-4377-2013; Porto-Foresti, Fabio/AAC-4797-2020; Gómez, ACUIGEN/ABD-5337-2020; Augusto, José Senhorini/S-2419-2016; Martínez, Paulino/K-8636-2014; Hashimoto, Diogo Teruo/AAP-7423-2020; Calado, Leonardo/H-1346-2016	Porto-Foresti, Fabio/0000-0001-8845-3845; Augusto, José Senhorini/0000-0002-5120-448X; Martínez, Paulino/0000-0001-8438-9305; Hashimoto, Diogo Teruo/0000-0002-8808-2498; Calado, Leonardo/0000-0003-2328-5267	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [481823/2011-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq number 481823/2011-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Almeida-Toledo L.F., 1996, Boletim Tecnico do CEPTA, V9, P31; Almeida-Toledo LF, 1987, SELECTION HYBRIDIZAT, V1; Amish SJ, 2012, MOL ECOL RESOUR, V12, P653, DOI 10.1111/j.1755-0998.2012.03157.x; Angienda PO, 2011, CONSERV GENET, V12, P243, DOI 10.1007/s10592-010-0136-2; Arai K, 2013, CYTOGENET GENOME RES, V140, P226, DOI 10.1159/000353301; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; BARTLEY DM, 1991, COPEIA, P854, DOI 10.2307/1446416; Bartley DM, 2000, REV FISH BIOL FISHER, V10, P325, DOI 10.1023/A:1016691725361; Boecklen WJ, 1997, ECOLOGY, V78, P2611, DOI 10.1890/0012-9658(1997)078[2611:GAOHZN]2.0.CO;2; Calcagnotto D, 1999, AQUACULTURE, V174, P51, DOI 10.1016/S0044-8486(99)00005-8; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; do Prado FD, 2012, FISH RES, V125, P300, DOI 10.1016/j.fishres.2012.02.030; do Prado FD, 2011, AQUAC RES, V42, P1890, DOI 10.1111/j.1365-2109.2010.02777.x; Docker MF, 2003, MOL ECOL, V12, P3515, DOI 10.1046/j.1365-294X.2003.02000.x; Flores Nava A., 2007, FAO Fisheries Technical Paper, P91; Food and Agriculture Organization, 2010, The State of World Fisheries and Aquaculture, 2010; FORESTI F, 1981, CYTOGENET CELL GENET, V31, P137, DOI 10.1159/000131639; Godinho H. P., 2007, Revista Brasileira de Reproducao Animal, V31, P351; Gomelsky B, 2003, AQUAT LIVING RESOUR, V16, P408, DOI 10.1016/S0990-7440(03)00085-8; Gomes F, 2012, AN ACAD BRAS CIENC, V84, P89; Gomes L. C., 2010, ESPECIES NATIVAS PIS, P175; Hallerman E., 2008, FAO Fisheries and Aquaculture Technical Paper, P47; Hashimoto DT, 2011, CYTOGENET GENOME RES, V134, P64, DOI 10.1159/000323512; Hashimoto DT, 2009, CYTOGENET GENOME RES, V124, P151, DOI 10.1159/000207523; Hashimoto DT, 2012, REV AQUACULT, V4, P108, DOI 10.1111/j.1753-5131.2012.01067.x; Hashimoto DT, 2013, AQUAC RES, V44, P876, DOI 10.1111/j.1365-2109.2012.03092.x; Hashimoto DT, 2011, AQUACULTURE, V321, P49, DOI 10.1016/j.aquaculture.2011.08.018; Hashimoto DT, 2010, AQUACULTURE, V298, P346, DOI 10.1016/j.aquaculture.2009.11.015; Hashimoto DT, 2009, GENETICA, V137, P135, DOI 10.1007/s10709-009-9366-y; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Hu HongLang, 2007, FAO Fisheries Technical Paper, P185; IBAMA, 2007, EST PESC 2007 BRAS G; Itono M, 2007, J EXP ZOOL PART A, V307A, P35, DOI 10.1002/jez.a.344; Lamatsch DK, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P399, DOI 10.1007/978-90-481-2770-2_19; Lampert KP, 2007, CURR BIOL, V17, P1948, DOI 10.1016/j.cub.2007.09.064; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Mair GC, 2007, ENV RISK ASSESS GENE, V3, P209, DOI 10.1079/9781845932961.0209; Mair GC, 2007, ASSESSMENT FRESHWATE, P519; Martino G, 2002, CIVA 2002 COMUNICACI, P688; Martins C., 2004, FOCUS GENOME RES, P289; Mia MY, 2005, AQUACULTURE, V247, P267, DOI 10.1016/j.aquaculture.2005.02.018; Na-Nakorn U, 2004, AQUACULTURE, V240, P145, DOI 10.1016/j.aquaculture.2004.08.001; Nirchio M, 2003, CARYOLOGIA, V56, P405, DOI 10.1080/00087114.2003.10589351; Orsi ML, 1999, REV BRAS ZOOL, V16, P557; Paiva MP, 2002, REPRESAS PEIXES NATI; PENDAS AM, 1994, CYTOGENET CELL GENET, V67, P31, DOI 10.1159/000133792; Porto-Foresti F, 2013, J APPL ICHTHYOL, V29, P643, DOI 10.1111/jai.12092; Porto-Foresti F, 2008, GENET MOL BIOL, V31, P195, DOI 10.1590/S1415-47572008000200005; Pullin RSV, 1988, INT CTR LIV AQ RES M; Senanan W, 2004, AQUACULTURE, V235, P167, DOI 10.1016/j.aquaculture.2003.08.020; Shimizu Y, 2000, ZOOL SCI, V17, P951, DOI 10.2108/zsj.17.951; Suplicy F. M., 2007, FAO Fisheries Technical Paper, P129; Toledo-Filho SA, 1994, CADERNOS ICTIOGENETI, V2; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/nmeth.2023, 10.1038/NMETH.2023]; Yang F, 1999, GENOMICS, V62, P189, DOI 10.1006/geno.1999.5989; Young WP, 2001, MOL ECOL, V10, P921, DOI 10.1046/j.1365-294X.2001.01247.x	57	29	30	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89902	10.1371/journal.pone.0089902	http://dx.doi.org/10.1371/journal.pone.0089902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594674	gold, Green Published, Green Submitted			2022-12-27	WOS:000332468900044
J	Wilding, C; Bell, K; Beck, S; Funke, S; Pfeiffer, N; Grus, FH				Wilding, Corina; Bell, Katharina; Beck, Sabine; Funke, Sebastian; Pfeiffer, Norbert; Grus, Franz H.			gamma-Synuclein Antibodies Have Neuroprotective Potential on Neuroretinal Cells via Proteins of the Mitochondrial Apoptosis Pathway	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; ALPHA-SYNUCLEIN; OPTIC-NERVE; MEDIATED ENDOCYTOSIS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; MYASTHENIA-GRAVIS; GLAUCOMA PATIENTS; MEDICAL PROGRESS; LEWY BODIES	The family of synuclein proteins (alpha, beta and gamma) are related to neurodegenerative disease e.g. Parkinson disease and Morbus Alzheimer. Additionally, a connection between gamma-synuclein and glaucoma, a neurodegenerative disease characterized by a progressive loss of retinal ganglion cells, which finally leads to blindness, exists. The reason for the development of glaucoma is still unknown. Recent studies evaluating the participation of immunological components, demonstrate complex changed antibody reactivities in glaucoma patients in comparison to healthy people, showing not only upregulations (e.g. alpha-fodrin antibody) but also down-regulations (e.g. gamma-synuclein antibody) of antibodies in glaucoma patients. Up-regulated antibodies could be auto-aggressive, but the role of down-regulated antibodies is still unclear. Previous studies show a significant influence of the serum and the antibodies of glaucoma patients on protein expression profiles of neuroretinal cells. The aim of this study was to investigate the effect of gamma-synuclein antibody on the viability and reactive oxygen species levels of a neuroretinal cell line (RGC-5) as well as their interaction with cellular proteins. We found a protective effect of gamma-synuclein antibody resulting in an increased viability (up to 15%) and decreased reactive oxygen species levels (up to -12%) of glutamate and oxidative stressed RGC-5. These can be traced back to anti-apoptotic altered protein expressions in the mitochondrial apoptosis pathway indicated by mass spectrometry and validated by microarray analysis such as active caspase 3, bcl-2 associated-x-protein, S100A4, voltage-dependent anion channel, extracellular-signal-regulated-kinase (down-regulated) and baculoviral IAP repeat-containing protein 6, phosphorylated extracellular-signal-regulated-kinase (up-regulated). These changed protein expression are triggered by the gamma-synuclein antibody internalization of RGC-5 we could see in immunohistochemical stainings. These findings let us assume a novel physiological function of gamma-synuclein antibodies and give insights in the role of autoantibodies in glaucoma. We hypothesize that the down-regulation of autoantibodies found in glaucoma patients lead to a loss of protective autoimmunity.	[Wilding, Corina; Bell, Katharina; Beck, Sabine; Funke, Sebastian; Pfeiffer, Norbert; Grus, Franz H.] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Grus, FH (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany.	grus@eye-research.org	Bell, Katharina/T-5802-2019; Pfeiffer, Norbert/AAO-7586-2020		Forschungsschwerpunkt Translationale Neurowissenschaften Mainz	Forschungsschwerpunkt Translationale Neurowissenschaften Mainz	Forschungsschwerpunkt Translationale Neurowissenschaften Mainz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamus G, 1998, J AUTOIMMUN, V11, P523, DOI 10.1006/jaut.1998.0221; ALARCONSEGOVIA D, 1978, NATURE, V271, P67, DOI 10.1038/271067a0; Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018; Bell K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046910; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Charest-Morin X, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00122; Congdon EE, 2013, J BIOL CHEM, V288, P35452, DOI 10.1074/jbc.M113.491001; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Dodel R, 2011, J NEUROSCI, V31, P5847, DOI 10.1523/JNEUROSCI.4401-10.2011; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; Du Y, 2001, NEUROLOGY, V57, P801, DOI 10.1212/WNL.57.5.801; Fewou SN, 2012, J CLIN INVEST, V122, P1037, DOI 10.1172/JCI59110; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; FUKUOKA SI, 1991, NUCLEIC ACIDS RES, V19, P6961, DOI 10.1093/nar/19.24.6961; GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0; GRAUS YMF, 1993, IMMUNOL RES, V12, P78, DOI 10.1007/BF02918370; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Grus FH, 2006, INVEST OPHTH VIS SCI, V47, P968, DOI 10.1167/iovs.05-0685; Gutteridge Ian F, 2000, Clin Exp Optom, V83, P161; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Iglesias-Bartolome R, 2009, BBA-BIOMEMBRANES, V1788, P2526, DOI 10.1016/j.bbamem.2009.09.018; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Ji JZ, 2005, VISION RES, V45, P169, DOI 10.1016/j.visres.2004.08.008; Joachim SC, 2008, GRAEF ARCH CLIN EXP, V246, P573, DOI 10.1007/s00417-007-0737-8; Joachim SC, 2007, CURR EYE RES, V32, P501, DOI 10.1080/02713680701375183; Klettner AK, 2009, GRAEF ARCH CLIN EXP, V247, P1601, DOI 10.1007/s00417-009-1136-0; Kohler H, 2003, SCAND J IMMUNOL, V58, P285, DOI 10.1046/j.1365-3083.2003.01314.x; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Kuida K, 2000, INT J BIOCHEM CELL B, V32, P121, DOI 10.1016/S1357-2725(99)00024-2; Kumarswamy R, 2009, MITOCHONDRION, V9, P1, DOI 10.1016/j.mito.2008.10.003; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Maurage CA, 2003, ANN NEUROL, V54, P542, DOI 10.1002/ana.10730; MCINTOSH LP, 1985, BIOCHEMISTRY-US, V24, P4806, DOI 10.1021/bi00339a014; Ninkina N, 2003, MOL CELL BIOL, V23, P8233, DOI 10.1128/MCB.23.22.8233-8245.2003; Ninkina N, 2009, HUM MOL GENET, V18, P1779, DOI 10.1093/hmg/ddp090; Papachroni KK, 2007, J NEUROCHEM, V101, P749, DOI 10.1111/j.1471-4159.2006.04365.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; Saha AR, 2000, EUR J NEUROSCI, V12, P3073, DOI 10.1046/j.1460-9568.2000.00210.x; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Surgucheva I, 2002, J NEUROSCI RES, V68, P97, DOI 10.1002/jnr.10198; Surgucheva I, 2008, J MOL NEUROSCI, V35, P267, DOI 10.1007/s12031-008-9074-6; Surgucheva I, 2008, J BIOL CHEM, V283, P36377, DOI 10.1074/jbc.M806660200; Surgucheva I, 2008, MOL VIS, V14, P1540; Surguchov A, 2001, J NEUROSCI RES, V65, P68, DOI 10.1002/jnr.1129; Surguchov A, 2001, CELL MOTIL CYTOSKEL, V49, P218, DOI 10.1002/cm.1035; Tajeddine N, 2008, ONCOGENE, V27, P4221, DOI 10.1038/onc.2008.63; Tezel G, 2000, J NEUROSCI, V20, P3552, DOI 10.1523/JNEUROSCI.20-10-03552.2000; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; WAX MB, 1994, AM J OPHTHALMOL, V117, P561, DOI 10.1016/S0002-9394(14)70059-5; Yanase K, 1997, J CLIN INVEST, V100, P25, DOI 10.1172/JCI119517; Yang XJ, 2008, INVEST OPHTH VIS SCI, V49, P2483, DOI 10.1167/iovs.07-1344; Yuan SP, 2008, FASEB J, V22, P2809, DOI 10.1096/fj.08-107417; Zalewska R, 2008, MED SCI MONITOR, V14, pBR274; Zhou Y, 2005, MOL THER, V12, P402, DOI 10.1016/j.ymthe.2005.04.004	60	21	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90737	10.1371/journal.pone.0090737	http://dx.doi.org/10.1371/journal.pone.0090737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595072	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900141
J	Boisgontier, MP; Wittenberg, GF; Fujiyama, H; Levin, O; Swinnen, SP				Boisgontier, Matthieu P.; Wittenberg, George F.; Fujiyama, Hakuei; Levin, Oron; Swinnen, Stephan P.			Complexity of Central Processing in Simple and Choice Multilimb Reaction-Time Tasks	PLOS ONE			English	Article							RAPID BIMANUAL MOVEMENT; INTERLIMB COORDINATION; VOLUNTARY CONTRACTION; CORPUS-CALLOSUM; HAND; FOOT; CONSTRAINTS; BRAIN; PERFORMANCE; RESPONSES	The default mode of the motor system is a coupling between limbs. However, in some movements, a decoupling is required and thus calls for selection and facilitation/inhibition processes. Here, we investigate the relative contribution of recruitment versus selection processes to the overall processing complexity. To this aim we proposed a new multilimb reaction-time task (MUL-RT). Simple, choice and normalized (choice minus simple) RT were analysed together with error rates in thirty-six young adults for 15 coordination modes including all possible configuration of limb recruitment. Simple and normalized RTs were respectively assumed to be indicative of the recruitment and selection processes. Results supported a model of coupling/decoupling interactions respectively reporting weak, intermediate and strong interaction for selecting diagonal, ipsilateral and homologous limbs. Movement laterality (left vs. right) had no effect on selection complexity, whereas selecting upper limbs was less challenging than selecting lower limbs. Results in the different coordination modes suggested that recruitment complexity decreased as follows: 3 limbs = 4 limbs > 2 limbs (homologous, ipsilateral and diagonal) > 1 limb, and selection complexity as follows: 2 diagonal limbs > 3 limbs > 2 ipsilateral limbs > 1 limb = 2 homologous limbs > 4 limbs. Based on these ordinal scales of recruitment and selection complexity, we extrapolated the overall processing complexity of the simple and choice MUL-RT. This method was efficient in reproducing the absolute results we obtained on a ratio scale (ms) and demonstrated that processing complexity in simple RT was mainly governed by the 'recruitment principle' (the more limbs recruited the lower the performance), whereas contributions of recruitment and 'selection principle' (nature of the coordination determines performance) to overall processing complexity were similar in choice RT.	[Boisgontier, Matthieu P.; Wittenberg, George F.; Fujiyama, Hakuei; Levin, Oron; Swinnen, Stephan P.] Katholieke Univ Leuven, Grp Biomed Sci, Movement Control & Neuroplast Res Grp, Louvain, Belgium; [Wittenberg, George F.] VA Maryland Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Baltimore, MD USA; [Wittenberg, George F.] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Swinnen, Stephan P.] Leuven Res Inst Neurosci & Dis LIND, Louvain, Belgium	KU Leuven; Geriatric Research Education & Clinical Center; University System of Maryland; University of Maryland Baltimore	Boisgontier, MP (corresponding author), Katholieke Univ Leuven, Grp Biomed Sci, Movement Control & Neuroplast Res Grp, Louvain, Belgium.	Matthieu.Boisgontier@faber.kuleuven.be	Fujiyama, Hakuei/O-4025-2019; Levin, Oron/J-9405-2015; Boisgontier, Matthieu P./P-6029-2018; Levin, Oron/GQP-4656-2022; Wittenberg, George/AAM-3428-2020; Wittenberg, George F/J-8698-2015	Levin, Oron/0000-0002-9072-5122; Boisgontier, Matthieu P./0000-0001-9376-3071; Wittenberg, George/0000-0001-5603-1197; Fujiyama, Hakuei/0000-0002-7546-6636	Interuniversity Attraction Poles Programme; Belgian Science Policy Office [P7/11]; Research Fund KU Leuven [OT/11/071]; FWO Vlaanderen [G.0483.10, G.0721.12]; NATIONAL INSTITUTE ON AGING [P30AG028747] Funding Source: NIH RePORTER	Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Belgian Science Policy Office(Belgian Federal Science Policy Office); Research Fund KU Leuven(KU Leuven); FWO Vlaanderen(FWO); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office (P7/11). Additional funding was obtained by the Research Fund KU Leuven (OT/11/071) and FWO Vlaanderen (G.0483.10; G.0721.12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldissera F, 1998, EXP BRAIN RES, V118, P427, DOI 10.1007/s002210050297; BARTLETT MS, 1947, BIOMETRICS, V3, P39, DOI 10.2307/3001536; BLYTH KW, 1963, NATURE, V199, P1312, DOI 10.1038/1991312a0; Byblow WD, 2007, J NEUROPHYSIOL, V98, P414, DOI 10.1152/jn.00325.2007; Carson RG, 2004, J PHYSIOL-LONDON, V560, P929, DOI 10.1113/jphysiol.2004.069088; CERNACEK J, 1961, ARCH NEUROL-CHICAGO, V4, P165, DOI 10.1001/archneur.1961.00450080047005; Davis RC, 1942, J EXP PSYCHOL, V31, P347, DOI 10.1037/h0055735; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; Franz EA, 1996, PSYCHOL SCI, V7, P306, DOI 10.1111/j.1467-9280.1996.tb00379.x; FRANZ EA, 1991, ACTA PSYCHOL, V77, P137, DOI 10.1016/0001-6918(91)90028-X; Fujiyama H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.019; Fujiyama H, 2009, BRAIN RES, V1262, P38, DOI 10.1016/j.brainres.2009.01.023; Gehring WJ, 2001, J NEUROSCI, V21, P9430, DOI 10.1523/JNEUROSCI.21-23-09430.2001; Gooijers J, 2013, HUM BRAIN MAPP, V34, P241, DOI 10.1002/hbm.21429; HESS CW, 1986, NEUROSCI LETT, V71, P235, DOI 10.1016/0304-3940(86)90565-3; Heuer H, 1998, EXP BRAIN RES, V118, P381, DOI 10.1007/s002210050292; Jarbo K, 2012, NEUROIMAGE, V59, P1988, DOI 10.1016/j.neuroimage.2011.09.056; Jensen A. R., 2006, CLOCKING MIND MENTAL; JENSEN AR, 1993, CURRENT DIRECTIONS P, V2, P53, DOI DOI 10.1111/1467-8721.EP10770697; Judd CM, 2014, HANDBOOK OF RESEARCH METHODS IN SOCIAL AND PERSONALITY PSYCHOLOGY, SECOND EDITION, P653; Kauranen K, 1996, PERCEPT MOTOR SKILL, V82, P515, DOI 10.2466/pms.1996.82.2.515; KELSO JAS, 1992, J EXP PSYCHOL HUMAN, V18, P645, DOI 10.1037/0096-1523.18.3.645; KELSO JAS, 1979, J EXP PSYCHOL HUMAN, V5, P229, DOI 10.1037/0096-1523.5.2.229; Kimura J, 2001, ELECTRODIAGNOSIS DIS; Kinsbourne M., 1978, ATTENTION PERFORM, VVII, P345; Kinsbourne M, 1978, ASYMMETRICAL FUNCTIO, P267; Luna B, 2004, ANN NY ACAD SCI, V1021, P296, DOI 10.1196/annals.1308.035; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; MARTENIUK RG, 1984, Q J EXP PSYCHOL-A, V36, P335, DOI 10.1080/14640748408402163; Mayston MJ, 1999, ANN NEUROL, V45, P583, DOI 10.1002/1531-8249(199905)45:5<583::AID-ANA6>3.0.CO;2-W; Miller J, 2012, PSYCHOPHYSIOLOGY, V49, P590, DOI 10.1111/j.1469-8986.2011.01338.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Philipp Andrea M, 2011, Adv Cogn Psychol, V7, P31, DOI 10.2478/v10053-008-0085-1; RABBITT PMA, 1966, Q J EXP PSYCHOL, V18, P334, DOI 10.1080/14640746608400051; Rokni U, 2003, J NEUROSCI, V23, P11577; Schmidt RA, 2005, MOTOR CONTROL LEARNI; Serrien DJ, 1997, J EXP PSYCHOL HUMAN, V23, P1493, DOI 10.1037/0096-1523.23.5.1493; SHERWOOD DE, 1994, J MOTOR BEHAV, V26, P123, DOI 10.1080/00222895.1994.9941667; SHERWOOD DE, 1991, RES Q EXERCISE SPORT, V62, P302, DOI 10.1080/02701367.1991.10608727; Simonen RL, 1998, J GERONTOL A-BIOL, V53, pM228, DOI 10.1093/gerona/53A.3.M228; SIMONEN RL, 1995, PERCEPT MOTOR SKILL, V80, P1243, DOI 10.2466/pms.1995.80.3c.1243; Sink CA, 2006, PROFESSIONAL SCH COU, P401, DOI DOI 10.5330/PRSC.9.4.283746K664204023; Sohn Y, 2005, EXP BRAIN RES, V162, P95, DOI 10.1007/s00221-004-2109-5; SPIJKERS W, 1995, Q J EXP PSYCHOL-A, V48, P716, DOI 10.1080/14640749508401412; Stinear CM, 2001, EXP BRAIN RES, V139, P101, DOI 10.1007/s002210100758; SWINNEN SP, 1995, EXP BRAIN RES, V105, P439; Swinnen SP, 1998, BEHAV BRAIN RES, V90, P79, DOI 10.1016/S0166-4328(97)00083-1; Swinnen SP, 1997, MOVEMENT DISORD, V12, P958, DOI 10.1002/mds.870120619; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; Swinnen SP, 2001, BEHAV BRAIN RES, V123, P201, DOI 10.1016/S0166-4328(01)00210-8; SWINNEN SP, 1995, EXP BRAIN RES, V104, P153; Swinnen SP, 2004, TRENDS COGN SCI, V8, P18, DOI 10.1016/j.tics.2003.10.017; Tazoe T, 2007, EXP BRAIN RES, V177, P419, DOI 10.1007/s00221-006-0686-1; THOMAS PK, 1959, J NEUROL NEUROSUR PS, V22, P175, DOI 10.1136/jnnp.22.3.175; Wahl M, 2007, J NEUROSCI, V27, P12132, DOI 10.1523/JNEUROSCI.2320-07.2007; Wiesendanger M, 1996, ADV NEUROL, V70, P85; WOLFF PH, 1983, DEV MED CHILD NEUROL, V25, P417	57	29	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90457	10.1371/journal.pone.0090457	http://dx.doi.org/10.1371/journal.pone.0090457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24587371	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200205
J	Spencer, EE; Crowther, MS; Dickman, CR				Spencer, Emma E.; Crowther, Mathew S.; Dickman, Christopher R.			Risky Business: Do Native Rodents Use Habitat and Odor Cues to Manage Predation Risk in Australian Deserts?	PLOS ONE			English	Article							PATCH USE; BEHAVIORAL-RESPONSES; FORAGING BEHAVIOR; TIME ALLOCATION; SMALL MAMMALS; BUSH RATS; PREY; RAINFALL; MARSUPIALIA; ASSEMBLAGES	In open, arid environments with limited shelter there may be strong selection on small prey species to develop behaviors that facilitate predator avoidance. Here, we predicted that rodents should avoid predator odor and open habitats to reduce their probability of encounter with potential predators, and tested our predictions using a native Australian desert rodent, the spinifex hopping-mouse (Notomys alexis). We tested the foraging and movement responses of N. alexis to non-native predator (fox and cat) odor, in sheltered and open macro-and microhabitats. Rodents did not respond to predator odor, perhaps reflecting the inconsistent selection pressure that is imposed on prey species in the desert environment due to the transience of predator-presence. However, they foraged primarily in the open and moved preferentially across open sand. The results suggest that N. alexis relies on escape rather than avoidance behavior when managing predation risk, with its bipedal movement probably allowing it to exploit open environments most effectively.	[Spencer, Emma E.; Crowther, Mathew S.; Dickman, Christopher R.] Univ Sydney, Sch Biol Sci, Desert Ecol Res Grp, Sydney, NSW 2006, Australia	University of Sydney	Spencer, EE (corresponding author), Univ Sydney, Sch Biol Sci, Desert Ecol Res Grp, Sydney, NSW 2006, Australia.	espe7638@uni.sydney.edu.au	Crowther, Mathew/M-7406-2013; Dickman, Christopher/Q-4662-2019	Crowther, Mathew/0000-0001-8968-1161; Dickman, Christopher/0000-0002-1067-3730	Australian Research Council (ARC) [DP 0988535]	Australian Research Council (ARC)(Australian Research Council)	Research contributing to this manuscript was funded by the Australian Research Council (ARC), with grant number: DP 0988535. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anson JR, 2013, OECOLOGIA, V171, P367, DOI 10.1007/s00442-012-2424-7; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Armstrong K.N., 2008, MAMMALS AUSTR, P470; Ayal Y, 2007, J ARID ENVIRON, V68, P171, DOI 10.1016/j.jaridenv.2006.05.013; Banks PB, 1998, J MAMMAL, V79, P1260, DOI 10.2307/1383017; Banks PB, 1999, J APPL ECOL, V36, P1063, DOI 10.1046/j.1365-2664.1999.00463.x; Barton K, 2020, MUMIN MULTIMODEL INF; Bates D, 2012, LME4 LINEAR MIXED EF; Blumstein DT, 2002, ANIM CONSERV, V5, P87, DOI 10.1017/S1367943002002123; BRANCH LC, 1995, MAMMALIA, V59, P152; Brostrom G., 2008, GLMMML GEN LINEAR MO; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; BUCKLEY R, 1981, AUST J ECOL, V6, P405, DOI 10.1111/j.1442-9993.1981.tb01495.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Bytheway JP, 2013, BEHAV ECOL SOCIOBIOL, V67, P715, DOI 10.1007/s00265-013-1494-9; CLOUDSLEYTHOMPS.JL, 1976, DESERTS GRASSLANDS 1; Cupples JB, 2011, J MAMMAL, V92, P590, DOI 10.1644/10-MAMM-A-164.1; Dickman C., 1996, OVERVIEW IMPACTS FER; Dickman C. R., 1993, Australian Mammalogy, V16, P69; Dickman CR, 1996, WILDLIFE BIOL, V2, P185, DOI 10.2981/wlb.1996.018; Dickman Chris R., 1993, Australian Natural History, V24, P44; Dickman CR, 2010, J MAMMAL, V91, P798, DOI 10.1644/09-MAMM-S-205.1; Dickman Christopher R., 2009, Human-Wildlife Conflicts, V3, P41; DICKMAN CR, 1984, J ZOOL, V204, P521, DOI 10.1111/j.1469-7998.1984.tb02384.x; DICKMAN CR, 1992, ECOLOGY, V73, P313, DOI 10.2307/1938742; DICKMAN CR, 1991, OIKOS, V62, P67, DOI 10.2307/3545447; Dickman CR, 2014, BIODIVERSITY ENV CHA, P389; Dielenberg RA, 2001, NEUROSCI BIOBEHAV R, V25, P597, DOI 10.1016/S0149-7634(01)00044-6; DJAWDAN M, 1993, FUNCT ECOL, V7, P195, DOI 10.2307/2389887; Edwards GP, 2008, AUSTRAL ECOLOGY, V26, P93; Embar K, 2011, OIKOS, V120, P1657, DOI 10.1111/j.1600-0706.2011.19278.x; Fendt M, 2005, J NEUROSCI, V25, P5998, DOI 10.1523/JNEUROSCI.1028-05.2005; Fey K, 2006, ANN ZOOL FENN, V43, P9; Greenville AC, 2009, INT J WILDLAND FIRE, V18, P631, DOI 10.1071/WF08093; Hancock C., 1991, REPORT DISTRIBUTION; Hayes RA, 2006, ANIM BEHAV, V71, P1307, DOI 10.1016/j.anbehav.2005.08.017; Herman CS, 2000, OIKOS, V91, P139, DOI 10.1034/j.1600-0706.2000.910113.x; Jones M, 2000, J CHEM ECOL, V26, P455, DOI 10.1023/A:1005417707588; KOTLER BP, 1984, ECOLOGY, V65, P689, DOI 10.2307/1938041; Kotler BP, 1998, AUST J ECOL, V23, P574, DOI 10.1111/j.1442-9993.1998.tb00767.x; Kotler BP, 2010, P ROY SOC B-BIOL SCI, V277, P1469, DOI 10.1098/rspb.2009.2036; Letnic M, 2006, BIODIVERS CONSERV, V15, P3847, DOI 10.1007/s10531-005-0601-2; Letnic M, 2011, J MAMMAL, V92, P1210, DOI 10.1644/10-MAMM-S-229.1; Letnic M, 2011, CURR ZOOL, V57, P668; Letnic Mike, 2002, Australian Mammalogy, V23, P125; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Mahon PS, 1999, THESIS U SYDNEY SYDN; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; McEvoy J, 2008, AUSTRAL ECOL, V33, P922, DOI 10.1111/j.1442-9993.2008.01863.x; McKenzie NL, 2007, J BIOGEOGR, V34, P597, DOI 10.1111/j.1365-2699.2006.01639.x; Mella VSA, 2010, AUST J ZOOL, V58, P267, DOI 10.1071/ZO10049; MURRAY BR, 1994, WILDLIFE RES, V21, P647, DOI 10.1071/WR9940647; Nersesian CL, 2012, BEHAV ECOL SOCIOBIOL, V66, P47, DOI 10.1007/s00265-011-1250-y; Orrock JL, 2004, BEHAV ECOL, V15, P433, DOI 10.1093/beheco/arh031; Osvaldo S. E., 1996, Rangelands in a sustainable biosphere. Proceedings of the Fifth International Rangeland Congress, Salt Lake City, Utah, USA, 23-28 July, 1995. Volume 2: Invited presentations., P29; Pastro LA, 2013, OECOLOGIA, V173, P603, DOI 10.1007/s00442-013-2642-7; Pastro LA, 2011, ECOL APPL, V21, P3238, DOI 10.1890/10-2351.1; Pavey CR, 2008, J MAMMAL, V89, P674, DOI 10.1644/07-MAMM-A-168R.1; Polis Gary A., 1993, Memoirs of the Queensland Museum, V33, P401; Purdie R., 1984, LAND SYSTEMS SIMPSON; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2012, R LANG ENV STAT COMP; Russell BG, 2007, AUSTRAL ECOL, V32, P277, DOI 10.1111/j.1442-9993.2007.01685.x; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Schooley RL, 1996, CAN J ZOOL, V74, P157, DOI 10.1139/z96-020; Spencer EE, 2013, THESIS U SYDNEY; STANLEY M, 1971, Zeitschrift fuer Tierpsychologie, V29, P225; STODDART DM, 1982, J ANIM ECOL, V51, P375, DOI 10.2307/3971; Taraborelli P, 2003, ETHOLOGY, V109, P475, DOI 10.1046/j.1439-0310.2003.00884.x; Thorson JM, 1998, BEHAV ECOL, V9, P151, DOI 10.1093/beheco/9.2.151; Triggs B., 1996, TRACKS SCATS OTHER T; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; WOOLHOUSE AD, 1995, J CHEM ECOL, V21, P1571, DOI 10.1007/BF02035153; Woolley P. A., 2005, Memoirs of Museum Victoria, V62, P213; Woolley P. A., 2006, Australian Mammalogy, V28, P117	75	23	23	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90566	10.1371/journal.pone.0090566	http://dx.doi.org/10.1371/journal.pone.0090566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587396	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200230
J	Merino, JJ; Arce, C; Naddaf, A; Bellver-Landete, V; Oset-Gasque, MJ; Gonzalez, MP				Joaquin Merino, Jose; Arce, Carmen; Naddaf, Ahmad; Bellver-Landete, Victor; Jesus Oset-Gasque, Maria; Pilar Gonzalez, Maria			The Nitric Oxide Donor SNAP-Induced Amino Acid Neurotransmitter Release in Cortical Neurons. Effects of Blockers of Voltage-Dependent Sodium and Calcium Channels	PLOS ONE			English	Article							LOWER ESOPHAGEAL SPHINCTER; RAT ANOCOCCYGEUS MUSCLE; S-NITROSYLATION; GLUTAMATE RELEASE; EVOKED RELEASE; NERVOUS-SYSTEM; PROTEIN-KINASE; GABA RELEASE; MODULATION; TRANSMISSION	Background: The discovery that nitric oxide (NO) functions as a signalling molecule in the nervous system has radically changed the concept of neuronal communication. NO induces the release of amino acid neurotransmitters but the underlying mechanisms remain to be elucidated. Findings: The aim of this work was to study the effect of NO on amino acid neurotransmitter release (Asp, Glu, Gly and GABA) in cortical neurons as well as the mechanism underlying the release of these neurotransmitters. Cortical neurons were stimulated with SNAP, a NO donor, and the release of different amino acid neurotransmitters was measured by HPLC. The involvement of voltage dependent Na+ and Ca2+ channels as well as cGMP in its mechanism of action was evaluated. Conclusions: Our results indicate that NO induces release of aspartate, glutamate, glycine and GABA in cortical neurons and that this release is inhibited by ODQ, an inhibitor of soluble guanylate cyclase. Thus, the NO effect on amino acid neurotransmission could be mediated by cGMP formation in cortical neurons. Our data also demonstrate that the Na+ and Ca2+ voltage-dependent calcium channels are involved in the NO effects on cortical neurons.	[Joaquin Merino, Jose; Arce, Carmen; Bellver-Landete, Victor; Jesus Oset-Gasque, Maria; Pilar Gonzalez, Maria] Univ Complutense Madrid, Fac Farm, Dept Bioquim & Biol Mol 2, E-28040 Madrid, Spain; [Joaquin Merino, Jose; Arce, Carmen; Bellver-Landete, Victor; Jesus Oset-Gasque, Maria; Pilar Gonzalez, Maria] Univ Complutense Madrid, IUIN, Madrid, Spain; [Naddaf, Ahmad] Isra Univ, Fac Pharm, Amman, Jordan	Complutense University of Madrid; Complutense University of Madrid; Isra University	Merino, JJ (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Bioquim & Biol Mol 2, E-28040 Madrid, Spain.	josem2005@yahoo.es; pilarg@ucm.es	Oset Gasque, María Jesús/I-1072-2015	Oset Gasque, María Jesús/0000-0002-7223-0222	"Ministry of Science and Innovation, Spain" (MICINN) [SAF2010-20337]; UCM (Complutense University of Madrid, Spain)-Santander [GR35/10-B]; Cienporciennatural Company	"Ministry of Science and Innovation, Spain" (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); UCM (Complutense University of Madrid, Spain)-Santander; Cienporciennatural Company	This study was supported by respective grants from "Ministry of Science and Innovation, Spain" (MICINN) (SAF2010-20337), UCM (Complutense University of Madrid, Spain)-Santander (GR35/10-B), and Cienporciennatural Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern GP, 2002, TRENDS NEUROSCI, V25, P510, DOI 10.1016/S0166-2236(02)02254-3; Artinian L, 2012, EUR J NEUROSCI, V36, P3333, DOI 10.1111/j.1460-9568.2012.08260.x; BARNETTE MS, 1990, EUR J PHARMACOL, V182, P363, DOI 10.1016/0014-2999(90)90295-H; Bartus K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057292; Bellamy TC, 2002, P NATL ACAD SCI USA, V99, P507, DOI 10.1073/pnas.012368499; Beltran B, 1999, BRIT J PHARMACOL, V127, P1603, DOI 10.1038/sj.bjp.0702717; Bieda MC, 1999, J NEUROPHYSIOL, V81, P3092, DOI 10.1152/jn.1999.81.6.3092; BOECKXSTAENS GE, 1993, BRIT J PHARMACOL, V109, P1079, DOI 10.1111/j.1476-5381.1993.tb13732.x; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; Currie DA, 2006, DEV DYNAM, V235, P1668, DOI 10.1002/dvdy.20732; Drapier JC, 1996, BIOESSAYS, V18, P549, DOI 10.1002/bies.950180706; Engelmann M, 2002, NEUROSCI LETT, V324, P252, DOI 10.1016/S0304-3940(02)00211-2; Figueroa S, 2006, J NEUROSCI RES, V83, P441, DOI 10.1002/jnr.20739; Figueroa S, 2005, BRAIN RES, V1034, P25, DOI 10.1016/j.brainres.2004.11.024; Gallo EF, 2011, J NEUROSCI, V31, P6947, DOI 10.1523/JNEUROSCI.0374-11.2011; Gao YS, 2010, PFLUG ARCH EUR J PHY, V459, P829, DOI 10.1007/s00424-009-0773-9; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; GUSTAFSSON LE, 1990, BIOCHEM BIOPH RES CO, V173, P106, DOI 10.1016/S0006-291X(05)81028-9; HANBAUER I, 1992, NEUROREPORT, V3, P409, DOI 10.1097/00001756-199205000-00008; Hirooka K, 2000, J NEUROPHYSIOL, V83, P198, DOI 10.1152/jn.2000.83.1.198; HORN T, 1994, AM J PHYSIOL, V266, P306; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jin XG, 2011, J BIOL CHEM, V286, P33190, DOI 10.1074/jbc.M111.270967; Kiss JP, 2001, TRENDS NEUROSCI, V24, P211, DOI 10.1016/S0166-2236(00)01745-8; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; KURIYAMA K, 1995, JPN J PHARMACOL, V69, P1, DOI 10.1254/jjp.69.1; Lane P., 2001, SCI STKE, V86, pre1; LI CG, 1989, CLIN EXP PHARMACOL P, V16, P933, DOI 10.1111/j.1440-1681.1989.tb02404.x; LI CG, 1989, EUR J PHARMACOL, V168, P107, DOI 10.1016/0014-2999(89)90640-7; Lopez E, 2001, NEUROCHEM INT, V39, P283, DOI 10.1016/S0197-0186(01)00035-3; MARQUEZ FJ, 1986, J CHROMATOGR, V380, P275, DOI 10.1016/S0378-4347(00)83656-7; MartinezMartos JM, 1997, BRAIN RES BULL, V43, P441; MEFFERT MK, 1994, NEURON, V12, P1235, DOI 10.1016/0896-6273(94)90440-5; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Moncada S, 1997, PHARMACOL REV, V49, P137; Mongin AA, 1998, BIOCHEMISTRY-MOSCOW+, V63, P662; MONTAGUE PR, 1994, SCIENCE, V263, P973, DOI 10.1126/science.7508638; OHKUMA S, 1995, J NEUROCHEM, V65, P1109; Pieper AA, 2000, P NATL ACAD SCI USA, V97, P1845, DOI 10.1073/pnas.97.4.1845; Reaume Christopher J., 2009, V191, P423, DOI 10.1007/978-3-540-68964-5_18; REISER G, 1990, EUR J BIOCHEM, V189, P547, DOI 10.1111/j.1432-1033.1990.tb15521.x; SEGAL M, 1983, J NEUROPHYSIOL, V50, P1249, DOI 10.1152/jn.1983.50.6.1249; SEGIETH J, 1995, NEUROSCI LETT, V200, P101, DOI 10.1016/0304-3940(95)12088-L; Sistiaga A, 1997, EUR J PHARMACOL, V321, P247, DOI 10.1016/S0014-2999(96)00937-5; SORKIN LS, 1993, NEUROREPORT, V4, P479, DOI 10.1097/00001756-199305000-00004; TORPHY TJ, 1986, AM J PHYSIOL, V251, pG786, DOI 10.1152/ajpgi.1986.251.6.G786; Tozer AJB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032256; TURNER TJ, 1992, SCIENCE, V258, P310, DOI 10.1126/science.1357749; WAGGONER AS, 1979, ANNU REV BIOPHYS BIO, V8, P47, DOI 10.1146/annurev.bb.08.060179.000403; WALAAS SI, 1991, PHARMACOL REV, V43, P299; Wang JQ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00164; Waterman SA, 1996, J NEUROSCI, V16, P4155; Xue L, 2000, P NATL ACAD SCI USA, V97, P1851, DOI 10.1073/pnas.97.4.1851; Yoshimura N, 2001, J NEUROPHYSIOL, V86, P304, DOI 10.1152/jn.2001.86.1.304	57	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90703	10.1371/journal.pone.0090703	http://dx.doi.org/10.1371/journal.pone.0090703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598811	gold, Green Accepted, Green Published			2022-12-27	WOS:000332479400121
J	Negrete, L; Colpo, KD; Brusa, F				Negrete, Lisandro; Colpo, Karine D.; Brusa, Francisco			Land Planarian Assemblages in Protected Areas of the Interior Atlantic Forest: Implications for Conservation	PLOS ONE			English	Article							SUBTROPICAL DECIDUOUS FOREST; MAN-INDUCED DISTURBANCE; FLATWORM PLATYHELMINTHES; COMMUNITY COMPOSITION; TRICLADIDA; TERRICOLA; BIODIVERSITY; DIVERSITY; GEOPLANIDAE; ARAUCARIA	Land planarians are an interesting group of free-living flatworms that can be useful as bioindicators because of their high sensitivity to environmental changes and low dispersal capacity. In this study, we describe and compare assemblages of land planarians from areas with different conservation degrees of the Interior Atlantic Forest (Misiones, Argentina), and assess factors that could be related to their abundance and richness. Eight sites were tracked in search of land planarians in Reserva de Vida Silvestre Urugua-i (RVSU) and Campo Anexo Manuel Belgrano (CAMB). Diurnal and nocturnal surveys were performed in each site along nine sampling campaigns. We collected 237 individuals belonging to 18 species of the subfamily Geoplaninae. All sites were dominated by Geoplana sp. 1 and Pasipha hauseri. The richness estimators showed that there would be more species in RVSU than in CAMB. The abundance and richness of land planarians was high during the night and after rainfalls, suggesting an increased activity of flatworms under such conditions. The abundance and richness of land planarians were also related to the conservation condition of the sites. Disturbed sites showed less abundance and richness, and were segregated from non-disturbed ones by nmMDS analysis. Beta diversity between sites was higher than expected, indicating that the species turnover between sites contributed more to the total richness (gamma diversity) than the alpha diversity.	[Negrete, Lisandro; Brusa, Francisco] Univ Nacl La Plata, Fac Ciencias Nat & Museo, Div Zool Invertebrados, La Plata, Buenos Aires, Argentina; [Colpo, Karine D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Lab Biol Reprod & Crecimiento Crustaceos Decapodo, Buenos Aires, DF, Argentina; [Negrete, Lisandro; Colpo, Karine D.; Brusa, Francisco] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	National University of La Plata; Museo La Plata; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Brusa, F (corresponding author), Univ Nacl La Plata, Fac Ciencias Nat & Museo, Div Zool Invertebrados, La Plata, Buenos Aires, Argentina.	fbrusa@fcnym.unlp.edu.ar	Brusa, Francisco/N-1250-2019	Brusa, Francisco/0000-0003-2206-1560; Colpo, Karine/0000-0003-4513-8620; Negrete, Lisandro/0000-0003-3398-6606	CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas); Agencia Nacional de Promocion Cientifica y Tecnologica (FONCyT) [PICT 2007-01287]; UNLP (Universidad Nacional de La Plata) [11/N600]	CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (FONCyT)(ANPCyTFONCyT); UNLP (Universidad Nacional de La Plata)(National University of La Plata)	This work was financed by CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas), Agencia Nacional de Promocion Cientifica y Tecnologica (FONCyT) PICT 2007-01287, and UNLP (Universidad Nacional de La Plata) 11/N600. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carbonari FA, 2009, ENCUENTROS LATINOAM, P49; Antunes M, 2012, PEDOBIOLOGIA, V55, P25, DOI 10.1016/j.pedobi.2011.09.010; Antunes Michelle Bicalho, 2008, Neotropical Biology and Conservation, V3, P34; Baptista VA, 2010, BELG J ZOOL, V140, P83; Baptista Vanessa A., 2006, Iheringia, Sér. Zool., V96, P293, DOI 10.1590/S0073-47212006000300004; Baptista VD, 2010, BIOTA NEOTROP, V10, P247, DOI 10.1590/S1676-06032010000200027; Carbayo F, 2002, BIODIVERS CONSERV, V11, P1091, DOI 10.1023/A:1015865005604; Carbayo F, 2001, BELG J ZOOL, V131, P223; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chao A, 2000, STAT SINICA, V10, P227; Colwell R.K., 2016, ESTIMATES STAT ESTIM; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Colwell RK, 1996, BIODIVERSITY MEASURE, P101; De Castro A., 2005, ACTA BIOL LEOPOLDENS, V27, P147; Di Bitetti M.S., 2003, VISION BIODIVERSIDAD; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Feinsinger P., 2001, DESIGNING FIELD STUD; Fick IA, 2006, INVERTEBR BIOL, V125, P306, DOI 10.1111/j.1744-7410.2006.00062.x; Fonseca CR, 2009, BIOL CONSERV, V142, P1209, DOI 10.1016/j.biocon.2009.02.017; Froelich C. G., 1955, Boletim da Faculdade de Filosofia Ciencias e Letras Universidade de Sao Paulo Zoologica, V20, P263; Galindo-Leal C, 2003, STATE HOTS, P3; Giraudo AR, 2003, STATE HOTS, P160; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kawaguti S, 1932, MEM FS AGR TAIHOKU I, V7, P15; Leal-Zanchet AM, 2011, INVERTEBR BIOL, V130, P25, DOI 10.1111/j.1744-7410.2010.00215.x; Magurran A.E., 2004, MEASURING BIOL DIVER; Moreno CE, 2011, REV MEX BIODIVERS, V82, P1249, DOI 10.22201/ib.20078706e.2011.4.745; Morrone Juan J., 2001, M&T Manuales y Tesis SEA, V3, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Negrete L, 2014, ZOOTAXA, V 3753, P177, DOI 10.11646/zootaxa.3753.2.7; Negrete L, 2012, STUD NEOTROP FAUNA E, V47, P227, DOI 10.1080/01650521.2012.735071; OGREN RE, 1995, HYDROBIOLOGIA, V305, P105, DOI 10.1007/BF00036370; Pfeiffer Martin, 2012, PLoS One, V7, pe40729, DOI 10.1371/journal.pone.0040729; Prasniski MET, 2009, ZOOLOGIA-CURITIBA, V26, P606, DOI 10.1590/S1984-46702009005000011; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Romeis B., 1989, MIKROSKOPISCHE TECHN; Sluys R, 1998, PEDOBIOLOGIA, V42, P490; Sluys R, 1999, BIODIVERS CONSERV, V8, P1663, DOI 10.1023/A:1008994925673; Terrace T. E., 1996, Transactions of the Royal Society of South Australia, V120, P177; TERRACE TE, 1994, J AUST ENTOMOL SOC, V33, P371; Veech JA, 2009, PARTITION SOFTWARE H; Winsor Leigh, 2004, P227, DOI 10.1079/9780851993195.0227	46	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90513	10.1371/journal.pone.0090513	http://dx.doi.org/10.1371/journal.pone.0090513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598934	gold, Green Published, Green Submitted			2022-12-27	WOS:000332479400087
J	Somers, JM; Moniruzzaman, A; Rezansoff, SN; Patterson, M				Somers, Julian M.; Moniruzzaman, Akm; Rezansoff, Stefanie N.; Patterson, Michelle			Examining the Impact of Case Management in Vancouver's Downtown Community Court: A Quasi-Experimental Design	PLOS ONE			English	Article							CRIME; RECIDIVISM	Background: Problem solving courts (PSC) have been implemented internationally, with a common objective to prevent reoffending by addressing criminogenic needs and strengthening social determinants of health. There has been no empirical research on the effectiveness of community courts, which are a form of PSC designed to harness community resources and inter-disciplinary expertise to reduce recidivism in a geographic catchment area. Method: We used the propensity score matching method to examine the effectiveness of Vancouver's Downtown Community Court (DCC). We focused on the subset of DCC participants who were identified as having the highest criminogenic risk and were assigned to a case management team (CMT). A comparison group was derived using one-to-one matching on a large array variables including static and dynamic criminogenic factors, geography, and time. Reductions in offences (one year pre minus one year post) were compared between CMT and comparison groups. Results: Compared to other DCC offenders, those triaged to CMT (9.5% of the DCC population) had significantly higher levels of healthcare, social service use, and justice system involvement over the ten years prior to the index offence. Compared to matched offenders who received traditional court outcomes, those assigned to CMT (n = 249) exhibited significantly greater reductions in overall offending (p<0.001), primarily comprised of significant reductions in property offences (p<0.001). Conclusions: Our findings indicate that CMT achieved significantly greater reductions in recidivism than traditional court among offenders with complex needs and high numbers of previous offences. Limitations of this research include a non-experimental design and one year follow up. Strengths include a robust matching process and extensive client level data spanning multiple sectors. Further research is needed to replicate the observed outcomes, to investigate the extension of community courts to settings with divergent offender needs and local resources, and to estimate potential cost avoidance attributable to this intervention.	[Somers, Julian M.; Moniruzzaman, Akm; Rezansoff, Stefanie N.; Patterson, Michelle] Simon Fraser Univ, Fac Hlth Sci, Somers Res Grp, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Somers, JM (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Somers Res Grp, Burnaby, BC V5A 1S6, Canada.	jsomers@sfu.ca						Andrews DA, 2007, CAN J CRIMINOL CRIM, V49, P439, DOI 10.3138/cjccj.49.4.439; Andrews D.A., 2006, PSYCHOL CRIMINAL CON, Vfourth; [Anonymous], COMMUNITY COURTS RES; Apel RJ, 2010, HANDBOOK OF QUANTITATIVE CRIMINOLOGY, P543, DOI 10.1007/978-0-387-77650-7_26; Berman G, 2001, LAW POLICY, V23; Case B, 2009, BEHAV SCI LAW, V27, P661, DOI 10.1002/bsl.883; Cook CL, 2011, VIOLENCE VICTIMS, V26, P684, DOI 10.1891/0886-6708.26.5.684; Cosden M, 2006, CRIME DELINQUENCY, V52, P599, DOI 10.1177/0011128705284287; DeMatteo D, 2013, J CRIM JUST, V41, P64, DOI 10.1016/j.jcrimjus.2012.09.002; Downtown Community Court, 2009, MAN OP UNPUB; Drake EK, 2009, VICTIMS OFFENDERS, V4, P170, DOI 10.1080/15564880802612615; Feinblatt J, 2001, RESPONDING COMMUNITY; Frazer M., 2006, IMPACT COMMUNITY COU; Galloway AL, 2006, INT J OFFENDER THER, V50, P280, DOI 10.1177/0306624X05285095; Gutierrez L., 2012, JUSTICE RES POLICY, V14, P47, DOI [10.3818/JRP.14.2.2012.47, https://doi.org/10.3818/JRP.14.2.2012.47, DOI 10.3818/JRP.14.2.2012.47]; Katz S, 2009, EXPANDING COMMUNITY; Krebs CP, 2007, DRUG ALCOHOL DEPEN, V91, P57, DOI 10.1016/j.drugalcdep.2007.05.011; Lang Julius, 2011, WHAT IS COMMUNITY CO; Latimer J, 2006, METAANALYTIC EXAMINA; Lee S, 2011, RES SOCIAL WORK PRAC, V21, P682, DOI 10.1177/1049731511410551; Leuven Edwin., 2003, PSMATCH2 STATA MODUL; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; McNiel DE, 2007, AM J PSYCHIAT, V164, P1395, DOI 10.1176/appi.ajp.2007.06101664; Ministry of Attorney General and Ministry of Public Safety and Solicitor General, 2010, DOWNT COMM COURT VAN; Rempel M., 2003, NEW YORK STATE ADULT; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Saum C.A., 2008, CRIMINAL JUSTICE REV, V33, P291, DOI DOI 10.1177/0734016808322267; Shaffer DK, 2009, J DRUG ISSUES, V39, P803, DOI 10.1177/002204260903900402; Slinger E, 2010, INT J LAW PSYCHIAT, V33, P258, DOI 10.1016/j.ijlp.2010.06.008; Weiner RL, 2013, PROBLEM SOLVING COUR	30	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90708	10.1371/journal.pone.0090708	http://dx.doi.org/10.1371/journal.pone.0090708			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24599022	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400124
J	Willcox, JM; Summerlee, AJS				Willcox, Jordan M.; Summerlee, Alastair J. S.			Relaxin Protects Astrocytes from Hypoxia In Vitro	PLOS ONE			English	Article							BOVINE HEART-MITOCHONDRIA; NF-KAPPA-B; NITRIC-OXIDE; SUPEROXIDE ANION; OXIDATIVE STRESS; ISCHEMIA-REPERFUSION; ANTIOXIDANT DEFENSE; RADICAL GENERATION; CEREBRAL-ISCHEMIA; ARTERY-OCCLUSION	The peptide relaxin has recently been shown to protect brain tissues from the detrimental effects of ischemia. To date, the mechanisms for this remain unclear. In order to investigate the neuroprotective mechanisms by which relaxin may protect the brain, we investigated the possibility that relaxin protects astrocytes from hypoxia or oxygen/glucose deprivation (OGD). Cultured astrocytes were pre-treated with either relaxin-2 or relaxin-3 and exposed to OGD for 24 or 48 hours. Following OGD exposure, viability assays showed that relaxin-treated cells exhibited a higher viability when compared to astrocytes that experienced OGD-alone. Next, to test whether relaxin reduced the production of reactive oxygen species (ROS) astrocytes were exposed to the same conditions as the previous experiment and a commercially available ROS detection kit was used to detect ROS production. Astrocytes that were treated with relaxin-2 and relaxin-3 showed a marked decrease in ROS production when compared to control astrocytes that were exposed only to OGD. Finally, experiments were performed to determine whether or not the mitochondrial membrane potential was affected by relaxin treatment during 24 hour OGD. Mitochondrial membrane potential was higher in astrocytes that were treated with relaxin-2 and relaxin-3 compared to untreated OGD-alone astrocytes. Taken together, these data present novel findings that show relaxin protects astrocytes from ischemic conditions through the reduction of ROS production and the maintenance of mitochondrial membrane potential.	[Willcox, Jordan M.; Summerlee, Alastair J. S.] Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Willcox, JM (corresponding author), Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	jwillcox@uoguelph.ca			University of Guelph; NSERC; Ontario Graduate Scholarship	University of Guelph; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	The authors wish to acknowledge funding from the University of Guelph and NSERC to AJS Summerlee. JM Willcox received salary support from an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoulnik AI, 2007, ADV EXP MED BIOL, V612, P49; Amantea D, 2009, INT REV NEUROBIOL, V85, P363, DOI 10.1016/S0074-7742(09)85025-3; Bani D, 1998, HYPERTENSION, V31, P1240, DOI 10.1161/01.HYP.31.6.1240; Bani D, 1998, AM J PATHOL, V152, P1367; BANISACCHI T, 1995, BRIT J PHARMACOL, V116, P1589, DOI 10.1111/j.1476-5381.1995.tb16377.x; Barja G, 1999, J BIOENERG BIOMEMBR, V31, P347, DOI 10.1023/A:1005427919188; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Bathgate RAD, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P679; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Cadenas S, 2000, BIOCHEM J, V351, P307, DOI 10.1042/0264-6021:3510307; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cheung NS, 1998, NEUROPHARMACOLOGY, V37, P1419, DOI 10.1016/S0028-3908(98)00123-3; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200; Danielson LA, 1999, J CLIN INVEST, V103, P525, DOI 10.1172/JCI5630; Das A, 2010, CANCER-AM CANCER SOC, V116, P164, DOI 10.1002/cncr.24699; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Ginsberg MD, 1997, AM J NEURORADIOL, V18, P1435; Grishko VI, 1999, NUCLEIC ACIDS RES, V27, P4510, DOI 10.1093/nar/27.22.4510; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Haugaard-Jonsson LM, 2008, J BIOL CHEM, V283, P23811, DOI 10.1074/jbc.M800489200; Haugaard-Jonsson LM, 2009, ANN NY ACAD SCI, V1160, P27, DOI 10.1111/j.1749-6632.2008.03805.x; Ho TY, 2007, J LEUKOCYTE BIOL, V81, P1303, DOI 10.1189/jlb.0906556; Hollensworth SB, 2000, FREE RADICAL BIO MED, V28, P1161, DOI 10.1016/S0891-5849(00)00214-8; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Cosen-Binker LI, 2006, WORLD J GASTROENTERO, V12, P1558; Ivell R, 2011, MOL HUM REPROD, V17, P71, DOI 10.1093/molehr/gaq086; Jordan Joaquin, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P98; KAUR H, 1994, ANAL BIOCHEM, V220, P11, DOI 10.1006/abio.1994.1291; Liu D, 1999, MOL BRAIN RES, V68, P29, DOI 10.1016/S0169-328X(99)00063-7; Martin LJ, 1997, ANN NEUROL, V42, P335, DOI 10.1002/ana.410420310; Masini E, 1997, ENDOCRINOLOGY, V138, P4713, DOI 10.1210/en.138.11.4713; Masini E, 1996, INFLAMM RES, V45, pS27, DOI 10.1007/BF03354073; Masini E, 2006, BRIT J PHARMACOL, V148, P1124, DOI 10.1038/sj.bjp.0706811; MCLENNAN H, 1976, CAN J PHYSIOL PHARM, V54, P70, DOI 10.1139/y76-011; Murley JS, 2001, FREE RADICAL BIO MED, V30, P1426, DOI 10.1016/S0891-5849(01)00554-8; OBERLEY LW, 1987, ARCH BIOCHEM BIOPHYS, V254, P69, DOI 10.1016/0003-9861(87)90082-8; RUBBO H, 1994, J BIOL CHEM, V269, P26066; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; SCHURR A, 1988, SCIENCE, V240, P1326, DOI 10.1126/science.3375817; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; SHANK RP, 1984, J NEUROCHEM, V42, P1153, DOI 10.1111/j.1471-4159.1984.tb12724.x; SONNEWALD U, 1991, NEUROSCI LETT, V128, P235, DOI 10.1016/0304-3940(91)90268-X; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; SUMMERLEE AJS, 1984, NATURE, V309, P372, DOI 10.1038/309372a0; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Tsan MF, 2001, AM J PHYSIOL-CELL PH, V280, pC1422; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; van der Westhuizen ET, 2007, MOL PHARMACOL, V71, P1618, DOI 10.1124/mol.106.032763; WESTERGAARD N, 1993, J NEUROSCI RES, V35, P540, DOI 10.1002/jnr.490350510; Wilson BC, 2006, NEUROSCI LETT, V393, P160, DOI 10.1016/j.neulet.2005.09.059; Wilson BC, 2005, ANN NY ACAD SCI, V1041, P223, DOI 10.1196/annals.1282.035; Wilson BC, 2009, ANN NY ACAD SCI, V1160, P265, DOI 10.1111/j.1749-6632.2008.03806.x; Wilson JX, 1997, CAN J PHYSIOL PHARM, V75, P1149, DOI 10.1139/cjpp-75-10-11-1149; Ying WH, 2000, NEUROREPORT, V11, P1385, DOI 10.1097/00001756-200005150-00007; Ying WH, 2000, J CEREBR BLOOD F MET, V20, P359, DOI 10.1097/00004647-200002000-00018; YUDKOFF M, 1990, J NEUROCHEM, V55, P137, DOI 10.1111/j.1471-4159.1990.tb08831.x; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972	60	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90864	10.1371/journal.pone.0090864	http://dx.doi.org/10.1371/journal.pone.0090864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598861	gold, Green Submitted, Green Published			2022-12-27	WOS:000332479400140
J	Huang, TS; Huang, SS; Shyu, YC; Lee, CH; Jwo, SC; Chen, PJ; Chen, HY				Huang, Ting-Shuo; Huang, Shie-Shian; Shyu, Yu-Chiau; Lee, Chun-Hui; Jwo, Shyh-Chuan; Chen, Pei-Jer; Chen, Huang-Yang			A Procalcitonin-Based Algorithm to Guide Antibiotic Therapy in Secondary Peritonitis following Emergency Surgery: A Prospective Study with Propensity Score Matching Analysis	PLOS ONE			English	Article							SURGICAL SITE INFECTION; INTENSIVE-CARE PATIENTS; PROGNOSTIC ACCURACY; SEVERE SEPSIS; ADULTS; MODEL; GENE	Background: Procalcitonin (PCT)-based algorithms have been used to guide antibiotic therapy in several clinical settings. However, evidence supporting PCT-based algorithms for secondary peritonitis after emergency surgery is scanty. In this study, we aimed to investigate whether a PCT-based algorithm could safely reduce antibiotic exposure in this population. Methods/Principal Findings: From April 2012 to March 2013, patients that had secondary peritonitis diagnosed at the emergency department and underwent emergency surgery were screened for eligibility. PCT levels were obtained pre-operatively, on post-operative days 1, 3, 5, and 7, and on subsequent days if needed. Antibiotics were discontinued if PCT was <1.0 ng/mL or decreased by 80% versus day 1, with resolution of clinical signs. Primary endpoints were time to discontinuation of intravenous antibiotics for the first episode and adverse events. Historical controls were retrieved for propensity score matching. After matching, 30 patients in the PCT group and 60 in the control were included for analysis. The median duration of antibiotic exposure in PCT group was 3.4 days (interquartile range [IQR] 2.2 days), while 6.1 days (IQR 3.2 days) in control (p < 0.001). The PCT algorithm significantly improves time to antibiotic discontinuation (p, 0.001, log-rank test). The rates of adverse events were comparable between 2 groups. Multivariate-adjusted extended Cox model demonstrated that the PCT-based algorithm was significantly associated with a 87% reduction in hazard of antibiotic exposure within 7 days (hazard ratio [HR] 0.13, 95% CI 0.07-0.21, p < 0.001), and a 68% reduction in hazard after 7 days (adjusted HR 0.32, 95% CI 0.11-0.99, p = 0.047). Advanced age, coexisting pulmonary diseases, and higher severity of illness were significantly associated with longer durations of antibiotic use. Conclusions/Significance: The PCT-based algorithm safely reduces antibiotic exposure in this study. Further randomized trials are needed to confirm our findings and incorporate cost-effectiveness analysis.	[Huang, Ting-Shuo; Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Huang, Ting-Shuo; Lee, Chun-Hui; Jwo, Shyh-Chuan; Chen, Huang-Yang] Chang Gung Mem Hosp, Div Gen Surg, Dept Surg, Keelung Branch, Keelung, Taiwan; [Huang, Shie-Shian] Chang Gung Mem Hosp, Div Infect Dis, Dept Med, Keelung Branch, Keelung, Taiwan; [Shyu, Yu-Chiau] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Shyu, Yu-Chiau] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	National Taiwan University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Yang Ming Chiao Tung University; Taipei City Hospital	Chen, HY (corresponding author), Chang Gung Mem Hosp, Div Gen Surg, Dept Surg, Keelung Branch, Keelung, Taiwan.	c00156@adm.cgmh.org.tw	Huang, Ting-Shuo/ABD-3205-2021	Huang, Ting-Shuo/0000-0002-2932-6878; Chen, Pei-Jer/0000-0001-8316-3785; Jwo, Shyh-Chuan/0000-0001-7546-5257	Chang Gung Memorial Hospital, Keelung Branch [CMRPG2B0311]	Chang Gung Memorial Hospital, Keelung Branch	This project was supported by an institutional grant (CMRPG2B0311) of Chang Gung Memorial Hospital, Keelung Branch. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker KL, 2004, J CLIN ENDOCR METAB, V89, P1512, DOI 10.1210/jc.2002-021444; BILLING A, 1994, BRIT J SURG, V81, P209, DOI 10.1002/bjs.1800810217; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Hansen BB, 2006, J COMPUT GRAPH STAT, V15, P609, DOI 10.1198/106186006X137047; Hennessey DB, 2010, ANN SURG, V252, P325, DOI 10.1097/SLA.0b013e3181e9819a; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Ho DE, 2011, J STAT SOFTW, V42; Hochreiter M, 2009, CRIT CARE, V13, DOI 10.1186/cc7903; Huang TS, 2010, DIGEST SURG, V27, P224, DOI 10.1159/000274485; Infectious Diseases Society of Taiwan, 2008, J Microbiol Immunol Infect, V41, P279; Kleinbaum DG, 2012, SURVIVAL ANAL SELF L; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Latouche A, 2004, STAT MED, V23, P3263, DOI 10.1002/sim.1915; Lindberg M, 2002, SCAND J CLIN LAB INV, V62, P189, DOI 10.1080/003655102317475443; Muller B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-10; Muller B, 2001, J CLIN ENDOCR METAB, V86, P396, DOI 10.1210/jc.86.1.396; Novotny AR, 2009, SURGERY, V145, P20, DOI 10.1016/j.surg.2008.08.009; Pugh R, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007577.pub2; Rau BM, 2007, ARCH SURG-CHICAGO, V142, P134, DOI 10.1001/archsurg.142.2.134; Rubin DB, 2010, AM J OPHTHALMOL, V149, P7, DOI 10.1016/j.ajo.2009.08.024; Schroeder S, 2009, LANGENBECK ARCH SURG, V394, P221, DOI 10.1007/s00423-008-0432-1; Schuetz P, 2007, CURR OPIN CRIT CARE, V13, P578, DOI 10.1097/MCC.0b013e3282c9ac2a; Schuetz P, 2013, JAMA-J AM MED ASSOC, V309, P717, DOI 10.1001/jama.2013.697; Schuetz P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007498.pub2; Schuetz P, 2011, ARCH INTERN MED, V171, P1322, DOI 10.1001/archinternmed.2011.318; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Swenson BR, 2009, SURG INFECT, V10, P29, DOI 10.1089/sur.2007.041; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7	29	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90539	10.1371/journal.pone.0090539	http://dx.doi.org/10.1371/journal.pone.0090539			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594916	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500062
J	Lai, CW; Chen, HL; Lin, KY; Liu, FC; Chong, KY; Cheng, WTK; Chen, CM				Lai, Cheng-Wei; Chen, Hsiao-Ling; Lin, Ken-Yo; Liu, Fang-Chueh; Chong, Kowit-Yu; Cheng, Winston T. K.; Chen, Chuan-Mu			FTSJ2, a Heat Shock-Inducible Mitochondrial Protein, Suppresses Cell Invasion and Migration	PLOS ONE			English	Article							ESCHERICHIA-COLI; MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; PICHIA-PASTORIS; FAT DIGESTION; RNA; EXPRESSION; METHYLATION; GROWTH; SPB1P	Ribosomal RNA large subunit methyltransferase J (RrmJ), an Escherichia coli heat shock protein, is responsible for 2'-O-ribose methylation in 23S rRNA. In mammals, three close homologs of RrmJ have been identified and have been designated as FTSJ1, FTSJ2 and FTSJ3; however, little is known about these genes. In this study, we characterized the mammalian FTSJ2, which was the most related protein to RrmJ in a phylogenetic analysis that had similar amino acid sequence features and tertiary protein structures of RrmJ. FTSJ2 was first identified in this study as a nucleus encoded mitochondrial protein that preserves the heat shock protein character in mammals in which the mRNA expressions was increased in porcine lung tissues and A549 cells after heat shock treatment. In addition, a recent study in non-small cell lung cancer (NSCLC) suggested that the FTSJ2 gene is located in a novel oncogenic locus. However, our results demonstrate that the expression of FTSJ2 mRNA was decreased in the more invasive subline (CL1-5) of the lung adenocarcinoma cells (CL1) compared with the less invasive subline (CL1-0), and overexpression of FTSJ2 resulted in the inhibition of cell invasion and migration in the rhabdomyosarcoma cell (TE671). In conclusion, our findings indicate that mammalian FTSJ2 is a mitochondrial ortholog of E. coli RrmJ and conserves the heat shock protein properties. Moreover, FTSJ2 possesses suppressive effects on the invasion and migration of cancer cells.	[Lai, Cheng-Wei; Lin, Ken-Yo; Liu, Fang-Chueh; Chen, Chuan-Mu] Natl Chung Hsing Univ, Dept Life Sci, Agr Biotechnol Ctr, iEGG Ctr, Taichung 40227, Taiwan; [Chen, Hsiao-Ling] Da Yeh Univ, Dept Bioresources, Changhua, Taiwan; [Liu, Fang-Chueh] Council Agr, Livestock Res Inst, Dept Anim Nutr, Tainan, Taiwan; [Chong, Kowit-Yu] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Cheng, Winston T. K.] Tunghai Univ, Dept Anim Sci & Biotechnol, Taichung 40704, Taiwan	National Chung Hsing University; Da Yeh University; Taiwan Livestock Research Institute; Chang Gung University; Tunghai University	Chen, CM (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Agr Biotechnol Ctr, iEGG Ctr, Taichung 40227, Taiwan.	chchen1@dragon.nchu.edu.tw	Chen, Chuan-Mu/K-7049-2013	Chen, Chuan-Mu/0000-0003-2461-9150; Chong, Kowit Yu/0000-0003-0974-0673	National Science Council [NSC-98-2313-b-005-012]; Ministry of Education, Taiwan, Republic of China [ATU-101-s0508]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, Republic of China(Ministry of Education, Taiwan)	This research was supported by grant NSC-98-2313-b-005-012 from the National Science Council and was partly supported by the Ministry of Education, Taiwan, Republic of China, under the aiming top university plan (ATU-101-s0508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANG D, 1991, J BIOL CHEM, V266, P24233; Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; Blanchard SC, 2001, P NATL ACAD SCI USA, V98, P3720, DOI 10.1073/pnas.051608498; Bonnerot C, 2003, MOL CELL, V12, P1309, DOI 10.1016/S1097-2765(03)00435-0; Bugl H, 2000, MOL CELL, V6, P349, DOI 10.1016/S1097-2765(00)00035-6; Caldas T, 2000, J BIOL CHEM, V275, P16414, DOI 10.1074/jbc.M001854200; Caldas T, 2000, BIOCHEM BIOPH RES CO, V271, P714, DOI 10.1006/bbrc.2000.2702; Campbell JM, 2008, GENOME, V51, P1032, DOI 10.1139/G08-086; Chang TP, 2010, CANCER RES, V70, P1656, DOI 10.1158/0008-5472.CAN-09-2453; Chen HL, 2010, BIOMETALS, V23, P543, DOI 10.1007/s10534-010-9298-0; Cheng ZY, 2013, ANTIOXID REDOX SIGN, V19, P240, DOI 10.1089/ars.2013.5255; Choi I, 2013, GLIA, V61, P800, DOI 10.1002/glia.22475; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Feder M, 2003, GENE, V302, P129, DOI 10.1016/S0378-1119(02)01097-1; Freude K, 2004, AM J HUM GENET, V75, P305, DOI 10.1086/422507; Hager J, 2002, J BIOL CHEM, V277, P41978, DOI 10.1074/jbc.M205423200; Hodel AE, 1998, MOL CELL, V1, P443, DOI 10.1016/S1097-2765(00)80044-1; Huang JT, 2013, J VIROL, V87, P4994, DOI 10.1128/JVI.02526-12; Kang R, 2014, ONCOGENE, V33, P567, DOI 10.1038/onc.2012.631; Kressler D, 1999, NUCLEIC ACIDS RES, V27, P4598, DOI 10.1093/nar/27.23.4598; Lapeyre B, 2005, TOP CURR GENET, V12, P263, DOI 10.1007/b105433; Lapeyre B, 2004, MOL CELL, V16, P663, DOI 10.1016/j.molcel.2004.10.022; Lee HW, 2013, VIRCHOWS ARCH, V463, P489, DOI 10.1007/s00428-013-1461-x; Lin CS, 2012, INT J MOL SCI, V13, P11228, DOI 10.3390/ijms130911228; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu FC, 2010, J AGR FOOD CHEM, V58, P3322, DOI 10.1021/jf903439q; Liu FC, 2008, BIOTECHNOL PROGR, V24, P1333, DOI 10.1002/btpr.46; Morello LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029174; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; OGURA T, 1991, RES MICROBIOL, V142, P279, DOI 10.1016/0923-2508(91)90041-8; Pintard L, 2002, EMBO J, V21, P1139, DOI 10.1093/emboj/21.5.1139; Pintard L, 2002, EMBO J, V21, P1811, DOI 10.1093/emboj/21.7.1811; Pintard L, 2000, MOL CELL BIOL, V20, P1370, DOI 10.1128/MCB.20.4.1370-1381.2000; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; Radosevic-Stasic Biserka, 2012, Curr Aging Sci, V5, P254; Richmond CS, 1999, NUCLEIC ACIDS RES, V27, P3821, DOI 10.1093/nar/27.19.3821; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Siegelin MD, 2013, CANCER LETT, V333, P133, DOI 10.1016/j.canlet.2013.01.045; Simabuco FM, 2012, J PROTEOME RES, V11, P3112, DOI 10.1021/pr201106n; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsai SW, 2013, J ORTHOP RES, V31, P125, DOI 10.1002/jor.22180; Tung YT, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/319247; Tung YT, 2013, J DAIRY SCI, V96, P2095, DOI 10.3168/jds.2012-6153; Verschuure P, 2003, EUR J CELL BIOL, V82, P523, DOI 10.1078/0171-9335-00337; VIDGREN J, 1994, NATURE, V368, P354, DOI 10.1038/368354a0; Wang HM, 2000, EMBO J, V19, P317, DOI 10.1093/emboj/19.3.317; Widerak M, 2005, GENE, V347, P109, DOI 10.1016/j.gene.2004.12.025; Wu H, 2009, PDB ID 2NYU; YANG D, 1985, P NATL ACAD SCI USA, V82, P4443, DOI 10.1073/pnas.82.13.4443; Yang XK, 2012, CANCER LETT, V321, P137, DOI 10.1016/j.canlet.2012.01.030; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494	51	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90818	10.1371/journal.pone.0090818	http://dx.doi.org/10.1371/journal.pone.0090818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595062	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500103
J	Mi, YN; Ping, NN; Xiao, X; Zhu, YB; Liu, J; Cao, YX				Mi, Yan-Ni; Ping, Na-Na; Xiao, Xue; Zhu, Yan-Bing; Liu, Jing; Cao, Yong-Xiao			The Severe Adverse Reaction to Vitamin K-1 Injection Is Anaphylactoid Reaction but Not Anaphylaxis	PLOS ONE			English	Article							IDIOSYNCRATIC DRUG-REACTIONS; PHYTONADIONE VITAMIN-K-1; ANIMAL-MODELS; BEAGLE DOGS; HYPERSENSITIVITY; POLYSORBATE-80; DEGRANULATION	The severe adverse reaction to vitamin K-1 injection is always remarkable and is thought to result from anaphylaxis. Paradoxically, however, some patients administered vitamin K-1 injection for the first time have adverse reactions. Using beagle dogs, the present study tested the hypothesis that the response to vitamin K-1 is an anaphylactoid reaction. The results showed that serious anaphylaxis-like symptoms appeared in beagle dogs after the administration of vitamin K-1 injection for the first time. The plasma histamine concentration increased, and blood pressure decreased sharply. After sensitization, dogs were challenged with vitamin K-1 injection and displayed the same degree of symptoms as prior to sensitization. However, when the vitamin K-1 injection-sensitized dogs were challenged with a vitamin K-1-fat emulsion without solubilizers such asTween-80, the abnormal reactions did not occur. Furthermore, there was no significant change in the plasma immunoglobulin E concentration after vitamin K-1 challenge. Following treatment with vitamin K-1 injection, the release of histamine and beta-hexosaminidase by rat basophilic leukemia-2H3 cells as well as the rate of apoptosis increased. The Tween-80 group displayed results similar to those observed following vitamin K-1 injection in vivo. However, the dogs in the vitamin K-1-fat emulsion group did not display any abnormal behavior or significant change in plasma histamine. Additionally, degranulation and apoptosis did not occur in rat basophilic leukemia-2H3 cells. Our results indicate that the adverse reaction induced by vitamin K-1 injection is an anaphylactoid reaction, not anaphylaxis. Vitamin K-1 injection induces the release of inflammatory factors via a non-IgE-mediated immune pathway, for which the trigger may be the solubilizer.	[Mi, Yan-Ni; Ping, Na-Na; Xiao, Xue; Zhu, Yan-Bing; Liu, Jing; Cao, Yong-Xiao] Xi An Jiao Tong Univ, Coll Med, Dept Pharmacol, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University	Cao, YX (corresponding author), Xi An Jiao Tong Univ, Coll Med, Dept Pharmacol, Xian 710049, Shaanxi, Peoples R China.	yxy@xjtu.edu.cn			Shaanxi province science and technology research and development programs of China [2012SP2-06]	Shaanxi province science and technology research and development programs of China	This work was supported by the Shaanxi province science and technology research and development programs of China (2012SP2-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coors EA, 2005, ANN ALLERG ASTHMA IM, V95, P593, DOI 10.1016/S1081-1206(10)61024-1; Fiore LD, 2001, J THROMB THROMBOLYS, V11, P175, DOI 10.1023/A:1011237019082; Funaba M, 2003, CELL BIOL INT, V27, P879, DOI 10.1016/S1065-6995(03)00177-X; He Ping, 2012, Zhongguo Zhong Yao Za Zhi, V37, P1880; Huang FH, 2010, ACTA PHARMACOL SIN, V31, P849, DOI 10.1038/aps.2010.63; Liang Aihua, 2010, Zhongguo Zhong Yao Za Zhi, V35, P2328; MARTIN JC, 1991, MED J AUSTRALIA, V155, P851, DOI 10.5694/j.1326-5377.1991.tb94070.x; Na HJ, 2005, J ETHNOPHARMACOL, V101, P43, DOI 10.1016/j.jep.2005.03.026; Ng WN, 2012, ADV PHARMACOL, V63, P81, DOI 10.1016/B978-0-12-398339-8.00003-3; Nishikawa H, 2011, TOXICOL APPL PHARM, V252, P228, DOI 10.1016/j.taap.2011.02.011; Pereira SP, 1998, PHARMACOEPIDEM DR S, V7, P173, DOI 10.1002/(SICI)1099-1557(199805/06)7:3<173::AID-PDS343>3.0.CO;2-8; Qiu SD, 2013, INT IMMUNOPHARMACOL, V15, P144, DOI 10.1016/j.intimp.2012.10.021; Riegert-Johnson DL, 2002, ANN ALLERG ASTHMA IM, V89, P400, DOI 10.1016/S1081-1206(10)62042-X; Riegert-Johnson DL, 2001, BONE MARROW TRANSPL, V28, P1176, DOI 10.1038/sj.bmt.1703305; SFDA PRC, 2011, AL REG SER ALL REACT; Shenton JM, 2004, CHEM-BIOL INTERACT, V150, P53, DOI 10.1016/j.cbi.2004.09.001; Sommer S, 2002, CONTACT DERMATITIS, V46, P94, DOI 10.1034/j.1600-0536.2002.460206.x; Sousa Tatiana, 2010, Dermatol Online J, V16, P16; Sun Wei-wei, 2011, Zhongguo Zhong Xi Yi Jie He Za Zhi, V31, P90; Sun Weiwei, 2011, Zhongguo Zhong Yao Za Zhi, V36, P1874; Van der Meer J, 1968, Thromb Diath Haemorrh Suppl, V29, P1; Vo TS, 2011, CARBOHYD POLYM, V84, P649, DOI 10.1016/j.carbpol.2010.12.046; Wang ZG, 2012, J TRADIT CHIN MED, V32, P641, DOI 10.1016/S0254-6272(13)60085-0; Wang Zhiguo, 2011, Zhongguo Zhong Yao Za Zhi, V36, P1842; Wang Zhiguo, 2011, Zhongguo Zhong Yao Za Zhi, V36, P1870; WEISS RB, 1990, J CLIN ONCOL, V8, P1263, DOI 10.1200/JCO.1990.8.7.1263; Wilkins K, 2000, J Cutan Med Surg, V4, P164; Yang G-H, 2009, CHIN J CLIN RATIONAL, V2	28	29	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90199	10.1371/journal.pone.0090199	http://dx.doi.org/10.1371/journal.pone.0090199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594861	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500037
J	Peng, XR; Liu, T; Shi, CY; Zhang, LQ; Wang, Y; Zhao, WY; Jiang, LH; Wu, MC; Zhang, Y; Qian, QJ				Peng, Xinrong; Liu, Tao; Shi, Chuanyin; Zhang, Liqing; Wang, Ying; Zhao, Wuyang; Jiang, Lihua; Wu, Mengchao; Zhang, Yong; Qian, Qijun			Germline Transmission of an Embryonic Stem Cell Line Derived from BALB/c Cataract Mice	PLOS ONE			English	Article							SELF-RENEWAL; CONGENITAL CATARACT; GROUND-STATE; MOUSE STRAIN; INHIBITORS; CULTURE; GENE; GSK3	Mice embryonic stem (ES) cells have enabled the generation of mouse strains with defined mutation(s) in their genome for putative disease loci analysis. In the study of cataract, the complex genetic background of this disease and lack of long-term self-renewal ES cells have hampered the functional researches of cataract-related genes. In this study, we aimed to establish ES cells from inherited cataract mice (BALB/C-Cat/Cat). Embryos of cataract mice were cultured in chemical-defined N2B27 medium with the presence of two small molecules PD0325901 and CHIR99021 (2i) and an ES cell line (named EH-BES) was successfully established. EH-BES showed long-term self-renewal in 2i medium and maintained capacity of germline transmission. Most importantly, the produced chimera and offspring developed congenital cataract as well. Flow cytometry assay revealed that EH-BES are homogeneous in expression of Oct4 and Rex1in 2i medium, which may account for their self-renewal ability. With long-term self-renewal ability and germline-competent, EH-BES cell line can facilitate genetic and functional researches of cataract-related genes and better address mechanisms of cataract.	[Peng, Xinrong; Zhang, Yong] Northwest Agr & Forestry Univ, Coll Vet Med, Xianyang, Shanxi, Peoples R China; [Peng, Xinrong; Liu, Tao; Shi, Chuanyin; Wang, Ying; Jiang, Lihua; Wu, Mengchao; Qian, Qijun] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China; [Zhang, Liqing; Zhao, Wuyang; Qian, Qijun] Zhejiang Sci Tech Univ, Xinyuan Inst Med & Biotechnol, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Northwest A&F University - China; Naval Medical University; Zhejiang Sci-Tech University	Zhang, Y (corresponding author), Northwest Agr & Forestry Univ, Coll Vet Med, Xianyang, Shanxi, Peoples R China.	zhangyong1956@nwsuaf.edu.cn; qianqj@sino-gene.cn	Wang, Ying/AAY-4117-2021	Wang, Ying/0000-0002-1819-294X	National Science Fund for distinguished Yong Scholar [30925037]; National Natural Science Foundation of China [81071850]; National High Technology Research and Development Program 863 [2012AA020806]; National Significant Science and Technology Special Projects of New Drugs Creation [2011ZX09102-010-02]	National Science Fund for distinguished Yong Scholar; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); National Significant Science and Technology Special Projects of New Drugs Creation	This work was supported by the National Science Fund for distinguished Yong Scholar (No. 30925037), National Natural Science Foundation of China (No. 81071850), National High Technology Research and Development Program 863 (No. 2012AA020806) and National Significant Science and Technology Special Projects of New Drugs Creation (No. 2011ZX09102-010-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Craig JE, 2008, MOL VIS, V14, P721; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; LEITER EH, 1985, CURR TOP MICROBIOL, V122, P78; Li L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012624; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; MATSUZAWA A, 1988, EXP EYE RES, V47, P705, DOI 10.1016/0014-4835(88)90038-3; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nakamura T, 1998, BIOCHEM BIOPH RES CO, V248, P22, DOI 10.1006/bbrc.1998.8900; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; NobenTrauth N, 1996, TRANSGENIC RES, V5, P487, DOI 10.1007/BF01980214; Pelton TA, 2002, J CELL SCI, V115, P329; Peng XR, 2013, CELL REPROGRAM, V15, P179, DOI 10.1089/cell.2012.0065; Santana A, 2011, ARQ BRAS OFTALMOL, V74, P136, DOI 10.1590/S0004-27492011000200016; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Wang J, 2007, CHINESE MED J-PEKING, V120, P820, DOI 10.1097/00029330-200705010-00015; YASUMURA Y, 1966, CANCER RES, V26, P529; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhao WX, 2012, MOLECULES, V17, P6196, DOI 10.3390/molecules17066196	29	0	0	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90707	10.1371/journal.pone.0090707	http://dx.doi.org/10.1371/journal.pone.0090707			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595217	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500089
J	Sletten, T; Kostas, M; Bober, J; Sorensen, V; Yadollahi, M; Olsnes, S; Tomala, J; Otlewski, J; Zakrzewska, M; Wiedlocha, A				Sletten, Torunn; Kostas, Michal; Bober, Joanna; Sorensen, Vigdis; Yadollahi, Mandana; Olsnes, Sjur; Tomala, Justyna; Otlewski, Jacek; Zakrzewska, Malgorzata; Wiedlocha, Antoni			Nucleolin Regulates Phosphorylation and Nuclear Export of Fibroblast Growth Factor 1 (FGF1)	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; RIBOSOMAL-PROTEIN L26; CELL-CYCLE ARREST; INTRACELLULAR PROTEIN; EXOGENOUS FGF1; WEB SERVER; TRANSLOCATION; CYTOSOL; BINDING; SEQUENCE	Extracellular fibroblast growth factor 1 (FGF1) acts through cell surface tyrosine kinase receptors, but FGF1 can also act directly in the cell nucleus, as a result of nuclear import of endogenously produced, non-secreted FGF1 or by transport of extracellular FGF1 via endosomes and cytosol into the nucleus. In the nucleus, FGF1 can be phosphorylated by protein kinase C delta (PKC delta), and this event induces nuclear export of FGF1. To identify intracellular targets of FGF1 we performed affinity pull-down assays and identified nucleolin, a nuclear multifunctional protein, as an interaction partner of FGF1. We confirmed a direct nucleolin-FGF1 interaction by surface plasmon resonance and identified residues of FGF1 involved in the binding to be located within the heparin binding site. To assess the biological role of the nucleolin-FGF1 interaction, we studied the intracellular trafficking of FGF1. In nucleolin depleted cells, exogenous FGF1 was endocytosed and translocated to the cytosol and nucleus, but FGF1 was not phosphorylated by PKC delta or exported from the nucleus. Using FGF1 mutants with reduced binding to nucleolin and a FGF1-phosphomimetic mutant, we showed that the nucleolin-FGF1 interaction is critical for the intranuclear phosphorylation of FGF1 by PKC delta and thereby the regulation of nuclear export of FGF1.	[Sletten, Torunn; Sorensen, Vigdis; Yadollahi, Mandana; Olsnes, Sjur; Wiedlocha, Antoni] Oslo Univ Hosp, Dept Biochem, Inst Canc Res, Norwegian Radium Hosp, Oslo, Norway; [Sletten, Torunn; Sorensen, Vigdis; Yadollahi, Mandana; Olsnes, Sjur; Wiedlocha, Antoni] Univ Oslo, Fac Med, Ctr Canc Biomed, N-0316 Oslo, Norway; [Bober, Joanna; Otlewski, Jacek; Zakrzewska, Malgorzata] Univ Wroclaw, Dept Prot Engn, Fac Biotechnol, PL-50138 Wroclaw, Poland; [Kostas, Michal; Tomala, Justyna] Univ Wroclaw, Dept Prot Biotechnol, Fac Biotechnol, PL-50138 Wroclaw, Poland	University of Oslo; University of Oslo; University of Wroclaw; University of Wroclaw	Zakrzewska, M (corresponding author), Univ Wroclaw, Dept Prot Engn, Fac Biotechnol, PL-50138 Wroclaw, Poland.	malgorzata.zakrzewska@uni.wroc.pl; antoni.wiedlocha@rr-research.no		Bober, Joanna/0000-0002-8588-0486; Zakrzewska, Malgorzata/0000-0001-8214-1533	Norway through the Norwegian Financial Mechanism within the Polish-Norwegian Research Fund [PNRF-87-AI-1/07]; Polish Ministry of Science and Higher Education [0627/IP1/2011/71]; Norwegian Cancer Society	Norway through the Norwegian Financial Mechanism within the Polish-Norwegian Research Fund; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grant PNRF-87-AI-1/07 from Norway through the Norwegian Financial Mechanism within the Polish-Norwegian Research Fund, and by the Polish Ministry of Science and Higher Education (grant 0627/IP1/2011/71) and the Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bhatt P, 2012, FEBS J, V279, P370, DOI 10.1111/j.1742-4658.2011.08430.x; Bonnet H, 1996, J BIOL CHEM, V271, P24781, DOI 10.1074/jbc.271.40.24781; Bossard C, 2003, NAT CELL BIOL, V5, P433, DOI 10.1038/ncb979; Bouleau S, 2005, ONCOGENE, V24, P7839, DOI 10.1038/sj.onc.1208932; Brand TM, 2011, DISCOV MED, V12, P419; BURGESS WH, 1991, ANN NY ACAD SCI, V638, P89, DOI 10.1111/j.1749-6632.1991.tb49020.x; Chandra M, 2012, MOL CELL BIOL, V32, P2183, DOI 10.1128/MCB.00320-12; Chen J, 2012, J BIOL CHEM, V287, P16467, DOI 10.1074/jbc.M112.349274; Daniely Y, 2002, MOL CELL BIOL, V22, P6014, DOI 10.1128/MCB.22.16.6014-6022.2002; Di Segni A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002310; Fu Y, 2009, BIOCHEMISTRY-US, V48, P11655, DOI 10.1021/bi901265z; Ginisty H, 1999, J CELL SCI, V112, P761; Greco A, 2012, J VIROL, V86, P1449, DOI 10.1128/JVI.06194-11; Haugsten EM, 2008, MOL BIOL CELL, V19, P3390, DOI 10.1091/mbc.E07-12-1219; Hong SK, 2009, P NATL ACAD SCI USA, V106, P2230, DOI 10.1073/pnas.0812880106; IMAMURA T, 1990, SCIENCE, V249, P1567, DOI 10.1126/science.1699274; IMAMURA T, 1992, J BIOL CHEM, V267, P5676; Jans DA, 1998, BIOESSAYS, V20, P400, DOI 10.1002/(SICI)1521-1878(199805)20:5<400::AID-BIES7>3.0.CO;2-R; Klingenberg O, 2000, J BIOL CHEM, V275, P11972, DOI 10.1074/jbc.275.16.11972; Klingenberg O, 2000, J CELL SCI, V113, P1827; Klingenberg O, 1999, J BIOL CHEM, V274, P18081, DOI 10.1074/jbc.274.25.18081; Kolpakova E, 1998, BIOCHEM J, V336, P213, DOI 10.1042/bj3360213; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Liang H, 2006, NUCLEIC ACIDS RES, V34, pW382, DOI 10.1093/nar/gkl272; Malecki J, 2002, EMBO J, V21, P4480, DOI 10.1093/emboj/cdf472; Meunier S, 2009, TRAFFIC, V10, P1765, DOI 10.1111/j.1600-0854.2009.00985.x; Mizukoshi E, 1999, BIOCHEM J, V343, P461, DOI 10.1042/0264-6021:3430461; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Nilsen T, 2007, J BIOL CHEM, V282, P26245, DOI 10.1074/jbc.M611234200; Olsnes S, 2003, PHYSIOL REV, V83, P163, DOI 10.1152/physrev.00021.2002; Ornitz DM, 2001, GENOME BIOL, V2; Planque Nathalie, 2006, Cell Commun Signal, V4, P7, DOI 10.1186/1478-811X-4-7; Qin S, 2007, BIOINFORMATICS, V23, P3386, DOI 10.1093/bioinformatics/btm434; Renaud F, 1996, J BIOL CHEM, V271, P2801, DOI 10.1074/jbc.271.5.2801; Rodriguez-Enfedaque A, 2009, BBA-MOL CELL RES, V1793, P1719, DOI 10.1016/j.bbamcr.2009.09.010; Saxena A, 2006, ONCOGENE, V25, P7274, DOI 10.1038/sj.onc.1209714; Sheng Z, 2005, MOL CELL BIOL, V25, P9419, DOI 10.1128/MCB.25.21.9419-9426.2005; Skjerpen CS, 2002, J BIOL CHEM, V277, P23864, DOI 10.1074/jbc.M112193200; Skjerpen CS, 2002, EMBO J, V21, P4058, DOI 10.1093/emboj/cdf402; Song N, 2012, ANGIOGENESIS, V15, P697, DOI 10.1007/s10456-012-9284-y; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Sorensen V, 2008, MOL CELL BIOL, V28, P4129, DOI 10.1128/MCB.02117-07; Sorensen V, 2006, J CELL SCI, V119, P4332, DOI 10.1242/jcs.03209; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Svitel J, 2003, BIOPHYS J, V84, P4062, DOI 10.1016/S0006-3495(03)75132-7; Tajrishi Marjan M, 2011, Commun Integr Biol, V4, P267, DOI 10.4161/cib.4.3.14884; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Wesche J, 2005, BIOCHEMISTRY-US, V44, P6071, DOI 10.1021/bi047403m; WIEDLOCHA A, 1994, CELL, V76, P1039, DOI 10.1016/0092-8674(94)90381-6; Wiedlocha A, 2005, MOL BIOL CELL, V16, P794; Wiedlocha A, 2004, CURR TOP MICROBIOL, V286, P45; Yang Chonglin, 2009, Mol Cell Pharmacol, V1, P130; Zakrzewska M, 2005, J MOL BIOL, V352, P860, DOI 10.1016/j.jmb.2005.07.066; Zakrzewska M, 2011, EXP CELL RES, V317, P1005, DOI 10.1016/j.yexcr.2011.01.003; Zakrzewska M, 2009, J BIOL CHEM, V284, P25388, DOI 10.1074/jbc.M109.001289; Zhen Y, 2012, TRAFFIC, V13, P650, DOI 10.1111/j.1600-0854.2012.01341.x	58	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90687	10.1371/journal.pone.0090687	http://dx.doi.org/10.1371/journal.pone.0090687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595027	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000332475500086
J	Dang, YY; Liu, B; Xu, P; Zhu, PY; Zhai, YM; Liu, MY; Ye, XY				Dang, Yongyan; Liu, Bei; Xu, Peng; Zhu, Pingya; Zhai, Yimiao; Liu, Mingyao; Ye, Xiyun			Gpr48 Deficiency Induces Polycystic Kidney Lesions and Renal Fibrosis in Mice by Activating Wnt Signal Pathway	PLOS ONE			English	Article							DOWN-REGULATION; TGF-BETA; INTERSTITIAL FIBROSIS; DISEASE; LGR4; INHIBITION; EXPRESSION; INDUCTION; CANCER; INJURY	G protein-coupled receptor 48 (Gpr48/Lgr4) is essential to regulate the development of multiple tissues in mice. The notion that Gpr48 functions in renal development prompted us to investigate the relation between Gpr48 and renal diseases. Using a Gpr48 knockout mice model, we observed that 66.7% Gpr48 null mice developed polycystic lesions in the kidney, while no cysts were observed in the kidneys of wild-type mice. Polycystic kidney disease 1 (PKD1) and PKD2 expressions were also markedly decreased in the Gpr48 knockout mice. Abnormal expressions of exra-cellular matrix protein lead to the progression of polycystic kidney disease and the formation of renal fibrosis in the Gpr48 null mice. The expressions of several Wnt molecules and its receptors were increased and marked beta-catenin nuclear accumulation was observed in the Gpr48 null mice. The inhibitors of Wnt/beta-catenin signal pathway such as GSK3 beta and axin2 were loss of function. The Wnt/PCP signaling pathway is also activated in Gpr48 null mice. However, TGF-beta expression and phosphorylated Smad2/3 levels were not altered. Collectively, our results showed that Gpr48 null mice are at a greater risk of suffering from polycystic lesions and renal fibrosis. Moreover, the formation of polycystic lesions and renal fibrosis induced by Gpr48 deficiency involves the activation of Wnt signaling pathway but not the TGF-beta/Smad pathway.	[Liu, Mingyao] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China; E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University	Liu, MY (corresponding author), E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China.	mliu@lm.bio.ecnu.edu; xyye@bio.ecnu.edu.cn		Liu, Mingyao/0000-0001-7339-5048	National Natural Science Foundation of China [81272226]; Key Science and Technology Projects from the Science and Technology Commission of Shanghai Municipality [13JC1405102]; Research Fund for the Doctoral Program of Higher Education [20100076120007]; National Basic Research Program of China [2012CB910400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Projects from the Science and Technology Commission of Shanghai Municipality; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (No. 81272226), Key Science and Technology Projects from the Science and Technology Commission of Shanghai Municipality (13JC1405102), Research Fund for the Doctoral Program of Higher Education (No. 20100076120007) and National Basic Research Program of China (2012CB910400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzing T, 2007, J AM SOC NEPHROL, V18, P1389, DOI 10.1681/ASN.2006121355; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Chia IV, 2005, MOL CELL BIOL, V25, P4371, DOI 10.1128/MCB.25.11.4371-4376.2005; Gao Y, 2006, CANCER RES, V66, P11623, DOI 10.1158/0008-5472.CAN-06-2629; Hao S, 2011, J AM SOC NEPHROL, V22, P1642, DOI 10.1681/ASN.2010101079; Hassane S, 2010, J PATHOL, V222, P21, DOI 10.1002/path.2734; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Iglesias DM, 2007, AM J PHYSIOL-RENAL, V293, pF494, DOI 10.1152/ajprenal.00416.2006; Jin C, 2008, INVEST OPHTH VIS SCI, V49, P4245, DOI 10.1167/iovs.08-1860; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Lancaster MA, 2010, TRENDS MOL MED, V16, P349, DOI 10.1016/j.molmed.2010.05.004; Li JH, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014252.37680.E4; Lyons JP, 2009, MECH DEVELOP, V126, P142, DOI 10.1016/j.mod.2008.11.007; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Mohri Y, 2008, DEV DYNAM, V237, P2235, DOI 10.1002/dvdy.21639; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; Obermuller N, 2001, AM J PHYSIOL-RENAL, V280, pF540, DOI 10.1152/ajprenal.2001.280.3.F540; Okada H, 2000, KIDNEY INT, V58, P587, DOI 10.1046/j.1523-1755.2000.00205.x; Okada S, 2003, DIABETES, V52, P2586, DOI 10.2337/diabetes.52.10.2586; Omori S, 2006, J AM SOC NEPHROL, V17, P1604, DOI 10.1681/ASN.2004090800; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Pulkkinen Kaisa, 2008, Organogenesis, V4, P55; Qian LH, 2011, P NATL ACAD SCI USA, V108, P8692, DOI 10.1073/pnas.1100328108; Rao VH, 2003, KIDNEY INT, V63, P1736, DOI 10.1046/j.1523-1755.2003.00939.x; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Song HP, 2008, J BIOL CHEM, V283, P36687, DOI 10.1074/jbc.M800721200; Spiegelberg BD, 2007, CURR OPIN GENET DEV, V17, P40, DOI 10.1016/j.gde.2006.12.002; Surendran K, 2002, AM J PHYSIOL-RENAL, V282, pF431, DOI 10.1152/ajprenal.0009.2001; Tan JH, 2006, CANCER RES, V66, P2320, DOI 10.1158/0008-5472.CAN-05-2700; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Wuthrich RP, 1999, NEPHROL DIAL TRANSPL, V14, P2554, DOI 10.1093/ndt/14.11.2554; Yamashita R, 2009, DEV DYNAM, V238, P993, DOI 10.1002/dvdy.21900; Zhang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026533	37	9	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89835	10.1371/journal.pone.0089835	http://dx.doi.org/10.1371/journal.pone.0089835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595031	gold, Green Published, Green Submitted			2022-12-27	WOS:000332468900039
J	de la Hera, B; Varade, J; Garcia-Montojo, M; Alcina, A; Fedetz, M; Alloza, I; Astobiza, I; Leyva, L; Fernandez, O; Izquierdo, G; Antiguedad, A; Arroyo, R; Alvarez-Lafuente, R; Vandenbroeck, K; Matesanz, F; Urcelay, E				de la Hera, Belen; Varade, Jezabel; Garcia-Montojo, Marta; Alcina, Antonio; Fedetz, Maria; Alloza, Iraide; Astobiza, Ianire; Leyva, Laura; Fernandez, Oscar; Izquierdo, Guillermo; Antigueedad, Alfredo; Arroyo, Rafael; Alvarez-Lafuente, Roberto; Vandenbroeck, Koen; Matesanz, Fuencisla; Urcelay, Elena			Human Endogenous Retrovirus HERV-Fc1 Association with Multiple Sclerosis Susceptibility: A Meta-Analysis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; RISK-FACTORS; FLIP-FLOP; EXPRESSION; LINKAGE	Background: Human endogenous retroviruses (HERVs) are repetitive sequences derived from ancestral germ-line infections by exogenous retroviruses and different HERV families have been integrated in the genome. HERV-Fc1 in chromosome X has been previously associated with multiple sclerosis (MS) in Northern European populations. Additionally, HERV-Fc1 RNA levels of expression have been found increased in plasma of MS patients with active disease. Considering the North-South latitude gradient in MS prevalence, we aimed to evaluate the role of HERV-Fc1on MS risk in three independent Spanish cohorts. Methods: A single nucleotide polymorphism near HERV-Fc1, rs391745, was genotyped by Taqman chemistry in a total of 2473 MS patients and 3031 ethnically matched controls, consecutively recruited from: Northern (569 patients and 980 controls), Central (883 patients and 692 controls) and Southern (1021 patients and 1359 controls) Spain. Our results were pooled in a meta-analysis with previously published data. Results: Significant associations of the HERV-Fc1 polymorphism with MS were observed in two Spanish cohorts and the combined meta-analysis with previous data yielded a significant association [rs391745 C-allele carriers: p(M-H) = 0.0005; ORM-H (95% CI) = 1.27 (1.11-1.45)]. Concordantly to previous findings, when the analysis was restricted to relapsing remitting and secondary progressive MS samples, a slight enhancement in the strength of the association was observed [p(M-H) = 0.0003, ORM-H (95% CI) = 1.32 (1.14-1.53)]. Conclusion: Association of the HERV-Fc1 polymorphism rs391745 with bout-onset MS susceptibility was confirmed in Southern European cohorts.	[de la Hera, Belen; Varade, Jezabel; Urcelay, Elena] Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Hosp Clin San Carlos, Dept Immunol, Madrid, Spain; [Garcia-Montojo, Marta; Arroyo, Rafael; Alvarez-Lafuente, Roberto] Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Hosp Clin San Carlos, Multiple Sclerosis Unit, Dept Neurol, Madrid, Spain; [Alcina, Antonio; Fedetz, Maria; Matesanz, Fuencisla] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Alloza, Iraide; Astobiza, Ianire; Vandenbroeck, Koen] Univ Pais Vasco UPV EHU, Neurogenomiks Grp, Leioa, Spain; [Leyva, Laura] Hosp Reg Univ, Inst Neurociencias Clin, Lab Invest, Malaga, Spain; [Fernandez, Oscar] Hosp Reg Univ, Inst Neurociencias Clin, Serv Neurol, Malaga, Spain; [Izquierdo, Guillermo] Hosp Virgen Macarena, Unidad Esclerosis Multiple, Seville, Spain; [Antigueedad, Alfredo] Hosp Basurto, Serv Neurol, Bilbao, Spain; [Vandenbroeck, Koen] Achucarro Basque Ctr Neurosci UPV EHU, Zamudio, Spain; [Vandenbroeck, Koen] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	Hospital Clinico San Carlos; Hospital Clinico San Carlos; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Basque Country; Hospital Universitario Virgen Macarena; Basurto Hospital; University of Basque Country; Basque Foundation for Science	Urcelay, E (corresponding author), Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Hosp Clin San Carlos, Dept Immunol, Madrid, Spain.	elena.urcelay@salud.madrid.org	Alcina, Antonio/T-1893-2017; Leyva, Laura/R-2187-2019; Varadé, Jezabel/Z-5054-2019; Alvarez-Lafuente, Roberto/AAJ-9980-2020; Leyva, Laura/B-5574-2019; Astobiza, Ianire/AAA-4265-2019; Matesanz, Fuencisla/F-3715-2016; Vandenbroeck, Koen/D-6845-2012; varade, jezabel/B-2771-2017	Alcina, Antonio/0000-0001-7294-0948; Leyva, Laura/0000-0003-0620-9625; Varadé, Jezabel/0000-0002-3964-110X; Leyva, Laura/0000-0003-0620-9625; Astobiza, Ianire/0000-0002-7142-7066; Matesanz, Fuencisla/0000-0002-9429-1819; Vandenbroeck, Koen/0000-0002-6967-6485; varade, jezabel/0000-0002-3964-110X; Alloza, Iraide/0000-0002-8949-7732; Urcelay, Elena/0000-0001-8470-8396; Garcia-Montojo, Marta/0000-0003-0664-3480; Alvarez-Lafuente, Roberto/0000-0002-3132-1486	Fondo de Investigaciones Sanitarias [FI11/00560]; Ministerio de Economia y Competitividad [PTA2011-6137-1]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Ministerio de Economia y Competitividad(Spanish Government)	Belen de la Hera is recipient of a PhD scholarship from "Fondo de Investigaciones Sanitarias" (FI11/00560), Jezabel Varade benefits from a contract of "Ministerio de Economia y Competitividad'' (PTA2011-6137-1) and Elena Urcelay Works for the Fundacion para la Investigacion Biomedica-Hospital Clinico San Carlos. This is a collaborative study promoted by "REEM: Red Espanola de Esclerosis Multiple'' (RETICS-REEM RD12/0032/009; www.reem.es). The funders did not play any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascherio A, 2000, EPIDEMIOLOGY, V11, P220, DOI 10.1097/00001648-200003000-00023; Ascherio A, 2012, NAT REV NEUROL, V8, P602, DOI 10.1038/nrneurol.2012.198; Barrio AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019832; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Benit L, 2003, VIROLOGY, V312, P159, DOI 10.1016/S0042-6822(03)00163-6; Brudek T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-104; Christensen T, 2007, Int MS J, V14, P41; Christensen T, 2005, REV MED VIROL, V15, P179, DOI 10.1002/rmv.465; Clarke GM, 2010, GENET EPIDEMIOL, V34, P266, DOI 10.1002/gepi.20458; de la Hera B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062090; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Faraone SV, 2002, AM J MED GENET, V114, P598, DOI 10.1002/ajmg.10601; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Garcia-Montojo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053623; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hansen B, 2011, PLOS ONE, V6; Hutchinson M, 2011, MULT SCLER J, V17, P1176, DOI 10.1177/1352458511421107; JERSILD C, 1972, LANCET, V1, P1240; Laska MJ, 2012, J VIROL, V86, P3713, DOI 10.1128/JVI.06723-11; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Lucas RM, 2011, NEUROLOGY, V76, P540, DOI 10.1212/WNL.0b013e31820af93d; Maher B, 2012, NATURE, V489, P46, DOI 10.1038/489046a; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Nexo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016652; Nissen KK, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-188; Owens GP, 2012, MULT SCLER J, V18, P1204, DOI 10.1177/1352458512448109; Pierrot-Deseilligny C, 2010, BRAIN, V133, P1869, DOI 10.1093/brain/awq147; Ryan FP, 2011, CURR NEUROPHARMACOL, V9, P360, DOI 10.2174/157015911795596568; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Simpson S, 2011, J NEUROL NEUROSUR PS, V82, P1132, DOI 10.1136/jnnp.2011.240432; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; Watson CT, 2012, SCI REP-UK, V2, DOI 10.1038/srep00770; Zaykin DV, 2008, AM J HUM GENET, V82, P794, DOI 10.1016/j.ajhg.2008.02.001	34	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90182	10.1371/journal.pone.0090182	http://dx.doi.org/10.1371/journal.pone.0090182			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594754	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900077
J	Frenzel, D; Gluck, JM; Brener, O; Oesterhelt, F; Nagel-Steger, L; Willbold, D				Frenzel, Daniel; Glueck, Julian M.; Brener, Oleksandr; Oesterhelt, Filipp; Nagel-Steger, Luitgard; Willbold, Dieter			Immobilization of Homogeneous Monomeric, Oligomeric and Fibrillar A beta Species for Reliable SPR Measurements	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; PEPTIDE; PROTEINS; AGGREGATION; DEMENTIA; BRAIN; ASSAY	There is strong evidence that the amyloid-beta peptide (Ab) plays a central role in the pathogenesis of Alzheimer's disease (AD). In this context, a detailed quantitative description of the interactions with different Ab species is essential for characterization of physiological and artificial ligands. However, the high aggregation propensity of Ab in concert with its susceptibility to structural changes due to even slight changes in solution conditions has impeded surface plasmon resonance (SPR) studies with homogeneous Ab conformer species. Here, we have adapted the experimental procedures to state-of-the-art techniques and established novel approaches to reliably overcome the aforementioned challenges. We show that the application of density gradient centrifugation (DGC) for sample purification and the use of a single chain variable fragment (scFv) of a monoclonal antibody directed against the amino-terminus of Ab allows reliable SPR measurements and quality control of the immobilized Ab aggregate species at any step throughout the experiment.	[Frenzel, Daniel; Glueck, Julian M.; Brener, Oleksandr; Nagel-Steger, Luitgard; Willbold, Dieter] Forschungszentrum Julich, ICS 6 Struct Biochem, D-52425 Julich, Germany; [Brener, Oleksandr; Oesterhelt, Filipp; Nagel-Steger, Luitgard; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf	Willbold, D (corresponding author), Forschungszentrum Julich, ICS 6 Struct Biochem, D-52425 Julich, Germany.	D.Willbold@fz-juelich.de	Nagel-Steger, Luitgard/H-6415-2013; Willbold, Dieter/A-6280-2013	Nagel-Steger, Luitgard/0000-0001-5232-2149; Willbold, Dieter/0000-0002-0065-7366; Brener, Oleksandr/0000-0001-9771-7515				Amijee H, 2012, BIOCHEMISTRY-US, V51, P8338, DOI 10.1021/bi300415v; Bruggink KA, 2013, ANAL BIOCHEM, V433, P112, DOI 10.1016/j.ab.2012.09.014; Cannon MJ, 2004, ANAL BIOCHEM, V328, P67, DOI 10.1016/j.ab.2004.01.014; Dornieden S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059820; Esparza TJ, 2013, ANN NEUROL, V73, P104, DOI 10.1002/ana.23748; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; FORD T, 1994, ANAL BIOCHEM, V220, P360, DOI 10.1006/abio.1994.1350; Gluck JM, 2011, ANAL BIOCHEM, V408, P46, DOI 10.1016/j.ab.2010.08.028; GREEN NM, 1963, BIOCHEM J, V89, P585, DOI 10.1042/bj0890585; Gulland A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2604; Johansson AS, 2006, FEBS J, V273, P2618, DOI 10.1111/j.1742-4658.2006.05263.x; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Milligan CE, 2000, NAT MED, V6, P385, DOI 10.1038/74644; Muller-Schiffmann A, 2010, ANGEW CHEM INT EDIT, V49, P8743, DOI 10.1002/anie.201004437; Nagel-Steger L, 2010, EUR BIOPHYS J BIOPHY, V39, P415, DOI 10.1007/s00249-009-0416-2; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SCHMIDT ML, 1994, EXP NEUROL, V130, P311, DOI 10.1006/exnr.1994.1209; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; Stine WB, 1996, J PROTEIN CHEM, V15, P193, DOI 10.1007/BF01887400; Stravalaci M, 2012, J BIOL CHEM, V287, P27796, DOI 10.1074/jbc.M111.334979; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Wang-Dietrich L, 2013, J ALZHEIMERS DIS, V34, P985, DOI 10.3233/JAD-122047; Wood SJ, 1996, J MOL BIOL, V256, P870, DOI 10.1006/jmbi.1996.0133; Xia N, 2010, ANAL CHEM, V82, P10151, DOI 10.1021/ac102257m	24	10	10	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89490	10.1371/journal.pone.0089490	http://dx.doi.org/10.1371/journal.pone.0089490			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594736	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900019
J	Kang, PC; Wan, M; Huang, P; Li, CL; Wang, ZD; Zhong, XY; Hu, ZL; Tai, S; Cui, YF				Kang, Pengcheng; Wan, Ming; Huang, Peng; Li, Chunlong; Wang, Zhidong; Zhong, Xiangyu; Hu, Zhanliang; Tai, Sheng; Cui, Yunfu			The Wnt Antagonist sFRP1 as a Favorable Prognosticator in Human Biliary Tract Carcinoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; BETA-CATENIN; ABERRANT METHYLATION; TARGET GENES; EXPRESSION; CHOLANGIOCARCINOMA; PROGRESSION; INHIBITION; PATHWAYS; MUTATION	Inactivation of Secreted Frizzled-Related wProtein-1 (SFRP1) and overexpression of beta-catenin play important roles in the development and progression of a wide range of malignancies. We sought to determine whether the expression of SFRP1 and beta-catenin correlates with clinicopathologic parameters in human biliary tract cancer (BTC) and to evaluate the potential roles of these proteins as prognostic indicators. The expression of SFRP1 and beta-catenin in 78 patients with BTC and 36 control patients as investigated by immunohistochemistry. A wide variety of statistical parameters were assessed to determine the association between these proteins and the occurrence, clinical features, and overall survival rate in BTC. SFRP1 and beta-catenin had an inverse correlation (r = -0.636, P<0.0001) as assessed by Spearman rank analysis, with 52 (66.7%) of the BTC samples negative for SFRP1 expression and 53 (68.0%) positive for beta-catenin expression. Expression of each protein was associated with the histological type and lymph node invasion of BTC. A significantly poorer overall survival rate was observed for patients with low SFRP1 expression (P< 0.0001) or high beta-catenin expression (P = 0.007). SFRP1 expression (P<0.0001), beta-catenin expression (P<0.01) and histological type (P<0.01) were correlated with overall survival rate as assessed by univariate analysis; while multivariate analysis suggested that SFRP1 (hazard ratio, 10.514; 95% confidence intervals, 2.381-39.048; P<0.0001) may serve as an independent prognostic factor for BTC. Collectively, these results demonstrate that SFRP1 is a favorable prognostic factor for human BTC and that its expression inversely correlates with that of beta-catenin.	[Kang, Pengcheng; Wan, Ming; Huang, Peng; Li, Chunlong; Wang, Zhidong; Zhong, Xiangyu; Hu, Zhanliang; Tai, Sheng; Cui, Yunfu] Harbin Med Univ, Affiliated Hosp 2, Dept Hepatopancreatobiliary Surg, Harbin, Peoples R China	Harbin Medical University	Cui, YF (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Hepatopancreatobiliary Surg, Harbin, Peoples R China.	yfcui777@hotmail.com		cui, yunfu/0000-0001-7393-1680	National Natural Science Foundation of China [81170426]; Heilongjiang Province Science and Technology Preferred Projects [297]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Province Science and Technology Preferred Projects	This study was supported by the National Natural Science Foundation of China (no. 81170426) and Heilongjiang Province Science and Technology Preferred Projects (2011, no. 297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen K, 2012, EPIGENETICS-US, V7, P1249, DOI 10.4161/epi.22191; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Byun T, 2005, J CLIN PATHOL, V58, P515, DOI 10.1136/jcp.2004.018598; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Caldwell GM, 2004, CANCER RES, V64, P883, DOI 10.1158/0008-5472.CAN-03-1346; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Figueras J, 2000, NEW ENGL J MED, V342, P663; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; FRAUMENI JF, 1996, CANC EPIDEMIOLOGY PR, P794; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Goeppert B, 2014, HEPATOLOGY, V59, P544, DOI 10.1002/hep.26721; Hsing AW, 1998, INT J CANCER, V75, P368, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt;368::AID-IJC7&gt;3.0.CO;2-0; Huang J, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-126; Jarnagin WR, 2004, SEMIN LIVER DIS, V24, P189, DOI 10.1055/s-2004-828895; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Klopocki E, 2004, INT J ONCOL, V25, P641; Lee AY, 2004, ONCOGENE, V23, P6672, DOI 10.1038/sj.onc.1207881; Lodygin D, 2005, CANCER RES, V65, P4218, DOI 10.1158/0008-5472.CAN-04-4407; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Malhi H, 2006, J HEPATOL, V45, P856, DOI 10.1016/j.jhep.2006.09.001; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Marsit CJ, 2005, CANCER RES, V65, P7081, DOI 10.1158/0008-5472.CAN-05-0267; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Stoehr R, 2004, LAB INVEST, V84, P465, DOI 10.1038/labinvest.3700068; Sun X, 2013, CELL SIGNAL, V25, P2805, DOI 10.1016/j.cellsig.2013.09.006; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Suzuki M, 2007, CLIN CANCER RES, V13, P6087, DOI 10.1158/1078-0432.CCR-07-0591; Takada T, 2004, CANCER SCI, V95, P741, DOI 10.1111/j.1349-7006.2004.tb03255.x; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Ugolini F, 2001, ONCOGENE, V20, P5810, DOI 10.1038/sj.onc.1204706; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; Wong CM, 2001, CANCER-AM CANCER SOC, V92, P136, DOI 10.1002/1097-0142(20010701)92:1<136::AID-CNCR1301>3.0.CO;2-R; Xi S, 2010, PLOS ONE, V29, P5; Yan D, 2001, P NATL ACAD SCI USA, V98, P3802, DOI 10.1073/pnas.071041898; You J, 2013, PLOS ONE, V18, P8; Zong YW, 2011, INT J BIOCHEM CELL B, V43, P257, DOI 10.1016/j.biocel.2010.06.020; Zou HZ, 2005, INT J CANCER, V116, P584, DOI 10.1002/ijc.21045	39	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90308	10.1371/journal.pone.0090308	http://dx.doi.org/10.1371/journal.pone.0090308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594839	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900093
J	Lee, HC; Lu, PN; Huang, HL; Chu, C; Li, HP; Tsai, HJ				Lee, Hung-Chieh; Lu, Po-Nien; Huang, Hui-Lan; Chu, Chien; Li, Hong-Ping; Tsai, Huai-Jen			Zebrafish Transgenic Line huORFZ Is an Effective Living Bioindicator for Detecting Environmental Toxicants	PLOS ONE			English	Article							OPEN READING FRAME; HUMAN HEALTH; WATER; FISH; POLLUTION; LIVER; ACTIVATION; BIOSENSOR; MONITOR; ENZYMES	Reliable animal models are invaluable for monitoring the extent of pollution in the aquatic environment. In this study, we demonstrated the potential of huORFZ, a novel transgenic zebrafish line that harbors a human upstream open reading frame of the chop gene fused with GFP reporter, as an animal model for monitoring environmental pollutants and stress-related cellular processes. When huORFZ embryos were kept under normal condition, no leaked GFP signal could be detected. When treated with hazardous chemicals, including heavy metals and endocrine-disrupting chemicals near their sublethal concentrations (LC50), huORFZ embryos exhibited different tissue-specific GFP expression patterns. For further analysis, copper (Cu2+), cadmium (Cd2+) and Chlorpyrifos were applied. Cu2+ triggered GFP responses in skin and muscle, whereas Cd2+ treatment triggered GFP responses in skin, olfactory epithelium and pronephric ducts. Moreover, fluorescence intensity, as exhibited by huORFZ embryos, was dose-dependent. After surviving treated embryos were returned to normal condition, survival rates, as well as TUNEL signals, returned to pretreatment levels with no significant morphological defects observed. Such results indicated the reversibility of treatment conditions used in this study, as long as embryos survived such conditions. Notably, GFP signals decreased along with recovery, suggesting that GFP signaling of huORFZ embryos likely reflected the overall physiological condition of the individual. To examine the performance of the huORFZ line under real-world conditions, we placed huORFZ embryos in different river water samples. We found that the huORFZ embryos correctly detected the presence of various kinds of pollutants. Based on these findings, we concluded that such uORF(chop) based system can be integrated into a first-line water alarm system monitoring the discharge of hazardous pollutants.	[Lee, Hung-Chieh; Lu, Po-Nien; Huang, Hui-Lan; Tsai, Huai-Jen] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Lu, Po-Nien; Huang, Hui-Lan] Liver Dis Prevent & Treatment Res Fdn, Taipei, Taiwan; [Chu, Chien; Li, Hong-Ping] Council Agr, Taiwan Agr Chem & Toxic Subst Res Inst, Taichung, Taiwan; [Chu, Chien] Natl Chung Hsing Univ, Dept Soil & Environm Sci, Taichung 40227, Taiwan	National Taiwan University; National Chung Hsing University	Tsai, HJ (corresponding author), Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan.	hjtsai@ntu.edu.tw		Lu, Po-Nien/0000-0003-1804-0177	National Science Council, Taiwan [NSC -01-2321-B-002-018-]; Liver Disease Prevention & Treatment Research Foundation, Taipei, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Liver Disease Prevention & Treatment Research Foundation, Taipei, Taiwan	This work was supported by the National Science Council, Taiwan (http://web1.nsc.gov.tw/mp.aspx?mp=7) with grant number: NSC-01-2321-B-002-018-. This study was also partially supported by the Liver Disease Prevention & Treatment Research Foundation, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg M, 2001, ENVIRON SCI TECHNOL, V35, P2621, DOI 10.1021/es010027y; Blechinger SR, 2002, ENVIRON HEALTH PERSP, V110, P1041, DOI 10.1289/ehp.021101041; Cardwell R D, 1976, Arch Environ Contam Toxicol, V4, P129; Chen H, 2010, AQUAT TOXICOL, V96, P53, DOI 10.1016/j.aquatox.2009.09.015; Dalton LE, 2013, BRIT J CANCER, V108, P1340, DOI 10.1038/bjc.2013.66; GILL TS, 1990, COMP BIOCHEM PHYS C, V97, P287, DOI 10.1016/0742-8413(90)90143-W; GOKSOYR A, 1991, FISH PHYSIOL BIOCHEM, V9, P1, DOI 10.1007/BF01987606; GOKSOYR A, 1991, COMP BIOCHEM PHYS C, V100, P157, DOI 10.1016/0742-8413(91)90144-I; HAASCH ML, 1989, TOXICOL APPL PHARM, V98, P362, DOI 10.1016/0041-008X(89)90240-8; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Hung KWV, 2012, BIOSENS BIOELECTRON, V31, P548, DOI 10.1016/j.bios.2011.10.004; Jousse C, 2001, NUCLEIC ACIDS RES, V29, P4341, DOI 10.1093/nar/29.21.4341; Kim KH, 2013, AQUAT TOXICOL, V134, P57, DOI 10.1016/j.aquatox.2013.03.010; Klecka G, 2010, REV ENVIRON CONTAM T, V207, P1, DOI 10.1007/978-1-4419-6406-9_1; Lee HC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr645; Lee O, 2012, ENVIRON HEALTH PERSP, V120, P990, DOI 10.1289/ehp.1104433; Morozova VS, 2005, J ANAL CHEM+, V60, P202, DOI 10.1007/s10809-005-0075-0; Mukhopadhyay I, 2003, J BIOCHEM MOL TOXIC, V17, P249, DOI 10.1002/jbt.10086; Noche RR, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-7; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; PAYNE JF, 1987, COMP BIOCHEM PHYS C, V86, P233, DOI 10.1016/0742-8413(87)90074-0; PAYNE JF, 1976, SCIENCE, V191, P945, DOI 10.1126/science.1251203; Rasband W., 2006, IMAGEJ; RODRIGUEZARIZA A, 1994, ENVIRON MOL MUTAGEN, V24, P116, DOI 10.1002/em.2850240207; Sakuma M, 1998, APPL ENTOMOL ZOOL, V33, P339, DOI 10.1303/aez.33.339; Schwarzenbach RP, 2010, ANNU REV ENV RESOUR, V35, P109, DOI 10.1146/annurev-environ-100809-125342; Sorg O, 2009, LANCET, V374, P1179, DOI 10.1016/S0140-6736(09)60912-0; STERNBERG SR, 1983, COMPUTER, V16, P22, DOI 10.1109/MC.1983.1654163; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wang YH, 2006, TOXICOL LETT, V163, P191, DOI 10.1016/j.toxlet.2005.10.024; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; World Health Organization, 2011, GUID DRINK WAT QUAL, Vxxiii; Wu YL, 2008, GENE, V408, P85, DOI 10.1016/j.gene.2007.10.027	33	17	18	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90160	10.1371/journal.pone.0090160	http://dx.doi.org/10.1371/journal.pone.0090160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594581	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900074
J	Pfortmueller, CA; Marti, M; Kunz, M; Lindner, G; Exadaktylos, AK				Pfortmueller, Carmen A.; Marti, Mariana; Kunz, Mirco; Lindner, Gregor; Exadaktylos, Aristomenis K.			Injury Severity and Mortality of Adult Zebra Crosswalk and Non-Zebra Crosswalk Road Crossing Accidents: A Cross-Sectional Analysis	PLOS ONE			English	Article							PEDESTRIANS; BEHAVIOR; DRIVERS; CRASHES; SPEED; RISK	Principals: Over a million people worldwide die each year from road traffic injuries and more than 10 million sustain permanent disabilities. Many of these victims are pedestrians. The present retrospective study analyzes the severity and mortality of injuries suffered by adult pedestrians, depending on whether they used a zebra crosswalk. Methods: Our retrospective data analysis covered adult patients admitted to our emergency department (ED) between 1 January 2000 and 31 December 2012 after being hit by a vehicle while crossing the road as a pedestrian. Patients were identified by using a string term. Medical, police and ambulance records were reviewed for data extraction. Results: A total of 347 patients were eligible for study inclusion. Two hundred and three (203; 58.5%) patients were on a zebra crosswalk and 144 (41.5%) were not. The mean ISS (injury Severity Score) was 12.1 (SD 14.7, range 1-75). The vehicles were faster in non-zebra crosswalk accidents (47.7 km/n, versus 41.4 km/h, p<0.027). The mean ISS score was higher in patients with non-zebra crosswalk accidents; 14.4 (SD 16.5, range 1-75) versus 10.5 (SD13.14, range 1-75) (p<0.019). Zebra crosswalk accidents were associated with less risk of severe injury (OR 0.61, 95% CI 0.38-0.98, p<0.042). Accidents involving a truck were associated with increased risk of severe injury (OR 3.53, 95% CI 1.21-10.26, p<0.02). Conclusion: Accidents on zebra crosswalks are more common than those not on zebra crosswalks. The injury severity of non-zebra crosswalk accidents is significantly higher than in patients with zebra crosswalk accidents. Accidents involving large vehicles are associated with increased risk of severe injury. Further prospective studies are needed, with detailed assessment of motor vehicle types and speed.	[Pfortmueller, Carmen A.; Lindner, Gregor] Univ Hosp Bern, Univ Dept Gen Internal Med, CH-3010 Bern, Switzerland; [Pfortmueller, Carmen A.; Marti, Mariana; Lindner, Gregor; Exadaktylos, Aristomenis K.] Univ Bern, Bern, Switzerland; [Marti, Mariana; Exadaktylos, Aristomenis K.] Univ Hosp Bern, Univ Dept Emergency Med, CH-3010 Bern, Switzerland; [Kunz, Mirco] Kantonsspital Winterthur, Dept Anesthesiol, Winterthur, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern	Pfortmueller, CA (corresponding author), Univ Hosp Bern, Univ Dept Gen Internal Med, CH-3010 Bern, Switzerland.	cpfortmueller@gmail.com	Lindner, Gregor/AAR-6761-2020	Lindner, Gregor/0000-0001-5551-8227; Pfortmueller, Carmen/0000-0003-0326-2770				[Anonymous], 2002, PEDESTRIAN AFETY NEW; [Anonymous], 1996, 136 U LUND, P136; [Anonymous], 1988, EVALUATION EFFECTIVE; BFU, 2012, STAT 2012; BFU, 2004, SICH SCHUL BFU SAF T; Bunn F., 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003110, DOI 10.1002/14651858.CD003110]; Duperrex O, 2002, BRIT MED J, V324, P1129, DOI 10.1136/bmj.324.7346.1129; Hamed MM, 2001, SAFETY SCI, V38, P63, DOI 10.1016/S0925-7535(00)00058-8; Herms BF, 1972, 406 HIGHW RES BOARD, P406; KALLINEN M, 1995, SPORTS MED, V20, P41, DOI 10.2165/00007256-199520010-00004; Koepsell T, 2002, JAMA-J AM MED ASSOC, V288, P2136, DOI 10.1001/jama.288.17.2136; Moudon AV, 2011, ACCIDENT ANAL PREV, V43, P11, DOI 10.1016/j.aap.2009.12.008; Muhammad M, 2009, MAKING ROADS SAFE PE; Rothman L, 2012, INJURY PREV, V18, P365, DOI 10.1136/injuryprev-2011-040246; Roudsari BS, 2004, INJURY PREV, V10, P154, DOI 10.1136/ip.2003.003814; Scaramuzza G, 1997, SICHERHEITSTECHNISCH; Tefft BC, 2013, ACCIDENT ANAL PREV, V50, P871, DOI 10.1016/j.aap.2012.07.022; Thompson JP, 2013, ACCIDENT ANAL PREV, V50, P768, DOI 10.1016/j.aap.2012.06.028; Tidwell JE, 1995, TRANSPORT RES REC, V1502, P119; Tobey H.N., 1983, TRANSPORT RES REC, P31; Varhelyi A, 1998, ACCIDENT ANAL PREV, V30, P731, DOI 10.1016/S0001-4575(98)00026-8	21	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90835	10.1371/journal.pone.0090835	http://dx.doi.org/10.1371/journal.pone.0090835			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4CT	24595100	Green Published, gold			2022-12-27	WOS:000332468900151
J	Sztiller-Sikorska, M; Koprowska, K; Majchrzak, K; Hartman, M; Czyz, M				Sztiller-Sikorska, Malgorzata; Koprowska, Kamila; Majchrzak, Kinga; Hartman, Mariusz; Czyz, Malgorzata			Natural Compounds' Activity against Cancer Stem-Like or Fast-Cycling Melanoma Cells	PLOS ONE			English	Article							SIDE-POPULATION CELLS; CYTOTOXIN ILLUDIN-M; HEPATOCELLULAR-CARCINOMA; IN-VIVO; MALIGNANT-MELANOMA; SIGNALING PATHWAY; HSP90 INHIBITORS; SELF-RENEWAL; TUMOR-GROWTH; LUNG-CANCER	Background: Accumulating evidence supports the concept that melanoma is highly heterogeneous and sustained by a small subpopulation of melanoma stem-like cells. Those cells are considered as responsible for tumor resistance to therapies. Moreover, melanoma cells are characterized by their high phenotypic plasticity. Consequently, both melanoma stem-like cells and their more differentiated progeny must be eradicated to achieve durable cure. By reevaluating compounds in heterogeneous melanoma populations, it might be possible to select compounds with activity not only against fast-cycling cells but also against cancer stem-like cells. Natural compounds were the focus of the present study. Methods: We analyzed 120 compounds from The Natural Products Set II to identify compounds active against melanoma populations grown in an anchorage-independent manner and enriched with cells exerting self-renewing capacity. Cell viability, cell cycle arrest, apoptosis, gene expression, clonogenic survival and label-retention were analyzed. Findings: Several compounds efficiently eradicated cells with clonogenic capacity and nanaomycin A, streptonigrin and toyocamycin were effective at 0.1 mu M. Other anti-clonogenic but not highly cytotoxic compounds such as bryostatin 1, siomycin A, illudin M, michellamine B and pentoxifylline markedly reduced the frequency of ABCB5 (ATP-binding cassette, sub-family B, member 5)-positive cells. On the contrary, treatment with maytansine and colchicine selected for cells expressing this transporter. Maytansine, streptonigrin, toyocamycin and colchicine, even if highly cytotoxic, left a small subpopulation of slow-dividing cells unaffected. Compounds selected in the present study differentially altered the expression of melanocyte/melanoma specific microphthalmia-associated transcription factor (MITF) and proto-oncogene c-MYC. Conclusion: Selected anti-clonogenic compounds might be further investigated as potential adjuvants targeting melanoma stem-like cells in the combined anti-melanoma therapy, whereas selected cytotoxic but not anti-clonogenic compounds, which increased the frequency of ABCB5-positive cells and remained slow-cycling cells unaffected, might be considered as a tool to enrich cultures with cells exhibiting melanoma stem cell characteristics.	[Sztiller-Sikorska, Malgorzata; Koprowska, Kamila; Majchrzak, Kinga; Hartman, Mariusz; Czyz, Malgorzata] Med Univ Lodz, Dept Mol Biol Canc, Lodz, Poland	Medical University Lodz	Czyz, M (corresponding author), Med Univ Lodz, Dept Mol Biol Canc, Lodz, Poland.	malgorzata.czyz@umed.lodz.pl	Sztiller-Sikorska, Malgorzata Magdalena/S-9581-2016; /S-9995-2016; Czyz, Malgorzata/AAD-1869-2020; Koprowska, Kamila/J-8550-2012	Czyz, Malgorzata/0000-0002-8279-4742; Majchrzak, Kinga/0000-0001-5978-7782; Hartman, Mariusz/0000-0002-2231-3740; Sztiller-Sikorska, Malgorzata/0000-0001-5827-7959	National Science Centre [2011/01/B/NZ4/04921]	National Science Centre(National Science Centre, Poland)	Funding: This work was financially supported by a grant 2011/01/B/NZ4/04921 from the National Science Centre. The Natural Products Set II was provided at no cost by the US National Cancer Institute (NCI, http://www.dtp.nci.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akunuru S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.93; Bhat UG, 2008, CELL CYCLE, V7, P1851, DOI 10.4161/cc.7.12.6032; Blanc V, 2011, CLIN CANCER RES, V17, P6448, DOI 10.1158/1078-0432.CCR-11-0485; Blum R H, 1978, Cancer Clin Trials, V1, P113; Bolzan AD, 2001, MUTAT RES-REV MUTAT, V488, P25, DOI 10.1016/S1383-5742(00)00062-4; BORDEN EC, 1982, AM J CLIN ONCOL-CANC, V5, P417, DOI 10.1097/00000421-198208000-00012; Bragado P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029974; Burris HA, 2011, J CLIN ONCOL, V29, P398, DOI 10.1200/JCO.2010.29.5865; Cassady JM, 2004, CHEM PHARM BULL, V52, P1, DOI 10.1248/cpb.52.1; Caulfield T, 2011, J STRUCT BIOL, V176, P185, DOI 10.1016/j.jsb.2011.07.015; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chartrain M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036762; Chen GJ, 2007, J CELL BIOCHEM, V101, P1492, DOI 10.1002/jcb.21265; Chen XM, 2012, TOXICOL IN VITRO, V26, P649, DOI 10.1016/j.tiv.2012.01.024; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Czyz M, 2013, CANCER BIOL THER, V14, P135, DOI 10.4161/cbt.22952; D'incalci M, 2007, CURR PHARM DESIGN, V13, P2744, DOI 10.2174/138161207781757097; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dua P, 2006, CANCER CHEMOTH PHARM, V58, P195, DOI 10.1007/s00280-005-0155-8; Elliott AM, 2009, MOL CANCER RES, V7, P79, DOI 10.1158/1541-7786.MCR-08-0235; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Frenzel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027988; Garate M, 2010, FREE RADICAL BIO MED, V48, P1601, DOI 10.1016/j.freeradbiomed.2010.03.003; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gavriil M, 2009, MOL CARCINOGEN, V48, P678, DOI 10.1002/mc.20550; Goding CR, 2011, ONCOGENE, V30, P2304, DOI 10.1038/onc.2010.641; Gomez-Cabrero A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073607; Gu JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062839; Hallett RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033976; Haq R, 2013, P NATL ACAD SCI USA, V110, P4321, DOI 10.1073/pnas.1205575110; He KJ, 2011, MOL CANCER THER, V10, P938, DOI 10.1158/1535-7163.MCT-10-1120; Helm F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077375; Hermann PC, 2010, SEMIN CANCER BIOL, V20, P77, DOI 10.1016/j.semcancer.2010.03.004; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Jain M, 2010, CHEMOTHERAPY, V56, P82, DOI 10.1159/000298823; Kamran MZ, 2013, BIOMED PHARMACOTHER, V67, P399, DOI 10.1016/j.biopha.2013.03.020; Kamran MZ, 2012, BIOMED PHARMACOTHER, V66, P617, DOI 10.1016/j.biopha.2012.03.006; Kiburu IN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037371; Kilarski WW, 2012, ANGIOGENESIS, V15, P643, DOI 10.1007/s10456-012-9287-8; Knauer S, 2009, ANTI-CANCER DRUG, V20, P676, DOI 10.1097/CAD.0b013e32832e056a; Koprowska K, 2013, ANTI-CANCER DRUG, V24, P835, DOI 10.1097/CAD.0b013e3283635a04; Kuck D, 2010, MOL CANCER THER, V9, P3015, DOI 10.1158/1535-7163.MCT-10-0609; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Leder K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014366; Lewis AM, 2005, MOL CARCINOGEN, V43, P215, DOI 10.1002/mc.20107; Lin ZY, 2013, LIFE SCI, V93, P323, DOI 10.1016/j.lfs.2013.07.002; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; MCMORRIS TC, 1990, CHEM RES TOXICOL, V3, P574, DOI 10.1021/tx00018a013; Murphy GF, 2014, MOL ASPECTS MED, V39, P33, DOI 10.1016/j.mam.2013.10.003; Nakano I, 2011, NEURO-ONCOLOGY, V13, P622, DOI 10.1093/neuonc/nor023; Park S, 2011, BBA-GEN SUBJECTS, V1810, P1340, DOI 10.1016/j.bbagen.2011.06.023; Perego M, 2010, J INVEST DERMATOL, V130, P1877, DOI 10.1038/jid.2010.69; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Rabindran SK, 2000, CANCER RES, V60, P47; Ramgolam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018784; Ri M, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.26; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Saez-Ayala M, 2013, CANCER CELL, V24, P105, DOI 10.1016/j.ccr.2013.05.009; Sawanyawisuth K, 2007, ACTA ONCOL, V46, P378, DOI 10.1080/02841860600871061; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schobert R, 2008, BIOORGAN MED CHEM, V16, P8592, DOI 10.1016/j.bmc.2008.08.015; Sheen IS, 2005, WORLD J GASTROENTERO, V11, P771, DOI 10.3748/wjg.v11.i6.771; Shukla V, 2003, CANCER BIOTHER RADIO, V18, P559, DOI 10.1089/108497803322287637; Singh S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-73; Sinnberg T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023429; SKOUFIAS DA, 1992, BIOCHEMISTRY-US, V31, P738, DOI 10.1021/bi00118a015; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; SUHADOLN.RJ, 1967, BIOCHIM BIOPHYS ACTA, V149, P41, DOI 10.1016/0005-2787(67)90689-2; Sztiller-Sikorska M, 2012, MELANOMA RES, V22, P215, DOI 10.1097/CMR.0b013e3283531317; TAVITIAN A, 1969, BIOCHIM BIOPHYS ACTA, V179, P50, DOI 10.1016/0005-2787(69)90121-X; Theron T, 2000, INT J RADIAT BIOL, V76, P1197, DOI 10.1080/09553000050134438; Thurber AE, 2011, ONCOGENE, V30, P3036, DOI 10.1038/onc.2011.33; Toyomura K, 2012, J TOXICOL SCI, V37, P1049, DOI 10.2131/jts.37.1049; Valkenburg Kenneth C, 2011, Cancers (Basel), V3, P2050, DOI 10.3390/cancers3022050; van der Kraan AGJ, 2013, BIOCHEM J, V451, P235, DOI 10.1042/BJ20121626; Zhai JM, 2013, DIGEST DIS SCI, V58, P1934, DOI 10.1007/s10620-013-2663-4; Zhao D, 2011, CELL IMMUNOL, V271, P392, DOI 10.1016/j.cellimm.2011.08.007	80	38	39	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90783	10.1371/journal.pone.0090783	http://dx.doi.org/10.1371/journal.pone.0090783			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595456	Green Submitted, gold, Green Published			2022-12-27	WOS:000332468900146
J	Wahlstrom, H; Lewerin, SS; Sundstrom, K; Ivarsson, S				Wahlstrom, Helene; Lewerin, Susanna Sternberg; Sundstrom, Kristian; Ivarsson, Sofie			Estimation of the Expected Change in Domestic Human Salmonella Cases in Sweden in 2010, Given a Hypothetical Relaxation of the Current Salmonella Control Programme	PLOS ONE			English	Article							COUNTRIES	The Swedish salmonella control programme has been very successful in reducing the number of salmonella infections in both humans and animals. However, the costs for the control have increased and it has thus been questioned if the control measures could be relaxed and, if so, what effect this would have on human and animal health. The aim of the present study is to evaluate the expected effects on human health of a relaxation of the Swedish control i.e. a substitution of the present programme with a programme similar to the ones present in Denmark or the Netherlands. Data from the year 2010 was used to illustrate this. It was assumed that the domestic exposure to salmonella would then become the same in Sweden as it was in Denmark or the Netherlands in that year. As official statistics on the number of reported salmonella cases are not comparable across European countries, data from five different sources were used to try to obtain comparable estimates of the domestic salmonella exposure in the three countries. The study shows that the number of reported domestic human salmonella cases in Sweden in 2010 would increase by approximately 900 to 2 400 cases in the Danish scenarios and 6 400 to 8 400 in the Dutch scenarios. Although uncertainty exists, it was concluded that the number of reported domestic salmonella cases would increase substantially in Sweden in case of a relaxation of the current control programme.	[Wahlstrom, Helene] Natl Vet Inst, Zoonosis Ctr, S-75007 Uppsala, Sweden; [Lewerin, Susanna Sternberg] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Sundstrom, Kristian] Lund Univ, Inst Food & Agr Econ, Lund, Sweden; [Ivarsson, Sofie] Swedish Inst Communicable Dis Control, Dept Preparedness, Solna, Sweden	National Veterinary Institute SVA; Swedish University of Agricultural Sciences; Lund University; Swedish Institute for Infectious Disease Control	Wahlstrom, H (corresponding author), Natl Vet Inst, Zoonosis Ctr, S-75007 Uppsala, Sweden.	helene.wahlstrom@sva.se	Lewerin, Susanna Sternberg/C-1621-2015	Lewerin, Susanna Sternberg/0000-0001-7907-8377				[Anonymous], 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.134r; [Anonymous], 2010, ANN REPORT ZOONOSES; [Anonymous], 2011, SURVEILLANCE ZOONOTI; de Jong B, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-4; EFSA, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.135r; EFSA, 2007, EFSA J, V97; EFSA, 2007, EFSA J, V98, P1; EFSA, 2009, EFSA J, V7; Engvall A, 1994, EC SWEDISH SALMONELL; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; Falkenhorst G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-523; Haagsma JA, 2013, EPIDEMIOL INFECT, V141, P1625, DOI 10.1017/S0950268812002166; Havelaar A, 2012, EPIDEMIOLOGY INFECT, V1, P1; Pires SM, 2011, ESTIMATION RELATIVE; RIVM, 2010, RIJKS VOLKSG MIL RIV; Smittskyddsinstitutet, 2011, SMITTSK EP ARSR 2010; Sundstrom K, 2010, FOLKHALSA DJURHALSA, V2010, P106; Wahlstrom H, 2011, EPIDEMIOL INFECT, V139, P1246, DOI 10.1017/S0950268810002293	18	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89833	10.1371/journal.pone.0089833	http://dx.doi.org/10.1371/journal.pone.0089833			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594989	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900038
J	Gelir, E; Basaran, C; Bayrak, S; Yagcioglu, S; Budak, MT; Firat, H; Ungan, P				Gelir, Ethem; Basaran, Cenk; Bayrak, Sibel; Yagcioglu, Suha; Budak, Murat Timur; Firat, Hikmet; Ungan, Pekcan			Electrophysiological Assessment of the Effects of Obstructive Sleep Apnea on Cognition	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; EXECUTIVE FUNCTIONS; WORKING-MEMORY; DEFICITS; PATHOGENESIS; ATTENTION; BATTERY; TASKS; MODEL	We used electrophysiological measures to investigate the effects of obstructive sleep apnea on attention, learning, and memory. Thirty subjects (OSA group, n = 15, control group n = 15) participated in n-back tests, accompanied by P300 recordings, to investigate working memory and attention. The mirror-drawing test was used to study procedural memory, and the trail-making test (TMT) was used to evaluate divided attention and executive function. No significant group difference in reaction time was found in the 0-back and 1-back tests. In the 2-back test, reaction times of patients were longer than those of the control group. No P300 wave was obtained in the OSA group in any (0-, 1-, or 2-back) n-back test. In contrast, in the control group, significant P300 waves were recorded except for the 2-back test. The mirror-drawing scores were unaffected by sleep apnea. There was no difference between groups in the TMT-A test on any of the trials. Although no group difference was found in the first or second trials of the TMT-B test, OSA patients were less successful in learning on the third trial. According to our study results, OSA affects attention and executive function adversely however, we could not detect a significant effect on working or procedural memory.	[Gelir, Ethem; Basaran, Cenk; Bayrak, Sibel; Budak, Murat Timur] Hacettepe Univ, Sch Med, Dept Physiol, Ankara, Turkey; [Yagcioglu, Suha] Hacettepe Univ, Sch Med, Dept Biophys, Ankara, Turkey; [Firat, Hikmet] SGK Ankara Educ Hosp, Sleep Lab, Dept Pulm Med, Ankara, Turkey; [Ungan, Pekcan] Koc Univ, Sch Med, Dept Biophys, Istanbul, Turkey	Hacettepe University; Hacettepe University; Ankara Training & Research Hospital; Koc University	Gelir, E (corresponding author), Hacettepe Univ, Sch Med, Dept Physiol, Ankara, Turkey.	egelir@hacettepe.edu.tr	BAYRAK, SIBEL/I-8359-2013; Ungan, Pekcan/W-2038-2019; FIRAT, ibrahim Hikmet/E-3047-2017; FIRAT, ibrahim Hikmet/GPP-5399-2022	Ungan, Pekcan/0000-0001-6682-3446; FIRAT, ibrahim Hikmet/0000-0003-2594-4887; FIRAT, ibrahim Hikmet/0000-0003-2594-4887	The Scientific and Technological Research Council of Turkey (TUBITAK) [107S122]	The Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This study was funded by The Scientific and Technological Research Council of Turkey (TUBITAK). Grant number: 107S122. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams N, 2001, AM J RESP CRIT CARE, V163, P1626, DOI 10.1164/ajrccm.163.7.2004014; Aloia MS, 2004, J INT NEUROPSYCH SOC, V10, P772, DOI 10.1017/S1355617704105134; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Archbold KH, 2009, J CLIN SLEEP MED, V5, P21; BEDARD MA, 1991, J CLIN EXP NEUROPSYC, V13, P950, DOI 10.1080/01688639108405110; Beebe DW, 2005, CURR OPIN PULM MED, V11, P494, DOI 10.1097/01.mcp.0000183059.52924.39; Beebe DW, 2002, J SLEEP RES, V11, P1, DOI 10.1046/j.1365-2869.2002.00289.x; BONNET M, 1993, SLEEP, V16, P748; Bornstein SK., 1982, SLEEPING WAKING DISO, P183; Cangoz B, 2009, J NEUROL SCI, V283, P73, DOI 10.1016/j.jns.2009.02.313; Decary A, 2000, SLEEP, V23, P369; Felver-Gant JC, 2007, J CLIN SLEEP MED, V3, P589; Feuerstein C, 1997, ACTA NEUROL BELG, V97, P96; Gosselin N, 2006, CLIN NEUROPHYSIOL, V117, P2228, DOI 10.1016/j.clinph.2006.07.130; Inoue Y, 2001, PSYCHIAT CLIN NEUROS, V55, P247, DOI 10.1046/j.1440-1819.2001.00844.x; Kennedy KM, 2005, CORTEX, V41, P560, DOI 10.1016/S0010-9452(08)70196-5; KRAMER AF, 1988, BIOL PSYCHOL, V26, P231, DOI 10.1016/0301-0511(88)90022-1; Lis S, 2008, J SLEEP RES, V17, P271, DOI 10.1111/j.1365-2869.2008.00660.x; Mazza S, 2005, EUR RESPIR J, V25, P75, DOI 10.1183/09031936.04.00011204; NAEGELE B, 1995, SLEEP, V18, P43; Oken Barry S., 1997, P529; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Prilipko O, 2011, SLEEP, V34, P293, DOI 10.1093/sleep/34.3.293; Raggi A, 2012, REV NEUROSCIENCE, V23, P311, DOI 10.1515/revneuro-2012-0027; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Redline S, 1997, SLEEP, V20, P160, DOI 10.1093/sleep/20.2.160; Rouleau I, 2002, SLEEP, V25, P401; RUMBACH L, 1991, ELECTROEN CLIN NEURO, V80, P454, DOI 10.1016/0168-5597(91)90094-E; Ryan CM, 2005, J APPL PHYSIOL, V99, P2440, DOI 10.1152/japplphysiol.00772.2005; Salorio CF, 2002, J CLIN EXP NEUROPSYC, V24, P93, DOI 10.1076/jcen.24.1.93.973; Sangal RB, 1997, SLEEP, V20, P702, DOI 10.1093/sleep/20.9.702; Saunamaki T, 2007, ACTA NEUROL SCAND, V115, P1, DOI 10.1111/j.1600-0404.2006.00744.x; Thomas RJ, 2005, J APPL PHYSIOL, V98, P2226, DOI 10.1152/japplphysiol.01225.2004; Verstraeten E, 2004, SLEEP, V27, P685; Vicari S, 2005, J NEUROL NEUROSUR PS, V76, P1392, DOI 10.1136/jnnp.2004.061093; WALSLEBEN JA, 1989, ELECTROEN CLIN NEURO, V74, P297, DOI 10.1016/0168-5597(89)90060-9; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207	37	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90647	10.1371/journal.pone.0090647	http://dx.doi.org/10.1371/journal.pone.0090647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587405	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200239
J	Prieto, MJ; Zabala, NED; Marotta, CH; Gutierrez, HC; Arevalo, RA; Chiaramoni, NS; Alonso, SD				Jimena Prieto, Maria; del Rio Zabala, Nahuel Eduardo; Hernan Marotta, Cristian; Carreno Gutierrez, Hector; Arevalo Arevalo, Rosario; Silvia Chiaramoni, Nadia; del Valle Alonso, Silvia			Optimization and In Vivo Toxicity Evaluation of G4.5 Pamam Dendrimer-Risperidone Complexes	PLOS ONE			English	Article							ORAL-DRUG DELIVERY; POLY(AMIDOAMINE) DENDRIMERS; ANTIPSYCHOTIC-DRUGS; VISUAL PATHWAY; CELL VIABILITY; ZEBRAFISH; CARRIERS; BRAIN; MODEL; AUTISM	Risperidone is an approved antipsychotic drug belonging to the chemical class of benzisoxazole. This drug has low solubility in aqueous medium and poor bioavailability due to extensive first-pass metabolism and high protein binding (>90%). Since new strategies to improve efficient treatments are needed, we studied the efficiency of anionic G4.5 PAMAM dendrimers as nanocarriers for this therapeutic drug. To this end, we explored dendrimer-risperidone complexation dependence on solvent concentration, pH and molar relationship. The best dendrimer-risperidone incorporation (46 risperidone molecules per dendrimer) was achieved with a mixture of chloroform: methanol 50:50 v/v solution pH 3. In addition, to explore the possible effects of this complex, in vivo studies were carried out in the zebrafish model. Changes in the development of dopaminergic neurons and motoneurons were studied using tyrosine hydroxylase and calretinin, respectively. Physiological changes were studied through histological sections stained with hematoxylin-eosin to observe possible morphological brain changes. The most significant changes were observed when larvae were treated with free risperidone, and no changes were observed when larvae were treated with the complex.	[Jimena Prieto, Maria; del Rio Zabala, Nahuel Eduardo; Hernan Marotta, Cristian; Silvia Chiaramoni, Nadia; del Valle Alonso, Silvia] Natl Univ Quilmes, Dept Sci & Technol, Biomembrane Lab, Buenos Aires, DF, Argentina; [Jimena Prieto, Maria; del Rio Zabala, Nahuel Eduardo; Hernan Marotta, Cristian; Silvia Chiaramoni, Nadia; del Valle Alonso, Silvia] CCT La Plata, CONICET, IMBICE, La Plata, Buenos Aires, Argentina; [Carreno Gutierrez, Hector; Arevalo Arevalo, Rosario] Univ Salamanca, Sch Med, Dept Cell Biol & Pathol, Inst Neurosci Castilla & Leon, E-37008 Salamanca, Spain	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; University of Salamanca	Prieto, MJ (corresponding author), Natl Univ Quilmes, Dept Sci & Technol, Biomembrane Lab, Buenos Aires, DF, Argentina.	jprieto@unq.edu.ar	del V. Alonso, Silvia/A-2064-2017; Arévalo, Rosario/L-5649-2014	del V. Alonso, Silvia/0000-0003-4243-2146; Arévalo, Rosario/0000-0001-5849-1736; Prieto, Maria Jimena/0000-0003-1111-1200	Universidad Nacional de Quilmes (Buenos Aires, Argentina); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina); Ministerio Nacional de Ciencia, Tecnologia e Innovacion Productiva (MINCYT), Buenos Aires (Argentina)	Universidad Nacional de Quilmes (Buenos Aires, Argentina); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Ministerio Nacional de Ciencia, Tecnologia e Innovacion Productiva (MINCYT), Buenos Aires (Argentina)	This research was supported by a grant from Universidad Nacional de Quilmes (Buenos Aires, Argentina), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina) and Ministerio Nacional de Ciencia, Tecnologia e Innovacion Productiva (MINCYT), Buenos Aires (Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airhart MJ, 2007, NEUROTOXICOL TERATOL, V29, P652, DOI 10.1016/j.ntt.2007.07.005; Alonso-Romanowski S, 2003, CHEM PHYS LIPIDS, V122, P191, DOI 10.1016/S0009-3084(02)00190-1; Arenzana FJ, 2006, ANAT EMBRYOL, V211, P323, DOI 10.1007/s00429-006-0084-2; Arenzana FJ, 2006, NEUROTOXICOL TERATOL, V28, P342, DOI 10.1016/j.ntt.2006.02.001; BOSCH P, 2003, REV PLASTICOS MODERN, V86, P242; Braun CS, 2005, J PHARM SCI-US, V94, P423, DOI 10.1002/jps.20251; Canetta E, 2004, NUCL INSTRUM METH B, V213, P71, DOI 10.1016/S0168-583X(03)01536-2; Chakraborty C, 2009, CURR DRUG METAB, V10, P116, DOI 10.2174/138920009787522197; Chen CZS, 2000, BIOMACROMOLECULES, V1, P473, DOI 10.1021/bm0055495; Cheng YY, 2008, EUR J MED CHEM, V43, P1791, DOI 10.1016/j.ejmech.2007.09.030; Cheng YY, 2007, EUR J MED CHEM, V42, P1032, DOI 10.1016/j.ejmech.2006.12.035; Chiaramoni NS, 2007, BIOTECHNOL LETT, V29, P1637, DOI 10.1007/s10529-007-9454-y; Choi JS, 2004, J CONTROL RELEASE, V99, P445, DOI 10.1016/j.jconrel.2004.07.027; Clemente D, 2002, BRAIN RES, V925, P183, DOI 10.1016/S0006-8993(01)03279-6; Connors K, 1996, J INORG BIOCHEM, V62, P155; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; D'Emanuele A, 2005, ADV DRUG DELIVER REV, V57, P2147, DOI 10.1016/j.addr.2005.09.012; Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3; Froehlich E, 2011, BIOMACROMOLECULES, V12, P511, DOI 10.1021/bm1013102; Giansante C, 2009, J ORG CHEM, V74, P7335, DOI 10.1021/jo9014134; Gutierrez-Nava M, 2004, CHEM-EUR J, V10, P5076, DOI 10.1002/chem.200400157; Han M, 2005, POLYMER, V46, P3481, DOI 10.1016/j.polymer.2005.02.107; Hu YL, 2011, INT J NANOMED, V6, P3351, DOI 10.2147/IJN.S25853; JANSEN JFGA, 1994, SCIENCE, V266, P1226, DOI 10.1126/science.266.5188.1226; Prieto MJ, 2011, EUR J MED CHEM, V46, P845, DOI 10.1016/j.ejmech.2010.12.021; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kumar M, 2008, INT J PHARM, V358, P285, DOI 10.1016/j.ijpharm.2008.03.029; Ma ML, 2007, EUR J MED CHEM, V42, P93, DOI 10.1016/j.ejmech.2006.07.015; Mallamace F, 2002, PHYSICA A, V304, P235, DOI 10.1016/S0378-4371(01)00548-9; Malone RP, 2009, DRUGS, V69, P535, DOI 10.2165/00003495-200969050-00003; MANNENS G, 1994, PSYCHOPHARMACOLOGY, V114, P566, DOI 10.1007/BF02244986; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McGrath P, 2008, DRUG DISCOV TODAY, V13, P394, DOI 10.1016/j.drudis.2008.03.002; Mecke A, 2004, CHEM PHYS LIPIDS, V132, P3, DOI 10.1016/j.chemphyslip.2004.09.001; Peterson RT, 2012, ANNU REV PHARMACOL, V52, P433, DOI 10.1146/annurev-pharmtox-010611-134751; Prieto M, 2013, J NANOMEDINE BIOTHER, V4; Prieto MJ, 2006, INT J PHARMACEUT, V326, P160, DOI 10.1016/j.ijpharm.2006.05.068; Prieto M, 2008, INT J PHARMACEUT, V360, P204, DOI 10.1016/j.ijpharm.2008.04.045; Prieto MJ, 2012, OPEN J MED CHEM, V02, P129, DOI DOI 10.4236/ojmc.2012.24016; Seibt KJ, 2009, TOXICOL IN VITRO, V23, P78, DOI 10.1016/j.tiv.2008.10.003; Sravan Kumar M, 2010, INT J PHARM SCI RES, P122; Svenson S, 2009, EUR J PHARM BIOPHARM, V71, P445, DOI 10.1016/j.ejpb.2008.09.023; Sweet DM, 2009, J CONTROL RELEASE, V138, P78, DOI 10.1016/j.jconrel.2009.04.022; Taira MC, 2004, DRUG DELIV, V11, P123, DOI 10.1080/10717540490280769; Tajarobi F, 2001, INT J PHARM, V215, P263, DOI 10.1016/S0378-5173(00)00679-7; Tessier C, 2008, J COLLOID INTERF SCI, V320, P469, DOI 10.1016/j.jcis.2008.01.034; Uppuluri S, 2000, MACROMOLECULES, V33, P2551, DOI 10.1021/ma990634u; Uppuluri S, 1998, MACROMOLECULES, V31, P4498, DOI 10.1021/ma971199b; Welch P, 1998, MACROMOLECULES, V31, P5892, DOI 10.1021/ma980198w; Weruaga E, 2000, J CHEM NEUROANAT, V19, P1, DOI 10.1016/S0891-0618(00)00046-6; Wong J, 2008, ADV DRUG DELIVER REV, V60, P939, DOI 10.1016/j.addr.2007.11.008; Xiangyang S, 2008, ADV MATER, V20, P1671	52	25	27	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90393	10.1371/journal.pone.0090393	http://dx.doi.org/10.1371/journal.pone.0090393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587349	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200188
J	Park, MJ; Kim, SY; Yoon, SM; Kim, JH; Park, SH; Lee, SS; Lee, Y; Lee, MG				Park, Mee Jin; Kim, So Yeon; Yoon, Sang Min; Kim, Jong Hoon; Park, Seong Ho; Lee, Seung Soo; Lee, Yedaun; Lee, Moon-Gyu			Stereotactic Body Radiotherapy-Induced Arterial Hypervascularity of Non-Tumorous Hepatic Parenchyma in Patients with Hepatocellular Carcinoma: Potential Pitfalls in Tumor Response Evaluation on Multiphase Computed Tomography	PLOS ONE			English	Article							FOCAL LIVER REACTION; RADIATION-THERAPY; HELICAL CT; PHASE-I; APPEARANCE; INJURY; CIRRHOSIS; TRIAL	Purpose: To evaluate temporal changes in contrast enhancement patterns of non-tumorous hepatic parenchyma with a focus on arterial hypervascularity on multiphase computed tomography (CT) in patients with hepatocellular carcinoma (HCC) treated with stereotactic body radiotherapy (SBRT). Methods: We retrospectively identified 61 patients who had undergone multiphase contrast-enhanced CT at one, three, and six months after SBRT. Irradiated versus non-irradiated liver parenchyma was delineated by cross-correlation with the dose-volume histogram of SBRT plan. Serial changes in the contrast enhancement patterns of the irradiated versus non-irradiated liver parenchyma were evaluated by two abdominal radiologists in consensus. We compared the frequency of the contrast enhancement patterns according to the follow-up period using the Fisher-Freeman-Halton exact test. Results: The irradiated non-tumorous hepatic parenchyma showed that the prevalence of arterial hypervascularity increased during the follow-up period (P<.01): 11.5% (7/61) in one, 45.9% (28/61) in three, and 54.1% (33/61) in six months. Contrast wash-out on the delayed phase was uncommon: 1.6% (1/61) in one, 3.3% (2/61) in three, and 0% in six months. Conclusion: The incidence of arterial hypervascularity of the irradiated hepatic parenchyma gradually increased until six months after SBRT, which could interfere with the accurate evaluation of treatment response. The lack of wash-out on the delayed phase in the hypervascular area would distinguish SBRT-related change from residual/recurred HCC.	[Park, Mee Jin; Kim, So Yeon; Park, Seong Ho; Lee, Seung Soo; Lee, Yedaun; Lee, Moon-Gyu] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Park, Mee Jin; Kim, So Yeon; Park, Seong Ho; Lee, Seung Soo; Lee, Yedaun; Lee, Moon-Gyu] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea; [Yoon, Sang Min; Kim, Jong Hoon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Kim, SY (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea.	sykimrad@amc.seoul.kr	Park, Seong Ho/E-2271-2014	Park, Seong Ho/0000-0002-1257-8315	Asan Institute for Life Science, Seoul, Korea [2013-546]; National Research Foundation of Korea (NRF) [2012R1A1A1012731]; Ministry of Education, Science and Technology, Korea	Asan Institute for Life Science, Seoul, Korea; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by Grant [2013-546] from the Asan Institute for Life Science, Seoul, Korea, and Grant [2012R1A1A1012731] by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi T, 1999, J COMPUT ASSIST TOMO, V23, P655, DOI 10.1097/00004728-199909000-00002; BARTOLOZZI C, 1994, RADIOLOGY, V191, P123, DOI 10.1148/radiology.191.1.8134557; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Cardenes HR, 2010, CLIN TRANSL ONCOL, V12, P218, DOI 10.1007/s12094-010-0492-x; Chiou SY, 2001, ACTA RADIOL, V42, P526, DOI 10.1034/j.1600-0455.2001.420515.x; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; Herfarth KK, 2003, INT J RADIAT ONCOL, V57, P444, DOI 10.1016/S0360-3016(03)00586-8; Herfarth KK, 2001, J CLIN ONCOL, V19, P164, DOI 10.1200/JCO.2001.19.1.164; Hygino da Cruz Jr LC, 2011, AM J NEURORADIOL, V32, P1978; Iannaccone R, 2005, RADIOLOGY, V234, P460, DOI 10.1148/radiol.2342031202; Kim T, 1999, ABDOM IMAGING, V24, P473, DOI 10.1007/s002619900543; LAX I, 1994, ACTA ONCOL, V33, P677, DOI 10.3109/02841869409121782; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 2005, J GASTROENTEROL, V40, P225, DOI 10.1007/s00535-005-1566-3; Lo SS, 2010, NAT REV CLIN ONCOL, V7, P44, DOI 10.1038/nrclinonc.2009.188; Mayo-Smith WW, 1999, RADIOLOGY, V210, P601, DOI 10.1148/radiology.210.3.r99mr07601; OKUMURA T, 1994, J COMPUT ASSIST TOMO, V18, P821, DOI 10.1097/00004728-199409000-00025; Olsen CC, 2009, INT J RADIAT ONCOL, V73, P1414, DOI 10.1016/j.ijrobp.2008.07.032; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Potters L, 2004, INT J RADIAT ONCOL, V60, P1026, DOI 10.1016/j.ijrobp.2004.07.701; Price TR, 2012, CANCER-AM CANCER SOC, V118, P3191, DOI 10.1002/cncr.26404; REED GB, 1966, AM J PATHOL, V48, P597; Sanuki-Fujimoto N, 2010, BRIT J RADIOL, V83, P1063, DOI 10.1259/bjr/74105551; Takeda A, 2012, RADIOTHER ONCOL, V104, P374, DOI 10.1016/j.radonc.2011.12.008; Tse RV, 2008, J CLIN ONCOL, V26, P657, DOI 10.1200/JCO.2007.14.3529; UNGER EC, 1987, J COMPUT ASSIST TOMO, V11, P264, DOI 10.1097/00004728-198703000-00013; Willemart S, 2000, BRIT J RADIOL, V73, P544, DOI 10.1259/bjr.73.869.10884753; Wulf J, 2001, STRAHLENTHER ONKOL, V177, P645, DOI 10.1007/PL00002379; Zech CJ, 2009, DIGEST DIS, V27, P114, DOI 10.1159/000218343	29	21	21	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90327	10.1371/journal.pone.0090327	http://dx.doi.org/10.1371/journal.pone.0090327			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587326	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200172
J	Churin, Y; Roderfeld, M; Stiefel, J; Wurger, T; Schroder, D; Matono, T; Mollenkopf, HJ; Montalbano, R; Pompaiah, M; Reifenberg, K; Zahner, D; Ocker, M; Gerlich, W; Glebe, D; Roeb, E				Churin, Yuri; Roderfeld, Martin; Stiefel, Johannes; Wuerger, Tilman; Schroeder, Dirk; Matono, Tomomitsu; Mollenkopf, Hans-Joachim; Montalbano, Roberta; Pompaiah, Malvika; Reifenberg, Kurt; Zahner, Daniel; Ocker, Matthias; Gerlich, Wolfram; Glebe, Dieter; Roeb, Elke			Pathological Impact of Hepatitis B Virus Surface Proteins on the Liver Is Associated with the Host Genetic Background	PLOS ONE			English	Article							LARGE ENVELOPE POLYPEPTIDE; C-JUN; KAPPA-B; MOUSE; EXPRESSION; INFECTION; STRESS; HEPATOCARCINOGENESIS; PATHOGENESIS; ACTIVATION	Background: While the immune pathogenesis caused by hepatitis B virus (HBV) infection has been studied extensively, little is known about direct pathogenic effects of HBV surface proteins. Here, we have investigated pathological cellular effects of HBV surface protein expression in the liver of transgenic mice with different genetic background. Methods: The impact of HBV surface protein expression on the liver was studied in two mouse strains, BALB/c and C57BL/6. Histology and hydroxyproline assays were performed to investigate liver morphology and fibrosis. Gene expression and signaling were analyzed by microarray, qPCR and Western blotting. Results: Expression of HBV surface proteins in the liver of transgenic mice induced activation of protein kinase-like endoplasmic reticulum kinase (PERK) and eukaryotic initiation factor 2 alpha (eIF2 alpha) phosphorylation. Phosphorylation of eIF2 alpha resulted in activation of the ER stress markers glucose regulated protein (GRP) 78 and pro-apoptotic C/EBP homologous protein (CHOP) in transgenic mice on BALB/c genetic background leading to stronger liver injury and fibrosis in comparison with transgenic mice on C57BL/6 background. Hepatic stellate cells represented the main collagen-producing liver cells in HBV transgenic mice. The key regulators of hepatocyte proliferation, transcription factors c-Jun and STAT3 were activated in HBV transgenic mice. Tumour incidence in transgenic mice was strain-and sex-dependent. Conclusions: Extent of liver injury, fibrosis, and tumour development induced by hepatic HBV surface protein expression considerably depends on host genetic background.	[Churin, Yuri; Roderfeld, Martin; Stiefel, Johannes; Wuerger, Tilman; Schroeder, Dirk; Matono, Tomomitsu; Roeb, Elke] Univ Giessen, Dept Gastroenterol, D-35390 Giessen, Germany; [Mollenkopf, Hans-Joachim] Max Planck Inst Infekt Biol, Core Facil Microarray, D-10117 Berlin, Germany; [Montalbano, Roberta; Ocker, Matthias] Univ Marburg, Inst Surg Res, Marburg, Germany; [Pompaiah, Malvika] Max Planck Inst Infekt Biol, Dept Mol Biol, D-10117 Berlin, Germany; [Reifenberg, Kurt] Johannes Gutenberg Univ Mainz, Cent Lab Anim Facil, D-55122 Mainz, Germany; [Zahner, Daniel] Univ Giessen, Div Anim Welf & Ethol, D-35390 Giessen, Germany; [Gerlich, Wolfram; Glebe, Dieter] Univ Giessen, Inst Med Virol, Natl Reference Ctr Hepatitis B & Viruses D, D-35390 Giessen, Germany	Justus Liebig University Giessen; Max Planck Society; Philipps University Marburg; Max Planck Society; Johannes Gutenberg University of Mainz; Justus Liebig University Giessen; Justus Liebig University Giessen	Roeb, E (corresponding author), Univ Giessen, Dept Gastroenterol, D-35390 Giessen, Germany.	elke.roeb@innere.med.uni-giessen.de	, Martin/AHD-5202-2022; Mollenkopf, Hans-Joachim/AAH-2500-2019	, Martin/0000-0002-3232-1277; Mollenkopf, Hans-Joachim/0000-0003-1167-4783; Ocker, Matthias/0000-0001-8263-6288	Deutsche Forschungsgemeinschaft [RO 957/7-1, RO 957/8-1]; ZooMAP (Bundesministerium fur Bildung und Forschung, BMBF); von-Behring-Roentgen Foundation; University Medical Center Giessen and Marburg (UKGM) [10/2012 GI]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ZooMAP (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF)); von-Behring-Roentgen Foundation; University Medical Center Giessen and Marburg (UKGM)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (RO 957/7-1 and RO 957/8-1), ZooMAP (Bundesministerium fur Bildung und Forschung, BMBF), the von-Behring-Roentgen Foundation and the University Medical Center Giessen and Marburg (10/2012 GI, UKGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobrovnikova-Marjon E, ONCOGENE, V29, P3881; Boigk G, 1997, HEPATOLOGY, V26, P643, DOI 10.1053/jhep.1997.v26.pm0009303494; Chisari FV, 2010, PATHOL BIOL, V58, P258, DOI 10.1016/j.patbio.2009.11.001; CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8; CHISARI FV, 1987, P NATL ACAD SCI USA, V84, P6909, DOI 10.1073/pnas.84.19.6909; CHISARI FV, 1986, J VIROL, V60, P880, DOI 10.1128/JVI.60.3.880-887.1986; DAVIES SE, 1991, HEPATOLOGY, V13, P150, DOI 10.1002/hep.1840130122; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; DRAGANI TA, 1990, CARCINOGENESIS, V11, P953, DOI 10.1093/carcin/11.6.953; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Glebe D, 2003, J VIROL, V77, P9511, DOI 10.1128/JVI.77.17.9511-9521.2003; Glebe D, 2013, SEMIN LIVER DIS, V33, P103, DOI 10.1055/s-0033-1345717; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Jin ZX, 2011, HEPATOLOGY, V53, P219, DOI 10.1002/hep.23983; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; LAU JYN, 1991, HEPATOLOGY, V14, P416, DOI 10.1002/hep.1840140303; LAU JYN, 1992, GASTROENTEROLOGY, V102, P956, DOI 10.1016/0016-5085(92)90182-X; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Machida K, 2010, HEPATOLOGY, V52, P480, DOI 10.1002/hep.23697; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Meuleman P, 2006, J VIROL, V80, P2797, DOI 10.1128/JVI.80.6.2797-2807.2006; Min LH, 2012, NAT CELL BIOL, V14, P1203, DOI 10.1038/ncb2590; Naoumov NV, GASTROENTEROLOGY, P1248; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Palacios RS, 2008, LAB INVEST, V88, P1192, DOI 10.1038/labinvest.2008.91; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pol S, 2013, LIVER INT, V33, P182, DOI 10.1111/liv.12055; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Reece ST, 2010, J CLIN INVEST, V120, P3365, DOI 10.1172/JCI42796; Roderfeld M, 2010, HEPATOLOGY, V51, P267, DOI 10.1002/hep.23274; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schonthal Axel H, 2012, Front Biosci (Schol Ed), V4, P412; Shi ZD, 1997, P NATL ACAD SCI USA, V94, P10663, DOI 10.1073/pnas.94.20.10663; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Sohlenius-Sternbeck AK, 2006, TOXICOL IN VITRO, V20, P1582, DOI 10.1016/j.tiv.2006.06.003; Spano D, 2008, J PROTEOME RES, V7, P2642, DOI 10.1021/pr7006522; Sugiyama M, 2009, GASTROENTEROLOGY, V136, P652, DOI 10.1053/j.gastro.2008.10.048; Wang HC, 2005, HEPATOLOGY, V41, P761, DOI 10.1002/hep.20615; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Xu ZC, 1997, J VIROL, V71, P7387, DOI 10.1128/JVI.71.10.7387-7392.1997; Zheng YY, 2007, HEPATOLOGY, V45, P16, DOI 10.1002/hep.21445	46	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90608	10.1371/journal.pone.0090608	http://dx.doi.org/10.1371/journal.pone.0090608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594856	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500073
J	Sun, YM; Li, FH; Sun, Z; Zhang, XJ; Li, SH; Zhang, CS; Xiang, JH				Sun, Yumiao; Li, Fuhua; Sun, Zheng; Zhang, Xiaojun; Li, Shihao; Zhang, Chengsong; Xiang, Jianhai			Transcriptome Analysis of the Initial Stage of Acute WSSV Infection Caused by Temperature Change	PLOS ONE			English	Article							WHITE-SPOT-SYNDROME; SYNDROME VIRUS WSSV; SHRIMP PENAEUS-JAPONICUS; CELL-CYCLE ARREST; WATER TEMPERATURE; LITOPENAEUS-VANNAMEI; IMMUNE-RESPONSE; GENE-EXPRESSION; APOPTOSIS; REPLICATION	White spot syndrome virus (WSSV) is the most devastating virosis threatening the shrimp culture industry worldwide. Variations of environmental factors in shrimp culture ponds usually lead to the outbreak of white spot syndrome (WSS). In order to know the molecular mechanisms of WSS outbreak induced by temperature variation and the biological changes of the host at the initial stage of WSSV acute infection, RNA-Seq technology was used to analyze the differentially expressed genes (DEGs) in shrimp with a certain amount of WSSV cultured at 18 degrees C and shrimp whose culture temperature were raised to 25 degrees C. To analyze whether the expression changes of the DEGs were due to temperature rising or WSSV proliferation, the expression of selected DEGs was analyzed by real-time PCR with another shrimp group, namely Group T, as control. Group T didn't suffer WSSV infection but was subjected to temperature rising in parallel. At the initial stage of WSSV acute infection, DEGs related to energy production were up-regulated, whereas most DEGs related to cell cycle and positive regulation of cell death and were down-regulated. Triose phosphate isomerase, enolase and alcohol dehydrogenase involved in glycosis were up-regulated, while pyruvate dehydrogenase, citrate synthase and isocitrate dehydrogenase with NAD as the coenzyme involved in TCA pathway were down-regulated. Also genes involved in host DNA replication, including DNA primase, DNA topoisomerase and DNA polymerase showed down-regulated expression. Several interesting genes including crustin genes, acting binding or inhibiting protein genes, a disintegrin and metalloproteinase domain-containing protein 9 (ADAM9) gene and a GRP 78 gene were also analyzed. Understanding the interactions between hosts and WSSV at the initial stage of acute infection will not only help to get a deep insight into the pathogenesis of WSSV but also provide clues for therapies.	[Sun, Yumiao; Li, Fuhua; Sun, Zheng; Zhang, Xiaojun; Li, Shihao; Zhang, Chengsong; Xiang, Jianhai] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS	Li, FH (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	fhli@qdio.ac.cn	Zhang, Chengsong/E-2211-2014; zhang, jin/GXV-9154-2022; xiang, jianhai/A-4767-2012	xiang, jianhai/0000-0001-5395-7787; Sun, Zheng/0000-0002-8537-8576	Major State Basic Research Development Program [2012CB114403]; National High Tech Research and Development Program [2012AA10A404, 2012AA092205]; National Natural Science Foundation Program [31072203]	Major State Basic Research Development Program(National Basic Research Program of China); National High Tech Research and Development Program(National High Technology Research and Development Program of China); National Natural Science Foundation Program(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Major State Basic Research Development Program (2012CB114403), National High Tech Research and Development Program (2012AA10A404, 2012AA092205), National Natural Science Foundation Program (31072203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony SP, 2011, IMMUNOBIOLOGY, V216, P184, DOI 10.1016/j.imbio.2010.05.030; Arockiaraj J, 2013, FISH SHELLFISH IMMUN, V34, P109, DOI 10.1016/j.fsi.2012.10.009; Braunagel SC, 1998, VIROLOGY, V244, P195, DOI 10.1006/viro.1998.9097; Bresnahan WA, 1996, VIROLOGY, V224, P150, DOI 10.1006/viro.1996.0516; Broemer M, 2009, TRENDS CELL BIOL, V19, P130, DOI 10.1016/j.tcb.2009.01.004; Chen CJ, 2004, J VIROL, V78, P5658, DOI 10.1128/JVI.78.11.5658-5669.2004; Chen IT, 2011, J VIROL, V85, P12919, DOI 10.1128/JVI.05385-11; Chen KY, 2009, FISH SHELLFISH IMMUN, V27, P460, DOI 10.1016/j.fsi.2009.06.018; Chen YH, 2011, MOL IMMUNOL, V48, P793, DOI 10.1016/j.molimm.2010.11.020; Chou HY, 1995, DIS AQUAT ORGAN, V23, P165, DOI 10.3354/dao023165; Chowdhury IH, 2003, VIROLOGY, V305, P371, DOI 10.1006/viro.2002.1777; Clavero-Salas A, 2007, FISH SHELLFISH IMMUN, V23, P459, DOI 10.1016/j.fsi.2007.01.010; CLEM RJ, 1993, J VIROL, V67, P3730, DOI 10.1128/JVI.67.7.3730-3738.1993; De Bolle L, 2004, FEBS LETT, V560, P25, DOI 10.1016/S0014-5793(04)00035-3; Du HH, 2006, DIS AQUAT ORGAN, V71, P175, DOI 10.3354/dao071175; Du HH, 2008, AQUACULTURE, V277, P149, DOI 10.1016/j.aquaculture.2008.03.003; Eto K, 2002, J BIOL CHEM, V277, P17804, DOI 10.1074/jbc.M200086200; Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0; FENWICK ML, 1978, J GEN VIROL, V41, P37, DOI 10.1099/0022-1317-41-1-37; Galvan-Alvarez D, 2012, J INVERTEBR PATHOL, V111, P60, DOI 10.1016/j.jip.2012.06.005; Gao HA, 2011, AQUACULTURE, V312, P26, DOI 10.1016/j.aquaculture.2010.12.022; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Granja CB, 2003, DIS AQUAT ORGAN, V54, P73, DOI 10.3354/dao054073; Guan YQ, 2003, J INVERTEBR PATHOL, V83, P257, DOI 10.1016/S0022-2011(03)00068-5; GUIR J, 1971, J GEN VIROL, V12, P293, DOI 10.1099/0022-1317-12-3-293; Hauton C, 2006, MOL IMMUNOL, V43, P1490, DOI 10.1016/j.molimm.2005.07.029; Hay S, 2002, J GEN VIROL, V83, P1547, DOI 10.1099/0022-1317-83-7-1547; He F, 2006, J VIROL, V80, P3884, DOI 10.1128/JVI.80.8.3884-3892.2006; He F, 2009, J GEN VIROL, V90, P1483, DOI 10.1099/vir.0.008912-0; He NH, 2005, ANTIVIR RES, V66, P39, DOI 10.1016/j.antiviral.2004.12.010; Huang XD, 2010, VIROLOGY, V406, P176, DOI 10.1016/j.virol.2010.06.046; Jiravanichpaisal P, 2004, FISH SHELLFISH IMMUN, V17, P265, DOI 10.1016/j.fsi.2004.03.010; Koyama AH, 2000, MICROBES INFECT, V2, P1111, DOI 10.1016/S1286-4579(00)01265-X; Leu JH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-120; Leu JH, 2013, FISH SHELLFISH IMMUN, V34, P1011, DOI 10.1016/j.fsi.2012.05.030; Leu JH, 2010, DEV COMP IMMUNOL, V34, P1068, DOI 10.1016/j.dci.2010.05.010; Li DF, 2007, VIROLOGY, V368, P122, DOI 10.1016/j.virol.2007.06.027; Liberman E, 1999, J VIROL, V73, P3718, DOI 10.1128/JVI.73.5.3718-3722.1999; Lin YR, 2011, J VIROL, V85, P3517, DOI 10.1128/JVI.01973-10; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Liu WJ, 2007, J VIROL, V81, P1461, DOI 10.1128/JVI.01880-06; Luan W, 2009, MOL BIOL REP, V36, P289, DOI 10.1007/s11033-007-9178-z; Ma Y, 2009, MOL CELL PROTEOMICS, V8, P2582, DOI 10.1074/mcp.M900180-MCP200; Moser JR, 2012, AQUACULTURE, V326, P9, DOI 10.1016/j.aquaculture.2011.10.033; Oidtmann B, 2011, TRANSBOUND EMERG DIS, V14; Ou DSC, 2011, CELL RES, V21, P642, DOI 10.1038/cr.2011.10; Pan D, 2005, DEV COMP IMMUNOL, V29, P103, DOI 10.1016/j.dci.2004.07.001; Pongsomboon S, 2011, FISH SHELLFISH IMMUN, V30, P439, DOI 10.1016/j.fsi.2010.10.015; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Reyes A, 2007, DEV COMP IMMUNOL, V31, P23, DOI 10.1016/j.dci.2006.05.003; Robalino J, 2009, VET IMMUNOL IMMUNOP, V128, P110, DOI 10.1016/j.vetimm.2008.10.329; Sritunyalucksana K, 2006, J VIROL, V80, P10734, DOI 10.1128/JVI.00349-06; Sun YM, 2013, ACTA OCEANOL SIN, V32, P52, DOI 10.1007/s13131-013-0261-0; Sun YM, 2013, AQUACULTURE, V376, P124, DOI 10.1016/j.aquaculture.2012.11.014; van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002; Wali A, 1999, EXP MOL PATHOL, V66, P31, DOI 10.1006/exmp.1999.2249; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Wang ZM, 2004, BIOCHEM BIOPH RES CO, V325, P899, DOI 10.1016/j.bbrc.2004.09.224; Wati S, 2009, J VIROL, V83, P12871, DOI 10.1128/JVI.01419-09; Withyachumnarnkul B, 2003, DIS AQUAT ORGAN, V53, P167, DOI 10.3354/dao053167; Xie XX, 2005, VIROLOGY, V336, P93, DOI 10.1016/j.virol.2005.03.011; Xu H, 2009, FISH SHELLFISH IMMUN, V26, P414, DOI 10.1016/j.fsi.2009.01.001; Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001; You XX, 2010, AQUACULTURE, V305, P133, DOI 10.1016/j.aquaculture.2010.04.024; Zhi B, 2011, MAR BIOTECHNOL, V13, P575, DOI 10.1007/s10126-010-9328-5; Zhou M, 2001, BIOCHEM BIOPH RES CO, V280, P574, DOI 10.1006/bbrc.2000.4155	66	19	19	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90732	10.1371/journal.pone.0090732	http://dx.doi.org/10.1371/journal.pone.0090732			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595043	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500093
J	Wang, LQ; Luo, HH; Chen, XH; Jiang, Y; Huang, QB				Wang, Liqun; Luo, Haihua; Chen, Xiaohuan; Jiang, Yong; Huang, Qiaobing			Functional Characterization of S100A8 and S100A9 in Altering Monolayer Permeability of Human Umbilical Endothelial Cells	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; CARBOXYLATED GLYCANS; SCAVENGER RECEPTOR; SIGNALING PATHWAY; EXPRESSION; MACROPHAGES; BARRIER; KINASE; ROLES; MRP14	S100A8, S100A9 and S100A8/A9 complexes have been known as important endogenous damage-associated molecular pattern (DAMP) proteins. But the pathophysiological roles of S100A8, S100A9 and S100A8/A9 in cardiovascular diseases are incompletely explained. In this present study, the effects of homo S100A8, S100A9 and their hetero-complex S100A8/A9 on endothelial barrier function were tested respectively in cultured human umbilical venous endothelial cells (HUVECs). The involvement of TLR4 and RAGE were observed by using inhibitor of TLR4 and blocking antibody of RAGE. The clarification of different MAPK subtypes in S100A8/A9-induced endothelial response was implemented by using specific inhibitors. The calcium-dependency was detected in the absence of Ca2+ or in the presence of gradient-dose Ca2+. The results showed that S100A8, S100A9 and S100A8/A9 could induce F-actin and ZO-1 disorganization in HUVECs and evoked the increases of HUVEC monolayer permeability in a dose- and time-dependent manner. The effects of S100A8, S100A9 and S100A8/A9 on endothelial barrier function depended on the activation of p38 and ERK1/2 signal pathways through receptors TLR4 and RAGE. Most importantly, we revealed the preference of S100A8 on TLR4 and S100A9 on RAGE in HUVECs. The results also showed the calcium dependency in S100A8- and S100A9-evoked endothelial response, indicating that calcium dependency on formation of S100A8 or A9 dimmers might be the prerequisite for this endothelial functional alteration.	[Wang, Liqun; Huang, Qiaobing] Southern Med Univ, Key Lab Shock & Microcirculat Res Guangdong, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China; [Luo, Haihua; Chen, Xiaohuan; Jiang, Yong] Southern Med Univ, Key Lab Funct Prote Guangdong Prov, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Jiang, Y (corresponding author), Southern Med Univ, Key Lab Funct Prote Guangdong Prov, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China.	jiang48231@163.com; bing@smu.edu.cn			National Key Basic Research (973) Program of China [2011CB510200]; National Natural Science Foundation of China [81030055, 30971201, 81170297]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT0731]; NSFC-Guangdong Joint Fund [U0632004]	National Key Basic Research (973) Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); NSFC-Guangdong Joint Fund	This work was supported by National Key Basic Research (973) Program of China (No. 2011CB510200 to Y.J.), National Natural Science Foundation of China (No. 81030055; No. 30971201, No. 81170297), Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) (No. IRT0731 to Y.J.) and NSFC-Guangdong Joint Fund (No. U0632004 to Y.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CL, 2009, DIABETES OBES METAB, V11, P480, DOI 10.1111/j.1463-1326.2008.00987.x; Andonegui G, 2009, J CLIN INVEST, V119, P1921, DOI 10.1172/JCI36411; Bhattacharjee R, 2012, CHEST, V141, P682, DOI 10.1378/chest.11-1777; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Borbiev T, 2004, AM J PHYSIOL-LUNG C, V287, pL911, DOI 10.1152/ajplung.00372.2003; Ehlermann P, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-6; Fontaine M, 2011, CRIT CARE MED, V39, P2684, DOI 10.1097/CCM.0b013e3182282a40; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; Hunter MJ, 1998, J BIOL CHEM, V273, P12427, DOI 10.1074/jbc.273.20.12427; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kerkhoff C, 2001, BIOCHEMISTRY-US, V40, P241, DOI 10.1021/bi001791k; LAU W, 1995, J CLIN INVEST, V95, P1957, DOI 10.1172/JCI117879; Legrand P, 2001, J BIOL CHEM, V276, P3581, DOI 10.1074/jbc.M002667200; Lim SY, 2011, ANTIOXID REDOX SIGN, V15, P2235, DOI 10.1089/ars.2010.3641; Lu Y, 2012, AMINO ACIDS, V43, P2125, DOI 10.1007/s00726-012-1298-7; Luo T, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0342-4; Mohammad G, 2013, EXP EYE RES, V107, P101, DOI 10.1016/j.exer.2012.12.009; Mukherjee TK, 2005, BBA-MOL CELL RES, V1744, P213, DOI 10.1016/j.bbamcr.2005.03.007; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; Oh CD, 2000, J BIOL CHEM, V275, P5613, DOI 10.1074/jbc.275.8.5613; Patabendige A, 2013, BRAIN RES, V1521, P1, DOI 10.1016/j.brainres.2012.06.057; Perera C, 2010, IMMUNOL CELL BIOL, V88, P41, DOI 10.1038/icb.2009.88; Rammes A, 1997, J BIOL CHEM, V272, P9496; Rauvala H, 2010, BBA-GENE REGUL MECH, V1799, P164, DOI 10.1016/j.bbagrm.2009.11.012; Riehl A, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-12; Robinson MJ, 2002, J BIOL CHEM, V277, P3658, DOI 10.1074/jbc.M102950200; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Sakaguchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023132; Schelbergen RFP, 2012, ARTHRITIS RHEUM-US, V64, P1477, DOI 10.1002/art.33495; Shimizu K, 2011, CIRCULATION, V124, P2920, DOI 10.1161/CIRCULATIONAHA.110.009910; Spirig R, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/181394; Srikrishna G, 2001, J IMMUNOL, V166, P4678, DOI 10.4049/jimmunol.166.7.4678; Srikrishna G, 2012, J INNATE IMMUN, V4, P31, DOI 10.1159/000330095; Stocca A, 2012, ATHEROSCLEROSIS, V221, P325, DOI 10.1016/j.atherosclerosis.2012.01.036; Strupat K, 2000, J AM SOC MASS SPECTR, V11, P780, DOI 10.1016/S1044-0305(00)00150-1; Sunahori K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1939; Tang BMP, 2009, CRIT CARE MED, V37, P882, DOI 10.1097/CCM.0b013e31819b52fd; TEIGELKAMP S, 1991, J BIOL CHEM, V266, P13462; Turovskaya O, 2008, CARCINOGENESIS, V29, P2035, DOI 10.1093/carcin/bgn188; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Viemann D, 2007, BLOOD, V109, P2453, DOI 10.1182/blood-2006-08-040444; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang Y, 2011, AM J PHYSIOL-HEART C, V300, pH1743, DOI 10.1152/ajpheart.01335.2008; Wu W, 2011, SHOCK, V35, P618, DOI 10.1097/SHK.0b013e31820e041f	45	50	50	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90472	10.1371/journal.pone.0090472	http://dx.doi.org/10.1371/journal.pone.0090472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595267	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900111
J	Zhou, QY; Wang, W; He, XY; Zhu, XY; Shen, YY; Yu, Z; Wang, XX; Qi, XC; Zhang, X; Fan, MJ; Dai, Y; Yang, SX; Yan, QF				Zhou, Qiyin; Wang, Wei; He, Xiangyu; Zhu, Xiaoyu; Shen, Yaoyao; Yu, Zhe; Wang, Xuexiang; Qi, Xuchen; Zhang, Xuan; Fan, Mingjie; Dai, Yu; Yang, Shuxu; Yan, Qingfeng			Mechanistic Study on the Nuclear Modifier Gene MSS1 Mutation Suppressing Neomycin Sensitivity of the Mitochondrial 15S rRNA C1477G Mutation Saccharomyces cerevisiae	PLOS ONE			English	Article							PAROMOMYCIN-RESISTANCE MUTATION; GLYCOLYTIC GENES; TRANSCRIPTIONAL ACTIVATION; PHENOTYPIC-EXPRESSION; PROTEIN; METABOLISM; OVEREXPRESSION; PATHOGENESIS; RESPIRATION; MUTANTS	The phenotypic manifestation of mitochondrial DNA (mtDNA) mutations can be modulated by nuclear genes and environmental factors. However, neither the interaction among these factors nor their underlying mechanisms are well understood. The yeast Saccharomyces cerevisiae mtDNA 15S rRNA C1477G mutation (P-R) corresponds to the human 12S rRNA A1555G mutation. Here we report that a nuclear modifier gene mss1 mutation suppresses the neomycin-sensitivity phenotype of a yeast C1477G mutant in fermentable YPD medium. Functional assays show that the mitochondrial function of the yeast C1477G mutant was impaired severely in YPD medium with neomycin. Moreover, the mss1 mutation led to a significant increase in the steady-state level of HAP5 (heme activated protein), which greatly up-regulated the expression of glycolytic transcription factors RAP1, GCR1, and GCR2 and thus stimulated glycolysis. Furthermore, the high expression of the key glycolytic enzyme genes HXK2, PFK1 and PYK1 indicated that enhanced glycolysis not only compensated for the ATP reduction from oxidative phosphorylation (OXPHOS) in mitochondria, but also ensured the growth of the mss1(P-R) mutant in YPD medium with neomycin. This study advances our understanding of the phenotypic manifestation of mtDNA mutations.	[Zhou, Qiyin; Wang, Wei; He, Xiangyu; Zhu, Xiaoyu; Shen, Yaoyao; Yu, Zhe; Wang, Xuexiang; Zhang, Xuan; Fan, Mingjie; Dai, Yu; Yan, Qingfeng] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Qi, Xuchen; Yang, Shuxu] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Dai, Yu] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Yan, QF (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	qfyan@zju.edu.cn	yan, qing/GZN-2287-2022; Fan, Mingjie/GZM-9365-2022	Yu, Zhe/0000-0002-6908-6135; Fan, Mingjie/0000-0002-2930-9998	National Basic Research Program of China [2012CB966800D, 2014CB943001]; National Natural Science Foundation of China [30971599/C060503]; Program for New Century Excellent Talents in University [NCET-06-0526]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Basic Research Program of China (Grant NO. 2012CB966800D, 2014CB943001), the National Natural Science Foundation of China (Grant NO. 30971599/C060503) and the Program for New Century Excellent Talents in University (Grant NO. NCET-06-0526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER DM, 1991, P NATL ACAD SCI USA, V88, P1968, DOI 10.1073/pnas.88.5.1968; Blom J, 2000, APPL ENVIRON MICROB, V66, P1970, DOI 10.1128/AEM.66.5.1970-1973.2000; Bourges I, 2009, J MOL BIOL, V387, P1081, DOI 10.1016/j.jmb.2009.02.039; Bregeon D, 2001, GENE DEV, V15, P2295, DOI 10.1101/gad.207701; Chambers A, 1995, CURR GENET, V29, P1, DOI 10.1007/BF00313187; Colby G, 1998, J BIOL CHEM, V273, P27945, DOI 10.1074/jbc.273.43.27945; DECOSTER E, 1993, J MOL BIOL, V232, P79, DOI 10.1006/jmbi.1993.1371; Deminoff SJ, 2001, GENETICS, V158, P133; Diaz-Ruiz R, 2009, BBA-REV CANCER, V1796, P252, DOI 10.1016/j.bbcan.2009.07.003; Duenas-Sanchez R, 2010, INT J FOOD MICROBIOL, V143, P150, DOI 10.1016/j.ijfoodmicro.2010.08.009; DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562; Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011; Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389; Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006; Hao WS, 2010, J BIOL CHEM, V285, P12647, DOI 10.1074/jbc.M109.084194; He XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081490; KUTZLEB R, 1973, MOL GEN GENET, V125, P91, DOI 10.1007/BF00292984; LI M, 1982, J BIOL CHEM, V257, P5921; Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; McNabb DS, 2005, EUKARYOT CELL, V4, P1829, DOI 10.1128/EC.4.11.1829-1839.2005; Menon BB, 2005, P NATL ACAD SCI USA, V102, P5749, DOI 10.1073/pnas.0501768102; Mizuno T, 2004, YEAST, V21, P851, DOI 10.1002/yea.1123; Ozalp VC, 2010, J BIOL CHEM, V285, P37579, DOI 10.1074/jbc.M110.155119; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Qiu JZ, 1998, NUCLEIC ACIDS RES, V26, P3077, DOI 10.1093/nar/26.13.3077; Raghevendran V, 2006, J BIOL CHEM, V281, P12308, DOI 10.1074/jbc.M512972200; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Sasaki H, 2005, YEAST, V22, P111, DOI 10.1002/yea.1198; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Schuurmans JM, 2008, FEMS YEAST RES, V8, P26, DOI 10.1111/j.1567-1364.2007.00309.x; SERAPHIN B, 1987, P NATL ACAD SCI USA, V84, P6810, DOI 10.1073/pnas.84.19.6810; Sherman F., 1983, METHODS YEAST GENETI; Suhane S, 2013, BIOL OPEN, V2, P295, DOI 10.1242/bio.20133244; Uemura H, 1997, GENETICS, V147, P521; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Wang XJ, 2007, FEBS LETT, V581, P4228, DOI 10.1016/j.febslet.2007.07.067; Wang XJ, 2010, J MOL BIOL, V395, P1038, DOI 10.1016/j.jmb.2009.12.002; Wang XJ, 2009, MITOCHONDRION, V9, P180, DOI 10.1016/j.mito.2009.01.010; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yan QF, 2005, J BIOL CHEM, V280, P29151, DOI 10.1074/jbc.M504247200; Zhang CK, 2012, FASEB J, V26, P4914, DOI 10.1096/fj.12-206532; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	45	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90336	10.1371/journal.pone.0090336	http://dx.doi.org/10.1371/journal.pone.0090336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595024	gold, Green Published, Green Submitted			2022-12-27	WOS:000332468900096
J	Feng, CH; He, K; Zhang, CY; Su, S; Li, B; Li, YX; Duan, CY; Chen, SK; Chen, R; Liu, YP; Li, H; Wei, M; Xia, XM; Dai, RY				Feng, Chunhong; He, Kai; Zhang, Chunyan; Su, Song; Li, Bo; Li, Yuxiao; Duan, Chun-Yan; Chen, Shaokun; Chen, Run; Liu, Youping; Li, Hong; Wei, Mei; Xia, Xianming; Dai, Rongyang			JNK Contributes to the Tumorigenic Potential of Human Cholangiocarcinoma Cells through the mTOR Pathway Regulated GRP78 Induction	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER STRESS; PROTEIN-KINASES; CANCER-CELLS; GROWTH; P38; ACTIVATION; CHAPERONE; APOPTOSIS; PROMOTES	Less is known about the roles of c-Jun N-terminal kinase (JNK) in cholangiocarcinoma (CCA). Here, we report that JNK exerts its oncogenic action in human CCA cells, partially due to the mammalian target of rapamycin (mTOR) pathway regulated glucose-regulated protein 78 (GRP78) induction. In human CCA cells, the phosphorylation of eukaryotic initiation factor alpha (eIF2 alpha) results in the accumulation of activating transcription factor 4 (ATF4) and GRP78 independent of unfolded protein response (UPR). Suppression of GRP78 expression decreases the proliferation and invasion of human CCA cells. It's notable that mTOR is required for eIF2 alpha phosphorylation-induced ATF4 and GRP78 expression. Importantly, JNK promotes eIF2 alpha/ATF4-mediated GRP78 induction through regulating the activity of mTOR. Thus, our study implicates JNK/mTOR signaling plays an important role in cholangiocarcinogenesis, partially through promoting the eIF2 alpha/ATF4/GRP78 pathway.	[Feng, Chunhong; He, Kai; Su, Song; Li, Bo; Xia, Xianming; Dai, Rongyang] Luzhou Med Coll, Affiliated Hosp, Dept Hepatobiliary Surg, Luzhou, Sichuan, Peoples R China; [Zhang, Chunyan; Li, Yuxiao; Duan, Chun-Yan; Chen, Shaokun; Liu, Youping; Li, Hong; Dai, Rongyang] Luzhou Med Coll, Dept Biochem & Mol Biol, Luzhou, Sichuan, Peoples R China; [Chen, Run] Luzhou Med Coll, Dept Publ Hlth, Luzhou, Sichuan, Peoples R China; [Wei, Mei] Luzhou Med Coll, Affiliated Hosp Chinese Tradit Med, Luzhou, Sichuan, Peoples R China	Southwest Medical University; Southwest Medical University; Southwest Medical University; Southwest Medical University	Xia, XM (corresponding author), Luzhou Med Coll, Affiliated Hosp, Dept Hepatobiliary Surg, Luzhou, Sichuan, Peoples R China.	xxm6202@163.com; dryrun2502@163.com			New Century Excellent Talents in University Grant [NCET-11-1058]; Sichuan Province Science Foundation for Youths [2013JQ0045]; Luzhou City-Luzhou Medical College Foundation [2013LZLY-J06]; National Natural Science Foundation of China [81000886]	New Century Excellent Talents in University Grant(Program for New Century Excellent Talents in University (NCET)); Sichuan Province Science Foundation for Youths; Luzhou City-Luzhou Medical College Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by grants from New Century Excellent Talents in University Grant (NCET-11-1058), Sichuan Province Science Foundation for Youths (2013JQ0045), Luzhou City-Luzhou Medical College Foundation (2013LZLY-J06), and the National Natural Science Foundation of China (81000886). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045606; Barr RK, 2001, INT J BIOCHEM CELL B, V33, P1047, DOI 10.1016/S1357-2725(01)00093-0; Bennett HL, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.50; Cargnello M, 2012, MOL CELL BIOL, V32, P4572, DOI 10.1128/MCB.00544-12; Clarke M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044073; Dai RY, 2009, CELL RES, V19, P1243, DOI 10.1038/cr.2009.104; Dai RY, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.406520; Dai RY, 2012, J BIOL CHEM, V287, P14586, DOI 10.1074/jbc.M111.333435; de Groen PC, 1999, NEW ENGL J MED, V341, P1368, DOI 10.1056/NEJM199910283411807; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dong DZ, 2011, CANCER RES, V71, P2848, DOI 10.1158/0008-5472.CAN-10-3151; Firczuk M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.265; Fujishita T, 2011, GASTROENTEROLOGY, V140, P1556, DOI 10.1053/j.gastro.2011.02.007; Han C, 2005, J BIOL CHEM, V280, P24053, DOI 10.1074/jbc.M500562200; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Huang GL, 2013, MOL CELL BIOL, V33, P3416, DOI 10.1128/MCB.00384-13; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98; Ki YW, 2013, TOXICOL LETT, V218, P235, DOI 10.1016/j.toxlet.2013.02.003; Kim AD, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.273; Kwak D, 2012, J BIOL CHEM, V287, P18398, DOI 10.1074/jbc.M111.326538; Lam D, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.44; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee E, 2011, INT J CANCER, V128, P726, DOI 10.1002/ijc.25370; Leyva-Illades Dinorah, 2012, Transl Gastrointest Cancer, V1, P71; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Li MJ, 2009, J CELL MOL MED, V13, P4540, DOI 10.1111/j.1582-4934.2008.00575.x; Lin YZ, 2013, MOL MED REP, V8, P1623, DOI 10.3892/mmr.2013.1711; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Meng F, 2006, J HEPATOL, V44, P1055, DOI 10.1016/j.jhep.2005.10.030; Mingo-Sion AM, 2004, ONCOGENE, V23, P596, DOI 10.1038/sj.onc.1207147; Misra UK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051735; Ng TL, 2012, CELL DEATH DIFFER, V19, P501, DOI 10.1038/cdd.2011.119; Olnes MJ, 2004, ONCOLOGY-BASEL, V66, P167, DOI 10.1159/000077991; Patel T, 2006, NAT CLIN PRACT GASTR, V3, P33, DOI 10.1038/ncpgasthep0389; Quintanilla RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065140; Raciti M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.167; Shinkai Y, 2010, TOXICOL SCI, V114, P378, DOI 10.1093/toxsci/kfq008; Su RJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-20; Tadlock L, 2001, HEPATOLOGY, V33, P43, DOI 10.1053/jhep.2001.20676; Tan FLS, 2010, INT J CANCER, V126, P2353, DOI 10.1002/ijc.24944; Taylor CA, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-35; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055981; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Wehbe H, 2006, CANCER RES, V66, P10517, DOI 10.1158/0008-5472.CAN-06-2130; Yamagiwa Y, 2003, HEPATOLOGY, V38, P158, DOI 10.1053/jhep.2003.50257; Yang YC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.122; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080071; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	59	16	17	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90388	10.1371/journal.pone.0090388	http://dx.doi.org/10.1371/journal.pone.0090388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587347	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200186
J	Li, YJ; Chen, J; Xian, M; Zhou, LG; Han, FXX; Gan, LJ; Shi, ZQ				Li, Yan-Jun; Chen, Jian; Xian, Ming; Zhou, Li-Gang; Han, Fengxiang X.; Gan, Li-Jun; Shi, Zhi-Qi			In Site Bioimaging of Hydrogen Sulfide Uncovers Its Pivotal Role in Regulating Nitric Oxide-Induced Lateral Root Formation	PLOS ONE			English	Article							SEED-GERMINATION; ALUMINUM TOXICITY; CARBON-MONOXIDE; TOLERANCE; GASOTRANSMITTER; INVOLVEMENT; ACTIVATION; EXPRESSION; SALINITY; MOLECULE	Hydrogen sulfide (H2S) is an important gasotransmitter in mammals. Despite physiological changes induced by exogenous H2S donor NaHS to plants, whether and how H2S works as a true cellular signal in plants need to be examined. A selfdeveloped specific fluorescent probe (WSP-1) was applied to track endogenous H2S in tomato (Solanum lycopersicum) roots in site. Bioimaging combined with pharmacological and biochemical approaches were used to investigate the cross-talk among H2S, nitric oxide (NO), and Ca2+ in regulating lateral root formation. Endogenous H2S accumulation was clearly associated with primordium initiation and lateral root emergence. NO donor SNP stimulated the generation of endogenous H2S and the expression of the gene coding for the enzyme responsible for endogenous H2S synthesis. Scavenging H2S or inhibiting H2S synthesis partially blocked SNP-induced lateral root formation and the expression of lateral root-related genes. The stimulatory effect of SNP on Ca2+ accumulation and CaM1 (calmodulin 1) expression could be abolished by inhibiting H2S synthesis. Ca2+ chelator or Ca2+ channel blocker attenuated NaHS-induced lateral root formation. Our study confirmed the role of H2S as a cellular signal in plants being a mediator between NO and Ca2+ in regulating lateral root formation.	[Li, Yan-Jun; Gan, Li-Jun] Nanjing Agr Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China; [Li, Yan-Jun; Chen, Jian; Shi, Zhi-Qi] Jiangsu Acad Agr Sci, Inst Food Qual & Safety, Nanjing, Jiangsu, Peoples R China; [Xian, Ming] Washington State Univ, Dept Chem, Pullman, WA 99164 USA; [Zhou, Li-Gang] China Agr Univ, Coll Agron & Biotechnol, Dept Plant Pathol, Beijing 100094, Peoples R China; [Han, Fengxiang X.] Jackson State Univ, Dept Chem & Biochem, Jackson, MS USA	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; Washington State University; China Agricultural University; Jackson State University	Chen, J (corresponding author), Jiangsu Acad Agr Sci, Inst Food Qual & Safety, Nanjing, Jiangsu, Peoples R China.	jacksonchen206@gmail.com; ganlj@njau.edu.cn; jaasinput@gmail.com	Zhou, Ligang/AAF-1485-2019	Zhou, Ligang/0000-0003-4681-191X	Hi-Tech R & D Program of China [2011AA10A202]	Hi-Tech R & D Program of China	This work was financed by the grant from the Hi-Tech R & D Program of China (2011AA10A202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez C, 2010, PLANT PHYSIOL, V152, P656, DOI 10.1104/pp.109.147975; Besson-Bard A, 2008, ANNU REV PLANT BIOL, V59, P21, DOI 10.1146/annurev.arplant.59.032607.092830; Chen J, 2011, J EXP BOT, V62, P4481, DOI 10.1093/jxb/err145; Christou A, 2013, J EXP BOT, V64, P1953, DOI 10.1093/jxb/ert055; Correa-Aragunde N, 2006, J EXP BOT, V57, P581, DOI 10.1093/jxb/erj045; Correa-Aragunde N, 2004, PLANTA, V218, P900, DOI 10.1007/s00425-003-1172-7; Dawood M, 2012, J HAZARD MATER, V209, P121, DOI 10.1016/j.jhazmat.2011.12.076; Devarie-Baez NO, 2013, ORG LETT, V15, P2786, DOI 10.1021/ol401118k; Duan CX, 2013, CURR MED CHEM, V20, P2929, DOI 10.2174/09298673113209990005; Gaedeke N, 2001, EMBO J, V20, P1875, DOI 10.1093/emboj/20.8.1875; Garcia-Mata C, 2010, NEW PHYTOL, V188, P977, DOI 10.1111/j.1469-8137.2010.03465.x; Gruhlke MCH, 2012, PLANT PHYSIOL BIOCH, V59, P98, DOI 10.1016/j.plaphy.2012.03.016; Guo K, 2008, J EXP BOT, V59, P3443, DOI 10.1093/jxb/ern194; Hou ZH, 2013, J INTEGR PLANT BIOL, V55, P277, DOI 10.1111/jipb.12004; Jeandroz S, 2013, PLANT PHYSIOL, DOI [10.1104/1113.220624, DOI 10.1104/1113.220624]; Jiang B, 2010, ANTIOXID REDOX SIGN, V12, P1167, DOI 10.1089/ars.2009.2894; Jin ZP, 2011, BIOCHEM BIOPH RES CO, V414, P481, DOI 10.1016/j.bbrc.2011.09.090; Kimura H, 2014, ANTIOXID REDOX SIGN, V20, P783, DOI 10.1089/ars.2013.5309; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Kimura H, 2011, AMINO ACIDS, V41, P113, DOI 10.1007/s00726-010-0510-x; Li L, 2012, BIOMETALS, V25, P617, DOI 10.1007/s10534-012-9551-9; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Li ZG, 2012, ACTA PHYSIOL PLANT, V34, P2207, DOI 10.1007/s11738-012-1021-z; Li ZG, 2012, PLANT SCI, V185, P185, DOI 10.1016/j.plantsci.2011.10.006; Liang GH, 2011, AM J PHYSIOL-HEART C, V300, pH2088, DOI 10.1152/ajpheart.01290.2010; Lisjak M, 2013, PLANT CELL ENVIRON, V36, P1607, DOI 10.1111/pce.12073; Lisjak M, 2011, PLANT SIGNAL BEHAV, V6, P1444, DOI 10.4161/psb.6.10.17104; Liu Chunrong, 2011, Angew Chem Int Ed Engl, V50, P10327, DOI 10.1002/anie.201104305; Liu YH, 2012, ANTIOXID REDOX SIGN, V17, P141, DOI 10.1089/ars.2011.4005; Martinoia E, 2002, PLANTA, V214, P345, DOI 10.1007/s004250100661; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Papenbrock J, 2007, PLANT BIOLOGY, V9, P582, DOI 10.1055/s-2007-965424; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; SEKIYA J, 1982, PLANT PHYSIOL, V70, P430, DOI 10.1104/pp.70.2.430; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Suh SJ, 2007, J BIOL CHEM, V282, P1916, DOI 10.1074/jbc.M607926200; Tian QY, 2007, NEW PHYTOL, V174, P322, DOI 10.1111/j.1469-8137.2007.02005.x; Vandiver MS, 2012, J MOL MED, V90, P255, DOI 10.1007/s00109-012-0873-4; Wang BL, 2010, PLANTA, V231, P1301, DOI 10.1007/s00425-010-1134-9; Wang H, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23106; Wang R, 2010, ANTIOXID REDOX SIGN, V12, P1061, DOI 10.1089/ars.2009.2938; Wang YQ, 2012, PLANT SOIL, V351, P107, DOI 10.1007/s11104-011-0936-2; Xuan W, 2008, PLANT SIGNAL BEHAV, V3, P381, DOI 10.4161/psb.3.6.5374; Yao XQ, 2003, TRENDS PHARMACOL SCI, V24, P263, DOI 10.1016/S0165-6147(03)00122-6; Yoon EK, 2010, NUCLEIC ACIDS RES, V38, P1382, DOI 10.1093/nar/gkp1128; Zhang H, 2010, BIOL PLANTARUM, V54, P743, DOI 10.1007/s10535-010-0133-9; Zhang H, 2008, J INTEGR PLANT BIOL, V50, P1518, DOI 10.1111/j.1744-7909.2008.00769.x; Zhang H, 2010, PLANT SIGNAL BEHAV, V5, P1031, DOI [10.4161/psb.5.8.12297, 10.1111/j.1744-7909.2010.00946.x]; Zhang H, 2011, POSTHARVEST BIOL TEC, V60, P251, DOI 10.1016/j.postharvbio.2011.01.006; Zhang H, 2010, J INTEGR PLANT BIOL, V52, P556, DOI 10.1111/j.1744-7909.2010.00946.x; Zhang H, 2009, J INTEGR PLANT BIOL, V51, P1086, DOI 10.1111/j.1744-7909.2009.00885.x; Zhang H, 2009, PLANT GROWTH REGUL, V58, P243, DOI 10.1007/s10725-009-9372-1	52	33	40	5	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90340	10.1371/journal.pone.0090340	http://dx.doi.org/10.1371/journal.pone.0090340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587333	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800103
J	Jaquet, A; Horo, A; Ekouevi, DK; Toure, B; Coffie, PA; Effi, B; Lenaud, S; Messou, E; Minga, A; Sasco, AJ; Dabis, F				Jaquet, Antoine; Horo, Apollinaire; Ekouevi, Didier K.; Toure, Badian; Coffie, Patrick A.; Effi, Benjamin; Lenaud, Severin; Messou, Eugene; Minga, Albert; Sasco, Annie J.; Dabis, Francois		IeDEA West Africa Collaboration	Risk Factors for Cervical Intraepithelial Neoplasia in HIV-Infected Women on Antiretroviral Treatment in Cote d'Ivoire, West Africa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; POSITIVE WOMEN; CANCER; LESIONS; PREVALENCE; PREDICTORS; SPECTRUM; THERAPY; ZAMBIA	Background: Facing the dual burden of invasive cervical cancer and HIV in sub-Saharan Africa, the identification of preventable determinants of Cervical Intraepithelial Neoplasia (CIN) in HIV-infected women is of paramount importance. Methods: A cervical cancer screening based on visual inspection methods was proposed to HIV-infected women in care in Abidjan, Cote d'Ivoire. Positively screened women were referred for a colposcopy to a gynaecologist who performed directed biopsies. Results: Of the 2,998 HIV-infected women enrolled, 132 (4.4%) CIN of any grade (CIN+) were identified. Women had been followed-up for a median duration of three years [IQR: 1-5] and 76% were on antiretroviral treatment (ART). Their median most recent CD4 count was 452 [IQR: 301-621] cells/mm(3). In multivariate analysis, CIN+ was associated with a most recent CD4 count >350 cells/mm(3) (OR: 0.3; 95% CI: 0.2-0.6) or >= 200-350 cells/mm(3) (OR 0.6; 95% CI 0.4-1.0) (Ref: <200 cells/mm(3) CD4) (p<10(-4)). Conclusions: The presence of CIN+ is less common among HIV-infected women with limited or no immune deficiency. Despite the potential impact of immunological recovery on the reduction of premalignant cervical lesions through the use of ART, cervical cancer prevention, including screening and vaccination remains a priority in West Africa while ART is rolled-out.	[Jaquet, Antoine; Ekouevi, Didier K.; Sasco, Annie J.; Dabis, Francois] Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Jaquet, Antoine; Ekouevi, Didier K.; Sasco, Annie J.; Dabis, Francois] INSERM, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Horo, Apollinaire; Toure, Badian] Ctr Hops Univ CHU Yopougon, Serv Gynecol Obstet, Abidjan, Cote Ivoire; [Ekouevi, Didier K.; Coffie, Patrick A.; Lenaud, Severin] CHU Treichville, Programme PACCI, Abidjan, Cote Ivoire; [Effi, Benjamin] CHU Treichville, Serv Anatomopathol, Abidjan, Cote Ivoire; [Messou, Eugene] ACONDA, CePReF, Abidjan, Cote Ivoire; [Minga, Albert] Ctr Med Suivi Donneurs Sang CNTS PRIMO CI, Abidjan, Cote Ivoire	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Jaquet, A (corresponding author), Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France.	antoine.jaquet@isped.u-bordeaux2.fr	EKOUEVI, Didier K/E-7960-2014; Leroy, Valeriane/AAO-5175-2020; Ostergaard, Lars/AAA-3020-2020; Leroy, Valeriane/GQB-1102-2022; Adebamowo, Clement/C-8778-2011; Jaquet, Antoine/T-2794-2019; DABIS, FRANCOIS/S-9298-2019; Leroy, Valeriane/F-8129-2013; Wejse, Christian/C-8468-2014	Leroy, Valeriane/0000-0003-3542-8616; Ostergaard, Lars/0000-0003-2459-0511; Leroy, Valeriane/0000-0003-3542-8616; Adebamowo, Clement/0000-0002-6571-2880; Jaquet, Antoine/0000-0002-3426-9492; DABIS, FRANCOIS/0000-0002-1614-8857; Leroy, Valeriane/0000-0003-3542-8616; Wejse, Christian/0000-0002-2534-2942; Gottlieb, Geoffrey/0000-0002-5749-481X	National Cancer Institute (NCI); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH), as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) [U01AI069919]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069919] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH), as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The National Cancer Institute (NCI), the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) and the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH), as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) under Award Number U01AI069919. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjorlolo-Johnson G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-242; Agaba PA, 2009, INT J GYNECOL OBSTET, V107, P99, DOI 10.1016/j.ijgo.2009.06.006; Anastos K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013525; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Arbyn M, 2008, INT J CANCER, V123, P153, DOI 10.1002/ijc.23489; De Vuyst H, 2012, BRIT J CANCER, V107, P1624, DOI 10.1038/bjc.2012.441; Ferlay J, 2013, IARC CANCERBASE; Fife KH, 2009, JAIDS-J ACQ IMM DEF, V51, P274, DOI 10.1097/QAI.0b013e3181a97be5; Firnhaber C, 2010, CANCER CAUSE CONTROL, V21, P433, DOI 10.1007/s10552-009-9475-z; Hawes SE, 2003, J INFECT DIS, V188, P555, DOI 10.1086/376996; Horo A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-237; Huchko MJ, 2014, INT J CANCER, V134, P740, DOI 10.1002/ijc.28401; Jaquet A, 2012, BRIT J CANCER, V107, P556, DOI 10.1038/bjc.2012.299; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; La Ruche G, 1998, CANCER-AM CANCER SOC, V82, P2401, DOI 10.1002/(SICI)1097-0142(19980615)82:12&lt;2401::AID-CNCR14&gt;3.3.CO;2-H; Mbulaiteye SM, 2006, INT J CANCER, V118, P985, DOI 10.1002/ijc.21443; Minkoff H, 2010, J INFECT DIS, V201, P681, DOI 10.1086/650467; Munoz N, 2002, LANCET, V359, P1093, DOI 10.1016/S0140-6736(02)08151-5; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Parham GP, 2006, GYNECOL ONCOL, V103, P1017, DOI 10.1016/j.ygyno.2006.06.015; Sahasrabuddhe VV, 2007, BRIT J CANCER, V96, P1480, DOI 10.1038/sj.bjc.6603737; Sahasrabuddhe VV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008634; Sankaranarayanan R, 2003, PRACTICAL MANUAL VIS, P1; Simen-Kapeu A, 2009, CANCER CAUSE CONTROL, V20, P163, DOI 10.1007/s10552-008-9230-x; Stein L, 2008, INT J CANCER, V122, P2260, DOI 10.1002/ijc.23391; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; de Andrade ACV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018297	27	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90625	10.1371/journal.pone.0090625	http://dx.doi.org/10.1371/journal.pone.0090625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595037	gold, Green Published, Green Submitted			2022-12-27	WOS:000332475500076
J	Wan, MW; Downey, D; Strachan, H; Elliott, R; Williams, SR; Abel, KM				Wan, Ming Wai; Downey, Darragh; Strachan, Hilary; Elliott, Rebecca; Williams, Steve R.; Abel, Kathryn M.			The Neural Basis of Maternal Bonding	PLOS ONE			English	Article							PARENT-INFANT SYNCHRONY; MOTHERS; BRAIN; RISK; RESPONSIVENESS; RECOGNITION; ACTIVATION; PICTURES; AMYGDALA; ANATOMY	Background: Accumulating evidence suggests that mothers show a different pattern of brain responses when viewing their own compared to other infants. However, there is inconsistency across functional imaging studies regarding the key areas involved, and none have examined relationships between brain and behavioural responses to infants. We examined the brain regions activated when mothers viewed videos of their own infant contrasted with an unknown infant, and whether these are associated with behavioural and self-reported measures of mother-infant relations. Method: Twenty right-handed mothers viewed alternating 30-sec blocks of video of own 4-9 month infant and an unfamiliar matched infant, interspersed with neutral video. Whole brain functional magnetic resonance images (fMRI) were acquired on a 1.5T Philips Intera scanner using a TR of 2.55 s. Videotaped mother-infant interactions were systematically evaluated blind to family information to generate behavioural measures for correlational analysis. Results: Enhanced blood oxygenation functional imaging responses were found in the own versus unknown infant contrast in the bilateral precuneus, right superior temporal gyrus, right medial and left middle frontal gyri and left amygdala. Positive mother-infant interaction (less directive parent behaviour; more positive/attentive infant behaviour) was significantly associated with greater activation in several regions on viewing own versus unknown infant, particularly the middle frontal gyrus. Mothers' perceived warmth of her infant was correlated with activations in the same contrast, particularly in sensory and visual areas. Conclusion: This study partially replicates previous reports of the brain regions activated in mothers in response to the visual presentation of their own infant. It is the first to report associations between mothers' unique neural responses to viewing their own infant with the quality of her concurrent behaviour when interacting with her infant and with her perceptions of infant warmth. These findings provide support for developing fMRI as a potential biomarker of parenting risk and change.	[Wan, Ming Wai; Abel, Kathryn M.] Univ Manchester, Ctr Womens Mental Hlth, Inst Brain Behav & Mental Hlth, Manchester, Lancs, England; [Downey, Darragh; Elliott, Rebecca] Univ Manchester, Neurosci & Psychiat Unit, Inst Brain Behav & Mental Hlth, Manchester, Lancs, England; [Strachan, Hilary] Bolton Natl Hlth Serv Fdn Trust, Bolton, Lancs, England; [Williams, Steve R.] Univ Manchester, Ctr Imaging Sci, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Wan, MW (corresponding author), Univ Manchester, Ctr Womens Mental Hlth, Inst Brain Behav & Mental Hlth, Manchester, Lancs, England.	m.w.wan@manchester.ac.uk	Williams, Steve R/C-8945-2011; Wan, Ming Wai/AAG-4688-2019; Williams, Steve C/D-6979-2011	Williams, Steve R/0000-0001-5940-1675; Williams, Steve C/0000-0003-4299-1941; Wan, Ming Wai/0000-0002-5353-786X; Downey, Darragh/0000-0003-2755-4049; Abel, Kathryn M/0000-0003-3538-8896; Elliott, Rebecca/0000-0002-7602-010X	Wellcome Trust Clinical Research Facility; Magnetic Resonance Imaging Facility	Wellcome Trust Clinical Research Facility(Wellcome Trust); Magnetic Resonance Imaging Facility	Wellcome Trust Clinical Research Facility and the Magnetic Resonance Imaging Facility paid for the scanning time. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbaum M, 2001, CHILD DEV, V72, P1478; Atzil S, 2011, NEUROPSYCHOPHARMACOL, V36, P2603, DOI 10.1038/npp.2011.172; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Belsky J, 2002, DEV PSYCHOPATHOL, V14, P293, DOI 10.1017/S0954579402002067; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Davies J, 2008, INFANT MENT HEALTH J, V29, P537, DOI 10.1002/imhj.20197; Farrow TFD, 2001, NEUROREPORT, V12, P2433, DOI 10.1097/00001756-200108080-00029; Feldman R, 1999, J CHILD PSYCHOL PSYC, V40, P929, DOI 10.1017/S0021963099004308; Feldman R, 2007, CURR DIR PSYCHOL SCI, V16, P340, DOI 10.1111/j.1467-8721.2007.00532.x; Feldman R, 2012, MONOGR SOC RES CHILD, V77, P42, DOI 10.1111/j.1540-5834.2011.00660.x; Field T, 2010, INFANT BEHAV DEV, V33, P1, DOI 10.1016/j.infbeh.2009.10.005; Green J, 2013, J AUTISM DEV DISORD, V43, P2502, DOI 10.1007/s10803-013-1797-8; Harvey PO, 2013, SCHIZOPHRENIA BULL, V39, P617, DOI 10.1093/schbul/sbs042; Kim P, 2011, J CHILD PSYCHOL PSYC, V52, P907, DOI 10.1111/j.1469-7610.2011.02406.x; Kim P, 2010, BEHAV NEUROSCI, V124, P695, DOI 10.1037/a0020884; Kinsey CB, 2013, MIDWIFERY, V29, P1314, DOI 10.1016/j.midw.2012.12.019; Leckman JF, 2004, J NEURAL TRANSM, V111, P753, DOI 10.1007/s00702-003-0067-x; Lee Y, 2012, NEUROIMAGE, V61, P1287, DOI 10.1016/j.neuroimage.2012.02.073; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Lenzi D, 2009, CEREB CORTEX, V19, P1124, DOI 10.1093/cercor/bhn153; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; Lorberbaum JP, 2002, BIOL PSYCHIAT, V51, P431, DOI 10.1016/S0006-3223(01)01284-7; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; McClure S, 2002, ANN SCI M SOC NEUR; Montoya JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036270; Nagasawa M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00031; Nitschke JB, 2004, NEUROIMAGE, V21, P583, DOI 10.1016/j.neuroimage.2003.10.005; Noriuchi M, 2008, BIOL PSYCHIAT, V63, P415, DOI 10.1016/j.biopsych.2007.05.018; O'Higgins M, 2013, ARCH WOMEN MENT HLTH, P1; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Parsons CE, 2010, PROG NEUROBIOL, V91, P220, DOI 10.1016/j.pneurobio.2010.03.001; Ranote S, 2004, NEUROREPORT, V15, P1825, DOI 10.1097/01.wnr.0000137078.64128.6a; Schore AN, 2001, INFANT MENT HEALTH J, V22, P7, DOI 10.1002/1097-0355(200101/04)22:1<7::AID-IMHJ2>3.0.CO;2-N; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Seifritz E, 2003, BIOL PSYCHIAT, V54, P1367, DOI 10.1016/S0006-3223(03)00697-8; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Squire S, 2003, BRIT J PSYCHIAT, V183, P481, DOI 10.1192/bjp.183.6.481; Strathearn L, 2008, PEDIATRICS, V122, P40, DOI 10.1542/peds.2007-1566; Swain JE, 2007, J CHILD PSYCHOL PSYC, V48, P262, DOI 10.1111/j.1469-7610.2007.01731.x; Swain JE, 2011, PROG NEURO-PSYCHOPH, V35, P1242, DOI 10.1016/j.pnpbp.2010.10.017; Wan MW, 2008, INFANT BEHAV DEV, V31, P532, DOI 10.1016/j.infbeh.2008.04.003; Wan MW, 2008, ARCH WOMEN MENT HLTH, V11, P171, DOI 10.1007/s00737-008-0010-0; Wan MW, 2008, GEN HOSP PSYCHIAT, V30, P177, DOI 10.1016/j.genhosppsych.2007.12.001; Wan MW, 2013, J CHILD PSYCHOL PSYC, V54, P763, DOI 10.1111/jcpp.12032; Wan MW, 2012, RES DEV DISABIL, V33, P924, DOI 10.1016/j.ridd.2011.12.011; White-Traut R, 2009, DEV PSYCHOBIOL, V51, P367, DOI 10.1002/dev.20376	46	48	48	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e88436	10.1371/journal.pone.0088436	http://dx.doi.org/10.1371/journal.pone.0088436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594508	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500004
J	Claessen, JHL; Sanyal, S; Ploegh, HL				Claessen, Jasper H. L.; Sanyal, Sumana; Ploegh, Hidde L.			The Chaperone BAG6 Captures Dislocated Glycoproteins in the Cytosol	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; N-GLYCANASE; DEGRADATION; ELIMINATION; PROTEASOME; TURNOVER; PEPTIDE; ER	Secretory and membrane (glyco) proteins are subject to quality control in the endoplasmic reticulum (ER) to ensure that only functional proteins reach their destination. Proteins deemed terminally misfolded and hence functionally defective may be dislocated to the cytosol, where the proteasome degrades them. What we know about this process stems mostly from overexpression of tagged misfolded proteins, or from situations where viruses have hijacked the quality control machinery to their advantage. We know of only very few endogenous substrates of ER quality control, most of which are degraded as part of a signaling pathway, such as Insig-1, but such examples do not necessarily represent terminally misfolded proteins. Here we show that endogenous dislocation clients are captured specifically in association with the cytosolic chaperone BAG6, or retrieved en masse via their glycan handle.	[Claessen, Jasper H. L.; Sanyal, Sumana; Ploegh, Hidde L.] MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Ploegh, HL (corresponding author), MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02139 USA.	ploegh@wi.mit.edu	Sanyal, Sumana/AAF-5155-2020; Sanyal, Sumana/I-7975-2013	Sanyal, Sumana/0000-0002-6230-5366	Boehringer Ingelheim Fonds; NIH [RO1 AI087879, RO1 AI033456]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087879, R01AI033456] Funding Source: NIH RePORTER	Boehringer Ingelheim Fonds(Boehringer Ingelheim); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JHLC was supported by a fellowship from the Boehringer Ingelheim Fonds. HLP receives funding from the NIH (RO1 AI087879 and RO1 AI033456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Chen X, 2011, J CELL BIOL, V192, P825, DOI 10.1083/jcb.201008090; Claessen JHL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028542; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; de Virgilio M, 1998, J BIOL CHEM, V273, P9734, DOI 10.1074/jbc.273.16.9734; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Leichner GS, 2009, MOL BIOL CELL, V20, P3330, DOI 10.1091/mbc.E08-09-0953; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Sanyal S, 2012, J BIOL CHEM, V287, P23594, DOI 10.1074/jbc.M112.365312; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Spooner RA, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-26; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Tortorella D, 1998, J CELL BIOL, V142, P365, DOI 10.1083/jcb.142.2.365; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Xu Y, 2013, J BIOL CHEM, V288, P18068, DOI 10.1074/jbc.M112.449199	24	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90204	10.1371/journal.pone.0090204	http://dx.doi.org/10.1371/journal.pone.0090204			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594942	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900080
J	Huynen, L; Lambert, DM				Huynen, Leon; Lambert, David M.			Complex Species Status for Extinct Moa (Aves: Dinornithiformes) from the Genus Euryapteryx	PLOS ONE			English	Article							ANCIENT DNA; SUBSTITUTIONS	The exact species status of New Zealand's extinct moa remains unknown. In particular, moa belonging to the genus Euryapteryx have been difficult to classify. We use the DNA barcoding sequence on a range of Euryapteryx samples in an attempt to resolve the species status for this genus. We obtained mitochondrial control region and the barcoding region from Cytochrome Oxidase Subunit I (COI) from a number of new moa samples and use available sequences from previous moa phylogenies and eggshell data to try and clarify the species status of Euryapteryx. Using the COI barcoding region we show that species status in Euryapteryx is complex with no clear separation between various individuals. Eggshell, soil, and bone data suggests that a Euryapteryx subspecies likely exists on New Zealand's North Island and can be characterized by a single mitochondrial control region SNP. COI divergences between Euryapteryx individuals from the south of New Zealand's South Island and those from the Far North of the North Island exceed 1.6% and are likely to represent separate species. Individuals from other areas of New Zealand were unable to be clearly separated based on COI differences possibly as a result of repeated hybridisation events. Despite the accuracy of the COI barcoding region to determine species status in birds, including that for the other moa genera, for moa from the genus Euryapteryx, COI barcoding fails to provide a clear result, possibly as a consequence of repeated hybridisation events between these moa. A single control region SNP was identified however that segregates with the two general morphological variants determined for Euryapteryx; a smaller subspecies restricted to the North Island of New Zealand, and a larger subspecies, found on both New Zealand's North and South Island.	[Lambert, David M.] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; Griffith Univ, Sch Biomol & Phys Sci, Nathan, Qld 4111, Australia	Griffith University; Griffith University	Lambert, DM (corresponding author), Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia.	D.Lambert@griffith.edu.au		Lambert, David/0000-0002-5821-3637	Australian Research Council [DP110101364]	Australian Research Council(Australian Research Council)	This work was carried out with support from the Australian Research Council (Grant number DP110101364; The molecular evolution of wings in ratites). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AJ, 2005, P NATL ACAD SCI USA, V102, P8257, DOI 10.1073/pnas.0409435102; Bunce M, 2003, NATURE, V425, P172, DOI 10.1038/nature01871; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; Burbidge ML, 2003, CONSERV GENET, V4, P167, DOI 10.1023/A:1023386506067; Cooper A, 2000, SCIENCE, V289, P1139; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Huynen L, 2003, NATURE, V425, P175, DOI 10.1038/nature01838; Huynen L, 2010, P NATL ACAD SCI USA, V107, P16201, DOI 10.1073/pnas.0914096107; Kerr KCR, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-29; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lambert DM, 2005, J HERED, V96, P279, DOI 10.1093/jhered/esi035; Oskam CL, 2011, J ARCHAEOL SCI, V38, P2589, DOI 10.1016/j.jas.2011.05.006; Rawlence NJ, 2009, P ROY SOC B-BIOL SCI, V276, P3395, DOI 10.1098/rspb.2009.0755; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; Waugh J, 2008, BIOESSAYS, V30, P92, DOI 10.1002/bies.20698; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Worthy TH, 2012, NEW ZEAL J ZOOL, V39, P87, DOI 10.1080/03014223.2012.665060; WORTHY TH, 2002, LOST WORLD MOA	20	0	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90212	10.1371/journal.pone.0090212	http://dx.doi.org/10.1371/journal.pone.0090212			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594991	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900081
J	Janson, IA; Kong, YP; Putnam, AJ				Janson, Isaac A.; Kong, Yen P.; Putnam, Andrew J.			Nanotopographic Substrates of Poly (Methyl Methacrylate) Do Not Strongly Influence the Osteogenic Phenotype of Mesenchymal Stem Cells In Vitro	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX; BONE-FORMATION; SURFACE-FEATURES; DIFFERENTIATION; ADHESION; COLLAGEN; ACTIVATION; BEHAVIOR; MINERALIZATION	The chemical, mechanical, and topographical features of the extracellular matrix (ECM) have all been documented to influence cell adhesion, gene expression, migration, proliferation, and differentiation. Topography plays a key role in the architecture and functionality of various tissues in vivo, thus raising the possibility that topographic cues can be instructive when incorporated into biomaterials for regenerative applications. In the literature, there are discrepancies regarding the potential roles of nanotopography to enhance the osteogenic phenotype of mesenchymal stem cells (MSC). In this study, we used thin film substrates of poly(methyl methacrylate) (PMMA) with nanoscale gratings to investigate the influence of nanotopography on the osteogenic phenotype of MSCs, focusing in particular on their ability to produce mineral similar to native bone. Topography influenced focal adhesion size and MSC alignment, and enhanced MSC proliferation after 14 days of culture. However, the osteogenic phenotype was minimally influenced by surface topography. Specifically, alkaline phosphatase (ALP) expression was not increased on nanotopographic films, nor was calcium deposition improved after 21 days in culture. Ca:P ratios were similar to native mouse bone on films with gratings of 415 nm width and 200 nm depth (G415) and 303 nm width and 190 nm depth (G303). Notably, all surfaces had Ca: P ratios significantly lower than G415 films. Collectively, these data suggest that, PMMA films with nanogratings are poor drivers of an osteogenic phenotype.	[Janson, Isaac A.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; [Kong, Yen P.; Putnam, Andrew J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Putnam, AJ (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	putnam@umich.edu	Putnam, Andrew J./E-8643-2010	Putnam, Andrew J./0000-0002-1262-4377; Janson, Isaac/0000-0002-8862-7785	University of Michigan	University of Michigan(University of Michigan System)	This work was funded by start-up funds from the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allori AC, 2008, TISSUE ENG PART B-RE, V14, P275, DOI 10.1089/ten.teb.2008.0083; Biggs MJP, 2007, J ORTHOP RES, V25, P273, DOI 10.1002/jor.20319; Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049; Bigi A, 1997, J INORG BIOCHEM, V68, P45, DOI 10.1016/S0162-0134(97)00007-X; Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y; BURSTONE MS, 1958, J NATL CANCER I, V21, P523; CASSELLA JP, 1992, BONE MINER, V17, P123, DOI 10.1016/0169-6009(92)90722-P; Chung JY, 2007, SOFT MATTER, V3, P1163, DOI 10.1039/b705112c; Coyer SR, 2012, J CELL SCI, V125, P5110, DOI 10.1242/jcs.108035; Cunningham JJ, 2002, ANN BIOMED ENG, V30, P927, DOI 10.1114/1.1500408; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Denis FA, 2005, SMALL, V1, P984, DOI 10.1002/smll.200500116; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; FARLEY JR, 1986, METABOLISM, V35, P563, DOI 10.1016/0026-0495(86)90016-8; Gao LC, 2007, LANGMUIR, V23, P3762, DOI 10.1021/la062634a; Gao LC, 2009, LANGMUIR, V25, P7249, DOI 10.1021/la901416m; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hermitte L, 2004, J COLLOID INTERF SCI, V272, P82, DOI 10.1016/j.jcis.2003.08.055; Hirvi JT, 2007, LANGMUIR, V23, P7724, DOI 10.1021/la700558v; Huebsch N, 2011, MECHANOBIOLOGY OF CELL-CELL AND CELL-MATRIX INTERACTIONS, P23, DOI 10.1007/978-1-4419-8083-0_3; Jaberi J, 2013, J ORAL MAXIL SURG, V71, pE81, DOI 10.1016/j.joms.2012.09.023; Kerschnitzki M, 2011, J STRUCT BIOL, V173, P303, DOI 10.1016/j.jsb.2010.11.014; Khang D, 2012, BIOMATERIALS, V33, P5997, DOI 10.1016/j.biomaterials.2012.05.005; Khatiwala CB, 2007, J CELL PHYSIOL, V211, P661, DOI 10.1002/jcp.20974; Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/jbmr.081240, 10.1359/JBMR.081240]; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107; Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042; Kim J, 2013, BIOMATERIALS, V34, P7257, DOI 10.1016/j.biomaterials.2013.06.029; Koh LB, 2010, PHYS CHEM CHEM PHYS, V12, P10301, DOI 10.1039/c001747g; Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022; Krause U, 2011, METHODS MOL BIOL, V698, P215, DOI 10.1007/978-1-60761-999-4_17; Kuhn LT, 2008, CALCIFIED TISSUE INT, V83, P146, DOI 10.1007/s00223-008-9164-z; Kulangara K, 2012, BIOMATERIALS, V33, P4998, DOI 10.1016/j.biomaterials.2012.03.053; Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110; Kusumaatmaja H, 2008, LANGMUIR, V24, P7299, DOI 10.1021/la800649a; Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034; Leroy F, 2012, J CHEM THEORY COMPUT, V8, P3724, DOI 10.1021/ct300089j; Lewis G, 2011, J BIOMED MATER RES B, V98B, P171, DOI 10.1002/jbm.b.31835; Li D, 2012, ACS SYM SER, V1120, P301; Li W, 2008, J PHYS CHEM B, V112, P7234, DOI 10.1021/jp712019y; Lim JY, 2008, BIOMATERIALS, V29, P1776, DOI 10.1016/j.biomaterials.2007.12.026; Liu YJ, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/46/465302; Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]; OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815; Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012; Prockop DJ, 2008, MESENCHYMAL STEM CEL; Prodanov L, 2013, BIOMATERIALS, V34, P2920, DOI 10.1016/j.biomaterials.2013.01.027; Prodanov L, 2010, BIOMATERIALS, V31, P7758, DOI 10.1016/j.biomaterials.2010.06.050; Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007; Rao MS, 2001, MECH AGEING DEV, V122, P713, DOI 10.1016/S0047-6374(01)00224-X; Rao RR, 2012, ACTA BIOMATER, V8, P1560, DOI 10.1016/j.actbio.2012.01.001; Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017; Salasznyk RM, 2007, J CELL BIOCHEM, V100, P499, DOI 10.1002/jcb.21074; Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z; Ter Brugge PJ, 2002, TISSUE ENG, V8, P321, DOI 10.1089/107632702753725076; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/nmat3339, 10.1038/NMAT3339]; Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y; Wang PY, 2012, J MATER SCI-MATER M, V23, P3015, DOI 10.1007/s10856-012-4748-6; Watari S, 2012, BIOMATERIALS, V33, P128, DOI 10.1016/j.biomaterials.2011.09.058; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098; Wood JA, 2012, EXP CELL RES, V318, P2438, DOI 10.1016/j.yexcr.2012.06.022; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058; Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037; Yong X, 2009, LANGMUIR, V25, P5045, DOI 10.1021/la804025h; You MH, 2010, BIOMACROMOLECULES, V11, P1856, DOI 10.1021/bm100374n; Zhao Y, 2007, LANGMUIR, V23, P6212, DOI 10.1021/la0702077	73	21	21	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90719	10.1371/journal.pone.0090719	http://dx.doi.org/10.1371/journal.pone.0090719			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594848	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900137
J	Li, S; Wu, Y; Yu, G; Xia, Q; Xu, YW				Li, Shuang; Wu, Yan; Yu, Ge; Xia, Qing; Xu, Yawei			Angiotensin II Receptor Blockers Improve Peripheral Endothelial Function: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							CORONARY-ARTERY; BRACHIAL-ARTERY; ACE-INHIBITION; DYSFUNCTION; CANDESARTAN; IRBESARTAN; LOSARTAN; ENZYME; RENIN; ANTAGONISM	Objective(s): Several studies have assessed the effect of angiotensin II receptor blockers (ARBs) on peripheral endothelial dysfunction as measured by flow-mediated vasodilatation (FMD), a widely-used indicator for endothelial function. We conducted a meta-analysis to investigate the effect in comparison to placebo or no treatment and other antihypertensives. Methods: MEDLINE, Cochrane library and EMBASE were searched to September 2013 for randomized controlled trials (RCTs) that assessed the effect of ARBs versus placebo or no treatment and other antihypertensives (angiotensin-converting enzyme inhibitors (ACEIs), calcium channel blockers (CCBs), beta-blockers, diuretics) by forearm FMD. Furthermore, we also use meta-regression to analyze the relationship between the endothelial function and the duration of ARBs treatments. Results: In 11 trials including 590 patients, ARBs (n = 315) significantly improved FMD (1.36%, 95% confidence internal [CI]: 1.28 to 1.44) versus placebo or no treatment (n = 275). In 16 trials that included 1028 patients, ARBs (n = 486) had a significant effect (0.59%, 95% CI: 0.25 to 0.94) on FMD when compared with other antihypertensives (n = 542). In 8 trials, ARBs (n = 174) had no significant effect (-0.14%, 95% CI: -0.32 to 0.03) compared with ACEI (n = 173). Compared with others, the benefits of ARBs, respectively, were 1.67% (95% CI: 0.65 to 0.93) in 7 trials with CCBs, 0.79% (95% CI: 0.42 to 1.01) with beta-blockers in 3 trials and 0.9% (95% CI: 0.77 to 1.03) with diuretics in 3 trials. Importantly, we found ARBs were less effective in a long time span (95% CI: -1.990 to -0.622) than the first 6 months (95% CI: -0.484 to 0.360). Conclusions: This study shows that ARBs improve peripheral endothelial function and are superior to CCBs, beta-blockers and diuretics. However, the effect couldn't be maintained for a long time. In addition, there was no significant difference between ARBs and ACEI.	[Li, Shuang; Xia, Qing; Xu, Yawei] Tongji Univ, Shanghai Tenth Peoples Hosp, Sch Med, Dept Cardiol, Shanghai 200092, Peoples R China; [Wu, Yan] Tongji Univ, Shanghai Tenth Peoples Hosp, Sch Med, Dept Ophthalmol, Shanghai 200092, Peoples R China; [Yu, Ge] Tongji Univ, Shanghai Tenth Peoples Hosp, Sch Med, Dept Gastroenterol, Shanghai 200092, Peoples R China	Tongji University; Tongji University; Tongji University	Xu, YW (corresponding author), Tongji Univ, Shanghai Tenth Peoples Hosp, Sch Med, Dept Cardiol, Shanghai 200092, Peoples R China.	xuyawei@tongji.edu.cn			National Natural Science Foundation of China [81270256, 81070107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported partly by grants from National Natural Science Foundation of China (Grant No. 81270256 and 81070107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alreja G, 2011, WORLD J CARDIOL, V3, P72, DOI 10.4330/wjc.v3.i3.72; ANDERSON TJ, 1995, AM J CARDIOL, V75, pB71, DOI 10.1016/0002-9149(95)80017-M; BARROW SE, 1986, BRIT J PHARMACOL, V87, P243, DOI 10.1111/j.1476-5381.1986.tb10177.x; BELL L, 1990, AM J PATHOL, V137, P7; Benndorf RA, 2007, J CARDIOVASC PHARM, V50, P367, DOI 10.1097/FJC.0b013e31811dfbe7; BIOLLAZ J, 1982, J CARDIOVASC PHARM, V4, P966, DOI 10.1097/00005344-198211000-00014; Chung NA, 2004, BLOOD PRESSURE, V13, P183, DOI 10.1080/08037050410033312; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Flammer AJ, 2007, J HYPERTENS, V25, P785, DOI 10.1097/HJH.0b013e3280287a72; Ghiadoni L, 2003, HYPERTENSION, V41, P1281, DOI 10.1161/01.HYP.0000070956.57418.22; Hornig B, 2001, CIRCULATION, V103, P799, DOI 10.1161/01.CIR.103.6.799; Inaba Y, 2010, INT J CARDIOVAS IMAG, V26, P631, DOI 10.1007/s10554-010-9616-1; James PA, 2013, JAMA; Kawano H, 2000, CIRCULATION, V101, P1130, DOI 10.1161/01.CIR.101.10.1130; Koh KK, 2004, AM J CARDIOL, V93, P1432, DOI 10.1016/j.amjcard.2004.02.050; Koh KK, 2007, EUR HEART J, V28, P1440, DOI 10.1093/eurheartj/ehm101; Koh KK, 2010, INT J CARDIOL, V140, P73, DOI 10.1016/j.ijcard.2008.11.017; Linz W, 1999, CARDIOVASC RES, V43, P549, DOI 10.1016/S0008-6363(99)00091-7; Lunder M, 2012, EUR J PREV CARDIOL, V19, P1243, DOI 10.1177/1741826711423104; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; MOMBOULI JV, 1992, CIRC RES, V71, P137, DOI 10.1161/01.RES.71.1.137; Morimoto S, 2006, HYPERTENS RES, V29, P567, DOI 10.1291/hypres.29.567; OKANE KPJ, 1994, BRIT J CLIN PHARMACO, V38, P311, DOI 10.1111/j.1365-2125.1994.tb04359.x; PANZA JA, 1993, J AM COLL CARDIOL, V21, P1145, DOI 10.1016/0735-1097(93)90238-V; PELLACANI A, 1994, CLIN SCI, V87, P567, DOI 10.1042/cs0870567; Pelliccia F, 2010, ATHEROSCLEROSIS, V210, P510, DOI 10.1016/j.atherosclerosis.2009.12.005; Perrone-Filardi P, 2009, J CLIN HYPERTENS, V11, P260, DOI 10.1111/j.1751-7176.2009.00108.x; Rajagopalan Sanjay, 2006, J Clin Hypertens (Greenwich), V8, P783, DOI 10.1111/j.1524-6175.2006.05797.x; Rossing K, 2005, KIDNEY INT, V68, P1190, DOI 10.1111/j.1523-1755.2005.00511.x; Schmieder RE, 2005, J AM SOC NEPHROL, V16, P3038, DOI 10.1681/ASN.2005020138; Shahin Y, 2011, ATHEROSCLEROSIS, V216, P7, DOI 10.1016/j.atherosclerosis.2011.02.044; Sola S, 2005, CIRCULATION, V111, P343, DOI 10.1161/01.CIR.0000153272.48711.B9; Souza-Barbosa LA, 2006, J CLIN HYPERTENS GRE, V8, P810; Souza-Barbosa Leon Adriana, 2006, J Clin Hypertens (Greenwich), V8, P803, DOI 10.1111/j.1524-6175.2006.05663.x; Sozen AB, 2009, J INT MED RES, V37, P996, DOI 10.1177/147323000903700403; Takiguchi S, 2011, HYPERTENS RES, V34, P686, DOI 10.1038/hr.2011.11; Trevelyan J, 2005, HEART, V91, P1053, DOI 10.1136/hrt.2004.036897; URATA H, 1990, J BIOL CHEM, V265, P22348; URATA H, 1990, CIRC RES, V66, P883, DOI 10.1161/01.RES.66.4.883; Warnholtz A, 2007, ATHEROSCLEROSIS, V194, P439, DOI 10.1016/j.atherosclerosis.2006.08.034; Watanabe T, 2005, HYPERTENSION, V45, P163, DOI 10.1161/01.HYP.0000153321.13792.b9; Wei D, 2012, CNS NEUROSCI THER, V18, P400, DOI 10.1111/j.1755-5949.2012.00304.x; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Yavuz D, 2003, J RENIN-ANGIO-ALDO S, V4, P197, DOI 10.3317/jraas.2003.032; Yilmaz MI, 2010, CLIN J AM SOC NEPHRO, V5, P1174, DOI 10.2215/CJN.01110210	45	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90217	10.1371/journal.pone.0090217	http://dx.doi.org/10.1371/journal.pone.0090217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595033	Green Submitted, gold, Green Published			2022-12-27	WOS:000332468900083
J	Wei, HW; Lu, XT; Lu, FM; Han, XG				Wei, Hai-Wei; Lu, Xiao-Tao; Lu, Fu-Mei; Han, Xing-Guo			Effects of Nitrogen Addition and Fire on Plant Nitrogen Use in a Temperate Steppe	PLOS ONE			English	Article							USE EFFICIENCY; NUTRIENT RESORPTION; TERRESTRIAL ECOSYSTEMS; MINERAL-NUTRITION; AVAILABILITY; PRODUCTIVITY; LIMITATION; DEPOSITION; GRASSLAND; LEAF	Plant nitrogen (N) use strategies have great implications for primary production and ecosystem nutrient cycling. Given the increasing atmospheric N deposition received by most of the terrestrial ecosystems, understanding the responses of plant N use would facilitate the projection of plant-mediated N cycling under global change scenarios. The effects of N deposition on plant N use would be affected by both natural and anthropogenic disturbances, such as prescribed fire in the grassland. We examined the effects of N addition (5.25 g N m(-2) yr(-1)) and prescribed fire (annual burning) on plant N concentrations and N use characters at both species and community levels in a temperate steppe of northern China. We found that N addition and fire independently affected soil N availability and plant N use traits. Nitrogen addition increased aboveground net primary productivity (ANPP), inorganic N, and N uptake, decreased N response efficiency (NRE), but did not affect biomass-weighed N concentrations at community level. Prescribed fire did not change the community level N concentrations, but largely decreased N uptake efficiency and NRE. At the species level, the effects of N addition and fire on plant N use were species-specific. The divergent responses of plant N use at community and species levels to N addition and fire highlight the importance of the hierarchical responses of plant N use at diverse biological organization levels to the alteration of soil N availability. This study will improve our understanding of the responses of plant-mediated N cycling to global change factors and ecosystem management strategies in the semiarid grasslands.	[Wei, Hai-Wei; Lu, Xiao-Tao; Han, Xing-Guo] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Wei, Hai-Wei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Lu, Fu-Mei; Han, Xing-Guo] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Botany, CAS	Lu, XT (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	lvxiaotao@iae.ac.cn	Han, Xingguo/K-7552-2016; Lu (ü), Xiao-Tao/B-3905-2008	Han, Xingguo/0000-0002-1836-975X; Lu (ü), Xiao-Tao/0000-0001-5571-1895	National Natural Science Foundation of China [41273094, 41173086, 31170433]; State Key Laboratory of Forest and Soil Ecology [LFSE2013-13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Forest and Soil Ecology	This research was supported by the National Natural Science Foundation of China (41273094, 41173086, and 31170433) and the State Key Laboratory of Forest and Soil Ecology (LFSE2013-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; AERTS R, 1994, ECOLOGY, V75, P2362, DOI 10.2307/1940890; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; BLAIR JM, 1990, ECOLOGY, V71, P1976, DOI 10.2307/1937606; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bowles ML, 2013, ECOL APPL, V23, P464, DOI 10.1890/12-0808.1; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Bradshaw SD, 2011, TRENDS PLANT SCI, V16, P405, DOI 10.1016/j.tplants.2011.05.005; BRIDGHAM SD, 1995, AM NAT, V145, P1, DOI 10.1086/285725; Britton AJ, 2008, ENVIRON POLLUT, V156, P409, DOI 10.1016/j.envpol.2008.01.029; CHAPIN FS, 1986, AM NAT, V127, P48, DOI 10.1086/284466; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Cole L, 2008, SOIL BIOL BIOCHEM, V40, P505, DOI 10.1016/j.soilbio.2007.09.018; Cui QA, 2010, PLANT SOIL, V334, P209, DOI 10.1007/s11104-010-0375-5; Freschet GT, 2010, NEW PHYTOL, V186, P879, DOI 10.1111/j.1469-8137.2010.03228.x; Heisler JL, 2004, ECOLOGY, V85, P2245, DOI 10.1890/03-0574; Hirose T, 2011, OECOLOGIA, V166, P863, DOI 10.1007/s00442-011-1942-z; Iversen CM, 2010, ECOLOGY, V91, P693, DOI 10.1890/09-0064.1; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Keuter A, 2013, PLANT SOIL, V364, P193, DOI 10.1007/s11104-012-1344-y; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Lu XT, 2012, J ARID ENVIRON, V78, P154, DOI 10.1016/j.jaridenv.2011.11.008; Lu XT, 2012, J ECOL, V100, P144, DOI 10.1111/j.1365-2745.2011.01881.x; Lu XT, 2012, OECOLOGIA, V168, P301, DOI 10.1007/s00442-011-2097-7; Lu XT, 2011, ECOL ENG, V37, P534, DOI 10.1016/j.ecoleng.2010.12.013; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Neary DG, 1999, FOREST ECOL MANAG, V122, P51, DOI 10.1016/S0378-1127(99)00032-8; OJIMA DS, 1994, BIOGEOCHEMISTRY, V24, P67, DOI 10.1007/BF02390180; OLear HA, 1996, SOIL BIOL BIOCHEM, V28, P323, DOI 10.1016/0038-0717(95)00138-7; Pastor J, 1999, OECOLOGIA, V118, P50, DOI 10.1007/s004420050702; Perakis SS, 2007, PLANT ECOL, V191, P209, DOI 10.1007/s11258-006-9238-9; Pilkington MG, 2007, J ECOL, V95, P1195, DOI 10.1111/j.1365-2745.2007.01292.x; Reich PB, 2001, ECOLOGY, V82, P1703; Reich PB, 1997, ECOLOGY, V78, P335, DOI 10.1890/0012-9658(1997)078[0335:NMAPIH]2.0.CO;2; SHAVER GR, 1984, ECOLOGY, V65, P1491, DOI 10.2307/1939129; VITOUSEK P, 1982, AM NAT, V119, P553, DOI 10.1086/283931; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wallenda T, 1998, NEW PHYTOL, V139, P169, DOI 10.1046/j.1469-8137.1998.00176.x; Wan SQ, 2001, ECOL APPL, V11, P1349, DOI 10.1890/1051-0761(2001)011[1349:FEONPA]2.0.CO;2; Watson PJ, 2009, AUSTRAL ECOL, V34, P218, DOI 10.1111/j.1442-9993.2008.01924.x; Yasumura Y, 2002, FUNCT ECOL, V16, P826, DOI 10.1046/j.1365-2435.2002.00691.x; Yuan ZY, 2006, OECOLOGIA, V148, P564, DOI 10.1007/s00442-006-0409-0; Yuan ZY, 2005, J INTEGR PLANT BIOL, V47, P539, DOI 10.1111/j.1744-7909.2005.00006.x; Zhou LS, 2009, SOIL BIOL BIOCHEM, V41, P796, DOI 10.1016/j.soilbio.2009.01.019	45	4	5	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90057	10.1371/journal.pone.0090057	http://dx.doi.org/10.1371/journal.pone.0090057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594654	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900060
J	Wu, LM; Li, YL; Yin, YH; Hou, GQ; Zhu, R; Hua, XL; Xu, JR; Chen, ZA				Wu, Lian-Ming; Li, Yu-Lai; Yin, Yu-Hua; Hou, Guo-Qiang; Zhu, Rong; Hua, Xiao-Lan; Xu, Jian-Rong; Chen, Zeng-Ai			Usefulness of Dual-Energy Computed Tomography Imaging in the Differential Diagnosis of Sellar Meningiomas and Pituitary Adenomas: Preliminary Report	PLOS ONE			English	Article							TUMORS	Objective: To quantitatively assess the imaging characteristics of sellar lesion in dual-energy computed tomography (CT) imaging for differentiation of sellar meningiomas and pituitary adenomas during the arterial phase (AP) and venous phase (VP). Materials and Methods: 51 patients with sellar/parasellar tumors (33 macroadenomas and 18 meningiomas) were examined with CT spectral imaging during the AP and the VP. Iodine concentrations were derived from iodine-based material-decomposition CT images and normalized to the iodine concentration in the aorta. The difference in Normalized iodine concentrations (NICs), HU curve slope (lambda HU), and mean CT values of lesions between the AP and VP were calculated. The two-sample t test was performed to compare quantitative parameters between sellar meningiomas and pituitary adenomas. Results: NICs, lambda HU, and mean CT values in patients with sellar meningiomas differed significantly from those in patients with pituitary adenomas: Mean NICs were 43.52 mg/mL +/- 1.35 versus 9.23 mg/mL +/- 2.44, respectively, during the AP and 52.13 mg/mL +/- 1.04 versus 24.37 mg/mL +/- 2.23 respectively, during the VP. lambda HU were -3.03 +/- 3.42 versus -0.53 +/- 0.23, respectively, during the AP and -2.96 +/- 0.41 versus -0.47 +/- 0.25, respectively, during the VP. Mean CT values were 193.63 +/- 2.08 versus 63.98 +/- 2.85, respectively, during the AP and 203.98 +/- 0.18 versus 77.66 +/- 0.91, respectively, during the VP. The combination of NIC and Mean CT value during VP had highest sensitivity (90.9%) and specificity (100%) among all phases. Conclusion: Quantitative dual-energy CT imaging has promising potential for diagnostic differentiation of sellar meningiomas and pituitary adenomas.	[Wu, Lian-Ming; Li, Yu-Lai; Zhu, Rong; Hua, Xiao-Lan; Xu, Jian-Rong; Chen, Zeng-Ai] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Yin, Yu-Hua; Hou, Guo-Qiang] Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Renji Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xu, JR (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Radiol, Shanghai 200030, Peoples R China.	xujianr@yeah.net; chenzengai@yeah.net						Bladowska J, 2012, PITUITARY ADENOMAS, P13; Bladowska J, 2010, POL J RADIOL, V75, P29; Boxerman JL, 2010, AM J ROENTGENOL, V195, P720, DOI 10.2214/AJR.09.4128; Drevelegas A, 2005, EUR RADIOL, V15, P453, DOI 10.1007/s00330-004-2557-0; Fischer MA, 2011, INVEST RADIOL, V46, P351, DOI 10.1097/RLI.0b013e31820e1486; JOHNSEN DE, 1991, RADIOGRAPHICS, V11, P727, DOI 10.1148/radiographics.11.5.1947311; Kasliwal MK, 2008, TURK NEUROSURG, V18, P232; Linden A, 2006, J EVAL CLIN PRACT, V12, P132, DOI 10.1111/j.1365-2753.2005.00598.x; Lv PJ, 2011, RADIOLOGY, V259, P720, DOI 10.1148/radiol.11101425; SAUTNER D, 1993, EXP CLIN ENDOCRINOL, V101, P283, DOI 10.1055/s-0029-1211245	10	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90658	10.1371/journal.pone.0090658	http://dx.doi.org/10.1371/journal.pone.0090658			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594782	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900130
J	Fox, KL; Atack, JM; Srikhanta, YN; Eckert, A; Novotny, LA; Bakaletz, LO; Jennings, MP				Fox, Kate L.; Atack, John M.; Srikhanta, Yogitha N.; Eckert, Anja; Novotny, Laura A.; Bakaletz, Lauren O.; Jennings, Michael P.			Selection for Phase Variation of LOS Biosynthetic Genes Frequently Occurs in Progression of Non-Typeable Haemophilus influenzae Infection from the Nasopharynx to the Middle Ear of Human Patients	PLOS ONE			English	Article							EXPERIMENTAL OTITIS-MEDIA; OUTER-MEMBRANE PROTEIN; RESPIRATORY-TRACT; CHINCHILLA MODEL; DNA REPEATS; SIALIC-ACID; LIPOPOLYSACCHARIDE; EXPRESSION; IDENTIFICATION; LIPOOLIGOSACCHARIDE	Surface structures in Haemophilus influenzae are subject to rapid ON/OFF switching of expression, a process termed phase variation. We analyse tetranucleotide repeats controlling phase variation in lipo-oligosaccharide (LOS) genes of H. influenzae in paired isolates from both the nasopharynx and middle ears of paediatric patients with chronic or recurrent otitis media. A change in expression of at least one of the seven phase variable LOS biosynthesis genes was seen in 12 of the 21 strain pairs. Several strains showed switching of expression in multiple LOS genes, consistent with a key role for phase variable LOS biosynthetic genes in human infection.	[Atack, John M.; Srikhanta, Yogitha N.; Jennings, Michael P.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Fox, Kate L.; Eckert, Anja] Univ Queensland, Sch Mol & Microbial Sci, St Lucia, Qld, Australia; [Novotny, Laura A.; Bakaletz, Lauren O.] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH USA	Griffith University; University of Queensland; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Jennings, MP (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia.	m.jennings@griffith.edu.au	Jennings, Michael P/G-4822-2013; Bakaletz, Lauren/GMW-8490-2022; Atack, John/B-7961-2015	Jennings, Michael P/0000-0002-1027-4684; Atack, John/0000-0002-7994-6995; Srikhanta, Yogitha/0000-0002-7513-9969	National Health and Medical Research Council (Australia) [565526, 1034401]; NIH/NIAID (USA) [N01-AI-30040]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030040] Funding Source: NIH RePORTER	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); NIH/NIAID (USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Health and Medical Research Council (Australia; www.nhmrc.gov.au), Program Grant 565526 and Project Grant 1034401, and NIH/NIAID (USA; www.nih.gov), grant N01-AI-30040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry DS, 2002, INFECT IMMUN, V70, P3707, DOI 10.1128/IAI.70.7.3707-3713.2002; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; Clark SE, 2013, MOL MICROBIOL, V88, P603, DOI 10.1111/mmi.12214; Dixon K, 2007, J BACTERIOL, V189, P511, DOI 10.1128/JB.00815-06; Duim B, 1997, INFECT IMMUN, V65, P1351, DOI 10.1128/IAI.65.4.1351-1356.1997; DUIM B, 1993, MICROB PATHOGENESIS, V14, P451, DOI 10.1006/mpat.1993.1044; Erwin AL, 2006, INFECT IMMUN, V74, P6226, DOI 10.1128/IAI.00722-06; Figueira MA, 2007, INFECT IMMUN, V75, P325, DOI 10.1128/IAI.01054-06; Fox KL, 2007, NUCLEIC ACIDS RES, V35, P5242, DOI 10.1093/nar/gkm571; Fox KL, 2006, J BIOL CHEM, V281, P40024, DOI 10.1074/jbc.M602314200; Fox KL, 2005, MOL MICROBIOL, V58, P207, DOI 10.1111/j.1365-2958.2005.04814.x; Greiner LL, 2004, INFECT IMMUN, V72, P4249, DOI 10.1128/IAI.72.7.4249-4260.2004; HIGH NJ, 1993, MOL MICROBIOL, V9, P1275, DOI 10.1111/j.1365-2958.1993.tb01257.x; Hood DW, 1996, P NATL ACAD SCI USA, V93, P11121, DOI 10.1073/pnas.93.20.11121; Hood DW, 1999, MOL MICROBIOL, V33, P679, DOI 10.1046/j.1365-2958.1999.01509.x; JAROSIK GP, 1994, INFECT IMMUN, V62, P4861, DOI 10.1128/IAI.62.11.4861-4867.1994; Klein JO, 1997, PEDIATR INFECT DIS J, V16, pS5, DOI 10.1097/00006454-199702001-00002; Lundstrom SL, 2008, INFECT IMMUN, V76, P3255, DOI 10.1128/IAI.01710-07; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; MURPHY TF, 1987, J INFECT DIS, V156, P723, DOI 10.1093/infdis/156.5.723; Murphy TF, 2007, J INFECT DIS, V195, P81, DOI 10.1086/509824; Poole J, 2013, J INFECT DIS, V208, P720, DOI 10.1093/infdis/jit240; SLAUCH JM, 1995, INFECT IMMUN, V63, P437, DOI 10.1128/IAI.63.2.437-441.1995; Swords WE, 2000, MOL MICROBIOL, V37, P13, DOI 10.1046/j.1365-2958.2000.01952.x; Tong HH, 2000, INFECT IMMUN, V68, P4593, DOI 10.1128/IAI.68.8.4593-4597.2000; Tsao D, 2012, MICROBES INFECT, V14, P509, DOI 10.1016/j.micinf.2011.12.010; Weiser JN, 1998, J EXP MED, V187, P631, DOI 10.1084/jem.187.4.631; WEISER JN, 1989, INFECT IMMUN, V57, P3045, DOI 10.1128/IAI.57.10.3045-3052.1989; WEISER JN, 1990, J BACTERIOL, V172, P3304, DOI 10.1128/jb.172.6.3304-3309.1990; WEISER JN, 1989, CELL, V59, P657, DOI 10.1016/0092-8674(89)90011-1	30	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90505	10.1371/journal.pone.0090505	http://dx.doi.org/10.1371/journal.pone.0090505			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587383	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200217
J	Gray, LR; Turville, SG; HItchen, TL; Cheng, WJ; Ellett, AM; Salimi, H; Roche, MJ; Wesselingh, SL; Gorry, PR; Churchill, MJ				Gray, Lachlan R.; Turville, Stuart G.; HItchen, Tina L.; Cheng, Wan-Jung; Ellett, Anne M.; Salimi, Hamid; Roche, Michael J.; Wesselingh, Steve L.; Gorry, Paul R.; Churchill, Melissa J.			HIV-1 Entry and Trans-Infection of Astrocytes Involves CD81 Vesicles	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYMERASE-CHAIN-REACTION; CENTRAL-NERVOUS-SYSTEM; HUMAN-FETAL-BRAIN; HUMAN GLIAL-CELLS; PRODUCTIVE INFECTION; CELLULAR RESERVOIRS; TYPE-1 INFECTION; GENE-EXPRESSION; POTENTIAL ROLE	Astrocytes are extensively infected with HIV-1 in vivo and play a significant role in the development of HIV-1-associated neurocognitive disorders. Despite their extensive infection, little is known about how astrocytes become infected, since they lack cell surface CD4 expression. In the present study, we investigated the fate of HIV-1 upon infection of astrocytes. Astrocytes were found to bind and harbor virus followed by biphasic decay, with HIV-1 detectable out to 72 hours. HIV-1 was observed to associate with CD81-lined vesicle structures. shRNA silencing of CD81 resulted in less cell-associated virus but no loss of co-localization between HIV-1 and CD81. Astrocytes supported trans-infection of HIV-1 to T-cells without de novo virus production, and the virus-containing compartment required 37 degrees C to form, and was trypsin-resistant. The CD81 compartment observed herein, has been shown in other cell types to be a relatively protective compartment. Within astrocytes, this compartment may be actively involved in virus entry and/or spread. The ability of astrocytes to transfer virus, without de novo viral synthesis suggests they are capable of sequestering and protecting virus and thus, they could potentially facilitate viral dissemination in the CNS.	[Gray, Lachlan R.; Cheng, Wan-Jung; Ellett, Anne M.; Salimi, Hamid; Roche, Michael J.; Wesselingh, Steve L.; Gorry, Paul R.; Churchill, Melissa J.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Gray, Lachlan R.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Turville, Stuart G.; HItchen, Tina L.] Kirby Inst, Darlinghurst, NSW, Australia; [Wesselingh, Steve L.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Gorry, Paul R.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Gorry, Paul R.] Monash Univ, Dept Infect Dis, Clayton, Vic 3800, Australia; [Churchill, Melissa J.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Churchill, Melissa J.] Monash Univ, Dept Med, Clayton, Vic 3800, Australia	Burnet Institute; Monash University; University of New South Wales Sydney; Kirby Institute; South Australian Health & Medical Research Institute (SAHMRI); University of Melbourne; Monash University; Monash University; Monash University	Churchill, MJ (corresponding author), Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia.	churchil@burnet.edu.au		Churchill, Melissa/0000-0001-5510-7954; Gray, Lachlan/0000-0002-9894-1049; Roche, Michael/0000-0001-8819-0096; Turville, Stuart/0000-0003-1918-5343	Australian National Health and Medical Research Council (NHMRC) [1051093]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funding from the Australian National Health and Medical Research Council (NHMRC) to MJC (APP#1051093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002762; Bagasra O, 1996, AIDS, V10, P573, DOI 10.1097/00002030-199606000-00002; Brack-Werner R, 1999, AIDS, V13, P1, DOI 10.1097/00002030-199901140-00003; Brew BJ, 2013, EXPERT OPIN BIOL TH, V13, P403, DOI 10.1517/14712598.2013.748029; Canki M, 2001, J VIROL, V75, P7925, DOI 10.1128/JVI.75.17.7925-7933.2001; Cavrois M, 2007, PLOS PATHOG, V3, P38, DOI 10.1371/journal.ppat.0030004; CHENGMAYER C, 1987, P NATL ACAD SCI USA, V84, P3526, DOI 10.1073/pnas.84.10.3526; CHIODI F, 1987, J VIROL, V61, P1244, DOI 10.1128/JVI.61.4.1244-1247.1987; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; Clarke JN, 2006, VIROLOGY, V348, P141, DOI 10.1016/j.virol.2005.12.004; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; DEWHURST S, 1987, J VIROL, V61, P3774, DOI 10.1128/JVI.61.12.3774-3782.1987; Galey D, 2003, J NEUROVIROL, V9, P358, DOI 10.1080/13550280390201119; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gorry P, 1998, J NEUROVIROL, V4, P377, DOI 10.3109/13550289809114536; Gorry PR, 2003, CURR HIV RES, V1, P463, DOI 10.2174/1570162033485122; Gorry PR, 1999, J VIROL, V73, P352, DOI 10.1128/JVI.73.1.352-361.1999; Gray LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062196; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Hubner W, 2007, J VIROL, V81, P12596, DOI 10.1128/JVI.01088-07; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Liu Y, 2004, J VIROL, V78, P4120, DOI 10.1128/JVI.78.8.4120-4133.2004; Ludwig E, 1999, J VIROL, V73, P8279, DOI 10.1128/JVI.73.10.8279-8289.1999; MA MH, 1994, J VIROL, V68, P6824, DOI 10.1128/JVI.68.10.6824-6828.1994; MAJOR EO, 1986, VIROLOGY, V148, P221, DOI 10.1016/0042-6822(86)90418-6; Messam CA, 2000, J NEUROVIROL, V6, pS90; NEUMANN M, 1995, J VIROL, V69, P2159, DOI 10.1128/JVI.69.4.2159-2167.1995; Ochsenbauer-Jambor C, 2006, BIOTECHNIQUES, V40, P91, DOI 10.2144/000112072; Ong CL, 2005, J VIROL, V79, P12763, DOI 10.1128/JVI.79.20.12763-12772.2005; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8; RANKI A, 1995, AIDS, V9, P1001, DOI 10.1097/00002030-199509000-00004; Schweighardt B, 2001, AIDS RES HUM RETROV, V17, P1133, DOI 10.1089/088922201316912745; SHAHABUDDIN M, 1992, PATHOBIOLOGY, V60, P195, DOI 10.1159/000163723; Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535; SWINGLER S, 1992, AIDS RES HUM RETROV, V8, P487, DOI 10.1089/aid.1992.8.487; Takahashi K, 1996, ANN NEUROL, V39, P705, DOI 10.1002/ana.410390606; TORNATORE C, 1991, J VIROL, V65, P6094, DOI 10.1128/JVI.65.11.6094-6100.1991; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Wang ZY, 2004, J NEUROVIROL, V10, P25, DOI 10.1080/13550280490270851; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; Yu HJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000134	47	42	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90620	10.1371/journal.pone.0090620	http://dx.doi.org/10.1371/journal.pone.0090620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587404	Green Published, gold			2022-12-27	WOS:000332396200238
J	Gonzalez-Suarez, M; Revilla, E				Gonzalez-Suarez, Manuela; Revilla, Eloy			Generalized Drivers in the Mammalian Endangerment Process	PLOS ONE			English	Article							EXTINCTION RISK; CONSERVATION; SYNERGIES; HISTORY; THREATS; LAND; WILD; SIZE	An important challenge for conservation today is to understand the endangerment process and identify any generalized patterns in how threats occur and aggregate across taxa. Here we use a global database describing main current external threats in mammals to evaluate the prevalence of distinct threatening processes, primarily of anthropogenic origin, and to identify generalized drivers of extinction and their association with vulnerability status and intrinsic species' traits. We detect several primary threat combinations that are generally associated with distinct species. In particular, large and widely distributed mammals are affected by combinations of direct exploitation and threats associated with increasing landscape modification that go from logging to intense human land-use. Meanwhile, small, narrowly distributed species are affected by intensifying levels of landscape modification but are not directly exploited. In general more vulnerable species are affected by a greater number of threats, suggesting increased extinction risk is associated with the accumulation of external threats. Overall, our findings show that endangerment in mammals is strongly associated with increasing habitat loss and degradation caused by human land-use intensification. For large and widely distributed mammals there is the additional risk of being hunted.	[Gonzalez-Suarez, Manuela; Revilla, Eloy] Estac Biol Donana EBD CSIC, Dept Conservat Biol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Gonzalez-Suarez, M (corresponding author), Estac Biol Donana EBD CSIC, Dept Conservat Biol, Calle Amer Vespucio S-N, Seville, Spain.	manuela.gonzalez@ebd.csic.es	Revilla, Eloy/B-5100-2008; González-Suárez, Manuela/B-9740-2008	Revilla, Eloy/0000-0001-5534-5581; González-Suárez, Manuela/0000-0001-5069-8900	European Community [235897]; Spanish Ministry of Science and Innovation; FEDER [CGL2009-07301/BOS, CGL2012-35931/BOS, JCI-2011-09158]	European Community(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission)	This work was funded by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 235897, and the Spanish Ministry of Science and Innovation co-funded by FEDER (CGL2009-07301/BOS, CGL2012-35931/BOS and JCI-2011-09158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baisre JA, 2013, CONSERV BIOL, V27, P927, DOI 10.1111/cobi.12107; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Calix M., 2018, EUROPEAN RED LIST SA; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Clavero M, 2009, BIOL CONSERV, V142, P2043, DOI 10.1016/j.biocon.2009.03.034; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; Fagan WF, 2006, ECOL LETT, V9, P51, DOI 10.1111/j.1461-0248.2005.00845.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fritts TH, 1998, ANNU REV ECOL SYST, V29, P113, DOI 10.1146/annurev.ecolsys.29.1.113; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Gonzalez-Suarez M, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00380.1; Gonzalez-Suarez M, 2013, ECOL LETT, V16, P242, DOI 10.1111/ele.12035; Gonzalez-Suarez M, 2012, J ANIM ECOL, V81, P1211, DOI 10.1111/j.1365-2656.2012.01999.x; Hayward MW, 2009, CONSERV BIOL, V23, P1568, DOI 10.1111/j.1523-1739.2009.01260.x; Hoffmann M, 2011, PHILOS T R SOC B, V366, P2598, DOI 10.1098/rstb.2011.0116; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; International Union for the Conservation of Nature (IUCN), 2012, IUCN THREATS CLASS S; Isaac NJB, 2004, P ROY SOC B-BIOL SCI, V271, P1135, DOI 10.1098/rspb.2004.2724; Jagers P, 2007, P NATL ACAD SCI USA, V104, P6107, DOI 10.1073/pnas.0610816104; Jeschke JM, 2009, EVOL ECOL, V23, P867, DOI 10.1007/s10682-008-9276-y; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Jono CMA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046235; Keane A, 2005, BIOL CONSERV, V126, P216, DOI 10.1016/j.biocon.2005.05.011; KOVACS K, 2008, IUCN 2012; Lotze HK, 2004, ECOL APPL, V14, P1428, DOI 10.1890/03-5027; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Price SA, 2007, P R SOC B, V274, P1845, DOI 10.1098/rspb.2007.0505; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Salafsky N, 2008, CONSERV BIOL, V22, P897, DOI 10.1111/j.1523-1739.2008.00937.x; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; SKOLE D, 1993, SCIENCE, V260, P1905, DOI 10.1126/science.260.5116.1905; Slatyer RA, 2013, ECOL LETT, V16, P1104, DOI 10.1111/ele.12140	42	18	19	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90292	10.1371/journal.pone.0090292	http://dx.doi.org/10.1371/journal.pone.0090292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587315	Green Published, Green Accepted, gold			2022-12-27	WOS:000332389000148
J	Liu, HS; Liao, J; Jiang, WX; Wang, W				Liu, Huasheng; Liao, Jian; Jiang, Weixiong; Wang, Wei			Changes in Low-Frequency Fluctuations in Patients with Antisocial Personality Disorder Revealed by Resting-State Functional MRI	PLOS ONE			English	Article							ORBITOFRONTAL CORTEX; DECISION-MAKING; FRONTAL-LOBE; CRIMINAL PSYCHOPATHS; SOCIAL COGNITION; BEHAVIOR; EMOTION; BRAIN; ABNORMALITIES; ASSOCIATION	Antisocial Personality Disorder (APD) is a personality disorder that is most commonly associated with the legal and criminal justice systems. The study of the brain in APD has important implications in legal contexts and in helping ensure social stability. However, the neural contribution to the high prevalence of APD is still unclear. In this study, we used resting-state functional magnetic resonance imaging (fMRI) to investigate the underlying neural mechanisms of APD. Thirty-two healthy individuals and thirty-five patients with APD were recruited. The amplitude of low-frequency fluctuations (ALFF) was analyzed for the whole brain of all subjects. Our results showed that APD patients had a significant reduction in the ALFF in the right orbitofrontal cortex, the left temporal pole, the right inferior temporal gyrus, and the left cerebellum posterior lobe compared to normal controls. We observed that the right orbitofrontal cortex had a negative correlation between ALFF values and MMPI psychopathic deviate scores. Alterations in ALFF in these specific brain regions suggest that APD patients may be associated with abnormal activities in the fronto-temporal network. We propose that our results may contribute in a clinical and forensic context to a better understanding of APD.	[Liu, Huasheng; Liao, Jian; Jiang, Weixiong; Wang, Wei] Cent S Univ, Xiangya Hosp 3, Dept Radiol, Changsha, Hunan, Peoples R China; [Liu, Huasheng; Jiang, Weixiong] Cent S Univ, Biomed Engn Lab, Sch Geosci & Info Phys, Changsha, Hunan, Peoples R China; [Jiang, Weixiong] Hunan First Normal Univ, Dept Informat Sci & Engn, Changsha, Hunan, Peoples R China	Central South University; Central South University; Hunan First Normal University	Wang, W (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Radiol, Changsha, Hunan, Peoples R China.	cjr.wangwei@vip.163.com			Education Ministry for the Development of Liberal Arts and Social Sciences [13YJCZH068, 2013GK1024]; Science and Technology Plan Funded of Hunan Province [2013GK1024, 2009JT3014]; National Education Department Key Laboratory [cqu-moekl-br-2011-3, 2012QNZT161]	Education Ministry for the Development of Liberal Arts and Social Sciences; Science and Technology Plan Funded of Hunan Province; National Education Department Key Laboratory	This study was supported by Education Ministry for the Development of Liberal Arts and Social Sciences (NO. 13YJCZH068, NO: 2013GK1024), Science and Technology Plan Funded of Hunan Province (NO: 2009JT3014, NO: 2013GK1024), and the National Education Department Key Laboratory (NO: cqu-moekl-br-2011-3, NO: 2012QNZT161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anckarsater H, 2007, PSYCHIAT RES-NEUROIM, V156, P87, DOI 10.1016/j.pscychresns.2006.12.008; Barkataki I, 2006, BEHAV BRAIN RES, V169, P239, DOI 10.1016/j.bbr.2006.01.009; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Berthoz S, 2002, BRAIN, V125, P1696, DOI 10.1093/brain/awf190; Bolla KI, 2003, NEUROIMAGE, V19, P1085, DOI 10.1016/S1053-8119(03)00113-7; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Cohen MX, 2005, COGNITIVE BRAIN RES, V23, P61, DOI 10.1016/j.cogbrainres.2005.01.010; Craig MC, 2009, MOL PSYCHIATR, V14, P946, DOI 10.1038/mp.2009.40; de Oliveira-Souza R, 2008, NEUROIMAGE, V40, P1202, DOI 10.1016/j.neuroimage.2007.12.054; Di X, 2013, FRONTIERS HUMAN NEUR, V7; Eronen M, 1996, PSYCHIAT SERVICES; Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1; Goldstein RZ, 2005, PSYCHIAT RES-NEUROIM, V138, P13, DOI 10.1016/j.pscychresns.2004.10.002; Green S, 2010, NEUROIMAGE, V52, P1720, DOI 10.1016/j.neuroimage.2010.05.038; Gregory S, 2012, ARCH GEN PSYCHIAT; Kiehl KA, 2004, PSYCHIAT RES-NEUROIM, V130, P27, DOI 10.1016/S0925-4927(03)00106-9; Kumari V, 2005, BEHAV BRAIN RES, V158, P159, DOI 10.1016/j.bbr.2004.08.021; Lilienfeld S. O., 2006, HDB PSYCHOPATHY, P107; Lucantonio F, 2012, NAT NEUROSCI, V15, P358, DOI 10.1038/nn.3014; Miller BL, 1997, BRIT J PSYCHIAT, V170, P150, DOI 10.1192/bjp.170.2.150; Muller JL, 2008, PSYCHIAT RES-NEUROIM, V163, P213, DOI 10.1016/j.pscychresns.2007.08.010; Muller JL, 2008, BEHAV SCI LAW, V26, P131, DOI 10.1002/bsl.796; Narayan VM, 2007, AM J PSYCHIAT, V164, P1418, DOI 10.1176/appi.ajp.2007.06101631; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Olson IR, 2013, SOC COGN AFFECT NEUR, V8, P123, DOI 10.1093/scan/nss119; Potegal M, 2012, BEHAV BRAIN RES, V231, P386, DOI 10.1016/j.bbr.2011.10.049; Raine A, 2000, ARCH GEN PSYCHIAT, V57, P119, DOI 10.1001/archpsyc.57.2.119; Raine A, 2011, MOL PSYCHIATR, V16, P227, DOI 10.1038/mp.2009.136; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Ross LA, 2010, NEUROIMAGE, V49, P3452, DOI 10.1016/j.neuroimage.2009.11.012; Sarkar S, 2013, PSYCHOL MED, V43, P401, DOI 10.1017/S003329171200116X; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Schneider F, 2000, NEUROPSYCHOBIOLOGY, V42, P192, DOI 10.1159/000026693; Seguin JR, 2004, BRAIN COGNITION, V55, P185, DOI 10.1016/s0278-2626(03)00273-2; Sellbom M, 2007, PSYCHOL ASSESSMENT, V19, P430, DOI 10.1037/1040-3590.19.4.430; Shimony JS, 2009, ACAD RADIOL, V16, P578, DOI 10.1016/j.acra.2009.02.001; Skipper LM, 2011, NEUROPSYCHOLOGIA, V49, P3419, DOI 10.1016/j.neuropsychologia.2011.07.033; Sundram F, 2012, CORTEX, V48, P216, DOI 10.1016/j.cortex.2011.06.005; Tang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060652; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; Wagner U, 2011, CEREB CORTEX, V21, P2461, DOI 10.1093/cercor/bhr016; Wen XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063691; Widiger T. A, 1995, DSM 4 PERSONALITY DI, P103; Xuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030570; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Zahn R, 2007, P NATL ACAD SCI USA, V104, P6430, DOI 10.1073/pnas.0607061104; Zahn R, 2009, BRAIN, V132, P604, DOI 10.1093/brain/awn343; Zahn R, 2009, CEREB CORTEX, V19, P276, DOI 10.1093/cercor/bhn080	49	18	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89790	10.1371/journal.pone.0089790	http://dx.doi.org/10.1371/journal.pone.0089790			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598769	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400027
J	Ma, YW; Shen, B; Zhang, X; Lu, YD; Chen, W; Ma, J; Huang, XX; Zhang, LF				Ma, Yuanwu; Shen, Bin; Zhang, Xu; Lu, Yingdong; Chen, Wei; Ma, Jing; Huang, Xingxu; Zhang, Lianfeng			Heritable Multiplex Genetic Engineering in Rats Using CRISPR/Cas9	PLOS ONE			English	Article							ONE-STEP GENERATION; KNOCKOUT RATS; EMBRYO MICROINJECTION; DNA CLEAVAGE; CAS SYSTEMS; HUMAN-CELLS; GENOME; NUCLEASES; IMMUNITY; MICE	The CRISPR/Cas9 system has been proven to be an efficient gene-editing tool for genome modification of cells and organisms. Multiplex genetic engineering in rat holds a bright future for the study of complex disease. Here, we show that this system enables the simultaneous disruption of four genes (ApoE, B2m, Prf1, and Prkdc) in rats in one-step, by co-injection of Cas9 mRNA and sgRNAs into fertilized eggs. We further observed the gene modifications are germline transmittable, and confirmed the off-target mutagenesis and mosaicism are rarely detected by comprehensive analysis. Thus, the CRISPR/Cas9 system makes it possible to efficiently and reliably generate gene knock-out rats.	[Ma, Yuanwu; Zhang, Xu; Lu, Yingdong; Chen, Wei; Ma, Jing; Zhang, Lianfeng] Chinese Acad Med Sci, Inst Lab Anim Sci, Minist Hlth, Key Lab Human Dis Comparat Med, Beijing 100730, Peoples R China; [Shen, Bin; Huang, Xingxu] Nanjing Univ, Nanjing Biomed Res Inst, Key Lab Model Anim Dis Study, MOE,Model Anim Res Ctr,Natl Resource Ctr Mutant M, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Nanjing University	Huang, XX (corresponding author), Nanjing Univ, Nanjing Biomed Res Inst, Key Lab Model Anim Dis Study, MOE,Model Anim Res Ctr,Natl Resource Ctr Mutant M, Nanjing, Jiangsu, Peoples R China.	xingxuhuang@mail.nju.edu.cn; zhanglf@cnilas.org	Shen, Bin/ABD-5084-2021	Shen, Bin/0000-0002-8946-8448; huang, xingxu/0000-0001-8934-1247; Ma, Yuanwu/0000-0002-1882-1777	National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BA139B02, 2009CB918700]; Youth Foundation of CAMS PUMC [2012J25]	National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Youth Foundation of CAMS PUMC	The present work was supported in part by the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2012BA139B02, 2009CB918700) and the Youth Foundation of CAMS & PUMC (2012J25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Brown AJ, 2013, NAT METHODS, V10, P638, DOI 10.1038/nmeth.2516; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hamra FK, 2010, NATURE, V467, P161, DOI 10.1038/467161a; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	24	74	88	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89413	10.1371/journal.pone.0089413	http://dx.doi.org/10.1371/journal.pone.0089413			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598943	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400012
J	Peters, VE				Peters, Valerie E.			Intercropping with Shrub Species That Display a 'Steady-State' Flowering Phenology as a Strategy for Biodiversity Conservation in Tropical Agroecosystems	PLOS ONE			English	Article							TREEFALL GAPS; EUGLOSSINE BEES; DIVERSITY; FOREST; POLLINATION; PATTERNS; HUMMINGBIRDS; UNDERSTOREY; TREELET; SYSTEMS	Animal species in the Neotropics have evolved under a lower spatiotemporal patchiness of food resources compared to the other tropical regions. Although plant species with a steady-state flowering/fruiting phenology are rare, they provide predictable food resources and therefore may play a pivotal role in animal community structure and diversity. I experimentally planted a supplemental patch of a shrub species with a steady-state flowering/fruiting phenology, Hamelia patens Jacq., into coffee agroforests to evaluate the contribution of this unique phenology to the structure and diversity of the flower-visiting community. After accounting for the higher abundance of captured animals in the coffee agroforests with the supplemental floral resources, species richness was 21% higher overall in the flower-visiting community in these agroforests compared to control agroforests. Coffee agroforests with the steady-state supplemental floral patch also had 31% more butterfly species, 29% more hummingbird species, 65% more wasps and 85% more bees than control coffee agroforests. The experimental treatment, together with elevation, explained 57% of the variation in community structure of the flower-visiting community. The identification of plant species that can support a high number of animal species, including important ecosystem service providers, is becoming increasingly important for restoration and conservation applications. Throughout the Neotropics plant species with a steady-state flowering/fruiting phenology can be found in all aseasonal forests and thus could be widely tested and suitable species used throughout the tropics to manage for biodiversity and potentially ecosystem services involving beneficial arthropods.	[Peters, Valerie E.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Peters, VE (corresponding author), Miami Univ, Dept Biol, Oxford, OH 45056 USA.	petersve@miamioh.edu			EarthWatch Institute; Andrew W. Mellon Foundation	EarthWatch Institute; Andrew W. Mellon Foundation	Funding for this study was provided by the EarthWatch Institute (www.earthwatch.org) and the Andrew W. Mellon Foundation (www.mellon.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN JD, 1983, ECOLOGY, V64, P274, DOI 10.2307/1937075; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; BAKER GH, 1963, SCIENCE, V139, P877, DOI 10.1126/science.139.3558.877; Bawa KS, 2003, AM J BOT, V90, P877, DOI 10.3732/ajb.90.6.877; Borrell BJ, 2005, BIOTROPICA, V37, P664, DOI 10.1111/j.1744-7429.2005.00084.x; Chauhan S, 2009, INT J PLANT REPROD B, V1, P63; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; COLWELL RK, 1995, BIOTROPICA, V27, P206, DOI 10.2307/2388996; Dalling JW, 2002, J ECOL, V90, P714, DOI 10.1046/j.1365-2745.2002.00706.x; DEVRIES PJ, 1997, BUTTERFLIES COSTA RI, V2; DeVries PJ, 1987, BUTTERFLIES COSTA RI; Diekotter T, 2013, INSECT CONSERV DIVER, V6, P607, DOI 10.1111/icad.12015; Dixon KW, 2009, SCIENCE, V325, P571, DOI 10.1126/science.1176295; FEINSINGER P, 1978, ECOL MONOGR, V48, P269, DOI 10.2307/2937231; FLEMING TH, 1987, ANNU REV ECOL SYST, V18, P91, DOI 10.1146/annurev.ecolsys.18.1.91; Fleming TH, 2008, J BIOGEOGR, V35, P764, DOI 10.1111/j.1365-2699.2007.01833.x; GENTRY A H, 1974, Biotropica, V6, P64, DOI 10.2307/2989698; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Greenberg R, 2008, ECOLOGY, V89, P913, DOI 10.1890/07-1578.1; Halvorsen R, 2009, LANDSCAPE ECOL, V24, P851, DOI 10.1007/s10980-009-9363-7; Hernandez SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065101; Hopwood JL, 2008, BIOL CONSERV, V141, P2632, DOI 10.1016/j.biocon.2008.07.026; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; Kang H, 2003, AM J BOT, V90, P865, DOI 10.3732/ajb.90.6.865; Kinnaird MF, 2005, TROPICAL FRUITS AND FRUGIVORES: THE SEARCH FOR STRONG INTERACTORS, P155, DOI 10.1007/1-4020-3833-X_9; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; KOPTUR S, 1988, J TROP ECOL, V4, P323, DOI 10.1017/S0266467400002984; Lasso E, 2003, BIOTROPICA, V35, P57; LEVEY DJ, 1987, OECOLOGIA, V74, P203, DOI 10.1007/BF00379360; LEVEY DJ, 1990, J TROP ECOL, V6, P409, DOI 10.1017/S026646740000479X; Menz MHM, 2011, TRENDS PLANT SCI, V16, P4, DOI 10.1016/j.tplants.2010.09.006; MILLS LS, 1993, BIOSCIENCE, V43, P219, DOI 10.2307/1312122; Milton K, 2005, TROPICAL FRUITS AND FRUGIVORES: THE SEARCH FOR STRONG INTERACTORS, P5, DOI 10.1007/1-4020-3833-X_2; Newstrom L. E., 1994, P142; NEWSTROM LE, 1994, BIOTROPICA, V26, P141, DOI 10.2307/2388804; Oliver I, 1996, CONSERV BIOL, V10, P99, DOI 10.1046/j.1523-1739.1996.10010099.x; OPLER PA, 1980, J ECOL, V68, P167, DOI 10.2307/2259250; Peres CA, 2000, J TROP ECOL, V16, P287, DOI 10.1017/S0266467400001413; Perfecto I, 2005, ECOL ECON, V54, P435, DOI 10.1016/j.ecolecon.2004.10.009; Peters VE, 2013, INSECT CONSERV DIVER, V6, P45, DOI 10.1111/j.1752-4598.2012.00189.x; Peters VE, 2013, BIOTROPICA, V45, P102, DOI 10.1111/j.1744-7429.2012.00891.x; Peters VE, 2010, J ANIM ECOL, V79, P824, DOI 10.1111/j.1365-2656.2010.01699.x; Philpott SM, 2011, AGR ECOSYST ENV; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; R Core Team, 2018, R LANG ENV STAT COMP; Russell KN, 2005, BIOL CONSERV, V124, P133, DOI 10.1016/j.biocon.2005.01.022; Sakai S, 2000, J TROP ECOL, V16, P337, DOI 10.1017/S0266467400001449; Sakai S, 2001, POPUL ECOL, V43, P77, DOI 10.1007/PL00012018; Scheper J, 2013, ECOL LETT, V16, P912, DOI 10.1111/ele.12128; Schnitzer SA, 2001, ECOLOGY, V82, P913, DOI 10.1890/0012-9658(2001)082[0913:TGATMO]2.0.CO;2; Stevenson P, 2005, TROPICAL FRUITS FRUG, P155; STILES FG, 1975, ECOLOGY, V56, P285, DOI 10.2307/1934961; Terborgh J., 1986, CONSERVATION BIOL SC, P330; THOMAS CD, 1986, BIOTROPICA, V18, P161, DOI 10.2307/2388759; Wunderle JM, 2005, IBIS, V147, P109, DOI 10.1111/j.1474-919x.2005.00382.x	56	4	4	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90510	10.1371/journal.pone.0090510	http://dx.doi.org/10.1371/journal.pone.0090510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598826	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400085
J	Taylor, CM; Coffey, PL; DeLay, BD; Dively, GP				Taylor, Christopher M.; Coffey, Peter L.; DeLay, Bridget D.; Dively, Galen P.			The Importance of Gut Symbionts in the Development of the Brown Marmorated Stink Bug, Halyomorpha halys (Stal)	PLOS ONE			English	Article							VERTICAL TRANSMISSION; PLATASPID STINKBUG; BACTERIA; HEMIPTERA; HETEROPTERA; INSECTS; CAPSULE	The invasive brown marmorated stink bug, Halyomorpha halys (Stal), has become a severe agricultural pest and nuisance problem since its introduction in the U. S. Research is being conducted to understand its biology and to find management solutions. Its symbiotic relationship with gut symbionts is one aspect of its biology that is not understood. In the family Pentatomidae, the reliance on gut symbionts for successful development seems to vary depending on the species of stink bug. This research assessed the role of gut symbionts in the development, survivorship, and fecundity of H. halys. We compared various fitness parameters of nymphs and adults reared from surface sterilized and untreated egg masses during two consecutive generations under laboratory conditions. Results provided direct evidence that H. halys is negatively impacted by the prevention of vertical transmission of its gut symbionts and that this impact is significant in the first generation and manifests dramatically in the subsequent generation. Developmental time and survivorship of treated cohorts in the first generation were significantly affected during third instar development through to the adult stage. Adults from the sterilized treatment group exhibited longer pre-oviposition periods, produced fewer egg masses, had significantly smaller clutch sizes, and the hatch rate and survivorship of those eggs were significantly reduced. Observations following hatch of surface sterilized eggs also revealed significant effects on wandering behavior of the first instars. The second generation progeny from adults of the sterilized cohorts showed significantly lower survival to adulthood, averaging only 0.3% compared to 20.8% for the control cohorts. Taken together, results demonstrate that H. halys is heavily impacted by deprival of its gut symbionts. Given the economic status of this invasive pest, further investigations may lead to management tactics that disrupt this close symbiotic relationship in the biology of H. halys.	[Taylor, Christopher M.; Coffey, Peter L.; DeLay, Bridget D.; Dively, Galen P.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Taylor, CM (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	cmjtaylor3@gmail.com	DeLay, Bridget/AAM-1497-2020	DeLay, Bridget/0000-0003-1354-1407	United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) Specialty Crop Research Initiative (SCRI) [2011-51181-30937]	United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) Specialty Crop Research Initiative (SCRI)	Grant: United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) Specialty Crop Research Initiative (SCRI) # 2011-51181-30937: Biology, Ecology, and Management of Brown Marmorated Stink Bug in orchard Crops, Small Fruit, Grapes, Vegetables and Ornamentals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE Y, 1995, JPN J APPL ENTOMOL Z, V39, P109, DOI 10.1303/jjaez.39.109; [Anonymous], IS BMSB STAT BY STAT; Baumann P, 1997, ANTON LEEUW INT J G, V72, P39, DOI 10.1023/A:1000239108771; Buchner P, 1965, ENDOSYMBIONTS ANIMAL; Dasch GA, 1984, BERGEYS MANUAL SYSTE, V1, P811; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Fukatsu T, 2002, APPL ENVIRON MICROB, V68, P389, DOI 10.1128/AEM.68.1.389-396.2002; Glasgow H, 1914, BIOL BULL-US, V26, P101, DOI 10.2307/1536004; Hamilton George C., 2009, American Entomologist, V55, P19; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; Hosokawa T, 2005, FEMS MICROBIOL ECOL, V54, P471, DOI 10.1016/j.femsec.2005.06.002; Hosokawa T, 2008, BIOL LETTERS, V4, P45, DOI 10.1098/rsbl.2007.0510; Hosokawa T, 2012, APPL ENVIRON MICROB, V78, P4758, DOI 10.1128/AEM.00867-12; Hosokawa T, 2012, ANIM BEHAV, V83, P293, DOI 10.1016/j.anbehav.2011.11.006; Kaiwa N, 2011, ZOOL SCI, V28, P169, DOI 10.2108/zsj.28.169; Kaiwa N, 2010, APPL ENVIRON MICROB, V76, P3486, DOI 10.1128/AEM.00421-10; Kashima T, 2006, J INSECT PHYSIOL, V52, P816, DOI 10.1016/j.jinsphys.2006.05.003; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kikuchi Y, 2012, APPL ENTOMOL ZOOL, V47, P1, DOI 10.1007/s13355-011-0081-7; Kikuchi Y, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-2; Kuhar T.P., 2012, PLANT HLTH PROG, V13, P41, DOI [10.1094/PHP-2012-0523-01-BR, DOI 10.1094/PHP-2012-0523-01-BR]; Lauzon CR, 2009, ANN ENTOMOL SOC AM, V102, P85, DOI 10.1603/008.102.0109; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; Leskey Tracy C., 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/535062; Lockwood JA, 1998, ENVIRON ENTOMOL, V14, P562; Moran NA, 1998, BIOSCIENCE, V48, P295, DOI 10.2307/1313356; Nielsen AL, 2008, ENVIRON ENTOMOL, V37, P348, DOI 10.1603/0046-225X(2008)37[348:DREALT]2.0.CO;2; Prado SS, 2006, ANN ENTOMOL SOC AM, V99, P577, DOI 10.1603/0013-8746(2006)99[577:VTOAPC]2.0.CO;2; Prado SS, 2010, APPL ENVIRON MICROB, V76, P1261, DOI 10.1128/AEM.02034-09; Prado SS, 2009, ENTOMOL EXP APPL, V132, P21, DOI 10.1111/j.1570-7458.2009.00863.x; Prado SS, 2009, CURR MICROBIOL, V58, P64, DOI 10.1007/s00284-008-9267-9; Prado Simone Souza, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/269473; Schorr H., 1957, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V45, P561, DOI 10.1007/BF00399596	34	72	77	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90312	10.1371/journal.pone.0090312	http://dx.doi.org/10.1371/journal.pone.0090312			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598598	gold, Green Published, Green Submitted			2022-12-27	WOS:000332479400063
J	Butt, AM; Nasrullah, I; Tong, YG				Butt, Azeem Mehmood; Nasrullah, Izza; Tong, Yigang			Genome-Wide Analysis of Codon Usage and Influencing Factors in Chikungunya Viruses	PLOS ONE			English	Article							ESCHERICHIA-COLI; PATTERNS; BIAS; EXPRESSION; GENES; REEMERGENCE; DROSOPHILA; EVOLUTION; HOST; CPG	Chikungunya virus (CHIKV) is an arthropod-borne virus of the family Togaviridae that is transmitted to humans by Aedes spp. mosquitoes. Its genome comprises a 12 kb single-strand positive-sense RNA. In the present study, we report the patterns of synonymous codon usage in 141 CHIKV genomes by calculating several codon usage indices and applying multivariate statistical methods. Relative synonymous codon usage (RSCU) analysis showed that the preferred synonymous codons were G/C and A-ended. A comparative analysis of RSCU between CHIKV and its hosts showed that codon usage patterns of CHIKV are a mixture of coincidence and antagonism. Similarity index analysis showed that the overall codon usage patterns of CHIKV have been strongly influenced by Pan troglodytes and Aedes albopictus during evolution. The overall codon usage bias was low in CHIKV genomes, as inferred from the analysis of effective number of codons (ENC) and codon adaptation index (CAI). Our data suggested that although mutation pressure dominates codon usage in CHIKV, patterns of codon usage in CHIKV are also under the influence of natural selection from its hosts and geography. To the best of our knowledge, this is first report describing codon usage analysis in CHIKV genomes. The findings from this study are expected to increase our understanding of factors involved in viral evolution, and fitness towards hosts and the environment.	[Butt, Azeem Mehmood] Univ Punjab, Ctr Excellence Mol Biol CEMB, Lahore, Pakistan; [Nasrullah, Izza] Quaid I Azam Univ, Fac Biol Sci, Dept Biochem, Islamabad, Pakistan; [Tong, Yigang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	University of Punjab; Quaid I Azam University; Beijing Institute of Microbiology & Epidemiology	Tong, YG (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	tong62035@gmail.com	Butt, Azeem Mehmood/B-6249-2014	Butt, Azeem Mehmood/0000-0001-5897-6848; Tong, Yigang/0000-0002-8503-8045	National Hi-Tech Research and Development (863) Program of China [2012AA022-003]; China Mega-Project on Major Drug Development [2011ZX09401-023]; China Mega-Project on Infectious Disease Prevention [2013ZX10004-605, 2013ZX10004-607, 2013ZX10004-217, 2011ZX10004-001]	National Hi-Tech Research and Development (863) Program of China; China Mega-Project on Major Drug Development; China Mega-Project on Infectious Disease Prevention	This research was supported by grants from the National Hi-Tech Research and Development (863) Program of China (No. 2012AA022-003), China Mega-Project on Major Drug Development (No. 2011ZX09401-023), and China Mega-Project on Infectious Disease Prevention (No. 2013ZX10004-605, No. 2013ZX10004-607, No. 2013ZX10004-217, and No. 2011ZX10004-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JW, 2006, VIRUS GENES, V33, P15, DOI 10.1007/s11262-005-0035-7; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Chen YH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/406342; Cheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074109; Chiusano ML, 2000, GENE, V261, P63, DOI 10.1016/S0378-1119(00)00521-7; Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384; Dorn A, 2008, CURR OPIN MOL THER, V10, P10; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; Greenacre Michael, 1984, THEORY APPL CORRES A; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; Gu WJ, 2004, VIRUS RES, V101, P155, DOI 10.1016/j.virusres.2004.01.006; Hassan Sameer, 2009, Advances in Bioinformatics, V2009, P316936, DOI 10.1155/2009/316936; Hu JS, 2011, INFECT GENET EVOL, V11, P2098, DOI 10.1016/j.meegid.2011.08.025; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; Jupp P. G., 1988, The arboviruses: epidemiology and ecology. Volume II., P137; KARLIN S, 1995, TRENDS GENET, V11, P283; Karlin S, 1997, P NATL ACAD SCI USA, V94, P10227, DOI 10.1073/pnas.94.19.10227; Kumar NP, 2008, J GEN VIROL, V89, P1945, DOI 10.1099/vir.0.83628-0; Liu YS, 2011, INFECT GENET EVOL, V11, P1168, DOI 10.1016/j.meegid.2011.02.018; Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282; Ma JJ, 2013, J ANIM VET ADV, V12, P88; MARIN A, 1989, NUCLEIC ACIDS RES, V17, P6181; Moratorio G, 2013, INFECT GENET EVOL, V14, P396, DOI 10.1016/j.meegid.2013.01.001; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; Sanchez G, 2003, J VIROL, V77, P452, DOI 10.1128/JVI.77.1.452-459.2003; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shi SL, 2013, VIRUS GENES, V46, P10, DOI 10.1007/s11262-012-0818-6; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tao P, 2009, VIRUS GENES, V38, P104, DOI 10.1007/s11262-008-0296-z; Tatarinova TV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-308; Theamboonlers A, 2009, JPN J INFECT DIS, V62, P303; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412; Van der Linden MG, 2006, EXTREMOPHILES, V10, P479, DOI 10.1007/s00792-006-0533-0; Wang M, 2011, ARCH VIROL, V156, P153, DOI 10.1007/s00705-010-0848-0; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Zhang ZC, 2013, ARCH VIROL, V158, P145, DOI 10.1007/s00705-012-1480-y; Zhang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0056344, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0065268]; Zhou H, 2005, ARCH VIROL, V150, P1591, DOI 10.1007/s00705-005-0510-4; Zhou JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077239	52	124	129	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90905	10.1371/journal.pone.0090905	http://dx.doi.org/10.1371/journal.pone.0090905			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595095	gold, Green Submitted, Green Published			2022-12-27	WOS:000332475500112
J	Palazzo, C; Ravaud, JF; Papelard, A; Ravaud, P; Poiraudeau, S				Palazzo, Clemence; Ravaud, Jean-Francois; Papelard, Agathe; Ravaud, Philippe; Poiraudeau, Serge			The Burden of Musculoskeletal Conditions	PLOS ONE			English	Article							ICF CORE SETS; LOW-BACK-PAIN; RHEUMATOID-ARTHRITIS; PREVALENCE; DISABILITY; DISEASES; IMPACT; EPIDEMIOLOGY	Objective: Despite the burden of rheumatic and musculoskeletal diseases (RMDs), these conditions probably deserve more attention from public health authorities in several countries including developed ones. We assessed their contribution to disability. Methods: Data on disabilities associated with RMDs were extracted from the national 2008-2009 Disability-Health Survey of 29,931 subjects representative of the population in France. We used the core set of disability categories for RMDs of the World Health Organization's International Classification of Functioning, Disability and Health for analysis. Diagnosis and disabilities were self-reported. We assessed the risk of disability associated with RMDs using odds ratios (ORs) and the societal impact of RMDs using the average attributable fraction (AAF). Results: Overall 27.7% (about 17.3 million people) (95% CI 26.9-28.4%) of the population reported having RMDs. The most prevalent RMDs were low back pain (12.5%, 12.1-13.1) and osteoarthritis (12.3%, 11.8-12.7). People reporting osteoarthritis were more disabled in walking (adjusted OR 1.9, 1.7-2.2) than those without. People reporting inflammatory arthritis were more limited in activities of daily living (from 1.4, 1.2-1.8 for walking to 2.1, 1.5-2.9 for moving around). From a societal perspective, osteoarthritis was the main contributor to activity limitations (AAF 22% for walking difficulties). Changing jobs was mainly attributed to neck pain (AAF 13%) and low back pain (11.5%). Conclusion: RMDs are highly prevalent and significantly affect activity limitations and participation restrictions. More effort is needed to improve care and research in this field.	[Palazzo, Clemence; Ravaud, Philippe; Poiraudeau, Serge] INSERM, U1153, Paris, France; [Palazzo, Clemence; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75181 Paris, France; [Palazzo, Clemence; Ravaud, Philippe; Poiraudeau, Serge] Univ Paris 05, PRES Sorbonne Paris Cite, Paris, France; [Palazzo, Clemence; Papelard, Agathe; Poiraudeau, Serge] Hop Cochin, AP HP, Serv Reeduc & Readaptat Appareil Locomoteur & Pat, F-75674 Paris, France; [Ravaud, Jean-Francois; Papelard, Agathe; Poiraudeau, Serge] INSERM, Inst Federatif Rech Handicap, Paris, France; [Ravaud, Jean-Francois] INSERM, U988, Villejuif, France; [Ravaud, Jean-Francois] CNRS, UMR 8211, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite Paris Cite	Palazzo, C (corresponding author), INSERM, U1153, Paris, France.	clemence.palazzo@cch.aphp.fr	ravaud, philippe/C-1694-2009; POIRAUDEAU, SERGE/P-5301-2016; RAVAUD, Jean-François/F-7190-2013	RAVAUD, Jean-François/0000-0003-3959-4195; Ravaud, Philippe/0000-0001-8264-9206; Poiraudeau, Serge/0000-0002-1988-9124	Head Office of Research, Studies, Evaluation and Statistics (DREES) of the Social Affairs Ministry of France [PA 11/R 10100LL]; Pfizer	Head Office of Research, Studies, Evaluation and Statistics (DREES) of the Social Affairs Ministry of France; Pfizer(Pfizer)	The Head Office of Research, Studies, Evaluation and Statistics (DREES) of the Social Affairs Ministry of France (contract PA 11/R 10100LL), Pfizer. The Head Office of Research, Studies, Evaluation and Statistics (DREES) of the Social Affairs Ministry of France and Pfizer had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Baumeister H, 2010, J CLIN EPIDEMIOL, V63, P558, DOI 10.1016/j.jclinepi.2009.08.009; Boonen A, 2005, ANN RHEUM DIS, V64, P396, DOI 10.1136/ard.2003.019711; Buchbinder R, 2001, SPINE, V26, P2535, DOI 10.1097/00007632-200112010-00005; Castro-Sanchez AM, 2012, PAIN MED, V13, P1639, DOI 10.1111/j.1526-4637.2012.01523.x; Chopra A, 2013, RHEUMATOLOGY, V52, P1925, DOI 10.1093/rheumatology/ket222; Cieza A, 2004, J REHABIL MED, V36, P69, DOI 10.1080/16501960410016037; Cieza A, 2004, J REHABIL MED, V36, P81, DOI 10.1080/16501960410016028; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; EIDE GE, 1995, J CLIN EPIDEMIOL, V48, P645, DOI 10.1016/0895-4356(94)00161-I; European Commision, 2007, HLTH EUR UN SPEC EUR; Gebhardt C, 2010, J REHABIL MED, V42, P780, DOI 10.2340/16501977-0599; Guo HR, 1999, AM J PUBLIC HEALTH, V89, P1029, DOI 10.2105/AJPH.89.7.1029; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Knight M, 2001, J PUBLIC HEALTH MED, V23, P179, DOI 10.1093/pubmed/23.3.179; Krishnan E, 2012, ANN RHEUM DIS, V71, P213, DOI 10.1136/annrheumdis-2011-200354; Kwok WY, 2011, ANN RHEUM DIS, V70, P334, DOI 10.1136/ard.2010.133603; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; Nikolaus S, 2013, ARTHRITIS CARE RES H, V17; Nuesch E, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1165; Palazzo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044994; Picavet HSJ, 2003, ANN RHEUM DIS, V62, P644, DOI 10.1136/ard.62.7.644; Ruckinger S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-7; Schwarzkopf SR, 2008, CLIN RHEUMATOL, V27, P1355, DOI 10.1007/s10067-008-0916-y; Song J, 2006, ARTHRIT RHEUM-ARTHR, V55, P248, DOI 10.1002/art.21842; Stucki G, 2005, ANN RHEUM DIS, V64, P664, DOI 10.1136/ard.2003.019356; The European Musculoskeletal Conditions Surveillance and Information Network, 2012, MUSC HLTH STAT EUR V; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wolfe F, 2010, J RHEUMATOL, V37, P305, DOI 10.3899/jrheum.090781; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646	30	119	122	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90633	10.1371/journal.pone.0090633	http://dx.doi.org/10.1371/journal.pone.0090633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595187	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500078
J	Patrone, M; Carinhas, N; Sousa, MQ; Peixoto, C; Ciferri, C; Carfi, A; Alves, PM				Patrone, Marco; Carinhas, Nuno; Sousa, Marcos Q.; Peixoto, Cristina; Ciferri, Claudio; Carfi, Andrea; Alves, Paula M.			Enhanced Expression of Full-Length Human Cytomegalovirus Fusion Protein in Non-Swelling Baculovirus-Infected Cells with a Minimal Fed-Batch Strategy	PLOS ONE			English	Article							SIMPLEX-VIRUS 1; GLYCOPROTEIN COMPLEX GB; ENDOTHELIAL-CELLS; VACCINE; GROWTH; ENTRY; HERPESVIRUSES; PREVENTION; GP55-116; EFFICACY	Human cytomegalovirus congenital infection represents an unmet medical issue and attempts are ongoing to develop an effective vaccine. The virion fusion players of this enveloped virus are the natural targets to achieve this goal and to develop novel anti-viral therapies. The secreted ectodomain of the viral fusion factor glycoprotein B (gB) has been exploited so far as an alternative to the cumbersome expression of the wild type trans-membrane protein. In the soluble form, gB showed encouraging but limited potential as antigen candidate calling for further efforts. Here, the exhaustive evaluation of the Baculovirus/insect cell expression system has been coupled to an orthogonal screening for expression additives to produce full-length gB. In detail, rapamycin was found to prolong gB intracellular accumulation while inhibiting the infection-induced cell swelling. Not obvious to predict, this inhibition did not affect Baculovirus growth, revealing that the virus-induced cell size increase is a dispensable side phenotype. In parallel, a feeding strategy for the limiting nutrient cysteine has been set up which improved gB stability. This multi-modal scheme allowed the production of full-length, mutation-free gB in the milligram scale. The recombinant full-length gB obtained was embedded into a stable mono-dispersed particle substantially larger than the protein trimer itself, according to the reported association of this protein with detergent-resistant lipid domains.	[Patrone, Marco; Carinhas, Nuno; Sousa, Marcos Q.; Peixoto, Cristina; Alves, Paula M.] iBET, Oeiras, Portugal; [Carinhas, Nuno; Alves, Paula M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Ciferri, Claudio; Carfi, Andrea] Novartis Vaccines & Diagnost, Cambridge, MA USA	Universidade Nova de Lisboa; Novartis	Patrone, M (corresponding author), Ist Sci San Raffaele, I-20132 Milan, Italy.	patrone.marco@hsr.it	Alves, Paula M/C-1070-2008; Patrone, Marco/M-5672-2013; Peixoto, Cristina/K-8945-2014	Alves, Paula M/0000-0003-1445-3556; Patrone, Marco/0000-0002-5164-2877; Peixoto, Cristina/0000-0002-0995-6637	Marie Curie post-doctoral grant SHerpA [251982]; EU project ComplexINC [270089]; Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/80514/2011]	Marie Curie post-doctoral grant SHerpA; EU project ComplexINC; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was partially supported by the Marie Curie post-doctoral grant SHerpA to M. P. (FP7-PEOPLE-2009-IEF, grant agreement No 251982) and EU project ComplexINC to P. M. A. (FP7/2007-2013, grant agreement No 270089, www.complexinc.eu). N.C. acknowledges Fundacao para a Ciencia e a Tecnologia (FCT) for his fellowship grant (SFRH/BPD/80514/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PRIORITIES NATL VACC; [Anonymous], 2000, VACCINES 21 CENTURY; Atanasiu D, 2010, J VIROL, V84, P12292, DOI 10.1128/JVI.01700-10; Backovic M, 2009, CURR OPIN STRUC BIOL, V19, P189, DOI 10.1016/j.sbi.2009.02.012; Backovic M, 2009, P NATL ACAD SCI USA, V106, P2880, DOI 10.1073/pnas.0810530106; Balcarcel RR, 2001, BIOTECHNOL BIOENG, V76, P1, DOI 10.1002/bit.1020; Bender FC, 2003, J VIROL, V77, P9542, DOI 10.1128/JVI.77.17.9542-9552.2003; Britt W, 2008, CURR TOP MICROBIOL, V325, P417; BRITT WJ, 1992, J VIROL, V66, P6747, DOI 10.1128/JVI.66.11.6747-6754.1992; BRITT WJ, 1989, J VIROL, V63, P403, DOI 10.1128/JVI.63.1.403-410.1989; Carinhas N, 2010, METAB ENG, V12, P39, DOI 10.1016/j.ymben.2009.08.008; Chauvin C., 2013, ONCOGENE, DOI 10.1038/onc.2012.606; Dempsey AF, 2012, VACCINE, V30, P4060, DOI 10.1016/j.vaccine.2012.04.011; Dollery SJ, 2011, J VIROL, V85, P9964, DOI 10.1128/JVI.05291-11; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Fernandes F, 2013, EXPERT REV VACCINES, V12, P225, DOI [10.1586/erv.12.153, 10.1586/ERV.12.153]; Hahn G, 2004, J VIROL, V78, P10023, DOI 10.1128/JVI.78.18.10023-10033.2004; Hahn G, 2002, J VIROL, V76, P9551, DOI 10.1128/JVI.76.18.9551-9555.2002; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Jewell JL, 2013, TRENDS BIOCHEM SCI, V38, P233, DOI 10.1016/j.tibs.2013.01.004; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Lopper M, 2002, J VIROL, V76, P6073, DOI 10.1128/JVI.76.12.6073-6082.2002; Martin S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002894; Monteiro F, 2013, BIOTECHNOL IN PRESS; Pass RF, 1999, J INFECT DIS, V180, P970, DOI 10.1086/315022; Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749; Patrone M, 2007, J VIROL, V81, P11479, DOI 10.1128/JVI.00788-07; Radford KM, 1997, BIOTECHNOL BIOENG, V56, P32, DOI 10.1002/(SICI)1097-0290(19971005)56:1<32::AID-BIT4>3.0.CO;2-W; Ryckman BJ, 2008, J VIROL, V82, P60, DOI 10.1128/JVI.01910-07; Schleiss MR, 2003, J VIROL METHODS, V108, P59, DOI 10.1016/S0166-0934(02)00258-6; Sharma S, 2013, VIROLOGY, V435, P239, DOI 10.1016/j.virol.2012.09.024; Silverman JL, 2013, J VIROL, V87, P10139, DOI 10.1128/JVI.01760-13; Silverman JL, 2012, J VIROL, V86, P8171, DOI 10.1128/JVI.00932-12; Strive T, 2002, J VIROL, V76, P1252, DOI 10.1128/JVI.76.3.1252-1264.2002; Treanor JJ, 2011, VACCINE, V29, P7733, DOI 10.1016/j.vaccine.2011.07.128; Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102	37	9	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90753	10.1371/journal.pone.0090753	http://dx.doi.org/10.1371/journal.pone.0090753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595278	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500096
J	Peng, YL; Gao, XF; Li, RY; Cao, GX				Peng, Yulan; Gao, Xinfen; Li, Renyuan; Cao, Guoxing			Transcriptome Sequencing and De Novo Analysis of Youngia japonica Using the Illumina Platform	PLOS ONE			English	Article							SSR MARKERS; TOOL; ANNOTATION; DIVERGENCE; ASTERACEAE; DISCOVERY; GENOMICS; PLANTS; WHEAT; GENE	Youngia japonica, a weed species distributed worldwide, has been widely used in traditional Chinese medicine. It is an ideal plant for studying the evolution of Asteraceae plants because of its short life history and abundant source. However, little is known about its evolution and genetic diversity. In this study, de novo transcriptome sequencing was conducted for the first time for the comprehensive analysis of the genetic diversity of Y. japonica. The Y. japonica transcriptome was sequenced using Illumina paired-end sequencing technology. We produced 21,847,909 high-quality reads for Y. japonica and assembled them into contigs. A total of 51,850 unigenes were identified, among which 46,087 were annotated in the NCBI non-redundant protein database and 41,752 were annotated in the Swiss-Prot database. We mapped 9,125 unigenes onto 163 pathways using the Kyoto Encyclopedia of Genes and Genomes Pathway database. In addition, 3,648 simple sequence repeats (SSRs) were detected. Our data provide the most comprehensive transcriptome resource currently available for Y. japonica. C-4 photosynthesis unigenes were found in the biological process of Y. japonica. There were 5596 unigenes related to defense response and 1344 ungienes related to signal transduction mechanisms (10.95%). These data provide insights into the genetic diversity of Y. japonica. Numerous SSRs contributed to the development of novel markers. These data may serve as a new valuable resource for genomic studies on Youngia and, more generally, Cichoraceae.	[Peng, Yulan; Gao, Xinfen] Chinese Acad Sci, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Peng, Yulan; Gao, Xinfen] Chinese Acad Sci, Ecol Restorat Biodivers Conservat Key Lab Sichuan, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Li, Renyuan; Cao, Guoxing] Sichuan Agr Univ, Forest Coll, Yaan, Sichuan, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Sichuan Agricultural University	Peng, YL (corresponding author), Chinese Acad Sci, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China.	pengyl@cib.ac.cn; xfgao@cib.ac.cn	peng, yu/GXW-2071-2022	gao, xin fen/0000-0002-5703-1639	National Natural Science Foundation for Young Scholars [31000096]; Knowledge Innovation Project of Chinese Academy of Sciences [Y1B2041100]; 12th Five-year Plan Project of the National Science and Technology of China [2011BAC09B04-04-02]; Sichuan Province Science and technology Project [2013NZ0037]	National Natural Science Foundation for Young Scholars; Knowledge Innovation Project of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); 12th Five-year Plan Project of the National Science and Technology of China; Sichuan Province Science and technology Project	This study was supported by the National Natural Science Foundation for Young Scholars (Grant No. 31000096), the Knowledge Innovation Project of Chinese Academy of Sciences (Grant No. Y1B2041100), the 12th Five-year Plan Project of the National Science and Technology of China (Grant No. 2011BAC09B04-04-02) and Sichuan Province Science and technology Project (No. 2013NZ0037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABC0CK E. B., 1937, CARNEGIE INST WASHINGTON PUBL, V484, P1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; De Cremer K, 2013, PLANT CELL ENVIRON, V36, P1992, DOI 10.1111/pce.12106; Dlugosch KM, 2013, G3-GENES GENOM GENET, V3, P359, DOI 10.1534/g3.112.003871; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guggisberg A, 2013, NEW PHYTOL, V199, P595, DOI 10.1111/nph.12258; Hong, 2011, FLORA CHINA, V20-21, P195; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Nakamura K, 2012, MOL PHYLOGENET EVOL, V63, P486, DOI 10.1016/j.ympev.2012.01.023; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ooi LSM, 2004, J ETHNOPHARMACOL, V94, P117, DOI 10.1016/j.jep.2004.05.004; Peng C.I, 1998, DIGITAL FLORA TAIWAN, V4; Raven P.H., 1992, BIOL PLANTS; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Scaglione D, 2012, PLANT BIOTECHNOL J, V10, P956, DOI 10.1111/j.1467-7652.2012.00725.x; TAIZ L, 1991, PLANT PHYSL; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Varshney RK, 2005, PLANT SCI, V168, P195, DOI 10.1016/j.plantsci.2004.08.001; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Xie QL, 2004, THESIS SW JIAOTONG U; Yae E, 2009, CHEM PHARM BULL, V57, P719, DOI 10.1248/cpb.57.719; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu JK, 2004, MOL GENET GENOMICS, V271, P742, DOI 10.1007/s00438-004-1027-3	34	24	24	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90636	10.1371/journal.pone.0090636	http://dx.doi.org/10.1371/journal.pone.0090636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595283	gold, Green Published, Green Submitted			2022-12-27	WOS:000332475500079
J	Taina, M; Sipola, P; Muuronen, A; Hedman, M; Mustonen, P; Kantanen, AM; Jakala, P; Vanninen, R				Taina, Mikko; Sipola, Petri; Muuronen, Antti; Hedman, Marja; Mustonen, Pirjo; Kantanen, Anne-Mari; Jakala, Pekka; Vanninen, Ritva			Determinants of Left Atrial Appendage Volume in Stroke Patients without Chronic Atrial Fibrillation	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; ACUTE ISCHEMIC-STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; PERICARDIAL FAT; SINUS RHYTHM; CARDIOVASCULAR-DISEASE; CRYPTOGENIC STROKE; VENTRICULAR VOLUME; THROMBUS FORMATION; RISK	Background: Left atrial appendage (LAA) volume has been shown to be increased in patients with acute cryptogenic stroke. Atrial fibrillation (AF) is a well-recognized risk factor but it is not the only one associated with LAA enlargement. The aim of the study was to clarify the multifactorial etiology of LAA enlargement in cardiogenic stroke/TIA patients without AF. Methods: Altogether 149 patients with suspected cardioembolic stroke/TIA (47 females; mean age 61 years) underwent cardiac CT. Diagnosed AF on admittance was an exclusion criteria but 24-hour Holter ambulatory ECG revealed paroxysmal AF (PAF) in 20 patients. Body surface area adjusted LAA volume was evaluated. Eighteen different variables were registered including general characteristics, definite and potential causal risk factors for ischemic stroke/TIA, clinical echoparameters and CT based cardiac volumetric and adipose tissue measurements. A stepwise linear regression analysis was performed to achieve a model adjusted for the number of predictors of LAA volume increase. Results: In linear regression analysis, the best model accounted for 30% of the variability in LAA volume, including PAF (19%) and enlarged left atrial volume (6%), enlarged left ventricle end-systolic diameter (3%) and decreased pericardial adipose tissue (2%). No multi-colinearity between variables was observed. In addition to PAF, no other definitive or potential causal risk factors could account for the LAA volume in these patients. Conclusions: LAA volume increase seems to be poorly associated with currently known stroke/TIA risk factors, except for AF. Targeting more comprehensive ECG monitoring for stroke patients with increased LAA volume should be considered.	[Taina, Mikko; Sipola, Petri; Muuronen, Antti; Vanninen, Ritva] Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland; [Taina, Mikko; Kantanen, Anne-Mari; Jakala, Pekka] Univ Eastern Finland, Neurol Unit, Inst Clin Med, Kuopio, Finland; [Taina, Mikko; Sipola, Petri; Muuronen, Antti; Hedman, Marja; Vanninen, Ritva] Univ Eastern Finland, Radiol Unit, Inst Clin Med, Kuopio, Finland; [Hedman, Marja] Kuopio Univ Hosp, Ctr Heart, SF-70210 Kuopio, Finland; [Mustonen, Pirjo] Keski Suomi Cent Hosp, Dept Cardiol, Jyvaskyla, Finland; [Kantanen, Anne-Mari; Jakala, Pekka] Kuopio Univ Hosp, NeuroCtr, SF-70210 Kuopio, Finland	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Central Finland Central Hospital; Kuopio University Hospital; University of Eastern Finland	Taina, M (corresponding author), Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland.	Mikko.Taina@kuh.fi			Kuopio University Hospital [5063519]	Kuopio University Hospital	This study was supported by the Kuopio University Hospital (grant number 5063519 - URL: http://www.psshp.fi/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Agmon Y, 2002, CIRCULATION, V105, P27, DOI 10.1161/hc0102.101776; Anselmino M, 2011, J CARDIOVASC ELECTR, V22, P1, DOI 10.1111/j.1540-8167.2010.01853.x; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bakalli A, 2013, J CLIN ULTRASOUND, V41, P38, DOI 10.1002/jcu.21953; Beinart R, 2011, J CARDIOVASC ELECTR, V22, P10, DOI 10.1111/j.1540-8167.2010.01854.x; BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; Bonita R, 1999, TOB CONTROL, V8, P156, DOI 10.1136/tc.8.2.156; COULSHED N, 1970, BRIT HEART J, V32, P26; Di Tullio MR, 1999, STROKE, V30, P2019, DOI 10.1161/01.STR.30.10.2019; DiTomasso D, 2010, ATHEROSCLEROSIS, V208, P531, DOI 10.1016/j.atherosclerosis.2009.08.015; Fox CS, 2009, CIRCULATION, V119, P1586, DOI 10.1161/CIRCULATIONAHA.108.828970; FROHLICH ED, 1992, NEW ENGL J MED, V327, P998, DOI 10.1056/NEJM199210013271406; GRAHAM TP, 1973, CIRCULATION, V47, P144, DOI 10.1161/01.CIR.47.1.144; Greif M, 2013, CLIN RES CARDIOL, V102, P555, DOI 10.1007/s00392-013-0566-1; Halliday A, 2004, LANCET, V363, P1491; Handke M, 2005, AM J CARDIOL, V96, P1342, DOI 10.1016/j.amjcard.2005.06.085; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Heist EK, 2006, HEART RHYTHM, V3, P1313, DOI 10.1016/j.hrthm.2006.07.022; Ito T, 1998, AM J CARDIOL, V81, P1056, DOI 10.1016/S0002-9149(98)00011-3; Jickling GC, 2012, STROKE, V43, P2036, DOI 10.1161/STROKEAHA.111.648725; Kizer JR, 2005, STROKE, V36, P2533, DOI 10.1161/01.STR.0000190005.09442.ad; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Langman J., 2003, LANGMANS MED EMBRYOL, P223; Lawes CMM, 2004, DIABETES CARE, V27, P2836; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Loh E, 1997, NEW ENGL J MED, V336, P251, DOI 10.1056/NEJM199701233360403; Mahilmaran Asha, 2004, Indian Heart J, V56, P293; MILLER JT, 1988, AM HEART J, V116, P1048, DOI 10.1016/0002-8703(88)90158-5; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Nucifora G, 2011, CIRC-CARDIOVASC IMAG, V4, P514, DOI 10.1161/CIRCIMAGING.111.963892; Okuyama H, 2006, CIRC J, V70, P971, DOI 10.1253/circj.70.971; Ozer N, 2005, J AM SOC ECHOCARDIOG, V18, P1362, DOI 10.1016/j.echo.2005.03.023; POLLICK C, 1991, CIRCULATION, V84, P223, DOI 10.1161/01.CIR.84.1.223; Rodriguez-Yanez M, 2013, NEUROLOGY, V81, P444, DOI 10.1212/WNL.0b013e31829d8773; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Sipola P, 2013, CEREBROVASC DIS, V35, P521, DOI 10.1159/000350734; Taina M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079519; Thanassoulis G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P345, DOI 10.1161/CIRCEP.109.912055; Therkelsen SK, 2005, J CARDIOVASC MAGN R, V7, P465, DOI 10.1081/JCMR-200053618; Walker DT, 2012, J INTERV CARD ELECTR, V34, P173, DOI 10.1007/s10840-011-9638-1; Wong CX, 2011, J AM COLL CARDIOL, V57, P1745, DOI 10.1016/j.jacc.2010.11.045	44	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90903	10.1371/journal.pone.0090903	http://dx.doi.org/10.1371/journal.pone.0090903			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595515	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500111
J	Cucak, H; Mayer, C; Tonnesen, M; Thomsen, LH; Grunnet, LG; Rosendahl, A				Cucak, Helena; Mayer, Christopher; Tonnesen, Morten; Thomsen, Lise Hoj; Grunnet, Lars Groth; Rosendahl, Alexander			Macrophage Contact Dependent and Independent TLR4 Mechanisms Induce beta-Cell Dysfunction and Apoptosis in a Mouse Model of Type 2 Diabetes	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; TOLL-LIKE RECEPTORS; FATTY-ACID; INNATE IMMUNITY; ADIPOSE-TISSUE; OBESITY; INFLAMMATION; EXPRESSION; DB/DB; TOLL-LIKE-RECEPTOR-4	Type 2 diabetes (T2D) is evolving into a global disease and patients have a systemic low-grade inflammation, yet the role of this inflammation is still not established. One plausible mechanism is enhanced expression and activity of the innate immune system. Therefore, we evaluated the expression and the function of the toll-like receptor 4 (TLR4) on pancreatic beta-cells in primary mouse islets and on the murine beta-cell line MIN6 in the presence or absence of macrophages. Diabetic islets have 40% fewer TLR4 positive beta-cells, but twice the number of TLR4 positive macrophages as compared to healthy islets. Healthy and diabetic islets respond to a TLR4 challenge with enhanced production of cytokines (5-10-fold), while the TLR4 negative beta-cell line MIN6 fails to produce cytokines. TLR4 stimulation induces beta-cell dysfunction in mouse islets, measured as reduced glucose stimulated insulin secretion. Diabetic macrophages from 4-months old mice have acquired a transient enhanced capacity to produce cytokines when stimulated with LPS. Interestingly, this is lost in 6-months old diabetic mice. TLR4 activation alone does not induce apoptosis in islets or MIN-6 cells. In contrast, macrophages mediate TLR4-dependent cell-contact dependent (3-fold) as well as cell-contact independent (2-fold) apoptosis of both islets and MIN-6 cells. Importantly, diabetic macrophages have a significantly enhanced capacity to induce beta-cell apoptosis compared to healthy macrophages. Taken together, the TLR4 responsiveness is elevated in the diabetic islets and mainly mediated by newly recruited macrophages. The TLR4 positive macrophages, in both a cell-contact dependent and independent manner, induce apoptosis of beta-cells in a TLR4 dependent fashion and TLR4 activation directly induces beta-cell dysfunction. Thus, targeting either the TLR4 pathway or the macrophages provides a novel attractive treatment regime for T2D.	[Cucak, Helena; Mayer, Christopher; Tonnesen, Morten; Thomsen, Lise Hoj; Rosendahl, Alexander] Hagedorn Res Inst, Dept Diabet Complicat Biol, Malov, Denmark; [Grunnet, Lars Groth] Dept Incretin & Islet Biol, Malov, Denmark	Novo Nordisk; Hagedorn Research Institute	Rosendahl, A (corresponding author), Hagedorn Res Inst, Dept Diabet Complicat Biol, Malov, Denmark.	AXRD@novonordisk.com			NovoNordisk foundation	NovoNordisk foundation(Novo Nordisk Foundation)	The study was funded through a post-doc grant from the NovoNordisk foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo J, 2012, DIABETES, V61, P2851, DOI 10.2337/db12-0134; Amyot J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036200; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bell E, 2009, NAT REV IMMUNOL, V9, P532, DOI 10.1038/nri2608; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Boyle JJ, 2001, ARTERIOSCL THROM VAS, V21, P1402, DOI 10.1161/hq0901.094279; CHAN TM, 1981, DIABETES, V30, P211, DOI 10.2337/diab.30.3.211; Chanchamroen S, 2009, INFECT IMMUN, V77, P456, DOI 10.1128/IAI.00503-08; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Chou DHC, 2010, ACS CHEM BIOL, V5, P729, DOI 10.1021/cb100129d; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; COLEMAN DL, 1982, DIABETES, V31, P1; Collier JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022485; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Cucak H, 2013, J LEUKOC BIOL; Donath MY, 2010, TRENDS ENDOCRIN MET, V21, P261, DOI 10.1016/j.tem.2009.12.010; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Flavin MP, 1997, NEUROSCIENCE, V80, P437, DOI 10.1016/S0306-4522(97)00078-X; Garay-Malpartida HM, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-18; Goldberg A, 2007, FASEB J, V21, P2840, DOI 10.1096/fj.06-7910com; HERBERG L, 1977, METABOLISM, V26, P59, DOI 10.1016/0026-0495(77)90128-7; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ikejima S, 2005, DIABETES, V54, P182, DOI 10.2337/diabetes.54.1.182; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; Ladefoged M, 2012, APMIS; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; MANDRUPPOULSEN T, 1985, ALLERGY, V40, P424, DOI 10.1111/j.1398-9995.1985.tb02681.x; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Orr JS, 2012, DIABETES, V61, P2718, DOI 10.2337/db11-1595; Park S, 2009, INFECT IMMUN, V77, P1008, DOI 10.1128/IAI.00976-08; Radin MS, 2008, DIABETOLOGIA, V51, P336, DOI 10.1007/s00125-007-0861-3; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Vives-Pi M, 2003, CLIN EXP IMMUNOL, V133, P208, DOI 10.1046/j.1365-2249.2003.02211.x; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yang YH, 2012, CANCER RES, V72, P5219, DOI 10.1158/0008-5472.CAN-12-1463; Zhou YP, 1996, DIABETES, V45, P580, DOI 10.2337/diabetes.45.5.580; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zykova SN, 2000, DIABETES, V49, P1451, DOI 10.2337/diabetes.49.9.1451	49	26	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90685	10.1371/journal.pone.0090685	http://dx.doi.org/10.1371/journal.pone.0090685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594974	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900133
J	Fujita, K; Okai, T; Hosono, T				Fujita, Kazuhiko; Okai, Takaaki; Hosono, Takashi			Oxygen Metabolic Responses of Three Species of Large Benthic Foraminifers with Algal Symbionts to Temperature Stress	PLOS ONE			English	Article							CLIMATE-CHANGE; MARGINOPORA-VERTEBRALIS; OCEAN ACIDIFICATION; CORAL-REEFS; BEARING FORAMINIFERA; NORTHWEST PACIFIC; PHOTOSYSTEM-II; ZOOXANTHELLAE; FUTURE; PHOTOSYNTHESIS	Water temperature affects the physiology of large benthic foraminifers (LBFs) with algal symbionts dwelling in coral reef environments. However, the detailed physiological responses of LBF holobionts to temperature ranges occurring in their habitats are not known. We report net oxygen (O-2) production and respiration rates of three LBF holobionts (Baculogypsina sphaerulata and Calcarina gaudichaudii hosting diatom symbionts, and Amphisorus kudakajimensis hosting dinoflagellate symbionts) measured in the laboratory at water temperatures ranging from 5 degrees C to 45 degrees C in 2.5 degrees C or 5 degrees C intervals and with light saturation levels of similar to 500 mu mol m(-2) s(-1). In addition, the recovery of net O-2 production and respiration rates after exposure to temperature stress was assessed. The net O-2 production and respiration rates of the three LBF holobionts peaked at similar to 30 degrees C, indicating their optimal temperature for a short exposure period. At extreme high temperatures (>= 40 degrees C), the net O-2 production rates of all three LBF holobionts declined to less than zero and the respiration rates slightly decreased, indicating that photosynthesis of algal symbionts was inactivated. At extreme low temperatures (<= 10 degrees C for two calcarinid species and <= 5 degrees C for A. kudakajimensis), the net O-2 production and respiration rates were near zero, indicating a weakening of holobiont activity. After exposure to extreme high or low temperature, the net O-2 production rates did not recover until the following day, whereas the respiration rates recovered rapidly, suggesting that a longer time (days) is required for recovery from damage to the photosystem by temperature stress compared to the respiration system. These results indicate that the oxygen metabolism of LBF holobionts can generally cope well with conditions that fluctuate diurnally and seasonally in their habitats. However, temporal heat and cold stresses with high light levels may induce severe damage to algal symbionts and also damage to host foraminifers.	[Fujita, Kazuhiko; Okai, Takaaki] Univ Ryukyus, Dept Phys & Earth Sci, Nishihara, Okinawa 90301, Japan; [Hosono, Takashi] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Tokyo 113, Japan	University of the Ryukyus; University of Tokyo	Fujita, K (corresponding author), Univ Ryukyus, Dept Phys & Earth Sci, Nishihara, Okinawa 90301, Japan.	fujitaka@sci.u-ryukyu.ac.jp		Kazuhiko, Fujita/0000-0002-9833-007X	JSPS KAKENHI [17740341]; JST/JICA SATREPS [0808918]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST/JICA SATREPS(Japan Science & Technology Agency (JST))	This work was supported by JSPS KAKENHI (17740341) and JST/JICA SATREPS (0808918, PI: H. Kayanne). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Doo SS, 2012, J EXP MAR BIOL ECOL, V430, P63, DOI 10.1016/j.jembe.2012.06.025; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Fujita K, 2004, J FORAMIN RES, V34, P169, DOI 10.2113/34.3.169; Fujita K, 2000, MAR MICROPALEONTOL, V38, P267, DOI 10.1016/S0377-8398(99)00042-0; Fujita K, 2008, J FORAMIN RES, V38, P117, DOI 10.2113/gsjfr.38.2.117; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; HALLOCK P, 1995, J FORAMIN RES, V25, P280, DOI 10.2113/gsjfr.25.3.280; Hill R, 2004, PHOTOSYNTH RES, V82, P59, DOI 10.1023/B:PRES.0000040444.41179.09; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hohenegger J, 2004, J FORAMIN RES, V34, P9, DOI 10.2113/0340009; Hohenegger J., 2011, LARGE FORAMINIFERA G; Hohenegger J, 2006, MAR MICROPALEONTOL, V61, P4, DOI 10.1016/j.marmicro.2006.05.007; Hohenegger Johann, 1994, Marine Ecology, V15, P291, DOI 10.1111/j.1439-0485.1994.tb00059.x; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kirk J.T.O., 2011, LIGHT PHOTOSYNTHESIS; Kohler-Rink S, 2001, OPHELIA, V55, P111; Langer MR, 2000, MICROPALEONTOLOGY, V46, P105; Lee JJ, 2006, SYMBIOSIS, V42, P63; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; Momigliano P, 2013, MAR ECOL PROG SER, V491, P33, DOI 10.3354/meps10465; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raja R, 2005, MAR MICROPALEONTOL, V58, P31, DOI 10.1016/j.marmicro.2005.08.001; Reymond CE, 2011, MAR ECOL PROG SER, V435, P97, DOI 10.3354/meps09172; Sakai K., 1981, P 4 INT COR REEF S M, V2, P763; Saraswati PK, 2004, MAR MICROPALEONTOL, V50, P339, DOI 10.1016/S0377-8398(03)00099-9; Saxby T, 2003, MAR ECOL PROG SER, V248, P85, DOI 10.3354/meps248085; Schmidt C, 2011, LIMNOL OCEANOGR, V56, P1587, DOI 10.4319/lo.2011.56.5.1587; Sheppard CRC, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198566359.001.0001; Sinutok S, 2013, MAR ECOL PROG SER, V478, P127, DOI 10.3354/meps10187; Sinutok S, 2011, LIMNOL OCEANOGR, V56, P1200, DOI 10.4319/lo.2011.56.4.1200; Smith DJ, 2005, GLOBAL CHANGE BIOL, V11, P1, DOI 10.1111/j.1529-8817.2003.00895.x; Talge HK, 2003, J EUKARYOT MICROBIOL, V50, P324, DOI 10.1111/j.1550-7408.2003.tb00143.x; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Uthicke S, 2012, CORAL REEFS, V31, P401, DOI 10.1007/s00338-011-0851-2; Uthicke S, 2012, GLOBAL CHANGE BIOL, V18, P2781, DOI 10.1111/j.1365-2486.2012.02715.x; van Dam JW, 2012, MAR POLLUT BULL, V65, P373, DOI 10.1016/j.marpolbul.2011.08.008; van Dam JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033900; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Weinmann AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062182; Williams DE, 2004, MAR BIOL, V145, P641, DOI 10.1007/s00227-004-1351-5; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Ziegler M, 2011, J EXP MAR BIOL ECOL, V407, P70, DOI 10.1016/j.jembe.2011.07.009; ZMIRI A, 1974, J PROTOZOOL, V21, P133, DOI 10.1111/j.1550-7408.1974.tb03626.x	47	26	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90304	10.1371/journal.pone.0090304	http://dx.doi.org/10.1371/journal.pone.0090304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594773	gold, Green Published, Green Submitted			2022-12-27	WOS:000332468900092
J	Hou, PP; Zhang, R; Liu, YF; Feng, J; Wang, W; Wu, YL; Ding, JP				Hou, Panpan; Zhang, Rong; Liu, Yongfeng; Feng, Jing; Wang, Wei; Wu, Yingliang; Ding, Jiuping			Physiological Role of Kv1.3 Channel in T Lymphocyte Cell Investigated Quantitatively by Kinetic Modeling	PLOS ONE			English	Article							ADRENAL CHROMAFFIN CELLS; GATED POTASSIUM CHANNEL; C-TYPE INACTIVATION; K+ CHANNEL; AUTOIMMUNE-DISEASES; CALCIUM INFLUX; RHEUMATOID-ARTHRITIS; JURKAT LYMPHOBLASTS; THERAPEUTIC TARGET; VOLUME REGULATION	Kv1.3 channel is a delayed rectifier channel abundant in human T lymphocytes. Chronic inflammatory and autoimmune disorders lead to the over-expression of Kv1.3 in T cells. To quantitatively study the regulatory mechanism and physiological function of Kv1.3 in T cells, it is necessary to have a precise kinetic model of Kv1.3. In this study, we firstly established a kinetic model capable to precisely replicate all the kinetic features for Kv1.3 channels, and then constructed a T-cell model composed of ion channels including Ca2+-release activated calcium (CRAC) channel, intermediate K+ (IK) channel, TASK channel and Kv1.3 channel for quantitatively simulating the changes in membrane potentials and local Ca2+ signaling messengers during activation of T cells. Based on the experimental data from current-clamp recordings, we successfully demonstrated that Kv1.3 dominated the membrane potential of T cells to manipulate the Ca2+ influx via CRAC channel. Our results revealed that the deficient expression of Kv1.3 channel would cause the less Ca2+ signal, leading to the less efficiency in secretion. This was the first successful attempt to simulate membrane potential in non-excitable cells, which laid a solid basis for quantitatively studying the regulatory mechanism and physiological role of channels in non-excitable cells.	[Hou, Panpan; Zhang, Rong; Liu, Yongfeng; Wang, Wei; Ding, Jiuping] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Hubei, Peoples R China; [Feng, Jing; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Liu, Yongfeng] Xinxiang Med Univ, Sch Publ Hlth, Xinxiang, Henan, Peoples R China	Huazhong University of Science & Technology; Wuhan University; Xinxiang Medical University	Wu, YL (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	ylwu@whu.edu.cn; jpding@mail.hust.edu.cn	Hou, Panpan/Q-2941-2019; Feng, Jing/C-1729-2018; Liu, Yongfeng/ABG-1361-2020	Feng, Jing/0000-0001-6726-7912; Liu, Yongfeng/0000-0002-8649-7892; Hou, Panpan/0000-0001-7694-2262	National Basic Research Program of China [2010CB529800]; National Science Foundation of China [30971179, 31170814]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (2010CB529800), the National Science Foundation of China (30971179, 31170814). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; Anangi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052965; Bajnok A, 2013, CYTOM PART A, V83A, P287, DOI 10.1002/cyto.a.22256; BEELER GW, 1977, J PHYSIOL-LONDON, V268, P177, DOI 10.1113/jphysiol.1977.sp011853; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Cabado AG, 1999, LIFE SCI, V64, P681, DOI 10.1016/S0024-3205(98)00610-9; Cahalan M D, 1988, Soc Gen Physiol Ser, V43, P281; CAHALAN MD, 1985, J PHYSIOL-LONDON, V358, P197, DOI 10.1113/jphysiol.1985.sp015548; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; CAI YC, 1992, DNA CELL BIOL, V11, P163, DOI 10.1089/dna.1992.11.163; CHANDY KG, 1990, EUR J IMMUNOL, V20, P747; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; DEUTSCH C, 1993, P NATL ACAD SCI USA, V90, P10036, DOI 10.1073/pnas.90.21.10036; DEUTSCH C, 1988, RENAL PHYSIOL BIOCH, V11, P260; EKEBERG O, 1991, BIOL CYBERN, V65, P81, DOI 10.1007/BF00202382; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Gocke AR, 2012, J IMMUNOL, V188, P5877, DOI 10.4049/jimmunol.1103095; GRISSMER S, 1993, J GEN PHYSIOL, V102, P601, DOI 10.1085/jgp.102.4.601; GRISSMER S, 1990, P NATL ACAD SCI USA, V87, P9411, DOI 10.1073/pnas.87.23.9411; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Levy DI, 1996, BIOPHYS J, V70, P798, DOI 10.1016/S0006-3495(96)79619-4; LEWIS RS, 1993, J GEN PHYSIOL, V101, P801, DOI 10.1085/jgp.101.6.801; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; MALTSEV VA, 1992, CELL SIGNAL, V4, P697, DOI 10.1016/0898-6568(92)90050-I; MALTSEV VA, 1990, IMMUNOL LETT, V26, P277, DOI 10.1016/0165-2478(90)90159-N; Marek N, 2010, HUM IMMUNOL, V71, P666, DOI 10.1016/j.humimm.2010.05.002; MAROM S, 1994, BIOPHYS J, V67, P579, DOI 10.1016/S0006-3495(94)80517-X; Meuth SG, 2008, J BIOL CHEM, V283, P14559, DOI 10.1074/jbc.M800637200; Naraghi M, 1997, J NEUROSCI, V17, P6961; Nicolaou SA, 2007, J IMMUNOL, V179, P346, DOI 10.4049/jimmunol.179.1.346; Numata T, 2007, AM J PHYSIOL-CELL PH, V292, pC460, DOI 10.1152/ajpcell.00367.2006; PAHAPILL PA, 1992, J PHYSIOL-LONDON, V445, P407, DOI 10.1113/jphysiol.1992.sp018931; Panyi G, 2006, CURR PHARM DESIGN, V12, P2199, DOI 10.2174/138161206777585120; PANYI G, 1995, BIOPHYS J, V69, P896, DOI 10.1016/S0006-3495(95)79963-5; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; RANDRIAMAMPITA C, 1991, CELL CALCIUM, V12, P313, DOI 10.1016/0143-4160(91)90005-Y; Rashid MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078712; ROSS PE, 1995, J GEN PHYSIOL, V106, P415, DOI 10.1085/jgp.106.3.415; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; SARKADI B, 1990, BIOCHIM BIOPHYS ACTA, V1027, P130, DOI 10.1016/0005-2736(90)90076-Z; SARKADI B, 1990, MOL IMMUNOL, V27, P1297, DOI 10.1016/0161-5890(90)90034-W; Sun L, 2009, BIOPHYS J, V97, P1832, DOI 10.1016/j.bpj.2009.06.042; Toldi G, 2013, IMMUNOBIOLOGY, V218, P311, DOI 10.1016/j.imbio.2012.05.013; Varga Z, 2010, IMMUNOL LETT, V130, P19, DOI 10.1016/j.imlet.2009.12.015; VERHEUGEN JAH, 1995, J GEN PHYSIOL, V105, P765, DOI 10.1085/jgp.105.6.765; VERHEUGEN JAH, 1995, CELL CALCIUM, V17, P287, DOI 10.1016/0143-4160(95)90075-6; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035208; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7	55	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89975	10.1371/journal.pone.0089975	http://dx.doi.org/10.1371/journal.pone.0089975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594979	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900051
J	Ihssen, J; Schubert, M; Thony-Meyer, L; Richter, M				Ihssen, Julian; Schubert, Mark; Thoeny-Meyer, Linda; Richter, Michael			Laccase Catalyzed Synthesis of Iodinated Phenolic Compounds with Antifungal Activity	PLOS ONE			English	Article							TRAMETES-VERSICOLOR; IODIDE OXIDATION; WOOD DECAY; MULTICOPPER OXIDASE; MASS-SPECTROMETRY; GREEN CHEMISTRY; POSTIA-PLACENTA; FUNGAL LACCASE; LIGNIN; BIOCATALYSTS	Iodine is a well known antimicrobial compound. Laccase, an oxidoreductase which couples the one electron oxidation of diverse phenolic and non-phenolic substrates to the reduction of oxygen to water, is capable of oxidizing unreactive iodide to reactive iodine. We have shown previously that laccase-iodide treatment of spruce wood results in a wash-out resistant antimicrobial surface. In this study, we investigated whether phenolic compounds such as vanillin, which resembles substructures of softwood lignin, can be directly iodinated by reacting with laccase and iodide, resulting in compounds with antifungal activity. HPLC-MS analysis showed that vanillin was converted to iodovanillin by laccase catalysis at an excess of potassium iodide. No conversion of vanillin occurred in the absence of enzyme. The addition of redox mediators in catalytic concentrations increased the rate of iodide oxidation ten-fold and the yield of iodovanillin by 50%. Iodinated phenolic products were also detected when o-vanillin, ethyl vanillin, acetovanillone and methyl vanillate were incubated with laccase and iodide. At an increased educt concentration of 0.1 M an almost one to one molar ratio of iodide to vanillin could be used without compromising conversion rate, and the insoluble iodovanillin product could be recovered by simple centrifugation. The novel enzymatic synthesis procedure fulfills key criteria of green chemistry. Biocatalytically produced iodovanillin and iodo-ethyl vanillin had significant growth inhibitory effects on several wood degrading fungal species. For Trametes versicolor, a species causing white rot of wood, almost complete growth inhibition and a partial biocidal effect was observed on agar plates. Enzymatic tests indicated that the iodinated compounds acted as enzyme responsive, antimicrobial materials.	[Ihssen, Julian; Thoeny-Meyer, Linda; Richter, Michael] Swiss Fed Labs Mat Sci & Technol, Empa, Lab Biomat, St Gallen, Switzerland; [Schubert, Mark] Swiss Fed Labs Mat Sci & Technol, Empa, Lab Appl Wood Mat, St Gallen, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Ihssen, J (corresponding author), Swiss Fed Labs Mat Sci & Technol, Empa, Lab Biomat, St Gallen, Switzerland.	julian.ihssen@empa.ch		Schubert, Mark/0000-0002-6900-0370	Empa, Swiss Federal Laboratories for Materials Science and Technology	Empa, Swiss Federal Laboratories for Materials Science and Technology	This study was funded internally by Empa, Swiss Federal Laboratories for Materials Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimurthy S, 2003, TETRAHEDRON LETT, V44, P5099, DOI 10.1016/S0040-4039(03)01144-4; Al-Adham ISI, 1998, J IND MICROBIOL BIOT, V21, P6, DOI 10.1038/sj.jim.2900554; Anastas P, 2010, CHEM SOC REV, V39, P301, DOI 10.1039/b918763b; Baier G, 2013, BIOMACROMOLECULES, V14, P1103, DOI 10.1021/bm302003m; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Borrelli F, 2004, EUR J ORG CHEM, V2004, P3227, DOI 10.1002/ejoc.200400181; Camarero S, 2005, APPL ENVIRON MICROB, V71, P1775, DOI 10.1128/AEM.71.4.1775-1784.2005; Deng YH, 2011, BIOMACROMOLECULES, V12, P1116, DOI 10.1021/bm101449b; Fernandez-Sanchez C, 2002, BIOELECTROCHEMISTRY, V58, P149, DOI 10.1016/S1567-5394(02)00119-6; Gitchaiwat A, 2013, J APPL POLYM SCI, V128, P371, DOI 10.1002/app.37675; GRIBBLE GW, 1992, J NAT PROD, V55, P1353, DOI 10.1021/np50088a001; Grover N, 2012, ENZYME MICROB TECH, V50, P271, DOI 10.1016/j.enzmictec.2012.01.006; Hammel KE, 2002, ENZYME MICROB TECH, V30, P445, DOI 10.1016/S0141-0229(02)00011-X; Herpoel I, 2000, FEMS MICROBIOL LETT, V183, P301, DOI 10.1016/S0378-1097(99)00616-3; Hoegger PJ, 2006, FEBS J, V273, P2308, DOI 10.1111/j.1742-4658.2006.05247.x; Hofrichter M, 2006, APPL MICROBIOL BIOT, V71, P276, DOI 10.1007/s00253-006-0417-3; Iniesta J, 2008, ARCH BIOCHEM BIOPHYS, V474, P1, DOI 10.1016/j.abb.2008.02.032; Intra A, 2005, ADV SYNTH CATAL, V347, P973, DOI 10.1002/adsc.200505043; Kiiskinen LL, 2004, J APPL MICROBIOL, V97, P640, DOI 10.1111/j.1365-2672.2004.02348.x; Kulys J, 2005, BIOTECHNOL BIOENG, V92, P124, DOI 10.1002/bit.20610; Lahtinen M, 2013, ORG BIOMOL CHEM, V11, P5454, DOI 10.1039/c3ob40783g; Marjasvaara A, 2008, J MASS SPECTROM, V43, P470, DOI 10.1002/jms.1332; Martorana A, 2013, J MOL CATAL B-ENZYM, V97, P203, DOI 10.1016/j.molcatb.2013.08.013; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; Mizrahi B, 2007, J PHARM SCI-US, V96, P3144, DOI 10.1002/jps.20876; Nishimura RT, 2010, J CHEM EDUC, V87, P526, DOI 10.1021/ed8001607; PEPPER JM, 1953, CAN J CHEM, V31, P476, DOI 10.1139/v53-064; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Ratto M, 2004, HOLZFORSCHUNG, V58, P440, DOI 10.1515/HF.2004.067; Xavier AMRB, 2007, ELECTRON J BIOTECHN, V10, P444, DOI 10.2225/vol10-issue3-fulltext-1; Reiss R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065633; Rekuc A, 2010, BIORESOURCE TECHNOL, V101, P2076, DOI 10.1016/j.biortech.2009.11.077; Riva S, 2006, TRENDS BIOTECHNOL, V24, P219, DOI 10.1016/j.tibtech.2006.03.006; Russell A. D., 1996, UNDERSTANDING ANTIBA; Said SS, 2012, EUR J PHARM BIOPHARM, V80, P85, DOI 10.1016/j.ejpb.2011.08.007; Schubert M, 2012, J BIOTECHNOL, V161, P429, DOI 10.1016/j.jbiotec.2012.08.003; Schubert M, 2012, APPL ENVIRON MICROB, V78, P7267, DOI 10.1128/AEM.01856-12; Seki M, 2013, ENVIRON SCI TECHNOL, V47, P390, DOI 10.1021/es303228n; Sheldon RA, 2007, ADV SYNTH CATAL, V349, P1289, DOI 10.1002/adsc.200700082; Shimamoto YS, 2011, ENVIRON SCI TECHNOL, V45, P2086, DOI 10.1021/es1032162; Stalpers J.A, 1978, IDENTIFICATION WOOD; Suzuki M, 2012, APPL ENVIRON MICROB, V78, P3941, DOI 10.1128/AEM.00084-12; Tao JH, 2009, CURR OPIN CHEM BIOL, V13, P43, DOI 10.1016/j.cbpa.2009.01.018; Voda K, 2003, INT BIODETER BIODEGR, V51, P51, DOI 10.1016/S0964-8305(02)00075-6; Wagner C, 2009, J NAT PROD, V72, P540, DOI 10.1021/np800651m; Wei DS, 2010, APPL ENVIRON MICROB, V76, P2091, DOI 10.1128/AEM.02929-09; Witayakran S, 2009, ADV SYNTH CATAL, V351, P1187, DOI 10.1002/adsc.200800775; Wohlgemuth R, 2010, CURR OPIN BIOTECH, V21, P713, DOI 10.1016/j.copbio.2010.09.016; Wymelenberg AV, 2010, APPL ENVIRON MICROB, V76, P3599, DOI 10.1128/AEM.00058-10; Xu F, 1996, APPL BIOCHEM BIOTECH, V59, P221, DOI 10.1007/BF02783566; Xu F, 1998, BIOCHEM J, V334, P63, DOI 10.1042/bj3340063; Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u; Zelzer M, 2013, BIOMATER SCI-UK, V1, P11, DOI 10.1039/c2bm00041e	53	39	41	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89924	10.1371/journal.pone.0089924	http://dx.doi.org/10.1371/journal.pone.0089924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594755	Green Published, gold			2022-12-27	WOS:000332468900047
J	Li, HF; Ji, Y; Chen, TY				Li, Haifeng; Ji, Yang; Chen, Tianyong			The Roles of Different Sources of Social Support on Emotional Well-Being among Chinese Elderly	PLOS ONE			English	Article							FAMILY SUPPORT; HONG-KONG; OLD-AGE; LIFE; LONELINESS; FRIENDS; DEPRESSION; NETWORKS; CONFIDANTS; BLACKS	Background: Social support has been widely known as a protective factor for the emotional well-being (EWB) of older adults, but less studies have investigated the roles of different sources of social support (i.e., family and friend support) on different facets of EWB (i.e., positive affect and negative affect) simultaneously. Methodology and Findings: In this study, the associations between family/friend support and positive/negative affect were investigated in a sample of 700 Chinese elderly. The EWB and social support were measured with a 12-item affective wordlist (Kahneman et al., 2004) and a self-prepared questionnaire. The results showed that (1) the order of contact frequency and mutual support followed a hierarchical order from spouse, children, to friends; (2) zero-order correlations of both family support and friend support were associated with more positive affect and less negative affect; and when compared with the relative role of family and friend support, (3) spouse (children if spouse is not available) support had greater contribution on decreasing negative affect, while friend support had greater influence on increasing positive affect, even after controlling the demographic, self-rated health and life events variables. Conclusion: Family and friend support play different roles on the two facets of EWB of the elderly. These results were better explained in light of the task specificity model rather than the hierarchical compensatory model. Moreover, positive affect may be enhanced by friend support (based on personal interests and selectable) rather than family support (bonded by kinship and not selectable), which added evidences to the socioemotional selectivity theory.	[Li, Haifeng; Ji, Yang; Chen, Tianyong] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Li, Haifeng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, TY (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	chenty@psych.ac.cn	Chen, Tianyong/M-6353-2013	Ji, Yang/0000-0001-7942-9333; chen, tian yong/0000-0001-8948-4969	Science Doctoral Dissertation of the Chinese Academy of Sciences	Science Doctoral Dissertation of the Chinese Academy of Sciences	This research was supported by Science Doctoral Dissertation of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RG, 1995, AM BEHAV SCI, V39, P209, DOI 10.1177/0002764295039002008; Agneessens F, 2006, SOC NETWORKS, V28, P427, DOI 10.1016/j.socnet.2005.10.001; [Anonymous], 1973, OLD AGE CHANGING SOC; [Anonymous], 1973, UNEXPECTED COMMUNITY; ANTONUCCI TC, 1985, HDB AGING SOCIAL SCI, P94; Antonucci TC, 1986, GENERATIONS, V10, P12; Antonucci TC, 2011, AGEING SOC, V31, P1084, DOI 10.1017/S0144686X1000098X; BEISER M, 1974, J HEALTH SOC BEHAV, V15, P320, DOI 10.2307/2137092; Bowling A, 1991, J GERONTOL, V46, P20, DOI 10.1093/geronj/46.1.S20; Bradburn N.M, 1965, REPORTS HAPPINESS PI; Bradburn N.M., 1969, STRUCTURE PSYCHOL WE, DOI DOI 10.1037/T10756-000; Brown B. B., 1981, RES INTERWEAVE SOCIA, V2, P23; Cantor M., 1985, HDB AGING SOCIAL SCI, P745; Cantor M.H., 1979, RES AGING, V1, P434, DOI [10.1177/016402757914002, DOI 10.1177/016402757914002]; CANTOR MH, 1991, GERONTOLOGIST, V31, P337, DOI 10.1093/geront/31.3.337; Carstensen L.L., 1987, HDB CLIN GERONTOLOGY, V146, P222; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; CHATTERS LM, 1985, J GERONTOL, V40, P605, DOI 10.1093/geronj/40.5.605; Chen FN, 2008, J FAM ISSUES, V29, P1379, DOI 10.1177/0192513X07313602; Cheng ST, 2006, J GERONTOL B-PSYCHOL, V61, pP262, DOI 10.1093/geronb/61.5.P262; Chi I, 2001, INT J AGING HUM DEV, V52, P231, DOI 10.2190/V5K8-CNMG-G2UP-37QV; Chou KL, 2003, AGING MENT HEALTH, V7, P224, DOI 10.1080/136031000101210; Chou RJA, 2011, GERONTOLOGIST, V51, P3, DOI 10.1093/geront/gnq059; Cibulski O, 1981, 12 INT C GER HAMB; Crohan SE, 1987, OLDER ADULT FRIENDSH; DEAN A, 1990, J HEALTH SOC BEHAV, V31, P148, DOI 10.2307/2137169; DIENER E, 1984, J PERS SOC PSYCHOL, V47, P1105, DOI 10.1037/0022-3514.47.5.1105; Diener E, 2009, SOC INDIC RES SER, V37, P11, DOI 10.1007/978-90-481-2350-6_2; Duck SW, 1991, FRIEND LIFE PSYCHOL; DuPertuis LL, 2001, J AGING HEALTH, V13, P494, DOI 10.1177/089826430101300403; Dykstra P. A, 1990, NEXT NONKIN IMPORTAN; Hess B, 1972, AGEING SOC, V3, P357; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Kahneman D., 1999, WELL BEING FDN HEDON; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; KENDIG HL, 1988, J GERONTOL, V43, pS31, DOI 10.1093/geronj/43.2.S31; Larson R, 1986, Psychol Aging, V1, P117, DOI 10.1037/0882-7974.1.2.117; LEE GR, 1987, RES AGING, V9, P459, DOI 10.1177/0164027587094001; LEE GR, 1989, RES AGING, V11, P427, DOI 10.1177/0164027589114002; LITWAK E, 1969, AM SOCIOL REV, V34, P465, DOI 10.2307/2091957; Litwin H, 2001, GERONTOLOGIST, V41, P516, DOI 10.1093/geront/41.4.516; LOWENTHAL MF, 1968, AM SOCIOL REV, V33, P20, DOI 10.2307/2092237; Lu L, 1997, J SOC PSYCHOL, V137, P618, DOI 10.1080/00224549709595483; MOEN P, 1992, ANNU REV SOCIOL, V18, P233, DOI 10.1146/annurev.so.18.080192.001313; MULLINS LC, 1987, J SOC BEHAV PERS, V2, P225; MULLINS LC, 1992, RES AGING, V14, P448, DOI 10.1177/0164027592144002; Okabayashi H, 2004, SOC SCI MED, V59, P2259, DOI 10.1016/j.socscimed.2004.02.024; Pei XM, 1999, INT J AGING HUM DEV, V49, P197, DOI 10.2190/QXLM-PN99-GPN7-32XF; PENNING MJ, 1990, GERONTOLOGIST, V30, P220, DOI 10.1093/geront/30.2.220; Pinquart M, 2000, PSYCHOL AGING, V15, P187, DOI 10.1037//0882-7974.15.2.187; Poulin J, 2012, J CROSS-CULT GERONTO, V27, P305, DOI 10.1007/s10823-012-9177-y; Prince MJ, 1997, PSYCHOL MED, V27, P323, DOI 10.1017/S0033291796004485; Riley M, 1968, AGING SOC INVENTORY; Shanas E., 1976, HDB AGING SOCIAL SCI, P432; Siu OL, 2002, INT J AGING HUM DEV, V55, P299, DOI 10.2190/2K1W-HWLP-JKD5-LRP6; STOLLER EP, 1983, GERONTOLOGIST, V23, P64, DOI 10.1093/geront/23.1.64; STRAIN LA, 1982, RES AGING, V4, P479, DOI 10.1177/0164027582004004004; THOMPSON MG, 1990, PSYCHOL AGING, V5, P535, DOI 10.1037/0882-7974.5.4.535; USUI WM, 1984, J GERONTOL, V39, P350, DOI 10.1093/geronj/39.3.350; Wang JF, 2014, AGING MENT HEALTH, V18, P232, DOI 10.1080/13607863.2013.837143; WELLMAN B, 1989, SOCIOL PERSPECT, V32, P273, DOI 10.2307/1389119; WOOD V, 1978, J MARRIAGE FAM, V40, P367, DOI 10.2307/350767; Yeung GTY, 2007, EUR J AGEING, V4, P219, DOI 10.1007/s10433-007-0065-1; Zeng Y, 2003, CHINA REV, V3, P95, DOI [DOI 10.1007/S42379-018-0010-3, 10.1007/978-90-481-8906-9_14]	64	81	88	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90051	10.1371/journal.pone.0090051	http://dx.doi.org/10.1371/journal.pone.0090051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4CT	24594546	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900058
J	Li, J; Lan, RT; Xiong, YW; Ye, CY; Yuan, M; Liu, XF; Chen, X; Yu, DS; Liu, B; Lin, WC; Bai, XM; Wang, Y; Sun, QZ; Wang, YT; Zhao, HQ; Meng, Q; Chen, Q; Zhao, AL; Xu, JG				Li, Juan; Lan, Ruiting; Xiong, Yanwen; Ye, Changyun; Yuan, Min; Liu, Xinfeng; Chen, Xia; Yu, Deshan; Liu, Bin; Lin, Wenchao; Bai, Xuemei; Wang, Yan; Sun, Qiangzheng; Wang, Yiting; Zhao, Hongqing; Meng, Qiong; Chen, Qiang; Zhao, Ailan; Xu, Jianguo			Sequential Isolation in a Patient of Raoultella planticola and Escherichia coli Bearing a Novel ISCR1 Element Carrying bla(NDM-1)	PLOS ONE			English	Article							MEDIATED QUINOLONE RESISTANCE; METALLO-BETA-LACTAMASE; ANTIBIOTIC-RESISTANCE; PLASMID; EMERGENCE; DISSEMINATION; ORF513; SYSTEM; GENE	Background: The gene for New Delhi metallo-beta-lactamase 1 (NDM-1) has been reported to be transmitted via plasmids which are easily transferable and capable of wide distribution. We report the isolation of two NDM-1 producing strains and possible in vivo transfer of bla(NDM-1) in a patient. Methods: Clinical samples were collected for bacterial culture and antibiotic susceptibility testing from a patient during a 34-day hospitalization. The presence of bla(NDM-1) was detected by PCR and sequencing. Plasmids of interest were sequenced. Medical records were reviewed for evidence of association between the administration of antibiotics and the acquisition of the NDM-1 resistance. Results: A NDM-1 positive Raoultella planticola was isolated from blood on the ninth day of hospitalization without administration of any carbapenem antibiotics and a NDM-1 positive Escherichia coli was isolated from feces on the 29th day of hospitalization and eight days after imipenem administration. The bla(NDM-1) was carried by a 280 kb plasmid pRpNDM1-1 in R. planticola and a 58 kb plasmid pEcNDM1-4 in E. coli. The two plasmids shared a 4812 bp NDM-1-ISCR1 element which was found to be excisable from the plasmid as a free form and transferrable in vitro to a NDM-1 negative plasmid from E. coli. Conclusion: bla(NDM-1) was embedded in an ISCR1 complex class 1 integron as a novel 4812 bp NDM-1-ISCR1 element. The element was found to be able to self excise to become a free form, which may provide a new vehicle for NDM-1 dissemination. This mechanism could greatly accelerate the spread of NDM-1 mediated broad spectrum beta-lactam resistance.	[Li, Juan; Xiong, Yanwen; Ye, Changyun; Yuan, Min; Chen, Xia; Bai, Xuemei; Wang, Yan; Sun, Qiangzheng; Wang, Yiting; Zhao, Hongqing; Meng, Qiong; Chen, Qiang; Zhao, Ailan; Xu, Jianguo] China CDC, Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Liu, Xinfeng; Yu, Deshan] Gansu Prov Ctr Dis Control & Prevent, Lanzhou, Gansu, Peoples R China; [Liu, Bin; Lin, Wenchao] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; University of New South Wales Sydney; Nankai University	Xu, JG (corresponding author), China CDC, Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	xujianguo@icdc.cn	wang, yiting/GYU-5306-2022	yuan, min/0000-0002-2723-2173; Meng, Qiong/0000-0002-8378-9021; Lan, Ruiting/0000-0001-9834-5258	State Key Laboratory for Infectious Disease Prevention and Control of China [2012SKLID205]; Priority Project on Infectious Disease Control and Prevention from the Ministry of Health [2013ZX10004217]; Ministry of Science and Technology	State Key Laboratory for Infectious Disease Prevention and Control of China; Priority Project on Infectious Disease Control and Prevention from the Ministry of Health; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the State Key Laboratory for Infectious Disease Prevention and Control of China [grant number 2012SKLID205] and the Priority Project on Infectious Disease Control and Prevention [grant number 2013ZX10004217] from the Ministry of Health and the Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutin L, 2005, J CLIN MICROBIOL, V43, P1552, DOI 10.1128/JCM.43.4.1552-1563.2005; Bonomo RA, 2011, CLIN INFECT DIS, V52, P485, DOI 10.1093/cid/ciq179; Chen Y, 2011, J ANTIMICROB CHEMOTH, V66, P1255, DOI 10.1093/jac/dkr082; Chen YT, 2009, ANTIMICROB AGENTS CH, V53, P1235, DOI 10.1128/AAC.00970-08; Ho PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017989; Ho PL, 2005, J ANTIMICROB CHEMOTH, V55, P326, DOI 10.1093/jac/dki010; Hu HY, 2012, ANTIMICROB AGENTS CH, V56, P1698, DOI 10.1128/AAC.06199-11; Huang TW, 2013, ANTIMICROB AGENTS CH, V57, P4072, DOI 10.1128/AAC.02266-12; Institute CaLS, 2011, M100S21 I CALS CLIN; Janvier F, 2013, ANTIMICROB AGENTS CH, V57, P3408, DOI 10.1128/AAC.02334-12; Jovcic B, 2011, ANTIMICROB AGENTS CH, V55, P3929, DOI 10.1128/AAC.00226-11; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Ma JY, 2009, ANTIMICROB AGENTS CH, V53, P519, DOI 10.1128/AAC.00886-08; Mammeri H, 2005, ANTIMICROB AGENTS CH, V49, P71, DOI 10.1128/AAC.49.1.71-76.2005; Nordmann P, 2011, J CLIN MICROBIOL, V49, P718, DOI 10.1128/JCM.01773-10; Partridge SR, 2003, ANTIMICROB AGENTS CH, V47, P342, DOI 10.1128/AAC.47.1.342-349.2003; Peirano G, 2011, DIAGN MICR INFEC DIS, V71, P106, DOI 10.1016/j.diagmicrobio.2011.06.013; Rodriguez-Martinez JM, 2006, ANTIMICROB AGENTS CH, V50, P2544, DOI 10.1128/AAC.00609-05; Sekizuka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025334; Shahid M, 2011, LANCET INFECT DIS, V11, P334, DOI 10.1016/S1473-3099(11)70074-3; Shen P, 2008, J ANTIMICROB CHEMOTH, V62, P1252, DOI 10.1093/jac/dkn397; Sole M, 2011, ANTIMICROB AGENTS CH, V55, P4402, DOI 10.1128/AAC.00642-11; STOKES HW, 1993, PLASMID, V30, P39, DOI 10.1006/plas.1993.1032; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Toleman MA, 2006, J ANTIMICROB CHEMOTH, V58, P1, DOI 10.1093/jac/dkl204; Vidal JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006232; Villa L, 2012, J ANTIMICROB CHEMOTH, V67, P1645, DOI 10.1093/jac/dks114; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09	29	28	34	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89893	10.1371/journal.pone.0089893	http://dx.doi.org/10.1371/journal.pone.0089893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594606	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900043
J	Liang, J; Wang, Y; Li, HY; Liu, XK; Qiu, QQ; Qi, L				Liang, Jun; Wang, Yu; Li, Hongyan; Liu, Xuekui; Qiu, Qinqin; Qi, Lu			Combination of Diabetes Risk Factors and Hepatic Steatosis in Chinese: The Cardiometabolic Risk in Chinese (CRC) Study	PLOS ONE			English	Article							FATTY LIVER-DISEASE; METABOLIC SYNDROME; DIAGNOSTIC-ACCURACY; INSULIN-RESISTANCE; NATURAL-HISTORY; PREVALENCE; EPIDEMIOLOGY; MELLITUS; SCORE; ASSOCIATION	Aims: Hepatic steatosis has been related to insulin resistance and increased diabetes risk. We assessed whether combination of diabetes risk factors, evaluated by the Finnish Diabetes Risk Score, was associated with risk of hepatic steatosis in an apparently healthy Chinese population. Research Design and Methods: The study samples were from a community-based health examination survey in central China. In total 1,780 men and women (18-64 y) were included in the final analyses. Hepatic steatosis was diagnosed by ultrasonography. We created combination of diabetes risk factors score on basis of age, Body Mass Index, waist circumference, physical activity at least 4 h a week, daily consumption of fruits, berries or vegetables, history of antihypertensive drug treatment, history of high blood glucose. The total risk score is a simple sum of the individual weights, and values range from 0 to 20. Results: Hepatic steatosis was present 18% in the total population. In multivariate models, the odds ratios of hepatic steatosis were 1.20 (95% CI 1.15-1.25) in men and 1.25 (95% CI 1.14-1.37) in women by each unit increase in the combination of diabetes risk factors score, after adjustment for blood pressure, liver enzymes, plasma lipids, and fasting glucose. The area under the receiver operating characteristic curve for hepatic steatosis was 0.78 (95% CI 0.76-0.80), 0.76 in men (95% CI 0.74-0.78) and 0.83 (95% CI 0.79-0.87) in women. Conclusions: Our data suggest that combination of major diabetes risk factors was significantly related to risk of hepatic steatosis in Chinese adults.	[Liang, Jun; Liu, Xuekui] Southeast Univ, Xuzhou Inst Med Sci, Xuzhou Inst Diabet,Xuzhou Med Coll,Affiliated Hos, Dept Endocrinol,Xuzhou Cent Hosp,Xuzhou Clin Sch, Xuzhou, Jiangsu, Peoples R China; [Wang, Yu; Li, Hongyan; Qiu, Qinqin] Xuzhou Med Coll, Xuzhou, Jiangsu, Peoples R China; [Qi, Lu] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Qi, Lu] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Qi, Lu] Harvard Univ, Sch Med, Boston, MA USA	Southeast University - China; Xuzhou Medical University; Xuzhou Medical University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Liang, J (corresponding author), Southeast Univ, Xuzhou Inst Med Sci, Xuzhou Inst Diabet,Xuzhou Med Coll,Affiliated Hos, Dept Endocrinol,Xuzhou Cent Hosp,Xuzhou Clin Sch, Xuzhou, Jiangsu, Peoples R China.	mwlj521@163.com; nhlqi@channing.harvard.edu			National Institutes of Health (NIH) [DK091718, HL071981]; American Heart Association; Boston Obesity Nutrition Research Center [DK46200]; Jiangsu Health International Exchange Program; Xuzhou Medical Leading Talent Grant & Xuzhou Science and Technology Board Foundation Grant [XF11C067]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091718, P30DK046200] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Boston Obesity Nutrition Research Center; Jiangsu Health International Exchange Program; Xuzhou Medical Leading Talent Grant & Xuzhou Science and Technology Board Foundation Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Qi's research is supported by National Institutes of Health (NIH) grants DK091718, HL071981, the American Heart Association Scientist Development Award, and the Boston Obesity Nutrition Research Center (DK46200). Dr. Liang's research was sponsored by Jiangsu Health International Exchange Program and supported by Xuzhou Medical Leading Talent Grant & Xuzhou Science and Technology Board Foundation Grant (XF11C067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67; Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Angulo P, 2007, ALIMENT PHARM THER, V25, P883, DOI 10.1111/j.1365-2036.2007.03246.x; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Bellentani S, 2009, ANN HEPATOL, V8, pS4, DOI 10.1016/S1665-2681(19)31820-4; Bohte AE, 2011, EUR RADIOL, V21, P87, DOI 10.1007/s00330-010-1905-5; Bugianesi E, 2010, CURR PHARM DESIGN, V16, P1941, DOI 10.2174/138161210791208875; Carvalho JAM, 2011, ANN MED, V43, P487, DOI 10.3109/07853890.2011.554428; Falck-Ytter Y, 2001, SEMIN LIVER DIS, V21, P17, DOI 10.1055/s-2001-12926; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Kelley DE, 2003, AM J PHYSIOL-ENDOC M, V285, pE906, DOI 10.1152/ajpendo.00117.2003; Laaksonen DE, 2002, AM J EPIDEMIOL, V156, P1070, DOI 10.1093/aje/kwf145; Li ZZ, 2014, J GASTROEN HEPATOL, V29, P42, DOI 10.1111/jgh.12428; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lonardo A, 1997, ITAL J GASTROENTEROL, V29, P351; Lorenzo C, 2003, DIABETES CARE, V26, P3153, DOI 10.2337/diacare.26.11.3153; Preiss D, 2008, CLIN SCI, V115, P141, DOI 10.1042/CS20070402; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Schwarz PEH, 2009, J CLIN ENDOCR METAB, V94, P920, DOI 10.1210/jc.2007-2427; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Targher G, 2007, DIABETES CARE, V30, P2119, DOI 10.2337/dc07-0349; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Zelber-Sagi S, 2006, LIVER INT, V26, P856, DOI 10.1111/j.1478-3231.2006.01311.x	27	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90101	10.1371/journal.pone.0090101	http://dx.doi.org/10.1371/journal.pone.0090101			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595017	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900068
J	Qiu, JM; Yang, GG; Lin, A; Shen, Z; Wang, D; Ding, L				Qiu, Jianming; Yang, Guangen; Lin, Ali; Shen, Zhong; Wang, Dong; Ding, Lei			Human Phosphatidylethanolamine-Binding Protein 4 Promoted the Radioresistance of Human Rectal Cancer by Activating Akt in an ROS-Dependent Way	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; ALPHA-INDUCED APOPTOSIS; CARCINOMA-CELLS; KINASE; RECEPTOR; HPEBP4; RADIOSENSITIZATION; PHOSPHORYLATION; ASSOCIATION; INHIBITION	Human phosphatidylethanolamine-binding protein 4(hPEBP4) is a novel anti-apoptosis molecule associated with the resistance of tumors to apoptotic agents. Here we sought to investigate the role of hPEBP4 in the radioresistance of rectal cancer. Immunohistochemistry analysis showed hPEBP4 was expressed in 27/33 of rectal cancer specimens, but only in 2/33 of neighboring normal mucosa. Silencing the expression of hPEBP4 with siRNA significantly reduced the clonogenic survival and enhanced the apoptosis of rectal cancer cells on irradiation. Instead, forced overexpression of hPEBP4 promoted its survival and decreased the apoptosis. Western blot showed hPEBP4 could increase the radiation-induced Akt activation, for which reactive oxygen specimen(ROS) was required. The radioresistance effect of hPEBP4 was reversed after given LY-294002 to inhibit Akt activation or antioxidant to abolish the ROS production. We also confirmed that effect of hPEBP4 in vivo with nude mice. Thus we concluded that hPEBP4, specifically expressed in rectal cancer cells, is associated with radioresistance of rectal cancer, implying that modulation of hPEBP4 may have important therapeutic implications in radiotherapy of rectal cancer.	[Qiu, Jianming; Yang, Guangen; Shen, Zhong; Wang, Dong; Ding, Lei] Third Peoples Hosp Hangzhou, Dept Colorectal Surg, Hangzhou, Zhejiang, Peoples R China; [Lin, Ali] Third Peoples Hosp Hangzhou, Dept Pathol, Hangzhou, Zhejiang, Peoples R China		Qiu, JM (corresponding author), Third Peoples Hosp Hangzhou, Dept Colorectal Surg, Hangzhou, Zhejiang, Peoples R China.	doctorjianmingqiu@163.com			National Natural Science Fund of China [81101876]; Medical Research Fund of Zhejiang Provincial Health Department [2011RCA035]; Natural Science Fund of Zhejiang Province [Y2110782]; Medical research fund of science technology department of Zhejiang province [2012C33SA100045]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Medical Research Fund of Zhejiang Provincial Health Department; Natural Science Fund of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Medical research fund of science technology department of Zhejiang province	This work was financially supported by the National Natural Science Fund of China (project number 81101876), the Medical Research Fund of Zhejiang Provincial Health Department (project number 2011RCA035), and the Natural Science Fund of Zhejiang Province (project number Y2110782) and the Medical research fund of science technology department of Zhejiang province (project number 2012C33SA100045). The above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanas'ev I, 2011, AGING DIS, V2, P219; Albanese C, 2003, MOL BIOL CELL, V14, P585, DOI 10.1091/mbc.02-06-0101; Birgisson H, 2005, J CLIN ONCOL, V23, P8697, DOI 10.1200/JCO.2005.02.9017; Cataldi A, 2001, CELL SIGNAL, V13, P369, DOI 10.1016/S0898-6568(01)00147-4; CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Esposito F, 2003, J BIOL CHEM, V278, P20828, DOI 10.1074/jbc.M211841200; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Kandel ES, 2002, MOL CELL BIOL, V22, P7831, DOI 10.1128/MCB.22.22.7831-7841.2002; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Krishnan S, 2006, INT J RADIAT ONCOL, V66, P762, DOI 10.1016/j.ijrobp.2006.05.063; Lacher MD, 2006, CANCER RES, V66, P1648, DOI 10.1158/0008-5472.CAN-05-2328; Leach JK, 2001, CANCER RES, V61, P3894; Li HZ, 2007, J BIOL CHEM, V282, P4943, DOI 10.1074/jbc.M609494200; Li P, 2006, INT J MOL MED, V18, P505; Liu HB, 2010, J BIOL CHEM, V285, P21934, DOI 10.1074/jbc.M110.109876; Mabuchi S, 2004, ENDOCRINOLOGY, V145, P49, DOI 10.1210/en.2003-0792; Meyn RE, 2009, INT J RADIAT BIOL, V85, P107, DOI 10.1080/09553000802662595; Oka N, 2005, CANCER RES, V65, P7546, DOI 10.1158/0008-5472.CAN-05-1197; Pollycove Myron, 2007, Dose-Response, V5, P26, DOI 10.2203/dose-response.06-112.Pollycove; POWELL S, 1990, RADIOTHER ONCOL, V19, P95, DOI 10.1016/0167-8140(90)90123-E; Qiu JM, 2013, INT J COLORECTAL DIS, V28, P241, DOI 10.1007/s00384-012-1534-3; Rodel C, 2003, INT J RADIAT ONCOL, V55, P1341, DOI 10.1016/S0360-3016(02)04618-7; Rosenzweig KE, 1997, CLIN CANCER RES, V3, P1149; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Shono T, 2008, INT J CANCER, V123, P787, DOI 10.1002/ijc.23569; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stelzmueller I, 2009, J GASTROINTEST SURG, V13, P657, DOI 10.1007/s11605-008-0760-z; Sun YL, 2010, CANCER RES, V70, P2880, DOI 10.1158/0008-5472.CAN-09-4572; Tanno S, 2004, CANCER RES, V64, P3486, DOI 10.1158/0008-5472.CAN-03-1788; Wang XJ, 2005, CLIN CANCER RES, V11, P7545, DOI 10.1158/1078-0432.CCR-05-0879; Wang XJ, 2004, J BIOL CHEM, V279, P45855, DOI 10.1074/jbc.M405147200; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; WARD JF, 1985, RADIAT RES, V104, pS103, DOI 10.2307/3576637; Zhang YY, 2007, INT J MOL MED, V19, P55	36	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90062	10.1371/journal.pone.0090062	http://dx.doi.org/10.1371/journal.pone.0090062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594691	Green Published, gold			2022-12-27	WOS:000332468900061
J	Tarapore, P; Ying, J; Ouyang, B; Burke, B; Bracken, B; Ho, SM				Tarapore, Pheruza; Ying, Jun; Ouyang, Bin; Burke, Barbara; Bracken, Bruce; Ho, Shuk-Mei			Exposure to Bisphenol A Correlates with Early-Onset Prostate Cancer and Promotes Centrosome Amplification and Anchorage-Independent Growth In Vitro	PLOS ONE			English	Article							CHROMOSOME INSTABILITY; EXPRESSION; CARCINOGENESIS; MICROTUBULES; VARIABILITY; ESTROGENS; RESPONSES; TUBULIN; TARGETS; BINDING	Human exposure to bisphenol A (BPA) is ubiquitous. Animal studies found that BPA contributes to development of prostate cancer, but human data are scarce. Our study examined the association between urinary BPA levels and Prostate cancer and assessed the effects of BPA on induction of centrosome abnormalities as an underlying mechanism promoting prostate carcinogenesis. The study, involving 60 urology patients, found higher levels of urinary BPA (creatinine-adjusted) in Prostate cancer patients (5.74 mu g/g [95% CI; 2.63, 12.51]) than in non-Prostate cancer patients (1.43 mu g/g [95% CI; 0.70, 2.88]) (p = 0.012). The difference was even more significant in patients <65 years old. A trend toward a negative association between urinary BPA and serum PSA was observed in Prostate cancer patients but not in non-Prostate cancer patients. In vitro studies examined centrosomal abnormalities, microtubule nucleation, and anchorage-independent growth in four Prostate cancer cell lines (LNCaP, C4-2, 22Rv1, PC-3) and two immortalized normal prostate epithelial cell lines (NPrEC and RWPE-1). Exposure to low doses (0.01-100 nM) of BPA increased the percentage of cells with centrosome amplification two- to eight-fold. Dose responses either peaked or reached the plateaus with 0.1 nM BPA exposure. This low dose also promoted microtubule nucleation and regrowth at centrosomes in RWPE-1 and enhanced anchorage-independent growth in C4-2. These findings suggest that urinary BPA level is an independent prognostic marker in Prostate cancer and that BPA exposure may lower serum PSA levels in Prostate cancer patients. Moreover, disruption of the centrosome duplication cycle by low-dose BPA may contribute to neoplastic transformation of the prostate.	[Tarapore, Pheruza; Ying, Jun; Ouyang, Bin; Ho, Shuk-Mei] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Tarapore, Pheruza; Ying, Jun; Ouyang, Bin; Ho, Shuk-Mei] Univ Cincinnati, Coll Med, Ctr Environm Genet, Cincinnati, OH USA; [Tarapore, Pheruza; Ouyang, Bin; Ho, Shuk-Mei] Univ Cincinnati, Coll Med, Cincinnati Canc Ctr, Cincinnati, OH USA; [Burke, Barbara; Bracken, Bruce] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45267 USA; [Ho, Shuk-Mei] Cincinnati Veteran Affairs Hosp Med Ctr, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Ho, SM (corresponding author), Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA.	shuk-mei.ho@uc.edu	Tarapore, Pheruza/A-8876-2013	Tarapore, Pheruza/0000-0003-0911-3661	National Institutes of Health [P30-ES006096, U01-ES019480, U01-ES020988]; Veterans Administration Merit Award [I01-BX000675]; University of Cincinnati; Congressionally Directed Medical Research Program Department of Defense Award [PC094619]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096, U01ES020988, U01ES019480] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000675] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Merit Award; University of Cincinnati; Congressionally Directed Medical Research Program Department of Defense Award; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by grants from the National Institutes of Health (P30-ES006096, U01-ES019480, U01-ES020988), a Veterans Administration Merit Award (I01-BX000675), an internal funding source from the University of Cincinnati to SMH and PT, and a Congressionally Directed Medical Research Program Department of Defense Award (PC094619) to PT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2013, CANC FACTS FIG; [Anonymous], 2013, SEER CANC STAT REV; Avidor-Reiss T, 2013, CURR OPIN CELL BIOL, V25, P72, DOI 10.1016/j.ceb.2012.10.016; Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; Brownlee CW, 2013, CELL MOL LIFE SCI, V70, P1021, DOI 10.1007/s00018-012-1102-6; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Carroll PE, 1999, ONCOGENE, V18, P1935, DOI 10.1038/sj.onc.1202515; Carwile JL, 2011, ENVIRON RES, V111, P825, DOI 10.1016/j.envres.2011.05.014; Chan JY, 2011, INT J BIOL SCI, V7, P1122, DOI 10.7150/ijbs.7.1122; Cheung CHA, 2011, EXPERT OPIN THER PAT, V21, P857, DOI 10.1517/13543776.2011.574614; Darshan MS, 2011, CANCER RES, V71, P6019, DOI 10.1158/0008-5472.CAN-11-1417; Davis JN, 2000, INT J ONCOL, V16, P1091; De Coster S, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/713696; De Flora S, 2011, TOXICOL SCI, V122, P45, DOI 10.1093/toxsci/kfr096; Dekant W, 2008, TOXICOL APPL PHARM, V228, P114, DOI 10.1016/j.taap.2007.12.008; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Derouiche S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-54; Donohue KM, 2013, J ALLERGY CLIN IMMUN, V131, P736, DOI 10.1016/j.jaci.2012.12.1573; Duan B, 2013, INT J CLIN ONCOL, V18, P492, DOI 10.1007/s10147-012-0408-6; Ehrlich S, 2012, HUM REPROD, V27, P3583, DOI 10.1093/humrep/des328; Erickson BE, 2008, CHEM ENG NEWS, V86, P36, DOI 10.1021/cen-v086n022.p036; Fiege H., 2002, ULLMANNS ENCY IND CH; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Geens T, 2012, FOOD CHEM TOXICOL, V50, P3725, DOI 10.1016/j.fct.2012.07.059; George O, 2008, ACS CHEM BIOL, V3, P167, DOI 10.1021/cb700210u; Gorlov IP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-599; Guay A T, 2000, Endocr Pract, V6, P132; Heidenreich A, 2014, EUR UROL, V65, P467, DOI 10.1016/j.eururo.2013.11.002; Hess-Wilson JK, 2007, ENVIRON HEALTH PERSP, V115, P1646, DOI 10.1289/ehp.10283; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Jenkins S, 2011, ENVIRON HEALTH PERSP, V119, P1604, DOI 10.1289/ehp.1103850; Keri RA, 2007, REPROD TOXICOL, V24, P240, DOI 10.1016/j.reprotox.2007.06.008; Korzeniewski N, 2013, EXPERT OPIN THER TAR, V17, P43, DOI 10.1517/14728222.2013.731396; Lam YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009075; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lee HH, 2008, ENDOCR-RELAT CANCER, V15, P765, DOI 10.1677/ERC-07-0213; Lehmann L, 2004, CHEM-BIOL INTERACT, V147, P273, DOI 10.1016/j.cbi.2004.01.005; Ling HB, 2012, CELL CYCLE, V11, P3779, DOI 10.4161/cc.21985; Lingle WL, 2005, ADV EXP MED BIOL, V570, P393, DOI 10.1007/1-4020-3764-3_14; Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605; Matsushima A, 2008, BIOCHEM BIOPH RES CO, V373, P408, DOI 10.1016/j.bbrc.2008.06.050; Mobley JA, 2003, CANCER EPIDEM BIOMAR, V12, P775; Morgentaler A, 2006, UROLOGY, V68, P1263, DOI 10.1016/j.urology.2006.08.1058; Nomura H, 2009, PROSTATE CANCER P D, V12, P375, DOI 10.1038/pcan.2009.20; Okada H, 2008, ENVIRON HEALTH PERSP, V116, P32, DOI 10.1289/ehp.10587; Ouyang B, 2009, J UROLOGY, V181, P2508, DOI 10.1016/j.juro.2009.01.110; Padmanabhan V, 2008, J PERINATOL, V28, P258, DOI 10.1038/sj.jp.7211913; Pfeiffer E, 1997, MUTAT RES-GEN TOX EN, V390, P21, DOI 10.1016/S0165-1218(96)00161-9; Prins GS, 2011, REPROD TOXICOL, V31, P1, DOI 10.1016/j.reprotox.2010.09.009; Prins Gail S, 2008, Fertil Steril, V89, pe41, DOI 10.1016/j.fertnstert.2007.12.023; Qin XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036711; Rhoden EL, 2008, J UROLOGY, V179, P1741, DOI 10.1016/j.juro.2008.01.045; Rogers JA, 2013, MOL IMMUNOL, V53, P421, DOI 10.1016/j.molimm.2012.09.013; Safe SH, 2002, ENVIRON HEALTH PERSP, V110, P925, DOI 10.1289/ehp.02110s6925; Schoffski P, 2009, ONCOLOGIST, V14, P559, DOI 10.1634/theoncologist.2009-0010; Sheng ZG, 2012, TOXICOL APPL PHARM, V259, P133, DOI 10.1016/j.taap.2011.12.018; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; STAVNEZER E, 1981, J VIROL, V39, P920, DOI 10.1128/JVI.39.3.920-934.1981; Tang WY, 2012, ENDOCRINOLOGY, V153, P42, DOI 10.1210/en.2011-1308; Tarapore P, 2012, CELL CYCLE, V11, P2931, DOI 10.4161/cc.21396; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Townsend MK, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-80; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; Walker CL, 2012, NAT REV CANCER, V12, P479, DOI 10.1038/nrc3220; Watson CS, 2005, STEROIDS, V70, P364, DOI 10.1016/j.steroids.2005.03.002; WHO (World Health Organization), 1996, BIOL MON CHEM EXP WO; Xi W, 2011, REPROD TOXICOL, V31, P409, DOI 10.1016/j.reprotox.2010.12.002; Ye XY, 2011, ENVIRON HEALTH PERSP, V119, P983, DOI 10.1289/ehp.1002701; Zhang ZF, 2011, ENVIRON SCI TECHNOL, V45, P7044, DOI 10.1021/es200976k; Zhu ML, 2010, CANCER RES, V70, P7992, DOI 10.1158/0008-5472.CAN-10-0585	72	75	80	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90332	10.1371/journal.pone.0090332	http://dx.doi.org/10.1371/journal.pone.0090332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594937	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900094
J	Bergman, JM; Hammarlof, DL; Hughes, D				Bergman, Jessica M.; Hammarlof, Disa L.; Hughes, Diarmaid			Reducing ppGpp Level Rescues an Extreme Growth Defect Caused by Mutant EF-Tu	PLOS ONE			English	Article							AMINOACYL-TRANSFER-RNA; ESCHERICHIA-COLI K-12; SALMONELLA-TYPHIMURIUM; PROTEIN-SYNTHESIS; IN-VIVO; TRANSCRIPTION INITIATION; RIBONUCLEIC-ACID; SPOT GENE; DKSA; MUTATIONS	Transcription and translation of mRNA's are coordinated processes in bacteria. We have previously shown that a mutant form of EF-Tu (Gln125Arg) in Salmonella Typhimurium with a reduced affinity for aa-tRNA, causes ribosome pausing, resulting in an increased rate of RNase E-mediated mRNA cleavage, causing extremely slow growth, even on rich medium. The slow growth phenotype is reversed by mutations that reduce RNase E activity. Here we asked whether the slow growth phenotype could be reversed by overexpression of a wild-type gene. We identified spoT (encoding ppGpp synthetase/hydrolase) as a gene that partially reversed the slow growth rate when overexpressed. We found that the slow-growing mutant had an abnormally high basal level of ppGpp that was reduced when spoT was overexpressed. Inactivating relA (encoding the ribosome-associated ppGpp synthetase) also reduced ppGpp levels and significantly increased growth rate. Because RelA responds specifically to deacylated tRNA in the ribosomal A-site this suggested that the tuf mutant had an increased level of deacylated tRNA relative to the wild-type. To test this hypothesis we measured the relative acylation levels of 4 families of tRNAs and found that proline isoacceptors were acylated at a lower level in the mutant strain relative to the wild-type. In addition, the level of the proS tRNA synthetase mRNA was significantly lower in the mutant strain. We suggest that an increased level of deacylated tRNA in the mutant strain stimulates RelA-mediated ppGpp production, causing changes in transcription pattern that are inappropriate for rich media conditions, and contributing to slow growth rate. Reducing ppGpp levels, by altering the activity of either SpoT or RelA, removes one cause of the slow growth and reveals the interconnectedness of intracellular regulatory mechanisms.	[Bergman, Jessica M.; Hammarlof, Disa L.; Hughes, Diarmaid] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Uppsala University	Hughes, D (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	diarmaid.hughes@imbim.uu.se	Hughes, Diarmaid/A-9487-2014	Hughes, Diarmaid/0000-0002-7456-9182; L. Hammarlof, Disa/0000-0002-8077-7615	Swedish Science Research Council (Vetenskapsradet); Knut and Alice Wallenberg Foundation (RiboCore project)	Swedish Science Research Council (Vetenskapsradet)(Swedish Research Council); Knut and Alice Wallenberg Foundation (RiboCore project)	This work was supported by grants from The Swedish Science Research Council (Vetenskapsradet), and the Knut and Alice Wallenberg Foundation (RiboCore project), to DH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULKARIM F, 1991, BIOCHIMIE, V73, P1457, DOI 10.1016/0300-9084(91)90178-4; ABDULKARIM F, 1994, FEBS LETT, V352, P118, DOI 10.1016/0014-5793(94)00937-6; Abdulkarim F, 1996, J MOL BIOL, V260, P506, DOI 10.1006/jmbi.1996.0418; Abdulkarim F, 1996, FEBS LETT, V382, P297, DOI 10.1016/0014-5793(96)00184-6; Aberg A, 2009, J BACTERIOL, V191, P3226, DOI 10.1128/JB.01410-08; AN G, 1979, J BACTERIOL, V137, P1100, DOI 10.1128/JB.137.3.1100-1110.1979; Bremer H, 1996, ESCHERICHIA COLI SAL; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Hammarlof DL, 2008, MOL MICROBIOL, V70, P1194, DOI 10.1111/j.1365-2958.2008.06472.x; HASELTIN.WA, 1972, NATURE, V238, P381, DOI 10.1038/238381a0; HASELTINE WA, 1973, P NATL ACAD SCI USA, V70, P1564, DOI 10.1073/pnas.70.5.1564; HERNANDEZ VJ, 1991, J BIOL CHEM, V266, P5991; HUGHES D, 1993, BIOCHEM SOC T, V21, P851, DOI 10.1042/bst0210851; HUGHES D, 1986, MOL GEN GENET, V202, P108, DOI 10.1007/BF00330525; HUGHES D, 1990, J MOL BIOL, V215, P41, DOI 10.1016/S0022-2836(05)80093-2; Jakubowski H, 2012, WIRES RNA, V3, P295, DOI 10.1002/wrna.122; KALMAN M, 1992, GENE, V110, P95, DOI 10.1016/0378-1119(92)90449-Y; Kanjee U, 2012, MOL MICROBIOL, V85, P1029, DOI 10.1111/j.1365-2958.2012.08177.x; Kohrer C, 2008, METHODS, V44, P129, DOI 10.1016/j.ymeth.2007.10.006; Kruger MK, 1998, J MOL BIOL, V284, P609, DOI 10.1006/jmbi.1998.2197; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Mechold U, 2013, NUCLEIC ACIDS RES, V41, P6175, DOI 10.1093/nar/gkt302; Murray KD, 1996, J MOL BIOL, V259, P41; Neidhardt FC, 1990, PHYSL BACTERIAL CELL, pxii; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Persson BC, 1997, NUCLEIC ACIDS RES, V25, P4093, DOI 10.1093/nar/25.20.4093; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Potrykus K, 2011, ENVIRON MICROBIOL, V13, P563, DOI 10.1111/j.1462-2920.2010.02357.x; ROJAS AM, 1984, MOL GEN GENET, V197, P36, DOI 10.1007/BF00327920; Ross W, 2013, MOL CELL, V50, P420, DOI 10.1016/j.molcel.2013.03.021; SARUBBI E, 1989, J BIOL CHEM, V264, P15074; SCHMIEGER H, 1971, MOL GEN GENET, V110, P378, DOI 10.1007/BF00438281; Stead MB, 2011, NUCLEIC ACIDS RES, V39, P3188, DOI 10.1093/nar/gkq1242; STENT GS, 1961, P NATL ACAD SCI USA, V47, P2005, DOI 10.1073/pnas.47.12.2005; TUBULEKAS I, 1993, MOL MICROBIOL, V8, P761, DOI 10.1111/j.1365-2958.1993.tb01619.x; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Vinella D, 2012, J BACTERIOL, V194, P261, DOI 10.1128/JB.06238-11; XIAO H, 1991, J BIOL CHEM, V266, P5980; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	43	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90486	10.1371/journal.pone.0090486	http://dx.doi.org/10.1371/journal.pone.0090486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587376	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200210
J	Irizar, H; Munoz-Culla, M; Sepulveda, L; Saenz-Cuesta, M; Prada, A; Castillo-Trivino, T; Zamora-Lopez, G; de Munain, AL; Olascoaga, J; Otaegui, D				Irizar, Haritz; Munoz-Culla, Maider; Sepulveda, Lucia; Saenz-Cuesta, Matias; Prada, Alvaro; Castillo-Trivino, Tamara; Zamora-Lopez, Gorka; Lopez de Munain, Adolfo; Olascoaga, Javier; Otaegui, David			Transcriptomic Profile Reveals Gender-Specific Molecular Mechanisms Driving Multiple Sclerosis Progression	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; RNA-POLYMERASE-III; B-CELLS; DEMYELINATION; GENES; EXPRESSION; VITAMIN-B12; ASSOCIATION; NEUTROPHILS; PHENOTYPE	Background: Although the most common clinical presentation of multiple sclerosis (MS) is the so called Relapsing-Remitting MS (RRMS), the molecular mechanisms responsible for its progression are currently unknown. To tackle this problem, a whole-genome gene expression analysis has been performed on RRMS patients. Results: The comparative analysis of the Affymetrix Human Gene 1.0 ST microarray data from peripheral blood leucocytes obtained from 25 patients in remission and relapse and 25 healthy subjects has revealed 174 genes altered in both remission and relapse, a high proportion of them showing what we have called "mirror pattern'': they are upregulated in remission and downregulated in relapse or vice versa. The coexpression analysis of these genes has shown that they are organized in three female-specific and one male-specific modules. Conclusions: The interpretation of the modules of the coexpression network suggests that Epstein-Barr virus (EBV) reactivation of B cells happens in MS relapses; however, qPCR expression data of the viral genes supports that hypothesis only in female patients, reinforcing the notion that different molecular processes drive disease progression in females and males. Besides, we propose that the "primed'' state showed by neutrophils in women is an endogenous control mechanism triggered to keep EBV reactivation under control through vitamin B12 physiology. Finally, our results also point towards an important sex-specific role of non-coding RNA in MS.	[Irizar, Haritz; Munoz-Culla, Maider; Sepulveda, Lucia; Saenz-Cuesta, Matias; Castillo-Trivino, Tamara; Olascoaga, Javier; Otaegui, David] Biodonostia Hlth Res Inst, Multiple Sclerosis Unit, Neurosci Area, Donostia San Sebastian, Spain; [Irizar, Haritz; Munoz-Culla, Maider; Saenz-Cuesta, Matias; Prada, Alvaro; Castillo-Trivino, Tamara; Olascoaga, Javier; Otaegui, David] Spanish Multiple Sclerosis Net REEM, Barcelona, Spain; [Prada, Alvaro] Hosp Univ Donostia, Dept Immunol, Donostia San Sebastian, Spain; [Zamora-Lopez, Gorka] Humboldt Univ, Bernstein Ctr Computat Neurosci, D-10099 Berlin, Germany; [Zamora-Lopez, Gorka] Univ Pompeu Fabra, Ctr Brain & Cognit, Barcelona, Spain; [Lopez de Munain, Adolfo; Olascoaga, Javier] Hosp Univ Donostia, Dept Neurol, Donostia San Sebastian, Spain; [Lopez de Munain, Adolfo] Ctr Invest Biomed Red Enfermedad Neurodegenerat C, Inst Carlos III, Minist Ciencia & Innovac, Madrid, Spain	Instituto de Investigacion Sanitaria Biodonostia; Humboldt University of Berlin; Pompeu Fabra University; University of Barcelona; CIBERNED	Otaegui, D (corresponding author), Biodonostia Hlth Res Inst, Multiple Sclerosis Unit, Neurosci Area, Donostia San Sebastian, Spain.	david.otaegui@biodonostia.org	Sepúlveda, Lucía/AAB-6210-2019; Otaegui, David/H-4390-2013; Muñoz-Culla, Maider/D-1668-2018; Sepúlveda, Lucía/AAB-6294-2019; Castillo, Tamara/ABH-4121-2020; Zamora-López, Gorka/A-2648-2012; Castillo, Tamara/GYQ-5428-2022; DE MUNAIN, ADOLFO LOPEZ/AAB-1824-2020	Otaegui, David/0000-0002-6625-5976; Sepúlveda, Lucía/0000-0002-8933-9080; Zamora-López, Gorka/0000-0001-9361-9619; Castillo-Trivino, Tamara/0000-0002-9249-3185; /0000-0002-9509-4032; Irizar, Haritz/0000-0002-8413-406X	Spanish Health Ministry (FIS project) of the Basque Government [PS09/02105]; Spanish Health Ministry (SAIOTEK program) of the Basque Government [SAIO11-PC11BN003]; Department of Education, University, and Research of the Basque Government; Rio Hortega Grant from the Spanish Health Ministry; German Federal Ministry of Education and Research (Bernstein Center II) [01GQ1001A]; European Union [PIEF-GA-2012-331800]	Spanish Health Ministry (FIS project) of the Basque Government; Spanish Health Ministry (SAIOTEK program) of the Basque Government; Department of Education, University, and Research of the Basque Government; Rio Hortega Grant from the Spanish Health Ministry; German Federal Ministry of Education and Research (Bernstein Center II)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	This project has been supported by the Spanish Health Ministry (FIS project (PS09/02105) and the SAIOTEK program (SAIO11-PC11BN003 project) of the Basque Government. MMC and HI are supported by predoctoral grants from the Department of Education, University, and Research of the Basque Government. TCT is supported by a Rio Hortega Grant from the Spanish Health Ministry. GZL is supported by the German Federal Ministry of Education and Research (Bernstein Center II, grant no. 01GQ1001A) and by the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement no PIEF-GA-2012-331800. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron A, 2009, J NEUROL SCI, V286, P47, DOI 10.1016/j.jns.2009.06.038; Baranzini SE, 2005, PLOS BIOL, V3, P166, DOI 10.1371/journal.pbio.0030002; Baranzini SE, 2012, CURR OPIN NEUROL, V25, P239, DOI 10.1097/WCO.0b013e3283533a93; Bennett JL, 2009, CLIN NEUROPHARMACOL, V32, P121, DOI 10.1097/WNF.0b013e3181880359; Camina-Tato M, 2010, J IMMUNOL, V185, P5392, DOI 10.4049/jimmunol.1000102; Castillo-Trivino T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016664; Correale J, 2010, J IMMUNOL, V185, P4948, DOI 10.4049/jimmunol.1000588; Davies ML, 2010, VIROLOGY, V400, P53, DOI 10.1016/j.virol.2010.01.002; De Jager PL, 2008, NEUROLOGY, V70, P1113, DOI 10.1212/01.wnl.0000294325.63006.f8; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Disanto G, 2012, NEUROLOGY, V78, P823, DOI 10.1212/WNL.0b013e318249f6f0; Eikelenboom MJ, 2009, J NEUROL SCI, V286, P40, DOI 10.1016/j.jns.2009.06.025; Elenein RGA, 2011, MULT SCLER J, V17, P1531, DOI 10.1177/1352458511414042; Felton-Edkins ZA, 2006, J BIOL CHEM, V281, P33871, DOI 10.1074/jbc.M600468200; Greer JM, 2011, J NEUROIMMUNOL, V234, P7, DOI 10.1016/j.jneuroim.2011.03.003; Hazra A, 2009, HUM MOL GENET, V18, P4677, DOI 10.1093/hmg/ddp428; Herges K, 2012, MULT SCLER J, V18, P398, DOI 10.1177/1352458512440060; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Irizar H, 2012, MULT SCLER J, V18, P569, DOI 10.1177/1352458511426813; Klein SL, 2012, ENDOCRINOLOGY, V153, P2544, DOI 10.1210/en.2011-2120; Kubota N, 2008, J VIROL METHODS, V147, P26, DOI 10.1016/j.jviromet.2007.08.012; Lin XL, 2012, HUM MOL GENET, V21, P2610, DOI 10.1093/hmg/dds062; Liu LP, 2010, NAT NEUROSCI, V13, P319, DOI 10.1038/nn.2491; Mastronardi FG, 2004, J IMMUNOL, V172, P6418, DOI 10.4049/jimmunol.172.10.6418; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Menon R, 2012, J AUTOIMMUN, V38, pJ144, DOI 10.1016/j.jaut.2011.11.004; MILATOVICH A, 1994, MAMM GENOME, V5, P211, DOI 10.1007/BF00360547; Miller A, 2005, J NEUROL SCI, V233, P93, DOI 10.1016/j.jns.2005.03.009; Mrazek J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm244; Naegele M, 2012, J NEUROIMMUNOL, V242, P60, DOI 10.1016/j.jneuroim.2011.11.009; Plessy C, 2012, GENOME RES, V22, P486, DOI 10.1101/gr.126201.111; Ramagopalan SV, 2010, EUR J NEUROL, V17, P634, DOI 10.1111/j.1468-1331.2009.02850.x; Saadoun S, 2012, ANN NEUROL, V71, P323, DOI 10.1002/ana.22686; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sayed BA, 2010, J IMMUNOL, V184, P6891, DOI 10.4049/jimmunol.1000126; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sundqvist E, 2012, GENES IMMUN, V13, P14, DOI 10.1038/gene.2011.42; Sundstrom P, 2009, J NEUROIMMUNOL, V215, P102, DOI 10.1016/j.jneuroim.2009.08.004; van der Mei IAF, 2011, NEUROL CLIN, V29, P233, DOI 10.1016/j.ncl.2010.12.007; van Rensburg SJ, 2006, METAB BRAIN DIS, V21, P121, DOI 10.1007/s11011-006-9019-0; WANG MM, 1993, MOL CELL BIOL, V13, P5805, DOI 10.1128/MCB.13.9.5805; Wang SS, 1997, J NEUROSCI, V17, P4149; Zhao B, 2011, P NATL ACAD SCI USA, V108, P14902, DOI 10.1073/pnas.1108892108	45	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90482	10.1371/journal.pone.0090482	http://dx.doi.org/10.1371/journal.pone.0090482			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587374	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200208
J	Salsoso, R; Guzman-Gutierrez, E; Arroyo, P; Salomon, C; Zambrano, S; Ruiz-Armenta, MV; Blanca, AJ; Pardo, F; Leiva, A; Mate, A; Sobrevia, L; Vazquez, CM				Salsoso, Rocio; Guzman-Gutierrez, Enrique; Arroyo, Pablo; Salomon, Carlos; Zambrano, Sonia; Victoria Ruiz-Armenta, Maria; Jesus Blanca, Antonio; Pardo, Fabian; Leiva, Andrea; Mate, Alfonso; Sobrevia, Luis; Maria Vazquez, Carmen			Reduced L-Carnitine Transport in Aortic Endothelial Cells from Spontaneously Hypertensive Rats	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTER; CATION/CARNITINE TRANSPORTER; OXIDATIVE STRESS; BLOOD-PRESSURE; AMINO-ACID; OCTN2; IDENTIFICATION; EXPRESSION; MECHANISM; DISCOVERY	Impaired L-carnitine uptake correlates with higher blood pressure in adult men, and L-carnitine restores endothelial function in aortic rings from spontaneously hypertensive rat (SHR). Thus, endothelial dysfunction in hypertension could result from lower L-carnitine transport in this cell type. L-Carnitine transport is mainly mediated by novel organic cation transporters 1 (Octn1, Na+-independent) and 2 (Octn2, Na+-dependent); however, their kinetic properties and potential consequences in hypertension are unknown. We hypothesize that L-carnitine transport kinetic properties will be altered in aortic endothelium from spontaneously hypertensive rats (SHR). L-Carnitine transport was measured at different extracellular pH (pH(o) 5.5-8.5) in the absence or presence of sodium in rat aortic endothelial cells (RAECs) from non-hypertensive Wistar-Kyoto (WKY) rats and SHR. Octn1 and Octn2 mRNA relative expression was also determined. Dilation of endothelium-intact or denuded aortic rings in response to calcitonine gene related peptide (CGRP, 0.1-100 nmol/L) was measured (myography) in the absence or presence of L-carnitine. Total L-carnitine transport was lower in cells from SHR compared with WKY rats, an effect due to reduced Na+-dependent (Na-dep(+)) compared with Na+-independent (Na-indep(+)) transport components. Saturable L-carnitine transport kinetics show maximal velocity (V-max), without changes in apparent K-m for Na-indep(+) transport in SHR compared with WKY rats. Total and Na-dep(+) component of transport were increased, but Na-indep(+) transport was reduced by extracellular alkalization in WKY rats. However, alkalization reduced total and Na-indep(+) transport in cells from SHR. Octn2 mRNA was higher than Octn-1 mRNA expression in cells from both conditions. Dilation of artery rings in response to CGRP was reduced in vessels from SHR compared with WKY rats. CGRP effect was endothelium-dependent and restored by L-carnitine. All together these results suggest that reduced L-carnitine transport (likely via Na+-dependent Octn2) could limit this compound's potential beneficial effects in RAECs from SHR.	[Salsoso, Rocio; Guzman-Gutierrez, Enrique; Arroyo, Pablo; Salomon, Carlos; Pardo, Fabian; Leiva, Andrea; Sobrevia, Luis] Pontificia Univ Catolica Chile, Fac Med, Sch Med, Div Obstet & Gynaecol,CMPL, Santiago, Chile; [Zambrano, Sonia; Victoria Ruiz-Armenta, Maria; Jesus Blanca, Antonio; Mate, Alfonso; Maria Vazquez, Carmen] Univ Seville, Fac Pharm, Dept Physiol, Seville, Spain; [Sobrevia, Luis] Univ Queensland, Fac Med & Biomed Sci, UQCCR, Herston, Qld, Australia	Pontificia Universidad Catolica de Chile; University of Sevilla; University of Queensland	Sobrevia, L (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Sch Med, Div Obstet & Gynaecol,CMPL, Alameda 340, Santiago, Chile.	sobrevia@med.puc.cl; vazquez@us.es	Salomon, Carlos F/L-2167-2013; Vazquez, Carmen/GVT-8878-2022; VAZQUEZ, CARMEN CM/K-7058-2014; Rodriguez, Maria/AAB-1401-2021; Mate, Alfonso/G-7418-2012; Sobrevia, Luis/H-9608-2016; Guzman-Gutierrez, Enrique/H-3536-2016	Salomon, Carlos F/0000-0003-4474-0046; VAZQUEZ, CARMEN CM/0000-0002-2999-3582; Mate, Alfonso/0000-0002-2719-8825; Zambrano Sevilla, Sonia/0000-0002-2613-9065; salsoso, rocio/0000-0002-8218-1882; Guzman-Gutierrez, Enrique/0000-0001-6589-5667; Sobrevia, Luis/0000-0001-5802-2243; Zambrano, Sonia/0000-0002-8727-2281	Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile [FONDECYT 1110977, 11100192, 3130583]; Programa de Investigacion Interdisciplinario (PIA) from Comision Nacional de Investigacion en Ciencia y Tecnologia (CONICYT) [Anillos ACT-73]; Fellowship Apoyo de Tesis CONICYT [AT-24120944, AT-24120940]; CONICYT (Chile); Faculty of Medicine, Pontificia Universidad Catolica de Chile; University of Queensland Centre for Clinical Research (Australia); Consejeria de Salud, Junta de Andalucia [PI 0034/2008, 0060/2012]; Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion, PN de I+D+I; Agencia Espanola de Cooperacion Internacional para el Desarrollo (AECID), Spain [C/024225/09, D/031187/10, A1/036123/11]	Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa de Investigacion Interdisciplinario (PIA) from Comision Nacional de Investigacion en Ciencia y Tecnologia (CONICYT); Fellowship Apoyo de Tesis CONICYT; CONICYT (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Faculty of Medicine, Pontificia Universidad Catolica de Chile; University of Queensland Centre for Clinical Research (Australia); Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion, PN de I+D+I; Agencia Espanola de Cooperacion Internacional para el Desarrollo (AECID), Spain	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 1110977, 11100192, 3130583), Chile; Programa de Investigacion Interdisciplinario (PIA) from Comision Nacional de Investigacion en Ciencia y Tecnologia (CONICYT) (Anillos ACT-73); and Fellowship Apoyo de Tesis CONICYT (AT-24120944, AT-24120940), Chile. E. Guzman-Gutierrez and P. Arroyo hold CONICYT-PhD (Chile) fellowships. P. Arroyo was a recipient of Faculty of Medicine, Pontificia Universidad Catolica de Chile-Ph.D. fellowship. C. Salomon holds a postdoctoral fellowship at The University of Queensland Centre for Clinical Research (Australia). S. Zambrano, M. V. Ruiz-Armenta and A.J. Blanca were supported by grants from Consejeria de Salud, Junta de Andalucia (PI 0034/2008, 0060/2012) and Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion, PN de I+D+I 2008-2011, Agencia Espanola de Cooperacion Internacional para el Desarrollo (AECID) (C/024225/09, D/031187/10, A1/036123/11), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravena C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051451; Arduini A, 2008, PHARMACOL THERAPEUT, V120, P149, DOI 10.1016/j.pharmthera.2008.08.008; Bueno R, 2005, LIFE SCI, V77, P2082, DOI 10.1016/j.lfs.2005.01.035; Deves R, 1998, PHYSIOL REV, V78, P487, DOI 10.1152/physrev.1998.78.2.487; Enomoto A, 2002, J BIOL CHEM, V277, P36262, DOI 10.1074/jbc.M203883200; FOSTER KA, 1985, AM J PHYSIOL, V249, pE183, DOI 10.1152/ajpendo.1985.249.2.E183; Furuichi Y, 2010, ACTA PHYSIOL, V200, P57, DOI 10.1111/j.1748-1716.2010.02101.x; Gomez-Amores L, 2007, J NUTR BIOCHEM, V18, P533, DOI 10.1016/j.jnutbio.2006.10.004; Grube M, 2006, CIRCULATION, V113, P1114, DOI 10.1161/CIRCULATIONAHA.105.586107; Grundemann D, 2005, P NATL ACAD SCI USA, V102, P5256, DOI 10.1073/pnas.0408624102; Guzman-Gutierrez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041705; Herrera MD, 2002, J PHARM PHARMACOL, V54, P1423, DOI 10.1211/002235702760345536; Iwata D, 2008, DRUG METAB PHARMACOK, V23, P207, DOI 10.2133/dmpk.23.207; Kanakasabai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050500; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Koepsell H, 2013, MOL ASPECTS MED, V34, P413, DOI 10.1016/j.mam.2012.10.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mancia G., 2007, REV ESP CARDIOL, V60, p968., DOI [10.1097/HJH.0b013e3282f857e7, DOI 10.1097/HJH.0B013E3282F857E7]; Mann GE, 2003, PHYSIOL REV, V83, P183, DOI 10.1152/physrev.00022.2002; McCarty MF, 2004, MED HYPOTHESES, V62, P62, DOI 10.1016/S0306-9877(03)00232-9; Melander O, 2001, BLOOD PRESSURE, V10, P254, DOI 10.1080/080370501753400575; Mels CMC, 2013, LIPIDS, V48, P63, DOI 10.1007/s11745-012-3732-8; Miguel-Carrasco JL, 2008, AM J HYPERTENS, V21, P1231, DOI 10.1038/ajh.2008.271; Mo JX, 2011, MOL PHARMACEUT, V8, P1629, DOI 10.1021/mp100412z; Ohashi R, 2001, MOL PHARMACOL, V59, P358, DOI 10.1124/mol.59.2.358; Ohashi R, 1999, J PHARMACOL EXP THER, V291, P778; Okura T, 2014, DRUG METAB PHARMACOK, V29, P69, DOI 10.2133/dmpk.DMPK-13-RG-058; OZA NB, 1990, J CLIN INVEST, V85, P597, DOI 10.1172/JCI114479; Rajasekar P, 2007, CLIN EXP HYPERTENS, V29, P517, DOI 10.1080/10641960701743998; Ruggenenti P, 2009, HYPERTENSION, V54, P567, DOI 10.1161/HYPERTENSIONAHA.109.132522; Seth P, 1999, J BIOL CHEM, V274, P33388, DOI 10.1074/jbc.274.47.33388; Sharma S, 2013, PEDIATR RES, V74, P39, DOI 10.1038/pr.2013.71; Shennan DB, 1998, BBA-BIOMEMBRANES, V1373, P252, DOI 10.1016/S0005-2736(98)00107-2; Srinivas SR, 2007, AM J PHYSIOL-GASTR L, V293, pG1046, DOI 10.1152/ajpgi.00233.2007; Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5; Tamai I, 2000, J BIOL CHEM, V275, P40064, DOI 10.1074/jbc.M005340200; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Tamai I, 2013, BIOPHARM DRUG DISPOS, V34, P29, DOI 10.1002/bdd.1816; Urban TJ, 2007, PHARMACOGENET GENOM, V17, P773, DOI 10.1097/FPC.0b013e3281c6d08e; Volek JS, 2008, AM J CARDIOL, V102, P1413, DOI 10.1016/j.amjcard.2008.07.022; Wu X, 1998, BIOCHEM BIOPH RES CO, V246, P589, DOI 10.1006/bbrc.1998.8669; Wu X, 1999, J PHARMACOL EXP THER, V290, P1482; Yabuuchi H, 1999, J PHARMACOL EXP THER, V289, P768; Zambrano S, 2013, BIOCHEM PHARMACOL, V85, P937, DOI 10.1016/j.bcp.2012.12.021	44	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90339	10.1371/journal.pone.0090339	http://dx.doi.org/10.1371/journal.pone.0090339			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587332	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200174
J	Clark, RW; Schuett, GW; Repp, RA; Amarello, M; Smith, CF; Herrmann, HW				Clark, Rulon W.; Schuett, Gordon W.; Repp, Roger A.; Amarello, Melissa; Smith, Charles F.; Herrmann, Hans-Werner			Mating Systems, Reproductive Success, and Sexual Selection in Secretive Species: A Case Study of the Western Diamond-Backed Rattlesnake, Crotalus atrox	PLOS ONE			English	Article							MICROSATELLITE LOCI; MULTIPLE PATERNITY; BODY-SIZE; GENOTYPING ERRORS; GENETIC-EVIDENCE; HOME-RANGE; SNAKES; POPULATION; VIPERIDAE; SERPENTES	Long-term studies of individual animals in nature contribute disproportionately to our understanding of the principles of ecology and evolution. Such field studies can benefit greatly from integrating the methods of molecular genetics with traditional approaches. Even though molecular genetic tools are particularly valuable for species that are difficult to observe directly, they have not been widely adopted. Here, we used molecular genetic techniques in a 10-year radio-telemetric investigation of the western diamond-backed rattlesnake (Crotalus atrox) for an analysis of its mating system and to measure sexual selection. Specifically, we used microsatellite markers to genotype 299 individuals, including neonates from litters of focal females to ascertain parentage using full-pedigree likelihood methods. We detected high levels of multiple paternity within litters, yet found little concordance between paternity and observations of courtship and mating behavior. Larger males did not father significantly more offspring, but we found evidence for size-specific male-mating strategies, with larger males guarding females for longer periods in the mating seasons. Moreover, the spatial proximity of males to mothers was significantly associated with reproductive success. Overall, our field observations alone would have been insufficient to quantitatively measure the mating system of this population of C. atrox, and we thus urge more widespread adoption of molecular tools by field researchers studying the mating systems and sexual selection of snakes and other secretive taxa.	[Clark, Rulon W.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Schuett, Gordon W.] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Schuett, Gordon W.] Georgia State Univ, Ctr Behav Neurosci, Atlanta, GA 30303 USA; [Schuett, Gordon W.; Smith, Charles F.] Copperhead Inst, Spartanburg, SC USA; [Schuett, Gordon W.; Smith, Charles F.] Chiricahua Desert Museum, Rodeo, NM USA; [Repp, Roger A.] Natl Opt Astron Observ, Tucson, AZ 85726 USA; [Amarello, Melissa] Social Snakes, Tucson, AZ USA; [Smith, Charles F.] Wofford Coll, Dept Biol, Spartanburg, SC USA; [Herrmann, Hans-Werner] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA	California State University System; San Diego State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; National Optical Astronomy Observatory; University of Arizona	Clark, RW (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	rclark@mail.sdsu.edu; gwschuett@yahoo.com		Amarello, Melissa/0000-0002-1596-5476	Arizona State University; Zoo Atlanta; Georgia State University; San Diego State University	Arizona State University; Zoo Atlanta; Georgia State University; San Diego State University	Arizona State University, Zoo Atlanta, Georgia State University, San Diego State University, and David L. Hardy Sr, funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge RD, 2002, HERPETOL MONOGR, V16, P1, DOI 10.1655/0733-1347(2002)016[0001:EOTMSI]2.0.CO;2; Amarello M, 2010, J ARID ENVIRON, V74, P1443, DOI 10.1016/j.jaridenv.2010.05.019; Andersson Malte, 1994; ARNOLD SJ, 1994, AM NAT, V143, P317, DOI 10.1086/285606; Avise JC, 2011, P NATL ACAD SCI USA, V108, P11512, DOI 10.1073/pnas.1109216108; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Beaupre SJ, 1998, COPEIA, P40, DOI 10.2307/1447700; Birkhead TR, 1998, SPERM COMPETITION SE; Blank S, 2001, RESAMPLING STATS; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Blouin-Demers G, 2005, ANIM BEHAV, V69, P225, DOI 10.1016/j.anbehav.2004.03.012; Blouin-Demers G, 2002, J ZOOL, V256, P1, DOI 10.1017/S0952836902000018; Bonnet X, 2002, TRENDS ECOL EVOL, V17, P1, DOI 10.1016/S0169-5347(01)02381-3; Booth W, 2012, BIOL LETTERS, V8, P983, DOI 10.1098/rsbl.2012.0666; Booth W, 2011, BIOL J LINN SOC, V104, P934, DOI 10.1111/j.1095-8312.2011.01782.x; Brown DE., 1994, BIOTIC COMMUNITIES S; Brown GP, 1999, BEHAV ECOL SOCIOBIOL, V47, P9, DOI 10.1007/s002650050644; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Campbell J. A., 2004, VENOMOUS REPTILES W; Castoe TA, 2007, MOL PHYLOGENET EVOL, V42, P193, DOI 10.1016/j.ympev.2006.07.002; Clark RW, 2012, ANIM BEHAV, V84, P183, DOI 10.1016/j.anbehav.2012.04.029; Clark RW, 2006, COPEIA, P181; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; DeNardo DF, 2011, REPROD BIOL PHYLOGEN, V9, P265; DeWoody JA, 2005, J WILDLIFE MANAGE, V69, P1400, DOI 10.2193/0022-541X(2005)69[1400:MATTSO]2.0.CO;2; Dewsbury DA, 2005, INTEGR COMP BIOL, V45, P831, DOI 10.1093/icb/45.5.831; DeYoung RW, 2005, J WILDLIFE MANAGE, V69, P1362, DOI 10.2193/0022-541X(2005)69[1362:TMTGTI]2.0.CO;2; Dibattista JD, 2008, MOL ECOL, V17, P783, DOI 10.1111/j.1365-294X.2007.03623.x; Dorcas Michael E., 2009, P5; Dubey S, 2009, ANIM BEHAV, V77, P177, DOI 10.1016/j.anbehav.2008.09.037; Duvall D, 1997, ANIM BEHAV, V54, P329, DOI 10.1006/anbe.1996.0418; Duvall David, 1992, P321; Duvall David, 1993, P165; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Epple A. E., 1995, PLANTS ARIZONA; Fisher DO, 1999, ANIM BEHAV, V58, P121, DOI 10.1006/anbe.1999.1119; FITCH H S, 1981, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Gibbs HL, 2001, J HERED, V92, P173, DOI 10.1093/jhered/92.2.173; Gibbs HL, 1998, J HERED, V89, P169, DOI 10.1093/jhered/89.2.169; GILLINGHAM JC, 1983, J HERPETOL, V17, P265, DOI 10.2307/1563829; Goldberg CS, 2003, MOL ECOL NOTES, V3, P539, DOI 10.1046/j.1471-8286.2003.00503.x; Goldberg Stephen R., 2007, Bulletin of the Maryland Herpetological Society, V43, P103; Graham SP, 2008, GEN COMP ENDOCR, V159, P226, DOI 10.1016/j.ygcen.2008.09.002; GRAVES BM, 1993, J HERPETOL, V27, P33, DOI 10.2307/1564902; GRAVES BM, 1995, HERPETOLOGICAL MONOGRAPHS, NO 9, 1995, P102; Greene Harry W., 2002, P179; Greene HW, 2005, TRENDS ECOL EVOL, V20, P23, DOI 10.1016/j.tree.2004.11.005; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Harrison HB, 2013, MOL ECOL, V22, P1158, DOI 10.1111/mec.12138; Holycross AT, 2002, MOL ECOL NOTES, V2, P537, DOI 10.1046/j.1471-8286.2002.00310.x; IMS RA, 1988, EVOL ECOL, V2, P338, DOI 10.1007/BF02207565; Jellen BC, 2011, REPROD BIOL PHYLOGEN, V9, P619; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; King Richard B., 2009, P78; KLAUBER L. M., 1972, RATTLESNAKES THEIR H, V2nd; Kokko H, 2007, EVOLUTION, V61, P1162, DOI 10.1111/j.1558-5646.2007.00090.x; Kvarnemo C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0042; Lukoschek V, 2011, J HERED, V102, P347, DOI 10.1093/jhered/esr017; MADSEN T, 1993, AM NAT, V141, P167, DOI 10.1086/285467; MADSEN T, 1993, ANIM BEHAV, V45, P491, DOI 10.1006/anbe.1993.1060; Mock CJ, 1996, J CLIMATE, V9, P1111, DOI 10.1175/1520-0442(1996)009<1111:CCASVO>2.0.CO;2; Munguia-Vega A, 2009, MOL ECOL RESOUR, V9, P1267, DOI 10.1111/j.1755-0998.2009.02661.x; Nowak EM, 2008, BIOL REV, V83, P601, DOI 10.1111/j.1469-185X.2008.00056.x; Oyler-McCance SJ, 2005, MOL ECOL NOTES, V5, P452, DOI 10.1111/j.1471-8286.2005.00961.x; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Parker GA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0335; Parker Joshua M., 2012, Herpetological Review, V43, P658; Phillips S.J., 2000, NATURAL HIST SONORAN; Pizzari T, 2013, PHILOS T R SOC B, V368, DOI [10.1111/j.1420-9101.2011.02271.x, DOI 10.1111/J.1420-9101.2011.02271.X]; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Pozarowski K, 2012, CONSERV GENET RESOUR, V4, P955, DOI 10.1007/s12686-012-9682-x; PRESTT I, 1971, J ZOOL, V164, P373; PRICE AH, 1988, SOUTHWEST NAT, V33, P370, DOI 10.2307/3671770; Prosser MR, 2002, BEHAV ECOL, V13, P800, DOI 10.1093/beheco/13.6.800; REINERT HK, 1982, COPEIA, P702, DOI 10.2307/1444674; Reinert Howard K., 1992, P185; Reiserer RS, 2008, J ZOOL, V274, P277, DOI 10.1111/j.1469-7998.2007.00383.x; Repp RA, 2008, SOUTHWEST NAT, V53, P108, DOI 10.1894/0038-4909(2008)53[108:WDRCAS]2.0.CO;2; Repp Roger A., 2009, Herpetological Review, V40, P353; Rivas JA, 2005, J COMP PSYCHOL, V119, P447, DOI 10.1037/0735-7036.119.4.447; Rosen PC, 2002, TEX J SCI, V54, P347; Row JR, 2006, COPEIA, P797, DOI 10.1643/0045-8511(2006)6[797:KANAEO]2.0.CO;2; Schmoll T, 2011, J ORNITHOL, V152, P265, DOI 10.1007/s10336-011-0683-4; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schuett GW, 2013, J ZOOL, V289, P101, DOI 10.1111/j.1469-7998.2012.00969.x; Schuett GW, 2011, J ZOOL, V284, P105, DOI 10.1111/j.1469-7998.2010.00786.x; Schuett Gordon W., 1992, P169; Schuett Gordon W., 2004, Herpetological Review, V35, P328; Schuett Gordon W., 2001, Acta Ethologica, V4, P31, DOI 10.1007/s102110100043; Schuett GW, 1997, ANIM BEHAV, V54, P213, DOI 10.1006/anbe.1996.0417; Sever DM, 2002, J EXP ZOOL, V292, P187, DOI 10.1002/jez.1154; Shine R, 2005, ANIM BEHAV, V70, P387, DOI 10.1016/j.anbehav.2005.04.001; SHINE R, 1994, COPEIA, P326; SHUSTER SM, 2003, MG BEH ECOL, pR7; Shuster SM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0046; Simonov E, 2011, ACTA HERPETOL, V6, P289; Spencer C.L., 2008, BIOL RATT, P55; Taylor EN, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 3: REPTILES, P355; Taylor EN, 2005, J EXP ZOOL PART A, V303A, P598, DOI 10.1002/jez.a.189; Trimbos KB, 2009, J ORNITHOL, V150, P915, DOI 10.1007/s10336-009-0422-2; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; Ursenbacher S, 2009, J HERED, V100, P365, DOI 10.1093/jhered/esn104; Walling CA, 2010, MOL ECOL, V19, P1914, DOI 10.1111/j.1365-294X.2010.04604.x; Wang JL, 2010, MOL ECOL, V19, P5061, DOI 10.1111/j.1365-294X.2010.04865.x; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Weatherhead PJ, 2002, BEHAV ECOL, V13, P808, DOI 10.1093/beheco/13.6.808; Wright LI, 2013, BEHAV ECOL, V24, P1022, DOI 10.1093/beheco/art003; Wusterbarth TL, 2010, HERPETOL CONSERV BIO, V5, P86; Zamudio KR, 2000, P NATL ACAD SCI USA, V97, P14427, DOI 10.1073/pnas.011544998; Zar J. H., 1996, BIOSTATISTICAL ANAL	111	32	34	0	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90616	10.1371/journal.pone.0090616	http://dx.doi.org/10.1371/journal.pone.0090616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598810	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400102
J	De Souza, CP; Hashmi, SB; Osmani, AH; Osmani, SA				De Souza, Colin P.; Hashmi, Shahr B.; Osmani, Aysha H.; Osmani, Stephen A.			Application of a New Dual Localization-Affinity Purification Tag Reveals Novel Aspects of Protein Kinase Biology in Aspergillus nidulans	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; SEPTATION INITIATION NETWORK; DNA-REPLICATION; MITOTIC CHECKPOINT; CELL-CYCLE; SEPTUM FORMATION; GLOBAL ANALYSIS; FISSION YEAST; NIMA KINASE; TRANSCRIPTION FACTOR	Filamentous fungi occupy critical environmental niches and have numerous beneficial industrial applications but devastating effects as pathogens and agents of food spoilage. As regulators of essentially all biological processes protein kinases have been intensively studied but how they regulate the often unique biology of filamentous fungi is not completely understood. Significant understanding of filamentous fungal biology has come from the study of the model organism Aspergillus nidulans using a combination of molecular genetics, biochemistry, cell biology and genomic approaches. Here we describe dual localization-affinity purification (DLAP) tags enabling endogenous N or C-terminal protein tagging for localization and biochemical studies in A. nidulans. To establish DLAP tag utility we endogenously tagged 17 protein kinases for analysis by live cell imaging and affinity purification. Proteomic analysis of purifications by mass spectrometry confirmed association of the CotA and NimX(Cdk1) kinases with known binding partners and verified a predicted interaction of the SldA(Bub1/R1) spindle assembly checkpoint kinase with SldB(Bub3). We demonstrate that the single TOR kinase of A. nidulans locates to vacuoles and vesicles, suggesting that the function of endomembranes as major TOR cellular hubs is conserved in filamentous fungi. Comparative analysis revealed 7 kinases with mitotic specific locations including An-Cdc7 which unexpectedly located to mitotic spindle pole bodies (SPBs), the first such localization described for this family of DNA replication kinases. We show that the SepH septation kinase locates to SPBs specifically in the basal region of apical cells in a biphasic manner during mitosis and again during septation. This results in gradients of SepH between G1 SPBs which shift along hyphae as each septum forms. We propose that SepH regulates the septation initiation network (SIN) specifically at SPBs in the basal region of G1 cells and that localized gradients of SIN activity promote asymmetric septation.	[De Souza, Colin P.; Hashmi, Shahr B.; Osmani, Aysha H.; Osmani, Stephen A.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	Ohio State University	Osmani, SA (corresponding author), Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA.	osmani.2@osu.edu	Osmani, Stephen A./AAS-3904-2021		NIH [P01 GM068087-08S1, GM042564]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068087, R01GM042564] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants P01 GM068087-08S1 and GM042564 from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenza JF, 2012, MOL BIOL CELL, V23, P1889, DOI 10.1091/mbc.E11-11-0925; Abenza JF, 2009, TRAFFIC, V10, P57, DOI 10.1111/j.1600-0854.2008.00848.x; Agromayor M, 2013, TRENDS CELL BIOL, V23, P433, DOI 10.1016/j.tcb.2013.04.006; Anaya P, 1998, GENE, V211, P323, DOI 10.1016/S0378-1119(98)00115-2; Andersen MR, 2008, P NATL ACAD SCI USA, V105, P4387, DOI 10.1073/pnas.0709964105; Apostolaki A, 2012, MOL MICROBIOL, V84, P530, DOI 10.1111/j.1365-2958.2012.08042.x; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Arnaud MB, 2010, NUCLEIC ACIDS RES, V38, pD420, DOI 10.1093/nar/gkp751; Arratia-Quijada J, 2012, EUKARYOT CELL, V11, P1132, DOI 10.1128/EC.00101-12; Bachewich C, 2005, MOL MICROBIOL, V55, P572, DOI 10.1111/j.1365-2958.2004.04404.x; Bailis JM, 2003, NAT CELL BIOL, V5, P1111, DOI 10.1038/ncb1069; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Borkovich KA, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P1; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Bruno KS, 2001, MOL MICROBIOL, V42, P3, DOI 10.1046/j.1365-2958.2001.02605.x; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; CLUTTERBUCK AJ, 1970, J GEN MICROBIOL, V60, P133, DOI 10.1099/00221287-60-1-133; De Souza CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058008; De Souza CP, 2011, EMBO J, V30, P2648, DOI 10.1038/emboj.2011.176; De Souza CP, 2009, MOL BIOL CELL, V20, P2146, DOI 10.1091/mbc.E08-08-0878; De Souza CPC, 2004, CURR BIOL, V14, P1973, DOI 10.1016/j.cub.2004.10.050; De Souza CPC, 1999, MOL BIOL CELL, V10, P3661, DOI 10.1091/mbc.10.11.3661; Efimov VP, 1998, GENETICS, V149, P101; Egan MJ, 2012, J CELL BIOL; Feoktistova A, 2012, MOL BIOL CELL; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Garcia-Cortes JC, 2009, J CELL BIOL, V186, P739, DOI 10.1083/jcb.200902116; Goldman G. H., 2008, ASPERGILLI GENOMICS; Goya A, 2011, CYTOSKELETON, V68, P69, DOI 10.1002/cm.20500; Grallert A, 2004, GENE DEV, V18, P1007, DOI 10.1101/gad.296204; Grallert A, 2012, NAT CELL BIOL, V14, P738, DOI 10.1038/ncb2514; Greer YE, 2011, CELL CYCLE, V10, P2605, DOI 10.4161/cc.10.16.16386; Guertin DA, 2000, EMBO J, V19, P1803, DOI 10.1093/emboj/19.8.1803; HARRIS SD, 1994, GENETICS, V136, P517; Harris SD, 2001, CURR OPIN MICROBIOL, V4, P736, DOI 10.1016/S1369-5274(01)00276-4; Hemerly AS, 2009, SCIENCE, V323, P789, DOI 10.1126/science.1166745; Hernandez-Rodriguez Y, 2012, EUKARYOT CELL, V11, P311, DOI 10.1128/EC.05164-11; Hofmann AF, 2000, GENETICS, V154, P1577; Horio T, 2005, MOL BIOL CELL, V16, P918, DOI 10.1091/mbc.E04-09-0798; Hossain M, 2012, GENE DEV, V26, P1797, DOI 10.1101/gad.197178.112; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; James SW, 1999, J CELL SCI, V112, P1313; Johns SA, 2006, MOL GENET GENOMICS, V275, P593, DOI 10.1007/S00438-006-0113-0; Johnson AE, 2013, CURR BIOL, V23, P1920, DOI 10.1016/j.cub.2013.07.077; Johnson AE, 2012, CYTOSKELETON, V69, P686, DOI 10.1002/cm.21044; Judelson HS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-700; Kafadar KA, 2003, GENE DEV, V17, P2698, DOI 10.1101/gad.1140603; KIM JS, 1993, PROTEIN SCI, V2, P348; Kim JM, 2006, GENETICS, V173, P685, DOI 10.1534/genetics.105.054304; Kim JM, 2009, MOL BIOL CELL, V20, P2874, DOI 10.1091/mbc.E08-12-1177; Kimata Y, 2011, CURR OPIN CELL BIOL, V23, P135, DOI 10.1016/j.ceb.2010.10.008; Knockleby JW, 2010, CELL CYCLE, V9, P4487, DOI 10.4161/cc.9.22.14047; Konzack S, 2005, MOL BIOL CELL, V16, P497, DOI 10.1091/mbc.E04-02-0083; KORNSTEIN LB, 1992, GENE, V113, P75, DOI 10.1016/0378-1119(92)90671-B; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lara-Rojas F, 2011, MOL MICROBIOL, V80, P436, DOI 10.1111/j.1365-2958.2011.07581.x; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Liu HL, 2010, EUKARYOT CELL, V9, P831, DOI 10.1128/EC.00032-10; Liu HL, 2009, MOL BIOL CELL, V20, P616, DOI 10.1091/mbc.E08-06-0628; Liu XD, 2012, ANNU REV BIOCHEM, V81, P561, DOI 10.1146/annurev-biochem-061611-090435; Lusk CP, 2007, TRAFFIC, V8, P647, DOI 10.1111/j.1600-0854.2007.00559.x; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Markina-Inarrairaegui A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067154; Martin-Castellanos C, 2000, MOL BIOL CELL, V11, P543, DOI 10.1091/mbc.11.2.543; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Miller CT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000498; Montembault E, 2007, J CELL BIOL, V179, P601, DOI 10.1083/jcb.200703133; Morozov IY, 2010, MOL MICROBIOL, V76, P503, DOI 10.1111/j.1365-2958.2010.07118.x; MORRIS NR, 1975, GENET RES, V26, P237, DOI 10.1017/S0016672300016049; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Natsume T, 2013, MOL CELL, V50, P661, DOI 10.1016/j.molcel.2013.05.011; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Nayak T, 2010, J CELL BIOL, V190, P317, DOI 10.1083/jcb.201002105; OSMANI AH, 1994, J CELL SCI, V107, P1519; Osmani AH, 2006, MOL BIOL CELL, V17, P4946, DOI 10.1091/mbc.E06-07-0657; OSMANI SA, 1988, CELL, V53, P237, DOI 10.1016/0092-8674(88)90385-6; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; Ovechkina Y, 2003, MOL BIOL CELL, V14, P2192, DOI 10.1091/mbc.e02-10-0641; Park G, 2011, EUKARYOT CELL, V10, P1553, DOI 10.1128/EC.05140-11; Pei Y, 2006, MOL CELL BIOL, V26, P777, DOI 10.1128/MCB.26.3.777-788.2006; Penalva Miguel A, 2012, Cell Logist, V2, P2; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Reyes-Dominguez Y, 2010, MOL MICROBIOL, V76, P1376, DOI 10.1111/j.1365-2958.2010.07051.x; RICHARDS FREDERIC M., 1955, COMPT REND TRAV LAB CARLSBERG SER CHIM, V29, P322; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Seiler S, 2010, MOL MICROBIOL, V78, P1058, DOI 10.1111/j.1365-2958.2010.07392.x; Shen KF, 2013, MOL BIOL CELL, V24, P3842, DOI 10.1091/mbc.E13-07-0422; Shi J, 2008, FUNGAL GENET BIOL, V45, P1570, DOI 10.1016/j.fgb.2008.08.011; Si HY, 2010, GENETICS, V185, P166, DOI 10.1534/genetics.110.114165; Sibthorp C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-847; Sohrmann M, 1998, GENE DEV, V12, P84, DOI 10.1101/gad.12.1.84; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Sturgill TW, 2008, EUKARYOT CELL, V7, P1819, DOI 10.1128/EC.00088-08; Suelmann R, 1997, MOL MICROBIOL, V25, P757, DOI 10.1046/j.1365-2958.1997.5131873.x; Suijkerbuijk SJE, 2012, DEV CELL, V22, P1321, DOI 10.1016/j.devcel.2012.03.009; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Taheri-Talesh N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031218; Takahashi TS, 2008, GENE DEV, V22, P1894, DOI 10.1101/gad.1683308; Takeshita N, 2007, FUNGAL GENET BIOL, V44, P1205, DOI 10.1016/j.fgb.2007.03.006; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Ukil L, 2008, EUKARYOT CELL, V7, P2087, DOI 10.1128/EC.00278-08; Valbuena N, 2012, J CELL SCI, V125, P1920, DOI 10.1242/jcs.094219; van der Waal MS, 2012, EXP CELL RES, V318, P1407, DOI 10.1016/j.yexcr.2012.03.015; Vanrobays E, 2001, EMBO J, V20, P4204, DOI 10.1093/emboj/20.15.4204; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Wakabayashi M, 2010, FUNGAL GENET BIOL, V47, P809, DOI 10.1016/j.fgb.2010.05.010; Wang CF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002460; Wang XS, 2001, J BIOL CHEM, V276, P26559, DOI 10.1074/jbc.M101083200; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Westfall PJ, 2002, MOL BIOL CELL, V13, P110, DOI 10.1091/mbc.01-06-0312; Wong KH, 2008, FUNGAL GENET BIOL, V45, P728, DOI 10.1016/j.fgb.2007.12.009; Wu L, 1998, J CELL BIOL, V141, P1575, DOI 10.1083/jcb.141.7.1575; Xiong Y, 2009, J CELL SCI; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004; YE XS, 1995, EMBO J, V14, P986, DOI 10.1002/j.1460-2075.1995.tb07079.x; Ye XS, 1997, J BIOL CHEM, V272, P33384, DOI 10.1074/jbc.272.52.33384; Zhang J, 2011, J CELL BIOL, V193, P1245, DOI 10.1083/jcb.201011022; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zyss D, 2011, J CELL BIOL, V195, P781, DOI 10.1083/jcb.201106025	131	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90911	10.1371/journal.pone.0090911	http://dx.doi.org/10.1371/journal.pone.0090911			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599037	Green Submitted, Green Published, gold			2022-12-27	WOS:000332479400143
J	Shiffman, S; Dunbar, MS; Li, XX; Scholl, SM; Tindle, HA; Anderson, SJ; Ferguson, SG				Shiffman, Saul; Dunbar, Michael S.; Li, Xiaoxue; Scholl, Sarah M.; Tindle, Hilary A.; Anderson, Stewart J.; Ferguson, Stuart G.			Smoking Patterns and Stimulus Control in Intermittent and Daily Smokers	PLOS ONE			English	Article							ECOLOGICAL MOMENTARY ASSESSMENT; SOCIAL SMOKING; NICOTINE DEPENDENCE; CIGARETTE-SMOKING; CUE-REACTIVITY; IMMEDIATE ANTECEDENTS; TOBACCO DEPENDENCE; LIGHT; INTERVENTION; CONSUMPTION	Intermittent smokers (ITS) - who smoke less than daily - comprise an increasing proportion of adult smokers. Their smoking patterns challenge theoretical models of smoking motivation, which emphasize regular and frequent smoking to maintain nicotine levels and avoid withdrawal, but yet have gone largely unexamined. We characterized smoking patterns among 212 ITS (smoking 4-27 days per month) compared to 194 daily smokers (DS; smoking 5-30 cigarettes daily) who monitored situational antecedents of smoking using ecological momentary assessment. Subjects recorded each cigarette on an electronic diary, and situational variables were assessed in a random subset (n = 21,539 smoking episodes); parallel assessments were obtained by beeping subjects at random when they were not smoking (n = 26,930 non-smoking occasions). Compared to DS, ITS' smoking was more strongly associated with being away from home, being in a bar, drinking alcohol, socializing, being with friends and acquaintances, and when others were smoking. Mood had only modest effects in either group. DS' and ITS' smoking were substantially and equally suppressed by smoking restrictions, although ITS more often cited self-imposed restrictions. ITS' smoking was consistently more associated with environmental cues and contexts, especially those associated with positive or "indulgent'' smoking situations. Stimulus control may be an important influence in maintaining smoking and making quitting difficult among ITS.	[Shiffman, Saul; Dunbar, Michael S.; Scholl, Sarah M.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Li, Xiaoxue; Anderson, Stewart J.] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15260 USA; [Tindle, Hilary A.] Univ Pittsburgh, Div Gen Internal Med, Pittsburgh, PA 15260 USA; [Ferguson, Stuart G.] Univ Tasmania, Sch Med, Hobart, Tas, Australia	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Tasmania	Shiffman, S (corresponding author), Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA.	shiffman@pitt.edu	Shiffman, Saul/K-7337-2012; Ferguson, Stuart G/H-8006-2013	Ferguson, Stuart G/0000-0001-7378-3497; Anderson, Stewart/0000-0001-8948-0650	National Institutes of Health, National Institute on Drug Abuse [R01-DA020742]; National Science Foundation Graduate Research Fellowship; National Center for Research Resources [KL2-RR024154-03]; National Cancer Institute [R25-CA057703-15, R01-CA141596-02]; Cancer Council Tasmania; NATIONAL CANCER INSTITUTE [R25CA057703, R01CA141596] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020742] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Council Tasmania(Cancer Council Tasmania); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grant R01-DA020742 (Shiffman) from the National Institutes of Health, National Institute on Drug Abuse. Additional support was provided by National Science Foundation Graduate Research Fellowship (Dunbar), National Center for Research Resources (KL2-RR024154-03; Tindle), and National Cancer Institute grants R25-CA057703-15 (Dunbar) and R01-CA141596-02 (Tindle), and Cancer Council Tasmania (Ferguson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Delaimy WK, 2007, TOB CONTROL, V16, P91, DOI 10.1136/tc.2006.017061; [Anonymous], 1992, TOB CONTROL; BAKER TB, 1987, NEBR SYM MOTIV, V34, P257; Benowitz NL, 2008, CLIN PHARMACOL THER, V83, P531, DOI 10.1038/clpt.2008.3; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; Brody AL, 2006, J PSYCHIATR RES, V40, P404, DOI 10.1016/j.jpsychires.2005.04.012; Cabriales JA, 2012, EXP CLIN PSYCHOPHARM, V20, P410, DOI 10.1037/a0029039; Caggiula AR, 2009, NEBR SYM MOTIV, V55, P91, DOI 10.1007/978-0-387-78748-0_6; Callinan JE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub2; Carpenter MJ, 2014, NICOTINE TOB RES, V16, P208, DOI 10.1093/ntr/ntt147; Carter BL, 1999, ADDICTION, V94, P327, DOI 10.1046/j.1360-0443.1999.9433273.x; Centers for Disease Control and Prevention, 2008, BEH RISK FACT SURV S; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P303; Collins RL, 1998, EXP CLIN PSYCHOPHARM, V6, P306, DOI 10.1037/1064-1297.6.3.306; Conklin CA, 2008, EXP CLIN PSYCHOPHARM, V16, P207, DOI 10.1037/1064-1297.16.3.207; Cooper TV, 2010, NICOTINE TOB RES, V12, P465, DOI 10.1093/ntr/ntq025; Cronk NJ, 2010, NICOTINE TOB RES, V12, P997, DOI 10.1093/ntr/ntq136; DiFranza JR, 2007, ARCH PEDIAT ADOL MED, V161, P704, DOI 10.1001/archpedi.161.7.704; Drobes DJ, 1997, J ABNORM PSYCHOL, V106, P15, DOI 10.1037/0021-843X.106.1.15; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; FRITH CD, 1971, BRIT J SOC CLIN PSYC, V10, P73, DOI 10.1111/j.2044-8260.1971.tb00714.x; Hassmiller KM, 2003, AM J PUBLIC HEALTH, V93, P1321, DOI 10.2105/AJPH.93.8.1321; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hufford MR, 2002, PSYCHOL ADDICT BEHAV, V16, P205, DOI 10.1037//0893-164X.16.3.205; IKARD FF, 1969, INT J ADDICT, V4, P649, DOI 10.3109/10826086909062040; Kassel JD, 2003, PSYCHOL BULL, V129, P270, DOI 10.1037/0033-2909.129.2.270; KOZLOWSKI LT, 1984, J APPL SOC PSYCHOL, V14, P244, DOI 10.1111/j.1559-1816.1984.tb02234.x; Levinson AH, 2007, NICOTINE TOB RES, V9, P845, DOI 10.1080/14622200701484987; Lewinsohn P M, 2000, Nicotine Tob Res, V2, P121, DOI 10.1080/713688129; McClernon FJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1940, DOI 10.1038/sj.npp.1300780; McFall RM, 1977, BEHAV SELF MANAGEMEN, P196; MCKENNEL.AC, 1970, BRIT J SOC CLIN PSYC, V9, P8, DOI 10.1111/j.2044-8260.1970.tb00632.x; Mermelstein R, 2007, SCI REAL TIME DATA C, P117; Moran S, 2004, PEDIATRICS, V114, P1028, DOI 10.1542/peds.2003-0558-L; National Institutes of Health (U.S.) National Cancer Institute (U.S.), 2003, THOS WHO CONT SMOK I, pxiv; Owen N, 1997, Tob Control, V6, P131; Parrott AC, 1998, ADDICTION, V93, P27, DOI 10.1046/j.1360-0443.1998.931274.x; Paty JA, 1992, EXPERIENCE PSYCHOPAT; PAYNE TJ, 1991, ADDICT BEHAV, V16, P467, DOI 10.1016/0306-4603(91)90054-L; Rock V. J., 2007, Morbidity and Mortality Weekly Report, V56, P1157; RUSSELL MAH, 1974, J ROY STAT SOC A STA, V137, P313, DOI 10.2307/2344953; RUSSELL MAH, 1971, BRIT J MED PSYCHOL, V44, P1, DOI 10.1111/j.2044-8341.1971.tb02141.x; Sayette MA, 2001, ADDICTION, V96, P1419, DOI 10.1046/j.1360-0443.2001.961014196.x; Schane RE, 2009, ARCH INTERN MED, V169, P1742, DOI 10.1001/archinternmed.2009.315; Schane RE, 2009, AM J PREV MED, V37, P124, DOI 10.1016/j.amepre.2009.03.020; Shiffman S, 1994, J Subst Abuse, V6, P21, DOI 10.1016/S0899-3289(94)90052-3; SHIFFMAN S, 1993, J CONSULT CLIN PSYCH, V61, P732, DOI 10.1037/0022-006X.61.5.732; SHIFFMAN S, 1989, PSYCHOPHARMACOLOGY, V97, P539, DOI 10.1007/BF00439561; Shiffman S, 2004, J ABNORM PSYCHOL, V113, P166, DOI 10.1037/0021-843X.113.1.166; Shiffman S, 2002, J ABNORM PSYCHOL, V111, P531, DOI 10.1037/0021-843X.111.4.531; SHIFFMAN S, 1988, ADDICT BEHAV, V13, P201, DOI 10.1016/0306-4603(88)90013-5; Shiffman S, 2007, DRUG ALCOHOL DEPEN, V91, P159, DOI 10.1016/j.drugalcdep.2007.05.017; Shiffman S, 2006, J ABNORM PSYCHOL, V115, P509, DOI 10.1037/0021-843X.115.3.509; Shiffman S, 2013, PSYCHOPHARMACOLOGY, V226, P321, DOI 10.1007/s00213-012-2909-4; Shiffman S, 2013, J ABNORM PSYCHOL, V122, P264, DOI 10.1037/a0028339; Shiffman S, 2012, DRUG ALCOHOL DEPEN, V126, P362, DOI 10.1016/j.drugalcdep.2012.05.037; Shiffman S, 2012, NICOTINE TOB RES, V14, P1372, DOI 10.1093/ntr/nts097; Shiffman S, 2012, EXP CLIN PSYCHOPHARM, V20, P264, DOI 10.1037/a0027546; Shiffman S, 2011, PSYCHOL ADDICT BEHAV, V25, P501, DOI 10.1037/a0022178; Shiffman S, 2009, PSYCHOL ASSESSMENT, V21, P486, DOI 10.1037/a0017074; Shiffman S, 2009, HEALTH PSYCHOL, V28, P519, DOI 10.1037/a0015197; Shiffman S, 2009, NICOTINE TOB RES, V11, P122, DOI 10.1093/ntr/ntn020; Shiffman S, 2009, ADDICT BEHAV, V34, P514, DOI 10.1016/j.addbeh.2009.01.004; Shmueli D, 2010, AM J PREV MED, V38, P351, DOI 10.1016/j.amepre.2009.12.025; Smolka MN, 2006, PSYCHOPHARMACOLOGY, V184, P577, DOI 10.1007/s00213-005-0080-x; Song AV, 2011, AM J PUBLIC HEALTH, V101, P1291, DOI 10.2105/AJPH.2010.300012; Song AV, 2008, AM J PREV MED, V34, P86; STOLERMAN IP, 1995, PSYCHOPHARMACOLOGY, V117, P2, DOI 10.1007/BF02245088; Stone Arthur S., 1994, Annals of Behavioral Medicine, V16, P199; Substance Abuse and Mental Health Services Administration, 2009, NSDUH SER H, VH-36; Tate J C, 1991, J Subst Abuse, V3, P441; Thorne S. L., 2008, Morbidity and Mortality Weekly Report, V57, P1221; Tindle Hilary A, 2011, Am J Public Health, V101, pe1, DOI 10.2105/AJPH.2011.300186; Upadhyaya HP, 2004, ADDICT BEHAV, V29, P849, DOI 10.1016/j.addbeh.2004.02.040; Wagner DD, 2011, J NEUROSCI, V31, P894, DOI 10.1523/JNEUROSCI.5174-10.2011; Wortley PM, 2003, NICOTINE TOB RES, V5, P755, DOI 10.1080/1462220031000158753; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	77	83	84	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89911	10.1371/journal.pone.0089911	http://dx.doi.org/10.1371/journal.pone.0089911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24599056	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400033
J	Siekmans, K; Receveur, O; Haddad, S				Siekmans, Kendra; Receveur, Olivier; Haddad, Slim			Can an Integrated Approach Reduce Child Vulnerability to Anaemia? Evidence from Three African Countries	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; HEMOGLOBIN CONCENTRATION; NUTRITIONAL-STATUS; YOUNG-CHILDREN; RISK-FACTORS; MALARIA; IRON; SUPPLEMENTATION; HEALTH; PREVALENCE	Addressing the complex, multi-factorial causes of childhood anaemia is best done through integrated packages of interventions. We hypothesized that due to reduced child vulnerability, a "buffering" of risk associated with known causes of anaemia would be observed among children living in areas benefiting from a community-based health and nutrition program intervention. Cross-sectional data on the nutrition and health status of children 24-59 mo (N = 2405) were obtained in 2000 and 2004 from program evaluation surveys in Ghana, Malawi and Tanzania. Linear regression models estimated the association between haemoglobin and immediate, underlying and basic causes of child anaemia and variation in this association between years. Lower haemoglobin levels were observed in children assessed in 2000 compared to 2004 (difference -3.30 g/L), children from Tanzania (-9.15 g/L) and Malawi (-2.96 g/L) compared to Ghana, and the youngest (24-35 mo) compared to oldest age group (48-59 mo; -5.43 g/L). Children who were stunted, malaria positive and recently ill also had lower haemoglobin, independent of age, sex and other underlying and basic causes of anaemia. Despite ongoing morbidity, risk of lower haemoglobin decreased for children with malaria and recent illness, suggesting decreased vulnerability to their anaemia-producing effects. Stunting remained an independent and unbuffered risk factor. Reducing chronic undernutrition is required in order to further reduce child vulnerability and ensure maximum impact of anaemia control programs. Buffering the impact of child morbidity on haemoglobin levels, including malaria, may be achieved in certain settings.	[Siekmans, Kendra] HealthBridge, Ottawa, ON, Canada; [Receveur, Olivier] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Haddad, Slim] Univ Montreal, Univ Montreal Hosp Res Ctr CRCHUM, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Siekmans, K (corresponding author), HealthBridge, Ottawa, ON, Canada.	ksiekmans@healthbridge.ca		Siekmans, Kendra/0000-0002-3116-2278	Canadian International Development Agency; World Vision Canada	Canadian International Development Agency; World Vision Canada	The MICAH program was funded by the Canadian International Development Agency and World Vision Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agho KE, 2008, J HEALTH POPUL NUTR, V26, P200; Barros FC, 2010, REV SAUDE PUBL, V44, P1, DOI 10.1590/S0034-89102010000100001; Bates I, 2004, LANCET INFECT DIS, V4, P267, DOI 10.1016/S1473-3099(04)01002-3; Bates L, 2004, LANCET INFECT DIS, V4, P368, DOI 10.1016/S1473-3099(04)01047-3; Berti PR, 2010, INT J EPIDEMIOL, V39, P613, DOI 10.1093/ije/dyp389; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Brooker S, 1999, T ROY SOC TROP MED H, V93, P240, DOI 10.1016/S0035-9203(99)90007-X; Cercamondi CI, 2010, AM J CLIN NUTR, V92, P1385, DOI 10.3945/ajcn.2010.30051; CHAMBERS R, 1989, IDS BULL-I DEV STUD, V20, P1, DOI 10.1111/j.1759-5436.1989.mp20002001.x; Cornet M, 1998, AM J TROP MED HYG, V58, P606, DOI 10.4269/ajtmh.1998.58.606; Custodio E, 2008, FOOD NUTR BULL, V29, P49, DOI 10.1177/156482650802900106; Delacollette C, 1996, B WORLD HEALTH ORGAN, V74, P423; Desai MR, 2005, AM J TROP MED HYG, V72, P47, DOI 10.4269/ajtmh.2005.72.47; Dewey KG, 2009, FOOD NUTR BULL, V30, pS187, DOI 10.1177/15648265090302S201; Drakeley CJ, 2005, J INFECT DIS, V191, P1589, DOI 10.1086/429669; Ekvall H, 2003, CURR OPIN HEMATOL, V10, P108, DOI 10.1097/00062752-200303000-00002; Eliades MJ, 2006, AM J TROP MED HYG, V75, P622, DOI 10.4269/ajtmh.2006.75.622; Ezeamama AE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000245; Foote EM, 2013, AM J TROP MED HYG, V88, P757, DOI 10.4269/ajtmh.12-0560; Friedman JF, 2005, AM J TROP MED HYG, V73, P698, DOI 10.4269/ajtmh.2005.73.698; Galea S, 2005, SOC SCI MED, V60, P2417, DOI 10.1016/j.socscimed.2004.11.028; Green HK, 2011, PARASITOLOGY, V138, P1534, DOI 10.1017/S0031182011001016; Haldar Kasturi, 2009, Hematology Am Soc Hematol Educ Program, P87, DOI 10.1182/asheducation-2009.1.87; Holtz TH, 2003, T ROY SOC TROP MED H, V97, P491, DOI 10.1016/S0035-9203(03)80003-2; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0; Magalhaes RJS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000438; Mason J, 2013, LANCET GLOB HEALTH, V1, pE4, DOI 10.1016/S2214-109X(13)70009-3; McElroy PD, 1999, AM J TROP MED HYG, V61, P932, DOI 10.4269/ajtmh.1999.61.932; Nestel P., 2002, ADJUSTING HEMOGLOBIN; Ngnie-Teta I, 2007, FOOD NUTR BULL, V28, P76, DOI 10.1177/156482650702800109; Onis M. de, 2006, Acta Paediatrica, V95, P76; Osorio MM, 2004, BRIT J NUTR, V91, P307, DOI 10.1079/BJN20031042; Payne LG, 2007, J NUTR, V137, P1455, DOI 10.1093/jn/137.6.1455; Pedro M. R. A., 2004, Food and Nutrition Bulletin, V25, P319; Ratledge C, 2007, FOOD NUTR BULL, V28, pS515, DOI 10.1177/15648265070284S405; Ronald LA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-105; Ruel MT, 2008, LANCET, V371, P588, DOI 10.1016/S0140-6736(08)60271-8; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Schellenberg D, 2003, B WORLD HEALTH ORGAN, V81, P581; Shrimpton R, 2009, FOOD NUTR BULL, V30, pS556, DOI 10.1177/15648265090304S410; Sirima SB, 2003, TROP MED INT HEALTH, V8, P133, DOI 10.1046/j.1365-3156.2003.00997.x; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Stoltzfus RJ, 2007, FOOD NUTR BULL, V28, pS572, DOI 10.1177/15648265070284S410; Stoltzfus RJ, 2000, J NUTR, V130, P1724, DOI 10.1093/jn/130.7.1724; Thurnham DI, 2007, NUTR ANEMIA; UNICEF, 1995, MON PROGR GOALS WORL; UNICEF, 1990, STRAT IMPR NUTR CHIL; World Vision Canada, 2006, WORLD VIS TANZ MICAH; World Vision Canada, 2006, WORLD VIS MAL MICAH; World Vision Canada, 2006, WORLD VIS GHAN MICAH	51	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90108	10.1371/journal.pone.0090108	http://dx.doi.org/10.1371/journal.pone.0090108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598692	Green Published, gold			2022-12-27	WOS:000332479400045
J	Wang, JM; Zhang, T; Du, J; Cui, S; Yang, F; Jin, Q				Wang, Jianmin; Zhang, Ting; Du, Jiang; Cui, Sheng; Yang, Fan; Jin, Qi			Anti-Enterovirus 71 Effects of Chrysin and Its Phosphate Ester	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; ALDOSE REDUCTASE; MOUTH-DISEASE; IN-VITRO; MOLECULAR EPIDEMIOLOGY; ANTIVIRAL ACTIVITY; WESTERN-AUSTRALIA; PROTEIN; VIRUS; INHIBITION	Enterovirus 71 (EV71) can cause severe disease and even lead to death in children, and an effective antiviral drug is currently unavailable. The anti-EV71 effect of chrysin (5,7-dihydroxyflavone), a natural flavonoid commonly found in many plants, was tested in this report. By using the predicting program Autodock 4.0 and an in vitro protease inhibition assay, we found that chrysin could suppress viral 3C(pro) activity. Replication of viral RNA and production of viral capsid protein and the infectious virion were strongly inhibited by chrysin, without noticeable cytotoxicity. Cytopathic effects on cells were also prevented. Diisopropyl chrysin-7-yl phosphate (CPI), the phosphate ester for chrysin, was generated through a simplified Atheron-Todd reaction to achieve stronger anti-viral activity. CPI was also able to bind with and inhibit viral 3C(pro) activity in vitro. As expected, CPI demonstrated more potent antiviral activity against EV71.	[Yang, Fan] Chinese Acad Med Sci, Inst Pathogen Biol, Key Lab Syst Biol Pathogens, MOH, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, F (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, Key Lab Syst Biol Pathogens, MOH, Beijing 100730, Peoples R China.	ymf129@163.com; zdsys@vip.sina.com	wang, jian/GVS-0711-2022; Zhang, Ting/S-8215-2019; Sheng, CUI/M-6405-2013; Cui, Sheng/AAQ-1721-2020	Sheng, CUI/0000-0001-6329-3582; 	National Science and Technology Major Project of China [2013ZX10004-601, 2011ZX10004-001, 2013ZX10004-101]	National Science and Technology Major Project of China	The work was supported by the National Science and Technology Major Project of China, project No. 2013ZX10004-601, No. 2011ZX10004-001 and No. 2013ZX10004-101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chen Xiao-lan, 2007, Yaoxue Xuebao, V42, P396; Chen XL, 2004, ANAL CHEM, V76, P211, DOI 10.1021/ac035027q; Chu PY, 2001, ARCH VIROL, V146, P589, DOI 10.1007/s007050170164; Cui S, 2011, J MOL BIOL, V408, P449, DOI 10.1016/j.jmb.2011.03.007; Fernandez M, 2005, BIOORGAN MED CHEM, V13, P3269, DOI 10.1016/j.bmc.2005.02.038; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; HARRIS KS, 1992, J VIROL, V66, P7481, DOI 10.1128/JVI.66.12.7481-7489.1992; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; Hu YC, 2003, BIOTECHNOL LETT, V25, P919, DOI 10.1023/A:1024071514438; Hung HC, 2010, J ANTIMICROB CHEMOTH, V65, P676, DOI 10.1093/jac/dkp502; Hwang YC, 2006, APPL ENVIRON MICROB, V72, P3710, DOI 10.1128/AEM.72.5.3710-3715.2006; Johari J, 2012, INT J MOL SCI, V13, P16785, DOI 10.3390/ijms131216785; Jung HA, 2012, CHEM-BIOL INTERACT, V197, P110, DOI 10.1016/j.cbi.2012.04.004; Kuo CJ, 2008, BIOORGAN MED CHEM, V16, P7388, DOI 10.1016/j.bmc.2008.06.015; Lei XB, 2013, J VIROL, V87, P1690, DOI 10.1128/JVI.01855-12; Lei XB, 2011, J VIROL, V85, P8811, DOI 10.1128/JVI.00447-11; Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li ML, 2002, VIROLOGY, V293, P386, DOI 10.1006/viro.2001.1310; Li ZH, 2008, J INFECT DIS, V197, P854, DOI 10.1086/527326; Liao Hung-Tsai, 2001, Acta Paediatrica Taiwanica, V42, P27; Liu AL, 2008, BIOORGAN MED CHEM, V16, P7141, DOI 10.1016/j.bmc.2008.06.049; Lyu SY, 2005, ARCH PHARM RES, V28, P1293, DOI 10.1007/BF02978215; Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Mercader AG, 2008, BIOORGAN MED CHEM, V16, P7470, DOI 10.1016/j.bmc.2008.06.004; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Nolan MA, 2003, NEUROLOGY, V60, P1651, DOI 10.1212/01.WNL.0000066810.62490.FF; Parsley TB, 1997, RNA, V3, P1124; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Tan CW, 2013, J VIROL, V87, P611, DOI 10.1128/JVI.02226-12; Wang JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052954; Wang JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038035; Weng KF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000593; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560; Zhang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030259	44	41	46	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89668	10.1371/journal.pone.0089668	http://dx.doi.org/10.1371/journal.pone.0089668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598537	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400024
J	Chen, YJ; Wang, YH; Wang, CZ; Ho, ML; Kuo, PL; Huang, MH; Chen, CH				Chen, Yi-Jen; Wang, Yan-Hsiung; Wang, Chau-Zen; Ho, Mei-Ling; Kuo, Po-Lin; Huang, Mao-Hsiung; Chen, Chia-Hsin			Effect of Low Level Laser Therapy on Chronic Compression of the Dorsal Root Ganglion	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; RAT SCIATIC-NERVE; FACTOR-ALPHA; NUCLEUS PULPOSUS; SENSORY NEURONS; MESSENGER-RNA; 780 NM; HYPERALGESIA; IRRADIATION; ALLODYNIA	Dorsal root ganglia (DRG) are vulnerable to physical injury of the intervertebral foramen, and chronic compression of the DRG (CCD) an result in nerve root damage with persistent morbidity. The purpose of this study was to evaluate the effects of low level laser therapy (LLLT) on the DRG in a CCD model and to determine the mechanisms underlying these effects. CCD rats had L-shaped stainless-steel rods inserted into the fourth and fifth lumbar intervertebral foramen, and the rats were then subjected to 0 or 8 J/cm(2) LLLT for 8 consecutive days following CCD surgery. Pain and heat stimuli were applied to test for hyperalgesia following CCD. The levels of TNF-alpha, IL-1 beta and growth-associated protein-43 (GAP-43) messenger RNA (mRNA) expression were measured via real-time PCR, and protein expression levels were analyzed through immunohistochemical analyses. Our data indicate that LLLT significantly decreased the tolerable sensitivity to pain and heat stimuli in the CCD groups. The expression levels of the pro-inflammatory cytokines TNF-alpha and IL-1 beta were increased following CCD, and we found that these increases could be reduced by the application of LLLT. Furthermore, the expression of GAP-43 was enhanced by LLLT. In conclusion, LLLT was able to enhance neural regeneration in rats following CCD and improve rat ambulatory behavior. The therapeutic effects of LLLT on the DRG during CCD may be exerted through suppression of the inflammatory response and induction of neuronal repair genes. These results suggest potential clinical applications for LLLT in the treatment of compression-induced neuronal disorders.	[Chen, Yi-Jen; Huang, Mao-Hsiung; Chen, Chia-Hsin] Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Yi-Jen; Kuo, Po-Lin] Kaohsiung Med Univ, Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Wang, Yan-Hsiung; Wang, Chau-Zen; Ho, Mei-Ling] Kaohsiung Med Univ, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Wang, Yan-Hsiung] Kaohsiung Med Univ, Sch Dent, Coll Dent Med, Kaohsiung, Taiwan; [Wang, Chau-Zen; Ho, Mei-Ling] Kaohsiung Med Univ, Dept Physiol, Coll Med, Kaohsiung, Taiwan; [Ho, Mei-Ling] Kaohsiung Med Univ, Grad Inst Med, Sch Med, Kaohsiung, Taiwan; [Kuo, Po-Lin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Huang, Mao-Hsiung] Kaohsiung Med Univ, Sch Med, Dept Phys Med & Rehabil, Fac Med, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Municipal Tatung Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital	Chen, CH (corresponding author), Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan.	chchen@kmu.edu.tw	Wang, Yan-Hsiung/ABD-4004-2020	Wang, Yan-Hsiung/0000-0001-8161-7472; Chen, Yi-Jen/0000-0002-5178-2335; Chen, Chia-Hsin/0000-0002-6557-9848; Ho, Mei-Ling/0000-0001-8064-8488	National Health Research Institutes [NHRI-EX 102-9914EC]; National Science Council [NSC97-2314-B-037-004-MY3]; Kaohsiung Medical University [KMU-Q098007, KMU-Q098025, KMU-Q099018]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University	This study was supported by a grant from the National Health Research Institutes (NHRI-EX 102-9914EC), a grant from the National Science Council (NSC97-2314-B-037-004-MY3) and grants from the Kaohsiung Medical University (KMU-Q098007, KMU-Q098025 and KMU-Q099018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa RI, 2010, LASER MED SCI, V25, P423, DOI 10.1007/s10103-009-0750-8; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chow RT, 2007, J PERIPHER NERV SYST, V12, P28, DOI 10.1111/j.1529-8027.2007.00114.x; Camara CND, 2011, ACTA CIR BRAS, V26, P12, DOI 10.1590/S0102-86502011000100004; Grava ALD, 2012, EUR SPINE J, V21, P537, DOI 10.1007/s00586-011-2027-8; Gigo-Benato D, 2005, MUSCLE NERVE, V31, P694, DOI 10.1002/mus.20305; Gigo-Benato D, 2010, LASER SURG MED, V42, P673, DOI 10.1002/lsm.20978; Gilchrist Russel V, 2002, Pain Physician, V5, P372; Gu XP, 2007, BRAIN RES, V1174, P39, DOI 10.1016/j.brainres.2007.08.030; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Ho ML, 2009, EUR J CLIN INVEST, V39, P296, DOI 10.1111/j.1365-2362.2009.02092.x; Hsieh YL, 2012, J COMP NEUROL, V520, P2903, DOI 10.1002/cne.23072; Hu SJ, 1998, PAIN, V77, P15, DOI 10.1016/S0304-3959(98)00067-0; Jimbo K, 1998, NEUROSCI LETT, V240, P93, DOI 10.1016/S0304-3940(97)00935-X; Liu B, 2002, J NEUROPHYSIOL, V88, P1393, DOI 10.1152/jn.2002.88.3.1393; Mohammed IFR, 2007, PHOTOMED LASER SURG, V25, P107, DOI 10.1089/pho.2006.1090; Ozaktay AC, 2002, EUR SPINE J, V11, P467, DOI 10.1007/s00586-002-0430-x; Rochkind S, 2007, PHOTOMED LASER SURG, V25, P436, DOI 10.1089/pho.2007.2093; Rothman SM, 2009, J PAIN, V10, P90, DOI 10.1016/j.jpain.2008.07.008; RYDEVIK BL, 1989, SPINE, V14, P574, DOI 10.1097/00007632-198906000-00004; Schaeffer V, 2010, PROG NEUROBIOL, V92, P33, DOI 10.1016/j.pneurobio.2010.04.009; Schafers M, 2003, J NEUROSCI, V23, P2517; Shin DH, 2003, NEUROSCI LETT, V344, P71, DOI 10.1016/S0304-3940(03)00354-9; Snyder SK, 2002, LASER SURG MED, V31, P216, DOI 10.1002/lsm.10098; Song XJ, 1999, J NEUROPHYSIOL, V82, P3347, DOI 10.1152/jn.1999.82.6.3347; VANDERZEE CEEM, 1989, J NEUROSCI, V9, P3505; Watanabe K, 2007, SPINE, V32, P1265, DOI 10.1097/BRS.0b013e318059aef8; Watanabe K, 2011, EUR SPINE J, V20, P1877, DOI 10.1007/s00586-011-1854-y; Wu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054067, 10.1371/journal.pone.0067644]; Yamashita M, 2008, SPINE, V33, P1836, DOI 10.1097/BRS.0b013e31817bab2a; Zhang JM, 2000, J NEUROPHYSIOL, V84, P798, DOI 10.1152/jn.2000.84.2.798	31	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89894	10.1371/journal.pone.0089894	http://dx.doi.org/10.1371/journal.pone.0089894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594641	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500027
J	Donati, V; Feltrin, F; Hendriksen, RS; Svendsen, CA; Cordaro, G; Garcia-Fernandez, A; Lorenzetti, S; Lorenzetti, R; Battisti, A; Franco, A				Donati, Valentina; Feltrin, Fabiola; Hendriksen, Rene S.; Svendsen, Christina Aaby; Cordaro, Gessica; Garcia-Fernandez, Aurora; Lorenzetti, Serena; Lorenzetti, Raniero; Battisti, Antonio; Franco, Alessia			Extended-Spectrum-Beta-Lactamases, AmpC Beta-Lactamases and Plasmid Mediated Quinolone Resistance in Klebsiella spp. from Companion Animals in Italy	PLOS ONE			English	Article							ESCHERICHIA-COLI; PNEUMONIAE CLONE; MULTIPLEX PCR; DETERMINANTS QNR; GENES; PREVALENCE; ENTEROBACTERIACEAE; AAC(6')-IB-CR; OUTBREAK; IDENTIFICATION	We report the genetic characterization of 15 Klebsiella pneumoniae (KP) and 4 isolates of K. oxytoca (KO) from clinical cases in dogs and cats and showing extended-spectrum cephalosporin (ESC) resistance. Extended spectrum beta-lactamase (ESBL) and AmpC genes, plasmid-mediated quinolone resistance (PMQR) and co-resistances were investigated. Among KP isolates, ST101 clone was predominant (8/15, 53%), followed by ST15 (4/15, 27%). ST11 and ST340, belonging to Clonal Complex (CC) 11, were detected in 2012 (3/15, 20%). MLST on KP isolates corresponded well with PFGE results, with 11 different PFGE patterns observed, including two clusters of two (ST340) and four (ST101) indistinguishable isolates, respectively. All isolates harbored at least one ESBL or AmpC gene, all carried on transferable plasmids (IncR, IncFII, IncI1, IncN), and 16/19 were positive for PMQR genes (qnr family or aac(6')-Ib-cr). The most frequent ESBL was CTX-M-15 (11/19, 58%), detected in all KP ST101, in one KP ST15 and in both KP ST340. bla(CTX-M-15) was carried on IncR plasmids in all but one KP isolate. All KP ST15 isolates harbored different ESC resistance genes and different plasmids, and presented the non-transferable bla(SHV-28) gene, in association with bla(CTX-M-15), bla(CTX-M-1) (on IncR, or on IncN), bla(SHV-2a) (on IncR) or bla(CMY-2) genes (on IncI1). KO isolates were positive for bla(CTX-M-9) gene (on IncHI2), or for the bla(SHV-12) and bla(DHA-1) genes (on IncL/M). They were all positive for qnr genes, and one also for the aac(6')-Ib-cr gene. All Klebsiella isolates showed multiresistance towards aminoglycosides, sulfonamides, tetracyclines, trimethoprim and amphenicols, mediated by strA/B, aadA2, aadB, ant (2")-Ia, aac(6')-Ib, sul, tet, dfr and cat genes in various combinations. The emergence in pets of multidrug-resistant Klebsiella with ESBL, AmpC and PMQR determinants, poses further and serious challenges in companion animal therapy and raise concerns for possible bidirectional transmission between pets and humans, especially at household level.	[Donati, Valentina; Feltrin, Fabiola; Cordaro, Gessica; Lorenzetti, Serena; Lorenzetti, Raniero; Battisti, Antonio; Franco, Alessia] Ist Zooprofilatt Sperimentale Regioni Lazio & Tos, Rome, Italy; [Hendriksen, Rene S.; Svendsen, Christina Aaby] Tech Univ Denmark, Natl Food Inst DTU Food, DK-2800 Lyngby, Denmark; [Garcia-Fernandez, Aurora] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy	Technical University of Denmark; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS)	Battisti, A (corresponding author), Ist Zooprofilatt Sperimentale Regioni Lazio & Tos, Rome, Italy.	antonio.battisti@izslt.it	García-Fernández, Aurora/K-2560-2016; Battisti, Antonio/AAQ-9243-2021	García-Fernández, Aurora/0000-0002-5070-6154; Battisti, Antonio/0000-0003-1308-199X; Aaby Svendsen, Christina/0000-0002-2532-6854; Franco, Alessia/0000-0001-6968-973X; Hendriksen, Rene S./0000-0003-2934-8214				ARLET G, 1995, FEMS MICROBIOL LETT, V134, P203, DOI 10.1111/j.1574-6968.1995.tb07938.x; Boccia D, 2005, Ann Ig, V17, P95; Briales A, 2012, INT J ANTIMICROB AG, V39, P431, DOI 10.1016/j.ijantimicag.2011.12.009; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Carter G., 2004, ESSENTIALS VET BACTE; Cattoir V, 2007, J ANTIMICROB CHEMOTH, V60, P394, DOI 10.1093/jac/dkm204; Cavaco LM, 2009, ANTIMICROB AGENTS CH, V53, P603, DOI 10.1128/AAC.00997-08; Cavaco LM, 2008, MICROB DRUG RESIST, V14, P163, DOI 10.1089/mdr.2008.0821; Chowdhury PR, 2011, ANTIMICROB AGENTS CH, V55, P3140, DOI 10.1128/AAC.01529-10; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; Coelho A, 2010, INT J ANTIMICROB AG, V36, P73, DOI 10.1016/j.ijantimicag.2010.03.005; D'Andrea MM, 2013, INT J MED MICROBIOL; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Durmaz R, 2009, JPN J INFECT DIS, V62, P372; Fontana C, 2005, J CLIN MICROBIOL, V43, P615, DOI 10.1128/JCM.43.2.615-619.2005; Fontana C, 2010, BMC RES NOTES, V23, P3; Frank T, 2007, J ANTIMICROB CHEMOTH, V59, P742, DOI 10.1093/jac/dkl538; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Garcia-Fernandez A, 2012, ANTIMICROB AGENTS CH, V56, P2143, DOI 10.1128/AAC.05308-11; Garcia-Fernandez A, 2010, ANTIMICROB AGENTS CH, V54, P4178, DOI 10.1128/AAC.01301-09; Haenni M, 2012, J ANTIMICROB CHEMOTH, V67, P770, DOI 10.1093/jac/dkr527; Hidalgo L, 2013, ANTIMICROB AGENTS CH, V57, P4532, DOI 10.1128/AAC.00491-13; Hujer AM, 2002, J CLIN MICROBIOL, V40, P1947, DOI 10.1128/JCM.40.6.1947-1957.2002; Jemima SA, 2009, INDIAN J MED MICROBI, V27, P51; Jonas D, 2004, RES MICROBIOL, V155, P17, DOI 10.1016/j.resmic.2003.09.011; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Lavilla S, 2008, J ANTIMICROB CHEMOTH, V61, P291, DOI 10.1093/jac/dkm448; Lavollay M, 2006, ANTIMICROB AGENTS CH, V50, P2433, DOI 10.1128/AAC.00150-06; Ma JY, 2009, ANTIMICROB AGENTS CH, V53, P519, DOI 10.1128/AAC.00886-08; Mammina C, 2012, EUROSURVEILLANCE, V17, P9; Mammina C, 2012, INT J ANTIMICROB AG, V39, P543, DOI 10.1016/j.ijantimicag.2012.02.012; Migliavacca R, 2013, NEW MICROBIOL, V36, P109; Miro E, 2010, J ANTIMICROB CHEMOTH, V65, P661, DOI 10.1093/jac/dkp504; Nielsen JB, 2011, EUR J CLIN MICROBIOL, V30, P773, DOI 10.1007/s10096-011-1153-x; Ode T, 2009, INT J ANTIMICROB AG, V34, P347, DOI 10.1016/j.ijantimicag.2009.05.007; Osterblad M, 2012, J ANTIMICROB CHEMOTH, V67, P2860, DOI 10.1093/jac/dks299; Park CH, 2006, ANTIMICROB AGENTS CH, V50, P3953, DOI 10.1128/AAC.00915-06; Paterson DL, 2003, ANTIMICROB AGENTS CH, V47, P3554, DOI 10.1128/AAC.47.11.3554-3560.2003; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Perichon B, 2007, ANTIMICROB AGENTS CH, V51, P2464, DOI 10.1128/AAC.00143-07; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Qi Y, 2011, J ANTIMICROB CHEMOTH, V66, P307, DOI 10.1093/jac/dkq431; Quinn P.J., 2004, CLIN VET MICROBIOLOG; Roberts DE, 2000, J VET DIAGN INVEST, V12, P168, DOI 10.1177/104063870001200215; Roh KH, 2008, YONSEI MED J, V49, P53, DOI 10.3349/ymj.2008.49.1.53; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Vo ATT, 2007, VET MICROBIOL, V124, P248, DOI 10.1016/j.vetmic.2007.04.027; Voulgari E, 2013, J ANTIMICROB CHEMOTH, V68, P84, DOI 10.1093/jac/dks356; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI 10.1093/jac/dki412; Yang JY, 2011, MICROB DRUG RESIST, V17, P363, DOI 10.1089/mdr.2011.0034; Yu VL, 2007, EMERG INFECT DIS, V13, P986, DOI 10.3201/eid1307.070187	54	67	68	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90564	10.1371/journal.pone.0090564	http://dx.doi.org/10.1371/journal.pone.0090564			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595207	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500068
J	Li, GC; Xie, RS; Zhu, XP; Mao, YL; Liu, SX; Jiao, HM; Yan, H; Xiong, K; Ji, MC				Li, Guocai; Xie, Rushan; Zhu, Xiaoping; Mao, Yanli; Liu, Shuangxi; Jiao, Hongmei; Yan, Hua; Xiong, Kun; Ji, Mingchun			Antibodies with Higher Bactericidal Activity Induced by a Neisseria gonorrhoeae Rmp Deletion Mutant Strain	PLOS ONE			English	Article							GONOCOCCAL PILUS VACCINE; OUTER-MEMBRANE PROTEIN; REPLICON PARTICLES; IMMUNE-RESPONSES; MICE; IMMUNIZATION; PEPTIDE; EPITOPE; TRANSMISSION; CULTIVATION	Neisseria gonorrhoeae (N. gonorrhoeae) outer membrane protein reduction modifiable protein (Rmp) has strong immunogenicity. However, anti-Rmp antibodies block rather than preserve the antibacterial effects of protective antibodies, which hampers the development of vaccines for gonococcal infections. We herein constructed an Rmp deletion mutant strain of N. gonorrhoeae by gene homologous recombination. The 261-460 nucleotide residues of Rmp gene amplified from N. gonorrhoeae WHO-A strain were replaced with a kanamycin-resistant Kan gene amplified from pET-28a. The resultant hybridized DNA was transformed into N. gonorrhoeae WHO-A strain. PCR was used to screen the colonies in which wild-type Rmp gene was replaced with a mutant gene fragment. Western blotting revealed that the Rmp deletion mutant strain did not express Rmp protein. Rmp deletion did not alter the morphological and Gram staining properties of the mutant strain that grew slightly more slowly than the wild-type one. Rmp gene mutated stably throughout 25 generations of passage. Antibody-mediated complement-dependent cytotoxicity assay indicated that the antibodies induced by the mutant strain had evidently higher bactericidal activities than those induced by the wild-type strain. Further modification of the Rmp deletion mutant strain is still required in the development of novel live attenuated vaccines for gonorrhea by Opa genes deletion or screening of phenotypic variant strains that do not express Opa proteins.	[Li, Guocai; Mao, Yanli; Liu, Shuangxi; Jiao, Hongmei; Yan, Hua; Ji, Mingchun] Yangzhou Univ, Sch Med, Dept Pathogen Biol & Immunol, Yangzhou, Jiangsu, Peoples R China; [Li, Guocai; Mao, Yanli; Liu, Shuangxi; Jiao, Hongmei] Yangzhou Univ, Jiangsu Key Lab Zoonosis, Yangzhou, Jiangsu, Peoples R China; [Xie, Rushan] Heze Med Coll, Dept Pathogen Biol, Heze, Shandong, Peoples R China; [Zhu, Xiaoping] Yangzhou Univ, Clin Testing Ctr, Coll Clin Med, Yangzhou, Jiangsu, Peoples R China; [Xiong, Kun] Cent S Univ, Dept Anatomyand Neurobiol, Sch Basic Med Sci, Changsha, Hunan, Peoples R China	Yangzhou University; Yangzhou University; Yangzhou University; Central South University	Li, GC (corresponding author), Yangzhou Univ, Sch Med, Dept Pathogen Biol & Immunol, Yangzhou, Jiangsu, Peoples R China.	gcli@yzu.edu.cn; xiongkun2001@163.com	Li, Guocai/HGC-9680-2022		National Natural Science Foundation of China [31100652]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (31100652). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barh Debmalya, 2009, In Silico Biology, V9, P225, DOI 10.3233/ISB-2009-0399; BOSLEGO JW, 1991, VACCINE, V9, P154, DOI 10.1016/0264-410X(91)90147-X; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; BROSSAY L, 1993, J IMMUNOL, V151, P234; CARTWRIGHT CP, 1994, J CLIN MICROBIOL, V32, P1825, DOI 10.1128/JCM.32.7.1825-1826.1994; Chen CC, 2011, J BACTERIOL, V193, P1788, DOI 10.1128/JB.00007-11; Chung GT, 2008, J BACTERIOL, V190, P6035, DOI 10.1128/JB.00566-08; Cole JG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008108; De Seta F, 2012, GIORN ITAL DERMAT V, V147, P423; del Rio Carlos, 2012, Morbidity and Mortality Weekly Report, V61, P590; Ding J, 2010, J IMMUNOL, V184, P2814, DOI 10.4049/jimmunol.0902125; GOTSCHLICH EC, 1986, J EXP MED, V164, P868, DOI 10.1084/jem.164.3.868; GOTSCHLICH EC, 1987, J EXP MED, V165, P471, DOI 10.1084/jem.165.2.471; Gulati S, 1996, J INFECT DIS, V174, P1238, DOI 10.1093/infdis/174.6.1238; Hansen JK, 2007, INFECT IMMUN, V75, P4138, DOI 10.1128/IAI.02015-06; Hauck CR, 2003, CURR OPIN MICROBIOL, V6, P43, DOI 10.1016/S1369-5274(03)00004-3; HECKELS JE, 1990, VACCINE, V8, P225, DOI 10.1016/0264-410X(90)90050-V; Javanbakht M., 2007, Morbidity and Mortality Weekly Report, V56, P222; JUDD RC, 1982, INFECT IMMUN, V37, P622, DOI 10.1128/IAI.37.2.622-631.1982; Klotman ME, 2008, J IMMUNOL, V180, P6176, DOI 10.4049/jimmunol.180.9.6176; Li GC, 2011, CLIN VACCINE IMMUNOL, V18, P1817, DOI 10.1128/CVI.05245-11; LYTTON EJ, 1986, J EXP MED, V164, P1749, DOI 10.1084/jem.164.5.1749; MCCHESNEY D, 1982, INFECT IMMUN, V36, P1006, DOI 10.1128/IAI.36.3.1006-1012.1982; MCDADE RL, 1980, J BACTERIOL, V141, P1183, DOI 10.1128/JB.141.3.1183-1191.1980; Ngampasutadol J, 2006, VACCINE, V24, P157, DOI 10.1016/j.vaccine.2005.07.065; Pantelic M, 2005, INFECT IMMUN, V73, P4171, DOI 10.1128/IAI.73.7.4171-4179.2005; Plante M, 1999, INFECT IMMUN, V67, P2855, DOI 10.1128/IAI.67.6.2855-2861.1999; Plante M, 2000, J INFECT DIS, V182, P848, DOI 10.1086/315801; PLUMMER FA, 1993, J CLIN INVEST, V91, P339, DOI 10.1172/JCI116190; Price GA, 2005, INFECT IMMUN, V73, P3945, DOI 10.1128/IAI.73.7.3945-3953.2005; RICE PA, 1986, J EXP MED, V164, P1735, DOI 10.1084/jem.164.5.1735; RICE PA, 1994, ANN NY ACAD SCI, V730, P7, DOI 10.1111/j.1749-6632.1994.tb44234.x; SIEGEL M, 1982, J INFECT DIS, V145, P300, DOI 10.1093/infdis/145.3.300; Takei M, 2005, J CLIN MICROBIOL, V43, P4321, DOI 10.1128/JCM.43.9.4321-4327.2005; Thomas CE, 2006, INFECT IMMUN, V74, P1612, DOI 10.1128/IAI.74.3.1612-1620.2006; TRAMONT EC, 1981, J CLIN INVEST, V68, P881, DOI 10.1172/JCI110343; Voges M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-117; WETZLER LM, 1989, J EXP MED, V169, P2199, DOI 10.1084/jem.169.6.2199; WHO, 2012, GLOB INC PREV SEL CU; WONG TP, 1981, INFECT IMMUN, V34, P739, DOI 10.1128/IAI.34.3.739-745.1981; Zhu W, 2004, VACCINE, V22, P660, DOI 10.1016/j.vaccine.2003.08.036; Zhu WY, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00124; Zhu WY, 2005, INFECT IMMUN, V73, P7558, DOI 10.1128/IAI.73.11.7558-7568.2005	43	3	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90525	10.1371/journal.pone.0090525	http://dx.doi.org/10.1371/journal.pone.0090525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594737	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500059
J	Ni, W; Lin, N; He, H; Zhu, JX; Zhang, YJ				Ni, Wensi; Lin, Ning; He, Hua; Zhu, Jianxing; Zhang, Yongjun			Lipopolysaccharide Induces Up-Regulation of TGF-alpha through HDAC2 in a Rat Model of Bronchopulmonary Dysplasia	PLOS ONE			English	Article							HISTONE DEACETYLASE ACTIVITY; LUNG INFLAMMATION; PULMONARY; HYPEROXIA; CYTOKINES; INTERLEUKIN-6; THEOPHYLLINE; EXPRESSION; BIRTH; EGF	Bronchopulmonary dysplasia (BPD) is characterized by alveolar simplification with decreased alveolar number and increased airspace. Previous studies suggested that transforming growth factor-alpha (TGF-alpha) may contribute to arrested alveolar development in BPD. Histone deacetylases (HDACs) control cellular signaling and gene expression. HDAC2 is crucial for suppression of inflammatory gene expression. Here we investigated whether HDAC2 was involved in the arrest of alveolarization, as well as the ability of HDAC2 to regulate TGF-alpha expression in a rat model of BPD induced by intra-amniotic injection of lipopolysaccharide (LPS). Results showed that LPS exposure led to a suppression of both HDAC1 and HDAC2 expression and activity, induced TGF-alpha expression, and disrupted alveolar morphology. Mechanistic studies showed that overexpression of HDAC2, but not HDAC1, suppressed LPS-induced TGF-alpha expression. Moreover, the HDAC inhibitor TSA or downregulation of HDAC2 by siRNA both significantly increased TGF-alpha expression in cultured myofibroblasts. Finally, preservation of HDAC activity by theophylline treatment improved alveolar development and attenuated TGF-alpha release. Together, these findings indicate that attenuation of TGF-alpha-mediated effects in the lung by enhancing HDAC2 may have a therapeutic effect on treating BPD.	[Ni, Wensi; Lin, Ning; He, Hua; Zhu, Jianxing; Zhang, Yongjun] Shanghai Jiao Tong Univ, Sch Med, XinHua Hosp, Shanghai 200030, Peoples R China; [Zhang, Yongjun] MOE, Shanghai, Peoples R China; [Zhang, Yongjun] Shanghai Key Lab Childrens Environm Hlth, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zhang, YJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, XinHua Hosp, Shanghai 200030, Peoples R China.	zhangyongjun@sjtu.edu.cn			Shanghai Natural Science Foundation [11ZR1423800]; National Natural Science Foundation of China [81270729]	Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Shanghai Natural Science Foundation (No. 11ZR1423800) and National Natural Science Foundation of China (No. 81270729 to Y. Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambalavanan N, 2009, PEDIATRICS, V123, P1132, DOI 10.1542/peds.2008-0526; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Brunmeir R, 2009, INT J DEV BIOL, V53, P275, DOI 10.1387/ijdb.082649rb; Cao L, 2009, AM J PHYSIOL-LUNG C, V296, pL726, DOI 10.1152/ajplung.90405.2008; Choi CW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035250500404085; Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8; Deng H, 2000, AM J RESP CRIT CARE, V162, P2316, DOI 10.1164/ajrccm.162.6.9911020; DiCamillo SJ, 2006, AM J PHYSIOL-LUNG C, V291, pL232, DOI 10.1152/ajplung.00530.2005; Husain AN, 1998, HUM PATHOL, V29, P710, DOI 10.1016/S0046-8177(98)90280-5; Ingram JL, 2006, CURR MOL MED, V6, P409, DOI 10.2174/156652406777435426; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Ito K, 2002, AM J RESP CRIT CARE, V166, P392, DOI 10.1164/rccm.2110060; Ito K, 2002, P NATL ACAD SCI USA, V99, P8921, DOI 10.1073/pnas.132556899; Jobe AH, 2001, RESP RES, V2, P27, DOI 10.1186/rr35; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Jobe Alan H, 2003, Semin Neonatol, V8, P9, DOI 10.1016/S1084-2756(02)00188-4; Kramer OH, 2009, TRENDS PHARMACOL SCI, V30, P647, DOI 10.1016/j.tips.2009.09.007; Kramer EL, 2007, AM J PHYSIOL-LUNG C, V293, pL314, DOI 10.1152/ajplung.00354.2006; Lei WW, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.21; Li HP, 2012, AM J PHYSIOL-LUNG C, V302, pL569, DOI 10.1152/ajplung.00217.2011; Li LL, 2012, INT IMMUNOPHARMACOL, V13, P15, DOI 10.1016/j.intimp.2012.03.001; Londhe VA, 2011, PEDIATR RES, V69, P371, DOI 10.1203/PDR.0b013e318211c917; Lordan JL, 2002, J IMMUNOL, V169, P407, DOI 10.4049/jimmunol.169.1.407; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Perl AKT, 2009, AM J PHYSIOL-LUNG C, V297, pL299, DOI 10.1152/ajplung.00008.2009; Prince LS, 2005, DEV DYNAM, V233, P553, DOI 10.1002/dvdy.20362; Speer CP, 2001, BIOL NEONATE, V79, P205; Sun XW, 2012, CAN J PHYSIOL PHARM, V90, P895, DOI [10.1139/Y2012-079, 10.1139/y2012-079]; Szulakowski P, 2006, AM J RESP CRIT CARE, V174, P41, DOI 10.1164/rccm.200505-725OC; Van Marter LJ, 2002, J PEDIATR-US, V140, P171, DOI 10.1067/mpd.2002.121381; Vigushin DM, 2001, CLIN CANCER RES, V7, P971; Viscardi RM, 2004, PEDIATR RES, V55, P1009, DOI 10.1203/01.pdr.0000127015.60185.8a; Waheed S, 2002, EXP LUNG RES, V28, P361, DOI 10.1080/01902140290091994; Wang Y, 2013, DEV CELL, V24, P345, DOI 10.1016/j.devcel.2013.01.012; Yamada M, 2005, J HISTOCHEM CYTOCHEM, V53, P735, DOI 10.1369/jhc.4A6483.2005; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P825, DOI 10.1016/S0002-9378(97)70276-X; Zhang J, 2011, CYTOKINE, V54, P289, DOI 10.1016/j.cyto.2011.02.018; Zhu LC, 2012, PEDIATR PULM, V47, P264, DOI 10.1002/ppul.21540	40	10	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e91083	10.1371/journal.pone.0091083	http://dx.doi.org/10.1371/journal.pone.0091083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595367	gold, Green Submitted, Green Published			2022-12-27	WOS:000332475500114
J	Perera, ND; Sheean, RK; Scott, JW; Kemp, BE; Horne, MK; Turner, BJ				Perera, Nirma D.; Sheean, Rebecca K.; Scott, John W.; Kemp, Bruce E.; Horne, Malcolm K.; Turner, Bradley J.			Mutant TDP-43 Deregulates AMPK Activation by PP2A in ALS Models	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN-KINASE; CALORIC RESTRICTION; TRANSGENIC MICE; MOTOR-NEURONS; DEGENERATION; MITOCHONDRIA; INDUCTION; PATHWAYS; MOUSE	Bioenergetic abnormalities and metabolic dysfunctionoccur in amyotrophic lateral sclerosis (ALS) patients and genetic mouse models. However, whether metabolic dysfunction occurs earlyin ALS pathophysiology linked to different ALS genes remains unclear. Here, we investigatedAMP-activated protein kinase (AMPK) activation, which is a key enzyme induced by energy depletion and metabolic stress, inneuronal cells and mouse models expressing mutantsuperoxide dismutase 1 (SOD1) or TAR DNA binding protein 43 (TDP-43) linked to ALS.AMPKphosphorylation was sharply increased in spinal cords of transgenic SOD1(G93A) mice at disease onset and accumulated incytoplasmic granules in motor neurons, but not in presymptomatic mice. AMPK phosphorylation also occurred in peripheraltissues, liver and kidney, in SOD1(G93A) mice at disease onset, demonstrating that AMPK activation occurs late and is not restricted to motor neurons. Conversely, AMPK activity was drastically diminished in spinal cords and brains of presymptomatic and symptomatictransgenic TDP-43(A315T) mice and motor neuronal cells expressing different TDP-43 mutants. We show that mutant TDP-43 induction of the AMPK phosphatase, protein phosphatase 2A (PP2A), is associated with AMPK inactivation in these ALS models. Furthermore, PP2A inhibition by okadaic acid reversed AMPK inactivation by mutant TDP-43 in neuronal cells. Our results suggest that mutant SOD1 and TDP-43 exert contrasting effects on AMPK activation which may reflect key differences in energy metabolism and neurodegeneration in spinal cords of SOD1(G93A) and TDP-43(A315T) mice. While AMPK activation in motor neurons correlateswith progressionin mutant SOD1-mediated disease, AMPK inactivation mediated by PP2Ais associated withmutant TDP-43-linked ALS.	[Perera, Nirma D.; Sheean, Rebecca K.; Horne, Malcolm K.; Turner, Bradley J.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Perera, Nirma D.; Sheean, Rebecca K.; Horne, Malcolm K.; Turner, Bradley J.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic, Australia; [Scott, John W.; Kemp, Bruce E.] Univ Melbourne, St Vincents Inst, Melbourne, Vic, Australia; [Scott, John W.; Kemp, Bruce E.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; University of Melbourne	Turner, BJ (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia.	bradley.turner@florey.edu.au	Kemp, Bruce/G-9602-2019; Scott, John W/P-1170-2018; Perera, Nirma/AAK-8871-2021; Horne, Malcolm/AAL-5214-2020; Scott, John W/AAA-2676-2021; Kemp, Bruce E/L-2633-2014	Kemp, Bruce/0000-0001-6735-5082; Scott, John W/0000-0002-1896-9798; Perera, Nirma/0000-0002-7695-6290; Horne, Malcolm/0000-0001-9427-2100; Scott, John W/0000-0002-1896-9798; Kemp, Bruce E/0000-0001-6735-5082; Turner, Bradley/0000-0001-6580-7655	Australian National Health and Medical Research Council [1008910]; MND Research Institute of Australia; Bethlehem Griffiths Research Foundation; Victorian Government through the Operational Infrastructure Scheme; Australian Postgraduate Award Scholarship	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); MND Research Institute of Australia; Bethlehem Griffiths Research Foundation; Victorian Government through the Operational Infrastructure Scheme; Australian Postgraduate Award Scholarship	This work was supported by the Australian National Health and Medical Research Council (Project Grant 1008910), MND Research Institute of Australia (Mick Rodger Benalla and Susie Harris Memorial Fund MND Research Grants), Bethlehem Griffiths Research Foundation and Victorian Government through the Operational Infrastructure Scheme. N.P. is supported by an Australian Postgraduate Award Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8; Browne SE, 2006, NEUROBIOL DIS, V22, P599, DOI 10.1016/j.nbd.2006.01.001; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; Desport JC, 1999, NEUROLOGY, V53, P1059, DOI 10.1212/WNL.53.5.1059; Desport JC, 2001, AM J CLIN NUTR, V74, P328; Dodge JC, 2013, P NATL ACAD SCI USA, V110, P10812, DOI 10.1073/pnas.1308421110; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Esmaeili MA, 2013, INT J EXP PATHOL, V94, P56, DOI 10.1111/iep.12006; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Ferraiuolo L, 2011, BRAIN, V134, P2627, DOI 10.1093/brain/awr193; Funalot B, 2009, AMYOTROPH LATERAL SC, V10, P113, DOI 10.1080/17482960802295192; Garcia-Haro L, 2010, FASEB J, V24, P5080, DOI 10.1096/fj.10-166306; Guo YS, 2012, BRAIN RES, V1460, P88, DOI 10.1016/j.brainres.2012.04.003; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hamadeh MJ, 2006, MUSCLE NERVE, V34, P709, DOI 10.1002/mus.20630; Kaneb HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024189; Kong JM, 1998, J NEUROSCI, V18, P3241; Li J, 2010, J CEREBR BLOOD F MET, V30, P480, DOI 10.1038/jcbfm.2009.255; Lim MA, 2012, J NEUROSCI, V32, P1123, DOI 10.1523/JNEUROSCI.6554-10.2012; Meyerowitz J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-57; Patel BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009386; Ravnskjaer K, 2006, J MOL ENDOCRINOL, V36, P289, DOI 10.1677/jme.1.01965; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Shaw PJ, 2000, J NEUROL, V247, P17; Soo KY, 2009, J NEUROCHEM, V108, P578, DOI 10.1111/j.1471-4159.2008.05799.x; Stallings NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071793; Turner BJ, 2005, J NEUROSCI, V25, P108, DOI 10.1523/JNEUROSCI.4253-04.2005; Vaisman N, 2009, J NEUROL SCI, V279, P26, DOI 10.1016/j.jns.2008.12.027; Voss M, 2011, CELL SIGNAL, V23, P114, DOI 10.1016/j.cellsig.2010.08.010; Wang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013096; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106	33	37	37	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90449	10.1371/journal.pone.0090449	http://dx.doi.org/10.1371/journal.pone.0090449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595038	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500050
J	Gao, Y; Liu, JJ; Zhu, SY; Yi, X				Gao, Yong; Liu, Jun-Jie; Zhu, Shang-Yong; Yi, Xiang			The Diagnostic Accuracy of Ultrasonography versus Endoscopy for Primary Nasopharyngeal Carcinoma	PLOS ONE			English	Article							TUMOR VOLUME; PROGNOSTIC-SIGNIFICANCE; PARAPHARYNGEAL SPACE; INVOLVEMENT; BIOPSY	Objective: To compare the accuracy of ultrasonography (US) with the current clinical standard of endoscopy for a diagnosis of nasopharyngeal carcinoma (NPC). Methods: A total of 150 patients suspected of having NPC underwent US and endoscopy. A diagnosis was obtained from an endoscopic biopsy collected from each suspected tumor and was compared with a biopsy obtained from a normal nasopharynx. The diagnostic accuracy of US and endoscopy for NPC was evaluated using receiver operating curve (ROC) analysis performed by MedCalc Software. Results: The sensitivity, specificity, and accuracy of US versus endoscopy for this cohort were 90.1%, 84.8%, and 87.3% for US, and 88.7%, 97.5%, and 93.3% for endoscopy, respectively. Both US and endoscopy exhibited good diagnostic accuracy for NPC with area under the curve (AUC) values of 0.929 and 0.938, respectively. However, this difference was not significant (Z = 0.36, P = 0.72). Conclusion: US is a useful tool for the detection of tumors in endoscopically suspicious nasopharynx tissues, and also for the detection of subclinical tumors in endoscopically normal nasopharynx tissues.	[Gao, Yong; Liu, Jun-Jie; Zhu, Shang-Yong] Guangxi Med Univ, Affiliated Hosp 1, Dept Ultrasonog, Nanning, Guangxi, Peoples R China; [Yi, Xiang] Guangxi Med Univ, Affiliated Hosp 1, Dept Otolaryngol, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Zhu, SY (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Ultrasonog, Nanning, Guangxi, Peoples R China.	zhushangyong2013@sina.com			Guangxi Science Fund Project [0832125]	Guangxi Science Fund Project	This work was supported by Guangxi Science Fund Project, grant number: 0832125. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan ATC, 2009, ANN ONCOL, V20, P123, DOI 10.1093/annonc/mdp150; Huang PY, 2012, ACTA OTO-LARYNGOL, V132, P1197, DOI 10.3109/00016489.2012.691211; King AD, 2006, AM J NEURORADIOL, V27, P1288; King AD, 2011, RADIOLOGY, V258, P531, DOI 10.1148/radiol.10101241; King AD, 2010, WORLD J RADIOL, V2, P159, DOI 10.4329/wjr.v2.i5.159; Lee CC, 2008, ACTA OTO-LARYNGOL, V128, P93, DOI 10.1080/00016480701361921; Ng WT, 2010, FAM CANCER, V9, P221, DOI 10.1007/s10689-009-9296-y; Pan D, 2013, J ULTRAS MED, V32, P1041, DOI 10.7863/ultra.32.6.1041; Razek AAKA, 2012, AM J ROENTGENOL, V198, P11, DOI 10.2214/AJR.11.6954; Sarisahin M, 2011, AURIS NASUS LARYNX, V38, P250, DOI 10.1016/j.anl.2010.09.002; SHAM JST, 1990, LANCET, V335, P371, DOI 10.1016/0140-6736(90)90206-K; Tang LL, 2010, RADIOLOGY, V257, P151, DOI 10.1148/radiol.10100033; WEI WI, 1991, CANCER, V67, P3127, DOI 10.1002/1097-0142(19910615)67:12<3127::AID-CNCR2820671231>3.0.CO;2-R; Zhou JY, 2007, EUR ARCH OTO-RHINO-L, V264, P169, DOI 10.1007/s00405-006-0163-2	14	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90412	10.1371/journal.pone.0090412	http://dx.doi.org/10.1371/journal.pone.0090412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594807	Green Published, gold			2022-12-27	WOS:000332468900107
J	Parashar, A; Gade, SK; Potnuru, M; Madhavan, N; Manoj, KM				Parashar, Abhinav; Gade, Sudeep Kumar; Potnuru, Mahesh; Madhavan, Nandita; Manoj, Kelath Murali			The Curious Case of Benzbromarone: Insight into Super-Inhibition of Cytochrome P450	PLOS ONE			English	Article							METABOLISM; SPECIFICITY; MOLECULES; KINETICS; P4502C9	Cytochrome P450 (CYP) family of redox enzymes metabolize drugs and xenobiotics in liver microsomes. Isozyme CYP2C9 is reported to be inhibited by benzbromarone (BzBr) and this phenomenon was hitherto explained by classical active-site binding. Theoretically, it was impossible to envisage the experimentally derived sub-nM K-i for an inhibitor, when supra-nM enzyme and 10X K-M substrate concentrations were employed. We set out to find a more plausible explanation for this highly intriguing "super-inhibition'' phenomenon. In silico docking of various BzBr analogs with known crystal structure of CYP2C9 did not provide any evidence in support of active-site based inhibition hypothesis. Experiments tested the effects of BzBr and nine analogs on CYPs in reconstituted systems of lab-purified proteins, complex baculosomes & crude microsomal preparations. In certain setups, BzBr and its analogs could even enhance reactions, which cannot be explained by an active site hypothesis. Generally, it was seen that Ki became smaller by orders of magnitude, upon increasing the dilution order of BzBr analogs. Also, it was seen that BzBr could also inhibit other CYP isozymes like CYP3A4, CYP2D6 and CYP2E1. Further, amphipathic derivatives of vitamins C & E (scavengers of diffusible reactive oxygen species or DROS) effectively inhibited CYP2C9 reactions in different reaction setups. Therefore, the inhibition of CYP activity by BzBr analogs (which are also surface-active redox agents) is attributed to catalytic scavenging of DROS at phospholipid interface. The current work expands the scope of interpretations of inhibitions in redox enzymes and ushers in a new cellular biochemistry paradigm that small amounts of DROS may be obligatorily required in routine redox metabolism for constructive catalytic roles.	[Manoj, Kelath Murali] PSG Inst Adv Studies, Biotechnol & Healthcare Div, REDOx Lab, Peelamedu, Tamil Nadu, India; [Parashar, Abhinav; Gade, Sudeep Kumar] VIT Univ, Sch Biosci & Technol, Vellore, Tamil Nadu, India; [Potnuru, Mahesh; Madhavan, Nandita] IIT Madras, Dept Chem, Chennai, Tamil Nadu, India	Vellore Institute of Technology; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Manoj, KM (corresponding author), PSG Inst Adv Studies, Biotechnol & Healthcare Div, REDOx Lab, Peelamedu, Tamil Nadu, India.	satyamjayatu@yahoo.com	Parashar, Abhinav/G-2921-2019	Parashar, Abhinav/0000-0003-4229-0248	DBT, Govt. of India [BT/PR/15226/BRB/10/905/2011]; TRR Research Grant from SASTRA University, Thanjavur, Tamil Nadu	DBT, Govt. of India(Department of Biotechnology (DBT) India); TRR Research Grant from SASTRA University, Thanjavur, Tamil Nadu	The research was funded by research grant BT/PR/15226/BRB/10/905/2011 from DBT, Govt. of India. (http://dbtindia.nic.in/index.asp) and TRR Research Grant from SASTRA University, Thanjavur, Tamil Nadu (http://www.sastra.edu/index.php?option = com_content&view = article&id = 1270&Itemid = 632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew D, 2011, BIOCHEM BIOPH RES CO, V415, P646, DOI 10.1016/j.bbrc.2011.10.128; Blanksby SJ, 2007, ANGEW CHEM INT EDIT, V46, P4948, DOI 10.1002/anie.200700219; Bort R, 1999, BIOCHEM PHARMACOL, V58, P787, DOI 10.1016/S0006-2952(99)00167-7; Chance B, 1943, J CELL COMPAR PHYSL, V22, P33, DOI 10.1002/jcp.1030220104; Chang T K, 1998, Methods Mol Biol, V107, P147; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; De Grey ADNJ, 2002, DNA CELL BIOL, V21, P251, DOI 10.1089/104454902753759672; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dickmann LJ, 2004, MOL PHARMACOL, V65, P842, DOI 10.1124/mol.65.4.842; Gade SK, 2012, BIOCHEM BIOPH RES CO, V419, P211, DOI 10.1016/j.bbrc.2012.01.149; Gasteiger J., 1990, TETRAHEDRON COMPUT M, V3, P537, DOI DOI 10.1016/0898-5529(90)90156-3; Gideon DA, 2012, CELL BIOCHEM BIOPHYS, V63, P35, DOI 10.1007/s12013-012-9339-0; Hutzler JM, 2002, DRUG METAB DISPOS, V30, P1194, DOI 10.1124/dmd.30.11.1194; Lake BG, 1987, BIOCH TOXICOLOGY PRA, P183; Locuson CW, 2004, BIOCHEMISTRY-US, V43, P6948, DOI 10.1021/bi049651o; Locuson CW, 2003, DRUG METAB DISPOS, V31, P967, DOI 10.1124/dmd.31.7.967; Manoj KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013272; Manoj KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010601; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Parashar A, 2012, BIOCHEM BIOPH RES CO, V417, P1041, DOI 10.1016/j.bbrc.2011.12.090; Peng CC, 2008, BIOORGAN MED CHEM, V16, P4064, DOI 10.1016/j.bmc.2008.01.021; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; REINKE LA, 1985, DRUG METAB DISPOS, V13, P548; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SAWYER DT, 1981, ACCOUNTS CHEM RES, V14, P393, DOI 10.1021/ar00072a005; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wester MR, 2004, J BIOL CHEM, V279, P35630, DOI 10.1074/jbc.M405427200; Williams PA, 2003, NATURE, V424, P464, DOI 10.1038/nature01862	29	16	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89967	10.1371/journal.pone.0089967	http://dx.doi.org/10.1371/journal.pone.0089967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594849	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900049
J	Quintino-dos-Santos, JW; Muller, CJT; Bernabe, CS; Rosa, CA; Tufik, S; Schenberg, LC				Quintino-dos-Santos, Jeyce Willig; Torres Mueller, Claudia Janaina; Bernabe, Cristie Setubal; Rosa, Caroline Azevedo; Tufik, Sergio; Schenberg, Luiz Carlos			Evidence That the Periaqueductal Gray Matter Mediates the Facilitation of Panic-Like Reactions in Neonatally-Isolated Adult Rats	PLOS ONE			English	Article							CHILDHOOD SEPARATION ANXIETY; HYPOXIC VENTILATORY RESPONSE; PITUITARY-ADRENAL AXIS; SEX-SPECIFIC AUGMENTATION; MATERNAL SEPARATION; ELECTRICAL-STIMULATION; DEFENSIVE BEHAVIORS; LIFE EVENTS; DISORDER; STRESS	Plenty of evidence suggests that childhood separation anxiety (CSA) predisposes the subject to adult-onset panic disorder (PD). As well, panic is frequently comorbid with both anxiety and depression. The brain mechanisms whereby CSA predisposes to PD are but completely unknown in spite of the increasing evidence that panic attacks are mediated at midbrain's dorsal periaqueductal gray matter (DPAG). Accordingly, here we examined whether the neonatal social isolation (NSI), a model of CSA, facilitates panic-like behaviors produced by electrical stimulations of DPAG of rats as adults. Eventual changes in anxiety and depression were also assessed in the elevated plus-maze (EPM) and forced-swimming test (FST) respectively. Male pups were subjected to 3-h daily isolations from post-natal day 2 (PN2) until weaning (PN21) allotting half of litters in individual boxes inside a sound-attenuated chamber (NSI, n = 26) whilst siblings (sham-isolated rats, SHAM, n = 27) and dam were moved to another box in a separate room. Non-handled controls (CTRL, n = 18) remained undisturbed with dams until weaning. As adults, rats were implanted with electrodes into the DPAG (PN60) and subjected to sessions of intracranial stimulation (PN65), EPM (PN66) and FST (PN67-PN68). Groups were compared by Fisher's exact test (stimulation sites), likelihood ratio chi-square tests (stimulus-response threshold curves) and Bonferroni's post hoc t-tests (EPM and FST), for P<0.05. Notably, DPAG-evoked panic-like responses of immobility, exophthalmus, trotting, galloping and jumping were markedly facilitated in NSI rats relative to both SHAM and CTRL groups. Conversely, anxiety and depression scores either did not change or were even reduced in neonatally-handled groups relative to CTRL, respectively. Data are the first behavioral evidence in animals that early-life separation stress produces the selective facilitation of panic-like behaviors in adulthood. Most importantly, results implicate the DPAG not only in panic attacks but also in separation-anxious children's predispositions to the late development of PD.	[Quintino-dos-Santos, Jeyce Willig; Torres Mueller, Claudia Janaina; Bernabe, Cristie Setubal; Rosa, Caroline Azevedo; Schenberg, Luiz Carlos] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil; [Quintino-dos-Santos, Jeyce Willig] Univ Fed Espirito Santo, Dept Sports, Vitoria, ES, Brazil; [Tufik, Sergio] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal de Sao Paulo (UNIFESP)	Schenberg, LC (corresponding author), Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil.	schenber@npd.ufes.br	Schenberg, Luiz/H-4816-2014	Schenberg, Luiz/0000-0003-3826-7010	Fundacao de Amparo a Pesquisa do Espirito Santo (FAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Associacao Fundo de Incentivo a Pesquisa (AFIP); Universidade Federal do Espirito Santo (UFES); FAPES [38.413.280/2007]; CNPq/FAPES [55203345/11]; UFES/AFIP [23068020409/2010-43]	Fundacao de Amparo a Pesquisa do Espirito Santo (FAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Associacao Fundo de Incentivo a Pesquisa (AFIP); Universidade Federal do Espirito Santo (UFES); FAPES(Fundacao de Amparo a Pesquisa do Estado de Espiritu Santo (FAPES)); CNPq/FAPES; UFES/AFIP	Research was funded by Fundacao de Amparo a Pesquisa do Espirito Santo (FAPES, www.fapes.es.gov.br), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, www.cnpq.br), Associacao Fundo de Incentivo a Pesquisa (AFIP, www.afip.com.br) and Universidade Federal do Espirito Santo (UFES, www.ufes.br), grants FAPES 38.413.280/2007, CNPq/FAPES 55203345/11 and UFES/AFIP (23068020409/2010-43). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JL, 1996, ARCH GEN PSYCHIAT, V53, P323; AMANO K, 1978, APPL NEUROPHYSIOL, V41, P66; Angst J, 1993, PSYCHOPHARMACOLOGY P, P7; APA, 2000, DIAGN STAT MAN MENT; BATTAGLIA M, 1995, AM J PSYCHIAT, V152, P1362; Battaglia M, 2008, AM J MED GENET B, V147B, P586, DOI 10.1002/ajmg.b.30647; Battaglia M, 2009, ARCH GEN PSYCHIAT, V66, P64, DOI 10.1001/archgenpsychiatry.2008.513; Bittencourt AS, 2005, NEUROSCIENCE, V133, P873, DOI 10.1016/j.neuroscience.2005.03.012; Bittencourt AS, 2004, NEUROSCIENCE, V125, P71, DOI 10.1016/j.neuroscience.2004.01.026; Brannan S, 2001, P NATL ACAD SCI USA, V98, P2029, DOI 10.1073/pnas.98.4.2029; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Collett D, 2002, MODELLING BINARY DAT; D'Amato FR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018637; Daniels WMU, 2004, METAB BRAIN DIS, V19, P3, DOI 10.1023/B:MEBR.0000027412.19664.b3; DEAKIN J F W, 1991, Journal of Psychopharmacology, V5, P305, DOI 10.1177/026988119100500414; Dumont FS, 2011, RESP PHYSIOL NEUROBI, V175, P288, DOI 10.1016/j.resp.2010.12.004; FARAVELLI C, 1989, AM J PSYCHIAT, V146, P622; Feinstein JS, 2013, NAT NEUROSCI, V16, P270, DOI 10.1038/nn.3323; Fournier S, 2007, J PHYSIOL-LONDON, V584, P951, DOI 10.1113/jphysiol.2007.141655; Fournier S, 2011, J APPL PHYSIOL, V111, P516, DOI 10.1152/japplphysiol.00370.2011; Francis DD, 1999, CURR OPIN NEUROBIOL, V9, P128, DOI 10.1016/S0959-4388(99)80016-6; Francis DD, 1999, ANN NY ACAD SCI, V896, P66, DOI 10.1111/j.1749-6632.1999.tb08106.x; Genest SE, 2004, J PHYSIOL-LONDON, V554, P543, DOI 10.1113/jphysiol.2003.052894; Genest SE, 2007, J PHYSIOL-LONDON, V583, P299, DOI 10.1113/jphysiol.2007.135160; Genest SE, 2007, J APPL PHYSIOL, V102, P1416, DOI 10.1152/japplphysiol.00454.2006; Goetz RR, 1996, NEUROPSYCHOPHARMACOL, V14, P355, DOI 10.1016/0893-133X(95)00147-6; GORMAN JM, 1984, AM J PSYCHIAT, V141, P857; Gorman JM, 1996, J CLIN PSYCHIAT, V57, P34; Grace L, 2009, METAB BRAIN DIS, V24, P643, DOI 10.1007/s11011-009-9162-5; Hayward LF, 2003, BRAIN RES, V974, P153, DOI 10.1016/S0006-8993(03)02573-3; Heim C, 2010, DEV PSYCHOBIOL, V52, P671, DOI 10.1002/dev.20494; HOFER MA, 1994, DEV PSYCHOBIOL, V27, P503, DOI 10.1002/dev.420270804; Hofer MA, 1996, PSYCHONEUROENDOCRINO, V21, P203, DOI 10.1016/0306-4530(95)00042-9; Hofer MA, 1996, BEHAV NEUROSCI, V110, P1158, DOI 10.1037/0735-7044.110.5.1158; Huot RL, 2001, PSYCHOPHARMACOLOGY, V158, P366, DOI 10.1007/s002130100701; JENCK F, 1995, PSYCHIAT RES, V57, P181, DOI 10.1016/0165-1781(95)02673-K; Kaufman J, 2000, DEPRESS ANXIETY, V12, P69, DOI 10.1002/1520-6394(2000)12:1+<69::AID-DA9>3.0.CO;2-K; Keay K.A., 2004, RAT NERVOUS SYSTEM, P243; Kent JM, 2001, AM J PSYCHIAT, V158, P58, DOI 10.1176/appi.ajp.158.1.58; Kinkead R, 2005, RESP PHYSIOL NEUROBI, V149, P313, DOI 10.1016/j.resp.2005.04.014; KLEIN DF, 1964, PSYCHOPHARMACOLOGIA, V5, P397, DOI 10.1007/BF02193476; KLEIN DF, 1993, ARCH GEN PSYCHIAT, V50, P306; Klein RG, 1995, CLIN NEUROPHARMACOL, V18, pS7; Kossowsky J, 2013, AM J PSYCHIAT, V170, P768, DOI 10.1176/appi.ajp.2012.12070893; Krout KE, 1998, J COMP NEUROL, V401, P437; Kuhn CM, 1998, INT J DEV NEUROSCI, V16, P261, DOI 10.1016/S0736-5748(98)00034-3; Kumar K, 1997, NEUROSURGERY, V40, P736, DOI 10.1097/00006123-199704000-00015; Lehmann J, 2000, REV NEUROSCIENCE, V11, P383; Levine S, 2001, PHYSIOL BEHAV, V73, P255, DOI 10.1016/S0031-9384(01)00496-6; MCGRATH PJ, 1988, PSYCHIAT RES, V25, P41, DOI 10.1016/0165-1781(88)90156-4; McIntosh J, 1999, DEV BRAIN RES, V113, P97, DOI 10.1016/S0165-3806(99)00005-X; Mobbs D, 2007, SCIENCE, V317, P1079, DOI 10.1126/science.1144298; NASHOLD BS, 1969, J NEUROSURG, V30, P14, DOI 10.3171/jns.1969.30.1.0014; Neumann ID, 2005, NEUROSCIENCE, V132, P867, DOI 10.1016/j.neuroscience.2005.01.034; Nixon RDV, 2004, J ANXIETY DISORD, V18, P193, DOI 10.1016/S0887-6185(02)00290-6; Nixon RDV, 2003, BEHAV RES THER, V41, P1237, DOI 10.1016/S0005-7967(03)00150-5; Ogliari A, 2010, J ANXIETY DISORD, V24, P433, DOI 10.1016/j.janxdis.2010.02.008; Ogliari A, 2010, PSYCHOTHER PSYCHOSOM, V79, P48, DOI 10.1159/000259417; Oreland S, 2009, BRAIN RES, V1305, pS37, DOI 10.1016/j.brainres.2009.08.069; Park HJ, 2005, NEUROSCI LETT, V377, P179, DOI 10.1016/j.neulet.2004.11.097; Pascual R, 2007, ACTA NEUROBIOL EXP, V67, P471; Casanova JP, 2013, BEHAV BRAIN RES, V253, P60, DOI 10.1016/j.bbr.2013.07.015; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PITTS FN, 1967, NEW ENGL J MED, V277, P1329, DOI 10.1056/NEJM196712212772502; Preter M, 2008, PROG NEURO-PSYCHOPH, V32, P603, DOI 10.1016/j.pnpbp.2007.07.029; Quintino-Dos-Santos JW, 2013, EUR J NEUROSCI, DOI [10.1111/ejn.12410, DOI 10.1111/EJN.12410)]; REIMAN EM, 1989, ARCH GEN PSYCHIAT, V46, P493; Rentesi G, 2010, NEUROSCI LETT, V480, P7, DOI 10.1016/j.neulet.2010.04.054; Roberson-Nay R, 2011, PSYCHOL MED, V41, P2411, DOI 10.1017/S0033291711000547; Roberson-Nay R, 2012, DEPRESS ANXIETY, V29, P320, DOI 10.1002/da.21931; Roberson-Nay R, 2010, BIOL PSYCHIAT, V67, P1171, DOI 10.1016/j.biopsych.2009.12.014; Roman E, 2006, HORM BEHAV, V50, P736, DOI 10.1016/j.yhbeh.2006.06.016; Rots NY, 1996, J NEUROENDOCRINOL, V8, P501, DOI 10.1046/j.1365-2826.1996.04843.x; ROYBYRNE PP, 1986, AM J PSYCHIAT, V143, P1424; Sampaio KN, 2012, NEUROSCIENCE, V210, P222, DOI 10.1016/j.neuroscience.2012.02.041; Savignac HM, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00013; Schenberg LC, 2005, NEUROSCI BIOBEHAV R, V29, P1279, DOI 10.1016/j.neubiorev.2005.05.006; Schenberg LC, 2001, NEUROSCI BIOBEHAV R, V25, P647, DOI 10.1016/S0149-7634(01)00060-4; SCHENBERG LC, 1990, NEUROSCI BIOBEHAV R, V14, P473, DOI 10.1016/S0149-7634(05)80070-3; SCHENBERG LC, 1993, BRAIN RES, V621, P50, DOI 10.1016/0006-8993(93)90296-Y; Schenberg LC, 2000, BEHAV BRAIN RES, V111, P175, DOI 10.1016/S0166-4328(00)00154-6; Schenberg LC, 1995, AM J PHYSIOL-REG I, V269, pR1378, DOI 10.1152/ajpregu.1995.269.6.R1378; Schenberg Luiz Carlos, 2010, Psychol. Neurosci., V3, P9, DOI 10.3922/j.psns.2010.1.003; Schimitel FG, 2012, NEUROSCIENCE, V200, P59, DOI 10.1016/j.neuroscience.2011.10.032; Schmidt M, 2002, J NEUROENDOCRINOL, V14, P450, DOI 10.1046/j.1365-2826.2002.00797.x; Schreiber W, 1996, NEUROPSYCHOPHARMACOL, V15, P7, DOI 10.1016/0893-133X(95)00146-5; Shalev U, 2002, PHARMACOL BIOCHEM BE, V73, P115, DOI 10.1016/S0091-3057(02)00756-6; Slotten HA, 2006, BRAIN RES, V1097, P123, DOI 10.1016/j.brainres.2006.04.066; Spatola CAM, 2011, AM J MED GENET B, V156B, P79, DOI 10.1002/ajmg.b.31144; SUCHECKI D, 1993, NEUROENDOCRINOLOGY, V57, P204, DOI 10.1159/000126361; Troakes C, 2009, STRESS, V12, P362, DOI 10.1080/10253890802506391; WHO, 2012, ICD 10 CLASS MENT BE; Wigger A, 1999, PHYSIOL BEHAV, V66, P293, DOI 10.1016/S0031-9384(98)00300-X; Wohr M, 2008, BEHAV NEUROSCI, V122, P310, DOI 10.1037/0735-7044.122.2.310	94	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90726	10.1371/journal.pone.0090726	http://dx.doi.org/10.1371/journal.pone.0090726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594924	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900139
J	Lee, SH; Kwon, HS; Park, YM; Ha, HS; Jeong, SH; Yang, HK; Lee, JH; Yim, HW; Kang, MI; Lee, WC; Son, HY; Yoon, KH				Lee, Seung-Hwan; Kwon, Hyuk-Sang; Park, Yong-Moon; Ha, Hee-Sung; Jeong, Seung Hee; Yang, Hae Kyung; Lee, Jin-Hee; Yim, Hyeon-Woo; Kang, Moo-Il; Lee, Won-Chul; Son, Ho-Young; Yoon, Kun-Ho			Predicting the Development of Diabetes Using the Product of Triglycerides and Glucose: The Chungju Metabolic Disease Cohort (CMC) Study	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; HOMEOSTASIS MODEL ASSESSMENT; FASTING PLASMA-GLUCOSE; INSULIN-RESISTANCE; YOUNG MEN; FOLLOW-UP; MELLITUS; RISK; SURROGATE; WOMEN	Background: To determine whether the TyG index, a product of the levels of triglycerides and fasting plasma glucose (FPG) might be a valuable marker for predicting future diabetes. Methods: A total of 5,354 nondiabetic subjects who had completed their follow-up visit for evaluating diabetes status were selected from a large cohort of middle-aged Koreans in the Chungju Metabolic Disease Cohort study. The risk of diabetes was assessed according to the baseline TyG index, calculated as ln[fasting triglycerides (mg/dL) x FPG (mg/dL)/2]. The median follow-up period was 4.6 years. Results: During the follow-up period, 420 subjects (7.8%) developed diabetes. The baseline values of the TyG index were significantly higher in these subjects compared with nondiabetic subjects (8.9 +/- 0.6 vs. 8.6 +/- 0.6; P < 0.0001) and the incidence of diabetes increased in proportion to TyG index quartiles. After adjusting for age, gender, body mass index, waist circumference, systolic blood pressure, high-density lipoprotein (HDL)-cholesterol level, a family history of diabetes, smoking, alcohol drinking, education level and serum insulin level, the risk of diabetes onset was more than fourfold higher in the highest vs. the lowest quartile of the TyG index (relative risk, 4.095; 95% CI, 2.701-6.207). The predictive power of the TyG index was better than the triglyceride/HDL-cholesterol ratio or the homeostasis model assessment of insulin resistance. Conclusions: The TyG index, a simple measure reflecting insulin resistance, might be useful in identifying individuals at high risk of developing diabetes.	[Lee, Seung-Hwan; Kwon, Hyuk-Sang; Yang, Hae Kyung; Kang, Moo-Il; Son, Ho-Young; Yoon, Kun-Ho] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, Seung-Hwan; Yang, Hae Kyung; Kang, Moo-Il; Son, Ho-Young; Yoon, Kun-Ho] Seoul St Marys Hosp, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea; [Kwon, Hyuk-Sang] Yeouido St Marys Hosp, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea; [Park, Yong-Moon; Ha, Hee-Sung; Yim, Hyeon-Woo; Lee, Won-Chul] Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Yong-Moon] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA; [Jeong, Seung Hee; Yim, Hyeon-Woo] Catholic Univ Korea, Coll Med, Clin Res Coordinating Ctr, Seoul, South Korea; [Lee, Jin-Hee] Catholic Univ Korea, Catholic Inst U Healthcare, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Catholic University of Korea; Catholic University of Korea	Yoon, KH (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea.	yoonk@catholic.ac.kr	Lee, Seung-Hwan/C-7568-2018; PARK, YONG-MOON ("MARK")/ABA-2765-2021; Lee, Seung-Hwan/AAG-1361-2019	Lee, Seung-Hwan/0000-0002-3964-3877; PARK, YONG-MOON ("MARK")/0000-0002-5879-6879; Lee, Seung-Hwan/0000-0002-3964-3877	National Research Foundation of Korea (NRF); Korea government (MSIP) [2013M3C8A2075675]; Catholic Medical Center Research Foundation	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MSIP); Catholic Medical Center Research Foundation	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP, 2013M3C8A2075675) and the grant from the Catholic Medical Center Research Foundation made in the program year of 2013 (to SHL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2011, METABOLISM, V60, P1673, DOI 10.1016/j.metabol.2011.04.006; Abdul-Ghani MA, 2007, DIABETES CARE, V30, P1544, DOI 10.2337/dc06-1331; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Dallmeier D, 2012, J AM HEART ASSOC, V1, DOI DOI 10.1161/JAHA.112.000869; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Dotevall A, 2004, DIABETIC MED, V21, P615, DOI 10.1111/j.1464-5491.2004.01189.x; Echouffo-Tcheugui JB, 2013, DIABETES RES CLIN PR, V101, P255, DOI 10.1016/j.diabres.2013.03.023; Gavin JR, 1997, DIABETES CARE, V20, P1183; Genuth S, 2003, DIABETES CARE, V26, P3160; Guerrero-Romero F, 2010, J CLIN ENDOCR METAB, V95, P3347, DOI 10.1210/jc.2010-0288; Hadaegh F, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-85; Hanley AJG, 2003, DIABETES, V52, P463, DOI 10.2337/diabetes.52.2.463; He S, 2012, METABOLISM, V61, P30, DOI 10.1016/j.metabol.2011.05.007; Hjellvik Vidar, 2012, Clin Epidemiol, V4, P213, DOI 10.2147/CLEP.S31830; Irace C, 2013, INT J CLIN PRACT, V67, P665, DOI 10.1111/ijcp.12124; Vasques ACJ, 2011, DIABETES RES CLIN PR, V93, pE98, DOI 10.1016/j.diabres.2011.05.030; KASHIMA S, 2013, PLOS ONE, V0008; Kelley DE, 2002, ANNU REV NUTR, V22, P325, DOI 10.1146/annurev.nutr.22.010402.102912; Kim-Dorner SJ, 2010, METABOLISM, V59, P299, DOI 10.1016/j.metabol.2009.07.027; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kolovou GD, 2011, CURR VASC PHARMACOL, V9, P258; Lorenzo C, 2012, J CLIN ENDOCR METAB, V97, P793, DOI 10.1210/jc.2011-2272; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McLaughlin T, 2003, ANN INTERN MED, V139, P802, DOI 10.7326/0003-4819-139-10-200311180-00007; Park IB, 2013, DIABETES METAB J, V37, P233, DOI 10.4093/dmj.2013.37.4.233; Rhee SY, 2011, DIABETES METAB J, V35, P107, DOI 10.4093/dmj.2011.35.2.107; Schulze MB, 2009, DIABETES CARE, V32, P2116, DOI 10.2337/dc09-0197; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Simental-Mendia Luis E., 2008, Metabolic Syndrome and Related Disorders, V6, P299, DOI 10.1089/met.2008.0034; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Tirosh A, 2008, DIABETES CARE, V31, P2032, DOI 10.2337/dc08-0825; Tripathy D, 2004, DIABETES CARE, V27, P2204, DOI 10.2337/diacare.27.9.2204; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	36	114	115	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90430	10.1371/journal.pone.0090430	http://dx.doi.org/10.1371/journal.pone.0090430			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587359	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200194
J	Xia, W; Jiang, Y; Li, YY; Wan, YJ; Liu, J; Ma, Y; Mao, ZX; Chang, HL; Li, GQ; Xu, B; Chen, X; Xu, SQ				Xia, Wei; Jiang, Ying; Li, Yuanyuan; Wan, Yanjian; Liu, Juan; Ma, Yue; Mao, Zhenxing; Chang, Huailong; Li, Gengqi; Xu, Bing; Chen, Xi; Xu, Shunqing			Early-Life Exposure to Bisphenol A Induces Liver Injury in Rats Involvement of Mitochondria-Mediated Apoptosis	PLOS ONE			English	Article							PERINATAL EXPOSURE; PRENATAL EXPOSURE; MASS-SPECTROMETRY; CYTOCHROME-C; CELL-DEATH; ACCUMULATION; METABOLISM; DIETHYLSTILBESTROL; DISRUPTION; EXPRESSION	Exposure to bisphenol A (BPA), a monomer widely used to manufacture polycarbonate plastics, has been reported to be associated with abnormalities of liver function and hepatic damage. However, the molecular mechanism under the pathogenesis of hepatic injury is unclear. In this study, the effect of perinatal exposure to BPA at the reference dose of 50 mg/kg/day on the apoptotic index in the liver of rat offspring was investigated. Increased levels of ALT and enhanced cell apoptosis were observed in the liver of rat offspring at 15 and 21 weeks, and significantly increased activity of caspase-3 and caspase-9 and elevated levels of cytochrome c were also confirmed. In addition, significant change in the expression levels of Bcl-2 and Bax were found in BPA-treated offspring at 21 weeks. For in vitro experiments, liver mitochondria were isolated from neonatal rats and were treated with BPA. BPA treatment led to a significant increase in mitochondrial permeability transition. Moreover, the supernatant from BPA-treated mitochondria significantly increased apoptotic changes in nuclei isolated from liver tissue. In conclusion, the study demonstrates that BPA induces mitochondria-mediated apoptosis in hepatic cells, which may contribute to long-term hepatotoxicity induced by early-life exposure to BPA.	[Xia, Wei] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; Huazhong Univ Sci & Technol, Minist Environm Protect, Wuhan 430074, Peoples R China; Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, State Key Lab Environm Hlth Incubating, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Xia, W (corresponding author), Huazhong Univ Sci & Technol, Minist Educ, Key Lab Environm & Hlth, Wuhan 430074, Peoples R China.	xiawei@hust.edu.cn; xust@hust.edu.cn	Chang, Huailong/P-7888-2019	Chang, Huailong/0000-0003-3994-6234	National Program on Key Basic Research Project of China (973 Program) [2012CB722401]; National Natural Science Foundation of China [81030051, 21177046]; R&D Special Fund for Public Welfare Industry (Environment) [201309048]; National Basic Research Development Program of China [2008CB418206]; Fundamental Research Funds for the Central Universities, HUST [2012QN240, 2012TS072]; Doctoral Fund of Ministry of Education of China [20120142120017]	National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); R&D Special Fund for Public Welfare Industry (Environment); National Basic Research Development Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities, HUST(Fundamental Research Funds for the Central Universities); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Program on Key Basic Research Project of China (973 Program) (2012CB722401), the National Natural Science Foundation of China (81030051, 21177046), the R&D Special Fund for Public Welfare Industry (Environment) (201309048), the National Basic Research Development Program of China (2008CB418206), the Fundamental Research Funds for the Central Universities, HUST (2012QN240, 2012TS072), and the Doctoral Fund of Ministry of Education of China (20120142120017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2010, ENVIRON HEALTH PERSP, V118, P1243, DOI 10.1289/ehp.1001993; Asahi J, 2010, LIFE SCI, V87, P431, DOI 10.1016/j.lfs.2010.08.007; Bindhumol V, 2003, TOXICOLOGY, V188, P117, DOI 10.1016/S0300-483X(03)00056-8; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Canbakan B, 2010, BIOMARK MED, V4, P205, DOI 10.2217/BMM.09.88; Cao XL, 2012, CHEMOSPHERE, V89, P505, DOI 10.1016/j.chemosphere.2012.05.003; Chen T, 2012, REPROD TOXICOL, V33, P538, DOI 10.1016/j.reprotox.2011.03.003; Cotney J, 2009, HUM MOL GENET, V18, P2670, DOI 10.1093/hmg/ddp208; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dini L, 2002, MICROSC RES TECHNIQ, V57, P530, DOI 10.1002/jemt.10107; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fujimoto T, 2006, BRAIN RES, V1068, P49, DOI 10.1016/j.brainres.2005.11.028; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guicciardi ME, 2005, GUT, V54, P1024, DOI 10.1136/gut.2004.053850; Hanioka N, 1998, ARCH TOXICOL, V72, P387, DOI 10.1007/s002040050518; Huc L, 2012, TOXICOL IN VITRO, V26, P709, DOI 10.1016/j.tiv.2012.03.017; Ikezuki Y, 2002, HUM REPROD, V17, P2839, DOI 10.1093/humrep/17.11.2839; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kosarac I, 2012, J CHROMATOGR B, V898, P90, DOI 10.1016/j.jchromb.2012.04.023; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kundakovic M, 2013, P NATL ACAD SCI USA, V110, P9956, DOI 10.1073/pnas.1214056110; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Liu JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064143; Markey CM, 2005, BIOL REPROD, V72, P1344, DOI 10.1095/biolreprod.104.036301; Marmugi A, 2012, HEPATOLOGY, V55, P395, DOI 10.1002/hep.24685; Nakagawa Y, 2000, ARCH TOXICOL, V74, P99, DOI 10.1007/s002040050659; Newbold RR, 2007, REPROD TOXICOL, V24, P253, DOI 10.1016/j.reprotox.2007.07.006; Newbold RR, 2004, TOXICOL APPL PHARM, V199, P142, DOI 10.1016/j.taap.2003.11.033; Ooe H, 2005, TOXICOL SCI, V88, P114, DOI 10.1093/toxsci/kfi278; Patel BB, 2013, TOXICOL SCI, V133, P174, DOI 10.1093/toxsci/kft026; Pottenger LH, 2000, TOXICOL SCI, V54, P3, DOI 10.1093/toxsci/54.1.3; Prins GS, 2007, REPROD TOXICOL, V23, P374, DOI 10.1016/j.reprotox.2006.10.001; Ronn M, 2013, TOXICOLOGY, V303, P125, DOI 10.1016/j.tox.2012.09.013; Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703, DOI 10.1289/ehp.021100703; Shao B, 2005, ANAL CHIM ACTA, V548, P41, DOI 10.1016/j.aca.2005.06.003; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Snyder RW, 2000, TOXICOL APPL PHARM, V168, P225, DOI 10.1006/taap.2000.9051; Somm E, 2009, ENVIRON HEALTH PERSP, V117, P1549, DOI 10.1289/ehp.11342; Sun Y, 2004, BIOMED CHROMATOGR, V18, P501, DOI 10.1002/bmc.345; Susin SA, 1998, BBA-BIOENERGETICS, V1366, P151, DOI 10.1016/S0005-2728(98)00110-8; Suzuki A, 2002, REPROD TOXICOL, V16, P107, DOI 10.1016/S0890-6238(02)00005-9; Upadhyay G, 2004, HEPATOLOGY, V39, P1120, DOI 10.1002/hep.20085; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Vaux DL, 2011, BBA-MOL CELL RES, V1813, P546, DOI 10.1016/j.bbamcr.2010.08.002; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713; Wan Y, 2010, ENVIRON SCI TECHNOL, V44, P5233, DOI 10.1021/es1002764; Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045; Yamada H, 2002, REPROD TOXICOL, V16, P735, DOI 10.1016/S0890-6238(02)00051-5	49	61	64	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90443	10.1371/journal.pone.0090443	http://dx.doi.org/10.1371/journal.pone.0090443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587367	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200201
J	Lee, CY; Tsai, YT; Loh, SH; Liu, JC; Chen, TH; Chao, HH; Cheng, TH; Chen, JJ				Lee, Chung-Yi; Tsai, Yi-Tin; Loh, Shih-Hurng; Liu, Ju-Chi; Chen, Tso-Hsiao; Chao, Hung-Hsing; Cheng, Tzu-Hurng; Chen, Jin-Jer			Urotensin II Induces Interleukin 8 Expression in Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							PRO-ANGIOGENIC ACTIVITY; CARDIAC FIBROBLASTS; ADVENTITIAL FIBROBLASTS; GENE-EXPRESSION; LUNG-CANCER; PATHWAY; PROLIFERATION; MAPK; INVOLVEMENT; ACTIVATION	Background: Urotensin II (U-II), an 11-amino acid peptide, exerts a wide range of actions in cardiovascular systems. Interleukin-8 (IL-8) is secreted by endothelial cells, thereby enhancing endothelial cell survival, proliferation, and angiogenesis. However, the interrelationship between U-II and IL-8 as well as the detailed intracellular mechanism of U-II in vascular endothelial cells remain unclear. The aim of this study was to investigate the effect of U-II on IL-8 expression and to explore its intracellular mechanism in human umbilical vein endothelial cells. Methods/Principal Findings: Primary human umbilical vein endothelial cells were used. Expression of IL-8 was determined by real-time quantitative polymerase chain reaction, enzyme-linked immunosorbent assay, and luciferase reporter assay. Western blot analyses and experiments with specific inhibitors were performed to reveal the downstream signaling pathways as concerned. U-II increased the mRNA/protein levels of IL-8 in human umbilical vein endothelial cells. The U-II effects were significantly inhibited by its receptor antagonist [Orn 5]-URP. Western blot analyses and experiments with specific inhibitors indicated the involvement of phosphorylation of p38 mitogen-activated protein kinase and extracellular signal-regulated kinase in U-II-induced IL-8 expression. Luciferase reporter assay further revealed that U-II induces the transcriptional activity of IL-8. The site-directed mutagenesis indicated that the mutation of AP-1 and NF-kB binding sites reduced U-II-increased IL-8 promoter activities. Proliferation of human umbilical vein endothelial cells induced by U-II could be inhibited significantly by IL-8 RNA interference. Conclusion/Significance: The results show that U-II induces IL-8 expression in human umbilical vein endothelial cells via p38 mitogen-activated protein kinase and extracellular signal-regulated kinase signaling pathways and IL-8 is involved in the U-II-induced proliferation of human umbilical vein endothelial cells.	[Lee, Chung-Yi; Tsai, Yi-Tin] Tri Serv Gen Hosp, Dept Cardiovasc Surg, Taipei, Taiwan; [Loh, Shih-Hurng] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Liu, Ju-Chi; Chen, Tso-Hsiao; Chao, Hung-Hsing] Taipei Med Univ, Dept Med, Taipei, Taiwan; [Chen, Tso-Hsiao] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Chao, Hung-Hsing] Shin Kong Wu Ho Su Mem Hosp, Taipei, Taiwan; [Cheng, Tzu-Hurng] China Med Univ, Sch Med, Dept Biochem, Taichung, Taiwan; [Chen, Jin-Jer] China Med Univ, Grad Inst Clin Med, Coll Med, Taichung, Taiwan; [Chen, Jin-Jer] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Shin Kong Wu Ho Su Memorial Hospital; China Medical University Taiwan; China Medical University Taiwan; Academia Sinica - Taiwan	Cheng, TH (corresponding author), China Med Univ, Sch Med, Dept Biochem, Taichung, Taiwan.	thcheng@mail.cmu.edu.tw		Loh, Shih-hurng/0000-0001-9269-5580	Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan, R.O.C [SKH-TMU-101-07, SKH-8302-102-DR-09]	Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan, R.O.C	This work was supported by the Shin Kong Wu Ho-Su Memorial Hospital (SKH-TMU-101-07; SKH-8302-102-DR-09), Taipei, Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertin G, 2011, REGUL PEPTIDES, V172, P16, DOI 10.1016/j.regpep.2011.08.001; Albertin G, 2009, REGUL PEPTIDES, V157, P64, DOI 10.1016/j.regpep.2009.04.006; Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Chen YL, 2008, EUR J PHARMACOL, V593, P24, DOI 10.1016/j.ejphar.2008.07.025; Cheng CM, 2003, MOL PHARMACOL, V63, P1002, DOI 10.1124/mol.63.5.1002; Cheng M, 2008, CLIN BIOMECH, V23, pS96, DOI 10.1016/j.clinbiomech.2008.06.003; Coulouarn Y, 1998, P NATL ACAD SCI USA, V95, P15803, DOI 10.1073/pnas.95.26.15803; Dai HY, 2007, REGUL PEPTIDES, V140, P88, DOI 10.1016/j.regpep.2006.11.015; Dong X, 2013, HEART VESSELS, V28, P514, DOI 10.1007/s00380-012-0291-0; Guidolin D, 2010, PEPTIDES, V31, P1219, DOI 10.1016/j.peptides.2010.03.022; Guidolin D, 2010, REGUL PEPTIDES, V162, P26, DOI 10.1016/j.regpep.2010.02.009; Hong HJ, 2011, CLIN EXP PHARM PHYSL; Hsu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030674; Lee CY, 2008, MOL CANCER THER, V7, P3527, DOI 10.1158/1535-7163.MCT-07-2288; Liu JC, 2009, MOL PHARMACOL, V76, P1186, DOI 10.1124/mol.109.058297; Meissner M, 2010, J BIOL CHEM, V285, P33797, DOI 10.1074/jbc.M110.137943; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; Nothacker HP, 1999, NAT CELL BIOL, V1, P383, DOI 10.1038/14081; Ross B, 2010, AM J PHYSIOL-REG I, V298, pR1156, DOI 10.1152/ajpregu.00706.2009; Shi LB, 2006, ATHEROSCLEROSIS, V188, P260, DOI 10.1016/j.atherosclerosis.2005.10.044; Song N, 2012, CIRC J, V76, P1267, DOI 10.1253/circj.CJ-11-0870; Tian L, 2008, AM J PHYSIOL-ENDOC M, V295, pE1234, DOI 10.1152/ajpendo.90672.2008; Tsai CJ, 2009, J NANOPART RES, V11, P1, DOI 10.1007/s11051-008-9474-0; Vita JA, 2011, CIRCULATION, V124, pE906, DOI 10.1161/CIRCULATIONAHA.111.078824; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Xu SK, 2012, MOL MED REP, V6, P197, DOI 10.3892/mmr.2012.899; Yang DF, 2011, MOL IMMUNOL, V48, P1784, DOI 10.1016/j.molimm.2011.05.003; Yao PL, 2005, AM J RESP CELL MOL, V32, P540, DOI 10.1165/rcmb.2004-0223OC	28	17	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e90278	10.1371/journal.pone.0090278	http://dx.doi.org/10.1371/journal.pone.0090278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24587311	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900153
J	Bhui, K; Warfa, N; Jones, E				Bhui, Kamaldeep; Warfa, Nasir; Jones, Edgar			Is Violent Radicalisation Associated with Poverty, Migration, Poor Self-Reported Health and Common Mental Disorders?	PLOS ONE			English	Article							TERRORISM; PREVALENCE; DEPRESSION; IDEOLOGIES; MORTALITY; SUICIDE; ANXIETY; VALIDITY; WORLD	Background: Doctors, lawyers and criminal justice agencies need methods to assess vulnerability to violent radicalization. In synergy, public health interventions aim to prevent the emergence of risk behaviours as well as prevent and treat new illness events. This paper describes a new method of assessing vulnerability to violent radicalization, and then investigates the role of previously reported causes, including poor self-reported health, anxiety and depression, adverse life events, poverty, and migration and socio-political factors. The aim is to identify foci for preventive intervention. Methods: A cross-sectional survey of a representative population sample of men and women aged 18-45, of Muslim heritage and recruited by quota sampling by age, gender, working status, in two English cities. The main outcomes include self-reported health, symptoms of anxiety and depression (common mental disorders), and vulnerability to violent radicalization assessed by sympathies for violent protest and terrorist acts. Results: 2.4% of people showed some sympathy for violent protest and terrorist acts. Sympathy was more likely to be articulated by the under 20s, those in full time education rather than employment, those born in the UK, those speaking English at home, and high earners (>75,000 pound a year). People with poor self-reported health were less likely to show sympathies for violent protest and terrorism. Anxiety and depressive symptoms, adverse life events and socio-political attitudes showed no associations. Conclusions: Sympathies for violent protest and terrorism were uncommon among men and women, aged 18-45, of Muslim heritage living in two English cities. Youth, wealth, and being in education rather than employment were risk factors.	[Bhui, Kamaldeep; Warfa, Nasir] Queen Mary Univ London, Wolfson Inst Prevent Med, London, England; [Jones, Edgar] Kings Coll London, Kings Ctr Mil Hlth Res, London, England	University of London; Queen Mary University London; University of London; King's College London	Bhui, K (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, London, England.	k.s.bhui@qmu.ac.uk	Torres, Raquel Alicia Benavides/A-7385-2015; Bhui, Kamaldeep/AAX-2576-2020	Torres, Raquel Alicia Benavides/0000-0001-5113-4250; Bhui, Kamaldeep/0000-0002-9205-2144; Jones, Edgar/0000-0002-4610-9584				ALLGULANDER C, 1994, ARCH GEN PSYCHIAT, V51, P708; Atran S, 2003, SCIENCE, V299, P1534, DOI 10.1126/science.1078854; Beardsley NL, 2013, J AGGRESSION CONFLIC, V5, P12; Berninger A, 2010, PUBLIC HEALTH REP, V125, P556, DOI 10.1177/003335491012500411; Bhui K, 2005, AM J PUBLIC HEALTH, V95, P496, DOI 10.2105/AJPH.2003.033274; Bhui K, 2012, BMC MED IN PRESS; Bhui Kamaldeep, 2013, Ment Health Today, P24; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; Committee HoCHA, 2012, ROOTS VIOL RAD; Crone MHM., 2010, TERR POLIT VIOLENCE, V23, P15; Eisenberg N, 2011, AM PSYCHOL, V66, P468, DOI 10.1037/a0024619; El Hajj T, 2011, INJURY PREV, V17, P401, DOI 10.1136/ip.2010.029124; Fair C, 2006, STUDIES CONFLICT TER, V29, P23; Feeney JM, 2011, LANCET, V378, P851, DOI 10.1016/S0140-6736(11)61309-3; Galea S, 2002, SOC SCI MED, V55, P1373, DOI 10.1016/S0277-9536(01)00274-X; Groves RM, 2009, SURVEY METHODOLOGY; Henderson S, 2003, LANCET, V362, P505, DOI 10.1016/S0140-6736(03)14150-5; HomeAffairsCommittee, 2012, ROOTS VIOL RAD; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; Kennedy D, 2008, J APPL SECURITY RES, V3, P3; Kenway P., 2007, POVERTY ETHNIC GROUP; Kohut A, 2011, MUSLIM AM; Kohut A, 2005, PEW GLOBAL ATTITUDES; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LaFree G, 2009, ANNU REV LAW SOC SCI, V5, P347, DOI 10.1146/annurev.lawsocsci.093008.131517; Lafree G, 2009, CRIMINOLOGY, V47, P17, DOI 10.1111/j.1745-9125.2009.00138.x; Loza W, 2011, J INTERPERS VIOLENCE, V26, P1388, DOI 10.1177/0886260510369133; Loza W, 2011, J INTERPERS VIOLENCE, V26, P522, DOI 10.1177/0886260510363417; Loza W, 2010, J INTERPERS VIOLENCE, V25, P919, DOI 10.1177/0886260509336966; McCauley C, 2011, RADICALIZATION HAPPE; Mckee M, 2009, J PUBLIC HEALTH-UK, V31, P462, DOI 10.1093/pubmed/fdp091; Mykletun A, 2007, PSYCHOSOM MED, V69, P323, DOI 10.1097/PSY.0b013e31803cb862; Neuman P, 2008, RECRUITMENT MOBILISA; O'Boyle Irene, 2008, J Health Hum Serv Adm, V30, P529; OfficeforNationalStatistics, 2002, SOC CAP QUEST BANK; Patel V, 2010, INT J EPIDEMIOL, V39, P1411, DOI 10.1093/ije/dyq199; Post JM, 2010, ANN NY ACAD SCI, V1208, P15, DOI 10.1111/j.1749-6632.2010.05694.x; Pressman DE, 2012, BRIT J FORENSIC PRAC, V14, P15; Rubin GJ, 2008, INT J METH PSYCH RES, V17, pS29, DOI 10.1002/mpr.270; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Schbley A, 2003, STUDIES CONFLICT TER, V26, P105; Shahar G, 2009, PEDIATRICS, V124, pE235, DOI 10.1542/peds.2008-2971; Sidel Victor W, 2008, Med Confl Surviv, V24 Suppl 1, pS13, DOI 10.1080/13623690801957315; Silber Mitch D., 2007, RADICALIZATION W HOM; Swinson Richard P, 2006, Evid Based Med, V11, P184, DOI 10.1136/ebm.11.6.184; Victoroff J, 2012, J CONFLICT RESOLUT, V49, P39; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	47	73	73	2	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90718	10.1371/journal.pone.0090718	http://dx.doi.org/10.1371/journal.pone.0090718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24599058	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400125
J	Dey, G; Gupta, GD; Ramalingam, B; Sathe, M; Mayor, S; Thattai, M				Dey, Gautam; Gupta, Gagan D.; Ramalingam, Balaji; Sathe, Mugdha; Mayor, Satyajit; Thattai, Mukund			Exploiting Cell-To-Cell Variability To Detect Cellular Perturbations	PLOS ONE			English	Article							GENE-EXPRESSION; ENDOCYTIC PATHWAYS; RNAI SCREEN; REVEALS; GENOME; NOISE	Any single-cell-resolved measurement generates a population distribution of phenotypes, characterized by a mean, a variance, and a shape. Here we show that changes in the shape of a phenotypic distribution can signal perturbations to cellular processes, providing a way to screen for underlying molecular machinery. We analyzed images of a Drosophila S2R+ cell line perturbed by RNA interference, and tracked 27 single-cell features which report on endocytic activity, and cell and nuclear morphology. In replicate measurements feature distributions had erratic means and variances, but reproducible shapes; RNAi down-regulation reliably induced shape deviations in at least one feature for 1072 out of 7131 genes surveyed, as revealed by a Kolmogorov-Smirnov-like statistic. We were able to use these shape deviations to identify a spectrum of genes that influenced cell morphology, nuclear morphology, and multiple pathways of endocytosis. By preserving single-cell data, our method was even able to detect effects invisible to a population-averaged analysis. These results demonstrate that cell-to-cell variability contains accessible and useful biological information, which can be exploited in existing cell-based assays.	[Dey, Gautam] Stanford Univ, Palo Alto, CA 94304 USA; [Gupta, Gagan D.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Ramalingam, Balaji] Ctr Cellular & Mol Platforms C CAMP, Bangalore, Karnataka, India; [Sathe, Mugdha; Mayor, Satyajit; Thattai, Mukund] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Stanford University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Thattai, M (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, UAS GKVK Campus, Bangalore, Karnataka, India.	thattai@ncbs.res.in	Dey, Gautam/GON-6083-2022; Dey, Gautam/AAQ-8917-2020	Dey, Gautam/0000-0003-1416-6223; Dey, Gautam/0000-0003-1416-6223; Gupta, Gagan/0000-0002-1089-965X; Sathe, Mugdha/0000-0002-1119-6542	Indo-US Science & Technology Forum through FOE Award [54-2006]; Natural Sciences and Engineering Research Council of Canada; WellcomeTrust-DBT India Alliance Intermediate Fellowship [500103/Z/09/Z]	Indo-US Science & Technology Forum through FOE Award; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); WellcomeTrust-DBT India Alliance Intermediate Fellowship(Wellcome Trust DBT India Alliance)	This project was initiated with support from the Indo-US Science & Technology Forum through FOE Award 54-2006. Support in developing the screening methodology was provided by the Nanoscience Mission of the Department of Science and Technology, Govt. of India, and the Department of Biotechnology, Govt. of India. GDG was partly supported by the Natural Sciences and Engineering Research Council of Canada. MT was partly supported by a WellcomeTrust-DBT India Alliance Intermediate Fellowship (500103/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Bakal C, 2007, SCIENCE, V316, P1753, DOI 10.1126/science.1140324; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Guha A, 2003, J CELL SCI, V116, P3373, DOI 10.1242/jcs.00637; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Gupta GD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006768; Gupta GD, 2014, PLOS ONE UNPUB; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Howes MT, 2010, CURR OPIN CELL BIOL, V22, P519, DOI 10.1016/j.ceb.2010.04.001; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; PRESS WH, 1992, NUMERICAL RECIPES C, P623; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Sacher R, 2008, CURR OPIN CELL BIOL, V20, P483, DOI 10.1016/j.ceb.2008.06.002; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	35	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90540	10.1371/journal.pone.0090540	http://dx.doi.org/10.1371/journal.pone.0090540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594940	gold, Green Published, Green Submitted			2022-12-27	WOS:000332475500063
J	Carrasco, JL; Castello, MJ; Naumann, K; Lassowskat, I; Navarrete-Gomez, M; Scheel, D; Vera, P				Luis Carrasco, Jose; Jose Castello, Maria; Naumann, Kai; Lassowskat, Ines; Navarrete-Gomez, Marisa; Scheel, Dierk; Vera, Pablo			Arabidopsis Protein Phosphatase DBP1 Nucleates a Protein Network with a Role in Regulating Plant Defense	PLOS ONE			English	Article							INNATE IMMUNITY; KINASE; MAPK; THALIANA; CALMODULINS; ACTIVATION; RESISTANCE; FAMILY; TARGET; ACID	Arabidopsis thaliana DBP1 belongs to the plant-specific family of DNA-binding protein phosphatases. Although recently identified as a novel host factor mediating susceptibility to potyvirus, little is known about DBP1 targets and partners and the molecular mechanisms underlying its function. Analyzing changes in the phosphoproteome of a loss-of-function dbp1 mutant enabled the identification of 14-3-3 lambda isoform (GRF6), a previously reported DBP1 interactor, and MAP kinase (MAPK) MPK11 as components of a small protein network nucleated by DBP1, in which GRF6 stability is modulated by MPK11 through phosphorylation, while DBP1 in turn negatively regulates MPK11 activity. Interestingly, grf6 and mpk11 loss-of-function mutants showed altered response to infection by the potyvirus Plum pox virus (PPV), and the described molecular mechanism controlling GRF6 stability was recapitulated upon PPV infection. These results not only contribute to a better knowledge of the biology of DBP factors, but also of MAPK signalling in plants, with the identification of GRF6 as a likely MPK11 substrate and of DBP1 as a protein phosphatase regulating MPK11 activity, and unveils the implication of this protein module in the response to PPV infection in Arabidopsis.	[Luis Carrasco, Jose; Jose Castello, Maria; Navarrete-Gomez, Marisa; Vera, Pablo] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain; [Naumann, Kai; Lassowskat, Ines; Scheel, Dierk; Vera, Pablo] Leibniz Inst Plant Biochem, Dept Stress & Dev Biol, Halle, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Leibniz Institut fur Pflanzenbiochemie	Vera, P (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain.	vera@ibmcp.upv.es	Carrasco, Jose Luis/M-5367-2015	Carrasco, Jose Luis/0000-0002-5905-8042; Vera, Pablo/0000-0002-7787-7519	Spanish MICINN [BFU2009-09771, EUI2009-04009]; Generalitat Valenciana [Prometeo2010/020]; German DFG [SCHE 235/15-1]	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); German DFG(German Research Foundation (DFG))	This work was supported by the Spanish MICINN (Grants BFU2009-09771, EUI2009-04009 to PV), Generalitat Valenciana (Prometeo2010/020 to PV) and the German DFG (SCHE 235/15-1 to DS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bethke G, 2012, MOL PLANT MICROBE IN, V25, P471, DOI 10.1094/MPMI-11-11-0281; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Carrasco JL, 2005, PLANT PHYSIOL, V137, P602, DOI 10.1104/pp.104.056002; Carrasco JL, 2003, EMBO J, V22, P3376, DOI 10.1093/emboj/cdg323; Carrasco JL, 2006, J BIOL CHEM, V281, P22875, DOI 10.1074/jbc.M512611200; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Denison FC, 2011, SEMIN CELL DEV BIOL, V22, P720, DOI 10.1016/j.semcdb.2011.08.006; Gokirmak T, 2010, CURR OPIN PLANT BIOL, V13, P527, DOI 10.1016/j.pbi.2010.06.001; Gupta R, 2003, PLANT PHYSIOL, V132, P1149, DOI 10.1104/pp.103.020792; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Castello MJ, 2011, PLANT PHYSIOL, V157, P2206, DOI 10.1104/pp.111.188953; Castello MJ, 2010, PLANT PHYSIOL, V153, P1521, DOI 10.1104/pp.110.158923; Katou S, 2005, J BIOL CHEM, V280, P39569, DOI 10.1074/jbc.M508115200; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kiegerl S, 2000, PLANT CELL, V12, P2247, DOI 10.1105/tpc.12.11.2247; Koroleva OA, 2005, PLANT J, V41, P162, DOI 10.1111/j.1365-313X.2004.02281.x; Kosetsu K, 2010, PLANT CELL, V22, P3778, DOI 10.1105/tpc.110.077164; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Sato T, 2011, PLANT J, V68, P137, DOI 10.1111/j.1365-313X.2011.04673.x; Schweighofer A, 2007, PLANT CELL, V19, P2213, DOI 10.1105/tpc.106.049585; Ulm R, 2001, GENE DEV, V15, P699, DOI 10.1101/gad.192601; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Wolschin F, 2005, PROTEOMICS, V5, P4389, DOI 10.1002/pmic.200402049; Yamakawa H, 2004, J BIOL CHEM, V279, P928, DOI 10.1074/jbc.M310277200	26	20	21	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90734	10.1371/journal.pone.0090734	http://dx.doi.org/10.1371/journal.pone.0090734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595057	Green Submitted, Green Published, gold			2022-12-27	WOS:000332475500094
J	Wang, XR; Lizier, JT; Nowotny, T; Berna, AZ; Prokopenko, M; Trowell, SC				Wang, X. Rosalind; Lizier, Joseph T.; Nowotny, Thomas; Berna, Amalia Z.; Prokopenko, Mikhail; Trowell, Stephen C.			Feature Selection for Chemical Sensor Arrays Using Mutual Information	PLOS ONE			English	Article							GENETIC ALGORITHM; PERFORMANCE	We address the problem of feature selection for classifying a diverse set of chemicals using an array of metal oxide sensors. Our aim is to evaluate a filter approach to feature selection with reference to previous work, which used a wrapper approach on the same data set, and established best features and upper bounds on classification performance. We selected feature sets that exhibit the maximal mutual information with the identity of the chemicals. The selected features closely match those found to perform well in the previous study using a wrapper approach to conduct an exhaustive search of all permitted feature combinations. By comparing the classification performance of support vector machines (using features selected by mutual information) with the performance observed in the previous study, we found that while our approach does not always give the maximum possible classification performance, it always selects features that achieve classification performance approaching the optimum obtained by exhaustive search. We performed further classification using the selected feature set with some common classifiers and found that, for the selected features, Bayesian Networks gave the best performance. Finally, we compared the observed classification performances with the performance of classifiers using randomly selected features. We found that the selected features consistently outperformed randomly selected features for all tested classifiers. The mutual information filter approach is therefore a computationally efficient method for selecting near optimal features for chemical sensor arrays.	[Wang, X. Rosalind; Lizier, Joseph T.; Prokopenko, Mikhail] CSIRO Computat Informat, Epping, NSW, Australia; [Nowotny, Thomas] Univ Sussex, Sch Engn & Informat, CCNR, Brighton, E Sussex, England; [Nowotny, Thomas; Berna, Amalia Z.; Trowell, Stephen C.] CSIRO Ecosyst Sci & Food Futures Flagship, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sussex; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Wang, XR (corresponding author), CSIRO Computat Informat, Epping, NSW, Australia.	Rosalind.Wang@csiro.au	Perez, Amalia Berna/C-2139-2008; Trowell, Stephen/AAG-8943-2019; Trowell, Stephen C/B-8043-2008; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008; Wang, X. Rosalind/AAY-2997-2021; Lizier, Joseph/B-8093-2008	Perez, Amalia Berna/0000-0003-4932-5415; Trowell, Stephen C/0000-0002-0505-8741; Prokopenko, Mikhail/0000-0002-4215-0344; Wang, X. Rosalind/0000-0001-5454-6197; Wang, X. Rosalind/0000-0001-5454-6197; Lizier, Joseph/0000-0002-9910-8972; Nowotny, Thomas/0000-0002-4451-915X	Science and Industry Endowment Fund	Science and Industry Endowment Fund	This research is supported by the Science and Industry Endowment Fund (http://www.sief.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleixandre M, 2004, SENSOR ACTUAT B-CHEM, V103, P122, DOI 10.1016/j.snb.2004.04.044; Avdiyenko Liliya, 2012, Proceedings of the 4th International Joint Conference on Computational Intelligence (IJCCI 2012), P474; BATTITI R, 1994, IEEE T NEURAL NETWOR, V5, P537, DOI 10.1109/72.298224; Berna AZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006406; Binions R, 2009, J ELECTROCHEM SOC, V156, pJ46, DOI 10.1149/1.3065436; Bishop C.M., 1995, NEURAL NETWORKS PATT; Breiman L., 2017, CLASSIFICATION REGRE; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; COVER T. M., 2012, ELEMENTS INFORM THEO, DOI 10.1002/0471200611; Dacres H, 2011, BIOSENS BIOELECTRON, V29, P119, DOI 10.1016/j.bios.2011.08.004; Fano RM., 1961, TRANSMISSION INFORM; Fonollosa J, 2013, SENSOR ACTUAT B-CHEM, V187, P331, DOI 10.1016/j.snb.2012.12.026; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Gardner JW, 2005, SENSOR ACTUAT B-CHEM, V106, P114, DOI 10.1016/j.snb.2004.05.043; Guestrin C., 2005, P 22 INT C MACH LEAR, V22, P265; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Krause A, 2008, J MACH LEARN RES, V9, P235; LIZIER JT, 2012, JIDT INFORM THEORETI; Llobet E, 2004, SENSOR ACTUAT B-CHEM, V99, P267, DOI 10.1016/j.snb.2003.11.019; Marco S, 2012, IEEE SENS J, V12, P3189, DOI 10.1109/JSEN.2012.2192920; Martinez S, 2006, AUTOMATICA, V42, P661, DOI 10.1016/j.automatica.2005.12.018; Muezzinoglu MK, 2010, SENSOR ACTUAT B-CHEM, V146, P472, DOI 10.1016/j.snb.2009.11.036; Murphy K, 2001, COMPUT SCI STAT, V33, P1024; Myung IJ, 2003, J MATH PSYCHOL, V47, P90, DOI 10.1016/S0022-2496(02)00028-7; NABNEY I, 2002, ADV PATTERN RECOGNIT; NELSON B, 1994, LECT NOTES CONTROL I, V200, P167, DOI DOI 10.1007/BFB0027593; Nowotny T, 2013, SENSOR ACTUAT B-CHEM, V187, P471, DOI 10.1016/j.snb.2013.01.088; OLSSON L, 2004, P 9 INT C ART LIF, P119; Pardo M, 2007, SENSOR ACTUAT B-CHEM, V123, P437, DOI 10.1016/j.snb.2006.09.041; Pardo M, 2005, SENSOR ACTUAT B-CHEM, V106, P136, DOI 10.1016/j.snb.2004.05.045; Pashami S, 2012, SENSORS-BASEL, V12, P16404, DOI 10.3390/s121216404; PEARCE TC, 2004, CHEM SENSOR ARRAY OP, P347, DOI DOI 10.1002/3527601597.CH14; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; PHIPPS MC, 1998, PRIMER STAT DATA ANA; Rakotomamonjy A., 2003, Journal of Machine Learning Research, V3, P1357, DOI 10.1162/153244303322753706; Raman B, 2009, SENSOR ACTUAT B-CHEM, V137, P617, DOI 10.1016/j.snb.2008.11.053; Rodriguez-Lujan I, 2014, CHEMOMETR INTELL LAB, V130, P123, DOI 10.1016/j.chemolab.2013.10.012; Rodriguez-Lujan I, 2010, J MACH LEARN RES, V11, P1491; Russell S., 1995, ARTIFICIAL INTELLIGE; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Vergara A, 2007, SENSOR ACTUAT B-CHEM, V123, P1002, DOI 10.1016/j.snb.2006.11.010; Vergara A., 2012, FRONTIERS NEUROENGIN, V4; Vergara A, 2012, SENSOR ACTUAT B-CHEM, V166, P320, DOI 10.1016/j.snb.2012.01.074; Vergara A, 2010, SENSOR ACTUAT B-CHEM, V148, P298, DOI 10.1016/j.snb.2010.04.040; Wang XR, 2009, INT CONF SELF SELF, P92, DOI 10.1109/SASO.2009.38; WILLIAMS PL, 2010, ABS10042515 CORR; Zheng HW, 2008, ADV SPACE RES, V41, P1960, DOI 10.1016/j.asr.2007.08.033	50	12	12	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89840	10.1371/journal.pone.0089840	http://dx.doi.org/10.1371/journal.pone.0089840			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595058	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000332475500023
J	Bertheleme, N; Strege, A; Bunting, SE; Dowell, SJ; Byrne, B				Bertheleme, Nicolas; Strege, Annette; Bunting, Sorrel E.; Dowell, Simon J.; Byrne, Bernadette			Arginine 199 and Leucine 208 Have Key Roles in the Control of Adenosine A(2A) Receptor Signalling Function	PLOS ONE			English	Article							CONSTITUTIVE ACTIVITY; NEUROTENSIN RECEPTOR; THERMOSTABILIZATION	One successful approach to obtaining high-resolution crystal structures of G-protein coupled receptors is the introduction of thermostabilising mutations within the receptor. This technique allows the generation of receptor constructs stabilised into different conformations suitable for structural studies. Previously, we functionally characterised a number of mutants of the adenosine A(2A) receptor, thermostabilised either in an agonist or antagonist conformation, using a yeast cell growth assay and demonstrated that there is a correlation between thermostability and loss of constitutive activity. Here we report the functional characterisation of 30 mutants intermediate between the Rag23 (agonist conformation mutant) and the wildtype receptor using the same yeast signalling assay with the aim of gaining greater insight into the role individual amino acids have in receptor function. The data showed that R199 and L208 have important roles in receptor function; substituting either of these residues for alanine abolishes constitutive activity. In addition, the R199A mutation markedly reduces receptor potency while L208A reduces receptor efficacy. A184L and L272A mutations also reduce constitutive activity and potency although to a lesser extent than the R199A and L208A. In contrast, the F79A mutation increases constitutive activity, potency and efficacy of the receptor. These findings shed new light on the role individual residues have on stability of the receptor and also provide some clues as to the regions of the protein responsible for constitutive activity. Furthermore, the available adenosine A(2A) receptor structures have allowed us to put our findings into a structural context.	[Bertheleme, Nicolas; Strege, Annette; Bunting, Sorrel E.; Byrne, Bernadette] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England; [Dowell, Simon J.] GlaxoSmithKline, Dept Mol Discovery Res, Stevenage, Herts, England	Imperial College London; GlaxoSmithKline	Byrne, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	b.byrne@imperial.ac.uk		Byrne, Bernadette/0000-0001-9598-9832; Dowell, Simon/0000-0001-6499-7573	Biotechnology and Biological Sciences Research Council; GlaxoSmithKline; Biotechnology and Biological Sciences Research Council [982182] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by the Biotechnology and Biological Sciences Research Council and GlaxoSmithKline. Dr. Simon Dowell, GSK, had a role in data analysis, decision to publish and preparation of the manuscript. However, the company (GSK) did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertheleme N, 2013, BRIT J PHARMACOL, V169, P988, DOI 10.1111/bph.12165; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Dowell SJ, 2009, METHODS MOL BIOL, V552, P213, DOI 10.1007/978-1-60327-317-6_15; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jiang QL, 1996, MOL PHARMACOL, V50, P512; Jiang QL, 1997, J MED CHEM, V40, P2588, DOI 10.1021/jm970084v; Klinger M, 2002, N-S ARCH PHARMACOL, V366, P287, DOI 10.1007/s00210-002-0617-z; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shibata Y, 2013, BBA-BIOMEMBRANES, V1828, P1293, DOI 10.1016/j.bbamem.2013.01.008; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	22	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89613	10.1371/journal.pone.0089613	http://dx.doi.org/10.1371/journal.pone.0089613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595172	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900025
J	Gerdin, M; Roy, N; Dharap, S; Kumar, V; Khajanchi, M; Tomson, G; Tsai, LF; Petzold, M; von Schreeb, J				Gerdin, Martin; Roy, Nobhojit; Dharap, Satish; Kumar, Vineet; Khajanchi, Monty; Tomson, Goran; Tsai, Li Fellander; Petzold, Max; von Schreeb, Johan			Early Hospital Mortality among Adult Trauma Patients Significantly Declined between 1998-2011: Three Single-Centre Cohorts from Mumbai, India	PLOS ONE			English	Article							SEVERELY INJURED PATIENTS; CARE; OUTCOMES; PERFORMANCE; MANAGEMENT; SYSTEMS; SERVICES; SURVIVAL; QUALITY; ICISS	Background: Traumatic injury causes more than five million deaths each year of which about 90% occur in low-and middle-income countries (LMIC). Hospital trauma mortality has been significantly reduced in high-income countries, but to what extent similar results have been achieved in LMIC has not been studied in detail. Here, we assessed if early hospital mortality in patients with trauma has changed over time in an urban lower middle-income setting. Methods: We conducted a retrospective study of patients admitted due to trauma in 1998, 2002, and 2011 to a large public hospital in Mumbai, India. Our outcome measure was early hospital mortality, defined as death between admission and 24-hours. We used multivariate logistic regression to assess the association between time and early hospital mortality, adjusting for patient case-mix. Injury severity was quantified using International Classification of Diseases-derived Injury Severity Score (ICISS). Major trauma was defined as ICISS, 0.90. Results: We analysed data on 4189 patients out of which 86.5% were males. A majority of patients were between 15 and 55 years old and 36.5% had major trauma. Overall early hospital mortality was 8.9% in 1998, 6.0% in 2002, and 8.1% in 2011. Among major trauma patients, early hospital mortality was 13.4%, in 1998, 11.3% in 2002, and 10.9% in 2011. Compared to trauma patients admitted in 1998, those admitted in 2011 had lower odds for early hospital mortality (OR = 0.56, 95% CI = 0.41-0.76) including those with major trauma (OR = 0.57, 95% CI = 0.41-0.78). Conclusions: We observed a significant reduction in early hospital mortality among patients with major trauma between 1998 and 2011. Improved survival was evident only after we adjusted for patient case-mix. This finding highlights the importance of risk-adjustment when studying longitudinal mortality trends.	[Gerdin, Martin; Roy, Nobhojit; Tomson, Goran; von Schreeb, Johan] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Roy, Nobhojit] Bhabha Atom Res Ctr Hosp, Dept Surg, Bombay, Maharashtra, India; [Roy, Nobhojit] Tata Inst Social Sci, Sch Habitat, Bombay, Maharashtra, India; [Dharap, Satish; Kumar, Vineet] Lokmanya Tilak Municipal Med Coll & Gen Hosp, Dept Surg, Bombay, Maharashtra, India; [Khajanchi, Monty] Seth GS Med Coll & King Edward Mem Hosp, Dept Surg, Bombay, Maharashtra, India; [Tomson, Goran] Karolinska Inst, Dept Learning Informat Management & Eth, Med Management Ctr, Stockholm, Sweden; [Tsai, Li Fellander] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Orthoped & Biotechnol, Stockholm, Sweden; [Petzold, Max] Univ Gothenburg, Sahlgrenska Acad, Ctr Appl Biostat Occupat & Environm Med, Gothenburg, Sweden	Karolinska Institutet; Bhabha Atomic Research Center (BARC); Tata Institute of Social Sciences; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Karolinska Institutet; Karolinska Institutet; University of Gothenburg	Gerdin, M (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	martin.gerdin@ki.se	Wärnberg, Martin Gerdin/D-7482-2019; Dharap, Satish/AAE-8565-2020	Wärnberg, Martin Gerdin/0000-0001-6069-4794; Dharap, Satish/0000-0002-9304-9617; Tomson, Goran/0000-0001-9222-3604; Fellander-Tsai, Li/0000-0003-0693-6080; Roy, Nobhojit/0000-0003-2022-7416	Swedish National Board of Health and Welfare	Swedish National Board of Health and Welfare	This research was funded through grants from the Second Assist and the Swedish National Board of Health and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balogh ZJ, 2012, LANCET, V380, P1109, DOI 10.1016/S0140-6736(12)60991-X; Blomberg H, 2013, J AM COLL SURGEONS, V217, P1010, DOI 10.1016/j.jamcollsurg.2013.08.002; Brennan PW, 2002, J TRAUMA, V53, P333, DOI 10.1097/00005373-200208000-00024; Cameron PA, 2008, MED J AUSTRALIA, V189, P546, DOI 10.5694/j.1326-5377.2008.tb02176.x; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Christensen MC, 2010, J TRAUMA, V69, P344, DOI 10.1097/TA.0b013e3181e74c69; Ciesla DJ, 2013, J AM COLL SURGEONS, V216, P687, DOI 10.1016/j.jamcollsurg.2012.12.033; Demyttenaere SV, 2009, CAN J SURG, V52, pE146; Diggs BS, 2008, J AM COLL SURGEONS, V206, P212, DOI 10.1016/j.jamcollsurg.2007.08.019; Gabbe BJ, 2012, ANN SURG, V255, P1009, DOI 10.1097/SLA.0b013e31824c4b91; Gedeborg R, 2010, INJURY PREV, V16, P302, DOI 10.1136/ip.2009.024414; Glance LG, 2012, ARCH SURG-CHICAGO, V147, P732, DOI 10.1001/archsurg.2012.1138; Gliklich R, 2007, REGISTRIES EVALUATIN; Gould W, 1999, DO I IDENTIFY DUPLIC; Gruen RL, 2012, BRIT J SURG, V99, P97, DOI 10.1002/bjs.7754; Gruen RL, 2012, LANCET, V380, P1099, DOI 10.1016/S0140-6736(12)61224-0; Gruen RL, 2012, LANCET, V380, P1033, DOI 10.1016/S0140-6736(12)61418-4; Gururaj G, 2008, NATL MED J INDIA, V21, P14; Gururaj G, 2005, NATL COMMISSION MACR, P325; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Henry JA, 2012, J TRAUMA ACUTE CARE, V73, P261, DOI 10.1097/TA.0b013e31824bde1e; Ichikawa M, 2003, ACCIDENT ANAL PREV, V35, P183, DOI 10.1016/S0001-4575(01)00102-6; International Institute for Population Sciences and Macro International, 2008, NAT FAM HLTH SURV NF; Ker K, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-3; Kilgo PD, 2003, J TRAUMA, V55, P599, DOI 10.1097/01.TA.0000085721.47738.BD; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marson AC, 2001, J TRAUMA, V50, P917; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Meredith JW, 2002, J TRAUMA, V53, P621, DOI 10.1097/00005373-200210000-00001; Mock C, 2012, WORLD J SURG, V36, P959, DOI 10.1007/s00268-012-1459-6; Moore L, 2010, WORLD J SURG, V34, P2069, DOI 10.1007/s00268-010-0588-z; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; National Crime Records Bureau, 2011, ACC DEATHS SUIC IND; O'Reilly GM, 2012, INJURY, V43, P1148, DOI 10.1016/j.injury.2012.03.003; O'Reilly GM, 2013, INJURY; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Press Information Bureau, 2011, INDIA STATS MILL PLU; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Roy N, 2010, PREHOSP DISASTER MED, V25, P145, DOI 10.1017/S1049023X00007883; Rutledge R, 1998, J TRAUMA, V44, P41, DOI 10.1097/00005373-199801000-00003; RUTLEDGE R, 1995, SURG CLIN N AM, V75, P305, DOI 10.1016/S0039-6109(16)46590-4; Sample Registration System, 2011, SPEC B MAT MORT IND; Sample Registration System, 2000, SRS B, V33; SHACKFORD SR, 1986, J TRAUMA, V26, P812, DOI 10.1097/00005373-198609000-00006; Tohira H, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-63; WEST JG, 1979, ARCH SURG-CHICAGO, V114, P455; Wong Sydney S N, 2008, Mcgill J Med, V11, P9; World Bank, 2013, COUNTR LEND GROUPS; World Health Organization, 2004, WORLD REPORT ROAD TR; World Health Organization, 2010, INJ VIOL FACTS	51	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90064	10.1371/journal.pone.0090064	http://dx.doi.org/10.1371/journal.pone.0090064			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594775	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900062
J	Haye, A; Albert, J; Rooman, M				Haye, Alexandre; Albert, Jaroslav; Rooman, Marianne			Modeling the Drosophila Gene Cluster Regulation Network for Muscle Development	PLOS ONE			English	Article							TIME-SERIES DATA; EXPRESSION DATA; MICROARRAY; NORMALIZATION; INFERENCE; VARIANCE	The development of accurate and reliable dynamical modeling procedures that describe the time evolution of gene expression levels is a prerequisite to understanding and controlling the transcription process. We focused on data from DNA microarray time series for 20 Drosophila genes involved in muscle development during the embryonic stage. Genes with similar expression profiles were clustered on the basis of a translation-invariant and scale-invariant distance measure. The time evolution of these clusters was modeled using coupled differential equations. Three model structures involving a transcription term and a degradation term were tested. The parameters were identified in successive steps: network construction, parameter optimization, and parameter reduction. The solutions were evaluated on the basis of the data reproduction and the number of parameters, as well as on two biology-based requirements: the robustness with respect to parameter variations and the values of the expression levels not being unrealistically large upon extrapolation in time. Various solutions were obtained that satisfied all our evaluation criteria. The regulatory networks inferred from these solutions were compared with experimental data. The best solution has half of the experimental connections, which compares favorably with previous approaches. Biasing the network toward the experimental connections led to the identification of a model that is only slightly less good on the basis of the evaluation criteria. The non-uniqueness of the solutions and the variable agreement with experimental connections were discussed in the context of the different hypotheses underlying this type of approach.	[Haye, Alexandre; Albert, Jaroslav; Rooman, Marianne] Univ Libre Bruxelles, BioModeling BioInformat & BioProc Dept, Brussels, Belgium	Universite Libre de Bruxelles	Rooman, M (corresponding author), Univ Libre Bruxelles, BioModeling BioInformat & BioProc Dept, Brussels, Belgium.	mrooman@ulb.ac.be			Belgian Fund for Scientific Research (FNRS); Belgian Fund for Scientific Research (FRIA)	Belgian Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Belgian Fund for Scientific Research (FRIA)(Fonds de la Recherche Scientifique - FNRS)	This research was supported by the Belgian Fund for Scientific Research (FNRS and FRIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert Jaroslav, 2011, Syst Synth Biol, V5, P33, DOI 10.1007/s11693-011-9079-2; Androulakis IP, 2007, ANNU REV BIOMED ENG, V9, P205, DOI 10.1146/annurev.bioeng.9.060906.151904; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bar-Joseph Z, 2004, BIOINFORMATICS, V20, P2493, DOI 10.1093/bioinformatics/bth283; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Dufva Martin, 2009, V529, P1, DOI 10.1007/978-1-59745-538-1_1; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Goutsias J, 2007, CURR PHARM DESIGN, V13, P1415, DOI 10.2174/138161207780765945; Guo F., 2007, P 24 INT C MACH LEAR, P321; Hartigan J., 1975, CLUSTERING ALGORITHM; Haye Alexandre, 2012, BMC Res Notes, V5, P46, DOI 10.1186/1756-0500-5-46; Haye A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016004; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hempel S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-292; Hickman R, 2013, PLANT J, V75, P26, DOI 10.1111/tpj.12194; Ingold A, 2002, THESIS U AIX MARSEIL, P3; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Konopka T, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-123; Kramer R, 2008, J SIGNAL PROCESS SYS, V50, P321, DOI 10.1007/s11265-007-0122-1; Krishnan A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000562; Li P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S13; Motakis ES, 2006, BIOINFORMATICS, V22, P2547, DOI 10.1093/bioinformatics/btl412; Mueller HG, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-60; Page Grier P., 2007, V404, P409, DOI 10.1007/978-1-59745-530-5_20; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rooman M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027948; Sima C, 2009, CURR GENOMICS, V10, P416, DOI 10.2174/138920209789177610; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Wu XW, 2006, METH MOL B, V316, P35; Yu JK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-461; Zhao WT, 2006, BIOINFORMATICS, V22, P2129, DOI 10.1093/bioinformatics/btl364; Zhou T, 2002, P NATL ACAD SCI USA, V99, P2049, DOI 10.1073/pnas.261714399	33	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90285	10.1371/journal.pone.0090285	http://dx.doi.org/10.1371/journal.pone.0090285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594656	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900089
J	Huguet, G; Nava, C; Lemiere, N; Patin, E; Laval, G; Ey, E; Brice, A; Leboyer, M; Szepetowski, P; Gillberg, C; Depienne, C; Delorme, R; Bourgeron, T				Huguet, Guillaume; Nava, Caroline; Lemiere, Nathalie; Patin, Etienne; Laval, Guillaume; Ey, Elodie; Brice, Alexis; Leboyer, Marion; Szepetowski, Pierre; Gillberg, Christopher; Depienne, Christel; Delorme, Richard; Bourgeron, Thomas			Heterogeneous Pattern of Selective Pressure for PRRT2 in Human Populations, but No Association with Autism Spectrum Disorders	PLOS ONE			English	Article							PAROXYSMAL DYSKINESIA; FUNCTIONAL IMPACT; HUMAN GENOME; 16P11.2; MICRODELETION; MUTATIONS; PHENOTYPES; EVOLUTION	Inherited and de novo genomic imbalances at chromosome 16p11.2 are associated with autism spectrum disorders (ASD), but the causative genes remain unknown. Among the genes located in this region, PRRT2 codes for a member of the synaptic SNARE complex that allows the release of synaptic vesicles. PRRT2 is a candidate gene for ASD since homozygote mutations are associated with intellectual disability and heterozygote mutations cause benign infantile seizures, paroxysmal dyskinesia, or hemiplegic migraine. Here, we explored the contribution of PRRT2 mutations in ASD by screening its coding part in a large sample of 1578 individuals including 431 individuals with ASD, 186 controls and 961 individuals from the human genome Diversity Panel. We detected 24 nonsynonymous variants, 1 frameshift (A217PfsX8) and 1 in-frame deletion of 6 bp (p. A361_P362del). The frameshift mutation was observed in a control with no history of neurological or psychiatric disorders. The p. A361_P362del was observed in two individuals with autism from sub-Saharan African origin. Overall, the frequency of PRRT2 deleterious variants was not different between individuals with ASD and controls. Remarkably, PRRT2 displays a highly significant excess of nonsynonymous (pN) vs synonymous (pS) mutations in Asia (pN/pS=4.85) and Europe (pN/pS=1.62) compared with Africa (pN/pS=0.26; Asia vs Africa: P=0.000087; Europe vs Africa P=0.00035; Europe vs Asia P=P=0.084). We also showed that whole genome amplification performed through rolling cycle amplification could artificially introduce the A217PfsX8 mutation indicating that this technology should not be performed prior to PRRT2 mutation screening. In summary, our results do not support a role for PRRT2 coding sequence variants in ASD, but provide an ascertainment of its genetic variability in worldwide populations that should help researchers and clinicians to better investigate the role of PRRT2 in human diseases.	[Huguet, Guillaume; Lemiere, Nathalie; Ey, Elodie; Delorme, Richard; Bourgeron, Thomas] Inst Pasteur, Paris, France; [Huguet, Guillaume; Lemiere, Nathalie; Ey, Elodie; Delorme, Richard; Bourgeron, Thomas] Inst Pasteur, CNRS, URA Genes Synapses & Cognit 2182, Paris, France; [Huguet, Guillaume; Lemiere, Nathalie; Ey, Elodie; Bourgeron, Thomas] Univ Paris 07, Paris, France; [Nava, Caroline; Brice, Alexis; Depienne, Christel] Hop La Pitie Salpetriere, INSERM, U975, CRICM,Inst Cerveau & Moelle Epiniere ICM, Paris, France; [Nava, Caroline; Brice, Alexis; Depienne, Christel] Hop La Pitie Salpetriere, CNRS 7225, CRICM, Paris, France; [Nava, Caroline; Brice, Alexis; Depienne, Christel] Univ Paris 06, UMR S 975, Paris, France; [Nava, Caroline] Hop La Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, Unite Fonct Genet Clin, Paris, France; [Patin, Etienne; Laval, Guillaume] Inst Pasteur, Unit Human Evolutionary Genet, Paris, France; [Brice, Alexis; Depienne, Christel] Hop La Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, Unite Fonct Neurogenet Mol & Cellulaire, Paris, France; [Leboyer, Marion] Hop Henri Mondor, INSERM, U955, Psychiat Genet Team, F-94010 Creteil, France; [Leboyer, Marion; Delorme, Richard; Bourgeron, Thomas] Fdn FondaMental, Creteil, France; [Szepetowski, Pierre] INSERM, UMR S901, F-13258 Marseille, France; [Szepetowski, Pierre] Aix Marseille Univ, Marseille, France; [Szepetowski, Pierre] Mediterranean Inst Neurobiol INMED, Marseille, France; [Gillberg, Christopher] Univ Gothenburg, Gillberg Neuropsychiat Ctr, Gothenburg, Sweden; [Gillberg, Christopher] Gothenburg Univ, Dept Pharmacol, Inst Neurosci & Physiol, Gothenburg, Sweden; [Gillberg, Christopher] UCL, Inst Child Hlth, London, England; [Delorme, Richard] Hop Robert Debre, AP HP, Dept Child & Adolescent Psychiat, F-75019 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Gothenburg; University of Gothenburg; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Bourgeron, T (corresponding author), Inst Pasteur, Paris, France.	thomasb@pasteur.fr	Leboyer, Marion/AAW-3648-2021; brice, alexis/AAE-8275-2019; Huguet, Guillaume/GPX-3656-2022; Brice, Alexis/A-2170-2009; Depienne, Christel/AAL-3835-2021	Leboyer, Marion/0000-0001-5473-3697; brice, alexis/0000-0002-0941-3990; Huguet, Guillaume/0000-0002-4746-6030; Depienne, Christel/0000-0002-7212-9554; Nava, Caroline/0000-0003-1272-0518; Patin, Etienne/0000-0002-9911-4459; Delorme, Richard/0000-0002-5614-3663; Ey, Elodie/0000-0002-8202-3163; Bourgeron, Thomas/0000-0001-8164-9220	Institut Pasteur; CNRS; INSERM; AP-HP; University Paris Diderot; Bettencourt-Schueller foundation; Orange foundation; FondaMental foundation; Conny-Maeva foundation; Cognacq-Jay foundation; ANR (SynDivAutism); Neuron-ERANET (EUHF-AUTISM)	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); AP-HP; University Paris Diderot; Bettencourt-Schueller foundation; Orange foundation; FondaMental foundation; Conny-Maeva foundation; Cognacq-Jay foundation; ANR (SynDivAutism)(French National Research Agency (ANR)); Neuron-ERANET (EUHF-AUTISM)	This work was funded by the Institut Pasteur, CNRS, INSERM, AP-HP, University Paris Diderot, the Bettencourt-Schueller foundation, the Orange foundation, the FondaMental foundation, the Conny-Maeva foundation, the Cognacq-Jay foundation, the ANR (SynDivAutism), Neuron-ERANET (EUHF-AUTISM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association AP, 1994, DIAGN STAT MAN MENT, V4th; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Ballif BC, 2007, NAT GENET, V39, P1071, DOI 10.1038/ng2107; Barge-Schaapveld DQCM, 2011, AM J MED GENET A, V155A, P1066, DOI 10.1002/ajmg.a.33991; Becker F, 2013, J NEUROL, V260, P1234, DOI 10.1007/s00415-012-6777-y; Cann HM, 2002, SCIENCE, V296, P261; Chen WJ, 2011, NAT GENET, V43, P1252, DOI 10.1038/ng.1008; Cloarec R, 2012, NEUROLOGY, V79, P2097, DOI 10.1212/WNL.0b013e3182752c46; Crepel A, 2011, AM J MED GENET B, V156B, P243, DOI 10.1002/ajmg.b.31163; Gardiner AR, 2012, NEUROLOGY, V79, P2115, DOI 10.1212/WNL.0b013e3182752c5a; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Huguet G, 2013, ANNU REV GENOM HUM G, V14, P191, DOI 10.1146/annurev-genom-091212-153431; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Kelley JL, 2008, ANNU REV GENOM HUM G, V9, P143, DOI 10.1146/annurev.genom.9.081307.164411; Konyukh M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017289; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Kumar RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004582; Lee HY, 2012, CELL REP, V1, P2, DOI 10.1016/j.celrep.2011.11.001; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	28	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e88600	10.1371/journal.pone.0088600	http://dx.doi.org/10.1371/journal.pone.0088600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594579	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900005
J	Kocharunchitt, C; King, T; Gobius, K; Bowman, JP; Ross, T				Kocharunchitt, Chawalit; King, Thea; Gobius, Kari; Bowman, John P.; Ross, Tom			Global Genome Response of Escherichia coli O157:H7 Sakai during Dynamic Changes in Growth Kinetics Induced by an Abrupt Downshift in Water Activity	PLOS ONE			English	Article							CYCLOPROPANE FATTY-ACIDS; LAG PHASE DURATION; GENE-EXPRESSION; COLANIC-ACID; STRESS-RESPONSE; MESSENGER-RNA; SIGMA(S)-DEPENDENT GENES; MEMBRANE-PERMEABILITY; PHOSPHORELAY SYSTEM; MICROARRAY ANALYSIS	The present study was undertaken to investigate growth kinetics and time-dependent change in global expression of Escherichia coli O157:H7 Sakai upon an abrupt downshift in water activity (a(w)). Based on viable count data, shifting E. coli from a(w) 0.993 to a(w) 0.985 or less caused an apparent loss, then recovery, of culturability. Exponential growth then resumed at a rate characteristic for the a(w) imposed. To understand the responses of this pathogen to abrupt osmotic stress, we employed an integrated genomic and proteomic approach to characterize its cellular response during exposure to a rapid downshift but still within the growth range from a(w) 0.993 to a(w) 0.967. Of particular interest, genes and proteins with cell envelope-related functions were induced during the initial loss and subsequent recovery of culturability. This implies that cells undergo remodeling of their envelope composition, enabling them to adapt to osmotic stress. Growth at low a(w), however, involved up-regulating additional genes and proteins, which are involved in the biosynthesis of specific amino acids, and carbohydrate catabolism and energy generation. This suggests their important role in facilitating growth under such stress. Finally, we highlighted the ability of E. coli to activate multiple stress responses by transiently inducing the RpoE and RpoH regulons to control protein misfolding, while simultaneously activating the master stress regulator RpoS to mediate long-term adaptation to hyperosmolality. This investigation extends our understanding of the potential mechanisms used by pathogenic E. coli to adapt, survive and grow under osmotic stress, which could potentially be exploited to aid the selection and/or development of novel strategies to inactivate this pathogen.	[Kocharunchitt, Chawalit; Bowman, John P.; Ross, Tom] Univ Tasmania, Tasmanian Inst Agr, Food Safety Ctr, Hobart, Tas, Australia; [King, Thea] Commonwealth Sci & Ind Res Org Anim Food & Hlth S, N Ryde, NSW, Australia; [Gobius, Kari] Commonwealth Sci & Ind Res Org Anim Food & Hlth S, Werribee, Vic, Australia	University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Kocharunchitt, C (corresponding author), Univ Tasmania, Tasmanian Inst Agr, Food Safety Ctr, Hobart, Tas, Australia.	chawalit.kocharunchitt@utas.edu.au	Gobius, Kari/I-4700-2013; Bowman, John P./ABF-5108-2020; Bowman, John P/C-2414-2014	Gobius, Kari/0000-0002-3653-2581; Bowman, John P./0000-0002-4528-9333; Bowman, John P/0000-0002-4528-9333; Kocharunchitt, Chawalit/0000-0003-3919-2401; Ross, Tom/0000-0001-9916-7772	Meat and Livestock Australia	Meat and Livestock Australia(Meat and Livestock Australia)	This study was supported by Meat and Livestock Australia (http://www.mla.com.au/Home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertsen A, 2004, CRIT REV MICROBIOL, V30, P263, DOI 10.1080/10408410490884757; Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; ALLEN PM, 1987, J MED MICROBIOL, V24, P363, DOI 10.1099/00222615-24-4-363; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BI E, 1993, J BACTERIOL, V175, P1118, DOI 10.1128/JB.175.4.1118-1125.1993; Bianchi AA, 1999, MOL MICROBIOL, V34, P1029, DOI 10.1046/j.1365-2958.1999.01664.x; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Brenner M, 1971, METABOLIC PATHWAYS; Brown JL, 1997, INT J FOOD MICROBIOL, V37, P163, DOI 10.1016/S0168-1605(97)00068-8; Busta F F, 1978, Adv Appl Microbiol, V23, P195, DOI 10.1016/S0065-2164(08)70069-8; Cagney C, 2004, FOOD MICROBIOL, V21, P203, DOI 10.1016/S0740-0020(03)00052-2; Canet S, 2003, FEMS MICROBIOL LETT, V225, P207, DOI 10.1016/S0378-1097(03)00515-9; CASADESUS J, 1989, MOL GEN GENET, V216, P210, DOI 10.1007/BF00334358; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Chen JR, 2004, INT J FOOD MICROBIOL, V93, P281, DOI 10.1016/j.ijfoodmicro.2003.12.004; CHIRIFE J, 1984, J FOOD SCI, V49, P1486, DOI 10.1111/j.1365-2621.1984.tb12827.x; Chung HJ, 2006, COMPR REV FOOD SCI F, V5, P52, DOI 10.1111/j.1541-4337.2006.00002.x; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; FITT PS, 1992, CURR MICROBIOL, V24, P251, DOI 10.1007/BF01577328; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; FRANDSEN N, 1993, MOL GEN GENET, V240, P348, DOI 10.1007/BF00280385; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Guillot A, 2000, INT J FOOD MICROBIOL, V55, P47, DOI 10.1016/S0168-1605(00)00193-8; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; Gur E, 2002, MOL MICROBIOL, V46, P1391, DOI 10.1046/j.1365-2958.2002.03257.x; Gyaneshwar P, 2005, P NATL ACAD SCI USA, V102, P3453, DOI 10.1073/pnas.0500141102; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hagiwara D, 2003, J BACTERIOL, V185, P5735, DOI 10.1128/JB.185.19.5735-5746.2003; Hatzimanikatis V, 1999, BIOTECHNOL PROGR, V15, P312, DOI 10.1021/bp990004b; Hatzimanikatis V, 1999, METAB ENG, V1, P275, DOI 10.1006/mben.1999.0115; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Horinouchi T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-579; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jung IL, 2003, ARCH BIOCHEM BIOPHYS, V418, P125, DOI 10.1016/j.abb.2003.08.003; KAWAMUKAI M, 1988, J BACTERIOL, V170, P3864, DOI 10.1128/jb.170.9.3864-3869.1988; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim YH, 2005, APPL MICROBIOL BIOT, V68, P786, DOI 10.1007/s00253-005-0053-3; King T, 2013, GLOBAL GENOME RESPON; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Kocharunchitt C, 2011, MOL CELL PROTEOMICS, DOI [10.1074/mcp.M1111.009019, DOI 10.1074/MCP.M1111.009019]; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; MACKEY BM, 1982, J APPL BACTERIOL, V53, P243, DOI 10.1111/j.1365-2672.1982.tb04683.x; Majdalani N, 2005, J BACTERIOL, V187, P6770, DOI 10.1128/JB.187.19.6770-6778.2005; Mao Y, 2006, LETT APPL MICROBIOL, V42, P642, DOI 10.1111/j.1472-765X.2006.01875.x; McClure P, 2000, WORLD J MICROB BIOT, V16, P749, DOI 10.1023/A:1008997310966; Mellefont LA, 2005, INT J FOOD MICROBIOL, V105, P399, DOI 10.1016/j.ijfoodmicro.2005.03.018; Mellefont LA, 2003, INT J FOOD MICROBIOL, V83, P281, DOI 10.1016/S0168-1605(02)00377-X; Mellefont LA, 2003, INT J FOOD MICROBIOL, V83, P295, DOI 10.1016/S0168-1605(02)00378-1; Meredith TC, 2007, J BIOL CHEM, V282, P7790, DOI 10.1074/jbc.M611034200; MEURY J, 1991, J BACTERIOL, V173, P4404, DOI 10.1128/JB.173.14.4404-4410.1991; MEURY J, 1994, FEMS MICROBIOL LETT, V121, P281, DOI 10.1016/0378-1097(94)90304-2; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; O'Byrne CP, 2002, INT J FOOD MICROBIOL, V74, P203, DOI 10.1016/S0168-1605(01)00681-X; OPHIR T, 1994, APPL ENVIRON MICROB, V60, P740, DOI 10.1128/AEM.60.2.740-745.1994; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Pham TV, 2010, BIOINFORMATICS, V26, P363, DOI 10.1093/bioinformatics/btp677; Pin C, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-108; Pratt LA, 1996, MOL MICROBIOL, V20, P911, DOI 10.1111/j.1365-2958.1996.tb02532.x; Price NL, 2009, J BACTERIOL, V191, P1798, DOI 10.1128/JB.00798-08; Rauch A, 2006, J PROTEOME RES, V5, P112, DOI 10.1021/pr0503533; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Ribeiro GF, 2006, MOL BIOL CELL, V17, P4584, DOI 10.1091/mbc.E06-05-0475; Robinson TP, 1998, INT J FOOD MICROBIOL, V44, P83, DOI 10.1016/S0168-1605(98)00120-2; Robinson TP, 2001, INT J FOOD MICROBIOL, V70, P163, DOI 10.1016/S0168-1605(01)00541-4; RON EZ, 1990, ANTON LEEUW INT J G, V58, P169, DOI 10.1007/BF00548929; Ross T, 2003, INT J FOOD MICROBIOL, V82, P33, DOI 10.1016/S0168-1605(02)00252-0; Rossouw D, 2010, APPL ENVIRON MICROB, V76, P3911, DOI 10.1128/AEM.00586-10; Russell NJ, 1995, INT J FOOD MICROBIOL, V28, P255, DOI 10.1016/0168-1605(95)00061-5; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shabala L, 2008, RES MICROBIOL, V159, P458, DOI 10.1016/j.resmic.2008.04.011; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; Sledjeski DD, 1996, J BACTERIOL, V178, P1204, DOI 10.1128/jb.178.4.1204-1206.1996; Thomas JG, 2000, MOL MICROBIOL, V36, P1360, DOI 10.1046/j.1365-2958.2000.01951.x; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; Vaara M, 1999, ANTIMICROB AGENTS CH, V43, P1459, DOI 10.1128/AAC.43.6.1459; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; VUORIO R, 1992, ANTIMICROB AGENTS CH, V36, P826, DOI 10.1128/AAC.36.4.826; Watanabe H, 1996, LANCET, V348, P831, DOI 10.1016/S0140-6736(05)65257-9; Weber A, 2002, J BACTERIOL, V184, P5502, DOI 10.1128/JB.184.19.5502-5507.2002; Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Wecker P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-410; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001; Zhou K, 2011, APPL ENVIRON MICROB, V77, P1758, DOI 10.1128/AEM.02629-10; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	95	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90422	10.1371/journal.pone.0090422	http://dx.doi.org/10.1371/journal.pone.0090422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594867	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900108
J	Riffel, P; Michaely, HJ; Morelli, JN; Pfeuffer, J; Attenberger, UI; Schoenberg, SO; Haneder, S				Riffel, Philipp; Michaely, Henrik J.; Morelli, John N.; Pfeuffer, Josef; Attenberger, Ulrike I.; Schoenberg, Stefan O.; Haneder, Stefan			Zoomed EPI-DWI of the Pancreas Using Two-Dimensional Spatially-Selective Radiofrequency Excitation Pulses	PLOS ONE			English	Article							DIFFUSION; REPRODUCIBILITY; EXPERIENCE; ABDOMEN	Background: Implementation of DWI in the abdomen is challenging due to artifacts, particularly those arising from differences in tissue susceptibility. Two-dimensional, spatially-selective radiofrequency (RF) excitation pulses for single-shot echo-planar imaging (EPI) combined with a reduction in the FOV in the phase-encoding direction (i.e. zooming) leads to a decreased number of k-space acquisition lines, significantly shortening the EPI echo train and potentially susceptibility artifacts. Purpose: To assess the feasibility and image quality of a zoomed diffusion-weighted EPI (z-EPI) sequence in MR imaging of the pancreas. The approach is compared to conventional single-shot EPI (c-EPI). Material and Methods: 23 patients who had undergone an MRI study of the abdomen were included in this retrospective study. Examinations were performed on a 3T whole-body MR system (Magnetom Skyra, Siemens) equipped with a two-channel fully dynamic parallel transmit array (TimTX TrueShape, Siemens). The acquired sequences consisted of a conventional EPI DWI of the abdomen and a zoomed EPI DWI of the pancreas. For z-EPI, the standard sinc excitation was replaced with a two-dimensional spatially-selective RF pulse using an echo-planar transmit trajectory. Images were evaluated with regard to image blur, respiratory motion artifacts, diagnostic confidence, delineation of the pancreas, and overall scan preference. Additionally ADC values of the pancreatic head, body, and tail were calculated and compared between sequences. Results: The pancreas was better delineated in every case (23/23) with z-EPI versus c-EPI. In every case (23/23), both readers preferred z-EPI overall to c-EPI. With z-EPI there was statistically significantly less image blur (p<0.0001) and respiratory motion artifact compared to c-EPI (p<0.0001). Diagnostic confidence was statistically significantly better with z-EPI (p<0.0001). No statistically significant differences in calculated ADC values were observed between the two sequences. Conclusion: Zoomed diffusion-weighted EPI leads to substantial image quality improvements with reduction of susceptibility artifacts in pancreatic DWI.	[Riffel, Philipp; Michaely, Henrik J.; Attenberger, Ulrike I.; Schoenberg, Stefan O.; Haneder, Stefan] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Inst Clin Radiol & Nucl Med, Mannheim, Germany; [Morelli, John N.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Pfeuffer, Josef] Siemens Healthcare Sect, Applicat Dev, Erlangen, Germany	Ruprecht Karls University Heidelberg; Johns Hopkins University; Siemens AG	Riffel, P (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Inst Clin Radiol & Nucl Med, Mannheim, Germany.	Philipp.Riffel@umm.de	Attenberger, Ulrike/HDN-2286-2022; Attenberger, Ulrike/ABD-8541-2020	Attenberger, Ulrike/0000-0002-8123-5447; Attenberger, Ulrike/0000-0002-8123-5447; Pfeuffer, Josef/0000-0001-9887-0458				Akisik MF, 2009, RADIOLOGY, V250, P103, DOI 10.1148/radiol.2493080160; [Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Barral M, 2013, Diagn Interv Imaging, V94, P619, DOI 10.1016/j.diii.2013.02.011; Barral M, 2013, Diagn Interv Imaging, V94, P418, DOI 10.1016/j.diii.2012.12.007; Bilgili MYK, 2012, EUR J RADIOL, V81, P2066, DOI 10.1016/j.ejrad.2011.06.045; Braithwaite AC, 2009, RADIOLOGY, V250, P459, DOI 10.1148/radiol.2502080849; Herrmann J, 2013, J MAGN RESON IMAGING, V37, P886, DOI 10.1002/jmri.23871; Ichikawa T, 1999, ABDOM IMAGING, V24, P456, DOI 10.1007/s002619900539; Kang KM, 2013, J MAGN RESON IMAGING; Kartalis N, 2009, EUR RADIOL, V19, P1981, DOI 10.1007/s00330-009-1384-8; Katscher U, 2003, MAGNET RESON MED, V49, P144, DOI 10.1002/mrm.10353; Klauss M, 2011, INVEST RADIOL, V46, P57, DOI 10.1097/RLI.0b013e3181fb3bf2; Kwee TC, 2008, J MAGN RESON IMAGING, V28, P1141, DOI 10.1002/jmri.21569; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Morelli J, 2013, ACTA RADIOL; MULLER MF, 1994, RADIOLOGY, V190, P475; Naganawa Shinji, 2005, Magn Reson Med Sci, V4, P175, DOI 10.2463/mrms.4.175; Pfeuffer J, 2002, NEUROIMAGE, V17, P272, DOI 10.1006/nimg.2002.1103; Rao RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032613; Rieseberg S, 2002, MAGN RESON MED, V47, P1186, DOI 10.1002/mrm.10157; Wang Y, 2011, J MAGN RESON IMAGING, V33, P136, DOI 10.1002/jmri.22414; Zhang JB, 2008, RADIOLOGY, V247, P458, DOI 10.1148/radiol.2472070823; Zhu YD, 2004, MAGNET RESON MED, V51, P775, DOI 10.1002/mrm.20011	23	43	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89468	10.1371/journal.pone.0089468	http://dx.doi.org/10.1371/journal.pone.0089468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594702	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900018
J	Zou, XL; Hu, CW; Zeng, L; Cheng, Y; Xu, MY; Zhang, XK				Zou, Xiling; Hu, Chengwei; Zeng, Liu; Cheng, Yong; Xu, Mingyue; Zhang, Xuekun			A Comparison of Screening Methods to Identify Waterlogging Tolerance in the Field in Brassica napus L. during Plant Ontogeny	PLOS ONE			English	Article							SUBMERGENCE TOLERANCE; NATURAL VARIATION; SEEDLING GROWTH; FLOODING STRESS; GERMINATION; RICE; IDENTIFICATION; RESPONSES; ROOTS; STAGE	Waterlogging tolerance is typically evaluated at a specific development stage, with an implicit assumption that differences in waterlogging tolerance expressed in these systems will result in improved yield performance in fields. It is necessary to examine these criteria in fields. In the present study, three experiments were conducted to screen waterlogging tolerance in 25 rapeseed (Brassica napus L.) varieties at different developmental stages, such as seedling establishment stage and seedling stage at controlled environment, and maturity stage in the fields. The assessments for physiological parameters at three growth stages suggest that there were difference of waterlogging tolerance at all the development stages, providing an important basis for further development of breeding more tolerant materials. The results indicated that flash waterlogging restricts plant growth and growth is still restored after removal of the stress. Correlation analysis between waterlogging tolerance coefficient (WTC) of yield and other traits revealed that there was consistency in waterlogging tolerance of the genotypes until maturity, and good tolerance at seedling establishment stage and seedling stage can guarantee tolerance in later stages. The waterlogging-tolerant plants could be selected using some specific traits at any stage, and selections would be more effective at the seedling establishment stage. Thus, our study provides a method for screening waterlogging tolerance, which would enable the suitable basis for initial selection of a large number of germplasm or breeding populations for waterlogging tolerance and help for verifying their potential utility in crop-improvement.	[Zou, Xiling; Hu, Chengwei; Zeng, Liu; Cheng, Yong; Xu, Mingyue; Zhang, Xuekun] Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Oil Crop Biol & Genet Improvement, Wuhan, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Zhang, XK (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Oil Crop Biol & Genet Improvement, Wuhan, Hubei, Peoples R China.	seedcq@263.net			National Science Foundation of China [31171589, 31201244]; Hi-Tech Research and Development Program of China [2011AA10A104]; Special Fund for Agroscientific Research in the Public Interest [2101203032]; China Postdoctoral Science Foundation [2013M530081]; Hubei agricultural science and Technology Innovation Center	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Special Fund for Agroscientific Research in the Public Interest; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Hubei agricultural science and Technology Innovation Center	This work is supported by National Science Foundation of China (31171589), (31201244), Hi-Tech Research and Development Program of China (2011AA10A104), Special Fund for Agroscientific Research in the Public Interest (2101203032), China Postdoctoral Science Foundation (2013M530081) and Hubei agricultural science and Technology Innovation Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/963525; ALANI A, 1985, PLANT PHYSIOL, V79, P885, DOI 10.1104/pp.79.3.885; ALPI A, 1983, PLANT PHYSIOL, V71, P30, DOI 10.1104/pp.71.1.30; Amador ML, 2012, PHYSIOL PLANTARUM, V144, P357, DOI 10.1111/j.1399-3054.2012.01568.x; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Chen X, 2010, PLANT PHYSIOL, V154, P969, DOI 10.1104/pp.110.162792; Christianson JA, 2010, PLANT CELL PHYSIOL, V51, P21, DOI 10.1093/pcp/pcp163; Cornelious B, 2005, MOL BREEDING, V16, P103, DOI 10.1007/s11032-005-5911-2; Fukao T, 2003, J EXP BOT, V54, P1421, DOI 10.1093/jxb/erg140; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Ismail AM, 2009, ANN BOT-LONDON, V103, P197, DOI 10.1093/aob/mcn211; Jackson MB, 2005, ANN BOT-LONDON, V96, P501, DOI 10.1093/aob/mci205; KENNEDY RA, 1992, PLANT PHYSIOL, V100, P1, DOI 10.1104/pp.100.1.1; Komatsu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065301; Kruse RL, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-61; Lee SC, 2011, NEW PHYTOL, V190, P457, DOI 10.1111/j.1469-8137.2010.03590.x; Magneschi L, 2009, ANN BOT-LONDON, V103, P181, DOI 10.1093/aob/mcn121; Nagai K, 2010, J PLANT RES, V123, P303, DOI 10.1007/s10265-010-0332-7; Pigliucci M, 2002, ANN BOT-LONDON, V90, P199, DOI 10.1093/aob/mcf164; Qiu FZ, 2007, ANN BOT-LONDON, V99, P1067, DOI 10.1093/aob/mcm055; Sauter M, 2013, CURR OPIN PLANT BIOL, V16, P282, DOI 10.1016/j.pbi.2013.03.013; Setter TL, 2009, ANN BOT-LONDON, V103, P221, DOI 10.1093/aob/mcn137; Shimono H, 2012, PLANT PROD SCI, V15, P238, DOI 10.1626/pps.15.238; Thomas AL, 2005, ANN BOT-LONDON, V96, P1191, DOI 10.1093/aob/mci272; VanToai TT, 2001, CROP SCI, V41, P1247, DOI 10.2135/cropsci2001.4141247x; Vashisht D, 2011, NEW PHYTOL, V190, P299, DOI 10.1111/j.1469-8137.2010.03552.x; Voesenek L, 2013, CURRENT OPINION PLAN; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Yu M, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-245; Yu XQ, 2012, J PLANT PHYSIOL, V169, P1040, DOI 10.1016/j.jplph.2012.03.001; Zaidi PH, 2003, EUR J AGRON, V19, P383, DOI 10.1016/S1161-0301(02)00090-4; Zeng FR, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00313; Zheng Chun-fang, 2009, Yingyong Shengtai Xuebao, V20, P2391; Zou XL, 2013, INT J MOL SCI, V14, P2637, DOI 10.3390/ijms14022637; Zou XL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-189	36	28	30	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89731	10.1371/journal.pone.0089731	http://dx.doi.org/10.1371/journal.pone.0089731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594687	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900032
J	Bareja, A; Holt, JA; Luo, GZ; Chang, C; Lin, JY; Hinken, AC; Freudenberg, JM; Kraus, WE; Evans, WJ; Billin, AN				Bareja, Akshay; Holt, Jason A.; Luo, Guizhen; Chang, Calvin; Lin, Junyu; Hinken, Aaron C.; Freudenberg, Johannes M.; Kraus, William E.; Evans, William J.; Billin, Andrew N.			Human and Mouse Skeletal Muscle Stem Cells: Convergent and Divergent Mechanisms of Myogenesis	PLOS ONE			English	Article							SATELLITE CELLS; PROGENITOR CELLS; SELF-RENEWAL; EXPRESSION; MYF5; DIFFERENTIATION; RECRUITMENT; MARKER	Satellite cells are the chief contributor to skeletal muscle growth and regeneration. The study of mouse satellite cells has accelerated in recent years due to technical advancements in the isolation of these cells. The study of human satellite cells has lagged and thus little is known about how the biology of mouse and human satellite cells compare. We developed a flow cytometry-based method to prospectively isolate human skeletal muscle progenitors from the satellite cell pool using positive and negative selection markers. Results show that this pool is enriched in PAX7 expressing cells that possess robust myogenic potential including the ability to give rise to de novo muscle in vivo. We compared mouse and human satellite cells in culture and identify differences in the elaboration of the myogenic genetic program and in the sensitivity of the cells to cytokine stimulation. These results indicate that not all mechanisms regulating mouse satellite cell activation are conserved in human satellite cells and that such differences may impact the clinical translation of therapeutics validated in mouse models. Thus, the findings of this study are relevant to developing therapies to combat muscle disease.	[Bareja, Akshay; Kraus, William E.] Duke Univ, Dept Med, Durham, NC USA; [Bareja, Akshay; Holt, Jason A.; Luo, Guizhen; Evans, William J.; Billin, Andrew N.] GlaxoSmithKline, Metab Pathways & Cardiovasc Therapeut Area, Muscle Metab Discovery Performance Unit, Res Triangle Pk, NC 27709 USA; [Chang, Calvin; Lin, Junyu; Hinken, Aaron C.] Five Prime Therapeut Inc, San Francisco, CA USA; [Freudenberg, Johannes M.] GlaxoSmithKline, Computat Biol, Quantitat Sci, Res Triangle Pk, NC USA	Duke University; GlaxoSmithKline; GlaxoSmithKline	Billin, AN (corresponding author), GlaxoSmithKline, Metab Pathways & Cardiovasc Therapeut Area, Muscle Metab Discovery Performance Unit, Res Triangle Pk, NC 27709 USA.	andrew.n.billin@gsk.com	Bareja, Akshay/AAD-2842-2019	Freudenberg, Johannes/0000-0002-5327-4414; Billin, Andrew/0000-0001-7752-0934	GlaxoSmithKline; Claude Pepper Older Americans Center [AG028716]	GlaxoSmithKline(GlaxoSmithKline); Claude Pepper Older Americans Center	All research was funded by GlaxoSmithKline. The authors also acknowledge support in part by the Claude Pepper Older Americans Center grant AG028716. The authors independently designed the experiments, collected and analyzed the data, decided to publish, and prepared the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri G, 2004, LANCET, V364, P1872, DOI 10.1016/S0140-6736(04)17443-6; Alsharidah M, 2013, AGING CELL, V12, P333, DOI 10.1111/acel.12051; Bajard L, 2006, GENE DEV, V20, P2450, DOI 10.1101/gad.382806; Bareja A, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-2; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; BOLDRIN L, 2010, HEALTH TECHNOL ASSES, V14, P941, DOI DOI 10.1369/JHC.2010.956201; Buchberger A, 2007, DEVELOPMENT, V134, P1171, DOI 10.1242/dev.02798; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kawabe YI, 2012, CELL STEM CELL, V11, P333, DOI 10.1016/j.stem.2012.07.001; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McKay BR, 2012, FASEB J, V26, P2509, DOI 10.1096/fj.11-198663; McKay BR, 2010, J PHYSIOL-LONDON, V588, P3307, DOI 10.1113/jphysiol.2010.190876; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Meng JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017454; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Montarras D, 2013, FEBS J, V280, P4036, DOI 10.1111/febs.12372; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Pasut A, 2012, METHODS MOL BIOL, V798, P53, DOI 10.1007/978-1-61779-343-1_3; Patten IS, 2012, TRENDS ENDOCRIN MET, V23, P90, DOI 10.1016/j.tem.2011.09.007; Pisani DF, 2010, STEM CELLS, V28, P2182, DOI 10.1002/stem.537; Pisani DF, 2010, STEM CELLS, V28, P753, DOI 10.1002/stem.317; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; SCHUBERT W, 1989, P NATL ACAD SCI USA, V86, P307, DOI 10.1073/pnas.86.1.307; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Skuk D, 2010, MOL THER, V18, P1689, DOI 10.1038/mt.2010.128; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Verdijk LB, 2007, AM J PHYSIOL-ENDOC M, V292, pE151, DOI 10.1152/ajpendo.00278.2006; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Yi L, 2011, JOVE-J VIS EXP, DOI 10.3791/2476; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	42	55	57	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90398	10.1371/journal.pone.0090398	http://dx.doi.org/10.1371/journal.pone.0090398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587351	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200190
J	Hansel, G; Ramos, DB; Delgado, CA; Souza, DG; Almeida, RF; Portela, LV; Quincozes-Santos, A; Souza, DO				Hansel, Gisele; Ramos, Denise Barbosa; Delgado, Camila Aguilar; Souza, Debora Guerini; Almeida, Roberto Farina; Portela, Luis Valmor; Quincozes-Santos, Andre; Souza, Diogo Onofre			The Potential Therapeutic Effect of Guanosine after Cortical Focal Ischemia in Rats	PLOS ONE			English	Article							OXIDATIVE STRESS; HIPPOCAMPAL SLICES; GLUTAMATE UPTAKE; NEUROBLASTOMA-CELLS; GLUCOSE DEPRIVATION; RODENT MODELS; VITAMIN-C; IN-VITRO; BRAIN; STROKE	Background and Purpose: Stroke is a devastating disease. Both excitotoxicity and oxidative stress play important roles in ischemic brain injury, along with harmful impacts on ischemic cerebral tissue. As guanosine plays an important neuroprotective role in the central nervous system, the purpose of this study was to evaluate the neuroprotective effects of guanosine and putative cerebral events following the onset of permanent focal cerebral ischemia. Methods: Permanent focal cerebral ischemia was induced in rats by thermocoagulation. Guanosine was administered immediately, 1 h, 3 h and 6 h after surgery. Behavioral performance was evaluated by cylinder testing for a period of 15 days after surgery. Brain oxidative stress parameters, including levels of ROS/RNS, lipid peroxidation, antioxidant nonenzymatic levels (GSH, vitamin C) and enzymatic parameters (SOD expression and activity and CAT activity), as well as glutamatergic parameters (EAAC1, GLAST and GLT1, glutamine synthetase) were analyzed. Results: After 24 h, ischemic injury resulted in impaired function of the forelimb, caused brain infarct and increased lipid peroxidation. Treatment with guanosine restored these parameters. Oxidative stress markers were affected by ischemic insult, demonstrated by increased ROS/RNS levels, increased SOD expression with reduced SOD activity and decreased nonenzymatic (GSH and vitamin C) antioxidant defenses. Guanosine prevented increased ROS/RNS levels, decreased SOD activity, further increased SOD expression, increased CAT activity and restored vitamin C levels. Ischemia also affected glutamatergic parameters, illustrated by increased EAAC1 levels and decreased GLT1 levels; guanosine reversed the decreased GLT1 levels and did not affect the EAAC1 levels. Conclusion: The effects of brain ischemia were strongly attenuated by guanosine administration. The cellular mechanisms involved in redox and glutamatergic homeostasis, which were both affected by the ischemic insult, were also modulated by guanosine. These observations reveal that guanosine may represent a potential therapeutic agent in cerebral ischemia by preventing oxidative stress and excitotoxicity.	[Hansel, Gisele; Ramos, Denise Barbosa; Delgado, Camila Aguilar; Souza, Debora Guerini; Almeida, Roberto Farina; Portela, Luis Valmor; Quincozes-Santos, Andre; Souza, Diogo Onofre] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Hansel, G (corresponding author), Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil.	gihansel@gmail.com	Souza, Diogo O/J-8894-2014; Quincozes-Santos, André/AAO-2714-2020; de Almeida, Roberto Farina F/A-6827-2018; Portela, Luis V/I-3410-2014; Hansel, Gisele/A-9150-2015	Souza, Diogo O/0000-0002-4322-0404; de Almeida, Roberto Farina F/0000-0002-2429-3309; Hansel, Gisele/0000-0001-5048-1293; Portela, Luis Valmor/0000-0001-6113-8466	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Financiadora de Estudos e Projetos (FINEP); IBN.Net [01.06.0842-00]; Instituto Nacional de Ciencia e Tecnologia para Excitotoxicidade e Neuroprotecao (INCTEN)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); IBN.Net; Instituto Nacional de Ciencia e Tecnologia para Excitotoxicidade e Neuroprotecao (INCTEN)	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), Financiadora de Estudos e Projetos (FINEP), IBN.Net 01.06.0842-00 and Instituto Nacional de Ciencia e Tecnologia para Excitotoxicidade e Neuroprotecao (INCTEN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Albrecht P, 2013, NEUROCHEM INT, V62, P610, DOI 10.1016/j.neuint.2013.01.019; Allen CL, 2009, INT J STROKE, V4, P461, DOI 10.1111/j.1747-4949.2009.00387.x; Aoyama K, 2008, J PHARMACOL SCI, V108, P227, DOI 10.1254/jphs.08R01CR; Biasibetti R, 2013, BEHAV BRAIN RES, V236, P186, DOI 10.1016/j.bbr.2012.08.039; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Browne R W, 1998, Methods Mol Biol, V108, P347; Chang R, 2008, NEUROSCI LETT, V431, P101, DOI 10.1016/j.neulet.2007.11.072; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Ciccarelli R, 1999, GLIA, V25, P93, DOI 10.1002/(SICI)1098-1136(19990101)25:1<93::AID-GLIA9>3.0.CO;2-N; Connell BJ, 2013, J NEUROSCI RES, V91, P262, DOI 10.1002/jnr.23156; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; Dal-Cim T, 2011, NEUROSCIENCE, V183, P212, DOI 10.1016/j.neuroscience.2011.03.022; Dal-Cim T, 2013, J NEUROCHEM, V126, P437, DOI 10.1111/jnc.12324; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; dos Santos AQ, 2006, ARCH BIOCHEM BIOPHYS, V453, P161, DOI 10.1016/j.abb.2006.06.025; dos Santos AD, 2010, BRAIN RES, V1306, P149, DOI 10.1016/j.brainres.2009.09.094; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Elkind MSV, 2010, STROKE, V41, pS3, DOI 10.1161/STROKEAHA.110.594945; Fujimura M, 2005, NEUROCRIT CARE, V2, P59, DOI 10.1385/NCC:2:1:059; Giuliani P, 2012, PANMINERVA MED S4, V54, P43; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gudkov SV, 2009, INT J RADIAT BIOL, V85, P116, DOI 10.1080/09553000802641144; Had-Aissouni L, 2012, AMINO ACIDS, V42, P181, DOI 10.1007/s00726-011-0863-9; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; Hertz L, 2008, NEUROPHARMACOLOGY, V55, P289, DOI 10.1016/j.neuropharm.2008.05.023; HEVEL JM, 1994, METHOD ENZYMOL, V233, P250; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu Shimin, 2009, J Exp Stroke Transl Med, V2, P2; Macrae IM, 2011, BRIT J PHARMACOL, V164, P1062, DOI 10.1111/j.1476-5381.2011.01398.x; Malarkey EB, 2008, NEUROCHEM INT, V52, P142, DOI 10.1016/j.neuint.2007.06.005; May James M, 2012, Subcell Biochem, V56, P85, DOI 10.1007/978-94-007-2199-9_6; Moretto MB, 2009, J MOL NEUROSCI, V38, P216, DOI 10.1007/s12031-008-9154-7; Moretto MB, 2005, EXP NEUROL, V195, P400, DOI 10.1016/j.expneurol.2005.06.005; Nanetti L, 2011, EUR J CLIN INVEST, V41, P1318, DOI 10.1111/j.1365-2362.2011.02546.x; Niizuma K, 2010, BBA-MOL BASIS DIS, V1802, P92, DOI 10.1016/j.bbadis.2009.09.002; Oleskovicz SPB, 2008, NEUROCHEM INT, V52, P411, DOI 10.1016/j.neuint.2007.07.017; Olmez I, 2012, NEUROCHEM INT, V60, P208, DOI 10.1016/j.neuint.2011.11.009; Petronilho F, 2012, BRAIN BEHAV IMMUN, V26, P904, DOI 10.1016/j.bbi.2012.03.007; Pettifer KM, 2007, PURINERG SIGNAL, V3, P399, DOI 10.1007/s11302-007-9073-z; Quincozes-Santos A, 2013, PURINERG SIGNAL; Rathbone M, 2008, NUCLEOS NUCLEOT NUCL, V27, P666, DOI 10.1080/15257770802143913; Rathbone MP, 2011, BRAIN RES, V1407, P79, DOI 10.1016/j.brainres.2011.06.027; Roos DH, 2009, TOXICOL IN VITRO, V23, P302, DOI 10.1016/j.tiv.2008.12.020; Sakata Y, 2010, EXP NEUROL, V224, P325, DOI 10.1016/j.expneurol.2010.03.032; Sanchez-Moreno C, 2004, STROKE, V35, P163, DOI 10.1161/01.STR.0000105391.62306.2E; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Schmidt AP, 2010, BRIT J PHARMACOL, V159, P1247, DOI 10.1111/j.1476-5381.2009.00597.x; Schmidt AP, 2007, PHARMACOL THERAPEUT, V116, P401, DOI 10.1016/j.pharmthera.2007.07.004; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; SZELE FG, 1995, J NEUROSCI, V15, P4429; Tarozzi A, 2010, J BIOL REG HOMEOS AG, V24, P297; Tavares RG, 2008, NEUROCHEM RES, V33, P97, DOI 10.1007/s11064-007-9421-y; Terpolilli NA, 2012, J CEREBR BLOOD F MET, V32, P1332, DOI 10.1038/jcbfm.2012.12; Thomazi AP, 2008, BRAIN RES, V1188, P233, DOI 10.1016/j.brainres.2007.10.037; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; UEMURA Y, 1991, STROKE, V22, P1548, DOI 10.1161/01.STR.22.12.1548; Vislisel JM, 2007, ANAL BIOCHEM, V365, P31, DOI 10.1016/j.ab.2007.03.002; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022; Zadori D, 2012, J NEUROL SCI, V322, P187, DOI 10.1016/j.jns.2012.06.004	65	40	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90693	10.1371/journal.pone.0090693	http://dx.doi.org/10.1371/journal.pone.0090693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587409	gold, Green Submitted, Green Published			2022-12-27	WOS:000332396200244
J	Korenic, A; Boltze, J; Deten, A; Peters, M; Andjus, P; Radenovic, L				Korenic, Andrej; Boltze, Johannes; Deten, Alexander; Peters, Myriam; Andjus, Pavle; Radenovic, Lidija			Astrocytic Mitochondrial Membrane Hyperpolarization following Extended Oxygen and Glucose Deprivation	PLOS ONE			English	Article							OXIDATIVE STRESS; SUBCELLULAR HETEROGENEITY; PRIMARY CULTURES; NITRIC-OXIDE; NEURONS; INHIBITION; INDICATOR; APOPTOSIS; DEPOLARIZATION; DYSFUNCTION	Astrocytes can tolerate longer periods of oxygen and glucose deprivation (OGD) as compared to neurons. The reasons for this reduced vulnerability are not well understood. Particularly, changes in mitochondrial membrane potential (Delta psi(m)) in astrocytes, an indicator of the cellular redox state, have not been investigated during reperfusion after extended OGD exposure. Here, we subjected primary mouse astrocytes to glucose deprivation (GD), OGD and combinations of both conditions varying in duration and sequence. Changes in Delta psi(m), visualized by change in the fluorescence of JC-1, were investigated within one hour after reconstitution of oxygen and glucose supply, intended to model in vivo reperfusion. In all experiments, astrocytes showed resilience to extended periods of OGD, which had little effect on Delta psi(m) during reperfusion, whereas GD caused a robust Delta psi(m) negativation. In case no Delta psi(m) negativation was observed after OGD, subsequent chemical oxygen deprivation (OD) induced by sodium azide caused depolarization, which, however, was significantly delayed as compared to normoxic group. When GD preceded OD for 12 h, Delta psi(m) hyperpolarization was induced by both GD and subsequent OD, but significant interaction between these conditions was not detected. However, when GD was extended to 48 h preceding OGD, hyperpolarization enhanced during reperfusion. This implicates synergistic effects of both conditions in that sequence. These findings provide novel information regarding the role of the two main substrates of electron transport chain (glucose and oxygen) and their hyperpolarizing effect on Delta psi(m) during substrate deprivation, thus shedding new light on mechanisms of astrocyte resilience to prolonged ischemic injury.	[Korenic, Andrej; Andjus, Pavle; Radenovic, Lidija] Univ Belgrade, Dept Physiol & Biochem, Ctr Laser Microscopy, Fac Biol, Belgrade, Serbia; [Boltze, Johannes; Deten, Alexander; Peters, Myriam] Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany; [Boltze, Johannes] Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany; [Boltze, Johannes] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Boltze, Johannes] Harvard Univ, Sch Med, Boston, MA USA	University of Belgrade; Fraunhofer Gesellschaft; Leipzig University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Korenic, A (corresponding author), Univ Belgrade, Dept Physiol & Biochem, Ctr Laser Microscopy, Fac Biol, Belgrade, Serbia.	agapije@gmail.com		Boltze, Johannes/0000-0003-3956-4164; Radenovic, Lidija/0000-0002-6632-0483; Korenic, Andrej/0000-0001-9476-7445	Fraunhofer Institute for Cell Therapy and Immunology (Department of Cell Therapy); DAAD (German Academic Exchange Service, Deutscher Akademischer Austauschdienst); Serbian Ministry of Education and Science [III 41005]	Fraunhofer Institute for Cell Therapy and Immunology (Department of Cell Therapy); DAAD (German Academic Exchange Service, Deutscher Akademischer Austauschdienst); Serbian Ministry of Education and Science(Ministry of Education, Science & Technological Development, Serbia)	This study was supported by intramural funds of the Fraunhofer Institute for Cell Therapy and Immunology (Department of Cell Therapy) and a DAAD (German Academic Exchange Service, Deutscher Akademischer Austauschdienst) short term research fellowship, as well as by the Serbian Ministry of Education and Science (III 41005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2002, NEUROSCI LETT, V326, P179, DOI 10.1016/S0304-3940(02)00347-6; Almeida A, 2001, P NATL ACAD SCI USA, V98, P15294, DOI 10.1073/pnas.261560998; Almeida A, 2002, J NEUROCHEM, V81, P207, DOI 10.1046/j.1471-4159.2002.00827.x; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Chinopoulos C, 1999, J NEUROCHEM, V73, P220, DOI 10.1046/j.1471-4159.1999.0730220.x; Davies KJA, 1999, IUBMB LIFE, V48, P41, DOI 10.1080/152165499307404; Diaz G, 1999, J CELL SCI, V112, P1077; DILISA F, 1995, J PHYSIOL-LONDON, V486, P1; Feeney CJ, 2003, J NEUROSCI METH, V125, P13, DOI 10.1016/S0165-0270(03)00027-X; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; GREGORY GA, 1989, J CEREBR BLOOD F MET, V9, P29, DOI 10.1038/jcbfm.1989.4; Jelluma N, 2006, MOL CANCER RES, V4, P319, DOI 10.1158/1541-7786.MCR-05-0061; Keil VC, 2011, PFLUG ARCH EUR J PHY, V462, P693, DOI 10.1007/s00424-011-1012-8; Kintner DB, 2007, AM J PHYSIOL-CELL PH, V292, pC1113, DOI 10.1152/ajpcell.00412.2006; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MUNEYUKI E, 1993, BIOCHIM BIOPHYS ACTA, V1144, P62, DOI 10.1016/0005-2728(93)90031-A; Ouyang YB, 2002, FREE RADICAL BIO MED, V33, P544, DOI 10.1016/S0891-5849(02)00912-7; Qin AP, 2010, AUTOPHAGY, V6, P738, DOI 10.4161/auto.6.6.12573; RAHN CA, 1991, FUND APPL TOXICOL, V16, P435, DOI 10.1016/0272-0590(91)90084-H; Rajapakse N, 2003, J NEUROSCI RES, V73, P206, DOI 10.1002/jnr.10657; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Reichert SA, 2001, J NEUROSCI, V21, P6608, DOI 10.1523/JNEUROSCI.21-17-06608.2001; Safiulina D, 2006, J CELL PHYSIOL, V206, P347, DOI 10.1002/jcp.20476; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Smith IF, 2003, J BIOL CHEM, V278, P4875, DOI 10.1074/jbc.M209206200; SOCHOCKA E, 1994, BRAIN RES, V638, P21, DOI 10.1016/0006-8993(94)90628-9; Takahashi S, 2012, J DIABETES MELLITUS, V02, P19; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; VASILYEVA EA, 1982, BIOCHEM J, V202, P15, DOI 10.1042/bj2020015; Xu M, 2012, BRAIN RES, V1454, P48, DOI 10.1016/j.brainres.2012.03.020; YOSHIKAWA S, 1992, J BIOL CHEM, V267, P9757; YU ACH, 1989, J CEREBR BLOOD F MET, V9, P20, DOI 10.1038/jcbfm.1989.3; Yu ACH, 2001, GLIA, V35, P121, DOI 10.1002/glia.1077	34	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90697	10.1371/journal.pone.0090697	http://dx.doi.org/10.1371/journal.pone.0090697			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587410	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200246
J	Weng, ZY; Patel, AB; Vasiadi, M; Therianou, A; Theoharides, TC				Weng, Zuyi; Patel, Arti B.; Vasiadi, Magdalini; Therianou, Anastasia; Theoharides, Theoharis C.			Luteolin Inhibits Human Keratinocyte Activation and Decreases NF-kappa B Induction That Is Increased in Psoriatic Skin	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; DIFFERENTIAL EXPRESSION; MAST-CELLS; INFLAMMATION; SAFETY; PROLIFERATION; DERMATOLOGY; FLAVONOIDS; QUERCETIN; TOXICITY	Psoriasis (Ps) is an autoimmune disease characterized by keratinocyte hyperproliferation and chronic inflammation, with increased expression of tumor necrosis factor (TNF) and vascular endothelial growth factor (VEGF). Anti-TNF biologic agents are effective in treating Ps, but are associated with increased risk of infections and blood malignancies. Moreover, keratinocyte hyperproliferation and activation have yet to be addressed. Flavonoids, such as luteolin, are natural compounds with potent anti-inflammatory properties, but their actions on keratinocytes remain unknown. We show that TNF (50 ng/mL) triggers significant production of inflammatory mediators interleukin-6, interleukin-8 and VEGF from both human HaCaT and primary keratinocytes. Pretreatment with the flavonoid luteolin (10-100 mu M) significantly inhibits mRNA expression and release of all three mediators in a concentration-dependent manner. More importantly, luteolin decreases TNF-induced phosphorylation, nuclear translocation and DNA binding of the nuclear factor-kappa B (NF-kappa B) typically involved in inflammatory mediator transcription. We also report that luteolin reduces TNF-induced mRNA expression of two genes (NFKB1 and RELA) encoding two NF-kappa B subunits (NF-kappa B p50 and NF-kappa B p65, respectively). Interestingly, we show that gene expression of RELA is increased in human psoriatic skin. Keratinocyte proliferation, which is a characteristic feature of psoriatic skin, is effectively reduced by luteolin in HaCaT cells, but not in primary keratinocytes. Finally, luteolin does not affect intracellular ATP production or viability. Appropriate formulations of luteolin and related flavones may be promising candidates to be developed into local and systemic treatments for Ps and other inflammatory skin diseases.	[Weng, Zuyi; Patel, Arti B.; Vasiadi, Magdalini; Theoharides, Theoharis C.] Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Mol Immunopharmacol & Drug Discovery Lab, Boston, MA 02111 USA; [Weng, Zuyi; Vasiadi, Magdalini; Theoharides, Theoharis C.] Tufts Univ, Grad Program Pharmacol & Expt Therapeut, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; [Patel, Arti B.; Theoharides, Theoharis C.] Tufts Univ, Grad Program Biochem, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; [Therianou, Anastasia] Univ Athens, Sch Med, Dept Dermatol 1, A Sygros Hosp, GR-11527 Athens, Greece; [Theoharides, Theoharis C.] Tufts Univ, Sch Med, Dept Internal Med, Boston, MA 02111 USA; [Theoharides, Theoharis C.] Tufts Med Ctr, Boston, MA USA	Tufts University; Tufts University; Tufts University; Athens Medical School; National & Kapodistrian University of Athens; Tufts University; Tufts Medical Center	Theoharides, TC (corresponding author), Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Mol Immunopharmacol & Drug Discovery Lab, Boston, MA 02111 USA.	theoharis.theoharides@tufts.edu	weng, zuyi/J-4147-2015		National Institute of Health [AR47652]; Theta Biomedical Consulting and Development Co., Inc. (Brookline, MA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047652] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Theta Biomedical Consulting and Development Co., Inc. (Brookline, MA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by the National Institute of Health Grant AR47652 (to TCT) and by Theta Biomedical Consulting and Development Co., Inc. (Brookline, MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asadi S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-85; Belso N, 2008, J INVEST DERMATOL, V128, P634, DOI 10.1038/sj.jid.5701059; Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; Canavese M, 2010, J DERMATOL SCI, V58, P171, DOI 10.1016/j.jdermsci.2010.03.023; Parrado AC, 2012, NEUROIMMUNOMODULAT, V19, P359, DOI 10.1159/000342140; Coimbra S, 2012, INT J DERMATOL, V51, P389, DOI 10.1111/j.1365-4632.2011.05154.x; Dello Russo C, 2009, BIOCHEM PHARMACOL, V78, P1242, DOI 10.1016/j.bcp.2009.06.097; Detmar M, 2004, J INVEST DERMATOL, V122, pXIV, DOI 10.1046/j.0022-202X.2003.22140.x; Domitrovic R, 2013, TOXICOLOGY, V310, P115, DOI 10.1016/j.tox.2013.05.015; Domitrovic R, 2009, EXP TOXICOL PATHOL, V61, P581, DOI 10.1016/j.etp.2008.12.005; Galli SJ, 1996, NATURE, V381, P21, DOI 10.1038/381021a0; Goldminz AM, 2013, J DERMATOL SCI, V69, P89, DOI 10.1016/j.jdermsci.2012.11.002; Gottlieb AB, 2005, NAT REV DRUG DISCOV, V4, P19, DOI 10.1038/nrd1607; GROSSMAN RM, 1989, P NATL ACAD SCI USA, V86, P6367, DOI 10.1073/pnas.86.16.6367; Guo WM, 2009, NUTR CANCER, V61, P807, DOI 10.1080/01635580903285098; Harvima IT, 2008, ARCH DERMATOL RES, V300, P461, DOI 10.1007/s00403-008-0874-x; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; Jiang WY, 2001, INT J DERMATOL, V40, P699, DOI 10.1046/j.1365-4362.2001.01262.x; Kandere-Grzybowska K, 2003, J IMMUNOL, V171, P4830, DOI 10.4049/jimmunol.171.9.4830; Kawanishi S, 2005, ANTIOXID REDOX SIGN, V7, P1728, DOI 10.1089/ars.2005.7.1728; Kempuraj D, 2008, BRIT J PHARMACOL, V155, P1076, DOI 10.1038/bjp.2008.356; Keystone EC, 2011, J RHEUMATOL, V38, P1552, DOI 10.3899/jrheum.100995; Kimata M, 2000, CLIN EXP ALLERGY, V30, P501, DOI 10.1046/j.1365-2222.2000.00768.x; Kimball AB, 2012, J EUR ACAD DERMATOL; Kunz Manfred, 2009, Curr Drug Discov Technol, V6, P231; KUTSCH CL, 1993, J INVEST DERMATOL, V101, P79, DOI 10.1111/1523-1747.ep12360119; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li LP, 2010, J FOOD SCI, V75, pT105, DOI 10.1111/j.1750-3841.2010.01702.x; Liu ZG, 2005, CELL RES, V15, P24, DOI 10.1038/sj.cr.7290259; Lizzul PF, 2005, J INVEST DERMATOL, V124, P1275, DOI 10.1111/j.0022-202X.2005.23735.x; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; Middleton E, 2000, PHARMACOL REV, V52, P673; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nickoloff BJ, 2007, NAT MED, V13, P242, DOI 10.1038/nm0307-242; Notas G, 2012, J NUTR BIOCHEM, V23, P656, DOI 10.1016/j.jnutbio.2011.03.010; Olivieri I, 2009, EXPERT OPIN PHARMACO, V10, P271, DOI [10.1517/14656560802653198 , 10.1517/14656560802653198]; Ozdamar SO, 1996, DERMATOLOGY, V192, P190; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Reuter J, 2010, AM J CLIN DERMATOL, V11, P247, DOI 10.2165/11533220-000000000-00000; Rosenblum H, 2011, AUTOIMMUN REV, V10, P563, DOI 10.1016/j.autrev.2011.04.010; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Slominski AT, 2013, ENDOCR REV; Theoharides TC, 2001, INT J IMMUNOPATH PH, V14, P119; Verbeek R, 2004, BIOCHEM PHARMACOL, V68, P621, DOI 10.1016/j.bcp.2004.05.012; Vicentini FTMC, 2011, J DERMATOL SCI, V61, P162, DOI 10.1016/j.jdermsci.2011.01.002; Victor FC, 2003, CLIN DERMATOL, V21, P392, DOI 10.1016/j.clindermatol.2003.08.015; Weng Z, 2012, PLOS ONE, V7; Young CN, 2008, J INVEST DERMATOL, V128, P2606, DOI 10.1038/jid.2008.122; Zampetti A, 2009, INT J IMMUNOPATH PH, V22, P1067, DOI 10.1177/039463200902200423; Zbytek B, 2003, J INVEST DERMATOL, V121, P1496, DOI 10.1111/j.1523-1747.2003.12612.x; Zhang BD, 2011, J ALLERGY CLIN IMMUN, V127, P1522, DOI 10.1016/j.jaci.2011.02.005	51	53	59	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90739	10.1371/journal.pone.0090739	http://dx.doi.org/10.1371/journal.pone.0090739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587411	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200247
J	Leal, ECP; de Almeida, P; Tomazoni, SS; de Carvalho, PDC; Lopes-Martins, RAB; Frigo, L; Joensen, J; Johnson, MI; Bjordal, JM				Pinto Leal-Junior, Ernesto Cesar; de Almeida, Patricia; Tomazoni, Shaiane Silva; Camillo de Carvalho, Paulo de Tarso; Brandao Lopes-Martins, Rodrigo Alvaro; Frigo, Lucio; Joensen, Jon; Johnson, Mark I.; Bjordal, Jan Magnus			Superpulsed Low-Level Laser Therapy Protects Skeletal Muscle of mdx Mice against Damage, Inflammation and Morphological Changes Delaying Dystrophy Progression	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; SIGNALING PATHWAY; ORAL MUCOSITIS; LIGHT THERAPY; IN-VIVO; 660 NM; IRRADIATION; PAIN	Aim: To evaluate the effects of preventive treatment with low-level laser therapy (LLLT) on progression of dystrophy in mdx mice. Methods: Ten animals were rando mu ly divided into 2 experimental groups treated with superpulsed LLLT (904 nm, 15 mW, 700 Hz, 1 J) or placebo-LLLT at one point overlying the tibialis anterior muscle (bilaterally) 5 times per week for 14 weeks (from 6th to 20th week of age). Morphological changes, creatine kinase (CK) activity and mRNA gene expression were assessed in animals at 20th week of age. Results: Animals treated with LLLT showed very few morphological changes in skeletal muscle, with less atrophy and fibrosis than animals treated with placebo-LLLT. CK was significantly lower (p = 0.0203) in animals treated with LLLT (864.70 U.l(-1), SEM 226.10) than placebo (1708.00 U.l(-1), SEM 184.60). mRNA gene expression of inflammatory markers was significantly decreased by treatment with LLLT (p<0.05): TNF-alpha (placebo-control = 0.51 mu g/mu l [SEM 0.12], - LLLT = 0.048 mu g/mu l [SEM 0.01]), IL-1 beta (placebo-control = 2.292 mu g/mu l [SEM 0.74], - LLLT = 0.12 mu g/mu l [SEM 0.03]), IL-6 (placebo-control = 3.946 mu g/mu l [SEM 0.98], - LLLT = 0.854 mu g/mu l [SEM 0.33]), IL-10 (placebo-control = 1.116 mu g/mu l [SEM 0.22], - LLLT = 0.352 mu g/mu l [SEM 0.15]), and COX-2 (placebo-control = 4.984 mu g/mu l [SEM 1.18], LLLT = 1.470 mu g/mu l [SEM 0.73]). Conclusion: Irradiation of superpulsed LLLT on successive days five times per week for 14 weeks decreased morphological changes, skeletal muscle damage and inflammation in mdx mice. This indicates that LLLT has potential to decrease progression of Duchenne muscular dystrophy.	[Pinto Leal-Junior, Ernesto Cesar; de Almeida, Patricia; Camillo de Carvalho, Paulo de Tarso] Univ Nove de Julho UNINOVE, Postgrad Program Rehabil Sci, Sao Paulo, Brazil; [Pinto Leal-Junior, Ernesto Cesar; Camillo de Carvalho, Paulo de Tarso] Univ Nove de Julho UNINOVE, Postgrad Program Biophoton Appl Hlth Sci, Sao Paulo, Brazil; [Tomazoni, Shaiane Silva; Brandao Lopes-Martins, Rodrigo Alvaro] Univ Sao Paulo, Dept Pharmacol, Sao Paulo, Brazil; [Frigo, Lucio] Univ Cruzeiro Sul, Biol Sci & Hlth Ctr, Sao Paulo, Brazil; [Joensen, Jon] Bergen Univ Coll, Dept Physiotherapy Occupat Therapy & Radiog, Bergen, Norway; [Johnson, Mark I.] Leeds Metropolitan Univ, Fac Hlth & Social Sci, Leeds LS1 3HE, W Yorkshire, England; [Bjordal, Jan Magnus] Univ Bergen, Physiotherapy Res Grp, Bergen, Norway	Universidade Nove de Julho; Universidade Nove de Julho; Universidade de Sao Paulo; Universidade Cruzeiro do Sul; Western Norway University of Applied Sciences; Leeds Beckett University; University of Bergen	Leal, ECP (corresponding author), Univ Nove de Julho UNINOVE, Postgrad Program Rehabil Sci, Sao Paulo, Brazil.	ernesto.leal.junior@gmail.com	Tomazoni, Shaiane Silva/H-9000-2016; Lopes-Martins, Rodrigo A B/E-2013-2013; Bjordal, Jan Magnus/T-7122-2019; Frigo, Lucio/K-1564-2015; Frigo, Lucio/D-1708-2017; Leal-Junior, Ernesto Cesar/H-8920-2016; de Tarso C de Carvalho, Paulo/G-5333-2011	Tomazoni, Shaiane Silva/0000-0002-0822-4864; Lopes-Martins, Rodrigo A B/0000-0002-4533-1335; Frigo, Lucio/0000-0001-9131-1071; Leal-Junior, Ernesto Cesar/0000-0001-6393-7616; de Tarso C de Carvalho, Paulo/0000-0001-9624-4103; de Almeida Mattos, Patricia/0000-0001-6738-094X	FAPESP [2010/52404-0, 2012/06832-5]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Professor Ernesto Cesar Pinto Leal-Junior would like to thank FAPESP research grant number 2010/52404-0. Professor Lucio Frigo would like to thank FAPESP research grant number 2012/06832-5. FAPESP had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimbire F, 2007, PHOTOMED LASER SURG, V25, P112, DOI 10.1089/pho.2006.1041; Aimbire F, 2006, PHOTOMED LASER SURG, V24, P33, DOI 10.1089/pho.2006.24.33; Albertini R, 2007, J PHOTOCH PHOTOBIO B, V89, P50, DOI 10.1016/j.jphotobiol.2007.08.005; Albertini R, 2004, J PHOTOCH PHOTOBIO B, V74, P101, DOI 10.1016/j.jphotobiol.2004.03.002; Avni D, 2005, PHOTOMED LASER SURG, V23, P273, DOI 10.1089/pho.2005.23.273; Barber BJ, 2013, J PEDIATR-US, V163, P1080, DOI 10.1016/j.jpeds.2013.05.060; Basford JR, 1999, ARCH PHYS MED REHAB, V80, P647, DOI 10.1016/S0003-9993(99)90167-3; Bjordal JM, 2006, BRIT J SPORT MED, V40, P76, DOI 10.1136/bjsm.2005.020842; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Chow RT, 2006, PAIN, V124, P201, DOI 10.1016/j.pain.2006.05.018; Chow RT, 2009, LANCET, V374, P1897, DOI 10.1016/S0140-6736(09)61522-1; Cox GF, 1997, CURR OPIN CARDIOL, V12, P329; de Almeida P, 2012, LASER MED SCI, V27, P453, DOI 10.1007/s10103-011-0957-3; de Almeida P, 2011, PHOTOCHEM PHOTOBIOL, V87, P1159, DOI 10.1111/j.1751-1097.2011.00968.x; De Marchi T, 2012, LASER MED SCI, V27, P231, DOI 10.1007/s10103-011-0955-5; Emery A.E.H., 1993, DUCHENNE MUSCULAR DY; Emery AEH, 2003, DUCHENNE MUSCULAR DY; Fairclough RJ, 2011, EXP PHYSIOL, V96, P1101, DOI 10.1113/expphysiol.2010.053025; Gautam AP, 2012, RADIOTHER ONCOL, V104, P349, DOI 10.1016/j.radonc.2012.06.011; Goldman J A, 1980, Lasers Surg Med, V1, P93, DOI 10.1002/lsm.1900010110; Gur A, 2004, LASER SURG MED, V35, P229, DOI 10.1002/lsm.20082; Hayworth CR, 2010, PHOTOCHEM PHOTOBIOL, V86, P673, DOI 10.1111/j.1751-1097.2010.00732.x; Hegedus B, 2009, PHOTOMED LASER SURG, V27, P577, DOI 10.1089/pho.2008.2297; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lebel DE, 2013, J BONE JOINT SURG AM, V95A, P1057, DOI 10.2106/JBJS.L.01577; Li M, 2013, NEUROREPORT, V24, P924, DOI 10.1097/WNR.0000000000000028; Lim W, 2013, PHOTOCHEM PHOTOBIOL, V89, P199, DOI 10.1111/j.1751-1097.2012.01225.x; MCGEACHIE JK, 1993, J NEUROL SCI, V119, P169, DOI 10.1016/0022-510X(93)90130-Q; Moriyama Y, 2005, PHOTOCHEM PHOTOBIOL, V81, P1351, DOI 10.1562/2005-02-28-RA-450; Ozcelik O, 2008, J CLIN PERIODONTOL, V35, P250, DOI 10.1111/j.1600-051X.2007.01194.x; Partridge TA, 2013, FEBS J, V280, P4177, DOI 10.1111/febs.12267; Leal ECP, 2008, PHOTOMED LASER SURG, V26, P419, DOI 10.1089/pho.2007.2160; Leal ECP, 2010, J ORTHOP SPORT PHYS, V40, P524, DOI 10.2519/jospt.2010.3294; Leal ECP, 2010, EUR J APPL PHYSIOL, V108, P1083, DOI 10.1007/s00421-009-1321-1; Leal ECP, 2009, LASER MED SCI, V24, P857, DOI 10.1007/s10103-008-0633-4; Leal ECP, 2009, LASER SURG MED, V41, P572, DOI 10.1002/lsm.20810; Leal ECP, 2009, PHOTOMED LASER SURG, V27, P617, DOI 10.1089/pho.2008.2350; Leal ECP, 2009, LASER MED SCI, V24, P425, DOI 10.1007/s10103-008-0592-9; Ramaswamy KS, 2011, J PHYSIOL-LONDON, V589, P1195, DOI 10.1113/jphysiol.2010.201921; Rao S, 2012, ARCH DIS CHILD, V97, P1000, DOI 10.1136/archdischild-2012-302457; Ricotti V, 2013, J NEUROL NEUROSUR PS, V84, P698, DOI 10.1136/jnnp-2012-303902; Rizzi CF, 2006, LASER SURG MED, V38, P704, DOI 10.1002/lsm.20371; Rochkind S, 2007, PHOTOMED LASER SURG, V25, P137, DOI 10.1089/pho.2007.2076; Schubert MM, 2007, SUPPORT CARE CANCER, V15, P1145, DOI 10.1007/s00520-007-0238-7; Serra F, 2012, MUSCLE NERVE, V46, P773, DOI 10.1002/mus.23432; Silveira PCL, 2009, J PHOTOCH PHOTOBIO B, V95, P89, DOI 10.1016/j.jphotobiol.2009.01.004; Stergioulas A, 2008, AM J SPORT MED, V36, P881, DOI 10.1177/0363546507312165; Takema T, 2000, LASER MED SCI, V15, P35, DOI 10.1007/s101030050045; Thomas GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049350; Tullberg M, 2003, PAIN, V105, P89, DOI 10.1016/S0304-3959(03)00166-0; Xu XY, 2008, PHOTOMED LASER SURG, V26, P197, DOI 10.1089/pho.2007.2125	53	28	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89453	10.1371/journal.pone.0089453	http://dx.doi.org/10.1371/journal.pone.0089453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599021	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000332479400013
J	Roberts, JD; Voss, JD; Knight, B				Roberts, Jennifer D.; Voss, Jameson D.; Knight, Brandon			The Association of Ambient Air Pollution and Physical Inactivity in the United States	PLOS ONE			English	Article							WITHIN-URBAN VARIABILITY; FINE PARTICULATE MATTER; LONG-TERM EXPOSURE; EXERCISE PERFORMANCE; DEPRESSIVE SYMPTOMS; HEART-DISEASE; LUNG-FUNCTION; OBESITY; MORTALITY; HEALTH	Background: Physical inactivity, ambient air pollution and obesity are modifiable risk factors for non-communicable diseases, with the first accounting for 10% of premature deaths worldwide. Although community level interventions may target each simultaneously, research on the relationship between these risk factors is lacking. Objectives: After comparing spatial interpolation methods to determine the best predictor for particulate matter (PM2.5; PM10) and ozone (O-3) exposures throughout the U. S., we evaluated the cross-sectional association of ambient air pollution with leisure-time physical inactivity among adults. Methods: In this cross-sectional study, we assessed leisure-time physical inactivity using individual self-reported survey data from the Centers for Disease Control and Prevention's 2011 Behavioral Risk Factor Surveillance System. These data were combined with county-level U. S. Environmental Protection Agency air pollution exposure estimates using two interpolation methods (Inverse Distance Weighting and Empirical Bayesian Kriging). Finally, we evaluated whether those exposed to higher levels of air pollution were less active by performing logistic regression, adjusting for demographic and behavioral risk factors, and after stratifying by body weight category. Results: With Empirical Bayesian Kriging air pollution values, we estimated a statistically significant 16-35% relative increase in the odds of leisure-time physical inactivity per exposure class increase of PM2.5 in the fully adjusted model across the normal weight respondents (p-value < 0.0001). Evidence suggested a relationship between the increasing dose of PM2.5 exposure and the increasing odds of physical inactivity. Conclusions: In a nationally representative, cross-sectional sample, increased community level air pollution is associated with reduced leisure-time physical activity particularly among the normal weight. Although our design precludes a causal inference, these results provide additional evidence that air pollution should be investigated as an environmental determinant of inactivity.	[Roberts, Jennifer D.; Voss, Jameson D.; Knight, Brandon] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Voss, Jameson D.] US Air Force Sch Aerosp Med, Epidemiol Consult Serv, Wright Patterson AFB, OH USA	Uniformed Services University of the Health Sciences - USA	Roberts, JD (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA.	jennifer.roberts@usuhs.edu	Voss, Jameson D/P-8392-2017	Voss, Jameson D/0000-0002-4104-1744; Knight, Brandon/0000-0003-4953-7194	Uniformed Services University of the Health Sciences	Uniformed Services University of the Health Sciences	Funding for this study was provided by a Uniformed Services University of the Health Sciences intramural start-up grant for newly appointed faculty. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeeff SE, 2007, CHEST, V132, P1890, DOI 10.1378/chest.07-1126; [Anonymous], 2012, EMPIRICAL BAYESIAN K; [Anonymous], 2008, SURVEY RES METHODS, DOI DOI 10.18148/SRM/2008.V2I1.597; Arsenault BJ, 2010, INT J OBESITY, V34, P340, DOI 10.1038/ijo.2009.229; Awatef M, 2011, CANCER EPIDEMIOL, V35, P540, DOI 10.1016/j.canep.2011.02.011; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Cakmak S, 2011, ENVIRON RES, V111, P1309, DOI 10.1016/j.envres.2011.09.016; Casazza K, 2013, NEW ENGL J MED, V368, P446, DOI 10.1056/NEJMsa1208051; CDC, 2012, MMWR-MORBID MORTAL W, P410; Centers for Disease Control and Prevention, 2011, OB RAT LOW INC PRESC; Cutrufello PT, 2011, INHAL TOXICOL, V23, P658, DOI 10.3109/08958378.2011.604106; Delfino RJ, 2010, EPIDEMIOLOGY, V21, P396, DOI 10.1097/EDE.0b013e3181d5e19b; EPA, 2008, APP G HLTH BAS COST; EPA, 2011, AQS DAT DICT; Fryar C., 2012, PREVALENCE OVERWEIGH; Gent JF, 2003, JAMA-J AM MED ASSOC, V290, P1859, DOI 10.1001/jama.290.14.1859; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Hankey S, 2012, ENVIRON HEALTH PERSP, V120, P247, DOI 10.1289/ehp.1103806; Herring MP, 2012, ARCH INTERN MED, V172, P101, DOI 10.1001/archinternmed.2011.696; Hystad P, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-22; Laden F, 2000, ENVIRON HEALTH PERSP, V108, P941, DOI 10.2307/3435052; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee IM, 2010, JAMA-J AM MED ASSOC, V303, P1173, DOI 10.1001/jama.2010.312; Marr LC, 2010, MED SCI SPORT EXER, V42, P585, DOI 10.1249/MSS.0b013e3181b84a85; Marshall JD, 2008, ATMOS ENVIRON, V42, P1359, DOI 10.1016/j.atmosenv.2007.08.012; Mokdad Ali H, 2003, MMWR Recomm Rep, V52, P1; Motl RW, 2004, PSYCHOSOM MED, V66, P336, DOI 10.1097/01.psy.0000126205.35683.0a; Nelson DE, 1998, AM STAT ASS 1998 P S, P214; Ogden CL, 2012, PREVALENCE OBESITY U; Peters A, 2000, EPIDEMIOLOGY, V11, P11, DOI 10.1097/00001648-200001000-00005; Pietilainen KH, 2008, OBESITY, V16, P409, DOI 10.1038/oby.2007.72; Pilz J, 2008, STOCH ENV RES RISK A, V22, P621, DOI 10.1007/s00477-007-0165-7; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Pratt M, 2012, LANCET, V380, P282, DOI 10.1016/S0140-6736(12)60736-3; Rundell KW, 2008, J STRENGTH COND RES, V22, P2, DOI 10.1519/JSC.0b013e31815ef98b; Singh GK, 2010, ARCH PEDIAT ADOL MED, V164, P598, DOI 10.1001/archpediatrics.2010.84; Son JY, 2010, ENVIRON RES, V110, P739, DOI 10.1016/j.envres.2010.08.003; United States Environmental Protection Agency (US EPA), 2004, DEV SPAT INT SURF ES; VDH, 2012, BRFSS METH; Voss JD, 2013, INT J OBES LOND, DOI [10.1038/ijo.2013.5, DOI 10.1038/IJ0.2013.5]; Wen XJ, 2009, J ENVIRON HEALTH, V72, P40	43	84	86	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90143	10.1371/journal.pone.0090143	http://dx.doi.org/10.1371/journal.pone.0090143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598907	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400049
J	Sousa-Ferreira, L; Aveleira, C; Botelho, M; Alvaro, AR; de Almeida, LP; Cavadas, C				Sousa-Ferreira, Ligia; Aveleira, Celia; Botelho, Mariana; Alvaro, Ana Rita; de Almeida, Luis Pereira; Cavadas, Claudia			Fluoxetine Induces Proliferation and Inhibits Differentiation of Hypothalamic Neuroprogenitor Cells In Vitro	PLOS ONE			English	Article							NEUROTROPHIC FACTOR BDNF; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; NEUROPEPTIDE-Y; ENERGY-BALANCE; HIPPOCAMPAL NEUROGENESIS; ANTIDEPRESSANT EXPOSURE; PROGENITOR CELLS; RAT HIPPOCAMPUS; MESSENGER-RNA	A significant number of children undergo maternal exposure to antidepressants and they often present low birth weight. Therefore, it is important to understand how selective serotonin reuptake inhibitors (SSRIs) affect the development of the hypothalamus, the key center for metabolism regulation. In this study we investigated the proliferative actions of fluoxetine in fetal hypothalamic neuroprogenitor cells and demonstrate that fluoxetine induces the proliferation of these cells, as shown by increased neurospheres size and number of proliferative cells (Ki-67(+) cells). Moreover, fluoxetine inhibits the differentiation of hypothalamic neuroprogenitor cells, as demonstrated by decreased number of mature neurons (Neu-N+ cells) and increased number of undifferentiated cells (SOX-2(+) cells). Additionally, fluoxetine-induced proliferation and maintenance of hypothalamic neuroprogenitor cells leads to changes in the mRNA levels of appetite regulator neuropeptides, including Neuropeptide Y (NPY) and Cocaine-and-Amphetamine-Regulated-Transcript (CART). This study provides the first evidence that SSRIs affect the development of hypothalamic neuroprogenitor cells in vitro with consequent alterations on appetite neuropeptides.	[Sousa-Ferreira, Ligia; Aveleira, Celia; Botelho, Mariana; Alvaro, Ana Rita; de Almeida, Luis Pereira; Cavadas, Claudia] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Alvaro, Ana Rita] Univ Tras Os Montes & Alto Douro, Dept Biol & Environm, Vila Real, Portugal; [Sousa-Ferreira, Ligia; Botelho, Mariana; de Almeida, Luis Pereira; Cavadas, Claudia] Univ Coimbra, Fac Pharm, Coimbra, Portugal	Universidade de Coimbra; University of Tras-os-Montes & Alto Douro; Universidade de Coimbra	Cavadas, C (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.	ccavadas@uc.pt	de Almeida, Luis Pereira/A-4605-2009; Cavadas, Claudia/AAB-6904-2021; Sousa-Ferreira, Lígia/M-4181-2013; Alvaro, Ana Rita/A-8168-2013; de Almeida, Luis Pereira/O-8196-2019; Aveleira, Célia A/L-1325-2014; Aveleira, Célia/AAI-2455-2021	de Almeida, Luis Pereira/0000-0001-5831-3307; Cavadas, Claudia/0000-0001-8020-9266; Sousa-Ferreira, Lígia/0000-0002-7169-9491; Alvaro, Ana Rita/0000-0002-2387-374X; de Almeida, Luis Pereira/0000-0001-5831-3307; Aveleira, Célia A/0000-0002-2191-0682; Aveleira, Célia/0000-0002-2191-0682; Botelho da Rocha, Mariana/0000-0002-5197-7159	Portuguese Foundation for Science and Technology; FEDER; COMPETE [PEst-C/SAU/LA0001/2013-2014, PTDC/SAU-FCF/099082/2008, PTDC/BIM-MED/0775/2012, SFRH/BD/30608/2006, SFRH/BPD/73942/2010, SFRH/BPD/78424/2011]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FEDER(European Commission); COMPETE	This work was supported by grants from the Portuguese Foundation for Science and Technology, FEDER and COMPETE (PEst-C/SAU/LA0001/2013-2014; PTDC/SAU-FCF/099082/2008; PTDC/BIM-MED/0775/2012; SFRH/BD/30608/2006; SFRH/BPD/73942/2010; SFRH/BPD/78424/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnea A, 2001, BRAIN RES, V919, P57, DOI 10.1016/S0006-8993(01)02999-7; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Benninghoff J, 2010, NEUROPSYCHOPHARMACOL, V35, P893, DOI 10.1038/npp.2009.181; Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008; CHENG B, 1994, J NEUROCHEM, V62, P1319; Choi S, 2006, BRAIN RES, V1087, P83, DOI 10.1016/j.brainres.2006.02.129; Conti B, 2007, MOL PSYCHIATR, V12, P167, DOI 10.1038/sj.mp.4001897; Cottrell EC, 2009, AM J PHYSIOL-REG I, V296, pR631, DOI 10.1152/ajpregu.90690.2008; CROLL SD, 1994, EUR J NEUROSCI, V6, P1343, DOI 10.1111/j.1460-9568.1994.tb00325.x; Davidson S, 2009, PEDIATR RES, V65, P236, DOI 10.1203/PDR.0b013e318193594a; De Foubert G, 2004, NEUROSCIENCE, V128, P597, DOI 10.1016/j.neuroscience.2004.06.054; Desai M, 2011, ENDOCRINOLOGY, V152, P3192, DOI 10.1210/en.2010-1217; Desai M, 2011, BRAIN RES, V1378, P29, DOI 10.1016/j.brainres.2010.12.080; Dryden S, 1996, NEUROSCIENCE, V72, P557, DOI 10.1016/0306-4522(95)00566-8; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Gutierrez A, 2002, OBES RES, V10, P532, DOI 10.1038/oby.2002.72; Homberg JR, 2010, TRENDS PHARMACOL SCI, V31, P60, DOI 10.1016/j.tips.2009.11.003; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kohl Z, 2012, EUR J NEUROSCI, V35, P10, DOI 10.1111/j.1460-9568.2011.07933.x; Kristensen JH, 1999, BRIT J CLIN PHARMACO, V48, P521, DOI 10.1046/j.1365-2125.1999.00040.x; Lee DA, 2012, NAT NEUROSCI, V15, P700, DOI 10.1038/nn.3079; Li JX, 2012, NAT CELL BIOL, V14, P999, DOI 10.1038/ncb2562; Loudes C, 2000, NEUROENDOCRINOLOGY, V72, P144, DOI 10.1159/000054581; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Manev H, 2001, EUR J PHARMACOL, V411, P67, DOI 10.1016/S0014-2999(00)00904-3; Marty S, 1996, NEURON, V16, P565, DOI 10.1016/S0896-6273(00)80075-6; Matrisciano F, 2008, NEUROPHARMACOLOGY, V54, P428, DOI 10.1016/j.neuropharm.2007.10.020; McNay DEG, 2012, J CLIN INVEST, V122, P142, DOI 10.1172/JCI43134; Mercer RE, 2011, FRONT NEUROENDOCRIN, V32, P398, DOI 10.1016/j.yfrne.2011.06.001; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nilsson I, 2005, DEV BRAIN RES, V155, P147, DOI 10.1016/j.devbrainres.2005.01.009; Oberlander TF, 2008, EARLY HUM DEV, V84, P689, DOI 10.1016/j.earlhumdev.2008.06.008; Olivier JDA, 2011, PSYCHOPHARMACOLOGY, V217, P419, DOI 10.1007/s00213-011-2299-z; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Pawluski JL, 2012, PSYCHONEUROENDOCRINO, V37, P1019, DOI 10.1016/j.psyneuen.2011.11.011; Pechnick RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027290; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010; Pinnock SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013652; Rampono J, 2004, INT J NEUROPSYCHOPH, V7, P329, DOI 10.1017/S1461145704004286; Rayen I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024003; Reibel S, 2000, EUR J NEUROSCI, V12, P595, DOI 10.1046/j.1460-9568.2000.00941.x; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Righi M, 2000, J NEUROSCI, V20, P3165, DOI 10.1523/JNEUROSCI.20-09-03165.2000; Saarelainen T, 2003, J NEUROSCI, V23, P349; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Simon GE, 2002, AM J PSYCHIAT, V159, P2055, DOI 10.1176/appi.ajp.159.12.2055; Sousa-Ferreira L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019745; Sugiyama N, 2003, MOL BRAIN RES, V115, P69, DOI 10.1016/S0169-328X(03)00184-0; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; TAPLEY P, 1992, ONCOGENE, V7, P371; Ververs T, 2006, EUR J CLIN PHARMACOL, V62, P863, DOI 10.1007/s00228-006-0177-0; Wisner KL, 2009, AM J PSYCHIAT, V166, P557, DOI 10.1176/appi.ajp.2008.08081170; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021; Zusso M, 2008, BIOCHEM PHARMACOL, V76, P391, DOI 10.1016/j.bcp.2008.05.014	58	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e88917	10.1371/journal.pone.0088917	http://dx.doi.org/10.1371/journal.pone.0088917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598761	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400007
J	Carlomagno, Y; Zhang, YJ; Davis, M; Lin, WL; Cook, C; Dunmore, J; Tay, W; Menkosky, K; Cao, XK; Petrucelli, L; DeTure, M				Carlomagno, Yari; Zhang, Yongjie; Davis, Mary; Lin, Wen-Lang; Cook, Casey; Dunmore, Judy; Tay, William; Menkosky, Kyle; Cao, Xiangkun; Petrucelli, Leonard; DeTure, Michael			Casein Kinase II Induced Polymerization of Soluble TDP-43 into Filaments Is Inhibited by Heat Shock Proteins	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN-43; MOLECULAR CHAPERONE; NEURONAL INCLUSIONS; ALZHEIMERS-DISEASE; TERMINAL FRAGMENTS; TAU-PROTEIN; AGGREGATION; MUTATIONS	Background: Trans-activation Response DNA-binding Protein-43 (TDP-43) lesions are observed in Amyotrophic Lateral (ALS), Frontotemporal Lobar Degeneration with ubiquitin inclusions (FTLD-TDP) and 25-50% of Alzheimer's Disease (AD) cases. These abnormal protein inclusions are composed of either amorphous TDP-43 aggregates or highly ordered filaments. The filamentous TDP-43 accumulations typically contain clean 10-12 nm filaments though wider 1820 nm coated filaments may be observed. The TDP-43 present within these lesions is phosphorylated, truncated and ubiquitinated, and these modifications appear to be abnormal as they are linked to both a cellular heat shock response and microglial activation. The mechanisms associated with this abnormal TDP-43 accumulation are believed to result in a loss of TDP-43 function, perhaps due to the post-translational modifications or resulting from physical sequestration of the TDP-43. The formation of TDP-43 inclusions involves cellular translocation and conversion of TDP-43 into fibrillogenic forms, but the ability of these accumulations to sequester normal TDP-43 and propagate this behavior between neurons pathologically is mostly inferred. The lack of methodology to produce soluble full length TDP-43 and recapitulate this polymerization into filaments as observed in disease has limited our understanding of these pathogenic cascades. Results: The protocols described here generate soluble, full-length and untagged TDP-43 allowing for a direct assessment of the impact of various posttranslational modifications on TDP-43 function. We demonstrate that Casein Kinase II (CKII) promotes the polymerization of this soluble TDP-43 into 10 nm diameter filaments that resemble the most common TDP-43 structures observed in disease. Furthermore, these filaments are recognized as abnormal by Heat Shock Proteins (HSPs) which can inhibit TDP-43 polymerization or directly promote TDP-43 filament depolymerization. Conclusion: These findings demonstrate CKII induces polymerization of soluble TDP-43 into filaments and Hsp90 promotes TDP-43 filament depolymerization. These findings provide rational for potential therapeutic intervention at these points in TDP-43 proteinopathies.	[Carlomagno, Yari; Zhang, Yongjie; Davis, Mary; Lin, Wen-Lang; Cook, Casey; Dunmore, Judy; Tay, William; Menkosky, Kyle; Cao, Xiangkun; Petrucelli, Leonard; DeTure, Michael] Maya Clin, Dept Neurosci, Jacksonville, FL 32224 USA		DeTure, M (corresponding author), Maya Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	deture.michael@mayo.edu			Mayo Clinic Foundation; National Institutes of Health/National Institute on Aging [R01AG026251]; National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01 NS 063964-01, R01 NS077402, ES20395-01, 1R21NS079807-01A1]; Amyotrophic Lateral Sclerosis Association; GHR Foundation; Department of Defense [W81XWH-10-1-0512-1, W81XWH-09-1-0315AL093108]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077402, R01NS063964, R21NS079807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026251] Funding Source: NIH RePORTER	Mayo Clinic Foundation; National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Amyotrophic Lateral Sclerosis Association; GHR Foundation; Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Mayo Clinic Foundation to L.P., National Institutes of Health/National Institute on Aging [R01AG026251 to L.P.], National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01 NS 063964-01 to L.P., R01 NS077402 to L.P., ES20395-01 to L.P., 1R21NS079807-01A1 to Y.Z.], Amyotrophic Lateral Sclerosis Association to L.P., GHR Foundation to Y.Z, and the Department of Defense [W81XWH-10-1-0512-1 to L.P. and W81XWH-09-1-0315AL093108 to L.P.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Brady OA, 2011, J NEUROCHEM, V116, P248, DOI 10.1111/j.1471-4159.2010.07098.x; Brettschneider J, 2012, ACTA NEUROPATHOL, V123, P395, DOI 10.1007/s00401-011-0932-x; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Choksi DK, 2013, HUMAN MOL GENETICS; Combs B, 2011, BIOCHEMISTRY-US, V50, P9446, DOI 10.1021/bi2010569; Dickey C, 2009, AM J PATHOL, V174, P228, DOI 10.2353/ajpath.2009.080764; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Gendron TF, 2012, J ALZHEIMERS DIS, V29, P29; Geser F, 2009, J NEUROL, V256, P1205, DOI 10.1007/s00415-009-5069-7; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Herman AM, 2011, BRAIN RES, V1386, P191, DOI 10.1016/j.brainres.2011.02.052; Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200; Higashi S, 2007, BRAIN RES, V1184, P284, DOI 10.1016/j.brainres.2007.09.048; IIMOTO DS, 1990, BRAIN RES, V507, P273, DOI 10.1016/0006-8993(90)90282-G; Jinwal UK, 2012, J BIOL CHEM, V287, P24814, DOI 10.1074/jbc.M112.367268; Jinwal UK, 2010, J BIOL CHEM, V285, P16798, DOI 10.1074/jbc.M110.113753; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; JOHNSON BS, 2009, J BIOL CHEM, V22, P22; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023075; Liachko NF, 2010, J NEUROSCI, V30, P16208, DOI 10.1523/JNEUROSCI.2911-10.2010; Lin WL, 2008, ACTA NEUROPATHOL, V116, P205, DOI 10.1007/s00401-008-0408-9; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; MASLIAH E, 1992, AM J PATHOL, V140, P263; MIYATA Y, 1992, J BIOL CHEM, V267, P7042; Neumann M, 2007, ACTA NEUROPATHOL, V113, P543, DOI 10.1007/s00401-007-0221-x; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; Patterson KR, 2011, BIOCHEMISTRY-US, V50, P10300, DOI 10.1021/bi2009147; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Sahara N, 2007, J NEUROSCI RES, V85, P3098, DOI 10.1002/jnr.21417; Sarkar M, 2008, J NEUROSCI RES, V86, P2763, DOI 10.1002/jnr.21721; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Thorpe J, 2008, J NEURAL TRANSM, V115, P1661, DOI 10.1007/s00702-008-0137-1; Tsuji H, 2012, BRAIN, V135, P3380, DOI 10.1093/brain/aws230; Udan-Johns M, 2013, HUMAN MOL GENETICS; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Wu LS, 2012, J BIOL CHEM, V287, P27335, DOI 10.1074/jbc.M112.359000; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-33; Zhao M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-104	54	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90452	10.1371/journal.pone.0090452	http://dx.doi.org/10.1371/journal.pone.0090452			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595055	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500051
J	Carrier, B; Wen, S; Zigouras, S; Browne, RW; Li, ZY; Patel, MS; Williamson, DL; Rideout, TC				Carrier, Bradley; Wen, Shin; Zigouras, Sophia; Browne, Richard W.; Li, Zhuyun; Patel, Mulchand S.; Williamson, David L.; Rideout, Todd C.			Alpha-Lipoic Acid Reduces LDL-Particle Number and PCSK9 Concentrations in High-Fat Fed Obese Zucker Rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DENSITY-LIPOPROTEIN CHOLESTEROL; RANDOMIZED CONTROLLED-TRIAL; APOLIPOPROTEIN-E-DEFICIENT; SUBTILISIN/KEXIN TYPE 9; HEPATIC STEATOSIS; LIPID-METABOLISM; PLANT STEROLS; MONOCLONAL-ANTIBODY; INSULIN-RESISTANCE	We characterized the hypolipidemic effects of alpha-lipoic acid (LA, R-form) and examined the associated molecular mechanisms in a high fat fed Zucker rat model. Rats (n = 8) were assigned to a high fat (HF) diet or the HF diet with 0.25% LA (HF-LA) for 30 days and pair fed to remove confounding effects associated with the anorectic properties of LA. Compared with the HF controls, the HF-LA group was protected against diet-induced obesity (102.5 +/- 3.1 vs. 121.5 +/- 3.6,% change BW) and hypercholesterolemia with a reduction in total-C (-21%), non-HDL-C (-25%), LDL-C (-16%), and total LDL particle number (-46%) and an increase in total HDL particles (-22%). This cholesterol-lowering response was associated with a reduction in plasma PCSK9 concentration (-70%) and an increase in hepatic LDLr receptor protein abundance (2 fold of HF). Compared with the HF-fed animals, livers of LA-supplemented animals were protected against TG accumulation (-46%), likely through multiple mechanisms including: a suppressed lipogenic response (down-regulation of hepatic acetyl-CoA carboxylase and fatty acid synthase expression); enhanced hepatic fat oxidation (increased carnitine palmitoyl-transferase I alpha expression); and enhanced VLDL export (increased hepatic diacylglycerol acyltransferase and microsomal triglyceride transfer protein expression and elevated plasma VLDL particle number). Study results also support an enhanced fatty acid uptake (2.8 fold increase in total lipase activity) and oxidation (increased CPT1 beta protein abundance) in muscle tissue in LA-supplemented animals compared with the HF group. In summary, in the absence of a change in caloric intake, LA was effective in protecting against hypercholesterolemia and hepatic fat accumulation under conditions of strong genetic and dietary predisposition toward obesity and dyslipidemia.	[Carrier, Bradley; Wen, Shin; Zigouras, Sophia; Li, Zhuyun; Williamson, David L.; Rideout, Todd C.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Exercise Sci, Buffalo, NY 14260 USA; [Carrier, Bradley; Wen, Shin; Zigouras, Sophia; Li, Zhuyun; Williamson, David L.; Rideout, Todd C.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Nutr Sci, Buffalo, NY 14260 USA; [Browne, Richard W.] SUNY Buffalo, Buffalo, NY 14260 USA; [Patel, Mulchand S.] SUNY Buffalo, Sch Med & Biomed Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Rideout, TC (corresponding author), SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Exercise Sci, Buffalo, NY 14260 USA.	rideout@buffalo.edu	Li, Zhuyun/L-4792-2016	Rideout, Todd C/0000-0002-1834-7083	University at Buffalo; National Center for Complementary and Alternative Medicine [KO1]	University at Buffalo; National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This research was supported by University at Buffalo startup funding and a KO1 grant from the National Center for Complementary and Alternative Medicine (to TCR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Amom Z, 2008, J CLIN BIOCHEM NUTR, V43, P88, DOI 10.3164/jcbn.2008051; Bartels ED, 2002, DIABETES, V51, P1233, DOI 10.2337/diabetes.51.4.1233; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; Ben-Shlomo S, 2011, J HEPATOL, V54, P1214, DOI 10.1016/j.jhep.2010.09.032; Bjermo H, 2012, AM J CLIN NUTR, V95, P1003, DOI 10.3945/ajcn.111.030114; Brouwers MCGJ, 2011, CURR OPIN LIPIDOL, V22, P317, DOI 10.1097/MOL.0b013e328348a5df; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Butler JA, 2009, ARCH BIOCHEM BIOPHYS, V485, P63, DOI 10.1016/j.abb.2009.01.024; Cao AQ, 2011, J LIPID RES, V52, P518, DOI 10.1194/jlr.M010603; Carbonelli MG, 2010, CURR PHARM DESIGN, V16, P840, DOI 10.2174/138161210790883589; Cariou B, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-4; Castro MC, 2013, BBA-GEN SUBJECTS, V1830, P2226, DOI 10.1016/j.bbagen.2012.10.010; Chen WL, 2012, DIABETOLOGIA, V55, P1824, DOI 10.1007/s00125-012-2530-4; Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; Farnier M, 2011, AM J CARDIOVASC DRUG, V11, P145, DOI 10.2165/11590330-000000000-00000; Fitzgerald KT, 2013, TOP COMPANION ANIM M, V28, P1, DOI 10.1053/j.tcam.2013.03.001; Ford I, 2001, METABOLISM, V50, P868, DOI 10.1053/meta.2001.24914; Giugliano RP, 2012, LANCET, V380, P2007, DOI 10.1016/S0140-6736(12)61770-X; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Harding SV, 2010, J NUTR, V140, P1249, DOI 10.3945/jn.109.120311; Hoekstra M, 2003, J BIOL CHEM, V278, P25448, DOI 10.1074/jbc.M301189200; Huong DTT, 2008, BRIT J NUTR, V100, P79, DOI 10.1017/S0007114507876227; Jung TS, 2012, LIVER INT, V32, P1565, DOI 10.1111/j.1478-3231.2012.02857.x; Kandeil MA, 2011, J DIABETES COMPLICAT, V25, P31, DOI 10.1016/j.jdiacomp.2009.09.007; Kim E, 2008, J CLIN PSYCHOPHARM, V28, P138, DOI 10.1097/JCP.0b013e31816777f7; Kim MS, 2004, NAT MED, V10, P727, DOI 10.1038/nm1061; Koh EH, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2010.08.005; Kuehl R, 2000, DESIGN EXPT STAT PRI; Lee WR, 2012, MOL BIOL REP, V39, P6857, DOI 10.1007/s11033-012-1511-5; Lee YN, 2006, BIOCHEM BIOPH RES CO, V344, P446, DOI 10.1016/j.bbrc.2006.03.062; LEWIS GF, 1995, J CLIN INVEST, V95, P158, DOI 10.1172/JCI117633; Lewis GF, 1996, DIABETES CARE, V19, P390, DOI 10.2337/diacare.19.4.390; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liang JJ, 2004, J BIOL CHEM, V279, P44938, DOI 10.1074/jbc.M408507200; Mackey RH, 2012, J AM COLL CARDIOL, V60, P508, DOI 10.1016/j.jacc.2012.03.060; Mater MK, 1999, J LIPID RES, V40, P1045; Moran-Ramos S, 2012, J NUTR, V142, P1956, DOI 10.3945/jn.112.165563; Nadeau KJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE90, DOI 10.1152/ajpendo.00543.2005; NESS GC, 1994, J BIOL CHEM, V269, P29168; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Parish S, 2012, CIRCULATION, V125, P2469, DOI 10.1161/CIRCULATIONAHA.111.073684; Park KG, 2008, HEPATOLOGY, V48, P1477, DOI 10.1002/hep.22496; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porasuphatana S, 2012, ASIA PAC J CLIN NUTR, V21, P12; Ratliff Joseph C, 2015, Clin Schizophr Relat Psychoses, V8, P196, DOI 10.3371/CSRP.RAPA.030113; Rector RS, 2008, WORLD J GASTROENTERO, V14, P185, DOI 10.3748/wjg.14.185; Richard C, 2012, BRIT J NUTR, V107, P705, DOI 10.1017/S0007114511003436; Rideout TC, 2007, J NUTR, V137, P568, DOI 10.1093/jn/137.3.568; Rideout TC, 2010, MOL NUTR FOOD RES, V54, pS7, DOI 10.1002/mnfr.201000027; Scoggan KA, 2009, J NUTR BIOCHEM, V20, P177, DOI 10.1016/j.jnutbio.2008.01.011; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seo EY, 2012, NUTR RES PRACT, V6, P195, DOI 10.4162/nrp.2012.6.3.195; Shay KP, 2009, BBA-GEN SUBJECTS, V1790, P1149, DOI 10.1016/j.bbagen.2009.07.026; Shrestha S, 2009, J NUTR, V139, P640, DOI 10.3945/jn.108.103341; Shukla A, 2006, BRIT J NUTR, V96, P674, DOI 10.1079/BJN20061895; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Sun YD, 2012, ANN NUTR METAB, V60, P293, DOI 10.1159/000338444; Timmers S, 2010, J LIPID RES, V51, P352, DOI 10.1194/jlr.M000992; TORNVALL P, 1995, ARTERIOSCL THROM VAS, V15, P1086, DOI 10.1161/01.ATV.15.8.1086; VANDERVUSSE GJ, 1985, J MOL CELL CARDIOL, V17, P527, DOI 10.1016/S0022-2828(85)80059-6; Xiao CT, 2011, AM J PHYSIOL-ENDOC M, V301, pE429, DOI 10.1152/ajpendo.00178.2011; Yamamoto T, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.16; Yang RL, 2008, NUTRITION, V24, P582, DOI 10.1016/j.nut.2008.02.002; Yi XW, 2011, J DIABETES COMPLICAT, V25, P193, DOI 10.1016/j.jdiacomp.2010.07.004; Ying ZK, 2010, LIFE SCI, V86, P95, DOI 10.1016/j.lfs.2009.11.009; Zhang WJ, 2008, CIRCULATION, V117, P421, DOI 10.1161/CIRCULATIONAHA.107.725275; Zhou YF, 2008, AM J PHYSIOL-RENAL, V295, pF662, DOI 10.1152/ajprenal.00046.2008; Zulkhairi A, 2008, BIOMED PHARMACOTHER, V62, P716, DOI 10.1016/j.biopha.2006.12.003	71	32	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90863	10.1371/journal.pone.0090863	http://dx.doi.org/10.1371/journal.pone.0090863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595397	gold, Green Published, Green Submitted			2022-12-27	WOS:000332475500107
J	Clay, CC; Maniar-Hew, K; Gerriets, JE; Wang, TT; Postlethwait, EM; Evans, MJ; Fontaine, JH; Miller, LA				Clay, Candice C.; Maniar-Hew, Kinjal; Gerriets, Joan E.; Wang, Theodore T.; Postlethwait, Edward M.; Evans, Michael J.; Fontaine, Justin H.; Miller, Lisa A.			Early Life Ozone Exposure Results in Dysregulated Innate Immune Function and Altered microRNA Expression in Airway Epithelium	PLOS ONE			English	Article							GENE-EXPRESSION; CELLS; LUNG; MORTALITY; LIPOPOLYSACCHARIDE; SUPPRESSION; ASSOCIATION; REGULATOR; INFECTION; POLLUTION	Exposure to ozone has been associated with increased incidence of respiratory morbidity in humans; however the mechanism(s) behind the enhancement of susceptibility are unclear. We have previously reported that exposure to episodic ozone during postnatal development results in an attenuated peripheral blood cytokine response to lipopolysaccharide (LPS) that persists with maturity. As the lung is closely interfaced with the external environment, we hypothesized that the conducting airway epithelium of neonates may also be a target of immunomodulation by ozone. To test this hypothesis, we evaluated primary airway epithelial cell cultures derived from juvenile rhesus macaque monkeys with a prior history of episodic postnatal ozone exposure. Innate immune function was measured by expression of the proinflammatory cytokines IL-6 and IL-8 in primary cultures established following in vivo LPS challenge or, in response to in vitro LPS treatment. Postnatal ozone exposure resulted in significantly attenuated IL-6 mRNA and protein expression in primary cultures from juvenile animals; IL-8 mRNA was also significantly reduced. The effect of antecedent ozone exposure was modulated by in vivo LPS challenge, as primary cultures exhibited enhanced cytokine expression upon secondary in vitro LPS treatment. Assessment of potential IL-6-targeting microRNAs miR-149, miR-202, and miR-410 showed differential expression in primary cultures based upon animal exposure history. Functional assays revealed that miR-149 is capable of binding to the IL-6 39 UTR and decreasing IL-6 protein synthesis in airway epithelial cell lines. Cumulatively, our findings suggest that episodic ozone during early life contributes to the molecular programming of airway epithelium, such that memory from prior exposures is retained in the form of a dysregulated IL-6 and IL-8 response to LPS; differentially expressed microRNAs such as miR-149 may play a role in the persistent modulation of the epithelial innate immune response towards microbes in the mature lung.	[Clay, Candice C.; Maniar-Hew, Kinjal; Gerriets, Joan E.; Wang, Theodore T.; Evans, Michael J.; Fontaine, Justin H.; Miller, Lisa A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Evans, Michael J.; Miller, Lisa A.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA; [Postlethwait, Edward M.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Environm Hlth Sci, Birmingham, AL 35294 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Alabama System; University of Alabama Birmingham	Miller, LA (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.	lmiller@ucdavis.edu			NIH [ES011617, ES000628, HL081286, HL097087, OD011107, T32 HL007013]; EPA STAR Grant [832947]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081286, R01HL097087, T32HL007013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011617] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPA STAR Grant(United States Environmental Protection Agency); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH ES011617, NIH ES000628, NIH HL081286, NIH HL097087, NIH OD011107, EPA STAR Grant 832947 and NIH T32 HL007013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hegelan M, 2011, IMMUNOL RES, V49, P173, DOI 10.1007/s12026-010-8180-z; Bai TR, 2005, CLIN SCI, V108, P463, DOI 10.1042/CS20040342; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bateson TF, 2008, J TOXICOL ENV HEAL A, V71, P238, DOI 10.1080/15287390701598234; Beane J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r201; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Burnett RT, 2001, AM J EPIDEMIOL, V153, P444, DOI 10.1093/aje/153.5.444; Chen LC, 2012, INT J BIOCHEM CELL B, V44, P1711, DOI 10.1016/j.biocel.2012.06.027; Delfino RJ, 1996, AM J RESP CRIT CARE, V154, P633, DOI 10.1164/ajrccm.154.3.8810598; DEVLIN RB, 1994, AM J PHYSIOL, V266, pL612, DOI 10.1152/ajplung.1994.266.6.L612; DEVLIN RB, 1991, AM J RESP CELL MOL, V4, P72, DOI 10.1165/ajrcmb/4.1.72; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Garg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077249; GILMOUR MI, 1993, EXP LUNG RES, V19, P299, DOI 10.3109/01902149309064348; GOLDSTEIN E, 1971, ARCH INTERN MED, V127, P1099, DOI 10.1001/archinte.127.6.1099; Goulding John, 2007, Proc Am Thorac Soc, V4, P618, DOI 10.1513/pats.200706-066TH; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gryparis A, 2004, AM J RESP CRIT CARE, V170, P1080, DOI 10.1164/rccm.200403-333OC; He Y, 2013, INFLAMMATION; Hollingsworth JW, 2004, AM J RESP CRIT CARE, V170, P126, DOI 10.1164/rccm.200311-1499OC; Holt PG, 2000, ALLERGY, V55, P688, DOI 10.1034/j.1398-9995.2000.00118.x; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; JAKAB GJ, 1995, ENVIRON HEALTH PERSP, V103, P77, DOI 10.2307/3432454; Jardim MJ, 2009, ENVIRON HEALTH PERSP, V117, P1745, DOI 10.1289/ehp.0900756; Jaspers I, 1997, AM J PHYSIOL-LUNG C, V272, pL504, DOI 10.1152/ajplung.1997.272.3.L504; Jin L, 2011, P NATL ACAD SCI USA, V108, P15840, DOI 10.1073/pnas.1019312108; KE Y, 1988, DIFFERENTIATION, V38, P60, DOI 10.1111/j.1432-0436.1988.tb00592.x; Kesic MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035108; Kleeberger SR, 1997, NAT GENET, V17, P475, DOI 10.1038/ng1297-475; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Lin RJ, 2010, MOL CARCINOGEN, V49, P719, DOI 10.1002/mc.20647; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Maniar-Hew K, 2010, AM J PHYSL LUNG CELL; Maniar-Hew K, 2013, AM J RESP CELL MOL, V49, P710, DOI 10.1165/rcmb.2012-0321OC; Manzer R, 2006, AM J RESP CELL MOL, V34, P158, DOI 10.1165/rcmb.2005-0205OC; Matsui H, 1998, J CLIN INVEST, V102, P1125, DOI 10.1172/JCI2687; Medina-Ramon M, 2006, AM J EPIDEMIOL, V163, P579, DOI 10.1093/aje/kwj078; Murphy SR, 2012, AM J RESP CELL MOL, V47, P815, DOI 10.1165/rcmb.2012-0110OC; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; PETERSON ML, 1978, ENVIRON RES, V15, P485, DOI 10.1016/0013-9351(78)90127-5; Pinkerton KE, 2000, ENVIRON HEALTH PERSP, V108, P457, DOI 10.2307/3454537; Plopper CG, 2000, ENVIRON HEALTH PERSP, V108, pA252, DOI 10.1289/ehp.108-a252; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Rossato M, 2012, P NATL ACAD SCI USA, V109, pE3101, DOI 10.1073/pnas.1209100109; Schelegle ES, 2003, TOXICOL APPL PHARM, V191, P74, DOI 10.1016/S0041-008X(03)00218-7; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Silveyra P, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13579; Sun YP, 2011, BLOOD, V117, P6172, DOI 10.1182/blood-2010-12-325647; Sweeney E, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011606, 10.1371/journal.pone.0009518]; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; VANLOVEREN H, 1988, TOXICOL APPL PHARM, V94, P374, DOI 10.1016/0041-008X(88)90279-7; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041693; Williams AS, 2007, J APPL PHYSIOL, V103, P1189, DOI 10.1152/japplphysiol.00172.2007; Xu Z, 2011, J BIOL CHEM, V286, P21401, DOI 10.1074/jbc.M110.198630; Yang X, 2013, HEPATOLOGY, V58, P158, DOI 10.1002/hep.26305; YANKASKAS JR, 1993, AM J PHYSIOL, V264, pC1219, DOI 10.1152/ajpcell.1993.264.5.C1219; Zhao YT, 2013, AM J PHYSIOL-LUNG C, V305, pL56, DOI 10.1152/ajplung.00417.2012	58	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90401	10.1371/journal.pone.0090401	http://dx.doi.org/10.1371/journal.pone.0090401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594710	gold, Green Published, Green Submitted			2022-12-27	WOS:000332475500048
J	Liu, MY; Blinn, C; McLeod, SM; Wiseman, JW; Newman, JV; Fisher, SL; Walkup, GK				Liu, Mingyu; Blinn, Christina; McLeod, Sarah M.; Wiseman, John W.; Newman, Joseph V.; Fisher, Stewart L.; Walkup, Grant K.			Secreted Gaussia princeps Luciferase as a Reporter of Escherichia coli Replication in a Mouse Tissue Cage Model of Infection	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; INTERLEUKIN-1 IL-1 PRODUCTION; FOREIGN-BODY INFECTION; IN-VIVO; FIREFLY LUCIFERASE; CHAMBER MODEL; GENE-EXPRESSION; BIOLUMINESCENCE; CELLS; MICE	Measurement of bacterial burden in animal infection models is a key component for both bacterial pathogenesis studies and therapeutic agent research. The traditional quantification means for in vivo bacterial burden requires frequent animal sacrifice and enumerating colony forming units (CFU) recovered from infection loci. To address these issues, researchers have developed a variety of luciferase-expressing bacterial reporter strains to enable bacterial detection in living animals. To date, all such luciferase-based bacterial reporters are in cell-associated form. Production of luciferase-secreting recombinant bacteria could provide the advantage of reporting CFU from both infection loci themselves and remote sampling (eg. body fluid and plasma). Toward this end, we have genetically manipulated a pathogenic Escherichia coli (E. coli) strain, ATCC25922, to secrete the marine copepod Gaussia princeps luciferase (Gluc), and assessed the use of Gluc as both an in situ and ex situ reporter for bacterial burden in mouse tissue cage infections. The E. coli expressing Gluc demonstrates in vivo imaging of bacteria in a tissue cage model of infection. Furthermore, secreted Gluc activity and bacterial CFUs recovered from tissue cage fluid (TCF) are correlated along 18 days of infection. Importantly, secreted Gluc can also be detected in plasma samples and serve as an ex situ indicator for the established tissue cage infection, once high bacterial burdens are achieved. We have demonstrated that Gluc from marine eukaryotes can be stably expressed and secreted by pathogenic E. coli in vivo to enable a facile tool for longitudinal evaluation of persistent bacterial infection.	[Liu, Mingyu; Blinn, Christina; McLeod, Sarah M.; Newman, Joseph V.; Fisher, Stewart L.; Walkup, Grant K.] AstraZeneca R&D Boston, Dept Biol, Infect Innovat Med, Waltham, MA 02451 USA; [Wiseman, John W.] AstraZeneca R&D, RAD Transgen, Discovery Sci, Molndal, Sweden	AstraZeneca; AstraZeneca	Liu, MY (corresponding author), AstraZeneca R&D Boston, Dept Biol, Infect Innovat Med, Waltham, MA 02451 USA.	Mingyu-mandy.liu@astrazeneca.com; Grant.walkup@astrazeneca.com			AstraZeneca RD	AstraZeneca RD(AstraZeneca)	This research was funded internally by AstraZeneca R&D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Andreu N, 2013, J ANTIMICROB CHEMOTH, V68, P2118, DOI 10.1093/jac/dkt155; Andreu N, 2011, FEMS MICROBIOL REV, V35, P360, DOI 10.1111/j.1574-6976.2010.00252.x; Andreu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010777; BAMBERGER DM, 1986, J ANTIMICROB CHEMOTH, V18, P51, DOI 10.1093/jac/18.1.51; Bamberger DM, 2002, ANTIMICROB AGENTS CH, V46, P2878, DOI 10.1128/AAC.46.9.2878-2884.2002; BAMBERGER DM, 1995, J ANTIMICROB CHEMOTH, V35, P623, DOI 10.1093/jac/35.5.623; BLASER J, 1995, ANTIMICROB AGENTS CH, V39, P1134, DOI 10.1128/AAC.39.5.1134; BOYLE VJ, 1973, ANTIMICROB AGENTS CH, V3, P418, DOI 10.1128/AAC.3.3.418; Chung E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008316; Contag CH, 2007, ANNU REV PATHOL-MECH, V2, P277, DOI 10.1146/annurev.pathol.2.010506.091930; Daniel C, 2013, APPL ENVIRON MICROB, V79, P1086, DOI 10.1128/AEM.03221-12; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAWSON J, 1993, AGENTS ACTIONS, V38, P255, DOI 10.1007/BF01976218; DAWSON J, 1993, AGENTS ACTIONS, V38, P247, DOI 10.1007/BF01976217; Degeling MH, 2013, ANAL CHEM, V85, P3006, DOI 10.1021/ac4003134; DEWET JR, 1985, P NATL ACAD SCI USA, V82, P7870; Enjalbert B, 2009, INFECT IMMUN, V77, P4847, DOI 10.1128/IAI.00223-09; Fernandez J, 1999, ANTIMICROB AGENTS CH, V43, P667, DOI 10.1128/AAC.43.3.667; Francis KP, 2001, INFECT IMMUN, V69, P3350, DOI 10.1128/IAI.69.5.3350-3358.2001; Galluzzi L, 2007, J BIOTECHNOL, V127, P188, DOI 10.1016/j.jbiotec.2006.06.019; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; GREEN AA, 1956, BIOCHIM BIOPHYS ACTA, V20, P170, DOI 10.1016/0006-3002(56)90275-X; Inouye S, 2008, BIOCHEM BIOPH RES CO, V365, P96, DOI 10.1016/j.bbrc.2007.10.152; Kim SB, 2011, ANAL CHEM, V83, P8732, DOI 10.1021/ac2021882; Koga K, 2005, MOL GENET GENOMICS, V274, P180, DOI 10.1007/s00438-005-0008-5; Kristian SA, 2004, MICROB PATHOGENESIS, V36, P237, DOI 10.1016/j.micpath.2003.12.004; Kristian SA, 2003, J INFECT DIS, V188, P414, DOI 10.1086/376533; LEMBERT N, 1995, BIOCHEM J, V305, P929, DOI 10.1042/bj3050929; Li CH, 2004, J ANTIMICROB CHEMOTH, V53, P297, DOI 10.1093/jac/dkh057; Lobo LA, 2013, MICROBIOLOGYOPEN, V2, P326, DOI 10.1002/mbo3.76; LUCET JC, 1990, ANTIMICROB AGENTS CH, V34, P2312, DOI 10.1128/AAC.34.12.2312; Maguire CA, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.25; Maguire CA, 2009, ANAL CHEM, V81, P7102, DOI 10.1021/ac901234r; McCallum N, 2006, ANTIMICROB AGENTS CH, V50, P2352, DOI 10.1128/AAC.00073-06; MEIGHEN EA, 1993, FASEB J, V7, P1016, DOI 10.1096/fasebj.7.11.8370470; MORRIS CE, 1986, GENE, V41, P193, DOI 10.1016/0378-1119(86)90098-3; Morse D, 2012, MOL THER, V20, P692, DOI 10.1038/mt.2012.38; Niers JM, 2011, MOL THER, V19, P1090, DOI 10.1038/mt.2011.17; Santos EB, 2009, NAT MED, V15, P338, DOI 10.1038/nm.1930; Shao N, 2008, CURR GENET, V53, P381, DOI 10.1007/s00294-008-0189-7; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; Welsh JP, 2009, BIOCHEM BIOPH RES CO, V389, P563, DOI 10.1016/j.bbrc.2009.09.006; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wiles S, 2005, APPL ENVIRON MICROB, V71, P3427, DOI 10.1128/AEM.71.7.3427-3432.2005; Wille T, 2012, APPL ENVIRON MICROB, V78, P250, DOI 10.1128/AEM.06670-11; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305	49	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90382	10.1371/journal.pone.0090382	http://dx.doi.org/10.1371/journal.pone.0090382			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595353	gold, Green Submitted, Green Published			2022-12-27	WOS:000332475500045
J	Shen, FF; Yue, WB; Zhou, FY; Pan, Y; Zhao, XK; Jin, Y; Song, X; Li, B; Han, XN; Tang, S; Li, Y; Yuan, G; Chen, LS; Liu, YL; Hu, YL; Li, XM; Ren, JL; Wang, LD				Shen, Fang-Fang; Yue, Wen-Bin; Zhou, Fu-You; Pan, Ying; Zhao, Xue-Ke; Jin, Yan; Song, Xin; Li, Bei; Han, Xue-Na; Tang, Sa; Li, Yan; Yuan, Guo; Chen, Li-Sha; Liu, Ya-Li; Hu, Yan-Long; Li, Xiu-Min; Ren, Jing-Li; Wang, Li-Dong			Variations in the MHC Region Confer Risk to Esophageal Squamous Cell Carcinoma on the Subjects from High-Incidence Area in Northern China	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CLASS-I; SUSCEPTIBILITY LOCI; HLA-DR; EXPRESSION; GENES; PROTEIN; CANCER; COMPONENTS; PLCE1	Background: The human major histocompatibility complex (MHC) is the most important region in vertebrate genome, and is crucial in innate immunity. Recent studies have demonstrated the possible role of polymorphisms in the MHC region to high risk for esophageal squamous cell carcinoma (ESCC). Our previous genome-wide association study (GWAS) has indicated that the MHC region may confer important risk loci for ESCC, but without further fine mapping. The aim of this study is to further identify the risk loci in the MHC region for ESCC in Chinese population. Methods: Conditional logistic regression analysis (CLRA) was performed on 24 single nucleotide polymorphisms (SNPs) within the MHC region, which were obtained from the genetically matched 937 cases and 692 controls of Chinese Han population. The identified promising SNPs were further correlated with clinical and clinicopathology characteristics. Immunohistochemistry was performed to explore the protein expression pattern of the related genes in ESCC and neighboring normal tissues. Results: Of the 24 promising SNPs analyzed, we identified three independent SNPs in the MHC region associated with ESCC: rs35399661 (P = 6.07E-06, OR = 1.71, 95% CI = 1.36-2.17), rs3763338 (P = 1.62E-05, OR = 0.63, 95% CI = 0.50-0.78) and rs2844695 (P = 7.60E-05, OR = 0.74, 95% CI = 0.64-0.86). These three SNPs were located at the genes of HLA-DQA1, TRIM27, and DPCR1, respectively. Further analyses showed that rs2844695 was preferentially associated with younger ESCC cases (P = 0.009). The positive immunostaining rates both for HLA-DQA1 and TRIM27 were much higher in ESCC tissues than in neighboring normal tissues (69.4% vs. 26.8% for HLA-DQA1 and 77.6% vs. 47.8% for TRIM27, P<0.001). Furthermore, the overexpression of HLA-DQA1 is correlated significantly with age (P = 0.001) and family history (P<0.001). Conclusion: This study for the first time provides evidence that multiple genetic factors within the MHC region confer risk to ESCC on the subjects from high-risk area in northern China.	[Shen, Fang-Fang; Yue, Wen-Bin; Zhao, Xue-Ke; Jin, Yan; Song, Xin; Li, Bei; Han, Xue-Na; Tang, Sa; Li, Yan; Yuan, Guo; Chen, Li-Sha; Liu, Ya-Li; Hu, Yan-Long; Wang, Li-Dong] Zhengzhou Univ, Affiliated Hosp 1, Henan Key Lab Esophageal Canc Res, Zhengzhou 450052, Henan, Peoples R China; [Shen, Fang-Fang; Pan, Ying; Yuan, Guo; Chen, Li-Sha; Liu, Ya-Li; Hu, Yan-Long; Li, Xiu-Min] Xinxiang Med Univ, Canc Res Ctr, Xinxiang, Henan, Peoples R China; [Shen, Fang-Fang; Pan, Ying; Yuan, Guo; Chen, Li-Sha; Liu, Ya-Li; Hu, Yan-Long; Li, Xiu-Min] Xinxiang Med Univ, Affiliated Hosp 3, Xinxiang, Henan, Peoples R China; [Zhou, Fu-You] Anyang Tumor Hosp, Dept Thorac Surg, Anyang, Henan, Peoples R China; [Ren, Jing-Li] Zhengzhou Univ, Affiliated Hosp 2, Dept Pathol, Zhengzhou 450052, Henan, Peoples R China	Zhengzhou University; Xinxiang Medical University; Xinxiang Medical University; Zhengzhou University	Wang, LD (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Henan Key Lab Esophageal Canc Res, Zhengzhou 450052, Henan, Peoples R China.	ldwang2007@126.com	li, xiu/GXV-1745-2022	ren, jingli/0000-0001-9891-0579; Zhou, Fu-You/0000-0002-6548-4099	National Natural Science Foundations [30670956, 30971133]; 863 HighTech Key Projects [2006AA02A403, 2007AA02Z161]; China Key Program on Basic Research [2007CB516812]; Special Scientific Programs from Science and Technology Department of Henan Province; Health Department of Henan Province; Education Department of Henan Province	National Natural Science Foundations(National Natural Science Foundation of China (NSFC)); 863 HighTech Key Projects(National High Technology Research and Development Program of China); China Key Program on Basic Research; Special Scientific Programs from Science and Technology Department of Henan Province; Health Department of Henan Province; Education Department of Henan Province	his project was funded by National Natural Science Foundations (30670956, 30971133), 863 HighTech Key Projects (2006AA02A403, 2007AA02Z161), China Key Program on Basic Research (2007CB516812), Special Scientific Programs from Science and Technology Department (2009-8), Health Department (2009-10) and Education Department (2008-7) of Henan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Daly JM, 2000, J AM COLL SURGEONS, V190, P562, DOI 10.1016/S1072-7515(00)00238-6; Dho SH, 2003, J BIOL CHEM, V278, P31902, DOI 10.1074/jbc.M304062200; Dura P, 2013, INT J CANCER, V133, P1751, DOI 10.1002/ijc.28160; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Guo W, 2009, CURR GENOMICS, V10, P534, DOI 10.2174/138920209789503888; Haocai L, 1983, Ecol Dis, V2, P249; Hiyama T, 2007, INT J CANCER, V121, P1643, DOI 10.1002/ijc.23044; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Huang Li-ming, 2012, Zhonghua Zhong Liu Za Zhi, V34, P269, DOI 10.3760/cma.j.issn.0253-3766.2012.04.007; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jordanova ES, 2003, IMMUNOGENETICS, V55, P203, DOI 10.1007/s00251-003-0563-z; Kohno T, 2011, J THORAC ONCOL, V6, P813, DOI 10.1097/JTO.0b013e3181ee80ef; LAZARIS AC, 1995, DIS COLON RECTUM, V38, P739, DOI 10.1007/BF02048033; Liu Q, 2009, SCAND J GASTROENTERO, V44, P960, DOI 10.1080/00365520902998679; Matsuzaka Y, 2002, IMMUNOGENETICS, V54, P301, DOI 10.1007/s00251-002-0470-8; Morita M, 2010, INT J CLIN ONCOL, V15, P126, DOI 10.1007/s10147-010-0056-7; Nie Y, 2001, CARCINOGENESIS, V22, P1615, DOI 10.1093/carcin/22.10.1615; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rajendra S, 2006, J CLIN PATHOL, V59, P952, DOI 10.1136/jcp.2005.031575; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; TAKAHASHI M, 1988, ONCOGENE, V3, P571; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WANG LD, 1993, CANCER RES, V53, P1783; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; YANG CS, 1980, CANCER RES, V40, P2633	29	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90438	10.1371/journal.pone.0090438	http://dx.doi.org/10.1371/journal.pone.0090438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595008	Green Submitted, gold, Green Published			2022-12-27	WOS:000332475500049
J	Deng, Y; Chen, KR; Teng, W; Zhan, A; Tong, YP; Feng, G; Cui, ZL; Zhang, FS; Chen, XP				Deng, Yan; Chen, Keru; Teng, Wan; Zhan, Ai; Tong, Yiping; Feng, Gu; Cui, Zhenling; Zhang, Fusuo; Chen, Xinping			Is the Inherent Potential of Maize Roots Efficient for Soil Phosphorus Acquisition?	PLOS ONE			English	Article							PHOSPHATE TRANSPORTERS; ARABIDOPSIS-THALIANA; MYCORRHIZAL FUNGI; PLANT; RICE; DEFICIENCY; MANAGEMENT; RESPONSES; NITROGEN; SYSTEMS	Sustainable agriculture requires improved phosphorus (P) management to reduce the overreliance on P fertilization. Despite intensive research of root adaptive mechanisms for improving P acquisition, the inherent potential of roots for efficient P acquisition remains unfulfilled, especially in intensive agriculture, while current P management generally focuses on agronomic and environmental concerns. Here, we investigated how levels of soil P affect the inherent potential of maize (Zea mays L.) roots to obtain P from soil. Responses of root morphology, arbuscular mycorrhizal colonization, and phosphate transporters were characterized and related to agronomic traits in pot and field experiments with soil P supply from deficiency to excess. Critical soil Olsen-P level for maize growth approximated 3.2 mg kg(-1), and the threshold indicating a significant environmental risk was about 15 mg kg(-1), which represented the lower and upper levels of soil P recommended in current P management. However, most root adaptations involved with P acquisition were triggered when soil Olsen-P was below 10 mg kg(-1), indicating a threshold for maximum root inherent potential. Therefore, to maintain efficient inherent potential of roots for P acquisition, we suggest that the target upper level of soil P in intensive agriculture should be reduced from the environmental risk threshold to the point maximizing the inherent potential of roots.	[Deng, Yan; Chen, Keru; Feng, Gu; Cui, Zhenling; Zhang, Fusuo; Chen, Xinping] China Agr Univ, Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China; [Teng, Wan; Tong, Yiping] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Zhan, Ai] Chinese Acad Sci, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China; [Zhan, Ai] Minist Water Resource, Yangling, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS	Chen, XP (corresponding author), China Agr Univ, Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China.	chenxp@cau.edu.cn	Zhang, Fusuo/AAV-4517-2021; Feng, Gu/K-8367-2012	Feng, Gu/0000-0002-1052-5009	National Natural Science Foundation of China [30890133, 30971872]; National Maize Production System in China [CARS-02-24]; Innovative Group Grant of NSFC [30971892]; Innovation Fund for Graduate Student of China Agricultural University [KYCX2011032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Maize Production System in China; Innovative Group Grant of NSFC; Innovation Fund for Graduate Student of China Agricultural University	This work was supported by the National Natural Science Foundation of China (30890133, 30971872), National Maize Production System in China (CARS-02-24), the Innovative Group Grant of NSFC (30971892), and the Innovation Fund for Graduate Student of China Agricultural University (KYCX2011032). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ABBOTT LK, 1991, AGR ECOSYST ENVIRON, V35, P121, DOI 10.1016/0167-8809(91)90048-3; Bates TR, 1996, PLANT CELL ENVIRON, V19, P529, DOI 10.1111/j.1365-3040.1996.tb00386.x; BOLAN NS, 1991, PLANT SOIL, V134, P189, DOI 10.1007/BF00012037; Brown LK, 2013, ANN BOT-LONDON, V112, P317, DOI 10.1093/aob/mcs231; Calderon-Vazquez C, 2008, J EXP BOT, V59, P2479, DOI 10.1093/jxb/ern115; Chin JH, 2011, PLANT PHYSIOL, V156, P1202, DOI 10.1104/pp.111.175471; Coelho GTCP, 2010, PLANT MOL BIOL REP, V28, P717, DOI 10.1007/s11105-010-0199-8; Colomb B, 2007, EUR J AGRON, V26, P154, DOI 10.1016/j.eja.2006.09.004; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Cordell D, 2011, CHEMOSPHERE, V84, P747, DOI 10.1016/j.chemosphere.2011.02.032; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Covacevich F, 2007, APPL SOIL ECOL, V35, P1, DOI 10.1016/j.apsoil.2006.06.001; Elliott HA, 2007, SOIL BIOL BIOCHEM, V39, P1318, DOI 10.1016/j.soilbio.2006.12.007; Fan MS, 2003, FUNCT PLANT BIOL, V30, P493, DOI 10.1071/FP03046; Fernandez M, 2009, P INT PLANT NUTR C; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; Gilbert N, 2009, NATURE, V461, P716, DOI 10.1038/461716a; Glassop D, 2007, CAN J BOT, V85, P644, DOI 10.1139/B07-070; Grant C, 2005, CAN J PLANT SCI, V85, P3, DOI 10.4141/P03-182; Grant CA, 2001, CAN J PLANT SCI, V81, P211, DOI 10.4141/P00-093; HECKRATH G, 1995, J ENVIRON QUAL, V24, P904, DOI 10.2134/jeq1995.00472425002400050018x; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Hesketh N, 2000, J ENVIRON QUAL, V29, P105, DOI 10.2134/jeq2000.00472425002900010013x; Higgs B, 2000, J ENVIRON QUAL, V29, P80, DOI 10.2134/jeq2000.00472425002900010010x; Hill JO, 2006, PLANT SOIL, V286, P7, DOI 10.1007/s11104-006-0014-3; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; Howard A. E., 2006, ALBERTA SOIL PHOSPHO, V5; Javot H, 2007, PLANT CELL ENVIRON, V30, P310, DOI 10.1111/j.1365-3040.2006.01617.x; Johnston A.E., 2005, PHOSPHORUS AGR RELAT; Kirkby Ernest A., 2008, V7, P177; Lambers H, 2006, ANN BOT-LONDON, V98, P693, DOI 10.1093/aob/mcl114; Li H, 2011, PLANT SOIL, V349, P157, DOI 10.1007/s11104-011-0909-5; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; Lynch Jonathan P., 2008, V7, P83; Ma Z, 2001, PLANT CELL ENVIRON, V24, P459, DOI 10.1046/j.1365-3040.2001.00695.x; MacDonald GK, 2011, P NATL ACAD SCI USA, V108, P3086, DOI 10.1073/pnas.1010808108; Mallarino AP, 2005, SOIL SCI SOC AM J, V69, P266, DOI 10.2136/sssaj2005.0266; MALLARINO AP, 1992, AGRON J, V84, P850, DOI 10.2134/agronj1992.00021962008400050017x; Nagy R, 2006, PLANT BIOLOGY, V8, P186, DOI 10.1055/s-2005-873052; Nussaume L, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00083; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Pierzynski, 2000, METHODS PHOSPHORUS A, V396, P1; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Ramaekers L, 2010, FIELD CROP RES, V117, P169, DOI 10.1016/j.fcr.2010.03.001; Richardson AE, 2009, CROP PASTURE SCI, V60, P124, DOI 10.1071/CP07125; ROMER W, 1986, PLANT SOIL, V91, P221, DOI 10.1007/BF02181789; Sharpley A., 2003, AGR PHOSPHORUS EUTRO; SHARPLEY AN, 1994, J ENVIRON QUAL, V23, P437, DOI 10.2134/jeq1994.00472425002300030006x; Shi R., 1986, SOIL AGR CHEM ANAL; Smith SE, 2011, ANNU REV PLANT BIOL, V62, P227, DOI 10.1146/annurev-arplant-042110-103846; Tang X, 2009, PLANT SOIL, V323, P143, DOI 10.1007/s11104-009-9919-y; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; Trouvelot A, 1986, PHYSIOLOGICAL GENETI, P217, DOI DOI 10.1177/004057368303900411; Vaccari DA, 2009, SCI AM, V300, P54, DOI 10.1038/scientificamerican0609-54; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558	57	39	41	5	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90287	10.1371/journal.pone.0090287	http://dx.doi.org/10.1371/journal.pone.0090287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594677	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900090
J	Grueber, CE; Wallis, GP; Jamieson, IG				Grueber, Catherine E.; Wallis, Graham P.; Jamieson, Ian G.			Episodic Positive Selection in the Evolution of Avian Toll-Like Receptor Innate Immunity Genes	PLOS ONE			English	Article							BALANCING SELECTION; NATURAL-SELECTION; STRUCTURAL BASIS; COMPLEX; IDENTIFICATION; RECOGNITION; LOCI; POPULATION; ACTIVATION; HOMOLOG	Toll-like receptors (TLRs) are a family of conserved pattern-recognition molecules responsible for initiating innate and acquired immune responses. Because they play a key role in host defence, these genes have received increasing interest in the evolutionary and population genetics literature, as their variation represents a potential target of adaptive evolution. However, the role of pathogen-mediated selection (i.e. episodic positive selection) in the evolution of these genes remains poorly known and has not been examined outside of mammals. A recent increase in the number of bird species for which TLR sequences are available has enabled us to examine the selective processes that have influenced evolution of the 10 known avian TLR genes. Specifically, we tested for episodic positive selection to identify codons that experience purifying selection for the majority of their evolution, interspersed with bursts of positive selection that may occur only in restricted lineages. We included up to 23 species per gene (mean = 16.0) and observed that, although purifying selection was evident, an average of 4.5% of codons experienced episodic positive selection across all loci. For four genes in which sequence coverage traversed both the extracellular leucine-rich repeat region (LRR) and transmembrane/intracellular domains of the proteins, increased positive selection was observed at the extracellular domain, consistent with theoretical predictions. Our results provide evidence that episodic positive selection has played an important role in the evolution of most avian TLRs, consistent with the role of these loci in pathogen recognition and a mechanism of host-pathogen coevolution.	[Grueber, Catherine E.; Jamieson, Ian G.] Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand; [Grueber, Catherine E.; Wallis, Graham P.; Jamieson, Ian G.] Univ Otago, Dept Zool, Dunedin, New Zealand	University of Otago	Grueber, CE (corresponding author), Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand.	catherine.grueber@otago.ac.nz	Grueber, Catherine E./H-4707-2011; Wallis, Graham/E-5410-2011	Grueber, Catherine E./0000-0002-8179-1822; Wallis, Graham/0000-0002-6408-7868	Allan Wilson Centre for Molecular Ecology and Evolution; Marsden Fund [UOO1009]; Landcare Research [C09X0503]; University of Otago	Allan Wilson Centre for Molecular Ecology and Evolution; Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Landcare Research; University of Otago	The authors' research received funding from the Allan Wilson Centre for Molecular Ecology and Evolution, the Marsden Fund (Contract no. UOO1009), Landcare Research (Contract no. C09X0503) and University of Otago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2006, TRENDS ECOL EVOL, V21, P433, DOI 10.1016/j.tree.2006.05.010; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alcaide M, 2011, MOL BIOL EVOL, V28, P1703, DOI 10.1093/molbev/msq351; Areal H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-368; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Boyd AC, 2012, J IMMUNOL, V189, P4930, DOI 10.4049/jimmunol.1101790; Brownlie R, 2011, CELL TISSUE RES, V343, P121, DOI 10.1007/s00441-010-1026-0; Brownlie R, 2009, MOL IMMUNOL, V46, P3163, DOI 10.1016/j.molimm.2009.06.002; Cadavid LF, 2013, IMMUNOGENETICS; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cormican P, 2009, DEV COMP IMMUNOL, V33, P967, DOI 10.1016/j.dci.2009.04.001; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Delport W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000885; Downing T, 2010, J IMMUNOL, V184, P6993, DOI 10.4049/jimmunol.0903092; Drummond AJ, 2010, GENEIOUS; Ellegren H, 2008, MOL ECOL, V17, P4586, DOI 10.1111/j.1365-294X.2008.03954.x; Ferrer-Admetlla A, 2008, J IMMUNOL, V181, P1315, DOI 10.4049/jimmunol.181.2.1315; Fornuskova A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-194; Gharib WH, 2013, MOL BIOL EVOL, V30, P1675, DOI 10.1093/molbev/mst062; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Grueber CE, 2013, CONSERV GENET RESOUR, V5, P1043, DOI 10.1007/s12686-013-9965-x; Grueber CE, 2013, MOL ECOL, V22, P4470, DOI 10.1111/mec.12404; Grueber CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045011; Hedrick PW, 1998, GENETICA, V104, P207, DOI 10.1023/A:1026494212540; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES AL, 1990, MOL BIOL EVOL, V7, P515; Jepson A, 1997, INFECT IMMUN, V65, P872, DOI 10.1128/IAI.65.3.872-876.1997; Keestra AM, 2008, J IMMUNOL, V181, P4354, DOI 10.4049/jimmunol.181.6.4354; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mukherjee S, 2009, P NATL ACAD SCI USA, V106, P7073, DOI 10.1073/pnas.0811357106; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; NEI M, 1986, MOL BIOL EVOL, V3, P418; Offord V, 2010, DEV COMP IMMUNOL, V34, P1035, DOI 10.1016/j.dci.2010.05.004; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; RCore Team, 2020, R LANG ENV STAT COMP; Rech GE, 2012, PLANT SIGNAL BEHAV, V7, P1667, DOI 10.4161/psb.22362; Saponaro C, 2011, IMMUNOPHARM IMMUNOT, V33, P64, DOI 10.3109/08923971003739244; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Streicker DG, 2012, P NATL ACAD SCI USA, V109, P19715, DOI 10.1073/pnas.1203456109; Sundar D.R, 2009, BINOM BINOMIAL CONFI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Temperley ND, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-62; Tschirren B, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0364; Turner AK, 2012, MOL ECOL, V21, P1632, DOI 10.1111/j.1365-294X.2012.05501.x; Uematsu Satoshi, 2008, V183, P1; Villasenor-Cardoso MI, 2011, PARASITE IMMUNOL, V33, P643, DOI 10.1111/j.1365-3024.2011.01327.x; Vinkler M, 2009, TISSUE ANTIGENS, V74, P32, DOI 10.1111/j.1399-0039.2009.01273.x; Vinkler M, 2009, FOLIA ZOOL, V58, P15; Wang YL, 2000, TRENDS BIOCHEM SCI, V25, P300, DOI 10.1016/S0968-0004(00)01561-9; Werling D, 2009, TRENDS IMMUNOL, V30, P124, DOI 10.1016/j.it.2008.12.001; Wlasiuk G, 2010, MOL BIOL EVOL, V27, P2172, DOI 10.1093/molbev/msq104; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010	61	74	78	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89632	10.1371/journal.pone.0089632	http://dx.doi.org/10.1371/journal.pone.0089632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595315	Green Submitted, gold, Green Published			2022-12-27	WOS:000332468900028
J	Lu, Y; Paraskevopoulos, E; Herholz, SC; Kuchenbuch, A; Pantev, C				Lu, Yao; Paraskevopoulos, Evangelos; Herholz, Sibylle C.; Kuchenbuch, Anja; Pantev, Christo			Temporal Processing of Audiovisual Stimuli Is Enhanced in Musicians: Evidence from Magnetoencephalography (MEG)	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; MISMATCH NEGATIVITY MMN; CORTICAL PLASTICITY; MUSICAL EXPERTISE; AUDITORY-CORTEX; BRAIN; INTEGRATION; PERCEPTION; REPRESENTATION; FMRI	Numerous studies have demonstrated that the structural and functional differences between professional musicians and non-musicians are not only found within a single modality, but also with regard to multisensory integration. In this study we have combined psychophysical with neurophysiological measurements investigating the processing of non-musical, synchronous or various levels of asynchronous audiovisual events. We hypothesize that long-term multisensory experience alters temporal audiovisual processing already at a non-musical stage. Behaviorally, musicians scored significantly better than non-musicians in judging whether the auditory and visual stimuli were synchronous or asynchronous. At the neural level, the statistical analysis for the audiovisual asynchronous response revealed three clusters of activations including the ACC and the SFG and two bilaterally located activations in IFG and STG in both groups. Musicians, in comparison to the non-musicians, responded to synchronous audiovisual events with enhanced neuronal activity in a broad left posterior temporal region that covers the STG, the insula and the Postcentral Gyrus. Musicians also showed significantly greater activation in the left Cerebellum, when confronted with an audiovisual asynchrony. Taken together, our MEG results form a strong indication that long-term musical training alters the basic audiovisual temporal processing already in an early stage (direct after the auditory N1 wave), while the psychophysical results indicate that musical training may also provide behavioral benefits in the accuracy of the estimates regarding the timing of audiovisual events.	[Lu, Yao; Paraskevopoulos, Evangelos; Kuchenbuch, Anja; Pantev, Christo] Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany; [Herholz, Sibylle C.] German Ctr Neurodegenerat Dis, Bonn, Germany	University of Munster; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Pantev, C (corresponding author), Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany.	pantev@uni-muenster.de		Paraskevopoulos, Evangelos/0000-0003-4063-4182	Deutsche Forschungsgemeinschaft [PA392/12-2, HE6067-1/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft [PA392/12-2 and HE6067-1/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besle J, 2005, EXP BRAIN RES, V166, P337, DOI 10.1007/s00221-005-2375-x; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bushara KO, 2003, NAT NEUROSCI, V6, P190, DOI 10.1038/nn993; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Fujioka T, 2005, J COGNITIVE NEUROSCI, V17, P1578, DOI 10.1162/089892905774597263; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Gaser C, 2003, J NEUROSCI, V23, P9240; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Gonzalo D, 2000, NEUROIMAGE, V11, P243, DOI 10.1006/nimg.2000.0540; Haueisen J, 2001, J COGNITIVE NEUROSCI, V13, P786, DOI 10.1162/08989290152541449; Herholz SC, 2008, EUR J NEUROSCI, V28, P2352, DOI 10.1111/j.1460-9568.2008.06515.x; Hutchinson S, 2003, CEREB CORTEX, V13, P943, DOI 10.1093/cercor/13.9.943; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Ivry R, 1997, INT REV NEUROBIOL, V41, P555; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; IVRY RB, 1995, J EXP PSYCHOL HUMAN, V21, P3, DOI 10.1037/0096-1523.21.1.3; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Johnsrude IS, 1997, NEUROREPORT, V8, P1761, DOI 10.1097/00001756-199705060-00038; Lee H, 2011, P NATL ACAD SCI USA, V108, pE1441, DOI 10.1073/pnas.1115267108; Lewis R, 2010, J NEUROSCI, V30, P12329, DOI 10.1523/JNEUROSCI.5745-09.2010; Liegeois-Chauvel C, 2004, CEREB CORTEX, V14, P731, DOI 10.1093/cercor/bhh033; Love Scott A., 2012, Cognitive Behavioural Systems (COST 2012). International Training School. Revised Selected Papers, P304, DOI 10.1007/978-3-642-34584-5_27; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Musacchia G, 2009, HEARING RES, V258, P72, DOI 10.1016/j.heares.2009.06.018; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 2004, CLIN NEUROPHYSIOL, V115, P140, DOI 10.1016/j.clinph.2003.04.001; Noesselt T, 2008, BRAIN RES, V1220, P132, DOI 10.1016/j.brainres.2007.09.045; Noesselt T, 2007, J NEUROSCI, V27, P11431, DOI 10.1523/JNEUROSCI.2252-07.2007; NYMAN G, 1990, ELECTROEN CLIN NEURO, V77, P436, DOI 10.1016/0168-5597(90)90004-W; O'Reilly JX, 2008, J NEUROSCI, V28, P2252, DOI 10.1523/JNEUROSCI.2742-07.2008; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveira FTP, 2007, J COGNITIVE NEUROSCI, V19, P1994, DOI 10.1162/jocn.2007.19.12.1994; Pantev C, 2003, ANN NY ACAD SCI, V999, P438, DOI 10.1196/annals.1284.054; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Pantev C, 2009, ANN NY ACAD SCI, V1169, P143, DOI 10.1111/j.1749-6632.2009.04588.x; Paraskevopoulos E, 2012, J NEUROSCI, V32, P18196, DOI 10.1523/JNEUROSCI.1947-12.2012; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Penhune VB, 1998, J COGNITIVE NEUROSCI, V10, P752, DOI 10.1162/089892998563149; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; Petrini K, 2011, NEUROIMAGE, V56, P1480, DOI 10.1016/j.neuroimage.2011.03.009; Petrini K, 2009, EXP BRAIN RES, V198, P339, DOI 10.1007/s00221-009-1817-2; Powers AR, 2009, J NEUROSCI, V29, P12265, DOI 10.1523/JNEUROSCI.3501-09.2009; Rodrigues AC, 2013, BRAIN COGNITION, V82, P229, DOI 10.1016/j.bandc.2013.04.009; Schlaug G, 2001, ANN NY ACAD SCI, V930, P281, DOI 10.1111/j.1749-6632.2001.tb05739.x; Schon D, 2005, J COGNITIVE NEUROSCI, V17, P694, DOI 10.1162/0898929053467532; Schon D, 2003, ANN NY ACAD SCI, V999, P193, DOI 10.1196/annals.1284.028; Schon D, 2002, NEUROREPORT, V13, P2285, DOI 10.1097/01.wnr.0000044224.79663.f5; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stewart L, 2003, NEUROIMAGE, V20, P71, DOI 10.1016/S1053-8119(03)00248-9; Teder-Salejarvi WA, 2005, J COGNITIVE NEUROSCI, V17, P1396, DOI 10.1162/0898929054985383; Vuust P, 2005, NEUROIMAGE, V24, P560, DOI 10.1016/j.neuroimage.2004.08.039; Zatorre R, 2005, NATURE, V434, P312, DOI 10.1038/434312a; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	60	16	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90686	10.1371/journal.pone.0090686	http://dx.doi.org/10.1371/journal.pone.0090686			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595014	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900134
J	Song, JQ; Dong, F; Li, X; Xu, CP; Cui, Z; Jiang, N; Jia, JJ; Yu, B				Song, Jin-qi; Dong, Fu; Li, Xue; Xu, Chang-peng; Cui, Zhuang; Jiang, Nan; Jia, Jun-jie; Yu, Bin			Effect of Treadmill Exercise Timing on Repair of Full-Thickness Defects of Articular Cartilage by Bone-Derived Mesenchymal Stem Cells: An Experimental Investigation in Rats	PLOS ONE			English	Article							CONTINUOUS PASSIVE MOTION; AUTOGENOUS PERIOSTEAL GRAFTS; EARLY CONDITIONING EXERCISE; EXTRACELLULAR-MATRIX; OXYGEN-CONSUMPTION; MIDCARPAL JOINT; EQUINE CARPUS; KNEE-JOINT; OSTEOARTHRITIS; IMMOBILIZATION	Objective: Current medical practice for the treatment of articular cartilage lesions remains a clinical challenge due to the limited self-repair ability of articular cartilage. Both experimental and clinical researches show that moderate exercise can improve articular cartilage repair process. However, optimal timing of moderate exercise is unclear. We aimed to evaluate the effect of timing of moderate treadmill exercise on repair of full-thickness defects of articular cartilage. Design: Full-thickness cartilage defects were drilled in the patellar groove of bilateral femoral condyles in a total of 40 male SD rats before they were randomly assigned into four even groups. In sedentary control (SED) group, no exercise was given; in 2-week (2W), 4-week (4W) and 8-week groups, moderate treadmill exercise was initiated respectively two, four and eight weeks after operation. Half of the animals were sacrificed at week 10 after operation and half at week 14 after operation. Femoral condyles were harvested for gross observation and histochemical measurement by O'Driscoll scoring system. Collagen type II was detected by immunohistochemistry and mRNA expressions of aggrecan and collagen type II cartilage by RT-PCR. Results: Both 10 and 14 weeks post-operation, the best results were observed in 4W group and the worst results appeared in 2W group. The histochemistry scores and the expressions of collagen type II and aggrecan were significantly higher in 4W group than that in other three groups (P<0.05). Conclusions: Moderate exercise at a selected timing (approximately 4 weeks) after injury can significantly promote the healing of cartilage defects but may hamper the repair process if performed too early while delayed intervention by moderate exercise may reduce its benefits in repair of the defects.	[Song, Jin-qi; Li, Xue; Xu, Chang-peng; Cui, Zhuang; Jiang, Nan; Jia, Jun-jie; Yu, Bin] Southern Med Univ, Nanfang Hosp, Dept Orthopaed & Traumatol, Guangzhou, Guangdong, Peoples R China; [Dong, Fu] Beihai Peoples Hosp Guangxi Prov, Dept Orthopaed, Bei Hai, Guangxi Provinc, Peoples R China; [Yu, Bin] Southern Med Univ, Nanfang Hosp, Key Lab Bone & Cartilage Regenerat Med Guangdong, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Yu, B (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Orthopaed & Traumatol, Guangzhou, Guangdong, Peoples R China.	orthop@sohu.com	Jiang, Nan/AAD-9841-2019	Jiang, Nan/0000-0003-2416-1653	Production, Academy and Research Foundation of Guangdong Province [2011B090400016]	Production, Academy and Research Foundation of Guangdong Province	This study was financially supported by Production, Academy and Research Foundation of Guangdong Province (2011B090400016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albro MB, 2008, J BIOMECH, V41, P3152, DOI 10.1016/j.jbiomech.2008.08.023; BEDFORD TG, 1979, J APPL PHYSIOL, V47, P1278, DOI 10.1152/jappl.1979.47.6.1278; Carver SE, 1999, BIOTECHNOL BIOENG, V62, P166, DOI 10.1002/(SICI)1097-0290(19990120)62:2<166::AID-BIT6>3.3.CO;2-B; Chahine NO, 2009, BIOPHYS J, V97, P968, DOI 10.1016/j.bpj.2009.05.047; Chang NJ, 2012, BIOMATERIALS, V33, P3153, DOI 10.1016/j.biomaterials.2011.12.054; Dausse Y, 2003, OSTEOARTHR CARTILAGE, V11, P16, DOI 10.1053/joca.2002.0859; DUDEK BC, 1983, J COMP PSYCHOL, V97, P249, DOI 10.1037/0735-7036.97.3.249; Elsaid KA, 2012, OSTEOARTHR CARTILAGE, V20, P940, DOI 10.1016/j.joca.2012.04.021; Espanha MM, 2001, CONNECT TISSUE RES, V42, P97, DOI 10.3109/03008200109014252; Fransen M, 2003, COCHRANE DB SYST REV, V3, pD4286; FRENCH DA, 1989, VET SURG, V18, P312, DOI 10.1111/j.1532-950X.1989.tb01091.x; Galois L, 2004, OSTEOARTHR CARTILAGE, V12, P779, DOI 10.1016/j.joca.2004.06.008; Haapala J, 2000, INT J SPORTS MED, V21, P76; Haller JM, 2013, ORTHOP CLIN N AM, V44, P509, DOI 10.1016/j.ocl.2013.06.005; Huang AH, 2010, EUR CELLS MATER, V19, P72, DOI 10.22203/eCM.v019a08; HURTIG MB, 1988, CAN J VET RES, V52, P137; Kim W, 2012, AM J VET RES, V73, P498, DOI 10.2460/ajvr.73.4.498; Kim W, 2009, AM J VET RES, V70, P589, DOI 10.2460/ajvr.70.5.589; KINCAID SA, 1982, AM J VET RES, V43, P1218; KIVIRANTA I, 1988, J ORTHOPAED RES, V6, P188, DOI 10.1002/jor.1100060205; KREDER HJ, 1994, CLIN ORTHOP RELAT R, P288; Laforgia J, 2006, J SPORT SCI, V24, P1247, DOI 10.1080/02640410600552064; Lammi PE, 2001, HISTOCHEM CELL BIOL, V115, P301; Lee YJ, 2011, RHEUMATOL INT, V31, P1571, DOI 10.1007/s00296-010-1520-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANKIN HJ, 1974, NEW ENGL J MED, V291, P1285, DOI 10.1056/NEJM197412122912406; Moffat PA, 2008, EQUINE VET J, V40, P136, DOI 10.2746/042516408X253109; MORAN ME, 1992, J BONE JOINT SURG BR, V74, P659, DOI 10.1302/0301-620X.74B5.1527109; Ni GX, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4101; Ni GX, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3521; Nugent GE, 2004, OSTEOARTHR CARTILAGE, V12, P826, DOI 10.1016/j.joca.2004.07.001; O'Conor Christopher J, 2013, Stem Cell Res Ther, V4, P61, DOI 10.1186/scrt211; ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; PALMOSKI MJ, 1980, ARTHRITIS RHEUM, V23, P325, DOI 10.1002/art.1780230310; Reinold MM, 2006, J ORTHOP SPORT PHYS, V36, P774, DOI 10.2519/jospt.2006.2228; Roos EM, 2005, ARTHRITIS RHEUM-US, V52, P3507, DOI 10.1002/art.21415; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simon TM, 2006, SPORTS MED ARTHROSC, V14, P146, DOI 10.1097/00132585-200609000-00006; Soder S, 2011, PATHOLOGE, V32, P183, DOI 10.1007/s00292-011-1419-1; TODHUNTER RJ, 1993, J ORTHOPAED RES, V11, P782, DOI 10.1002/jor.1100110603; TROYER H, 1975, CLIN ORTHOP RELAT R, P249; van Weerew PR, 2008, EQUINE VET J, V40, P128, DOI 10.2746/042516408X253091; Vanwanseele B, 2002, OSTEOARTHR CARTILAGE, V10, P408, DOI 10.1053/joca.2002.0529; VIDEMAN T, 1981, BIOCHEM J, V200, P435, DOI 10.1042/bj2000435; VIDEMAN T, 1982, RHEUMATOL REHABIL, V21, P1, DOI 10.1093/rheumatology/21.1.1; Widuchowski W, 2008, ACTA CHIR ORTHOP TR, V75, P382; WILLIAMS JM, 1984, J ANAT, V139, P599; Zhuo Q, 2012, NAT REV RHEUMATOL, V8, P729, DOI 10.1038/nrrheum.2012.135	49	14	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90858	10.1371/journal.pone.0090858	http://dx.doi.org/10.1371/journal.pone.0090858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595327	Green Submitted, gold, Green Published			2022-12-27	WOS:000332468900153
J	Xu, YQ; He, BS; Li, R; Pan, YQ; Gao, TY; Deng, QW; Sun, HL; Song, GQ; Wang, SK				Xu, Yeqiong; He, Bangshun; Li, Rui; Pan, Yuqin; Gao, Tianyi; Deng, Qiwen; Sun, Huiling; Song, Guoqi; Wang, Shukui			Association of the Polymorphisms in the Fas/FasL Promoter Regions with Cancer Susceptibility: A Systematic Review and Meta-Analysis of 52 Studies	PLOS ONE			English	Article							DEATH PATHWAY GENES; SQUAMOUS-CELL CARCINOMA; NORTH INDIAN POPULATION; FAS LIGAND GENES; GASTRIC CARDIAC ADENOCARCINOMA; EPITHELIAL OVARIAN-CANCER; CERVICAL-CANCER; LUNG-CANCER; FUNCTIONAL POLYMORPHISMS; BREAST-CANCER	Fas and its ligand (FasL) play an important role in apoptosis and carcinogenesis. Therefore, the potential association of polymorphisms in the Fas (-670A > G, rs1800682; -1377G > A, rs2234767) and FasL (-844C > T, rs763110) with cancer risk has been widely investigated. However, all the currently available results are not always consistent. In this work, we performed a meta-analysis to further determine whether carriers of the polymorphisms in Fas and FasL of interest could confer an altered susceptibility to cancer. All relevant data were retrieved by PubMed and Web of Science, and 52 eligible studies were chosen for this meta-analysis. There was no association of the Fas -670A > G polymorphism with cancer risk in the pooled data. For the Fas -1377G > A and FasL -844C > T polymorphisms, results revealed that the homozygotes of -1377A and -844C were associated with elevated risk of cancer as a whole. Further stratified analysis indicated markedly increased risk for developing breast cancer, gastric cancer, and esophageal cancer, in particular in Asian population. We conclude that carriers of the Fas-1377A and the FasL -844C are more susceptible to the majority of cancers than non-carriers.	[Xu, Yeqiong; He, Bangshun; Pan, Yuqin; Gao, Tianyi; Deng, Qiwen; Song, Guoqi; Wang, Shukui] Nanjing Med Univ, Nanjing Hosp 1, Cent Lab, Nanjing, Jiangsu, Peoples R China; [Li, Rui; Sun, Huiling] Nanjing Normal Univ, Dept Life Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Normal University	Wang, SK (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Cent Lab, Nanjing, Jiangsu, Peoples R China.	shukwang@163.com	Deng, Qi-Wen/E-9434-2016; Deng, Qi-Wen/AAL-3005-2021	Deng, Qi-Wen/0000-0003-4324-8009; Deng, Qi-Wen/0000-0003-4324-8009	Program of Healthy Talents' Cultivation for Nanjing City; Social Development Technology Projects of Nanjing City, China [QYK11175]	Program of Healthy Talents' Cultivation for Nanjing City; Social Development Technology Projects of Nanjing City, China	This work was supported by Program of Healthy Talents' Cultivation for Nanjing City, and Social Development Technology Projects of Nanjing City, China (QYK11175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andera L, 2009, BIOMED PAP, V153, P173, DOI 10.5507/bp.2009.029; Bye H, 2011, CARCINOGENESIS, V32, P1855, DOI 10.1093/carcin/bgr211; Cao Y, 2010, MOL CARCINOGEN, V49, P944, DOI 10.1002/mc.20676; Crew KD, 2007, CARCINOGENESIS, V28, P2548, DOI 10.1093/carcin/bgm211; Crnogorac-Jurcevic T, 2001, ONCOGENE, V20, P7437, DOI 10.1038/sj.onc.1204935; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dybikowska A, 2004, INT J MOL MED, V14, P475; Erdogan M, 2007, J ENDOCRINOL INVEST, V30, P411, DOI 10.1007/BF03346319; Gangwar R, 2010, DNA CELL BIOL, V29, P349, DOI 10.1089/dna.2009.0982; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gormus U, 2007, IN VIVO, V21, P663; Gormus U, 2007, ANTICANCER RES, V27, P991; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Hashemi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053075; He J, 2012, HUM GENET, V131, P1235, DOI 10.1007/s00439-012-1152-8; Ho T, 2008, HEAD NECK-J SCI SPEC, V30, P297, DOI 10.1002/hed.20699; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; Hsu PI, 2008, ANTICANCER RES, V28, P97; Huang QR, 1997, MOL IMMUNOL, V34, P577, DOI 10.1016/S0161-5890(97)00081-3; Ikehara SK, 2006, J HUM GENET, V51, P927, DOI 10.1007/s10038-006-0040-2; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Ivansson EL, 2007, INT J CANCER, V121, P2451, DOI 10.1002/ijc.22989; Jain M, 2007, CANCER DETECT PREV, V31, P225, DOI 10.1016/j.cdp.2007.04.005; Jrad BBH, 2006, CANCER LETT, V233, P21, DOI 10.1016/j.canlet.2005.02.037; Kang S, 2008, CANCER GENET CYTOGEN, V180, P1, DOI 10.1016/j.cancergencyto.2007.09.002; Kim R, 2004, CANCER-AM CANCER SOC, V100, P2281, DOI 10.1002/cncr.20270; Koshkina NV, 2007, J PEDIAT HEMATOL ONC, V29, P815, DOI 10.1097/MPH.0b013e3181581506; Krippl P, 2004, J NATL CANCER I, V96, P1478, DOI 10.1093/jnci/djh289; Kupcinskas J, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-112; Lai HC, 2005, GYNECOL ONCOL, V99, P113, DOI 10.1016/j.ygyno.2005.05.010; Lai HC, 2003, INT J CANCER, V103, P221, DOI 10.1002/ijc.10800; Li CP, 2006, PHARMACOGENET GENOM, V16, P245, DOI 10.1097/01.fpc.0000194425.58511.a7; Li CY, 2006, PHARMACOGENET GENOM, V16, P253, DOI 10.1097/01.fpc.0000199501.54466.de; Li Y, 2013, GYNECOL ONCOL, V128, P584, DOI 10.1016/j.ygyno.2012.12.002; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lima L, 2008, PROSTATE CANCER P D, V11, P94, DOI 10.1038/sj.pcan.4501002; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Mahfoudh W, 2012, HUM IMMUNOL, V73, P932, DOI 10.1016/j.humimm.2012.06.001; Mandal RK, 2012, UROL ONCOL-SEMIN ORI, V30, P555, DOI 10.1016/j.urolonc.2010.05.006; MANTEL N, 1959, J NATL CANCER I, V22, P719; Nelson HH, 2001, CANCER EPIDEM BIOMAR, V10, P809; OEHM A, 1992, J BIOL CHEM, V267, P10709; Park SH, 2006, LUNG CANCER, V54, P303, DOI 10.1016/j.lungcan.2006.09.002; Qureshi A, 2010, J DERMATOL SCI, V58, P78, DOI 10.1016/j.jdermsci.2010.01.003; Rabinowich H, 1998, J CLIN INVEST, V101, P2579, DOI 10.1172/JCI1518; Reichmann E, 2002, SEMIN CANCER BIOL, V12, P309, DOI 10.1016/S1044-579X(02)00017-2; Shao P, 2011, PROSTATE; Shao PF, 2011, PROSTATE, V71, P1122, DOI 10.1002/pros.21328; Sibley K, 2003, CANCER RES, V63, P4327; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sun T, 2004, JNCI-J NATL CANCER I, V96, P1030, DOI 10.1093/jnci/djh187; Sun T, 2005, J EXP MED, V202, P967, DOI 10.1084/jem.20050707; Tamandani DMK, 2008, CLIN EXP OBSTET GYN, V35, P183; Ter-Minassian M, 2008, CARCINOGENESIS, V29, P2147, DOI 10.1093/carcin/bgn205; Ueda M, 2006, INT J GYNECOL CANCER, V16, P179, DOI 10.1111/j.1525-1438.2006.00505.x; Wang LE, 2003, LUNG CANCER-J IASLC, V42, P1, DOI 10.1016/S0169-5002(03)00276-9; Wang LH, 2010, J ORAL PATHOL MED, V39, P155, DOI 10.1111/j.1600-0714.2009.00873.x; Wang ML, 2009, BIOCHEM GENET, V47, P559, DOI 10.1007/s10528-009-9264-0; Wang WM, 2012, ONCOL LETT, V3, P625, DOI 10.3892/ol.2011.541; Wu JM, 2003, J IMMUNOL, V170, P132, DOI 10.4049/jimmunol.170.1.132; Yang M, 2008, CLIN CANCER RES, V14, P3230, DOI 10.1158/1078-0432.CCR-08-0177; Zhang BL, 2007, CARCINOGENESIS, V28, P1067, DOI 10.1093/carcin/bgl250; Zhang H, 2007, CANCER J, V13, P233, DOI 10.1097/PPO.0b013e318046f214; Zhang WM, 2012, HEPATO-GASTROENTEROL, V59, P141, DOI 10.5754/hge11300; Zhang X, 2005, J MED GENET, V42, P479, DOI 10.1136/jmg.2004.030106; Zhang Z, 2006, CLIN CANCER RES, V12, P5596, DOI 10.1158/1078-0432.CCR-05-1739; Zhou RM, 2010, J GASTROEN HEPATOL, V25, P555, DOI 10.1111/j.1440-1746.2009.06116.x; Zhu JA, 2010, MOL CARCINOGEN, V49, P810, DOI 10.1002/mc.20656; Zhu QY, 2010, CLIN CHIM ACTA, V411, P179, DOI 10.1016/j.cca.2009.10.024; Zoodsma M, 2005, INT J GYNECOL CANCER, V15, P282, DOI 10.1111/j.1525-1438.2005.00433.x; Zucchi F, 2009, EUR J GYNAECOL ONCOL, V30, P142	72	36	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90090	10.1371/journal.pone.0090090	http://dx.doi.org/10.1371/journal.pone.0090090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598538	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400043
J	Kashdan, TB; DeWall, CN; Masten, CL; Pond, RS; Powell, C; Combs, D; Schurtz, DR; Farmer, AS				Kashdan, Todd B.; DeWall, C. Nathan; Masten, Carrie L.; Pond, Richard S., Jr.; Powell, Caitlin; Combs, David; Schurtz, David R.; Farmer, Antonina S.			Who Is Most Vulnerable to Social Rejection? The Toxic Combination of Low Self-Esteem and Lack of Negative Emotion Differentiation on Neural Responses to Rejection	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; EXCLUSION; ACCEPTANCE; MOOD; INTELLIGENCE; PERFORMANCE; RESILIENCE; VALIDATION; EXPERIENCE; ATTENTION	People have a fundamental need to belong that, when satisfied, is associated with mental and physical well-being. The current investigation examined what happens when the need to belong is thwarted-and how individual differences in self-esteem and emotion differentiation modulate neural responses to social rejection. We hypothesized that low self-esteem would predict heightened activation in distress-related neural responses during a social rejection manipulation, but that this relationship would be moderated by negative emotion differentiation-defined as adeptness at using discrete negative emotion categories to capture one's felt experience. Combining daily diary and neuroimaging methodologies, the current study showed that low self-esteem and low negative emotion differentiation represented a toxic combination that was associated with stronger activation during social rejection (versus social inclusion) in the dorsal anterior cingulate cortex and anterior insula-two regions previously shown to index social distress. In contrast, individuals with greater negative emotion differentiation did not show stronger activation in these regions, regardless of their level of self-esteem; fitting with prior evidence that negative emotion differentiation confers equanimity in emotionally upsetting situations.	[Kashdan, Todd B.; Farmer, Antonina S.] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Kashdan, Todd B.; Farmer, Antonina S.] George Mason Univ, Ctr Adv Well Being, Fairfax, VA 22030 USA; [DeWall, C. Nathan; Combs, David; Schurtz, David R.] Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA; [Masten, Carrie L.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Pond, Richard S., Jr.] Univ N Carolina, Dept Psychol, Wilmington, NC 28401 USA; [Powell, Caitlin] Georgia Coll & State Univ, Dept Psychol, Milledgeville, GA USA	George Mason University; George Mason University; University of Kentucky; University of California System; University of California Davis; University of North Carolina; University of North Carolina Wilmington; University System of Georgia; Georgia College & State University	Kashdan, TB (corresponding author), George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA.	tkashdan@gmu.edu	Farmer, Antonina/M-8914-2013	Farmer, Antonina/0000-0002-3305-8300	George Mason University Libraries Open Access Publishing Fund	George Mason University Libraries Open Access Publishing Fund	Publication of this article was funded in part by the George Mason University Libraries Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Barrett LF, 2006, J RES PERS, V40, P35, DOI 10.1016/j.jrp.2005.08.006; Barrett LF, 2004, PSYCHOL BULL, V130, P553, DOI 10.1037/0033-2909.130.4.553; Baumeister RF, 2005, J PERS SOC PSYCHOL, V88, P589, DOI 10.1037/0022-3514.88.4.589; Baumeister RF, 2003, PSYCHOL SCI, P1, DOI 10.1111/1529-1006.01431; Baumeister RF, 2002, J PERS SOC PSYCHOL, V83, P817, DOI 10.1037//0022-3514.83.4.817; Blackhart GC, 2007, BIOL PSYCHOL, V75, P267, DOI 10.1016/j.biopsycho.2007.03.005; Boden MT, 2013, COGNITION EMOTION, V27, P961, DOI 10.1080/02699931.2012.751899; Bolling DZ, 2011, NEUROIMAGE, V54, P2462, DOI 10.1016/j.neuroimage.2010.10.049; Brackett MA, 2006, J PERS SOC PSYCHOL, V91, P780, DOI 10.1037/0022-3514.91.4.780; Cacioppo JT, 2003, CURR DIR PSYCHOL SCI, V12, P71, DOI 10.1111/1467-8721.01232; Cutrona CE, 1982, LONELINESS SOURCEBOO, P291; DeWall CN, 2012, SOC COGN AFFECT NEUR, V7, P184, DOI 10.1093/scan/nsq107; DeWall CN, 2010, SOC PSYCHOL PERS SCI, V1, P168, DOI 10.1177/1948550610361387; DeWall CN, 2010, PSYCHOL SCI, V21, P931, DOI 10.1177/0956797610374741; DeWall CN, 2008, J PERS SOC PSYCHOL, V95, P1367, DOI 10.1037/a0012632; DeWall CN, 2009, J PERS SOC PSYCHOL, V96, P45, DOI 10.1037/a0013196; Dickerson SS, 2009, PSYCHOL SCI, V20, P1237, DOI 10.1111/j.1467-9280.2009.02437.x; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Ford MB, 2010, J PERS SOC PSYCHOL, V98, P405, DOI 10.1037/a0017345; Gohm CL, 2000, PERS SOC PSYCHOL B, V26, P679, DOI 10.1177/0146167200268004; Gohm CL, 2002, COGNITION EMOTION, V16, P495, DOI 10.1080/02699930143000374; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P895, DOI 10.1037/0022-3514.60.6.895; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Kang SM, 2004, J PERS, V72, P687, DOI 10.1111/j.0022-3506.2004.00277.x; Kashdan TB, 2010, CLIN PSYCHOL REV, V30, P865, DOI 10.1016/j.cpr.2010.03.001; Kashdan TB, 2010, PSYCHOL SCI, V21, P1341, DOI 10.1177/0956797610379863; Kross E, 2007, J COGNITIVE NEUROSCI, V19, P945, DOI 10.1162/jocn.2007.19.6.945; Larsen R.J., 1992, EMOTION, P25; Leary MR, 2000, ADV EXP SOC PSYCHOL, V32, P1, DOI 10.1016/S0065-2601(00)80003-9; LEARY MR, 1995, J PERS SOC PSYCHOL, V68, P518, DOI 10.1037/0022-3514.68.3.518; LEARY MR, 1990, J SOC CLIN PSYCHOL, V9, P221, DOI 10.1521/jscp.1990.9.2.221; Leary MR, 1995, PLENUM SERIES SOCIAL, P123; Lischetzke T, 2003, EMOTION, V3, P361, DOI 10.1037/1528-3542.3.4.361; MacDonald G, 2005, PSYCHOL BULL, V131, P202, DOI 10.1037/0033-2909.131.2.202; Masten CL, 2011, J COGNITIVE NEUROSCI, V23, P1042, DOI 10.1162/jocn.2010.21520; Mayer JD, 2008, AM PSYCHOL, V63, P503, DOI 10.1037/0003-066X.63.6.503; Nezlek JB, 2007, EUR J PERSONALITY, V21, P789, DOI 10.1002/per.640; Ong AD, 2004, J GERONTOL B-PSYCHOL, V59, pP117, DOI 10.1093/geronb/59.3.P117; Onoda K, 2010, SOC COGN AFFECT NEUR, V5, P385, DOI 10.1093/scan/nsq002; Palmieri PA, 2009, J PERS ASSESS, V91, P560, DOI 10.1080/00223890903228539; Pond RS, 2012, EMOTION, V12, P326, DOI 10.1037/a0025762; Raudenbush SW, 2004, SSI; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Salovey P, 2002, PSYCHOL HEALTH, V17, P611, DOI 10.1080/08870440290025812; Salovey P., 1995, EMOTION DISCLOSURE H, P125; Schilbach L, 2010, J COGNITIVE NEUROSCI, V22, P2702, DOI 10.1162/jocn.2009.21401; Slavich GM, 2010, P NATL ACAD SCI USA, V107, P14817, DOI 10.1073/pnas.1009164107; Somerville LH, 2010, CEREB CORTEX, V20, P3005, DOI 10.1093/cercor/bhq049; Stone AA, 2007, SCI REAL TIME DATA C; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Thompson RJ, 2009, J RES PERS, V43, P875, DOI 10.1016/j.jrp.2009.07.006; Tugade MM, 2004, J PERS, V72, P1161, DOI 10.1111/j.1467-6494.2004.00294.x; Twenge JM, 2002, J PERS SOC PSYCHOL, V83, P606, DOI 10.1037//0022-3514.83.3.606; van Beest I, 2006, J PERS SOC PSYCHOL, V91, P918, DOI 10.1037/0022-3514.91.5.918; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WEGNER DM, 1993, J PERS SOC PSYCHOL, V65, P1093, DOI 10.1037/0022-3514.65.6.1093; Wild LG, 2004, J CHILD PSYCHOL PSYC, V45, P1454, DOI 10.1111/j.1469-7610.2004.00330.x; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams KD, 2009, ADV EXP SOC PSYCHOL, V41, P275, DOI 10.1016/S0065-2601(08)00406-1; Winkielman, 2007, SOCIAL NEUROSCIENCE, P106	61	31	35	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90651	10.1371/journal.pone.0090651	http://dx.doi.org/10.1371/journal.pone.0090651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4FD	24594689	Green Submitted, gold, Green Published			2022-12-27	WOS:000332475500082
J	Shah, AT; Beckler, MD; Walsh, AJ; Jones, WP; Pohlmann, PR; Skala, MC				Shah, Amy T.; Beckler, Michelle Demory; Walsh, Alex J.; Jones, William P.; Pohlmann, Paula R.; Skala, Melissa C.			Optical Metabolic Imaging of Treatment Response in Human Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							MULTIPHOTON MICROSCOPY; CANCER; CETUXIMAB; GROWTH; PATHWAY; THERAPY; NADH	Optical metabolic imaging measures fluorescence intensity and lifetimes from metabolic cofactors nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FAD). These molecular level measurements provide unique biomarkers for early cellular responses to cancer treatments. Head and neck squamous cell carcinoma (HNSCC) is an attractive target for optical imaging because of easy access to the site using fiber optic probes. Two HNSCC cell lines, SCC25 and SCC61, were treated with Cetuximab (anti-EGFR antibody), BGT226 (PI3K/mTOR inhibitor), or cisplatin (chemotherapy) for 24 hours. Results show increased redox ratio, NADH alpha(1) (contribution from free NADH), and FAD alpha(1) (contribution from protein-bound FAD) for malignant cells compared with the nonmalignant cell line OKF6 (p<0.05). In SCC25 and SCC61 cells, the redox ratio is unaffected by cetuximab treatment and decreases with BGT226 and cisplatin treatment (p<0.05), and these results agree with standard measurements of proliferation rates after treatment. For SCC25, NADH alpha(1) is reduced with BGT226 and cisplatin treatment. For SCC61, NADH alpha(1) is reduced with cetuximab, BGT226, and cisplatin treatment. Trends in NADH alpha(1) are statistically similar to changes in standard measurements of glycolytic rates after treatment. FAD alpha(1) is reduced with cisplatin treatment (p<0.05). These shifts in optical endpoints reflect early metabolic changes induced by drug treatment. Overall, these results indicate that optical metabolic imaging has potential to detect early response to cancer treatment in HNSCC, enabling optimal treatment regimens and improved patient outcomes.	[Shah, Amy T.; Walsh, Alex J.; Jones, William P.; Skala, Melissa C.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Beckler, Michelle Demory] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Beckler, Michelle Demory] Vanderbilt Univ, Med Ctr, Dept Radiol, Nashville, TN 37232 USA; [Pohlmann, Paula R.] Georgetown Univ, Med Ctr, Dept Med, Washington, DC 20007 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Georgetown University	Skala, MC (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.	m.skala@vanderbilt.edu		Walsh, Alex/0000-0003-3832-8207; Pohlmann, Paula/0000-0001-7914-5162	National Institutes of Health/National Cancer Institute [R00 CA142888]; National Science Foundation Graduate Research Fellowship [DGE-0909667]; NATIONAL CANCER INSTITUTE [R00CA142888] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by National Institutes of Health/National Cancer Institute R00 CA142888 and National Science Foundation Graduate Research Fellowship (DGE-0909667; A. T. Shah). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANERJEE S, 1989, Indian Journal of Cancer, V26, P21; Bernier J, 2009, NAT REV CLIN ONCOL, V6, P266, DOI 10.1038/nrclinonc.2009.40; Bird DK, 2005, CANCER RES, V65, P8766, DOI 10.1158/0008-5472.CAN-04-3922; BOARD M, 1990, BIOCHEM J, V265, P503, DOI 10.1042/bj2650503; CHANCE B, 1979, J BIOL CHEM, V254, P4764; Chang KY, 2011, CLIN CANCER RES, V17, P7116, DOI 10.1158/1078-0432.CCR-11-0796; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Drezek R, 2001, PHOTOCHEM PHOTOBIOL, V73, P636, DOI 10.1562/0031-8655(2001)073<0636:AMOFCT>2.0.CO;2; Eastman A., 1999, CISPLATIN CHEM BIOCH, P111, DOI [DOI 10.1002/9783906390420.CH4, 10.1002/9783906390420.ch4]; Eng J, 1989, SPECTROSCOPY, V55; Erlich RB, 2012, BRIT J CANCER, V106, P107, DOI 10.1038/bjc.2011.495; Fung C, 2010, EXPERT OPIN EMERG DR, V15, P355, DOI 10.1517/14728214.2010.497754; Georgakoudi I, 2012, ANNU REV BIOMED ENG, V14, P351, DOI 10.1146/annurev-bioeng-071811-150108; Gleysteen JP, 2007, CANCER BIOL THER, V6, P1181; Helman EE, 2010, CANCER BIOL THER, V10, P166, DOI 10.4161/cbt.10.2.12164; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; HU L, 1991, CANCER RES, V51, P3972; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Jabbour JM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046012; KIM KH, 1984, P NATL ACAD SCI-BIOL, V81, P4280, DOI 10.1073/pnas.81.14.4280; Kimura H, 2007, CANCER SCI, V98, P1275, DOI 10.1111/j.1349-7006.2007.00510.x; Kundu SK, 2012, TUMOR BIOL, V33, P707, DOI 10.1007/s13277-012-0350-2; LAKOWICZ JR, 1992, P NATL ACAD SCI USA, V89, P1271, DOI 10.1073/pnas.89.4.1271; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Levitt JM, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2401149; Machtay M, 2008, J CLIN ONCOL, V26, P3582, DOI 10.1200/JCO.2007.14.8841; Nestor M, 2010, TUMOR BIOL, V31, P141, DOI 10.1007/s13277-010-0018-8; Ostrander JH, 2010, CANCER RES, V70, P4759, DOI 10.1158/0008-5472.CAN-09-2572; Pavlova I, 2008, CLIN CANCER RES, V14, P2396, DOI 10.1158/1078-0432.CCR-07-1609; Pedrero JMG, 2005, INT J CANCER, V114, P242, DOI 10.1002/ijc.20711; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Rousseau a, 2012, ATLAS GENET CYTOGENE; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Seiwert TY, 2009, CANCER RES, V69, P3021, DOI 10.1158/0008-5472.CAN-08-2881; Skala MC, 2005, CANCER RES, V65, P1180, DOI 10.1158/0008-5472.CAN-04-3031; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Skala MC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717503; Sun J, 2004, OPT EXPRESS, V12, P2478, DOI 10.1364/OPEX.12.002478; Sun Y, 2009, OPT LETT, V34, P2081, DOI 10.1364/OL.34.002081; Walsh A, 2012, BIOMED OPT EXPRESS, V3, P75, DOI 10.1364/BOE.3.000075; Walsh AJ, 2013, CANCER RES, V73, P6164, DOI 10.1158/0008-5472.CAN-13-0527; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WEICHSELBAUM R, 1984, BRIT J CANCER, V49, P595, DOI 10.1038/bjc.1984.94; Wendt BTG, 2013, ALONE ADV HEAD NECK, V16, P1318; Yarbrough WG, 2007, INT J RADIAT ONCOL, V69, pS98, DOI 10.1016/j.ijrobp.2007.04.082; Zhang N, 2009, RADIOTHER ONCOL, V92, P388, DOI 10.1016/j.radonc.2009.04.019	46	51	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90746	10.1371/journal.pone.0090746	http://dx.doi.org/10.1371/journal.pone.0090746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595244	gold, Green Submitted, Green Published			2022-12-27	WOS:000332475500095
J	Galay, RL; Umemiya-Shirafuji, R; Bacolod, ET; Maeda, H; Kusakisako, K; Koyama, J; Tsuji, N; Mochizuki, M; Fujisaki, K; Tanaka, T				Galay, Remil Linggatong; Umemiya-Shirafuji, Rika; Bacolod, Eugene T.; Maeda, Hiroki; Kusakisako, Kodai; Koyama, Jiro; Tsuji, Naotoshi; Mochizuki, Masami; Fujisaki, Kozo; Tanaka, Tetsuya			Two Kinds of Ferritin Protect Ixodid Ticks from Iron Overload and Consequent Oxidative Stress	PLOS ONE			English	Article							LIPID-PEROXIDATION; CATTLE TICK; HARD TICK; HEME DETOXIFICATION; METABOLISM; MIDGUT; MALONDIALDEHYDE; REPRODUCTION	Ticks are obligate hematophagous parasites that have successfully developed counteractive means against their hosts' immune and hemostatic mechanisms, but their ability to cope with potentially toxic molecules in the blood remains unclear. Iron is important in various physiological processes but can be toxic to living cells when in excess. We previously reported that the hard tick Haemaphysalis longicornis has an intracellular (HlFER1) and a secretory (HlFER2) ferritin, and both are crucial in successful blood feeding and reproduction. Ferritin gene silencing by RNA interference caused reduced feeding capacity, low body weight and high mortality after blood meal, decreased fecundity and morphological abnormalities in the midgut cells. Similar findings were also previously reported after silencing of ferritin genes in another hard tick, Ixodes ricinus. Here we demonstrated the role of ferritin in protecting the hard ticks from oxidative stress. Evaluation of oxidative stress in Hlfer-silenced ticks was performed after blood feeding or injection of ferric ammonium citrate (FAC) through detection of the lipid peroxidation product, malondialdehyde (MDA) and protein oxidation product, protein carbonyl. FAC injection in Hlfer-silenced ticks resulted in high mortality. Higher levels of MDA and protein carbonyl were detected in Hlfer-silenced ticks compared to Luciferase-injected (control) ticks both after blood feeding and FAC injection. Ferric iron accumulation demonstrated by increased staining on native HlFER was observed from 72 h after iron injection in both the whole tick and the midgut. Furthermore, weak iron staining was observed after Hlfer knockdown. Taken together, these results show that tick ferritins are crucial antioxidant molecules that protect the hard tick from iron-mediated oxidative stress during blood feeding.	[Galay, Remil Linggatong; Maeda, Hiroki; Mochizuki, Masami; Tanaka, Tetsuya] Yamaguchi Univ, United Grad Sch Vet Sci, Dept Pathol & Prevent Vet Sci, Yamaguchi, Japan; [Galay, Remil Linggatong; Maeda, Hiroki; Kusakisako, Kodai; Mochizuki, Masami; Tanaka, Tetsuya] Kagoshima Univ, Joint Fac Vet Med, Lab Emerging Infect Dis, Kagoshima 890, Japan; [Umemiya-Shirafuji, Rika] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan; [Bacolod, Eugene T.] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan; [Bacolod, Eugene T.] Univ San Carlos, Coll Arts & Sci, Dept Chem, Cebu, Philippines; [Koyama, Jiro] Kagoshima Univ, Fac Fisheries, Educ & Res Ctr Marine Resources & Environm, Kagoshima 890, Japan; [Tsuji, Naotoshi; Fujisaki, Kozo] Natl Agr & Food Res Org, Tsukuba, Ibaraki, Japan	Yamaguchi University; Kagoshima University; Obihiro University of Agriculture & Veterinary Medicine; Kagoshima University; University of San Carlos; Kagoshima University; National Agriculture & Food Research Organization - Japan	Tanaka, T (corresponding author), Yamaguchi Univ, United Grad Sch Vet Sci, Dept Pathol & Prevent Vet Sci, Yamaguchi, Japan.	tetsuya@ms.kagoshima-u.ac.jp	Umemiya-Shirafuji, Rika/AFT-5139-2022; Galay, Remil/AAN-4392-2021	Umemiya-Shirafuji, Rika/0000-0001-7641-5526; Galay, Remil/0000-0001-9749-8308	National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine [25-joint-2]; Morinaga Foundation; Japan Society for the Promotion of Science (JSPS); Japanese Government Ministry of Education, Culture, Sports, Science, and Technology Scholarship (Monbukagakusho: MEXT)	National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine; Morinaga Foundation; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Government Ministry of Education, Culture, Sports, Science, and Technology Scholarship (Monbukagakusho: MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a joint research grant (25-joint-2) of the National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Morinaga Foundation, and grants-in-aid for Scientific Research (B) from the Japan Society for the Promotion of Science (JSPS). RLG and ETB are supported by the Japanese Government Ministry of Education, Culture, Sports, Science, and Technology Scholarship (Monbukagakusho: MEXT) for doctoral fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Anderson JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-552; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Aung KM, 2011, PARASITOL RES, V108, P273, DOI 10.1007/s00436-010-2053-1; BRAUGHLER JM, 1986, J BIOL CHEM, V261, P282; Chauhan A, 2004, LIFE SCI, V75, P2539, DOI 10.1016/j.lfs.2004.04.038; Citelli M, 2007, MOL BIOCHEM PARASIT, V151, P81, DOI 10.1016/j.molbiopara.2006.10.008; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Dunkov Boris C, 2002, J Insect Sci, V2, P7; Fedorova M, 2013, MASS SPECTROM REV, DOI 10.1002/mas.21381; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; FUHRMAN B, 1994, ATHEROSCLEROSIS, V111, P65, DOI 10.1016/0021-9150(94)90192-9; FUJISAKI K, 1978, NATL I ANIM HEALTH Q, V18, P27; Galay RL, 2013, J EXP BIOL, V216, P1905, DOI 10.1242/jeb.081240; Geiser DL, 2006, INSECT BIOCHEM MOLEC, V36, P177, DOI 10.1016/j.ibmb.2005.12.001; Gkouvatsos K, 2012, BBA-GEN SUBJECTS, V1820, P188, DOI 10.1016/j.bbagen.2011.10.013; Grotto D, 2009, QUIM NOVA, V32, P169, DOI 10.1590/S0100-40422009000100032; Hajdusek O, 2009, P NATL ACAD SCI USA, V106, P1033, DOI 10.1073/pnas.0807961106; Ibrahim MA, 2013, COMP BIOCHEM PHYS B, V164, P221, DOI 10.1016/j.cbpb.2013.01.002; Lang ML, 2012, P NATL ACAD SCI USA, V109, P13337, DOI 10.1073/pnas.1208703109; Lara FA, 2003, J EXP BIOL, V206, P1707, DOI 10.1242/jeb.00334; Lara FA, 2005, J EXP BIOL, V208, P3093, DOI 10.1242/jeb.01749; Mandilaras K, 2013, NUTRIENTS, V5, P1622, DOI 10.3390/nu5051622; Mans BJ, 2004, INSECT BIOCHEM MOLEC, V34, P1, DOI 10.1016/j.ibmb.2003.09.002; Maya-Monteiro CM, 2000, J BIOL CHEM, V275, P36584, DOI 10.1074/jbc.M007344200; Missirlis F, 2006, P NATL ACAD SCI USA, V103, P5893, DOI 10.1073/pnas.0601471103; Niki E., 2013, BIOCH BIOPHYS ACTA; Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032; Ong ST, 2006, IMMUNOBIOLOGY, V211, P295, DOI 10.1016/j.imbio.2006.02.004; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; Pham DQD, 2010, BBA-GEN SUBJECTS, V1800, P824, DOI 10.1016/j.bbagen.2010.03.004; Pham DQD, 1999, EUR J BIOCHEM, V266, P236, DOI 10.1046/j.1432-1327.1999.00849.x; Qiu GF, 2008, COMP BIOCHEM PHYS B, V150, P320, DOI 10.1016/j.cbpb.2008.03.016; Tang X, 2013, FASEB J, V27, P1; Umemiya-Shirafuji R, 2012, INSECT BIOCHEM MOLEC, V42, P164, DOI 10.1016/j.ibmb.2011.12.001; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Wang D, 2009, COMP BIOCHEM PHYS B, V152, P20, DOI 10.1016/j.cbpb.2008.09.082; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Winzerling JJ, 2006, INSECT BIOCHEM MOLEC, V36, P310, DOI 10.1016/j.ibmb.2006.01.006	39	33	36	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90661	10.1371/journal.pone.0090661	http://dx.doi.org/10.1371/journal.pone.0090661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594832	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900131
J	Hirsh, S; Hindiyeh, M; Kolet, L; Regev, L; Sherbany, H; Yaary, K; Mendelson, E; Mandelboim, M				Hirsh, Shira; Hindiyeh, Musa; Kolet, Liat; Regev, Liora; Sherbany, Hilda; Yaary, Karnit; Mendelson, Ella; Mandelboim, Michal			Epidemiological Changes of Respiratory Syncytial Virus (RSV) Infections in Israel	PLOS ONE			English	Article							SUBGROUP-B STRAINS; REAL-TIME PCR; GROUP-A; CLINICAL SEVERITY; G-PROTEIN; MOLECULAR EPIDEMIOLOGY; GENETIC-VARIABILITY; TRACT INFECTION; YOUNG-CHILDREN; INFANTS	RSV is the leading cause of lower respiratory-tract infections in infants and therefore demands in-depth epidemiological characterization. We investigated here the distribution of RSV types in Israel between the years 2005-2012. Clinical samples were collected from 11,018 patients hospitalized due to respiratory illnesses and were evaluated for the presence of various respiratory viruses, including RSV A and RSV B. Until 2008, each year was characterized by the presence of one dominant type of RSV. However, from 2008, both RSV A and B types were detected at significant levels, particularly among infants aged 0-2 years. Furthermore, significant changes in the RSV A and RSV B subtypes circulating in Israel since 2008 were observed. Finally, we demonstrate that, irrespectively of the changes observed in RSV epidemiology, when the pandemic H1N1pdm09 influenza virus appeared in 2009, RSV infections were delayed and were detected when infection with H1N1pdm09 had declined.	[Hirsh, Shira; Mendelson, Ella] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Hindiyeh, Musa; Kolet, Liat; Regev, Liora; Sherbany, Hilda; Yaary, Karnit; Mandelboim, Michal] Chaim Sheba Med Ctr, Cent Virol Lab, Minist Hlth, Ramat Gan, Israel; [Mendelson, Ella] Tel Aviv Univ, Sackler Fac Med, Dept Epidemiol & Prevent Med, Sch Publ Hlth, IL-69978 Tel Aviv, Israel	Bar Ilan University; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Mandelboim, M (corresponding author), Chaim Sheba Med Ctr, Cent Virol Lab, Minist Hlth, Ramat Gan, Israel.	michalman@sheba.health.gov.il						BLACK CP, 2003, RESP CARE, V48, P231; Black Craig Patrick, 2003, Respir Care, V48, P209; Boivin G, 2004, J CLIN MICROBIOL, V42, P45, DOI 10.1128/JCM.42.1.45-51.2004; Brandenburg AH, 2000, J CLIN MICROBIOL, V38, P3849, DOI 10.1128/JCM.38.10.3849-3852.2000; Cane PA, 2001, REV MED VIROL, V11, P103, DOI 10.1002/rmv.305; Cane PA, 1999, EPIDEMIOL INFECT, V122, P155, DOI 10.1017/S0950268896001872; Chi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064012; Debiaggi M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-247; DeVincenzo JP, 2004, PEDIATR RES, V56, P914, DOI 10.1203/01.PDR.0000145255.86117.6A; Tran DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045436; Goto-Sugai K, 2010, JPN J INFECT DIS, V63, P393; Green HK, 2013, EURO SURVEILL, V18; Grondahl B, 2013, INFECTION; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; HALL CB, 1990, J INFECT DIS, V162, P1283, DOI 10.1093/infdis/162.6.1283; HEIKKINEN T, 1995, ACTA PAEDIATR, V84, P419, DOI 10.1111/j.1651-2227.1995.tb13663.x; HENDRY RM, 1985, J GEN VIROL, V66, P1705, DOI 10.1099/0022-1317-66-8-1705; HENDRY RM, 1986, J INFECT DIS, V153, P291, DOI 10.1093/infdis/153.2.291; Hindiyeh M, 2005, J CLIN MICROBIOL, V43, P589, DOI 10.1128/JCM.43.2.589-595.2005; Hindiyeh M, 2010, J CLIN MICROBIOL, V48, P1884, DOI 10.1128/JCM.02540-09; Hornsleth A, 1998, PEDIATR INFECT DIS J, V17, P1114, DOI 10.1097/00006454-199812000-00003; Hu AZ, 2003, J CLIN MICROBIOL, V41, P149, DOI 10.1128/JCM.41.1.149-154.2003; Jafri HS, 2013, PEDIATR INFECT DIS J, V32, P335, DOI 10.1097/INF.0b013e318282603a; JOHNSON PR, 1987, J VIROL, V61, P3163, DOI 10.1128/JVI.61.10.3163-3166.1987; Jones LP, 2002, CLIN DIAGN LAB IMMUN, V9, P633, DOI 10.1128/CDLI.9.3.633-638.2002; Kneyber MCJ, 1996, ARCH DIS CHILD, V75, P137, DOI 10.1136/adc.75.2.137; Levine DA, 2004, PEDIATRICS, V113, P1728, DOI 10.1542/peds.113.6.1728; MCCONNOCHIE KM, 1990, J PEDIATR-US, V117, P52, DOI 10.1016/S0022-3476(05)82443-6; MCINTOSH EDG, 1993, PEDIATR INFECT DIS J, V12, P815, DOI 10.1097/00006454-199310000-00004; MONTO AS, 1990, J INFECT DIS, V161, P781, DOI 10.1093/infdis/161.4.781; MUFSON MA, 1988, J INFECT DIS, V157, P143, DOI 10.1093/infdis/157.1.143; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Queiroz DAO, 2002, BRAZ J MED BIOL RES, V35, P1183, DOI 10.1590/S0100-879X2002001000011; Rebuffo-Scheer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025468; Regev L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034750; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; Ren L, 2009, CLIN MICROBIOL INFEC, V15, P1146, DOI 10.1111/j.1469-0691.2009.02746.x; RUSSI JC, 1989, LANCET, V2, P1039; SALOMON HE, 1991, J INFECT DIS, V163, P1167, DOI 10.1093/infdis/163.5.1167; Sande CJ, 2013, J INFECT DIS, V207, P489, DOI 10.1093/infdis/jis700; Sullender WM, 2000, CLIN MICROBIOL REV, V13, P1, DOI 10.1128/CMR.13.1.1-15.2000; TSUTSUMI H, 1991, SCAND J INFECT DIS, V23, P671, DOI 10.3109/00365549109024291; TSUTSUMI H, 1988, J CLIN MICROBIOL, V26, P1171, DOI 10.1128/JCM.26.6.1171-1174.1988; van Niekerk S, 2011, J VIROL, V85, P8789, DOI 10.1128/JVI.02623-10; WANG EEL, 1995, J PEDIATR-US, V126, P212, DOI 10.1016/S0022-3476(95)70547-3; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	48	27	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90515	10.1371/journal.pone.0090515	http://dx.doi.org/10.1371/journal.pone.0090515			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594694	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900114
J	Jonczyk, MS; Simon, M; Kumar, S; Fernandes, VE; Sylvius, N; Mallon, AM; Denny, P; Andrew, PW				Jonczyk, Magda S.; Simon, Michelle; Kumar, Saumya; Fernandes, Vitor E.; Sylvius, Nicolas; Mallon, Ann-Marie; Denny, Paul; Andrew, Peter W.			Genetic Factors Regulating Lung Vasculature and Immune Cell Functions Associate with Resistance to Pneumococcal Infection	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NECROSIS-FACTOR-ALPHA; AIRWAY SMOOTH-MUSCLE; PERIVASCULAR ADIPOSE-TISSUE; TRKB NEUROTROPHIN RECEPTOR; GROWTH-FACTOR-BETA; STREPTOCOCCUS-PNEUMONIAE; ACTIN GENE; DISEASE; SUSCEPTIBILITY	Streptococcus pneumoniae is an important human pathogen responsible for high mortality and morbidity worldwide. The susceptibility to pneumococcal infections is controlled by as yet unknown genetic factors. To elucidate these factors could help to develop new medical treatments and tools to identify those most at risk. In recent years genome wide association studies (GWAS) in mice and humans have proved successful in identification of causal genes involved in many complex diseases for example diabetes, systemic lupus or cholesterol metabolism. In this study a GWAS approach was used to map genetic loci associated with susceptibility to pneumococcal infection in 26 inbred mouse strains. As a result four candidate QTLs were identified on chromosomes 7, 13, 18 and 19. Interestingly, the QTL on chromosome 7 was located within S. pneumoniae resistance QTL (Spir1) identified previously in a linkage study of BALB/cOlaHsd and CBA/CaOlaHsd F2 intercrosses. We showed that only a limited number of genes encoded within the QTLs carried phenotype-associated polymorphisms (22 genes out of several hundred located within the QTLs). These candidate genes are known to regulate TGF beta signalling, smooth muscle and immune cells functions. Interestingly, our pulmonary histopathology and gene expression data demonstrated, lung vasculature plays an important role in resistance to pneumococcal infection. Therefore we concluded that the cumulative effect of these candidate genes on vasculature and immune cells functions as contributory factors in the observed differences in susceptibility to pneumococcal infection. We also propose that TGF beta-mediated regulation of fibroblast differentiation plays an important role in development of invasive pneumococcal disease. Gene expression data submitted to the NCBI Gene Expression Omnibus Accession No: GSE49533 SNP data submitted to NCBI dbSNP Short Genetic Variation http://www.ncbi.nlm.nih.gov/projects/SNP/snp_viewTable.cgi?handle = MUS PNEUMONIA.	[Jonczyk, Magda S.; Fernandes, Vitor E.; Andrew, Peter W.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Simon, Michelle; Kumar, Saumya; Mallon, Ann-Marie; Denny, Paul] MRC Harwell, Mammalian Genet Unit, Oxford, England; [Sylvius, Nicolas] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Leicester; MRC Harwell; University of Leicester	Andrew, PW (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England.	pwa@le.ac.uk	Jonczyk, Magdalena/I-2153-2013; Andrew, Peter W/G-7526-2012	Jonczyk, Magdalena/0000-0003-2117-1143; Kumar, Saumya/0000-0001-9481-1944; E. Fernandes, Vitor/0000-0001-5179-2122; Sylvius, Nicolas/0000-0002-3470-3711; Denny, Paul/0000-0003-4659-6893	European Union [HEALTH-F3-2009-222983]; Medical Research Council [MC_U142684174, G0501416, MC_U142684171] Funding Source: researchfish; MRC [MC_U142684171, G0501416, MC_U142684174] Funding Source: UKRI	European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Union-funded Pneumopath Project HEALTH-F3-2009-222983. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behzad AR, 1996, MICROVASC RES, V51, P303, DOI 10.1006/mvre.1996.0029; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Besser M, 1999, J IMMUNOL, V162, P6303; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Blomberg C, 2009, J INFECT DIS, V199, P1032, DOI 10.1086/597205; Brenner D, 2008, CRIT REV ONCOL HEMAT, V66, P52, DOI 10.1016/j.critrevonc.2008.01.002; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Chapman SJ, 2010, GENES IMMUN, V11, P319, DOI 10.1038/gene.2009.76; Chapman SJ, 2007, AM J RESP CRIT CARE, V176, P181, DOI 10.1164/rccm.200702-169OC; Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114; Chapman SJ, 2010, CRIT CARE, V14, DOI 10.1186/cc9377; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Cruse G, 2010, J IMMUNOL, V184, P7108, DOI 10.4049/jimmunol.0900802; Degn SE, 2011, AM J HUM GENET, V88, P689, DOI 10.1016/j.ajhg.2011.05.011; Denny P, 2003, MAMM GENOME, V14, P448, DOI 10.1007/S00335-002-2261-9; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Du WL, 2005, J BIOL CHEM, V280, P26287, DOI 10.1074/jbc.M502905200; Fernebro J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-65; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Flint J, 2013, CURR BIOL, V23, pR265, DOI 10.1016/j.cub.2013.01.040; Flint J, 2012, NAT REV GENET, V13, P807, DOI 10.1038/nrg3335; Gingles NA, 2001, INFECT IMMUN, V69, P426, DOI 10.1128/IAI.69.1.426-434.2001; Glavan BJ, 2011, AM J RESP CRIT CARE, V183, P356, DOI 10.1164/rccm.201003-0351OC; Guzik TJ, 2007, J PHYSIOL PHARMACOL, V58, P591; Halestrap AP, 2013, MOL ASPECTS MED, V34, P337, DOI 10.1016/j.mam.2012.05.003; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hollingsworth JW, 2007, IMMUNOGENETICS, V59, P713, DOI 10.1007/s00251-007-0242-6; Hunter KW, 2008, ANNU REV GENET, V42, P131, DOI 10.1146/annurev.genet.42.110807.091659; Ibarrola N, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-2; Ichikawa T, 2013, EXP CELL RES, V319, P1176, DOI 10.1016/j.yexcr.2013.02.014; Kadioglu A, 2004, INFECT IMMUN, V72, P2689, DOI 10.1128/IAI.72.5.2689-2697.2004; Kadioglu A, 2004, TRENDS IMMUNOL, V25, P143, DOI 10.1016/j.it.2003.12.006; Kadioglu A, 2000, INFECT IMMUN, V68, P492, DOI 10.1128/IAI.68.2.492-501.2000; Kadioglu A, 2011, J INFECT DIS, V204, P1971, DOI 10.1093/infdis/jir657; Kanayama S, 2007, J ENDOTOXIN RES, V13, P369, DOI 10.1177/0968051907086464; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kathiresan S, 2008, CURR OPIN LIPIDOL, V19, P122, DOI 10.1097/MOL.0b013e3282f70296; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kemp K, 2002, INFECT IMMUN, V70, P5019, DOI 10.1128/IAI.70.9.5019-5025.2002; Kermani P, 2005, J CLIN INVEST, V115, P653, DOI 10.1172/JCI200522655; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; Kerr AR, 2002, INFECT IMMUN, V70, P1547, DOI 10.1128/IAI.70.3.1547-1557.2002; Kirby A, 2010, GENETICS, V185, P1081, DOI 10.1534/genetics.110.115014; Koziol-White CJ, 2011, EXPERT REV RESP MED, V5, P767, DOI [10.1586/ERS.11.77, 10.1586/ers.11.77]; Kwapiszewska G, 2012, AM J PATHOL, V181, P2018, DOI 10.1016/j.ajpath.2012.08.028; Leduc MS, 2011, J LIPID RES, V52, P1139, DOI 10.1194/jlr.M009175; LeMessurier K, 2010, INFECT IMMUN, V78, P5287, DOI 10.1128/IAI.00431-10; Li L, 2011, WORLD J PEDIATR, V7, P250, DOI 10.1007/s12519-011-0285-5; Lingappa JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023413; Liu PY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000651; Liu XY, 2009, MOL BIOL CELL, V20, P2174, DOI 10.1091/mbc.E08-10-0994; Lloyd EE, 2011, HYPERTENSION, V58, P672, DOI 10.1161/HYPERTENSIONAHA.111.175349; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P571, DOI 10.1007/s00424-003-1141-9; MALO D, 1994, GENOMICS, V23, P51, DOI 10.1006/geno.1994.1458; Mandelkow E, 2002, TRENDS CELL BIOL, V12, P585, DOI 10.1016/S0962-8924(02)02400-5; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Maroder M, 1996, J IMMUNOL, V157, P2864; Marriott HM, 2006, INT J BIOCHEM CELL B, V38, P1848, DOI 10.1016/j.biocel.2006.06.001; Martens P, 2004, BMC INFECT DIS, V30, P4; Matsuzaki H, 2004, CLIN DIAGN LAB IMMUN, V11, P1140, DOI 10.1128/CDLI.11.6.1140-1147.2004; McGettrick HM, 2012, J LEUKOCYTE BIOL, V91, P385, DOI 10.1189/jlb.0911458; Meneghin A, 2007, J CLIN INVEST, V117, P530, DOI 10.1172/JCI30595; Miao CY, 2012, BRIT J PHARMACOL, V165, P643, DOI 10.1111/j.1476-5381.2011.01404.x; Mirakaj V, 2010, AM J RESP CRIT CARE, V181, P815, DOI 10.1164/rccm.200905-0717OC; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Mizrachi-Nebenzahl Y, 2003, CLIN EXP IMMUNOL, V134, P23, DOI 10.1046/j.1365-2249.2003.02261.x; Morote-Garcia JC, 2012, P NATL ACAD SCI USA, V109, P14146, DOI 10.1073/pnas.1202165109; Neill DR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002660; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pagiatakis C, 2012, J BIOL CHEM, V287, P8361, DOI 10.1074/jbc.M111.286203; Parsonage G, 2005, TRENDS IMMUNOL, V26, P150, DOI 10.1016/j.it.2004.11.014; Pechkovsky DV, 2010, AM J RESP CELL MOL, V43, P641, DOI 10.1165/rcmb.2009-0318OC; Prakash Ys, 2010, Expert Rev Respir Med, V4, P395, DOI 10.1586/ers.10.29; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ripoll VM, 2010, J LEUKOCYTE BIOL, V87, P735, DOI 10.1189/jlb.0509359; Romano V, 2012, J MOL MODEL, V18, P3617, DOI 10.1007/s00894-012-1370-y; Roy SG, 2001, INT J BIOCHEM CELL B, V33, P723, DOI 10.1016/S1357-2725(01)00041-3; Sanderson Michael J, 2008, Proc Am Thorac Soc, V5, P23, DOI 10.1513/pats.200704-050VS; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Su ZG, 2010, J LIPID RES, V51, P2706, DOI 10.1194/jlr.M008110; Suire S, 2012, EMBO J, V31, P3118, DOI 10.1038/emboj.2012.167; Sun K, 2011, INFECT IMMUN, V79, P1842, DOI 10.1128/IAI.01143-10; Szasz T, 2013, VASC HEALTH RISK MAN, V9, P105, DOI 10.2147/VHRM.S33760; Tong WD, 2003, ENVIRON HEALTH PERSP, V111, P1819, DOI 10.1289/ehp.6497; van Rossum AMC, 2005, INFECT IMMUN, V73, P7718, DOI 10.1128/IAI.73.11.7718-7726.2005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wagner N, 2005, GENE DEV, V19, P2631, DOI 10.1101/gad.346405; Wakahara K, 2005, J INFECT DIS, V191, P930, DOI 10.1086/428134; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xia YXC, 2013, PULM PHARMACOL THER, V26, P64, DOI 10.1016/j.pupt.2012.05.006	92	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89831	10.1371/journal.pone.0089831	http://dx.doi.org/10.1371/journal.pone.0089831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594938	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900037
J	Ouyang, K; Woodiga, SA; Dwivedi, V; Buckwalter, CM; Singh, AK; Binjawadagi, B; Hiremath, J; Manickam, C; Schleappi, R; Khatri, M; Wu, JM; King, SJ; Renukaradhya, GJ				Ouyang, Kang; Woodiga, Shireen A.; Dwivedi, Varun; Buckwalter, Carolyn M.; Singh, Anirudh K.; Binjawadagi, Basavaraj; Hiremath, Jagadish; Manickam, Cordelia; Schleappi, Rose; Khatri, Mahesh; Wu, Jianmin; King, Samantha J.; Renukaradhya, Gourapura J.			Pretreatment of Epithelial Cells with Live Streptococcus pneumoniae Has No Detectable Effect on Influenza A Virus Replication In Vitro	PLOS ONE			English	Article							MDCK CELLS; SWINE; MODEL; EXOGLYCOSIDASES; SUSCEPTIBILITY; INFECTION; DISEASE; TRYPSIN; GROWTH; LINE	Influenza A virus (IAV) and Streptococcus pneumoniae (pneumococcus) are two major upper respiratory tract pathogens responsible for exacerbated disease in coinfected individuals. Despite several studies showing increased susceptibility to secondary bacterial infections following IAV infection, information on the direct effect of S. pneumoniae on IAV in vitro is unknown. This is an important area of investigation as S. pneumoniae is a common commensal of the human upper respiratory tract, present as an important coinfecting pathogen with IAV infection. A recent study showed that S. pneumoniae enhances human metapneumovirus infection in polarized bronchial epithelial cells in vitro. The aim of the current study was to determine whether treatment of epithelial cells with S. pneumoniae affects IAV replication using a standard immunofluorescence assay (IFA). For this study we used four IAV permissive epithelial cell lines including two human-derived cell lines, 12 pneumococcal strains including recent human clinical isolates which represent different genetic backgrounds and serotypes, and six IAV strains of varying genetic nature and pathogenic potential including the pandemic 2009 H1N1 virus. Our results suggested that pretreatment of MDCK cells with 7.5x10(6) colony-forming units (CFUs) of live S. pneumoniae resulted in gradual cell-death in a time-dependent manner (0.5 to 4 hr). But, pretreatment of cell lines with 7.5x10(5) and lower CFUs of S. pneumoniae had no detectable effect on either the morphology of cells or on the IAV replication. However, unlike in epithelial cell lines, due to influence of secreted host factors the effect of pneumococci on IAV replication may be different during coinfections in vivo in the human upper respiratory tract, and in vitro with primary human polarized bronchial epithelial cells.	[Ouyang, Kang; Wu, Jianmin] Guangxi Univ, Coll Anim Sci & Technol, Nanning 530004, Peoples R China; [Ouyang, Kang; Dwivedi, Varun; Binjawadagi, Basavaraj; Hiremath, Jagadish; Manickam, Cordelia; Schleappi, Rose; Khatri, Mahesh; Renukaradhya, Gourapura J.] Ohio State Univ, OARDC, Dept Vet Prevent Med, Food Anim Hlth Res Program FAHRP, Wooster, OH USA; [Woodiga, Shireen A.; Buckwalter, Carolyn M.; Singh, Anirudh K.; King, Samantha J.] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA; [Buckwalter, Carolyn M.; King, Samantha J.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	Guangxi University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	King, SJ (corresponding author), Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA.	Samantha.King@nationwidechildrens.org; gourapura.1@osu.edu	king, samantha/AAS-4813-2021	Gourapura, Renukaradhya/0000-0003-2861-180X	National Center For Advancing Translational Sciences [UL1TR001070]; state and federal funds; China Scholarship Council (CSC) [2011666005]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	National Center For Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); state and federal funds; China Scholarship Council (CSC)(China Scholarship Council); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The project described was supported by award number grant UL1TR001070 from the National Center For Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Advancing Translational Sciences or the National Institutes of Health. Pilot funding from this grant was awarded to SJK and RJG. Salaries and research support were provided by state and federal funds appropriated to Ohio Agricultural Research and Development Center, The Ohio State University. The fellowship support by China Scholarship Council (CSC#2011666005) during KO's visit to OSU is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07; Diavatopoulos DA, 2010, FASEB J, V24, P1789, DOI 10.1096/fj.09-146779; Garthoff LH, 2002, FOOD CHEM TOXICOL, V40, P487, DOI 10.1016/S0278-6915(01)00120-X; Genzel Y, 2006, VACCINE, V24, P6074, DOI 10.1016/j.vaccine.2006.05.023; Groves IJ, 2009, J GEN VIROL, V90, P2364, DOI 10.1099/vir.0.012526-0; Haynes L, 2012, J IMMUNOL, V189, P4921, DOI 10.4049/jimmunol.1201916; Huang YT, 2000, J CLIN MICROBIOL, V38, P422; Iannelli F, 1999, J BACTERIOL, V181, P2652, DOI 10.1128/JB.181.8.2652-2654.1999; Inman CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033707; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Khatri M, 2010, J VIROL, V84, P11210, DOI 10.1128/JVI.01211-10; Kim JO, 1999, INFECT IMMUN, V67, P2327, DOI 10.1128/IAI.67.5.2327-2333.1999; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Liu J, 2009, VACCINE, V27, P6460, DOI 10.1016/j.vaccine.2009.06.024; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; Marion C, 2009, INFECT IMMUN, V77, P1389, DOI 10.1128/IAI.01215-08; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; McCullers JA, 2010, J INFECT DIS, V202, P1287, DOI 10.1086/656333; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Pang XY, 2007, ISME J, V1, P156, DOI 10.1038/ismej.2007.23; PETERSON WD, 1971, P SOC EXP BIOL MED, V136, P1187; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sghir A, 2000, APPL ENVIRON MICROB, V66, P2263, DOI 10.1128/AEM.66.5.2263-2266.2000; Shakl JR, 2013, TRENDS MICROBIOL, V21, P129, DOI 10.1016/j.tim.2012.11.005; Short KR, 2012, FUTURE MICROBIOL, V7, P609, DOI [10.2217/FMB.12.29, 10.2217/fmb.12.29]; Smith AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003238; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; Verkaik NJ, 2011, CLIN MICROBIOL INFEC, V17, P1840, DOI 10.1111/j.1469-0691.2011.03480.x; Wang KC, 2008, BERL MUNCH TIERARZTL, V121, P198, DOI 10.2376/0005-9366-121-198; Yassine HM, 2009, VET MICROBIOL, V139, P132, DOI 10.1016/j.vetmic.2009.04.028	32	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90066	10.1371/journal.pone.0090066	http://dx.doi.org/10.1371/journal.pone.0090066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594847	gold, Green Published, Green Submitted			2022-12-27	WOS:000332468900064
J	Chen, PI; Schauer, K; Kong, C; Harding, AR; Goud, B; Stahl, PD				Chen, Pin-I; Schauer, Kristine; Kong, Chen; Harding, Andrew R.; Goud, Bruno; Stahl, Philip D.			Rab5 Isoforms Orchestrate a "Division of Labor" in the Endocytic Network; Rab5C Modulates Rac-Mediated Cell Motility	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; EPIDERMAL-GROWTH-FACTOR; GTP-BINDING-PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASE; ENDOSOME FUSION; TRAFFICKING; ACTIVATION; ADHESION; LOCALIZATION; DEGRADATION	Rab5, the prototypical Rab GTPase and master regulator of the endocytic pathway, is encoded as three differentially expressed isoforms, Rab5A, Rab5B and Rab5C. Here, we examined the differential effects of Rab5 isoform silencing on cell motility and report that Rab5C, but neither Rab5A nor Rab5B, is selectively associated with the growth factor-activation of Rac1 and with enhanced cell motility. Initial observations revealed that silencing of Rab5C expression, but neither Rab5A nor Rab5C, led to spindle-shaped cells that displayed reduced formation of membrane ruffles. When subjected to a scratch wound assay, cells depleted of Rab5C, but not Rab5A or Rab5B, demonstrated reduced cell migration. U937 cells depleted of Rab5C also displayed reduced cell motility in a Transwell plate migration assay. To examine activation of Rac, HeLa cells stably expressing GFP-Rac1 were independently depleted of Rab5A, Rab5B or Rab5C and seeded onto coverslips imprinted with a crossbow pattern. 3-D GFP-Rac1 images of micro-patterned cells show that GFP-Rac1 was less localized to the cell periphery in the absence of Rab5C. To confirm the connection between Rab5C and Rac activation, HeLa cells depleted of Rab5 isoforms were starved and then stimulated with EGF. Rac1 pull-down assays revealed that EGF-stimulated Rac1 activity was significantly suppressed in Rab5C-suppressed cells. To determine whether events upstream of Rac activation were affected by Rab5C, we observed that EGF-stimulated Akt phosphorylation was suppressed in cells depleted of Rab5C. Finally, since spatio-temporal assembly/disassembly of adhesion complexes are essential components of cell migration, we examined the effect of Rab5 isoform depletion on the formation of focal adhesion complexes. Rab5C-depleted HeLa cells have significantly fewer focal adhesion foci, in accordance with the lack of persistent lamellipodial protrusions and reduced directional migration. We conclude that Rab5 isoforms selectively oversee the multiple signaling and trafficking events associated with the endocytic network.	[Chen, Pin-I; Kong, Chen; Harding, Andrew R.; Stahl, Philip D.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Schauer, Kristine; Goud, Bruno] Inst Curie, Paris, France	Washington University (WUSTL); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Stahl, PD (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	pstahl@wustl.edu	Goud, Bruno/GWC-4807-2022	Schauer, Kristine/0000-0002-6102-8790	National Institutes of Health (NIH); McDonnell Center for Cellular and Molecular Neurobiology at Washington University St. Louis	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Center for Cellular and Molecular Neurobiology at Washington University St. Louis	This work was supported by a grant from the National Institutes of Health (NIH) and by the McDonnell Center for Cellular and Molecular Neurobiology at Washington University St. Louis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; BARBIERI MA, 1994, J BIOL CHEM, V269, P18720; Bhattacharya M, 2006, EMBO J, V25, P2878, DOI 10.1038/sj.emboj.7601170; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Callaghan L, 1999, EUR J BIOCHEM, V265, P361; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Gurkan C, 2005, MOL BIOL CELL, V16, P3847, DOI 10.1091/mbc.E05-01-0062; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Kajiho H, 2011, J BIOL CHEM, V286, P24364, DOI 10.1074/jbc.M110.172445; Kimura T, 2006, J BIOL CHEM, V281, P10598, DOI 10.1074/jbc.M510531200; KODAKI T, 1994, CURR BIOL, V4, P798, DOI 10.1016/S0960-9822(00)00177-9; Kurosu H, 2001, J BIOCHEM-TOKYO, V130, P73, DOI 10.1093/oxfordjournals.jbchem.a002964; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Mattera R, 2003, EMBO J, V22, P78, DOI 10.1093/emboj/cdg015; Mendoza P, 2013, J CELL SCI, V126, P3835, DOI 10.1242/jcs.119727; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Onodera Y, 2012, J CELL BIOL, V197, P983, DOI 10.1083/jcb.201201065; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Palamidessi A, 2013, CURR BIOL, V23, P2355, DOI 10.1016/j.cub.2013.09.060; Parrini Maria Carla, 2011, Commun Integr Biol, V4, P772; Parrini MC, 2011, MOL CELL, V42, P650, DOI 10.1016/j.molcel.2011.03.032; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Royal I, 2000, MOL BIOL CELL, V11, P1709, DOI 10.1091/mbc.11.5.1709; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Su X, 2007, J BIOL CHEM, V282, P21278, DOI 10.1074/jbc.M703725200; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Wainszelbaum MJ, 2006, EXP CELL RES, V312, P2238, DOI 10.1016/j.yexcr.2006.03.025; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133	42	32	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90384	10.1371/journal.pone.0090384	http://dx.doi.org/10.1371/journal.pone.0090384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587345	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200184
J	Landeira, JM; Ferron, B; Lunven, M; Morin, P; Marie, L; Sourisseau, M				Landeira, Jose M.; Ferron, Bruno; Lunven, Michel; Morin, Pascal; Marie, Louis; Sourisseau, Marc			Biophysical Interactions Control the Size and Abundance of Large Phytoplankton Chains at the Ushant Tidal Front	PLOS ONE			English	Article							NITRATE FLUXES; DIATOM CHAINS; SHELF EDGE; MARINE; PARTICLES; NUTRIENTS; DINOFLAGELLATE; DISSIPATION; TEMPERATURE; ACQUISITION	Phytoplankton blooms are usually dominated by chain-forming diatom species that can alter food pathways from primary producers to predators by reducing the interactions between intermediate trophic levels. The food-web modifications are determined by the length of the chains; however, the estimation is biased because traditional sampling strategies damage the chains and, therefore, change the phytoplankton size structure. Sedimentological studies around oceanic fronts have shown high concentrations of giant diatom mats (>1 cm in length), suggesting that the size of diatom chains is underestimated in the pelagic realm. Here, we investigate the variability in size and abundance of phytoplankton chains at the Ushant tidal front (NW France) using the Video Fluorescence Analyzer (VFA), a novel and non-invasive system. CTD and Scanfish profiling characterized a strong temperature and chlorophyll front, separating mixed coastal waters from the oceanic-stratified domain. In order to elucidate spring-neap variations in the front, vertical microstructure profiler was used to estimate the turbulence and vertical nitrate flux. Key findings were: (1) the VFA system recorded large diatom chains up to 10.7 mm in length; (2) chains were mainly distributed in the frontal region, with maximum values above the pycnocline in coincidence with the maximum chlorophyll; (3) the diapycnal fluxes of nitrate enabled the maintenance of the bloom in the frontal area throughout the spring-neap tidal cycle; (4) from spring to neap tide the chains length was significantly reduced; (5) during neap tide, the less intense vertical diffusion of nutrients, as well as the lower turbulence around the chains, intensified nutrient-depleted conditions and, thus, very large chains became disadvantageous. To explain this pattern, we suggest that size plasticity is an important ecological trait driving phytoplankton species competition. Although this plasticity behavior is well known from experiments in the laboratory, it has never been reported from observations in the field.	[Landeira, Jose M.; Lunven, Michel; Sourisseau, Marc] IFREMER, Ctr Brest, Dept Dynam Environm Cotier Pelagos, Plouzane, France; [Ferron, Bruno; Marie, Louis] IFREMER, Ctr Brest, Lab Phys Oceans, CNRS,UMR,IRD,UBO 6523, Plouzane, France; [Morin, Pascal] UPMC, CNRS, UMR 7144, Stn Biol Roscoff, Roscoff, France	Ifremer; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Landeira, JM (corresponding author), IFREMER, Ctr Brest, Dept Dynam Environm Cotier Pelagos, Plouzane, France.	jm_landeira@yahoo.es	Marié, Louis/A-1815-2016; FERRON, Bruno/L-5649-2015; Morin, Pascal/A-1112-2016; Landeira, Jose Maria/AAB-2183-2019	Marié, Louis/0000-0003-2583-0994; FERRON, Bruno/0000-0002-2107-0900; Morin, Pascal/0000-0003-2766-1821; Landeira, Jose Maria/0000-0001-6419-2046; sourisseau, marc/0000-0002-0778-0076	GIS EUROPOLE MER; Axis 2 "Global change, Ocean and Marine Ecosystems"; ANR [ANR-05-JCJC-0153]; IFREMER	GIS EUROPOLE MER; Axis 2 "Global change, Ocean and Marine Ecosystems"; ANR(French National Research Agency (ANR)); IFREMER	GIS EUROPOLE MER (http://www.europolemer.eu/en/home.php) and in particular the Axis 2 "Global change, Ocean and Marine Ecosystems" funded the postdoctoral fellowship to JM Landeira. VMP instrumentation was funded by ANR grant ANR-05-JCJC-0153 and IFREMER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JT, 2005, NATURE, V437, P728, DOI 10.1038/nature03948; Aminot A., 1983, MANUEL ANAL CHIMIQUE; Arin L, 2002, AQUAT MICROB ECOL, V29, P51, DOI 10.3354/ame029051; Beardall J, 2009, NEW PHYTOL, V181, P295, DOI 10.1111/j.1469-8137.2008.02660.x; Benfield MC, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.63; Bergkvist J, 2012, LIMNOL OCEANOGR, V57, P318, DOI 10.4319/lo.2012.57.1.0318; Cambon G., 2008, THESIS U BRETAGNE OC; Cavender-Bares KK, 2001, LIMNOL OCEANOGR, V46, P778, DOI 10.4319/lo.2001.46.4.0778; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; DEMOTT WR, 1991, J PLANKTON RES, V13, P1203, DOI 10.1093/plankt/13.6.1203; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fawcett SE, 2011, MAR ECOL PROG SER, V428, P13, DOI 10.3354/meps09070; Franks PJS, 2008, J MARINE SYST, V69, P254, DOI 10.1016/j.jmarsys.2006.03.027; FRANKS PJS, 1992, MAR ECOL PROG SER, V82, P1, DOI 10.3354/meps082001; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Goodman L, 2006, J ATMOS OCEAN TECH, V23, P977, DOI 10.1175/JTECH1889.1; Gorley C.K., 2006, GETTING STARTED PRIM; Holliday DV, 2003, AQUAT LIVING RESOUR, V16, P131, DOI 10.1016/S0990-7440(03)00023-8; Karp-Boss L, 1998, LIMNOL OCEANOGR, V43, P1767, DOI 10.4319/lo.1998.43.8.1767; Kemp AES, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002894; KIORBOE T, 1993, ADV MAR BIOL, V29, P1, DOI 10.1016/S0065-2881(08)60129-7; Le Boyer A, 2009, CONT SHELF RES, V29, P1026, DOI 10.1016/j.csr.2008.12.020; LEFEVRE J, 1986, ADV MAR BIOL, V23, P163; Legendre L., 1991, PARTICLE ANAL OCEANO, P261, DOI [DOI 10.1007/978-3-642-75121-9_11, 10.1007/978-3-642-75121-9_11]; Li QP, 2012, J PLANKTON RES, V34, P790, DOI 10.1093/plankt/fbs006; Long JD, 2007, P NATL ACAD SCI USA, V104, P10512, DOI 10.1073/pnas.0611600104; Louanchi F, 2001, DEEP-SEA RES PT II, V48, P2155, DOI 10.1016/S0967-0645(00)00185-5; Lough RG, 2001, DEEP-SEA RES PT II, V48, P631; Lunven M, 2012, LIMNOL OCEANOGR-METH, V10, P807, DOI 10.4319/lom.2012.10.807; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; Menden-Deuer S, 2001, MAR ECOL PROG SER, V222, P41, DOI 10.3354/meps222041; MORIN P, 1993, J GEOPHYS RES-OCEANS, V98, P4689, DOI 10.1029/92JC02445; MORIN P, 1985, J MAR BIOL ASSOC UK, V65, P677, DOI 10.1017/S0025315400052528; Musielak MM, 2009, J FLUID MECH, V638, P401, DOI 10.1017/S0022112009991108; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; Padisak J, 2003, HYDROBIOLOGIA, V500, P243, DOI 10.1023/A:1024613001147; Pahlow M, 1997, LIMNOL OCEANOGR, V42, P1660, DOI 10.4319/lo.1997.42.8.1660; PINGREE RD, 1978, J MAR BIOL ASSOC UK, V58, P955, DOI 10.1017/S0025315400056885; PINGREE RD, 1978, DEEP-SEA RES, V25, P1011, DOI 10.1016/0146-6291(78)90584-2; PINGREE RD, 1977, NATURE, V265, P266, DOI 10.1038/265266a0; Prairie J. C., 2011, LIMNOLOGY OCEANOGRAP, V1, P75, DOI DOI 10.1215/21573698-1267403; Prairie JC, 2010, LIMNOL OCEANOGR, V55, P1943, DOI 10.4319/lo.2010.55.5.1943; Reul A, 2005, CONT SHELF RES, V25, P589, DOI 10.1016/j.csr.2004.09.016; Rodriguez J, 2001, NATURE, V410, P360, DOI 10.1038/35066560; Rodriguez Jaime, 1994, Scientia Marina, V58, P1; Schultes S, 2013, J MARINE SYST, V109, pS191, DOI 10.1016/j.jmarsys.2011.11.025; Selander E, 2011, P NATL ACAD SCI USA, V108, P4030, DOI 10.1073/pnas.1011870108; Sharples J, 2001, J GEOPHYS RES-OCEANS, V106, P14069, DOI 10.1029/2000JC000604; Sharples J, 2007, LIMNOL OCEANOGR, V52, P1735, DOI 10.4319/lo.2007.52.5.1735; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P327, DOI 10.4319/lo.1972.17.3.0327; SIMPSON JH, 1974, NATURE, V250, P404, DOI 10.1038/250404a0; SIMPSON JH, 1981, PHILOS T R SOC A, V302, P531, DOI 10.1098/rsta.1981.0181; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; SMAYDA TJ, 1966, LIMNOL OCEANOGR, V11, P18, DOI 10.4319/lo.1966.11.1.0018; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; Stibor H, 2004, ECOL LETT, V7, P321, DOI 10.1111/j.1461-0248.2004.00580.x; Takabayashi M, 2006, J PLANKTON RES, V28, P831, DOI 10.1093/plankt/fbl018; Talapatra S, 2013, MAR ECOL PROG SER, V473, P29, DOI 10.3354/meps10049; Treguer P., 1975, MANUEL ANAL SELS NUT; Vlietstra LS, 2005, FISH OCEANOGR, V14, P196, DOI 10.1111/j.1365-2419.2005.00369.x; Young AM, 2012, LIMNOL OCEANOGR, V57, P1789, DOI 10.4319/lo.2012.57.6.1789; Zar JH, 1999, BIOSTATISTICAL ANAL	63	11	12	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90507	10.1371/journal.pone.0090507	http://dx.doi.org/10.1371/journal.pone.0090507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587384	Green Published, gold			2022-12-27	WOS:000332396200218
J	Mobarrez, F; Antoniewicz, L; Bosson, JA; Kuhl, J; Pisetsky, DS; Lundback, M				Mobarrez, Fariborz; Antoniewicz, Lukasz; Bosson, Jenny A.; Kuhl, Jeanette; Pisetsky, David S.; Lundback, Magnus			The Effects of Smoking on Levels of Endothelial Progenitor Cells and Microparticles in the Blood of Healthy Volunteers	PLOS ONE			English	Article							CIGARETTE-SMOKING; RHEUMATOID-ARTHRITIS; SECONDHAND SMOKE; RISK-FACTORS; PLATELETS; DISEASE; NUMBER; HMGB1	Background: Cigarette smoking, both active and passive, is one of the leading causes of morbidity and mortality in cardiovascular disease. To assess the impact of brief smoking on the vasculature, we determined levels of circulating endothelial progenitor cells (EPCs) and circulating microparticles (MPs) following the smoking of one cigarette by young, healthy intermittent smokers. Materials and Methods: 12 healthy volunteers were randomized to either smoking or not smoking in a crossover fashion. Blood sampling was performed at baseline, 1, 4 and 24 hours following smoking/not smoking. The numbers of EPCs and MPs were determined by flow cytometry. MPs were measured from platelets, leukocytes and endothelial cells. Moreover, MPs were also labelled with anti-HMGB1 and SYTO 13 to assess the content of nuclear molecules. Results: Active smoking of one cigarette caused an immediate and significant increase in the numbers of circulating EPCs and MPs of platelet-, endothelial-and leukocyte origin. Levels of MPs containing nuclear molecules were increased, of which the majority were positive for CD41 and CD45 (platelet-and leukocyte origin). CD144 (VE-cadherin) or HMGB1 release did not significantly change during active smoking. Conclusion: Brief active smoking of one cigarette generated an acute release of EPC and MPs, of which the latter contained nuclear matter. Together, these results demonstrate acute effects of cigarette smoke on endothelial, platelet and leukocyte function as well as injury to the vascular wall.	[Mobarrez, Fariborz; Antoniewicz, Lukasz; Kuhl, Jeanette; Lundback, Magnus] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Div Cardiovasc Med, Stockholm, Sweden; [Bosson, Jenny A.] Umea Univ, Dept Publ Hlth & Clin Med, Div Med Resp Med, Umea, Sweden; [Pisetsky, David S.] Durham VA Hosp, Med Res Serv, Durham, NC USA; [Pisetsky, David S.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Danderyds Hospital; Karolinska Institutet; Umea University; Duke University	Mobarrez, F (corresponding author), Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Div Cardiovasc Med, Stockholm, Sweden.	fariborz.mobarrez@ki.se	Antoniewicz, Lukasz/AAL-8165-2020; Mobarrez, Fariborz/AAK-8929-2020	Antoniewicz, Lukasz/0000-0001-5969-8165; Mobarrez, Fariborz/0000-0002-7106-6248; Bosson Damewood, Jenny/0000-0003-2380-2607				Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Burger D, 2012, J AM SOC HYPERTENS, V6, P85, DOI 10.1016/j.jash.2011.11.003; Elzey BD, 2011, THROMB RES, V127, P180, DOI 10.1016/j.thromres.2010.10.011; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gordon C, 2011, AM J RESP CRIT CARE, V184, P224, DOI 10.1164/rccm.201012-2061OC; Grisar J, 2007, ANN RHEUM DIS, V66, P1284, DOI 10.1136/ard.2006.066605; Guidollet J, 1999, J BIOMED MATER RES, V44, P156, DOI 10.1002/(SICI)1097-4636(199902)44:2<156::AID-JBM5>3.0.CO;2-H; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Heiss C, 2008, J AM COLL CARDIOL, V51, P1760, DOI 10.1016/j.jacc.2008.01.040; Hibbert B, 2003, TRENDS CARDIOVAS MED, V13, P322, DOI 10.1016/j.tcm.2003.09.002; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Imaoka H, 2011, AM J RESP CRIT CARE, V184, P771, DOI 10.1164/rccm.201102-0272OC; Jacobs DR, 1999, ARCH INTERN MED, V159, P733, DOI 10.1001/archinte.159.7.733; Kondo T, 2004, ARTERIOSCL THROM VAS, V24, P1442, DOI 10.1161/01.ATV.0000135655.52088.c5; Lekakis J, 2011, EUR J CARDIOV PREV R, V18, P775, DOI 10.1177/1741826711398179; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Li MZ, 2010, ARTERIOSCL THROM VAS, V30, P1818, DOI 10.1161/ATVBAHA.110.209577; Lievens D, 2010, BLOOD, V116, P4317, DOI 10.1182/blood-2010-01-261206; Martinez MC, 2011, TRENDS PHARMACOL SCI, V32, P659, DOI 10.1016/j.tips.2011.06.005; Maugeri N, 2013, ANTIOXID REDOX SIGN; Maugeri N, 2012, AUTOIMMUNITY, V45, P584, DOI 10.3109/08916934.2012.719946; Mobarrez F, 2010, THROMB RES, V125, pE110, DOI 10.1016/j.thromres.2009.10.006; Morel O, 2006, ARTERIOSCL THROM VAS, V26, P2594, DOI 10.1161/01.ATV.0000246775.14471.26; Newby DE, 1999, CIRCULATION, V99, P1411, DOI 10.1161/01.CIR.99.11.1411; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Padfield GJ, 2010, AM J PHYSIOL-HEART C, V298, pH2054, DOI 10.1152/ajpheart.00921.2009; Raveendran M, 2005, FEBS LETT, V579, P733, DOI 10.1016/j.febslet.2004.12.052; Rodriguez-Carrio J, 2012, RHEUMATOLOGY, V51, P1775, DOI 10.1093/rheumatology/kes152; Rouhiainen A, 2000, THROMB HAEMOSTASIS, V84, P1087; Sambola A, 2003, CIRCULATION, V107, P973, DOI 10.1161/01.CIR.0000050621.67499.7D; Schniedermann J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-50; Soop A, 2013, SCAND J IMMUNOL, V78, P205, DOI 10.1111/sji.12076; SOSLAU G, 1983, ARCH BIOCHEM BIOPHYS, V226, P252, DOI 10.1016/0003-9861(83)90291-6; Tanaka K, 2003, CIRC RES, V93, P783, DOI 10.1161/01.RES.0000096651.13001.B4; Tarnok A, 2008, CYTOM PART A, V73A, P477, DOI 10.1002/cyto.a.20588; Tsuchiya M, 2002, CIRCULATION, V105, P1155, DOI 10.1161/hc1002.105935; Ullal AJ, 2011, J AUTOIMMUN, V36, P173, DOI 10.1016/j.jaut.2011.02.001; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Viera AJ, 2012, J AM SOC HYPERTENS, V6, P243, DOI 10.1016/j.jash.2012.06.003; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124	41	55	57	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90314	10.1371/journal.pone.0090314	http://dx.doi.org/10.1371/journal.pone.0090314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587320	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200166
J	Robertson, MJ; Dries-Devlin, JL; Kren, SM; Burchfield, JS; Taylor, DA				Robertson, Matthew J.; Dries-Devlin, Jessica L.; Kren, Stefan M.; Burchfield, Jana S.; Taylor, Doris A.			Optimizing Recellularization of Whole Decellularized Heart Extracellular Matrix	PLOS ONE			English	Article							TISSUE; ANGIOGENESIS; SCAFFOLDS; SURVIVAL; DISEASE; MUSCLE	Rationale: Perfusion decellularization of cadaveric hearts removes cells and generates a cell-free extracellular matrix scaffold containing acellular vascular conduits, which are theoretically sufficient to perfuse and support tissue-engineered heart constructs. However, after transplantation, these acellular vascular conduits clot, even with anti-coagulation. Here, our objective was to create a less thrombogenic scaffold and improve recellularized-left ventricular contractility by re-lining vascular conduits of a decellularized rat heart with rat aortic endothelial cells (RAECs). Methods and Results: We used three strategies to recellularize perfusion-decellularized rat heart vasculature with RAECs: retrograde aortic infusion, brachiocephalic artery (BA) infusion, or a combination of inferior vena cava (IVC) plus BA infusion. The re-endothelialized scaffolds were maintained under vascular flow in vitro for 7 days, and then cell morphology, location, and viability were examined. Thrombogenicity of the scaffold was assessed in vitro and in vivo. Both BA and IVC+BA cell delivery resulted in a whole heart distribution of RAECs that proliferated, retained an endothelial phenotype, and expressed endothelial nitric oxide synthase and von Willebrand factor. Infusing RAECs via the combination IVC+BA method increased scaffold cellularity and the number of vessels that were lined with endothelial cells; re-endothelialization by using BA or IVC+BA cell delivery significantly reduced in vitro thrombogenicity. In vivo, both acellular and re-endothelialized scaffolds recruited non-immune host cells into the organ parenchyma and vasculature. Finally, re-endothelialization before recellularization of the left ventricular wall with neonatal cardiac cells enhanced construct contractility. Conclusions: This is the first study to re-endothelialize whole decellularized hearts throughout both arterial and venous beds and cavities by using arterial and venous delivery. The combination (IVC+BA) delivery strategy results in enhanced scaffold vessel re-endothelialization compared to single-route strategies. Re-endothelialization reduced scaffold thrombogencity and improved contractility of left ventricular-recellularized constructs. Thus, vessel and cavity reendothelialization creates superior vascularized scaffolds for use in whole-organ recellularization applications.	[Robertson, Matthew J.; Kren, Stefan M.; Taylor, Doris A.] Univ Minnesota, Ctr Cardiovasc Repair, Minneapolis, MN 55455 USA; [Robertson, Matthew J.] Texas Heart Inst, Dept Mol Cardiol, Houston, TX 77025 USA; [Dries-Devlin, Jessica L.] Medtronic, Mounds View, MN USA; [Burchfield, Jana S.; Taylor, Doris A.] Texas Heart Inst, Dept Regenerat Med Res, Houston, TX 77025 USA; [Taylor, Doris A.] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Texas Heart Institute; Medtronic; Texas Heart Institute; University of Minnesota System; University of Minnesota Twin Cities	Taylor, DA (corresponding author), Univ Minnesota, Ctr Cardiovasc Repair, Minneapolis, MN 55455 USA.	dtaylor@texasheart.org			National Institutes of Health Safety and Efficacy of Cellular Cardiomyoplasty [2R01HL063346]; National Heart Lung and Blood Institute [1U01HL100407-1]; American Heart Association's Jon Holden DeHaan Cardiac Myogenesis Research Center [AHA09070499N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100407, R01HL063346] Funding Source: NIH RePORTER	National Institutes of Health Safety and Efficacy of Cellular Cardiomyoplasty(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association's Jon Holden DeHaan Cardiac Myogenesis Research Center(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded in part by National Institutes of Health Safety and Efficacy of Cellular Cardiomyoplasty #2R01HL063346, the National Heart Lung and Blood Institute #1U01HL100407-1, and the American Heart Association's Jon Holden DeHaan Cardiac Myogenesis Research Center #AHA09070499N awarded to Dr. Doris Taylor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin Hug, 2013, Methods Mol Biol, V1036, P163, DOI 10.1007/978-1-62703-511-8_14; Butcher JT, 2011, ADV DRUG DELIVER REV, V63, P242, DOI 10.1016/j.addr.2011.01.008; Calnek DS, 1998, EXP CELL RES, V238, P294, DOI 10.1006/excr.1997.3812; Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff; Dean Ethan W., 2012, Yale Journal of Biology and Medicine, V85, P229; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; Gaballa MA, 2006, J HEART LUNG TRANSPL, V25, P946, DOI 10.1016/j.healun.2006.04.008; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Ibrahim S, 2008, J TISSUE ENG REGEN M; Karikkineth BC, 2013, CURR PHARM BIOTECHNO, V14, P4; Kim MH, 2010, BIOMATERIALS, V31, P1213, DOI 10.1016/j.biomaterials.2009.10.057; Kochupura PV, 2005, CIRCULATION, V112, pI144, DOI 10.1161/CIRCULATIONAHA.104.524355; KORECKY B, 1982, CAN J PHYSIOL PHARM, V60, P23, DOI 10.1139/y82-003; Kutschka I, 2006, CIRCULATION, V114, pI167, DOI 10.1161/CIRCULATIONAHA.105.001297; Lu TY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3307; Mbemba E, 2000, GLYCOBIOLOGY, V10, P21, DOI 10.1093/glycob/10.1.21; Morritt AN, 2007, CIRCULATION, V115, P353, DOI 10.1161/CIRCULATIONAHA.106.657379; Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07; Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029; ONO K, 1969, J THORAC CARDIOV SUR, V57, P225, DOI 10.1016/S0022-5223(19)42744-X; Ota T, 2005, ANN THORAC SURG, V80, P1794, DOI 10.1016/j.athoracsur.2005.05.002; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Park KM, 2012, TRANSPL P, V44, P1151, DOI 10.1016/j.transproceed.2012.03.017; Radisic M, 2008, NAT PROTOC, V3, P719, DOI 10.1038/nprot.2008.40; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; STRATER J, 1995, HISTOCHEM CELL BIOL, V103, P157, DOI 10.1007/BF01454013; Suuronen EJ, 2006, CIRCULATION, V114, pI138, DOI 10.1161/CIRCULATIONAHA.105.001081; Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI [10.1089/ten.teb.2009.0352, 10.1089/ten.TEB.2009.0352]; Wainwright JM, 2010, TISSUE ENG PART C-ME, V16, P525, DOI [10.1089/ten.tec.2009.0392, 10.1089/ten.TEC.2009.0392]; Zhang ZM, 2002, CHINESE MED J-PEKING, V115, P878; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394; Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8	32	108	115	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90406	10.1371/journal.pone.0090406	http://dx.doi.org/10.1371/journal.pone.0090406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587354	gold, Green Published, Green Submitted			2022-12-27	WOS:000332390800106
J	Sanz, AB; Aroeira, LS; Bellon, T; del Peso, G; Jimenez-Heffernan, J; Santamaria, B; Sanchez-Nino, MD; Blanco-Colio, LM; Lopez-Cabrera, M; Ruiz-Ortega, M; Egido, J; Selgas, R; Ortiz, A				Belen Sanz, Ana; Stark Aroeira, Luiz; Bellon, Teresa; del Peso, Gloria; Jimenez-Heffernan, Jose; Santamaria, Beatriz; Dolores Sanchez-Nino, Maria; Miguel Blanco-Colio, Luis; Lopez-Cabrera, Manuel; Ruiz-Ortega, Marta; Egido, Jesus; Selgas, Rafael; Ortiz, Alberto			TWEAK Promotes Peritoneal Inflammation	PLOS ONE			English	Article							NF-KAPPA-B; TO-MESENCHYMAL TRANSITION; NECROSIS-FACTOR-ALPHA; MESOTHELIAL CELLS; WEAK INDUCER; APOPTOSIS; CYTOKINES; DIALYSIS; PATHWAY; PROLIFERATION	Peritoneal dialysis (PD) is complicated by peritonitis episodes that cause loss of mesothelium and eventually sclerosing peritonitis. An improved understanding of the molecular contributors to peritoneal injury and defense may increase the therapeutic armamentarium to optimize peritoneal defenses while minimizing peritoneal injury. There is no information on the expression and function of the cytokine TWEAK and its receptor Fn14 during peritoneal injury. Fn14 expression and soluble TWEAK levels were measured in human PD peritoneal effluent cells or fluids with or without peritonitis. Fn14 expression was also analyzed in peritoneal biopsies from PD patients. Actions of intraperitoneal TWEAK were studied in mice in vivo. sTWEAK levels were increased in peritoneal effluent in PD peritonitis. Effluent sTWEAK levels correlated with the number of peritoneal macrophages (r = 0.491, p = 0.002). Potential TWEAK targets that express the receptor Fn14 include mesothelial cells and macrophages, as demonstrated by flow cytometry of peritoneal effluents and by analysis of peritoneal biopsies. Peritoneal biopsy Fn14 correlated with mesothelial injury, fibrosis and inflammation, suggesting a potential deleterious effect of TWEAK/Fn14. In this regard, intraperitoneal TWEAK administration to mice promoted peritoneal inflammation characterized by increased peritoneal effluent MCP-1, Fn14 and Gr1(+) macrophages, increased mesothelial Fn14, MCP-1 and CCL21 expression and submesothelial tissue macrophage recruitment. Taken together these data suggest that the TWEAK/Fn14 system may promote inflammation and tissue injury during peritonitis and PD.	[Belen Sanz, Ana; Santamaria, Beatriz; Miguel Blanco-Colio, Luis; Ruiz-Ortega, Marta; Egido, Jesus; Ortiz, Alberto] IIS Fdn Jimenez Diaz, Lab Nephrol, Madrid, Spain; [Stark Aroeira, Luiz] IBIV, Dept Immunol, Vigo, Pontevedra, Spain; [Bellon, Teresa; del Peso, Gloria; Dolores Sanchez-Nino, Maria; Selgas, Rafael] IDIPAZ, Dept Nephrol, Madrid, Spain; [Belen Sanz, Ana; del Peso, Gloria; Dolores Sanchez-Nino, Maria; Lopez-Cabrera, Manuel; Ruiz-Ortega, Marta; Selgas, Rafael; Ortiz, Alberto] REDinREN, Madrid, Spain; [Jimenez-Heffernan, Jose] Hosp Univ Princesa, Madrid, Spain; [Lopez-Cabrera, Manuel] Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Ruiz-Ortega, Marta; Egido, Jesus; Selgas, Rafael; Ortiz, Alberto] Univ Autonoma Madrid, Madrid, Spain; [Egido, Jesus; Selgas, Rafael; Ortiz, Alberto] IRSIN, Madrid, Spain	Fundacion Jimenez Diaz; Hospital de La Princesa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Sanz, AB (corresponding author), IIS Fdn Jimenez Diaz, Lab Nephrol, Madrid, Spain.	asanz@fjd.es	Ortega, Marta Ruiz/AAN-2136-2020; Bellón, Teresa/ABF-4916-2020; Sanz, Ana Belen/C-9489-2013; Cabrera, Manuel López/AAA-5463-2019; Ruiz-Ortega, Marta/D-3584-2012; Santamaria, Beatriz/B-3469-2015; Blanco-Colio, Luis M./Z-2390-2019; Aroeira, Luiz Stark/D-7558-2014; Sanchez-Niño, Maria Dolores/B-7350-2019; ortiz, alberto/Y-7582-2018; ruiz-ortega, marta/D-3584-2012	Ortega, Marta Ruiz/0000-0002-1495-6535; Bellón, Teresa/0000-0002-0138-6879; Sanz, Ana Belen/0000-0002-0255-5689; Ruiz-Ortega, Marta/0000-0002-1495-6535; Santamaria, Beatriz/0000-0002-1990-2106; Aroeira, Luiz Stark/0000-0001-9391-1409; Sanchez-Niño, Maria Dolores/0000-0001-7110-6409; ortiz, alberto/0000-0002-9805-9523; ruiz-ortega, marta/0000-0002-1403-2690; Blanco-Colio, Luis Miguel/0000-0002-1560-6609; Lopez Cabrera, Manuel/0000-0002-0976-9719	FIS [PS09/00447, PI08/1564, PI10/00234, MS12/03262]; FEDER funds ISCIII-RETIC [REDinREN/RD06/0016, RD12/0021]; Comunidad de Madrid [S2010/BMD-2321, S2010/BMD-2378]; Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM); Programa Estabilizacion Investigadores; Miguel Servet; Sara Borrell	FIS(Instituto de Salud Carlos III); FEDER funds ISCIII-RETIC; Comunidad de Madrid(Comunidad de Madrid); Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM)(Instituto de Salud Carlos III); Programa Estabilizacion Investigadores; Miguel Servet; Sara Borrell	This work was supported by FIS PS09/00447, PI08/1564, PI10/00234, MS12/03262, FEDER funds ISCIII-RETIC REDinREN/RD06/0016, RD12/0021, Comunidad de Madrid (Fibroteam S2010/BMD-2321, S2010/BMD-2378). Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM) to AO, Programa Estabilizacion Investigadores to LB-C, Miguel Servet to ABS, Sara Borrell to BS, MDSN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroeira LS, 2008, PERITON DIALYSIS INT, V28, pS29; Sanz AB, 2011, KIDNEY INT, V80, P708, DOI 10.1038/ki.2011.180; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; Blake PG, 2010, PERITON DIALYSIS INT, V30, P391, DOI 10.3747/pdi.2010.00142; Blanco-Colio LM, 2007, ARTERIOSCL THROM VAS, V27, P916, DOI 10.1161/01.ATV.0000258972.10109.ff; Brauner A, 1996, AM J KIDNEY DIS, V27, P402, DOI 10.1016/S0272-6386(96)90364-9; Campbell S, 2004, FRONT BIOSCI-LANDMRK, V9, P2273, DOI 10.2741/1395; Catalan MP, 2003, KIDNEY INT, V64, P321, DOI 10.1046/j.1523-1755.2003.00062.x; Chicheportiche Y, 2002, ARTHRITIS RES, V4, P126, DOI 10.1186/ar388; Cina D, 2009, NEPHROL DIAL TRANSPL, V24, P448, DOI 10.1093/ndt/gfn498; DASGUPTA MK, 1994, KIDNEY INT, V46, P475, DOI 10.1038/ki.1994.297; del Peso G, 2008, KIDNEY INT, V73, pS26, DOI 10.1038/sj.ki.5002598; Desplat-Jego S, 2002, J NEUROIMMUNOL, V133, P116, DOI 10.1016/S0165-5728(02)00368-5; Sanchez-Nino MD, 2010, J AM SOC NEPHROL, V21, P610, DOI 10.1681/ASN.2009020227; Sanchez-Nino MD, 2009, J AM SOC NEPHROL, V20, P353, DOI 10.1681/ASN.2008020194; Flessner MF, 2007, CLIN NEPHROL, V68, P341; Harada N, 2002, BIOCHEM BIOPH RES CO, V299, P488, DOI 10.1016/S0006-291X(02)02670-0; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Lai KN, 2010, NEPHRON CLIN PRACT, V116, pC11, DOI 10.1159/000314544; Loureiro J, 2011, J AM SOC NEPHROL, V22, P1682, DOI 10.1681/ASN.2010111197; Margetts PJ, 2002, AM J PATHOL, V160, P2285, DOI 10.1016/S0002-9440(10)61176-5; Margetts PJ, 2001, J AM SOC NEPHROL, V12, P2029, DOI 10.1681/ASN.V12102029; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; Merkle M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/709673; Michaelson JS, 2012, J AUTOIMMUN, V39, P130, DOI 10.1016/j.jaut.2012.05.003; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Munoz-Garcia B, 2011, CARDIOVASC RES, V89, P225, DOI 10.1093/cvr/cvq278; Munoz-Garcia B, 2009, ARTERIOSCL THROM VAS, V29, P2061, DOI 10.1161/ATVBAHA.109.194852; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Santamaria B, 2006, NEPHROL DIAL TRANSPL, V21, pii12; Santamaria B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006634; Sanz AB, 2009, J CELL MOL MED, V13, P3329, DOI 10.1111/j.1582-4934.2009.00766.x; Sanz AB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008955; Sanz AB, 2008, J AM SOC NEPHROL, V19, P695, DOI 10.1681/ASN.2007050577; Schwartz N, 2006, J AUTOIMMUN, V27, P242, DOI 10.1016/j.jaut.2006.12.003; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Xia YM, 2012, CLIN IMMUNOL, V145, P108, DOI 10.1016/j.clim.2012.08.008; Yilmaz MI, 2009, CLIN J AM SOC NEPHRO, V4, P1716, DOI 10.2215/CJN.02760409; Yung S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/484167; ZEMEL D, 1994, KIDNEY INT, V46, P1422, DOI 10.1038/ki.1994.414	43	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90399	10.1371/journal.pone.0090399	http://dx.doi.org/10.1371/journal.pone.0090399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599047	Green Submitted, Green Published, gold			2022-12-27	WOS:000332479400070
J	Carviel, JL; Wilson, DC; Isaacs, M; Carella, P; Catana, V; Golding, B; Weretilnyk, EA; Cameron, RK				Carviel, Jessie L.; Wilson, Daniel C.; Isaacs, Marisa; Carella, Philip; Catana, Vasile; Golding, Brian; Weretilnyk, Elizabeth A.; Cameron, Robin K.			Investigation of Intercellular Salicylic Acid Accumulation during Compatible and Incompatible Arabidopsis-Pseudomonas syringae Interactions Using a Fast Neutron-Generated Mutant Allele of EDS5 Identified by Genetic Mapping and Whole-Genome Sequencing	PLOS ONE			English	Article							AGE-RELATED RESISTANCE; ENHANCED DISEASE SUSCEPTIBILITY; DEFENSE RESPONSES; REVERSE GENETICS; AVIRULENCE GENE; PV. TOMATO; HYPERSENSITIVE RESPONSE; BASAL DEFENSE; THALIANA; LOCUS	A whole-genome sequencing technique developed to identify fast neutron-induced deletion mutations revealed that iap1-1 is a new allele of EDS5 (eds5-5). RPS2-AvrRpt2-initiated effector-triggered immunity (ETI) was compromised in iap1-1/eds5-5 with respect to in planta bacterial levels and the hypersensitive response, while intra-and intercellular free salicylic acid (SA) accumulation was greatly reduced, suggesting that SA contributes as both an intracellular signaling molecule and an antimicrobial agent in the intercellular space during ETI. During the compatible interaction between wild-type Col-0 and virulent Pseudomonas syringae pv. tomato (Pst), little intercellular free SA accumulated, which led to the hypothesis that Pst suppresses intercellular SA accumulation. When Col-0 was inoculated with a coronatine-deficient strain of Pst, high levels of intercellular SA accumulation were observed, suggesting that Pst suppresses intercellular SA accumulation using its phytotoxin coronatine. This work suggests that accumulation of SA in the intercellular space is an important component of basal/PAMP-triggered immunity as well as ETI to pathogens that colonize the intercellular space.	[Carviel, Jessie L.; Wilson, Daniel C.; Isaacs, Marisa; Carella, Philip; Catana, Vasile; Golding, Brian; Weretilnyk, Elizabeth A.; Cameron, Robin K.] McMaster Univ, Dept Biol, Hamilton, ON, Canada	McMaster University	Cameron, RK (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	rcamero@mcmaster.ca			Natural Sciences and Engineering Research Council of Canada; Ontario Research Excellence Fund; Ontario Graduate Scholarships; McMaster University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Research Excellence Fund; Ontario Graduate Scholarships(Ontario Graduate Scholarship); McMaster University	This research was funded by a Natural Sciences and Engineering Research Council of Canada grant to RKC, an Ontario Research Excellence Fund grant to EAW, Ontario Graduate Scholarships to DW and MI, and McMaster University for growth chamber maintenance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Agrios G. N., 2005, PLANT PATHOL; Ashelford K, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r28; Austin RS, 2011, PLANT J, V67, P715, DOI 10.1111/j.1365-313X.2011.04619.x; Bruggemann E, 1996, PLANT J, V10, P755, DOI 10.1046/j.1365-313X.1996.10040755.x; Cameron RK, 2004, PHYSIOL MOL PLANT P, V65, P197, DOI 10.1016/j.pmpp.2005.02.002; Cameron RK, 1999, PHYSIOL MOL PLANT P, V55, P121, DOI 10.1006/pmpp.1999.0214; Carviel JL, 2009, MOL PLANT PATHOL, V10, P621, DOI [10.1111/j.1364-3703.2009.00557.x, 10.1111/J.1364-3703.2009.00557.X]; Clarke JD, 2000, PLANT CELL, V12, P2175, DOI 10.1105/tpc.12.11.2175; Comai L, 2006, PLANT J, V45, P684, DOI 10.1111/j.1365-313X.2006.02670.x; Cuperus JT, 2010, P NATL ACAD SCI USA, V107, P466, DOI 10.1073/pnas.0913203107; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Torres M, 2006, PLANT J, V47, P368, DOI 10.1111/j.1365-313X.2006.02798.x; DeFraia CT, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-28; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Dempsey D'Maris Amick, 2011, Arabidopsis Book, V9, pe0156, DOI 10.1199/tab.0156; Develey-Riviere MP, 2007, NEW PHYTOL, V175, P405, DOI 10.1111/j.1469-8137.2007.02130.x; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Fragniere C, 2011, FEBS LETT, V585, P1847, DOI 10.1016/j.febslet.2011.04.039; Garcion C, 2008, PLANT PHYSIOL, V147, P1279, DOI 10.1104/pp.108.119420; Gassmann W, 1999, PLANT J, V20, P265, DOI 10.1046/j.1365-313X.1999.t01-1-00600.x; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Glazebrook J, 1996, GENETICS, V143, P973; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Henikoff S, 2003, ANNU REV PLANT BIOL, V54, P375, DOI 10.1146/annurev.arplant.54.031902.135009; Hinsch M, 1996, MOL PLANT MICROBE IN, V9, P55, DOI 10.1094/MPMI-9-0055; Huang WE, 2006, PLANT J, V46, P1073, DOI 10.1111/j.1365-313X.2006.02758.x; Hunter CA, 2003, PLANT PHYSIOL, V132, P2135, DOI 10.1104/pp.103.023309; Jagadeeswaran G, 2007, PLANT J, V51, P234, DOI 10.1111/j.1365-313X.2007.03130.x; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; Jing BB, 2011, PLANT PHYSIOL, V157, P973, DOI 10.1104/pp.111.182089; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; KOORNNEEF M, 1982, MUTAT RES, V93, P109, DOI 10.1016/0027-5107(82)90129-4; KUNKEL BN, 1993, PLANT CELL, V5, P865, DOI 10.1105/tpc.5.8.865; Kus JV, 2002, PLANT CELL, V14, P479, DOI 10.1105/tpc.010481; Lee MW, 2007, MOL PLANT MICROBE IN, V20, P1192, DOI 10.1094/MPMI-20-10-1192; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li X, 2001, PLANT J, V27, P235, DOI 10.1046/j.1365-313x.2001.01084.x; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; MA SW, 1991, MOL PLANT MICROBE IN, V4, P69, DOI 10.1094/MPMI-4-069; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Nobuta K, 2007, PLANT PHYSIOL, V144, P1144, DOI [10.1104/pp.107.097691, 10.1104/PP.107.097691]; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Pike SM, 2005, PLANT PHYSIOL, V138, P1009, DOI 10.1104/pp.104.047142; Rairdan GJ, 2002, GENETICS, V161, P803; Rogers C, 2009, PLANT PHYSIOL, V151, P1077, DOI 10.1104/pp.109.142919; Rogers EE, 1997, PLANT CELL, V9, P305, DOI 10.1105/tpc.9.3.305; Schneeberger K, 2011, TRENDS PLANT SCI, V16, P282, DOI 10.1016/j.tplants.2011.02.006; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Serrano M, 2013, PLANT PHYSIOL, V162, P1815, DOI 10.1104/pp.113.218156; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; van Wees S, 2008, CSH PROTOC, DOI [10.1101/pdb.prot4982, DOI 10.1101/PDB.PR0T4982]; Venugopal SC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000545; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Whalen MC, 2005, MOL PLANT PATHOL, V6, P347, DOI [10.1111/j.1364-3703.2005.00286.x, 10.1111/J.1364-3703.2005.00286.X]; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wolfe J, 2000, PHYSIOL MOL PLANT P, V56, P253, DOI 10.1006/pmpp.2000.0270; Yamasaki K, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23603; YU GL, 1993, MOL PLANT MICROBE IN, V6, P434, DOI 10.1094/MPMI-6-434; Zabala MD, 2009, PLANT J, V59, P375, DOI 10.1111/j.1365-313X.2009.03875.x; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zheng XY, 2012, CELL HOST MICROBE, V11, P587, DOI 10.1016/j.chom.2012.04.014; Zheng ZY, 2009, PLANT J, V57, P1040, DOI 10.1111/j.1365-313X.2008.03747.x; Zhu Y, 2012, GENETICS, V192, P139, DOI 10.1534/genetics.112.141986	74	16	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e88608	10.1371/journal.pone.0088608	http://dx.doi.org/10.1371/journal.pone.0088608			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594657	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500006
J	Li, ZJ; Tu, M; Han, B; Gu, YQ; Xue, XF; Sun, J; Ge, QQ; Miao, Y; Qian, ZY; Gao, WT				Li, Zhanjun; Tu, Min; Han, Bei; Gu, Yuqing; Xue, Xiaofeng; Sun, Jie; Ge, Qianqian; Miao, Yi; Qian, Zhuyin; Gao, Wentao			Vasohibin 2 Decreases the Cisplatin Sensitivity of Hepatocarcinoma Cell Line by Downregulating p53	PLOS ONE			English	Article							NEGATIVE FEEDBACK REGULATOR; HEPATOCELLULAR-CARCINOMA; ANGIOGENESIS INHIBITOR; RESISTANCE; ENDOTHELIUM; EXPRESSION; CANCER; LIVER; GENE; DIFFERENTIATION	Hepatocellular carcinoma (HCC) is a prevalent problem worldwide. Chemotherapy, especially cisplatin (CDDP)-based systemic chemotherapy, is the best option for advanced liver cancer. However, CDDP resistance is becoming common and hindering the clinical application of CDDP. Meanwhile, no consensus has been reached regarding the chemotherapeutic use of vasohibin 2 (VASH2), which promotes the angiogenesis and proliferation of cancer cells. In this work, a tissue microarray was used to observe VASH2 and its possible role in cancer treatment. Results showed that VASH2 was highly expressed in HCC tissues and was significantly correlated with cancer differentiation. To further investigate the efficacy and mechanism of the combination of VASH2 with anti-cancer drugs in liver cancer cells, we stably built VASH2 overexpression and knockdown cell lines. We found that VASH2 can influence the CDDP sensitivity and that the cell overexpression of VASH2 had a higher cell viability and lower apoptosis rate after CDDP exposure. We also observed that VASH2 overexpression downregulated wild-type p53, as well as suppressed the expression of the pro-apoptotic protein BCL2-associated X protein (Bax) and cleaved caspase-3 (CC-3) after treatment by CDDP. Conversely, the knockdown of VASH2 significantly inhibited these effects. In an in vivo chemosensitivity study, nude mice were subcutaneously injected with tumor cells and received CDDP treatment through intraperitoneal administration every 3 days. We found that VASH2 knockdown markedly limited the tumor growth and enhanced the CDDP toxicity and apoptosis of tumor cells. Western blot analysis revealed that tumor cells with downregulated VASH2 had a higher expression of wild-type p53, Bax, and CC-3 than control cells. Overall, our results indicated the novel roles of VASH2 in the chemoresistance of hepatocarcinoma cells to CDDP and suggested that VASH2 may be a promising anticancer target.	[Li, Zhanjun; Tu, Min; Ge, Qianqian; Miao, Yi] Nanjing Med Univ, Affiliated Hosp 1, Lab Gen Surg, Nanjing, Jiangsu, Peoples R China; [Miao, Yi; Qian, Zhuyin; Gao, Wentao] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Han, Bei] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Gu, Yuqing] Taicang City First Peoples Hosp, Dept Gen Surg, Suzhou, Peoples R China; [Xue, Xiaofeng] Suzhou Univ, Affiliated Hosp 1, Dept Gen Surg, Suzhou 215006, Peoples R China; [Sun, Jie] Fuyang Peoples Hosp, Dept Gen Surg, Fuyang, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Soochow University - China	Qian, ZY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.	qianzhusilver@163.com; gao11@hotmail.com			National Nature Science Foundation of China [81172267]; Public Welfare Industry of Health [201202007]; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Welfare Industry of Health; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grants from the National Nature Science Foundation of China (No. 81172267), the Public Welfare Industry of Health (No. 201202007) and the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU and the Priority Academic Program Development of Jiangsu Higher Education Institutions (JX10231801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Chang CL, 2013, CANCER RES, V73, P119, DOI 10.1158/0008-5472.CAN-12-2225; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Dror N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073625; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandez-Sanchez M, 2006, MED ONCOL, V23, P171, DOI 10.1385/MO:23:2:171; Fuertes MA, 2003, CURR MED CHEM, V10, P257, DOI 10.2174/0929867033368484; Geng W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027362; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gu B, 2012, INT J BIOL SCI, V8, P672, DOI 10.7150/ijbs.4283; Gully CP, 2012, P NATL ACAD SCI USA, V109, pE1513, DOI 10.1073/pnas.1110287109; Hosaka T, 2009, AM J PATHOL, V175, P430, DOI 10.2353/ajpath.2009.080788; Hu RZ, 2011, CANCER RES, V71, P6524, DOI 10.1158/0008-5472.CAN-11-0853; Huang JT, 2013, J CANCER RES CLIN, V139, P1709, DOI 10.1007/s00432-013-1497-y; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kataria H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055316; Kimura H, 2009, BLOOD, V113, P4810, DOI 10.1182/blood-2008-07-170316; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lin XJ, 2001, CANCER RES, V61, P1508; Liu CL, 2013, MAR DRUGS, V11, P50, DOI 10.3390/md11010050; Martinez-Becerra P, 2012, MOL PHARMACEUT, V9, P1693, DOI 10.1021/mp300028a; Sato Y, 2007, ARTERIOSCL THROM VAS, V27, P37, DOI 10.1161/01.ATV.0000252062.48280.61; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Shen ZL, 2012, MED ONCOL, V29, P2718, DOI 10.1007/s12032-012-0212-1; Shibuya T, 2006, ARTERIOSCL THROM VAS, V26, P1051, DOI 10.1161/01.ATV.0000216747.66660.26; Shimizu K, 2005, BIOCHEM BIOPH RES CO, V327, P700, DOI 10.1016/j.bbrc.2004.12.073; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sun J, 2013, INT J ONCOL, V43, P255, DOI 10.3892/ijo.2013.1919; Takahashi Y, 2012, MOL CANCER RES, V10, P1135, DOI 10.1158/1541-7786.MCR-12-0098-T; Tamaki K, 2009, CANCER SCI, V100, P88, DOI 10.1111/j.1349-7006.2008.01015.x; Terry S, 2013, NEOPLASIA, V15, P761, DOI 10.1593/neo.122070; Vashchenko N, 2005, EUR UROL, V47, P147, DOI 10.1016/j.eururo.2004.09.007; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang G, 2004, CELL RES, V14, P303, DOI 10.1038/sj.cr.7290375; Warnock LJ, 2011, CANCER BIOL THER, V12, P1059, DOI 10.4161/cbt.12.12.18141; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Woo HG, 2011, GASTROENTEROLOGY, V140, P1063, DOI 10.1053/j.gastro.2010.11.034; Xue X, 2013, ONCOGENE, V32, P1724, DOI 10.1038/onc.2012.177; Xylinas E, 2013, EUR J CANCER, V49, P1889, DOI 10.1016/j.ejca.2013.02.001; Yoshinaga K, 2011, CANCER SCI, V102, P446, DOI 10.1111/j.1349-7006.2010.01812.x; Zhang Y, 2013, J HEPATOL, V59, P1255, DOI 10.1016/j.jhep.2013.07.009	44	13	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90358	10.1371/journal.pone.0090358	http://dx.doi.org/10.1371/journal.pone.0090358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595063	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500044
J	Mao, JJ; Zhao, Y; She, RP; Cao, BB; Xiao, P; Wu, QX; Guo, ZJ; Ma, LH; Soomro, MH				Mao, Jingjing; Zhao, Yue; She, Ruiping; Cao, Binbin; Xiao, Peng; Wu, Qiaoxing; Guo, Zhaojie; Ma, Longhuan; Soomro, Majid Hussain			Detection and Localization of Rabbit Hepatitis E Virus and Antigen in Systemic Tissues from Experimentally Intraperitoneally Infected Rabbits	PLOS ONE			English	Article							GENETIC IDENTIFICATION; CYNOMOLGUS MACAQUES; HEV INFECTION; UNITED-STATES; SWINE; REPLICATION; DIAGNOSIS; PREVALENT; CHICKENS; STRAINS	Rabbit hepatitis E virus (HEV) is a novel genotype of HEV, and is considered to pose a risk of zoonotic transmission. Research into the systemic distribution of rabbit HEV in rabbits during different periods of infection has rarely been reported. To better understand this virus, we infected rabbits with second-passage rabbit HEV via an intraperitoneal route. After inoculation, the infection showed two types, temporary and constant infection. The detection of HEV RNA in the feces varied with time, and serum antigen correlated with fecal HEV RNA. Viremia only appeared 72 days after inoculation. The rabbits remained antibody negative throughout the experimental period. When HEV was localized, several organs besides the liver were HEV RNA positive. Tissue antigen was observed immunohistochemically in the different cells of various organs, especially in parts of the small intestine and the characteristic rabbit gut-associated lymphoid tissue. These data provide valuable information for future research into the pathogenesis of HEV.	[Mao, Jingjing; Zhao, Yue; She, Ruiping; Cao, Binbin; Xiao, Peng; Wu, Qiaoxing; Guo, Zhaojie; Ma, Longhuan; Soomro, Majid Hussain] China Agr Univ, Key Lab Zoonosis, Lab Vet Pathol & Publ Hlth, Dept Vet Pathol,Coll Vet Med,Minist Agr, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	She, RP (corresponding author), China Agr Univ, Key Lab Zoonosis, Lab Vet Pathol & Publ Hlth, Dept Vet Pathol,Coll Vet Med,Minist Agr, Beijing 100094, Peoples R China.	sheruiping@126.com	Ma, Longhuan/AGL-2659-2022		National Natural Science Foundation of China [31072110, 31272515]; Program for Changjiang Scholars and Innovative Research Team in University of China [IRT0866]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (Grant No. 31072110, 31272515), and the Program for Changjiang Scholars and Innovative Research Team in University of China (Grant No. IRT0866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari IH, 2000, J MED VIROL, V60, P275, DOI 10.1002/(SICI)1096-9071(200003)60:3<275::AID-JMV5>3.3.CO;2-0; Beyaz F, 2010, VET RES COMMUN, V34, P255, DOI 10.1007/s11259-010-9349-6; Billam P, 2005, J VIROL, V79, P3429, DOI 10.1128/JVI.79.6.3429-3437.2005; Cossaboom CM, 2011, EMERG INFECT DIS, V17, P2047, DOI 10.3201/eid1711.110428; Geng YS, 2011, INFECT GENET EVOL, V11, P476, DOI 10.1016/j.meegid.2010.12.012; Haqshenas G, 2001, J GEN VIROL, V82, P2449, DOI 10.1099/0022-1317-82-10-2449; Huang F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-93; Huang FF, 2002, J CLIN MICROBIOL, V40, P1326, DOI 10.1128/JCM.40.4.1326-1332.2002; Huang YW, 2007, J VIROL, V81, P3018, DOI 10.1128/JVI.02259-06; Izopet J, 2012, EMERG INFECT DIS, V18, P1274, DOI 10.3201/eid1808.120057; Johne R, 2010, EMERG INFECT DIS, V16, P1452, DOI 10.3201/eid1609.100444; Lhomme S, 2013, J CLIN VIROLOGY; Li TC, 2001, VACCINE, V19, P3476, DOI 10.1016/S0264-410X(01)00059-7; Liu P, 2013, EMERG INFECT DIS, V19, P559, DOI 10.3201/eid1904.120827; Ma HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009160; Meng XJ, 1998, ARCH VIROL, V143, P1405, DOI 10.1007/s007050050384; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; NANDA SK, 1995, GASTROENTEROLOGY, V108, P225, DOI 10.1016/0016-5085(95)90028-4; Purcell R.H., 2001, FIELDS VIROLOGY, P3051; Purdy MA, 1993, HEPATITIS E VIRUS NO, P319; Purdy MA, 2011, VIRUS RES, V161, P31, DOI 10.1016/j.virusres.2011.04.030; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; Sonoda H, 2004, J CLIN MICROBIOL, V42, P5371, DOI 10.1128/JCM.42.11.5371-5374.2004; Takahashi M, 2011, J GEN VIROL, V92, P902, DOI 10.1099/vir.0.029470-0; TSAREV SA, 1994, J MED VIROL, V43, P135, DOI 10.1002/jmv.1890430207; van Cuyck-Gandre H, 1998, J MED VIROL, V55, P197, DOI 10.1002/(SICI)1096-9071(199807)55:3<197::AID-JMV3>3.0.CO;2-X; Williams TPE, 2001, J CLIN MICROBIOL, V39, P3040, DOI 10.1128/JCM.39.9.3040-3046.2001; Zhang F, 2006, J MED VIROL, V78, P1441, DOI 10.1002/jmv.20717; Zhang J, 2003, J MED VIROL, V71, P518, DOI 10.1002/jmv.10523; Zhao CY, 2007, J MED VIROL, V79, P1966, DOI 10.1002/jmv.21040; Zhao CY, 2009, J MED VIROL, V81, P1371, DOI 10.1002/jmv.21536	31	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e88607	10.1371/journal.pone.0088607	http://dx.doi.org/10.1371/journal.pone.0088607			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594631	Green Submitted, Green Published, gold			2022-12-27	WOS:000332475500005
J	Vanyushkina, AA; Fisunov, GY; Gorbachev, AY; Kamashev, DE; Govorun, VM				Vanyushkina, Anna A.; Fisunov, Gleb Y.; Gorbachev, Alexey Y.; Kamashev, Dmitri E.; Govorun, Vadim M.			Metabolomic Analysis of Three Mollicute Species	PLOS ONE			English	Article							T-STRAIN MYCOPLASMA; ACHOLEPLASMA-LAIDLAWII; UREAPLASMA-UREALYTICUM; ESCHERICHIA-COLI; COMPLETE GENOME; GALLISEPTICUM; PROTEIN; PATHOGENICITY; SPIROPLASMA; DATABASE	We present a systematic study of three bacterial species that belong to the class Mollicutes, the smallest and simplest bacteria, Spiroplasma melliferum, Mycoplasma gallisepticum, and Acholeplasma laidlawii. To understand the difference in the basic principles of metabolism regulation and adaptation to environmental conditions in the three species, we analyzed the metabolome of these bacteria. Metabolic pathways were reconstructed using the proteogenomic annotation data provided by our lab. The results of metabolome, proteome and genome profiling suggest a fundamental difference in the adaptation of the three closely related Mollicute species to stress conditions. As the transaldolase is not annotated in Mollicutes, we propose variants of the pentose phosphate pathway catalyzed by annotated enzymes for three species. For metabolite detection we employed high performance liquid chromatography coupled with mass spectrometry. We used liquid chromatography method - hydrophilic interaction chromatography with silica column - as it effectively separates highly polar cellular metabolites prior to their detection by mass spectrometer.	[Vanyushkina, Anna A.; Fisunov, Gleb Y.; Gorbachev, Alexey Y.; Kamashev, Dmitri E.; Govorun, Vadim M.] Russian Inst Physicochem Med, Moscow, Russia; [Kamashev, Dmitri E.] Russian Res Ctr, Kurchatov Inst, Moscow, Russia; [Govorun, Vadim M.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Govorun, Vadim M.] State Univ, Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia	National Research Centre - Kurchatov Institute; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Moscow Institute of Physics & Technology	Kamashev, DE (corresponding author), Russian Inst Physicochem Med, Moscow, Russia.	dkamashev@gmail.com	Govorun, Vadim M/A-9043-2018; Kamashev, Dmitri/K-6560-2017; Gorbachev, Alexey/ABH-4273-2020	Kamashev, Dmitri/0000-0003-4158-5300; Gorbachev, Alexey/0000-0002-2743-5835	Russian Foundation for Basic Research (RFBR) [12-04-31696]; Russian Science Foundation [14-24-00159] Funding Source: Russian Science Foundation	Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by a Grant (12-04-31696) from Russian Foundation for Basic Research (RFBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJELLO F, 1977, B I SIEROTER MILAN, V56, P343; Alexeev D, 2012, J PROTEOME RES, V11, P224, DOI 10.1021/pr2008626; Boer VM, 2010, MOL BIOL CELL, V21, P198, DOI 10.1091/mbc.E09-07-0597; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; Castanie-Cornet MP, 2001, MICROBIOL-UK, V147, P709, DOI 10.1099/00221287-147-3-709; Chernov VM, 2007, DOKL BIOCHEM BIOPHYS, V413, P57, DOI 10.1134/S1607672907020056; Cocaign-Bousquet M, 2002, APPL MICROBIOL BIOT, V60, P24, DOI 10.1007/s00253-002-1065-x; COLE RM, 1973, J BACTERIOL, V115, P367, DOI 10.1128/JB.115.1.367-386.1973; David SAW, 2010, APPL ENVIRON MICROB, V76, P2718, DOI 10.1128/AEM.02776-09; Folmsbee M, 2010, BIOLOGICALS, V38, P214, DOI 10.1016/j.biologicals.2009.11.001; Gorbachev AY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-726; HAHN RG, 1974, J BACTERIOL, V117, P611, DOI 10.1128/JB.117.2.611-618.1974; Kamashev D, 2011, BIOCHEMISTRY-US, V50, P8692, DOI 10.1021/bi2009097; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; KARADSHEH NS, 1973, BIOCHIM BIOPHYS ACTA, V327, P66, DOI 10.1016/0005-2744(73)90104-6; Laidlaw PP, 1936, PROC R SOC SER B-BIO, V120, P292, DOI 10.1098/rspb.1936.0036; Lazarev VN, 2011, J BACTERIOL, V193, P4943, DOI 10.1128/JB.05059-11; LEACH RH, 1967, ANN NY ACAD SCI, V143, P305, DOI 10.1111/j.1749-6632.1967.tb27670.x; Lee IM, 2000, ANNU REV MICROBIOL, V54, P221, DOI 10.1146/annurev.micro.54.1.221; Lehninger A, 2008, PRINCIOALS BIOL; Levitskiy SA, 2011, BIOCHIMIE, V93, P1102, DOI 10.1016/j.biochi.2011.03.005; Ley D., 2003, MYCOPLASMA GALLISEPT; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Maharjan RP, 2003, ANAL BIOCHEM, V313, P145; Maier T, 2013, MOL BIOSYST, V9, P1743, DOI 10.1039/c3mb70113a; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Moat A.G., 2002, MICROBIAL PHYSL; Papazisi L, 2003, MICROBIOL-SGM, V149, P2307, DOI 10.1099/mic.0.26427-0; Pereyre S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000677; POLLACK JD, 1986, J BACTERIOL, V165, P53, DOI 10.1128/jb.165.1.53-60.1986; POLLACK JD, 1983, YALE J BIOL MED, V56, P709; PONTREMO.S, 1965, J BIOL CHEM, V240, P3459; RAZIN S, 1964, J DENT RES, V43, P402, DOI 10.1177/00220345640430031101; Razin S, 1973, Adv Microb Physiol, V10, P1, DOI 10.1016/S0065-2911(08)60086-7; ROBERTSON J, 1976, J BACTERIOL, V128, P658, DOI 10.1128/JB.128.2.658-660.1976; Rohdich F, 2002, P NATL ACAD SCI USA, V99, P1158, DOI 10.1073/pnas.032658999; SCHIEFER HG, 1974, J BACTERIOL, V120, P81, DOI 10.1128/JB.120.1.81-88.1974; Scripal IG, 1988, MICROORGANISMS AGENT; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; STIPKOVITS L, 1979, ZBL BAKT-INT J MED M, V245, P171; Tautenhahn R, 2012, NAT BIOTECHNOL, V30, P826, DOI 10.1038/nbt.2348; TERRY TM, 1973, BIOCHIM BIOPHYS ACTA, V291, P144, DOI 10.1016/0005-2736(73)90069-2; TULLY JG, 1977, SCIENCE, V195, P892, DOI 10.1126/science.841314; Urano K, 2010, CURR OPIN PLANT BIOL, V13, P132, DOI 10.1016/j.pbi.2009.12.006; van der Greef J, 2004, CURR OPIN CHEM BIOL, V8, P559, DOI 10.1016/j.cbpa.2004.08.013; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308; Vogl G, 2008, INFECT IMMUN, V76, P71, DOI 10.1128/IAI.00871-07; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263	49	19	20	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89312	10.1371/journal.pone.0089312	http://dx.doi.org/10.1371/journal.pone.0089312			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595068	Green Submitted, gold, Green Published			2022-12-27	WOS:000332475500012
J	Alcantara, S; Ree, RH; Martins, FR; Lohmann, LG				Alcantara, Suzana; Ree, Richard H.; Martins, Fernando R.; Lohmann, Lucia G.			The Effect of Phylogeny, Environment and Morphology on Communities of a Lianescent Clade (Bignonieae-Bignoniaceae) in Neotropical Biomes	PLOS ONE			English	Article							FUNCTIONAL TRAITS; RELATIVE IMPORTANCE; SEED PLANTS; EVOLUTION; ECOLOGY; POLLINATION; DIVERSITY; DIVERSIFICATION; BIOGEOGRAPHY; CONVERGENCE	The influence of ecological traits to the distribution and abundance of species is a prevalent issue in biodiversity science. Most studies of plant community assembly have focused on traits related to abiotic aspects or direct interactions among plants, with less attention paid to ignore indirect interactions, as those mediated by pollinators. Here, we assessed the influence of phylogeny, habitat, and floral morphology on ecological community structure in a clade of Neotropical lianas (tribe Bignonieae, Bignoniaceae). Our investigation was guided by the long-standing hypothesis that habitat specialization has promoted speciation in Bignonieae, while competition for shared pollinators influences species co-occurrence within communities. We analyzed a geo-referenced database for 94 local communities occurring across the Neotropics. The effect of floral morphological traits and abiotic variables on species co-occurrence was investigated, taking into account phylogenetic relationships. Habitat filtering seems to be the main process driving community assembly in Bignonieae, with environmental conditions limiting species distributions. Differing specialization to abiotic conditions might have evolved recently, in contrast to the general pattern of phylogenetic clustering found in communities of other diverse regions. We find no evidence that competition for pollinators affects species co-occurrence; instead, pollinator occurrence seems to have acted as an "environmental filter'' in some habitats.	[Alcantara, Suzana; Lohmann, Lucia G.] Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, Brazil; [Alcantara, Suzana; Ree, Richard H.] Field Museum Nat Hist, Dept Bot, Chicago, IL 60605 USA; [Martins, Fernando R.] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Vegetal, Campinas, SP, Brazil	Universidade de Sao Paulo; Field Museum of Natural History (Chicago); Universidade de Sao Paulo; Universidade Estadual de Campinas	Alcantara, S (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	suzanaalcantara@gmail.com; llohmann@usp.br	Lohmann, Lucia G./AAF-7259-2021; Martins, Fernando R./F-5652-2012; Fapesp, Biota/F-8655-2017; Alcantara, Suzana/J-8225-2012	Lohmann, Lucia G./0000-0003-4960-0587; Martins, Fernando R./0000-0002-3068-7099; Fapesp, Biota/0000-0002-9887-8449; Alcantara, Suzana/0000-0001-9666-460X	FAPESP [2006/59916-0]; CCSD-Missouri Botanical Garden: Elizabeth E. Bascom Fellowships for Latin American Female Botanists	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CCSD-Missouri Botanical Garden: Elizabeth E. Bascom Fellowships for Latin American Female Botanists	This study has been funded by FAPESP: doctoral grant 2006/59916-0; and CCSD-Missouri Botanical Garden: Elizabeth E. Bascom Fellowships for Latin American Female Botanists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 1999, AM J BOT, V86, P1272, DOI 10.2307/2656775; Ackerly DD, 2003, INT J PLANT SCI, V164, pS1, DOI 10.1086/374729; Alcantara S, 2013, J EVOLUTION BIOL, V26, DOI 10.1111/jeb.12228; Alcantara S, 2011, BIOL J LINN SOC, V102, P378, DOI 10.1111/j.1095-8312.2010.01567.x; Alcantara S, 2010, AM J BOT, V97, P782, DOI 10.3732/ajb.0900182; [Anonymous], 1986, MULTIVARIATE STAT ME; Becerra JX, 2007, P NATL ACAD SCI USA, V104, P7483, DOI 10.1073/pnas.0608253104; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Buzato S, 2000, BIOTROPICA, V32, P824, DOI 10.1111/j.1744-7429.2000.tb00621.x; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Diamond J.M., 1975, P342; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Eaton DAR, 2012, ECOLOGY, V93, pS182, DOI 10.1890/11-0501.1; Environmental Systems Research Institute Inc. (ESRI), 2005, ARCGIS 9 1; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fine PVA, 2005, EVOLUTION, V59, P1464; GENTRY A H, 1974, Biotropica, V6, P64, DOI 10.2307/2989698; GENTRY A H, 1990, Memoirs of the New York Botanical Garden, V55, P118; GENTRY AH, 1974, ANN MO BOT GARD, V61, P728, DOI 10.2307/2395026; Gotelli NJ, 2003, ECOLOGY, V84, P532, DOI 10.1890/0012-9658(2003)084[0532:SAINMA]2.0.CO;2; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Hegland SJ, 2009, ECOL RES, V24, P929, DOI 10.1007/s11284-008-0572-3; HILL MO, 1976, TAXON, V25, P249, DOI 10.2307/1219449; Kay KM, 2009, ANNU REV ECOL EVOL S, V40, P637, DOI 10.1146/annurev.ecolsys.110308.120310; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Lohmann LG, 2006, AM J BOT, V93, P304, DOI 10.3732/ajb.93.2.304; Lohmann LG, 2014, ANN MISSOUR IN PRESS; Lohmann LG, 2003, THESIS U MISSOURI ST; Lohmann LG, 2013, BOT J LINN SOC, V171, P154, DOI 10.1111/j.1095-8339.2012.01311.x; Losos JB, 2003, NATURE, V424, P542, DOI 10.1038/nature01814; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; McCarthy MC, 2007, INT J PLANT SCI, V168, P751, DOI 10.1086/513491; MICHENER CD, 1979, ANN MO BOT GARD, V66, P277, DOI 10.2307/2398833; Moeller DA, 2004, ECOLOGY, V85, P3289, DOI 10.1890/03-0810; Nuismer SL, 2013, EVOLUTION, V67, P338, DOI 10.1111/j.1558-5646.2012.01801.x; Oliver P, 2002, GLOBAL PATTERNS PLAN; Olmstead RG, 2009, AM J BOT, V96, P1731, DOI 10.3732/ajb.0900004; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pausas JG, 2008, ECOLOGY, V89, P2181, DOI 10.1890/07-1737.1; Pausas JG, 2010, BIOSCIENCE, V60, P614, DOI 10.1525/bio.2010.60.8.7; Pennington RT, 2009, ANNU REV ECOL EVOL S, V40, P437, DOI 10.1146/annurev.ecolsys.110308.120327; PLEASANTS JM, 1980, ECOLOGY, V61, P1446, DOI 10.2307/1939053; Ricklefs RE, 2006, ECOLOGY, V87, pS3, DOI 10.1890/0012-9658(2006)87[3:EDATOO]2.0.CO;2; Sargent RD, 2008, TRENDS ECOL EVOL, V23, P123, DOI 10.1016/j.tree.2007.11.003; Sargent RD, 2011, AM J BOT, V98, P283, DOI 10.3732/ajb.1000329; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Sokal R.R., 2012, BIOMETRY; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Vamosi JC, 2006, P NATL ACAD SCI USA, V103, P956, DOI 10.1073/pnas.0507165103; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Walsh R.P.D., 1996, PW RICHARDS 1996 TRO, P159; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WEBB CO, 2008, PHYLOCOM SOFTWARE AN; Weiher E, 1998, OIKOS, V81, P309, DOI 10.2307/3547051; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011	64	11	11	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90177	10.1371/journal.pone.0090177	http://dx.doi.org/10.1371/journal.pone.0090177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594706	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900076
J	Chakraborty, S; Alhazzaa, M; Wasserman, JK; Sun, YY; Stotts, G; Hogan, MJ; Demchuk, A; Aviv, RI; Dowlatshahi, D				Chakraborty, Santanu; Alhazzaa, Mohammed; Wasserman, Jason K.; Sun, Yang Yang; Stotts, Grant; Hogan, Mathew J.; Demchuk, Andrew; Aviv, Richard I.; Dowlatshahi, Dar			Dynamic Characterization of the CT Angiographic 'Spot Sign'	PLOS ONE			English	Article							PRIMARY INTRACEREBRAL HEMORRHAGE; HEMATOMA EXPANSION; POSTCONTRAST CT; EXTRAVASATION	Background and purpose: Standard (static) CT angiography is used to identify the intracerebral hemorrhage (ICH) spot sign. We used dynamic CT-angiography to describe spot sign characteristics and measurement parameters over 60-seconds of image acquisition. Methods: We prospectively identified consecutive patients presenting with acute ICH within 4.5 hours of symptom onset, and collected whole brain dynamic CT-angiography (dCTA). Spot parameters (earliest appearance, duration, maximum Hounsfield unit (HU), time to maximum HU, time to spot diagnostic definition, spot volume and hematoma volumes) were measured using volumetric analysis software. Result: We enrolled 34 patients: three were excluded due to secondary causes of ICH. Of the remaining 31 patients there were 18 females (58%) with median age 70 (range 47-86) and baseline hematoma volume 33 ml (range 0.7-103 ml). Positive dCTA spot sign was present in 13 patients (42%) visualized as an expanding 3-dimensional structure temporally evolving its morphology over the scan period. Median time to spot appearance was 21 s (range 15-35 seconds). This method allowed tracking of spots evolution until the end of venous phase (active extravasation) with median duration of 39 s (range 25-45 seconds). The average density and time to maximum density was 204HU and 30.8 s (range 23-31 s) respectively. Median time to spot diagnosis was 20.8 s using either 100 or 120HU definitions. Conclusion: Dynamic CTA allows a 3-dimensional assessment of spot sign formation during acute ICH, and captured higher spot sign prevalence than previously reported. This is the first study to describe and quantify spot sign characteristics using dCTA; these can be used in ongoing and upcoming ICH studies.	[Chakraborty, Santanu] Ottawa Hosp Res Inst, Div Neuroradiol, Dept Med Imaging, Ottawa, ON, Canada; [Chakraborty, Santanu; Alhazzaa, Mohammed; Wasserman, Jason K.; Sun, Yang Yang; Stotts, Grant; Hogan, Mathew J.; Dowlatshahi, Dar] Univ Ottawa, Ottawa, ON K1N 6N5, Canada; [Alhazzaa, Mohammed; Sun, Yang Yang; Stotts, Grant; Hogan, Mathew J.; Dowlatshahi, Dar] Ottawa Hosp Res Inst, Dept Med, Ottawa, ON, Canada; [Dowlatshahi, Dar] Ottawa Hosp Res Inst, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Wasserman, Jason K.] Ottawa Hosp Res Inst, Dept Pathol, Ottawa, ON, Canada; [Alhazzaa, Mohammed] King Fahad Med City, Dept Neurol, Riyadh, Saudi Arabia; [Aviv, Richard I.] Univ Toronto, Div Neuroradiol, Toronto, ON, Canada; [Aviv, Richard I.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med Imaging, Toronto, ON, Canada; [Demchuk, Andrew] Calgary Hlth Reg, Foothills Med Ctr, Dept Clin Neurosci, Calgary, AB, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; King Fahad Medical City; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Calgary	Chakraborty, S (corresponding author), Ottawa Hosp Res Inst, Div Neuroradiol, Dept Med Imaging, Ottawa, ON, Canada.	santanoo@gmail.com	Alhazzaa, Mohammed/AAO-9581-2020; Demchuk, Andrew M/E-1103-2012; Hogan, Matthew/AAP-4735-2020	Demchuk, Andrew M/0000-0002-4930-7789; Hogan, Matthew/0000-0003-4660-8743; Dowlatshahi, Dar/0000-0003-1379-3612; Wasserman, Jason/0000-0003-3821-8956	Heart and Stroke Foundation of Ontario; Department of Medicine, University of Ottawa; Heart and Stroke Foundation of Canada	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Department of Medicine, University of Ottawa; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This study was funded by a Heart and Stroke Foundation of Ontario grant (DD and SC are Co-Principal Investigators), and by the Department of Medicine (DD), University of Ottawa. DD is supported by a New Investigator Award from the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almandoz JED, 2009, STROKE, V40, P2994, DOI 10.1161/STROKEAHA.109.554667; Becker KJ, 1999, STROKE, V30, P2025, DOI 10.1161/01.STR.30.10.2025; Chakraborty S, 2011, CASE REP NEUROL, V3, P154, DOI 10.1159/000330304; Chakraborty S, 2010, BRIT J RADIOL, V83, pE216, DOI 10.1259/bjr/74416385; Demchuk AM, 2012, LANCET NEUROL, V11, P307, DOI 10.1016/S1474-4422(12)70038-8; Dowlatshahi D, 2014, STROKE, V45, P277, DOI 10.1161/STROKEAHA.113.003387; Dowlatshahi D, 2013, LANCET, V381, P152, DOI 10.1016/S0140-6736(12)60829-0; Dowlatshahi D, 2012, STROKE, V43, P1961, DOI 10.1161/STROKEAHA.112.654970; Ederies A, 2009, STROKE, V40, P1672, DOI 10.1161/STROKEAHA.108.541201; Koculym A, 2013, AM J NEURORADIOL, V34, P965, DOI 10.3174/ajnr.A3338; Kosior JC, 2011, INT J STROKE, V6, P302, DOI 10.1111/j.1747-4949.2010.00579.x; Romero JM, 2012, NAT REV NEUROL, V8, P300, DOI 10.1038/nrneurol.2012.93; Salomon EJ, 2009, CLIN NEURORADIOL, V19, P187, DOI 10.1007/s00062-009-9019-7; Sun SJ, 2013, EUR RADIOL, V23, P1846, DOI 10.1007/s00330-013-2803-4; Thompson AL, 2009, CAN J NEUROL SCI, V36, P456, DOI 10.1017/S0317167100007782; Wada R, 2007, STROKE, V38, P1257, DOI 10.1161/01.STR.0000259633.59404.f3	16	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90431	10.1371/journal.pone.0090431	http://dx.doi.org/10.1371/journal.pone.0090431			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594897	gold, Green Submitted, Green Published			2022-12-27	WOS:000332468900109
J	Huang, YY; Harding, JCS				Huang, Yanyun; Harding, John C. S.			Attempted Experimental Reproduction of Porcine Periweaning-Failure-to-Thrive Syndrome Using Tissue Homogenates	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE PCR; EXPERIMENTAL-INFECTION; ASSAY; PIGS; DIFFERENTIATION; COLOSTRUM; TYPE-2; SERUM; MODEL; BIRTH	Porcine periweaning failure-to-thrive syndrome (PFTS) is characterized by anorexia and progressive debilitation of newly weaned pigs, of which some also demonstrate repetitive oral behaviour. Although no relevant porcine pathogens have been shown to be causally associated, inoculation of susceptible pigs using tissue homogenates is needed to rule out infectious etiologies. Eight snatched-farrowed porcine-colostrum-deprived (SF-pCD) pigs were inoculated with tissue homogenates made from PFTS-affected pigs orally, or combined orally, intraperitoneally (IP) and intramuscularly (IM) at day (D) 14 of age (INOC). On D21, IP and IM inoculation were repeated. Four sham-inoculated pigs served as control (CTRL). Three INOC pigs developed mixed bacterial septicemia between the first and second inoculation. All other pigs survived until termination on D49. Average daily gain (ADG) and the frequencies of diarrhea did not differ between INOC and CTRL pigs D14 and D29. Additionally, the progressive debilitation characteristic of PFTS was not observed in any pig, and repetitive oral behaviour was observed in both groups. In conclusion, PFTS was not experimentally reproduced by the current experimental approach providing evidence that PFTS may not have an infectious etiology.	[Huang, Yanyun; Harding, John C. S.] Univ Saskatchewan, Western Coll Vet Med, Dept Large Anim Clin Sci, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan	Harding, JCS (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Large Anim Clin Sci, Saskatoon, SK S7N 0W0, Canada.	John.harding@usask.ca			Saskatchewan Agricultural Development Fund [20090268]	Saskatchewan Agricultural Development Fund	This research was made possible with funding from Saskatchewan Agricultural Development Fund (www.agriculture.gov.sk.ca/ADF) (grant 20090268). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco I, 2004, VET MICROBIOL, V103, P21, DOI 10.1016/j.vetmic.2004.06.011; Butler JE, 2002, J IMMUNOL, V169, P6822, DOI 10.4049/jimmunol.169.12.6822; Chisholm SA, 2003, DIAGN MICR INFEC DIS, V46, P1, DOI 10.1016/S0732-8893(02)00547-3; Fowden AL, 1998, P NUTR SOC, V57, P113, DOI 10.1079/PNS19980017; Gagnon CA, 2008, J VET DIAGN INVEST, V20, P545, DOI 10.1177/104063870802000503; Hamel AL, 1999, J CLIN MICROBIOL, V37, P3767, DOI 10.1128/JCM.37.11.3767-3768.1999; Hellemans A, 2007, VET RES COMMUN, V31, P385, DOI 10.1007/s11259-006-3448-4; Huang YY, 2013, CAN J VET RES, V77, P81; Huang YY, 2012, J VET DIAGN INVEST, V24, P96, DOI 10.1177/1040638711425939; Huang YY, 2011, J SWINE HEALTH PROD, V19, P340; LAWRENCE AB, 1993, J ANIM SCI, V71, P2815, DOI 10.2527/1993.71102815x; MATTSSON JG, 1995, J CLIN MICROBIOL, V33, P893, DOI 10.1128/JCM.33.4.893-897.1995; McIntosh KA, 2009, VET MICROBIOL, V133, P23, DOI 10.1016/j.vetmic.2008.06.010; O'Sullivan TL, 2014, J SWINE HEALTH PROD, V22, P24; Oliveira S, 2003, CAN J VET RES, V67, P146; Pittman J. S., 2011, Evidence-based practice: how do we get there? American Association of Swine Veterinarians 42nd Annual Meeting Proceedings, 5-8 March, 2011, Phoenix, Arizona, USA, P367; Sangild PT, 1997, COMP BIOCHEM PHYS A, V118, P359, DOI 10.1016/S0300-9629(96)00319-2; Sekiguchi Y, 2004, J VET MED SCI, V66, P367, DOI 10.1292/jvms.66.367; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stelwagen K, 2009, J ANIM SCI, V87, P3, DOI 10.2527/jas.2008-1377; Tousignant S, 2013, 44 ANN M AM ASS SWIN, P421; Vemulapalli R, 2009, J VIROL METHODS, V162, P231, DOI 10.1016/j.jviromet.2009.08.016; Wang QH, 2005, EMERG INFECT DIS, V11, P1874, DOI 10.3201/eid1112.050485; Zell R, 2000, J VIROL METHODS, V88, P205, DOI 10.1016/S0166-0934(00)00189-0	24	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90065	10.1371/journal.pone.0090065	http://dx.doi.org/10.1371/journal.pone.0090065			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594806	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900063
J	Hulovatyy, Y; Solava, RW; Milenkovic, T				Hulovatyy, Yuriy; Solava, Ryan W.; Milenkovic, Tijana			Revealing Missing Parts of the Interactome via Link Prediction	PLOS ONE			English	Article							SCALE-FREE NETWORKS; PROTEIN-INTERACTION NETWORK; INTERACTION MAP; ALIGNMENT; TOPOLOGY; GENOMICS; BIOLOGY; YEAST	Protein interaction networks (PINs) are often used to "learn'' new biological function from their topology. Since current PINs are noisy, their computational de-noising via link prediction (LP) could improve the learning accuracy. LP uses the existing PIN topology to predict missing and spurious links. Many of existing LP methods rely on shared immediate neighborhoods of the nodes to be linked. As such, they have limitations. Thus, in order to comprehensively study what are the topological properties of nodes in PINs that dictate whether the nodes should be linked, we introduce novel sensitive LP measures that are expected to overcome the limitations of the existing methods. We systematically evaluate the new and existing LP measures by introducing "synthetic" noise into PINs and measuring how accurate the measures are in reconstructing the original PINs. Also, we use the LP measures to de-noise the original PINs, and we measure biological correctness of the de-noised PINs with respect to functional enrichment of the predicted interactions. Our main findings are: 1) LP measures that favor nodes which are both "topologically similar'' and have large shared extended neighborhoods are superior; 2) using more network topology often though not always improves LP accuracy; and 3) LP improves biological correctness of the PINs, plus we validate a significant portion of the predicted interactions in independent, external PIN data sources. Ultimately, we are less focused on identifying a superior method but more on showing that LP improves biological correctness of PINs, which is its ultimate goal in computational biology. But we note that our new methods outperform each of the existing ones with respect to at least one evaluation criterion. Alarmingly, we find that the different criteria often disagree in identifying the best method(s), which has important implications for LP communities in any domain, including social networks.	[Milenkovic, Tijana] Univ Notre Dame, ECK Inst Global Hlth, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; Univ Notre Dame, Interdisciplinary Ctr Network Sci & Applicat, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Milenkovic, T (corresponding author), Univ Notre Dame, ECK Inst Global Hlth, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA.	tmilenko@nd.edu			National Science Foundation [EAGER CCF-124329]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation EAGER CCF-124329 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic LA, 2003, SOC NETWORKS, V25, P211, DOI 10.1016/S0378-8733(03)00009-1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Edwards AM, 2002, TRENDS GENET, V18, P529, DOI 10.1016/S0168-9525(02)02763-4; Getoor L., 2005, ACM SIGKDD EXPLORATI, V7, P3, DOI DOI 10.1145/1117454.1117456; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Han JDJ, 2005, NAT BIOTECHNOL, V23, P839, DOI 10.1038/nbt1116; Ho H, 2010, BMC SYSTEMS BIOL, V4, P1; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Katz L., 1953, PSYCHOMETRIKA, V18, P39, DOI [DOI 10.1007/BF02289026, 10.1007/BF02289026]; Kuchaiev O, 2011, BIOINFORMATICS, V27, P1390, DOI 10.1093/bioinformatics/btr127; Kuchaiev O, 2010, J R SOC INTERFACE, V7, P1341, DOI 10.1098/rsif.2010.0063; Kuchaiev O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000454; Lei CW, 2013, BIOINFORMATICS, V29, P355, DOI 10.1093/bioinformatics/bts688; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Lichtenwalter R.N., 2012, P 21 INT C WORLD WID, P1019, DOI [10.1145/2187836.2187973, DOI 10.1145/2187836.2187973]; Lichtenwalter R.N., 2010, P 16 ACM SIGKDD INT, P243; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Lu LY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046122; Marcus D, 2012, COMPUT NETW, V56, P810, DOI 10.1016/j.comnet.2011.08.019; Memisevic V, 2010, J INTEGR BIOINFORM, V7, P120; Milenkovic T, 2008, CANCER INFORM, V6, P257; Milenkovic T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-70; Milenkovic T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023016; Milenkovic T, 2010, CANCER INFORM, V9, P121, DOI 10.4137/CIN.S4744; Milenkovic T, 2010, J R SOC INTERFACE, V7, P423, DOI 10.1098/rsif.2009.0192; Milenkovic T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005967; Newman ME, 2001, PHYS REV E, V64; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Rattigan M., 2005, SIGKDD EXPLORATIONS, V7, P41, DOI DOI 10.1145/1117454.1117460; Salton Gerard, 1984, INTRO MODERN INFORM; Sarac OS, 2012, BIOINFORMATICS, V28, P2137, DOI 10.1093/bioinformatics/bts351; Sharan R, 2006, NAT BIOTECHNOL, V24, P427, DOI 10.1038/nbt1196; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Solava RW, 2012, BIOINFORMATICS, V28, pI480, DOI 10.1093/bioinformatics/bts376; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wodak SJ, 2009, MOL CELL PROTEOMICS, V8, P3, DOI 10.1074/mcp.R800014-MCP200; Xie YB, 2008, PHYSICA A, V387, P1683, DOI 10.1016/j.physa.2007.11.005; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055437; Zhong WC, 2012, PHYSICA A, V391, P2163, DOI 10.1016/j.physa.2011.10.025; Zhou T, 2009, EUR PHYS J B, V71, P623, DOI 10.1140/epjb/e2009-00335-8	53	37	37	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90073	10.1371/journal.pone.0090073	http://dx.doi.org/10.1371/journal.pone.0090073			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594900	gold, Green Published, Green Submitted			2022-12-27	WOS:000332468900065
J	Odek, WO; Githuka, GN; Avery, L; Njoroge, PK; Kasonde, L; Gorgens, M; Kimani, J; Gelmon, L; Gakii, G; Isac, S; Faran, E; Musyoki, H; Maina, W; Blanchard, JF; Moses, S				Odek, Willis Omondi; Githuka, George N.; Avery, Lisa; Njoroge, Peter K.; Kasonde, Lombe; Gorgens, Marelize; Kimani, Joshua; Gelmon, Lawrence; Gakii, Gloria; Isac, Shajy; Faran, Emmanuel; Musyoki, Helgar; Maina, William; Blanchard, James F.; Moses, Stephen			Estimating the Size of the Female Sex Worker Population in Kenya to Inform HIV Prevention Programming	PLOS ONE			English	Article							RISK; TRANSMISSION; HIGHWAY; AFRICA	Background: The high burden of HIV infections among female sex workers (FSW) in sub-Saharan Africa has been long recognised, but effective preventive interventions have largely not been taken to scale. We undertook a national geographical mapping exercise in 2011/2012 to assess the locations and population size of FSW in Kenya, to facilitate targeted HIV prevention services for this population. Methods and Findings: We used a geographical mapping approach, consisting of interviews with secondary key informants to identify "hot" spots frequented by FSW, their operational dynamics and the estimated numbers of FSW in those spots. This was followed by validation of the estimates through interviews with FSW at each spot identified. The mapping covered Nairobi, the capital city of Kenya, and 50 other major urban centres. In total, 11,609 secondary key informant interviews were conducted to identify FSW spots. Further, a total of 6,360 FSW were interviewed for spot validation purposes. A total of 10,670 spots where FSW congregate were identified. The estimated FSW population in all the towns mapped was 103,298 (range 77,878 to 128, 717). Size estimates in the towns mapped were extended to smaller towns that were not mapped, using a statistical model. The national urban FSW population estimate was 138,420 (range 107, 552 to 169, 288), covering all towns of over 5,000 population. We estimated that approximately 5% of the urban female population of reproductive age in Kenya could be sex workers, which is consistent with previous estimates from other sub-Saharan African countries. Conclusions: This study provides the first national level data on the size of the FSW population in Kenya. These data can be used to enhance HIV prevention programme planning and implementation for FSW, to form the basis for impact evaluations, and to improve programme coverage by directing efforts to locations with the greatest need.	[Odek, Willis Omondi; Avery, Lisa; Isac, Shajy; Faran, Emmanuel; Blanchard, James F.; Moses, Stephen] Univ Manitoba, Dept Community Hlth Sci, Ctr Global Publ Hlth, Winnipeg, MB R3T 2N2, Canada; [Githuka, George N.; Musyoki, Helgar; Maina, William] Minist Hlth, Natl AIDS STI Control Programme NASCOP, Nairobi, Kenya; [Njoroge, Peter K.] Univ Nairobi, Sch Publ Hlth, Nairobi, Kenya; [Kasonde, Lombe; Gorgens, Marelize] Int Bank Reconstruct & Dev, Washington, DC USA; [Kimani, Joshua; Gelmon, Lawrence; Gakii, Gloria] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; University of Nairobi; University of Manitoba	Odek, WO (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Ctr Global Publ Hlth, Winnipeg, MB R3T 2N2, Canada.	odekw@yahoo.co.uk	Odek, W./ABB-2958-2021; Maina, William/L-6650-2017	Maina, William/0000-0002-3184-9854; Blanchard, James/0000-0002-4701-590X	US President's Emergency Plan for AIDS Relief (PEPFAR), through the US Centres for Disease Control and Prevention (CDC); US Agency for International Development (USAID); World Bank; Bill & Melinda Gates Foundation	US President's Emergency Plan for AIDS Relief (PEPFAR), through the US Centres for Disease Control and Prevention (CDC); US Agency for International Development (USAID)(United States Agency for International Development (USAID)); World Bank(The World Bank India); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was implemented jointly with the following organisations: the Kenya AIDS Control Project, Universities of Manitoba and Nairobi (KACP); the Centre for HIV Prevention and Research, University of Nairobi (CHIVPR); Impact Research and Development Organisation (IRDO); Hope Worldwide Kenya (HWWK); and the International Centre for Reproductive Health, Kenya (ICRH-K). The study implementing partners were supported by the US President's Emergency Plan for AIDS Relief (PEPFAR), through the US Centres for Disease Control and Prevention (CDC) and the US Agency for International Development (USAID). The study was funded by The World Bank and the Bill & Melinda Gates Foundation. The technical approach adopted was developed in India by the Centre for Global Public Health, University of Manitoba (CGPH), with funding support from the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], KEN POP DAT SHEET 20; [Anonymous], STAT MODELS CAUSAL A; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Berchenko Y, 2011, SEX TRANSM INFECT, V87, P267, DOI 10.1136/sti.2011.049171; Blanchard JF, 2008, SEX TRANSM INFECT S2, V84, pii19; Cuadros DF, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-28; Emmanuel F, 2013, EXPERT REV ANTI-INFE, V11, P451, DOI [10.1586/ERI.13.33, 10.1586/eri.13.33]; Emmanuel F, 2010, AIDS, V24, pS77, DOI 10.1097/01.aids.0000386737.25296.c4; Ferguson AG, 2007, HEALTH PLACE, V13, P504, DOI 10.1016/j.healthplace.2006.05.009; Goitom M., 1998, THESIS ADDIS ABABA; Kimani J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054354; Kruse N, 2003, SEX TRANSM DIS, V30, P664, DOI 10.1097/01.OLQ.0000079523.04451.82; Ministry of Public Health and Sanitation Kenya (MOPHS), 2010, NAT GUID HIV STI PRO, P17; Morris CN, 2006, SEX TRANSM INFECT, V82, P368, DOI 10.1136/sti.2006.020933; Msisha WM, 2008, AIDS, V22, P741, DOI 10.1097/QAD.0b013e3282f3947f; National AIDS/ STI Control Programme Kenya (NASCOP), 2012, MOST RISK POP UNV NE; National Coordinating Agency for Population and Development (NCAPD), 2011, STAT KEN POP 2011 KE; NGUGI EN, 1988, LANCET, V2, P887, DOI 10.1016/S0140-6736(88)92480-4; Okal J, 2013, SEX TRANSM INFECT, V89, P366, DOI 10.1136/sextrans-2013-051071; Salganik MJ, 2012, EPIDEMIOLOGY, V23, P148, DOI 10.1097/EDE.0b013e31823b6979; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; Vuylsteke B, 2010, TROP MED INT HEALTH, V15, P1537, DOI 10.1111/j.1365-3156.2010.02654.x; World Health Organization (WHO) and The Joint United Nations Programme on HIV and AIDS (UNAIDS), 2010, GUID EST SIZ POP MOS	24	54	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89180	10.1371/journal.pone.0089180	http://dx.doi.org/10.1371/journal.pone.0089180			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595029	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900011
J	Tiedke, J; Thiel, R; Burmester, T				Tiedke, Jessica; Thiel, Ralf; Burmester, Thorsten			Molecular Response of Estuarine Fish to Hypoxia: A Comparative Study with Ruffe and Flounder from Field and Laboratory	PLOS ONE			English	Article							ACID-BASE REGULATION; GENE-EXPRESSION; OXIDATIVE STRESS; CRUCIAN CARP; PLATICHTHYS-FLESUS; QUANTITATIVE PCR; OXYGEN; TEMPERATURE; NEUROGLOBIN; GILL	On a global scale, the frequencies and magnitudes of hypoxic events in coastal and estuarine waters have increased dramatically over the past 20 years. Fish populations are suitable indicators for the assessment of the quality of aquatic ecosystems, as they are omnipresent and often comprise a variety of different lifestyles and adaption strategies. We have investigated on the molecular level the impact of hypoxia on two fish species typical of European estuaries. We monitored the expression of eleven putatively hypoxia-responsive genes by means of quantitative real-time RT-PCR in brains, gills and hearts of the ruffe (Gymnocephalus cernua) and the flounder (Platichthys flesus). We first investigated the effect of naturally occurring hypoxia in the Elbe estuary. In a second approach, expression changes in the response to hypoxia were monitored under controlled laboratory conditions. The genes that showed the strongest effect were two respiratory proteins, myoglobin and neuroglobin, as well as the apoptosis enzyme caspase 3. As previously observed in other fish, myoglobin, which was considered to be muscle-specific, was found in brain and gills as well. Comparison of field and laboratory studies showed that - with the exception of the heart of flounder - that mRNA levels of the selected genes were about the same, suggesting that laboratory conditions reflect natural conditions. Likewise, trends of gene expression changes under hypoxia were the same, although hypoxia response was more pronounced in the Elbe estuary. In general, the flounder displayed a stronger response to hypoxia than the ruffe, suggesting that the flounder is more susceptible to hypoxia. The most pronounced differences were found among tissues within a species, demonstrating that hypoxia response is largely tissue-specific. In summary, our data suggest that laboratory experiments essentially mimic field data, but additional environmental factors enhance hypoxia response in nature.	[Burmester, Thorsten] Univ Hamburg, Inst Zool, Hamburg, Germany; Univ Hamburg, Zool Museum, Hamburg, Germany	University of Hamburg; University of Hamburg	Burmester, T (corresponding author), Univ Hamburg, Inst Zool, Martin Luther King Pl 3, Hamburg, Germany.	thorsten.burmester@uni-hamburg.de	Burmester, Thorsten/I-7225-2013	Burmester, Thorsten/0000-0002-5772-7863	Estuary and Wetland Research Graduate School Hamburg (ESTRADE) of the State Excellence Initiative (LExI); Hamburg Science and Research Foundation	Estuary and Wetland Research Graduate School Hamburg (ESTRADE) of the State Excellence Initiative (LExI); Hamburg Science and Research Foundation	This study was supported by the Estuary and Wetland Research Graduate School Hamburg (ESTRADE) as member of the State Excellence Initiative (LExI) funded by the Hamburg Science and Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2002, J EXP BIOL, V205, P1831; Adams SM, 2005, MAR POLLUT BULL, V51, P649, DOI 10.1016/j.marpolbul.2004.11.040; Awenius C, 2001, BIOCHEM BIOPH RES CO, V287, P418, DOI 10.1006/bbrc.2001.5614; Behrendt H, 2004, MASSGEBLICHE ANTHROP; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Blank M, 2012, MOL BIOL EVOL, V29, P3553, DOI 10.1093/molbev/mss164; Blank M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025292; Boutilier RG, 2001, J EXP BIOL, V204, P3171; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2007, ADV EXP MED BIOL, V618, P169; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; BUSHNELL PG, 1992, J COMP PHYSIOL B, V162, P131, DOI 10.1007/BF00398338; Claiborne JB, 2002, J EXP ZOOL, V293, P302, DOI 10.1002/jez.10125; Conley DJ, 2007, ECOL APPL, V17, pS165, DOI 10.1890/05-0766.1; Connor KM, 2011, P NATL ACAD SCI USA, V108, P16110, DOI 10.1073/pnas.1111076108; Cossins AR, 2009, J EXP BIOL, V212, P627, DOI 10.1242/jeb.026286; Diaz RJ, 2001, J ENVIRON QUAL, V30, P275, DOI 10.2134/jeq2001.302275x; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Eick D, 2012, J APPL ICHTHYOL, V28, P637, DOI 10.1111/j.1439-0426.2011.01926.x; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Fago A, 2004, IUBMB LIFE, V56, P689, DOI 10.1080/15216540500037299; Fraser J, 2006, P NATL ACAD SCI USA, V103, P2977, DOI 10.1073/pnas.0508270103; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Fuchs C, 2004, J BIOL CHEM, V279, P24116, DOI 10.1074/jbc.M402011200; Geret F, 2002, BIOMARKERS, V7, P242, DOI 10.1080/13547500210125040; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gracey AY, 2001, P NATL ACAD SCI USA, V98, P1993, DOI 10.1073/pnas.98.4.1993; Hedges JI, 1999, MAR CHEM, V65, P55, DOI 10.1016/S0304-4203(99)00010-9; Heip CHR, 1995, OCEANOGR MAR BIOL, V33, P1; Heise K, 2003, COMP BIOCHEM PHYS C, V134, P79, DOI 10.1016/S1532-0456(02)00212-0; Hemmer-Brepson C, 2013, J EXP BIOL IN PRESS; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; JORGENSEN JB, 1980, COMP BIOCHEM PHYS B, V67, P243, DOI 10.1016/0305-0491(80)90139-X; Kammer AR, 2011, J EXP BIOL, V214, P1248, DOI 10.1242/jeb.053207; Kubrak OI, 2012, ECOTOX ENVIRON SAFE, V85, P37, DOI 10.1016/j.ecoenv.2012.08.021; Law SHW, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-15; Leal W, 2006, RIVER ELBE HAMBURG D; Lefrancois C, 2003, MAR ECOL PROG SER, V259, P273, DOI 10.3354/meps259273; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lushchak VI, 2006, COMP BIOCHEM PHYS C, V143, P36, DOI 10.1016/j.cbpc.2005.11.018; LYNDON AR, 1994, J FISH BIOL, V44, P707, DOI 10.1111/j.1095-8649.1994.tb01246.x; Mazon AF, 2002, ENVIRON RES, V88, P52, DOI 10.1006/enrs.2001.4315; McLusky D.S., 2004, ESTUARINE ECOSYSTEM; Mendonca PC, 2009, J EXP BIOL, V212, P934, DOI 10.1242/jeb.027680; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Near TJ, 2009, J EXP ZOOL PART B, V312B, P749, DOI 10.1002/jez.b.21293; Nikinmaa M, 2005, AM J PHYSIOL-REG I, V288, pR1079, DOI 10.1152/ajpregu.00626.2004; Nikinmaa M, 2001, RESP PHYSIOL, V128, P317, DOI 10.1016/S0034-5687(01)00309-7; Nilsson GE, 2004, J EXP BIOL, V207, P3131, DOI 10.1242/jeb.00979; Nilsson GE, 2007, J EXP BIOL, V210, P2403, DOI 10.1242/jeb.000281; Ogle DH, 1998, J GREAT LAKES RES, V24, P170, DOI 10.1016/S0380-1330(98)70811-1; Padilla PA, 2001, P NATL ACAD SCI USA, V98, P7331, DOI 10.1073/pnas.131213198; Podrabsky JE, 2004, J EXP BIOL, V207, P2237, DOI 10.1242/jeb.01016; Rabalais NN, 2001, J ENVIRON QUAL, V30, P320, DOI 10.2134/jeq2001.302320x; Rabalais NN, 2002, BIOSCIENCE, V52, P129, DOI 10.1641/0006-3568(2002)052[0129:BSIPGO]2.0.CO;2; Reuss S, 2002, NEUROSCIENCE, V115, P645, DOI 10.1016/S0306-4522(02)00536-5; Richards J, 2009, FISH PHYSL; Rissanen E, 2006, J EXP BIOL, V209, P994, DOI 10.1242/jeb.02103; Roberts JJ, 2009, J EXP MAR BIOL ECOL, V381, pS132, DOI 10.1016/j.jembe.2009.07.017; ROCHARD E, 1994, ETAT CONNAISSANCES E, P115; RODRIGUEZARIZA A, 1993, CAN J FISH AQUAT SCI, V50, P2568, DOI 10.1139/f93-280; Roesner A, 2005, MOL BIOL EVOL, V22, P12, DOI 10.1093/molbev/msh258; Roesner A, 2008, FEBS J, V275, P3633, DOI 10.1111/j.1742-4658.2008.06508.x; Roesner A, 2006, J EXP BIOL, V209, P2129, DOI 10.1242/jeb.02243; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; SEMENZA GL, 2006, NOVART FDN SYMP, V272, P33, DOI DOI 10.1002/9780470035009.CH2; SEMENZA GL, 2006, NOVART FDN SYMP, V272, P8, DOI DOI 10.1002/9780470035009.CH2; Semenza Gregg L, 2006, Novartis Found Symp, V272, P2; Sies H, 1996, J PHYSIOL-LONDON, V491P, pS2; Sokolova IM, 2008, CLIM RES, V37, P181, DOI 10.3354/cr00764; Sollid J, 2003, J EXP BIOL, V206, P3667, DOI 10.1242/jeb.00594; Sollid J, 2006, RESP PHYSIOL NEUROBI, V154, P241, DOI 10.1016/j.resp.2006.02.006; STANLEY DW, 1992, ESTUARIES, V15, P270, DOI 10.2307/1352775; STEFFENSEN JF, 1982, ENVIRON BIOL FISH, V7, P157, DOI 10.1007/BF00001786; Thiel R, 2011, FISCHFAUNA ERUOPAISC; Thomas P, 2007, P ROY SOC B-BIOL SCI, V274, P2693, DOI 10.1098/rspb.2007.0921; Tichopad A, 2009, CLIN CHEM, V55, P1816, DOI 10.1373/clinchem.2009.126201; Tiedke J, 2011, J COMP PHYSIOL B, V181, P1011, DOI 10.1007/s00360-011-0588-9; Todgham AE, 2006, PHYSIOL BIOCHEM ZOOL, V79, P1033, DOI 10.1086/507664; Ton C, 2003, PHYSIOL GENOMICS, V13, P97, DOI 10.1152/physiolgenomics.00128.2002; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Tyler RM, 2007, MAR ECOL PROG SER, V333, P257, DOI 10.3354/meps333257; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; van der Meer DLM, 2005, AM J PHYSIOL-REG I, V289, pR1512, DOI 10.1152/ajpregu.00089.2005; Van Ginneken VJT, 1998, NETH J ZOOL, V48, P65, DOI 10.1163/156854298X00228; Waede M., 1954, Kieler Meeresforschungen, V10, P58; Wawrowski A, 2011, J COMP PHYSIOL B, V181, P199, DOI 10.1007/s00360-010-0518-2; WEBER RE, 1975, J COMP PHYSIOL, V101, P99, DOI 10.1007/BF00694151; Welker AF, 2013, COMP BIOCHEM PHYS A, V165, P384, DOI 10.1016/j.cbpa.2013.04.003; Wetzel MA, 2013, SCI TOTAL ENVIRON, V449, P199, DOI 10.1016/j.scitotenv.2013.01.016; Wittenberg JB, 2003, J EXP BIOL, V206, P2011, DOI 10.1242/jeb.00243; Wu RSS, 2002, MAR POLLUT BULL, V45, P35, DOI 10.1016/S0025-326X(02)00061-9; WWF, 2005, ELB 1999 TATS PROGN; Yang QL, 2012, COMP BIOCHEM PHYS C, V155, P190, DOI 10.1016/j.cbpc.2011.08.003	99	38	39	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90778	10.1371/journal.pone.0090778	http://dx.doi.org/10.1371/journal.pone.0090778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595439	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900144
J	Wang, X; Fang, Y; Yang, SM; Jiang, MH; Yan, KK; Wu, LN; Lv, B; Shen, Q				Wang, Xiao; Fang, Yu; Yang, Shimin; Jiang, Minghuan; Yan, Kangkang; Wu, Lina; Lv, Bing; Shen, Qian			Access to Paediatric Essential Medicines: A Survey of Prices, Availability, Affordability and Price Components in Shaanxi Province, China	PLOS ONE			English	Article							CHILDREN; LIST	Objective: To evaluate the prices and availability of paediatric essential medicines in Shaanxi Province, China. Methods: Price and availability data for 28 paediatric essential medicines were collected from 60 public hospitals and 60 retail pharmacies in six areas of Shaanxi Province using a standardised methodology developed by the World Health Organization and Health Action International, during November to December 2012. Affordability was measured as the number of days' wages required for the lowest-paid unskilled government worker to purchase standard treatments for common conditions. Data on medicine price components were collected from hospitals, wholesalers and distributors to obtain price mark-ups. Findings: The mean availabilities of originator brands (OBs) and lowest-priced generics (LPGs) were 10.8% and 27.3% in the public hospitals and 11.9% and 20.6% in the private pharmacies. The public procurement and retail prices were 2.25 and 2.59 times the international reference prices (IRPs) for three OBs, and 0.52 and 0.93 times for 20 LPGs. In the private sector, the final prices for OBs and LPGs were 3.89 and 1.25 times their IRPs. The final price in the private sector was 2.7% lower than in the public sector for OBs, and 14.1% higher for LPGs. Generally, standard treatments cost less than 1 day's wages in both sectors. Distribution mark-ups applied to brand salbutamol in Xi'an was 65.5%, and up to 185.3% for generic. Cumulative mark-ups for LPGs in Ankang were also high, from 33% to 50%. The manufacturer's selling price is the largest contributor to the final price in both areas. Conclusions: The government should approve a list of national paediatric essential medicines. The availability, price and affordability of these should be improved in both public hospitals and private pharmacies to enable children to obtain effective treatment. Measures should be taken to improve the efficiency of the centralised medicine purchasing system.	[Wang, Xiao; Fang, Yu; Yang, Shimin; Jiang, Minghuan; Yan, Kangkang; Wu, Lina; Lv, Bing; Shen, Qian] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharm Adm, Xian 710049, Peoples R China; [Fang, Yu] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Fang, Yu] Harvard Pilgrim Hlth Care Inst, Boston, MA USA	Xi'an Jiaotong University; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Fang, Y (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharm Adm, Xian 710049, Peoples R China.	yufang@mail.xjtu.edu.cn; lvb1990@163.com			National Natural Science Fund [71103141/G0308]; Fundamental Research Funds for the Central Universities [2011jdhz62]; Shaanxi Provincial Social Science Fund [10E066]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Shaanxi Provincial Social Science Fund	This medicine price survey was conducted with financial support from the National Natural Science Fund (No: 71103141/G0308), the Fundamental Research Funds for the Central Universities (No: 2011jdhz62) and the Shaanxi Provincial Social Science Fund (No: 10E066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1977, WHO TECHN REP SER; [Anonymous], 2013, PEOPLES DAILY ONLINE; [Anonymous], 2004, INCR ACC ESS MED DEV; [Anonymous], 2011, RD WHO MOD LIST ESS; Anson A, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-22; Babar ZUD, 2007, PLOS MED, V4, P466, DOI 10.1371/journal.pmed.0040082; Balasubramaniam R., 2011, CEYLON MEDICAL JOURNAL, V56, P101, DOI 10.4038/cmj.v56i3.3597; Braine T, 2007, B WORLD HEALTH ORGAN, V85, P249; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Chen W, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-211; Department of Human Resources and Social Security of Shaanxi Province, 2012, LOW WAG REG SHAANX P; Fang Y, 2013, LANCET GLOB HEALTH, V1, pE227, DOI 10.1016/S2214-109X(13)70072-X; Finney E, 2011, CHILDRENS MED SITUAT; Gitanjali B, 2011, J PHARMACOL PHARMACO, V2, P95, DOI 10.4103/0976-500X.81900; Health Action International, 2012, MED PRIC AV AFF PRIC; Hu S., 2010, FINANCING PRICING UT; IMS Consulting Group, 2013, EXPL IMP REV EDL ASS; Jiang MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070836; Laing R, 2003, LANCET, V361, P1723, DOI 10.1016/S0140-6736(03)13375-2; Management Sciences for Health, 2011, INT DRUG PRIC IND GU; Niens LM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000333; Ravindran L, 2012, INDIAN J PHARMACOL, V44, P536, DOI 10.4103/0253-7613.99347; Robertson J, 2009, B WORLD HEALTH ORGAN, V87, P231, DOI 10.2471/BLT.08.053645; Seiter A, 2010, GENERIC DRUG POLICY; State Food and Drug Administration, 2011, NOT STOPP SAIL US AM; Sun Q., 2004, SURVEY MED PRICES AV; The Ministry of Health, 2012, CHIN NAT EML; The Shaanxi Provincial Government, 2012, IMPL OP SHAANX PROV; Tian X, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-401; WHO Health Action International, 2008, MEAS MED PRIC AV AFF, V2nd; World Health Organization, 2012, WORLD HLTH STAT 2012; World Health Organization, 2011, SEL ESS MED; World Health Organization, 2013, CHILDR RED MORT; World Health Organization, 2009, BETT MED CHILDR PROJ; World Health Organization and Health Action International, 2003, MED PRIC NEW APPR ME; Yang H, 2010, HEALTH POLICY PLANN, V25, P219, DOI 10.1093/heapol/czp056; Ye L., 2006, SURVEY MED PRICES AV	37	23	27	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90365	10.1371/journal.pone.0090365	http://dx.doi.org/10.1371/journal.pone.0090365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595099	gold, Green Published, Green Submitted			2022-12-27	WOS:000332468900098
J	Aravena, G; Broitman, B; Stenseth, NC				Aravena, Guillermo; Broitman, Bernardo; Stenseth, Nils Christian			Twelve Years of Change in Coastal Upwelling along the Central-Northern Coast of Chile: Spatially Heterogeneous Responses to Climatic Variability	PLOS ONE			English	Article							HUMBOLDT CURRENT SYSTEM; SATELLITE-DERIVED SST; OCEANOGRAPHIC VARIABILITY; TEMPERATURE VARIABILITY; CALIFORNIA CURRENT; EL-NINO; RECRUITMENT; OCEAN; CIRCULATION; WATER	We use time-series analyses to characterize the effects of recent climate variability upon the local physical conditions at 11 study sites along the northern-central coast of Chile (29-34 degrees S). Environmental indices show that the 1 degrees Bakun upwelling index in this coastal region has fluctuated in time, starting from a stable period around the 1980's, peaking during the mid 90s, decreasing during the next ten years and increasing at a steep rate since 2010. Upwelling intensity decreased with increasing latitude, showing also a negative correlation with climate patterns (El Nino3 sea surface temperature-SST anomalies and the Multivariate El Nino Index). We hypothesize that the impacts of climate variability on upwelling events seem to be spatially heterogeneous along the region. Non-sheltered locations and, particularly, sites on prominent headlands show an immediate (lag = 0) and negative correlation between local SST, upwelling events and wind stress. We suggest that near-shore thermal conditions are closely coupled to large-scale forcing of upwelling variability and that this influence is modulated through local topographic factors.	[Aravena, Guillermo; Broitman, Bernardo] Univ Catolica Norte, Fac Ciencias Mar, Ctr Estudios Avanzados Zonas Aridas, Coquimbo, Chile; [Stenseth, Nils Christian] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway	Universidad Catolica del Norte; University of Oslo	Aravena, G (corresponding author), Univ Catolica Norte, Fac Ciencias Mar, Ctr Estudios Avanzados Zonas Aridas, Coquimbo, Chile.	guillermo.aravena@ceaza.cl	Stenseth, Nils Chr./G-5212-2016; Broitman, Bernardo R/D-6007-2013	Stenseth, Nils Chr./0000-0002-1591-5399; Broitman, Bernardo R/0000-0001-6582-3188	FONDECYT [3120163, 1120988]; Ministry of Economy, Development and Tourism, Chile [ICM P10-033F-]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Ministry of Economy, Development and Tourism, Chile	This research was supported by FONDECYT 3120163 to G. A., FONDECYT 1120988 to B. B. and Project ICM P10-033F- Fund for Innovation and Competitiveness, Ministry of Economy, Development and Tourism, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CM, 2008, CONT SHELF RES, V28, P2371, DOI 10.1016/j.csr.2008.05.006; Arcos D, 1986, INVEST PESQ, V33, P91; Arntz W. E., 2006, ADV GEOSCI, V6, P243, DOI DOI 10.5194/ADGE0-6-243-2006; Ashok K, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003798; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Bakun A, 2010, GLOBAL CHANGE BIOL, V16, P1213, DOI 10.1111/j.1365-2486.2009.02094.x; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Broitman BR, 2006, MAR ECOL PROG SER, V327, P15, DOI 10.3354/meps327015; Broitman BR, 2005, LIMNOL OCEANOGR, V50, P1473, DOI 10.4319/lo.2005.50.5.1473; Bylhouwer B, 2013, J GEOPHYS RES-OCEANS, V118, P2565, DOI 10.1002/jgrc.20194; Casey KS, 1999, J CLIMATE, V12, P1848, DOI 10.1175/1520-0442(1999)012<1848:ACOSAI>2.0.CO;2; Chavez FP, 2008, PROG OCEANOGR, V79, P95, DOI 10.1016/j.pocean.2008.10.012; Cowpertwait PSP, 2009, USE R, P1, DOI 10.1007/978-0-387-88698-5_1; Cryer JD, 2008, SPRINGER TEXTS STAT, P1; Dewitte B, 2012, DEEP-SEA RES PT II, V77-80, P143, DOI 10.1016/j.dsr2.2012.04.011; Dewitte B, 2013, CLIM DYNAM, V41, P819, DOI 10.1007/s00382-012-1504-z; Dufois F, 2012, OCEAN MODEL, V47, P113, DOI 10.1016/j.ocemod.2012.01.007; Echevin V, 2012, CLIM DYNAM, V38, P761, DOI 10.1007/s00382-011-1085-2; Echevin V, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006684; Escribano R, 2012, PROG OCEANOGR, V92-95, P1, DOI 10.1016/j.pocean.2011.07.019; Falvey M, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010519; Figueroa D, 2000, GEOPHYS RES LETT, V27, P3905, DOI 10.1029/1999GL011302; Freeland HJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016663; Gan JP, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001190; Garcia-Reyes M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005576; Garreaud RD, 2009, INT J CLIMATOL, V29, P543, DOI 10.1002/joc.1716; Goubanova K, 2011, CLIM DYNAM, V36, P1365, DOI 10.1007/s00382-010-0824-0; Graham WM, 1997, CONT SHELF RES, V17, P509, DOI 10.1016/S0278-4343(96)00045-3; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; GROSSMANN A, 1984, SIAM J MATH ANAL, V15, P723, DOI 10.1137/0515056; Gutierrez D, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046324; Hormazabal S, 2002, GEOPHYS RES LETT, V29, P51; Iles AC, 2012, GLOBAL CHANGE BIOL, V18, P783, DOI 10.1111/j.1365-2486.2011.02567.x; JOHNSON DR, 1980, J MAR RES, V38, P1; Kirincich AR, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002611; Lagos NA, 2005, MAR ECOL PROG SER, V290, P165, DOI 10.3354/meps290165; Lagos NA, 2008, ECOL MONOGR, V78, P245, DOI 10.1890/07-0041.1; Lathlean JA, 2011, MAR ECOL PROG SER, V439, P83, DOI 10.3354/meps09317; Leth O, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003070; Macias D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030436; McGregor HV, 2007, SCIENCE, V315, P637, DOI 10.1126/science.1134839; Mendelssohn R, 2002, PROG OCEANOGR, V53, P141, DOI 10.1016/S0079-6611(02)00028-9; Menge BA, 2008, ECOL LETT, V11, P151, DOI 10.1111/j.1461-0248.2007.01135.x; Montecinos A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017345; Montecinos A, 1991, THESIS CATHOLIC U VA; Pinones A, 2007, CIENC MAR, V33, P37, DOI 10.7773/cm.v33i1.1226; Pizarro O., 1994, INVESTIGACIONES MARI, V22, P83; R Development Core Team, 2011, R LANG ENV STAT COMP; Ramos M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025882; Ramos M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004681; Shaffer G, 1997, J PHYS OCEANOGR, V27, P217, DOI 10.1175/1520-0485(1997)027<0217:CALFVN>2.0.CO;2; Shaffer G, 1999, J GEOPHYS RES-OCEANS, V104, P29951, DOI 10.1029/1999JC900253; Silva N, 2003, INVESTIGACIONES MARI, V31, P73; Smale DA, 2009, MAR ECOL PROG SER, V387, P27, DOI 10.3354/meps08132; Sobarzo M, 2007, PROG OCEANOGR, V75, P363, DOI 10.1016/j.pocean.2007.08.022; Tapia FJ, 2009, PROG OCEANOGR, V83, P278, DOI 10.1016/j.pocean.2009.07.035; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Weeks SJ, 2004, DEEP-SEA RES PT I, V51, P153, DOI 10.1016/j.dsr.2003.10.004; Wilson JR, 2008, ESTUAR COAST SHELF S, V79, P483, DOI 10.1016/j.ecss.2008.05.001; WOLTER K, 1987, J CLIM APPL METEOROL, V26, P540, DOI 10.1175/1520-0450(1987)026<0540:TSOISC>2.0.CO;2; Yeh SW, 2009, NATURE, V461, P511, DOI 10.1038/nature08316	62	59	59	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90276	10.1371/journal.pone.0090276	http://dx.doi.org/10.1371/journal.pone.0090276			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587310	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200159
J	Kilic, U; Gok, O; Bacaksiz, A; Izmirli, M; Elibol-Can, B; Uysal, O				Kilic, Ulkan; Gok, Ozlem; Bacaksiz, Ahmet; Izmirli, Muzeyyen; Elibol-Can, Birsen; Uysal, Omer			SIRT1 Gene Polymorphisms Affect the Protein Expression in Cardiovascular Diseases	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CORONARY-ARTERY-DISEASE; OXIDATIVE STRESS; MYOCARDIAL-INFARCTION; HEART-DISEASE; MICE; ACTIVATION; PROMOTES; DNA; ATHEROSCLEROSIS	Cardiovascular disease (CVD), the leading cause of death worldwide, is related to gene-environment interactions due to epigenetic factors. SIRT1 protein and its downstream pathways are critical for both normal homeostasis and protection from CVD-induced defects. The aim of this study was to investigate the association between SIRT1 single nucleotide polymorphisms (SNPs) (rs7895833 A>G in the promoter region, rs7069102 C>G in intron 4 and rs2273773 C>T in exon 5 silent mutation) and SIRT1 and eNOS (endothelial nitric oxide synthase) protein expression as well as total antioxidant status (TAS), total oxidant status (TOS) and oxidative stress index (OSI) in CVD patients as compared to controls. The frequencies of mutant genotypes and alleles for rs7069102 and rs2273773 were significantly higher in patients with CVD compared to control group. The risk for CVD was increased by 2.4 times for rs7069102 and 1.9 times for rs2273773 in carriers of mutant allele compared with carriers of wild-type allele pointing the protective role of C allele for both SNPs against CVD. For rs7895833, there was no significant difference in genotype and allele distributions between groups. SIRT1 protein, TAS, TOS and OSI levels significantly increased in patients as compared to control group. In contrast, level of eNOS protein was considerably low in the CVD patients. An increase in the SIRT1 expression in the CVD patients carrying mutant genotype for rs7069102 and heterozygote genotype for all three SNPs was observed. This is the first study reporting an association between SIRT1 gene polymorphisms and the levels of SIRT1 and eNOS expressions as well as TAS, TOS and OSI.	[Kilic, Ulkan; Gok, Ozlem; Izmirli, Muzeyyen; Elibol-Can, Birsen] Bezmialem Vakif Univ, Fac Med, Dept Med Biol, Istanbul, Turkey; [Bacaksiz, Ahmet] Bezmialem Vakif Univ, Fac Med, Dept Cardiol, Istanbul, Turkey; [Izmirli, Muzeyyen] Mustafa Kemal Univ, Fac Med, Dept Med Biol, Antakya, Turkey; [Uysal, Omer] Bezmialem Vakif Univ, Fac Med, Dept Biostat, Istanbul, Turkey	Bezmialem Vakif University; Bezmialem Vakif University; Mustafa Kemal University; Bezmialem Vakif University	Kilic, U (corresponding author), Bezmialem Vakif Univ, Fac Med, Dept Med Biol, Istanbul, Turkey.	uckilic@yahoo.com	Uysal, Ömer/AAR-4220-2020; Elibol, Birsen/C-8369-2018; Elibol, Birsen/AAQ-7696-2020	Uysal, Ömer/0000-0002-8833-697X; Elibol, Birsen/0000-0002-9462-0862; Elibol, Birsen/0000-0002-9462-0862	University Research Council, Bezmialem Vakif University [BAP:6.2013/21]	University Research Council, Bezmialem Vakif University(Bezmialem Vakif University)	This study was supported by grants from the University Research Council, Bezmialem Vakif University (BAP:6.2013/21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Atsuta Yoshiko, 2003, Rinsho Byori, V51, P886; Aydin M, 2012, J CLIN EXP INVEST, V3, P22, DOI [10.5799/ahinjs.01.2012.01.0105, DOI 10.5799/AHINJS.01.2012.01.0105]; Blum CA, 2011, J MED CHEM, V54, P417, DOI 10.1021/jm100861p; Botden IPG, 2012, DIABETES CARE, V35, P424, DOI 10.2337/dc11-1203; Braam B, 2007, CURR PHARM DESIGN, V13, P1727, DOI 10.2174/138161207780831275; Brede M, 2003, HYPERTENSION, V42, P1177, DOI 10.1161/01.HYP.0000100445.80029.8E; Breitenstein A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053106; Chong ZZ, 2012, FUTUR CARDIOL, V8, P89, DOI [10.2217/FCA.11.76, 10.2217/fca.11.76]; Cui YH, 2012, BIOCHEM BIOPH RES CO, V426, P232, DOI 10.1016/j.bbrc.2012.08.071; Demirbag R, 2005, MUTAT RES-FUND MOL M, V570, P197, DOI 10.1016/j.mrfmmm.2004.11.003; Demirbag R, 2010, TURK GOGUS KALP DAMA, V18, P79; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Durand JL, 2012, J CELL BIOCHEM, V113, P3276, DOI 10.1002/jcb.24206; Erel O, 2004, CLIN BIOCHEM, V37, P112, DOI 10.1016/j.clinbiochem.2003.10.014; Erel O, 2005, CLIN BIOCHEM, V38, P1103, DOI 10.1016/j.clinbiochem.2005.08.008; Gandhi, 2012, INT J LIFE SC BT PHA, V1, P236; Gogen S, 2011, TURK KARDIYOL DERN A, V39, P248, DOI 10.5543/tkda.2011.01214; Hoppner S, 2013, RAPID COMMUN MASS SP, V27, P35, DOI 10.1002/rcm.6421; Hsu CP, 2010, CIRCULATION, V122, P2170, DOI 10.1161/CIRCULATIONAHA.110.958033; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kathiresan S, 2012, CELL, V148, P1242, DOI 10.1016/j.cell.2012.03.001; Kavakli HS, 2010, HONG KONG J EMERG ME, V17, P250, DOI 10.1177/102490791001700308; Kawashima T, 2011, J MOL CELL CARDIOL, V51, P1026, DOI 10.1016/j.yjmcc.2011.09.013; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; Li HG, 2002, NITRIC OXIDE-BIOL CH, V7, P149, DOI 10.1016/S1089-8603(02)00111-8; LoPresti R, 2008, CLIN APPL THROMB-HEM, V14, P421, DOI 10.1177/1076029607308406; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Musunuru K, 2010, ANNU REV GENOM HUM G, V11, P91, DOI 10.1146/annurev-genom-082509-141637; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Oemar BS, 1998, CIRCULATION, V97, P2494, DOI 10.1161/01.CIR.97.25.2494; Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104; Peeters AV, 2008, HUM GENET, V124, P431, DOI 10.1007/s00439-008-0567-8; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Salazar LA, 1998, CLIN CHEM, V44, P1748; Salminen A, 2013, INT J MOL SCI, V14, P3834, DOI 10.3390/ijms14023834; Schug TT, 2011, ANN MED, V43, P198, DOI 10.3109/07853890.2010.547211; Schunkert H, 2010, EUR HEART J, V31, P918, DOI 10.1093/eurheartj/ehq038; Shan T, 2009, J ANIM SCI, V87, P895, DOI 10.2527/jas.2008-1344; Shimoyama Y, 2012, J RENAL NUTR, V22, P114, DOI 10.1053/j.jrn.2011.10.025; Shimoyama Y, 2011, TRANSL RES, V157, P339, DOI 10.1016/j.trsl.2011.02.004; Stein S, 2010, AGING-US, V2, P353, DOI 10.18632/aging.100162; Sun Xue-lin, 2012, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V28, P972; Tang BL, 2011, TRANSL RES, V157, P276, DOI 10.1016/j.trsl.2010.11.006; Tanno M, 2010, J BIOL CHEM, V285, P8375, DOI 10.1074/jbc.M109.090266; Turan N, 2010, EPIGENETICS-US, V5, P16, DOI 10.4161/epi.5.1.10557; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Wakeling LA, 2009, AGE, V31, P327, DOI 10.1007/s11357-009-9104-5; Wang Ke, 2011, Yichuan, V33, P182, DOI 10.3724/SP.J.1005.2011.00182; Zillikens MC, 2009, FREE RADICAL BIO MED, V46, P836, DOI 10.1016/j.freeradbiomed.2008.12.022	52	57	61	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90428	10.1371/journal.pone.0090428	http://dx.doi.org/10.1371/journal.pone.0090428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587358	gold, Green Submitted, Green Published			2022-12-27	WOS:000332396200193
J	Ohashi, J; Suzuki, Y; Naka, I; Hananantachai, H; Patarapotikul, J				Ohashi, Jun; Suzuki, Yuji; Naka, Izumi; Hananantachai, Hathairad; Patarapotikul, Jintana			Diversifying Selection on the Thrombospondin-Related Adhesive Protein (TRAP) Gene of Plasmodium falciparum in Thailand	PLOS ONE			English	Article							T-LYMPHOCYTE RESPONSES; ANONYMOUS PROTEIN; SPOROZOITE; EPITOPES; VACCINE; INFECTIVITY; SOFTWARE	Sporozoites of Plasmodium falciparum are transmitted to human hosts by Anopheles mosquitoes. Thrombospondin-related adhesive protein (TRAP) is expressed in sporozoites and plays a crucial role in sporozoite gliding and invasion of human hepatocytes. A previous study showed that the TRAP gene has been subjected to balancing selection in the Gambian P. falciparum population. To further study the molecular evolution of the TRAP gene in Plasmodium falciparum, we investigated TRAP polymorphisms in P. falciparum isolates from Suan Phueng District in Ratchaburi Province, Thailand. The analysis of the entire TRAP coding sequences in 32 isolates identified a total of 39 single nucleotide polymorphisms (SNPs), which comprised 37 nonsynonymous and two synonymous SNPs. McDonald-Kreitman test showed that the ratio of the number of nonsynonymous to synonymous polymorphic sites within P. falciparum was significantly higher than that of the number of nonsynonymous to synonymous fixed sites between P. falciparum and P. reichenowi. Furthermore, the rate of nonsynonymous substitution was significantly higher than that of synonymous substitution within Thai P. falciparum. These results indicate that the TRAP gene has been subject to diversifying selection in the Thai P. falciparum population as well as the Gambian P. falciparum population. Comparison of our P. falciparum isolates with those from another region of Thailand (Tak province, Thailand) revealed that TRAP was highly differentiated between geographically close regions. This rapid diversification seems to reflect strong recent positive selection on TRAP. Our results suggest that the TRAP molecule is a major target of the human immune response to pre-erythrocytic stages of P. falciparum.	[Ohashi, Jun; Suzuki, Yuji; Naka, Izumi] Univ Tsukuba, Fac Med, Ibaraki, Japan; [Hananantachai, Hathairad; Patarapotikul, Jintana] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand	University of Tsukuba; Mahidol University	Ohashi, J (corresponding author), Univ Tsukuba, Fac Med, Ibaraki, Japan.	juno-tky@umin.ac.jp	OHASHI, JUN/G-5907-2015; NAKA, IZUMI/G-5495-2015		KAKENHI [25650125, 25133702]; Takeda Science Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was partly supported by a KAKENHI (25650125) Grant-in-Aid for Challenging Exploratory Research, the Takeda Science Foundation, and a KAKENHI (25133702) Grant-in-Aid for Scientific Research on Innovative Areas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDOO M, 1995, LANCET, V345, P1003, DOI 10.1016/S0140-6736(95)90754-8; Doolan DL, 1997, IMMUNITY, V7, P97, DOI 10.1016/S1074-7613(00)80513-0; ESCALANTE AA, 1994, P NATL ACAD SCI USA, V91, P11373, DOI 10.1073/pnas.91.24.11373; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gantt S, 2000, INFECT IMMUN, V68, P3667, DOI 10.1128/IAI.68.6.3667-3673.2000; Jongwutiwes S, 1998, MOL BIOCHEM PARASIT, V92, P349, DOI 10.1016/S0166-6851(98)00004-8; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MULLER HM, 1993, EMBO J, V12, P2881, DOI 10.1002/j.1460-2075.1993.tb05950.x; NEI M, 1986, MOL BIOL EVOL, V3, P418; Plebanski M, 1997, J IMMUNOL, V158, P2849; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; ROBSON KJH, 1995, EMBO J, V14, P3883, DOI 10.1002/j.1460-2075.1995.tb00060.x; ROBSON KJH, 1988, NATURE, V335, P79, DOI 10.1038/335079a0; ROGERS WO, 1992, P NATL ACAD SCI USA, V89, P9176, DOI 10.1073/pnas.89.19.9176; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WATTERSON GA, 1978, GENETICS, V88, P405; Weedall GD, 2007, INT J PARASITOL, V37, P77, DOI 10.1016/j.ijpara.2006.09.001; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WIZEL B, 1995, J EXP MED, V182, P1435, DOI 10.1084/jem.182.5.1435; WIZEL B, 1995, J IMMUNOL, V155, P766	28	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90522	10.1371/journal.pone.0090522	http://dx.doi.org/10.1371/journal.pone.0090522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587387	gold, Green Submitted, Green Published			2022-12-27	WOS:000332396200221
J	Schulz, P; Jansseune, K; Degenkolbe, T; Meret, M; Claeys, H; Skirycz, A; Teige, M; Willmitzer, L; Hannah, MA				Schulz, Philipp; Jansseune, Karel; Degenkolbe, Thomas; Meret, Michael; Claeys, Hannes; Skirycz, Aleksandra; Teige, Markus; Willmitzer, Lothar; Hannah, Matthew A.			Poly(ADP-Ribose)Polymerase Activity Controls Plant Growth by Promoting Leaf Cell Number	PLOS ONE			English	Article							DARK-INDUCIBLE GENES; ARABIDOPSIS-THALIANA; ADP-RIBOSYLATION; OXIDATIVE STRESS; POLYMERASE; PROTEINS; POLY(ADP-RIBOSYL)ATION; STARCH; GLUTATHIONE; INHIBITION	A changing global environment, rising population and increasing demand for biofuels are challenging agriculture and creating a need for technologies to increase biomass production. Here we demonstrate that the inhibition of poly (ADPribose) polymerase activity is a promising technology to achieve this under non-stress conditions. Furthermore, we investigate the basis of this growth enhancement via leaf series and kinematic cell analysis as well as single leaf transcriptomics and plant metabolomics under non-stress conditions. These data indicate a regulatory function of PARP within cell growth and potentially development. PARP inhibition enhances growth of Arabidopsis thaliana by enhancing the cell number. Time course single leaf transcriptomics shows that PARP inhibition regulates a small subset of genes which are related to growth promotion, cell cycle and the control of metabolism. This is supported by metabolite analysis showing overall changes in primary and particularly secondary metabolism. Taken together the results indicate a versatile function of PARP beyond its previously reported roles in controlling plant stress tolerance and thus can be a useful target for enhancing biomass production.	[Schulz, Philipp; Jansseune, Karel; Hannah, Matthew A.] Bayer CropSci NV, Innovat Ctr, Zwijnaarde, Belgium; [Schulz, Philipp; Teige, Markus] Univ Vienna, Dept Mol Syst Biol MOSYS, Vienna, Austria; [Degenkolbe, Thomas; Meret, Michael; Willmitzer, Lothar] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Claeys, Hannes; Skirycz, Aleksandra] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Claeys, Hannes; Skirycz, Aleksandra] VIB, Dept Plant Syst Biol, Ghent, Belgium	Bayer AG; Bayer CropScience; University of Vienna; Max Planck Society; Ghent University; Flanders Institute for Biotechnology (VIB)	Hannah, MA (corresponding author), Bayer CropSci NV, Innovat Ctr, Zwijnaarde, Belgium.	matthew.hannah@bayer.com	Skirycz, Aleksandra/AAM-7911-2021; Teige, Markus/R-6443-2016	Teige, Markus/0000-0001-7204-1379; Hannah, Matthew/0000-0002-4889-490X; Claeys, Hannes/0000-0001-9384-4138; Skirycz, Aleksandra/0000-0002-7627-7925	Marie Curie Chloroplast Signals (COSI) ITN [ITN-GA-2008-215174]; Austrian Science Fund (FWF) [P 25359] Funding Source: researchfish	Marie Curie Chloroplast Signals (COSI) ITN; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors acknowledge the Marie Curie Chloroplast Signals (COSI) ITN for financial support to PS (ITN-GA-2008-215174). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JAT, 2011, ANN BOT-LONDON, V107, P1141, DOI 10.1093/aob/mcr034; Adams-Phillips L, 2008, MOL PLANT MICROBE IN, V21, P646, DOI 10.1094/MPMI-21-5-0646; Adams-Phillips L, 2010, PLANT PHYSIOL, V152, P267, DOI 10.1104/pp.109.148049; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Amor Y, 1998, FEBS LETT, V440, P1, DOI 10.1016/S0014-5793(98)01408-2; Babiychuk E, 2001, PLANT J, V28, P245, DOI 10.1046/j.1365-313X.2001.01143.x; Babiychuk E, 1998, PLANT J, V15, P635, DOI 10.1046/j.1365-313x.1998.00240.x; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; BANASIK M, 1992, J BIOL CHEM, V267, P1569; Baroja-Fernandez E, 2012, P NATL ACAD SCI USA, V109, P321, DOI 10.1073/pnas.1117099109; Berglund T, 1996, FEBS LETT, V380, P188, DOI 10.1016/0014-5793(96)00027-0; Boruc J, 2010, PLANT CELL, V22, P1264, DOI 10.1105/tpc.109.073635; Boruc J, 2010, PLANT PHYSIOL, V152, P553, DOI 10.1104/pp.109.148643; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Briggs AG, 2011, TRENDS PLANT SCI, V16, P372, DOI 10.1016/j.tplants.2011.03.008; Burkle A, 2013, MOL ASPECTS MED, V34, P1046, DOI 10.1016/j.mam.2012.12.010; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; CHEN YM, 1994, EUR J BIOCHEM, V224, P135, DOI 10.1111/j.1432-1033.1994.tb20004.x; Claeys H, 2012, PLANT PHYSIOL, V159, P739, DOI 10.1104/pp.112.195032; Cuadros-Inostroza A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-428; De Block M, 2005, PLANT J, V41, P95, DOI 10.1111/j.1365-313X.2004.02277.x; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Doucet-Chabeaud G, 2001, MOL GENET GENOMICS, V265, P954, DOI 10.1007/s004380100506; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Ford KA, 2010, P NATL ACAD SCI USA, V107, P17527, DOI 10.1073/pnas.1013020107; Fujiki Y, 2005, PLANT CELL PHYSIOL, V46, P1741, DOI 10.1093/pcp/pci174; Fujiki Y, 2001, PHYSIOL PLANTARUM, V111, P345, DOI 10.1034/j.1399-3054.2001.1110312.x; Fujikura U, 2007, PLANT CELL PHYSIOL, V48, P278, DOI 10.1093/pcp/pcm002; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gebbie LK, 2005, J EXP BOT, V56, P1079, DOI 10.1093/jxb/eri099; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giacomelli L, 2006, PLANT PHYSIOL, V141, P685, DOI 10.1104/pp.106.080150; Giavalisco P, 2009, ANAL CHEM, V81, P6546, DOI 10.1021/ac900979e; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gonzalez N, 2010, PLANT PHYSIOL, V153, P1261, DOI 10.1104/pp.110.156018; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; Hannah MA, 2010, PLANT PHYSIOL, V152, P2120, DOI 10.1104/pp.109.147306; Hashida SN, 2009, ANN BOT-LONDON, V103, P819, DOI 10.1093/aob/mcp019; Heyman J, 2011, PLANT CELL, V23, P4394, DOI 10.1105/tpc.111.091793; Hutin C, 2003, P NATL ACAD SCI USA, V100, P4921, DOI 10.1073/pnas.0736939100; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Jaspers P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-170; Jia Q, 2013, PLANT MOL BIOL, V82, P339, DOI 10.1007/s11103-013-0065-9; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Poupin MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069435; Kircher S, 2012, P NATL ACAD SCI USA, V109, P11217, DOI 10.1073/pnas.1203746109; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; KUPPER JH, 1995, BIOCHIMIE, V77, P450, DOI 10.1016/0300-9084(96)88159-4; LEPINIEC L, 1995, FEBS LETT, V364, P103, DOI 10.1016/0014-5793(95)00335-7; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Ogawa T, 2009, PLANT J, V57, P289, DOI 10.1111/j.1365-313X.2008.03686.x; Page M, 2012, PLANT CELL ENVIRON, V35, P388, DOI 10.1111/j.1365-3040.2011.02369.x; Panda S, 2002, DEV CELL, V3, P51, DOI 10.1016/S1534-5807(02)00200-9; Pellny TK, 2009, MOL PLANT, V2, P442, DOI 10.1093/mp/ssp008; PHILLIPS R, 1985, J EXP BOT, V36, P119, DOI 10.1093/jxb/36.1.119; Pourcel L, 2013, PLANT J, V74, P383, DOI 10.1111/tpj.12129; Preuss SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030717; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Ruf A, 1996, P NATL ACAD SCI USA, V93, P7481, DOI 10.1073/pnas.93.15.7481; Schulz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037287; Skirycz A, 2011, PLANT CELL, V23, P1876, DOI 10.1105/tpc.111.084160; Skirycz A, 2010, PLANT PHYSIOL, V152, P226, DOI 10.1104/pp.109.148965; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; Storozhenko S, 2001, J EXP BOT, V52, P1375, DOI 10.1093/jexbot/52.359.1375; Sulpice R, 2009, P NATL ACAD SCI USA, V106, P10348, DOI 10.1073/pnas.0903478106; Thielert W., 2006, Pflanzenschutz-Nachrichten Bayer, V59, P73; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tian RH, 2000, FEBS LETT, V474, P11, DOI 10.1016/S0014-5793(00)01561-1; Trivino M, 2013, PLANT J, V75, P808, DOI 10.1111/tpj.12244; Van Leene J, 2011, TRENDS PLANT SCI, V16, P141, DOI 10.1016/j.tplants.2010.12.004; Van Leene J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.53; Vanderauwera S, 2007, P NATL ACAD SCI USA, V104, P15150, DOI 10.1073/pnas.0706668104; Vernoux T, 2000, PLANT CELL, V12, P97, DOI 10.1105/tpc.12.1.97; Weckwerth W, 2004, PROTEOMICS, V4, P78, DOI 10.1002/pmic.200200500; WHITBY AJ, 1979, BIOCHEM BIOPH RES CO, V90, P1295, DOI 10.1016/0006-291X(79)91177-X; WILLMITZER L, 1979, FEBS LETT, V108, P13, DOI 10.1016/0014-5793(79)81167-9; Xiang CB, 2001, PLANT PHYSIOL, V126, P564, DOI 10.1104/pp.126.2.564; Yao YY, 2009, J INTEGR PLANT BIOL, V51, P35, DOI 10.1111/j.1744-7909.2008.00792.x; Zeeman SC, 1998, PLANT CELL, V10, P1699, DOI 10.1105/tpc.10.10.1699	87	26	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90322	10.1371/journal.pone.0090322	http://dx.doi.org/10.1371/journal.pone.0090322			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587323	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200169
J	Wang, HP; Ke, ZJ; Alimov, A; Xu, M; Frank, JA; Fang, SY; Luo, J				Wang, Haiping; Ke, Zunji; Alimov, Alexander; Xu, Mei; Frank, Jacqueline A.; Fang, Shengyun; Luo, Jia			Spatiotemporal Expression of MANF in the Developing Rat Brain	PLOS ONE			English	Article							ARGININE-RICH PROTEIN; NEUROTROPHIC FACTOR; DOPAMINERGIC-NEURONS; STRESS; GENE; ISCHEMIA; ORGANIZATION; ANXIETY; MATRIX; ARMET	Mesencephalic astrocyte-derived neurotrophic factor (MANF) is an evolutionarily conserved neurotrophic factor which exhibited neuroprotective properties. Recent studies suggested that MANF may play a role in the neural development of Drosophila and zebra fishes. In this study, we investigated the spatiotemporal expression of MANF in the brain of postnatal and adult rats. MANF expression appeared wide spread and mainly localized in neurons. In the cerebral cortex, neurons in layer IV and VI displayed particularly strong MANF immunoreactivity. In the hippocampus, intensive MANF expression was observed throughout the subfields of Cornu Amonis (CA1, CA2, and CA3) and the granular layer of the dentate gyrus (DG). In the substantia nigra, high MANF expression was shown in the substantia nigra pars compacta (SNpc). In the thalamus, the anterodorsal thalamic nucleus (ADTN) exhibited the highest MANF immunoreactivity. In the hypothalamus, intensive MANF immunoreactivity was shown in the supraoptic nucleus (SON) and tuberomammillary nucleus (TMN). In the cerebellum, MANF was localized in the external germinal layer (EGL), Purkinje cell layer (PCL), internal granule layer (IGL) and the deep cerebellar nuclei (DCN). We examined the developmental expression of MANF on postnatal day (PD) 3, 5, 7, 9, 15, 21, 30 and adulthood. In general, the levels of MANF were high in the early PDs (PD3 and PD5), and declined gradually as the brain matured; MANF expression in the adult brain was the lowest among all time points examined. However, in some structures, such as PCL, IGL, SON, TMN and locus coeruleus (LC), high expression of MANF sustained throughout the postnatal period and persisted into adulthood. Our results indicated that MANF was developmentally regulated and may play a role in the maturation of the central nervous system (CNS).	[Wang, Haiping; Alimov, Alexander; Xu, Mei; Frank, Jacqueline A.; Luo, Jia] Univ Kentucky, Coll Med, Dept Mol & Biochem Pharmacol, Lexington, KY 40506 USA; [Ke, Zunji] Chinese Acad Sci, SIBS, Inst Nutr Sci, Shanghai, Peoples R China; [Fang, Shengyun] Univ Maryland, Sch Med, Dept Physiol, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA	University of Kentucky; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University System of Maryland; University of Maryland Baltimore	Luo, J (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Biochem Pharmacol, Lexington, KY 40506 USA.	jialuo888@uky.edu	Ke, Zun-Ji/N-5689-2014; Ke, Zunji/E-4822-2010; Fang, Shengyun/H-3802-2011; Luo, Jia/E-4674-2012	Ke, Zun-Ji/0000-0003-4038-2456; Ke, Zunji/0000-0003-4038-2456; Luo, Jia/0000-0002-6968-3618; Fang, Shengyun/0000-0001-7280-5463	National Institutes of Health (NIH) [AA015407-09]; National Natural and Science Foundation of China [81100247]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015407] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001721] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural and Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This research is supported by National Institutes of Health (NIH) (AA015407-09) and National Natural and Science Foundation of China (81100247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airavaara M, 2009, J COMP NEUROL, V515, P116, DOI 10.1002/cne.22039; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Ayoub AE, 2005, J COMP NEUROL, V481, P403, DOI 10.1002/cne.20375; Chang MS, 2000, NEUROSCIENCE, V101, P131, DOI 10.1016/S0306-4522(00)00352-3; Chen YC, 2012, DEV BIOL, V370, P237, DOI 10.1016/j.ydbio.2012.07.030; Chen YC, 2012, DEV BIOL; Evron E, 1997, CANCER RES, V57, P2888; Glembotski CC, 2012, J BIOL CHEM, V287, P25893, DOI 10.1074/jbc.M112.356345; Hellman M, 2011, J BIOL CHEM, V286, P2675, DOI 10.1074/jbc.M110.146738; Itoi K, 2010, J NEUROENDOCRINOL, V22, P355, DOI 10.1111/j.1365-2826.2010.01988.x; Jones EG, 1998, NEUROSCIENCE, V85, P331, DOI 10.1016/S0306-4522(97)00581-2; Ke ZJ, 2011, ALCOHOL CLIN EXP RES, V35, P1574, DOI 10.1111/j.1530-0277.2011.01503.x; Lam YW, 2010, CEREB CORTEX, V20, P13, DOI 10.1093/cercor/bhp077; Lindholm P, 2008, MOL CELL NEUROSCI, V39, P356, DOI 10.1016/j.mcn.2008.07.016; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Mizobuchi N, 2007, CELL STRUCT FUNCT, V32, P41, DOI 10.1247/csf.07001; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Palgi M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-134; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Shen YJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-254; Shridhar V, 1996, ONCOGENE, V12, P1931; Suarez MM, 2004, STRESS, V7, P195, DOI 10.1080/10253890400010705; Tadimalla A, 2008, CIRC RES, V103, P1249, DOI 10.1161/CIRCRESAHA.108.180679; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Yu YQ, 2010, J CEREBR BLOOD F MET, V30, P79, DOI 10.1038/jcbfm.2009.181	26	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90433	10.1371/journal.pone.0090433	http://dx.doi.org/10.1371/journal.pone.0090433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587361	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200196
J	Xue, Y; Vashisht, AA; Tan, YL; Su, T; Wohlschlegel, JA				Xue, Yong; Vashisht, Ajay A.; Tan, Yuliang; Su, Trent; Wohlschlegel, James A.			PRB1 Is Required for Clipping of the Histone H3 N Terminal Tail in Saccharomyces cerevisiae	PLOS ONE			English	Article							PROTEASE-B; YEAST PROTEOME; IDENTIFICATION; ACETYLATION; GENE; PURIFICATION; PROTEINS; EXPRESSION; REPRESSION; MUTATIONS	Cathepsin L, a lysosomal protein in mouse embryonic stem cells has been shown to clip the histone H3 N-terminus, an activity associated with gene activity during mouse cell development. Glutamate dehydrogenase (GDH) was also identified as histone H3 specific protease in chicken liver, which has been connected to gene expression during aging. In baker's yeast, Saccharomyces cerevisiae, clipping the histone H3 N-terminus has been associated with gene activation in stationary phase but the protease responsible for the yeast histone H3 endopeptidase activity had not been identified. In searching for a yeast histone H3 endopeptidase, we found that yeast vacuolar protein Prb1 is present in the cellular fraction enriched for the H3 N-terminus endopeptidase activity and this endopeptidase activity is lost in the PRB1 deletion mutant (prb1D). In addition, like Cathepsin L and GDH, purified Prb1 from yeast cleaves H3 between Lys23 and Ala24 in the N-terminus in vitro as shown by Edman degradation. In conclusion, our data argue that PRB1 is required for clipping of the histone H3 N-terminal tail in Saccharomyces cerevisiae.	[Xue, Yong; Vashisht, Ajay A.; Tan, Yuliang; Su, Trent; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Xue, Y (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	yong.xue@outlook.com	xue, yong/F-3527-2011	xue, yong/0000-0002-7229-7232	National Institutes of Health [GM42421, GM23674]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023674, R37GM023674, R01GM089778, R01GM042421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM42421 and GM23674) to Michael Grunstein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Chatterjee N, 2011, NUCLEIC ACIDS RES, V39, P8378, DOI 10.1093/nar/gkr535; Chen XF, 2012, CURR BIOL, V22, P56, DOI 10.1016/j.cub.2011.11.042; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Feser J, 2011, FEBS LETT, V585, P2041, DOI 10.1016/j.febslet.2010.11.016; FUJISHIRO K, 1980, J BIOCHEM-TOKYO, V87, P1321, DOI 10.1093/oxfordjournals.jbchem.a132870; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hiwasa T, 1996, CANCER LETT, V99, P87, DOI 10.1016/0304-3835(95)04041-2; Kaiser P, 2005, METHOD ENZYMOL, V399, P266, DOI 10.1016/S0076-6879(05)99018-6; Kitada T, 2012, GENE DEV, V26, P2443, DOI 10.1101/gad.201095.112; Kizer KO, 2006, METHODS, V40, P296, DOI 10.1016/j.ymeth.2006.06.022; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Ling XF, 1996, GENE DEV, V10, P686, DOI 10.1101/gad.10.6.686; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mandal P, 2013, J BIOL CHEM, V288, P18743, DOI 10.1074/jbc.M113.462531; Mandal P, 2012, BIOCHEM BIOPH RES CO, V421, P261, DOI 10.1016/j.bbrc.2012.03.149; MANN RK, 1992, EMBO J, V11, P3297, DOI 10.1002/j.1460-2075.1992.tb05408.x; MOEHLE CM, 1990, GENETICS, V124, P39; MOEHLE CM, 1987, MOL CELL BIOL, V7, P4390, DOI 10.1128/MCB.7.12.4390; MOEHLE CM, 1989, J CELL BIOL, V108, P309, DOI 10.1083/jcb.108.2.309; MOEHLE CM, 1987, GENETICS, V115, P255; NOWAK J, 1989, CAN J MICROBIOL, V35, P295, DOI 10.1139/m89-044; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Purohit JS, 2013, BIOCHIMIE, V95, P1999, DOI 10.1016/j.biochi.2013.07.005; SAHEKI T, 1975, BIOCHIM BIOPHYS ACTA, V384, P203, DOI 10.1016/0005-2744(75)90109-6; Santos-Rosa H, 2009, NAT STRUCT MOL BIOL, V16, P17, DOI 10.1038/nsmb.1534; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Sperling AS, 2009, P NATL ACAD SCI USA, V106, P13153, DOI 10.1073/pnas.0906866106; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; THOMPSON JS, 1994, NATURE, V369, P245, DOI 10.1038/369245a0; ULANE RE, 1976, J BIOL CHEM, V251, P3367; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; WAN JS, 1995, P NATL ACAD SCI USA, V92, P5664, DOI 10.1073/pnas.92.12.5664; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wohlschlegel James A., 2009, V497, P33, DOI 10.1007/978-1-59745-566-4_3; WOLF DH, 1979, EUR J BIOCHEM, V98, P375, DOI 10.1111/j.1432-1033.1979.tb13197.x	43	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90496	10.1371/journal.pone.0090496	http://dx.doi.org/10.1371/journal.pone.0090496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587380	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200214
J	Gu, WJ; Wan, YD; Tie, HT; Kan, QC; Sun, TW				Gu, Wan-Jie; Wan, You-Dong; Tie, Hong-Tao; Kan, Quan-Cheng; Sun, Tong-Wen			Risk of Acute Lung Injury/Acute Respiratory Distress Syndrome in Critically Ill Adult Patients with Pre-Existing Diabetes: A Meta-Analysis	PLOS ONE			English	Article							INTENSIVE INSULIN THERAPY; GLYCATION END-PRODUCTS; NEUTROPHIL MIGRATION; PREDICTION SCORE; MORTALITY; OUTCOMES; RECEPTOR; IDENTIFICATION; SEPSIS	Background: The impact of pre-existing diabetes on the development of acute lung injury/acute respiratory distress syndrome (ALI/ARDS) in critically ill patients remains unclear. We performed a meta-analysis of cohort studies to evaluate the risk of ALI/ARDS in critically ill patients with and without pre-existing diabetes. Materials and Methods: We searched PubMed and Embase from the inception to September 2013 for cohort studies assessing the effect of pre-existing diabetes on ALI/ARDS occurrence. Pooled odds ratio (OR) with 95% confidence interval (CI) was calculated using random-or fixed-effect models when appropriate. Results: Seven cohort studies with a total of 12,794 participants and 2,937 cases of pre-existing diabetes, and 2,457 cases of ALI/ARDS were included in the meta-analysis. A fixed-effects model meta-analysis showed that pre-existing diabetes was associated with a reduced risk of ALI/ARDS (OR 0.66; 95% CI, 0.55-0.80; p<0.001), with low heterogeneity among the studies (I-2 = 18.9%; p = 0.286). However, the asymmetric funnel plot and Egger's test (p = 0.007) suggested publication bias may exist. Conclusions: Our meta-analysis suggests that pre-existing diabetes was associated with a decreased risk of ALI/ARDS in critically ill adult patients. However, the result should be interpreted with caution because of the potential bias and confounding in the included studies.	[Gu, Wan-Jie] Guangxi Med Univ, Affiliated Hosp 1, Dept Anaesthesiol, Nanning, Peoples R China; [Gu, Wan-Jie; Wan, You-Dong; Sun, Tong-Wen] Zhengzhou Univ, Affiliated Hosp 1, Dept Integrated Intens Care Unit, Zhengzhou, Peoples R China; [Tie, Hong-Tao] Chongqing Med Univ, Affiliated Hosp 1, Coll Clin Med 1, Chongqing, Peoples R China; [Kan, Quan-Cheng] Zhengzhou Univ, Affiliated Hosp 1, Dept Pharmaceut, Zhengzhou, Peoples R China	Guangxi Medical University; Zhengzhou University; Chongqing Medical University; Zhengzhou University	Sun, TW (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Integrated Intens Care Unit, Zhengzhou, Peoples R China.	tongwensun1964@sina.com	Sun, Tongwen/AAQ-7741-2020; Gu, Wan-Jie/AAN-5417-2020; Tie, Hongtao/X-7863-2019; Tie, Hongtao/ACH-7435-2022	Gu, Wan-Jie/0000-0003-4923-8282; Tie, Hongtao/0000-0003-1058-6407; 				BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Calfee CS, 2008, THORAX, V63, P1083, DOI 10.1136/thx.2008.095588; Cartin-Ceba R, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/691013; Cepkova M, 2006, CRIT CARE, V10, DOI 10.1186/cc5037; Christiansen CF, 2013, EUR J CLIN INVEST, V43, P238, DOI 10.1111/eci.12036; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Filgueiras LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044987; Gajic O, 2005, INTENS CARE MED, V31, P922, DOI 10.1007/s00134-005-2625-1; Gajic O, 2011, AM J RESP CRIT CARE, V183, P462, DOI 10.1164/rccm.201004-0549OC; Genovese T, 2005, SHOCK, V24, P547, DOI 10.1097/01.shk.0000190825.28783.a4; Gong MN, 2010, THORAX, V65, P44, DOI 10.1136/thx.2009.117572; Gong MN, 2005, CRIT CARE MED, V33, P1191, DOI 10.1097/01.CCM.0000165566.82925.14; Graham BB, 2010, CRIT CARE MED, V38, P16, DOI 10.1097/CCM.0b013e3181b9eaa5; Hansen TK, 2003, J CLIN ENDOCR METAB, V88, P1082, DOI 10.1210/jc.2002-021478; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Honiden S, 2009, CRIT CARE MED, V37, P2455, DOI 10.1097/CCM.0b013e3181a0fea5; Iscimen R, 2008, CRIT CARE MED, V36, P1518, DOI 10.1097/CCM.0b013e31816fc2c0; Janz DR, 2013, SEMIN RESP CRIT CARE, V34, P537, DOI 10.1055/s-0033-1351124; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Koh GCKW, 2012, CRIT CARE MED, V40, P1835, DOI 10.1097/CCM.0b013e31824e1696; KOLLEF MH, 1995, NEW ENGL J MED, V332, P27, DOI 10.1056/NEJM199501053320106; Krein PM, 2003, AM J RESP CRIT CARE, V167, P83, DOI 10.1164/rccm.2201012; Mangialardi RJ, 2000, CRIT CARE MED, V28, P3137, DOI 10.1097/00003246-200009000-00001; Mestriner FLAC, 2007, P NATL ACAD SCI USA, V104, P19595, DOI 10.1073/pnas.0709681104; Moss M, 1996, JAMA-J AM MED ASSOC, V275, P50, DOI 10.1001/jama.275.1.50; Moss M, 2000, CRIT CARE MED, V28, P2187, DOI 10.1097/00003246-200007000-00001; Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976; Schnapp LM, 2006, AM J PATHOL, V169, P86, DOI 10.2353/ajpath.2006.050612; Siegelaar SE, 2011, CRIT CARE, V15, DOI 10.1186/cc10440; Spiller F, 2012, DIABETES, V61, P1584, DOI 10.2337/db11-0825; Stegenga ME, 2010, CRIT CARE MED, V38, P539, DOI 10.1097/CCM.0b013e3181c02726; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Trillo-Alvarez C, 2011, EUR RESPIR J, V37, P604, DOI 10.1183/09031936.00036810; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8866; Wells G., 2013, NEWCASTLE OTTAWA SCA; Yu S, 2013, CRIT CARE MED, V41, P2720, DOI 10.1097/CCM.0b013e318298a2eb; Zhang HY, 2008, AM J RESP CRIT CARE, V178, P356, DOI 10.1164/rccm.200707-1069OC; Zmijewski JW, 2008, AM J RESP CRIT CARE, V178, P168, DOI 10.1164/rccm.200710-1602OC	41	27	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90426	10.1371/journal.pone.0090426	http://dx.doi.org/10.1371/journal.pone.0090426			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587357	gold, Green Published, Green Submitted			2022-12-27	WOS:000332390800108
J	Kinaston, R; Buckley, H; Valentin, F; Bedford, S; Spriggs, M; Hawkins, S; Herrscher, E				Kinaston, Rebecca; Buckley, Hallie; Valentin, Frederique; Bedford, Stuart; Spriggs, Matthew; Hawkins, Stuart; Herrscher, Estelle			Lapita Diet in Remote Oceania: New Stable Isotope Evidence from the 3000-Year-Old Teouma Site, Efate Island, Vanuatu	PLOS ONE			English	Article							WATER FISH CONSUMPTION; BONE-COLLAGEN; CARBON-ISOTOPE; NEW-GUINEA; TERRESTRIAL COMPONENTS; MANGROVE COMMUNITY; C-13/C-12 RATIOS; SULFUR ISOTOPES; ORGANIC-MATTER; FAUNAL REMAINS	Remote Oceania was colonized ca. 3000 BP by populations associated with the Lapita Cultural Complex, marking a major event in the prehistoric settlement of the Pacific Islands. Although over 250 Lapita sites have been found throughout the Western Pacific, human remains associated with Lapita period sites are rare. The site of Teouma, on Efate Island, Vanuatu has yielded the largest burial assemblage (n = 68 inhumations) of Lapita period humans ever discovered, providing a unique opportunity for assessing human adaptation to the environment in a colonizing population. Stable isotope ratios (delta C-13, delta N-15, delta S-34) of human bone collagen from forty-nine Teouma adults were analyzed against a comprehensive dietary baseline to assess the paleodiet of some of Vanuatu's earliest inhabitants. The isotopic dietary baseline included both modern plants and animals (n = 98) and prehistoric fauna from the site (n = 71). The human stable isotope data showed that dietary protein at Teouma included a mixture of reef fish and inshore organisms and a variety of higher trophic marine (e. g. marine turtle) and terrestrial animals (e. g. domestic animals and fruit bats). The domestic pigs and chickens at Teouma primarily ate food from a C-3 terrestrial environment but their delta N-15 values indicated that they were eating foods from higher trophic levels than those of plants, such as insects or human fecal matter, suggesting that animal husbandry at the site may have included free range methods. The dietary interpretations for the humans suggest that broad-spectrum foraging and the consumption of domestic animals were the most important methods for procuring dietary protein at the site. Males displayed significantly higher delta N-15 values compared with females, possibly suggesting dietary differences associated with labor specialization or socio-cultural practices relating to food distribution.	[Kinaston, Rebecca; Buckley, Hallie] Univ Otago, Dept Anat, Dunedin, New Zealand; [Valentin, Frederique] CNRS, Nanterre, France; [Bedford, Stuart] Australian Natl Univ, Dept Archaeol & Nat Hist, Coll Asia & Pacific, Canberra, ACT, Australia; [Spriggs, Matthew; Hawkins, Stuart] Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT, Australia; [Herrscher, Estelle] Aix Marseille Univ, CNRS, Lab Mediterraneen Prehist Europe Afrique, Aix En Provence, France	University of Otago; Centre National de la Recherche Scientifique (CNRS); Australian National University; Australian National University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Kinaston, R (corresponding author), Univ Otago, Dept Anat, Dunedin, New Zealand.	rebecca.kinaston@anatomy.otago.ac.nz	Buckley, Hallie/Q-5458-2019	Bedford, Stuart/0000-0001-6476-5617; Spriggs, Matthew/0000-0002-7293-6778; Valentin, Frederique/0000-0002-0575-7681	Australian Research Council (ARC) [DP 0556874]; Pacific Biological Foundation [PBF04-1]; National Geographic Scientific Research Grant [8038-06]; ARC Discovery Grant [DP 0556874, DP 0880789]; Two Royal Society of New Zealand Marsden Grants [04-UOO-007, 09-UOO-106]; University of Otago Research Grant; CNRS: Aix-Marseille Universite; MCC/CNRS (UMR LAMPEA); UMR ArScAn	Australian Research Council (ARC)(Australian Research Council); Pacific Biological Foundation; National Geographic Scientific Research Grant(National Geographic Society); ARC Discovery Grant(Australian Research Council); Two Royal Society of New Zealand Marsden Grants; University of Otago Research Grant; CNRS: Aix-Marseille Universite; MCC/CNRS (UMR LAMPEA); UMR ArScAn	Funding of the project during 2004 and 2005 was provided by the Australian Research Council (ARC) (DP 0556874, www.arc.gov.au), Pacific Biological Foundation (PBF04-1, www.apscience.org.au). The excavations in 2006 were funded primarily through a National Geographic Scientific Research Grant (8038-06, www.nationalgeographic.com/explorers/), with further support from the ARC Discovery Grant (DP 0556874, www.arc.gov.au). Excavations from 2008 to 2010 were primarily funded by an ARC Discovery Grant (DP 0880789, www.arc.gov.au). Funding for the excavation and analysis of the humans remains, prehistoric fauna and collection and analysis of the modern plants and animals was provided by Two Royal Society of New Zealand Marsden Grants (04-UOO-007 and 09-UOO-106, http://www.royalsociety.org.nz/programmes/funds/marsden/) and a University of Otago Research Grant during 2009 (no number, http://www.otago.ac.nz/research/otago004140.html). Further funding for the stable isotope analysis was provided by CNRS: Aix-Marseille Universite, MCC/CNRS (UMR 7269 LAMPEA, http://lampea.cnrs.fr/) and UMR 7041 ArScAn, http://www.mae.u-paris10.fr/arscan/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL KM, 1984, PLANT PHYSIOL, V76, P776, DOI 10.1104/pp.76.3.776; Allen MS, 2009, PAC SCI, V63, P477, DOI 10.2984/049.063.0403; Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; Ambrose S.H., 1993, INVESTIGATIONS ANCIE, P59; Ambrose SH, 1997, AM J PHYS ANTHROPOL, V104, P343; Ambrose SH, 2003, J ANTHROPOL ARCHAEOL, V22, P217, DOI 10.1016/S0278-4165(03)00036-9; Anderson A, 2002, WORLD ARCHAEOL, V33, P375, DOI 10.1080/00438240120107431; Arthur KE, 2008, MAR ECOL PROG SER, V362, P303, DOI 10.3354/meps07440; Athfield NB, 2008, J ROY SOC NEW ZEAL, V38, P1, DOI 10.1080/03014220809510543; Banack SA, 1998, ECOLOGY, V79, P1949, DOI 10.1890/0012-9658(1998)079[1949:DSARUB]2.0.CO;2; BARRAU J, 1965, ETHNOLOGY, V4, P282, DOI 10.2307/3772988; Bashan Y, 2002, TREES-STRUCT FUNCT, V16, P159, DOI 10.1007/s00468-001-0152-4; Bedford S., 2009, NZ ARCHAEOLOGICAL AS, V28, P215; Bedford S, 2011, LAPITA OCEANIC ANCES, P141; Bedford S., 2006, PIECES VANUATU PUZZL; Bedford S, 2007, TERRA AUSTRALIS, V26, P1; Bedford S, 2006, ANTIQUITY, V80, P812, DOI 10.1017/S0003598X00094448; BEER S, 1979, AQUAT BOT, V7, P129, DOI 10.1016/0304-3770(79)90017-2; Bell FLS, 1931, OCEANIA, V2, P117, DOI 10.1002/j.1834-4461.1931.tb01661.x; Bellwood P, 2006, COMP AUSTRO SER, P19; Biasatti DM, 2004, PALAEOGEOGR PALAEOCL, V206, P203, DOI 10.1016/j.palaeo.2004.01.004; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; BOCHERENS H, 1991, J HUM EVOL, V20, P481, DOI 10.1016/0047-2484(91)90021-M; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; Buikstra J. E., 1994, STANDARDS DATA COLLE; Burley DV., 2001, ARCHAEOL OCEAN, V36, P89, DOI [10.1002/j.1834-4453.2001.tb00481.x, DOI 10.1002/J.1834-4453.2001.TB00481.X]; Canfield DE, 2001, REV MINERAL GEOCHEM, V43, P607, DOI 10.2138/gsrmg.43.1.607; Casu D, 2009, AQUAT ECOL, V43, P1023, DOI 10.1007/s10452-008-9223-6; Clark G, 2013, ARCHAEOL OCEAN, V48, P141, DOI 10.1002/arco.5012; Cohen M.N., 1989, HLTH RISE CIVILIZATI; Cohen MN, 1984, PALEOPATHOLGY ORIGIN; Collins M., 1998, ANCIENT BIOMOLECULES, V2, P209; Craig OE, 2006, J ARCHAEOL SCI, V33, P1642, DOI 10.1016/j.jas.2006.05.006; Craig OE, 2010, J ARCHAEOL SCI, V37, P2504, DOI 10.1016/j.jas.2010.05.010; Currie TE, 2010, NATURE, V467, P801, DOI 10.1038/nature09461; DAVIDSON J, 2002, NZ ARCHAEOLOGICAL AS, V25, P153; DAVIDSON J, 2001, ARCHAEOLOGY LAPITA D, V17, P115; Davidson JM, 2012, ARCHAEOL OCEAN, V47, P1; Denham T, 2004, REC AUST MUS, P47; Denham TP, 2003, SCIENCE, V301, P189, DOI 10.1126/science.1085255; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Faure G., 1977, PRINCIPLES ISOTOPE G; Field JS, 2009, J ARCHAEOL SCI, V36, P1547, DOI 10.1016/j.jas.2009.03.016; Firth Raymond, 1967, WORK GODS TIKOPIA; Flannery T. F., 1995, MAMMALS SW PACIFIC M; Froehle AW, 2012, AM J PHYS ANTHROPOL, V147, P352, DOI 10.1002/ajpa.21651; Froehle AW, 2010, J ARCHAEOL SCI, V37, P2662, DOI 10.1016/j.jas.2010.06.003; FRY B, 1983, AUST J MAR FRESH RES, V34, P707; FRY B, 1982, GEOCHIM COSMOCHIM AC, V46, P1121, DOI 10.1016/0016-7037(82)90063-1; GALIPAUD JC, 2000, WORLD ARCHAEOLOGICAL, V12, P41; Golson J., 1990, PACIFIC PRODUCTION S, V18, P139; Green R.C., 1976, SE SOLOMON ISLANDS C, P245; Green R.C., 1979, PREHISTORY POLYNESIA, P27; Green R.C., 1991, MAN HALF ESSAYS PACI, P491; Green R. C., 1997, NZ J ARCHAEOL, V17, P5; Green RC, 1974, MANKIND, V9, P253; GROSS GF, 1975, PHILOS T ROY SOC B, V272, P391, DOI 10.1098/rstb.1975.0095; GROUBE LM, 1971, J POLYNESIAN SOC, V80, P278; Guiry EJ, 2012, J ARCHAEOL METHOD TH, V19, P351, DOI 10.1007/s10816-011-9118-z; Hage P., 1999, ASIAN PERSPECT, V38, P200; Hayden B, 1983, B INDOPACIFIC PREHIS, V4, P123; Hedges REM, 2007, AM J PHYS ANTHROPOL, V133, P808, DOI 10.1002/ajpa.20598; Hide R., 2003, ACIAR MONOGRAPH, V108; Horrocks M, 2014, J ROY SOC NEW ZEAL, V44, P17, DOI 10.1080/03036758.2013.842177; Horrocks M, 2010, NEW ZEAL J BOT, V48, P179, DOI 10.1080/0028825X.2010.502238; Horrocks M, 2009, J ARCHAEOL SCI, V36, P2048, DOI 10.1016/j.jas.2009.05.024; Horrocks M, 2007, J ARCHAEOL SCI, V34, P739, DOI 10.1016/j.jas.2006.07.011; Horrocks Mark, 2005, Archaeology in Oceania, V40, P67; Jenkins SG, 2001, OECOLOGIA, V129, P336, DOI 10.1007/s004420100755; Jim S, 2004, GEOCHIM COSMOCHIM AC, V68, P61, DOI 10.1016/S0016-7037(03)00216-3; Jones S, 2009, J ARCHAEOL SCI, V36, P2742, DOI 10.1016/j.jas.2009.08.014; Katzenberg M. A., 2008, BIOL ANTHR HUMAN SKE, V2, P413; Katzenberg MA, 2012, J ARCHAEOL SCI, V39, P2612, DOI 10.1016/j.jas.2011.08.010; Katzenberg M. Anne, 1995, BODIES EVIDENCE RECO, P221; KEEGAN WF, 1988, AM ANTIQUITY, V53, P320, DOI 10.2307/281022; Keenleyside A, 2009, J ARCHAEOL SCI, V36, P51, DOI 10.1016/j.jas.2008.07.008; Kellner CM, 2007, AM J PHYS ANTHROPOL, V133, P1112, DOI 10.1002/ajpa.20618; Kennett D, 2006, ORIG HUM BEHAV, V1, P265; Keppel G, 2008, J BIOGEOGR, V35, P1004, DOI 10.1111/j.1365-2699.2007.01869.x; Kinaston RL, 2009, J ARCHAEOL SCI, V36, P2780, DOI 10.1016/j.jas.2009.09.004; Kinaston R, 2013, J ARCHAEOL SCI, V40, P904, DOI 10.1016/j.jas.2012.09.002; Kinaston RL, 2013, AM J PHYS ANTHROPOL, V151, P589, DOI 10.1002/ajpa.22314; Kirch PV, 2003, WORLD ARCHAEOL, V34, P484, DOI 10.1080/0043824021000026468; KIRCH PV, 1979, J POLYNESIAN SOC, V88, P53; KIRCH PV, 1997, LAPITA PEOPLES ANCES; KIRCH PV, 2000, ROAD WINDS ARCHAEOLO; Kirsch P., 2001, FEASTS ARCHAEOLOGICA, P168; Krouse H. R., 1989, Ecological Studies, V68, P424; KROUSE H.R., 1988, DIET SUBSISTENCE CUR, P315; Krouse HR., 1987, APPL GEOCHEM, V2, P205, DOI DOI 10.1016/0883-2927(87)90034-5; KUSAKABE M, 1976, NEW ZEAL J SCI, V19, P433; Le Huray JD, 2005, J ANTHROPOL ARCHAEOL, V24, P135, DOI 10.1016/j.jaa.2004.09.002; Leach B, 2003, NZ J ARCHAEOL, V23, P31; LEACH BF, 1996, TUHINGA REC MUS N Z, P1; Leach H, 2003, WORLD ARCHAEOL, V34, P442, DOI 10.1080/0043824021000026440; Lebot V, 1997, KAVA PACIFIC ELIXIR; Linderholm A, 2008, ANTIQUITY, V82, P446, DOI 10.1017/S0003598X00096939; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; MARSHALL AG, 1976, BIOL J LINN SOC, V8, P319, DOI 10.1111/j.1095-8312.1976.tb00253.x; McClatchey WC, 2012, ACTA SOC BOT POL, V81, P371, DOI 10.5586/asbp.2012.034; Mead JI, 2002, COPEIA, P632; Medway L, 1975, BIOL SCI, V272, P423; Mekhtiyeva V. L., 1976, GEOCHEM INT, V13, P82; Meyer E, 2008, RAFFLES B ZOOL, P41; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Muldner G, 2007, AM J PHYS ANTHROPOL, V133, P682, DOI 10.1002/ajpa.20561; Muzuka ANN, 2006, ESTUAR COAST SHELF S, V66, P447, DOI 10.1016/j.ecss.2005.10.007; Nehlich O, 2012, AM J PHYS ANTHROPOL, V149, P115, DOI 10.1002/ajpa.22104; Nehlich O, 2011, GEOCHIM COSMOCHIM AC, V75, P4963, DOI 10.1016/j.gca.2011.06.009; Nehlich O, 2010, J ARCHAEOL SCI, V37, P1131, DOI 10.1016/j.jas.2009.12.013; Nehlich O, 2009, ARCHAEOL ANTHROP SCI, V1, P59, DOI 10.1007/s12520-009-0003-6; Nelson SL, 2000, ECOGRAPHY, V23, P393, DOI 10.1034/j.1600-0587.2000.230402.x; Nimoho LT, 2000, FRESHWATER FISH CRUS; Nriagu J.O., 1991, STABLE ISOTOPES NATU, P177; O'Connell TC, 2012, AM J PHYS ANTHROPOL, V149, P426, DOI 10.1002/ajpa.22140; O'Connell TC, 2001, J ARCHAEOL SCI, V28, P1247, DOI 10.1006/jasc.2001.0698; Oelze VM, 2012, AM J PHYS ANTHROPOL, V148, P406, DOI 10.1002/ajpa.22063; Oliver D, 1989, OCEANIA NATIVE CULTU; Oliver D., 2002, POLYNESIA EARLY HIST; Oomen H, 1958, 118 S PAC COMM; Parslow BH, 1993, THESIS U OTAGO DUNED; Petchey F, 2005, RADIOCARBON, V47, P181, DOI 10.1017/S0033822200019688; Petchey F, 2011, J ARCHAEOL SCI, V38, P29, DOI 10.1016/j.jas.2010.07.029; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; PETERSON BJ, 1985, SCIENCE, V227, P1361, DOI 10.1126/science.227.4692.1361; Pollock N., 1992, THESE ROOTS REMAIN F; POLLOCK NJ, 1986, ETHNOLOGY, V25, P107, DOI 10.2307/3773663; Pregill GK, 2004, J HERPETOL, V38, P15, DOI 10.1670/73-03A; Privat KL, 2007, J ARCHAEOL SCI, V34, P1197, DOI 10.1016/j.jas.2006.10.008; Privat KL, 2002, J ARCHAEOL SCI, V29, P779, DOI 10.1006/jasc.2001.0785; REES CE, 1978, GEOCHIM COSMOCHIM AC, V42, P377, DOI 10.1016/0016-7037(78)90268-5; Richards MP, 2009, ARCHAEOL OCEAN, V44, P29, DOI 10.1002/j.1834-4453.2009.tb00042.x; Richards MP, 2003, INT J OSTEOARCHAEOL, V13, P37, DOI 10.1002/oa.654; Richards MP, 2001, EARTH PLANET SC LETT, V191, P185, DOI 10.1016/S0012-821X(01)00427-7; Scanlon AT, 2013, AUST J ZOOL, V61, P342, DOI 10.1071/ZO13047; SCHOENINGER MJ, 1992, J WORLD PREHIST, V6, P247, DOI 10.1007/BF00975551; SCHOENINGER MJ, 1983, SCIENCE, V220, P1381, DOI 10.1126/science.6344217; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; SCHWARCZ HP, 1991, YEARB PHYS ANTHROPOL, V34, P283; Scott RM, 2010, J ARCHAEOL SCI, V37, P901, DOI 10.1016/j.jas.2009.11.020; Sealy J., 2005, HDB ARCHAEOLOGICAL S, P269; Sheppard P, 2011, GREAT OCEAN LAPITA M, P105; SPRIGGS M, 1984, J POLYNESIAN SOC, V93, P71; Spriggs M., 1997, ISLAND MELANESIANS P; Spriggs M., 1993, OCCASIONAL PAPERS PR, V21, P187; STEADMAN DW, 1993, P NATL ACAD SCI USA, V90, P818, DOI 10.1073/pnas.90.3.818; STEADMAN DW, 1995, SCIENCE, V267, P1123, DOI 10.1126/science.267.5201.1123; Steadman DW, 1999, COLLOQ SEMI, P375; Steadman DW, 2006, EXTINCTION BIOGEOGRA; Steckel R.H., 2002, BACKBONE HIST HLTH N, DOI DOI 10.1017/CBO9780511549953.004; Storey AA, 2010, J ARCHAEOL SCI, V37, P2459, DOI 10.1016/j.jas.2010.05.006; Summerhayes G, 2001, ARCHAEOLOGY LAPITA D, V17, P25; Summerhayes Glenn R., 2001, ARCHAEOL OCEAN, V36, P53, DOI DOI 10.1002/J.1834-4453.2001.TB00478.X; Taylor JD, 2010, TOP GEOBIOL, V33, P107, DOI 10.1007/978-90-481-9572-5_5; Tieszen Larry L., 1993, MOL ARCHAEOLOGY PREH, P121, DOI DOI 10.1007/978-3-662-02894-0_5; TIESZEN LL, 1991, J ARCHAEOL SCI, V18, P227, DOI 10.1016/0305-4403(91)90063-U; TRUST BA, 1992, PLANT CELL ENVIRON, V15, P1105, DOI 10.1111/j.1365-3040.1992.tb01661.x; UBELAKER DH, 1995, AM J PHYS ANTHROPOL, V97, P403, DOI 10.1002/ajpa.1330970407; Valentin F, 2006, J ARCHAEOL SCI, V33, P1396, DOI 10.1016/j.jas.2006.01.012; Valentin F, 2010, J ISLAND CO IN PRESS; Valentin F, 2010, J ARCHAEOL SCI, V37, P1820, DOI 10.1016/j.jas.2010.01.039; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; VANDERMERWE NJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1091, DOI 10.1016/0016-7037(89)90213-5; VANDERMERWE NJ, 1991, J ARCHAEOL SCI, V18, P249, DOI 10.1016/0305-4403(91)90064-V; Vika E, 2009, J ARCHAEOL SCI, V36, P2024, DOI 10.1016/j.jas.2009.05.022; Voznesenskaya EV, 2010, J EXP BOT, V61, P3647, DOI 10.1093/jxb/erq178; Walter A, 2007, ACIR MONOGRAPH, V122; Walter A, 1993, SOC URBANISATION DEV, V15; Walter A., 2002, FRUITS OCEANIA; White A, 2010, LIBR J, V135, P107; WHITE CD, 1994, AM J PHYS ANTHROPOL, V93, P165, DOI 10.1002/ajpa.1330930203; YAMAMURO M, 1995, LIMNOL OCEANOGR, V40, P617, DOI 10.4319/lo.1995.40.3.0617; Yen D.E., 1990, PACIFIC PRODUCTION S, P258; YOSHINAGA J, 1991, ECOL FOOD NUTR, V26, P17, DOI 10.1080/03670244.1991.9991185	176	49	49	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90376	10.1371/journal.pone.0090376	http://dx.doi.org/10.1371/journal.pone.0090376			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AC4GP	24598939	Green Published, gold			2022-12-27	WOS:000332479400068
J	Pons, C; Marti, C; Forment, J; Crisosto, CH; Dandekar, AM; Granell, A				Pons, Clara; Marti, Cristina; Forment, Javier; Crisosto, Carlos H.; Dandekar, Abhaya M.; Granell, Antonio			A Bulk Segregant Gene Expression Analysis of a Peach Population Reveals Components of the Underlying Mechanism of the Fruit Cold Response	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GENE; ABSCISIC-ACID RESPONSES; GAIN-OF-FUNCTION; FREEZING TOLERANCE; CHILLING INJURY; NEGATIVE REGULATOR; LOW-TEMPERATURE; NUCLEAR-PROTEIN; STRESS-RESPONSE; PLANT-GROWTH	Peach fruits subjected for long periods of cold storage are primed to develop chilling injury once fruits are shelf ripened at room temperature. Very little is known about the molecular changes occurring in fruits during cold exposure. To get some insight into this process a transcript profiling analyses was performed on fruits from a PopDG population segregating for chilling injury CI responses. A bulked segregant gene expression analysis based on groups of fruits showing extreme CI responses indicated that the transcriptome of peach fruits was modified already during cold storage consistently with eventual CI development. Most peach cold-responsive genes have orthologs in Arabidopsis that participate in cold acclimation and other stresses responses, while some of them showed expression patterns that differs in fruits according to their susceptibility to develop mealiness. Members of ICE1, CBF1/3 and HOS9 regulons seem to have a prominent role in differential cold responses between low and high sensitive fruits. In high sensitive fruits, an alternative cold response program is detected. This program is probably associated with dehydration/osmotic stress and regulated by ABA, auxins and ethylene. In addition, the observation that tolerant siblings showed a series of genes encoding for stress protective activities with higher expression both at harvest and during cold treatment, suggests that preprogrammed mechanisms could shape fruit ability to tolerate postharvest cold-induced stress. A number of genes differentially expressed were validated and extended to individual genotypes by medium-throughput RT-qPCR. Analyses presented here provide a global view of the responses of peach fruits to cold storage and highlights new peach genes that probably play important roles in the tolerance/sensitivity to cold storage. Our results provide a roadmap for further experiments and would help to develop new postharvest protocols and gene directed breeding strategies to better cope with chilling injury.	[Pons, Clara; Marti, Cristina; Forment, Javier; Granell, Antonio] Univ Politecn Valencia, Consejo Super Invest Cient, Plant Genom & Biotechnol Lab, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain; [Crisosto, Carlos H.; Dandekar, Abhaya M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); University of California System; University of California Davis	Granell, A (corresponding author), Univ Politecn Valencia, Consejo Super Invest Cient, Plant Genom & Biotechnol Lab, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain.	agranell@ibmcp.upv.es	Pons, Clara/AAA-6233-2020; Granell, Antonio/G-3664-2010; Marti, Cristina/I-4535-2015	Pons, Clara/0000-0002-8296-2937; Marti, Cristina/0000-0002-8918-8147; Dandekar, Abhaya/0000-0001-7925-4086	National Research Initiative of USDA's National Institute of Food and Agriculture (NIFA) [2008-35300-04432]; US-Israel Binational Agriculture Research and Development Fund (BARD) [US-4027-07]	National Research Initiative of USDA's National Institute of Food and Agriculture (NIFA); US-Israel Binational Agriculture Research and Development Fund (BARD)	This work was supported by the National Research Initiative of USDA's National Institute of Food and Agriculture (NIFA) grant # 2008-35300-04432 and US-Israel Binational Agriculture Research and Development Fund (BARD) Grant no. US-4027-07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amil-Ruiz F, 2011, PLANT CELL PHYSIOL, V52, P1873, DOI 10.1093/pcp/pcr136; Bassa C, 2012, PLANT CELL PHYSL; Begheldo M, 2008, POSTHARVEST BIOL TEC, V48, P84, DOI 10.1016/j.postharvbio.2007.09.023; Belin C, 2009, PLANT CELL, V21, P2253, DOI 10.1105/tpc.109.067702; BENARIE R, 1980, PHYTOCHEMISTRY, V19, P2553, DOI 10.1016/S0031-9422(00)83917-5; Bindon KA, 2012, J AGR FOOD CHEM, V60, P9249, DOI 10.1021/jf301552t; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Brummell DA, 2004, J EXP BOT, V55, P2041, DOI 10.1093/jxb/erh228; BUESCHER RW, 1978, J FOOD SCI, V43, P264, DOI 10.1111/j.1365-2621.1978.tb09788.x; Campos-Vargas R, 2006, SCI HORTIC-AMSTERDAM, V110, P79, DOI 10.1016/j.scienta.2006.06.019; Carvallo MA, 2011, J EXP BOT, V62, P3807, DOI 10.1093/jxb/err066; Catala R, 2011, P NATL ACAD SCI USA, V108, P16475, DOI 10.1073/pnas.1107161108; Cheung KJ, 2003, GENOME RES, V13, P206, DOI 10.1101/gr.401003; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Crisosto CH, 1999, HORTSCIENCE, V34, P1116, DOI 10.21273/HORTSCI.34.6.1116; Crisosto CH, 1997, HORTSCIENCE, V32, P820, DOI 10.21273/HORTSCI.32.5.820; Crisosto CH, 2002, POSTHARVEST BIOL TEC, V25, P151, DOI 10.1016/S0925-5214(01)00183-1; Dagar A, 2013, TREE GENET GENOMES, V9, P223, DOI 10.1007/s11295-012-0549-9; Dai F, 2009, BIOL PLANTARUM, V53, P257, DOI 10.1007/s10535-009-0048-5; Dhanaseely A. J., 2012, P INT C SOFTW ENG MO, P1; Doherty CJ, 2009, PLANT CELL, V21, P972, DOI 10.1105/tpc.108.063958; Dong CH, 2006, P NATL ACAD SCI USA, V103, P8281, DOI 10.1073/pnas.0602874103; El-Sharkawy I, 2004, PLANT CELL ENVIRON, V27, P1197, DOI 10.1111/j.1365-3040.2004.01218.x; Falara V, 2011, FUNCT INTEGR GENOMIC, V11, P357, DOI 10.1007/s10142-010-0204-1; Feng XM, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-22; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; GIOVANNONI JJ, 1991, NUCLEIC ACIDS RES, V19, P6553, DOI 10.1093/nar/19.23.6553; Gonzalez-Aguero M, 2008, J EXP BOT, V59, P1973, DOI 10.1093/jxb/em69; Guo Y, 2002, P NATL ACAD SCI USA, V99, P7786, DOI 10.1073/pnas.112040099; Han SK, 2012, PLANT CELL, V24, P4892, DOI 10.1105/tpc.112.105114; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hannah MA, 2006, PLANT PHYSIOL, V142, P98, DOI 10.1104/pp.106.081141; Hardenburg R.E., 1986, COMMERCIAL STORAGE F; HARDING PAUL L., 1934, PROC AMER SOC HORT SCI, V32, P160; Hugouvieux V, 2002, PLANT PHYSIOL, V130, P1276, DOI 10.1104/pp.009480; Huq E, 2000, P NATL ACAD SCI USA, V97, P9789, DOI 10.1073/pnas.170283997; Iriti M, 2009, INT J MOL SCI, V10, P3371, DOI 10.3390/ijms10083371; Jaglo KR, 2001, PLANT PHYSIOL, V127, P910, DOI 10.1104/pp.010548; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; JOHNSON E, 1994, PLANT PHYSIOL, V105, P141, DOI 10.1104/pp.105.1.141; Ju ZG, 2000, J HORTIC SCI BIOTECH, V75, P86, DOI 10.1080/14620316.2000.11511205; Jung C, 2007, PLANT CELL REP, V26, P1053, DOI 10.1007/s00299-007-0311-1; Jung S, 2008, NUCLEIC ACIDS RES, V36, pD1034, DOI 10.1093/nar/gkm803; KADER AA, 1989, PEACHES PLUMS NECTAR, P191; Kariola T, 2006, PLANT PHYSIOL, V142, P1559, DOI 10.1104/pp.106.086223; Kelley DR, 2012, PLANT PHYSIOL, V160, P47, DOI 10.1104/pp.112.200527; Kim DH, 2002, PLANT CELL, V14, P3043, DOI 10.1105/tpc.005306; Kim HJ, 2002, PLANT J, V29, P693, DOI 10.1046/j.1365-313X.2002.01249.x; Kitamura S, 2004, PLANT J, V37, P104, DOI 10.1046/j.1365-313X.2003.01943.x; Kitamura S, 2010, PLANT J, V62, P549, DOI 10.1111/j.1365-313X.2010.04174.x; KIYOSUE T, 1993, BIOCHEM BIOPH RES CO, V196, P1214, DOI 10.1006/bbrc.1993.2381; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; LAM HM, 1994, PLANT PHYSIOL, V106, P1347, DOI 10.1104/pp.106.4.1347; Lazzari B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S16; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lee BH, 2006, PLANT CELL, V18, P1736, DOI 10.1105/tpc.106.042184; Lee YP, 2009, PLANT BIOLOGY, V11, P273, DOI 10.1111/j.1438-8677.2008.00122.x; Lim GH, 2010, NEW PHYTOL, V185, P103, DOI 10.1111/j.1469-8137.2009.03032.x; Lin JF, 2004, PLANT J, V39, P612, DOI 10.1111/j.1365-313X.2004.02160.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYONS JM, 1973, ANNU REV PLANT PHYS, V24, P445, DOI 10.1146/annurev.pp.24.060173.002305; Martinez-Garcia PJ, 2012, EUPHYTICA, V185, P267, DOI 10.1007/s10681-011-0572-1; Medina J, 2011, PLANT SCI, V180, P3, DOI 10.1016/j.plantsci.2010.06.019; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Miura K, 2012, PLANT BIOTECHNOLOGY; Miura K, 2007, PLANT CELL, V19, P1403, DOI 10.1105/tpc.106.048397; Nakashima K, 1997, PLANT J, V12, P851, DOI 10.1046/j.1365-313X.1997.12040851.x; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Ogundiwin EA, 2008, TREE GENET GENOMES, V4, P543, DOI 10.1007/s11295-007-0130-0; Ogundiwin EA, 2008, PLANT MOL BIOL, V68, P379, DOI 10.1007/s11103-008-9378-5; Ogundiwin EA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-587; Park JE, 2007, J BIOL CHEM, V282, P10036, DOI 10.1074/jbc.M610524200; Peace CP, 2006, ACTA HORTIC, P489, DOI 10.17660/ActaHortic.2006.713.73; Peace CP, 2005, MOL BREEDING, V16, P21, DOI 10.1007/s11032-005-0828-3; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Provart NJ, 2003, PLANT PHYSIOL, V132, P893, DOI 10.1104/pp.103.021261; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rinaldi MA, 2012, PLANT MOL BIOL, V79, P359, DOI 10.1007/s11103-012-9917-y; Ruelland E, 2009, ADV BOT RES, V49, P35, DOI 10.1016/S0065-2296(08)00602-2; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Scott IM, 2004, PLANT PHYSIOL, V135, P1040, DOI 10.1104/pp.104.041293; Sevillano L, 2009, J SCI FOOD AGR, V89, P555, DOI 10.1002/jsfa.3468; Shi YT, 2012, PLANT CELL, V24, P2578, DOI 10.1105/tpc.112.098640; Soitamo AJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-13; Tacken E, 2010, PLANT PHYSIOL, V153, P294, DOI 10.1104/pp.109.151092; Takase T, 2003, PLANT CELL PHYSIOL, V44, P1071, DOI 10.1093/pcp/pcg130; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tittarelli A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-121; Trainotti L, 2007, J EXP BOT, V58, P3299, DOI 10.1093/jxb/erm178; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ueda A, 2008, PLANT MOL BIOL, V67, P683, DOI 10.1007/s11103-008-9348-y; Usadel B, 2008, PLANT CELL ENVIRON, V31, P518, DOI 10.1111/j.1365-3040.2007.01763.x; Vergne E., 2010, BMC PLANT BIOL, V10, P206, DOI DOI 10.1186/1471-2229-10-206; Vizoso P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-423; Von Mollendorf LJ, 1987, J HORTIC SCI, V5, P1; Wang YN, 2007, PLANT MOL BIOL, V64, P633, DOI 10.1007/s11103-007-9182-7; Wisniewski M, 2011, PLANTA, V233, P971, DOI 10.1007/s00425-011-1358-3; Xiong LM, 2002, P NATL ACAD SCI USA, V99, P10899, DOI 10.1073/pnas.162111599; Xiong LM, 1999, PLANT J, V19, P569, DOI 10.1046/j.1365-313X.1999.00558.x; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128; Zhang SC, 2011, J PLANT PHYSIOL, V168, P2093, DOI 10.1016/j.jplph.2011.06.010; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhao DY, 2009, J FOOD SCI, V74, pC348, DOI 10.1111/j.1750-3841.2009.01156.x; Zhao DY, 2009, FEBS LETT, V583, P3329, DOI 10.1016/j.febslet.2009.09.029; Zhao J, 2010, TRENDS PLANT SCI, V15, P72, DOI 10.1016/j.tplants.2009.11.006; Zhu JH, 2005, P NATL ACAD SCI USA, V102, P9966, DOI 10.1073/pnas.0503960102; Zhu JH, 2004, P NATL ACAD SCI USA, V101, P9873, DOI 10.1073/pnas.0403166101; Zhu J, 2008, P NATL ACAD SCI USA, V105, P4945, DOI 10.1073/pnas.0801029105	110	31	31	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90706	10.1371/journal.pone.0090706	http://dx.doi.org/10.1371/journal.pone.0090706			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598973	Green Published, gold			2022-12-27	WOS:000332479400123
J	Seabert, TA; Pal, S; Pinet, BM; Haman, F; Robidoux, MA; Imbeault, P; Krummel, EM; Kimpe, LE; Blais, JM				Seabert, Timothy A.; Pal, Shinjini; Pinet, Bernard M.; Haman, Francois; Robidoux, Michael A.; Imbeault, Pascal; Kruemmel, Eva M.; Kimpe, Linda E.; Blais, Jules M.			Elevated Contaminants Contrasted with Potential Benefits of omega-3 Fatty Acids in Wild Food Consumers of Two Remote First Nations Communities in Northern Ontario, Canada	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; POLYCHLORINATED-BIPHENYLS; ENVIRONMENTAL CONTAMINANTS; ORGANOCHLORINE PESTICIDES; MERCURY EXPOSURE; FISH CONSUMPTION; ADIPOSE-TISSUE; RISK-FACTORS; HUMAN HEALTH; FATTY-ACIDS	Indigenous communities in Boreal environments rely on locally-harvested wild foods for sustenance. These foods provide many nutritional benefits including higher levels of polyunsaturated fatty acids (PUFAs; such as omega-3) than what is commonly found in store-bought foods. However, wild foods can be a route of exposure to dietary mercury and persistent organic pollutants (POPs) such as polychlorinated biphenyls (PCBs). Here, we show a strong association between the frequency of wild food consumption in adults (N = 72) from two remote First Nations communities of Northern Ontario and environmental contaminants in blood (POPs) and hair (mercury). We observed that POPs and mercury were on average 3.5 times higher among those consuming wild foods more often, with many frequent wild food consumers exceeding Canadian and international health guidelines for PCB and mercury exposures. Contaminants in locally-harvested fish and game from these communities were sufficiently high that many participants exceeded the monthly consumption limits for methylmercury and PCBs. Those consuming more wild foods also had higher proportions of potentially beneficial omega-3 fatty acids including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). These results show that the benefits of traditional dietary choices in Boreal regions of Canada must be weighed against the inherent risks of contaminant exposure from these foods.	[Seabert, Timothy A.; Pal, Shinjini; Kruemmel, Eva M.; Kimpe, Linda E.; Blais, Jules M.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Pinet, Bernard M.; Haman, Francois; Robidoux, Michael A.] Univ Ottawa, Indigenous Hlth Res Grp, Ottawa, ON, Canada; [Imbeault, Pascal] Univ Ottawa, Fac Hlth Sci, Behav & Metab Res Unit, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa	Blais, JM (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	Jules.Blais@uottawa.ca	Blais, Jules/AAV-2321-2020	Blais, Jules/0000-0002-7188-3598	Canadian federal government, specifically Health Canada's National First Nations Environmental Contaminant Program	Canadian federal government, specifically Health Canada's National First Nations Environmental Contaminant Program	This research was supported by the Canadian federal government, specifically Health Canada's National First Nations Environmental Contaminant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, or did they assume any role in the generation or interpretation of results.	Arsenescu V, 2008, ENVIRON HEALTH PERSP, V116, P761, DOI 10.1289/ehp.10554; Belanger MC, 2008, METABOLISM, V57, P630, DOI 10.1016/j.metabol.2007.12.006; Bharadwaj L, 2006, J ENVIRON HEALTH, V68, P35; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; BLOOM NS, 1992, CAN J FISH AQUAT SCI, V49, P1010, DOI 10.1139/f92-113; Boucher O, 2012, ENVIRON HEALTH PERSP, V120, P1456, DOI 10.1289/ehp.1204976; Bourdon JA, 2010, FOOD CHEM TOXICOL, V48, P3093, DOI 10.1016/j.fct.2010.07.051; Burger J, 2008, SCI TOTAL ENVIRON, V390, P346, DOI 10.1016/j.scitotenv.2007.10.016; Chan HM, 1999, ENVIRON RES, V80, pS213, DOI 10.1006/enrs.1998.3930; Committee on the Toxicological Effects of Methylmercury Board on Environmental Studies and Toxicology National Research Council, 2000, TOX EFF METH; Das UN, 2000, PROSTAG LEUKOTR ESS, V63, P351, DOI 10.1054/plef.2000.0226; Dewailly E, 2002, AM J CLIN NUTR, V76, P85, DOI 10.1093/ajcn/76.1.85; Dewailly F, 2003, LIPIDS, V38, P359, DOI 10.1007/s11745-003-1070-4; Dietz R, 2004, SCI TOTAL ENVIRON, V331, P107, DOI 10.1016/j.scitotenv.2004.03.025; Dionex, 2011, SEL EXTR PCBS FISH T; Donaldson SG, 2010, SCI TOTAL ENVIRON, V408, P5165, DOI 10.1016/j.scitotenv.2010.04.059; Eaton SB, 1998, WORLD REV NUTR DIET, V83, P12; Eichelberger JW, 1994, DETERMINATION CHLORI; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gardner RM, 2010, ENVIRON RES, V110, P345, DOI 10.1016/j.envres.2010.02.001; Gardner RM, 2009, ENVIRON HEALTH PERSP, V117, P1932, DOI 10.1289/ehp.0900855; Garriguet Didier, 2008, Health Rep, V19, P21; Haman F, 2010, INT J OBESITY, V34, pS24, DOI 10.1038/ijo.2010.236; Hennig B, 2002, TOXICOL APPL PHARM, V181, P174, DOI 10.1006/taap.2002.9408; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Ibrahim MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025170; Imbeault P, 2012, PLOS ONE, V7; Imbeault P, 2011, J OBES, V2011, DOI 10.1155/2011/267509; Indian and Northern Affairs Canada, 2009, CAN ARCT CONT HLTH A, V2009; Iwasaki T, 2002, BIOCHEM BIOPH RES CO, V299, P384, DOI 10.1016/S0006-291X(02)02659-1; Jacobson JL, 2003, J PEDIATR-US, V143, P780, DOI 10.1067/S0022-3476(03)00577-8; JACOBSON JL, 1992, DEV PSYCHOL, V28, P297, DOI 10.1037/0012-1649.28.2.297; Jacobson JL, 1996, NEW ENGL J MED, V335, P783, DOI 10.1056/NEJM199609123351104; Kempuraj D, 2010, J NEUROINFLAMM, V7; Kim KY, 2010, ENVIRON HEALTH PERSP, V118, P370, DOI 10.1289/ehp.0901131; Kuhnlein H V, 2001, Int J Circumpolar Health, V60, P112; Kuhnlein HV, 2004, J NUTR, V134, P1447, DOI 10.1093/jn/134.6.1447; Kuhnlein HV, 2002, J FOOD COMPOS ANAL, V15, P545, DOI 10.1016/S0889-1575(02)91066-5; Lee D, 2011, PLOS ONE, V6; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Liberda EN, 2007, CAN J PUBLIC HEALTH, V98, P407, DOI 10.1007/BF03405429; LOCKHART WL, 1993, WATER SCI TECHNOL, V28, P43, DOI 10.2166/wst.1993.0602; Medehouenou TCM, 2011, ENVIRON RES, V111, P1313, DOI 10.1016/j.envres.2011.09.017; Mergler D, 2007, AMBIO, V36, P3, DOI 10.1579/0044-7447(2007)36[3:MEAHEI]2.0.CO;2; MILLER MA, 1995, B ENVIRON CONTAM TOX, V55, P96, DOI 10.1007/BF00212394; MITANI K, 1976, Eisei Kagaku, V22, P333; Munoz-de-Toro M, 2006, ENVIRON RES, V102, P107, DOI 10.1016/j.envres.2005.12.017; Myre M, 2013, OBESITY REV; Pal S, 2013, DIABETES METAB, V39, P497, DOI 10.1016/j.diabet.2013.01.006; Patterson D G Jr, 1991, IARC Sci Publ, P299; Patton M. Q., 1990, QUALITATIVE EVALUATI; PHILLIPS DL, 1989, ARCH ENVIRON CON TOX, V18, P495, DOI 10.1007/BF01055015; Plomgaard P, 2007, DIABETOLOGIA, V50, P2562, DOI 10.1007/s00125-007-0834-6; Receveur O, 1998, Int J Circumpolar Health, V57 Suppl 1, P219; Rice DC, 2003, RISK ANAL, V23, P107, DOI 10.1111/1539-6924.00294; Robidoux M. A., 2012, CAN J NATIVE STUD, V32, P59; Rylander L, 2005, ENV HLTH GLOBAL ACCE, V4; Seabert T, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.34; Seo T, 2005, CURR OPIN LIPIDOL, V16, P11, DOI 10.1097/00041433-200502000-00004; Tjepkema M, 2012, CHRON DIS INJ CAN, V32, P200; Turunen AW, 2013, ENVIRON RES, V120, P43, DOI 10.1016/j.envres.2012.09.007; U.S. Environmental Protection Agency, 2000, GUID ASS CHEM CONT D, V2; Uemura H, 2008, CHEMOSPHERE, V73, P30, DOI 10.1016/j.chemosphere.2008.05.066; *US EPA, 1994, 3640A US EPA; USEPA, 1996, 3630C USEPA; Vaillancourt E, 2007, J EXP BIOL, V210, P1161, DOI 10.1242/jeb.003012; Valera B, 2013, ENVIRON RES, V120, P102, DOI 10.1016/j.envres.2012.08.002; Van Oostdam J, 2005, SCI TOTAL ENVIRON, V351, P165, DOI 10.1016/j.scitotenv.2005.03.034; Van Oostdarn J., 2009, AMAP ASSESSMENT 2009, P61; Verbeke W, 2008, RISK ANAL, V28, P951, DOI 10.1111/j.1539-6924.2008.01075.x; VERDIER P, 1984, J CAN DIET ASSOC, V45, P52; Willows ND, 2005, CAN J PUBLIC HEALTH, V96, pS32, DOI 10.1007/BF03405199; Wilson K, 2003, HEALTH PLACE, V9, P83, DOI 10.1016/S1353-8292(02)00016-3; Zumbado M, 2005, SCI TOTAL ENVIRON, V339, P49, DOI 10.1016/j.scitotenv.2004.07.022	74	18	18	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90351	10.1371/journal.pone.0090351	http://dx.doi.org/10.1371/journal.pone.0090351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24598815	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400066
J	Shim, U; Kim, HN; Roh, SJ; Cho, NH; Shin, C; Ryu, S; Sung, YA; Kim, HL				Shim, Unjin; Kim, Han-Na; Roh, Seung-Ju; Cho, Nam H.; Shin, Chol; Ryu, Seungho; Sung, Yeon-Ah; Kim, Hyung-Lae			Personality Traits and Body Mass Index in a Korean Population	PLOS ONE			English	Article							METABOLIC SYNDROME; 5-FACTOR MODEL; WAIST CIRCUMFERENCE; ABDOMINAL OBESITY; EATING BEHAVIOR; ALL-CAUSE; ADULTS; ASSOCIATION; NEUROTICISM; OVERWEIGHT	Background: Overweight and obesity is a serious problem worldwide related to cardiovascular and other diseases. Personality traits are associated with the abnormal body mass indices (BMIs) indicative of overweight and obesity. However, the links between personality traits and BMI have been little studied in Korea. Methods: We evaluated the association between personality traits and BMI in men and women using the rural Ansung and urban Ansan cohort from the Korean Genome Epidemiology Study, and the Kangbuk Samsung Hospital Cohort Study datasets. A shorter version of the original Revised Neuroticism-Extroversion-Openness Personality Inventory (NEO-PI-R) was used to measure the five-factor model of personality (neuroticism, extraversion, openness to experience, agreeableness, and conscientiousness). Results: Data from a total of 1,495 men (mean age 60.0 +/- 9.8 years; mean BMI 24.3 +/- 3.0 kg/m(2)) and 2,547 women (mean age 47.0 +/- 15.5 years; mean BMI 22.8 +/- 3.4 kg/m(2)) were included in the analysis. Compared with the normal weight groups, overweight and obese men scored higher on openness to experience and lower on conscientiousness. Overweight and obese women scored lower on neuroticism and openness to experience and higher on agreeableness. Extraversion was positively associated with BMI in men (beta = 0.032, P < 0.05). BMI and waist circumference were significantly increased in individuals who were less dutiful. In women, neuroticism was inversely associated with BMI (beta = -0.026, P < 0.05). Openness to experience was negatively, and agreeableness was positively, associated with BMI (openness to experience: beta = -0.072, agreeableness beta = 0.068) and waist circumference (openness to experience: beta = -0.202, agreeableness: beta = 0.227) (P < 0.05). Conclusion: Personality traits were associated with underweight, overweight, and obesity in men and women. Increased understanding of the underlying factors contributing to this association will aid in the prevention and treatment of abnormal BMI.	[Shim, Unjin] Ewha Womans Univ, Med Ctr, Dept Internal Med, Seoul Seonam Hosp, Seoul, South Korea; [Kim, Han-Na; Roh, Seung-Ju; Kim, Hyung-Lae] Ewha Womans Univ, Dept Biochem, Sch Med, Seoul, South Korea; [Cho, Nam H.] Ajou Univ, Sch Med, Dept Prevent Med, Suwon 441749, South Korea; [Shin, Chol] Korea Univ, Dept Internal Med, Ansan Hosp, Div Pulm & Crit Care Med, Ansan, South Korea; [Ryu, Seungho] Sungkyunkwan Univ, Sch Med, Dept Occupat Med, Kangbuk Samsung Hosp, Seoul, South Korea; [Sung, Yeon-Ah] Ewha Womans Univ, Dept Internal Med, Sch Med, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ajou University; Korea University; Korea University Medicine (KU Medicine); Sungkyunkwan University (SKKU); Samsung Medical Center; Ewha Womans University	Kim, HN (corresponding author), Ewha Womans Univ, Dept Biochem, Sch Med, Seoul, South Korea.	o147942@gmail.com; hyung@ewha.ac.kr		Ryu, Seungho/0000-0002-3927-8646	National Research Foundation of Korea; Ministry of Education [NRF-2010-0026606]; Center for Disease Control and Prevention, Republic of Korea	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education; Center for Disease Control and Prevention, Republic of Korea	This research was supported by the National Research Foundation of Korea, which is funded by the Ministry of Education (NRF-2010-0026606). The Ansan/Ansung cohort data was obtained from the Korean Genome and Epidemiology Study (4851-302), which is supported by the Center for Disease Control and Prevention, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn C-K., 1997, KOREAN J COUNS PSYCH, V9, P443; Aitsi-Selmi A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-769; [Anonymous], 1995, PHYS STAT US INT ANT; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; Bjornelv S, 2011, SOC PSYCH PSYCH EPID, V46, P353, DOI 10.1007/s00127-010-0197-z; Brummett BH, 2006, J RES PERS, V40, P222, DOI 10.1016/j.jrp.2004.12.002; Cassin SE, 2005, CLIN PSYCHOL REV, V25, P895, DOI 10.1016/j.cpr.2005.04.012; Chapman BP, 2009, HEALTH PSYCHOL, V28, P419, DOI 10.1037/a0015212; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Costa PT, 2007, REVISED NEO PERSONAL; Daigre JL, 2012, DIABETES METAB, V38, P404, DOI 10.1016/j.diabet.2012.03.008; de Wit LM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-14; Dortland AKBV, 2012, PROG NEURO-PSYCHOPH, V36, P85, DOI 10.1016/j.pnpbp.2011.10.001; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; Elfhag Kristina, 2008, Eat Behav, V9, P285, DOI 10.1016/j.eatbeh.2007.10.003; Elovainio M, 2011, BIOL PSYCHOL, V87, P234, DOI 10.1016/j.biopsycho.2011.03.002; Goldbacher EM, 2009, PSYCHOSOM MED, V71, P266, DOI 10.1097/PSY.0b013e318197a4d5; Hagger-Johnson G, 2012, J PSYCHOSOM RES, V73, P98, DOI 10.1016/j.jpsychores.2012.05.007; Hernandez N, 2012, NUTR HOSP, V27, P1148, DOI 10.3305/nh.2012.27.4.5829; Human LJ, 2013, J PERS, V81, P249, DOI 10.1111/jopy.12002; International Association for the study of Obesity, 2000, AS PAC PERSP RED OB; Jokela M, 2013, OBES REV, V14, P315, DOI 10.1111/obr.12007; Jokela M, 2013, HLTH PSYCHOL; Jokela M, 2013, AM J EPIDEMIOL, V178, P667, DOI 10.1093/aje/kwt170; Jokela M, 2011, J AFFECT DISORDERS, V130, P454, DOI 10.1016/j.jad.2010.10.047; Jonassaint CR, 2010, ETHNIC DIS, V20, P11; Kakizaki M, 2008, J PSYCHOSOM RES, V64, P71, DOI 10.1016/j.jpsychores.2007.07.008; Koorevaar AML, 2013, J AFFECT DISORDERS, V151, P178, DOI 10.1016/j.jad.2013.05.075; Lawlor DA, 2005, AM J PUBLIC HEALTH, V95, P1245, DOI 10.2105/AJPH.2004.041129; Mase T, 2013, EAT WEIGHT DISORD-ST, V18, P125, DOI 10.1007/s40519-013-0019-x; McCann SJH, 2011, J PSYCHOL, V145, P419, DOI 10.1080/00223980.2011.584081; Miller Jessie L, 2006, Eat Behav, V7, P69, DOI 10.1016/j.eatbeh.2005.07.003; Mommersteeg PMC, 2012, J PSYCHOSOM RES, V73, P326, DOI 10.1016/j.jpsychores.2012.08.019; Ormel J, 2013, NEUROSCI BIOBEHAV R, V37, P59, DOI 10.1016/j.neubiorev.2012.09.004; Petry NM, 2008, PSYCHOSOM MED, V70, P288, DOI 10.1097/PSY.0b013e3181651651; Piedmont RL, 1997, J CROSS CULT PSYCHOL, V28, P131, DOI 10.1177/0022022197282001; Provencher Veronique, 2008, Eat Behav, V9, P294, DOI 10.1016/j.eatbeh.2007.10.004; Schneider TR, 2012, STRESS HEALTH, V28, P102, DOI 10.1002/smi.1409; Segerstrom SC, 2003, BRAIN BEHAV IMMUN, V17, pS92; Sutin AR, 2013, PSYCHOSOM MED, V75, P505, DOI 10.1097/PSY.0b013e3182919ff4; Sutin AR, 2011, J PERS SOC PSYCHOL, V101, P579, DOI 10.1037/a0024286; Sutin AR, 2010, AGE, V32, P513, DOI 10.1007/s11357-010-9153-9; Sutin AR, 2010, BIOL PSYCHOL, V84, P186, DOI 10.1016/j.biopsycho.2010.01.012; Terracciano A, 2008, PSYCHOSOM MED, V70, P621, DOI 10.1097/PSY.0b013e31817b9371; Terracciano A, 2009, PSYCHOSOM MED, V71, P682, DOI 10.1097/PSY.0b013e3181a2925b; Torres SJ, 2007, NUTRITION, V23, P887, DOI 10.1016/j.nut.2007.08.008; Wilson RS, 2005, PSYCHOSOM MED, V67, P841, DOI 10.1097/01.psy.0000190615.20656.83; Winograd RP, 2012, ALCOHOL CLIN EXP RES, V36, P1787, DOI 10.1111/j.1530-0277.2012.01796.x	49	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90516	10.1371/journal.pone.0090516	http://dx.doi.org/10.1371/journal.pone.0090516			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24598991	Green Submitted, Green Published, gold			2022-12-27	WOS:000332479400088
J	Sun, LP; Quan, HT; Xie, CY; Wang, L; Hu, YH; Lou, LG				Sun, Liping; Quan, Haitian; Xie, Chengying; Wang, Lei; Hu, Youhong; Lou, Liguang			Phosphodiesterase 3/4 Inhibitor Zardaverine Exhibits Potent and Selective Antitumor Activity against Hepatocellular Carcinoma Both In Vitro and In Vivo Independently of Phosphodiesterase Inhibition	PLOS ONE			English	Article							CELL-CYCLE; NUCLEOTIDE PHOSPHODIESTERASE; III INHIBITOR; APOPTOSIS; KINASE; CAMP; PROLIFERATION; PATHWAY; SUPPRESSION; SORAFENIB	Hepatocellular carcinoma (HCC) is the fifth common malignancy worldwide and the third leading cause of cancer-related death. Targeted therapies for HCC are being extensively developed with the limited success of sorafinib. In the present study, we investigated the potential antitumor activity of zardaverine, a dual-selective phosphodiesterase (PDE) 3/4 inhibitor in HCC cells both in vitro and in vivo. Although all zardaverine, PDE3 inhibitor trequinsin and PDE4 inhibitor rolipram increased intracellular cAMP levels through inhibiting PDE activity, only zardaverine significantly and selectively inhibited the proliferation of certain HCC cells, indicating that the antitumor activity of zardaverine is independent of PDE3/4 inhibition and intracellular cAMP levels. Further studies demonstrated that zardaverine induced G0/G1 phase cell cycle arrest of sensitive HCC cells through dysregulating cell cycle-associated proteins, including Cdk4, Cdk6, Cdk2, Cyclin A, Cyclin E, p21 and Rb. Notably, Rb expression was reversely related to the cell sensitivity to zardaverine. The present findings indicate that zardaverine may have potential as targeted therapies for some HCC, and the likely mechanism of action underlying its selective antitumor activity may be related to its regulation of Rb or Rb-associated signaling in cell cycles.	[Sun, Liping; Quan, Haitian; Xie, Chengying; Wang, Lei; Hu, Youhong; Lou, Liguang] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Lou, LG (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China.	lglou@mail.shcnc.ac.cn			National Natural Science Foundation of China [Y201181042, 81273546]; National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China [2013ZX09102008, 2013ZX09402102-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China	This work was supported by research funding from the National Natural Science Foundation of China (numbers Y201181042 and 81273546) and the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China (numbers 2013ZX09102008 and 2013ZX09402102-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banner KH, 1995, BRIT J PHARMACOL, V116, P3169, DOI 10.1111/j.1476-5381.1995.tb15120.x; Chau BN, 2003, NAT REV CANCER, V3, P130, DOI 10.1038/nrc993; Chen TC, 1998, LAB INVEST, V78, P165; Conti M, 2000, PROG NUCLEIC ACID RE, V63, P1; DREES M, 1993, CANCER RES, V53, P3058; DUMONT JE, 1989, TRENDS BIOCHEM SCI, V14, P67, DOI 10.1016/0968-0004(89)90046-7; Gantner F, 1997, J ALLERGY CLIN IMMUN, V100, P527, DOI 10.1016/S0091-6749(97)70146-5; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; Grader-Beck T, 2003, BLOOD, V101, P998, DOI 10.1182/blood-2002-06-1665; Hamada Y, 1999, JPN CIRC J, V63, P605, DOI 10.1253/jcj.63.605; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Lee J, 1999, BBA-MOL CELL RES, V1449, P261, DOI 10.1016/S0167-4889(99)00019-1; Liu LH, 2005, CANCER BIOL THER, V4, P1240, DOI 10.4161/cbt.4.11.2099; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; MacKenzie SJ, 2000, BIOCHEM J, V347, P571, DOI 10.1042/0264-6021:3470571; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Marko D, 2000, CHEM RES TOXICOL, V13, P944, DOI 10.1021/tx000090l; McEwan DG, 2007, CANCER RES, V67, P5248, DOI 10.1158/0008-5472.CAN-07-0097; Merz KH, 1998, J MED CHEM, V41, P4733, DOI 10.1021/jm981021v; Molinari M, 2000, CELL PROLIFERAT, V33, P261, DOI 10.1046/j.1365-2184.2000.00191.x; Moon E, 2002, CLIN CANCER RES, V8, P589; Murata K, 1999, CLIN EXP METASTAS, V17, P525, DOI 10.1023/A:1006626529536; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Ogawa R, 2002, BLOOD, V99, P3390, DOI 10.1182/blood.V99.9.3390; Osinski MT, 2000, BIOCHEM PHARMACOL, V60, P381, DOI 10.1016/S0006-2952(00)00328-2; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Quan HT, 2009, J PHARMACOL EXP THER, V330, P326, DOI 10.1124/jpet.109.153320; RUPPERT D, 1982, LIFE SCI, V31, P2037, DOI 10.1016/0024-3205(82)90095-9; Schafer KA, 1998, VET PATHOL, V35, P461, DOI 10.1177/030098589803500601; Schmitt JM, 2001, MOL CELL BIOL, V21, P3671, DOI 10.1128/MCB.21.11.3671-3683.2001; SCHUDT C, 1991, BIOCHEM PHARMACOL, V42, P153, DOI 10.1016/0006-2952(91)90694-Z; Schudt C, 2011, HANDB EXP PHARMACOL, V204, P1, DOI 10.1007/978-3-642-17969-3_1; Sherr CJ, 2000, CANCER RES, V60, P3689; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Soderling SH, 2000, CURR OPIN CELL BIOL, V12, P174, DOI 10.1016/S0955-0674(99)00073-3; Swanton C, 2004, LANCET ONCOL, V5, P27, DOI 10.1016/S1470-2045(03)01321-4; Tan XQ, 1998, TRENDS CELL BIOL, V8, P116, DOI 10.1016/S0962-8924(97)01208-7; Timoshenko AV, 2003, EXP CELL RES, V289, P265, DOI 10.1016/S0014-4827(03)00269-6; Wei ZY, 2013, CLIN MED INSIGHTS-ON, V7, P87, DOI 10.4137/CMO.S7633; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Yamanaka Y, 2002, CANCER LETT, V176, P143, DOI 10.1016/S0304-3835(01)00764-9; Yang LH, 2007, CANCER RES, V67, P651, DOI 10.1158/0008-5472.CAN-06-2762	43	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90627	10.1371/journal.pone.0090627	http://dx.doi.org/10.1371/journal.pone.0090627			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598942	Green Submitted, gold, Green Published			2022-12-27	WOS:000332479400105
J	Allenbach, Y; Chaara, W; Rosenzwajg, M; Six, A; Prevel, N; Mingozzi, F; Wanschitz, J; Musset, L; Charuel, JL; Eymard, B; Salomon, B; Duyckaerts, C; Maisonobe, T; Dubourg, O; Herson, S; Klatzmann, D; Benveniste, O				Allenbach, Yves; Chaara, Wahiba; Rosenzwajg, Michelle; Six, Adrien; Prevel, Nicolas; Mingozzi, Federico; Wanschitz, Julia; Musset, Lucile; Charuel, Jean-Luc; Eymard, Bruno; Salomon, Benoit; Duyckaerts, Charles; Maisonobe, Thierry; Dubourg, Odile; Herson, Serge; Klatzmann, David; Benveniste, Olivier			Th1 Response and Systemic Treg Deficiency in Inclusion Body Myositis	PLOS ONE			English	Article							REGULATORY T-CELLS; INFLAMMATION; CYTOKINES; BLOOD	Objective: Sporadic inclusion body myositis (sIBM), the most frequent myositis in elderly patients, is characterized by the presence muscle inflammation and degeneration. We aimed at characterizing immune responses and regulatory T cells, considered key players in the maintenance of peripheral immune tolerance, in sIBM. Methods: Serum and muscle tissue levels of 25 cytokines and phenotype of circulating immune cells were measured in 22 sIBM patients and compared with 22 healthy subjects. Cytokine data were analysed by unsupervised hierarchical clustering and principal components analysis. Results: Compared to healthy controls, sIBM patients had increased levels of Th-1 cytokines and chemokines such as IL-12 (261 +/- 138 pg/mL vs. 88 +/- 19 pg/mL; p<0.0001), CXCL-9 (186 +/- 12 pg/mL vs. 13 +/- 7 pg/mL; p<0.0001), and CXCL-10 (187 +/- 62 pg/mL vs. 13 +/- 6 pg/mL; p<0.0001). This was associated with an increased frequency of CD8(+)CD28(-) T cells (45.6 +/- 18.5% vs. 13.5 +/- 9.9%; p<0.0001), which were more prone to produce IFN-gamma (45.6 +/- 18.5% vs. 13.5 +/- 9.9%; p<0.0001). sIBM patients also had a decreased frequency of circulating regulatory T cells (CD4(+)CD25(+) CD127(low)FOXP3(+), 6.9 +/- 1.7%; vs. 5.2 +/- 1.1%, p = 0.01), which displayed normal suppressor function and were also present in affected muscle. Conclusion: sIBM patients present systemic immune activation with Th1 polarization involving the IFN-gamma pathway and CD8(+)CD28(-) T cells associated with peripheral regulatory T cell deficiency.	[Allenbach, Yves; Chaara, Wahiba; Rosenzwajg, Michelle; Six, Adrien; Prevel, Nicolas; Salomon, Benoit; Klatzmann, David] Univ Paris 06, Sorbonne Univ, Paris, France; [Allenbach, Yves; Chaara, Wahiba; Rosenzwajg, Michelle; Six, Adrien; Prevel, Nicolas; Salomon, Benoit; Klatzmann, David] CNRS, UMR 7211, Paris, France; [Allenbach, Yves; Chaara, Wahiba; Rosenzwajg, Michelle; Six, Adrien; Prevel, Nicolas; Klatzmann, David] INSERM, UMRS 959, Paris, France; [Allenbach, Yves; Chaara, Wahiba; Rosenzwajg, Michelle; Six, Adrien; Herson, Serge; Klatzmann, David; Benveniste, Olivier] Hop La Pitie Salpetriere, AP HP, Paris, France; [Allenbach, Yves; Herson, Serge; Benveniste, Olivier] Hop La Pitie Salpetriere, AP HP, Dept Internal Med 1, Ctr Reference Malad Neuromusculaire, Paris, France; [Mingozzi, Federico; Benveniste, Olivier] Univ Paris 06, Sorbonne Univ, U974, Paris, France; [Mingozzi, Federico; Benveniste, Olivier] INSERM, U974, Paris, France; [Mingozzi, Federico] Genethon, Evry, France; [Wanschitz, Julia] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Musset, Lucile; Charuel, Jean-Luc] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, Dept Immunochem, Paris, France; [Eymard, Bruno] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, Dept Neurol, Paris, France; [Duyckaerts, Charles; Maisonobe, Thierry; Dubourg, Odile] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, Dept Neuropathol, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Medical University of Innsbruck; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Allenbach, Y (corresponding author), Univ Paris 06, Sorbonne Univ, Paris, France.	yves.allenbach@psl.aphp.fr	Salomon, Benoit L/M-2421-2017; Salomon, Benoit/AAP-5209-2021; Rosenzwajg, Michelle/AAF-6276-2019	Salomon, Benoit L/0000-0001-9673-5578; Salomon, Benoit/0000-0001-9673-5578; Rosenzwajg, Michelle/0000-0001-5312-6203; Six, Adrien/0000-0001-5898-555X; Klatzmann, David/0000-0002-0054-3422; Allenbach, Yves/0000-0002-3185-7993	French state funds within the Investissementsd'Avenir programme [ANR-11-IDEX-0004-02]; association francaise contre les myopathies; Societe francaise nationale de medicine interne	French state funds within the Investissementsd'Avenir programme(French National Research Agency (ANR)); association francaise contre les myopathies(Association Francaise contre les Myopathies); Societe francaise nationale de medicine interne	This work was supported by French state funds within the Investissementsd'Avenir programme under reference ANR-11-IDEX-0004-02 (LabExTransimmunom), association francaise contre les myopathies, and Societe francaise nationale de medicine interne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antiga E, 2010, J AUTOIMMUN, V35, P342, DOI 10.1016/j.jaut.2010.07.006; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Askanas V, 2008, ACTA NEUROPATHOL, V116, P583, DOI 10.1007/s00401-008-0449-0; Baird GS, 2008, ARCH PATHOL LAB MED, V132, P232, DOI 10.1043/1543-2165(2008)132[232:MIAOCI]2.0.CO;2; Banica L, 2009, AUTOIMMUNITY, V42, P41, DOI 10.1080/08916930802282651; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Benveniste O, 2011, BRAIN, V134, P3176, DOI 10.1093/brain/awr213; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chi L, 2007, J NEUROIMMUNOL, V192, P206, DOI 10.1016/j.jneuroim.2007.09.034; De Paepe B, 2005, ACTA NEUROPATHOL, V109, P576, DOI 10.1007/s00401-005-0989-5; Dimitri D, 2006, BRAIN, V129, P986, DOI 10.1093/brain/awl020; Dubourg O, 2011, Acta Myol, V30, P103; Effros RB, 2005, IMMUNOL REV, V205, P147, DOI 10.1111/j.0105-2896.2005.00259.x; Greenberg SA, 2010, BRAIN, V133, DOI 10.1093/brain/awp275; Gregg R, 2005, CLIN EXP IMMUNOL, V140, P540, DOI 10.1111/j.1365-2249.2005.02798.x; GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504; Guillot-Delost M, 2008, J GENE MED, V10, P834, DOI 10.1002/jgm.1220; Hoogendijk Jessica E, 2004, Neuromuscul Disord, V14, P337, DOI 10.1016/j.nmd.2004.02.006; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Li X, 2008, CLIN IMMUNOL, V126, P180, DOI 10.1016/j.clim.2007.10.001; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Pandya JM, 2010, ARTHRITIS RHEUM-US, V62, P3457, DOI 10.1002/art.27665; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schmidt J, 2008, BRAIN, V131, P1228, DOI 10.1093/brain/awn053; Szodoray P, 2010, RHEUMATOLOGY, V49, P1867, DOI 10.1093/rheumatology/keq151; Taflin C, 2009, AM J PATHOL, V174, P497, DOI 10.2353/ajpath.2009.080580; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Terrier B, 2012, ARTHRITIS RHEUM-US, V64, P2001, DOI 10.1002/art.34327; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Zhang B, 2008, CLIN EXP IMMUNOL, V153, P182, DOI 10.1111/j.1365-2249.2008.03686.x	31	54	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e88788	10.1371/journal.pone.0088788	http://dx.doi.org/10.1371/journal.pone.0088788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594700	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500007
J	Cho, E; Kim, HC; Lee, JH; Yoo, JJ; Choi, WM; Cho, YY; Lee, MJ; Cho, Y; Lee, DH; Lee, YB; Yu, SJ; Kim, YJ; Yoon, JH; Chung, JW; Kim, CY; Lee, HS				Cho, Eunju; Kim, Hyo-Cheol; Lee, Jeong-Hoon; Yoo, Jeong-ju; Choi, Won-Mook; Cho, Young Youn; Lee, Min Jong; Cho, Yuri; Lee, Dong Hyeon; Lee, Yun Bin; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan; Chung, Jin Wook; Kim, Chung Yong; Lee, Hyo-Suk			Serum Insulin-Like Growth Factor-1 Predicts Disease Progression and Survival in Patients with Hepatocellular Carcinoma Who Undergo Transarterial Chemoembolization	PLOS ONE			English	Article							CANCER RISK; HEPATITIS-C; IGF-I; CIRRHOSIS; HCC; EXPRESSION; RESECTION; INFUSION; THERAPY; MRECIST	Insulin like-growth factor-1 (IGF-1) reflects hepatic synthetic function and plays a major role in the development and progression of various cancers. In the present study, we investigated whether baseline serum IGF-1 levels predict time-to-progression (TTP) and overall survival (OS) in hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization (TACE). A total of 155 consecutive treatment-naive patients with HCC who had undergone TACE as initial treatment were included from a prospective cohort. Baseline serum IGF-1 levels were analyzed with regard to their associations with disease progression and survival. During a median follow-up period of 41.8 months, patients with low IGF-1 levels showed significantly shorter TTP (median, 6.0 months; 95% confidence interval [CI], 4.5-7.6) than patients with high IGF-1 levels (median, 16.5 months; 95% CI, 4.9-28.1; p = 0.003). In the multivariate analysis, BCLC stage, serum vascular endothelial growth factorlevels, and IGF-1 levels were independent risk factors for disease progression. The hazard ratio (HR) of progression for each 10 ng/mL decrease in IGF-1 level was 1.072 (95% CI, 1.029-1.117; p = 0.001). Furthermore, together with tumor size, stage, and treatment response, IGF-1 levels were an independent predictor of poorer survival (for each 10 ng/mL decrease in IGF-1 level; HR, 1.057; 95% CI, 1.001-1.115; p = 0.045). In conclusion, low baseline IGF-1 levels independently correlated with shorter TTP and poorer OS in patients with HCC who underwent TACE.	[Cho, Eunju] Kangwon Natl Univ Hosp, Dept Internal Med, Chunchon, South Korea; [Kim, Hyo-Cheol; Chung, Jin Wook] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Lee, Jeong-Hoon; Yoo, Jeong-ju; Choi, Won-Mook; Cho, Young Youn; Lee, Min Jong; Cho, Yuri; Lee, Dong Hyeon; Lee, Yun Bin; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan; Kim, Chung Yong; Lee, Hyo-Suk] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Lee, Jeong-Hoon; Yoo, Jeong-ju; Choi, Won-Mook; Cho, Young Youn; Lee, Min Jong; Cho, Yuri; Lee, Dong Hyeon; Lee, Yun Bin; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan; Kim, Chung Yong; Lee, Hyo-Suk] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea	Kangwon National University; Kangwon National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	pindra@empal.com	Lee, Jeong-Hoon/Q-1055-2018	Lee, Jeong-Hoon/0000-0002-0315-2080; Chung, Jin Wook/0000-0002-1090-6872; Yu, Su Jong/0000-0001-8888-7977; , minjong/0000-0002-3159-5444; Cho, Eun Ju/0000-0002-2677-3189; Kim, Yoon Jun/0000-0001-9141-7773; Cho, Young Youn/0000-0002-9384-5357; Yoo, Jeong-Ju/0000-0002-7802-0381; Yoon, Jung-Hwan/0000-0002-9128-3610; Kim, Hyo-Cheol/0000-0002-6016-247X; Lee, Yun Bin/0000-0002-3193-9745	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-000-7381]; Kangwon National University Hospital Grant	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Kangwon National University Hospital Grant	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-000-7381) and Kangwon National University Hospital Grant (2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assy N, 2008, J HEPATOL, V49, P34, DOI 10.1016/j.jhep.2008.02.013; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; CastillaCortazar I, 1997, GASTROENTEROLOGY, V113, P1682, DOI 10.1053/gast.1997.v113.pm9352873; Catrina SB, 2006, CLIN CANCER RES, V12, P4506, DOI 10.1158/1078-0432.CCR-05-2473; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Cho EJ, 2013, CLIN CANC RES; Conchillo M, 2005, J HEPATOL, V43, P630, DOI 10.1016/j.jhep.2005.03.025; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Jung ES, 2013, J HEPATOL, V58, P1181, DOI 10.1016/j.jhep.2013.01.039; Kaseb AO, 2011, J CLIN ONCOL, V29, P3892, DOI 10.1200/JCO.2011.36.0636; Kaseb AO, 2011, ONCOLOGY-BASEL, V80, P373, DOI 10.1159/000329040; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Kim BK, 2013, EUR J CANCER, V49, P826, DOI 10.1016/j.ejca.2012.08.022; Kim HC, 2013, J VASC INTERV RADIOL, V24, P274, DOI 10.1016/j.jvir.2012.11.002; Lee HS, 2002, J CLIN ONCOL, V20, P4459, DOI 10.1200/JCO.2002.02.013; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Lorenzo-Zuniga V, 2007, DIGEST DIS SCI, V52, P3245, DOI 10.1007/s10620-006-9437-1; Maki RG, 2010, J CLIN ONCOL, V28, P4985, DOI 10.1200/JCO.2009.27.5040; Mazziotti G, 2002, CANCER, V95, P2539, DOI 10.1002/cncr.11002; Niizeki T, 2012, J GASTROENTEROL, V47, P686, DOI 10.1007/s00535-012-0555-6; Poon RTP, 2009, ANN SURG ONCOL, V16, P792, DOI 10.1245/s10434-009-0330-y; Poon RTP, 2003, CANCER RES, V63, P3121; Prajapati HJ, 2013, ANN ONCOL, V24, P965, DOI 10.1093/annonc/mds605; Shao YY, 2012, CLIN CANCER RES, V18, P3992, DOI 10.1158/1078-0432.CCR-11-2853; Sobrevals L, 2010, HEPATOLOGY, V51, P912, DOI 10.1002/hep.23412; Wu YP, 2002, CANCER RES, V62, P1030; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Zhu AX, 2011, NAT REV CLIN ONCOL, V8, P292, DOI 10.1038/nrclinonc.2011.30	31	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90862	10.1371/journal.pone.0090862	http://dx.doi.org/10.1371/journal.pone.0090862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595361	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500106
J	Hai, RT; Wang, YL; Wang, XH; Li, Y; Du, ZZ				Hai, Reti; Wang, Yulin; Wang, Xiaohui; Li, Yuan; Du, Zhize			Bacterial Community Dynamics and Taxa-Time Relationships within Two Activated Sludge Bioreactors	PLOS ONE			English	Article							WATER TREATMENT PLANTS; WASTE-WATER; RELATIVE ABUNDANCE; MICROBIAL ECOLOGY; AREA RELATIONSHIP; DIVERSITY; INSTABILITY; REACTORS; SYSTEMS; NITRIFICATION	Background: Biological activated sludge process must be functionally stable to continuously remove contaminants while relying upon the activity of complex microbial communities. However the dynamics of these communities are as yet poorly understood. A macroecology metric used to quantify community dynamic is the taxa-time relationship (TTR). Although the TTR of animal and plant species has been well documented, knowledge is still lacking in regard to TTR of microbial communities in activated sludge bioreactors. Aims: 1) To characterize the temporal dynamics of bacterial taxa in activated sludge from two bioreactors of different scale and investigate factors affecting such dynamics; 2) to evaluate the TTRs of activated sludge microbial communities in two bioreactors of different scale. Methods: Temporal variation of bacterial taxa in activated sludge collected from a full-and lab-scale activated sludge bioreactor was monitored over a one-year period using pyrosequencing of 16S rRNA genes. TTR was employed to quantify the bacterial taxa shifts based on the power law equation S = cT(w). Results: The power law exponent w for the full-scale bioreactor was 0.43 (R-2 = 0.970), which is lower than that of the lab-scale bioreactor (w = 0.55, R-2 = 0.971). The exponents for the dominant phyla were generally higher than that of the rare phyla. Canonical correspondence analysis (CCA) result showed that the bacterial community variance was significantly associated with water temperature, influent (biochemical oxygen demand) BOD, bioreactor scale and dissolved oxygen (DO). Variance partitioning analyses suggested that wastewater characteristics had the greatest contribution to the bacterial community variance, explaining 20.3% of the variance of bacterial communities independently, followed by operational parameters (19.9%) and bioreactor scale (3.6%). Conclusions: Results of this study suggest bacterial community dynamics were likely driven partly by wastewater and operational parameters and provide evidence that the TTR may be a fundamental ecological pattern in macro- and microbial systems.	[Hai, Reti; Wang, Yulin; Wang, Xiaohui; Li, Yuan; Du, Zhize] Beijing Univ Chem Technol, Dept Environm Sci & Engn, Beijing 100029, Peoples R China	Beijing University of Chemical Technology	Wang, XH (corresponding author), Beijing Univ Chem Technol, Dept Environm Sci & Engn, Beijing 100029, Peoples R China.	wangxiaohui2008@gmail.com	Yulin, Wang/AAL-3345-2021	Wang, Yulin/0000-0002-9899-7712	Fundamental Research Funds for the Central Universities [ZY1306]; special fund of State Key Joint Laboratory of Environment Simulation and Pollution Control [3K06ESPCT]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); special fund of State Key Joint Laboratory of Environment Simulation and Pollution Control	This study was supported by the Fundamental Research Funds for the Central Universities (ZY1306) and special fund of State Key Joint Laboratory of Environment Simulation and Pollution Control (3K06ESPCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2005, ECOLOGY, V86, P2032, DOI 10.1890/05-0067; Ayarza JM, 2011, MICROB ECOL, V61, P486, DOI 10.1007/s00248-010-9762-y; Briones A, 2003, CURR OPIN BIOTECH, V14, P270, DOI 10.1016/S0958-1669(03)00065-X; Cocolin L, 2000, FEMS MICROBIOL LETT, V189, P81, DOI 10.1016/S0378-1097(00)00257-3; Curtis TP, 2006, WATER SCI TECHNOL, V54, P227, DOI 10.2166/wst.2006.391; Fernandez AS, 2000, APPL ENVIRON MICROB, V66, P4058, DOI 10.1128/AEM.66.9.4058-4067.2000; Gentile ME, 2007, APPL ENVIRON MICROB, V73, P680, DOI 10.1128/AEM.01519-06; Gentile ME, 2007, ISME J, V1, P714, DOI 10.1038/ismej.2007.87; Graham DW, 2007, ISME J, V1, P385, DOI 10.1038/ismej.2007.45; Hu M, 2012, BIORESOURCE TECHNOL, V117, P72, DOI 10.1016/j.biortech.2012.04.061; Kim TS, 2013, APPL MICROBIOL BIOT, V97, P1755, DOI 10.1007/s00253-012-4002-7; Liu GQ, 2013, ENVIRON SCI TECHNOL, V47, P5109, DOI 10.1021/es304647y; Marzorati M, 2008, ENVIRON MICROBIOL, V10, P1571, DOI 10.1111/j.1462-2920.2008.01572.x; Matthews B, 2012, ECOLOGY, V93, P2435, DOI 10.1890/11-2289.1; Mcglinn DJ, 2009, ECOLOGY, V90, P836, DOI 10.1890/08-0377.1; Ofiteru ID, 2010, P NATL ACAD SCI USA, V107, P15345, DOI 10.1073/pnas.1000604107; Park HD, 2004, WATER RES, V38, P3275, DOI 10.1016/j.watres.2004.04.047; Pholchan MK, 2010, WATER RES, V44, P1341, DOI 10.1016/j.watres.2009.11.005; Rittmann BE, 2006, ENVIRON SCI TECHNOL, V40, P1096, DOI 10.1021/es062631k; Shade A, 2013, ISME J, V7, P1493, DOI 10.1038/ismej.2013.54; Shade A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00417; Siggins A, 2011, BIORESOURCE TECHNOL, V102, P7645, DOI 10.1016/j.biortech.2011.05.055; Slater FR, 2010, WATER RES, V44, P4908, DOI 10.1016/j.watres.2010.07.028; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; van der Gast CJ, 2008, ENVIRON MICROBIOL, V10, P1411, DOI 10.1111/j.1462-2920.2007.01550.x; van der Gast CJ, 2006, ENVIRON MICROBIOL, V8, P1048, DOI 10.1111/j.1462-2920.2006.00996.x; Wang XH, 2012, APPL ENVIRON MICROB, V78, P7042, DOI 10.1128/AEM.01617-12; Wang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036272; Wang XH, 2011, BIORESOURCE TECHNOL, V102, P2352, DOI 10.1016/j.biortech.2010.10.095; Wells GF, 2011, WATER RES, V45, P5476, DOI 10.1016/j.watres.2011.08.006; Wells GF, 2009, ENVIRON MICROBIOL, V11, P2310, DOI 10.1111/j.1462-2920.2009.01958.x; Werner JJ, 2011, P NATL ACAD SCI USA, V108, P4158, DOI 10.1073/pnas.1015676108; White EP, 2006, OIKOS, V112, P185; Wittebolle L, 2008, APPL ENVIRON MICROB, V74, P286, DOI 10.1128/AEM.01006-07; Ye L, 2011, WATER RES, V45, P4390, DOI 10.1016/j.watres.2011.05.028; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188	36	27	29	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90175	10.1371/journal.pone.0090175	http://dx.doi.org/10.1371/journal.pone.0090175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594695	Green Submitted, gold, Green Published			2022-12-27	WOS:000332475500036
J	Roy, I; Zimmerman, NP; Mackinnon, AC; Tsai, S; Evans, DB; Dwinell, MB				Roy, Ishan; Zimmerman, Noah P.; Mackinnon, A. Craig; Tsai, Susan; Evans, Douglas B.; Dwinell, Michael B.			CXCL12 Chemokine Expression Suppresses Human Pancreatic Cancer Growth and Metastasis	PLOS ONE			English	Article							ORGAN-SPECIFIC METASTASIS; RECEPTOR CXCR4; BREAST-CANCER; TUMOR-CELLS; DUCTAL ADENOCARCINOMA; SIGNALING PATHWAYS; CARCINOMA CELLS; FACTOR-I; MIGRATION; SURVIVAL	Pancreatic ductal adenocarcinoma is an unsolved health problem with nearly 75% of patients diagnosed with advanced disease and an overall 5-year survival rate near 5%. Despite the strong link between mortality and malignancy, the mechanisms behind pancreatic cancer dissemination and metastasis are poorly understood. Correlative pathological and cell culture analyses suggest the chemokine receptor CXCR4 plays a biological role in pancreatic cancer progression. In vivo roles for the CXCR4 ligand CXCL12 in pancreatic cancer malignancy were investigated. CXCR4 and CXCR7 were consistently expressed in normal and cancerous pancreatic ductal epithelium, established cell lines, and patient-derived primary cancer cells. Relative to healthy exocrine ducts, CXCL12 expression was pathologically repressed in pancreatic cancer tissue specimens and patient-derived cell lines. To test the functional consequences of CXCL12 silencing, pancreatic cancer cell lines stably expressingthe chemokine were engineered. Consistent with a role for CXCL12 as a tumor suppressor, cells producing the chemokine wereincreasingly adherent and migration deficient in vitro and poorly metastatic in vivo, compared to control cells. Further, CXCL12 reintroduction significantly reduced tumor growth in vitro, with significantly smaller tumors in vivo, leading to a pronounced survival advantage in a preclinical model. Together, these data demonstrate a functional tumor suppressive role for the normal expression of CXCL12 in pancreatic ducts, regulating both tumor growth andcellulardissemination to metastatic sites.	[Roy, Ishan; Zimmerman, Noah P.; Dwinell, Michael B.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Mackinnon, A. Craig] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Tsai, Susan; Evans, Douglas B.] Med Coll Wisconsin, Dept Surg, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Dwinell, MB (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA.	mdwinell@mcw.edu		Mackinnon, Alexander/0000-0002-2036-8529; Roy, Ishan/0000-0002-9109-0421	A Healthier Wisconsin; MCW Cancer Center	A Healthier Wisconsin; MCW Cancer Center	This work was supported in part by grants from the A Healthier Wisconsin and the MCW Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Abul K., 2010, BASIC IMMUNOLOGY FUN; Adams EJ, 1999, J CLIN PATHOL, V52, P75, DOI 10.1136/jcp.52.1.75; Arya M, 2003, CURR MED RES OPIN, V19, P557, DOI 10.1185/030079903125002216; Baumhoer D, 2012, MODERN PATHOL, V25, P522, DOI 10.1038/modpathol.2011.193; Billadeau DD, 2006, J GASTROINTEST CANC, V37, P110, DOI 10.1007/s12029-007-0011-7; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cabioglu N, 2007, ANN ONCOL, V18, P1021, DOI 10.1093/annonc/mdm060; Clatot F, 2011, ORAL ONCOL, V47, P1062, DOI 10.1016/j.oraloncology.2011.07.021; Cui K, 2010, J SURG RES; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Drury LJ, 2011, P NATL ACAD SCI USA, V108, P17655, DOI 10.1073/pnas.1101133108; Drury LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012895; Dwinell MB, 2004, AM J PHYSIOL-GASTR L, V286, pG844, DOI 10.1152/ajpgi.00112.2003; Dwinell MB, 2003, SURGERY, V133, P601, DOI 10.1067/msy.2003.143; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; Haeno H, 2012, CELL, V148, P362, DOI 10.1016/j.cell.2011.11.060; Hassan S, 2009, AM J PATHOL, V175, P66, DOI 10.2353/ajpath.2009.080948; Heidemann J, 2004, AM J PHYSIOL-GASTR L, V286, pG1059, DOI 10.1152/ajpgi.00417.2003; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2005, METH MOLEC MED, V103, P1; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Hruban RH, 2001, CANCER J, V7, P251; Hwang S, 2012, J BIOL CHEM, V287, P22227, DOI 10.1074/jbc.M112.367979; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Katz MHG, 2008, J AM COLL SURGEONS, V206, P833, DOI 10.1016/j.jamcollsurg.2007.12.020; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Kobayashi T, 2010, BREAST CANCER RES TR, V123, P733, DOI 10.1007/s10549-009-0672-y; Koorstra JBM, 2008, PANCREATOLOGY, V8, P110, DOI 10.1159/000123838; Koshiba T, 2000, CLIN CANCER RES, V6, P3530; Liang JJ, 2010, CANCER EPIDEM BIOMAR, V19, P2598, DOI 10.1158/1055-9965.EPI-10-0405; Maitra A, 2005, ADV ANAT PATHOL, V12, P81, DOI 10.1097/01.pap.0000155055.14238.25; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Marchesi F, 2004, CANCER RES, V64, P8420, DOI 10.1158/0008-5472.CAN-04-1343; Mirisola V, 2009, EUR J CANCER, V45, P2579, DOI 10.1016/j.ejca.2009.06.026; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Ramos EAS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-23; Satoi S, 2012, J GASTROINTEST SURG, V16, P784, DOI 10.1007/s11605-011-1795-0; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smith JM, 2005, AM J PHYSIOL-GASTR L, V288, pG316, DOI 10.1152/ajpgi.00208.2004; Spicer JD, 2012, CANCER RES, V72, P3919, DOI 10.1158/0008-5472.CAN-11-2393; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tessema M, 2010, ONCOGENE, V29, P5159, DOI 10.1038/onc.2010.255; Veldkamp CT, 2009, PROTEIN SCI, V18, P1359, DOI 10.1002/pro.167; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; Wendt MK, 2008, ONCOGENE, V27, P1461, DOI 10.1038/sj.onc.1210751; Wendt MK, 2006, ONCOGENE, V25, P4986, DOI 10.1038/sj.onc.1209505; Wendt MK, 2008, GASTROENTEROLOGY, V135, P508, DOI 10.1053/j.gastro.2008.05.033; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zhi Y, 2012, DIGEST DIS SCI, V57, P650, DOI 10.1007/s10620-011-1922-5; Zhong WX, 2012, EXP THER MED, V4, P363, DOI 10.3892/etm.2012.631; Zimmerman NP, 2011, LAB INVEST, V91, P1040, DOI 10.1038/labinvest.2011.77; Zlotnik A, 2008, J PATHOL, V215, P211, DOI 10.1002/path.2350; Zlotnik A, 2004, SEMIN CANCER BIOL, V14, P181, DOI 10.1016/j.semcancer.2003.10.004; Zlotnik A, 2006, CONTRIB MICROBIOL, V13, P191, DOI 10.1159/000092973; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	62	59	62	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90400	10.1371/journal.pone.0090400	http://dx.doi.org/10.1371/journal.pone.0090400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594697	gold, Green Published, Green Submitted			2022-12-27	WOS:000332475500047
J	Gao, JL; Liu, Q; Liu, X; Ji, CY; Qu, SQ; Wang, SS; Luo, Y				Gao, Jinlan; Liu, Qi; Liu, Xing; Ji, Chunyan; Qu, Shengqiang; Wang, Shusen; Luo, Yang			Cyclin G2 Suppresses Estrogen-Mediated Osteogenesis through Inhibition of Wnt/beta-Catenin Signaling	PLOS ONE			English	Article							HIGH BONE MASS; POSTMENOPAUSAL WOMEN; PHOSPHOINOSITIDE 3-KINASE; NEGATIVE REGULATOR; SEX STEROIDS; EXPRESSION; DIFFERENTIATION; OSTEOPOROSIS; MARROW; TRANSCRIPTION	Estrogen plays an important role in the maintenance of bone formation, and deficiency in the production of estrogen is directly linked to postmenopausal osteoporosis. To date, the underlying mechanisms of estrogen-mediated osteogenic differentiation are not well understood. In this study, a pluripotent mesenchymal precursor cell line C2C12 was used to induce osteogenic differentiation and subjected to detection of gene expressions or to manipulation of cyclin G2 expressions. C57BL/6 mice were used to generate bilateral ovariectomized and sham-operated mice for analysis of bone mineral density and protein expression. We identified cyclin G2, an unconventional member of cyclin, is involved in osteoblast differentiation regulated by estrogen in vivo and in vitro. In addition, the data showed that ectopic expression of cyclin G2 suppressed expression of osteoblast transcription factor Runx2 and osteogenic differentiation marker genes, as well as ALP activity and in vitro extracellular matrix mineralization. Mechanistically, Wnt/beta-catenin signaling pathway is essential for cyclin G2 to inhibit osteogenic differentiation. To the best of our knowledge, the current study presents the first evidence that cyclin G2 serves as a negative regulator of both osteogenesis and Wnt/beta-catenin signaling. Most importantly, the basal and 17 beta-estradiol-induced osteogenic differentiation was restored by overexpression of cyclin G2. These results taken together suggest that cyclin G2 may function as an endogenous suppressor of estrogen-induced osteogenic differentiation through inhibition of Wnt/beta-catenin signaling.	[Gao, Jinlan; Liu, Qi; Liu, Xing; Ji, Chunyan; Qu, Shengqiang; Wang, Shusen; Luo, Yang] China Med Univ, Minist Educ, Key Lab Med Cell Biol, Res Ctr Med Genom,Key Lab Cell Biol,Minist Publ H, Shenyang, Peoples R China	China Medical University	Luo, Y (corresponding author), China Med Univ, Minist Educ, Key Lab Med Cell Biol, Res Ctr Med Genom,Key Lab Cell Biol,Minist Publ H, Shenyang, Peoples R China.	luoyang@mail.cmu.edu.cn			National Natural Science Foundation of China;  [81170543];  [81100419]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ; 	This work was supported by Grants 81170543 and 81100419 form the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar V, 2010, ENDOCRINOLOGY, V151, P5247, DOI 10.1210/en.2010-0461; Ai M, 2005, MOL CELL BIOL, V25, P4946, DOI 10.1128/MCB.25.12.4946-4955.2005; Aubin JE, 1998, J CELL BIOCHEM, V147, P1531; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bates S, 1996, ONCOGENE, V13, P1103; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; BERESFORD JN, 1992, J CELL SCI, V102, P341; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Choi MG, 2009, J SURG RES, V157, P168, DOI 10.1016/j.jss.2008.06.020; Clements WM, 2002, CANCER RES, V62, P3503; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Fu G, 2011, ONCOGENE, V30, P3953, DOI 10.1038/onc.2011.127; Gambacciani M, 2001, MATURITAS, V39, P125, DOI 10.1016/S0378-5122(01)00194-3; Gao JL, 2011, AFR J BIOTECHNOL, V10, P14618; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Horne MC, 1997, J BIOL CHEM, V272, P12650, DOI 10.1074/jbc.272.19.12650; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Karsenty G, 2001, ENDOCRINOLOGY, V142, P2731, DOI 10.1210/en.142.7.2731; KITAZAWA R, 1994, J CLIN INVEST, V94, P2397, DOI 10.1172/JCI117606; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kulkarni NH, 2006, J BONE MINER RES, V21, P910, DOI 10.1359/JBMR.060316; Le XF, 2007, MOL CANCER THER, V6, P2843, DOI 10.1158/1535-7163.MCT-07-0109; Liu J, 2004, WORLD J GASTROENTERO, V10, P1357; Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; Masuda H, 2007, CIRC RES, V101, P598, DOI 10.1161/CIRCRESAHA.106.144006; Matsumoto Y, 2010, MOL CELL ENDOCRINOL, V325, P118, DOI 10.1016/j.mce.2010.05.004; NAKAMURA T, 1995, EXP CELL RES, V221, P534, DOI 10.1006/excr.1995.1406; Nuttall ME, 2000, BONE, V27, P177, DOI 10.1016/S8756-3282(00)00317-3; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Siris ES, 2001, JAMA-J AM MED ASSOC, V286, P2815, DOI 10.1001/jama.286.22.2815; Sowa H, 2004, J BIOL CHEM, V279, P40267, DOI 10.1074/jbc.M401312200; Spelsberg TC, 1999, MOL ENDOCRINOL, V13, P819, DOI 10.1210/me.13.6.819; Stossi F, 2006, J BIOL CHEM, V281, P16272, DOI 10.1074/jbc.M513405200; Wang Q, 2006, BIOCHEM BIOPH RES CO, V347, P117, DOI 10.1016/j.bbrc.2006.06.070; Waters KM, 2001, J CELL BIOCHEM, V83, P448, DOI 10.1002/jcb.1242; Yu HC, 2010, J BONE MINER RES, V25, P1128, DOI 10.1002/jbmr.9; Zhou S, 2001, BIOCHEM BIOPH RES CO, V210, P102	46	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89884	10.1371/journal.pone.0089884	http://dx.doi.org/10.1371/journal.pone.0089884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595300	gold, Green Published, Green Submitted			2022-12-27	WOS:000332468900042
J	Luchtmann, M; Steinecke, Y; Baecke, S; Lutzkendorf, R; Bernarding, J; Kohl, J; Jollenbeck, B; Tempelmann, C; Ragert, P; Firsching, R				Luchtmann, Michael; Steinecke, Yvonne; Baecke, Sebastian; Luetzkendorf, Ralf; Bernarding, Johannes; Kohl, Jana; Joellenbeck, Boris; Tempelmann, Claus; Ragert, Patrick; Firsching, Raimund			Structural Brain Alterations in Patients with Lumbar Disc Herniation: A Preliminary Study	PLOS ONE			English	Article							CHRONIC BACK-PAIN; VOXEL-BASED MORPHOMETRY; GRAY-MATTER DECREASE; RESEARCH TRIAL SPORT; NONSURGICAL MANAGEMENT; NONOPERATIVE TREATMENT; COST-EFFECTIVENESS; PREFRONTAL CORTEX; SCIATICA; SPINE	Chronic pain is one of the most common health complaints in industrial nations. For example, chronic low back pain (cLBP) disables millions of people across the world and generates a tremendous economic burden. While previous studies provided evidence of widespread functional as well as structural brain alterations in chronic pain, little is known about cortical changes in patients suffering from lumbar disc herniation. We investigated morphometric alterations of the gray and white matter of the brain in patients suffering from LDH. The volumes of the gray and white matter of 12 LDH patients were determined in a prospective study and compared to the volumes of healthy controls to distinguish local differences. High-resolution MRI brain images of all participants were performed using a 3 Tesla MRI scanner. Voxel-based morphometry was used to investigate local differences in gray and white matter volume between patients suffering from LDH and healthy controls. LDH patients showed significantly reduced gray matter volume in the right anterolateral prefrontal cortex, the right temporal lobe, the left premotor cortex, the right caudate nucleus, and the right cerebellum as compared to healthy controls. Increased gray matter volume, however, was found in the right dorsal anterior cingulate cortex, the left precuneal cortex, the left fusiform gyrus, and the right brainstem. Additionally, small subcortical decreases of the white matter were found adjacent to the left prefrontal cortex, the right premotor cortex and in the anterior limb of the left internal capsule. We conclude that the lumbar disk herniation can lead to specific local alterations of the gray and white matter in the human brain. The investigation of LDH-induced brain alterations could provide further insight into the underlying nature of the chronification processes and could possibly identify prognostic factors that may improve the conservative as well as the operative treatment of the LDH.	[Luchtmann, Michael; Steinecke, Yvonne; Kohl, Jana; Joellenbeck, Boris; Firsching, Raimund] Univ Magdeburg, Fac Med, Dept Neurosurg, D-39106 Magdeburg, Germany; [Baecke, Sebastian; Luetzkendorf, Ralf; Bernarding, Johannes] Univ Magdeburg, Fac Med, Inst Biometry & Med Informat, D-39106 Magdeburg, Germany; [Tempelmann, Claus] Univ Magdeburg, Fac Med, Dept Neurol, D-39106 Magdeburg, Germany; [Ragert, Patrick] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany	Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; Max Planck Society	Luchtmann, M (corresponding author), Univ Magdeburg, Fac Med, Dept Neurosurg, D-39106 Magdeburg, Germany.	Michael.Luchtmann@med.ovgu.de	Ragert, Patrick/AAI-7290-2020	Tempelmann, Claus/0000-0001-8570-4960; Luchtmann, Michael/0000-0002-9947-9095				Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Atlas SJ, 2005, SPINE, V30, P936, DOI 10.1097/01.brs.0000158953.57966.c0; Atlas SJ, 2001, SPINE, V26, P1179, DOI 10.1097/00007632-200105150-00017; Bingel U, 2007, PAIN, V131, P21, DOI 10.1016/j.pain.2006.12.005; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; Borsook D, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-27; Borsook D, 2010, NEUROSCIENTIST, V16, P171, DOI 10.1177/1073858409349902; Carragee EJ, 1997, SPINE, V22, P1650, DOI 10.1097/00007632-199707150-00025; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; Dichgans M, 2005, NEUROLOGY, V64, P608, DOI 10.1212/01.WNL.0000151855.98318.50; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Duerden EG, 2013, HUM BRAIN MAPP, V34, P109, DOI 10.1002/hbm.21416; Dunckley P, 2005, J NEUROSCI, V25, P7333, DOI 10.1523/JNEUROSCI.1100-05.2005; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; el Barzouhi A, 2013, NEW ENGL J MED, V368, P999, DOI 10.1056/NEJMoa1209250; Fairhurst M, 2007, PAIN, V128, P101, DOI 10.1016/j.pain.2006.09.001; Flor H, 2004, NEUROSCI LETT, V361, P147, DOI 10.1016/j.neulet.2003.12.064; Freund W, 2009, SOMATOSENS MOT RES, V26, P1, DOI 10.1080/08990220902738243; Freund W, 2007, SOMATOSENS MOT RES, V24, P203, DOI 10.1080/08990220701723636; Giesecke T, 2005, ARTHRITIS RHEUM-US, V52, P1577, DOI 10.1002/art.21008; Gracely RH, 2004, BRAIN, V127, P835, DOI 10.1093/brain/awh098; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; Ingvar M, 1999, PHILOS T R SOC B, V354, P1347, DOI 10.1098/rstb.1999.0483; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Jin CW, 2013, NMR BIOMED, V26, P58, DOI 10.1002/nbm.2819; Karppinen J, 2001, SPINE, V26, P2587, DOI 10.1097/00007632-200112010-00013; Kattoor J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051149; Kim J, 2008, CEPHALALGIA, V28, P598, DOI 10.1111/j.1468-2982.2008.01550.x; KORTELAINEN P, 1985, SPINE, V10, P88, DOI 10.1097/00007632-198501000-00014; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Markham JA, 2004, NEURON GLIA BIOL, V1, P351, DOI 10.1017/S1740925X05000219; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; May A, 2011, NEUROSCIENTIST, V17, P209, DOI 10.1177/1073858410396220; Moschetti W, 2009, SEMIN SPINE SURG, V21, P223; Mysliwiec LW, 2010, EUR SPINE J, V19, P1087, DOI 10.1007/s00586-009-1274-4; Obermann M, 2013, NEUROIMAGE, V74, P352, DOI 10.1016/j.neuroimage.2013.02.029; Ohnmeiss DD, 1997, SPINE, V22, P1600, DOI 10.1097/00007632-199707150-00015; PETERS ML, 1989, PAIN, V39, P69, DOI 10.1016/0304-3959(89)90176-0; Petrovic P, 2002, PAIN, V95, P1, DOI 10.1016/S0304-3959(01)00467-5; Petrovic P, 2004, NEUROIMAGE, V22, P995, DOI 10.1016/j.neuroimage.2004.01.046; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; Rodriguez-Raecke R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054475; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Sandor PS, 2001, ANN NEUROL, V49, P668, DOI 10.1002/ana.1019; Schmidt-Wilcke T, 2007, PAIN, V132, pS109, DOI 10.1016/j.pain.2007.05.010; Schmidt-Wilcke T, 2006, PAIN, V125, P89, DOI 10.1016/j.pain.2006.05.004; Schmidt-Wilcke T, 2005, NEUROLOGY, V65, P1483, DOI 10.1212/01.wnl.0000183067.94400.80; Schweinhardt P, 2008, PAIN, V140, P411, DOI 10.1016/j.pain.2008.09.014; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; SHVARTZMAN L, 1992, SPINE, V17, P176, DOI 10.1097/00007632-199202000-00010; Sonntag VKH, 2012, WORLD NEUROSURG, V77, P71, DOI 10.1016/j.wneu.2011.06.007; Sonntag VKH, 2010, WORLD NEUROSURG, V74, P574, DOI 10.1016/j.wneu.2010.08.006; Teutsch S, 2008, NEUROIMAGE, V42, P845, DOI 10.1016/j.neuroimage.2008.05.044; Ung H, 2012, CEREB CORTEX; Vlaeyen JWS, 2012, PAIN, V153, P1144, DOI 10.1016/j.pain.2011.12.009; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wand BM, 2011, MANUAL THER, V16, P15, DOI 10.1016/j.math.2010.06.008; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; Weinstein JN, 2008, SPINE, V33, P2789, DOI 10.1097/BRS.0b013e31818ed8f4; Wenig CM, 2009, EUR J PAIN, V13, P280, DOI 10.1016/j.ejpain.2008.04.005; Wiech K, 2006, J NEUROSCI, V26, P11501, DOI 10.1523/JNEUROSCI.2568-06.2006; Wood Patrick B, 2010, Curr Rheumatol Rep, V12, P462, DOI 10.1007/s11926-010-0129-7; Younger JW, 2011, PAIN, V152, P1803, DOI 10.1016/j.pain.2011.03.028	71	38	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90816	10.1371/journal.pone.0090816	http://dx.doi.org/10.1371/journal.pone.0090816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595036	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900150
J	Rastogi, N; Nagpal, N; Alam, H; Pandey, S; Gautam, L; Sinha, M; Shin, K; Manzoor, N; Virdi, JS; Kaur, P; Sharma, S; Singh, TP				Rastogi, Nilisha; Nagpal, Nitish; Alam, Hammad; Pandey, Sadanand; Gautam, Lovely; Sinha, Mau; Shin, Kouichirou; Manzoor, Nikhat; Virdi, Jugsharan S.; Kaur, Punit; Sharma, Sujata; Singh, Tej P.			Preparation and Antimicrobial Action of Three Tryptic Digested Functional Molecules of Bovine Lactoferrin	PLOS ONE			English	Article							2.6 ANGSTROM RESOLUTION; IRON-BINDING PROPERTIES; HUMAN-MILK; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; BUFFALO LACTOFERRIN; CANDIDA-ALBICANS; N-TERMINUS; PEPTIDES; APOLACTOFERRIN	Lactoferrin is an 80 kDa bilobal, iron binding glycoprotein which is primarily antimicrobial in nature. The hydrolysis of lactoferrin by various proteases in the gut produces several functional fragments of lactoferrin which have varying molecular sizes and properties. Here, bovine lactoferrin has been hydrolyzed by trypsin, the major enzyme present in the gut, to produce three functional molecules of sizes approximately 21 kDa, 38 kDa and 45 kDa. The molecules have been purified using ion exchange and gel filtration chromatography and identified using N-terminal sequencing, which reveals that while the 21 kDa molecule corresponds to the N2 domain (21LF), the 38 kDa represents the whole C-lobe (38LF) and the 45 kDa is a portion of N1 domain of N-lobe attached to the C-lobe (45LF). The iron binding and release properties of 21LF, 38LF and 45LF have been studied and compared. The sequence and structure analysis of the portions of the excision sites of LF from various species have been done. The antibacterial properties of these three molecules against bacterial strains, Streptococcus pyogenes, Escherichia coli, Yersinia enterocolitica and Listeria monocytogenes were investigated. The antifungal action of the molecules was also evaluated against Candida albicans. This is the first report on the antimicrobial actions of the trypsin cleaved functional molecules of lactoferrin from any species.	[Rastogi, Nilisha; Pandey, Sadanand; Gautam, Lovely; Sinha, Mau; Kaur, Punit; Sharma, Sujata; Singh, Tej P.] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Nagpal, Nitish; Virdi, Jugsharan S.] Univ Delhi, Dept Microbiol, New Delhi, India; [Alam, Hammad; Manzoor, Nikhat] Jamia Milia Islamia, Dept Biosci, New Delhi, India; [Shin, Kouichirou] Morinaga Milk Ind Co Ltd, Food Sci & Technol Inst, Zama, Kanagawa, Japan	All India Institute of Medical Sciences (AIIMS) New Delhi; University of Delhi; Jamia Millia Islamia; Morinaga Milk Industry Company, Ltd	Sharma, S (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	afrank2@gmail.com; tpsingh.aiims@gmail.com	; Virdi, Jugsharan Singh/L-8241-2015	SINHA, MAU/0000-0003-3011-9160; Virdi, Jugsharan Singh/0000-0002-6282-0018; Manzoor, Nikhat/0000-0002-6850-6142	Department of Biotechnology (DBT); Indian Council of Medical Research (ICMR), New Delhi; University Grant Commission (UGC); Council of Scientific and Industrial Research (CSIR)	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Indian Council of Medical Research (ICMR), New Delhi(Indian Council of Medical Research (ICMR)); University Grant Commission (UGC)(University Grants Commission, India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	TPS thanks the Department of Biotechnology (DBT), for the award of Distinguished Biotechnology Research Professorship to him. NR and SP thanks Indian Council of Medical Research (ICMR), New Delhi and University Grant Commission (UGC) for the award of fellowships. NN and HA thanks Council of Scientific and Industrial Research (CSIR) and Indian Council of Medical Research (ICMR), New Delhi for their fellowships. MS thanks Department of Science and Technology (DST), Ministry of Science and Technology, New Delhi and LG thanks Council of Scientific and Industrial Research (CSIR) for their fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrink M, 2000, KIDNEY INT, V57, P2004, DOI 10.1046/j.1523-1755.2000.00050.x; Ahmad A, 2010, J MED MICROBIOL, V59, P1178, DOI 10.1099/jmm.0.020693-0; ANDERSON BF, 1987, P NATL ACAD SCI USA, V84, P1769, DOI 10.1073/pnas.84.7.1769; ARNOLD RR, 1977, SCIENCE, V197, P263, DOI 10.1126/science.327545; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; BELLAMY W, 1992, J APPL BACTERIOL, V73, P472, DOI 10.1111/j.1365-2672.1992.tb05007.x; BELLAMY WR, 1993, J APPL BACTERIOL, V75, P478; BLUARDDECONINCK JM, 1978, BIOCHEM J, V171, P321, DOI 10.1042/bj1710321; BRINES RD, 1983, BIOCHIM BIOPHYS ACTA, V759, P229, DOI 10.1016/0304-4165(83)90317-3; BROCK JH, 1980, ARCH DIS CHILD, V55, P417, DOI 10.1136/adc.55.6.417; BROCK JH, 1976, BIOCHIM BIOPHYS ACTA, V446, P214, DOI 10.1016/0005-2795(76)90112-4; BROEKHUYSE RM, 1974, INVEST OPHTH VISUAL, V13, P550; Chierici R, 2001, ADV NUTR RES, V10, P247; DAVIDSSON L, 1994, PEDIATR RES, V35, P117, DOI 10.1203/00006450-199401000-00025; DAY CL, 1993, J MOL BIOL, V232, P1084, DOI 10.1006/jmbi.1993.1462; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; FOX PC, 1987, J GERONTOL, V42, P466, DOI 10.1093/geronj/42.5.466; GRIFFITHS E, 1977, INFECT IMMUN, V15, P396, DOI 10.1128/IAI.15.2.396-401.1977; Groenink J, 1999, FEMS MICROBIOL LETT, V179, P217, DOI 10.1016/S0378-1097(99)00414-0; Hagiwara S, 2003, J VET MED SCI, V65, P319, DOI 10.1292/jvms.65.319; HARIDAS M, 1994, ADV EXP MED BIOL, V357, P235; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; JONES EM, 1994, J APPL BACTERIOL, V77, P208, DOI 10.1111/j.1365-2672.1994.tb03065.x; Karthikeyan S, 1999, ACTA CRYSTALLOGR D, V55, P1805, DOI 10.1107/S0907444999010951; Khan JA, 2001, J MOL BIOL, V309, P751, DOI 10.1006/jmbi.2001.4692; KIRKPATRICK CH, 1971, J INFECT DIS, V124, P539, DOI 10.1093/infdis/124.6.539; KUROKAWA H, 1995, J MOL BIOL, V254, P196, DOI 10.1006/jmbi.1995.0611; LEGRAND D, 1986, BIOCHEM J, V236, P839, DOI 10.1042/bj2360839; Li KJ, 2006, J LEUKOCYTE BIOL, V80, P350, DOI 10.1189/jlb.1105668; LONGHI C, 1994, MED MICROBIOL IMMUN, V183, P77, DOI 10.1007/BF00277158; Lupetti A, 2000, ANTIMICROB AGENTS CH, V44, P3257, DOI 10.1128/AAC.44.12.3257-3263.2000; MASSON PL, 1968, FERTIL STERIL, V19, P679; MASSON PL, 1966, CLIN CHIM ACTA, V14, P735, DOI 10.1016/0009-8981(66)90004-0; MAZURIER J, 1980, BIOCHIM BIOPHYS ACTA, V629, P399, DOI 10.1016/0304-4165(80)90112-9; Mirza S, 2011, INFECT IMMUN, V79, P2440, DOI 10.1128/IAI.00489-10; Nibbering PH, 2001, INFECT IMMUN, V69, P1469, DOI 10.1128/IAI.69.3.1469-1476.2001; NIEMELA A, 1989, HUM REPROD, V4, P99, DOI 10.1093/oxfordjournals.humrep.a136854; NONNECKE BJ, 1984, J DAIRY SCI, V67, P606, DOI 10.3168/jds.S0022-0302(84)81345-4; Onyewu C, 2003, ANTIMICROB AGENTS CH, V47, P956, DOI 10.1128/AAC.47.3.956-964.2003; REITER B, 1975, IMMUNOLOGY, V28, P83; Sharma AK, 1999, J MOL BIOL, V289, P303, DOI 10.1006/jmbi.1999.2767; Sharma S, 1999, J DAIRY RES, V66, P81, DOI 10.1017/S0022029998003343; Sharma S, 2003, J MOL BIOL, V331, P485, DOI 10.1016/S0022-2836(03)00717-4; SHIMAZAKI K, 1993, J DAIRY SCI, V76, P946, DOI 10.3168/jds.S0022-0302(93)77421-4; Sinha Mau, 2013, Int J Pept, V2013, P390230, DOI 10.1155/2013/390230; Toma C, 1996, FEMS MICROBIOL LETT, V135, P143, DOI 10.1016/0378-1097(95)00463-7; TOMITA M, 1991, J DAIRY SCI, V74, P4137, DOI 10.3168/jds.S0022-0302(91)78608-6; TOMITA M, 1994, ADV EXP MED BIOL, V357, P209; Valenti P, 1998, ADV EXP MED BIOL, V443, P199; van der Does AM, 2012, J INNATE IMMUN, V4, P284, DOI 10.1159/000332941; YAMAUCHI K, 1993, INFECT IMMUN, V61, P719, DOI 10.1128/IAI.61.2.719-728.1993	51	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90011	10.1371/journal.pone.0090011	http://dx.doi.org/10.1371/journal.pone.0090011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595088	gold, Green Published, Green Submitted			2022-12-27	WOS:000332468900054
J	Tseng, YC; Glaser, JI; Caddigan, E; Lleras, A				Tseng, Yuan-Chi; Glaser, Joshua I.; Caddigan, Eamon; Lleras, Alejandro			Modeling the Effect of Selection History on Pop-Out Visual Search	PLOS ONE			English	Article							DIFFUSION-MODEL; SUPERIOR COLLICULUS; DISTRACTOR INHIBITION; INTERTRIAL INHIBITION; TARGET ACTIVATION; GUIDED SEARCH; NEURAL BASIS; REPETITION; SALIENCE; ATTENTION	While attentional effects in visual selection tasks have traditionally been assigned "top-down'' or "bottom-up'' origins, more recently it has been proposed that there are three major factors affecting visual selection: (1) physical salience, (2) current goals and (3) selection history. Here, we look further into selection history by investigating Priming of Pop-out (POP) and the Distractor Preview Effect (DPE), two inter-trial effects that demonstrate the influence of recent history on visual search performance. Using the Ratcliff diffusion model, we model observed saccadic selections from an oddball search experiment that included a mix of both POP and DPE conditions. We find that the Ratcliff diffusion model can effectively model the manner in which selection history affects current attentional control in visual inter-trial effects. The model evidence shows that bias regarding the current trial's most likely target color is the most critical parameter underlying the effect of selection history. Our results are consistent with the view that the 3-item color-oddball task used for POP and DPE experiments is best understood as an attentional decision making task.	[Tseng, Yuan-Chi; Caddigan, Eamon; Lleras, Alejandro] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Glaser, Joshua I.] Univ Illinois, Dept Math, Urbana, IL USA; [Tseng, Yuan-Chi; Caddigan, Eamon; Lleras, Alejandro] Univ Illinois, Dept Psychol, Urbana, IL USA; [Tseng, Yuan-Chi] Natl Cheng Kung Univ, Dept Ind Design, Tainan 70101, Taiwan; [Glaser, Joshua I.] Northwestern Univ, Interdept Neurosci Program, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; National Cheng Kung University; Northwestern University	Tseng, YC (corresponding author), Univ Illinois, Beckman Inst, Urbana, IL 61801 USA.	yuanchi.tseng@gmail.com	Lleras, Alejandro/AAA-5446-2020	Glaser, Joshua/0000-0003-2906-115X	National Science Council [NSC 101-2218-E-006-021]; National Science Foundation [BCS 07-46586 CAR]	National Science Council(Ministry of Science and Technology, Taiwan); National Science Foundation(National Science Foundation (NSF))	This work was funded with support from a grant (# NSC 101-2218-E-006-021) from National Science Council (YCT, PI; http://web1.nsc.gov.tw/mp.aspx?mp=7) and with a grant (# BCS 07-46586 CAR) from National Science Foundation (AL, PI; http://www.nsf.gov/div/index.jsp?div=BCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027926; Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Ariga A, 2004, J VISION, V4, P891, DOI 10.1167/4.10.5; Awh E, 2012, TRENDS COGNITIVE SCI; Bichot NP, 2002, J NEUROSCI, V22, P4675, DOI 10.1523/JNEUROSCI.22-11-04675.2002; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; Boucher L, 2007, PSYCHOL REV, V114, P376, DOI 10.1037/0033-295X.114.2.376; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Caddigan E, 2010, J VISION, P10; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Eimer M, 2010, VISION RES, V50, P1353, DOI 10.1016/j.visres.2009.11.001; Fecteau JH, 2003, NAT REV NEUROSCI, V4, P435, DOI 10.1038/nrn1114; Fecteau JH, 2007, J VISION, V7, DOI 10.1167/7.6.1; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Found A, 1996, PERCEPT PSYCHOPHYS, V58, P88, DOI 10.3758/BF03205479; Geyer T, 2007, J EXP PSYCHOL HUMAN, V33, P788, DOI 10.1037/0096-1523.33.4.788; Goolsby BA, 2005, VISION RES, V45, P901, DOI 10.1016/j.visres.2004.10.003; Goolsby BA, 2001, PERCEPT PSYCHOPHYS, V63, P929, DOI 10.3758/BF03194513; Hastie TJ, 2011, ELEMENTS STAT LEARNI; Hickey C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014087; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; Huang LQ, 2005, PERCEPT PSYCHOPHYS, V67, P150, DOI 10.3758/BF03195018; Huang LQ, 2004, MEM COGNITION, V32, P12, DOI 10.3758/BF03195816; HURVICH CM, 1991, BIOMETRIKA, V78, P499; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Krajbich I, 2011, P NATL ACAD SCI USA, V108, P13852, DOI 10.1073/pnas.1101328108; Kristjansson A, 2001, PERCEPTION, V30, P1375, DOI 10.1068/p3251; Kristjansson A, 2005, PRIMING COLOR POSITI; Kristjansson A, 2008, VISION RES, V48, P1217, DOI 10.1016/j.visres.2008.02.007; Kristjansson A, 2007, CEREB CORTEX, V17, P1612, DOI 10.1093/cercor/bhl072; Lamy D, 2013, VISION RES; Lamy D, 2008, VISION RES, V48, P30, DOI 10.1016/j.visres.2007.10.009; Lee H, 2009, ATTEN PERCEPT PSYCHO, V71, P1059, DOI 10.3758/APP.71.5.1059; Levinthal BR, 2008, J VISION, V8, DOI 10.1167/8.15.12; Lleras A, 2008, PERCEPT PSYCHOPHYS, V70, P114, DOI 10.3758/PP.70.1.114; Lleras A, 2009, PROG BRAIN RES, V176, P195, DOI 10.1016/S0079-6123(09)17611-2; Lleras A, 2009, J VISION, V9, DOI 10.1167/9.3.26; Maljkovic V, 1996, PERCEPT PSYCHOPHYS, V58, P977, DOI 10.3758/BF03206826; Maljkovic V, 2000, VIS COGN, V7, P571, DOI 10.1080/135062800407202; Maljkovic V, 1994, MEMORY COGNITION, V22; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; Meeter M, 2006, VIS COGN, V13, P202, DOI 10.1080/13506280500277488; Mozer M, 2006, NEURAL INFORM PROCES, V18, P923; Peremen Z, 2013, J VISION, V13, DOI 10.1167/13.5.1; Purcell BA, 2012, J NEUROSCI, V32, P3433, DOI 10.1523/JNEUROSCI.4622-11.2012; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; Ratcliff R, 2004, PSYCHOL AGING, V19, P278, DOI 10.1037/0882-7974.19.2.278; Ratcliff R, 2002, PSYCHON B REV, V9, P278, DOI 10.3758/BF03196283; Ratcliff R, 2002, PSYCHON B REV, V9, P438, DOI 10.3758/BF03196302; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ratcliff R, 2001, NATURE NEUROSCIENCE, V4; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Ratcliff R, 2007, J NEUROPHYSIOL, V97, P1756, DOI 10.1152/jn.00393.2006; Ratcliff R, 2006, PSYCHOL AGING, V21, P353, DOI 10.1037/0882-7974.21.2.353; Scalf PE, TRIAL HIST EFF UNPUB; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Schall JD, 2007, COGN AFFECT BEHAV NE, V7, P396, DOI 10.3758/CABN.7.4.396; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Serences JT, 2007, NEURON, V55, P301, DOI 10.1016/j.neuron.2007.06.015; Sigurdardottir HM, 2008, VIS COGN, V16, P643, DOI 10.1080/13506280701218364; Simen P, 2006, NEURAL NETWORKS, V19, P1013, DOI 10.1016/j.neunet.2006.05.038; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Tseng YC, 2004, PERCEPT PSYCHOPHYS, V66, P1363, DOI 10.3758/BF03195004; Tseng YC, 2013, ATTEN PERCEPT PSYCHO, V75, P287, DOI 10.3758/s13414-012-0400-2; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Vandekerckhove J, 2008, BEHAV RES METHODS, V40, P61, DOI 10.3758/BRM.40.1.61; Voss A, 2004, MEM COGNITION, V32, P1206, DOI 10.3758/BF03196893; Wan XA, 2010, VIS COGN, V18, P920, DOI 10.1080/13506280903507143; White CN, 2010, EMOTION, V10, P662, DOI 10.1037/a0019474; Wnuczko M, 2012, J GERONTOL B-PSYCHOL, V67, P325, DOI 10.1093/geronb/gbr114; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; Wolfe JM, 2003, J EXP PSYCHOL HUMAN, V29, P483, DOI 10.1037/0096-1523.29.2.483; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Yantis S., 1998, ATTENTION, V1, P223, DOI DOI 10.1037/0096-1523.16.4.812; Yashar A, 2010, J VISION, V10, DOI 10.1167/10.14.3	79	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89996	10.1371/journal.pone.0089996	http://dx.doi.org/10.1371/journal.pone.0089996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595032	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900053
J	Wang, B; Kagemann, L; Schuman, JS; Ishikawa, H; Bilonick, RA; Ling, Y; Sigal, IA; Nadler, Z; Francis, A; Sandrian, MG; Wollstein, G				Wang, Bo; Kagemann, Larry; Schuman, Joel S.; Ishikawa, Hiroshi; Bilonick, Richard A.; Ling, Yun; Sigal, Ian A.; Nadler, Zach; Francis, Andrew; Sandrian, Michelle G.; Wollstein, Gadi			Gold Nanorods as a Contrast Agent for Doppler Optical Coherence Tomography	PLOS ONE			English	Article							BLOOD-FLOW; ULTRASOUND; FLOWMETRY; VELOCITY	Purpose: To investigate gold nanorods (GNRs) as a contrast agent to enhance Doppler optical coherence tomography (OCT) imaging of the intrascleral aqueous humor outflow. Methods: A serial dilution of GNRs was scanned with a spectral-domain OCT device (Bioptigen, Durham, NC) to visualize Doppler signal. Doppler measurements using GNRs were validated using a controlled flow system. To demonstrate an application of GNR enhanced Doppler, porcine eyes were perfused at constant pressure with mock aqueous alone or 1.0x10(12) GNR/mL mixed with mock aqueous. Twelve Doppler and volumetric SD-OCT scans were obtained from the limbus in a radial fashion incremented by 30 degrees, forming a circular scan pattern. Volumetric flow was computed by integrating flow inside non-connected vessels throughout all 12 scans around the limbus. Results: At the GNR concentration of 0.7x10(12) GNRs/mL, Doppler signal was present through the entire depth of the testing tube without substantial attenuation. A well-defined laminar flow profile was observed for Doppler images of GNRs flowing through the glass capillary tube. The Doppler OCT measured flow profile was not statistically different from the expected flow profile based upon an autoregressive moving average model, with an error of -0.025 to 0.037 mm/s (p = 0.6435). Cross-sectional slices demonstrated the ability to view anterior chamber outflow ex-vivo using GNR-enhanced Doppler OCT. Doppler volumetric flow measurements were comparable to flow recorded by the perfusion system. Conclusions: GNRs created a measureable Doppler signal within otherwise silent flow fields in OCT Doppler scans. Practical application of this technique was confirmed in a constant pressure ex-vivo aqueous humor outflow model in porcine eyes.	[Wang, Bo; Kagemann, Larry; Schuman, Joel S.; Ishikawa, Hiroshi; Bilonick, Richard A.; Ling, Yun; Sigal, Ian A.; Nadler, Zach; Francis, Andrew; Sandrian, Michelle G.; Wollstein, Gadi] Univ Pittsburgh, Sch Med, Dept Ophthalmol, UPMC Eye Ctr,Eye & Ear Inst,Ophthalmol & Visual S, Pittsburgh, PA 15261 USA; [Wang, Bo; Kagemann, Larry; Schuman, Joel S.; Ishikawa, Hiroshi; Sigal, Ian A.; Sandrian, Michelle G.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA USA; [Wang, Bo] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Bilonick, Richard A.; Ling, Yun] Carnegie Mellon Univ, Med Scientist Training Program, Pittsburgh, PA 15213 USA; [Bilonick, Richard A.; Ling, Yun] Univ Pittsburgh, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Schuman, JS (corresponding author), UPMC Eye Ctr, Inst Eye & Ear, Pittsburgh, PA 15213 USA.	schumanjs@upmc.edu	Schuman, Joel S/K-7304-2012; Schuman, Joel S/M-2389-2019; Ishikawa, Hiroshi/ABC-6293-2020	Schuman, Joel S/0000-0002-8885-3766; Schuman, Joel S/0000-0002-8885-3766; Ishikawa, Hiroshi/0000-0001-6310-5748; Kagemann, Larry/0000-0001-8961-0187; Wang, Bo/0000-0003-4785-3361	American Health Assistance Foundation (AHAF); National Institute of Health [R21-019092, R01-013178, T32-008208, P30-008098]; Eye and Ear Foundation (Pittsburgh, PA); Research to Prevent Blindness (New York, NY); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008208] Funding Source: NIH RePORTER	American Health Assistance Foundation (AHAF); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eye and Ear Foundation (Pittsburgh, PA); Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by the American Health Assistance Foundation (AHAF); National Institute of Health R21-019092, R01-013178, T32-008208, P30-008098; Eye and Ear Foundation (Pittsburgh, PA); Research to Prevent Blindness (New York, NY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; BARANY EH, 1964, INVEST OPHTH VISUAL, V3, P135; Chen J, 2005, NANO LETT, V5, P473, DOI 10.1021/nl047950t; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; Ehlers JP, 2010, INVEST OPHTH VIS SCI, V51, P6614, DOI 10.1167/iovs.10-6195; Ernst H, 1996, J CLIN ULTRASOUND, V24, P31, DOI 10.1002/(SICI)1097-0096(199601)24:1<31::AID-JCU5>3.3.CO;2-1; Goertz DE, 2000, ULTRASOUND MED BIOL, V26, P63, DOI 10.1016/S0301-5629(99)00101-5; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Izatt JA, 1997, OPT LETT, V22, P1439, DOI 10.1364/OL.22.001439; Lee TM, 2003, OPT LETT, V28, P1546, DOI 10.1364/OL.28.001546; Leitgeb RA, 2003, OPT EXPRESS, V11, P3116, DOI 10.1364/OE.11.003116; Mornet S, 2004, J MATER CHEM, V14, P2161, DOI 10.1039/b402025a; Nahrendorf M, 2008, CIRCULATION, V117, P379, DOI 10.1161/CIRCULATIONAHA.107.741181; Oldenburg AL, 2006, OPT EXPRESS, V14, P6724, DOI 10.1364/OE.14.006724; Oldenburg AL, 2009, J MATER CHEM, V19, P6407, DOI 10.1039/b823389f; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Rajan V, 2009, LASER MED SCI, V24, P269, DOI 10.1007/s10103-007-0524-0; Sandrian MG, 2012, BR J OPHTHALMOL; Yazdanfar S, 1998, ADV OPTICAL IMAGING; Zhao YH, 2000, OPT LETT, V25, P114, DOI 10.1364/OL.25.000114	20	23	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90690	10.1371/journal.pone.0090690	http://dx.doi.org/10.1371/journal.pone.0090690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595044	Green Published, Green Accepted, gold			2022-12-27	WOS:000332468900135
J	Dema, B; Pellefigues, C; Hasni, S; Gault, N; Jiang, C; Ricks, TK; Bonelli, MM; Scheffel, J; Sacre, K; Jablonski, M; Gobert, D; Papo, T; Daugas, E; Illei, G; Charles, N; Rivera, J				Dema, Barbara; Pellefigues, Christophe; Hasni, Sarfaraz; Gault, Nathalie; Jiang, Chao; Ricks, Tiffany K.; Bonelli, Michael M.; Scheffel, Joerg; Sacre, Karim; Jablonski, Mathieu; Gobert, Delphine; Papo, Thomas; Daugas, Eric; Illei, Gabor; Charles, Nicolas; Rivera, Juan			Autoreactive IgE Is Prevalent in Systemic Lupus Erythematosus and Is Associated with Increased Disease Activity and Nephritis	PLOS ONE			English	Article							ANTI-DSDNA ANTIBODIES; CLINICAL-SIGNIFICANCE; REVISED CRITERIA; DNA ANTIBODIES; AUTOANTIBODIES; BASOPHILS; CLASSIFICATION; MECHANISMS; DEPOSITS; ONSET	The presence of autoantibodies in systemic lupus erythematosus, particularly those of the IgG subclass, have long been associated with disease onset and activity. Here we explored the prevalence of autoreactive IgE in SLE and its relevance to disease in French (n = 79) and United States (US) (n = 117) cohorts with a mean age of 41.5 +/- 12.7 and 43.6 +/- 15.3 years and disease duration of 13.5 +/- 8.5 and 16.6 +/- 11.9 years, respectively. Our findings show that approximately 65% of all SLE subjects studied produced IgE antibodies to the seven autoantigens tested. This positivity was increased to almost 83% when only those subjects with active disease were considered. SLE subjects who were positive for anti-dsDNA, -Sm, and -SSB/La -specific IgE showed a highly significant association in the levels of these antibodies with disease activity similar to that of the corresponding IgG's. A strong association of IgE autoantibodies with active nephritis was also found in the combined cohort analysis. A test of the predictive value of autoreactive IgE's and IgGs for disease activity (SLE Disease Activity Index (SLEDAI) >= 4) revealed that the best predictors were dsDNA-specific IgE and IgG, and that the age of an SLE subject influenced this predictive model. The finding argue that the overall levels of IgE autoantibodies, independently or in combination with IgG autoantibodies, may serve as indicators of active disease.	[Dema, Barbara; Jiang, Chao; Ricks, Tiffany K.; Scheffel, Joerg; Rivera, Juan] NIAMSD, Immunogenet Mol Lab, NIH, Bethesda, MD 20892 USA; [Pellefigues, Christophe; Sacre, Karim; Papo, Thomas; Daugas, Eric; Charles, Nicolas] Univ Paris Diderot, INSERM, U699, Paris, France; [Hasni, Sarfaraz] NIAMSD, Off Clin Director, NIH, Bethesda, MD 20892 USA; [Sacre, Karim; Gobert, Delphine; Papo, Thomas] Univ Paris Diderot, Fac Med Site Bichat, Hop Bichat, AP HP,Dept Internal Med, Paris, France; [Jablonski, Mathieu; Daugas, Eric] Univ Paris Diderot, Fac Med Site Bichat, Hop Bichat, AP HP,Dept Nephrol, Paris, France; [Gault, Nathalie] Univ Paris Diderot, Fac Med Site Bichat, Hop Bichat, AP HP,Clin Res Unit, Paris, France; [Illei, Gabor] Natl Inst Dent & Craniofacial Res, Sjogrens Syndrome Clin, NIH, Bethesda, MD USA; [Bonelli, Michael M.] NIAMSD, Lymphocyte Biol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Charles, N (corresponding author), Univ Paris Diderot, INSERM, U699, Paris, France.	nicolas.charles@inserm.fr; juan_rivera@nih.gov	CHARLES, Nicolas/S-2214-2019; GAULT, Nathalie/Y-9693-2019; CHARLES, Nicolas/P-5430-2014; Pellefigues, Christophe/AAY-3941-2020; Dema, Barbara/AAM-2354-2020	CHARLES, Nicolas/0000-0002-5416-5834; GAULT, Nathalie/0000-0002-9913-9760; CHARLES, Nicolas/0000-0002-5416-5834; Pellefigues, Christophe/0000-0001-7036-0763; Sacre, Karim/0000-0002-6544-234X; Bonelli, Michael/0000-0002-6122-7482; DAUGAS, Eric/0000-0001-7256-7979	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH); French Institut National de la Sante Et de la Recherche Medicale (INSERM); Assistance Publique - Hopitaux de Paris (AP-HP); Mairie de Paris; ANR JCJC SVSE1 BASILE; French Kidney Foundation (Fondation du Rein); AP-HP (CHRT)	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); French Institut National de la Sante Et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Assistance Publique - Hopitaux de Paris (AP-HP); Mairie de Paris(Region Ile-de-France); ANR JCJC SVSE1 BASILE(French National Research Agency (ANR)); French Kidney Foundation (Fondation du Rein); AP-HP (CHRT)	This work was supported by the Intramural Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH), by the French Institut National de la Sante Et de la Recherche Medicale (INSERM), by the Assistance Publique - Hopitaux de Paris (AP-HP) and by grants from the Mairie de Paris (Emergences 2010), ANR JCJC SVSE1 2011 BASILE and the French Kidney Foundation (Fondation du Rein) to NC. NC is under a translational research contract with the AP-HP (CHRT). The authors wish to acknowledge the invaluable support of the Office of the Clinical Director, NIAMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altin J, 2010, BLOOD REV, V24, P163, DOI 10.1016/j.blre.2010.06.002; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Atta AM, 2010, INT ARCH ALLERGY IMM, V152, P401, DOI 10.1159/000288293; Bijl M, 2002, RHEUMATOLOGY, V41, P62, DOI 10.1093/rheumatology/41.1.62; Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; Bosch X, 2011, J IMMUNOL, V186, P6083, DOI 10.4049/jimmunol.1002648; CAPRON A, 1977, PATHOL BIOL, V25, P287; Charles N, 2011, CURR ALLERGY ASTHM R, V11, P378, DOI 10.1007/s11882-011-0216-5; Charles N, 2010, NAT MED, V16, P701, DOI 10.1038/nm.2159; Forger F, 2004, LUPUS, V13, P36, DOI 10.1191/0961203304lu485oa; Mantovani APF, 2010, REV BRAS REUMATOL, V50, P278; Frieri M, 2013, ANN ALLERG ASTHMA IM, V110, P228, DOI 10.1016/j.anai.2012.12.010; Gomez MR, 2010, J IMMUNOL, V185, P7180, DOI 10.4049/jimmunol.1002319; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Kalaaji M, 2007, KIDNEY INT, V71, P664, DOI 10.1038/sj.ki.5002133; Kallenberg CGM, 2006, LUPUS, V15, P397, DOI 10.1191/0961203306lu2323oa; Kenderov A, 2002, CLIN EXP IMMUNOL, V129, P169, DOI 10.1046/j.1365-2249.2002.01887.x; Latiff AHA, 2007, ANN CLIN BIOCHEM, V44, P131, DOI 10.1258/000456307780117993; Livingston B, 2012, SEMIN ARTHRITIS RHEU, V42, P271, DOI 10.1016/j.semarthrit.2012.05.001; MADAIO MP, 1987, J IMMUNOL, V138, P2883; Mehrani T, 2011, J RHEUMATOL, V38, P64, DOI 10.3899/jrheum.100568; MILTENBURG AMM, 1993, J RHEUMATOL, V20, P53; PANKEWYCZ OG, 1987, J IMMUNOL, V139, P3287; Pate Mariah B, 2010, Clin Mol Allergy, V8, P3, DOI 10.1186/1476-7961-8-3; PERMIN H, 1978, ACTA PATH MICRO IM C, V86, P245; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Sawalha AH, 2004, CURR OPIN RHEUMATOL, V16, P534, DOI 10.1097/01.bor.0000135452.62800.8f; Schroeder K, 2013, AUTOIMMUNITY, V46, P121, DOI 10.3109/08916934.2012.748751; Sweiss NJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012280; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TUMA SN, 1981, AM J NEPHROL, V1, P31, DOI 10.1159/000166485; Villalta D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071458; Werwitzke S, 2005, ARTHRITIS RHEUM-US, V52, P3629, DOI 10.1002/art.21379; Witte T, 1998, RHEUMATOL INT, V18, P85, DOI 10.1007/s002960050063; Witte T, 1998, RHEUMATOL INT, V18, P63, DOI 10.1007/s002960050059	35	87	89	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90424	10.1371/journal.pone.0090424	http://dx.doi.org/10.1371/journal.pone.0090424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587356	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200192
J	Fernandez-Ruiz, R; Vieira, E; Garcia-Roves, PM; Gomis, R				Fernandez-Ruiz, Rebeca; Vieira, Elaine; Garcia-Roves, Pablo M.; Gomis, Ramon			Protein Tyrosine Phosphatase-1B Modulates Pancreatic beta-cell Mass	PLOS ONE			English	Article							INSULIN-RESISTANCE; 1B; PHOSPHORYLATION; APOPTOSIS; FOXO1; MICE; TRANSACTIVATION; EXPRESSION; FORKHEAD; BINDING	Protein tyrosine phosphatase 1B (PTP1B) is a negative regulator of the insulin signalling pathway. It has been demonstrated that PTP1B deletion protects against the development of obesity and Type 2 Diabetes, mainly through its action on peripheral tissues. However, little attention has been paid to the role of PTP1B in beta-cells. Therefore, our aim was to study the role of PTP1B in pancreatic beta-cells. Silencing of PTP1B expression in a pancreatic beta-cell line (MIN6 cells) reveals the significance of this endoplasmic reticulum bound phosphatase in the regulation of cell proliferation and apoptosis. Furthermore, the ablation of PTP1B is able to regulate key proteins involved in the proliferation and/or apoptosis pathways, such as STAT3, AKT, ERK1/2 and p53 in isolated islets from PTP1B knockout (PTP1B (-)/(-)) mice. Morphometric analysis of pancreatic islets from PTP1B (-)/(-) mice showed a higher beta-cell area, concomitantly with higher beta-cell proliferation and a lower beta-cell apoptosis when compared to islets from their respective wild type (WT) littermates. At a functional level, isolated islets from 8 weeks old PTP1B (-)/(-) mice exhibit enhanced glucose-stimulated insulin secretion. Moreover, PTP1B (-)/(-) mice were able to partially reverse streptozotocin-induced beta-cell loss. Together, our data highlight for the first time the involvement of PTP1B in beta-cell physiology, reinforcing the potential of this phosphatase as a therapeutical target for the treatment of beta-cell failure, a central aspect in the pathogenesis of Type 2 Diabetes.	[Fernandez-Ruiz, Rebeca; Vieira, Elaine; Garcia-Roves, Pablo M.; Gomis, Ramon] IDIBAPS, Diabet & Obes Res Lab, Barcelona, Spain; [Fernandez-Ruiz, Rebeca; Vieira, Elaine; Garcia-Roves, Pablo M.; Gomis, Ramon] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Gomis, Ramon] Univ Barcelona, Barcelona, Spain; [Gomis, Ramon] Hosp Clin Barcelona, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Gomis, R (corresponding author), IDIBAPS, Diabet & Obes Res Lab, Barcelona, Spain.	rgomis@clinic.ub.es	Roves, Pablo Garcia/A-7113-2015; Vieira, Elaine/F-7273-2019; Vieira, Elaine/AAG-1127-2020; Garcia-Roves, Pablo M./X-4585-2018	Vieira, Elaine/0000-0002-0621-9367; Vieira, Elaine/0000-0002-0621-9367; Garcia-Roves, Pablo M./0000-0002-8371-2067; Fernandez-Ruiz, Rebeca/0000-0002-9692-6697	Spanish Ministry of Science and Innovation (MICINN) [SAF 2010-19527]; Government of Catalonia [2009 SGR 1426]; Ramon y Cajal contract from MICINN [RYC-2009-05158];  [BFU2011-24679]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Government of Catalonia(Generalitat de Catalunya); Ramon y Cajal contract from MICINN; 	This work was sponsored by the Spanish Ministry of Science and Innovation (MICINN) under the grant agreement number SAF 2010-19527 (RG), the Government of Catalonia under the grant agreement number 2009 SGR 1426 (RG), and grant BFU2011-24679 (PMG-R). PGR is a recipient of a Ramon y Cajal contract (RYC-2009-05158) from MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani M, 2005, J BIOL CHEM, V280, P12096, DOI 10.1074/jbc.M412171200; Altirriba J, 2010, DIABETOLOGIA, V53, P1406, DOI 10.1007/s00125-010-1728-6; Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; Banno R, 2010, J CLIN INVEST, V120, P720, DOI 10.1172/JCI39620; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Benito Manuel, 2011, Archives of Physiology and Biochemistry, V117, P96, DOI 10.3109/13813455.2011.563748; Bettaieb A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034412; Bonner-Weir S, 2001, DIABETES, V50, pS20, DOI 10.2337/diabetes.50.2007.S20; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Casas S, 2008, DIABETOLOGIA, V51, P2252, DOI 10.1007/s00125-008-1111-z; de Chantemele EJB, 2009, CIRCULATION, V120, P753, DOI 10.1161/CIRCULATIONAHA.109.853077; Delibegovic M, 2007, MOL CELL BIOL, V27, P7727, DOI 10.1128/MCB.00959-07; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Folli F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028050; Gonzalez-Rodriguez A, 2007, J CELL PHYSIOL, V212, P76, DOI 10.1002/jcp.21004; Gonzalez-Rodriguez A, 2012, AGING CELL, V11, P284, DOI 10.1111/j.1474-9726.2011.00786.x; Gonzalez-Rodriguez A, 2010, DIABETES, V59, P588, DOI 10.2337/db09-0796; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Henquin JC, 2008, DIABETES OBES METAB, V10, P1, DOI 10.1111/j.1463-1326.2008.00968.x; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kobayashi M, 2012, AM J PHYSIOL-ENDOC M, V302, pE603, DOI 10.1152/ajpendo.00469.2011; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kousteni S, 2012, BONE, V50, P437, DOI 10.1016/j.bone.2011.06.034; Kushner JA, 2004, DIABETES, V53, P61, DOI 10.2337/diabetes.53.1.61; Lebovitz HE, 2001, EXP CLIN ENDOCR DIAB, V109, pS135, DOI 10.1055/s-2001-18576; Lu B, 2012, J ENDOCRINOL INVEST, V35, P63, DOI 10.3275/7766; Mashili F, 2013, DIABETES, V62, P457, DOI 10.2337/db12-0337; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; Owen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032700; Popov D, 2011, BIOCHEM BIOPH RES CO, V410, P377, DOI 10.1016/j.bbrc.2011.06.009; Rena G, 2001, BIOCHEM J, V354, P605, DOI 10.1042/0264-6021:3540605; Revuelta-Cervantes J, 2011, AM J PATHOL, V178, P1591, DOI 10.1016/j.ajpath.2010.12.020; Sainz-Perez A, 2008, J IMMUNOL, V181, P6051, DOI 10.4049/jimmunol.181.9.6051; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tsou RC, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00192; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Xue B, 2007, J BIOL CHEM, V282, P23829, DOI 10.1074/jbc.M609680200; Zhang JJ, 2012, DIABETES, V61, P3189, DOI 10.2337/db12-0249; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	46	22	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90344	10.1371/journal.pone.0090344	http://dx.doi.org/10.1371/journal.pone.0090344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587334	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200175
J	Flinspach, K; Kapitzke, C; Tocchetti, A; Sosio, M; Apel, AK				Flinspach, Katrin; Kapitzke, Claudia; Tocchetti, Arianna; Sosio, Margherita; Apel, Alexander K.			Heterologous Expression of the Thiopeptide Antibiotic GE2270 from Planobispora rosea ATCC 53733 in Streptomyces coelicolor Requires Deletion of Ribosomal Genes from the Expression Construct	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; NATURAL-PRODUCTS; CRE RECOMBINASE; MARKER REMOVAL; BIOSYNTHESIS; INHIBITOR; CLUSTER; CLONING; DNA	GE2270 is a thiopeptide antibiotic generated by extensive posttranslational modifications of a ribosomally generated precursor peptide. Thiopeptides are especially active against Gram-positive bacteria, including methicillin resistant Staphylococcus aureus (MRSA). In this study the GE2270 biosynthetic gene cluster (pbt) from Planobispora rosea ATCC 53733 was successfully expressed in the heterologous host strain Streptomyces coelicolor M1146. Notably, exconjugants containing the pbt gene cluster could only be obtained after deletion of the major part of the ribosomal genes flanking the gene cluster. This is a striking example that genes belonging to primary metabolism can prevent the successful conjugative transfer of DNA from phylogenetic distant species and thus complicate heterologous expression of secondary metabolite gene clusters. GE2270 production in the heterologous producer strain increased after introduction of the constitutive ermE* promoter upstream of the GE2270 resistance gene tuf from P. rosea. Insertion of the inducible tcp830 promoter resulted in inducible GE2270 production. When the regulatory gene pbtR was deleted, the resulting strain ceased to produce GE2270, suggesting an essential role of PbtR as a putative transcriptional activator of GE2270 expression.	[Flinspach, Katrin; Kapitzke, Claudia; Apel, Alexander K.] Univ Tubingen, Inst Pharmaceut, Tubingen, Germany; [Flinspach, Katrin; Apel, Alexander K.] Partner Site Tubingen, German Ctr Infect Res DZIF, Tubingen, Germany; [Tocchetti, Arianna; Sosio, Margherita] KtedoGen Srl, Milan, Italy; [Sosio, Margherita] NAICONS Srl, Milan, Italy	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; German Center for Infection Research	Apel, AK (corresponding author), Univ Tubingen, Inst Pharmaceut, Tubingen, Germany.	kristian.apel@uni-tuebingen.de		Sosio, Margherita/0000-0003-4297-6936; Tocchetti, Arianna/0000-0001-7004-7582	German Federal Ministry of Education and Research (ERA-IB GenoDrug) [FK20315930]; Italian MIUR; Regione Lombardia	German Federal Ministry of Education and Research (ERA-IB GenoDrug); Italian MIUR(Ministry of Education, Universities and Research (MIUR)); Regione Lombardia(Regione Lombardia)	Financial support was provided from the German Federal Ministry of Education and Research (ERA-IB GenoDrug, FK20315930). AT and MS were partially supported by grants from Italian MIUR and Regione Lombardia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANBORGH PH, 1991, EMBO J, V10, P779, DOI 10.1002/j.1460-2075.1991.tb08009.x; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Bagley MC, 2005, CHEM REV, V105, P685, DOI 10.1021/cr0300441; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; BIBB MJ, 1985, GENE, V38, P215, DOI 10.1016/0378-1119(85)90220-3; Butler MS, 2005, NAT PROD REP, V22, P162, DOI 10.1039/b402985m; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Dangel V, 2010, APPL MICROBIOL BIOT, V87, P261, DOI 10.1007/s00253-009-2435-4; Dey ES, 2004, APPL MICROBIOL BIOT, V64, P187, DOI 10.1007/s00253-003-1454-9; Donadio S, 2009, METHOD ENZYMOL, V458, P3, DOI 10.1016/S0076-6879(09)04801-0; Doumith M, 2000, MOL GEN GENET, V264, P477, DOI 10.1007/s004380000329; Fedoryshyn M, 2008, GENE, V419, P43, DOI 10.1016/j.gene.2008.04.011; Fedoryshyn M, 2008, APPL MICROBIOL BIOT, V78, P1065, DOI 10.1007/s00253-008-1382-9; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Flinspach K, 2010, BIOPOLYMERS, V93, P823, DOI 10.1002/bip.21493; Floriano B, 1996, MOL MICROBIOL, V21, P385, DOI 10.1046/j.1365-2958.1996.6491364.x; Gartel AL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00150; Gastaldo L, 2003, MICROBIOL-SGM, V149, P1523, DOI 10.1099/mic.0.26157-0; Gomez-Escribano JP, 2011, MICROB BIOTECHNOL, V4, P207, DOI 10.1111/j.1751-7915.2010.00219.x; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; IMADA A, 1978, J ANTIBIOT, V31, P7, DOI 10.7164/antibiotics.31.7; Jones AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069319; Khodakaramian G, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj019; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KING A, 1993, ANTIMICROB AGENTS CH, V37, P746, DOI 10.1128/AAC.37.4.746; LaMarche MJ, 2012, J MED CHEM, V55, P2376, DOI 10.1021/jm201685h; Li SM, 2006, PLANTA MED, V72, P1093, DOI 10.1055/s-2006-946699; Liao RJ, 2009, CHEM BIOL, V16, P141, DOI 10.1016/j.chembiol.2009.01.007; LOMINEK LA, 1972, ANTIMICROB AGENTS CH, V1, P123, DOI 10.1128/AAC.1.2.123; Malcolmson SJ, 2013, P NATL ACAD SCI USA, V110, P8483, DOI 10.1073/pnas.1307111110; McConkey GA, 1997, J BIOL CHEM, V272, P2046, DOI 10.1074/jbc.272.4.2046; Mohrle VG, 1997, BIOCHEM BIOPH RES CO, V230, P320, DOI 10.1006/bbrc.1996.5947; Morris RP, 2009, J AM CHEM SOC, V131, P5946, DOI 10.1021/ja900488a; Pozzi R, 2011, J ANTIBIOT, V64, P133, DOI 10.1038/ja.2010.149; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rodriguez-Garcia A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni086; Rogers MJ, 1998, ANTIMICROB AGENTS CH, V42, P715, DOI 10.1128/AAC.42.3.715; Saleh O, 2012, MEDCHEMCOMM, V3, P1009, DOI 10.1039/c2md20045g; Sambrook J., 2001, MOL CLONING LAB MANU; SEDMERA P, 1991, J NAT PROD, V54, P870, DOI 10.1021/np50075a022; SELVA E, 1991, J ANTIBIOT, V44, P693, DOI 10.7164/antibiotics.44.693; SELVA E, 1995, J ANTIBIOT, V48, P1039, DOI 10.7164/antibiotics.48.1039; Shima J, 1996, J BACTERIOL, V178, P3785, DOI 10.1128/jb.178.13.3785-3790.1996; Siebenberg S, 2010, J BIOSCI BIOENG, V109, P230, DOI 10.1016/j.jbiosc.2009.08.479; Sosio M, 2003, CHEM BIOL, V10, P541, DOI 10.1016/S1074-5521(03)00120-0; Sosio M, 1996, MOL MICROBIOL, V22, P43, DOI 10.1111/j.1365-2958.1996.tb02654.x; SU TL, 1948, BRIT J EXP PATHOL, V29, P473; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tocchetti A, 2013, CHEM BIOL, V20, P1067, DOI 10.1016/j.chembiol.2013.07.005; Young TS, 2011, P NATL ACAD SCI USA, V108, P13053, DOI 10.1073/pnas.1110435108; Zhang Q, 2013, NAT PROD REP, V30, P218, DOI 10.1039/c2np20107k	51	33	33	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90499	10.1371/journal.pone.0090499	http://dx.doi.org/10.1371/journal.pone.0090499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598591	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400082
J	Lim, J; Liu, ZB; Apontes, P; Feng, DR; Pessin, JE; Sauve, AA; Angeletti, RH; Chi, YL				Lim, Jihyeon; Liu, Zhongbo; Apontes, Pasha; Feng, Daorong; Pessin, Jeffrey E.; Sauve, Anthony A.; Angeletti, Ruth H.; Chi, Yuling			Dual Mode Action of Mangiferin in Mouse Liver under High Fat Diet	PLOS ONE			English	Article							STEAROYL-COA DESATURASE-1; ALPHA-KETOGLUTARATE DEHYDROGENASE; FUMARATE-HYDRATASE; HEPATIC TRIGLYCERIDE; RECEPTOR-ALPHA; ACID SYNTHESIS; PROTECTS MICE; MITOCHONDRIAL; DEFICIENCY; EXPRESSION	Chronic over-nutrition is a major contributor to the spread of obesity and its related metabolic disorders. Development of therapeutics has been slow compared to the speedy increase in occurrence of these metabolic disorders. We have identified a natural compound, mangiferin (MGF) (a predominant component of the plants of Anemarrhena asphodeloides and Mangifera indica), that can protect against high fat diet (HFD) induced obesity, hyperglycemia, insulin resistance and hyperlipidemia in mice. However, the molecular mechanisms whereby MGF exerts these beneficial effects are unknown. To understand MGF mechanisms of action, we performed unbiased quantitative proteomic analysis of protein profiles in liver of mice fed with HFD utilizing N-15 metabolically labeled liver proteins as internal standards. We found that out of 865 quantified proteins 87 of them were significantly differentially regulated by MGF. Among those 87 proteins, 50% of them are involved in two major processes, energy metabolism and biosynthesis of metabolites. Further classification indicated that MGF increased proteins important for mitochondrial biogenesis and oxidative activity including oxoglutarate dehydrogenase E1 (Dhtkd1) and cytochrome c oxidase subunit 6B1 (Cox6b1). Conversely, MGF reduced proteins critical for lipogenesis such as fatty acid stearoyl-CoA desaturase 1 (Scd1) and acetyl-CoA carboxylase 1 (Acac1). These mass spectrometry data were confirmed and validated by western blot assays. Together, data indicate that MGF upregulates proteins pivotal for mitochondrial bioenergetics and downregulates proteins controlling de novo lipogenesis. This novel mode of dual pharmacodynamic actions enables MGF to enhance energy expenditure and inhibit lipogenesis, and thereby correct HFD induced liver steatosis and prevent adiposity. This provides a molecular basis supporting development of MGF or its metabolites into therapeutics to treat metabolic disorders.	[Lim, Jihyeon; Angeletti, Ruth H.] Yeshiva Univ Albert Einstein Coll Med, Lab Macromol Anal & Prote, Bronx, NY 10461 USA; [Lim, Jihyeon; Angeletti, Ruth H.] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Liu, Zhongbo; Apontes, Pasha; Feng, Daorong; Pessin, Jeffrey E.; Chi, Yuling] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Pessin, Jeffrey E.] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Sauve, Anthony A.] Weill Cornell Med Coll, Dept, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Cornell University	Lim, J (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Lab Macromol Anal & Prote, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	yuling.chi@einstein.yu.edu	Liu, Zhongbo/U-3004-2017		American Heart Association [0735066N]; American Diabetes Association [1-11-JF-06]; NIH/NIDDK [DK41296]; NIH [RO1-DK-49688]; Laboratory for Macromolecular Analysis Proteomics [1S10RR15859., 1S10RR021056];  [NIH/5R01GM106072-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015859, S10RR021056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541, R01DK049688, R01DK098439, P30DK041296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106072] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laboratory for Macromolecular Analysis Proteomics; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the grants from the American Heart Association (0735066N to Yuling Chi), American Diabetes Association (1-11-JF-06 to Yuling Chi), and partially from NIH/NIDDK DK41296 to Einstein liver center and NIH RO1-DK-49688 to Einstein Liver center. This work was also partially supported by the Laboratory for Macromolecular Analysis & Proteomics grants 1S10RR15859 and 1S10RR021056. Additional support was from NIH/5R01GM106072-01 to Anthony A Sauve. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Andreu GP, 2005, EUR J PHARMACOL, V513, P47, DOI 10.1016/j.ejphar.2005.03.007; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133; BONNEFONT JP, 1992, J PEDIATR-US, V121, P255, DOI 10.1016/S0022-3476(05)81199-0; Bunik VI, 2009, BIOCHEM J, V422, P405, DOI 10.1042/BJ20090722; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; DANIEL J, 1986, BIOCHIMIE, V68, P303, DOI 10.1016/S0300-9084(86)80027-X; Dunckelmann RJ, 2000, NEUROPEDIATRICS, V31, P35, DOI 10.1055/s-2000-15295; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; ELSISSI HI, 1965, PLANTA MED, V13, P346, DOI 10.1055/s-0028-1100128; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; Gazzana G, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-35; Goldberg IJ, 2006, GASTROENTEROLOGY, V130, P1343, DOI 10.1053/j.gastro.2006.02.040; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; GUFFON N, 1993, J INHERIT METAB DIS, V16, P821, DOI 10.1007/BF00714273; Guo FC, 2011, MOL NUTR FOOD RES, V55, P1809, DOI 10.1002/mnfr.201100392; Hodges M, 2002, J EXP BOT, V53, P905, DOI 10.1093/jexbot/53.370.905; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Johnson MT, 1997, P NATL ACAD SCI USA, V94, P14512, DOI 10.1073/pnas.94.26.14512; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Leiro JM, 2003, BIOCHEM PHARMACOL, V65, P1361, DOI 10.1016/S0006-2952(03)00041-8; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002; McLain AL, 2011, FREE RADICAL RES, V45, P29, DOI 10.3109/10715762.2010.534163; McLendon AN., 2013, J NUTR THER, V2, P53; Miura T, 2001, PHYTOMEDICINE, V8, P85, DOI 10.1078/0944-7113-00009; Miyazaki M, 2004, J BIOL CHEM, V279, P35017, DOI 10.1074/jbc.M405327200; Miyazaki M, 2004, J BIOL CHEM, V279, P25164, DOI 10.1074/jbc.M402781200; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Monsalve FA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/549627; Muruganandan S, 2005, J ETHNOPHARMACOL, V97, P497, DOI 10.1016/j.jep.2004.12.010; Neufeld D S, 1997, Methods Mol Biol, V75, P145; Niu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030782; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Odievre MH, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9319; Pecina P, 2004, PHYSIOL RES, V53, pS213; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Ratcliffe PJ, 2007, CANCER CELL, V11, P303, DOI 10.1016/j.ccr.2007.03.015; Sanchez GM, 2000, PHARMACOL RES, V42, P565, DOI 10.1006/phrs.2000.0727; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Schmid GM, 2004, PROTEOMICS, V4, P2270, DOI 10.1002/pmic.200300810; Sellamuthu PS, 2009, J HEALTH SCI, V55, P206, DOI 10.1248/jhs.55.206; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Surendran S, 2002, AM J MED GENET, V113, P371, DOI 10.1002/ajmg.b.10804; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Toro JR, 2003, AM J HUM GENET, V73, P95, DOI 10.1086/376435; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Vyas A, 2012, MINI-REV MED CHEM, V12, P412, DOI 10.2174/138955712800493870; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Wu CC, 2004, ANAL CHEM, V76, P4951, DOI 10.1021/ac049208j; WU M, 1987, J BIOL CHEM, V262, P12275; Wu YF, 2002, J BIOL CHEM, V277, P8898, DOI 10.1074/jbc.M110761200; Xu WY, 2013, FEBS LETT, V587, P3587, DOI 10.1016/j.febslet.2013.08.047	61	43	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90137	10.1371/journal.pone.0090137	http://dx.doi.org/10.1371/journal.pone.0090137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598864	Green Submitted, Green Published, gold			2022-12-27	WOS:000332479400048
J	Cebrian, R; Rodriguez-Ruano, S; Martinez-Bueno, M; Valdivia, E; Maqueda, M; Montalban-Lopez, M				Cebrian, Ruben; Rodriguez-Ruano, Sonia; Martinez-Bueno, Manuel; Valdivia, Eva; Maqueda, Mercedes; Montalban-Lopez, Manuel			Analysis of the Promoters Involved in Enterocin AS-48 Expression	PLOS ONE			English	Article							LACTOCOCCUS-LACTIS; BACTERIOCIN PRODUCTION; BACILLUS-SUBTILIS; ANTIBIOTIC AS-48; MODELING GROWTH; PLASMID; PH; TEMPERATURE; TRANSFORMATION; IMMUNITY	The enterocin AS-48 is the best characterized antibacterial circular protein in prokaryotes. It is a hydrophobic and cationic bacteriocin, which is ribosomally synthesized by enterococcal cells and post-translationally cyclized by a head-to-tail peptide bond. The production of and immunity towards AS-48 depend upon the coordinated expression of ten genes organized in two operons, as-48ABC (where genes encoding enzymes with processing, secretion, and immunity functions are adjacent to the structural as-48A gene) and as-48C(1)DD(1)EFGH. The current study describes the identification of the promoters involved in AS-48 expression. Seven putative promoters have been here amplified, and separately inserted into the promoter-probe vector pTLR1, to create transcriptional fusions with the mCherry gene used as a reporter. The activity of these promoter regions was assessed measuring the expression of the fluorescent mCherry protein using the constitutive pneumococcal promoter P-X as a reference. Our results revealed that only three promoters P-A, P-2(2) and P-D1 were recognized in Enterococcus faecalis, Lactococcus lactis and Escherichia coli, in the conditions tested. The maximal fluorescence was obtained with P-X in all the strains, followed by the P-2(2) promoter, which level of fluorescence was 2-fold compared to P-A and 4-fold compared to P-D1. Analysis of putative factors influencing the promoter activity in single and double transformants in E. faecalis JH2-2 demonstrated that, in general, a better expression was achieved in presence of pAM401-81. In addition, the P-2(2) promoter could be regulated in a negative fashion by genes existing in the native pMB-2 plasmid other than those of the as-48 cluster, while the pH seems to affect differently the as-48 promoter expression.	[Cebrian, Ruben; Rodriguez-Ruano, Sonia; Martinez-Bueno, Manuel; Valdivia, Eva; Maqueda, Mercedes; Montalban-Lopez, Manuel] Univ Granada, Fac Ciencias, Dept Microbiol, E-18071 Granada, Spain	University of Granada	Maqueda, M (corresponding author), Univ Granada, Fac Ciencias, Dept Microbiol, E-18071 Granada, Spain.	mmaqueda@ugr.es; m.montalban.lopez@rug.nl	CEBRIÁN, RUBÉN/M-3311-2014; Martínez-Bueno, Manuel/N-7021-2016; Montalban-Lopez, Manuel/AAA-2871-2019; Valdivia, Eva/R-9978-2018; Rodríguez-Ruano, Sonia María/AAA-9938-2020; Maqueda, Mercedes/K-9667-2014	CEBRIÁN, RUBÉN/0000-0003-1575-1846; Martínez-Bueno, Manuel/0000-0002-1488-5642; Montalban-Lopez, Manuel/0000-0002-2936-9077; Valdivia, Eva/0000-0002-9429-9634; Rodríguez-Ruano, Sonia María/0000-0001-6863-717X; Maqueda, Mercedes/0000-0002-5874-9343	Ministerio de Ciencia e Innovacion [BIO2008-01708]; Plan Propio from the University of Granada (Spain); Research Plan Group [BIO 160]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Plan Propio from the University of Granada (Spain); Research Plan Group	This work was supported in part by the Ministerio de Ciencia e Innovacion project BIO2008-01708, the Plan Propio from the University of Granada (Spain) and by the Research Plan Group (BIO 160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriouel F, 2005, SYST APPL MICROBIOL, V28, P383, DOI 10.1016/j.syapm.2005.01.007; Ananou S, 2008, INT DAIRY J, V18, P923, DOI 10.1016/j.idairyj.2008.02.001; Bourgeois PLF, 1991, GENETIC MOL BIOL STR, P301; Cebrian R, 2012, FOOD MICROBIOL, V30, P59, DOI 10.1016/j.fm.2011.12.002; Cebrian R, 2010, APPL ENVIRON MICROB, V76, P7268, DOI 10.1128/AEM.01154-10; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Diaz M, 2003, APPL ENVIRON MICROB, V69, P1229, DOI 10.1128/AEM.69.2.1229-1236.2003; Fernandez M, 2007, J APPL MICROBIOL, V102, P1350, DOI 10.1111/j.1365-2672.2006.03194.x; Fernandez M, 2008, J BACTERIOL, V190, P240, DOI 10.1128/JB.01528-07; FRIESENEGGER A, 1991, FEMS MICROBIOL LETT, V79, P323, DOI 10.1016/0378-1097(91)90106-K; GALVEZ A, 1986, CAN J MICROBIOL, V32, P765, DOI 10.1139/m86-141; Garcia-Cayuela T, 2011, Spanish patent, Patent No. [P201130356, 201130356]; Garcia-Cayuela T, 2012, APPL MICROBIOL BIOT, V96, P171, DOI 10.1007/s00253-012-4087-z; Goel A, 2012, APPL ENVIRON MICROB, V78, P134, DOI 10.1128/AEM.05276-11; GOMORI G, 1955, METHOD ENZYMOL, V1, P138, DOI 10.1016/0076-6879(55)01020-3; Guerra NP, 2003, LETT APPL MICROBIOL, V37, P51, DOI 10.1046/j.1472-765X.2003.01346.x; Holo H, 1995, Methods Mol Biol, V47, P195; Khan H, 2010, INT J FOOD MICROBIOL, V141, P1, DOI 10.1016/j.ijfoodmicro.2010.03.005; Leaes FL, 2013, ANTON LEEUW INT J G, V104, P149, DOI 10.1007/s10482-013-9935-z; Maqueda Abreu M, 2012, Spanish patent, Patent No. [P201231060-IPR-416- ES-2387425-B2, 201231060]; Maqueda M, 2004, CURR PROTEIN PEPT SC, V5, P399, DOI 10.2174/1389203043379567; Maqueda M, 2008, FEMS MICROBIOL REV, V32, P2, DOI 10.1111/j.1574-6976.2007.00087.x; Martinez-Bueno M, 1998, MOL MICROBIOL, V27, P347, DOI 10.1046/j.1365-2958.1998.00682.x; MARTINEZBUENO M, 1990, J BACTERIOL, V172, P2817, DOI 10.1128/jb.172.5.2817-2818.1990; Meng WM, 2001, NUCLEIC ACIDS RES, V29, P4166, DOI 10.1093/nar/29.20.4166; Messens W, 2002, APPL ENVIRON MICROB, V68, P1431, DOI 10.1128/AEM.68.3.1431-1435.2002; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Montalban-Lopez M, 2008, FEBS LETT, V582, P3237, DOI 10.1016/j.febslet.2008.08.018; Mu DD, 2013, APPL ENVIRON MICROB, V79, P4503, DOI 10.1128/AEM.00866-13; Mu F, 2013, J BIOSCI BIOENG, DOI [10.1016/j.jbiosc.2013.06.023, DOI 10.1016/J.JBI0SC.2013.06.023]; Nakano MM, 2000, J BACTERIOL, V182, P3274, DOI 10.1128/JB.182.11.3274-3277.2000; PEREZMARTIN J, 1994, MICROBIOL REV, V58, P268; POOLMAN B, 1988, J BACTERIOL, V170, P700, DOI 10.1128/jb.170.2.700-707.1988; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Ruiz-Cruz S, 2010, J MICROBIOL METH, V83, P156, DOI 10.1016/j.mimet.2010.08.004; Sanchez-Hidalgo M, 2011, CELL MOL LIFE SCI, V68, P2845, DOI 10.1007/s00018-011-0724-4; Seidman CE, 1997, CURRENT PROTOCOL S37; Solovjev V, 2011, METAGENOMICITAPP, P61; Strauch MA, 2007, J BACTERIOL, V189, P7720, DOI 10.1128/JB.01081-07; Tomita H, 1997, J BACTERIOL, V179, P7843, DOI 10.1128/jb.179.24.7843-7855.1997; Usui M, 2012, JPN J INFECT DIS, V65, P252, DOI 10.7883/yoken.65.252; Voskuil MI, 1998, NUCLEIC ACIDS RES, V26, P3584, DOI 10.1093/nar/26.15.3584; YAGI Y, 1980, J BACTERIOL, V143, P966, DOI 10.1128/JB.143.2.966-970.1980; Zhang J, 2012, APPL BIOCHEM BIOTECH, V166, P1388, DOI 10.1007/s12010-011-9532-4	44	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90603	10.1371/journal.pone.0090603	http://dx.doi.org/10.1371/journal.pone.0090603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594763	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500072
J	Gugerell, A; Kober, J; Laube, T; Walter, T; Nurnberger, S; Gronniger, E; Bronneke, S; Wyrwa, R; Schnabelrauch, M; Keck, M				Gugerell, Alfred; Kober, Johanna; Laube, Thorsten; Walter, Torsten; Nuernberger, Sylvia; Groenniger, Elke; Broenneke, Simone; Wyrwa, Ralf; Schnabelrauch, Matthias; Keck, Maike			Electrospun Poly(ester-Urethane)- and Poly(ester-Urethane-Urea) Fleeces as Promising Tissue Engineering Scaffolds for Adipose-Derived Stem Cells	PLOS ONE			English	Article							IN-VITRO; BIODEGRADABLE POLYURETHANES; FIBROUS SCAFFOLDS; NANOFIBER; MATRIX; BIOCOMPATIBILITY; BIOMATERIALS; DEGRADATION; SUBSTITUTE; EXPRESSION	An irreversible loss of subcutaneous adipose tissue in patients after tumor removal or deep dermal burns makes soft tissue engineering one of the most important challenges in biomedical research. The ideal scaffold for adipose tissue engineering has yet not been identified though biodegradable polymers gained an increasing interest during the last years. In the present study we synthesized two novel biodegradable polymers, poly(epsilon-caprolactone-co-urethane-co-urea) (PEUU) and poly[(L-lactide-co-epsilon-caprolactone)-co-(L-lysine ethyl ester diisocyanate)-block-oligo(ethylene glycol)-urethane] (PEU), containing different types of hydrolytically cleavable bondings. Solutions of the polymers at appropriate concentrations were used to fabricate fleeces by electrospinning. Ultrastructure, tensile properties, and degradation of the produced fleeces were evaluated. Adipose-derived stem cells (ASCs) were seeded on fleeces and morphology, viability, proliferation and differentiation were assessed. The biomaterials show fine micro-and nanostructures composed of fibers with diameters of about 0.5 to 1.3 mu m. PEUU fleeces were more elastic, which might be favourable in soft tissue engineering, and degraded significantly slower compared to PEU. ASCs were able to adhere, proliferate and differentiate on both scaffolds. Morphology of the cells was slightly better on PEUU than on PEU showing a more physiological appearance. ASCs differentiated into the adipogenic lineage. Gene analysis of differentiated ASCs showed typical expression of adipogenetic markers such as PPARgamma and FABP4. Based on these results, PEUU and PEU meshes show a promising potential as scaffold materials in adipose tissue engineering.	[Gugerell, Alfred; Kober, Johanna; Keck, Maike] Med Univ Vienna, Div Plast & Reconstruct Surg, Dept Surg, Vienna, Austria; [Laube, Thorsten; Walter, Torsten; Wyrwa, Ralf; Schnabelrauch, Matthias] INNOVENT eV, Biomat Dept, Jena, Germany; [Nuernberger, Sylvia] Austrian Cluster Tissue Regenerat, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria; [Nuernberger, Sylvia] Med Univ Vienna, Dept Traumatol, Vienna, Austria; [Groenniger, Elke; Broenneke, Simone] Beiersdorf AG, Res Dept Appl Skin Biol, Hamburg, Germany	Medical University of Vienna; Ludwig Boltzmann Institute; Medical University of Vienna; Beiersdorf AG	Gugerell, A (corresponding author), Med Univ Vienna, Div Plast & Reconstruct Surg, Dept Surg, Vienna, Austria.	alfred.gugerell@meduniwien.ac.at	Gugerell, Alfred/W-8542-2019	Gugerell, Alfred/0000-0002-5178-9967; Nurnberger, Sylvia/0000-0002-5175-5118	European Union Seventh Framework Programme (FP7) through the ArtiVasc 3D project [263416]	European Union Seventh Framework Programme (FP7) through the ArtiVasc 3D project	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7) through the ArtiVasc 3D project under grant agreement no263416. http://ec.europa.eu/research/fp7/index_en.cfm. http://www.artivasc.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashammakhi N, 2006, J NANOSCI NANOTECHNO, V6, P2693, DOI 10.1166/jnn.2006.485; Bottcher-Haberzeth S, 2010, BURNS, V36, P450, DOI 10.1016/j.burns.2009.08.016; BRUIN P, 1990, BIOMATERIALS, V11, P291, DOI 10.1016/0142-9612(90)90013-G; Casadei A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/462543; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Chen Q, 2012, BIOMATERIALS, V1; Chen SD, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-21; Chung S, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015019; Cohn D, 2005, BIOMATERIALS, V26, P2297, DOI 10.1016/j.biomaterials.2004.07.052; Cordewener FW, 2000, BIOMATERIALS, V21, P2433, DOI 10.1016/S0142-9612(00)00111-3; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Fan WW, 2013, STEM CELLS, V31, P203, DOI 10.1002/stem.1265; Fu XB, 2007, WOUND REPAIR REGEN, V15, P540, DOI 10.1111/j.1524-475X.2007.00262.x; Gentleman E, 2006, TISSUE ENG, V12, P1639, DOI 10.1089/ten.2006.12.1639; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Guelcher SA, 2008, TISSUE ENG PART B-RE, V14, P3, DOI 10.1089/teb.2007.0133; Gunatillake PA, 2003, EUR CELLS MATER, V5, P16; Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1; Halbleib M, 2003, BIOMATERIALS, V24, P3125, DOI 10.1016/S0142-9612(03)00156-X; Han JA, 2011, J BIOMED MATER RES A, V96A, P705, DOI 10.1002/jbm.a.33023; Hemmrich K, 2006, EXPERT REV MED DEVIC, V3, P635, DOI 10.1586/17434440.3.5.635; Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9; Jeun JP, 2007, J IND ENG CHEM, V13, P592; Jung Y, 2013, J BIOMAT SCI-POLYM E, V24, P386, DOI 10.1080/09205063.2012.690281; Kawaguchi N, 1998, P NATL ACAD SCI USA, V95, P1062, DOI 10.1073/pnas.95.3.1062; Keck M, 2011, BURNS, V37, P626, DOI 10.1016/j.burns.2010.07.016; Khil MS, 2005, J BIOMED MATER RES B, V72B, P117, DOI 10.1002/jbm.b.30122; Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1; Kim WS, 2009, ARCH DERMATOL RES, V301, P329, DOI 10.1007/s00403-009-0951-9; Kim YJ, 2013, WOUND REPAIR REGEN, V21, P456, DOI 10.1111/wrr.12041; Kluger PJ, 2010, J MATER SCI-MATER M, V21, P2665, DOI 10.1007/s10856-010-4128-z; Kral JG, 1999, PLAST RECONSTR SURG, V104, P1732, DOI 10.1097/00006534-199911000-00018; Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002; Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005; Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101; Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017; Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042; Mun CH, 2012, TISSUE ENG PT A, V18, P1608, DOI [10.1089/ten.tea.2011.0695, 10.1089/ten.TEA.2011.0695]; Park DJ, 2010, J PLAST RECONSTR AES, V63, P561, DOI 10.1016/j.bjps.2008.11.042; Ravichandran R, 2012, MACROMOL BIOSCI, V12, P286, DOI 10.1002/mabi.201100325; Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035; Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197; Rosen ED, 2000, GENE DEV, V14, P1293; Ruwald MH, 2013, J AM COLL CARDIOL, V61, P326; Schoeller T, 2001, AESTHET PLAST SURG, V25, P57, DOI 10.1007/s002660010096; Shanti RM, 2008, ANN PLAS SURG, V61, P566, DOI 10.1097/SAP.0b013e31816d9579; Shenaq SM, 2002, CLIN PLAST SURG, V29, P111, DOI 10.1016/S0094-1298(03)00089-0; Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011; SMAHEL J, 1989, BRIT J PLAST SURG, V42, P207, DOI 10.1016/0007-1226(89)90205-1; Stride N, 2013, EUR J HEART FAIL, V15, P150, DOI 10.1093/eurjhf/hfs172; Surrao DC, 2012, ACTA BIOMATER, V8, P3997, DOI 10.1016/j.actbio.2012.07.012; Tanzi MC, 2009, EXPERT REV MED DEVIC, V6, P533, DOI 10.1586/ERD.09.37; Tatai L, 2007, BIOMATERIALS, V28, P5407, DOI 10.1016/j.biomaterials.2007.08.035; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Traurig MT, 2006, DIABETES, V55, P3160, DOI 10.2337/db06-0373; Vermette M, 2007, BIOMATERIALS, V28, P2850, DOI 10.1016/j.biomaterials.2007.02.030; von Heimburg D, 2005, RESP PHYSIOL NEUROBI, V146, P107, DOI 10.1016/j.resp.2004.12.013; Wacker SA, 2011, J AM CHEM SOC, V133, P12386, DOI 10.1021/ja204561q; Wendorff J. H., 2012, ELECTROSPINNING; Wu HX, 2011, MOLECULES, V16, P6489, DOI 10.3390/molecules16086489; Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X; Young DA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024104; Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k; Zhang JY, 2002, TISSUE ENG, V8, P771, DOI 10.1089/10763270260424132; Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044; 付小兵, 2004, [中国修复重建外科杂志, Chinese Journal of Reparative and Reconstructive Surgery], V18, P447	66	17	17	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90676	10.1371/journal.pone.0090676	http://dx.doi.org/10.1371/journal.pone.0090676			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594923	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500085
J	Li, Z; Shen, JX; Qiu, GX; Yu, HQ; Wang, YP; Zhang, JG; Zhao, H; Zhao, Y; Li, SG; Weng, XS; Liang, JQ; Zhao, LJ				Li, Zheng; Shen, Jianxiong; Qiu, Guixing; Yu, Haiquan; Wang, Yipeng; Zhang, Jianguo; Zhao, Hong; Zhao, Yu; Li, Shugang; Weng, Xisheng; Liang, Jinqian; Zhao, Lijuan			Unplanned Reoperation within 30 Days of Fusion Surgery for Spinal Deformity	PLOS ONE			English	Article							ADOLESCENT IDIOPATHIC SCOLIOSIS; DEFINITIVE INSTRUMENTATION; COLORECTAL-CANCER; REVISION SURGERY; ADULT SCOLIOSIS; RISK-FACTORS; COMPLICATIONS; PSEUDOARTHROSIS; INFECTION; QUALITY	No recent studies have analyzed the rates of or reasons for unanticipated revision surgery within 30 days of primary surgery in spinal deformity patients. Our aim was to examine the incidence, characteristics, reasons, and risk factors for unplanned revision surgery in spinal deformity patients treated at one institution. All patients with a diagnosis of spinal deformity presenting for primary instrumented spinal fusion at a single institution from 1998 to 2012 were reviewed. All unplanned reoperations performed within 30 days after primary surgery were analyzed in terms of demographics, surgical data, and complications. Statistical analyses were performed to obtain correlations and risk factors for anticipated revision. Of 2758 patients [aged 16.07 years (range, 2-71), 69.8% female] who underwent spinal fusion surgery, 59 (2.1%) required reoperation within 30 days after primary surgery. The length of follow up for each patient was more than 30 days. Of those that required reoperation, 87.0% had posterior surgery only, 5.7% had anterior surgery, and 7.3% underwent an anteroposterior approach. The reasons for reoperation included implant failure (n = 20), wound infection (n = 12), neurologic deficit (n = 9), pulmonary complications (n = 17), and coronal plane imbalance (n = 1). The risk factors for reoperation were age, diagnosis, and surgical procedure with osteotomy.	[Shen, Jianxiong] Chinese Acad Med Sci, Dept Orthopaed Surg, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Shen, JX (corresponding author), Chinese Acad Med Sci, Dept Orthopaed Surg, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.	shenjianxiong@medmail.com.cn	Shen, Jianxiong/AAH-6200-2019; ZHAO, YU/GZL-3154-2022	ZHAO, YU/0000-0001-9025-2014; Qiu, Guixing/0000-0002-4597-9350; Wang, Yipeng/0000-0001-9769-9839; Weng, Xisheng/0000-0002-6021-1462	National Natural Science Foundation of P.R. China [81272053, 81330044]	National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of P.R. China (Grant Number: 81272053 and 81330044; http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almoudaris AM, 2013, GUT, V62, P423, DOI 10.1136/gutjnl-2011-301489; Campos M, 2012, SPINE, V37, P1048, DOI 10.1097/BRS.0b013e31823ced6f; Carreon LY, 2007, J BONE JOINT SURG AM, V89A, P2427, DOI 10.2106/JBJS.F.00995; Charosky S, 2012, SPINE, V37, P693, DOI 10.1097/BRS.0b013e31822ff5c1; Csernatony Z, 2013, EUR SPINE J; Davis MA, 2009, SPINE, V34, P2318, DOI 10.1097/BRS.0b013e3181adb296; Froschl Uwe, 2006, Surg Infect (Larchmt), V7, P263, DOI 10.1089/sur.2006.7.263; Lehman RA, 2011, SPINE J, V11, P684, DOI 10.1016/j.spinee.2011.05.012; Liang CZ, 2012, J INT MED RES, V40, P399, DOI 10.1177/147323001204000201; Lykissas MG, 2013, SPINE, V38, pE113, DOI 10.1097/BRS.0b013e31827ae3d0; McSorley S, 2013, COLORECTAL DIS, V15, P689, DOI 10.1111/codi.12135; Mok JM, 2009, SPINE, V34, P578, DOI 10.1097/BRS.0b013e31819a827c; Mok JM, 2009, SPINE, V34, P832, DOI 10.1097/BRS.0b013e31819f2080; Mukerji N, 2012, J NEUROSURG-PEDIATR, V9, P665, DOI 10.3171/2012.2.PEDS11305; Muschik M, 2004, EUR SPINE J, V13, P645, DOI 10.1007/s00586-004-0694-4; Pateder DB, 2006, SPINE, V31, pE314, DOI 10.1097/01.brs.0000217619.57333.96; Pichelmann MA, 2010, SPINE, V35, P219, DOI 10.1097/BRS.0b013e3181c91180; Price JD, 2013, J AM COLL SURGEONS, V216, P412, DOI 10.1016/j.jamcollsurg.2012.11.009; Rama-Maceiras P, 2011, EUR J ANAESTH, V28, P10, DOI 10.1097/EJA.0b013e32833e33b0; Ramo BA, 2012, SPINE, V37, P1211, DOI 10.1097/BRS.0b013e31824b6b05; Richards BS, 2006, SPINE, V31, P3018, DOI 10.1097/01.brs.0000249553.22138.58; Sponseller PD, 2010, SPINE, V35, P2205, DOI 10.1097/BRS.0b013e3181e7d675; Sponseller PD, 2010, CLIN ORTHOP RELAT R, V468, P711, DOI 10.1007/s11999-009-0933-4; Theiss SM, 1996, ORTHOP CLIN N AM, V27, P105; Wiggins GC, 2001, J NEUROSURG, V95, P17, DOI 10.3171/spi.2001.95.1.0017	25	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e87172	10.1371/journal.pone.0087172	http://dx.doi.org/10.1371/journal.pone.0087172			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595145	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500002
J	Muster, C; Meyer, M; Sattler, T				Muster, Christoph; Meyer, Marc; Sattler, Thomas			Spatial Arrangement Overrules Environmental Factors to Structure Native and Non-Native Assemblages of Synanthropic Harvestmen	PLOS ONE			English	Article							ECOLOGICAL COMMUNITIES; BIOLOGICAL INVASIONS; NEIGHBOR MATRICES; HABITAT; URBANIZATION; FRAMEWORK; ALIEN; SCALE; BIODIVERSITY; DIVERSITY	Understanding how space affects the occurrence of native and non-native species is essential for inferring processes that shape communities. However, studies considering spatial and environmental variables for the entire community - as well as for the native and non-native assemblages in a single study - are scarce for animals. Harvestmen communities in central Europe have undergone drastic turnovers during the past decades, with several newly immigrated species, and thus provide a unique system to study such questions. We studied the wall-dwelling harvestmen communities from 52 human settlements in Luxembourg and found the assemblages to be largely dominated by non-native species (64% of specimens). Community structure was analysed using Moran's eigenvector maps as spatial variables, and landcover variables at different radii (500 m, 1000 m, 2000 m) in combination with climatic parameters as environmental variables. A surprisingly high portion of pure spatial variation (15.7% of total variance) exceeded the environmental (10.6%) and shared (4%) components of variation, but we found only minor differences between native and non-native assemblages. This could result from the ecological flexibility of both, native and non-native harvestmen that are not restricted to urban habitats but also inhabit surrounding semi-natural landscapes. Nevertheless, urban landcover variables explained more variation in the non-native community, whereas coverage of semi-natural habitats (forests, rivers) at broader radii better explained the native assemblage. This indicates that some urban characteristics apparently facilitate the establishment of non-native species. We found no evidence for competitive replacement of native by invasive species, but a community with novel combination of native and non-native species.	[Muster, Christoph] Ernst Moritz Arndt Univ Greifswald, Museum & Inst Zool, Greifswald, Germany; [Meyer, Marc] Musee Natl Hist Nat Luxembourg, Luxembourg, Luxembourg; [Sattler, Thomas] Swiss Fed Inst Forest Snow & Landscape Res WSL, Bellinzona, Switzerland; [Sattler, Thomas] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Sattler, Thomas] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	Ernst Moritz Arndt Universitat Greifswald; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute	Muster, C (corresponding author), Ernst Moritz Arndt Univ Greifswald, Museum & Inst Zool, Greifswald, Germany.	christoph.muster@uni-greifswald.de	Muster, Christoph/AAZ-1101-2021	Sattler, Thomas/0000-0001-5359-6387	Fonds National de la Recherche Luxembourg through an AMC2 - Mobility Mobility of researchers grant [FNR/09/AM2c/03]; Federal Office for the Environment Switzerland; Swiss National Science Foundation	Fonds National de la Recherche Luxembourg through an AMC2 - Mobility Mobility of researchers grant(Luxembourg National Research Fund); Federal Office for the Environment Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Field work of CM in Luxembourg was funded by the Fonds National de la Recherche Luxembourg through an AMC2 - Mobility Mobility of researchers grant (FNR/09/AM2c/03)(http://www.fnr.lu/). The salary of TS was funded by the Federal Office for the Environment Switzerland (http://www.bafu.admin.ch/index.html?lang = en) and the Swiss National Science Foundation (http://www.snf.ch/E/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta Luis E., 2007, P309; ADAMS J, 1984, OIKOS, V42, P361, DOI 10.2307/3544406; Anderson D. R., 2008, MODEL BASED INFERENC; Benedetti-Cecchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012946; Bennett AB, 2012, LANDSCAPE URBAN PLAN, V104, P26, DOI 10.1016/j.landurbplan.2011.09.007; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Blick T., 2004, CHECKLISTE WEBERKNEC; Boieiro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064591; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 1994, ENVIRON ECOL STAT, V1, P37, DOI 10.1007/BF00714196; Bossard M., 2000, 40 EUR ENV AG; Brunzel S, 2009, J BIOGEOGR, V36, P835, DOI 10.1111/j.1365-2699.2008.02044.x; Buczkowski G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041729; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calcagno V., 2011, GLMULTI MODEL SELECT; Calcagno V, 2010, J STAT SOFTW, V34, P1; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Central Intelligence Agency, 2011, WORLD FACTB 2010; Chytry M, 2012, J BIOGEOGR, V39, P1101, DOI 10.1111/j.1365-2699.2011.02664.x; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Diamond J.M., 1975, P342; Dray S., 2013, SPACEMAKER SPATIAL M; Dray S., 2011, PACKFOR FORWARD SELE; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Dunlop J.A., 2007, HARVESTMEN BIOL OPIL, DOI [10.4159/9780674276833-007, DOI 10.4159/9780674276833-007]; Entling W, 2007, GLOBAL ECOL BIOGEOGR, V16, P440, DOI 10.1111/j.1466-8238.2006.00305.x; Gilbert B, 2010, J APPL ECOL, V47, P1071, DOI 10.1111/j.1365-2664.2010.01861.x; Griffith DA, 1998, J STAT PLAN INFER, V69, P153, DOI 10.1016/S0378-3758(97)00156-0; Hajek M, 2011, J BIOGEOGR, V38, P1683, DOI 10.1111/j.1365-2699.2011.02503.x; Hirzel AH, 2004, J APPL ECOL, V41, P1103, DOI 10.1111/j.0021-8901.2004.00980.x; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; JAROMCZYK JW, 1992, P IEEE, V80, P1502, DOI 10.1109/5.163414; Kobelt M, 2008, DIVERS DISTRIB, V14, P273, DOI 10.1111/j.1472-4642.2007.00426.x; Komposch C., 2002, NEOBIOTA STERREICH, P250; KOWARIK I, 1995, PLANT INVASIONS, P85; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Leprieur F, 2009, J BIOGEOGR, V36, P1899, DOI 10.1111/j.1365-2699.2009.02107.x; Lososova Z, 2011, J BIOGEOGR, V38, P1152, DOI 10.1111/j.1365-2699.2011.02475.x; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Muster C, 2014, NATURSCHUTZ IN PRESS; Muster Christoph, 2014, Ferrantia, V70, P5; Niedringhaus R, 2010, TEXTBAND FERRANTIA, V60, P5; Noordijk Jinze, 2007, Nederlandse Faunistische Mededelingen, V26, P65; Novak Tone, 2002, Acta Entomologica Slovenica, V10, P131; Oksanen J., 2016, R PACKAG; Pecarevic M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013222; Peres-Neto PR, 2010, GLOBAL ECOL BIOGEOGR, V19, P174, DOI 10.1111/j.1466-8238.2009.00506.x; Pysek P, 1998, J BIOGEOGR, V25, P155, DOI 10.1046/j.1365-2699.1998.251177.x; Pysek P, 2010, GLOBAL ECOL BIOGEOGR, V19, P317, DOI 10.1111/j.1466-8238.2009.00514.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Sattler T, 2010, ECOLOGY, V91, P3343, DOI 10.1890/09-1810.1; Sattler T, 2010, LANDSCAPE ECOL, V25, P941, DOI 10.1007/s10980-010-9473-2; Sattler T, 2011, LANDSCAPE URBAN PLAN, V103, P347, DOI 10.1016/j.landurbplan.2011.08.008; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Sharma S, 2011, ECOGRAPHY, V34, P762, DOI 10.1111/j.1600-0587.2010.06811.x; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Toft S, 2004, MEJERNE; Toft Soren, 2011, Flora og Fauna, V117, P47; Von Holle B, 2013, BIOL INVASIONS, V15, P417, DOI 10.1007/s10530-012-0297-7; Wijnhoven H., 2009, ENTOMOL TABELLEN, V3, P1; Wijnhoven Hay, 2007, Arachnologische Mitteilungen, P27; Zar JH, 1999, BIOSTATISTICAL ANAL; Zulka P, 2009, MEJERNE, P397	70	10	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90474	10.1371/journal.pone.0090474	http://dx.doi.org/10.1371/journal.pone.0090474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595309	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500055
J	Do, BH; Ryu, HB; Hoang, P; Koo, BK; Choe, H				Do, Bich Hang; Ryu, Han-Bong; Hoang, Phuong; Koo, Bon-Kyung; Choe, Han			Soluble Prokaryotic Overexpression and Purification of Bioactive Human Granulocyte Colony-Stimulating Factor by Maltose Binding Protein and Protein Disulfide Isomerase	PLOS ONE			English	Article							FACTOR G-CSF; FACTOR HG-CSF; ESCHERICHIA-COLI; PERIPLASMIC PRODUCTION; EXTRACELLULAR DOMAIN; FACTOR-RECEPTOR; LIGAND-BINDING; FUSION PROTEIN; HUMAN PDI; EXPRESSION	Human granulocyte colony-stimulating factor (hGCSF), a neutrophil-promoting cytokine, is an effective therapeutic agent for neutropenia patients who have undergone several cancer treatments. Efficient production of hGCSF using E. coli is challenging because the hormone tends to aggregate and forms inclusion bodies. This study examined the ability of seven different N-terminal fusion tags to increase expression of soluble hGCSF in E. coli. Four tag proteins, namely maltose-binding protein (MBP), N-utilization substance protein A, protein disulfide isomerase (PDI), and the b'a' domain of PDI (PDIb'a'), increased the solubility of hGCSF under normal conditions. Lowering the expression temperature from 30 degrees C to 18 degrees C also increased the solubility of thioredoxin-tagged and glutathione S-transferase-tagged hGCSF. By contrast, hexahistidine-tagged hGCSF was insoluble at both temperatures. Simple conventional chromatographic methods were used to purify hGCSF from the overexpressed PDIb'a'-hGCSF and MBP-hGCSF proteins. In total, 11.3 mg or 10.2 mg of pure hGCSF were obtained from 500 mL cultures of E. coli expressing PDIb'a'-hGCSF or MBP-hGCSF, respectively. SDS-PAGE analysis and silver staining confirmed high purity of the isolated hGCSF proteins, and the endotoxin levels were less than 0.05 EU/mu g of protein. Subsequently, the bioactivity of the purified hGCSF proteins similar to that of the commercially available hGCSF was confirmed using the mouse M-NFS-60 myelogenous leukemia cell line. The EC(50)s of the cell proliferation dose-response curves for hGCSF proteins purified from MBP-hGCSF and PDIb'a'-hGCSF were 2.83 +/- 0.31 pM, and 3.38 +/- 0.41 pM, respectively. In summary, this study describes an efficient method for the soluble overexpression and purification of bioactive hGCSF in E. coli.	[Choe, Han] Univ Ulsan, Coll Med, Dept Physiol, Seoul, South Korea; Univ Ulsan, Coll Med, Biomed Inst Technol, Seoul, South Korea	University of Ulsan; University of Ulsan	Choe, H (corresponding author), Univ Ulsan, Coll Med, Dept Physiol, Seoul, South Korea.	hchoe@ulsan.ac.kr	Hang, Bich/AAI-6230-2021	Hang, Bich/0000-0002-8951-175X; choe, han/0000-0003-4604-647X	MRC [2008-0062286]; Priority Research Center Program of National Research Foundation [2009-0094054]; Ministry of Education, Science and Technology of Korea	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Priority Research Center Program of National Research Foundation; Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by MRC grant (2008-0062286) and Priority Research Center Program (2009-0094054) of National Research Foundation funded by the Ministry of Education, Science and Technology of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alrokayan S, 2011, GENET MOL RES, V10, P2671, DOI 10.4238/2011.October.31.18; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Bach H, 2001, J MOL BIOL, V312, P79, DOI 10.1006/jmbi.2001.4914; Bai Y, 2005, P NATL ACAD SCI USA, V102, P7292, DOI 10.1073/pnas.0500062102; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Bath PMW, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005207.pub2; Bonig H, 2001, BONE MARROW TRANSPL, V28, P259, DOI 10.1038/sj.bmt.1703136; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Chen X, 2010, PROTEIN SCI, V19, P449, DOI 10.1002/pro.323; Chung HK, 2011, BMB REP, V44, P686, DOI 10.5483/BMBRep.2011.44.10.686; Conzelmann Nadine, 2011, BMC Res Notes, V4, P194, DOI 10.1186/1756-0500-4-194; Cox GN, 2004, EXP HEMATOL, V32, P441, DOI 10.1016/j.exphem.2004.01.012; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; DEMETRI GD, 1991, BLOOD, V78, P2791; Diaz AA, 2010, BIOTECHNOL BIOENG, V105, P374, DOI 10.1002/bit.22537; Fahnert B, 2004, ADV BIOCHEM ENG BIOT, V89, P93; Ferrer M, 2004, APPL ENVIRON MICROB, V70, P4499, DOI 10.1128/AEM.70.8.4499-4504.2004; Gascon P, 2012, TARGET ONCOL, V7, pS29, DOI 10.1007/s11523-011-0190-9; Ghalaut P S, 2008, J Assoc Physicians India, V56, P942; Haniu M, 1995, ARCH BIOCHEM BIOPHYS, V324, P344, DOI 10.1006/abbi.1995.0047; HARA K, 1988, EXP HEMATOL, V16, P256; HOLLINGSHEAD LM, 1991, DRUGS, V42, P300, DOI 10.2165/00003495-199142020-00009; Horan T, 1996, BIOCHEMISTRY-US, V35, P4886, DOI 10.1021/bi9525841; Imsoonthornruksa S, 2011, J BIOTECHNOL, V151, P295, DOI 10.1016/j.jbiotec.2010.12.020; Jeong KJ, 2001, PROTEIN EXPRES PURIF, V23, P311, DOI 10.1006/prep.2001.1508; Jiang YP, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-28; Jin HF, 2011, PROTEIN EXPRES PURIF, V78, P69, DOI 10.1016/j.pep.2011.03.002; Kandror O, 1997, P NATL ACAD SCI USA, V94, P4978, DOI 10.1073/pnas.94.10.4978; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kim CW, 2007, PROTEIN SCI, V16, P635, DOI 10.1110/ps.062330907; Kim EE, 2012, CURR MED IMAGING REV, V8, P1; Kurokawa Y, 2001, J BIOL CHEM, V276, P14393, DOI 10.1074/jbc.M100132200; Lasnik MA, 2001, PFLUG ARCH EUR J PHY, V442, pR184, DOI 10.1007/s004240100018; Lefebvre J, 2009, MOL HUM REPROD, V15, P105, DOI 10.1093/molehr/gan077; Li M, 2012, APPL BIOCHEM BIOTECH, V166, P1264, DOI 10.1007/s12010-011-9512-8; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Liu Y, 2005, PROTEIN EXPRES PURIF, V44, P155, DOI 10.1016/j.pep.2005.03.030; Magistrelli G, 2005, BIOCHEM BIOPH RES CO, V334, P370, DOI 10.1016/j.bbrc.2005.06.091; Metcalf D, 2010, NAT REV CANCER, V10, P425, DOI 10.1038/nrc2843; Meuer K, 2006, J NEUROCHEM, V97, P675, DOI 10.1111/j.1471-4159.2006.03727.x; NICOLA NA, 1983, J BIOL CHEM, V258, P9017; NOMURA H, 1986, EMBO J, V5, P871, DOI 10.1002/j.1460-2075.1986.tb04297.x; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Pollari E, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-74; Rao DVK, 2008, BIOTECHNOL APPL BIOC, V50, P77, DOI 10.1042/BA20070130; Roberts AW, 2005, GROWTH FACTORS, V23, P33, DOI 10.1080/08977190500055836; Roessl U, 2012, BIOTECHNOL J, V7, P1014, DOI 10.1002/biot.201100436; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; SHIRANO Y, 1990, FEBS LETT, V271, P128, DOI 10.1016/0014-5793(90)80388-Y; Song JA, 2009, FEMS MICROBIOL LETT, V296, P60, DOI 10.1111/j.1574-6968.2009.01616.x; Song JA, 2013, APPL BIOCHEM BIOTECH, V170, P67, DOI 10.1007/s12010-013-0140-3; Vanz ALS, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-13; Vera A, 2007, BIOTECHNOL BIOENG, V96, P1101, DOI 10.1002/bit.21218; Villaverde A, 2003, BIOTECHNOL LETT, V25, P1385, DOI 10.1023/A:1025024104862; Wang CZ, 2008, BIOTECHNOL PROGR, V24, P209, DOI 10.1021/bp070263y; Wang Yanan, 2012, Sheng Wu Gong Cheng Xue Bao, V28, P1388; WEINSTEIN Y, 1986, P NATL ACAD SCI USA, V83, P5010, DOI 10.1073/pnas.83.14.5010; WINGFIELD P, 1988, BIOCHEM J, V256, P213, DOI 10.1042/bj2560213; Yamamoto A, 2002, VET IMMUNOL IMMUNOP, V90, P169, DOI 10.1016/S0165-2427(02)00259-3; Yi AR, 2009, J MICROBIOL BIOTECHN, V19, P829, DOI 10.4014/jmb.0812.683; Young DC, 1997, PROTEIN SCI, V6, P1228, DOI 10.1002/pro.5560060611; ZSEBO KM, 1986, IMMUNOBIOLOGY, V172, P175, DOI 10.1016/S0171-2985(86)80097-3	62	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89906	10.1371/journal.pone.0089906	http://dx.doi.org/10.1371/journal.pone.0089906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594699	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900045
J	Frings, L; Yew, B; Flanagan, E; Lam, BYK; Hull, M; Huppertz, HJ; Hodges, JR; Hornberger, M				Frings, Lars; Yew, Belinda; Flanagan, Emma; Lam, Bonnie Y. K.; Huell, Michael; Huppertz, Hans-Juergen; Hodges, John R.; Hornberger, Michael			Longitudinal Grey and White Matter Changes in Frontotemporal Dementia and Alzheimer's Disease	PLOS ONE			English	Article							BEHAVIORAL VARIANT; LOBAR DEGENERATION; DIAGNOSTIC-CRITERIA; SEMANTIC DEMENTIA; CEREBRAL ATROPHY; BRAIN ATROPHY; PATTERNS; MRI; AD; RATES	Behavioural variant frontotemporal dementia (bvFTD) and Alzheimer's disease (AD) dementia are characterised by progressive brain atrophy. Longitudinal MRI volumetry may help to characterise ongoing structural degeneration and support the differential diagnosis of dementia subtypes. Automated, observer-independent atlas-based MRI volumetry was applied to analyse 102 MRI data sets from 15 bvFTD, 14 AD, and 10 healthy elderly control participants with consecutive scans over at least 12 months. Anatomically defined targets were chosen a priori as brain structures of interest. Groups were compared regarding volumes at clinic presentation and annual change rates. Baseline volumes, especially of grey matter compartments, were significantly reduced in bvFTD and AD patients. Grey matter volumes of the caudate and the gyrus rectus were significantly smaller in bvFTD than AD. The bvFTD group could be separated from AD on the basis of caudate volume with high accuracy (79% cases correct). Annual volume decline was markedly larger in bvFTD and AD than controls, predominantly in white matter of temporal structures. Decline in grey matter volume of the lateral orbitofrontal gyrus separated bvFTD from AD and controls. Automated longitudinal MRI volumetry discriminates bvFTD from AD. In particular, greater reduction of orbitofrontal grey matter and temporal white matter structures after 12 months is indicative of bvFTD.	[Frings, Lars; Huell, Michael] Univ Med Ctr, Ctr Geriatr & Gerontol, Freiburg, Germany; [Frings, Lars] Univ Med Ctr, Dept Nucl Med, Freiburg, Germany; [Yew, Belinda; Flanagan, Emma; Lam, Bonnie Y. K.; Hodges, John R.; Hornberger, Michael] Neurosci Res Australia, Sydney, NSW, Australia; [Huppertz, Hans-Juergen] Swiss Epilepsy Ctr, Zurich, Switzerland; [Hodges, John R.; Hornberger, Michael] ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Lam, Bonnie Y. K.; Hodges, John R.; Hornberger, Michael] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia	University of Freiburg; University of Freiburg; Neuroscience Research Australia; University of New South Wales Sydney	Hornberger, M (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	m.hornberger@neura.edu.au	Hornberger, Michael/C-9610-2011; Lam, Bonnie Yin Ka/J-7578-2016	Hornberger, Michael/0000-0002-2214-3788; Lam, Bonnie Yin Ka/0000-0002-1656-2433; Huppertz, Hans-Jurgen/0000-0003-3856-9094; Frings, Lars/0000-0001-9377-8935; Flanagan, Emma/0000-0003-1492-7061	Australian Research Council [DP110104202, FF0776229]; German Federal Ministry of Education and Research (BMBF) [01GW0662]	Australian Research Council(Australian Research Council); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Australian Research Council (DP110104202 to M Hornberger, FF0776229 to JR Hodges) and by the German Federal Ministry of Education and Research (BMBF grant 01GW0662 to M Hull). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2012, CEREB CORTEX, V22, P2705, DOI 10.1093/cercor/bhr288; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boccardi M, 2003, NEUROBIOL AGING, V24, P95, DOI 10.1016/S0197-4580(02)00045-3; Bocti C, 2006, DEMENT GERIATR COGN, V21, P364, DOI 10.1159/000091838; Broe M, 2003, NEUROLOGY, V60, P1005, DOI 10.1212/01.WNL.0000052685.09194.39; Chan D, 2001, NEUROLOGY, V57, P1756, DOI 10.1212/WNL.57.10.1756; Chow TW, 2008, DEMENT GERIATR COGN, V26, P79, DOI 10.1159/000144028; Dalton MA, 2013, NEUROIMAGE-CLIN, V2, P56, DOI 10.1016/j.nicl.2012.11.001; Davatzikos C, 2008, NEUROIMAGE, V41, P1220, DOI 10.1016/j.neuroimage.2008.03.050; Davies RR, 2009, NEURORADIOLOGY, V51, P491, DOI 10.1007/s00234-009-0521-z; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Du AT, 2007, BRAIN, V130, P1159, DOI 10.1093/brain/awm016; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Frings L, 2012, HUM BRAIN MAPP, V33, P1526, DOI 10.1002/hbm.21304; Hampel H, 2008, ALZHEIMERS DEMENT, V4, P38, DOI 10.1016/j.jalz.2007.08.006; Hornberger M, 2010, DEMENT GERIATR COGN, V30, P547, DOI 10.1159/000321670; Hornberger M, 2012, BRAIN, V135, P3015, DOI 10.1093/brain/aws239; Hornberger M, 2011, BRAIN, V134, P2502, DOI 10.1093/brain/awr173; Huppertz HJ, 2010, NEUROIMAGE, V49, P2216, DOI 10.1016/j.neuroimage.2009.10.066; Knopman DS, 2008, BRAIN, V131, P2957, DOI 10.1093/brain/awn234; Krueger CE, 2010, ALZ DIS ASSOC DIS, V24, P43, DOI 10.1097/WAD.0b013e3181a6f101; Lillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043993; Looi JCL, 2008, AM J NEURORADIOL, V29, P1537, DOI 10.3174/ajnr.A1168; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mioshi E, 2010, NEUROLOGY, V74, P1591, DOI 10.1212/WNL.0b013e3181e04070; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nestor PJ, 2003, EUR J NEUROSCI, V18, P2663, DOI 10.1046/j.1460-9568.2003.02999.x; O'Callaghan C, 2013, CORTEX, V49, P1833, DOI 10.1016/j.cortex.2012.12.003; Perry RJ, 2006, DEMENT GERIATR COGN, V22, P278, DOI 10.1159/000095128; Piguet O, 2009, NEUROLOGY, V72, P732, DOI 10.1212/01.wnl.0000343004.98599.45; Pleizier CM, 2012, J NEUROL NEUROSUR PS, V83, P1145, DOI 10.1136/jnnp-2012-302437; Rascovsky K, 2007, ALZ DIS ASSOC DIS, V21, pS14, DOI 10.1097/WAD.0b013e31815c3445; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Resnick SM, 2003, J NEUROSCI, V23, P3295; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Whitwell JL, 2007, BRAIN, V130, P1148, DOI 10.1093/brain/awm021; Yi Dong Seok, 2013, Dement. neuropsychol., V7, P75, DOI 10.1590/S1980-57642013DN70100012	42	47	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90814	10.1371/journal.pone.0090814	http://dx.doi.org/10.1371/journal.pone.0090814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595028	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000332468900149
J	Kunz, P; Fellenberg, J; Moskovszky, L; Sapi, Z; Krenacs, T; Poeschl, J; Lehner, B; Szendroi, M; Ewerbeck, V; Kinscherf, R; Fritzsching, B				Kunz, Pierre; Fellenberg, Joerg; Moskovszky, Linda; Sapi, Zoltan; Krenacs, Tibor; Poeschl, Johannes; Lehner, Burkhard; Szendroi, Miklos; Ewerbeck, Volker; Kinscherf, Ralf; Fritzsching, Benedikt			Osteosarcoma Microenvironment: Whole-Slide Imaging and Optimized Antigen Detection Overcome Major Limitations in Immunohistochemical Quantification	PLOS ONE			English	Article							INVASIVE BREAST-CARCINOMA; ENDOTHELIAL GROWTH-FACTOR; REGULATORY T-CELLS; SOLID HUMAN TUMORS; PROGNOSTIC-FACTORS; INTERNATIONAL CONSENSUS; DENDRITIC CELLS; ANGIOGENESIS; CANCER; RETRIEVAL	Background: In osteosarcoma survival rates could not be improved over the last 30 years. Novel biomarkers are warranted to allow risk stratification of patients for more individual treatment following initial diagnosis. Although previous studies of the tumor microenvironment have identified promising candidates, novel biomarkers have not been translated into routine histopathology. Substantial difficulties regarding immunohistochemical detection and quantification of antigens in decalcified and heterogeneous osteosarcoma might largely explain this translational short-coming. Furthermore, we hypothesized that conventional hot spot analysis is often not representative for the whole section when applied to heterogeneous tissues like osteosarcoma. We aimed to overcome these difficulties for major biomarkers of the immunovascular microenvironment. Methods: Immunohistochemistry was systematically optimized for cell surface (CD31, CD8) and intracellular antigens (FOXP3) including evaluation of 200 different antigen retrieval conditions. Distribution patterns of these antigens were analyzed in formalin-fixed and paraffin-embedded samples from 120 high-grade central osteosarcoma biopsies and computer-assisted whole-slide analysis was compared with conventional quantification methods including hot spot analysis. Results: More than 96% of osteosarcoma samples were positive for all antigens after optimization of immunohistochemistry. In contrast, standard immunohistochemistry retrieved false negative results in 35-65% of decalcified osteosarcoma specimens. Standard hot spot analysis was applicable for homogeneous distributed FOXP3(+) and CD8(+) cells. However, heterogeneous distribution of vascular CD31 did not allow reliable quantification with hot spot analysis in 85% of all samples. Computer-assisted whole-slide analysis of total CD31-immunoreactive area proved as the most appropriate quantification method. Conclusion: Standard staining and quantification procedures are not applicable in decalcified formalin-fixed and paraffin-embedded samples for major parameters of the immunovascular microenvironment in osteosarcoma. Whole-slide imaging and optimized antigen retrieval overcome these limitations.	[Kunz, Pierre; Fellenberg, Joerg; Lehner, Burkhard; Ewerbeck, Volker] Univ Heidelberg Hosp, Dept Orthoped & Traumatol, Heidelberg, Germany; [Moskovszky, Linda; Sapi, Zoltan; Krenacs, Tibor] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, Fac Med, H-1085 Budapest, Hungary; [Poeschl, Johannes; Fritzsching, Benedikt] Univ Heidelberg Hosp, Dept Pediat, Heidelberg, Germany; [Szendroi, Miklos] Semmelweis Univ, Dept Orthoped, H-1085 Budapest, Hungary; [Kinscherf, Ralf] Univ Marburg, Dept Med Cell Biol, Inst Anat & Cell Biol, Marburg, Germany; [Fritzsching, Benedikt] Heidelberg Univ, TLRC, Dept Translat Pulmonol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Semmelweis University; Ruprecht Karls University Heidelberg; Semmelweis University; Philipps University Marburg; Ruprecht Karls University Heidelberg	Kunz, P (corresponding author), Univ Heidelberg Hosp, Dept Orthoped & Traumatol, Heidelberg, Germany.	Pierre.Kunz@med.uni-heidelberg.de	Kinscherf, Ralf/AAV-7164-2021		Deutsche Kinderkrebsstifting [DKS2009.05, DKS2012.09]; Junior Group Leader "Airway Inflammation"; TLRC/German Center for Lung Research; EuroBoNeT; Stiftung Landesbank Baden-Wuerttemberg	Deutsche Kinderkrebsstifting; Junior Group Leader "Airway Inflammation"; TLRC/German Center for Lung Research; EuroBoNeT(European CommissionEuropean Commission Joint Research Centre); Stiftung Landesbank Baden-Wuerttemberg	This work was supported by the Deutsche Kinderkrebsstifting (http://www.kinderkrebsstiftung.de/ Grant number DKS2009.05, DKS2012.09), Junior Group Leader "Airway Inflammation", TLRC/German Center for Lung Research (http://www.dzl.de), EuroBoNeT (http://eurobonet.pathobiology.eu/cd/index.php), and Stiftung Landesbank Baden-Wuerttemberg, (http://www.lbbw.de/lbbwde/1000010859-de.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsat C, 2011, ISRN Obstet Gynecol, V2011, P354861, DOI 10.5402/2011/354861; Buckanovich RJ, 2008, NAT MED, V14, P28, DOI 10.1038/nm1699; Chantrain CF, 2003, J HISTOCHEM CYTOCHEM, V51, P151, DOI 10.1177/002215540305100203; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; Curiel TJ, 2004, CANCER RES, V64, P5535, DOI 10.1158/0008-5472.CAN-04-1272; D'Amico F, 2009, J IMMUNOL METHODS, V341, P1, DOI 10.1016/j.jim.2008.11.007; Ek Eugene T H, 2006, Int Semin Surg Oncol, V3, P7, DOI 10.1186/1477-7800-3-7; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966; FOX SB, 1995, J PATHOL, V177, P275, DOI 10.1002/path.1711770310; FOX SB, 1994, BREAST CANCER RES TR, V29, P109, DOI 10.1007/BF00666186; Franz B, 2007, ARTHRITIS RHEUM-US, V56, P1910, DOI 10.1002/art.22699; Fritzsching B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017988; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Goldstein NS, 2007, APPL IMMUNOHISTO M M, V15, P124, DOI 10.1097/PAI.0b013e31804c7283; Gorlick R, 2003, CLIN CANCER RES, V9, P5442; Guo XJ, 2008, MODERN PATHOL, V21, P1101, DOI 10.1038/modpathol.2008.72; Haas J, 2008, BLOOD, V111, P761, DOI 10.1182/blood-2007-08-104877; Hammond MEH, 2000, ARCH PATHOL LAB MED, V124, P958; HASEGAWA T, 1991, HUM PATHOL, V22, P583, DOI 10.1016/0046-8177(91)90236-I; Hughes DPM, 2009, CURR OPIN ONCOL, V21, P332, DOI 10.1097/CCO.0b013e32832c94e2; Kaya M, 2000, CLIN CANCER RES, V6, P572; Kim NT, 2003, ANAL CELL PATHOL, V25, P63, DOI 10.1155/2003/473902; Klein MJ, 2006, AM J CLIN PATHOL, V125, P555, DOI 10.1309/UC6KQHLD9LV2KENN; Klemke CD, 2006, LEUKEMIA, V20, P1123, DOI 10.1038/sj.leu.2404182; Kreuter M, 2004, CLIN CANCER RES, V10, P8531, DOI 10.1158/1078-0432.CCR-04-0969; Kunz P, 2006, J NUCL MED, V47, P1515; Mangham DC, 2011, CLIN SARCOMA RES, V1, DOI 10.1186/2045-3329-1-6; Mantadakis E, 2001, J PEDIAT HEMATOL ONC, V23, P286, DOI 10.1097/00043426-200106000-00010; Mikulic D, 2004, PEDIATR HEMAT ONCOL, V21, P611, DOI 10.1080/08880010490501015; Osada T, 2008, CANCER IMMUNOL IMMUN, V57, P1115, DOI 10.1007/s00262-007-0441-x; Quintanilla-Martinez L, 2012, PATHOLOGE, V33, P481, DOI 10.1007/s00292-012-1647-z; Schoell WMJ, 1997, CANCER, V80, P2257; Shi SR, 1996, J PATHOL, V179, P347; SHI SR, 1992, J HISTOCHEM CYTOCHEM, V40, P787, DOI 10.1177/40.6.1588025; Shi SR, 2001, J HISTOCHEM CYTOCHEM, V49, P931, DOI 10.1177/002215540104900801; Simpson JF, 1996, CANCER, V77, P2077, DOI 10.1002/(SICI)1097-0142(19960515)77:10<2077::AID-CNCR17>3.3.CO;2-N; Sorensen Flemming Brandt, 2008, Sarcoma, V2008, P874075, DOI 10.1155/2008/874075; Sullivan CAW, 2009, HUM PATHOL, V40, P156, DOI 10.1016/j.humpath.2008.07.005; Tomlinson J, 1999, CLIN CANCER RES, V5, P3516; van Niekerk CG, 2009, PROSTATE, V69, P62, DOI 10.1002/pros.20855; Vermeulen PB, 1996, EUR J CANCER, V32A, P2474, DOI 10.1016/S0959-8049(96)00379-6; Vermeulen PB, 2002, EUR J CANCER, V38, P1564, DOI 10.1016/S0959-8049(02)00094-1; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Wilson E, 2007, J IMMUNOL METHODS, V322, P137, DOI 10.1016/j.jim.2007.01.020; Xu M, 2013, BONE, V57, P111, DOI 10.1016/j.bone.2013.07.035; Yamashita S, 2007, PROG HISTOCHEM CYTO, V41, P141, DOI 10.1016/j.proghi.2006.09.001; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	48	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90727	10.1371/journal.pone.0090727	http://dx.doi.org/10.1371/journal.pone.0090727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594971	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900140
J	Ma, QL; Deng, P; Zhu, G; Liu, C; Zhang, L; Zhou, Z; Luo, X; Li, M; Zhong, M; Yu, ZP; Chen, CH; Zhang, YW				Ma, Qinlong; Deng, Ping; Zhu, Gang; Liu, Chuan; Zhang, Lei; Zhou, Zhou; Luo, Xue; Li, Min; Zhong, Min; Yu, Zhengping; Chen, Chunhai; Zhang, Yanwen			Extremely Low-Frequency Electromagnetic Fields Affect Transcript Levels of Neuronal Differentiation-Related Genes in Embryonic Neural Stem Cells	PLOS ONE			English	Article							IN-VITRO; 50 HZ; MAGNETIC-FIELD; PRECURSOR CELLS; DNA-DAMAGE; EXPOSURE; PROLIFERATION; NEUROGENESIS; MAINTENANCE; MATURATION	Previous studies have reported that extremely low-frequency electromagnetic fields (ELF-EMF) can affect the processes of brain development, but the underlying mechanism is largely unknown. The proliferation and differentiation of embryonic neural stem cells (eNSCs) is essential for brain development during the gestation period. To date, there is no report about the effects of ELF-EMF on eNSCs. In this paper, we studied the effects of ELF-EMF on the proliferation and differentiation of eNSCs. Primary cultured eNSCs were treated with 50 Hz ELF-EMF; various magnetic intensities and exposure times were applied. Our data showed that there was no significant change in cell proliferation, which was evaluated by cell viability (CCK-8 assay), DNA synthesis (Edu incorporation), average diameter of neurospheres, cell cycle distribution (flow cytometry) and transcript levels of cell cycle related genes (P53, P21 and GADD45 detected by real-time PCR). When eNSCs were induced to differentiation, real-time PCR results showed a down-regulation of Sox2 and up-regulation of Math1, Math3, Ngn1 and Tuj1 mRNA levels after 50 Hz ELF-EMF exposure (2 mT for 3 days), but the percentages of neurons (Tuj1 positive cells) and astrocytes (GFAP positive cells) were not altered when detected by immunofluorescence assay. Although cell proliferation and the percentages of neurons and astrocytes differentiated from eNSCs were not affected by 50 Hz ELF-EMF, the expression of genes regulating neuronal differentiation was altered. In conclusion, our results support that 50 Hz ELF-EMF induce molecular changes during eNSCs differentiation, which might be compensated by post-transcriptional mechanisms to support cellular homeostasis.	[Ma, Qinlong; Deng, Ping; Zhu, Gang; Liu, Chuan; Zhang, Lei; Zhou, Zhou; Luo, Xue; Li, Min; Zhong, Min; Yu, Zhengping; Chen, Chunhai; Zhang, Yanwen] Third Mil Med Univ, Fac Prevent Med, Dept Occupat Hlth, Chongqing, Peoples R China	Army Medical University	Chen, CH (corresponding author), Third Mil Med Univ, Fac Prevent Med, Dept Occupat Hlth, Chongqing, Peoples R China.	chunhai2000@163.com; zhangyw20022002@aliyun.com		Chen, Chunhai/0000-0002-7549-213X	National Natural Science Foundation of China [30770507]; National Basic Research Program of China (National 973 Program) [2011CB503700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (National 973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (No. 30770507) and a grant from the National Basic Research Program of China (National 973 Program) (Grant No.: 2011CB503700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 1998, HEALTH PHYS, V74, P494; BAE IS, 1995, CANCER RES, V55, P2387; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bodega G, 2005, ENVIRON RES, V98, P355, DOI 10.1016/j.envres.2004.12.010; Burdak-Rothkamm S, 2009, MUTAT RES-GEN TOX EN, V672, P82, DOI 10.1016/j.mrgentox.2008.10.016; Carlessi L, 2009, CELL DEATH DIFFER, V16, P795, DOI 10.1038/cdd.2009.10; Chen CH, 2011, NEUROTOX RES, V20, P15, DOI 10.1007/s12640-010-9214-y; Cuccurazzu B, 2010, EXP NEUROL, V226, P173, DOI 10.1016/j.expneurol.2010.08.022; Czyz J, 2004, MUTAT RES-GEN TOX EN, V557, P63, DOI 10.1016/j.mrgentox.2003.09.011; Das S, 2012, ELECTROMAGN BIOL MED, V31, P180, DOI 10.3109/15368378.2012.695706; Del Vecchio G, 2009, NEUROSCI LETT, V455, P173, DOI 10.1016/j.neulet.2009.03.061; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Focke F, 2010, MUTAT RES-FUND MOL M, V683, P74, DOI 10.1016/j.mrfmmm.2009.10.012; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Grassi C, 2004, CELL CALCIUM, V35, P307, DOI 10.1016/j.ceca.2003.09.001; Harry GJ, 2000, RADIAT RES, V153, P642; Hashimoto D, 2008, J CELL BIOL, V181, P1065, DOI 10.1083/jcb.200712156; Hirsch Matthew L., 2011, PLOS ONE, V6; Huang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030638; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; Ivancsits S, 2002, MUTAT RES-GEN TOX EN, V519, P1, DOI 10.1016/S1383-5718(02)00109-2; Kheifets LI, 1995, J OCCUP ENVIRON MED, V37, P1327, DOI 10.1097/00043764-199512000-00002; Lacy-Hulbert A, 1998, FASEB J, V12, P395, DOI 10.1096/fasebj.12.6.395; Lisi A, 2005, J CELL PHYSIOL, V204, P532, DOI 10.1002/jcp.20322; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Liu Yun, 2003, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V21, P339; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis Sharon A, 2013, Methods Mol Biol, V946, P479, DOI 10.1007/978-1-62703-128-8_30; McFarlane EH, 2000, BIOELECTROCHEMISTRY, V52, P23, DOI 10.1016/S0302-4598(00)00078-7; Nam C, 2010, HISTOL HISTOPATHOL, V25, P485, DOI 10.14670/HH-25.485; Nikolova T, 2005, FASEB J, V19, P1686, DOI 10.1096/fj.04-3549fje; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Piacentini R, 2008, J CELL PHYSIOL, V215, P129, DOI 10.1002/jcp.21293; Qiu CX, 2004, EPIDEMIOLOGY, V15, P687, DOI 10.1097/01.ede.0000142147.49297.9d; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Ruzhynsky VA, 2007, J NEUROSCI, V27, P5926, DOI 10.1523/JNEUROSCI.1538-07.2007; Schuderer J, 2004, BIOELECTROMAGNETICS, V25, P582, DOI 10.1002/bem.20037; Sikorska M, 2008, J NEUROSCI RES, V86, P1680, DOI 10.1002/jnr.21635; Vanderluit JL, 2004, J CELL BIOL, V166, P853, DOI 10.1083/jcb.200403156; Vazquez-Garcia M, 2004, PHYSIOL BEHAV, V82, P685, DOI 10.1016/j.physbeh.2004.06.004; Yao L, 2012, MOL BIOL REP, V39, P569, DOI 10.1007/s11033-011-0772-8; Yoshimatsu T, 2006, DEVELOPMENT, V133, P2553, DOI 10.1242/dev.02419	43	40	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90041	10.1371/journal.pone.0090041	http://dx.doi.org/10.1371/journal.pone.0090041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595264	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900056
J	Su, XQ; Pan, WH; Song, BX; Xu, J; Ning, K				Su, Xiaoquan; Pan, Weihua; Song, Baoxing; Xu, Jian; Ning, Kang			Parallel-META 2.0: Enhanced Metagenomic Data Analysis with Functional Annotation, High Performance Computing and Advanced Visualization	PLOS ONE			English	Article							RESOURCE; GENOMES; PROJECT; HMMER	The metagenomic method directly sequences and analyses genome information from microbial communities. The main computational tasks for metagenomic analyses include taxonomical and functional structure analysis for all genomes in a microbial community (also referred to as a metagenomic sample). With the advancement of Next Generation Sequencing (NGS) techniques, the number of metagenomic samples and the data size for each sample are increasing rapidly. Current metagenomic analysis is both data-and computation-intensive, especially when there are many species in a metagenomic sample, and each has a large number of sequences. As such, metagenomic analyses require extensive computational power. The increasing analytical requirements further augment the challenges for computation analysis. In this work, we have proposed Parallel-META 2.0, a metagenomic analysis software package, to cope with such needs for efficient and fast analyses of taxonomical and functional structures for microbial communities. Parallel-META 2.0 is an extended and improved version of Parallel-META 1.0, which enhances the taxonomical analysis using multiple databases, improves computation efficiency by optimized parallel computing, and supports interactive visualization of results in multiple views. Furthermore, it enables functional analysis for metagenomic samples including short-reads assembly, gene prediction and functional annotation. Therefore, it could provide accurate taxonomical and functional analyses of the metagenomic samples in high-throughput manner and on large scale.	[Su, Xiaoquan; Song, Baoxing; Xu, Jian; Ning, Kang] Chinese Acad Sci, Shandong Key Lab Energy Genet, CAS Key Lab Biofuels, Qingdao, Peoples R China; [Su, Xiaoquan; Song, Baoxing; Xu, Jian; Ning, Kang] Chinese Acad Sci, BioEnergy Genome Ctr, Qingdao Inst Bioenergy & Bioproc Technol, Computat Biol Grp,Single Cell Ctr, Qingdao, Peoples R China; [Pan, Weihua] Univ Sci & Technol China, Sch Comp Sci & Technol, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Ning, K (corresponding author), Chinese Acad Sci, Shandong Key Lab Energy Genet, CAS Key Lab Biofuels, Qingdao, Peoples R China.	ningkang@qibebt.ac.cn	Song, Baoxing/AAQ-3563-2021; Xu, Jian/G-8430-2012; Su, Xiaoquan/CAF-9832-2022; Ning, Kang/ABD-3446-2020	Song, Baoxing/0000-0003-1478-9228; Xu, Jian/0000-0002-0548-8477; Su, Xiaoquan/0000-0003-2144-1991; Ning, Kang/0000-0003-3325-5387	Chinese Academy of Sciences [INFO-115-D01-Z006]; Ministry of Science and Technology [2009AA02Z310]; National Science Foundation of China [61103167, 31271410, 61303161]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported in part by Chinese Academy of Sciences' e-Science grant INFO-115-D01-Z006, Ministry of Science and Technology's high-tech (863) grant 2009AA02Z310 & microbial database, as well as National Science Foundation of China grant 61103167, 31271410 and 61303161. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Eisen JA, 2007, PLOS BIOL, V5, P384, DOI 10.1371/journal.pbio.0050082; Glass EM, 2010, COLD SPRING HARB PRO; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Griffen AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019051; Haque MM, 2009, BIOINFORMATICS, V25, P1722, DOI 10.1093/bioinformatics/btp317; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Jurkowski Anne, 2007, CBE Life Sci Educ, V6, P260, DOI 10.1187/cbe.07-09-0075; Krause L, 2008, NUCLEIC ACIDS RES, V36, P2230, DOI 10.1093/nar/gkn038; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; PROCTOR GN, 1994, PLASMID, V32, P101, DOI 10.1006/plas.1994.1051; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Shah N, 2011, BIOCOMPUT-PAC SYM, P165; Song BX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048998; Su XQ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S1-S16; Sun YT, 2009, INT PARALL DISTRIB P, P1570; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Walters JP, 2009, INT PARALL DISTRIB P, P1010; Yang F, 2011, ISME J; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	35	43	50	8	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89323	10.1371/journal.pone.0089323	http://dx.doi.org/10.1371/journal.pone.0089323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595159	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900014
J	Vedam-Mai, V; Gardner, B; Okun, MS; Siebzehnrubl, FA; Kam, M; Aponso, P; Steindler, DA; Yachnis, AT; Neal, D; Oliver, BU; Rath, SJ; Faull, RLM; Reynolds, BA; Curtis, MA				Vedam-Mai, Vinata; Gardner, Bronwen; Okun, Michael S.; Siebzehnrubl, Florian A.; Kam, Monica; Aponso, Palingu; Steindler, Dennis A.; Yachnis, Anthony T.; Neal, Dan; Oliver, Brittany U.; Rath, Sean J.; Faull, Richard L. M.; Reynolds, Brent A.; Curtis, Maurice A.			Increased Precursor Cell Proliferation after Deep Brain Stimulation for Parkinson's Disease: A Human Study	PLOS ONE			English	Article							SUBVENTRICULAR ZONE; HUNTINGTONS-DISEASE; PROGENITOR CELLS; SUBTHALAMIC NUCLEUS; SUBEPENDYMAL LAYER; NEUROGENIC ZONES; BASAL GANGLIA; HIPPOCAMPUS; DISORDERS; ANATOMY	Objective: Deep brain stimulation (DBS) has been used for more than a decade to treat Parkinson's disease (PD); however, its mechanism of action remains unknown. Given the close proximity of the electrode trajectory to areas of the brain known as the "germinal niches," we sought to explore the possibility that DBS influences neural stem cell proliferation locally, as well as more distantly. Methods: We studied the brains of a total of 12 idiopathic Parkinson's disease patients that were treated with DBS (the electrode placement occurred 0.5-6 years before death), and who subsequently died of unrelated illnesses. These were compared to the brains of 10 control individuals without CNS disease, and those of 5 PD patients with no DBS. Results: Immunohistochemical analyses of the subventricular zone (SVZ) of the lateral ventricles, the third ventricle lining, and the tissue surrounding the DBS lead revealed significantly greater numbers of proliferating cells expressing markers of the cell cycle, plasticity, and neural precursor cells in PD-DBS tissue compared with both normal brain tissue and tissue from PD patients not treated with DBS. The level of cell proliferation in the SVZ in PD-DBS brains was 2-6 fold greater than that in normal and untreated PD brains. Conclusions: Our data suggest that DBS is capable of increasing cellular plasticity in the brain, and we hypothesize that it may have more widespread effects beyond the electrode location. It is unclear whether these effects of DBS have any symptomatic or other beneficial influences on PD.	[Vedam-Mai, Vinata; Okun, Michael S.; Siebzehnrubl, Florian A.; Steindler, Dennis A.; Oliver, Brittany U.; Rath, Sean J.; Reynolds, Brent A.] Univ Florida, Dept Neurosurg, McKnight Brain Inst, Gainesville, FL USA; [Vedam-Mai, Vinata] Univ Florida, Dept Neurol, UF Ctr Movement Disorders & Restorat, Gainesville, FL USA; [Gardner, Bronwen; Kam, Monica; Aponso, Palingu; Faull, Richard L. M.; Curtis, Maurice A.] Univ Auckland, Dept Anat Radiol, Auckland 1, New Zealand; [Gardner, Bronwen; Kam, Monica; Aponso, Palingu; Faull, Richard L. M.; Curtis, Maurice A.] Univ Auckland, Sch Med & Hlth Sci, Ctr Brain Res, Auckland 1, New Zealand; [Yachnis, Anthony T.] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA; [Neal, Dan] Univ Florida, Dept Biostat, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Auckland; University of Auckland; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Curtis, MA (corresponding author), Univ Auckland, Dept Anat Radiol, Auckland 1, New Zealand.	m.curtis@auckland.ac.nz	Steindler, Dennis/AAJ-5811-2020; Siebzehnrubl, Florian/AAF-1496-2020	Siebzehnrubl, Florian/0000-0001-8411-8775; Okun, Michael/0000-0002-6247-9358; Curtis, Maurice/0000-0003-4496-0233; Gardner, Bronwen/0000-0001-6429-0535; Faull, Richard/0000-0003-3385-9498; Yachnis, Anthony/0000-0002-6971-0698	National Institute of Neurological Disorders and Stroke [U24 NS072026]; National Institute on Aging [P30 AG19610]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Health Research Council of New Zealand; Gus Fisher Trust; UF Foundation; National Parkinson Foundation Center of Excellence; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS072026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG019610] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Health Research Council of New Zealand(Health Research Council of New Zealand); Gus Fisher Trust; UF Foundation; National Parkinson Foundation Center of Excellence; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This program is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001 the Michael J. Fox Foundation for Parkinson's Research. The Neurological Foundation of New Zealand for support of the brain bank, the Health Research Council of New Zealand Programme grant and the Gus Fisher Trust for research funding. Further funding was provided by the UF Foundation and the National Parkinson Foundation Center of Excellence located at the University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Beurrier C, 2001, J NEUROPHYSIOL, V85, P1351, DOI 10.1152/jn.2001.85.4.1351; Boekhoorn K, 2006, NEUROBIOL DIS, V24, P1, DOI 10.1016/j.nbd.2006.04.017; Butson CR, 2007, NEUROIMAGE, V34, P661, DOI 10.1016/j.neuroimage.2006.09.034; Castrioto A, 2011, ARCH NEUROL-CHICAGO, V68, P1550, DOI 10.1001/archneurol.2011.182; Chesselet MF, 1996, TRENDS NEUROSCI, V19, P417; Curtis MA, 2006, J CHEM NEUROANAT, V31, P210, DOI 10.1016/j.jchemneu.2006.01.005; Curtis MA, 2005, NEUROSCIENCE, V132, P777, DOI 10.1016/j.neuroscience.2004.12.051; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Curtis MA, 2007, NAT REV NEUROSCI, V8, P712, DOI 10.1038/nrn2216; DeLong MR, 2001, ANN NEUROL, V49, P142, DOI 10.1002/1531-8249(20010201)49:2<142::AID-ANA32>3.0.CO;2-O; Dostrovsky JO, 2000, J NEUROPHYSIOL, V84, P570, DOI 10.1152/jn.2000.84.1.570; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Halpern C, 2007, PARKINSONISM RELAT D, V13, P1, DOI 10.1016/j.parkreldis.2006.03.001; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Low VF, 2011, NEUROSCIENCE, V199, P577, DOI 10.1016/j.neuroscience.2011.09.010; Lozano AM, 2001, PARKINSONISM RELAT D, V7, P199, DOI 10.1016/S1353-8020(00)00057-2; Mai KM, 2008, ATLAS HUMAN BRAIN; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P589, DOI 10.1016/j.clinph.2003.10.033; Mercier F, 2002, J COMP NEUROL, V451, P170, DOI 10.1002/cne.10342; Migaud M, 2010, EUR J NEUROSCI, V32, P2042, DOI 10.1111/j.1460-9568.2010.07521.x; Montgomery EB, 2000, NEUROL RES, V22, P259; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Nait-Oumesmar B, 2007, P NATL ACAD SCI USA, V104, P4694, DOI 10.1073/pnas.0606835104; Okun MS, 2010, EXPERT REV NEUROTHER, V10, P1847, DOI 10.1586/ERN.10.156; Song SJ, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/205878; Tattersfield AS, 2004, NEUROSCIENCE, V127, P319, DOI 10.1016/j.neuroscience.2004.04.061; Urbano Francisco J., 2002, Thalamus & Related Systems, V1, P371, DOI 10.1016/S1472-9288(02)00009-2; van den Berge SA, 2011, BRAIN, V134, P3249, DOI 10.1093/brain/awr256; Verwer RWH, 2007, BRAIN, V130, P3321, DOI 10.1093/brain/awm264	34	37	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e88770	10.1371/journal.pone.0088770	http://dx.doi.org/10.1371/journal.pone.0088770			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594681	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000332468900006
J	Walter, WD; Smith, R; Vanderklok, M; VerCauteren, KC				Walter, W. David; Smith, Rick; Vanderklok, Mike; VerCauteren, Kurt C.			Linking Bovine Tuberculosis on Cattle Farms to White-Tailed Deer and Environmental Variables Using Bayesian Hierarchical Analysis	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; MYCOBACTERIUM-BOVIS; ODOCOILEUS-VIRGINIANUS; WILDLIFE; MICHIGAN; CONVERGENCE; PREVALENCE; MANAGEMENT; INFECTION; EPIDEMIOLOGY	Bovine tuberculosis is a bacterial disease caused by Mycobacterium bovis in livestock and wildlife with hosts that include Eurasian badgers (Meles meles), brushtail possum (Trichosurus vulpecula), and white-tailed deer (Odocoileus virginianus). Risk-assessment efforts in Michigan have been initiated on farms to minimize interactions of cattle with wildlife hosts but research on M. bovis on cattle farms has not investigated the spatial context of disease epidemiology. To incorporate spatially explicit data, initial likelihood of infection probabilities for cattle farms tested for M. bovis, prevalence of M. bovis in white-tailed deer, deer density, and environmental variables for each farm were modeled in a Bayesian hierarchical framework. We used geo-referenced locations of 762 cattle farms that have been tested for M. bovis, white-tailed deer prevalence, and several environmental variables that may lead to long-term survival and viability of M. bovis on farms and surrounding habitats (i.e., soil type, habitat type). Bayesian hierarchical analyses identified deer prevalence and proportion of sandy soil within our sampling grid as the most supported model. Analysis of cattle farms tested for M. bovis identified that for every 1% increase in sandy soil resulted in an increase in odds of infection by 4%. Our analysis revealed that the influence of prevalence of M. bovis in white-tailed deer was still a concern even after considerable efforts to prevent cattle interactions with white-tailed deer through on-farm mitigation and reduction in the deer population. Cattle farms test positive for M. bovis annually in our study area suggesting that the potential for an environmental source either on farms or in the surrounding landscape may contributing to new or re-infections with M. bovis. Our research provides an initial assessment of potential environmental factors that could be incorporated into additional modeling efforts as more knowledge of deer herd factors and cattle farm prevalence is documented.	[Walter, W. David] Penn State Univ, US Geol Survey, Penn Cooperat Fish & Wildlife Res Unit, University Pk, PA 16802 USA; [Smith, Rick; Vanderklok, Mike] Michigan Dept Agr & Rural Dev, Anim Ind Div, Lansing, MI USA; [VerCauteren, Kurt C.] US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA)	Walter, WD (corresponding author), Penn State Univ, US Geol Survey, Penn Cooperat Fish & Wildlife Res Unit, University Pk, PA 16802 USA.	wdwalter@psu.edu			National Wildlife Research Center of the United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services	National Wildlife Research Center of the United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services	Funding for this research was provided by the National Wildlife Research Center of the United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, MODEL SELECTION MULT; [Anonymous], 2011, VET MED INT, DOI DOI 10.4061/2011/874924; Banerjee S., 2004, HIERARCHICAL MODELIN, P1; Berentsen AR, 2013, EUROPEAN J IN PRESS; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Brook RK, 2010, PREV VET MED, V94, P301, DOI 10.1016/j.prevetmed.2010.01.010; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Carstensen Michelle, 2011, Veterinary Medicine International, P413240, DOI 10.4061/2011/413240; CLIFTONHADLEY RS, 1993, EPIDEMIOL INFECT, V111, P9, DOI 10.1017/S0950268800056624; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Creed WA, 1984, WHITE TAILED DEER EC; de Lisle GW, 2002, REV SCI TECH OIE, V21, P317, DOI 10.20506/rst.21.2.1339; DUFFIELD BJ, 1985, VET MICROBIOL, V10, P193, DOI 10.1016/0378-1135(85)90021-5; Eberhardt LL, 1960, ESTIMATION VITAL CHA; Eberly LE, 2000, STAT MED, V19, P2279, DOI 10.1002/1097-0258(20000915/30)19:17/18<2279::AID-SIM569>3.0.CO;2-R; Farnsworth ML, 2006, ECOL APPL, V16, P1026, DOI 10.1890/1051-0761(2006)016[1026:LCWDTM]2.0.CO;2; Fine AE, 2011, VET MED INT, V2011, P1; Fine AE, 2011, ISRN VET SCI; Gelman A., 2004, BAYESIAN DATA ANAL, P1; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; GRIFFIN JM, 1993, PREV VET MED, V17, P145, DOI 10.1016/0167-5877(93)90025-O; Hill JA, 2005, THESIS UTAH STATE U; Hughey BD, 2003, THESIS MICHIGAN STAT; Hutchings MR, 1997, VET J, V153, P149, DOI 10.1016/S1090-0233(97)80035-4; Imrie CE, 2009, ENVIRON GEOCHEM HLTH, V31, P133, DOI 10.1007/s10653-008-9172-y; Jackson R, 1995, NEW ZEAL VET J, V43, P346, DOI 10.1080/00480169./1995.35918; Kaneene JB, 2004, JAVMA-J AM VET MED A, V224, P685, DOI 10.2460/javma.2004.224.685; Kaneene JB, 2002, J AM VET MED ASSOC, V221, P837, DOI 10.2460/javma.2002.221.837; Knust BM, 2011, AM J VET RES, V72, P924, DOI 10.2460/ajvr.72.7.924; Mathews F, 2006, BIOL LETTERS, V2, P271, DOI 10.1098/rsbl.2006.0461; Miller R, 2003, J WILDLIFE DIS, V39, P84, DOI 10.7589/0090-3558-39.1.84; Miller RA, 2006, AM J VET RES, V67, P604, DOI 10.2460/ajvr.67.4.604; Miller R, 2007, PREV VET MED, V82, P111, DOI 10.1016/j.prevetmed.2007.05.011; Mitscherlich E, 1984, MICROBIAL SURVIVAL E, P1; O'Brien DJ, 2011, VET MICROBIOL, V151, P179, DOI 10.1016/j.vetmic.2011.02.042; O'Brien DJ, 2004, J WILDLIFE DIS, V40, P42, DOI 10.7589/0090-3558-40.1.42; O'Brien DJ, 2002, PREV VET MED, V54, P47, DOI 10.1016/S0167-5877(02)00010-7; O'Brien DJ, 2006, VET MICROBIOL, V112; Osnas EE, 2009, ECOL APPL, V19, P1311, DOI 10.1890/08-0578.1; Phillips CJC, 2003, RES VET SCI, V74, P1, DOI 10.1016/S0034-5288(02)00145-5; Phillips Clive J. C., 2002, Animal Health Research Reviews, V3, P3, DOI 10.1079/AHRR200236; Smith BJ, 2007, J STAT SOFTW, V21, P1; Spiegelhalter D, 2003, WINBUGS VERSION 1 4; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; USDA NRCS, 2007, SOIL DAT VIEW 5 2 US; VANDONSEL DJ, 1977, J FOOD PROTECT, V40, P160, DOI 10.4315/0362-028X-40.3.160; Walter WD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1203; Walter WD., 2012, VET MED INT, V2012, P1, DOI [10.1155/2012/616318, DOI 10.1155/2012/616318]; Williams RS, 1930, J HYG-CAMBRIDGE, V30, P413, DOI 10.1017/S0022172400010561; Witmer G, 2010, J WILDLIFE DIS, V46, P368, DOI 10.7589/0090-3558-46.2.368; Young JS, 2005, APPL ENVIRON MICROB, V71, P1946, DOI 10.1128/AEM.71.4.1946-1952.2005	51	10	10	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90925	10.1371/journal.pone.0090925	http://dx.doi.org/10.1371/journal.pone.0090925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595231	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900158
J	Xiao, F; Ma, L; Zhao, M; Huang, GC; Mirenda, V; Dorling, A; Lechler, R; Lombardi, G				Xiao, Fang; Ma, Liang; Zhao, Min; Huang, Guocai; Mirenda, Vincenzo; Dorling, Anthony; Lechler, Robert; Lombardi, Giovanna			Ex Vivo Expanded Human Regulatory T Cells Delay Islet Allograft Rejection via Inhibiting Islet-Derived Monocyte Chemoattractant Protein-1 Production in CD34(+) Stem Cells-Reconstituted NOD-scid IL2r gamma(null) Mice	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IN-VITRO; RAG2(-/-)GAMMA(-/-)(C) MICE; INTERFERON-GAMMA; IMMUNE CELLS; TRANSPLANTATION; BLOOD; ENGRAFTMENT; MODEL; DIFFERENTIATION	Type 1 diabetes mellitus (T1DM) is an autoimmune disease caused by immune-mediated destruction of insulin-secreting beta cells of the pancreas. Near complete dependence on exogenous insulin makes T1DM very difficult to control, with the result that patients are exposed to high blood glucose and risk of diabetic complications and/or intermittent low blood glucose that can cause unconsciousness, fits and even death. Allograft transplantation of pancreatic islets restores normoglycemia with a low risk of surgical complications. However, although successful immediately after transplantation, islets are progressively lost, with most of the patients requiring exogenous insulin within 2 years post-transplant. Therefore, there is an urgent requirement for the development of new strategies to prevent islet rejection. In this study, we explored the importance of human regulatory T cells in the control of islets allograft rejection. We developed a pre-clinical model of human islet transplantation by reconstituting NOD-scid IL2r gamma(null) mice with cord blood-derived human CD34(+) stem cells and demonstrated that although the engrafted human immune system mediated the rejection of human islets, their survival was significantly prolonged following adoptive transfer of ex vivo expanded human T-regs. Mechanistically, T-regs inhibited the infiltration of innate immune cells and CD4(+) T cells into the graft by down-regulating the islet graft-derived monocyte chemoattractant protein-1. Our findings might contribute to the development of clinical strategies for T-reg therapy to control human islet rejection. We also show for the first time that CD34(+) cells-reconstituted NOD-scid IL2r gamma(null) mouse model could be beneficial for investigating human innate immunity in vivo.	[Xiao, Fang; Ma, Liang; Mirenda, Vincenzo; Dorling, Anthony; Lechler, Robert; Lombardi, Giovanna] Kings Coll London, Med Res Council MRC Transplantat, London WC2R 2LS, England; [Zhao, Min; Huang, Guocai] Kings Coll London, Dept Endocrinol & Diabet, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Lombardi, G (corresponding author), Kings Coll London, Med Res Council MRC Transplantat, London WC2R 2LS, England.	giovanna.lombardi@kcl.ac.uk		Dorling, Anthony/0000-0003-3102-2600	National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; National Institute for Health Research (NIHR) Biomedical Research Centre based at King's College London; Guy's and St Thomas' Charity Trust [R070723]; Medical Research Council in the UK [MR/J006742/1]; British Heart Foundation in the UK [RG/08/005/25303]; MRC [G0801965] Funding Source: UKRI; British Heart Foundation [RG/13/12/30395, RG/08/005/25303] Funding Source: researchfish; Medical Research Council [MR/J006742/1, G0801965] Funding Source: researchfish	National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; National Institute for Health Research (NIHR) Biomedical Research Centre based at King's College London(National Institute for Health Research (NIHR)); Guy's and St Thomas' Charity Trust; Medical Research Council in the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation in the UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research was funded by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The authors acknowledge financial support from Guy's and St Thomas' Charity Trust (R070723), Medical Research Council in the UK (MR/J006742/1), and British Heart Foundation in the UK (RG/08/005/25303). The funders had no role in study, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzali B, 2013, CLIN J AM SOC NEPHRO, V8, P1396, DOI 10.2215/CJN.12931212; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Brehm MA, 2012, BLOOD, V119, P2778, DOI 10.1182/blood-2011-05-353243; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; Chen DM, 2006, DIABETES, V55, P1011, DOI 10.2337/diabetes.55.04.06.db05-1048; Chen P, 2012, ACTA HISTOCHEM; Danner R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019826; Di Ianni M, 2012, TRANSFUS APHER SCI, V47, P213, DOI 10.1016/j.transci.2012.06.007; Ehrnfelt C, 2004, XENOTRANSPLANTATION, V11, P184, DOI 10.1046/j.1399-3089.2003.00104.x; Fiorina P, 2007, ENDOCRIN METAB CLIN, V36, px; Fiorina P, 2011, ENDOCR REV, V32, P725, DOI 10.1210/er.2011-0008; Florina P, 2007, ENDOCRIN METAB CLIN, V36, P999, DOI 10.1016/j.ecl.2007.07.004; Garcia S, 2012, IMMUNOL LETT, V146, P1, DOI 10.1016/j.imlet.2012.03.009; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; Harrison OJ, 2013, COLD SPRING HARB PER, V5; Hofer U, 2008, J VIROL, V82, P12145, DOI 10.1128/JVI.01105-08; Hu Z, 2012, CELL MOL IMMUNOL, V9, P232, DOI 10.1038/cmi.2011.63; Huang SJ, 2006, J REPROD IMMUNOL, V72, P60, DOI 10.1016/j.jri.2006.03.002; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Issa F, 2010, TRANSPLANTATION, V90, P1321, DOI 10.1097/TP.0b013e3181ff8772; Jacobson S, 2010, SCAND J IMMUNOL, V71, P83, DOI 10.1111/j.1365-3083.2009.02356.x; Jaiswal S, 2012, IMMUNOLOGY, V136, P334, DOI 10.1111/j.1365-2567.2012.03585.x; King M, 2008, CLIN IMMUNOL, V126, P303, DOI 10.1016/j.clim.2007.11.001; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Kolev M, 2013, SEMIN IMMUNOL, V25, P12, DOI 10.1016/j.smim.2013.04.012; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Lee YW, 2003, AM J PHYSIOL-HEART C, V284, pH185, DOI 10.1152/ajpheart.00524.2002; Li K, 2007, MOL IMMUNOL, V44, P3866, DOI 10.1016/j.molimm.2007.06.006; Maffi P, 2007, DIABETES CARE, V30, P1150, DOI 10.2337/dc06-1794; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Matsumura B, 2003, EXP HEMATOL, V31, P789, DOI 10.1016/S0301-472X(03)00193-0; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Nadig SN, 2010, NAT MED, V16, P809, DOI 10.1038/nm.2154; Piemonti L, 2002, DIABETES, V51, P55, DOI 10.2337/diabetes.51.1.55; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Sagoo P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002076; Sawitzki B, 2005, J EXP MED, V201, P1925, DOI 10.1084/jem.20050419; Schmidt A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00051; Scotta C, 2013, HAEMATOLOGICA, V98, P1291, DOI 10.3324/haematol.2012.074088; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tang QZ, 2012, CURR OPIN ORGAN TRAN, V17, P349, DOI 10.1097/MOT.0b013e328355a992; Tanriver Y, 2009, J IMMUNOL, V183, P2946, DOI 10.4049/jimmunol.0803953; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Tresoldi E, 2011, HAEMATOL-HEMATOL J, V96, P1357, DOI 10.3324/haematol.2011.041483; Vergani A, 2013, DIABETES, V62, P1665, DOI 10.2337/db12-0242; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; Watanabe S, 2007, J VIROL, V81, P13259, DOI 10.1128/JVI.01353-07; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050; Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227; Wood KJ, 2006, TRENDS IMMUNOL, V27, P183, DOI 10.1016/j.it.2006.02.008; Wu DC, 2013, TRANSPLANTATION; Yi SN, 2012, DIABETES, V61, P1180, DOI 10.2337/db11-1306; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022; Zhao M, 2002, TRANSPLANTATION, V73, P1454, DOI 10.1097/00007890-200205150-00015	63	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90387	10.1371/journal.pone.0090387	http://dx.doi.org/10.1371/journal.pone.0090387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594640	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900104
J	Breed, MF; Christmas, MJ; Lowe, AJ				Breed, Martin F.; Christmas, Matthew J.; Lowe, Andrew J.			Higher Levels of Multiple Paternities Increase Seedling Survival in the Long-Lived Tree Eucalyptus gracilis	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; FOREST FRAGMENTATION; MATING PATTERNS; GENETIC LOAD; SOUTHEASTERN AUSTRALIA; COMPUTER-PROGRAM; POLLEN; DIVERSITY; POPULATION; INCRASSATA	Studying associations between mating system parameters and fitness in natural populations of trees advances our understanding of how local environments affect seed quality, and thereby helps to predict when inbreeding or multiple paternities should impact on fitness. Indeed, for species that demonstrate inbreeding avoidance, multiple paternities (i.e. the number of male parents per half-sib family) should still vary and regulate fitness more than inbreeding - named here as the 'constrained inbreeding hypothesis'. We test this hypothesis in Eucalyptus gracilis, a predominantly insect-pollinated tree. Fifty-eight open-pollinated progeny arrays were collected from trees in three populations. Progeny were planted in a reciprocal transplant trial. Fitness was measured by family establishment rates. We genotyped all trees and their progeny at eight microsatellite loci. Planting site had a strong effect on fitness, but seed provenance and seed provenance x planting site did not. Populations had comparable mating system parameters and were generally outcrossed, experienced low biparental inbreeding and high levels of multiple paternity. As predicted, seed families that had more multiple paternities also had higher fitness, and no fitness-inbreeding correlations were detected. Demonstrating that fitness was most affected by multiple paternities rather than inbreeding, we provide evidence supporting the constrained inbreeding hypothesis; i.e. that multiple paternity may impact on fitness over and above that of inbreeding, particularly for preferentially outcrossing trees at life stages beyond seed development.	[Breed, Martin F.; Christmas, Matthew J.; Lowe, Andrew J.] Univ Adelaide, Australian Ctr Evolutionary Biol & Biodivers ACEB, Adelaide, SA, Australia; [Breed, Martin F.; Christmas, Matthew J.; Lowe, Andrew J.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Lowe, Andrew J.] State Herbarium South Australia, Sci Resource Ctr, Dept Environm Water & Nat Resources, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Lowe, AJ (corresponding author), Univ Adelaide, Australian Ctr Evolutionary Biol & Biodivers ACEB, Adelaide, SA, Australia.	andrew.lowe@adelaide.edu.au	Breed, Martin/G-5482-2011	Breed, Martin/0000-0001-7810-9696; Christmas, Matthew/0000-0002-6355-7581; Lowe, Andrew/0000-0003-1139-2516	Australian Research Council [LP110200805]; South Australian Premier's Science and Research Fund; Native Vegetation Council of South Australia [09/10/27]; Nature Foundation SA Inc.; Australian Geographic Society; Biological Society of South Australia; Field Naturalist Society of South Australia; Wildlife Preservation Society of Australia; NCCARF Travel Grants	Australian Research Council(Australian Research Council); South Australian Premier's Science and Research Fund; Native Vegetation Council of South Australia; Nature Foundation SA Inc.; Australian Geographic Society; Biological Society of South Australia; Field Naturalist Society of South Australia; Wildlife Preservation Society of Australia; NCCARF Travel Grants	This work was supported by Australian Research Council Linkage project (www.arc.gov.au/, LP110200805) and South Australian Premier's Science and Research Fund awarded to AJL (http://www.dfeest.sa.gov.au/); funding from the Native Vegetation Council of South Australia (www.nvc.sa.gov.au/, grant 09/10/27), Nature Foundation SA Inc. (http://www.naturefoundation.org.au/), Australian Geographic Society (http://www.australiangeographic.com.au/society/), Biological Society of South Australia (http://www.biologysocietysa.com/), Field Naturalist Society of South Australia (http://www.fnssa.org.au/), Wildlife Preservation Society of Australia (http://www.australianwildlife.net.au/); and NCCARF Travel Grants (http://www.nccarf.edu.au/) awarded to MFB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDELMAN S, 1969, AM STAT, V23, P35, DOI 10.2307/2681737; Aldrich PR, 1998, SCIENCE, V281, P103, DOI 10.1126/science.281.5373.103; Ashley MV, 2009, MOL ECOL RESOUR, V9, P1127, DOI 10.1111/j.1755-0998.2009.02562.x; Berger-Wolf TY, 2007, BIOINFORMATICS, V23, pI49, DOI 10.1093/bioinformatics/btm219; Bianchi FJJA, 2012, OIKOS, V121, P219, DOI 10.1111/j.1600-0706.2011.19842.x; Bradshaw CJA, 2012, J PLANT ECOL, V5, P109, DOI 10.1093/jpe/rtr038; Breed MF, 2013, CONSERV GENET, V14, P1, DOI 10.1007/s10592-012-0425-z; Breed MF, 2012, MOL ECOL, V21, P5955, DOI 10.1111/mec.12056; Breed MF, 2012, ECOL LETT, V15, P444, DOI 10.1111/j.1461-0248.2012.01752.x; Breed MF, HEREDITY IN PRESS; Broadhurst LM, 2008, EVOL APPL, V1, P587, DOI 10.1111/j.1752-4571.2008.00045.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cascante A, 2002, CONSERV BIOL, V16, P137, DOI 10.1046/j.1523-1739.2002.00317.x; CHARLESWORTH D, 1990, EVOLUTION, V44, P1469, DOI 10.1111/j.1558-5646.1990.tb03839.x; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Cheptou PO, 2011, NEW PHYTOL, V189, P395, DOI 10.1111/j.1469-8137.2010.03541.x; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Clarke MF, 2010, AUST J BOT, V58, P363, DOI 10.1071/BT10051; Crnokrak P, 2002, EVOLUTION, V56, P2347, DOI 10.1111/j.0014-3820.2002.tb00160.x; Eckert CG, 2010, TRENDS ECOL EVOL, V25, P35, DOI 10.1016/j.tree.2009.06.013; Faria DA, 2010, J HERED, V101, P512, DOI 10.1093/jhered/esq024; Fuchs EJ, 2003, CONSERV BIOL, V17, P149, DOI 10.1046/j.1523-1739.2003.01140.x; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Gonzalez-Varo JP, 2010, J APPL ECOL, V47, P1242, DOI 10.1111/j.1365-2664.2010.01879.x; Hirao AS, 2010, ANN BOT-LONDON, V105, P637, DOI 10.1093/aob/mcq018; Hirayama K, 2007, BIOL CONSERV, V136, P315, DOI 10.1016/j.biocon.2006.12.004; Hoebee SE, 2001, HEREDITY, V86, P489, DOI 10.1046/j.1365-2540.2001.00857.x; Horsley TN, 2007, ANN BOT-LONDON, V100, P1373, DOI 10.1093/aob/mcm223; House SM, 1997, EUCALYPT ECOLOGY IND; House Susan M., 1997, P30; Hufford KM, 2003, EVOLUTION, V57, P518, DOI 10.1111/j.0014-3820.2003.tb01543.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Klekowski EJ, 1988, TREES-STRUCT FUNCT, V2, P195, DOI 10.1007/BF00202374; Llorens TM, 2012, MOL ECOL, V21, P314, DOI 10.1111/j.1365-294X.2011.05396.x; Lowe AJ, 2005, HEREDITY, V95, P255, DOI 10.1038/sj.hdy.6800725; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Morrant DS, 2010, ECOL RES, V25, P579, DOI 10.1007/s11284-009-0687-1; Nason JD, 1998, NATURE, V391, P685, DOI 10.1038/35607; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; Nicolle D, 1997, EUCALYPTS S AUSTR; Ottewell KM, 2009, BIOL CONSERV, V142, P888, DOI 10.1016/j.biocon.2008.12.019; PARSONS RF, 1969, ECOLOGY, V50, P386, DOI 10.2307/1933887; PARSONS RF, 1968, AUST J BOT, V16, P109, DOI 10.1071/BT9680109; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; Pound LM, 2002, ANN BOT-LONDON, V89, P613, DOI 10.1093/aob/mcf089; Quesada M, 2004, BIOTROPICA, V36, P131, DOI 10.1111/j.1744-7429.2004.tb00305.x; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Salzer K, 2012, ALPINE BOT, V122, P75, DOI 10.1007/s00035-012-0106-z; SILVA JCE, 2010, ANN FOREST SCI, V67; Skogsmyr I, 2002, BIOL REV, V77, P537, DOI 10.1017/S1464793102005973; Slee A, 2006, EUCLID EUCALYPTUS AU; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vranckx G, 2012, CONSERV BIOL, V26, P228, DOI 10.1111/j.1523-1739.2011.01778.x; WELLINGTON AB, 1985, J ECOL, V73, P645, DOI 10.2307/2260501; WELLINGTON AB, 1985, J ECOL, V73, P657, DOI 10.2307/2260502; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4	61	18	18	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90478	10.1371/journal.pone.0090478	http://dx.doi.org/10.1371/journal.pone.0090478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587373	gold, Green Submitted, Green Published			2022-12-27	WOS:000332396200207
J	Fried, EI; Nesse, RM				Fried, Eiko I.; Nesse, Randolph M.			The Impact of Individual Depressive Symptoms on Impairment of Psychosocial Functioning	PLOS ONE			English	Article							SEQUENCED TREATMENT ALTERNATIVES; STAR-ASTERISK-D; RELATIVE IMPORTANCE; QUICK INVENTORY; RATING-SCALE; ASSOCIATION; SYMPTOMATOLOGY; COMORBIDITY; RATIONALE; DISORDER	Previous studies have established that scores on Major Depressive Disorder scales are correlated with measures of impairment of psychosocial functioning. It remains unclear, however, whether individual depressive symptoms vary in their effect on impairment, and if so, what the magnitude of these differences might be. We analyzed data from 3,703 depressed outpatients in the first treatment stage of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Participants reported on the severity of 14 depressive symptoms, and stated to what degree their depression impaired psychosocial functioning (in general, and in the five domains work, home management, social activities, private activities, and close relationships). We tested whether symptoms differed in their associations with impairment, estimated unique shared variances of each symptom with impairment to assess the degree of difference, and examined whether symptoms had variable impacts across impairment domains. Our results show that symptoms varied substantially in their associations with impairment, and contributed to the total explained variance in a range from 0.7% (hypersomnia) to 20.9% (sad mood). Furthermore, symptoms had significantly different impacts on the five impairment domains. Overall, sad mood and concentration problems had the highest unique associations with impairment and were among the most debilitating symptoms in all five domains. Our findings are in line with a growing chorus of voices suggesting that symptom sum-scores obfuscate relevant differences between depressed patients and that substantial rewards will come from close attention to individual depression symptoms.	[Fried, Eiko I.] Free Univ Berlin, Cluster Excellence Languages Emot, Berlin, Germany; [Fried, Eiko I.] Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany; [Nesse, Randolph M.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Free University of Berlin; Free University of Berlin; Arizona State University; Arizona State University-Tempe	Fried, EI (corresponding author), Free Univ Berlin, Cluster Excellence Languages Emot, Berlin, Germany.	eiko.fried@gmail.com	Fried, Eiko/H-3174-2019	Fried, Eiko/0000-0001-7469-594X	NIMH [N01MH90003]; Cluster of Excellence "Languages of Emotion" [EXC302]; German Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [N01MH090003] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Cluster of Excellence "Languages of Emotion"; German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The STAR*D study was supported by NIMH Contract # N01MH90003 to the University of Texas Southwestern Medical Center (http://www.nimh.nih.gov). The ClinicalTrials.gov identifier is NCT00021528. This manuscript reflects the views of the authors and may not reflect the opinions or views of the STAR*D study investigators or the NIMH. Mr. Fried is supported by fellowships from the Cluster of Excellence "Languages of Emotion" (grant no. EXC302, http://www.loe.fu-berlin.de) and the German Research Foundation (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2004, STAT ANAL DATA DISPL; [Anonymous], 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Bollen KA, 1989, STRUCTURAL EQUATIONS; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; CORYELL W, 1994, AM J PSYCHIAT, V151, P199; Cramer AOJ, 2012, PSYCHOL MED, V42, P957, DOI 10.1017/S003329171100211X; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; Dew MA, 1997, ARCH GEN PSYCHIAT, V54, P1016; Fava M, 2003, PSYCHIAT CLIN N AM, V26, P457, DOI 10.1016/S0193-953X(02)00107-7; Fava M, 2008, AM J PSYCHIAT, V165, P342, DOI 10.1176/appi.ajp.2007.06111868; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Fried EI, 2014, PSYCHOL MED, V44, P2067, DOI 10.1017/S0033291713002900; Groemping U., 2006, J STAT SOFTW, V17, P1, DOI DOI 10.18637/JSS.V017.I01; Gromping U, 2007, AM STAT, V61, P139, DOI 10.1198/000313007X188252; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Harald B, 2012, J AFFECT DISORDERS, V139, P126, DOI 10.1016/j.jad.2011.07.015; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; HAYS RD, 1995, ARCH GEN PSYCHIAT, V52, P11; Hek K, 2013, BIOL PSYCHIAT, V73, P667, DOI 10.1016/j.biopsych.2012.09.033; Hirschfeld RMA, 2002, BIOL PSYCHIAT, V51, P123, DOI 10.1016/S0006-3223(01)01291-4; Jang KL, 2004, J AFFECT DISORDERS, V80, P125, DOI 10.1016/S0165-0327(03)00108-3; Johnson JW, 2004, ORGAN RES METHODS, V7, P238, DOI 10.1177/1094428104266510; Judd LL, 2013, JAMA PSYCHIAT, V70, P1171, DOI 10.1001/jamapsychiatry.2013.1957; Judd LL, 1996, AM J PSYCHIAT, V153, P1411; Katschnig H, 1986, LIFE EVENTS PSYCHIAT; Keller MC, 2007, AM J PSYCHIAT, V164, P1521, DOI 10.1176/appi.ajp.2007.06091564; Keller MC, 2006, J PERS SOC PSYCHOL, V91, P316, DOI 10.1037/0022-3514.91.2.316; Keller MC, 2005, J AFFECT DISORDERS, V86, P27, DOI 10.1016/j.jad.2004.12.005; Kendler KS, 2013, JAMA PSYCHIAT, V70, P599, DOI 10.1001/jamapsychiatry.2013.751; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; KRUSKAL W, 1989, AM STAT, V43, P2, DOI 10.2307/2685157; Lichstein KL, 2000, PSYCHOL AGING, V15, P232, DOI 10.1037/0882-7974.15.2.232; Lichtenberg P, 2010, PSYCHOTHER PSYCHOSOM, V79, P131, DOI 10.1159/000286957; Lux V, 2010, PSYCHOL MED, V40, P1679, DOI 10.1017/S0033291709992157; Marks I, 1986, BEHAV PSYCHOTHERAPY; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McKnight PE, 2009, CLIN PSYCHOL REV, V29, P243, DOI 10.1016/j.cpr.2009.01.005; Mundt JC, 2002, BRIT J PSYCHIAT, V180, P461, DOI 10.1192/bjp.180.5.461; Murray C.J, 1996, GLOBAL BURDEN DIS CO; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Myung W, 2012, PSYCHIAT RES, V198, P400, DOI 10.1016/j.psychres.2011.12.037; Oquendo MA, 2004, AM J PSYCHIAT, V161, P255, DOI 10.1176/appi.ajp.161.2.255; Ostergaard SD, 2011, ACTA PSYCHIAT SCAND, V124, P495, DOI 10.1111/j.1600-0447.2011.01744.x; Pigeon WR, 2008, SLEEP, V31, P481, DOI 10.1093/sleep/31.4.481; Pigott HE, 2010, PSYCHOTHER PSYCHOSOM, V79, P267, DOI 10.1159/000318293; R Core Team, 2021, R LANGUAGE ENV STAT; Regier DA, 2013, AM J PSYCHIAT, V170, P59, DOI 10.1176/appi.ajp.2012.12070999; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Rush AJ, 2006, BIOL PSYCHIAT, V59, P493, DOI 10.1016/j.biopsych.2005.08.022; Rybarczyk B, 2002, PSYCHOL AGING, V17, P288, DOI 10.1037/0882-7974.17.2.288; Schmittmann VD, 2013, NEW IDEAS PSYCHOL, V31, P43, DOI 10.1016/j.newideapsych.2011.02.007; Katherine E, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001326; TWEED DL, 1993, PSYCHOL MED, V23, P373, DOI 10.1017/S0033291700028476; Zimmerman M, 2006, J NERV MENT DIS, V194, P313, DOI 10.1097/01.nmd.0000217806.16329.ff	56	204	209	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90311	10.1371/journal.pone.0090311	http://dx.doi.org/10.1371/journal.pone.0090311			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24587318	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200164
J	Gowert, NS; Donner, L; Chatterjee, M; Eisele, YS; Towhid, ST; Munzer, P; Walker, B; Ogorek, I; Borst, O; Grandoch, M; Schaller, M; Fischer, JW; Gawaz, M; Weggen, S; Lang, F; Jucker, M; Elvers, M				Gowert, Nina S.; Donner, Lili; Chatterjee, Madhumita; Eisele, Yvonne S.; Towhid, Seyda T.; Muenzer, Patrick; Walker, Britta; Ogorek, Isabella; Borst, Oliver; Grandoch, Maria; Schaller, Martin; Fischer, Jens W.; Gawaz, Meinrad; Weggen, Sascha; Lang, Florian; Jucker, Mathias; Elvers, Margitta			Blood Platelets in the Progression of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDE; PRECURSOR PROTEIN; PHOSPHOLIPASE C-GAMMA-2; BRAIN-BARRIER; ACTIVATION; ANGIOPATHY; EXPRESSION; VESSELS; CALCIUM; RISK	Alzheimer's disease (AD) is characterized by neurotoxic amyloid-beta plaque formation in brain parenchyma and cerebral blood vessels known as cerebral amyloid angiopathy (CAA). Besides CAA, AD is strongly related to vascular diseases such as stroke and atherosclerosis. Cerebrovascular dysfunction occurs in AD patients leading to alterations in blood flow that might play an important role in AD pathology with neuronal loss and memory deficits. Platelets are the major players in hemostasis and thrombosis, but are also involved in neuroinflammatory diseases like AD. For many years, platelets were accepted as peripheral model to study the pathophysiology of AD because platelets display the enzymatic activities to generate amyloid-beta (A beta) peptides. In addition, platelets are considered to be a biomarker for early diagnosis of AD. Effects of A beta peptides on platelets and the impact of platelets in the progression of AD remained, however, ill-defined. The present study explored the cellular mechanisms triggered by A beta in platelets. Treatment of platelets with A beta led to platelet activation and enhanced generation of reactive oxygen species (ROS) and membrane scrambling, suggesting enhanced platelet apoptosis. More important, platelets modulate soluble A beta into fibrillar structures that were absorbed by apoptotic but not vital platelets. This together with enhanced platelet adhesion under flow ex vivo and in vivo and platelet accumulation at amyloid deposits of cerebral vessels of AD transgenic mice suggested that platelets are major contributors of CAA inducing platelet thrombus formation at vascular amyloid plaques leading to vessel occlusion critical for cerebrovascular events like stroke.	[Gowert, Nina S.; Donner, Lili; Elvers, Margitta] Univ Dusseldorf, Dept Clin & Expt Hemostasis Hemotherapy & Transfu, Dusseldorf, Germany; [Chatterjee, Madhumita; Borst, Oliver; Gawaz, Meinrad; Elvers, Margitta] Univ Tubingen, Med Klin Kardiol & Kreislauferkrankungen 3, Tubingen, Germany; [Eisele, Yvonne S.; Jucker, Mathias] Univ Tubingen, Dept Cellular Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany; [Eisele, Yvonne S.] German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany; [Towhid, Seyda T.; Muenzer, Patrick; Walker, Britta; Borst, Oliver; Lang, Florian] Univ Tubingen, Dept Physiol, Tubingen, Germany; [Ogorek, Isabella; Weggen, Sascha] Univ Dusseldorf, Dept Neuropathol, Dusseldorf, Germany; [Grandoch, Maria; Fischer, Jens W.] Univ Dusseldorf, Univ Klinikum, Inst Pharmakol Klin Pharmakol, Dusseldorf, Germany; [Schaller, Martin] Univ Tubingen, Dept Dermatol, Tubingen, Germany	Heinrich Heine University Dusseldorf; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Elvers, M (corresponding author), Univ Dusseldorf, Dept Clin & Expt Hemostasis Hemotherapy & Transfu, Dusseldorf, Germany.	margitta.elvers@med.uni-duesseldorf.de	Rezzani, Rita/E-9528-2010; Stacchiotti, Alessandra/E-8706-2010; Borsani, Elisa/K-7676-2019; Eisele, Yvonne/E-7897-2015; Chatterjee, Madhumita/AAJ-1802-2020	Eisele, Yvonne/0000-0002-3868-4327; Chatterjee, Madhumita/0000-0002-3428-4107; Munzer, Patrick/0000-0001-5357-038X; Borst, Oliver/0000-0003-4002-4085	Medical Faculty of the Heinrich Heine University, Dusseldorf; Tuebingen Platelet Investigative Consortium [TuePIC]; Deutsche Forschungsgemeinschaft - Klinische Forschergruppe [DFG-KFO 274, SFB766]	Medical Faculty of the Heinrich Heine University, Dusseldorf; Tuebingen Platelet Investigative Consortium [TuePIC]; Deutsche Forschungsgemeinschaft - Klinische Forschergruppe(German Research Foundation (DFG))	This work was supported in part by the Medical Faculty of the Heinrich Heine University, Dusseldorf, the Tuebingen Platelet Investigative Consortium [TuePIC] and the Deutsche Forschungsgemeinschaft - Klinische Forschergruppe [DFG-KFO 274 and SFB766]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arianna V, 2007, NEUROBIOL AGING, V28, P987, DOI 10.1016/j.neurobiolaging.2006.05.010; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Baskin F, 2000, NEUROLOGY, V54, P1907, DOI 10.1212/WNL.54.10.1907; Borst O, 2012, BLOOD, V119, P251, DOI 10.1182/blood-2011-06-359976; BUSH AI, 1990, J BIOL CHEM, V265, P15977; Cadavid D, 2000, J NEUROPATH EXP NEUR, V59, P768, DOI 10.1093/jnen/59.9.768; Casoli T, 2007, ANN NY ACAD SCI, V1096, P170, DOI 10.1196/annals.1397.082; Catricala S, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-20; Chatterjee M, 2008, FREE RADICAL BIO MED, V45, P1084, DOI 10.1016/j.freeradbiomed.2008.06.028; CHEN M, 1995, BIOCHEM BIOPH RES CO, V213, P96, DOI 10.1006/bbrc.1995.2103; COHEN BM, 1987, LIFE SCI, V40, P2445, DOI 10.1016/0024-3205(87)90760-0; Davies TA, 2000, AMYLOID, V7, P153, DOI 10.3109/13506120009146830; Deane R, 2007, CURR ALZHEIMER RES, V4, P191, DOI 10.2174/156720507780362245; Eder L, 2007, NEW ENGL J MED, V356, P2406, DOI 10.1056/NEJMicm061510; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Elvers M, 2010, J THROMB HAEMOST, V8, P1353, DOI 10.1111/j.1538-7836.2010.03838.x; Elvers M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000551; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; GhersiEgea JF, 1996, J NEUROCHEM, V67, P880; Hardy J, 2007, NEUROCHEM RES, V32, P833, DOI 10.1007/s11064-006-9221-9; Hermann R, 1996, HISTOCHEM CELL BIOL, V106, P31; Honig LS, 2003, ARCH NEUROL-CHICAGO, V60, P1707, DOI 10.1001/archneur.60.12.1707; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Kimberly WT, 2009, NEUROLOGY, V72, P1230, DOI 10.1212/01.wnl.0000345666.83318.03; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KROLL MH, 1989, BLOOD, V74, P1181; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; Langer HF, 2010, J MOL MED, V88, P687, DOI 10.1007/s00109-010-0614-5; Leytin V, 2006, J THROMB HAEMOST, V4, P2656, DOI 10.1111/j.1538-7836.2006.02200.x; Li QX, 1998, LAB INVEST, V78, P461; Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; MATTSON MP, 1994, ANN NY ACAD SCI, V747, P50; Mielke MM, 2007, NEUROLOGY, V69, P1850, DOI 10.1212/01.wnl.0000279520.59792.fe; Pereira J, 2002, THROMB HAEMOSTASIS, V87, P905; PILETZ JE, 1991, NEUROBIOL AGING, V12, P401, DOI 10.1016/0197-4580(91)90064-Q; Pleines I, 2009, PFLUG ARCH EUR J PHY, V457, P1173, DOI 10.1007/s00424-008-0573-7; Prodan CI, 2006, PLATELETS, V17, P56, DOI 10.1080/09537100500181913; Racchi M, 2003, EXP GERONTOL, V38, P145, DOI 10.1016/S0531-5565(02)00158-4; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Riess T, 2004, J EXP MED, V200, P1267, DOI 10.1084/jem.20040500; Roher AE, 2009, ALZHEIMERS DEMENT, V5, P18, DOI 10.1016/j.jalz.2008.10.004; Rosenberg RN, 1997, ARCH NEUROL-CHICAGO, V54, P139, DOI 10.1001/archneur.1997.00550140019007; Schmidt EM, 2013, FASEB J; Schneider JA, 2007, ANN NEUROL, V62, P59, DOI 10.1002/ana.21142; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Shcherbina A, 1999, BLOOD, V93, P4222, DOI 10.1182/blood.V93.12.4222.412k34_4222_4231; Sheehan JP, 1997, J NEUROSCI, V17, P4612; Shen MY, 2008, EUR J PHARMACOL, V588, P259, DOI 10.1016/j.ejphar.2008.04.040; Shen MY, 2008, PHARMACOL RES, V57, P151, DOI 10.1016/j.phrs.2008.01.004; Smirnov A, 2009, NEUROBIOL AGING, V30, P1552, DOI 10.1016/j.neurobiolaging.2007.12.009; Smith CCT, 1997, NEUROSCI LETT, V235, P157, DOI 10.1016/S0304-3940(97)00738-6; Smith EE, 2009, STROKE, V40, P2601, DOI 10.1161/STROKEAHA.108.536839; Staffen W, 2009, EUR J NUCL MED MOL I, V36, P801, DOI 10.1007/s00259-008-1028-2; Thal DR, 2008, ACTA NEUROPATHOL, V115, P599, DOI 10.1007/s00401-008-0366-2; Weindl G, 2007, J CLIN INVEST, V117, P3664, DOI 10.1172/JCI28115; Weller RO, 2003, NEUROL RES, V25, P611, DOI 10.1179/016164103101202057; WISNIEWSKI HM, 1995, NEUROSCI LETT, V183, P120, DOI 10.1016/0304-3940(94)11129-7; Wolf BB, 1999, BLOOD, V94, P1683, DOI 10.1182/blood.V94.5.1683.417k37_1683_1692; Wolfs JLN, 2005, CELL MOL LIFE SCI, V62, P1514, DOI 10.1007/s00018-005-5099-y; Yazawa H, 2001, FASEB J, V15, P2454, DOI 10.1096/fj.01-0251com; Zaghi J, 2009, ACTA NEUROPATHOL, V117, P111, DOI 10.1007/s00401-008-0481-0; Zlokovic BV, 2000, NAT MED, V6, P718, DOI 10.1038/77397; ZUBENKO GS, 1987, ANN NEUROL, V22, P237, DOI 10.1002/ana.410220208	64	88	92	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90523	10.1371/journal.pone.0090523	http://dx.doi.org/10.1371/journal.pone.0090523			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587388	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200222
J	Skorup, P; Maudsdotter, L; Lipcsey, M; Castegren, M; Larsson, A; Jonsson, AB; Sjolin, J				Skorup, Paul; Maudsdotter, Lisa; Lipcsey, Miklos; Castegren, Markus; Larsson, Anders; Jonsson, Ann-Beth; Sjolin, Jan			Beneficial Antimicrobial Effect of the Addition of an Aminoglycoside to a beta-Lactam Antibiotic in an E. coli Porcine Intensive Care Severe Sepsis Model	PLOS ONE			English	Article							GRAM-NEGATIVE BACTEREMIA; PSEUDOMONAS-AERUGINOSA; COMBINATION THERAPY; SEPTIC SHOCK; TOBRAMYCIN; SURVIVAL; EPIDEMIOLOGY; MONOTHERAPY; SYNERGY; ENDOCARDITIS	This study aimed to determine whether the addition of an aminoglycoside to a beta-lactam antibiotic increases the antimicrobial effect during the early phase of Gram-negative severe sepsis/septic shock. A porcine model was selected that considered each animal's individual blood bactericidal capacity. Escherichia coli, susceptible to both antibiotics, was given to healthy pigs intravenously during 3 h. At 2 h, the animals were randomized to a 20-min infusion with either cefuroxime alone (n = 9), a combination of cefuroxime+tobramycin (n = 9), or saline (control, n = 9). Blood samples were collected hourly for cultures and quantitative polymerase chain reaction (PCR). Bacterial growth in the organs after 6 h was chosen as the primary endpoint. A blood sample was obtained at baseline before start of bacterial infusion for ex vivo investigation of the blood bactericidal capacity. At 1 h after the administration of the antibiotics, a second blood sample was taken for ex vivo investigation of the antibiotic-induced blood killing activity. All animals developed severe sepsis/septic shock. Blood cultures and PCR rapidly became negative after completed bacterial infusion. Antibiotic-induced blood killing activity was significantly greater in the combination group than in the cefuroxime group (p < 0.001). Growth of bacteria in the spleen was reduced in the two antibiotic groups compared with the controls (p < 0.01); no difference was noted between the two antibiotic groups. Bacterial growth in the liver was significantly less in the combination group than in the cefuroxime group (p < 0.05). High blood bactericidal capacity at baseline was associated with decreased growth in the blood and spleen (p < 0.05). The addition of tobramycin to cefuroxime results in increased antibiotic-induced blood killing activity and less bacteria in the liver than cefuroxime alone. Individual blood bactericidal capacity may have a significant effect on antimicrobial outcome.	[Skorup, Paul; Sjolin, Jan] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden; [Maudsdotter, Lisa; Jonsson, Ann-Beth] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden; [Lipcsey, Miklos] Uppsala Univ, Dept Surg Sci, Sect Anesthesiol & Intens Care, Uppsala, Sweden; [Castegren, Markus] Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden; [Larsson, Anders] Uppsala Univ, Dept Med Sci, Sect Clin Chem, Uppsala, Sweden	Uppsala University; Stockholm University; Uppsala University; Uppsala University; Uppsala University	Skorup, P (corresponding author), Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden.	paul.skorup@medsci.uu.se	Castegren, Markus/AAF-2620-2019; Lipcsey, Miklos/K-4308-2012	Lipcsey, Miklos/0000-0002-1976-4129; Castegren, Markus/0000-0002-9292-0298; skorup, paul/0000-0002-5407-6612	Uppsala University Hospital; Swedish Research Council [2010-3826]; Olinder-Nielsen Family fund	Uppsala University Hospital; Swedish Research Council(Swedish Research CouncilEuropean Commission); Olinder-Nielsen Family fund	The R&D funds of Uppsala University Hospital, the Swedish Research Council (2010-3826) and the Olinder-Nielsen Family fund contributed with financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaroli J, 2005, SHOCK, V24, P300, DOI 10.1097/01.shk.0000180621.52058.e1; Avolio M, 2010, SHOCK, V34, P27, DOI 10.1097/SHK.0b013e3181d49299; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; BRUMMETT RE, 1989, ANTIMICROB AGENTS CH, V33, P797, DOI 10.1128/AAC.33.6.797; Brun-Buisson C, 2004, INTENS CARE MED, V30, P580, DOI 10.1007/s00134-003-2121-4; Buijk SE, 2002, INTENS CARE MED, V28, P936, DOI 10.1007/s00134-002-1313-7; CALANDRA T, 1986, AM J MED, V80, P45; CANTU TG, 1988, ANN INTERN MED, V109, P989, DOI 10.7326/0003-4819-109-12-989_2; Castegren M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053221; Castegren M, 2012, SHOCK, V37, P501, DOI 10.1097/SHK.0b013e318249bb0d; Chung LP, 2011, CRIT REV CL LAB SCI, V48, P250, DOI 10.3109/10408363.2011.641517; CHUSID MJ, 1983, J LAB CLIN MED, V101, P441; Clark C, 1988, CRITICAL CARE, P293; COMBER KR, 1977, ANTIMICROB AGENTS CH, V11, P956, DOI 10.1128/AAC.11.6.956; Croisier D, 2008, INT J ANTIMICROB AG, V32, P494, DOI 10.1016/j.ijantimicag.2008.07.010; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; DEZIELEVANS LM, 1986, CLIN PHARMACY, V5, P319; ELIOPOULOS GM, 1982, REV INFECT DIS, V4, P282; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; FANTIN B, 1989, ANTIMICROB AGENTS CH, V33, P767, DOI 10.1128/AAC.33.5.767; GIAMARELLOU H, 1986, AM J MED, V80, P126, DOI 10.1016/0002-9343(86)90490-0; Gilbert DN, 2009, MANDELL DOUGLAS BENN, P359; GLAUSER MP, 1982, CHEMOTHERAPY, V28, P410, DOI 10.1159/000238130; Goldfarb RD, 2003, AM J PHYSIOL-REG I, V284, pR550, DOI 10.1152/ajpregu.00285.2002; GORDIN FM, 1987, ANTIMICROB AGENTS CH, V31, P398, DOI 10.1128/AAC.31.3.398; Goscinski G, 2004, CRIT CARE, V8, pR35, DOI 10.1186/cc2415; GROOM AC, 1991, SCANNING MICROSCOPY, V5, P159; Hanberger H, 2013, SCAND J INFECT DIS, V45, P161, DOI 10.3109/00365548.2012.747694; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Josefson P, 2011, EUR J CLIN MICROBIOL, V30, P1127, DOI 10.1007/s10096-011-1201-6; KALMAN D, 1990, TEX HEART I J, V17, P203; KITAURA K, 1984, J ANTIBIOT, V37, P1681, DOI 10.7164/antibiotics.37.1681; KOFF WC, 1986, LYMPHOKINE RES, V5, P239; KORVICK JA, 1992, ANTIMICROB AGENTS CH, V36, P2639, DOI 10.1128/AAC.36.12.2639; Kumar A, 2010, CRIT CARE MED, V38, P1773, DOI 10.1097/CCM.0b013e3181eb3ccd; Kumar A, 2010, CRIT CARE MED, V38, P1651, DOI 10.1097/CCM.0b013e3181e96b91; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Leibovici L, 1997, ANTIMICROB AGENTS CH, V41, P1127, DOI 10.1128/AAC.41.5.1127; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Lipcsey M, 2006, J ENDOTOXIN RES, V12, P99, DOI 10.1179/096805106X89053; Lipcsey M, 2009, CRIT CARE MED, V37, P2782, DOI 10.1097/CCM.0b013e3181a988f8; Lopez-Novoa JM, 2011, KIDNEY INT, V79, P33, DOI 10.1038/ki.2010.337; LOVETT EJ, 1980, J SURG ONCOL, V15, P327, DOI 10.1002/jso.2930150405; Madera-Salcedo IK, 2011, J NEUROIMMUNOL, V232, P101, DOI 10.1016/j.jneuroim.2010.10.017; MAINARDI JL, 1994, J INFECT DIS, V169, P1318, DOI 10.1093/infdis/169.6.1318; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; MOORE RD, 1987, J INFECT DIS, V155, P93, DOI 10.1093/infdis/155.1.93; NAGATOMO H, 1974, J ANTIBIOT, V27, P199, DOI 10.7164/antibiotics.27.199; Navas D, 2004, J ANTIMICROB CHEMOTH, V54, P767, DOI 10.1093/jac/dkh381; Pannu N, 2008, CRIT CARE MED, V36, pS216, DOI 10.1097/CCM.0b013e318168e375; Parker GA, 2005, TOXICOL PATHOL, V33, P52, DOI 10.1080/01926230590522365; Paul M, 2004, BMJ-BRIT MED J, V328, P668, DOI 10.1136/bmj.38028.520995.63; Perletti G, 2008, MOL MED REP, V1, P3; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; RYAN DM, 1986, SCAND J INFECT DIS, V18, P381, DOI 10.3109/00365548609032352; Safdar N, 2004, LANCET INFECT DIS, V4, P519, DOI 10.1016/S1473-3099(04)01108-9; Tamma PD, 2012, CLIN MICROBIOL REV, V25, P450, DOI 10.1128/CMR.05041-11; Tauber S C, 2008, Curr Mol Pharmacol, V1, P68; Udy AA, 2011, NAT REV NEPHROL, V7, P539, DOI 10.1038/nrneph.2011.92; Valiant ME, 1989, J ANTIBIOT TOKYO, V42, P807	61	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90441	10.1371/journal.pone.0090441	http://dx.doi.org/10.1371/journal.pone.0090441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587365	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200200
J	Beune, EJAJ; van Charante, EPM; Beem, L; Mohrs, J; Agyemang, CO; Ogedegbe, G; Haafkens, JA				Beune, Erik J. A. J.; van Charante, Eric P. Moll; Beem, Leo; Mohrs, Jacob; Agyemang, Charles O.; Ogedegbe, Gbenga; Haafkens, Joke A.			Culturally Adapted Hypertension Education (CAHE) to Improve Blood Pressure Control and Treatment Adherence in Patients of African Origin with Uncontrolled Hypertension: Cluster-Randomized Trial	PLOS ONE			English	Article							MEDICATION ADHERENCE; PREDICTIVE-VALIDITY; ETHNIC DISPARITIES; PRACTICE GUIDELINE; CLINICAL-PRACTICE; HEALTH-PROMOTION; INTERVENTIONS; CARE; DUTCH; SURINAMESE	Objectives: To evaluate the effect of a practice-based, culturally appropriate patient education intervention on blood pressure (BP) and treatment adherence among patients of African origin with uncontrolled hypertension. Methods: Cluster randomised trial involving four Dutch primary care centres and 146 patients (intervention n = 75, control n = 71), who met the following inclusion criteria: self-identified Surinamese or Ghanaian; >= 20 years; treated for hypertension; SBP >= 140 mmHg. All patients received usual hypertension care. The intervention-group was also offered three nurse-led, culturally appropriate hypertension education sessions. BP was assessed with Omron 705-IT and treatment adherence with lifestyle-and medication adherence scales. Results: 139 patients (95%) completed the study (intervention n = 71, control n = 68). Baseline characteristics were largely similar for both groups. At six months, we observed a SBP reduction of >= 10 mmHg -primary outcome-in 48% of the intervention group and 43% of the control group. When adjusted for pre-specified covariates age, sex, hypertension duration, education, baseline measurement and clustering effect, the between-group difference was not significant (OR; 0.42; 95% CI: 0.11 to 1.54; P = 0.19). At six months, the mean SBP/DBD had dropped by 10/5.7 (SD 14.3/9.2) mmHg in the intervention group and by 6.3/1.7 (SD 13.4/8.6) mmHg in the control group. After adjustment, between-group differences in SBP and DBP reduction were -1.69 mmHg (95% CI: -6.01 to 2.62, P = 0.44) and -3.01 mmHg (-5.73 to -0.30, P = 0.03) in favour of the intervention group. Mean scores for adherence to lifestyle recommendations increased in the intervention group, but decreased in the control group. Mean medication adherence scores improved slightly in both groups. After adjustment, the between-group difference for adherence to lifestyle recommendations was 0.34 (0.12 to 0.55; P = 0.003). For medication adherence it was -0.09 (-0.65 to 0.46; P = 0.74). Conclusion: This intervention led to significant improvements in DBP and adherence to lifestyle recommendations, supporting the need for culturally appropriate hypertension care.	[Beune, Erik J. A. J.; van Charante, Eric P. Moll; Beem, Leo; Mohrs, Jacob; Haafkens, Joke A.] Univ Amsterdam, Acad Med Ctr, Div Clin Methods & Publ Hlth, Dept Gen Practice, NL-1105 AZ Amsterdam, Netherlands; [Beune, Erik J. A. J.; Agyemang, Charles O.] Univ Amsterdam, Acad Med Ctr, Div Clin Methods & Publ Hlth, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [Ogedegbe, Gbenga] NYU, Sch Med, Dept Med, Ctr Healthful Behav Change,Div Gen Internal Med, New York, NY 10016 USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; New York University	Beune, EJAJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Div Clin Methods & Publ Hlth, Dept Gen Practice, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.j.beune@amc.uva.nl	van Charante, Eric Moll/L-4856-2019	van Charante, Eric Moll/0000-0002-1489-5218	ZonMw; Netherlands organisation for health research and development [122000008]	ZonMw(Netherlands Organization for Health Research and Development); Netherlands organisation for health research and development(Netherlands Organization for Health Research and Development)	This study was funded by ZonMw, the Netherlands organisation for health research and development (grant no. 122000008). ZonMw-website: http://www.zonmw.nl/en/. The study sponsor funded the study and carried out annual and mid-term reviews of the study's progress. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyemang C, 2006, J HUM HYPERTENS, V20, P874, DOI 10.1038/sj.jhh.1002073; Agyemang C, 2005, J HYPERTENS, V23, P1971, DOI 10.1097/01.hjh.0000186835.63996.d4; Agyemang C, 2013, EUR J PREV CARDIOL, V20, P938, DOI 10.1177/2047487312451540; Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Aspinall PJ, 2001, SOCIOL HEALTH ILL, V23, P829, DOI 10.1111/1467-9566.00277; Beach MC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-104; Beune EJAJ, 2006, J HUM HYPERTENS, V20, P946, DOI 10.1038/sj.jhh.1002094; Beune EJAJ, 2010, J HUM HYPERTENS, V24, P280, DOI 10.1038/jhh.2009.61; Beune EJAJ, 2008, J HYPERTENS, V26, P648, DOI 10.1097/HJH.0b013e3282f4d20b; Beune EJAJ, 2011, PATIENT EDUC COUNS, V82, P74, DOI 10.1016/j.pec.2010.02.015; Bosworth HB, 2006, AM J MED, V119, P791, DOI 10.1016/j.amjmed.2006.02.013; Bosworth HB, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2010.11.024; Boulware LE, 2001, AM J PREV MED, V21, P221, DOI 10.1016/S0749-3797(01)00356-7; Brown CM, 1996, J HEALTH SOC BEHAV, V37, P350, DOI 10.2307/2137262; Brown CM, 1996, SOC SCI MED, V43, P903, DOI 10.1016/0277-9536(95)00434-3; Campbell M, 2000, J Health Serv Res Policy, V5, P12; Cappuccio FP, 1997, J HUM HYPERTENS, V11, P571, DOI 10.1038/sj.jhh.1000516; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Connell P, 2008, HEALTH SOC CARE COMM, V16, P165, DOI 10.1111/j.1365-2524.2007.00737.x; COOK NR, 1995, ARCH INTERN MED, V155, P701, DOI 10.1001/archinte.155.7.701; Cooper LA, 2002, J GEN INTERN MED, V17, P477, DOI 10.1046/j.1525-1497.2002.10633.x; Cooper LA, 2011, J GEN INTERN MED, V26, P1297, DOI 10.1007/s11606-011-1794-6; Cooper LA, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-7; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; Douglas JG, 2003, ARCH INTERN MED, V163, P525, DOI 10.1001/archinte.163.5.525; Haafkens JA, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-193; HEURTINROBERTS S, 1992, AM J HYPERTENS, V5, P787, DOI 10.1093/ajh/5.11.787; Houston TK, 2011, ANN INTERN MED, V154, P77, DOI 10.7326/0003-4819-154-2-201101180-00004; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; Krousel-Wood M, 2005, CURR OPIN CARDIOL, V20, P296, DOI 10.1097/01.hco.0000166597.52335.23; Krousel-Wood M, 2009, AM J MANAG CARE, V15, P59; LIU K, 1979, HYPERTENSION, V1, P529, DOI 10.1161/01.HYP.1.5.529; Miller NH, 1997, CIRCULATION, V95, P1085; MORGAN M, 1995, INT J EPIDEMIOL, V24, pS79, DOI 10.1093/ije/24.Supplement_1.S79; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Netto G, 2010, HEALTH PROMOT INT, V25, P248, DOI 10.1093/heapro/daq012; Odedosu T, 2012, CLEV CLIN J MED, V79, P46, DOI 10.3949/ccjm.79a.11068; Ogedegbe G, 2008, AM J HYPERTENS, V21, P1137, DOI 10.1038/ajh.2008.240; Ogedegbe G, 2007, CONTEMP CLIN TRIALS, V28, P169, DOI 10.1016/j.cct.2006.04.002; Raleigh VS, 1997, BMJ-BRIT MED J, V314, P209, DOI 10.1136/bmj.314.7075.209; Saha S, 2008, J NATL MED ASSOC, V100, P1275, DOI 10.1016/S0027-9684(15)31505-4; Schoenthaler A, 2009, PATIENT EDUC COUNS, V75, P185, DOI 10.1016/j.pec.2008.09.018; SHEA S, 1992, AM J PUBLIC HEALTH, V82, P1607, DOI 10.2105/AJPH.82.12.1607; Smulders YM, 2008, NETH J MED, V66, P169; Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X; van den Born BJH, 2006, J HYPERTENS, V24, P2299, DOI 10.1097/01.hjh.0000249710.21146.38; Vollmer WM, 2001, ANN INTERN MED, V135, P1019, DOI 10.7326/0003-4819-135-12-200112180-00005; Whitlock EP, 2002, AM J PREV MED, V22, P267, DOI 10.1016/S0749-3797(02)00415-4; Wiersma Tj, 2004, Ned Tijdschr Geneeskd, V148, P923; Wilson RP, 2002, AM J MED, V112, P26, DOI 10.1016/S0002-9343(01)01049-X	51	44	46	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90103	10.1371/journal.pone.0090103	http://dx.doi.org/10.1371/journal.pone.0090103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24598584	Green Submitted, gold, Green Published			2022-12-27	WOS:000332479400044
J	Kim, D; Song, S; Lee, M; Go, H; Shin, E; Yeom, JH; Ha, NC; Lee, K; Kim, YH				Kim, Daeyoung; Song, Saemee; Lee, Minho; Go, Hayoung; Shin, Eunkyoung; Yeom, Ji-Hyun; Ha, Nam-Chul; Lee, Kangseok; Kim, Yong-Hak			Modulation of RNase E Activity by Alternative RNA Binding Sites	PLOS ONE			English	Article							ESCHERICHIA-COLI-CELLS; CATALYTIC DOMAIN; MEMBRANE-BINDING; MUTATION; RRAA; AUTOREGULATION; COMPLEXES; ABUNDANCE; CLEAVAGE; GROWTH	Endoribonuclease E (RNase E) affects the composition and balance of the RNA population in Escherichia coli via degradation and processing of RNAs. In this study, we investigated the regulatory effects of an RNA binding site between amino acid residues 25 and 36 ((24)LYDLDIESPGHEQK(37)) of RNase E. Tandem mass spectrometry analysis of the N-terminal catalytic domain of RNase E (N-Rne) that was UV crosslinked with a 5'-P-32-end-labeled, 13-nt oligoribonucleotide (p-BR13) containing the RNase E cleavage site of RNA I revealed that two amino acid residues, Y25 and Q36, were bound to the cytosine and adenine of BR13, respectively. Based on these results, the Y25A N-Rne mutant was constructed, and was found to be hypoactive in comparison to wild-type and hyperactive Q36R mutant proteins. Mass spectrometry analysis showed that Y25A and Q36R mutations abolished the RNA binding to the uncompetitive inhibition site of RNase E. The Y25A mutation increased the RNA binding to the multimer formation interface between amino acid residues 427 and 433 ((427)LIEEEALK(433)), whereas the Q36R mutation enhanced the RNA binding to the catalytic site of the enzyme ((65)HGFLPL*K-71). Electrophoretic mobility shift assays showed that the stable RNA-protein complex formation was positively correlated with the extent of RNA binding to the catalytic site and ribonucleolytic activity of the N-Rne proteins. These mutations exerted similar effects on the ribonucleolytic activity of the full-length RNase E in vivo. Our findings indicate that RNase E has two alternative RNA binding sites for modulating RNA binding to the catalytic site and the formation of a functional catalytic unit.	[Kim, Daeyoung; Song, Saemee; Lee, Minho; Go, Hayoung; Shin, Eunkyoung; Yeom, Ji-Hyun; Lee, Kangseok] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Go, Hayoung] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Ha, Nam-Chul] Pusan Natl Univ, Dept Mfg Pharm, Pusan, South Korea; [Kim, Yong-Hak] Catholic Univ Daegu Sch Med, Dept Microbiol, Taegu, South Korea	Chung Ang University; Stanford University; Pusan National University; Catholic University of Daegu	Lee, K (corresponding author), Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea.	kangseok@cau.ac.kr; ykim@cu.ac.kr	Lee, Minho/AAK-4109-2021	Lee, Minho/0000-0002-8404-5702	NRF [2011-0028553, 2013R1A1A2061369]; Ministry of Education, Science and Technology, Republic of Korea	NRF; Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by NRF grants (2011-0028553 to K Lee and 2013R1A1A2061369 to YH Kim) funded by the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Callaghan AJ, 2004, J MOL BIOL, V340, P965, DOI 10.1016/j.jmb.2004.05.046; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gao JJ, 2006, MOL MICROBIOL, V61, P394, DOI 10.1111/j.1365-2958.2006.05246.x; Go H, 2011, RNA BIOL, V8, P1022, DOI 10.4161/rna.8.6.18063; GOLDBLUM K, 1981, J BACTERIOL, V146, P128, DOI 10.1128/JB.146.1.128-132.1981; Gorna MW, 2010, RNA, V16, P553, DOI 10.1261/rna.1858010; Jain C, 1995, Nucleic Acids Symp Ser, P85; Khemici V, 2008, MOL MICROBIOL, V70, P799, DOI 10.1111/j.1365-2958.2008.06454.x; Kido M, 1996, J BACTERIOL, V178, P3917, DOI 10.1128/jb.178.13.3917-3925.1996; Kime L, 2010, MOL MICROBIOL, V76, P590, DOI 10.1111/j.1365-2958.2009.06935.x; Koslover DJ, 2008, STRUCTURE, V16, P1238, DOI 10.1016/j.str.2008.04.017; Lee K, 2003, MOL MICROBIOL, V48, P349, DOI 10.1046/j.1365-2958.2003.03435.x; Lee K, 2002, MOL MICROBIOL, V43, P1445, DOI 10.1046/j.1365-2958.2002.02848.x; Lee KS, 2003, CELL, V114, P623, DOI 10.1016/j.cell.2003.08.003; LINCHAO S, 1994, J BIOL CHEM, V269, P10797; Liou GG, 2001, P NATL ACAD SCI USA, V98, P63, DOI 10.1073/pnas.011535498; Mackie GA, 2013, NAT REV MICROBIOL, V11, P45, DOI 10.1038/nrmicro2930; MCDOWALL KJ, 1995, NATURE, V374, P287, DOI 10.1038/374287a0; McDowall KJ, 1996, J MOL BIOL, V255, P349, DOI 10.1006/jmbi.1996.0027; MUDD EA, 1993, MOL MICROBIOL, V9, P557, DOI 10.1111/j.1365-2958.1993.tb01716.x; Murashko ON, 2012, P NATL ACAD SCI USA, V109, P7019, DOI 10.1073/pnas.1120181109; Shin E, 2008, GENETICS, V179, P1871, DOI 10.1534/genetics.108.088492; Sousa S, 2001, MOL MICROBIOL, V42, P867, DOI 10.1046/j.1365-2958.2001.02687.x; Tamura M, 2006, J BACTERIOL, V188, P5145, DOI 10.1128/JB.00367-06; Urlaub Henning, 2008, V488, P221, DOI 10.1007/978-1-60327-475-3_16; Wurtmann EJ, 2009, CRIT REV BIOCHEM MOL, V44, P34, DOI [10.1080/10409230802594043, 10.1080/10409230802594043 ]; Yeom JH, 2006, BIOCHEM BIOPH RES CO, V345, P1372, DOI 10.1016/j.bbrc.2006.05.018	29	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90610	10.1371/journal.pone.0090610	http://dx.doi.org/10.1371/journal.pone.0090610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598695	Green Submitted, Green Published, gold			2022-12-27	WOS:000332479400100
J	Govender, S; Otwombe, K; Essien, T; Panchia, R; de Bruyn, G; Mohapi, L; Gray, G; Martinson, N				Govender, Sarishen; Otwombe, Kennedy; Essien, Thandekile; Panchia, Ravindre; de Bruyn, Guy; Mohapi, Lerato; Gray, Glenda; Martinson, Neil			CD4 Counts and Viral Loads of Newly Diagnosed HIV-Infected Individuals: Implications for Treatment as Prevention	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL TREATMENT; CELL COUNT; RNA LEVELS; AIDS; TRANSMISSION; SEROCONVERSION; PROGRESSION; THERAPY; MARKERS	Objective: To report the viral load and CD4 count in HIV-infected, antiretroviral naive, first - time HIV-testers, not immediately eligible for treatment initiation by current South Africa treatment guidelines. Design: This was a cross-sectional study in a high-volume, free-of-charge HIV testing centre in Soweto, South Africa. Methods: We enrolled first time HIV testers and collected demographic and risk-behaviour data and measured CD4 count and viral load. Results: Between March and October 2011, a total of 4793 adults attended VCT and 1062 (22%) tested positive. Of the 1062, 799 (75%) were ART naive and 348/799 (44%) were first-time HIV testers. Of this group of 348, 225 (65%) were female. Overall their median age, CD4 count and viral load was 34 years (IQR: 28-41), 364 (IQR: 238-542) cells/mm(3) and 13,000 (IQR: 2050-98171) copies/ml, respectively. Female first time HIV testers had higher CD4 counts (419 IQR: 262-582 vs. 303 IQR: 199418 cells/mm(3)) and lower viral loads (9,100 vs. 34,000 copies/ml) compared to males. Of 183 participants with CD4 count >350 cells/mm(3), 62 (34%) had viral loads. 10,000 copies/ml. Conclusions: A large proportion of HIV infected adults not qualifying for immediate ART at the CD4 count threshold of 350 cells/mm(3) have high viral loads. HIV-infected men at their first HIV diagnosis are more likely to have lower CD4 counts and higher viral loads than women.	[Govender, Sarishen; Otwombe, Kennedy; Essien, Thandekile; Panchia, Ravindre; de Bruyn, Guy; Mohapi, Lerato; Gray, Glenda; Martinson, Neil] Univ Witwatersrand, PHRU, Soweto, South Africa; [Govender, Sarishen; Otwombe, Kennedy; Essien, Thandekile; Panchia, Ravindre; de Bruyn, Guy; Mohapi, Lerato; Gray, Glenda; Martinson, Neil] Baragwanath Hosp, Soweto, South Africa; [Martinson, Neil] Johns Hopkins Univ, Ctr TB Res, Baltimore, MD USA; [Govender, Sarishen] Ottawa Hosp Gen Campus, Canada Africa Prevent Trials Network, Ottawa, ON, Canada	University of Witwatersrand; Johns Hopkins University; University of Ottawa; Ottawa Hospital Research Institute	Govender, S (corresponding author), Univ Witwatersrand, PHRU, Soweto, South Africa.	sarisheng@gmail.com		de Bruyn, Guy/0000-0002-8028-4474	Canadian African Prevention Trials Network (CAPT); Presidents Emergency Plan For AIDS Relief (PEPFAR)	Canadian African Prevention Trials Network (CAPT); Presidents Emergency Plan For AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by Canadian African Prevention Trials Network (CAPT) and Presidents Emergency Plan For AIDS Relief (PEPFAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KO has received research training from the Fogarty International Center (TW007373/0).	Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Department of Health,, S AFR ANT TREATM GUI; deWolf F, 1997, AIDS, V11, P1799, DOI 10.1097/00002030-199715000-00003; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Glencross D, 2002, CYTOMETRY, V50, P69, DOI 10.1002/cyto.10068; Granich R, 2010, CURR OPIN HIV AIDS, V5, P298, DOI 10.1097/COH.0b013e32833a6c32; Granich R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-1; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Meintjes G, 2012, S AFR J HIV MED, DOI 10.7196/SAJHIVMED.862; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Murnane PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051192; Prins M, 1999, AIDS, V13, P2361, DOI 10.1097/00002030-199912030-00007; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; Touloumi G, 2004, AIDS, V18, P1697, DOI 10.1097/01.aids.0000131395.14339.f5	16	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90754	10.1371/journal.pone.0090754	http://dx.doi.org/10.1371/journal.pone.0090754			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595317	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500097
J	Deng, J; Zhou, P; Tian, SM; Zhang, L; Li, JL; Qian, Y				Deng, Jin; Zhou, Ping; Tian, Shuang-ming; Zhang, Lu; Li, Jia-le; Qian, Ying			Comparison of Diagnostic Efficacy of Contrast-Enhanced Ultrasound, Acoustic Radiation Force Impulse Imaging, and Their Combined Use in Differentiating Focal Solid Thyroid Nodules	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; BENIGN; CYTOLOGY	Background: A key limitation of conventional ultrasound (US) includes poor differentiation of benign from malignant thyroid nodules. Contrast-enhanced US (CEUS) and acoustic radiation force impulse (ARFI) could provide better characterization of focal thyroid nodules; however, no studies have compared their efficacies. Objective: To evaluate the diagnostic efficacy of conventional US, CEUS, ARFI, and their combined use in differentiating focal solid thyroid nodules. Methods: One-hundred-forty-six Chinese patients with 175 thyroid nodules (119 benign and 56 malignant) were prospectively enrolled. Each patients underwent conventional US, CEUS and ARFI, respectively. The diagnostic performance of the conventional US, CEUS, ARFI, combined use of either CEUS or ARFI and combined use of the three modalities were assessed and compared using Pathological diagnosis (histological/cytological) as the reference method. Results: There were no significant differences between individual groups (CEUS vs US, P = 0.279, ARFI vs US, P = 0.372, CEUS vs ARFI, P = 0.849), combined use of US and CEUS or combined use of US and ARFI yielded significant difference compared to US. (combination of US & CEUS vs US, P = 0.021; combination of US & ARFI vs US, P = 0.036). The combination of three modalities significantly improved the diagnostic accuracy compared with either combination of conventional US and CEUS or combination of conventional US and ARFI (P = 0.045 and P = 0.027, respectively). Conclusions: CEUS and ARFI can be used as an additional tool in the diagnostic work up of thyroid nodules. The combination of CEUS with ARFI can significantly improve the diagnostic accuracy.	[Deng, Jin; Zhou, Ping; Tian, Shuang-ming; Zhang, Lu; Li, Jia-le; Qian, Ying] Cent South Univ, Xiangya Hosp 3, Dept Ultrasound, Changsha, Hunan, Peoples R China	Central South University	Zhou, P (corresponding author), Cent South Univ, Xiangya Hosp 3, Dept Ultrasound, Changsha, Hunan, Peoples R China.	zhouping1000@hotmail.com	li, jia/GVT-7587-2022					Al-azawi D, 2012, WORLD J SURG, V36, P1947, DOI 10.1007/s00268-012-1592-2; Bohacek L, 2012, ANN SURG ONCOL, V19, P45, DOI 10.1245/s10434-011-1807-z; Bojunga J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042735; Chow LS, 2001, THYROID, V11, P1147, DOI 10.1089/10507250152740993; Fleischer AC, 2004, J ULTRAS MED, V23, P1499, DOI 10.7863/jum.2004.23.11.1499; Friedrich-Rust M, 2012, ULTRASONICS, V52, P69, DOI 10.1016/j.ultras.2011.06.012; Gu JY, 2012, J ULTRAS MED, V31, P763; [顾继英 GU Jiying], 2008, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V24, P1018; Guth S, 2009, EUR J CLIN INVEST, V39, P699, DOI 10.1111/j.1365-2362.2009.02162.x; Hou XJ, 2013, EUR J RADIOL, V82, P797, DOI 10.1016/j.ejrad.2012.12.023; Mitchell JC, 2005, THYROID, V15, P494, DOI 10.1089/thy.2005.15.494; Moon HJ, 2010, RADIOLOGY, V255, P260, DOI 10.1148/radiol.09091284; Nemec U, 2012, EUR RADIOL, V22, P1357, DOI 10.1007/s00330-012-2385-6; Ogilvie Jennifer B, 2006, Adv Surg, V40, P223, DOI 10.1016/j.yasu.2006.06.003; Pinchot SN, 2009, ARCH SURG-CHICAGO, V144, P649, DOI 10.1001/archsurg.2009.116; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Yang J, 2007, CANCER CYTOPATHOL, V111, P306, DOI 10.1002/cncr.22955; Yeh MW, 2004, THYROID, V14, P207, DOI 10.1089/105072504773297885; Zhang B, 2010, THYROID, V20, P51, DOI 10.1089/thy.2009.0045; Zhang Xiu-fang, 2008, Zhejiang Da Xue Xue Bao Yi Xue Ban, V37, P515; Zhang YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049094	21	44	57	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90674	10.1371/journal.pone.0090674	http://dx.doi.org/10.1371/journal.pone.0090674			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594879	gold, Green Published, Green Submitted			2022-12-27	WOS:000332468900132
J	Kadiyala, SB; Papandrea, D; Herron, BJ; Ferland, RJ				Kadiyala, Sridhar B.; Papandrea, Dominick; Herron, Bruce J.; Ferland, Russell J.			Segregation of Seizure Traits in C57 Black Mouse Substrains Using the Repeated-Flurothyl Model	PLOS ONE			English	Article							GENERALIZED TONICCLONIC SEIZURES; PONTINE TEGMENTAL LESIONS; TEMPORAL-LOBE EPILEPSY; BRAIN-STEM; INBRED MICE; C57BL/6 SUBSTRAINS; SPATIAL-PATTERNS; MITOTIC-ACTIVITY; TONIC SEIZURES; KINDLING MODEL	Identifying the genetic basis of epilepsy in humans is difficult due to its complexity, thereby underlying the need for preclinical models with specific aspects of seizure susceptibility that are tractable to genetic analyses. In the repeated-flurothyl model, mice are given 8 flurothyl-induced seizures, once per day (the induction phase), followed by a 28-day rest period (incubation phase) and final flurothyl challenge. This paradigm allows for the tracking of multiple phenotypes including: initial generalized seizure threshold, decreases in generalized seizure threshold with repeated flurothyl exposures, and changes in the complexity of seizures over time. Given the responses we previously reported in C57BL/6J mice, we analyzed substrains of the C57BL lineage to determine if any of these phenotypes segregated in these substrains. We found that the generalized seizure thresholds of C57BL/10SNJ and C57BL/10J mice were similar to C57BL/6J mice, whereas C57BL/6NJ and C57BLKS/J mice showed lower generalized seizure thresholds. In addition, C57BL/6J mice had the largest decreases in generalized seizure thresholds over the induction phase, while the other substrains were less pronounced. Notably, we observed only clonic seizures during the induction phase in all substrains, but when rechallenged with flurothyl after a 28-day incubation phase, similar to 80% of C57BL/6J and 25% of C57BL/10SNJ and C57BL/10J mice expressed more complex seizures with tonic manifestations with none of the C57BL/6NJ and C57BLKS/J mice having complex seizures with tonic manifestations. These data indicate that while closely related, the C57BL lineage has significant diversity in aspects of epilepsy that are genetically controlled. Such differences further highlight the importance of genetic background in assessing the effects of targeted deletions of genes in preclinical epilepsy models.	[Kadiyala, Sridhar B.; Papandrea, Dominick; Ferland, Russell J.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Herron, Bruce J.] Wadsworth Ctr, Albany, NY USA; [Herron, Bruce J.] SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY USA; [Ferland, Russell J.] Albany Med Coll, Dept Neurol, Albany, NY 12208 USA	Albany Medical College; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Albany Medical College	Ferland, RJ (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA.	ferlanr@mail.amc.edu	Ferland, Russell/Q-6793-2019	Ferland, Russell/0000-0002-8044-2479	National Institutes of Health [NS064283, AR054828]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health [NS064283 to R.J.F., AR054828 to B.J.H.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLEGATE CD, 1991, EPILEPSY RES, V10, P142, DOI 10.1016/0920-1211(91)90006-2; Applegate CD, 1997, EPILEPSIA, V38, P631, DOI 10.1111/j.1528-1157.1997.tb01231.x; Aydin-Abidin S, 2011, NEUROSCI LETT, V504, P165, DOI 10.1016/j.neulet.2011.09.030; Bankstahl M, 2012, BEHAV BRAIN RES, V230, P182, DOI 10.1016/j.bbr.2012.02.004; BLUM K, 1982, EXPERIENTIA, V38, P1469, DOI 10.1007/BF01955775; Blumenfeld H, 2009, BRAIN, V132, P999, DOI 10.1093/brain/awp028; BROWNING R, 1993, EPILEPSIA, V34, P393, DOI 10.1111/j.1528-1157.1993.tb02579.x; BROWNING RA, 1986, EXP NEUROL, V93, P546, DOI 10.1016/0014-4886(86)90174-3; BROWNING RA, 1985, EPILEPSIA, V26, P175, DOI 10.1111/j.1528-1157.1985.tb05402.x; BROWNING RA, 1981, EPILEPSIA, V22, P595, DOI 10.1111/j.1528-1157.1981.tb04131.x; BROWNING RA, 1981, EPILEPSIA, V22, P583, DOI 10.1111/j.1528-1157.1981.tb04130.x; Bryant CD, 2008, J NEUROGENET, V22, P315, DOI 10.1080/01677060802357388; Buono RJ, 2004, EPILEPSY RES, V58, P175, DOI 10.1016/j.eplepsyres.2004.02.003; Cortez Miguel A, 2006, Adv Neurol, V97, P293; DeSarro A, 1996, J ANTIMICROB CHEMOTH, V38, P475, DOI 10.1093/jac/38.3.475; ENGEL J, 1978, ANN NEUROL, V3, P538, DOI 10.1002/ana.410030615; Engel J Jr, 1996, Epilepsy Res Suppl, V12, P9; Ferland RJ, 1998, EXP NEUROL, V151, P124, DOI 10.1006/exnr.1998.6794; Ferland RJ, 1998, NEUROREPORT, V9, P3623, DOI 10.1097/00001756-199811160-00013; Ferland RJ, 2002, NEUROSCI LETT, V332, P131, DOI 10.1016/S0304-3940(02)00808-X; Ferland RJ, 2002, NEUROSCIENCE, V115, P669, DOI 10.1016/S0306-4522(02)00514-6; Ferland RJ, 1999, EPILEPSIA, V40, P144, DOI 10.1111/j.1528-1157.1999.tb02067.x; Ferland RJ, 1998, EPILEPSY RES, V30, P49, DOI 10.1016/S0920-1211(97)00093-4; Ferraro TN, 2011, GENES BRAIN BEHAV, V10, P309, DOI 10.1111/j.1601-183X.2010.00668.x; Ferraro TN, 2010, PHYSIOL GENOMICS, V42A, P1, DOI 10.1152/physiolgenomics.00096.2010; Ferraro TN, 2004, MAMM GENOME, V15, P239, DOI 10.1007/s00335-003-2270-3; GREEN RC, 1991, EPILEPSIA, V32, P22, DOI 10.1111/j.1528-1157.1991.tb05605.x; Holmes Gregory L, 2006, Adv Neurol, V97, P323; KREINDLER A, 1958, J NEUROPHYSIOL, V21, P430, DOI 10.1152/jn.1958.21.5.430; Kumar V, 2013, SCIENCE, V342, P1508, DOI 10.1126/science.1245503; LOTHMAN EW, 1985, BRAIN RES, V360, P92, DOI 10.1016/0006-8993(85)91224-7; MAGISTRIS MR, 1988, EPILEPSIA, V29, P379, DOI 10.1111/j.1528-1157.1988.tb03735.x; McKhann GM, 2003, NEUROSCIENCE, V122, P551, DOI 10.1016/S0306-4522(03)00562-1; Merrill MA, 2003, EPILEPSIA, V44, P305, DOI 10.1046/j.1528-1157.2003.31802.x; Mhyre TR, 2003, NEUROSCIENCE, V121, P1031, DOI 10.1016/S0306-4522(03)00475-5; Muller CJ, 2009, GENES BRAIN BEHAV, V8, P481, DOI 10.1111/j.1601-183X.2009.00490.x; Mulligan MK, 2008, GENES BRAIN BEHAV, V7, P677, DOI 10.1111/j.1601-183X.2008.00405.x; NAMBA H, 1991, EPILEPSIA, V32, P27, DOI 10.1111/j.1528-1157.1991.tb05606.x; Papandrea D, 2009, EPILEPSY RES, V87, P130, DOI 10.1016/j.eplepsyres.2009.08.003; Papandrea D, 2009, EXP NEUROL, V215, P60, DOI 10.1016/j.expneurol.2008.09.016; Pitkanen A, 2006, MODELS OF SEIZURES AND EPILEPSY, P1; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Radulovic J, 1998, BEHAV BRAIN RES, V95, P179, DOI 10.1016/S0166-4328(98)00039-4; RISE ML, 1991, SCIENCE, V253, P669, DOI 10.1126/science.1871601; Samoriski GM, 1998, NEUROSCIENCE, V84, P1209, DOI 10.1016/S0306-4522(97)00571-X; Samoriski GM, 1997, EXP NEUROL, V143, P255, DOI 10.1006/exnr.1996.6368; Samoriski GM, 1997, J NEUROSCI, V17, P5581; Stiedl O, 1999, BEHAV BRAIN RES, V104, P1, DOI 10.1016/S0166-4328(99)00047-9; Tsuchiya K, 2011, EPILEPSY RES, V95, P144, DOI 10.1016/j.eplepsyres.2011.03.015; Varghese GI, 2009, BRAIN, V132, P2102, DOI 10.1093/brain/awp027; Wang JR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S3-S13	51	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90506	10.1371/journal.pone.0090506	http://dx.doi.org/10.1371/journal.pone.0090506			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594686	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900113
J	Lian, PW; Li, A; Li, Y; Liu, HC; Liang, D; Hu, B; Lin, D; Jiang, T; Moeckel, G; Qin, DH; Wu, GQ				Lian, Peiwen; Li, Ao; Li, Yuan; Liu, Haichao; Liang, Dan; Hu, Bo; Lin, De; Jiang, Tang; Moeckel, Gilbert; Qin, Dahui; Wu, Guanqing			Loss of Polycystin-1 Inhibits Bicc1 Expression during Mouse Development	PLOS ONE			English	Article							KIDNEY-DISEASE; BICAUDAL-C; EPITHELIAL-CELLS; PRIMARY CILIA; MDCK CELLS; KH-DOMAIN; PROTEIN; RNA; MUTATIONS; GENE	Bicc1 is a mouse homologue of Drosophila Bicaudal-C (dBic-C), which encodes an RNA-binding protein. Orthologs of dBic-C have been identified in many species, from C. elegans to humans. Bicc1-mutant mice exhibit a cystic phenotype in the kidney that is very similar to human polycystic kidney disease. Even though many studies have explored the gene characteristics and its functions in multiple species, the developmental profile of the Bicc1 gene product (Bicc1) in mammal has not yet been completely characterized. To this end, we generated a polyclonal antibody against Bicc1 and examined its spatial and temporal expression patterns during mouse embryogenesis and organogenesis. Our results demonstrated that Bicc1 starts to be expressed in the neural tube as early as embryonic day (E) 8.5 and is widely expressed in epithelial derivatives including the gut and hepatic cells at E10.5, and the pulmonary bronchi at E11.5. In mouse kidney development, Bicc1 appears in the early ureteric bud and mesonephric tubules at E11.5 and is also expressed in the metanephros at the same stage. During postnatal kidney development, Bicc1 expression gradually expands from the cortical to the medullary and papillary regions, and it is highly expressed in the proximal tubules. In addition, we discovered that loss of the Pkd1 gene product, polycystin-1 (PC1), whose mutation causes human autosomal dominant polycystic kidney disease (ADPKD), downregulates Bicc1 expression in vitro and in vivo. Our findings demonstrate that Bicc1 is developmentally regulated and reveal a new molecular link between Bicc1 and Pkd1.	[Lian, Peiwen; Li, Ao; Li, Yuan; Liu, Haichao; Wu, Guanqing] Chinese Acad Med Sci, Canc Hosp & Inst, State Key Lab Mol Oncol, Div Translat Canc Res & Therapy, Beijing 100730, Peoples R China; [Lian, Peiwen; Li, Ao; Li, Yuan; Liu, Haichao; Wu, Guanqing] Peking Union Med Coll, Beijing 100021, Peoples R China; [Lian, Peiwen; Li, Ao; Liang, Dan; Hu, Bo; Wu, Guanqing] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Wu, Guanqing] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA; [Lin, De] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Jiang, Tang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Med, Guangzhou 510275, Guangdong, Peoples R China; [Moeckel, Gilbert] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Qin, Dahui] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Pathol, Tampa, FL 33682 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Vanderbilt University; Vanderbilt University; Vanderbilt University; Sun Yat Sen University; Yale University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Wu, GQ (corresponding author), Chinese Acad Med Sci, Canc Hosp & Inst, State Key Lab Mol Oncol, Div Translat Canc Res & Therapy, Beijing 100730, Peoples R China.	guanqing.wu@vanderbilt.edu	Li, Ao/W-2833-2019	Moeckel, Gilbert/0000-0002-6059-0837	National Institutes of Health of the USA [RR033682]; National 973 program [2012CB517700, 2011EG150311, 81173114, 81072688]	National Institutes of Health of the USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National 973 program(National Basic Research Program of China)	This work was supported by the National Institutes of Health of the USA (RR033682) to G. W and by National 973 program (2012CB517700) (2011EG150311) (81173114) (81072688). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; Bouvrette DJ, 2008, NEPHRON EXP NEPHROL, V108, pE27, DOI 10.1159/000112913; Bouvrette DJ, 2010, COMPARATIVE MED, V60, P96; Chen TP, 1997, MOL CELL BIOL, V17, P5707, DOI 10.1128/MCB.17.10.5707; Cogswell C, 2003, MAMM GENOME, V14, P242, DOI 10.1007/s00335-002-2241-0; FLAHERTY L, 1995, KIDNEY INT, V47, P552, DOI 10.1038/ki.1995.69; Fu YL, 2010, EUR J CELL BIOL, V89, P428, DOI 10.1016/j.ejcb.2010.01.002; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hu B, 2011, EXP CELL RES, V317, P173, DOI 10.1016/j.yexcr.2010.09.012; Kim IY, 2008, J BIOL CHEM, V283, P31559, DOI 10.1074/jbc.M805452200; Kim IY, 2008, J AM SOC NEPHROL, V19, P455, DOI 10.1681/ASN.2007070770; Kim I, 2009, J AM SOC NEPHROL, V20, P2556, DOI 10.1681/ASN.2009030271; Kokot F, 2000, NEPHRON, V85, P97, DOI 10.1159/000045640; Kraus MRC, 2012, HUM MUTAT, V33, P86, DOI 10.1002/humu.21610; MAHONE M, 1995, EMBO J, V14, P2043, DOI 10.1002/j.1460-2075.1995.tb07196.x; Maisonneuve C, 2009, DEVELOPMENT, V136, P3019, DOI 10.1242/dev.038174; NAUTA J, 1995, PEDIATR RES, V37, P755, DOI 10.1203/00006450-199506000-00014; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Piazzon N, 2012, J MOL CELL BIOL; Streets AJ, 2009, J CELL SCI, V122, P1410, DOI 10.1242/jcs.045021; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Tran U, 2010, DEVELOPMENT, V137, P1107, DOI 10.1242/dev.046045; Wessely O, 2000, DEVELOPMENT, V127, P2053; Wessely O, 2001, MECH DEVELOP, V101, P267, DOI 10.1016/S0925-4773(00)00568-2; Wheatley DN, 1995, PATHOBIOLOGY, V63, P222, DOI 10.1159/000163955; Wilson PD, 2007, ANNU REV PATHOL-MECH, V2, P341, DOI 10.1146/annurev.pathol.2.010506.091850; Wu GQ, 2000, NAT GENET, V24, P75, DOI 10.1038/71724; Wu GQ, 2002, HUM MOL GENET, V11, P1845, DOI 10.1093/hmg/11.16.1845; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215; Zhang MZ, 2004, P NATL ACAD SCI USA, V101, P2311, DOI 10.1073/pnas.0400073101; Zhou L, 2008, INT J GENET, V31, P432	31	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e88816	10.1371/journal.pone.0088816	http://dx.doi.org/10.1371/journal.pone.0088816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594709	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900007
J	Rao, A; Mukherjee, S				Rao, Aparna; Mukherjee, Sujoy			Anatomical Attributes of the Optic Nerve Head in Eyes with Parafoveal Scotoma in Normal Tension Glaucoma	PLOS ONE			English	Article							RETINAL VESSEL TRUNK; FIBER LAYER DEFECTS; OPEN-ANGLE GLAUCOMA; VISUAL-FIELD; GANGLION-CELLS; INITIAL PARAFOVEAL; RISK-FACTORS; HEMORRHAGES; PROGRESSION; MORPHOLOGY	Purpose: To evaluate optic nerve characteristics independent of systemic factors predisposing to parafoveal scotoma in normal tension glaucoma. Methods: We included 40 patients with bilateral normal tension glaucoma with parafoveal scotoma (visual field defect in one hemifield within 10 degrees of fixation with at least one point at p < 1% lying at the two innermost paracentral points) in only one eye (Parafoveal group, PF, n = 40) identified from the hospital database in this observational cross sectional study. The other eye with no parafoveal scotoma constituted the control group (n = 32). Red free fundus photographs were evaluated using Image J software analyzing parameters including vertical and horizontal disc diameter, disc haemorrhage, location and angular width of the retinal nerve fibre layer depth and displacement of the central vessel trunk, CVT (vertical and horizontal). Clinical characteristics and disc parameters were compared in the two groups. Results: The PF group had lower mean deviation(MD) and visual field index (VFI) and higher pattern standard deviation (PSD) than control group (p <= 0.001) for similar untreated IOP, (p = 0.9). Disc haemorrhages were more frequent in the PF group, p = 0.01. The PF group had greater width of nerve fibre layer defects, p = 0.05 and greater vertical displacement of the central vessel trunk, p = 0.001. On multivariate logistic regression, parafoveal scotoma was significantly associated with increased vertical distance of the CVT, p = 0.0001. Conclusion: Increased vertical displacement of the CVT is associated with parafoveal scotoma in normal tension glaucoma. Localising the vessel trunk may help clinicians in identifying patients at risk for parafoveal involvement.	[Rao, Aparna] LV Prasad Eye Inst, Glaucoma Serv, Bhubaneswar, Orissa, India; [Mukherjee, Sujoy] LV Prasad Eye Inst, Diagnost Serv, Bhubaneswar, Orissa, India; [Mukherjee, Sujoy] LV Prasad Eye Inst, Imaging Serv, Bhubaneswar, Orissa, India	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute	Rao, A (corresponding author), LV Prasad Eye Inst, Glaucoma Serv, Bhubaneswar, Orissa, India.	aparna@lvpei.org		rao, Aparna/0000-0001-8120-8740				CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; DACEY DM, 1992, P NATL ACAD SCI USA, V89, P9666, DOI 10.1073/pnas.89.20.9666; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P167, DOI 10.1113/jphysiol.1975.sp011086; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; FECHTNER RD, 1994, SURV OPHTHALMOL, V39, P23, DOI 10.1016/S0039-6257(05)80042-6; Grieshaber MC, 2006, ACTA OPHTHALMOL SCAN, V84, P62, DOI 10.1111/j.1600-0420.2005.00590.x; HENDRICKX KH, 1994, OPHTHALMOLOGY, V101, P1165; HITCHINGS RA, 1983, BRIT J OPHTHALMOL, V67, P818, DOI 10.1136/bjo.67.12.818; Hood DC, 2011, INVEST OPHTH VIS SCI, V52, P940, DOI 10.1167/iovs.10-5803; Huang HL, 2013, BRIT J OPHTHALMOL, V97, P96, DOI 10.1136/bjophthalmol-2012-302068; Ishida K, 2000, AM J OPHTHALMOL, V129, P707, DOI 10.1016/S0002-9394(00)00441-4; JONAS JB, 1994, BRIT J OPHTHALMOL, V78, P99, DOI 10.1136/bjo.78.2.99; Jonas JB, 2001, OPHTHALMOLOGY, V108, P1059, DOI 10.1016/S0161-6420(01)00571-1; Jung KI, 2012, INVEST OPHTH VIS SCI, V53, P4813, DOI 10.1167/iovs.12-9908; Kim DM, 2007, J GLAUCOMA, V16, P293, DOI 10.1097/IJG.0b013e31803bda3d; Kim TW, 2007, INVEST OPHTH VIS SCI, V48, P1635, DOI 10.1167/iovs.06-0800; Lee J, 2013, J GLAU IN PRESS 0606; LEE SS, 1992, OPHTHALMOLOGY, V99, P696; Ong LS, 1999, INVEST OPHTH VIS SCI, V40, P849; Park SC, 2011, OPHTHALMOLOGY, V118, P1782, DOI 10.1016/j.ophtha.2011.02.013; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Su D, 2013, OPHTHALMOLOGY, V120, P520, DOI 10.1016/j.ophtha.2012.08.018; Walsh N, 1999, J NEUROCYTOL, V28, P989, DOI 10.1023/A:1007083920206; Wang XH, 1996, ACTA OPHTHALMOL SCAN, V74, P364; YAMAGAMI J, 1990, Nippon Ganka Gakkai Zasshi, V94, P514	25	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90554	10.1371/journal.pone.0090554	http://dx.doi.org/10.1371/journal.pone.0090554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595065	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900116
J	van Tussenbroek, BI; Cortes, J; Collin, R; Fonseca, AC; Gayle, PMH; Guzman, HM; Jacome, GE; Juman, R; Koltes, KH; Oxenford, HA; Rodriguez-Ramirez, A; Samper-Villarreal, J; Smith, SR; Tschirky, JJ; Weil, E				van Tussenbroek, Brigitta I.; Cortes, Jorge; Collin, Rachel; Fonseca, Ana C.; Gayle, Peter M. H.; Guzman, Hector M.; Jacome, Gabriel E.; Juman, Rahanna; Koltes, Karen H.; Oxenford, Hazel A.; Rodriguez-Ramirez, Alberto; Samper-Villarreal, Jimena; Smith, Struan R.; Tschirky, John J.; Weil, Ernesto			Caribbean-Wide, Long-Term Study of Seagrass Beds Reveals Local Variations, Shifts in Community Structure and Occasional Collapse	PLOS ONE			English	Article							CORAL-REEF; WATER-QUALITY; SEDIMENT NUTRIENTS; CARICOMP SITE; FLORIDA-KEYS; PATTERNS; PHOSPHORUS; HABITATS; MANGROVE; DYNAMICS	The CARICOMP monitoring network gathered standardized data from 52 seagrass sampling stations at 22 sites (mostly Thalassia testudinum-dominated beds in reef systems) across the Wider Caribbean twice a year over the period 1993 to 2007 (and in some cases up to 2012). Wide variations in community total biomass (285 to >2000 g dry m(-2)) and annual foliar productivity of the dominant seagrass T. testudinum (<200 and >2000 g dry m(-2)) were found among sites. Solar-cycle related intra-annual variations in T. testudinum leaf productivity were detected at latitudes > 16 degrees N. Hurricanes had little to no long-term effects on these well-developed seagrass communities, except for 1 station, where the vegetation was lost by burial below similar to 1 m sand. At two sites (5 stations), the seagrass beds collapsed due to excessive grazing by turtles or sea-urchins (the latter in combination with human impact and storms). The low-cost methods of this regional-scale monitoring program were sufficient to detect long-term shifts in the communities, and fifteen (43%) out of 35 long-term monitoring stations (at 17 sites) showed trends in seagrass communities consistent with expected changes under environmental deterioration.	[van Tussenbroek, Brigitta I.] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Cancun, Mexico; [Cortes, Jorge; Fonseca, Ana C.; Samper-Villarreal, Jimena] Univ Costa Rica, Ctr Invest Ciencias Mar & Limnol CIMAR, San Pedro, Costa Rica; [Collin, Rachel; Guzman, Hector M.; Jacome, Gabriel E.] Smithsonian Trop Res Inst, Panama City, Panama; [Gayle, Peter M. H.] Discovery Bay Marine Lab, Discovery Bay, Hong Kong, Peoples R China; [Juman, Rahanna] Inst Marine Affairs, Trinidad, Trinidad Tobago; [Koltes, Karen H.] Off Insular Affairs, Dept Interior, Washington, DC USA; [Oxenford, Hazel A.] Univ W Indies, CERMES, Wanstead, Barbados; [Rodriguez-Ramirez, Alberto] Inst Invest Marinas & Costeras INVEMAR, Santa Marta, Colombia; [Smith, Struan R.] Bermuda Biol Stn Res, St George, Bermuda; [Weil, Ernesto] Univ Puerto Rico, Dept Marine Sci, Mayaguez, PR 00709 USA	Universidad Nacional Autonoma de Mexico; Universidad Costa Rica; Smithsonian Institution; Smithsonian Tropical Research Institute; United States Department of the Interior; University of Puerto Rico; University of Puerto Rico Mayaguez	van Tussenbroek, BI (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Cancun, Mexico.	vantuss@cmarl.unam.mx	Collin, Rachel/G-2001-2010; Weil, Ernesto/AAI-3591-2020; van Tussenbroek, Brigitta/P-2517-2017; Cortés, Jorge/AAC-9782-2020; Collin, Rachel/Q-7100-2019; Weil, Ernesto/ABF-1290-2020	van Tussenbroek, Brigitta/0000-0002-6447-7479; Cortés, Jorge/0000-0001-7004-8649; Collin, Rachel/0000-0001-5103-4460; Weil, Ernesto/0000-0001-5275-1584; Rodriguez-Ramirez, Alberto/0000-0003-4855-7345; Samper-Villarreal, Jimena/0000-0002-7513-7293; Guzman, Hector M./0000-0001-9928-8523	John D. and Catherine T. MacArthur Foundation; UNESCO Environment and Development in Coastal Regions and in Small Islands (CSI); US National Science Foundation-Division of International Programs and Division of Ocean Sciences; CARICOMP data Management Centre; Centre for Marine Sciences; University of West Indies, Jamaica	John D. and Catherine T. MacArthur Foundation; UNESCO Environment and Development in Coastal Regions and in Small Islands (CSI); US National Science Foundation-Division of International Programs and Division of Ocean Sciences(National Science Foundation (NSF)); CARICOMP data Management Centre; Centre for Marine Sciences; University of West Indies, Jamaica	CARICOMP received support from the John D. and Catherine T. MacArthur Foundation, UNESCO Environment and Development in Coastal Regions and in Small Islands (CSI), US National Science Foundation-Division of International Programs and Division of Ocean Sciences, CARICOMP data Management Centre, Centre for Marine Sciences, University of West Indies, Jamaica, and the directors and administrators of the participating institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage AR, 2011, ECOSYSTEMS, V14, P430, DOI 10.1007/s10021-011-9421-2; Byron D, 2006, ESTUARIES COASTS, V29, P939, DOI 10.1007/BF02798654; CARICOMP, 1994, CARICOMP METH MAN LE; CARICOMP, 1997, P 8 INT COR REEF S, V1, P663; Carruthers TJB, 2005, ESTUAR COAST SHELF S, V64, P191, DOI 10.1016/j.ecss.2005.01.015; Chollett I, 2012, LIMNOL OCEANOGR, V57, P1233, DOI 10.4319/lo.2012.57.4.1233; Cortes J, 2010, REV BIOL TROP, V58, P1; Cruz-Palacios V, 2005, J EXP MAR BIOL ECOL, V324, P44, DOI 10.1016/j.jembe.2005.04.002; D'Croz L, 2005, CARIBB J SCI, V41, P414; Davis SE, 2004, J COASTAL RES, V20, P1198, DOI 10.2112/03-0072R.1; DENNISON WC, 1993, BIOSCIENCE, V43, P86, DOI 10.2307/1311969; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; DUARTE CM, 1991, AQUAT BOT, V40, P363, DOI 10.1016/0304-3770(91)90081-F; DUARTE CM, 1990, MAR ECOL PROG SER, V67, P201, DOI 10.3354/meps067201; Fonseca ACE, 2007, REV BIOL TROP, V55, P55; Fonseca M. S., 2000, P 4 INT SEAGR BIOL W, V7, P373; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Fourqurean JW, 2010, MAR ECOL PROG SER, V419, P223, DOI 10.3354/meps08853; Fourqurean JW, 2003, ECOL APPL, V13, P474, DOI 10.1890/1051-0761(2003)013[0474:FROSDT]2.0.CO;2; FOURQUREAN JW, 1992, LIMNOL OCEANOGR, V37, P162, DOI 10.4319/lo.1992.37.1.0162; Fourqurean JW, 2002, BIOGEOCHEMISTRY, V61, P229, DOI 10.1023/A:1020293503405; Fourqurean JW, 2001, MAR BIOL, V138, P341, DOI 10.1007/s002270000448; Gillanders BM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P503; Green E.P., 2003, WORLD ATLAS SEAGRASS; Heck KL, 2008, ECOSYSTEMS, V11, P1198, DOI 10.1007/s10021-008-9155-y; Jordan-Dahlgren E, 1997, P 8 INT COR REEF S 1, V1, P647; Kjerve B, 1998, COASTAL REGION SMALL; Koltes Karen H., 2009, Smithsonian Contributions to the Marine Sciences, P379; Liaw A., 2012, CRAN R RANDOMFOREST; Linton D, 2004, CARIBBEAN COASTAL MA; Linton DM, 2003, OCEAN COAST MANAGE, V46, P261, DOI 10.1016/S0964-5691(03)00007-3; Livingston RJ, 1998, AQUAT BOT, V60, P135, DOI 10.1016/S0304-3770(97)00079-X; Madsen JD, 2001, HYDROBIOLOGIA, V444, P71, DOI 10.1023/A:1017520800568; Marba N, 2003, AQUAT BOT, V77, P87, DOI 10.1016/S0304-3770(03)00079-2; McKenzie L.J., 2000, Biologia Marina Mediterranea, V7, P393; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Montcreiff CA, 1999, GULF RES REP, V11, P74; Murdoch TJT, 2007, MAR ECOL PROG SER, V339, P123, DOI 10.3354/meps339123; Nagelkerken I, 2001, MAR ECOL PROG SER, V214, P225, DOI 10.3354/meps214225; NELSEN JE, 1986, J SEDIMENT PETROL, V56, P622; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Rodriguez-Martinez RE, 2010, REV BIOL TROP, V58, P23; Rodriguez-Ramirez A, 2008, B INVESTIGACIONES MA, V37; Rodriguez-Ramirez A, 2010, REV BIOL TROP, V58, P45; Romero J, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P227; Short F, 2007, J EXP MAR BIOL ECOL, V350, P3, DOI 10.1016/j.jembe.2007.06.012; Short FT, 2006, MAR ECOL-EVOL PERSP, V27, P277, DOI 10.1111/j.1439-0485.2006.00095.x; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; SHORT FT, 1987, AQUAT BOT, V27, P41, DOI 10.1016/0304-3770(87)90085-4; Szmant AM, 1996, CORAL REEFS, V15, P21, DOI 10.1007/BF01626075; Udy JW, 1997, J EXP MAR BIOL ECOL, V217, P253, DOI 10.1016/S0022-0981(97)00060-9; Unsworth RKF, 2008, MAR ECOL PROG SER, V353, P213, DOI 10.3354/meps07199; van Tussenbroek BI, 2008, J COASTAL RES, V24, P278, DOI 10.2112/06-0777.1; van Tussenbroek BI, 2007, J PHYCOL, V43, P69, DOI 10.1111/j.1529-8817.2006.00307.x; van Tussenbroek BI, 2011, HIDROBIOLOGICA, V21, P293; Verweij MC, 2006, MAR ECOL PROG SER, V306, P257, DOI 10.3354/meps306257; WEFER G, 1980, NATURE, V285, P323, DOI 10.1038/285323a0; Whitfield PE, 2002, J COASTAL RES, V37, P68	58	53	55	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90600	10.1371/journal.pone.0090600	http://dx.doi.org/10.1371/journal.pone.0090600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594732	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900123
J	Marco, A; Gallego, C; Cayla, JA				Marco, Andres; Gallego, Carlos; Cayla, Joan A.			Incidence of Hepatitis C Infection among Prisoners by Routine Laboratory Values during a 20-Year Period	PLOS ONE			English	Article							INJECTING DRUG-USERS; VIRUS-INFECTION; UNITED-STATES; RISK-FACTORS; HIV TRANSMISSION; SEROCONVERSION; CITIES; NEEDLE; COHORT; EPIDEMIOLOGY	Background: To estimate the incidence of Hepatitis C virus (HCV) and the predictive factors through repeated routine laboratory analyses. Methods: An observational cohort study was carried out in Quatre Camins Prison, Barcelona. The study included subjects with an initial negative HCV result and routine laboratory analyses containing HCV serology from 1992 to 2011. The incidence of infection was calculated for the study population and for sub-groups by 100 person-years of follow-up (100 py). The predictive factors were determined through Kaplan-Meier curves and a Cox regression. Hazard ratios (HR) and 95% confidence intervals (CI) were calculated. Results: A total of 2,377 prisoners were included with a median follow-up time of 1,540.9 days per patient. Among the total population, 117 HCV seroconversions were detected (incidence of 1.17/100 py). The incidence was higher between 1992 and 1995 (2.57/100 py), among cases with HIV co-infection (8.34/100 py) and among intravenous drug users (IDU) without methadone treatment (MT) during follow-up (6.66/100 py). The incidence rate of HCV seroconversion among cases with a history of IDU and current MT was 1.35/100 py, which is close to that of the total study population. The following variables had a positive predictive value for HCV infection: IDU (p<0.001; HR = 7,30; CI: 4.83-11.04), Spanish ethnicity (p = 0.009; HR = 2,03; CI: 1.93-3.44) and HIV infection (p = 0.015; HR = 1.97; CI: 1.14-3.39). Conclusion: The incidence of HCV infection among prisoners was higher during the first part of the study and among IDU during the entire study period. Preventative programs should be directed toward this sub-group of the prison population.	[Marco, Andres] Barcelona Mens Penitentiary Ctr, Hlth Serv, Barcelona, Spain; [Marco, Andres; Gallego, Carlos] Govt Catalonia, Dept Justice, Barcelona, Spain; [Gallego, Carlos] Quatre Camins Penitentiary Ctr, Hlth Serv, Barcelona, Spain; [Cayla, Joan A.] CIBER Epidemiol & Publ Hlth CIBERESP, Publ Hlth Agcy Barcelona, Epidemiol Serv, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Public Health Agency of Barcelona	Marco, A (corresponding author), Barcelona Mens Penitentiary Ctr, Hlth Serv, Barcelona, Spain.	andres.marco.m@gmail.com		Cayla, Joan A./0000-0003-3891-111X				Aitken CK, 2008, HEPATOLOGY, V48, P1746, DOI 10.1002/hep.22534; Allen EJ, 2012, INT J DRUG POLICY, V23, P346, DOI 10.1016/j.drugpo.2012.07.006; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P421; [Anonymous], SER TEMP AN; Barrio Flores LF, 2003, REV ESP SANID PENIT, V5, P21; Bravo MJ, 2012, INT J DRUG POLICY, V23, P415, DOI 10.1016/j.drugpo.2012.02.002; Bruguera M, 2006, MED CLIN-BARCELONA, V127, P113, DOI 10.1157/13090276; Champion JK, 2004, AM J EPIDEMIOL, V159, P514, DOI 10.1093/aje/kwh061; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; de la Fuente L, 2012, Rev Esp Sanid Penit, V14, P86, DOI 10.4321/S1575-06202012000300003; Esteban JI, 2008, J HEPATOL, V48, P148, DOI 10.1016/j.jhep.2007.07.033; Folch C, 2012, GAC SANIT, V26, P37, DOI 10.1016/j.gaceta.2011.07.022; Guadagnino V, 2013, DIGEST LIVER DIS, V45, P403, DOI 10.1016/j.dld.2012.10.014; Hagan H, 2004, EPIDEMIOLOGY, V15, P543, DOI 10.1097/01.ede.0000135170.54913.9d; Hagan H, 2010, J INFECT DIS, V201, P378, DOI 10.1086/649783; Holtzman D, 2009, PREV MED, V49, P68, DOI 10.1016/j.ypmed.2009.04.014; Jafa K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005416; Jahani MR, 2009, AIDS, V23, P538, DOI 10.1097/QAD.0b013e3283269e3c; Klevens RM, 2012, CLIN INFECT DIS, V55, pS3, DOI 10.1093/cid/cis393; Koulierakis G, 2000, ADDICTION, V95, P1207, DOI 10.1046/j.1360-0443.2000.95812077.x; MacArthur GJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5945; Maher L, 2007, AUST NZ J PUBL HEAL, V31, P30, DOI 10.1111/j.1753-6405.2007.00007.x; Marco A, 2010, REV ESP SALUD PUBLIC, V84, P421; Martin Sanchez V, 1998, Rev Esp Salud Publica, V72, P43; Miller ER, 2009, INT J INFECT DIS, V13, P201, DOI 10.1016/j.ijid.2008.06.011; Nagami EH, 2011, CLIN INFECT DIS, V52, P361, DOI 10.1093/cid/ciq159; O'Sullivan BG, 2003, MED J AUSTRALIA, V178, P546, DOI 10.5694/j.1326-5377.2003.tb05356.x; Palacios Rosario, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P100, DOI 10.1177/1545109709331474; Peles E, 2011, J ADDICT MED, V5, P214, DOI 10.1097/ADM.0b013e31820e13dd; Rantala Merja, 2008, Euro Surveill, V13; Razavi H, 2013, HEPATOLOGY, V57, P2164, DOI 10.1002/hep.26218; Robotin MC, 2011, ARCH INTERN MED, V171, P242; Roy E, 2009, DRUG ALCOHOL DEPEN, V102, P158, DOI 10.1016/j.drugalcdep.2009.01.006; de la Hoya PS, 2011, EUR J CLIN MICROBIOL, V30, P857, DOI 10.1007/s10096-011-1166-5; Spittal PM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-632; Stein MD, 2009, J ADDICT DIS, V28, P389, DOI 10.1080/10550880903183034; Su YY, 2013, HEMODIAL INT, V17, P532, DOI 10.1111/j.1542-4758.2012.00761.x; Sweeting MJ, 2009, AM J EPIDEMIOL, V170, P352, DOI 10.1093/aje/kwp141; TESTA AC, 2006, EUROSURVEILLANCE, V11; Teutsch S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-633; Tohme RA, 2012, CLIN INFECT DIS, V54, P1167, DOI 10.1093/cid/cir991; Turner KME, 2011, ADDICTION, V106, P1978, DOI 10.1111/j.1360-0443.2011.03515.x; Vescio MF, 2008, J EPIDEMIOL COMMUN H, V62, P305, DOI 10.1136/jech.2006.051599; Wang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045632; Wiessing L, 2011, EUROSURVEILLANCE, V16, P9; Williams IT, 2008, EURO SURVEILL, V13; Zahariadis G, 2007, AM J TRANSPLANT, V7, P226, DOI 10.1111/j.1600-6143.2006.01607.x	47	22	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90560	10.1371/journal.pone.0090560	http://dx.doi.org/10.1371/journal.pone.0090560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24587394	Green Submitted, gold, Green Published			2022-12-27	WOS:000332396200228
J	Rytelewski, M; Meilleur, CE; Yekta, MA; Szabo, PA; Garg, N; Schell, TD; Jevnikar, AM; Sharif, S; Singh, B; Haeryfar, SMM				Rytelewski, Mateusz; Meilleur, Courtney E.; Yekta, Maryam Atef; Szabo, Peter A.; Garg, Nitan; Schell, Todd D.; Jevnikar, Anthony M.; Sharif, Shayan; Singh, Bhagirath; Haeryfar, S. M. Mansour			Suppression of Immunodominant Antitumor and Antiviral CD8(+) T Cell Responses by Indoleamine 2,3-Dioxygenase	PLOS ONE			English	Article							INFLUENZA-A VIRUS; DRAINING LYMPH-NODES; MHC CLASS-I; DENDRITIC CELLS; TRYPTOPHAN CATABOLISM; CROSS-PRESENTATION; TUMOR-ANTIGEN; EPITOPE; POLYOMAVIRUS; INHIBITION	Indoleamine 2,3-dioxygenase (IDO) is a tryptophan-degrading enzyme known to suppress antitumor CD8(+) T cells (T-CD8). The role of IDO in regulation of antiviral T-CD8 responses is far less clear. In addition, whether IDO controls both immunodominant and subdominant T-CD8 is not fully understood. This is an important question because the dominance status of tumor- and virus-specific T-CD8 may determine their significance in protective immunity and in vaccine design. We evaluated the magnitude and breadth of cross-primed T-CD8 responses to simian virus 40 (SV40) large T antigen as well as primary and recall T-CD8 responses to influenza A virus (IAV) in the absence or presence of IDO. IDO-/- mice and wild-type mice treated with 1-methyl-D-tryptophan, a pharmacological inhibitor of IDO, exhibited augmented responses to immunodominant epitopes encoded by T antigen and IAV. IDO-mediated suppression of these responses was independent of CD4(+)CD25(+)FoxP3(+) regulatory T cells, which remained numerically and functionally intact in IDO-/- mice. Treatment with L-kynurenine failed to inhibit T-CD8 responses, indicating that tryptophan metabolites are not responsible for the suppressive effect of IDO in our models. Immunodominant T antigen-specific T-CD8 from IDO-/- mice showed increased Ki-67 expression, suggesting that they may have acquired a more vigorous proliferative capacity in vivo. In conclusion, IDO suppresses immunodominant T-CD8 responses to tumor and viral antigens. Our work also demonstrates that systemic primary and recall T-CD8 responses to IAV are controlled by IDO. Inhibition of IDO thus represents an attractive adjuvant strategy in boosting anticancer and antiviral T-CD8 targeting highly immunogenic antigens.	[Rytelewski, Mateusz; Meilleur, Courtney E.; Yekta, Maryam Atef; Szabo, Peter A.; Garg, Nitan; Jevnikar, Anthony M.; Singh, Bhagirath; Haeryfar, S. M. Mansour] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Schell, Todd D.] Penn State Univ, Dept Microbiol & Immunol, Hershey, PA USA; [Jevnikar, Anthony M.] Univ Western Ontario, Dept Med, London, ON, Canada; [Jevnikar, Anthony M.] Univ Western Ontario, Dept Pathol, London, ON, Canada; [Jevnikar, Anthony M.; Singh, Bhagirath; Haeryfar, S. M. Mansour] Univ Western Ontario, Ctr Human Immunol, London, ON, Canada; [Sharif, Shayan] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada	Western University (University of Western Ontario); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Guelph	Haeryfar, SMM (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada.	Mansour.Haeryfar@schulich.uwo.ca	Rytelewski, Mateusz/J-6184-2019; Singh, Bhagirath/C-4010-2013; Schell, Todd/AAC-7261-2021; Jevnikar, Anthony M./G-3309-2011	Singh, Bhagirath/0000-0002-9792-8694; Schell, Todd/0000-0002-6788-6518; Szabo, Peter Anthony/0000-0003-1603-761X	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); National Institutes of Health (NIH) [RO1 CA-025000]; Ontario Ministry of Research and Innovation; Canada Graduate Scholarship from NSERC; NATIONAL CANCER INSTITUTE [R01CA025000] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Canada Graduate Scholarship from NSERC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from Canadian Institutes of Health Research (CIHR) and Natural Sciences and Engineering Research Council of Canada (NSERC) to SMMH, and by grant RO1 CA-025000 from National Institutes of Health (NIH) to TDS. SMMH holds a Canada Research Chair in Viral Immunity & Pathogenesis and is a recipient of an Early Researcher Award from the Ontario Ministry of Research and Innovation. MR was and CEM is a recipient of a Canada Graduate Scholarship from NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becerra A, 2009, J GEN VIROL, V90, P810, DOI 10.1099/vir.0.004416-0; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; CADY SG, 1991, ARCH BIOCHEM BIOPHYS, V291, P326, DOI 10.1016/0003-9861(91)90142-6; Chen W, 2004, J IMMUNOL, V173, P5021, DOI 10.4049/jimmunol.173.8.5021; Chen WS, 2004, EUR J IMMUNOL, V34, P194, DOI 10.1002/eji.200324257; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Crowe SR, 2006, VACCINE, V24, P452, DOI 10.1016/j.vaccine.2005.07.090; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; Della Chiesa M, 2006, BLOOD, V108, P4118, DOI 10.1182/blood-2006-06-006700; Dolan BP, 2006, J IMMUNOL, V177, P6018, DOI 10.4049/jimmunol.177.9.6018; FALK K, 1991, J EXP MED, V174, P425, DOI 10.1084/jem.174.2.425; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Fox JM, 2013, J GEN VIROL, V94, P1451, DOI 10.1099/vir.0.053124-0; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Fu TM, 1998, J VIROL, V72, P1469, DOI 10.1128/JVI.72.2.1469-1481.1998; Gomez BP, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-36; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Haeryfar SMM, 2005, J IMMUNOL, V174, P3344, DOI 10.4049/jimmunol.174.6.3344; Hoshi M, 2010, J IMMUNOL, V185, P3305, DOI 10.4049/jimmunol.0901150; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; Huang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066546; Inaba T, 2009, GYNECOL ONCOL, V115, P185, DOI 10.1016/j.ygyno.2009.07.015; Ino K, 2008, CLIN CANCER RES, V14, P2310, DOI 10.1158/1078-0432.CCR-07-4144; Irvine Kari, 2006, Expert Rev Clin Immunol, V2, P135, DOI 10.1586/1744666X.2.1.135; Iyer JG, 2011, CLIN CANCER RES, V17, P6671, DOI 10.1158/1078-0432.CCR-11-1513; Kassem A, 2008, CANCER RES, V68, P5009, DOI 10.1158/0008-5472.CAN-08-0949; KNOWLES BB, 1979, J IMMUNOL, V122, P1798; Lee GK, 2002, IMMUNOLOGY, V107, P452, DOI 10.1046/j.1365-2567.2002.01526.x; Leon-Ponte M, 2008, IMMUNOL INVEST, V37, P714, DOI 10.1080/08820130802349908; Liu HZ, 2009, J IMMUNOL, V183, P1022, DOI 10.4049/jimmunol.0900408; Liu ZW, 2007, J IMMUNOL, V178, P4260, DOI 10.4049/jimmunol.178.7.4260; LIVINGSTON DM, 1987, MOL BIOL MED, V4, P63; Mao RC, 2011, J VIROL, V85, P1048, DOI 10.1128/JVI.01998-10; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mellor AL, 2002, J IMMUNOL, V168, P3771, DOI 10.4049/jimmunol.168.8.3771; Molano A, 2008, IMMUNOL LETT, V117, P81, DOI 10.1016/j.imlet.2007.12.013; Morse MA, 2008, BLOOD, V112, P610, DOI 10.1182/blood-2008-01-135319; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn David H, 2012, Front Biosci (Elite Ed), V4, P734; Munn DH, 2004, J IMMUNOL, V172, P4100, DOI 10.4049/jimmunol.172.7.4100; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Mylin LM, 2000, J VIROL, V74, P6922, DOI 10.1128/JVI.74.15.6922-6934.2000; OKAMOTO H, 1988, J LEUKOCYTE BIOL, V43, P502, DOI 10.1002/jlb.43.6.502; Opitz CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019823; Orabona C, 2011, METHODS MOL BIOL, V677, P269, DOI 10.1007/978-1-60761-869-0_19; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Rimmelzwaan GF, 2004, VIRUS RES, V103, P97, DOI 10.1016/j.virusres.2004.02.020; Schell TD, 2001, J IMMUNOL, V167, P6947, DOI 10.4049/jimmunol.167.12.6947; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Sharma MD, 2010, IMMUNITY, V33, P942, DOI 10.1016/j.immuni.2010.11.022; Sharma MD, 2009, BLOOD, V113, P6102, DOI 10.1182/blood-2008-12-195354; Sharpe AH, 2009, IMMUNOL REV, V229, P5, DOI 10.1111/j.1600-065X.2009.00784.x; Shen ZH, 1997, J IMMUNOL, V158, P2723; Sihto H, 2012, CLIN CANCER RES, V18, P2872, DOI 10.1158/1078-0432.CCR-11-3020; Spurgeon ME, 2013, VIROLOGY, V435, P118, DOI 10.1016/j.virol.2012.09.029; Tatum AM, 2008, J IMMUNOL, V181, P4406, DOI 10.4049/jimmunol.181.6.4406; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; TRINCHIERI G, 1976, NATURE, V261, P312, DOI 10.1038/261312a0; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Vareki SM, 2012, AM J TRANSPLANT, V12, P233, DOI 10.1111/j.1600-6143.2011.03811.x; Vitiello A, 1996, J IMMUNOL, V157, P5555; Wakim LM, 2011, NATURE, V471, P629, DOI 10.1038/nature09863; Watson AM, 2012, J IMMUNOL, V189, P5549, DOI 10.4049/jimmunol.1102221; Weber WP, 2006, EUR J IMMUNOL, V36, P296, DOI 10.1002/eji.200535616; YANG L, 1992, CURR OPIN IMMUNOL, V4, P265, DOI 10.1016/0952-7915(92)90075-P; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; YOSHIDA R, 1979, P NATL ACAD SCI USA, V76, P4084, DOI 10.1073/pnas.76.8.4084; Yoshikawa T, 2010, EUR J HAEMATOL, V84, P304, DOI 10.1111/j.1600-0609.2009.01393.x; Zhang G, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/384726	76	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90439	10.1371/journal.pone.0090439	http://dx.doi.org/10.1371/journal.pone.0090439			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587363	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200198
J	Borkotoky, K; Unisa, S				Borkotoky, Kakoli; Unisa, Sayeed			Indicators to Examine Quality of Large Scale Survey Data: An Example through District Level Household and Facility Survey	PLOS ONE			English	Article								Background: Large scale surveys are the main source of data pertaining to all the social and demographic indicators, hence its quality is also of great concern. In this paper, we discuss the indicators used to examine the quality of data. We focus on age misreporting, incompleteness and inconsistency of information; and skipping of questions on reproductive and sexual health related issues. In order to observe the practical consequences of errors in a survey; the District Level Household and Facility Survey (DLHS-3) is used as an example dataset. Methods: Whipple's and Myer's indices are used to identify age misreporting. Age displacements are identified by estimating downward and upward transfers for women from bordering age groups of the eligible age range. Skipping pattern is examined by recording the responses to the questions which precede the sections on birth history, immunization, and reproductive and sexual health. Results: The study observed errors in age reporting, in all the states, but the extent of misreporting differs by state and individual characteristics. Illiteracy, rural residence and poor economic condition are the major factors that lead to age misreporting. Female were excluded from the eligible age group, to reduce the duration of interview. The study further observed that respondents tend to skip questions on HIV/RTI and other questions which follow a set of questions. Conclusion: The study concludes that age misreporting, inconsistency and incomplete response are three sources of error that need to be considered carefully before drawing conclusions from any survey. DLHS-3 also suffers from age misreporting, particularly for female in the reproductive ages. In view of the coverage of the survey, it may not be possible to control age misreporting completely, but some extra effort to probe a better answer may help in improving the quality of data in the survey.	[Borkotoky, Kakoli] Int Inst Populat Sci IIPS, Bombay, Maharashtra, India; [Unisa, Sayeed] IIPS, Dept Math Demog & Stat, Bombay, Maharashtra, India	International Institute for Population Sciences; International Institute for Population Sciences	Borkotoky, K (corresponding author), Int Inst Populat Sci IIPS, Bombay, Maharashtra, India.	kakoli.26nov@gmail.com	Unisa, Sayeed/AAS-9588-2020					Ann KB, 1990, METHODOLOGICAL REPOR; [Anonymous], 2001, MEAS REP SOUR ERR SU; Arnold F., 1990, METHODOLOGICAL REPOR; Bhat P., 1995, DEMOGRAPHY INDIA, V24, P59; Bhat PNM, 1999, ECON POLIT WEEKLY; Deming WE, 1944, AM SOCIOL REV, V9, P359, DOI 10.2307/2085979; Denic S, 2004, J PUBLIC HEALTH, V26, P168, DOI 10.1093/pubmed/fdh131; Ewbank D., 1981, 4 COMM POP DEM; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; Jaipal PA, 1975, DEMOGRAPHY INDIA, V4, P11; James KS, 2004, EC POLITICAL WEEKLY; Johnson K, 2009, DHS ANAL STUDIES, V19; Kasprzyk D, 2005, MEASUREMENT ERROR HO; Mari Bhat P. N., 1995, DEMOGRAPHY INDIA, V24, P245; Mason KO, 1987, J DEMOGRAPHY, V24; Pullum T, 2006, METH REP; Shea OR, 1990, METHODOLOGICAL REPOR; Talib AL, 2010, AGE REPORTING BEHAV, P61; Unisa S, 2009, 16 IUSSP INT POP C M; United Nations, 1995, IND TECHN DEM EST; United Nations Population Fund (UNFPA), 1996, IND AN SER; United Nations Population Fund (UNFPA), 1996, SER POP DEV STUD AR; Shryock Henry S, 1980, METHODS MAT DEMOGRAP	23	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90113	10.1371/journal.pone.0090113	http://dx.doi.org/10.1371/journal.pone.0090113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598760	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400046
J	Kuo, WL; Sharifi, MN; Lingen, MW; Ahmed, O; Liu, J; Nagilla, M; Macleod, KF; Cohen, EEW				Kuo, Wen-Liang; Sharifi, Marina N.; Lingen, Mark W.; Ahmed, Omar; Liu, Jing; Nagilla, Madhavi; Macleod, Kay F.; Cohen, Ezra E. W.			p62/SQSTM1 Accumulation in Squamous Cell Carcinoma of Head and Neck Predicts Sensitivity to Phosphatidylinositol 3-Kinase Pathway Inhibitors	PLOS ONE			English	Article							AUTOPHAGY; CANCER; ACTIVATION; SURVIVAL; DEATH; PI3K	The phosphoinositol-3 kinase (PI3K) pathway is highly dysregulated in squamous cell carcinoma of the head and neck (SCCHN). While inhibitors of the PI3K/AKT pathway are being developed in cancer, their efficacy does not appear to be related to the presence of mutations or amplification in pathway genes. The PI3K pathway is a major regulator of macro-autophagy, an evolutionarily conserved catabolic process that degrades cellular materials to promote cellular homeostasis and survival under stress. Employing a panel of SCCHN cell lines, we observed a significant correlation between the activity of PI3K/AKT inhibitors and their ability to induce autophagy. More specifically, resistance to these inhibitors was associated with accumulation of p62/SQSTM1, a pleotropic protein that is consumed during autophagy, while loss of autophagy was, for the first time, found to be due to silencing of an essential autophagy gene, ATG7. Moreover, modulating ATG7 and p62/SQSTM1 could regulate sensitivity to PI3K/AKT inhibitors, underscoring a mechanistic link between autophagy and drug sensitivity. Analysis of human tissues revealed progressive accumulation of p62/SQSTM1 in a significant proportion of cancer samples compared to normal tissue, suggesting that defective autophagy has relevance to SCCHN. These findings are further validated by analysis of TCGA data confirming homozygous deletion and mRNA down-regulation of ATG7 in 10.0% of SCCHN samples. Taken together, these data indicate that p62/SQSTM1 levels modulate sensitivity to PI3K/AKT inhibitors; cancers vary in their capacity to undergo autophagy through epigenetic modification and, when deficient, accumulate p62/SQSTM1; and expression of autophagy-related proteins may serve as markers for resistance to PI3K/AKT inhibitors in SCCHN.	[Kuo, Wen-Liang; Ahmed, Omar; Liu, Jing; Nagilla, Madhavi; Cohen, Ezra E. W.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Sharifi, Marina N.; Lingen, Mark W.; Macleod, Kay F.; Cohen, Ezra E. W.] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; [Sharifi, Marina N.; Macleod, Kay F.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Lingen, Mark W.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Lingen, Mark W.; Macleod, Kay F.; Cohen, Ezra E. W.] Univ Chicago, Comprehens Canc Ctr, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago	Cohen, EEW (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	ecohen@.ucsd.edu		Sharifi, Marina/0000-0003-0128-3033	Developmental Research Project University of Chicago Head and Neck Cancer Research Program; NCI [RO1 CA162405]; MSTP Training Program; NATIONAL CANCER INSTITUTE [R01CA162405] Funding Source: NIH RePORTER	Developmental Research Project University of Chicago Head and Neck Cancer Research Program; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MSTP Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Developmental Research Project University of Chicago Head and Neck Cancer Research Program (WLK, EEWC); Grant Achatz, Nick Kokonas; Alinea Restauran; NCI RO1 CA162405 (KFM); MSTP Training Program (MNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Bialik S, 2008, ADV EXP MED BIOL, V615, P177, DOI 10.1007/978-1-4020-6554-5_9; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cohen Y, 2011, ORAL ONCOL, V47, P946, DOI 10.1016/j.oraloncology.2011.07.013; COWAN JM, 1992, J NATL CANCER I, V84, P793, DOI 10.1093/jnci/84.10.793; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; EASTY DM, 1981, BRIT J CANCER, V43, P772, DOI 10.1038/bjc.1981.115; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Ghadimi MP, 2012, MOL CANCER THER, V11, P1758, DOI 10.1158/1535-7163.MCT-12-0015; Hayes JR David N., 2013, J CLIN ONCOL, V31; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Jaakkola PM, 2009, AUTOPHAGY, V5, P410, DOI 10.4161/auto.5.3.7823; Janku F, 2011, NATURE REV CLIN ONCO, V8; Janku F, 2011, MOL CANCER THER, V10, P558, DOI 10.1158/1535-7163.MCT-10-0994; Kaushik S, 2008, MOL BIOL CELL, V19, P2179, DOI 10.1091/mbc.E07-11-1155; Keck Michaela K., 2013, J CLIN ONCOL, V31; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kon M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003182; Kuo WL, 2010, MOL CANCER THER, V9, P2814, DOI 10.1158/1535-7163.MCT-10-0352; Kwon J, 2012, EMBO REP, V13, P150, DOI 10.1038/embor.2011.246; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Lee HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036221; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee IH, 2012, SCIENCE, V336, P225, DOI 10.1126/science.1218395; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; Ma XH, 2011, CLIN CANCER RES, V17, P3478, DOI 10.1158/1078-0432.CCR-10-2372; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Pankiv S, 2010, J BIOL CHEM, V285, P5941, DOI 10.1074/jbc.M109.039925; Parzych K. R., 2013, ANTIOXID REDOX SIGNA; Puissant A, 2012, AM J CANCER RES, V2, P397; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Saman DM, 2012, HEAD NECK ONCOL, V4, DOI 10.1186/1758-3284-4-1; Sangai T, 2012, CLIN CANCER RES, V18, P5816, DOI 10.1158/1078-0432.CCR-12-1141; Shanware NP, 2013, ANNU REV PHARMACOL, V53, P89, DOI 10.1146/annurev-pharmtox-010611-134717; Simard EP, 2012, CA-CANCER J CLIN, V62, P118, DOI 10.3322/caac.20141; Sridhar S, 2012, J PATHOL, V226, P255, DOI 10.1002/path.3025; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Young NR, 2013, MOL ONCOL, V7, P359, DOI 10.1016/j.molonc.2012.11.001; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645	48	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90171	10.1371/journal.pone.0090171	http://dx.doi.org/10.1371/journal.pone.0090171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599075	Green Submitted, Green Published, gold			2022-12-27	WOS:000332479400053
J	Liu, BG; Badeaux, MD; Choy, G; Chandra, D; Shen, I; Jeter, CR; Rycaj, K; Lee, CF; Person, MD; Liu, C; Chen, YP; Shen, JJ; Jung, SY; Qin, J; Tang, DG				Liu, Bigang; Badeaux, Mark D.; Choy, Grace; Chandra, Dhyan; Shen, Irvin; Jeter, Collene R.; Rycaj, Kiera; Lee, Chia-Fang; Person, Maria D.; Liu, Can; Chen, Yueping; Shen, Jianjun; Jung, Sung Yun; Qin, Jun; Tang, Dean G.			Nanog1 in NTERA-2 and Recombinant NanogP8 from Somatic Cancer Cells Adopt Multiple Protein Conformations and Migrate at Multiple M.W Species	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NF-KAPPA-B; SELF-RENEWAL; INITIATING CELLS; MARKER NANOG; EXPRESSION; PLURIPOTENCY; IDENTIFICATION; TRANSCRIPTION; BREAST	Human Nanog1 is a 305-amino acid (aa) homeodomain-containing transcription factor critical for the pluripotency of embryonic stem (ES) and embryonal carcinoma (EC) cells. Somatic cancer cells predominantly express a retrogene homolog of Nanog1 called NanogP8, which is similar to 99% similar to Nanog at the aa level. Although the predicted M. W of Nanog1/NanogP8 is similar to 35 kD, both have been reported to migrate, on Western blotting (WB), at apparent molecular masses of 29-80 kD. Whether all these reported protein bands represent authentic Nanog proteins is unclear. Furthermore, detailed biochemical studies on Nanog1/NanogpP8 have been lacking. By combining WB using 8 anti-Nanog1 antibodies, immunoprecipitation, mass spectrometry, and studies using recombinant proteins, here we provide direct evidence that the Nanog1 protein in NTERA-2 EC cells exists as multiple M.W species from similar to 22 kD to 100 kD with a major 42 kD band detectable on WB. We then demonstrate that recombinant NanogP8 (rNanogP8) proteins made in bacteria using cDNAs from multiple cancer cells also migrate, on denaturing SDS-PAGE, at similar to 28 kD to 180 kD. Interestingly, different anti-Nanog1 antibodies exhibit differential reactivity towards rNanogP8 proteins, which can spontaneously form high M.W protein species. Finally, we show that most long-term cultured cancer cell lines seem to express very low levels of or different endogenous NanogP8 protein that cannot be readily detected by immunoprecipitation. Altogether, the current study reveals unique biochemical properties of Nanog1 in EC cells and NanogP8 in somatic cancer cells.	[Liu, Bigang; Badeaux, Mark D.; Choy, Grace; Chandra, Dhyan; Shen, Irvin; Jeter, Collene R.; Rycaj, Kiera; Liu, Can; Chen, Yueping; Shen, Jianjun; Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA; [Lee, Chia-Fang; Person, Maria D.] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Jung, Sung Yun; Qin, Jun] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; [Tang, Dean G.] Tongji Univ, Sch Med, Canc Stem Cell Inst, Res Ctr Translat Med,East Hosp, Shanghai 200092, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; Baylor College of Medicine; Tongji University	Tang, DG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Sci Pk, Smithville, TX 78957 USA.	dtang@mdanderson.org	Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174; Jeter, Collene/0000-0002-9627-4529; Jung, Sung Yun/0000-0003-1521-7977; Chandra, Dhyan/0000-0001-7272-9384	NIH [R01-CA155693]; Department of Defense [W81XWH-13-1-0352]; CPRIT [RP120380, RP120394, RP110782]; MDACC Center for Cancer Epigenetics; RNA Center-Laura & John Arnold Foundation; DOD [PC121553];  [CCSG-5 P30 CA166672];  [ES007784]; NATIONAL CANCER INSTITUTE [R01CA166672, R01CA155693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); CPRIT; MDACC Center for Cancer Epigenetics; RNA Center-Laura & John Arnold Foundation; DOD(United States Department of Defense); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in part, by grants from NIH (R01-CA155693), Department of Defense (W81XWH-13-1-0352), CPRIT (RP120380), the MDACC Center for Cancer Epigenetics and RNA Center-Laura & John Arnold Foundation grant (D. G. Tang), and by two Center Grants (CCSG-5 P30 CA166672 and ES007784). C. Jeter, M. Person, and C. Liu were supported, in part, by CPRIT RP120394, CPRIT RP110782, and DOD post-doctoral fellowship (PC121553), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldridge L, 2008, J PROTEOME RES, V7, P1458, DOI 10.1021/pr7007829; Badeaux MA, 2013, CELL CYCLE, V12, P2395, DOI 10.4161/cc.25402; Booth HAF, 2004, GENOMICS, V84, P229, DOI 10.1016/j.ygeno.2004.02.014; Bourguignon LYW, 2012, ONCOGENE, V31, P149, DOI 10.1038/onc.2011.222; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Bussolati B, 2008, FASEB J, V22, P3696, DOI 10.1096/fj.08-102590; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; Chang DF, 2009, STEM CELLS, V27, P812, DOI 10.1634/stemcells.2008-0657; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Do HJ, 2007, BIOCHEM BIOPH RES CO, V353, P770, DOI 10.1016/j.bbrc.2006.12.100; Eberle I, 2010, NUCLEIC ACIDS RES, V38, P5384, DOI 10.1093/nar/gkq307; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Gorini G, 2010, FEBS LETT, V584, P845, DOI 10.1016/j.febslet.2009.12.061; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Ho BT, 2012, J BIOL CHEM, V287, P18656, DOI 10.1074/jbc.M111.322883; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Ibrahim EE, 2012, STEM CELLS, V30, P2076, DOI 10.1002/stem.1182; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Jung SY, 2005, MOL ENDOCRINOL, V19, P2451, DOI 10.1210/me.2004-0476; Kalbermatten DF, 2011, CELL TISSUE RES, V344, P251, DOI 10.1007/s00441-011-1142-5; Kim JS, 2005, EXP MOL MED, V37, P601, DOI 10.1038/emm.2005.73; Kochupurakkal BS, 2008, BIOCHEM BIOPH RES CO, V365, P846, DOI 10.1016/j.bbrc.2007.11.073; Kuijk EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010987; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Liu M, 2010, CANCER RES, V70, P10464, DOI 10.1158/0008-5472.CAN-10-0732; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Meng HM, 2010, CANC BIOL THER, V9; Meyer MJ, 2010, CANCER RES, V70, P4624, DOI 10.1158/0008-5472.CAN-09-3619; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Mullin NP, 2008, BIOCHEM J, V411, P227, DOI 10.1042/BJ20080134; Noh KH, 2012, J CLIN INVEST, V122, P4077, DOI 10.1172/JCI64057; Noh KH, 2012, CANCER RES, V72, P1717, DOI 10.1158/0008-5472.CAN-11-3758; Oh JH, 2005, EXP MOL MED, V37, P250, DOI 10.1038/emm.2005.33; Palla AR, 2014, ONCOGENE, V33, P2513, DOI 10.1038/onc.2013.196; Pan GJ, 2005, J BIOL CHEM, V280, P1401, DOI 10.1074/jbc.M407847200; Pei DQ, 2009, J BIOL CHEM, V284, P3365, DOI 10.1074/jbc.R800063200; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; PERSSON H, 1984, SCIENCE, V225, P687, DOI 10.1126/science.6431612; Po A, 2010, EMBO J, V29, P2646, DOI 10.1038/emboj.2010.131; Qin JC, 2012, CELL STEM CELL, V10, P556, DOI 10.1016/j.stem.2012.03.009; Ramakrishna S, 2011, STEM CELLS DEV, V20, P1512, DOI 10.1089/scd.2010.0410; RAMSAY G, 1984, P NATL ACAD SCI-BIOL, V81, P7742, DOI 10.1073/pnas.81.24.7742; Salmina K, 2010, EXP CELL RES, V316, P2099, DOI 10.1016/j.yexcr.2010.04.030; Santini R, 2012, STEM CELLS, V30, P1808, DOI 10.1002/stem.1160; Shan JJ, 2012, HEPATOLOGY, V56, P1004, DOI 10.1002/hep.25745; Siu MKY, 2013, ONCOGENE, V32, P3500, DOI 10.1038/onc.2012.363; Siu MKY, 2008, AM J PATHOL, V173, P1165, DOI 10.2353/ajpath.2008.080288; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Ye F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-108; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137; Zhang J, 2013, ONCOGENE, V32, P4397, DOI 10.1038/onc.2012.461; Zhang JY, 2006, FEBS J, V273, P1723, DOI 10.1111/j.1742-4658.2006.05186.x; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhang X, 2009, J CELL BIOL, V184, P67, DOI 10.1083/jcb.200801009	68	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90615	10.1371/journal.pone.0090615	http://dx.doi.org/10.1371/journal.pone.0090615			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598770	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400101
J	Liu, YW; Su, CT; Chang, YT; Tsai, WC; Su, YR; Wang, SPH; Yang, CS; Tsai, LM; Chen, JH; Sung, JM				Liu, Yen-Wen; Su, Chi-Ting; Chang, Yu-Tzu; Tsai, Wei-Chuan; Su, Yu-Ru; Wang, Saprina P. H.; Yang, Chun-Shin; Tsai, Liang-Miin; Chen, Jyh-Hong; Sung, Junne-Ming			Elevated Serum Interleukin-18 Level Is Associated with All-Cause Mortality in Stable Hemodialysis Patients Independently of Cardiac Dysfunction	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; C-REACTIVE PROTEIN; NECROSIS-FACTOR-ALPHA; VENA-CAVA DIAMETER; TROPONIN-T; CARDIOVASCULAR MORTALITY; DIASTOLIC DYSFUNCTION; EUROPEAN-ASSOCIATION; AMERICAN-SOCIETY	Background: High circulating interleukin (IL)-18 level predicts a higher hospitalization rate among dialysis patients, possibly through cardiovascular mechanisms; however, whether higher IL-18 level is associated with mortality in dialysis patients is less clear. In addition, its impacts on left ventricular (LV) function are also unknown. We conducted a cohort study to examine the impacts of IL-18 level on LV function and prognosis among clinically stable hemodialysis patients. Methods: Clinically stable patients undergoing maintenance hemodialysis (>= 3 months) were prospectively enrolled from December 2008 to January 2009, and were followed up for 31 months. The enrolled patients (41% male, 66.4 +/- 10.9 years of age) received 2-dimensional echocardiography and myocardial deformation (strain) analysis, including LV peak systolic longitudinal strain (GLS) and circumferential strain (CS). Laboratory measurements were also performed. Cox regression analysis was used to investigate prognostic factors. Results: Seventy-five patients were stratified into 2 groups by the median value of IL-18 (654.2 pg/ml). Between these 2 groups, there was no significant difference in baseline characteristics including LV ejection fraction. The high IL-18 group had a worse LV systolic function as demonstrated by reduced GLS and CS. Seventeen patients (22.7%) died during the follow-up period. Multivariate Cox regression analysis showed that low serum albumin, the presence of hypertension, high serum IL-18, and less negative GLS (>-15%) were independently associated with all-cause mortality. No significant interaction between IL-18 and less negative GLS was noted in the final Cox model. Conclusion: Hemodialysis patients with high IL-18 levels tend to have worse LV systolic function and higher mortality rate. However, elevated serum IL-18 level is predictive of poor prognosis among stable hemodialysis patients, independently of LV dysfunction. This suggests an additional value of IL-18 to echocardiographic study in predicting all-cause mortality, and IL-18 may be helpful in early risk stratification of hemodialysis patients.	[Liu, Yen-Wen; Tsai, Wei-Chuan; Tsai, Liang-Miin; Chen, Jyh-Hong] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Div Cardiol,Dept Internal Med, Tainan 70101, Taiwan; [Su, Chi-Ting] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Internal Med, Div Nephrol, Yunlin, Taiwan; [Chang, Yu-Tzu; Sung, Junne-Ming] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Div Nephrol, Dept Internal Med, Tainan 70101, Taiwan; [Su, Yu-Ru] Natl Cheng Kung Univ, Dept Stat, Tainan 70101, Taiwan; [Wang, Saprina P. H.] Natl Cheng Kung Univ, Grad Inst Biomed Engn, Tainan 70101, Taiwan; [Yang, Chun-Shin] Cathol Fu An Hosp, Dept Internal Med, Div Nephrol, Yunlin, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Taiwan University; National Taiwan University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University	Sung, JM (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Div Nephrol, Dept Internal Med, Tainan 70101, Taiwan.	jmsung@mail.ncku.edu.tw	Chang, Yu-Tzu/AAE-6781-2022	Chang, Yu-Tzu/0000-0003-1449-9431; Sung, Junne-Ming/0000-0003-1916-7815	National Science Council (NSC), Executive Yuan, Taipei, Taiwan [NSC 98-2314-B-006-051, 101-2314-B-006-035]	National Science Council (NSC), Executive Yuan, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council (NSC), Executive Yuan, Taipei, Taiwan: Grants NSC 98-2314-B-006-051 and 101-2314-B-006-035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akdag I, 2008, NEPHRON CLIN PRACT, V108, pC99, DOI 10.1159/000113526; Ando Y, 1995, ARTIF ORGANS, V19, P1237, DOI 10.1111/j.1525-1594.1995.tb02292.x; Blankenberg S, 2003, CIRCULATION, V108, P2453, DOI 10.1161/01.CIR.0000099509.76044.A2; Blankenberg S, 2002, CIRCULATION, V106, P24, DOI 10.1161/01.CIR.0000020546.30940.92; Cain BS, 1999, CRIT CARE MED, V27, P1309, DOI 10.1097/00003246-199907000-00018; Chandrasekar B, 2005, J BIOL CHEM, V280, P4553, DOI 10.1074/jbc.M411787200; Chiang CK, 2004, NEPHROL DIAL TRANSPL, V19, P2810, DOI 10.1093/ndt/gfh475; deFilippi C, 2003, JAMA-J AM MED ASSOC, V290, P353, DOI 10.1001/jama.290.3.353; Edwards NC, 2008, J AM SOC ECHOCARDIOG, V21, P1293, DOI 10.1016/j.echo.2008.09.013; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; Goicoechea M, 2005, KIDNEY INT, V67, pS35, DOI 10.1111/j.1523-1755.2005.09308.x; Ikizler TA, 1999, KIDNEY INT, V55, P1945, DOI 10.1046/j.1523-1755.1999.00410.x; Konopleva M, 1999, ADV EXP MED BIOL, V457, P217; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Leavey SF, 1998, AM J KIDNEY DIS, V31, P997, DOI 10.1053/ajkd.1998.v31.pm9631845; Li SH, 2007, AM J PHYSIOL-HEART C, V293, pH1847, DOI 10.1152/ajpheart.00578.2007; Liao XD, 2006, FASEB J, V20, P1883, DOI 10.1096/fj.06-5717fje; Liu YW, 2013, CLIN J AM SOC NEPHRO, V8, P1564, DOI 10.2215/CJN.10671012; Liu YW, 2011, AM J NEPHROL, V33, P84, DOI 10.1159/000322709; Liu YW, 2009, J CARD FAIL, V15, P782, DOI 10.1016/j.cardfail.2009.05.006; Mallat Z, 2001, CIRCULATION, V104, P1598, DOI 10.1161/hc3901.096721; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; Reddy VS, 2008, J CELL PHYSIOL, V215, P697, DOI 10.1002/jcp.21348; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sharma R, 2006, HEART, V92, P804, DOI 10.1136/hrt.2005.069666; Stanton T, 2009, CIRC-CARDIOVASC IMAG, V2, P356, DOI 10.1161/CIRCIMAGING.109.862334; Su CT, 2012, J AM SOC ECHOCARDIOG, V25, P895, DOI 10.1016/j.echo.2012.04.025; Tripepi G, 2005, J AM SOC NEPHROL, V16, pS83, DOI 10.1681/ASN.2004110972; Vanholder R, 2008, PEDIATR NEPHROL, V23, P1211, DOI 10.1007/s00467-008-0762-9; Wang AYM, 2006, KIDNEY INT, V70, P444, DOI 10.1038/sj.ki.5001605; Wang J, 2008, EUR HEART J, V29, P1283, DOI 10.1093/eurheartj/ehn141; Wang MJ, 2007, AM J PHYSIOL-HEART C, V292, pH1694, DOI 10.1152/ajpheart.01063.2006; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Whitman SC, 2002, CIRC RES, V90, pE34, DOI 10.1161/hh0202.105292; Woldbaek PR, 2005, AM J PHYSIOL-HEART C, V289, pH708, DOI 10.1152/ajpheart.01179.2004; Wong CK, 2007, IMMUNOL INVEST, V36, P47, DOI 10.1080/08820130600745505; Xing SS, 2010, MOL MED, V16, P465, DOI 10.2119/molmed.2010.00028; Yamagami H, 2005, ARTERIOSCL THROM VAS, V25, P1458, DOI 10.1161/01.ATV.0000168417.52486.56; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406; Yano A, 2005, NEPHROLOGY, V10, P576, DOI 10.1111/j.1440-1797.2005.00497.x; Yashiro M, 2007, THER APHER DIAL, V11, P131, DOI 10.1111/j.1744-9987.2007.00471.x; Yingchoncharoen T, 2013, J AM SOC ECHOCARDIOG, V26, P185, DOI 10.1016/j.echo.2012.10.008; Zoccali C, 2006, J AM SOC NEPHROL, V17, pS169, DOI 10.1681/ASN.2006080910	45	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89457	10.1371/journal.pone.0089457	http://dx.doi.org/10.1371/journal.pone.0089457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599060	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400014
J	Nwosu, BU; Maranda, L; Berry, R; Colocino, B; Flores, CD; Folkman, K; Groblewski, T; Ruze, P				Nwosu, Benjamin Udoka; Maranda, Louise; Berry, Rosalie; Colocino, Barbara; Flores, Carlos D., Sr.; Folkman, Kerry; Groblewski, Thomas; Ruze, Patricia			The Vitamin D Status of Prison Inmates	PLOS ONE			English	Article							D DEFICIENCY; MUSCLE STRENGTH; SKIN	Introduction: There is no comprehensive, systematic analysis of the vitamin D status of prisoners in the scientific literature. Objective: To investigate the vitamin D status and its determinants in US prison inmates. Hypothesis: Given the uniformity of dietary intake amongst inmates, vitamin D status will be determined by non-dietary factors such as skin pigmentation, security level-, and the duration of incarceration. Subjects and Methods: A retrospective study of 526 inmates (males, n = 502, age 48.6 +/- 12.5 years; females, n = 24, age 44.1 +/- 12.2) in Massachusetts prisons. Vitamin D sufficiency, insufficiency, and deficiency were respectively defined as a 25(OH)D concentration 75 nmol/L; 50 to 75 nmol/L; and,50 nmol/L. The Massachusetts Department of Correction Statement of Nutritional Adequacy stated that each inmate received the recommended daily allowance of vitamin D daily. Security level of incarceration was designated as minimum, medium, and maximum. Racial groups were categorized as Black, white, Asian, and Others. Results: Serum 25(OH)D levels peaked in summer and autumn, and decreased in winter and spring. Vitamin D deficiency occurred in 50.5% of blacks, 29.3% of whites, and 14.3% of Asian inmates (p = 0.007). Black inmates had significantly lower serum 25(OH)D level than white inmates at the maximum security level (p = 0.015), medium security level (p = 0.001), but not at the minimum security level (p = 0.40). After adjusting for covariates black inmates at a maximum security level had a four-fold higher risk for vitamin D deficiency than white inmates at the same security level (OR 3.9 [95% CI 1.3-11.7]. Conclusions: The vitamin D status of prison inmates is determined by skin pigmentation, seasons, and the security level of incarceration.	[Nwosu, Benjamin Udoka] Univ Massachusetts, Sch Med, Dept Pediat, Div Endocrinol, Worcester, MA 01655 USA; [Maranda, Louise] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA; [Berry, Rosalie; Colocino, Barbara; Flores, Carlos D., Sr.; Folkman, Kerry] Massachusetts Partnership Correct Healthcare, Dept Correct, Norton, MA USA; [Groblewski, Thomas; Ruze, Patricia] Univ Massachusetts, Sch Med, Dept Family & Community Med, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Nwosu, BU (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, Div Endocrinol, Worcester, MA 01655 USA.	Benjamin.Nwosu@umassmemorial.org			Faculty Diversity Scholars Program; Department of Pediatrics, University of Massachusetts Medical School; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	Faculty Diversity Scholars Program; Department of Pediatrics, University of Massachusetts Medical School; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the Faculty Diversity Scholars Program, and the Department of Pediatrics, University of Massachusetts Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Carson SA, 2008, J ECON HIST, V68, P1; CLEMENS TL, 1982, LANCET, V1, P74; Collins SA, 2012, J CORRECT HEALTH CAR, V18, P210, DOI 10.1177/1078345812444875; Cranney Ann, 2007, Evid Rep Technol Assess (Full Rep), P1; Cropsey KL, 2012, J NATL MED ASSOC, V104, P487, DOI 10.1016/S0027-9684(15)30214-5; Dhesi JK, 2002, J BONE MINER RES, V17, P891, DOI 10.1359/jbmr.2002.17.5.891; Eves A, 2003, J HUM NUTR DIET, V16, P167, DOI 10.1046/j.1365-277X.2003.00438.x; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Makimura H, 2012, CLIN ENDOCRINOL, V76, P220, DOI 10.1111/j.1365-2265.2011.04195.x; Pfeifer M, 2001, EXP CLIN ENDOCR DIAB, V109, P87, DOI 10.1055/s-2001-14831; Plum LA, 2010, NAT REV DRUG DISCOV, V9, P941, DOI 10.1038/nrd3318; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Sohl E, 2013, J CLIN ENDOCRINOL ME; Stewart R, 2010, PSYCHOSOM MED, V72, P608, DOI 10.1097/PSY.0b013e3181e9bf15; Strathdee A, 1994, J FORENSIC PSYCHIATR, V5, P83, DOI DOI 10.1080/09585189408410899; Svoren BM, 2009, J PEDIATR-US, V154, P132, DOI 10.1016/j.jpeds.2008.07.015; Visser M, 2003, J CLIN ENDOCR METAB, V88, P5766, DOI 10.1210/jc.2003-030604; Yetley EA, 2009, AM J CLIN NUTR, V89, P719, DOI 10.3945/ajcn.2008.26903	22	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90623	10.1371/journal.pone.0090623	http://dx.doi.org/10.1371/journal.pone.0090623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598840	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400103
J	Petiwala, SM; Berhe, S; Li, GB; Puthenveetil, AG; Rahman, O; Nonn, L; Johnson, JJ				Petiwala, Sakina M.; Berhe, Saba; Li, Gongbo; Puthenveetil, Angela G.; Rahman, Ozair; Nonn, Larisa; Johnson, Jeremy J.			Rosemary (Rosmarinus officinalis) Extract Modulates CHOP/GADD153 to Promote Androgen Receptor Degradation and Decreases Xenograft Tumor Growth	PLOS ONE			English	Article							PROSTATE-CANCER; DEPRIVATION THERAPY; MEDITERRANEAN DIET; CHEMOPREVENTION; POLYPHENOLS; PREVENTION; DITERPENE; CARNOSOL; TARGETS; CELLS	The Mediterranean diet has long been attributed to preventing or delaying the onset of cardiovascular disease, diabetes and various solid organ cancers. In this particular study, a rosemary extract standardized to carnosic acid was evaluated for its potential in disrupting the endoplasmic reticulum machinery to decrease the viability of prostate cancer cells and promote degradation of the androgen receptor. Two human prostate cancer cell lines, 22Rv1 and LNCaP, and prostate epithelial cells procured from two different patients undergoing radical prostatectomy were treated with standardized rosemary extract and evaluated by flow cytometry, MTT, BrdU, Western blot and fluorescent microscopy. A significant modulation of endoplasmic reticulum stress proteins was observed in cancer cells while normal prostate epithelial cells did not undergo endoplasmic reticulum stress. This biphasic response suggests that standardized rosemary extract may preferentially target cancer cells as opposed to "normal'' cells. Furthermore, we observed standardized rosemary extract to decrease androgen receptor expression that appears to be regulated by the expression of CHOP/GADD153. Using a xenograft tumor model we observed standardized rosemary extract when given orally to significantly suppress tumor growth by 46% compared to mice not receiving standardized rosemary extract. In the last several years regulatory governing bodies ( e. g. European Union) have approved standardized rosemary extracts as food preservatives. These results are especially significant as it is becoming more likely that individuals will be receiving standardized rosemary extracts that are a part of a natural preservative system in various food preparations. Taken a step further, it is possible that the potential benefits that are often associated with a "Mediterranean Diet'' in the future may begin to extend beyond the Mediterranean diet as more of the population is consuming standardized rosemary extracts.	[Petiwala, Sakina M.; Berhe, Saba; Li, Gongbo; Puthenveetil, Angela G.; Rahman, Ozair; Johnson, Jeremy J.] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL 60607 USA; [Nonn, Larisa; Johnson, Jeremy J.] Univ Illinois, Ctr Canc, Chicago, IL USA; [Nonn, Larisa] Univ Illinois, Coll Med, Dept Pathol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Johnson, JJ (corresponding author), Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL 60607 USA.	jjjohn@uic.edu	li, gongbo/C-6778-2008		University of Illinois at Chicago College of Pharmacy; American Cancer Society [RSG CNE - 122480]	University of Illinois at Chicago College of Pharmacy; American Cancer Society(American Cancer Society)	This work was supported by funding from the University of Illinois at Chicago College of Pharmacy and the American Cancer Society RSG CNE - 122480 (to J.J.J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar F, 2008, EFSA J, V8, P1; Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; Asoh S, 2000, J BIOL CHEM, V275, P37240, DOI 10.1074/jbc.M005841200; Doolaege EHA, 2011, PLANT FOOD HUM NUTR, V66, P196, DOI 10.1007/s11130-011-0233-5; Fortes C, 2003, NUTR CANCER, V46, P30, DOI 10.1207/S15327914NC4601_04; Gregersen N, 2010, METHODS MOL BIOL, V648, P3, DOI 10.1007/978-1-60761-756-3_1; Haddad E, 2006, ANN UROL, V40, pS49, DOI 10.1016/S0003-4401(06)80021-5; Johnson JJ, 2010, PHYTOMEDICINE, V17, P3, DOI 10.1016/j.phymed.2009.09.011; Johnson JJ, 2011, CANCER LETT, V305, P1, DOI 10.1016/j.canlet.2011.02.005; Johnson JJ, 2010, CANCER PREV RES, V3, P1112, DOI 10.1158/1940-6207.CAPR-10-0168; Johnson JJ, 2008, PHARM RES-DORDR, V25, P2125, DOI 10.1007/s11095-008-9552-0; Johnson JJ, 2007, CANCER LETT, V255, P170, DOI 10.1016/j.canlet.2007.03.005; Johnson JJ, 2012, CARCINOGENESIS; Kawata H, 2010, PROSTATE, V70, P745, DOI 10.1002/pros.21107; KEYS A, 1986, AM J EPIDEMIOL, V124, P903, DOI 10.1093/oxfordjournals.aje.a114480; Li GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081572; Liu KC, 2012, ENV TOXICOL; Macvicar GR, 2013, CURR OPIN ONCOL; McLaughlin M, 2011, BRIT J PHARMACOL, V162, P328, DOI 10.1111/j.1476-5381.2010.01064.x; Nonn L, 2006, CANCER RES, V66, P4516, DOI 10.1158/0008-5472.CAN-05-3796; Petiwala SM, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00029; Piscopo S, 2009, PUBLIC HEALTH NUTR, V12, P1648, DOI 10.1017/S1368980009990504; Ramaiya A, 2012, CURR DRUG TARGETS, V13, P1698, DOI 10.2174/138945012804545524; Rodriguez-Gonzalez A, 2008, ONCOGENE, V27, P7201, DOI 10.1038/onc.2008.320; Ross RW, 2002, J UROLOGY, V167, P1952, DOI 10.1016/S0022-5347(05)65060-4; SANTEN RJ, 1992, J CLIN ENDOCR METAB, V75, P685, DOI 10.1210/jc.75.3.685; Savarese DM, 2001, J CLIN ONCOL, V19, P2509, DOI 10.1200/JCO.2001.19.9.2509; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Verfaillie T, 2010, CANC LETT; Yannucci J, 2006, J UROLOGY, V176, P520, DOI 10.1016/j.juro.2006.03.057	30	46	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89772	10.1371/journal.pone.0089772	http://dx.doi.org/10.1371/journal.pone.0089772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598693	gold, Green Published, Green Submitted			2022-12-27	WOS:000332479400026
J	Sabouri, S; Matene, E; Vinet, A; Richer, LP; Cardinal, R; Armour, JA; Page, P; Kus, T; Jacquemet, V				Sabouri, Sepideh; Matene, Elhacene; Vinet, Alain; Richer, Louis-Philippe; Cardinal, Rene; Armour, J. Andrew; Page, Pierre; Kus, Teresa; Jacquemet, Vincent			Simultaneous Epicardial and Noncontact Endocardial Mapping of the Canine Right Atrium: Simulation and Experiment	PLOS ONE			English	Article							REPOLARIZATION ALTERNANS; ACTIVATION; FIBRILLATION; TACHYARRHYTHMIAS; CONDUCTION; CATHETER; STIMULATION; PROPAGATION; VALIDATION; KINETICS	Epicardial high-density electrical mapping is a well-established experimental instrument to monitor in vivo the activity of the atria in response to modulations of the autonomic nervous system in sinus rhythm. In regions that are not accessible by epicardial mapping, noncontact endocardial mapping performed through a balloon catheter may provide a more comprehensive description of atrial activity. We developed a computer model of the canine right atrium to compare epicardial and noncontact endocardial mapping. The model was derived from an experiment in which electroanatomical reconstruction, epicardial mapping (103 electrodes), noncontact endocardial mapping (2048 virtual electrodes computed from a 64-channel balloon catheter), and direct-contact endocardial catheter recordings were simultaneously performed in a dog. The recording system was simulated in the computer model. For simulations and experiments (after atrio-ventricular node suppression), activation maps were computed during sinus rhythm. Repolarization was assessed by measuring the area under the atrial T wave (ATa), a marker of repolarization gradients. Results showed an epicardial-endocardial correlation coefficients of 0.80 and 0.63 (two dog experiments) and 0.96 (simulation) between activation times, and a correlation coefficients of 0.57 and 0.46 (two dog experiments) and 0.92 (simulation) between ATa values. Despite distance (balloon-atrial wall) and dimension reduction (64 electrodes), some information about atrial repolarization remained present in noncontact signals.	[Sabouri, Sepideh; Matene, Elhacene; Vinet, Alain; Cardinal, Rene; Kus, Teresa; Jacquemet, Vincent] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Sabouri, Sepideh; Matene, Elhacene; Vinet, Alain; Page, Pierre; Jacquemet, Vincent] Hop Sacre Coeur, Ctr Rech, Montreal, PQ H4J 1C5, Canada; [Richer, Louis-Philippe] Conseil Natl Rech Canada, Montreal, PQ, Canada; [Cardinal, Rene; Kus, Teresa] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Armour, J. Andrew] E Tennessee State Univ, Dept Pharmacol, Johnson City, TN 37614 USA; [Page, Pierre] Univ Montreal, Dept Chirurg, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; National Research Council Canada; Universite de Montreal; East Tennessee State University; Universite de Montreal	Jacquemet, V (corresponding author), Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada.	vincent.jacquemet@umontreal.ca			Heart and Stroke Foundation of Quebec; Natural Sciences and Engineering Research Council of Canada [386647-2010]; Fonds de Recherche du Quebec Sante	Heart and Stroke Foundation of Quebec; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de Recherche du Quebec Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Heart and Stroke Foundation of Quebec (www.heartandstroke.ca), by the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca, grant No 386647-2010) and by the Fonds de Recherche du Quebec Sante (www.frsq.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DJ, 2007, CIRCULATION, V115, P1738, DOI 10.1161/CIRCULATIONAHA.106.633982; Armour JA, 2005, AUTON NEUROSCI-BASIC, V118, P68, DOI 10.1016/j.autneu.2005.01.006; Armour JA, 2004, BASIC CLIN NEUROCARD; Bland M., 2000, INTRO MED STAT, V3rd; Botev ZI, 2010, ANN STAT, V38, P2916, DOI 10.1214/10-AOS799; Buzzard GT, 2008, SIAM J SCI COMPUT, V30, P837, DOI 10.1137/060653378; Cardinal R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P511, DOI 10.1161/CIRCEP.110.938050; Catanchin A, 2010, CLIN CARDIOL, V33, pE19, DOI 10.1002/clc.20421; Chen J, 2003, PACE, V26, P318, DOI 10.1046/j.1460-9592.2003.00041.x; DEMUNCK JC, 1992, IEEE T BIO-MED ENG, V39, P986, DOI 10.1109/10.256433; Dixit S, 2011, J CARDIOVASC ELECTR, V22, P422, DOI 10.1111/j.1540-8167.2010.01917.x; Dube B, 2009, PHYSIOL MEAS, V30, P1303, DOI 10.1088/0967-3334/30/12/002; Earley MJ, 2006, J AM COLL CARDIOL, V48, P485, DOI 10.1016/j.jacc.2006.04.069; Eckstein J, 2013, CIRC-ARRHYTHMIA ELEC, V6, P334, DOI 10.1161/CIRCEP.113.000342; Efimov IR, 2005, AM J PHYSIOL-HEART C, V289, pH977, DOI 10.1152/ajpheart.00456.2005; Everett TH, 2010, HEART RHYTHM, V7, P506, DOI 10.1016/j.hrthm.2009.12.030; Gornick CC, 1999, CIRCULATION, V99, P829, DOI 10.1161/01.CIR.99.6.829; Gulrajani R.M., 1998, BIOELECTRICITY BIOMA; Harley D, 2009, Patent US, Patent No. [7,505,810 B2, 7505810B2]; Herlin A, 2011, CHAOS, V21, DOI 10.1063/1.3670060; Hindricks G, 2001, CIRCULATION, V104, P297, DOI 10.1161/01.CIR.104.3.297; Jacquemet V, 2003, J CARDIOVASC ELECTR, V14, pS172, DOI 10.1046/j.1540.8167.90308.x; Jacquemet Vincent, 2008, IEEE Rev Biomed Eng, V1, P94, DOI 10.1109/RBME.2008.2008242; Jousset F, 2012, J CARDIOVASC ELECTR, V23, P1003, DOI 10.1111/j.1540-8167.2012.02336.x; Juneja R, 2009, CURR SCI INDIA, V97, P416; Kadish A, 1999, CIRCULATION, V99, P1906, DOI 10.1161/01.CIR.99.14.1906; Kawara T, 2001, CIRCULATION, V104, P3069, DOI 10.1161/hc5001.100833; Kneller J, 2002, CIRC RES, V90, pE73, DOI 10.1161/01.RES.0000019783.88094.BA; Krueger MW, 2011, LECT NOTES COMPUT SC, V6666, P223, DOI 10.1007/978-3-642-21028-0_28; Page P, 2006, AUTON NEUROSCI-BASIC, V128, P9, DOI 10.1016/j.autneu.2005.11.006; PAGE PL, 1995, J THORAC CARDIOV SUR, V109, P377, DOI 10.1016/S0022-5223(95)70400-0; Potse M, 2006, IEEE T BIO-MED ENG, V53, P2425, DOI 10.1109/TBME.2006.880875; Pruvot E, 2007, EUROPACE, V9, P83, DOI 10.1093/europace/eum211; Ramirez RJ, 2000, AM J PHYSIOL-HEART C, V279, pH1767, DOI 10.1152/ajpheart.2000.279.4.H1767; Rao LY, 2001, ANN BIOMED ENG, V29, P493, DOI 10.1114/1.1376389; Schilling RJ, 2000, EUR HEART J, V21, P550, DOI 10.1053/euhj.1999.1851; Schilling RJ, 1998, CIRCULATION, V98, P887, DOI 10.1161/01.CIR.98.9.887; Schilling RJ, 2001, J AM COLL CARDIOL, V38, P385, DOI 10.1016/S0735-1097(01)01401-2; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; SCHUESSLER RB, 1993, CIRCULATION, V88, P250, DOI 10.1161/01.CIR.88.1.250; Sharifov OF, 2000, J CARDIOVASC ELECTR, V11, P1029, DOI 10.1111/j.1540-8167.2000.tb00176.x; van Oosterom A, 2012, MED BIOL ENG COMPUT, V50, P1, DOI 10.1007/s11517-011-0837-9; Vigmond EJ, 2009, IEEE T BIO-MED ENG, V56, P1546, DOI 10.1109/TBME.2009.2014740; Vigmond EJ, 2004, HEART RHYTHM, V1, P334, DOI 10.1016/j.hrthm.2004.03.077; Voth E. J., 2005, IJBEM, V7, P191	45	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e91165	10.1371/journal.pone.0091165	http://dx.doi.org/10.1371/journal.pone.0091165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598778	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400157
J	Bolivar, W; Antoniazzi, MM; Grant, T; Jared, C				Bolivar-G, Wilmar; Antoniazzi, Marta M.; Grant, Taran; Jared, Carlos			Discovery of a Novel Accessory Structure of the Pitviper Infrared Receptor Organ (Serpentes: Viperidae)	PLOS ONE			English	Article							FACIAL PIT; PHYLOGENY; SNAKES; HEAT	The facial pits of rattlesnakes, copperheads, lanceheads, bushmasters and other American and Asian pitvipers (Crotalinae) are highly innervated and densely vascularized infrared (IR) receptor organs. For over a century, studies have focused on a small sample of model species from North America and Asia. Based on an expanded survey of Central and South American crotalines, we report a conspicuous accessory structure composed of well-defined papillae that project from the anterior orbital adnexa. The papillae are continuous with the inner chamber of the IR receptor organ and our histological and ultrastructural data suggest that they possess a well-developed nervous network and extensive vascularization; however, they lack the characteristic IR-sensitive terminal nerve masses found in the IR-receptive pit membrane. The function of the IR receptor organ papillae is unknown.	[Bolivar-G, Wilmar] Univ Valle, Dept Biol, Programa Posgrad, Cali, Valle Del Cauca, Colombia; [Bolivar-G, Wilmar] Univ Valle, Grp Invest Ecol Anim, Cali, Valle Del Cauca, Colombia; [Antoniazzi, Marta M.; Jared, Carlos] Inst Butantan, Lab Biol Celular, Sao Paulo, Brazil; [Grant, Taran] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil	Universidad del Valle; Universidad del Valle; Instituto Butantan; Universidade de Sao Paulo	Grant, T (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil.	taran.grant@gmail.com; jared@butantan.gov.br	Antoniazzi, Marta/A-3495-2017; Jared, Carlos/D-3299-2012; Antoniazzi, Marta Maria/AAF-1942-2021; Grant, Taran/B-7703-2012; Grant, Taran/ABD-6313-2020	Jared, Carlos/0000-0002-9117-6276; Antoniazzi, Marta Maria/0000-0002-0575-7921; Grant, Taran/0000-0003-1726-999X; Grant, Taran/0000-0003-1726-999X	Programa de Postgrado en Ciencias-Biologia, Departamento de Biologia, Universidad del Valle; Conselho Nacional de Desenvolvimento Cientifico [307029/2009-3, 306529/2010-6, 307001/2011-3]; Instituto Nacional de Ciencia e Tecnologia em Toxinologia; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/10000-5]	Programa de Postgrado en Ciencias-Biologia, Departamento de Biologia, Universidad del Valle; Conselho Nacional de Desenvolvimento Cientifico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia em Toxinologia; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Programa de Postgrado en Ciencias-Biologia, Departamento de Biologia, Universidad del Valle, the Conselho Nacional de Desenvolvimento Cientifico (Proc. 307029/2009-3, 306529/2010-6, 307001/2011-3), the Instituto Nacional de Ciencia e Tecnologia em Toxinologia, and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Proc. 2012/10000-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya F, 1996, ANAT RECORD, V246, P135; Amemiya F, 1999, ANAT RECORD, V254, P107, DOI 10.1002/(SICI)1097-0185(19990101)254:1<107::AID-AR14>3.0.CO;2-Y; Amemiya F, 1995, BIOMED RES-TOKYO, V16, P411, DOI 10.2220/biomedres.16.411; BULLOCK TH, 1957, Q J MICROSC SCI, V98, P219; Carrasco PA, 2012, ZOOL SCR, V41, P109, DOI 10.1111/j.1463-6409.2011.00511.x; Castoe TA, 2006, MOL PHYLOGENET EVOL, V39, P91, DOI 10.1016/j.ympev.2005.12.014; Fenwick AM, 2009, ZOOL J LINN SOC-LOND, V156, P617, DOI 10.1111/j.1096-3642.2008.00495.x; Goris RC, 2007, MICROCIRCULATION, V14, P99, DOI 10.1080/10739680601131184; Goris RC, 2011, J HERPETOL, V45, P2, DOI 10.1670/10-238.1; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Jadin RC, 2011, ZOOL J LINN SOC-LOND, V163, P943, DOI 10.1111/j.1096-3642.2011.00748.x; Junqueira Luiz Carlos U., 1995, Ciencia e Cultura (Sao Paulo), V47, P92; Krochmal AR, 2004, J EXP BIOL, V207, P4231, DOI 10.1242/jeb.01278; Lynn WG, 1931, AM J ANAT, V49, P97, DOI 10.1002/aja.1000490105; NOBLE G. K., 1937, PROC AMER PHIL SOC, V77, P263; Terashima S-I, 1974, PROG NEUROBIOL, V2, P309; TERASHIMA SI, 1970, J ULTRA MOL STRUCT R, V31, P494, DOI 10.1016/S0022-5320(70)90165-6; Wuster W, 2008, MOL PHYLOGENET EVOL, V49, P445, DOI 10.1016/j.ympev.2008.08.019	18	1	1	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90622	10.1371/journal.pone.0090622	http://dx.doi.org/10.1371/journal.pone.0090622			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595025	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500075
J	Giesbrecht, CJ; Thornton, AE; Hall-Patch, C; Maan, EJ; Cote, HCF; Money, DM; Murray, M; Pick, N				Giesbrecht, Chantelle J.; Thornton, Allen E.; Hall-Patch, Clare; Maan, Evelyn J.; Cote, Helene C. F.; Money, Deborah M.; Murray, Melanie; Pick, Neora			Select Neurocognitive Impairment in HIV-Infected Women: Associations with HIV Viral Load, Hepatitis C Virus, and Depression, but Not Leukocyte Telomere Length	PLOS ONE			English	Article							NEUROPSYCHOLOGICAL PERFORMANCE; ANTIRETROVIRAL THERAPY; COGNITIVE FUNCTION; EXECUTIVE FUNCTION; INSTRUMENTAL ACTIVITIES; MEDICATION ADHERENCE; MEMORY PERFORMANCE; PREFRONTAL CORTEX; DECISION-MAKING; T-CELLS	Background: Through implementation of combination antiretroviral therapy (cART) remarkable gains have been achieved in the management of HIV infection; nonetheless, the neurocognitive consequences of infection remain a pivotal concern in the cART era. Research has often employed norm-referenced neuropsychological scores, derived from healthy populations (excluding many seronegative individuals at high risk for HIV infection), to characterize impairments in predominately male HIV-infected populations. Methods: Using matched-group methodology, we assessed 81 HIV-seropositive (HIV+) women with established neuropsychological measures validated for detection of HIV-related impairments, as well as additional detailed tests of executive function and decision-making from the Cambridge Neuropsychological Test Automated Battery (CANTAB). Results: On validated tests, the HIV+ women exhibited impairments that were limited to significantly slower information processing speed when compared with 45 HIV-seronegative (HIV-) women with very similar demographic backgrounds and illness comorbidities. Additionally, select executive impairments in shifting attention (i.e., reversal learning) and in decision-making quality were revealed in HIV+ participants. Modifiers of neurocognition in HIV-infected women included detectable HIV plasma viral load, active hepatitis C virus co-infection, and self-reported depression symptoms. In contrast, leukocyte telomere length (LTL), a marker of cellular aging, did not significantly differ between HIV+ and HIV- women, nor was LTL associated with overall neurocognition in the HIV+ group. Conclusions: The findings suggest that well-managed HIV infection may entail a more circumscribed neurocognitive deficit pattern than that reported in many norm-referenced studies, and that common comorbidities make a secondary contribution to HIV-related neurocognitive impairments.	[Giesbrecht, Chantelle J.; Thornton, Allen E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Giesbrecht, Chantelle J.; Thornton, Allen E.] British Columbia Mental Hlth & Addict Res Inst, Vancouver, BC, Canada; [Hall-Patch, Clare; Maan, Evelyn J.; Money, Deborah M.; Murray, Melanie; Pick, Neora] BC Womens Hosp, Oak Tree Clin, Vancouver, BC, Canada; [Hall-Patch, Clare; Maan, Evelyn J.; Cote, Helene C. F.; Money, Deborah M.; Murray, Melanie; Pick, Neora] CIHR Emerging Team HIV Therapy & Aging CARMA, Vancouver, BC, Canada; [Cote, Helene C. F.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Cote, Helene C. F.; Money, Deborah M.; Murray, Melanie; Pick, Neora] Womens Hlth Res Inst, Vancouver, BC, Canada; [Money, Deborah M.] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada; [Murray, Melanie; Pick, Neora] Univ British Columbia, Div Infect Dis, Vancouver, BC V5Z 1M9, Canada	Simon Fraser University; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Thornton, AE (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada.	aethornt@sfu.ca		Thornton, Allen/0000-0002-9942-0122	Canadian Institute of Health Research (CIHR) [Het-85515]; CIHR [218622, YSH-80511, GXSR010]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institute of Health Research (CIHR) Emerging Team Grant (Het-85515 to HCFC and DMM), CIHR Catalyst Grant (218622 to NP), CIHR New Investigator Award (#YSH-80511 to HCFC), and CIHR Doctoral Research Award (GXSR010 to CJG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khindi T, 2011, J INT NEUROPSYCH SOC, V17, P956, DOI 10.1017/S1355617711000968; Ances BM, 2012, JAIDS-J ACQ IMM DEF, V59, P469, DOI 10.1097/QAI.0b013e318249db17; Anthony IC, 2005, J NEUROPATH EXP NEUR, V64, P529, DOI 10.1093/jnen/64.6.529; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Becker JT, 2012, NEURORADIOLOGY, V54, P113, DOI 10.1007/s00234-011-0854-2; Bell-McGinty S, 2002, INT J GERIATR PSYCH, V17, P828, DOI 10.1002/gps.646; BENOWITZ NL, 1993, PHARMACOL TOXICOL, V72, P3, DOI 10.1111/j.1600-0773.1993.tb01331.x; Brandt J, 2001, HOPKINS VERBAL LEARN; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Cahn-Weiner Deborah A, 2002, Appl Neuropsychol, V9, P187, DOI 10.1207/S15324826AN0903_8; Carey CL, 2006, J CLIN EXP NEUROPSYC, V28, P536, DOI 10.1080/13803390590949494; Carey CL, 2004, CLIN NEUROPSYCHOL, V18, P234, DOI 10.1080/13854040490501448; Carter AJ, 2013, CAN J INFECT DIS MED, V24, p19A; Cattie JE, 2012, J CLIN EXP NEUROPSYC, V34, P906, DOI 10.1080/13803395.2012.692772; Chang L, 2002, NEUROIMAGE, V17, P1638, DOI 10.1006/nimg.2002.1254; Chang L, 2011, NEUROIMAGE, V58, P1017, DOI 10.1016/j.neuroimage.2011.07.010; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Clifford DB, 2005, AIDS, V19, pS64, DOI 10.1097/01.aids.0000192072.80572.43; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2003, APPL MULTIPLE REGRES, P302; Cote HCF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039266; Dawes S, 2008, J CLIN EXP NEUROPSYC, V30, P613, DOI 10.1080/13803390701565225; Devlin KN, 2012, J INT NEUROPSYCH SOC, V18, P68, DOI 10.1017/S1355617711001408; Durvasula RS, 2006, J CLIN EXP NEUROPSYC, V28, P383, DOI 10.1080/13803390590935408; Durvasula RS, 2001, J CLIN EXP NEUROPSYC, V23, P149, DOI 10.1076/jcen.23.2.149.1211; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; Ellis RJ, 2011, AIDS, V25, P1747, DOI 10.1097/QAD.0b013e32834a40cd; Ettenhofer ML, 2010, NEUROLOGY, V74, P1217, DOI 10.1212/WNL.0b013e3181d8c1ca; Ettenhofer ML, 2009, AM J GERIAT PSYCHIAT, V17, P281, DOI 10.1097/JGP.0b013e31819431bd; Failde-Garrido JM, 2008, PSYCHIAT CLIN NEUROS, V62, P494, DOI 10.1111/j.1440-1819.2008.01841.x; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Fray PJ, 1996, INT J GERIATR PSYCH, V11, P329; Fray PJ, 1996, NEUROTOXICOL TERATOL, V18, P499, DOI 10.1016/0892-0362(96)00027-X; Gatali Marene, 2004, BMC Womens Health, V4 Suppl 1, pS27; Gibbie T, 2006, HIV MED, V7, P112, DOI 10.1111/j.1468-1293.2006.00350.x; Gonzalez R, 2003, J INT NEUROPSYCH SOC, V9, P64, DOI 10.1017/S1355617703910071; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hampshire A, 2006, CEREB CORTEX, V16, P1679, DOI 10.1093/cercor/bhj116; Hardy DJ, 2006, NEUROPSYCHOLOGY, V20, P355, DOI 10.1037/0894-4105.20.3.355; HART RP, 1990, J CLIN EXP NEUROPSYC, V12, P72; Hearps AC, 2012, AIDS, V26, P843, DOI 10.1097/QAD.0b013e328351f756; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; HEDGES LV, 1984, PSYCHOL BULL, V96, P573, DOI 10.1037/0033-2909.96.3.573; Hestad KA, 2012, J NERV MENT DIS, V200, P336, DOI 10.1097/NMD.0b013e31824cc225; Hinkin CH, 2002, J INT NEUROPSYCH SOC, V8, P532, DOI 10.1017/S1355617702814278; Hinkin CH, 2008, J ADDICT DIS, V27, P11, DOI 10.1300/J069v27n02_02; Honig LS, 2006, ANN NEUROL, V60, P181, DOI 10.1002/ana.20894; Hornak J, 2004, J COGNITIVE NEUROSCI, V16, P463, DOI 10.1162/089892904322926791; Iudicello JE, 2008, J CLIN EXP NEUROPSYC, V30, P797, DOI 10.1080/13803390701779578; Iudicello JE, 2007, J INT NEUROPSYCH SOC, V13, P183, DOI 10.1017/S1355617707070221; Judd F, 2005, AUST NZ J PSYCHIAT, V39, P826, DOI 10.1111/j.1440-1614.2005.01659.x; Kyo S, 1999, CANCER RES, V59, P5917; Leeson VC, 2009, BIOL PSYCHIAT, V66, P586, DOI 10.1016/j.biopsych.2009.05.016; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Levine AJ, 2007, J CLIN EXP NEUROPSYC, V29, P669, DOI 10.1080/13803390600920471; Llorente AM, 1998, J CLIN EXP NEUROPSYC, V20, P60, DOI 10.1076/jcen.20.1.60.1489; Logie CH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001124; Lopez OL, 1999, EUR J NEUROL, V6, P205, DOI 10.1111/j.1468-1331.1999.tb00014.x; Maki PM, 2009, NEUROLOGY, V72, P1661, DOI 10.1212/WNL.0b013e3181a55f65; Maki PM, 2009, NEUROPSYCHOL REV, V19, P204, DOI 10.1007/s11065-009-9093-2; Malan-Muller S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058351; Manly JJ, 2011, J CLIN EXP NEUROPSYC, V33, P853, DOI 10.1080/13803395.2010.547662; Margolin A, 2002, AIDS PATIENT CARE ST, V16, P255, DOI 10.1089/10872910260066697; Martin EM, 2007, J CLIN EXP NEUROPSYC, V29, P496, DOI 10.1080/13803390600800970; Martin EM, 2004, J INT NEUROPSYCH SOC, V10, P931, DOI 10.1017/S1355617704107054; Martin-Ruiz C, 2006, ANN NEUROL, V60, P174, DOI 10.1002/ana.20869; Mather KA, 2011, J GERONTOL A-BIOL, V66, P202, DOI 10.1093/gerona/glq180; Meyer JS, 2005, PSYCHOPHARMACOLOGY D, P276; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Munoz-Moreno JA, 2008, AIDS RES HUM RETROV, V24, P1301, DOI 10.1089/aid.2007.0310; Owsley C, 2002, GERONTOLOGY, V48, P254, DOI 10.1159/000058360; Palmer LD, 1997, J EXP MED, V185, P1381, DOI 10.1084/jem.185.7.1381; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Patel SH, 2002, AM J NEURORADIOL, V23, P543; Pathai S, 2013, AIDS, V27, P2375, DOI 10.1097/QAD.0b013e328363bf7f; Paul R, 2005, J NEUROPSYCH CLIN N, V17, P114, DOI 10.1176/appi.neuropsych.17.1.114; Paul R, 2002, NEUROSCI BIOBEHAV R, V26, P353, DOI 10.1016/S0149-7634(02)00006-4; PEAVY G, 1994, J CLIN EXP NEUROPSYC, V16, P508, DOI 10.1080/01688639408402662; Pommier JP, 1997, VIROLOGY, V231, P148, DOI 10.1006/viro.1997.8512; Potter GG, 2012, INT J GERIATR PSYCH, V27, P1172, DOI 10.1002/gps.3764; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Richardson JL, 2005, AIDS, V19, P1659, DOI 10.1097/01.aids.0000186824.53359.62; Richardson JL, 2002, J INT NEUROPSYCH SOC, V8, P781, DOI 10.1017/S1355617702860064; Rickabaugh TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016459; Robbins TW, 1998, J INT NEUROPSYCH SOC, V4, P474, DOI 10.1017/s1355617798455073; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; Shimizu Sheri M, 2011, World J AIDS, V1, P139; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Spronk DB, 2013, NEUROSCI BIOBEHAV R, V37, P1838, DOI 10.1016/j.neubiorev.2013.07.003; Stern RA, 1998, J INT NEUROPSYCH SOC, V4, P172, DOI 10.1017/S1355617798001726; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; Testa R, 2012, ARCH CLIN NEUROPSYCH, V27, P213, DOI 10.1093/arclin/acr112; The Psychological Corporation, 2001, WECHSLER TEST ADULT; Thompson PM, 2005, P NATL ACAD SCI USA, V102, P15647, DOI 10.1073/pnas.0502548102; Towgood KJ, 2012, CORTEX, V48, P230, DOI 10.1016/j.cortex.2011.03.006; Tozzi V, 1999, AIDS, V13, P1889, DOI 10.1097/00002030-199910010-00011; Valdes AM, 2008, NEUROBIOL AGING, P1; Van der Molen MJW, 2012, BRAIN COGNITION, V78, P206, DOI 10.1016/j.bandc.2011.12.008; Vigil O, 2008, J CLIN EXP NEUROPSYC, V30, P805, DOI 10.1080/13803390701802354; Vitiello B, 2007, AIDS, V21, P1415, DOI 10.1097/QAD.0b013e328220e71a; von Zglinicki T, 2000, LAB INVEST, V80, P1739, DOI 10.1038/labinvest.3780184; Wang Xuetao, 2012, AIDS Res Treat, V2012, P560361, DOI 10.1155/2012/560361; Wechsler D., 2008, WAIS 4 ADM SCORING M; Woods SP, 2005, ARCH CLIN NEUROPSYCH, V20, P1061, DOI 10.1016/j.acn.2005.06.007; Yaffe K, 2011, NEUROBIOL AGING, V32, P2055, DOI 10.1016/j.neurobiolaging.2009.12.006; Zanet D L, 2012, CAN J INFECT DIS SA, V23; Zanet DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057787	110	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89556	10.1371/journal.pone.0089556	http://dx.doi.org/10.1371/journal.pone.0089556			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595021	gold, Green Submitted, Green Published			2022-12-27	WOS:000332475500017
J	Skaaby, T; Husemoen, LLN; Thuesen, BH; Pisinger, C; Jorgensen, T; Fenger, RV; Linneberg, A				Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Thuesen, Betina Heinsbaek; Pisinger, Charlotta; Jorgensen, Torben; Fenger, Runa Vavia; Linneberg, Allan			Vitamin D Status and Chronic Obstructive Pulmonary Disease: A Prospective General Population Study	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; 3RD NATIONAL-HEALTH; ACUTE EXACERBATIONS; D LEVEL; BLOOD; RISK; STABILITY	Objectives: Vitamin D deficiency is common among persons with chronic obstructive pulmonary disease (COPD). Whether vitamin D affects the development and deterioration of COPD or is a consequence of the disease lacks clarity. We investigated the association between vitamin D status and prevalent and incident COPD in the general population. Methods: We included a total of 12,041 individuals from three general population studies conducted in 1993-94, 1999-2001, and 2006-2008, respectively, with vitamin D measurements. Information on COPD was obtained from the Danish National Patient Register and The Danish Registry of Causes of Death. Results: There were 85 prevalent and 463 incident cases of COPD (median follow-up 9.7 years). We found a statistically significant inverse association between vitamin D status and prevalent COPD with odds ratio = 0.89 (95% confidence interval, CI: 0.79, 1.0), but no statistically significant association with incident COPD with a hazard ratio = 0.98 (95% CI: 0.94, 1.0), respectively, per 10 nmol/l higher vitamin D status, when adjusted for possible confounders. Conclusions: We found a statistically significant inverse cross-sectional association between vitamin D status and COPD, but no association between vitamin D status and incident COPD.	[Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Thuesen, Betina Heinsbaek; Pisinger, Charlotta; Jorgensen, Torben; Fenger, Runa Vavia; Linneberg, Allan] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Fac Med, Aalborg, Denmark; [Linneberg, Allan] Glostrup Univ Hosp, Dept Clin Expt Res, Glostrup, Denmark; [Linneberg, Allan] Univ Copenhagen, Dept Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Aalborg University; University of Copenhagen; University of Copenhagen	Skaaby, T (corresponding author), Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark.	tea.skaaby.01@regionh.dk	Jørgensen, Torben/Z-1335-2018	Jorgensen, Torben/0000-0001-9453-2830; Pisinger, Charlotta/0000-0002-7970-3168; Skaaby, Tea/0000-0003-0031-5726; Linneberg, Allan/0000-0002-0994-0184; Thuesen, Betina/0000-0001-9772-4344	Health Insurance Foundation [2010 B 131]; Lundbeck Foundation [R108-2012-10225] Funding Source: researchfish	Health Insurance Foundation; Lundbeck Foundation(Lundbeckfonden)	The present study was financially supported by the Health Insurance Foundation (grant No. 2010 B 131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Andersen TF, 1999, DAN MED BULL, V46, P263; Bender AM, 2012, EUR J PREV CARDIOL; Berg ND, 2012, J ALLERGY CLIN IMMUN, V129, P374, DOI 10.1016/j.jaci.2011.08.045; Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792; Carter GD, 2004, CLIN CHEM, V50, P2195, DOI 10.1373/clinchem.2004.040683; Davey Smith G, 2008, ANN MED, V40, P524, DOI 10.1080/07853890802010709; Dobak John, 1994, Journal of Dermatological Science, V8, P18, DOI 10.1016/0923-1811(94)90316-6; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; GOLD, 2011, GLOB STRAT DIAGN MAN; Grant WB, 2012, DERM-ENDOCRINOL, V4, P198, DOI 10.4161/derm.20514; Grant WB, 2011, DERM-ENDOCRINOL, V3, P199, DOI [10.4161/derm.3.3.15364, 10.4161/derm.15364]; Hersoug LG, 2010, RESPIROLOGY, V15, P993, DOI 10.1111/j.1440-1843.2010.01758.x; Holmgaard DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053670; Hoogendoorn M, 2011, EUR RESPIR J, V37, P508, DOI 10.1183/09031936.00043710; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Juel K, 1999, DAN MED BULL, V46, P354; Kunisaki KM, 2012, AM J RESP CRIT CARE, V185, P286, DOI 10.1164/rccm.201109-1644OC; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Nathell L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-89; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; OCKE MC, 1995, J CLIN EPIDEMIOL, V48, P1077, DOI 10.1016/0895-4356(94)00232-F; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Persson LJP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038934; Pfeffer PE, 2012, THORAX, V67, P1018, DOI 10.1136/thoraxjnl-2012-202139; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rasmussen SL, 1998, J HYPERTENS, V16, P1415, DOI 10.1097/00004872-199816100-00004; Romme EA, 2012, ANN MED; Sethi S, 2000, CHEST, V117, p380S, DOI 10.1378/chest.117.5_suppl_2.380S; Skaaby T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052423; Snellman G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011555; Strandhagen E, 2010, EUR J EPIDEMIOL, V25, P163, DOI 10.1007/s10654-010-9427-7; Thomsen RW, 2011, RESP MED, V105, P1063, DOI 10.1016/j.rmed.2011.01.012; Thuesen B, 2012, BONE, V50, P605, DOI 10.1016/j.bone.2011.12.016; Thyssen JP, 2012, J ALLERGY CLIN IMMUN; Wielders JPM, 2009, CLIN CHEM, V55, P1584, DOI 10.1373/clinchem.2008.117366	39	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90654	10.1371/journal.pone.0090654	http://dx.doi.org/10.1371/journal.pone.0090654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594696	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500083
J	Diaz, P; Wood, AM; Sibley, CP; Greenwood, SL				Diaz, Paula; Wood, Amber M.; Sibley, Colin P.; Greenwood, Susan L.			Intermediate Conductance Ca2+-Activated K+ Channels Modulate Human Placental Trophoblast Syncytialization	PLOS ONE			English	Article							REGULATORY VOLUME DECREASE; HUMAN CHORIONIC-GONADOTROPIN; CYTOTROPHOBLAST CELLS; SYNCYTIN EXPRESSION; INCREASED APOPTOSIS; POTASSIUM CHANNEL; IN-VITRO; DIFFERENTIATION; PROLIFERATION; PREECLAMPSIA	Regulation of human placental syncytiotrophoblast renewal by cytotrophoblast migration, aggregation/fusion and differentiation is essential for successful pregnancy. In several tissues, these events are regulated by intermediate conductance Ca2+-activated K+ channels (IKCa), in part through their ability to regulate cell volume. We used cytotrophoblasts in primary culture to test the hypotheses that IKCa participate in the formation of multinucleated syncytiotrophoblast and in syncytiotrophoblast volume homeostasis. Cytotrophoblasts were isolated from normal term placentas and cultured for 66 h. This preparation recreates syncytiotrophoblast formation in vivo, as mononucleate cells (15 h) fuse into multinucleate syncytia (66 h) concomitant with elevated secretion of human chorionic gonadotropin (hCG). Cells were treated with the IKCa inhibitor TRAM-34 (10 mu M) or activator DCEBIO (100 mu M). Culture medium was collected to measure hCG secretion and cells fixed for immunofluorescence with anti-IKCa and anti-desmoplakin antibodies to assess IKCa expression and multinucleation respectively. K+ channel activity was assessed by measuring Rb-86 efflux at 66 h. IKCa immunostaining was evident in nucleus, cytoplasm and surface of mono- and multinucleate cells. DCEBIO increased Rb-86 efflux 8.3-fold above control and this was inhibited by TRAM-34 (85%; p<0.0001). Cytotrophoblast multinucleation increased 12-fold (p<0.05) and hCG secretion 20-fold (p<0.05), between 15 and 66 h. Compared to controls, DCEBIO reduced multinucleation by 42% (p<0.05) and hCG secretion by 80% (p<0.05). TRAM-34 alone did not affect cytotrophoblast multinucleation or hCG secretion. Hyposmotic solution increased Rb-86 efflux 3.8-fold (p<0.0001). This effect was dependent on extracellular Ca2+, inhibited by TRAM-34 and 100 nM charybdotoxin (85% (p<0.0001) and 43% respectively) but unaffected by 100 nM apamin. In conclusion, IKCa are expressed in cytotrophoblasts and their activation inhibits the formation of multinucleated cells in vitro. IKCa are stimulated by syncytiotrophoblast swelling implicating a role in syncytiotrophoblast volume homeostasis. Inappropriate activation of IKCa in pathophysiological conditions could compromise syncytiotrophoblast turnover and volume homeostasis in pregnancy disease.	[Diaz, Paula; Wood, Amber M.; Sibley, Colin P.; Greenwood, Susan L.] Univ Manchester, Inst Human Dev, Fac Med & Human Sci, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Diaz, Paula; Wood, Amber M.; Sibley, Colin P.; Greenwood, Susan L.] Cent Manchester Univ Hosp Natl Hlth Serv NHS Fdn, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	University of Manchester; University of Manchester	Diaz, P (corresponding author), Univ Manchester, Inst Human Dev, Fac Med & Human Sci, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England.	pdiaztm@gmail.com	DIAZ, PAULA/ABG-5263-2021	DIAZ, PAULA/0000-0003-1479-7340; Greenwood, Susan/0000-0003-2867-4368	CONICYT-Becas Chile Doctoral Scholarship [72090593]; Tommy's the baby charity; Action Medical Research; Medical Research Council [1343194] Funding Source: researchfish	CONICYT-Becas Chile Doctoral Scholarship; Tommy's the baby charity; Action Medical Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	CONICYT-Becas Chile Doctoral Scholarship to Paula Diaz (72090593); Tommy's the baby charity; Action Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire AD, 2000, OBSTET GYNECOL, V96, P271, DOI 10.1016/S0029-7844(00)00895-4; ARNHOLDT H, 1991, VIRCHOWS ARCH B, V60, P365, DOI 10.1007/BF02899568; Ashcroft FM, 1999, DIABETOLOGIA, V42, P903, DOI 10.1007/s001250051247; Bakker WW, 2007, HYPERTENS PREGNANCY, V26, P227, DOI 10.1080/10641950701274896; Barfod ET, 2007, J BIOL CHEM, V282, P8984, DOI 10.1074/jbc.M607730200; Birdsey TJ, 1999, AM J PHYSIOL-REG I, V276, pR1479, DOI 10.1152/ajpregu.1999.276.5.R1479; Brown LM, 2005, HISTOCHEM CELL BIOL, V124, P499, DOI 10.1007/s00418-005-0051-7; Chen Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019257; Cheong A, 2005, MOL CELL, V20, P45, DOI 10.1016/j.molcel.2005.08.030; Clarson LH, 2002, AM J PHYSIOL-REG I, V282, pR1077, DOI 10.1152/ajpregu.00564.2001; Clarson LH, 2001, PLACENTA, V22, P328, DOI 10.1053/plac.2000.0622; Correa RRM, 2008, ARCH GYNECOL OBSTET, V277, P201, DOI 10.1007/s00404-007-0452-z; Correa SAL, 2009, J CELL SCI, V122, P4186, DOI 10.1242/jcs.058420; Crocker IP, 2004, J PATHOL, V204, P11, DOI 10.1002/path.1610; CRONIER L, 1994, ENDOCRINOLOGY, V135, P402, DOI 10.1210/en.135.1.402; Desforges M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.81; DOUGLAS GC, 1990, J CELL SCI, V96, P131; DOUGLAS GC, 1989, J IMMUNOL METHODS, V119, P259, DOI 10.1016/0022-1759(89)90405-5; Fioretti B, 2005, AM J PHYSIOL-CELL PH, V289, pC89, DOI 10.1152/ajpcell.00369.2004; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Gow IF, 2005, BBA-BIOMEMBRANES, V1712, P52, DOI 10.1016/j.bbamem.2005.04.002; Greenwood S, 1993, TROPHOBLAST RES, V7, P53; Grunnet M, 2002, PFLUG ARCH EUR J PHY, V444, P167, DOI 10.1007/s00424-002-0782-4; Higgins L, 2013, J MATERN-FETAL NEO M, V26, P783, DOI 10.3109/14767058.2012.760539; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Huppertz B, 2004, J SOC GYNECOL INVEST, V11, P353, DOI 10.1016/j.jsgi.2004.06.002; Huppertz B, 2002, FET MAT MED REV, V13, P103, DOI [10.1017/S0965539502000220, DOI 10.1017/S0965539502000220]; Huppertz B, 2011, ADV EXP MED BIOL, V713, P81, DOI 10.1007/978-94-007-0763-4_6; Ishihara N, 2002, AM J OBSTET GYNECOL, V186, P158, DOI 10.1067/mob.2002.119176; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Jensen BS, 1998, AM J PHYSIOL-CELL PH, V275, pC848, DOI 10.1152/ajpcell.1998.275.3.C848; Johnstone ED, 2005, BIOL REPROD, V73, P1282, DOI 10.1095/biolreprod.105.044206; Keith JC, 2002, AM J OBSTET GYNECOL, V187, P1122, DOI 10.1067/mob.2002.128512; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lang PA, 2003, AM J PHYSIOL-CELL PH, V285, pC1553, DOI 10.1152/ajpcell.00186.2003; Langbein M, 2008, MOL REPROD DEV, V75, P175, DOI 10.1002/mrd.20729; Lee X, 2001, PLACENTA, V22, P808, DOI 10.1053/plac.2001.0722; Leung DN, 2001, AM J OBSTET GYNECOL, V184, P1249, DOI 10.1067/mob.2001.112906; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; Li XY, 2013, IEEE T VIS COMPUT GR, V19, P344, DOI 10.1109/TVCG.2012.109; Liang Z, 2011, J PHYSIOL-LONDON, V589, P5965, DOI 10.1113/jphysiol.2011.219378; Lim KH, 1997, AM J PATHOL, V151, P1809; Longtine MS, 2012, PLACENTA, V33, P971, DOI 10.1016/j.placenta.2012.09.013; Longtine MS, 2012, REPRODUCTION, V143, P107, DOI 10.1530/REP-11-0340; MARUYAMA Y, 1995, PFLUG ARCH EUR J PHY, V430, P148, DOI 10.1007/BF00373851; Mauro T, 1997, J INVEST DERMATOL, V108, P864, DOI 10.1111/1523-1747.ep12292585; Mayhew TM, 2007, PLACENTA, V28, P233, DOI 10.1016/j.placenta.2006.02.011; Mayhew TM, 2009, J ANAT, V215, P77, DOI 10.1111/j.1469-7580.2008.00994.x; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Miller MJ, 2001, J BIOL CHEM, V276, P27753, DOI 10.1074/jbc.C100221200; Millership JE, 2011, AM J PHYSIOL-CELL PH, V300, pC792, DOI 10.1152/ajpcell.00274.2010; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Redel A, 2008, ANESTH ANALG, V106, P384, DOI 10.1213/ane.0b013e318160650f; Roberts VHJ, 2007, PLACENTA, V28, P270, DOI 10.1016/j.placenta.2006.04.008; ROBERTSON EG, 1972, J OBSTET GYN BR COMM, V79, P769; Sand P, 2004, ACTA PHYSIOL SCAND, V182, P361, DOI 10.1111/j.1365-201X.2004.01366.x; Schwab A, 2006, J CELL PHYSIOL, V206, P86, DOI 10.1002/jcp.20434; SCHWAB A, 1995, PFLUG ARCH EUR J PHY, V430, P802, DOI 10.1007/BF00386179; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; SHI QJ, 1993, ENDOCRINOLOGY, V132, P1387, DOI 10.1210/en.132.3.1387; Siman CM, 2001, AM J PHYSIOL-REG I, V280, pR1116, DOI 10.1152/ajpregu.2001.280.4.R1116; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P1395, DOI 10.1016/S0002-9378(97)70081-4; Tao R, 2008, AM J PHYSIOL-CELL PH, V295, pC1409, DOI 10.1152/ajpcell.00268.2008; van de Put FHMM, 1996, PLACENTA, V17, pA15; Vargas A, 2011, REPROD SCI, V18, P1085, DOI 10.1177/1933719111404608; Vargas A, 2009, J MOL BIOL, V392, P301, DOI 10.1016/j.jmb.2009.07.025; Vazquez E, 2001, P NATL ACAD SCI USA, V98, P5329, DOI 10.1073/pnas.091096498; Wang J, 2003, AM J PHYSIOL-CELL PH, V284, pC77, DOI 10.1152/ajpcell.00132.2002; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; Weskamp M, 2000, J MEMBRANE BIOL, V178, P11, DOI 10.1007/s002320010010; Williams JLR, 2008, AM J PHYSIOL-REG I, V295, pR1204, DOI 10.1152/ajpregu.00193.2008; Yang M, 2003, ENDOCRINOLOGY, V144, P1108, DOI 10.1210/en.2002-220922	74	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90961	10.1371/journal.pone.0090961	http://dx.doi.org/10.1371/journal.pone.0090961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595308	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900160
J	Mehl, A; Ghorbani, P; Douda, D; Huang, H; Palaniyar, N; Ratjen, F; Grasemann, H				Mehl, Anne; Ghorbani, Peyman; Douda, David; Huang, Hailu; Palaniyar, Nades; Ratjen, Felix; Grasemann, Hartmut			Effect of Arginase Inhibition on Pulmonary L-Arginine Metabolism in Murine Pseudomonas Pneumonia	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; AIRWAY HYPERRESPONSIVENESS; HELICOBACTER-PYLORI; MOUSE MODEL; AERUGINOSA; EXPRESSION; LOCALIZATION; INFECTION	Rationale: Infection of the lung with Pseudomonas aeruginosa results in upregulation of nitric oxide synthases (NOS) and arginase expression, and both enzymes compete for L-arginine as substrate. Nitric oxide (NO) production may be regulated by arginase as it controls L-arginine availability for NOS. We here studied the effect of systemic arginase inhibition on pulmonary L-arginine metabolism in Pseudomonas pneumonia in the mouse. Methods: Mice (C57BL/6, 8-10 weeks old, female) underwent direct tracheal instillation of Pseudomonas (PAO-1)-coated agar beads and were treated by repeated intra-peritoneal injections of the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH) or PBS until lungs were harvested on day 3 of the infection. L-arginine metabolites were quantified using liquid chromatography-tandem mass spectrometry, NO metabolites nitrate and nitrite by Griess reagent and cytokines by ELISA. Results: NO metabolite concentrations (48.5 +/- 2.9 vs. 10.9 +/- 2.3 mu M, p<0.0001), as well as L-ornithine (29.6 +/- 1.7 vs 2.3 +/- 0.4 mu M, p<0.0001), the product of arginase activity, were increased in Pseudomonas infected lungs compared to naive controls. Concentrations of the NOS inhibitor asymmetric dimethylarginine (ADMA) were also increased (0.44 +/- 0.02 vs. 0.16 +/- 0.01 mu M, p<0.0001). Arginase inhibition in the infected animals resulted in a significant decrease in L-ornithine (14.6 +/- 1.6 mu M, p<0.0001) but increase in L-arginine concentration (p<0.001), L-arginine/ADMA ratio (p<0.001), L-arginine availability for NOS (p<0.001), and NO metabolite concentrations (67.3 +/- 5.7 mu M, p<0.05). Arginase inhibitor treatment also resulted in an increase in NO metabolite levels in animals following intratracheal injection of LPS (p=0.015). Arginase inhibition was not associated with an increase in inflammatory markers (IFN-gamma, IL-1 beta, IL-6, MIP-2, KC or TNF-alpha) in lung. Concentrations of the L-ornithine-dependent polyamines putrescine, spermidine and spermine were increased in Pseudomonas infected lungs (p<0.001, respectively) but were unaffected by ABH treatment. Conclusions: Systemic arginase inhibition with ABH during Pseudomonas pneumonia in mice results in an increase in pulmonary NO formation but no pro-inflammatory effect.	[Mehl, Anne; Ghorbani, Peyman; Douda, David; Huang, Hailu; Palaniyar, Nades; Ratjen, Felix; Grasemann, Hartmut] Hosp Sick Children, SickKids Res Inst, Program Physiol & Expt Med, Toronto, ON M5G 1X8, Canada; [Mehl, Anne; Ghorbani, Peyman; Douda, David; Huang, Hailu; Palaniyar, Nades; Ratjen, Felix; Grasemann, Hartmut] Univ Toronto, Toronto, ON, Canada; [Mehl, Anne; Ratjen, Felix; Grasemann, Hartmut] Hosp Sick Children, Dept Pediat, Div Resp Med, Toronto, ON M5G 1X8, Canada; [Mehl, Anne] Charite, Dept Pediat Pulmonol & Immunol, D-13353 Berlin, Germany; [Douda, David] Brigham & Womens Hosp, Pulm & Crit Care Med Div, Boston, MA 02115 USA; [Douda, David] Harvard Univ, Sch Med, Boston, MA USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Grasemann, H (corresponding author), Hosp Sick Children, SickKids Res Inst, Program Physiol & Expt Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	hartmut.grasemann@sickkids.ca		Ratjen, Felix/0000-0003-4057-6592; Ghorbani, Peyman/0000-0002-7398-5141; Palaniyar, Nades/0000-0002-2170-8548	Canadian Institute of Health Research [XNO-83101]; Cystic Fibrosis Canada; Lynne and Arnold Irwin Foundation; Canadian Foundation for Innovation (CFI)	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; Lynne and Arnold Irwin Foundation; Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This research was supported by grants from the Canadian Institute of Health Research (XNO-83101), Cystic Fibrosis Canada, and the Lynne and Arnold Irwin Foundation. Mass spectrometry analyses were performed at the Analytical Facility for Bioactive Molecules (AFBM) of the Centre for the Study of Complex Childhood Diseases (CSCCD), the Hospital for Sick Children, Toronto, Ontario. The CSCCD was supported by the Canadian Foundation for Innovation (CFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belik J, 2008, AM J PHYSIOL-LUNG C, V294, pL498, DOI 10.1152/ajplung.00242.2007; Bussiere FI, 2005, J BIOL CHEM, V280, P2409, DOI 10.1074/jbc.C400498200; BUTTERY LDK, 1994, LAB INVEST, V71, P755; Chaturvedi R, 2012, AMINO ACIDS, V42, P627, DOI 10.1007/s00726-011-1038-4; Douda DN, 2011, J IMMUNOL, V187, P1856, DOI 10.4049/jimmunol.1004201; Dowling RB, 1998, AM J RESP CELL MOL, V19, P950, DOI 10.1165/ajrcmb.19.6.2904; Forte P, 1998, HYPERTENSION, V32, P730, DOI 10.1161/01.HYP.32.4.730; GASTON B, 1994, AM J RESP CRIT CARE, V149, P538, DOI 10.1164/ajrccm.149.2.7508323; Grasemann H, 2013, J CYST FIBROS, V12, P468, DOI 10.1016/j.jcf.2012.12.008; Grasemann H, 2003, AM J RESP CRIT CARE, V167, P1113, DOI 10.1164/rccm.200211-1342OC; Grasemann H, 2012, CURR PHARM DESIGN, V18, P726, DOI 10.2174/138161212799315911; Guilbault C, 2005, LAB ANIM-UK, V39, P336, DOI 10.1258/0023677054306944; Hopkins N, 2006, J PATHOL, V209, P198, DOI 10.1002/path.1963; Kenyon NJ, 2011, PHARMACEUTICALS, V4, P187, DOI 10.3390/ph4010187; Kim JH, 2009, J APPL PHYSIOL, V107, P1249, DOI 10.1152/japplphysiol.91393.2008; Lewis ND, 2010, J IMMUNOL, V184, P2572, DOI 10.4049/jimmunol.0902436; Liu SF, 1997, CRIT CARE MED, V25, P512, DOI 10.1097/00003246-199703000-00022; Maarsingh H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-23; Maarsingh H, 2011, EUR RESPIR J, V38, P318, DOI 10.1183/09031936.00057710; Maarsingh H, 2008, AM J RESP CRIT CARE, V178, P565, DOI 10.1164/rccm.200710-1588OC; Mehl A, 2010, PEDIATR PULM, V33, P134; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; North M.L., 2010, OPEN NITRIC OXIDE J, V2, P20, DOI DOI 10.2174/1875042701002020020; North ML, 2013, AM J RESP CELL MOL, V48, P694, DOI 10.1165/rcmb.2012-0323OC; North ML, 2009, AM J PHYSIOL-LUNG C, V296, pL911, DOI 10.1152/ajplung.00025.2009; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Rackef K., 2010, OPEN NITRIC OXIDE J, V2, P9, DOI [DOI 10.2174/1875042701002020009, 10.2174/1875042701002020009]; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; Scott JA, 2011, AM J RESP CRIT CARE, V184, P779, DOI 10.1164/rccm.201011-1810OC; Shatanawi A, 2011, AM J PHYSIOL-CELL PH, V300, pC1181, DOI 10.1152/ajpcell.00328.2010; Sun JH, 2006, CIRC RES, V98, P403, DOI 10.1161/01.RES.0000202707.79018.0a; Tang WHW, 2009, J AM COLL CARDIOL, V53, P2061, DOI 10.1016/j.jacc.2009.02.036; Tsai WC, 1997, INFECT IMMUN, V65, P1870, DOI 10.1128/IAI.65.5.1870-1875.1997; Wang-Rosenke Y, 2012, J UROLOGY, V188, P316, DOI 10.1016/j.juro.2012.02.2552; Xu LY, 2003, IMMUNOLOGY, V110, P141, DOI 10.1046/j.1365-2567.2003.01713.x; Yoon SS, 2007, EMBO J, V26, P3662, DOI 10.1038/sj.emboj.7601787; Yu H, 2000, INFECT IMMUN, V68, P2142, DOI 10.1128/IAI.68.4.2142-2147.2000	39	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90232	10.1371/journal.pone.0090232	http://dx.doi.org/10.1371/journal.pone.0090232			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595185	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900085
J	Reed, CJ; Bushnell, S; Evilia, C				Reed, Christopher J.; Bushnell, Sarah; Evilia, Caryn			Circular Dichroism and Fluorescence Spectroscopy of Cysteinyl-tRNA Synthetase from Halobacterium salinarum ssp NRC-1 Demonstrates that Group I Cations Are Particularly Effective in Providing Structure and Stability to This Halophilic Protein	PLOS ONE			English	Article							AMINO-ACID DISCRIMINATION; STABILIZATION; ADAPTATION; TRYPTOPHAN; AMINOACYLATION; ORIGINS; ENZYMES	Proteins from extremophiles have the ability to fold and remain stable in their extreme environment. Here, we investigate the presence of this effect in the cysteinyl-tRNA synthetase from Halobacterium salinarum ssp. NRC-1 (NRC-1), which was used as a model halophilic protein. The effects of salt on the structure and stability of NRC-1 and of E. coli CysRS were investigated through far-UV circular dichroism (CD) spectroscopy, fluorescence spectroscopy, and thermal denaturation melts. The CD of NRC-1 CysRS was examined in different group I and group II chloride salts to examine the effects of the metal ions. Potassium was observed to have the strongest effect on NRC-1 CysRS structure, with the other group I salts having reduced strength. The group II salts had little effect on the protein. This suggests that the halophilic adaptations in this protein are mediated by potassium. CD and fluorescence spectra showed structural changes taking place in NRC-1 CysRS over the concentration range of 0-3 M KCl, while the structure of E. coli CysRS was relatively unaffected. Salt was also shown to increase the thermal stability of NRC-1 CysRS since the melt temperature of the CysRS from NRC-1 was increased in the presence of high salt, whereas the E. coli enzyme showed a decrease. By characterizing these interactions, this study not only explains the stability of halophilic proteins in extremes of salt, but also helps us to understand why and how group I salts stabilize proteins in general.	[Reed, Christopher J.; Bushnell, Sarah; Evilia, Caryn] Idaho State Univ, Dept Chem, Pocatello, ID 83209 USA	Idaho; Idaho State University	Evilia, C (corresponding author), Idaho State Univ, Dept Chem, Pocatello, ID 83209 USA.	evilcary@isu.edu		Reed, Christopher J/0000-0002-8774-5106	S-STEM program at Idaho State University; National Science Foundation (NSF) [0965939, 0730265]; BS/MS program through the Department of Chemistry at ISU	S-STEM program at Idaho State University; National Science Foundation (NSF)(National Science Foundation (NSF)); BS/MS program through the Department of Chemistry at ISU	C. Reed was supported through the S-STEM program at Idaho State University, which is funded through a grant from the National Science Foundation (NSF # 0965939) and through the BS/MS program through the Department of Chemistry at ISU. Part of this research was funded by a National Science Foundation start-up grant to C. Evilia (NSF #0730265). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADEA MG, 1978, BIOPHYS J, V24, P197, DOI 10.1016/S0006-3495(78)85356-9; Bae E, 2004, J BIOL CHEM, V279, P28202, DOI 10.1074/jbc.M401865200; CHRISTIAN JHB, 1962, BIOCHIM BIOPHYS ACTA, V65, P506, DOI 10.1016/0006-3002(62)90453-5; Ebel C, 1999, BIOCHEMISTRY-US, V38, P9039, DOI 10.1021/bi9900774; Ellis RJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0398; Engel MB, 2005, CELL BIOL INT, V29, P616, DOI 10.1016/j.cellbi.2005.03.024; Evilia C, 2003, RNA, V9, P794, DOI 10.1261/rna.5320603; Evilia C, 2006, BIOCHEMISTRY-US, V45, P6835, DOI 10.1021/bi0521386; Feller G, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/32/323101; Golynskiy MV, 2005, BIOCHEMISTRY-US, V44, P3380, DOI 10.1021/bi0480741; Hauenstein S, 2004, NAT STRUCT MOL BIOL, V11, P1134, DOI 10.1038/nsmb849; Karan Ram, 2012, Aquat Biosyst, V8, P4, DOI 10.1186/2046-9063-8-4; Kumar S, 2004, CHEMBIOCHEM, V5, P280, DOI 10.1002/cbic.200300627; Large AT, 2009, BIOCHEM SOC T, V37, P46, DOI 10.1042/BST0370046; Luke KA, 2007, FEBS J, V274, P4023, DOI 10.1111/j.1742-4658.2007.05955.x; Lund P, 2011, BIOCHEM SOC T, V39, P94, DOI 10.1042/BST0390094; Melo EP, 2001, PROTEINS, V42, P542, DOI 10.1002/1097-0134(20010301)42:4<542::AID-PROT120>3.3.CO;2-W; Mevarech M, 2000, BIOPHYS CHEM, V86, P155, DOI 10.1016/S0301-4622(00)00126-5; Mozo-Villarias A, 2002, J BIOCHEM BIOPH METH, V50, P163, DOI 10.1016/S0165-022X(01)00181-6; Muller-Santos M, 2009, BBA-MOL CELL BIOL L, V1791, P719, DOI 10.1016/j.bbalip.2009.03.006; Muino PL, 2009, J PHYS CHEM B, V113, P2572, DOI 10.1021/jp711513b; Newberry KJ, 2002, EMBO J, V21, P2778, DOI 10.1093/emboj/21.11.2778; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Piette F, 2010, MOL MICROBIOL, V76, P120, DOI 10.1111/j.1365-2958.2010.07084.x; Powers ET, 2013, NAT REV MOL CELL BIO, V14, P237, DOI 10.1038/nrm3542; Quinlan RA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0091; Reed C, 2013, ARCHAEA, V2013, P14; Siglioccolo A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-50; Tannous E, 2012, FEBS OPEN BIO, V2, P345, DOI 10.1016/j.fob.2012.10.003; Taupin CMJ, 1997, EUR J BIOCHEM, V243, P141, DOI 10.1111/j.1432-1033.1997.0141a.x; Tehei M, 2007, FEBS J, V274, P4034, DOI 10.1111/j.1742-4658.2007.05953.x; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Vrbka L, 2006, P NATL ACAD SCI USA, V103, P15440, DOI 10.1073/pnas.0606959103; Yamaguchi R, 2011, APPL MICROBIOL BIOT, V89, P673, DOI 10.1007/s00253-010-2882-y; ZACCAI G, 1989, J MOL BIOL, V208, P491, DOI 10.1016/0022-2836(89)90512-3; Zhang CM, 2003, BIOCHEMISTRY-US, V42, P10931, DOI 10.1021/bi034812u; Zhang CM, 2003, J MOL BIOL, V327, P911, DOI 10.1016/S0022-2836(03)00241-9; Zhang GY, 2013, PROTEIN J, V32, P239, DOI 10.1007/s10930-013-9484-3; Zhang GY, 2013, INT J BIOL MACROMOL, V53, P1, DOI 10.1016/j.ijbiomac.2012.10.031	39	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89452	10.1371/journal.pone.0089452	http://dx.doi.org/10.1371/journal.pone.0089452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594651	gold, Green Submitted, Green Published			2022-12-27	WOS:000332468900016
J	Philippe, A; Schaumann, GE				Philippe, Allan; Schaumann, Gabriele E.			Evaluation of Hydrodynamic Chromatography Coupled with UV-Visible, Fluorescence and Inductively Coupled Plasma Mass Spectrometry Detectors for Sizing and Quantifying Colloids in Environmental Media	PLOS ONE			English	Article							SIZE-EXCLUSION CHROMATOGRAPHY; NATURAL ORGANIC-MATTER; SILVER NANOPARTICLES; PARTICLE; AGGREGATION; SILICA; FATE	In this study, we evaluated hydrodynamic chromatography (HDC) coupled with inductively coupled plasma mass spectrometry (ICP-MS) for the analysis of nanoparticles in environmental samples. Using two commercially available columns (Polymer Labs-PDSA type 1 and 2), a set of well characterised calibrants and a new external time marking method, we showed that flow rate and eluent composition have few influence on the size resolution and, therefore, can be adapted to the sample particularity. Monitoring the agglomeration of polystyrene nanoparticles over time succeeded without observable disagglomeration suggesting that even weak agglomerates can be measured using HDC. Simultaneous determination of gold colloid concentration and size using ICP-MS detection was validated for elemental concentrations in the ppb range. HDC-ICP-MS was successfully applied to samples containing a high organic and ionic background. Indeed, online combination of UV-visible, fluorescence and ICP-MS detectors allowed distinguishing between organic molecules and inorganic colloids during the analysis of Ag nanoparticles in synthetic surface waters and TiO2 and ZnO nanoparticles in commercial sunscreens. Taken together, our results demonstrate that HDC-ICP-MS is a flexible, sensitive and reliable method to measure the size and the concentration of inorganic colloids in complex media and suggest that there may be a promising future for the application of HDC in environmental science. Nonetheless the rigorous measurements of agglomerates and of matrices containing natural colloids still need to be studied in detail.	[Philippe, Allan; Schaumann, Gabriele E.] Univ Koblenz Landau, Inst Environm Sci, Dept Environm & Soil Chem, Landau, Germany	University of Koblenz & Landau	Schaumann, GE (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Dept Environm & Soil Chem, Landau, Germany.	schaumann@uni-landau.de	Schaumann, Gabriele E/B-4283-2015	Schaumann, Gabriele E/0000-0003-1788-2751	german research Foundation (DFG) within the research unit INTERNANO, FOR 1536 [SCHA849/16-1]	german research Foundation (DFG) within the research unit INTERNANO, FOR 1536(German Research Foundation (DFG))	The authors acknowledge financial support of the german research Foundation (DFG), project SCHA849/16-1 within the research unit INTERNANO, FOR 1536. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken GR, 2011, ENVIRON SCI TECHNOL, V45, P3196, DOI 10.1021/es103992s; Baalousha M, 2009, SCI TOTAL ENVIRON, V407, P2093, DOI 10.1016/j.scitotenv.2008.11.022; Brewer AK, 2011, ANAL CHEM, V83, P3068, DOI 10.1021/ac103314c; Brewer AK, 2009, ANAL BIOANAL CHEM, V393, P295, DOI 10.1007/s00216-008-2319-y; Burleson DJ, 2004, J ENVIRON SCI HEAL A, V39, P2707, DOI [10.1081/LESA-200027029, 10.1081/ESE-200027029]; Chinnapongse SL, 2011, SCI TOTAL ENVIRON, V409, P2443, DOI 10.1016/j.scitotenv.2011.03.020; Christian P, 2008, ECOTOXICOLOGY, V17, P326, DOI 10.1007/s10646-008-0213-1; DOSRAMOS JG, 1990, J COLLOID INTERF SCI, V135, P165, DOI 10.1016/0021-9797(90)90297-2; Dubascoux S, 2010, J ANAL ATOM SPECTROM, V25, P613, DOI 10.1039/b927500b; Fedotov PS, 2011, ANAL BIOANAL CHEM, V400, P1787, DOI 10.1007/s00216-011-4704-1; Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2; FINSY R, 1994, ADV COLLOID INTERFAC, V52, P79, DOI 10.1016/0001-8686(94)80041-3; Gray EP, 2012, J ANAL ATOM SPECTROM, V27, P1532, DOI 10.1039/c2ja30069a; Hanus LH, 2001, LANGMUIR, V17, P3136, DOI 10.1021/la000927c; Hassellov M, 2008, ECOTOXICOLOGY, V17, P344, DOI 10.1007/s10646-008-0225-x; Hotze EM, 2010, J ENVIRON QUAL, V39, P1909, DOI 10.2134/jeq2009.0462; Jarvis P, 2005, ENVIRON SCI TECHNOL, V39, P2307, DOI 10.1021/es048854x; Labille J, 2010, ENVIRON POLLUT, V158, P3482, DOI 10.1016/j.envpol.2010.02.012; Lead JR, 2006, ENVIRON CHEM, V3, P159, DOI 10.1071/EN06025; Lespes G, 2011, ANAL CHIM ACTA, V692, P26, DOI 10.1016/j.aca.2011.02.052; MCGOWAN GR, 1982, J COLLOID INTERF SCI, V89, P94, DOI 10.1016/0021-9797(82)90124-2; MCHUGH AJ, 1984, CRC CR REV ANAL CHEM, V15, P63, DOI 10.1080/10408348408085429; Nowack B, 2012, ENVIRON TOXICOL CHEM, V31, P50, DOI 10.1002/etc.726; OUALI L, 1994, J COLLOID INTERF SCI, V168, P315, DOI 10.1006/jcis.1994.1425; PENLIDIS A, 1983, J LIQ CHROMATOGR, V6, P179, DOI 10.1080/01483918308062874; PRIEVE DC, 1978, J COLLOID INTERF SCI, V64, P201, DOI 10.1016/0021-9797(78)90356-9; Rakcheev D, 2013, ANAL CHEM, V85, P10643, DOI 10.1021/ac4019395; Simonet BM, 2009, ANAL BIOANAL CHEM, V393, P17, DOI 10.1007/s00216-008-2484-z; SMALL H, 1974, J COLLOID INTERF SCI, V48, P147, DOI 10.1016/0021-9797(74)90337-3; SMALL H, 1976, ADV COLLOID INTERFAC, V6, P237, DOI 10.1016/0001-8686(76)85004-X; Striegel AM, 2012, ANNU REV ANAL CHEM, V5, P15, DOI 10.1146/annurev-anchem-062011-143107; Takeuchi T, 2009, ANAL SCI, V25, P301, DOI 10.2116/analsci.25.301; Tiede K, 2008, FOOD ADDIT CONTAM A, V25, P795, DOI 10.1080/02652030802007553; Tiede K, 2010, J ANAL ATOM SPECTROM, V25, P1149, DOI 10.1039/b926029c; Tiede K, 2009, J ANAL ATOM SPECTROM, V24, P964, DOI 10.1039/b822409a; Venema E, 1996, J CHROMATOGR A, V740, P159, DOI 10.1016/0021-9673(96)00135-5; von der Kammer F, 2012, ENVIRON TOXICOL CHEM, V31, P32, DOI 10.1002/etc.723; Walker HW, 2001, WATER RES, V35, P875, DOI 10.1016/S0043-1354(00)00333-X; Wigginton NS, 2007, J ENVIRON MONITOR, V9, P1306, DOI 10.1039/b712709j; Williams A, 2002, INT J PHARM, V242, P295, DOI 10.1016/S0378-5173(02)00191-6; Wohlleben W, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1300-z; ZARRIN F, 1985, ANAL CHEM, V57, P1826, DOI 10.1021/ac00286a010	42	40	40	4	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90559	10.1371/journal.pone.0090559	http://dx.doi.org/10.1371/journal.pone.0090559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587393	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200227
J	Boit, A; Gaedke, U				Boit, Alice; Gaedke, Ursula			Benchmarking Successional Progress in a Quantitative Food Web	PLOS ONE			English	Article							BIOMASS SIZE DISTRIBUTIONS; OLD-FIELD SUCCESSION; SECONDARY SUCCESSION; SEASONAL SUCCESSION; COMMUNITY DYNAMICS; SPECIES RICHNESS; INTERMEDIATE DISTURBANCE; RELATIVE IMPORTANCE; INSECT HERBIVORES; TROPHIC STRUCTURE	Central to ecology and ecosystem management, succession theory aims to mechanistically explain and predict the assembly and development of ecological communities. Yet processes at lower hierarchical levels, e. g. at the species and functional group level, are rarely mechanistically linked to the under-investigated system-level processes which drive changes in ecosystem properties and functioning and are comparable across ecosystems. As a model system for secondary succession, seasonal plankton succession during the growing season is readily observable and largely driven autogenically. We used a long-term dataset from large, deep Lake Constance comprising biomasses, auto-and heterotrophic production, food quality, functional diversity, and mass-balanced food webs of the energy and nutrient flows between functional guilds of plankton and partly fish. Extracting population-and system-level indices from this dataset, we tested current hypotheses about the directionality of successional progress which are rooted in ecosystem theory, the metabolic theory of ecology, quantitative food web theory, thermodynamics, and information theory. Our results indicate that successional progress in Lake Constance is quantifiable, passing through predictable stages. Mean body mass, functional diversity, predator-prey weight ratios, trophic positions, system residence times of carbon and nutrients, and the complexity of the energy flow patterns increased during succession. In contrast, both the mass-specific metabolic activity and the system export decreased, while the succession rate exhibited a bimodal pattern. The weighted connectance introduced here represents a suitable index for assessing the evenness and interconnectedness of energy flows during succession. Diverging from earlier predictions, ascendency and eco-exergy did not increase during succession. Linking aspects of functional diversity to metabolic theory and food web complexity, we reconcile previously disjoint bodies of ecological theory to form a complete picture of successional progress within a pelagic food web. This comprehensive synthesis may be used as a benchmark for quantifying successional progress in other ecosystems.	[Boit, Alice; Gaedke, Ursula] Univ Potsdam, Inst Biochem & Biol, Dept Ecol & Ecosyst Modelling, Potsdam, Germany; [Boit, Alice] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Gaedke, Ursula] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany	University of Potsdam; Potsdam Institut fur Klimafolgenforschung	Boit, A (corresponding author), Univ Potsdam, Inst Biochem & Biol, Dept Ecol & Ecosyst Modelling, Potsdam, Germany.	boit@pik-potsdam.de			Microsoft Research; Heinrich Boll Foundation Berlin; German Research Foundation (DFG) [(SFB) 248]	Microsoft Research(Microsoft); Heinrich Boll Foundation Berlin; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was funded by Microsoft Research, the Heinrich Boll Foundation Berlin, and benefitted from the EU Project FEMMES. Data acquisition was mostly performed within the Special Collaborative Program (SFB) 248 "Cycling of Matter in Lake Constance'' supported by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca-Arenas LG, 2002, ECOL MODEL, V149, P285, DOI 10.1016/S0304-3800(01)00474-4; Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; ANDERSON TR, 1992, J PLANKTON RES, V14, P1645, DOI 10.1093/plankt/14.12.1645; Antoniou IE, 2008, DISCRETE DYN NAT SOC, V2008, DOI 10.1155/2008/375452; Aoki I, 2001, ECOL RES, V16, P65, DOI 10.1046/j.1440-1703.2001.00372.x; Appenzeller Alfred R., 1998, Advances in Limnology, V53, P303; Arthaud F, 2013, J VEG SCI, V24, P148, DOI 10.1111/j.1654-1103.2012.01436.x; Baird D, 2009, ECOL MODEL, V220, P3465, DOI 10.1016/j.ecolmodel.2009.09.008; Banasek-Richter C, 2009, ECOLOGY, V90, P1470, DOI 10.1890/08-2207.1; Barnes C, 2010, ECOLOGY, V91, P222, DOI 10.1890/08-2061.1; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bauerle E., 1998, LAKE CONSTANCE CHARA; Boit A, 2012, ECOL LETT, V15, P594, DOI 10.1111/j.1461-0248.2012.01777.x; Brose U, 2005, ECOL LETT, V8, P1317, DOI 10.1111/j.1461-0248.2005.00838.x; Brose U, 2008, P ROY SOC B-BIOL SCI, V275, P2507, DOI 10.1098/rspb.2008.0718; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; BROWN VK, 1985, OIKOS, V44, P17, DOI 10.2307/3544037; Carson WP, 1999, OECOLOGIA, V121, P260, DOI 10.1007/s004420050928; Chazdon RL, 2007, PHILOS T R SOC B, V362, P273, DOI 10.1098/rstb.2006.1990; Chen HYH, 2012, GLOBAL ECOL BIOGEOGR, V21, P441, DOI 10.1111/j.1466-8238.2011.00689.x; CHRISTENSEN V, 1995, ECOL MODEL, V77, P3, DOI 10.1016/0304-3800(93)E0073-C; Clements FE, 1916, WASHINGTON PUBL CARN, V242, P3; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; COOKE GD, 1967, BIOSCIENCE, V17, P717, DOI 10.2307/1294089; DAVIDSON DW, 1993, OIKOS, V68, P23, DOI 10.2307/3545305; de Castro F, 2008, OIKOS, V117, P1218, DOI 10.1111/j.0030-1299.2008.16547.x; De Wit R, 2005, SCI MAR, V69, P427, DOI 10.3989/scimar.2005.69n3427; Decaens T, 2010, GLOBAL ECOL BIOGEOGR, V19, P287, DOI 10.1111/j.1466-8238.2009.00517.x; DESTEVEN D, 1991, ECOLOGY, V72, P1066, DOI 10.2307/1940606; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; DYGERT PH, 1981, OIKOS, V36, P93, DOI 10.2307/3544384; EBENHOH W, 1988, THEOR POPUL BIOL, V34, P130, DOI 10.1016/0040-5809(88)90038-X; Eckmann R, 2010, HYDROAKUSTISCHE UNTE; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Elton C., 1927, ANIMAL ECOLOGY; Fath BD, 2004, BIOSYSTEMS, V77, P213, DOI 10.1016/j.biosystems.2004.06.001; Fox JW, 2013, TRENDS ECOL EVOL, V28, P86, DOI 10.1016/j.tree.2012.08.014; Fussmann GF, 2005, ADV ECOL RES, V37, P221, DOI 10.1016/S0065-2504(04)37007-8; GAEDKE U, 1994, ECOL MODEL, V75, P435, DOI 10.1016/0304-3800(94)90038-8; Gaedke U, 2004, AQUAT MICROB ECOL, V34, P247, DOI 10.3354/ame034247; GAEDKE U, 1992, LIMNOL OCEANOGR, V37, P1202, DOI 10.4319/lo.1992.37.6.1202; GAEDKE U, 1992, ECOL MODEL, V63, P277, DOI 10.1016/0304-3800(92)90073-N; Gaedke U, 2002, ECOL MONOGR, V72, P251, DOI 10.1890/0012-9615(2002)072[0251:IBELAN]2.0.CO;2; GAEDKE U, 1993, LIMNOL OCEANOGR, V38, P112, DOI 10.4319/lo.1993.38.1.0112; GAEDKE U, 1994, MARINE MICROBIAL FOOD WEBS, 1994, VOL 8, NO 1 AND 2, P163; Gaedke U., 1998, LAKE CONST CHARACT E, V53, P143; Gaedke Ursula, 1998, Advances in Limnology, V53, P565; Gaedke Ursula, 1996, P60; GELLER W, 1991, PROC INT ASSOC THE 2, V24, P831, DOI DOI 10.1080/03680770.1989.118; GRIMM NB, 1987, ECOLOGY, V68, P1157, DOI 10.2307/1939200; Gude Hans, 1998, Advances in Limnology, V53, P505; Guo QF, 2003, J VEG SCI, V14, P121, DOI 10.1111/j.1654-1103.2003.tb02134.x; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; HAIRSTON NG, 1993, AM NAT, V142, P379, DOI 10.1086/285546; Hartwich M, 2013, J PLANKTON RES, V35, P121, DOI 10.1093/plankt/fbs078; Hase C, 1998, ARCH HYDROBIOL ADV L, V53, P143; Hobbs NT, 1996, J WILDLIFE MANAGE, V60, P695, DOI 10.2307/3802368; Hochstadter S, 2000, FRESHWATER BIOL, V44, P453, DOI 10.1046/j.1365-2427.2000.00597.x; Hochstadter S., 1997, THESIS U CONSTANCE C; Holtkamp R, 2007, ECOL MODEL, V208, P41, DOI 10.1016/j.ecolmodel.2007.04.019; Horn H. S., 1974, Annual Review of Ecology and Systematics, V5, P25, DOI 10.1146/annurev.es.05.110174.000325; HUMPHREYS WF, 1979, J ANIM ECOL, V48, P427, DOI 10.2307/4171; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; INOUYE RS, 1987, ECOLOGY, V68, P12, DOI 10.2307/1938801; INSAM H, 1989, OECOLOGIA, V79, P174, DOI 10.1007/BF00388474; JETZ W, 2009, SCIENCES, V276, P269, DOI DOI 10.1098/RSPB.2008.1005; Jorgensen SE, 2005, ECOL MODEL, V185, P165, DOI 10.1016/j.ecolmodel.2004.11.020; Jorgensen SE, 2000, ECOL MODEL, V126, P249, DOI 10.1016/S0304-3800(00)00268-4; Jorgensen SE, 2004, THERMODYNAMIC THEORY, P301; Jorgensen SE., 2004, THERMODYNAMIC THEORY, V1; Jorgensen SE, 2007, ECOL MODEL, V204, P22, DOI 10.1016/j.ecolmodel.2006.12.034; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; LAMB D, 1980, OECOLOGIA, V47, P257, DOI 10.1007/BF00346829; LAMPERT W, 1978, ARCH HYDROBIOL, V82, P364; Lang M M., 1997, KONSTANZER DISSERTAT; LAWTON JH, 1983, ANNU REV ENTOMOL, V28, P23, DOI 10.1146/annurev.en.28.010183.000323; LAWTON JH, 1993, ECOL STU AN, V99, P255; LEIBOLD MA, 1995, ECOLOGY, V76, P1371, DOI 10.2307/1938141; LEVINE S, 1980, J THEOR BIOL, V83, P195, DOI 10.1016/0022-5193(80)90288-X; LEWIS WM, 1978, AM NAT, V112, P401, DOI 10.1086/283282; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Lohbeck M, 2012, PERSPECT PLANT ECOL, V14, P89, DOI 10.1016/j.ppees.2011.10.002; LOUCKS OL, 1970, AM ZOOL, V10, P17; Ludovisi A, 2005, J THEOR BIOL, V235, P33, DOI 10.1016/j.jtbi.2004.12.017; Ludovisi A, 2014, ECOL INDIC, V36, P617, DOI 10.1016/j.ecolind.2013.09.020; Ludovisi A, 2012, ECOL MODEL, V245, P125, DOI 10.1016/j.ecolmodel.2012.02.009; Mackey RL, 2001, ECOLOGY, V82, P3479, DOI 10.1890/0012-9658(2001)082[3479:TDDRII]2.0.CO;2; Mageau MT, 1998, ECOL MODEL, V112, P1, DOI 10.1016/S0304-3800(98)00092-1; Makino W, 2004, AQUAT MICROB ECOL, V34, P33, DOI 10.3354/ame034033; MARGALEF R, 1963, AM NAT, V97, P357, DOI 10.1086/282286; MARTINEZ ND, 1992, AM NAT, V139, P1208, DOI 10.1086/285382; May R.M., 1973, STABILITY COMPLEXITY; MCCOOK LJ, 1994, VEGETATIO, V110, P115, DOI 10.1007/BF00033394; Miller TE, 2005, AM NAT, V165, P439, DOI 10.1086/428681; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; MOLONEY CL, 1989, LIMNOL OCEANOGR, V34, P1290, DOI 10.4319/lo.1989.34.7.1290; MONK CD, 1983, B TORREY BOT CLUB, V110, P449, DOI 10.2307/2996278; Montoya JM, 2002, J THEOR BIOL, V214, P405, DOI 10.1006/jtbi.2001.2460; Morris JT, 2005, AQUATIC FOOD WEBS: AN ECOSYSTEM APPROACH, P73; MULLER H, 1989, MICROBIAL ECOL, V18, P261, DOI 10.1007/BF02075813; Neutel AM, 2007, NATURE, V449, P599, DOI 10.1038/nature06154; NICHOLSO.SA, 1974, ECOLOGY, V55, P1075, DOI 10.2307/1940357; Norberg J, 2001, P NATL ACAD SCI USA, V98, P11376, DOI 10.1073/pnas.171315998; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; ODUM EP, 1960, ECOLOGY, V41, P34, DOI 10.2307/1931937; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PADISAK J, 1994, NEW ZEAL J ECOL, V18, P169; PADISAK J, 2003, LAKES HDB, V1, P251; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; PEET RK, 1978, VEGETATIO, V37, P65, DOI 10.1007/BF00126830; Peeters F, 2007, LIMNOL OCEANOGR, V52, P286, DOI 10.4319/lo.2007.52.1.0286; Peltzer DA, 2010, ECOL MONOGR, V80, P509, DOI 10.1890/09-1552.1; Pickett STA, 2009, APPL VEG SCI, V12, P9, DOI 10.1111/j.1654-109X.2009.01019.x; PICKETT STA, 1989, TRENDS ECOL EVOL, V4, P241, DOI 10.1016/0169-5347(89)90170-5; PICKETT STA, 1987, BOT REV, V53, P335, DOI 10.1007/BF02858321; PIMM SL, 1982, FOOD WEBS; Prach K, 2011, TRENDS ECOL EVOL, V26, P119, DOI 10.1016/j.tree.2010.12.007; Reynolds CS, 2006, ECOL BIODIVERS CONS, P302, DOI 10.1017/CBO9780511542145.008; Reynolds C.S., 1997, VEGETATION PROCESSES, V9, DOI 10.1017/S0025315400036432; REYNOLDS CS, 1993, HYDROBIOLOGIA, V249, P183, DOI 10.1007/BF00008853; Reynolds CS, 1995, BIODIVERSITY ECOLOGI, P167; RICE EL, 1972, AM J BOT, V59, P1033, DOI 10.2307/2441488; Riede JO, 2011, ECOL LETT, V14, P169, DOI 10.1111/j.1461-0248.2010.01568.x; Rocha MR, 2011, OIKOS, V120, P17, DOI 10.1111/j.1600-0706.2010.18786.x; Roy S, 2007, ECOL COMPLEX, V4, P26, DOI 10.1016/j.ecocom.2007.02.016; SARNELLE O, 1993, ECOL MONOGR, V63, P129, DOI 10.2307/2937177; Scheffer M, 2003, HYDROBIOLOGIA, V491, P9, DOI 10.1023/A:1024404804748; SCHOONMAKER P, 1988, FOREST SCI, V34, P960; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P327, DOI 10.4319/lo.1972.17.3.0327; Shurin JB, 2006, P ROY SOC B-BIOL SCI, V273, P1, DOI 10.1098/rspb.2005.3377; Simon M, 1998, ARCH HYDROBIOL SPEC, V53, P195; Smayda TJ, 2001, J PLANKTON RES, V23, P447, DOI 10.1093/plankt/23.5.447; SOMMER U, 1989, LIMNOL OCEANOGR, V34, P1109, DOI 10.4319/lo.1989.34.6.1109; SOMMER U, 1985, BIOSCIENCE, V35, P351, DOI 10.2307/1309903; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; SOMMER U, 1986, HYDROBIOLOGIA, V138, P1, DOI 10.1007/BF00027228; SOMMER U, 1991, MOSAIC CYCLE CONCEPT, P132; Sommer U, 2012, ANN REV ECO IN PRESS, V43; Straile Dietmar, 1998, Advances in Limnology, V53, P255; Stuber K, 1998, INFLUENCE VARYING NU; Suding KN, 2011, ANNU REV ECOL EVOL S, V42, P465, DOI 10.1146/annurev-ecolsys-102710-145115; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; TILMAN D, 1985, AM NAT, V125, P827, DOI 10.1086/284382; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; TILMAN D, 1990, OIKOS, V58, P3, DOI 10.2307/3565355; TILZER MM, 1988, SCHWEIZ Z HYDROL, V50, P1, DOI 10.1007/BF02538370; Tirok K, 2006, J PLANKTON RES, V28, P361, DOI 10.1093/plankt/fbi121; Tirok K, 2007, OECOLOGIA, V150, P625, DOI 10.1007/s00442-006-0547-4; Ulanowicz R.E., 1997, ECOLOGY ASCENDENT PE; ULANOWICZ RE, 1980, J THEOR BIOL, V85, P223, DOI 10.1016/0022-5193(80)90019-3; Ulanowicz RE, 2002, BIOSYSTEMS, V64, P13, DOI 10.1016/S0303-2647(01)00170-8; ULANOWICZ RE, 1990, INT J SYST SCI, V21, P429, DOI 10.1080/00207729008910372; Ulanowicz RE, 2006, ECOL MODEL, V198, P520, DOI 10.1016/j.ecolmodel.2006.06.004; Ulanowicz RE, 2009, ECOL MODEL, V220, P1886, DOI 10.1016/j.ecolmodel.2009.04.015; Ulanowicz Robert E., 1997, P125; VADSTEIN O, 1989, LIMNOL OCEANOGR, V34, P939, DOI 10.4319/lo.1989.34.5.0939; van Breugel M, 2006, J TROP ECOL, V22, P663, DOI 10.1017/S0266467406003452; Vasseur DA, 2005, OIKOS, V110, P507, DOI 10.1111/j.0030-1299.2005.14006.x; Vitousek P, 1989, ECOLOGY ARABLE LAND, P161; VITOUSEK PM, 1975, BIOSCIENCE, V25, P376, DOI 10.2307/1297148; Wacker A, 2001, ECOLOGY, V82, P2507, DOI 10.2307/2679932; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Walker Lawrence R., 2007, P1, DOI 10.1007/978-0-387-35303-6_1; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weisse Thomas, 1998, Advances in Limnology, V53, P223; Williams RJ, 2004, AM NAT, V163, P458, DOI 10.1086/381964; Williams RJ, 2002, P NATL ACAD SCI USA, V99, P12913, DOI 10.1073/pnas.192448799; WILSON JB, 1990, NEW ZEAL J ECOL, V13, P17; Wurtz P, 2010, BIOSYSTEMS, V100, P70, DOI 10.1016/j.biosystems.2010.01.004; Yvon-Durocher G, 2011, OIKOS, V120, P550, DOI 10.1111/j.1600-0706.2010.18863.x; Zorach A. C., 2003, Complexity, V8, P68, DOI 10.1002/cplx.10075	175	24	25	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90404	10.1371/journal.pone.0090404	http://dx.doi.org/10.1371/journal.pone.0090404			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587353	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800105
J	Jamal, S; Cheriyan, VT; Muthu, M; Munie, S; Levi, E; Ashour, AE; Pass, HI; Wali, A; Singh, M; Rishi, AK				Jamal, Shazia; Cheriyan, Vino T.; Muthu, Magesh; Munie, Sara; Levi, Edi; Ashour, Abdelkader E.; Pass, Harvey I.; Wali, Anil; Singh, Mandip; Rishi, Arun K.			CARP-1 Functional Mimetics Are a Novel Class of Small Molecule Inhibitors of Malignant Pleural Mesothelioma Cells	PLOS ONE			English	Article							NF-KAPPA-B; APOPTOSIS-REGULATORY PROTEIN-1; ANAPHASE-PROMOTING COMPLEX; DNA-DAMAGE; CANCER CELLS; DEATH DOMAIN; IN-VITRO; RECEPTOR; PODOPLANIN; TRAIL	Malignant pleural mesothelioma (MPM) is an asbestos-related thoracic malignancy that is characterized by late metastases, and resistance to therapeutic modalities. The toxic side-effects of MPM therapies often limit their clinical effectiveness, thus necessitating development of new agents to effectively treat and manage this disease in clinic. CARP-1 functional mimetics (CFMs) are a novel class of compounds that inhibit growth of diverse cancer cell types. Here we investigated MPM cell growth suppression by the CFMs and the molecular mechanisms involved. CFM-1, -4, and -5 inhibited MPM cell growth, in vitro, in part by stimulating apoptosis. Apoptosis by CFM-4 involved activation of pro-apoptotic stress-activated protein kinases (SAPKs) p38 and JNK, elevated CARP-1 expression, cleavage of PARP1, and loss of the oncogene c-myc as well as mitotic cyclin B1. Treatments of MPM cells with CFM-4 resulted in depletion of NF-kappa B signaling inhibitor ABIN1 and Inhibitory kappa B (I kappa B) alpha and beta, while increasing expression of pro-apoptotic death receptor (DR) 4 protein. CFM-4 enhanced expression of serine-phosphorylated podoplanin and cleavage of vimetin. CFMs also attenuated biological properties of the MPM cells by blocking their abilities to migrate, form colonies in suspension, and invade through the matrix-coated membranes. Both podoplanin and vimentin regulate processes of cell motility and invasion, and their expression often correlates with metastatic disease, and poor prognosis. The fact that phosphorylation of serines in the cytoplasmic domain of podoplanin interferes with processes of cellular motility, CFM-4-dependent elevated phosphorylated podoplanin and cleavage of vimentin underscore a metastasis inhibitory property of these compounds, and suggest that CFMs and/or their future analogs have potential as anti-MPM agents.	[Jamal, Shazia; Cheriyan, Vino T.; Muthu, Magesh; Munie, Sara; Levi, Edi; Wali, Anil; Rishi, Arun K.] Wayne State Univ, John D Dingell VA Med Ctr, Detroit, MI 48202 USA; [Wali, Anil; Rishi, Arun K.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Jamal, Shazia; Cheriyan, Vino T.; Muthu, Magesh; Munie, Sara; Rishi, Arun K.] Wayne State Univ, Dept Oncol, Detroit, MI USA; [Levi, Edi] Wayne State Univ, Dept Pathol, Detroit, MI 48202 USA; [Ashour, Abdelkader E.] King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi Arabia; [Pass, Harvey I.] NYU, Ctr Canc, Div Cardiothorac Surg, New York, NY USA; [Singh, Mandip] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; King Saud University; New York University; State University System of Florida; Florida A&M University	Rishi, AK (corresponding author), Wayne State Univ, John D Dingell VA Med Ctr, Detroit, MI 48202 USA.	Rishia@Karmanos.org	Ashour, Abdelkader/ABH-8235-2020; muthu, magesh/N-6987-2017	Ashour, Abdelkader/0000-0003-3978-8045; muthu, magesh/0000-0003-3311-8120; jamal, shazia/0000-0003-4555-9513; Pass, Harvey/0000-0003-3222-3471; Levi, Edi/0000-0003-1809-2866	Department of Veterans Affairs Merit Review grant; NCI/NIH Cancer Center Support Grant; National Plan of Science, Technology and Innovation, King Saud University, Riyadh, Saudi Arabia [MED-1768-02]	Department of Veterans Affairs Merit Review grant(US Department of Veterans Affairs); NCI/NIH Cancer Center Support Grant; National Plan of Science, Technology and Innovation, King Saud University, Riyadh, Saudi Arabia	This work was supported by the Department of Veterans Affairs Merit Review grant (AKR), the NCI/NIH Cancer Center Support Grant to Karmanos Cancer Institute, Detroit, Michigan, and a grant from the National Plan of Science, Technology and Innovation, King Saud University, Riyadh, Saudi Arabia (Grant No. MED-1768-02; AEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2013, J IMMUNOL, V190, P6239, DOI 10.4049/jimmunol.1300448; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Ashour AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066733; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Berger R, 2011, MOL CANCER THER, V10, P1867, DOI 10.1158/1535-7163.MCT-11-0218; Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Fennell DA, 2008, NAT CLIN PRACT ONCOL, V5, P136, DOI 10.1038/ncponc1039; Gilles C, 1999, J CELL SCI, V112, P4615; Hendrix MJC, 1997, AM J PATHOL, V150, P483; Hoshino A, 2011, CANCER RES, V71, P4769, DOI 10.1158/0008-5472.CAN-10-3228; Jiang Yan, 2010, J Mol Signal, V5, P7, DOI 10.1186/1750-2187-5-7; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kamp DW, 2009, TRANSL RES, V153, P143, DOI 10.1016/j.trsl.2009.01.004; Karl S, 2009, J CELL MOL MED, V13, P4239, DOI 10.1111/j.1582-4934.2009.00888.x; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Kimura N, 2005, PATHOL INT, V55, P83, DOI 10.1111/j.1440-1827.2005.01791.x; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Krishnan H, 2013, J BIOL CHEM, V288, P12215, DOI 10.1074/jbc.C112.446823; Kunita A, 2007, AM J PATHOL, V170, P1337, DOI 10.2353/ajpath.2007.060790; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lang SH, 2002, PROSTATE, V52, P253, DOI 10.1002/pros.10088; Lehman NL, 2007, AM J PATHOL, V170, P1793, DOI 10.2353/ajpath.2007.060767; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Liu WK, 2004, BIOCHEM J, V378, P867, DOI 10.1042/BJ20031736; Marsters SA, 1997, CURR BIOL, V7, P1003, DOI 10.1016/S0960-9822(06)00422-2; Martin-Villar E, 2010, MOL BIOL CELL, V21, P4387, DOI 10.1091/mbc.E10-06-0489; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Okada M, 2001, CANCER RES, V61, P6201; PASS HI, 1995, ANN THORAC SURG, V59, P835, DOI 10.1016/0003-4975(95)00045-M; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; Puliyappadamba VT, 2011, J BIOL CHEM, V286, P38000, DOI 10.1074/jbc.M111.222398; Ravi R, 2004, CANCER RES, V64, P9105, DOI 10.1158/0008-5472.CAN-04-2488; Rieser E, 2013, TRENDS BIOCHEM SCI, V38, P94, DOI 10.1016/j.tibs.2012.11.007; Rishi AK, 2006, J BIOL CHEM, V281, P13188, DOI 10.1074/jbc.M512279200; Rishi AK, 2003, J BIOL CHEM, V278, P33422, DOI 10.1074/jbc.M303173200; Schwenger P, 1998, MOL CELL BIOL, V18, P78, DOI 10.1128/MCB.18.1.78; Singh S, 2003, CANCER RES, V63, P2306; Su S, 2009, SEMIN THORAC CARDIOV, V21, P125, DOI 10.1053/j.semtcvs.2009.07.006; Tan JL, 2009, APOPTOSIS, V14, P764, DOI 10.1007/s10495-009-0345-7; Van TT, 2011, CANCER CHEMOTH PHARM, V68, P497, DOI 10.1007/s00280-010-1503-x; Tsao AS, 2009, J CLIN ONCOL, V27, P2081, DOI 10.1200/JCO.2008.19.8523; Verstrepen L, 2009, BIOCHEM PHARMACOL, V78, P105, DOI 10.1016/j.bcp.2009.02.009; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Yang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041214; Yuan BZ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-140; Yuan P, 2006, CANCER, V107, P563, DOI 10.1002/cncr.22061; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang LY, 2007, MOL CANCER THER, V6, P1661, DOI 10.1158/1535-7163.MCT-06-0653	57	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89146	10.1371/journal.pone.0089146	http://dx.doi.org/10.1371/journal.pone.0089146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598827	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400009
J	Naoumkina, M; Thyssen, G; Fang, DD; Hinchliffe, DJ; Florane, C; Yeater, KM; Page, JT; Udall, JA				Naoumkina, Marina; Thyssen, Gregory; Fang, David D.; Hinchliffe, Doug J.; Florane, Christopher; Yeater, Kathleen M.; Page, Justin T.; Udall, Joshua A.			The Li-2 Mutation Results in Reduced Subgenome Expression Bias in Elongating Fibers of Allotetraploid Cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							DUPLICATE GENE-EXPRESSION; PLANT-GROWTH SUBSTANCES; LIGON LINTLESS-2 MUTANT; IN-VITRO; TRANSCRIPTION FACTORS; CELL ELONGATION; RNA-SEQ; XYLOGLUCAN; EVOLUTION; LINKAGE	Next generation sequencing (RNA-seq) technology was used to evaluate the effects of the Ligon lintless-2 (Li-2) short fiber mutation on transcriptomes of both subgenomes of allotetraploid cotton (Gossypium hirsutum L.) as compared to its near-isogenic wild type. Sequencing was performed on 4 libraries from developing fibers of Li-2 mutant and wild type near-isogenic lines at the peak of elongation followed by mapping and PolyCat categorization of RNA-seq data to the reference D-5 genome (G. raimondii) for homeologous gene expression analysis. The majority of homeologous genes, 83.6% according to the reference genome, were expressed during fiber elongation. Our results revealed: 1) approximately two times more genes were induced in the A(T) subgenome comparing to the D-T subgenome in wild type and mutant fiber; 2) the subgenome expression bias was significantly reduced in the Li-2 fiber transcriptome; 3) Li-2 had a significantly greater effect on the D-T than on the A(T) subgenome. Transcriptional regulators and cell wall homeologous genes significantly affected by the Li-2 mutation were reviewed in detail. This is the first report to explore the effects of a single mutation on homeologous gene expression in allotetraploid cotton. These results provide deeper insights into the evolution of allotetraploid cotton gene expression and cotton fiber development.	[Naoumkina, Marina; Thyssen, Gregory; Fang, David D.; Florane, Christopher] USDA ARS, Cotton Fiber Biosci Res Unit, So Reg Res Ctr, New Orleans, LA USA; [Hinchliffe, Doug J.] USDA ARS, Cotton Chem & Utilizat Res Unit, So Reg Res Ctr, New Orleans, LA USA; [Yeater, Kathleen M.] USDA ARS, Southern Plains Area, College Stn, TX USA; [Page, Justin T.; Udall, Joshua A.] Brigham Young Univ, Plant & Wildlife Sci Dept, Provo, UT 84602 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Brigham Young University	Naoumkina, M (corresponding author), USDA ARS, Cotton Fiber Biosci Res Unit, So Reg Res Ctr, New Orleans, LA USA.	marina.naoumkina@ars.usda.gov	Udall, Joshua A/A-7298-2009; FANG, DAVID/AAV-5774-2020	Udall, Joshua A/0000-0003-0978-4764; FANG, DAVID/0000-0003-0036-5459	United States Department of Agriculture-Agricultural Research Service [6435-21000-017-00D, 58-6435-2-663]	United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded by United States Department of Agriculture-Agricultural Research Service project number 6435-21000-017-00D and Cotton Incorporated project number 58-6435-2-663. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; BEASLEY CA, 1974, AM J BOT, V61, P188, DOI 10.2307/2441189; BEASLEY CA, 1973, AM J BOT, V60, P130, DOI 10.2307/2441099; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brubaker CL, 1999, GENOME, V42, P184, DOI 10.1139/gen-42-2-184; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chaudhary B, 2009, GENETICS, V182, P503, DOI 10.1534/genetics.109.102608; Chee Peng W., 2009, V3, P283, DOI 10.1007/978-0-387-70810-2_12; Cosgrove DJ, 2001, PLANT PHYSIOL, V125, P131, DOI 10.1104/pp.125.1.131; Dong SW, 2011, NEW PHYTOL, V190, P1045, DOI 10.1111/j.1469-8137.2011.03650.x; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; Drenkard E, 2000, PLANT PHYSIOL, V124, P1483, DOI 10.1104/pp.124.4.1483; Flagel L, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-16; Flagel LE, 2010, NEW PHYTOL, V186, P184, DOI 10.1111/j.1469-8137.2009.03107.x; Friedrichsen DM, 2002, GENETICS, V162, P1445; FRY SC, 1992, BIOCHEM J, V282, P821, DOI 10.1042/bj2820821; Gilbert MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075268; Grover CE, 2004, GENOME RES, V14, P1474, DOI 10.1101/gr.2673204; Ha M, 2009, P NATL ACAD SCI USA, V106, P17835, DOI 10.1073/pnas.0907003106; HAYASHI T, 1988, CARBOHYD RES, V181, P273, DOI 10.1016/0008-6215(88)84047-3; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Hinchliffe DJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-445; Hovav R, 2008, P NATL ACAD SCI USA, V105, P6191, DOI 10.1073/pnas.0711569105; HUWYLER HR, 1979, PLANTA, V146, P635, DOI 10.1007/BF00388844; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Kohel RJ, 2001, EUPHYTICA, V121, P163, DOI 10.1023/A:1012263413418; KOHEL RJ, 1992, CROP SCI, V32, P733, DOI 10.2135/cropsci1992.0011183X003200030031x; Kohel RJ, 2002, J HERED, V93, P130, DOI 10.1093/jhered/93.2.130; Kohno M, 2012, MOL BIOL REP, V39, P911, DOI 10.1007/s11033-011-0816-0; Lacape JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048855; Lee C, 2012, PLANT CELL PHYSIOL, V53, P135, DOI 10.1093/pcp/pcr158; Lee J, 2010, PLANTA, V232, P1191, DOI 10.1007/s00425-010-1246-2; Lee KJD, 2005, PLANT CELL, V17, P3051, DOI 10.1105/tpc.105.034413; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Madlung A, 2005, PLANT J, V41, P221, DOI 10.1111/j.1365-313X.2004.02297.x; Madson M, 2003, PLANT CELL, V15, P1662, DOI 10.1105/tpc.009837; Mei M, 2004, THEOR APPL GENET, V108, P280, DOI 10.1007/s00122-003-1433-7; Naoumkina M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-155; NARBUTH EV, 1990, J HERED, V81, P131; NISHITANI K, 1992, J BIOL CHEM, V267, P21058; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Page JT, 2013, G3-GENES GENOM GENET, V3, P517, DOI 10.1534/g3.112.005298; Papuga J, 2010, PLANT CELL, V22, P3034, DOI 10.1105/tpc.110.075960; Park YW, 2004, FEBS LETT, V564, P183, DOI 10.1016/S0014-5793(04)00346-1; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rong JK, 2005, THEOR APPL GENET, V111, P1137, DOI 10.1007/s00122-005-0041-0; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Shimizu Y, 1997, PLANT CELL PHYSIOL, V38, P375, DOI 10.1093/oxfordjournals.pcp.a029178; Takeda T, 2002, P NATL ACAD SCI USA, V99, P9055, DOI 10.1073/pnas.132080299; Taliercio EW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-22; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Ulloa M, 2005, J HERED, V96, P132, DOI 10.1093/jhered/esi020; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yang J, 2007, PLANTA, V226, P169, DOI 10.1007/s00425-007-0478-2; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; Yoo MJ, 2013, HEREDITY, V110, P171, DOI 10.1038/hdy.2012.94	62	21	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90830	10.1371/journal.pone.0090830	http://dx.doi.org/10.1371/journal.pone.0090830			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598808	Green Submitted, Green Published, gold			2022-12-27	WOS:000332479400139
J	Tsai, CH; Wu, JS; Chang, YF; Lu, FH; Yang, YC; Chang, CJ				Tsai, Chung-Hung; Wu, Jin-Shang; Chang, Yin-Fan; Lu, Feng-Hwa; Yang, Yi-Ching; Chang, Chih-Jen			The Number of Metabolic Abnormalities Associated with the Risk of Gallstones in a Non-diabetic Population	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INSULIN-RESISTANCE; GALLBLADDER-DISEASE; CHOLESTEROL GALLSTONES; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; UNITED-STATES; RAT-LIVER; PREVALENCE; INFECTION	Aim: To evaluate whether metabolic syndrome is associated with gallstones, independent of hepatitis C infection or chronic kidney disease (CKD), in a non-diabetic population. Materials and Methods: A total of 8,188 Chinese adult participants that underwent a self-motivated health examination were recruited into the final analysis after excluding the subjects who had a history of cholecystectomy, diabetes mellitus, or were currently using antihypertensive or lipid-lowering agents. Gallstones were defined by the presence of strong intraluminal echoes that were gravity-dependent or that attenuated ultrasound transmission. Results: A total of 447 subjects (5.5%) had gallstones, with 239 (5.1%) men and 208 (6.0%) women. After adjusting for age, gender, obesity, education level, and lifestyle factors, included current smoking, alcohol drinking, regular exercise, hepatitis B, hepatitis C, and CKD, there was a positive association between metabolic syndrome and gallstones. Moreover, as compared to subjects without metabolic abnormalities, subjects with one, two, and three or more suffered from a 35, 40, and 59% higher risk of gallstones, respectively. Conclusions: Non-diabetic subjects with metabolic syndrome had a higher risk of gallstones independent of hepatitis C or CKD, and a dose-dependent effect of metabolic abnormalities also exists.	[Tsai, Chung-Hung] China Med Univ, Tainan Municipal An Nan Hosp, Dept Family Med, Tainan, Taiwan; [Chang, Yin-Fan] Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan; [Wu, Jin-Shang; Lu, Feng-Hwa; Yang, Yi-Ching; Chang, Chih-Jen] Natl Cheng Kung Univ, Coll Med, Dept Family Med, Tainan 70101, Taiwan	China Medical University Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Chang, CJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Family Med, Tainan 70101, Taiwan.	em75210@email.ncku.edu.tw	Yang, Yi-Ching/C-7033-2014	Yang, Yi-Ching/0000-0003-1391-8040	Department of Family Medicine, National Cheng-Kung University Hospital [NCKUHFM-101-002]; National Sciene Council, Taiwan, R.O.C.	Department of Family Medicine, National Cheng-Kung University Hospital; National Sciene Council, Taiwan, R.O.C.	This study was supported by the grants from the Department of Family Medicine, National Cheng-Kung University Hospital (NCKUHFM-101-002). The authors would like to thank the National Sciene Council, Taiwan, R.O.C. for financially supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acalovschi M, 2009, J VIRAL HEPATITIS, V16, P860, DOI 10.1111/j.1365-2893.2009.01141.x; American College of Sports Medicine (ACSM), 2014, ACSMS GUIDELINES EXE; [Anonymous], 2010, DIABETES CARE; [Anonymous], 2002, AM J KIDNEY DIS OFFI, V39, pS1; Biddinger SB, 2008, NAT MED, V14, P778, DOI 10.1038/nm1785; Chang Y, 2008, J KOREAN MED SCI, V23, P644, DOI 10.3346/jkms.2008.23.4.644; Chen CH, 2006, J GASTROEN HEPATOL, V21, P1737, DOI 10.1111/j.1440-1746.2006.04381.x; DeSantis A, 1997, HEPATOLOGY, V25, P787, DOI 10.1002/hep.510250401; Eguchi Y, 2009, LIVER INT, V29, P213, DOI 10.1111/j.1478-3231.2008.01853.x; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fu D, 2011, P NATL ACAD SCI USA, V108, P1403, DOI 10.1073/pnas.1018376108; Grundy SM, 2004, AM J CLIN NUTR, V80, P1; HAFFNER SM, 1990, AM J EPIDEMIOL, V132, P327, DOI 10.1093/oxfordjournals.aje.a115662; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3; Kim Sang Soo, 2011, Korean Journal of Internal Medicine, V26, P285, DOI 10.3904/kjim.2011.26.3.285; Lai SW, 2009, MEDICINE, V88, P46, DOI 10.1097/MD.0b013e318194183f; Loriot MA, 1999, HEPATOLOGY, V29, P1587, DOI 10.1002/hep.510290527; Magi Lorenzo, 2005, Recenti Progressi in Medicina, V96, P280; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Mendez-Sanchez N, 2005, WORLD J GASTROENTERO, V11, P1653, DOI 10.3748/wjg.v11.i11.1653; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; NEPOKROEFF CM, 1974, ARCH BIOCHEM BIOPHYS, V160, P387, DOI 10.1016/0003-9861(74)90412-3; Nervi F, 2006, J HEPATOL, V45, P299, DOI 10.1016/j.jhep.2006.01.026; Ruhl CE, 2000, HEPATOLOGY, V31, P299, DOI 10.1002/hep.510310206; Stinton LM, 2010, GASTROENTEROL CLIN N, V39, P157, DOI 10.1016/j.gtc.2010.02.003; STORER GB, 1981, FEBS LETT, V136, P135, DOI 10.1016/0014-5793(81)81231-8; Uebi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037803; VanPatten S, 2001, AM J PHYSIOL-GASTR L, V281, pG393, DOI 10.1152/ajpgi.2001.281.2.G393; Weikert C, 2010, AM J EPIDEMIOL, V171, P447, DOI 10.1093/aje/kwp411; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Wittenburg H, 2003, GASTROENTEROLOGY, V125, P868, DOI 10.1016/S0016-5085(03)01053-9; Woods A, 2011, BIOCHEM J, V434, P49, DOI 10.1042/BJ20101721; Xie Y, 2009, J LIPID RES, V50, P977, DOI 10.1194/jlr.M800645-JLR200	35	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90310	10.1371/journal.pone.0090310	http://dx.doi.org/10.1371/journal.pone.0090310			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598574	gold, Green Published, Green Submitted			2022-12-27	WOS:000332479400062
J	BenMohamed, F; Medina, M; Wu, YZ; Maschalidi, S; Jouvion, G; Guillemot, L; Chignard, M; Manoury, B; Touqui, L				BenMohamed, Fatima; Medina, Mathieu; Wu, Yong-Zheng; Maschalidi, Sophia; Jouvion, Gregory; Guillemot, Laurent; Chignard, Michel; Manoury, Benedicte; Touqui, Lhousseine			Toll-Like Receptor 9 Deficiency Protects Mice against Pseudomonas aeruginosa Lung Infection	PLOS ONE			English	Article							NITRIC-OXIDE; EPITHELIAL-CELLS; INNATE IMMUNITY; TLR9; FLAGELLIN; DNA; RECOGNITION; MODULATION; MECHANISMS; INDUCTION	Pseudomonas aeruginosa is an opportunistic pathogen involved in nosocomial infections. While a number of studies have demonstrated the roles of TLR2, TLR4 and TLR5 in host defense againt P. aeruginosa infection, the implication of TLR9 in this process has been overlooked. Here, we show that P. aeruginosa DNA stimulates the inflammatory response through TLR9 pathway in both a cell line and primary alveolar macrophages (AMs). This activation requires asparagine endopeptidase-and endosomal acidification. Interestingly, TLR9(-/-) mice resisted to lethal lung infection by P. aeruginosa, compared to WT C57BL/6 mice. The resistance of TLR9(-/-) mice to P. aeruginosa infection was associated with: (i) a higher ability of TLR9(-/-) AMs to kill P. aeruginosa; (ii) a rapid increase in the pro-inflammatory cytokines such as TNF alpha, IL-1 beta and IL-6 production; and (iii) an increase in nitric oxide (NO) production and inductible NO synthase expression in AMs. In addition, inhibition of both IL-1 beta and NO production resulted in a significant decrease of P. aeruginosa clearance by AMs. Altogether these results indicate that TLR9 plays a detrimental role in pulmonary host defense toward P. aeruginosa by reducing the AMs clearance activity and production of IL-1 beta and NO necessary for bacteria killing.	[BenMohamed, Fatima; Medina, Mathieu; Wu, Yong-Zheng; Guillemot, Laurent; Chignard, Michel; Touqui, Lhousseine] Inst Pasteur, Unite Defense Innee & Inflammat, Paris, France; [BenMohamed, Fatima; Medina, Mathieu; Wu, Yong-Zheng; Guillemot, Laurent; Chignard, Michel; Touqui, Lhousseine] INSERM, U874, Paris, France; [Maschalidi, Sophia; Manoury, Benedicte] INSERM, U1013, Paris, France; [Jouvion, Gregory] Inst Pasteur, Unite Histopathol Humaine & Modeles Animaux, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Touqui, L (corresponding author), Inst Pasteur, Unite Defense Innee & Inflammat, Paris, France.	touqui@pasteur.fr	Jouvion, Grégory/AAL-2620-2021; Guillemot, Laurent/I-3166-2017	Guillemot, Laurent/0000-0002-5979-5501; Manoury, Benedicte/0000-0001-7784-3389	ANR [ANR 2010 MIDI 008 01]; Association Vaincre la Mucoviscidose [RF20120600716]	ANR(French National Research Agency (ANR)); Association Vaincre la Mucoviscidose	This work was supported by ANR (ANR 2010 MIDI 008 01) and the Association Vaincre la Mucoviscidose (RF20120600716). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Assis MC, 2006, INT J MOL MED, V18, P355; Balloy V, 2007, J INFECT DIS, V196, P289, DOI 10.1086/518610; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Bamboat ZM, 2010, HEPATOLOGY, V51, P621, DOI 10.1002/hep.23365; Ben Mohamed F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039888; Bhan U, 2007, J IMMUNOL, V179, P3937, DOI 10.4049/jimmunol.179.6.3937; Bhan U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009896; Darling KEA, 2003, INFECT IMMUN, V71, P2341, DOI 10.1128/IAI.71.5.2341-2349.2003; Descamps D, 2012, P NATL ACAD SCI USA, V109, P1619, DOI 10.1073/pnas.1108464109; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Gwinn MR, 2006, J TOXICOL ENV HEAL B, V9, P27, DOI 10.1080/15287390500196081; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hemmi Hiroaki, 2005, V86, P120, DOI 10.1159/000086657; Hiramatsu Y, 2013, MICROBES INFECT, V15, P96, DOI 10.1016/j.micinf.2012.11.003; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kasperkovitz PV, 2011, INFECT IMMUN, V79, P4858, DOI 10.1128/IAI.05626-11; Kleinbongard P, 2002, METHOD ENZYMOL, V359, P158; Kwon S, 1999, NITRIC OXIDE-BIOL CH, V3, P348, DOI 10.1006/niox.1999.0242; LaBaer J, 2004, GENOME RES, V14, P2190, DOI 10.1101/gr.2482804; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lau GW, 2005, TRENDS MICROBIOL, V13, P389, DOI 10.1016/j.tim.2005.05.011; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Loak K, 2003, BIOL CHEM, V384, P1239, DOI 10.1515/BC.2003.136; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P403, DOI 10.1513/pats.200508-090JS; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Parratt JR, 1998, J ANTIMICROB CHEMOTH, V41, P31, DOI 10.1093/jac/41.suppl_1.31; Ramphal R, 2008, J IMMUNOL, V181, P586, DOI 10.4049/jimmunol.181.1.586; Raoust E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007259; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Sodhi C, 2011, AM J PHYSIOL-GASTR L, V300, pG862, DOI 10.1152/ajpgi.00373.2010; Spitsin SV, 1996, MOL MED, V2, P226, DOI 10.1007/BF03401619; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; Verma A, 2005, INFECT IMMUN, V73, P8237, DOI 10.1128/IAI.73.12.8237-8246.2005; XIE QW, 1994, J BIOL CHEM, V269, P4705	36	24	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90466	10.1371/journal.pone.0090466	http://dx.doi.org/10.1371/journal.pone.0090466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595157	gold, Green Published			2022-12-27	WOS:000332475500053
J	Evans, SE; Goult, BT; Fairall, L; Jamieson, AG; Ferrigno, PK; Ford, R; Schwabe, JWR; Wagner, SD				Evans, Sian E.; Goult, Benjamin T.; Fairall, Louise; Jamieson, Andrew G.; Ferrigno, Paul Ko; Ford, Robert; Schwabe, John W. R.; Wagner, Simon D.			The Ansamycin Antibiotic, Rifamycin SV, Inhibits BCL6 Transcriptional Repression and Forms a Complex with the BCL6-BTB/POZ Domain	PLOS ONE			English	Article							GERMINAL-CENTER FORMATION; NEGATIVE AUTOREGULATION; BTB DOMAIN; CELL; EXPRESSION; INFLAMMATION; GENE; ONCOPROTEIN; PREDICTION; MUTATIONS	BCL6 is a transcriptional repressor that is over-expressed due to chromosomal translocations, or other abnormalities, in similar to 40% of diffuse large B-cell lymphoma. BCL6 interacts with co-repressor, SMRT, and this is essential for its role in lymphomas. Peptide or small molecule inhibitors, which prevent the association of SMRT with BCL6, inhibit transcriptional repression and cause apoptosis of lymphoma cells in vitro and in vivo. In order to discover compounds, which have the potential to be developed into BCL6 inhibitors, we screened a natural product library. The ansamycin antibiotic, rifamycin SV, inhibited BCL6 transcriptional repression and NMR spectroscopy confirmed a direct interaction between rifamycin SV and BCL6. To further determine the characteristics of compounds binding to BCL6-POZ we analyzed four other members of this family and showed that rifabutin, bound most strongly. An X-ray crystal structure of the rifabutin-BCL6 complex revealed that rifabutin occupies a partly non-polar pocket making interactions with tyrosine58, asparagine21 and arginine24 of the BCL6-POZ domain. Importantly these residues are also important for the interaction of BLC6 with SMRT. This work demonstrates a unique approach to developing a structure activity relationship for a compound that will form the basis of a therapeutically useful BCL6 inhibitor.	[Evans, Sian E.; Goult, Benjamin T.; Fairall, Louise; Schwabe, John W. R.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Evans, Sian E.; Wagner, Simon D.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England; [Evans, Sian E.; Wagner, Simon D.] Univ Leicester, MRC Toxicol Unit, Leicester, Leics, England; [Jamieson, Andrew G.] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England; [Ferrigno, Paul Ko; Ford, Robert] Univ Leeds, Sect Expt Therapeut, Leeds Inst Mol Med, Leeds, W Yorkshire, England	University of Leicester; University of Leicester; University of Leicester; University of Leicester; University of Leeds	Wagner, SD (corresponding author), Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England.	sw227@le.ac.uk	Schwabe, John WR/A-9132-2008; Goult, Benjamin T/B-3127-2009	Schwabe, John WR/0000-0003-2865-4383; Goult, Benjamin T/0000-0002-3438-2807; Jamieson, Andrew/0000-0003-1726-7353; Wagner, Simon/0000-0002-8914-0370; Fairall, Louise/0000-0001-9456-3047; Ko Ferrigno, Paul/0000-0002-5922-4100	University of Leicester; Wellcome Trust [WT091820, WT100237]	University of Leicester; Wellcome Trust(Wellcome TrustEuropean Commission)	SEE is supported by a University of Leicester PhD Studentship (http://www.le.ac.uk). The work is supported by a Wellcome Trust Programme Grant WT091820 and Senior Investigator Grant WT100237 to JWRS (http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Auld DS, 2008, J MED CHEM, V51, P2372, DOI 10.1021/jm701302v; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Cerchietti LC, 2010, J CLIN INVEST, V120, P4569, DOI 10.1172/JCI42869; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Cerchietti LC, 2009, BLOOD, V113, P3397, DOI 10.1182/blood-2008-07-168773; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dhordain P, 1998, NUCLEIC ACIDS RES, V26, P4645, DOI 10.1093/nar/26.20.4645; Dhordain P, 1995, ONCOGENE, V11, P2689; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Ghetu AF, 2008, MOL CELL, V29, P384, DOI 10.1016/j.molcel.2007.12.026; Huang CX, 2013, NAT IMMUNOL, V14, P380, DOI 10.1038/ni.2543; Iqbal J, 2007, LEUKEMIA, V21, P2332, DOI 10.1038/sj.leu.2404856; Kunin CM, 1996, CLIN INFECT DIS, V22, pS3, DOI 10.1093/clinids/22.Supplement_1.S3; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; OFFIT K, 1994, NEW ENGL J MED, V331, P74, DOI 10.1056/NEJM199407143310202; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang X, 2002, P NATL ACAD SCI USA, V99, P15018, DOI 10.1073/pnas.232581199; Woods LA, 2011, NAT CHEM BIOL, V7, P730, DOI [10.1038/nchembio.635, 10.1038/NCHEMBIO.635]; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161	41	18	19	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90889	10.1371/journal.pone.0090889	http://dx.doi.org/10.1371/journal.pone.0090889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595451	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500109
J	Guo, YS; Zhao, R; Ma, J; Cui, W; Sun, Z; Gao, B; He, S; Han, YH; Fan, J; Yang, L; Tang, J; Luo, ZJ				Guo, Yun-Shan; Zhao, Rui; Ma, Jie; Cui, Wei; Sun, Zhen; Gao, Bo; He, Shu; Han, Yue-Hu; Fan, Jing; Yang, Liu; Tang, Juan; Luo, Zhuo-Jing			beta ig-h3 Promotes Human Osteosarcoma Cells Metastasis by Interacting with Integrin alpha 2 beta 1 and Activating PI3K Signaling Pathway	PLOS ONE			English	Article							BREAST-CANCER CELLS; NUDE-MICE; OSTEOGENIC-SARCOMA; IN-VITRO; ADHESION; BETA; INVASION; PROTEIN; GROWTH; LUNG	Osteosarcoma, the most common primary bone tumor in children and young adolescents, is characterized by local invasion and distant metastasis. But the detailed mechanisms of osteosarcoma metastasis are not well known. In the present study, we found that beta ig-h3 promotes metastatic potential of human osteosarcoma cells in vitro and in vivo. Furthermore, beta ig-h3 co-localized with integrin alpha 2 beta 1 in osteosarcoma cells. But beta ig-h3 did not change integrin alpha 2 beta 1 expression in Saos-2 cells. Interaction of beta ig-h3 with integrin alpha 2 beta 1 mediates metastasis of human osteosarcoma cells. The second FAS1 domain of beta ig-h3 but not the first FAS1 domain, the third FAS1 domain or the fourth FAS1 domain mediates human osteosarcoma cells metastasis, which is the alpha 2 beta 1 integrin-interacting domain. We further demonstrated that PI3K/AKT signaling pathway is involved in beta ig-h3-induced human osteosarcoma cells metastasis process. Together, these results reveal beta ig-h3 enhances the metastasis potentials of human osteosarcoma cells via integrin alpha 2 beta 1-mediated PI3K/AKT signal pathways. The discovery of beta ig-h3-mediated pathway helps us to understand the mechanism of human osteosarcoma metastasis and provides evidence for the possibility that beta ig-h3 can be a potential therapeutic target for osteosarcoma treatment.	[Guo, Yun-Shan; Zhao, Rui; Sun, Zhen; Gao, Bo; He, Shu; Han, Yue-Hu; Fan, Jing; Yang, Liu; Luo, Zhuo-Jing] Fourth Mil Med Univ, Xijing Hosp, Dept Osteol, Xian 710032, Peoples R China; [Guo, Yun-Shan; Tang, Juan] Fourth Mil Med Univ, Cell Engn Res Ctr, Xian 710032, Peoples R China; [Guo, Yun-Shan; Tang, Juan] Fourth Mil Med Univ, Dept Cell Biol, State Key Lab Canc Biol, State Key Discipline Cell Biol, Xian 710032, Peoples R China; [Ma, Jie] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Cui, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol & Metab, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yang, L (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Osteol, Xian 710032, Peoples R China.	yangliu@fmmu.edu.cn; tangjuan1@fmmu.edu.cn; zjluo@fmmu.edu.cn			National Basic Research Program of China [2011CB964703]; National Natural Science Foundation of China [31101005]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Basic Research Program of China (2011CB964703) and the National Natural Science Foundation of China (31101005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JS, 2002, BIOCHEM BIOPH RES CO, V294, P940, DOI 10.1016/S0006-291X(02)00576-4; Bernstein Lori R., 1994, Current Opinion in Oncology, V6, P106, DOI 10.1097/00001622-199401000-00015; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris MB, 1998, J CLIN ONCOL, V16, P3641, DOI 10.1200/JCO.1998.16.11.3641; Izmailyan R, 2012, J VIROL, V86, P6677, DOI 10.1128/JVI.06860-11; Jin S, 2007, APOPTOSIS, V12, P1317, DOI 10.1007/s10495-007-0062-z; Kawamoto T, 1998, BBA-GENE STRUCT EXPR, V1395, P288, DOI 10.1016/S0167-4781(97)00172-3; Kim HJ, 2010, CURR OPIN PEDIATR, V22, P61, DOI 10.1097/MOP.0b013e328334581f; Kim JE, 2000, J BIOL CHEM, V275, P30907, DOI 10.1074/jbc.M002752200; Kim JE, 2002, J BIOL CHEM, V277, P46159, DOI 10.1074/jbc.M207055200; Kimura H, 2012, INT J CANCER, V131, P2027, DOI 10.1002/ijc.27475; Krishnamurthy M, 2011, ENDOCRINOLOGY, V152, P424, DOI 10.1210/en.2010-0877; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Ma J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037297; Messerschmitt PJ, 2009, J AM ACAD ORTHOP SUR, V17, P515, DOI 10.5435/00124635-200908000-00005; MEYERS PA, 1993, J CLIN ONCOL, V11, P449, DOI 10.1200/JCO.1993.11.3.449; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Murillo CA, 2004, SURGERY, V136, P143, DOI 10.1016/j.surg.2004.04.006; Nissinen L, 1998, EXP CELL RES, V243, P1, DOI 10.1006/excr.1998.4128; Park SW, 2004, EXP MOL MED, V36, P211, DOI 10.1038/emm.2004.29; Qin J, 2013, LIFE SCI, V93, P655, DOI 10.1016/j.lfs.2013.09.002; SCOTLANDI K, 1993, INT J ONCOL, V3, P963; Shah JN, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-284; Shaw LM, 2001, MOL CELL BIOL, V21, P5082, DOI 10.1128/MCB.21.15.5082-5093.2001; SKONIER J, 1994, DNA CELL BIOL, V13, P571, DOI 10.1089/dna.1994.13.571; Son HN, 2013, BBA-MOL CELL RES, V1833, P2378, DOI 10.1016/j.bbamcr.2013.06.012; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Tang J, 2008, CELL MOL LIFE SCI, V65, P2933, DOI 10.1007/s00018-008-8315-8; Tang J, 2012, CELL DEATH DIFFER, V19, P1779, DOI 10.1038/cdd.2012.60; Tang J, 2009, EXP BIOL MED, V234, P35, DOI 10.3181/0806-RM-187; Tome Y, 2013, ANTICANCER RES, V33, P3623; Tome Y, 2013, ANTICANCER RES, V33, P3021; Tsubaki M, 2012, TOXICOL APPL PHARM, V259, P402, DOI 10.1016/j.taap.2012.01.024; Uehara F, 2013, ANTICANCER RES, V33, P1361; Vihinen P, 1996, CELL GROWTH DIFFER, V7, P439; Ween MP, 2011, INT J CANCER, V128, P1570, DOI 10.1002/ijc.25494; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; Zamilpa R, 2009, MATRIX BIOL, V28, P347, DOI 10.1016/j.matbio.2009.05.004	44	16	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90220	10.1371/journal.pone.0090220	http://dx.doi.org/10.1371/journal.pone.0090220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595049	gold, Green Published, Green Submitted			2022-12-27	WOS:000332475500038
J	Helland, O; Popa, M; Vintermyr, OK; Molven, A; Gjertsen, BT; Bjorge, L; McCormack, E				Helland, Oystein; Popa, Mihaela; Vintermyr, Olav K.; Molven, Anders; Gjertsen, Bjorn Tore; Bjorge, Line; McCormack, Emmet			First In-Mouse Development and Application of a Surgically Relevant Xenograft Model of Ovarian Carcinoma	PLOS ONE			English	Article							CYTOREDUCTIVE SURGERY; PRECLINICAL MODELS; PLUS PACLITAXEL; TUMOR-MODELS; PHASE-III; CANCER; CISPLATIN; GROWTH; SURVIVAL; DISEASE	Purpose: Preclinical models of epithelial ovarian cancer have not been exploited to evaluate the clinical standard combination therapy of surgical debulking with follow-up chemotherapy. As surgery is critical to patient survival, here we establish a combined surgical/chemotherapy xenograft model of epithelial ovarian cancer and demonstrate its translational relevance. Experimental Design: SKOV-3(luc+) ovary cancer cells were injected topically into the ovaries of immunodeficient mice. Disease development and effect of clinical standard treatment including hysterectomy, bilateral salpingoophorectomy and removal of metastasis with follow up chemotherapy (carboplatin 12 mg/kg + paclitaxel 15 mg/kg) was evaluated by clinical parameters. Tumor burden was quantified by bioluminescence imaging (BLI). Results: The xenograft ovarian tumors developed were poorly differentiated and multicystic and the disease disseminated into the peritoneal cavity. When compared to the controls with a mean survival time of 4.9 weeks, mice treated with surgery and chemotherapy, surgery or chemotherapy demonstrated significantly improved mean survival of 16.1 weeks (p = 0.0008), 12.7 weeks (p = 0.0008), or 10.4 weeks (p = 0.008), respectively. Conclusion: Combined surgical intervention and adjuvant chemotherapy was demonstrated for the first time in an orthotopic xenograft model of ovarian cancer. Similar to observation in human studies the combined approach resulted in the longest medial survival time, advocating application of this strategy in future preclinical therapeutic development for this disease.	[Helland, Oystein; Bjorge, Line] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; [Helland, Oystein; Gjertsen, Bjorn Tore; Bjorge, Line; McCormack, Emmet] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Popa, Mihaela] KinN Therapeut, Bergen, Norway; [Vintermyr, Olav K.; Molven, Anders] Univ Bergen, Gade Lab Pathol, Dept Clin Med, Bergen, Norway; [Vintermyr, Olav K.; Molven, Anders] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Gjertsen, Bjorn Tore; McCormack, Emmet] Haukeland Hosp, Dept Med, Hematol Sect, N-5021 Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	McCormack, E (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	Emmet.Mc.Cormack@med.uib.no	Bjorge, Line/C-1307-2017; Gjertsen, Bjørn T/AAP-3281-2020; Bjorge, Line/AAD-6179-2021; Cormack, Emmet Mc/D-2922-2012; Gjertsen, Bjorn T/O-1542-2015	Bjorge, Line/0000-0002-0240-2770; Gjertsen, Bjørn T/0000-0001-9358-9704; Bjorge, Line/0000-0002-0240-2770; Cormack, Emmet Mc/0000-0002-7621-4625; Gjertsen, Bjorn T/0000-0001-9358-9704	Norwegian Cancer Society; Western Health Board of Norway; Bergen Research Foundation; MedViz; medical imaging and visualization R&D cluster in Western Norway founded by Haukeland University Hospital; University of Bergen; Christian Michelsen Research	Norwegian Cancer Society(Norwegian Cancer Society); Western Health Board of Norway; Bergen Research Foundation; MedViz; medical imaging and visualization R&D cluster in Western Norway founded by Haukeland University Hospital; University of Bergen; Christian Michelsen Research	This study has been supported by the Norwegian Cancer Society, Western Health Board of Norway, Bergen Research Foundation and MedViz (www.medviz.uib.no), a medical imaging and visualization R&D cluster in Western Norway founded by Haukeland University Hospital, University of Bergen, and Christian Michelsen Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; [Anonymous], 2009, INT J GYNECOL OBSTET, V105, P3; Bankert RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024420; Benencia F, 2005, MOL THER, V12, P789, DOI 10.1016/j.ymthe.2005.03.026; Bibby MC, 2004, EUR J CANCER, V40, P852, DOI 10.1016/j.ejca.2003.11.021; Bjorge L, 2005, BRIT J CANCER, V92, P895, DOI 10.1038/sj.bjc.6602334; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; Connolly DC, 2009, CANCER TREAT RES, V149, P353, DOI 10.1007/978-0-387-98094-2_17; Cordero A. B., 2010, J VIS EXP, DOI 10.3791/2125; CZERNOBILSKY B, 1985, EUR J CELL BIOL, V37, P175; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; du Bois A, 1999, ANN ONCOL, V10, P35, DOI 10.1023/A:1008355317514; FU XY, 1993, ANTICANCER RES, V13, P283; GRIFFITHS CT, 1975, NATL CANCER I MONOGR, P101; HACKER NF, 1983, OBSTET GYNECOL, V61, P413; Harlaar NJ, 2013, GYNECOL ONCOL, V128, P590, DOI 10.1016/j.ygyno.2012.12.011; Jarzabek MA, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2012.00029; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ke XS, 2011, EXP CELL RES, V317, P234, DOI 10.1016/j.yexcr.2010.10.009; Kerbel RS, 2003, CANCER BIOL THER, V2, pS134; Kiguchi K, 1998, CLIN EXP METASTAS, V16, P751, DOI 10.1023/A:1006537013317; Kotopoulis S, 2013, MOL IMAGING BIOL; Lorens JB, 2000, VIROLOGY, V272, P7, DOI 10.1006/viro.2000.0353; McCormack E, 2012, LEUKEMIA, V26, P910, DOI 10.1038/leu.2011.315; Mutch DG, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.31589; Nadeau ME, 2009, COMPARATIVE MED, V59, P553; Oliva P, 2012, BRIT J CANCER, V107, P360, DOI 10.1038/bjc.2012.261; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Morelli MP, 2012, J CLIN ONCOL, V30, pE45, DOI 10.1200/JCO.2011.36.9678; Piccart MJ, 2000, JNCI-J NATL CANCER I, V92, P699, DOI 10.1093/jnci/92.9.699; Ray P, 2011, NEOPLASIA, V13, P1152, DOI 10.1593/neo.111076; Ricci F, 2013, CANCER TREAT REV, V39, P561, DOI 10.1016/j.ctrv.2013.01.005; Schorge John O, 2010, Rev Obstet Gynecol, V3, P111; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Singer G, 2005, AM J SURG PATHOL, V29, P218, DOI 10.1097/01.pas.0000146025.91953.8d; Stewart JM, 2011, P NATL ACAD SCI USA, V108, P6468, DOI 10.1073/pnas.1005529108; Teefey P, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.03.012; Teicher BA, 2006, MOL CANCER THER, V5, P2435, DOI 10.1158/1535-7163.MCT-06-0391; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; van Scheltinga AGTT, 2011, J NUCL MED, V52, P1778, DOI 10.2967/jnumed.111.092833; Vidal A, 2012, CLIN CANCER RES, V18, P5399, DOI 10.1158/1078-0432.CCR-12-1513; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227; Wang J, 2011, NEUROPATH APPL NEURO, V37, P189, DOI 10.1111/j.1365-2990.2010.01119.x; Wimberger P, 2007, GYNECOL ONCOL, V106, P69, DOI 10.1016/j.ygyno.2007.02.026; Wu R, 2011, CLIN CANCER RES, V17, P7359, DOI 10.1158/1078-0432.CCR-11-1388; YANCIK R, 1993, CANCER, V71, P517; Zivanovic O, 2009, GYNECOL ONCOL, V114, pS3, DOI 10.1016/j.ygyno.2008.11.033	48	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89527	10.1371/journal.pone.0089527	http://dx.doi.org/10.1371/journal.pone.0089527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594904	Green Submitted, Green Published, gold			2022-12-27	WOS:000332475500016
J	Witztum, J; Persi, E; Horn, D; Pasmanik-Chor, M; Chor, B				Witztum, Jonathan; Persi, Erez; Horn, David; Pasmanik-Chor, Metsada; Chor, Benny			Hierarchical Partitioning of Metazoan Protein Conservation Profiles Provides New Functional Insights	PLOS ONE			English	Article							GENE ONTOLOGY; GAP-JUNCTIONS; GENOME; TOOL; ANNOTATION; METABOLISM; EVOLUTION; SEQUENCE	The availability of many complete, annotated proteomes enables the systematic study of the relationships between protein conservation and functionality. We explore this question based solely on the presence or absence of protein homologues (a.k.a. conservation profiles). We study 18 metazoans, from two distinct points of view: the human's and the fly's. Using the GOrilla gene ontology (GO) analysis tool, we explore functional enrichment of the "universal proteins'', those with homologues in all 17 other species, and of the "non-universal proteins''. A large number of GO terms are strongly enriched in both human and fly universal proteins. Most of these functions are known to be essential. A smaller number of GO terms, exhibiting markedly different properties, are enriched in both human and fly non-universal proteins. We further explore the non-universal proteins, whose conservation profiles are consistent with the "tree of life'' (TOL consistent), as well as the TOL inconsistent proteins. Finally, we applied Quantum Clustering to the conservation profiles of the TOL consistent proteins. Each cluster is strongly associated with one or a small number of specific monophyletic clades in the tree of life. The proteins in many of these clusters exhibit strong functional enrichment associated with the "life style'' of the related clades. Most previous approaches for studying function and conservation are "bottom up'', studying protein families one by one, and separately assessing the conservation of each. By way of contrast, our approach is "top down''. We globally partition the set of all proteins hierarchically, as described above, and then identify protein families enriched within different subdivisions. While supporting previous findings, our approach also provides a tool for discovering novel relations between protein conservation profiles, functionality, and evolutionary history as represented by the tree of life.	[Witztum, Jonathan; Pasmanik-Chor, Metsada] Tel Aviv Univ, Fac Life Sci, IL-69978 Tel Aviv, Israel; [Persi, Erez; Horn, David] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Chor, Benny] Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University	Chor, B (corresponding author), Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel.	benny@cs.tau.ac.il		Horn, David/0000-0003-2708-186X; Witztum, Jonathan/0000-0003-0092-2366				Alexopoulos H, 2004, CURR BIOL, V14, pR879, DOI 10.1016/j.cub.2004.09.067; Alibes A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-9; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; BERNACKI RJ, 1977, SCIENCE, V195, P577, DOI 10.1126/science.835014; Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Cooper GM, 2008, GENOME RES, V18, P201, DOI 10.1101/gr.7205808; de Bruyne M, 2006, BIOESSAYS, V28, P23, DOI 10.1002/bies.20338; DeVries ME, 2006, J IMMUNOL, V176, P401, DOI 10.4049/jimmunol.176.1.401; Dollo L., 1893, B SOC BELG GEOL, V7, P164; Eck R.V., 1966, ATLAS PROTEIN SEQUEN; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fang H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02015; Fox BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004933; Georgi B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003484; Getahun MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058889; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Horn D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.018702; KAM J, 2004, GENOME RES, V14, P109; Karabinos A, 2004, GENE, V326, P123, DOI 10.1016/j.gene.2003.10.019; Kimura M., 1983, NEUTRAL THEORY MOL E; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liolios K, 2010, NUCLEIC ACIDS RES, V38, pD346, DOI 10.1093/nar/gkp848; Liu ZH, 2013, ACTA BIOCH BIOPH SIN, V45, P44, DOI 10.1093/abbs/gms105; Lopez-Bigas N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r33; Luz H, 2006, BIOINFORMATICS, V22, P1166, DOI 10.1093/bioinformatics/btl073; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Malagoli D, 2010, ISJ-INVERT SURVIV J, V7, P1; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Martin MJ, 2003, GENOME RES, V13, P991, DOI 10.1101/gr.678303; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Schultz U, 2004, DEV COMP IMMUNOL, V28, P499, DOI 10.1016/j.dci.2003.09.009; Shen HB, 2007, BIOCHEM BIOPH RES CO, V364, P53, DOI 10.1016/j.bbrc.2007.09.098; Tekaia F, 2005, PLOS COMPUT BIOL, V1, P604, DOI 10.1371/journal.pcbi.0010075; Yang S, 2005, P NATL ACAD SCI USA, V102, P373, DOI 10.1073/pnas.0408810102	39	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90282	10.1371/journal.pone.0090282	http://dx.doi.org/10.1371/journal.pone.0090282			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594619	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500040
J	Zambrano, S; Bianchi, ME; Agresti, A				Zambrano, Samuel; Bianchi, Marco E.; Agresti, Alessandra			High-Throughput Analysis of NF-kappa B Dynamics in Single Cells Reveals Basal Nuclear Localization of NF-kappa B and Spontaneous Activation of Oscillations	PLOS ONE			English	Article							TEMPORAL CONTROL; SPECIFICITY; ROBUSTNESS; RESPONSES	NF-kappa B is a transcription factor that upon activation undergoes cycles of cytoplasmic-to-nuclear and nuclear-to-cytoplasmic transport, giving rise to so called "oscillations''. In turn, oscillations tune the transcriptional output. Since a detailed understanding of oscillations requires a systems biology approach, we developed a method to acquire and analyze large volumes of data on NF-kappa B dynamics in single cells. We measured the time evolution of the nuclear to total ratio of GFP-p65 in knock-in mouse embryonic fibroblasts using time-lapse imaging. We automatically produced a precise segmentation of nucleus and cytoplasm based on an accurate estimation of the signal and image background. Finally, we defined a set of quantifiers that describe the oscillatory dynamics, which are internally normalized and can be used to compare data recorded by different labs. Using our method, we analyzed NF-kappa B dynamics in over 2000 cells exposed to different concentrations of TNF-alpha alpha. We reproduced known features of the NF-kappa B system, such as the heterogeneity of the response in the cell population upon stimulation and we confirmed that a fraction of the responding cells does not oscillate. We also unveiled important features: the second and third oscillatory peaks were often comparable to the first one, a basal amount of nuclear NF-kappa B could be detected in unstimulated cells, and at any time a small fraction of unstimulated cells showed spontaneous random activation of the NF-kappa B system. Our work lays the ground for systematic, high-throughput, and unbiased analysis of the dynamics of transcription factors that can shuttle between the nucleus and other cell compartments.	[Zambrano, Samuel; Bianchi, Marco E.] San Raffaele Univ, Milan, Italy; [Bianchi, Marco E.; Agresti, Alessandra] Ist Sci San Raffaele, Genet & Cell Biol Div, I-20132 Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Agresti, A (corresponding author), Ist Sci San Raffaele, Genet & Cell Biol Div, I-20132 Milan, Italy.	agresti.alessandra@hsr.it	Agresti, Alessandra/K-5228-2016; Bianchi, Marco Emilio/K-3417-2018; Agresti, Alessandra/Q-4394-2019; Zambrano, Samuel/K-5244-2016	Agresti, Alessandra/0000-0001-5006-9506; Bianchi, Marco Emilio/0000-0002-5329-6445; Agresti, Alessandra/0000-0001-5006-9506; Zambrano, Samuel/0000-0002-9384-2017	Intra-European Fellowships for career development [2011-298447NonLinKB]; Italian AIRC [R0444];  [IEF-2011-298447]	Intra-European Fellowships for career development; Italian AIRC(Fondazione AIRC per la ricerca sul cancro); 	SZ is supported by the Intra-European Fellowships for career development-2011-298447NonLinKB. The work was supported by the IEF-2011-298447 research funding to SZ and the Italian AIRC 2010/2013 project No R0444 - to MEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Chazotte B, 2008, CSH PROTOCOLS; De Lorenzi R, 2009, GENESIS, V47, P323, DOI 10.1002/dvg.20468; Di Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052337; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Hao N, 2012, NAT STRUCT MOL BIOL, V19, P31, DOI 10.1038/nsmb.2192; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Kalita MK, 2011, J BIOL CHEM, V286, P37741, DOI 10.1074/jbc.M111.280925; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Lipniacki T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-376; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; Mora-Bermudez F, 2007, METHODS, V41, P158, DOI 10.1016/j.ymeth.2006.07.035; Nedelec F, 2001, PHYS REV LETT, V86, P3192, DOI 10.1103/PhysRevLett.86.3192; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Paszek P, 2010, P NATL ACAD SCI USA, V107, P11644, DOI 10.1073/pnas.0913798107; Purschke M, 2010, PHOTOCH PHOTOBIO SCI, V9, P1634, DOI 10.1039/c0pp00234h; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Schwarzfischer M, 2011, P MICR AN APPL BIOL; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Tay S, 2010, NATURE; Turner DA, 2010, J CELL SCI, V123, P2834, DOI 10.1242/jcs.069641; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Zambrano S, 2014, J THEORETIC IN PRESS	29	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90104	10.1371/journal.pone.0090104	http://dx.doi.org/10.1371/journal.pone.0090104			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595030	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500034
J	Das, S; Pal, U; Das, S; Bagga, K; Roy, A; Mrigwani, A; Maiti, NC				Das, Swagata; Pal, Uttam; Das, Supriya; Bagga, Khyati; Roy, Anupam; Mrigwani, Arpita; Maiti, Nakul C.			Sequence Complexity of Amyloidogenic Regions in Intrinsically Disordered Human Proteins	PLOS ONE			English	Article							MOLECULAR RECOGNITION FEATURES; FIBRIL-FORMING SEGMENTS; AGGREGATION-PRONE; ALPHA-SYNUCLEIN; UNSTRUCTURED PROTEINS; BINDING REGIONS; TAU-PROTEIN; WEB SERVER; PREDICTION; DETERMINANTS	An amyloidogenic region (AR) in a protein sequence plays a significant role in protein aggregation and amyloid formation. We have investigated the sequence complexity of AR that is present in intrinsically disordered human proteins. More than 80% human proteins in the disordered protein databases (DisProt+IDEAL) contained one or more ARs. With decrease of protein disorder, AR content in the protein sequence was decreased. A probability density distribution analysis and discrete analysis of AR sequences showed that similar to 8% residue in a protein sequence was in AR and the region was in average 8 residues long. The residues in the AR were high in sequence complexity and it seldom overlapped with low complexity regions (LCR), which was largely abundant in disorder proteins. The sequences in the AR showed mixed conformational adaptability towards alpha-helix, beta-sheet/strand and coil conformations.	[Das, Swagata; Pal, Uttam; Das, Supriya; Bagga, Khyati; Roy, Anupam; Mrigwani, Arpita; Maiti, Nakul C.] Indian Inst Chem Biol, Council Sci & Ind Res, Struct Biol & Bioinformat Div, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Maiti, NC (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Struct Biol & Bioinformat Div, Kolkata, India.	ncmaiti@iicb.res.in	Mrigwani, Arpita/AAA-7227-2022; Pal, Uttam/A-8544-2013; Maiti, Nakul/GLR-3207-2022	Pal, Uttam/0000-0003-2110-4610; Maiti, Nakul/0000-0002-8498-6502	grant GENESIS from the Council of Scientific & Industrial Research (CSIR), India [BSC0121]; grant miND from the Council of Scientific & Industrial Research (CSIR), India	grant GENESIS from the Council of Scientific & Industrial Research (CSIR), India; grant miND from the Council of Scientific & Industrial Research (CSIR), India	This work was supported by grants GENESIS (BSC0121) and miND from the Council of Scientific & Industrial Research (CSIR), India. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; Al-Ali H, 2010, BIOCHEM BIOPH RES CO, V391, P1104, DOI 10.1016/j.bbrc.2009.12.032; Alba MM, 2002, BIOINFORMATICS, V18, P672, DOI 10.1093/bioinformatics/18.5.672; Bemporad F, 2006, ACCOUNTS CHEM RES, V39, P620, DOI 10.1021/ar050067x; Bryson K, 2007, CURR PROTEIN PEPT SC, V8, P181, DOI 10.2174/138920307780363415; Burra PV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012069; Caflisch A, 2006, CURR OPIN CHEM BIOL, V10, P437, DOI 10.1016/j.cbpa.2006.07.009; Calamai M, 2005, BIOPHYS J, V89, P4201, DOI 10.1529/biophysj.105.068726; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dosztanyi Z, 2010, BRIEF BIOINFORM, V11, P225, DOI 10.1093/bib/bbp061; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Du ZQ, 2011, PRION, V5, P311, DOI [10.4161/pri.5.4.18304, 10.4161/pri.18304]; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dunker K, 2002, HUM GENOME NEWS, V12, P13; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Angarica VE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-316; Esteras-Chopo A, 2005, P NATL ACAD SCI USA, V102, P16672, DOI 10.1073/pnas.0505905102; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Frousios KK, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-44; Fukuchi S, 2012, NUCLEIC ACIDS RES, V40, pD507, DOI 10.1093/nar/gkr884; Galzitskaya OV, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/28/285225; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Halfmann R, 2011, MOL CELL, V43, P72, DOI 10.1016/j.molcel.2011.05.013; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; Hegyi H, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000552; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Huang K, 2006, BIOCHEMISTRY-US, V45, P10278, DOI 10.1021/bi060879g; Huntley MA, 2002, PROTEINS, V48, P134, DOI 10.1002/prot.10150; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karlin S, 1996, P NATL ACAD SCI USA, V93, P1560, DOI 10.1073/pnas.93.4.1560; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Lise S, 2005, PROTEINS, V58, P144, DOI 10.1002/prot.20279; Maestro B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056904; Magrane M, 2011, UNIPROT KNOWLEDGEBAS; Malinovska L, 2013, BBA-PROTEINS PROTEOM, V1834, P918, DOI 10.1016/j.bbapap.2013.01.003; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Mohan A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000497; Monsellier E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000199; Orosz F, 2011, BIOINFORMATICS, V27, P1449, DOI 10.1093/bioinformatics/btr175; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Pedersen JS, 2004, J MOL BIOL, V341, P575, DOI 10.1016/j.jmb.2004.06.020; Pietrosemoli N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055524; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Raghava G, 2000, APSSP ADV PROTEIN SE, V4, P75; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schad E, 2013, NUCLEIC ACIDS RES, V41, P4409, DOI 10.1093/nar/gkt110; Schlessinger A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004433; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Shin SW, 2005, BIOINFORMATICS, V21, P160, DOI 10.1093/bioinformatics/bth497; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tartaglia GG, 2005, PROTEIN SCI, V14, P2723, DOI 10.1110/ps.051471205; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Teng PK, 2009, PROTEIN ENG DES SEL, V22, P531, DOI 10.1093/protein/gzp037; Thompson A, 2000, J NEUROSCI RES, V62, P293, DOI 10.1002/1097-4547(20001015)62:2<293::AID-JNR14>3.0.CO;2-Y; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tian J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S45; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wang X, J BIOL CHEM, V285, P4951; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; WOOTTON JC, 1994, CURR OPIN STRUC BIOL, V4, P413, DOI 10.1016/S0959-440X(94)90111-2; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yagi H, 2010, BBA-PROTEINS PROTEOM, V1804, P2077, DOI 10.1016/j.bbapap.2010.07.007; Yoon S, 2004, PROTEIN SCI, V13, P2149, DOI 10.1110/ps.04790604; Zhang ZQ, 2007, BIOINFORMATICS, V23, P2218, DOI 10.1093/bioinformatics/btm325	89	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89781	10.1371/journal.pone.0089781	http://dx.doi.org/10.1371/journal.pone.0089781			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594841	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900035
J	Olson, CO; Zachariah, RM; Ezeonwuka, CD; Liyanage, VRB; Rastegar, M				Olson, Carl O.; Zachariah, Robby M.; Ezeonwuka, Chinelo D.; Liyanage, Vichithra R. B.; Rastegar, Mojgan			Brain Region-Specific Expression of MeCP2 Isoforms Correlates with DNA Methylation within Mecp2 Regulatory Elements	PLOS ONE			English	Article							RETT-SYNDROME PHENOTYPES; CPG-BINDING PROTEIN-2; LEUKEMIA-CELL LINE; MOUSE MODEL; GENE-EXPRESSION; BASOLATERAL AMYGDALA; TRANSCRIPTION; NEURONS; PROMOTER; AUTISM	MeCP2 is a critical epigenetic regulator in brain and its abnormal expression or compromised function leads to a spectrum of neurological disorders including Rett Syndrome and autism. Altered expression of the two MeCP2 isoforms, MeCP2E1 and MeCP2E2 has been implicated in neurological complications. However, expression, regulation and functions of the two isoforms are largely uncharacterized. Previously, we showed the role of MeCP2E1 in neuronal maturation and reported MeCP2E1 as the major protein isoform in the adult mouse brain, embryonic neurons and astrocytes. Recently, we showed that DNA methylation at the regulatory elements (REs) within the Mecp2 promoter and intron 1 impact the expression of Mecp2 isoforms in differentiating neural stem cells. This current study is aimed for a comparative analysis of temporal, regional and cell type-specific expression of MeCP2 isoforms in the developing and adult mouse brain. MeCP2E2 displayed a later expression onset than MeCP2E1 during mouse brain development. In the adult female and male brain hippocampus, both MeCP2 isoforms were detected in neurons, astrocytes and oligodendrocytes. Furthermore, MeCP2E1 expression was relatively uniform in different brain regions (olfactory bulb, striatum, cortex, hippocampus, thalamus, brainstem and cerebellum), whereas MeCP2E2 showed differential enrichment in these brain regions. Both MeCP2 isoforms showed relatively similar distribution in these brain regions, except for cerebellum. Lastly, a preferential correlation was observed between DNA methylation at specific CpG dinucleotides within the REs and Mecp2 isoform-specific expression in these brain regions. Taken together, we show that MeCP2 isoforms display differential expression patterns during brain development and in adult mouse brain regions. DNA methylation patterns at the Mecp2 REs may impact this differential expression of Mecp2/MeCP2 isoforms in brain regions. Our results significantly contribute towards characterizing the expression profiles of Mecp2/MeCP2 isoforms and thereby provide insights on the potential role of MeCP2 isoforms in the developing and adult brain.	[Rastegar, Mojgan] Univ Manitoba, Fac Med, Regenerat Med Program, Winnipeg, MB, Canada; Univ Manitoba, Fac Med, Dept Biochem & Med Genet, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Rastegar, M (corresponding author), Univ Manitoba, Fac Med, Regenerat Med Program, Winnipeg, MB, Canada.	rastegar@cc.umanitoba.ca	Rastegar, Mojgan/T-9394-2019	Rastegar, Mojgan/0000-0003-3619-6116	Scottish Rite Charitable Foundation of Canada (SRCFC) [10110]; Manitoba Health Research Council (MHRC); Health Sciences Centre Foundation (HSCF); MHRC/MICH/UMGF	Scottish Rite Charitable Foundation of Canada (SRCFC); Manitoba Health Research Council (MHRC); Health Sciences Centre Foundation (HSCF); MHRC/MICH/UMGF	This work is supported by funds from the Scottish Rite Charitable Foundation of Canada (SRCFC, grant 10110), Manitoba Health Research Council (MHRC) Establishment Award, and Health Sciences Centre Foundation (HSCF) grant to MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RMZ, CDE and VRBL are recipients of MHRC/MICH/UMGF studentship awards.	Adachi M, 2005, HUM MOL GENET, V14, P3709, DOI 10.1093/hmg/ddi402; Adachi M, 2009, J NEUROSCI, V29, P4218, DOI 10.1523/JNEUROSCI.4225-08.2009; Alcobia I, 2000, BLOOD, V95, P1608, DOI 10.1182/blood.V95.5.1608.005k32_1608_1615; Armstrong DD, 2005, J CHILD NEUROL, V20, P747, DOI 10.1177/08830738050200082401; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Barber BA, 2013, ANN ANAT; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Cartron Pierre-Francois, 2013, Genes Cancer, V4, P235, DOI 10.1177/1947601913489020; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cusack SM, 2004, EXP CELL RES, V299, P442, DOI 10.1016/j.yexcr.2004.05.035; Dastidar SG, 2012, J NEUROSCI, V32, P2846, DOI 10.1523/JNEUROSCI.5841-11.2012; Delcuve GP, 2009, J CELL PHYSIOL, V219, P243, DOI 10.1002/jcp.21678; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Dragich JM, 2007, J COMP NEUROL, V501, P526, DOI 10.1002/cne.21264; Ezeonwuka Chinelo D, 2014, Diseases, V2, P45, DOI 10.3390/diseases2010045; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Furuta T, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-39; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Gordon J, 2003, INT J CANCER, V103, P316, DOI 10.1002/ijc.10828; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Itoh M, 2012, J BIOL CHEM, V287, P13859, DOI 10.1074/jbc.M111.309864; Jugloff DGM, 2008, HUM MOL GENET, V17, P1386, DOI 10.1093/hmg/ddn026; Jung BP, 2003, J NEUROBIOL, V55, P86, DOI 10.1002/neu.10201; Kim P, 2013, NEUROCHEM RES, V38, P620, DOI 10.1007/s11064-012-0960-5; Kobrossy L, 2006, J BIOL CHEM, V281, P25926, DOI 10.1074/jbc.M602555200; Kriaucionis S, 2004, NUCLEIC ACIDS RES, V32, P1818, DOI 10.1093/nar/gkh349; LaSalle JM, 2009, EPIGENOMICS-UK, V1, P119, DOI [10.2217/epi.09.13, 10.2217/EPI.09.13]; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Liu J, 2006, HUM MOL GENET, V15, P1769, DOI 10.1093/hmg/ddl099; Liyanage V.R.B., 2012, NEW DEV CHROMATIN RE, P29; Liyanage VRB, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-46; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Mayer R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-44; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Mnatzakanian GN, 2004, NAT GENET, V36, P339, DOI 10.1038/ng1327; Na ES, 2012, J NEUROSCI, V32, P3109, DOI 10.1523/JNEUROSCI.6000-11.2012; Nagarajan RP, 2006, EPIGENETICS-US, V1, P172, DOI 10.4161/epi.1.4.3514; Nagarajan RP, 2008, AUTISM RES, V1, P169, DOI 10.1002/aur.24; Nestor C, 2010, BIOTECHNIQUES, V48, P317, DOI 10.2144/000113403; Nolte C, 2006, DEV BIOL, V299, P582, DOI 10.1016/j.ydbio.2006.08.061; Okabe Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035354; OLDFORS A, 1990, PEDIATR NEUROL, V6, P310, DOI 10.1016/0887-8994(90)90022-S; Petel-Galil Y, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041285; Rastegar M, 2000, ENDOCRINOLOGY, V141, P1686, DOI 10.1210/en.141.5.1686; Rastegar M, 2004, MOL CELL BIOL, V24, P8090, DOI 10.1128/MCB.24.18.8090-8103.2004; Rastegar M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006810; REISS AL, 1993, ANN NEUROL, V34, P227, DOI 10.1002/ana.410340220; Repunte-Canonigo V., 2013, ADDICT BIOL; Romano-Lopez A, 2012, NEUROSCIENCE, V223, P296, DOI 10.1016/j.neuroscience.2012.07.071; Ronnett GV, 2003, ANN NEUROL, V54, P206, DOI 10.1002/ana.10633; Samaco RC, 2004, HUM MOL GENET, V13, P629, DOI 10.1093/hmg/ddh063; Saxena A, 2006, J MED GENET, V43, P470, DOI 10.1136/jmg.2005.036244; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Sheikh TI, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-108; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Singh J, 2008, NUCLEIC ACIDS RES, V36, P6035, DOI 10.1093/nar/gkn591; Subramaniam B, 1997, NEUROLOGY, V48, P399, DOI 10.1212/WNL.48.2.399; Taylor MM, 2012, J NEUROSCI, V32, P9451, DOI 10.1523/JNEUROSCI.2043-12.2012; Tunc-Ozcan E, 2013, ALCOHOL CLIN EXP RES; Vora P, 2010, NEUROREPORT, V21, P917, DOI 10.1097/WNR.0b013e32833da500; Wither RG, 2013, EXP NEUROL, V239, P49, DOI 10.1016/j.expneurol.2012.09.005; Wu CH, 2001, ONCOGENE, V20, P7006, DOI 10.1038/sj.onc.1204893; Wu SH, 2009, J NEUROSCI, V29, P9941, DOI 10.1523/JNEUROSCI.2540-09.2009; Wu W, 2012, NEUROL RES, V34, P107, DOI 10.1179/016164111X13214359296301; Yasui DH, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-3; Yasui DH, 2014, HUM MOL GENET; Zachariah RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049763; Zachariah RM, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/415825; Zhu WG, 2003, MOL CELL BIOL, V23, P4056, DOI 10.1128/MCB.23.12.4056-4065.2003	76	56	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90645	10.1371/journal.pone.0090645	http://dx.doi.org/10.1371/journal.pone.0090645			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594659	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900129
J	Storm, MP; Kumpfmueller, B; Bone, HK; Buchholz, M; Ripoll, YS; Chaudhuri, JB; Niwa, H; Tosh, D; Welham, MJ				Storm, Michael P.; Kumpfmueller, Benjamin; Bone, Heather K.; Buchholz, Michael; Ripoll, Yolanda Sanchez; Chaudhuri, Julian B.; Niwa, Hitoshi; Tosh, David; Welham, Melanie J.			Zscan4 Is Regulated by PI3-Kinase and DNA-Damaging Agents and Directly Interacts with the Transcriptional Repressors LSD1 and CtBP2 in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							SELF-RENEWAL; SCAN DOMAIN; GENOMIC STABILITY; GENE-EXPRESSION; PLURIPOTENCY; ACTIVATION; DIFFERENTIATION; PROTEIN; PROLIFERATION; INVOLVEMENT	The Zscan4 family of genes, encoding SCAN-domain and zinc finger-containing proteins, has been implicated in the control of early mammalian embryogenesis as well as the regulation of pluripotency and maintenance of genome integrity in mouse embryonic stem cells. However, many features of this enigmatic family of genes are poorly understood. Here we show that undifferentiated mouse embryonic stem cell (ESC) lines simultaneously express multiple members of the Zscan4 gene family, with Zscan4c, Zscan4f and Zscan4-ps2 consistently being the most abundant. Despite this, between only 0.1 and 0.7% of undifferentiated mouse pluripotent stem cells express Zscan4 protein at a given time, consistent with a very restricted pattern of Zscan4 transcripts reported previously. Herein we demonstrate that Zscan4 expression is regulated by the p110 alpha catalytic isoform of phosphoinositide 3-kinases and is induced following exposure to a sub-class of DNA-damage-inducing agents, including Zeocin and Cisplatin. Furthermore, we observe that Zscan4 protein expression peaks during the G2 phase of the cell cycle, suggesting that it may play a critical role at this checkpoint. Studies with GAL4-fusion proteins suggest a role for Zscan4 in transcriptional regulation, further supported by the fact that protein interaction analyses demonstrate that Zscan4 interacts with both LSD1 and CtBP2 in ESC nuclei. This study advances and extends our understanding of Zscan4 expression, regulation and mechanism of action. Based on our data we propose that Zscan4 may regulate gene transcription in mouse ES cells through interaction with LSD1 and CtBP2.	[Storm, Michael P.; Kumpfmueller, Benjamin; Bone, Heather K.; Ripoll, Yolanda Sanchez; Welham, Melanie J.] Univ Bath, Ctr Regenerat Med, Bath BA2 7AY, Avon, England; [Storm, Michael P.; Kumpfmueller, Benjamin; Bone, Heather K.; Ripoll, Yolanda Sanchez; Welham, Melanie J.] Univ Bath, Dept Pharm, Bath BA2 7AY, Avon, England; [Storm, Michael P.; Kumpfmueller, Benjamin; Bone, Heather K.; Ripoll, Yolanda Sanchez; Welham, Melanie J.] Univ Bath, Dept Pharmacol, Bath BA2 7AY, Avon, England; [Buchholz, Michael; Tosh, David] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Kumpfmueller, Benjamin; Chaudhuri, Julian B.] Univ Bath, Dept Chem Engn, Bath, Avon, England; [Niwa, Hitoshi] RIKEN, Ctr Dev Biol, Kobe, Hyogo, Japan	University of Bath; University of Bath; University of Bath; University of Bath; University of Bath; RIKEN	Welham, MJ (corresponding author), Univ Bath, Ctr Regenerat Med, Bath BA2 7AY, Avon, England.	M.J.Welham@bath.ac.uk	Storm, Mike/AAC-8733-2020		Medical Research Council [G0801108]; Marie Curie Early Stage Training programme [MEST-CT-2005-019822]; MRC; MRC [G0801108] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie Early Stage Training programme(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by grant G0801108 from The Medical Research Council (http://www.mrc.ac.uk/index.htm). BK and MB were supported by the Marie Curie Early Stage Training programme MEST-CT-2005-019822. YSR was the recipient of an MRC Capacity Building Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2966; Boeuf H, 1997, J CELL BIOL, V138, P1207, DOI 10.1083/jcb.138.6.1207; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Bone HK, 2009, CHEM BIOL, V16, P15, DOI 10.1016/j.chembiol.2008.11.003; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Carter MG, 2008, GENE EXPR PATTERNS, V8, P181, DOI 10.1016/j.gep.2007.10.009; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Costello I, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-54; Crabbe T, 2007, TRENDS BIOCHEM SCI, V32, P450, DOI 10.1016/j.tibs.2007.09.001; Craddock BL, 2001, J BIOL CHEM, V276, P24274, DOI 10.1074/jbc.M009098200; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Edelstein LC, 2005, GENE, V359, P1, DOI 10.1016/j.gene.2005.06.022; Era T, 2000, P NATL ACAD SCI USA, V97, P1737, DOI 10.1073/pnas.97.4.1737; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hirata T, 2012, SCI REPORTS, V2, P1; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Jiang J, 2013, CELL RES, V23, P92, DOI 10.1038/cr.2012.157; Kingham E, 2009, J CELL SCI, V122, P2311, DOI 10.1242/jcs.046557; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Marmorstein R, 2009, BIOCH BIOPHYS ACTA, V1789; Nagaria P, 2013, BBA-GEN SUBJECTS, V1830, P2345, DOI 10.1016/j.bbagen.2012.09.001; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Orlando L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030234; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SAVATIER P, 1994, ONCOGENE, V9, P809; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; Schumacher C, 2000, J BIOL CHEM, V275, P17173, DOI 10.1074/jbc.M000119200; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; SMITH AG, 1987, DEV BIOL, V121, P1, DOI 10.1016/0012-1606(87)90132-1; Stone JR, 2002, J BIOL CHEM, V277, P5448, DOI 10.1074/jbc.M109815200; Storm MP, 2009, STEM CELLS, V27, P764, DOI 10.1002/stem.3; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Turinetto V, 2012, STEM CELLS, V30, P1414, DOI 10.1002/stem.1133; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Welham MJ, 2011, BIOCHEM SOC T, V39, P674, DOI 10.1042/BST0390674; WELHAM MJ, 1994, J BIOL CHEM, V269, P21165; Williams AJ, 1999, MOL CELL BIOL, V19, P8526; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zhang W, 2006, NUCLEIC ACIDS RES, V34, P4780, DOI 10.1093/nar/gkl631	60	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89821	10.1371/journal.pone.0089821	http://dx.doi.org/10.1371/journal.pone.0089821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594919	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900036
J	Xiong, CR; Fang, FJ; Chen, L; Yang, QG; He, J; Zhou, D; Shen, B; Ma, L; Sun, Y; Zhang, DH; Zhu, CL				Xiong, Chunrong; Fang, Fujin; Chen, Lin; Yang, Qinggui; He, Ji; Zhou, Dan; Shen, Bo; Ma, Lei; Sun, Yan; Zhang, Donghui; Zhu, Changliang			Trypsin-Catalyzed Deltamethrin Degradation	PLOS ONE			English	Article							CHYMOTRYPSIN; METABOLISM; ABSORPTION; DIGESTION	To explore if trypsin could catalyze the degradation of non-protein molecule deltamethrin, we compared in vitro hydrolytic reactions of deltamethrin in the presence and absence of trypsin with ultraviolet-visible (UV/Vis) spectrophotometry and gas chromatography-mass spectrometry (GC/MS). In addition, acute oral toxicity of the degradation products was determined in Wistar rats. The results show that the absorption peak of deltamethrin is around 264 nm, while the absorption peaks of eltamethrin degradation products are around 250 nm and 296 nm. In our GC setting, the retention time of undegraded deltamethrin was 37.968 min, while those of deltamethrin degradation products were 15.289 min and 18.730 min. The LD50 of deltamethrin in Wistar rats is 55 mg/kg, while that of deltamethrin degradation products is 3358 mg/kg in female rats and 1045 mg/kg in male rates (61-fold and 19-fold reductions in toxicity), suggesting that trypsin could directly degrade deltamethrin, which significantly reduces the toxicity of deltamethrin. These results expand people's understanding of the functions of proteases and point to potential applications of trypsin as an attractive agent to control residual pesticides in the environment and on agricultural products.	[Xiong, Chunrong; Fang, Fujin; Chen, Lin; Yang, Qinggui; He, Ji; Zhou, Dan; Shen, Bo; Ma, Lei; Sun, Yan; Zhang, Donghui; Zhu, Changliang] Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Xiong, Chunrong; Fang, Fujin; Chen, Lin; Yang, Qinggui; He, Ji; Zhou, Dan; Shen, Bo; Ma, Lei; Sun, Yan; Zhang, Donghui; Zhu, Changliang] Jiangsu Prov Key Lab Modern Pathogen Biol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zhang, DH (corresponding author), Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China.	donghuizhang2004@gmail.com			Academic Natural Science Foundation of Jiangsu Province [07KJD180137]; National Institutes of Health of the USA [R01AI075746]; National Natural Science Foundation of China [30972564, 81171900, 30901244]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075746] Funding Source: NIH RePORTER	Academic Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Institutes of Health of the USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Academic Natural Science Foundation of Jiangsu Province (No. 07KJD180137 to Donghui Zhang), the National Institutes of Health of the USA (No. R01AI075746 to Changliang Zhu) and the National Natural Science Foundation of China (Nos. 30972564 and 81171900 to Changliang Zhu, No. 30901244 to Yan Sun). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, World Health Organ Tech Rep Ser, V818, P1; Chen SH, 2011, APPL MICROBIOL BIOT, V90, P755, DOI 10.1007/s00253-010-3035-z; ERICKSON RH, 1990, ANNU REV MED, V41, P133; FREEMAN HJ, 1978, ANNU REV MED, V29, P99, DOI 10.1146/annurev.me.29.020178.000531; Gong MQ, 2005, ARCH BIOCHEM BIOPHYS, V438, P53, DOI 10.1016/j.abb.2005.03.021; Krem MM, 2001, EMBO J, V20, P3036, DOI 10.1093/emboj/20.12.3036; KUNDU N, 1970, NATURE, V226, P1171, DOI 10.1038/2261171a0; Kushida K, 2001, J CHROMATOGR B, V762, P137, DOI 10.1016/S0378-4347(01)00353-X; Leng G, 2005, J CHROMATOGR B, V814, P285, DOI 10.1016/j.jchromb.2004.10.044; MCLAREN AD, 1957, ARCH BIOCHEM BIOPHYS, V68, P157, DOI 10.1016/0003-9861(57)90336-3; Modi SJ, 2006, J CHROMATOGR A, V1118, P125, DOI 10.1016/j.chroma.2006.02.045; Muhlia-Almazan A, 2008, J COMP PHYSIOL B, V178, P655, DOI 10.1007/s00360-008-0263-y; Ramesh A, 2004, J CHROMATOGR B, V802, P371, DOI 10.1016/j.jchromb.2003.12.016; Rawlings N.D., 1998, HDB PROTEOLYTIC ENZY, P369; Ross MK, 2006, BIOCHEM PHARMACOL, V71, P657, DOI 10.1016/j.bcp.2005.11.020; Wu HW, 2004, PESTIC BIOCHEM PHYS, V79, P75, DOI 10.1016/j.pestbp.2004.04.004; Yang QG, 2008, TOXICOL IN VITRO, V22, P1528, DOI 10.1016/j.tiv.2008.05.007; Zheng YZ, 2007, APPL BIOCHEM BIOTECH, V136, P233, DOI 10.1007/s12010-007-9022-x	18	13	13	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89517	10.1371/journal.pone.0089517	http://dx.doi.org/10.1371/journal.pone.0089517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594869	Green Submitted, gold, Green Published			2022-12-27	WOS:000332468900021
J	Adam, M; Heuer, H; Hallmann, J				Adam, Mohamed; Heuer, Holger; Hallmann, Johannes			Bacterial Antagonists of Fungal Pathogens Also Control Root-Knot Nematodes by Induced Systemic Resistance of Tomato Plants	PLOS ONE			English	Article							MELOIDOGYNE-INCOGNITA; PARASITIC NEMATODES; RHIZOCTONIA-SOLANI; FUSARIUM-OXYSPORUM; BIOLOGICAL-CONTROL; POTATO; BIOCONTROL; BACILLUS; DISEASE; G12	The potential of bacterial antagonists of fungal pathogens to control the root-knot nematode Meloidogyne incognita was investigated under greenhouse conditions. Treatment of tomato seeds with several strains significantly reduced the numbers of galls and egg masses compared with the untreated control. Best performed Bacillus subtilis isolates Sb4-23, Mc5-Re2, and Mc2-Re2, which were further studied for their mode of action with regard to direct effects by bacterial metabolites or repellents, and plant mediated effects. Drenching of soil with culture supernatants significantly reduced the number of egg masses produced by M. incognita on tomato by up to 62% compared to the control without culture supernatant. Repellence of juveniles by the antagonists was shown in a linked twin-pot set-up, where a majority of juveniles penetrated roots on the side without inoculated antagonists. All tested biocontrol strains induced systemic resistance against M. incognita in tomato, as revealed in a split-root system where the bacteria and the nematodes were inoculated at spatially separated roots of the same plant. This reduced the production of egg masses by up to 51%, while inoculation of bacteria and nematodes in the same pot had only a minor additive effect on suppression of M. incognita compared to induced systemic resistance alone. Therefore, the plant mediated effect was the major reason for antagonism rather than direct mechanisms. In conclusion, the bacteria known for their antagonistic potential against fungal pathogens also suppressed M. incognita. Such "multi-purpose" bacteria might provide new options for control strategies, especially with respect to nematode-fungus disease complexes that cause synergistic yield losses.	[Adam, Mohamed; Heuer, Holger; Hallmann, Johannes] Fed Res Ctr Cultivated Plants JKI, Julius Kuhn Inst, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Germany; [Adam, Mohamed] Cairo Univ, Dept Zool & Nematol, Giza, Egypt	Julius Kuhn-Institut; Egyptian Knowledge Bank (EKB); Cairo University	Hallmann, J (corresponding author), Fed Res Ctr Cultivated Plants JKI, Julius Kuhn Inst, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Germany.	johannes.hallmann@jki.bund.de		Heuer, Holger/0000-0001-6044-8171	Egyptian government	Egyptian government	MA was funded by a scholarship of the Egyptian government. The Julius Kuehn-Institut provided consumables and a place for greenhouse experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay E, 2013, EUR J PLANT PATHOL, V135, P137, DOI 10.1007/s10658-012-0073-7; Aballay E, 2011, PLANT SOIL, V347, P313, DOI 10.1007/s11104-011-0851-6; Adesina MF, 2009, FEMS MICROBIOL ECOL, V69, P62, DOI 10.1111/j.1574-6941.2009.00685.x; Ali NI, 2002, SOIL BIOL BIOCHEM, V34, P1051, DOI 10.1016/S0038-0717(02)00029-9; Atkinson GF, 1892, ALA AGR EXP ST B, V41, P65; Back MA, 2002, PLANT PATHOL, V51, P683, DOI 10.1046/j.1365-3059.2002.00785.x; BECKER JO, 1988, PHYTOPATHOLOGY, V78, P1466, DOI 10.1094/Phyto-78-1466; Burkett-Cadena M, 2008, BIOL CONTROL, V47, P55, DOI 10.1016/j.biocontrol.2008.07.008; Dababat AEFA, 2007, BIOCONTROL SCI TECHN, V17, P969, DOI 10.1080/09583150701582057; El-Fattah A, 2007, NEMATOLOGY, V9, P771, DOI 10.1163/156854107782331225; Hallmann J, 2001, PHYTOPATHOLOGY, V91, P415, DOI 10.1094/PHYTO.2001.91.4.415; Hallmann J, 2010, ROOT-KNOT NEMATODES, P380, DOI 10.1079/9781845934927.0380; Hasky-Gunther K, 1998, FUND APPL NEMATOL, V21, P511; Hauschild R, 2000, INT S CROP, V65, P527; Hooper D. J., 2005, PLANT PARASIT NEMAT, V2, P53, DOI DOI 10.1079/9780851997278.0053; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; Kerry, 1987, PRINCIPLES PRACTICE, P294; Koberl M, 2013, FEMS MICROBIOL LETT, V342, P168, DOI 10.1111/1574-6968.12089; Krechel A, 2002, CAN J MICROBIOL, V48, P772, DOI [10.1139/w02-071, 10.1139/W02-071]; Mansoori Mahdiyeh, 2013, Journal of Plant Protection Research, V53, P154, DOI 10.2478/jppr-2013-0023; Martinuz A, 2012, PHYTOPATHOLOGY, V102, P260, DOI 10.1094/PHYTO-04-11-0120; Muller H, 2009, FEMS MICROBIOL ECOL, V67, P468, DOI 10.1111/j.1574-6941.2008.00635.x; Oliveira DF, 2007, EUR J PLANT PATHOL, V119, P477, DOI 10.1007/s10658-007-9176-y; Padgham JL, 2007, CROP PROT, V26, P971, DOI 10.1016/j.cropro.2006.09.004; Pengnoo A, 2006, WORLD J MICROB BIOT, V22, P9, DOI 10.1007/s11274-005-2820-9; Reitz M, 2000, APPL ENVIRON MICROB, V66, P3515, DOI 10.1128/AEM.66.8.3515-3518.2000; Reitz M, 2002, NEMATOLOGY, V4, P73, DOI 10.1163/156854102760082221; SASSER JN, 1983, ANNU REV PHYTOPATHOL, V21, P271, DOI 10.1146/annurev.py.21.090183.001415; Schafer K., 2007, THESIS RHEINISCHE FR; Scherwinski K, 2008, FEMS MICROBIOL ECOL, V64, P106, DOI 10.1111/j.1574-6941.2007.00421.x; Siddiqui IA, 2000, PLANT SOIL, V227, P163, DOI 10.1023/A:1026599532684; Siddiqui ZA, 1999, BIORESOURCE TECHNOL, V69, P167, DOI 10.1016/S0960-8524(98)00122-9; Sikora RA, 2007, AUSTRALAS PLANT PATH, V36, P124, DOI 10.1071/AP07008; Sikora R.A, 1995, NEMATOLOGICA, V41, P306; Tariq S, 2009, PAK J BOT, V41, P3191; Trudgill DL, 2001, ANNU REV PHYTOPATHOL, V39, P53, DOI 10.1146/annurev.phyto.39.1.53; Verma KK, 2007, HARYANA J HORTIC SCI, V36, P297	37	70	76	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90402	10.1371/journal.pone.0090402	http://dx.doi.org/10.1371/journal.pone.0090402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587352	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200191
J	Fuermaier, ABM; Tucha, L; Koerts, J; van Heuvelen, MJG; van der Zee, EA; Lange, KW; Tucha, O				Fuermaier, Anselm B. M.; Tucha, Lara; Koerts, Janneke; van Heuvelen, Marieke J. G.; van der Zee, Eddy A.; Lange, Klaus W.; Tucha, Oliver			Good Vibrations - Effects of Whole Body Vibration on Attention in Healthy Individuals and Individuals with ADHD	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY-DISORDER; COGNITIVE PERFORMANCE; SUBJECTIVE EXPERIENCE; ADULT ADHD; CHILDREN; EXPOSURE; NOISE; METHYLPHENIDATE; INHIBITION; DOPAMINE	Objectives: Most of the current treatment strategies of ADHD are associated with a number of disadvantages which strengthen the need for alternative or additional approaches for the treatment of ADHD. In this respect, Whole Body Vibration (WBV) might be interesting as it was found to have beneficial effects on a variety of physiological measures. The present study explored the effects of WBV on attention of healthy individuals and adults diagnosed with ADHD. Methods: Eighty-three healthy individuals and seventeen adults diagnosed with ADHD participated in the study. WBV treatment was applied passively, while participants were sitting on a chair which was mounted on a vibrating platform. A repeated measure design was employed in order to explore potential effects of WBV treatment on attention within subjects. Attention (i.e. inhibitory control) was measured with a color-word interference paradigm. Results: A period of two minutes of WBV treatment had significant beneficial effects of small to medium size on attention of both healthy individuals and adults with ADHD. The effect of WBV treatment on attention did not differ significantly between groups. Conclusions: WBV was demonstrated to improve cognitive performance of healthy individuals as well as of individuals with ADHD. WBV treatment is relatively inexpensive and easy to apply and might therefore be of potential relevance for clinical use. The application of WBV treatment as a cognitive enhancement strategy and as a potential treatment of cognitive impairments is discussed.	[Fuermaier, Anselm B. M.; Tucha, Lara; Koerts, Janneke; Tucha, Oliver] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [van Heuvelen, Marieke J. G.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [van der Zee, Eddy A.] Univ Groningen, Dept Mol Neurobiol, Ctr Behav & Neurosci, Groningen, Netherlands; [Lange, Klaus W.] Univ Regensburg, Dept Expt Psychol, D-93053 Regensburg, Germany	University of Groningen; University of Groningen; University of Groningen; University of Regensburg	Lange, KW (corresponding author), Univ Regensburg, Dept Expt Psychol, D-93053 Regensburg, Germany.	klaus.lange@ur.de	van der Zee, Eddy/AAZ-2120-2020; Tucha, Oliver/AAD-1403-2019	Fuermaier, Anselm/0000-0002-2331-0840				Abbate C, 2004, PSYCHOTHER PSYCHOSOM, V73, P375, DOI 10.1159/000080391; Adler LA, 2009, J ATTEN DISORD, V12, P449, DOI 10.1177/1087054708320397; Agarwal Rashi, 2012, Innov Clin Neurosci, V9, P10; Arias-Carrion O, 2007, ACTA NEUROBIOL EXP, V67, P481; Arnsten AFT, 2012, NEURON, V76, P223, DOI 10.1016/j.neuron.2012.08.038; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2006, ATTENTION DEFICIT HY; Barkley RA, 2010, ARCH CLIN NEUROPSYCH, V25, P157, DOI 10.1093/arclin/acq014; Biederman J, 2008, J ATTEN DISORD, V12, P92, DOI 10.1177/1087054707305111; Bogaerts A, 2007, GAIT POSTURE, V26, P309, DOI 10.1016/j.gaitpost.2006.09.078; Boonstra AM, 2010, NEUROPSYCHOLOGY, V24, P209, DOI 10.1037/a0017670; Boonstra AM, 2005, PSYCHOL MED, V35, P1097, DOI 10.1017/S003329170500499X; Canu Will H, 2007, J Atten Disord, V10, P261, DOI 10.1177/1087054706288106; Cardinale M, 2003, EXERC SPORT SCI REV, V31, P3, DOI 10.1097/00003677-200301000-00002; Cochrane DI, 2008, ARCH PHYS MED REHAB, V89, P815, DOI 10.1016/j.apmr.2007.09.055; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costa N, 2012, WORK, V41, P3039, DOI [10.3233/WOR-2012-0561, 10.3233/WOR-2012-0561-3039]; Daley D, 2010, CHILD CARE HLTH DEV, V36, P455, DOI 10.1111/j.1365-2214.2009.01046.x; del Pozo-Cruz B, 2012, J ALTERN COMPLEM MED, V18, P29, DOI 10.1089/acm.2010.0691; DuPaul G. J., 1998, ADHD RATING SCALE 4; Durston S, 2007, DEV REV, V27, P374, DOI 10.1016/j.dr.2007.05.001; Fuermaier ABM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065134; Fuermaier ABM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058338; Heckman J.J., 2011, AM EDUC, V35, P31; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Ishihara S., 1917, TESTS COLOR BLINDNES; Kawanabe Kazuhiro, 2007, Keio Journal of Medicine, V56, P28, DOI 10.2302/kjm.56.28; Keijser N, 2011, 9 DUTCH ENP M, P125; King LK, 2009, NEUROREHABILITATION, V25, P297, DOI 10.3233/NRE-2009-0528; Kooij JJS, 2008, J ATTEN DISORD, V11, P445, DOI 10.1177/1087054707299367; Kooij JJS, 2005, PSYCHOL MED, V35, P817, DOI 10.1017/S003329170400337X; Lahr MMH, 2009, 8 DUTCH END M, V170; Lam FMH, 2012, MATURITAS, V72, P206, DOI 10.1016/j.maturitas.2012.04.009; Lange KW, 2010, ADHD-ATTEND DEFICIT, V2, P241, DOI 10.1007/s12402-010-0045-8; Ljungberg J, 2004, INT ARCH OCC ENV HEA, V77, P217, DOI 10.1007/s00420-003-0497-7; Ljungberg JK, 2007, J ENVIRON PSYCHOL, V27, P44, DOI 10.1016/j.jenvp.2006.12.003; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mueller AK, 2012, ADHD-ATTEND DEFICIT, V4, P101, DOI 10.1007/s12402-012-0085-3; Muller SV, 2002, ARCH PHYS MED REHAB, V83, P115, DOI 10.1053/apmr.2002.27472; Pescosolido BA, 2007, PSYCHIAT SERV, V58, P619, DOI 10.1176/appi.ps.58.5.619; POULTON EC, 1978, APPL ERGON, V9, P73, DOI 10.1016/0003-6870(78)90151-5; Regterschot R, WHOLE BODY VIB UNPUB; Rosler M., 2008, HOMBURGER ADHS SKALE; SANDOVER J, 1984, J SOUND VIB, V95, P203, DOI 10.1016/0022-460X(84)90542-X; Santos SD, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/274728; Schoechlin C, 2005, ARCH CLIN NEUROPSYCH, V20, P727, DOI 10.1016/j.acn.2005.04.005; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; SHERWOOD N, 1990, AVIAT SPACE ENVIR MD, V61, P1092; SHERWOOD N, 1992, J SOUND VIB, V152, P219, DOI 10.1016/0022-460X(92)90357-4; Rabert MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009097.pub2; Soderlund G, 2007, J CHILD PSYCHOL PSYC, V48, P840, DOI 10.1111/j.1469-7610.2007.01749.x; Soderlund GBW, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-55; Sonuga-Barke EJS, 2013, AM J PSYCHIAT, V170, P275, DOI 10.1176/appi.ajp.2012.12070991; Stark C, 2010, J MUSCULOSKEL NEURON, V10, P151; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stewart JM, 2005, AM J PHYSIOL-REG I, V288, pR623, DOI 10.1152/ajpregu.00513.2004; Tannock R, 1998, J CHILD PSYCHOL PSYC, V39, P65, DOI 10.1017/S0021963097001777; Timmer M, 2006, FED EUR NEUR SOC ABS, V3; Tripp G, 2009, NEUROPHARMACOLOGY, V57, P579, DOI 10.1016/j.neuropharm.2009.07.026; Tucha L, 2008, J NEURAL TRANSM, V115, P269, DOI 10.1007/s00702-007-0836-z; Tucha L, 2011, J ATTEN DISORD, V15, P161, DOI 10.1177/1087054709356391; Tucha O, 2006, J NEURAL TRANSM, V113, P1943, DOI 10.1007/s00702-006-0496-4; Tucha O, 2006, J NEURAL TRANSM, V113, P1575, DOI 10.1007/s00702-005-0437-7; Tucha Oliver, 2005, Cogn Neuropsychiatry, V10, P231, DOI 10.1080/13546800444000047; Van der Zee EA, 2010, FED EUR NEUR SOC ABS, V5; Vidal-Estrada R, 2012, ACTAS ESP PSIQUIATRI, V40, P147; WARD MF, 1993, AM J PSYCHIAT, V150, P885; WEALE RA, 1953, BRIT MED J, V1, P1148, DOI 10.1136/bmj.1.4820.1148; Wigal SB, 2009, CNS DRUGS, V23, P21, DOI 10.2165/00023210-200923000-00004; Wigal T, 1999, MENT RETARD DEV D R, V5, P215, DOI 10.1002/(SICI)1098-2779(1999)5:3<215::AID-MRDD8>3.0.CO;2-K; Wilens Timothy E, 2002, J Atten Disord, V5, P189	71	36	39	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90747	10.1371/journal.pone.0090747	http://dx.doi.org/10.1371/journal.pone.0090747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587412	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200248
J	Hall, BG				Hall, Barry G.			SNP-Associations and Phenotype Predictions from Hundreds of Microbial Genomes without Genome Alignments	PLOS ONE			English	Article								SNP-association studies are a starting point for identifying genes that may be responsible for specific phenotypes, such as disease traits. The vast bulk of tools for SNP-association studies are directed toward SNPs in the human genome, and I am unaware of any tools designed specifically for such studies in bacterial or viral genomes. The PPFS (Predict Phenotypes From SNPs) package described here is an add-on to kSNP, a program that can identify SNPs in a data set of hundreds of microbial genomes. PPFS identifies those SNPs that are non-randomly associated with a phenotype based on the chi(2) probability, then uses those diagnostic SNPs for two distinct, but related, purposes: (1) to predict the phenotypes of strains whose phenotypes are unknown, and (2) to identify those diagnostic SNPs that are most likely to be causally related to the phenotype. In the example illustrated here, from a set of 68 E. coli genomes, for 67 of which the pathogenicity phenotype was known, there were 418,500 SNPs. Using the phenotypes of 36 of those strains, PPFS identified 207 diagnostic SNPs. The diagnostic SNPs predicted the phenotypes of all of the genomes with 97% accuracy. It then identified 97 SNPs whose probability of being causally related to the pathogenic phenotype was >0.999. In a second example, from a set of 116 E. coli genome sequences, using the phenotypes of 65 strains PPFS identified 101 SNPs that predicted the source host (human or non-human) with 90% accuracy.	Bellingham Res Inst, Bellingham, WA 98225 USA		Hall, BG (corresponding author), Bellingham Res Inst, Bellingham, WA 98225 USA.	barryghall@gmail.com						Gardner SN, 2013, PLOS ONE, V8; Gardner SN, 2010, J FORENSIC RES, V01, P2, DOI [10.4172/2157-7145.1000107, DOI 10.4172/2157-7145.1000107]; Hall B.G., 2016, PHYLOGENETIC TREES M; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Luo CW, 2011, P NATL ACAD SCI USA, V108, P7200, DOI 10.1073/pnas.1015622108; Nye TMW, 2006, BIOINFORMATICS, V22, P117, DOI 10.1093/bioinformatics/bti720; Sinclair RG, 2012, APPL ENVIRON MICROB, V78, P1969, DOI 10.1128/AEM.06582-11; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121	8	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90490	10.1371/journal.pone.0090490	http://dx.doi.org/10.1371/journal.pone.0090490			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587377	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200211
J	Kankaanranta, H; Ilmarinen, P; Zhang, XZ; Adcock, IM; Lahti, A; Barnes, PJ; Giembycz, MA; Lindsay, MA; Moilanen, E				Kankaanranta, Hannu; Ilmarinen, Pinja; Zhang, Xianzhi; Adcock, Ian M.; Lahti, Aleksi; Barnes, Peter J.; Giembycz, Mark A.; Lindsay, Mark A.; Moilanen, Eeva			Tumour Necrosis Factor-alpha Regulates Human Eosinophil Apoptosis via Ligation of TNF-Receptor 1 and Balance between NF-kappa B and AP-1	PLOS ONE			English	Article							CELL LIFE; IN-VITRO; ACTIVATION; INHIBITION; KINASE; SURVIVAL; JNK; TRANSCRIPTION; EXPRESSION; INDUCTION	Eosinophils play a central role in asthma. The present study was performed to investigate the effect of tumour necrosis factor-alpha (TNF-alpha) on longevity of isolated human eosinophils. In contrast to Fas, TNF-alpha inhibited eosinophil apoptosis as evidenced by a combination of flow cytometry, DNA fragmentation assay and morphological analyses. The effect of TNF-alpha on eosinophil apoptosis was reversed by a TNF-alpha neutralising antibody. The anti-alpha poptotic effect of TNF-alpha was not due to autocrine release of known survival-prolonging cytokines interleukins 3 and 5 or granulocyte-macrophage-colony-stimulating factor as their neutralisation did not affect the effect of TNF-alpha. The anti-alpha poptotic signal was mediated mainly by the TNF-receptor 1. TNF-alpha induced phosphorylation and degradation of I kappa B and an increase in NF-kappa B DNA-binding activity. The survival-prolonging effect of TNF-alpha was reversed by inhibitors of NF-kappa B pyrrolidinedithiocarbamate and gliotoxin and by an inhibitor of IkB kinase, BMS-345541. TNF-alpha induced also an increase in AP-1 DNA-binding activity and the antiapoptotic effect of TNF-alpha was potentiated by inhibitors of AP-1, SR 11302 and tanshinone IIA and by an inhibitor of c-jun-N-terminal kinase, SP600125, which is an upstream kinase activating AP-1. Our results thus suggest that TNF-alpha delays human eosinophil apoptosis via TNF-receptor 1 and the resulting changes in longevity depend on yin-yang balance between activation of NF-kappa B and AP-1.	[Kankaanranta, Hannu; Ilmarinen, Pinja; Zhang, Xianzhi; Lahti, Aleksi; Moilanen, Eeva] Univ Tampere, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland; [Kankaanranta, Hannu; Ilmarinen, Pinja; Zhang, Xianzhi; Lahti, Aleksi; Moilanen, Eeva] Tampere Univ Hosp, Tampere, Finland; [Kankaanranta, Hannu] Seinajoki Cent Hosp, Dept Resp Med, Seinajoki, Finland; [Kankaanranta, Hannu] Univ Tampere, FIN-33101 Tampere, Finland; [Adcock, Ian M.; Barnes, Peter J.] Natl Heart & Lung Inst, Imperial Coll Sch Med, Airway Dis Sect, London, England; [Giembycz, Mark A.] Univ Calgary, Fac Med, Snyder Inst Chron Dis, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Lindsay, Mark A.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England	Tampere University; Tampere University; Tampere University Hospital; Seinajoki Central Hospital; Imperial College London; University of Calgary; University of Bath	Kankaanranta, H (corresponding author), Univ Tampere, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland.	hannu.kankaanranta@epshp.fi	Adcock, Ian/L-3217-2019	Ilmarinen, Pinja/0000-0002-8758-2431; Barnes, Peter/0000-0002-5122-4018; Lindsay, Mark/0000-0003-4807-5506; Adcock, Ian/0000-0003-2101-8843	Tampere Tuberculosis Foundation (Tampere, Finland); Finnish Anti-Tuberculosis Association Foundation (Helsinki, Finland); Seinajoki Central Hospital; Tampere University Hospital [VTR15, EVO1115, 9N023, 9M059, 9K048, 9H031]; Medical Research Council [G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10148] Funding Source: researchfish	Tampere Tuberculosis Foundation (Tampere, Finland); Finnish Anti-Tuberculosis Association Foundation (Helsinki, Finland); Seinajoki Central Hospital; Tampere University Hospital; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by grants obtained from Tampere Tuberculosis Foundation (Tampere, Finland), the Finnish Anti-Tuberculosis Association Foundation (Helsinki, Finland), and the Competitive Research Funding of Seinajoki Central Hospital and Tampere University Hospital (Grants VTR15, EVO1115, 9N023, 9M059, 9K048 and 9H031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Adcock IM, 2000, EUR RESPIR REV, V10, P289; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Druilhe A, 1996, BLOOD, V87, P2822, DOI 10.1182/blood.V87.7.2822.bloodjournal8772822; Duffin R, 2010, IMMUNOL REV, V236, P28, DOI 10.1111/j.1600-065X.2010.00922.x; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; FANJUL A, 1994, NATURE, V372, P107, DOI 10.1038/372107a0; Fujihara S, 2002, EUR J IMMUNOL, V32, P457, DOI 10.1002/1521-4141(200202)32:2<457::AID-IMMU457>3.0.CO;2-1; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Giembycz MA, 1999, PHARMACOL REV, V51, P213; Hebestreit H, 1996, EUR J IMMUNOL, V26, P1775, DOI 10.1002/eji.1830260817; Ilmarinen P, 2014, BASIC CLIN PHARMACOL, V114, P109, DOI 10.1111/bcpt.12163; Ilmarinen P, 2009, PULM PHARMACOL THER, V22, P167, DOI 10.1016/j.pupt.2008.11.012; Ilmarinen-Salo P, 2010, PULM PHARMACOL THER, V23, P365, DOI 10.1016/j.pupt.2010.04.001; Kankaanranta H, 2000, J ALLERGY CLIN IMMUN, V106, P77; Kankaanranta H, 1999, J PHARMACOL EXP THER, V290, P621; Kankaanranta Hannu, 2005, Current Drug Targets - Inflammation and Allergy, V4, P433, DOI 10.2174/1568010054526395; Kankaanranta H, 2006, MOL PHARMACOL, V69, P1861, DOI 10.1124/mol.105.021170; Kankaanranta H, 2011, PULM PHARMACOL THER, V24, P394, DOI 10.1016/j.pupt.2011.03.002; Keystone EC, 2010, J RHEUMATOL, V37, P27, DOI 10.3899/jrheum.091463; Kriehuber E, 2005, BLOOD, V106, P175, DOI 10.1182/blood-2004-08-3072; Lahti A, 2003, MOL PHARMACOL, V64, P308, DOI 10.1124/mol.64.2.308; Levi-Schaffer F, 1998, J IMMUNOL, V160, P5554; Li HX, 2008, CYTOKINE, V41, P1, DOI 10.1016/j.cyto.2007.09.016; Liu HL, 2002, HEPATOLOGY, V35, P772, DOI 10.1053/jhep.2002.32534; Matera MG, 2010, PULM PHARMACOL THER, V23, P121, DOI 10.1016/j.pupt.2009.10.007; MATSUMOTO K, 1995, BLOOD, V86, P1437, DOI 10.1182/blood.V86.4.1437.bloodjournal8641437; Pahl HL, 1996, J EXP MED, V183, P1829, DOI 10.1084/jem.183.4.1829; Park YM, 2010, ALLERGY ASTHMA IMMUN, V2, P87, DOI 10.4168/aair.2010.2.2.87; Rennard SI, 2007, AM J RESP CRIT CARE, V175, P926, DOI 10.1164/rccm.200607-995OC; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Simon HU, 2009, APOPTOSIS, V14, P439, DOI 10.1007/s10495-008-0299-1; Sung HJ, 1999, EXP MOL MED, V31, P174, DOI 10.1038/emm.1999.28; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tchikov V, 2011, EUR J CELL BIOL, V90, P467, DOI 10.1016/j.ejcb.2010.11.002; Temkin V, 2001, CYTOKINE, V15, P20, DOI 10.1006/cyto.2001.0890; Tsukahara K, 1999, INT ARCH ALLERGY IMM, V120, P54, DOI 10.1159/000053596; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Walsh Garry M, 2013, J Cell Death, V6, P17, DOI 10.4137/JCD.S10818; Ward C, 1999, J BIOL CHEM, V274, P4309, DOI 10.1074/jbc.274.7.4309; Watt A. P., 2005, Current Drug Targets - Inflammation and Allergy, V4, P415, DOI 10.2174/1568010054526313; Wedi B, 1997, J ALLERGY CLIN IMMUN, V100, P536, DOI 10.1016/S0091-6749(97)70147-7; Wenzel SE, 2009, NEW ENGL J MED, V360, P1026, DOI 10.1056/NEJMe0900334; Wenzel SE, 2009, AM J RESP CRIT CARE, V179, P549, DOI 10.1164/rccm.200809-1512OC; Zhang XZ, 2002, LIFE SCI, V71, P1523, DOI 10.1016/S0024-3205(02)01921-5	47	38	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90298	10.1371/journal.pone.0090298	http://dx.doi.org/10.1371/journal.pone.0090298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587316	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200162
J	Bieber, AGD; Silva, PSD; Sendoya, SF; Oliveira, PS				Bieber, Ana Gabriela D.; Silva, Paulo S. D.; Sendoya, Sebastian F.; Oliveira, Paulo S.			Assessing the Impact of Deforestation of the Atlantic Rainforest on Ant-Fruit Interactions: A Field Experiment Using Synthetic Fruits	PLOS ONE			English	Article							SEED DISPERSAL; HABITAT FRAGMENTATION; BIODIVERSITY CONSERVATION; SPECIES RICHNESS; DRY FORESTS; TREE; DISTURBANCE; EDGE; COMMUNITIES; RECRUITMENT	Ants frequently interact with fleshy fruits on the ground of tropical forests. This interaction is regarded as mutualistic because seeds benefit from enhanced germination and dispersal to nutrient-rich microsites, whereas ants benefit from consuming the nutritious pulp/aril. Considering that the process of deforestation affects many attributes of the ecosystem such as species abundance and composition, and interspecific interactions, we asked whether the interaction between ants and fallen fleshy fruits in the Brazilian Atlantic forest differs between human-created fragments and undisturbed forests. We controlled diaspore type and quantity by using synthetic fruits (a plastic 'seed' covered by a lipid-rich 'pulp'), which were comparable to lipid-rich fruits. Eight independent areas (four undisturbed forests, and four disturbed forest fragments) were used in the field experiment, in which we recorded the attracted ant species, ant behaviour, and fruit removal distance. Fruits in undisturbed forest sites attracted a higher number of species than those in disturbed forests. Moreover, the occurrence of large, fruit-carrying ponerine ants (Pachycondyla, Odontomachus; 1.1 to 1.4 cm) was higher in undisturbed forests. Large species (>= 3 mm) of Pheidole (Myrmicinae), also able to remove fruits, did not differ between forest types. Following these changes in species occurrence, fruit displacement was more frequent in undisturbed than in disturbed forests. Moreover, displacement distances were also greater in the undisturbed forests. Our data suggest that fallen fleshy fruits interacting with ants face different fates depending on the conservation status of the forest. Together with the severe loss of their primary dispersers in human-disturbed tropical forest sites, vertebrate-dispersed fruits may also be deprived of potential ant-derived benefits in these habitats due to shifts in the composition of interacting ant species. Our data illustrate the use of synthetic fruits to better understand the ecology of ant-fruit interactions in variable ecological settings, including human-disturbed landscapes.	[Bieber, Ana Gabriela D.; Sendoya, Sebastian F.] Univ Estadual Campinas, Inst Biol, Programa Posgrad Ecol, Campinas, SP, Brazil; [Silva, Paulo S. D.] Univ Estadual Sudoeste da Bahia, Lab Biossistemat Anim, Itapetinga, BA, Brazil; [Oliveira, Paulo S.] Univ Estadual Campinas, Dept Biol Anim, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Oliveira, PS (corresponding author), Univ Estadual Campinas, Dept Biol Anim, Campinas, SP, Brazil.	pso@unicamp.br	Oliveira, Paulo S./E-1910-2013; Sendoya, Sebastian/J-9716-2012	Sendoya, Sebastian/0000-0003-3728-9090; Delgado Bieber, Ana Gabriela/0000-0002-6450-537X; Silva, Paulo Savio Damasio/0000-0002-4923-425X	Sao Paulo Research Foundation (FAPESP) [07/54739-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [160083/2012-5]; Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) [3178/2010]; FAPESP [12/23399-3, 08/54058-1, 11/18580-8, 12/23671-5]; CNPq [301853/2009-6]; Fundo de Apoio ao Ensino, a Pesquisa e a Extensao da Universidade Estadual de Campinas (FAEPEX)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundo de Apoio ao Ensino, a Pesquisa e a Extensao da Universidade Estadual de Campinas (FAEPEX)	AGDB was supported by a PhD fellowship from the Sao Paulo Research Foundation (FAPESP; URL: www.fapesp.br; grant #07/54739-6), and is currently funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; URL: www.cnpq.br; grant #160083/2012-5). PSDS was funded by the Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB; URL: http://www.fapesb.ba.gov.br/; grant #3178/2010), and SFS by FAPESP (grant #12/23399-3). PSO was supported by FAPESP (grants #08/54058-1; #11/18580-8; #12/23671-5), CNPq (grant #301853/2009-6), and the Fundo de Apoio ao Ensino, a Pesquisa e a Extensao da Universidade Estadual de Campinas (FAEPEX; URL: www.prp.gr.unicamp.br/faepex/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZEN MA, 1994, ECOL APPL, V4, P378, DOI 10.2307/1941941; Alves-Costa CP, 2001, BIOTROPICA, V33, P713, DOI 10.1646/0006-3606(2001)033[0713:UAFTEF]2.0.CO;2; Andersen AN, 1998, AUST J ECOL, V23, P483, DOI 10.1111/j.1442-9993.1998.tb00756.x; Banks-Leite C, 2012, BIOTROPICA, V44, P378, DOI 10.1111/j.1744-7429.2011.00801.x; Banks-Leite C, 2010, OIKOS, V119, P918, DOI 10.1111/j.1600-0706.2009.18061.x; Bieber AGD, 2012, THESIS U ESTADUAL CA; Bieber AGD, 2013, ECOSCIENCE, V20, P85, DOI 10.2980/20-1-3573; Bohning-Gaese K, 1999, ECOLOGY, V80, P821, DOI 10.1890/0012-9658(1999)080[0821:IOPASS]2.0.CO;2; Bruhl CA, 2003, BIODIVERS CONSERV, V12, P1371, DOI 10.1023/A:1023621609102; Bruna EM, 2005, BIOL CONSERV, V124, P209, DOI 10.1016/j.biocon.2005.01.026; CHAPMAN CA, 1995, CONSERV BIOL, V9, P675, DOI 10.1046/j.1523-1739.1995.09030675.x; Christianini AV, 2013, ARTHROPOD-PLANT INTE, V7, P191, DOI 10.1007/s11829-012-9229-9; Christianini AV, 2012, BIOTROPICA, V44, P360, DOI 10.1111/j.1744-7429.2011.00822.x; Christianini AV, 2010, J ECOL, V98, P573, DOI 10.1111/j.1365-2745.2010.01653.x; Christianini AV, 2009, OECOLOGIA, V160, P735, DOI 10.1007/s00442-009-1349-2; Cordeiro NJ, 2003, P NATL ACAD SCI USA, V100, P14052, DOI 10.1073/pnas.2331023100; Cramer JM, 2007, BIOL CONSERV, V137, P415, DOI 10.1016/j.biocon.2007.02.019; Crist TO, 2009, MYRMECOL NEWS, V12, P3; da Silva JMC, 2000, NATURE, V404, P72, DOI 10.1038/35003563; Dausmann KH, 2008, OECOLOGIA, V157, P307, DOI 10.1007/s00442-008-1070-6; Diamond SE, 2012, GLOBAL CHANGE BIOL, V18, P448, DOI 10.1111/j.1365-2486.2011.02542.x; Didham RK, 1996, TRENDS ECOL EVOL, V11, P255, DOI 10.1016/0169-5347(96)20047-3; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FOWLER HG, 1989, ENVIRON MANAGE, V13, P671, DOI 10.1007/BF01868306; FRANKIE GW, 1974, J ECOL, V62, P881, DOI 10.2307/2258961; Guimaraes PR, 2002, J TROP ECOL, V18, P303, DOI 10.1017/S0266467402002213; Holldobler B., 1990, pi; HORVITZ CC, 1980, AM J BOT, V67, P321, DOI 10.2307/2442342; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Krebs CJ, 1998, ECOLOGICAL METHODOLO, V2; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Leal IR, 2012, BIODIVERS CONSERV, V21, P1687, DOI 10.1007/s10531-012-0271-9; Leal IR, 1998, BIOTROPICA, V30, P170, DOI 10.1111/j.1744-7429.1998.tb00052.x; Leal LC, 2014, OECOLOGIA, V174, P173, DOI 10.1007/s00442-013-2740-6; Lira PK, 2012, FOREST ECOL MANAG, V278, P80, DOI 10.1016/j.foreco.2012.05.008; Markl JS, 2012, CONSERV BIOL, V26, P1072, DOI 10.1111/j.1523-1739.2012.01927.x; Michalski F, 2005, BIOL CONSERV, V124, P383, DOI 10.1016/j.biocon.2005.01.045; Mittermeier RA, 2005, CONSERV BIOL, V19, P601, DOI 10.1111/j.1523-1739.2005.00709.x; Ohkawara K, 2005, J ETHOL, V23, P93, DOI 10.1007/s10164-004-0132-4; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Oliveira PS, 1995, BIOTROPICA, V27, P518, DOI 10.2307/2388966; Passos L, 2004, OECOLOGIA, V139, P376, DOI 10.1007/s00442-004-1531-5; Passos L, 2003, J TROP ECOL, V19, P261, DOI 10.1017/S0266467403003298; Passos L, 2002, J ECOL, V90, P517, DOI 10.1046/j.1365-2745.2002.00687.x; Pizo MA, 1998, AM J BOT, V85, P669, DOI 10.2307/2446536; Pizo MA, 2001, PLANT ECOL, V157, P37, DOI 10.1023/A:1013735305100; Pizo MA, 2000, BIOTROPICA, V32, P851, DOI 10.1111/j.1744-7429.2000.tb00623.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raimundo RLG, 2004, SOCIOBIOLOGY, V44, P261; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Silva RR, 2007, FOREST ECOL MANAG, V240, P61, DOI 10.1016/j.foreco.2006.12.002; Sobrinho TG, 2007, BIODIVERS CONSERV, V16, P1459, DOI 10.1007/s10531-006-9011-3; Sokal RR, 1995, BIOMETRY; Suarez AV, 1998, ECOLOGY, V79, P2041, DOI 10.1890/0012-9658(1998)079[2041:EOFAIO]2.0.CO;2; Tabarelli M, 2010, BIOL CONSERV, V143, P2328, DOI 10.1016/j.biocon.2010.02.005; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Uehara-Prado M, 2007, GLOBAL ECOL BIOGEOGR, V16, P43, DOI 10.1111/j.1466-8238.2006.00267.x; Vander Wall SB, 2004, TRENDS ECOL EVOL, V19, P155, DOI 10.1016/j.tree.2003.12.004; Vasconcelos HL, 1999, BIODIVERS CONSERV, V8, P409, DOI 10.1023/A:1008891710230; Vasconcelos HL, 2000, J APPL ECOL, V37, P508, DOI 10.1046/j.1365-2664.2000.00512.x; Ward Philip S., 2000, P99; Wilcock C, 2002, TRENDS PLANT SCI, V7, P270, DOI 10.1016/S1360-1385(02)02258-6; Wilson E.O., 2003, PHEIDOLE NEW WORLD D, V1; Zelikova TJ, 2008, J TROP ECOL, V24, P309, DOI 10.1017/S0266467408004999; Zuur Alain F., 2009, P1; Zwiener VP, 2012, REV BIOL TROP, V60, P933	69	9	9	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e90369	10.1371/journal.pone.0090369	http://dx.doi.org/10.1371/journal.pone.0090369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24587341	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000150
J	Hendrickx, C; Mateus, O				Hendrickx, Christophe; Mateus, Octavio			Torvosaurus gurneyi n. sp., the Largest Terrestrial Predator from Europe, and a Proposed Terminology of the Maxilla Anatomy in Nonavian Theropods	PLOS ONE			English	Article							DINOSAURIA THEROPODA; CARCHARODONTOSAURID DINOSAURIA; ABELISAURIDAE DINOSAURIA; CRANIAL ANATOMY; CONSENSUS TREES; PHYLOGENY; OSTEOLOGY; SKULL; PORTUGAL; IDENTIFICATION	The Lourinha Formation (Kimmeridgian-Tithonian) of Central West Portugal is well known for its diversified dinosaur fauna similar to that of the Morrison Formation of North America; both areas share dinosaur taxa including the top predator Torvosaurus, reported in Portugal. The material assigned to the Portuguese T. tanneri, consisting of a right maxilla and an incomplete caudal centrum, was briefly described in the literature and a thorough description of these bones is here given for the first time. A comparison with material referred to Torvosaurus tanneri allows us to highlight some important differences justifying the creation of a distinct Eastern species. Torvosaurus gurneyi n. sp. displays two autapomorphies among Megalosauroidea, a maxilla possessing fewer than eleven teeth and an interdental wall nearly coincidental with the lateral wall of the maxillary body. In addition, it differs from T. tanneri by a reduced number of maxillary teeth, the absence of interdental plates terminating ventrally by broad V-shaped points and falling short relative to the lateral maxillary wall, and the absence of a protuberant ridge on the anterior part of the medial shelf, posterior to the anteromedial process. T. gurneyi is the largest theropod from the Lourinha Formation of Portugal and the largest land predator discovered in Europe hitherto. This taxon supports the mechanism of vicariance that occurred in the Iberian Meseta during the Late Jurassic when the proto-Atlantic was already well formed. A fragment of maxilla from the Lourinha Formation referred to Torvosaurus sp. is ascribed to this new species, and several other bones, including a femur, a tibia and embryonic material all from the Kimmeridgian-Tithonian of Portugal, are tentatively assigned to T. gurneyi. A standard terminology and notation of the theropod maxilla is also proposed and a record of the Torvosaurus material from Portugal is given.	[Hendrickx, Christophe; Mateus, Octavio] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencias Terra, Caparica, Portugal; [Hendrickx, Christophe; Mateus, Octavio] Museu Lourinha, Lourinha, Portugal	Universidade Nova de Lisboa	Hendrickx, C (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencias Terra, Caparica, Portugal.	christophe.hendrickx@hotmail.com	Mateus, Octávio/F-2910-2010; Hendrickx, Christophe/D-6120-2016	Mateus, Octávio/0000-0003-1253-3616; Hendrickx, Christophe/0000-0002-8500-2405	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/62979/2009]; Dinoeggs Project [PTDC/BIA-EVF/113222/2009]; FCT/MEC (PIDDAC)	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Dinoeggs Project; FCT/MEC (PIDDAC)	This research was supported by the Fundacao para a Ciencia e a Tecnologia (FCT) scholarship SFRH/BD/62979/2009 (Ministerio da Ciencia, Tecnologia e Ensino superior, Portugal) and the Dinoeggs Project (PTDC/BIA-EVF/113222/2009) financed by FCT/MEC (PIDDAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes MT, 2003, CR PALEVOL, V2, P77, DOI 10.1016/S1631-0683(03)00003-4; Araujo R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01924; Balanoff AM, 2012, B AM MUS NAT HIST, P1; Barsbold R, 1999, ACTA PALAEONTOL POL, V44, P189; Benson RBJ, 2008, ZOOTAXA, P57, DOI 10.11646/zootaxa.1931.1.5; Benson RBJ, 2010, ZOOL J LINN SOC-LOND, V158, P882, DOI 10.1111/j.1096-3642.2009.00569.x; Bever GS, 2009, AM MUS NOVIT, P1, DOI 10.1206/650.1; Bonaparte JF., 1980, MEMOIRES SOC GEOLOGI, V139, P19; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Britt B.B., 1991, Brigham Young University Geology Studies, V37, P1; Brusatte SL, 2007, J VERTEBR PALEONTOL, V27, P1052, DOI 10.1671/0272-4634(2007)27[1052:TSUOTE]2.0.CO;2; Brusatte SL, 2007, J VERTEBR PALEONTOL, V27, P902, DOI 10.1671/0272-4634(2007)27[902:ANSOCD]2.0.CO;2; Brusatte SL, 2010, ZOOTAXA, P1; Brusatte SL, 2012, B AM MUS NAT HIST, P1; Brusatte SL, 2010, ZOOL J LINN SOC-LOND, V158, P573, DOI 10.1111/j.1096-3642.2009.00563.x; Brusatte SL, 2009, NATURWISSENSCHAFTEN, V96, P1051, DOI 10.1007/s00114-009-0565-2; Carpenter K., 1992, ASPECTS NONMARINE CR, P250; Carr TD, 2005, J VERTEBR PALEONTOL, V25, P119, DOI 10.1671/0272-4634(2005)025[0119:ANGASO]2.0.CO;2; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Carrano MT, 2002, J VERTEBR PALEONTOL, V22, P510, DOI 10.1671/0272-4634(2002)022[0510:TOOMKA]2.0.CO;2; Castanhinha R, 2006, J VERTEBR PALEONTOL, V26, p48A; Choiniere JN, 2010, J VERTEBR PALEONTOL, V30, P1773, DOI 10.1080/02724634.2010.520779; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Clark James M., 1994, American Museum Novitates, V3115, P1; Clark JM, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)364<0001:CAOCOT>2.0.CO;2; Colbert E.H., 1990, P81, DOI 10.1017/CBO9780511608377.009; Coria RA, 2006, GEODIVERSITAS, V28, P71; Coria RA, 2002, J VERTEBR PALEONTOL, V22, P460, DOI 10.1671/0272-4634(2002)022[0460:ANCROC]2.0.CO;2; Currie Philip J., 2000, Geodiversitas, V22, P207; Currie PJ, 2004, LIFE O PAST, P112; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; CURRIE PJ, 1985, CAN J EARTH SCI, V22, P1643, DOI 10.1139/e85-173; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2037, DOI 10.1139/e93-179; Dal Sasso C, 2005, J VERTEBR PALEONTOL, V25, P888, DOI 10.1671/0272-4634(2005)025[0888:NIOTSO]2.0.CO;2; Eddy DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017932; Ezcurra Martin D., 2007, Historical Biology, V19, P185, DOI 10.1080/08912960600861467; Filla J., 1992, HUNTERIA, V2, P1; Fitzinger L, 1843, SYSTEMA REPTORILUSM; Galton P.M., 1979, Brigham Young University Geology Studies, V26, P1; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gilmore CW., 1920, B US NATL MUSEUM, V110, P1, DOI [10.5479/si.03629236.110.i, DOI 10.5479/SI.03629236.110.I]; Godefroit P, 2013, NATURE, DOI [10.1038/nature12168, DOI 10.1038/NATURE12168.101]; Godefroit P, 2008, J VERTEBR PALEONTOL, V28, P432, DOI 10.1671/0272-4634(2008)28[432:ANSOVD]2.0.CO;2; Gold MEL, 2013, AM MUS NOVIT, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hanson M, 2014, HIST BIOL, V26, P775, DOI 10.1080/08912963.2013.853056; Hendrickx C, 2014, ZOOTAXA, V 3759, P1, DOI 10.11646/zootaxa.3759.1.1; HILL G, 1989, J GEOL SOC LONDON, V146, P539, DOI 10.1144/gsjgs.146.3.0539; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P71; Hone DWE, 2011, CRETACEOUS RES, V32, P495, DOI 10.1016/j.cretres.2011.03.005; Hurum JH, 2003, ACTA PALAEONTOL POL, V48, P161; JENSEN JA, 1985, GREAT BASIN NAT, V45, P710; Kundrat M, 2008, ACTA ZOOL-STOCKHOLM, V89, P231, DOI 10.1111/j.1463-6395.2007.00311.x; Lamanna MC, 2002, J VERTEBR PALEONTOL, V22, P58, DOI 10.1671/0272-4634(2002)022[0058:ADATDF]2.0.CO;2; Larson Peter, 2008, P233; Madsen JH., 2000, UTAH GEOLOGICAL SURV, V2, P1; Madsen JH., 1976, UTAH GEOLOGICAL MINI, V109, P1; Mahler L, 2005, J VERTEBR PALEONTOL, V25, P236, DOI 10.1671/0272-4634(2005)025[0236:ROADTF]2.0.CO;2; Makovicky PJ, 2003, AM MUS NOVIT, P1; Malafaia E, 2007, CANTERA PALEONTOLOGI, P255; Malafaia E., 2009, ACT 4 JORN INT PAL D, P243; Malafaia E., 2008, PALAEONTOLOGICA NOVA, P273; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Mateus Isabel, 1998, Memorias de Academia de Ciencias de Lisboa, V37, P101; Mateus O., 2006, N MEX MUS NAT HIST S, V36, P223; Mateus O., 2000, 1 C IB PAL 16 JORN S, P115; Mateus O., 2006, PALEONTOLOGY GEOLOGY, V36, P123; Mateus O, 2013, CIENCEIAS TERRA SPEI; Mateus O, 2000, 31 INT GEOL C; Mateus Octavio, 1998, Memorias de Academia de Ciencias de Lisboa, V37, P111; Mateus O, 2010, LETHAIA, V43, P245, DOI 10.1111/j.1502-3931.2009.00190.x; MOLNAR R E, 1991, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V217, P137; Norell MA, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)446<0001:ATDFUT>2.0.CO;2; Norell MA, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3545[1:ANDTFU]2.0.CO;2; Osborn H. F., 1912, Memoirs of the American Museum of Natural History New York, V1; Osmolska H, 2004, DINOSAURIA, 2ND EDITION, P165; OSTROM J H, 1978, Zitteliana, V4, P73; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Paul G., 1988, PREDATORY DINOSAURS; Perez-Moreno BP, 1999, J GEOL SOC LONDON, V156, P449, DOI 10.1144/gsjgs.156.3.0449; Rauhut Oliver W.M., 1994, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V13, P179; Rauhut OWM, 2012, P NATL ACAD SCI USA, V109, P11746, DOI 10.1073/pnas.1203238109; Rauhut OWM, 2010, ZOOL J LINN SOC-LOND, V158, P155, DOI 10.1111/j.1096-3642.2009.00591.x; Rauhut Oliver W.M., 2000, P75; Rauhut OWM, 2005, P ROY SOC B-BIOL SCI, V272, P1179, DOI 10.1098/rspb.2005.3071; Rauhut OWM, 2004, J VERTEBR PALEONTOL, V24, P894, DOI 10.1671/0272-4634(2004)024[0894:PAAOGS]2.0.CO;2; Rauhut OWM, 2003, PALAEONTOLOGY, V46, P903, DOI 10.1111/1475-4983.00325; Ribeiro V, 2012, J VERTEBR PALEONTOL, V32, P161; Sadleir Rudyard W., 2008, Monograph of the Palaeontographical Society, P1; Sampson SD, 2007, J VERTEBR PALEONTOL, V27, P32, DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO;2; Seeley H.G., 1887, GEOL MAG, V5, P45, DOI [10.1017/s0016756800156006, DOI 10.1017/S0016756800156006]; Sereno PC, 2008, ACTA PALAEONTOL POL, V53, P15, DOI 10.4202/app.2008.0102; Sereno PC, 2012, J VERTEBR PALEONTOL, V32, P83, DOI 10.1080/02724634.2013.820113; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P451; Siegwarth J. D., 1997, CONTRIBUTIONS TATE M, V2, P1; Smith DK, 2010, J VERTEBR PALEONTOL, V30, P1466, DOI 10.1080/02724634.2010.501434; Smith JB, 2005, ANAT REC PART A, V285A, P699, DOI 10.1002/ar.a.20206; Sues HD, 2011, P ROY SOC B-BIOL SCI, V278, P3459, DOI 10.1098/rspb.2011.0410; Therrien F, 2007, J VERTEBR PALEONTOL, V27, P108, DOI 10.1671/0272-4634(2007)27[108:MTIBTY]2.0.CO;2; Turner AH, 2012, B AM MUS NAT HIST, P5; Turner AH, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3557[1:ASDTFS]2.0.CO;2; Tykoski RS, 2005, THESIS U TEXAS AUSTI; Weigert Andrea, 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V9, P562; WELLES S P, 1984, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V185, P85; Wiechmann Marc Filip, 2000, P83; Wilkinson M, 1996, MOL BIOL EVOL, V13, P437, DOI 10.1093/oxfordjournals.molbev.a025604; WILKINSON M, 1995, SYST BIOL, V44, P435, DOI 10.2307/2413604; WILKINSON M, 1994, SYST BIOL, V43, P343, DOI 10.2307/2413673; Witmer L.M., 1997, ENCY DINOSAURS, P151; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Xu X, 2009, NATURE, V459, P940, DOI 10.1038/nature08124; Zinke Jens, 1998, Palaeontologische Zeitschrift, V72, P179; Zinke Jens, 1994, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V13, P163	116	68	68	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e88905	10.1371/journal.pone.0088905	http://dx.doi.org/10.1371/journal.pone.0088905			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598585	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400006
J	Adler, BJ; Green, DE; Pagnotti, GM; Chan, ME; Rubin, CT				Adler, Benjamin J.; Green, Danielle E.; Pagnotti, Gabriel M.; Chan, M. Ete; Rubin, Clinton T.			High Fat Diet Rapidly Suppresses B Lymphopoiesis by Disrupting the Supportive Capacity of the Bone Marrow Niche	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; T-CELLS; CALORIC RESTRICTION; PROGENITOR CELLS; SELF-RENEWAL; OBESITY; MICE; ADIPOSITY; MICROENVIRONMENT; DIFFERENTIATION	The bone marrow (BM) niche is the primary site of hematopoiesis, and cues from this microenvironment are critical to maintain hematopoiesis. Obesity increases lifetime susceptibility to a host of chronic diseases, and has been linked to defective leukogenesis. The pressures obesity exerts on hematopoietic tissues led us to study the effects of a high fat diet (HFD: 60% Kcal from fat) on B cell development in BM. Seven week old male C57Bl/6J mice were fed either a high fat (HFD) or regular chow (RD) diet for periods of 2 days, 1 week and 6 weeks. B-cell populations (B220+) were not altered after 2 d of HFD, within 1 w B-cell proportions were reduced by -10%, and by 6 w by -25% as compared to RD (p<0.05). BM RNA was extracted to track the expression of B-cell development markers Il-7, Ebf-1 and Pax-5. At 2 d, the expression of Il-7 and Ebf-1 were reduced by -20% (p = 0.08) and -11% (p = 0.06) whereas Pax-5 was not significantly impacted. At one week, however, the expressions of Il-7, Ebf-1, and Pax-5 in HFD mice fell by -19%, -20% and -16%, and by six weeks were further reduced to -23%, -29% and -34% as compared to RD (p<0.05 for all), a suppression paralleled by a +363% increase in adipose encroachment within the marrow space (p<0.01). Il-7 is a critical factor in the early B-cell lineage which is secreted by supportive cells in the BM niche, and is necessary for B-cell commitment. These data indicate that BM Il-7 expression, and by extension B-cell differentiation, are rapidly impaired by HFD. The trend towards suppressed expression of Il-7 following only 2 d of HFD demonstrates how susceptible the BM niche, and the cells which rely on it, are to diet, which ultimately could contribute to disease susceptibility in metabolic disorders such as obesity.	[Adler, Benjamin J.; Green, Danielle E.; Pagnotti, Gabriel M.; Chan, M. Ete; Rubin, Clinton T.] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Rubin, CT (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.	Clinton.Rubin@stonybrook.edu	Pagnotti, Gabriel/AAF-7280-2020	Pagnotti, Gabriel/0000-0003-0888-5117	National Institutes of Health (NIH) [AR 43498, EB 14351]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014351] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding provided by National Institutes of Health (NIH) AR 43498 and EB 14351. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila HL, 2012, J BONE MINER RES, V27, P1030, DOI 10.1002/jbmr.1553; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Biro FM, 2010, AM J CLIN NUTR, V91, p1499S, DOI 10.3945/ajcn.2010.28701B; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Challen GA, 2010, EXP HEMATOL, V38, P403, DOI 10.1016/j.exphem.2010.02.011; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chan ME, 2012, FASEB J, V26, P4855, DOI 10.1096/fj.12-209841; Cheshier SH, 2007, STEM CELLS DEV, V16, P707, DOI 10.1089/scd.2007.0017; Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82; Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P882, DOI 10.1189/jlb.0108028; Feng J, 2009, BRIT J HAEMATOL, V145, P412, DOI 10.1111/j.1365-2141.2009.07632.x; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gottschling S, 2007, STEM CELLS, V25, P798, DOI 10.1634/stemcells.2006-0513; Green DE, 2011, J BONE MINER RES; Gyory I, 2012, GENE DEV, V26, P668, DOI 10.1101/gad.187328.112; Jacob B, 2010, BLOOD, V115, P1610, DOI 10.1182/blood-2009-07-232249; Kajkenova O, 1997, J BONE MINER RES, V12, P1772, DOI 10.1359/jbmr.1997.12.11.1772; Karlsson EA, 2010, EXP BIOL MED, V235, P1412, DOI 10.1258/ebm.2010.010227; Karlsson EA, 2010, J NUTR, V140, P1691, DOI 10.3945/jn.110.123653; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Lemieux ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024153; Lublinsky S, 2009, J DIGIT IMAGING, V22, P222, DOI 10.1007/s10278-008-9152-x; Luu YK, 2009, MED ENG PHYS, V31, P34, DOI 10.1016/j.medengphy.2008.03.006; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nieman DC, 1999, J AM DIET ASSOC, V99, P294, DOI 10.1016/S0002-8223(99)00077-2; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Noda S, 2009, BIOCHEM BIOPH RES CO, V383, P210, DOI 10.1016/j.bbrc.2009.03.153; Singh P, 2008, STEM CELLS, V26, P1009, DOI 10.1634/stemcells.2007-0461; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; Telford WG, 2007, STEM CELLS, V25, P1029, DOI 10.1634/stemcells.2006-0567; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Trudel G, 2009, J APPL PHYSIOL, V107, P540, DOI 10.1152/japplphysiol.91530.2008; Tsapogas P, 2011, BLOOD, V118, P1283, DOI 10.1182/blood-2011-01-332189; Vilagos B, 2012, J EXP MED, V209, P775, DOI 10.1084/jem.20112422; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006; Wijga AH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-184; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Yang H, 2009, BLOOD, V114, P3803, DOI 10.1182/blood-2009-03-213595; Zimmer SN, 2011, BLOOD, V118, P69, DOI 10.1182/blood-2010-09-307942	42	52	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90639	10.1371/journal.pone.0090639	http://dx.doi.org/10.1371/journal.pone.0090639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595332	gold, Green Published, Green Submitted			2022-12-27	WOS:000332475500080
J	Sheehy, EJ; Vinardell, T; Toner, ME; Buckley, CT; Kelly, DJ				Sheehy, Eamon J.; Vinardell, Tatiana; Toner, Mary E.; Buckley, Conor T.; Kelly, Daniel J.			Altering the Architecture of Tissue Engineered Hypertrophic Cartilaginous Grafts Facilitates Vascularisation and Accelerates Mineralisation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ENDOCHONDRAL OSSIFICATION; ARTICULAR-CARTILAGE; BONE-FORMATION; SCAFFOLD; CHONDROGENESIS; CANALS; HYDROGELS	Cartilaginous tissues engineered using mesenchymal stem cells (MSCs) can be leveraged to generate bone in vivo by executing an endochondral program, leading to increased interest in the use of such hypertrophic grafts for the regeneration of osseous defects. During normal skeletogenesis, canals within the developing hypertrophic cartilage play a key role in facilitating endochondral ossification. Inspired by this developmental feature, the objective of this study was to promote endochondral ossification of an engineered cartilaginous construct through modification of scaffold architecture. Our hypothesis was that the introduction of channels into MSC-seeded hydrogels would firstly facilitate the in vitro development of scaled-up hypertrophic cartilaginous tissues, and secondly would accelerate vascularisation and mineralisation of the graft in vivo. MSCs were encapsulated into hydrogels containing either an array of micro-channels, or into non-channelled 'solid' controls, and maintained in culture conditions known to promote a hypertrophic cartilaginous phenotype. Solid constructs accumulated significantly more sGAG and collagen in vitro, while channelled constructs accumulated significantly more calcium. In vivo, the channels acted as conduits for vascularisation and accelerated mineralisation of the engineered graft. Cartilaginous tissue within the channels underwent endochondral ossification, producing lamellar bone surrounding a hematopoietic marrow component. This study highlights the potential of utilising engineering methodologies, inspired by developmental skeletal processes, in order to enhance endochondral bone regeneration strategies.	[Sheehy, Eamon J.; Vinardell, Tatiana; Buckley, Conor T.; Kelly, Daniel J.] Univ Dublin Trinity Coll, Trinity Ctr Bioengn, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Sheehy, Eamon J.; Vinardell, Tatiana; Buckley, Conor T.; Kelly, Daniel J.] Univ Dublin Trinity Coll, Sch Engn, Dept Mech & Mfg Engn, Dublin 2, Ireland; [Kelly, Daniel J.] Univ Dublin Trinity Coll, Adv Mat & Bioengn Res Ctr AMBER, Dublin 2, Ireland; [Vinardell, Tatiana] Univ Coll Dublin, Sch Agr & Food Sci, Dublin 2, Ireland; [Toner, Mary E.] Univ Dublin Trinity Coll, Dept Pathol, Sch Dent Sci, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; University College Dublin; Trinity College Dublin	Kelly, DJ (corresponding author), Univ Dublin Trinity Coll, Trinity Ctr Bioengn, Trinity Biomed Sci Inst, Dublin 2, Ireland.	kellyd9@tcd.ie	Sheehy`, Eamon/AAR-8961-2020; Buckley, Conor/C-3575-2014	Sheehy`, Eamon/0000-0002-2902-4562; Vinardell, Tatiana/0000-0002-4902-6725; Buckley, Conor/0000-0001-7452-4534; Kelly, Daniel/0000-0003-4091-0992	Science Foundation Ireland [SFI/08/Y15/B1336]; European Research Council [258463]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Research Council(European Research Council (ERC)European Commission)	This work was supported by Science Foundation Ireland under the President of Ireland Young Researcher Award (Grant No. SFI/08/Y15/B1336) and a starter grant from the European Research Council (Stem Repair Project No. 258463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian L, 2009, OSTEOARTHR CARTILAGE, V17, P677, DOI 10.1016/j.joca.2008.10.003; Blumer MJF, 2008, ANN ANAT, V190, P305, DOI 10.1016/j.aanat.2008.02.004; Blumer MJF, 2006, J ANAT, V208, P695, DOI 10.1111/j.1469-7580.2006.00578.x; Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917; Buckley CT, 2012, TISSUE ENG PT A, V18, P382, DOI [10.1089/ten.tea.2011.0145, 10.1089/ten.TEA.2011.0145]; Buckley CT, 2009, TISSUE ENG PT A, V15, P3213, DOI [10.1089/ten.tea.2008.0531, 10.1089/ten.TEA.2008.0531]; Buckley CT, 2010, J BIOMED MATER RES B, V93B, P459, DOI 10.1002/jbm.b.31603; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Erickson IE, 2011, CLIN ORTHOP RELAT R, V469, P2744, DOI 10.1007/s11999-011-1869-z; Farrell E, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-31; Farrell E, 2009, TISSUE ENG PART C-ME, V15, P285, DOI 10.1089/ten.tec.2008.0297; GANEY TM, 1995, ANAT RECORD, V241, P425, DOI 10.1002/ar.1092410318; Gawlitta D, 2012, TISSUE ENG PT A, V18, P1957, DOI [10.1089/ten.tea.2011.0657, 10.1089/ten.TEA.2011.0657]; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Ignat'eva NY, 2007, J ANAL CHEM+, V62, P51, DOI 10.1134/S106193480701011X; Janicki P, 2010, ACTA BIOMATER, V6, P3292, DOI 10.1016/j.actbio.2010.01.037; Jukes JM, 2008, P NATL ACAD SCI USA, V105, P6840, DOI 10.1073/pnas.0711662105; Kafienah W, 2003, METH MOL B, V238, P217; Koh CJ, 2004, J AM SOC NEPHROL, V15, P1113, DOI 10.1097/01.ASN.0000119683.59068.F0; Langer R, 2000, MOL THER, V1, P12, DOI 10.1006/mthe.1999.0003; Lau TT, 2012, BIOMATERIALS, V33, P8406, DOI 10.1016/j.biomaterials.2012.08.025; Lee CH, 2009, TISSUE ENG PT A, V15, P3923, DOI 10.1089/ten.TEA.2008.0653; Lenas P, 2009, TISSUE ENG PART B-RE, V15, P381, DOI 10.1089/ten.TEB.2008.0575; Lennon DP, 2006, EXP HEMATOL, V34, P1604, DOI 10.1016/j.exphem.2006.07.014; Lyons FG, 2010, BIOMATERIALS, V31, P9232, DOI 10.1016/j.biomaterials.2010.08.056; Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001; Mauck RL, 2003, TISSUE ENG, V9, P597, DOI 10.1089/107632703768247304; Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656; Meijer GJ, 2007, PLOS MED, V4, P260, DOI 10.1371/journal.pmed.0040009; Mesallati T, 2012, BIOMECHANICS MODELIN, P1; Meyer EG, 2010, J BIOMECH, V43, P2516, DOI 10.1016/j.jbiomech.2010.05.020; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107; Scotti C, 2013, P NATL ACAD SCI USA, V110, P3997, DOI 10.1073/pnas.1220108110; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; Sheehy EJ, 2013, ACTA BIOMATER, V9, P5484, DOI 10.1016/j.actbio.2012.11.008; Sheehy EJ, 2012, BIOCHEM BIOPH RES CO, V417, P305, DOI 10.1016/j.bbrc.2011.11.105; Sheehy EJ, 2011, J TISSUE ENG REGEN M, V5, P747, DOI 10.1002/term.385; Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027; Thorpe SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060764; Thorpe SD, 2010, ANN BIOMED ENG, V38, P2896, DOI 10.1007/s10439-010-0059-6; Tortelli F, 2010, BIOMATERIALS, V31, P242, DOI 10.1016/j.biomaterials.2009.09.038; Vinardell T, 2012, TISSUE ENG PT A, V18, P1161, DOI [10.1089/ten.tea.2011.0544, 10.1089/ten.TEA.2011.0544]; Weiss HE, 2012, TISSUE ENG PT A, V18, P1334, DOI [10.1089/ten.TEA.2011.0602, 10.1089/ten.tea.2011.0602]; Yang WX, 2013, ACTA BIOMATER, V9, P4505, DOI 10.1016/j.actbio.2012.10.003; Ytrehus B, 2004, BONE, V34, P454, DOI 10.1016/j.bone.2003.07.011; Zhang YY, 2012, BIOMATERIALS, V33, P2926, DOI 10.1016/j.biomaterials.2012.01.006	47	25	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90716	10.1371/journal.pone.0090716	http://dx.doi.org/10.1371/journal.pone.0090716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595316	gold, Green Published, Green Submitted			2022-12-27	WOS:000332475500091
J	Yan, YH; Li, JL; Zhang, XQ; Yang, WY; Wan, Y; Ma, YM; Zhu, YQ; Peng, Y; Huang, LK				Yan, Yan-Hong; Li, Jun-Lin; Zhang, Xin-Quan; Yang, Wen-Yu; Wan, Yan; Ma, Ying-Mei; Zhu, Yong-Qun; Peng, Yan; Huang, Lin-Kai			Effect of Naphthalene Acetic Acid on Adventitious Root Development and Associated Physiological Changes in Stem Cutting of Hemarthria compressa	PLOS ONE			English	Article							INDOLE-3-BUTYRIC ACID; DONOR PLANTS; AUXIN; PEROXIDASE; INDUCTION; SEEDLINGS; GROWTH; NAA; AGE	In order to find a way to induce rooting on cuttings of Hemarthria compressa cv. Ya'an under controlled conditions, a project was carried out to study the effect of naphthalene acetic acid (NAA) on rooting in stem cuttings and related physiological changes during the rooting process of Hemarthria compressa. The cuttings were treated with five concentrations of NAA (0, 100, 200 300, 400 mg/l) at three soaking durations (10, 20, 30 minutes), and cuttings without treatment were considered as control. Samples were planted immediately into pots after treatment. IAA-oxidase (IAAO) activity, peroxidase (POD) activity and polyphenol oxidase (PPO) activity were determined after planting. Results showed that NAA had positive effect on rooting at the concentration of 200 mg/l compared to other concentrations at 30 days after planting (DAP). Among the three soaking durations, 20 minutes (min) of 200 mg/l NAA resulted in higher percentages of rooting, larger numbers of adventitious roots and heavier root dry weight per cutting. The lowest IAAO activity was obtained when soaked at 200 mg/l NAA for 20 min soaking duration. This was consistent with the best rooting ability, indicating that the lower IAAO activity, the higher POD activity and PPO activity could be used as an indicator of better rooting ability for whip grass cuttings and might serve as a good marker for rooting ability in cuttings.	[Yan, Yan-Hong; Li, Jun-Lin; Zhang, Xin-Quan; Ma, Ying-Mei; Peng, Yan; Huang, Lin-Kai] Sichuan Agr Univ, Dept Grassland Sci, Coll Anim Sci & Technol, Yaan, Sichuan, Peoples R China; [Yang, Wen-Yu; Wan, Yan] Sichuan Agr Univ, Coll Agron, Wenjiang, Sichuan, Peoples R China; [Zhu, Yong-Qun] Sichuan Acad Agr Sci, Inst Soil & Fertilizer, Chengdu, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Academy of Agricultural Sciences (SAAS)	Zhang, XQ (corresponding author), Sichuan Agr Univ, Dept Grassland Sci, Coll Anim Sci & Technol, Yaan, Sichuan, Peoples R China.	zhangxq@sicau.edu.cn	Ma, Yingmei/J-7409-2019		earmarked fund for Modern Agro-Industry Technology Research System [CARS-35-05]; National Science & Technology Pillar Program in the Twelfth Five-Year Plan [2011BAD17B03]	earmarked fund for Modern Agro-Industry Technology Research System; National Science & Technology Pillar Program in the Twelfth Five-Year Plan	This work was supported by the earmarked fund for Modern Agro-Industry Technology Research System (#CARS-35-05) and the National Science & Technology Pillar Program in the Twelfth Five-Year Plan (#2011BAD17B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AESCHBACHER RA, 1994, ANNU REV PLANT PHYS, V45, P25, DOI 10.1146/annurev.pp.45.060194.000325; BEFFA R, 1990, PLANT PHYSIOL, V94, P485, DOI 10.1104/pp.94.2.485; Cui X. D., 2010, NO HORTIC, V2, P10; De Klerk GJ, 1999, IN VITRO CELL DEV-PL, V35, P189, DOI 10.1007/s11627-999-0076-z; DeKlerk GJ, 1996, AGRONOMIE, V16, P609, DOI 10.1051/agro:19961003; DEKLERK GJ, 1992, AGRONOMIE, V12, P747, DOI 10.1051/agro:19921002; Dick J, 1998, ACIAR P, V86, P188; GASPAR T, 1992, AGRONOMIE, V12, P757, DOI 10.1051/agro:19921003; Gaspar T., 1997, BIOL ROOT FORMATION, P57; Hartmann HT, 1968, PLANT PROPAGATION PR; Hausman JF, 1997, J APPL BOT-ANGEW BOT, V71, P104; Hentig W., 1987, ACTA HORTIC, V226, P479; [胡宗达 HU Zongda], 2008, [水土保持研究, Research of Soil and Water Conservation], V15, P120; Huang L., 2012, ADV SCI LETT, V7, P328, DOI [10.1166/asl.2012.2075, DOI 10.1166/ASL.2012.2075]; Hunt MA, 2011, NEW FOREST, V41, P349, DOI 10.1007/s11056-010-9227-7; Hunt RW, 2010, APPL BIOCHEM BIOTECH, V162, P2400, DOI 10.1007/s12010-010-9012-2; Husen A, 2006, NEW FOREST, V31, P57, DOI 10.1007/s11056-004-6794-5; Husen A, 2007, NEW FOREST, V33, P309, DOI 10.1007/s11056-006-9030-7; JAMES DJ, 1983, PHYSIOL PLANTARUM, V57, P154, DOI 10.1111/j.1399-3054.1983.tb00746.x; Kaur S, 2002, PLANT GROWTH REGUL, V37, P63, DOI 10.1023/A:1020355505105; Kevers C, 1997, J APPL BOT-ANGEW BOT, V71, P71; Khan S, 2012, PAK J BOT, V44, P1965; Khorsheduzzaman A. K. M., 2010, Bangladesh Journal of Agricultural Research, V35, P149, DOI 10.3329/bjar.v35i1.5876; Kowalczyk S, 2002, PLANT GROWTH REGUL, V38, P127, DOI 10.1023/A:1021232511258; LASKOWSKI MJ, 1995, DEVELOPMENT, V121, P3303; [李芳 LI Fang], 2009, [湖北农业科学, Hubei Agricultural Sciences], V48, P1210; Li Z, 2013, ACTA PHYSIOL PLANT, V35, P213, DOI 10.1007/s11738-012-1066-z; LIU JH, 1992, PHYSIOL PLANTARUM, V86, P285, DOI 10.1034/j.1399-3054.1992.860214.x; Liu ZH, 1996, BOT BULL ACAD SINICA, V37, P247; Mishra BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004502; Mori Y, 2011, PLANT GROWTH REGUL, V63, P271, DOI 10.1007/s10725-010-9524-3; Nag S, 2001, J PLANT GROWTH REGUL, V20, P182, DOI 10.1007/s003440010016; Raju NL, 2010, AGROFOREST SYST, V79, P249, DOI 10.1007/s10457-009-9251-9; Rivero RM, 2001, PLANT SCI, V160, P315, DOI 10.1016/S0168-9452(00)00395-2; Rout GR, 2006, PLANT GROWTH REGUL, V48, P111, DOI 10.1007/s10725-005-5665-1; SATO Y, 1993, PLANTA, V189, P584, DOI 10.1007/BF00198223; Srivastava L.M, 2002, PLANT GROWTH DEV HOR, DOI 10.1016/B978-012660570-9/50152-0; Sun YL, 2010, PLANT CELL TISS ORG, V100, P317, DOI 10.1007/s11240-009-9653-4; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068220; WIESMAN Z, 1988, PHYSIOL PLANTARUM, V74, P556, DOI 10.1111/j.1399-3054.1988.tb02018.x; Yan YH, 2013, RES CROP, V14, P907; Yang CH, 2010, TROP GRASSLANDS, V44, P47	42	50	56	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90700	10.1371/journal.pone.0090700	http://dx.doi.org/10.1371/journal.pone.0090700			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595064	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500087
J	Cannon, MV; Buchner, DA; Hester, J; Miller, H; Sehayek, E; Nadeau, JH; Serre, D				Cannon, Matthew V.; Buchner, David A.; Hester, James; Miller, Hadley; Sehayek, Ephraim; Nadeau, Joseph H.; Serre, David			Maternal Nutrition Induces Pervasive Gene Expression Changes but No Detectable DNA Methylation Differences in the Liver of Adult Offspring	PLOS ONE			English	Article							DIET-INDUCED OBESITY; ELEMENT-BINDING PROTEIN-1C; BOUND TRANSCRIPTION FACTOR; HIGH-FAT DIET; PRENATAL EXPOSURE; COMPLEX TRAITS; HUMAN GENOME; CROSS-TALK; LATER LIFE; MICE	Aims: Epidemiological and animal studies have shown that maternal diet can influence metabolism in adult offspring. However, the molecular mechanisms underlying these changes remain poorly understood. Here, we characterize the phenotypes induced by maternal obesity in a mouse model and examine gene expression and epigenetic changes induced by maternal diet in adult offspring. Methods: We analyzed genetically identical male mice born from dams fed a high-or low-fat diet throughout pregnancy and until day 21 postpartum. After weaning, half of the males of each group were fed a high-fat diet, the other half a low-fat diet. We first characterized the genome-wide gene expression patterns of six tissues of adult offspring - liver, pancreas, white adipose, brain, muscle and heart. We then measured DNA methylation patterns in liver at selected loci and throughout the genome. Results: Maternal diet had a significant effect on the body weight of the offspring when they were fed an obesogenic diet after weaning. Our analyses showed that maternal diet had a pervasive effect on gene expression, with a pronounced effect in liver where it affected many genes involved in inflammation, cholesterol synthesis and RXR activation. We did not detect any effect of the maternal diet on DNA methylation in the liver. Conclusions: Overall, our findings highlighted the persistent influence of maternal diet on adult tissue regulation and suggested that the transcriptional changes were unlikely to be caused by DNA methylation differences in adult liver.	[Cannon, Matthew V.; Hester, James; Miller, Hadley; Sehayek, Ephraim; Serre, David] Cleveland Clin, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44106 USA; [Buchner, David A.; Nadeau, Joseph H.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Nadeau, Joseph H.] Pacific Northwest Res Inst, Seattle, WA USA	Cleveland Clinic Foundation; Case Western Reserve University	Serre, D (corresponding author), Cleveland Clin, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44106 USA.	serred@ccf.org		Hester, James/0000-0002-2739-7082; Cannon, Matthew/0000-0002-3035-9490; Buchner, David/0000-0003-3920-4871	National Institutes of Health [R01 DK08824, DP1HD075624]; NIDDK [K01 DK084079]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD075624] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076174, K01DK084079, R01DK088824] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health awards to DS (R01 DK08824) and to JHN (DP1HD075624). DAB was supported by a NIDDK award (K01 DK084079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; Bayol SA, 2010, ENDOCRINOLOGY, V151, P1451, DOI 10.1210/en.2009-1192; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Bouchard L, 2010, DIABETES CARE, V33, P2436, DOI 10.2337/dc10-1024; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Buchner DA, 2012, MAMM GENOME, V23, P431, DOI 10.1007/s00335-012-9400-8; Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662; Erhuma A, 2007, BRIT J NUTR, V98, P517, DOI 10.1017/S0007114507721505; Giraudo SQ, 2010, PHARMACOL BIOCHEM BE, V97, P121, DOI 10.1016/j.pbb.2010.04.017; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361; Hoile SP, 2012, J NUTR BIOCH; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hsiao A, 2005, NUCLEIC ACIDS RES, V33, pW627, DOI 10.1093/nar/gki443; Jones HN, 2009, FASEB J, V23, P271, DOI 10.1096/fj.08-116889; Kim TH, 2009, J BIOL CHEM, V284, P15071, DOI 10.1074/jbc.M109.006742; Kral JG, 2006, PEDIATRICS, V118, pE1644, DOI 10.1542/peds.2006-1379; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Levin BE, 1998, AM J PHYSIOL-REG I, V275, pR1374, DOI 10.1152/ajpregu.1998.275.4.R1374; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Millward CA, 2009, MAMM GENOME, V20, P71, DOI 10.1007/s00335-008-9165-2; Murphy SK, 2012, GENE, V494, P36, DOI 10.1016/j.gene.2011.11.062; Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005; Plagemann A, 1997, INT J OBESITY, V21, P451, DOI 10.1038/sj.ijo.0800429; Plagemann A, 1997, DIABETOLOGIA, V40, P1094, DOI 10.1007/s001250050792; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rizzo TA, 1995, AM J OBSTET GYNECOL, V173, P1753, DOI 10.1016/0002-9378(95)90422-0; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roth A, 2008, MOL PHARMACOL, V73, P1282, DOI 10.1124/mol.107.041012; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Tamashiro KLK, 2009, DIABETES, V58, P1116, DOI 10.2337/db08-1129; Thompson RF, 2010, J BIOL CHEM, V285, P15111, DOI 10.1074/jbc.M109.095133; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Whitaker RC, 1998, J PEDIATR-US, V132, P768, DOI 10.1016/S0022-3476(98)70302-6; Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190	46	32	33	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90335	10.1371/journal.pone.0090335	http://dx.doi.org/10.1371/journal.pone.0090335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594983	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900095
J	Sun, ZY; Blanchard, JL				Sun, Zhiyi; Blanchard, Jeffrey L.			Strong Genome-Wide Selection Early in the Evolution of Prochlorococcus Resulted in a Reduced Genome through the Loss of a Large Number of Small Effect Genes	PLOS ONE			English	Article							CYANOBACTERIUM PROCHLOROCOCCUS; MICROBIAL GENOME; SEQUENCE; REDUCTION; ECOTYPES; ADAPTATION; EUKARYOTES; PROKARYOTE; SYMBIONT; DYNAMICS	The smallest genomes of any photosynthetic organisms are found in a group of free-living marine cyanobacteria, Prochlorococcus. To determine the underlying evolutionary mechanisms, we developed a new method to reconstruct the steps leading to the Prochlorococcus genome reduction using 12 Prochlorococcus and 6 marine Synechococcus genomes. Our results reveal that small genome sizes within Prochlorococcus were largely determined shortly after the split of Prochlorococcus and Synechococcus (an early big shrink) and thus for the first time decouple the genome reduction from Prochlorococcus diversification. A maximum likelihood approach was then used to estimate changes of nucleotide substitution rate and selection strength along Prochlorococcus evolution in a phylogenetic framework. Strong genome wide purifying selection was associated with the loss of many genes in the early evolutionary stage. The deleted genes were distributed around the genome, participated in many different functional categories and in general had been under relaxed selection pressure. We propose that shortly after Prochlorococcus diverged from its common ancestor with marine Synechococcus, its population size increased quickly thus increasing efficacy of selection. Due to limited nutrients and a relatively constant environment, selection favored a streamlined genome for maximum economy. Strong genome wide selection subsequently caused the loss of genes with small functional effect including the loss of some DNA repair genes. In summary, genome reduction in Prochlorococcus resulted in genome features that are similar to symbiotic bacteria and pathogens, however, the small genome sizes resulted from an increase in genome wide selection rather than a consequence of a reduced ecological niche or relaxed selection due to genetic drift.	[Sun, Zhiyi; Blanchard, Jeffrey L.] Univ Massachusetts, Grad Program Organism & Evolutionary Biol, Amherst, MA 01003 USA; [Blanchard, Jeffrey L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Blanchard, JL (corresponding author), Univ Massachusetts, Grad Program Organism & Evolutionary Biol, Amherst, MA 01003 USA.	jeffb@bio.umass.edu	Blanchard, Jeffrey/AAA-5173-2020	Blanchard, Jeffrey/0000-0002-7310-9678; Sun, Zhiyi/0000-0002-6106-5356	UMass Healy Foundation; USDA [MAS00898, MAS009582]	UMass Healy Foundation; USDA(United States Department of Agriculture (USDA))	We are grateful for funding from the UMass Healy Foundation (http://www.umass.edu/research/faculty-research-granthealey-endowment-grant) and USDA Hatch grants MAS00898 and MAS009582. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren NA, 2006, ENVIRON MICROBIOL, V8, P441, DOI 10.1111/j.1462-2920.2005.00910.x; Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson JO, 1999, MOL BIOL EVOL, V16, P1178, DOI 10.1093/oxfordjournals.molbev.a026208; Andersson JO, 2001, MOL BIOL EVOL, V18, P829, DOI 10.1093/oxfordjournals.molbev.a003864; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Coleman ML, 2010, P NATL ACAD SCI USA, V107, P18634, DOI 10.1073/pnas.1009480107; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Degnan PH, 2005, GENOME RES, V15, P1023, DOI 10.1101/gr.3771305; Dufresne A, 2003, P NATL ACAD SCI USA, V100, P10020, DOI 10.1073/pnas.1733211100; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Dufresne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r90; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Gil R, 2003, P NATL ACAD SCI USA, V100, P9388, DOI 10.1073/pnas.1533499100; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hu JH, 2009, MOL BIOL EVOL, V26, P5, DOI 10.1093/molbev/msn217; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Luo HW, 2011, MOL BIOL EVOL, V28, P2751, DOI 10.1093/molbev/msr081; Lynch M, 2006, ANNU REV MICROBIOL, V60, P327, DOI 10.1146/annurev.micro.60.080805.142300; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Marais Gabriel A B, 2008, Genetica, V134, P205; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Moran NA, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-12-research0054; Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Palenik B, 2006, P NATL ACAD SCI USA, V103, P13555, DOI 10.1073/pnas.0602963103; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Partensky F., 1999, B I OCEANOGRAPHIQUE, V19, P457; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Xu L, 2006, MOL BIOL EVOL, V23, P1107, DOI 10.1093/molbev/msk019; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zinser ER, 2003, GENETICS, V164, P1271	54	40	42	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e88837	10.1371/journal.pone.0088837	http://dx.doi.org/10.1371/journal.pone.0088837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594762	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900008
J	Andrukhov, O; Andrukhova, O; Hulan, U; Tang, Y; Bantleon, HP; Rausch-Fan, X				Andrukhov, Oleh; Andrukhova, Olena; Hulan, Ulamnemekh; Tang, Yan; Bantleon, Hans-Peter; Rausch-Fan, Xiaohui			Both 25-Hydroxyvitamin-D-3 and 1,25-Dihydroxyvitamin-D-3 Reduces Inflammatory Response in Human Periodontal Ligament Cells	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; SERUM CONCENTRATIONS; PORPHYROMONAS-GINGIVALIS; CALCIUM SUPPLEMENTATION; TANNERELLA-FORSYTHIA; EXPRESSION; INNATE; DISEASES; DIFFERENTIATION; PROLIFERATION	Periodontitis is an inflammatory disease leading to the destruction of periodontal tissue. Vitamin D-3 is an important hormone involved in the preservation of serum calcium and phosphate levels, regulation of bone metabolism and inflammatory response. Recent studies suggest that vitamin D-3 metabolism might play a role in the progression of periodontitis. The aim of the present study was to examine the effects of 25(OH)D-3, which is stable form of vitamin D-3 in blood, and biologically active form 1,25(OH)(2)D-3 on the production of interleukin-6 (IL-6), interleukin-8 (IL-8), and monocyte chemotactic protein-1 (MCP-1) by cells of periodontal ligament. Commercially available human periodontal ligament fibroblasts (hPdLF) and primary human periodontal ligament cells (hPdLC) were used. Cells were stimulated with either Porphyromonas gingivalis lipopolysaccharide (LPS) or heat-killed P. ginigvalis in the presence or in the absence of 25(OH)D-3 or 1,25(OH)(2)D-3 at concentrations of 10-100 nM. Stimulation of cells with either P. gingivalis LPS or heat-killed P. gingivalis resulted in a significant increase of the expression levels of IL-6, IL-8, and MCP-1 in gene as well as in protein levels, measured by qPCR and ELISA, respectively. The production of these pro-inflammatory mediators in hPdLF was significantly inhibited by both 25(OH)D-3 and 1,25(OH)(2)D-3 in a dose-dependent manner. In primary hPdLCs, both 25(OH)D-3 and 1,25(OH)(2)D-3 inhibited the production of IL-8 and MCP-1 but have no significant effect on the IL-6 production. The effect of both 25(OH)D-3 and 1,25(OH)(2)D-3 was abolished by specific knockdown of vitamin D-3 receptor by siRNA. Our data suggest that vitamin D-3 might play an important role in the modulation of periodontal inflammation via regulation of cytokine production by cells of periodontal ligament. Further studies are required for better understanding of the extents of this anti-inflammatory effect and its involvement in the progression of periodontal disease.	[Andrukhov, Oleh; Hulan, Ulamnemekh; Tang, Yan; Rausch-Fan, Xiaohui] Med Univ Vienna, Bernhard Gottlieb Sch Dent, Div Oral Biol, Vienna, Austria; [Andrukhova, Olena] Univ Vet Med, Dept Biomed Sci, Vienna, Austria; [Hulan, Ulamnemekh] Hlth Sci Univ Mongolia, Sch Dent, Dept Restorat Sci, Ulaanbaatar, Mongolia; [Tang, Yan] Capital Med Univ, Xuanwu Hosp, Dept Stomatol, Beijing, Peoples R China; [Bantleon, Hans-Peter; Rausch-Fan, Xiaohui] Med Univ Vienna, Bernhard Gottlieb Sch Dent, Div Orthodont, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; Mongolian National University of Medical Sciences; Capital Medical University; Medical University of Vienna	Andrukhov, O (corresponding author), Med Univ Vienna, Bernhard Gottlieb Sch Dent, Div Oral Biol, Vienna, Austria.	oleh.andrukhov@meduniwien.ac.at; xiaohui.rausch-fan@meduniwien.ac.at	Andrukhov, Oleh/H-9851-2018	Andrukhov, Oleh/0000-0002-0485-2142; Rausch-Fan, Xiaohui/0000-0002-8010-1914	Bernhard Gottlieb School of Dentistry, Medical University of Vienna; International Team of Implantology Foundation [781_2011]	Bernhard Gottlieb School of Dentistry, Medical University of Vienna; International Team of Implantology Foundation	The study was supported by authors' institution (Bernhard Gottlieb School of Dentistry, Medical University of Vienna) and by International Team of Implantology Foundation (Project No. 781_2011). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andrukhov O, 2013, ACTA ODONTOL SCAND; Andrukhov O, 2010, ACTA ODONTOL SCAND, V68, P329, DOI 10.3109/00016357.2010.514717; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Bashutski JD, 2011, J DENT RES, V90, P1007, DOI 10.1177/0022034511407771; Beertsen W, 1997, PERIODONTOL 2000, V13, P20, DOI 10.1111/j.1600-0757.1997.tb00094.x; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Brett PM, 2005, J DENT RES, V84, P1149, DOI 10.1177/154405910508401211; Dietrich T, 2005, AM J CLIN NUTR, V82, P575, DOI 10.1093/ajcn/82.3.575; Dietrich T, 2004, AM J CLIN NUTR, V80, P108; Dixon DR, 2004, PERIODONTOL 2000, V35, P53, DOI 10.1111/j.0906-6713.2004.003556.x; Fonseca JE, 2009, AUTOIMMUN REV, V8, P538, DOI 10.1016/j.autrev.2009.01.012; Garcia MN, 2011, J PERIODONTOL, V82, P25, DOI 10.1902/jop.2010.100207; GENCO RJ, 1992, J PERIODONTOL, V63, P338, DOI 10.1902/jop.1992.63.4s.338; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; ISHIMI Y, 1990, J IMMUNOL, V145, P3297; Jacobs C, 2013, CLIN ORAL INVESTIG; Jacobs C, 2013, ARCH ORAL BIOL, V58, P896, DOI 10.1016/j.archoralbio.2013.01.009; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; Jonsson D, 2011, J PERIODONTAL RES, V46, P153, DOI 10.1111/j.1600-0765.2010.01331.x; Kinane DF, 2001, PERIODONTOL 2000, V25, P8, DOI 10.1034/j.1600-0757.2001.22250102.x; Kocgozlu L, 2009, J DENT RES, V88, P741, DOI 10.1177/0022034509341166; Krieger E, 2013, HEAD FACE MED, V9, DOI 10.1186/1746-160X-9-22; Kumada Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010305; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; Liu KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052053; Liu KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039878; Liu KN, 2010, J PERIODONTOL, V81, P260, DOI 10.1902/jop.2009.090355; Liu KN, 2009, J PERIODONTOL, V80, P1114, DOI 10.1902/jop.2009.080675; Martelli FS, 2011, ARCH ORAL BIOL, V56, P1494, DOI 10.1016/j.archoralbio.2011.06.012; McMahon L, 2011, INFECT IMMUN, V79, P2250, DOI 10.1128/IAI.00099-11; Miley DD, 2009, J PERIODONTOL, V80, P1433, DOI 10.1902/jop.2009.090077; Pathirana RD, 2010, PERIODONTOL 2000, V52, P218, DOI 10.1111/j.1600-0757.2009.00330.x; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Scheres N, 2011, J PERIODONTAL RES, V46, P407, DOI 10.1111/j.1600-0765.2011.01353.x; Scheres N, 2010, J PERIODONTAL RES, V45, P262, DOI 10.1111/j.1600-0765.2009.01229.x; Sekot G, 2011, J DENT RES, V90, P109, DOI 10.1177/0022034510384622; Shu L, 2008, J DENT RES, V87, P142, DOI 10.1177/154405910808700214; Silva TA, 2007, J DENT RES, V86, P306, DOI 10.1177/154405910708600403; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Stein SH, 2013, J PERIODONTAL RES; Tanaka K, 2013, SCAND J IMMUNOL, V78, P371, DOI 10.1111/sji.12095; Tanaka K, 2011, ARCH ORAL BIOL, V56, P380, DOI 10.1016/j.archoralbio.2010.10.013; Tang XL, 2013, ARCH ORAL BIOL, V58, P397, DOI 10.1016/j.archoralbio.2012.09.010; Tang XL, 2009, ARCH ORAL BIOL, V54, P625, DOI 10.1016/j.archoralbio.2009.04.009; Teng YTA, 2006, J DENT RES, V85, P198, DOI 10.1177/154405910608500301; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Van Peer G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00222; White JH, 2008, INFECT IMMUN, V76, P3837, DOI 10.1128/IAI.00353-08; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888	50	43	44	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90301	10.1371/journal.pone.0090301	http://dx.doi.org/10.1371/journal.pone.0090301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587317	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200163
J	Tadros, SF; D'Souza, M; Zhu, XX; Frisina, RD				Tadros, Sherif F.; D'Souza, Mary; Zhu, Xiaoxia; Frisina, Robert D.			Gene Expression Changes for Antioxidants Pathways in the Mouse Cochlea: Relations to Age-related Hearing Deficits	PLOS ONE			English	Article							PRODUCT OTOACOUSTIC EMISSIONS; OUTER HAIR CELL; OXIDATIVE STRESS; THIOREDOXIN REDUCTASE; CONTRALATERAL SUPPRESSION; CISPLATIN OTOTOXICITY; GLUTATHIONE; DAMAGE; NOISE; SELENOCYSTEINE	Age-related hearing loss - presbycusis - is the number one neurodegenerative disorder and top communication deficit of our aged population. Like many aging disorders of the nervous system, damage from free radicals linked to production of reactive oxygen and/or nitrogen species (ROS and RNS, respectively) may play key roles in disease progression. The efficacy of the antioxidant systems, e. g., glutathione and thioredoxin, is an important factor in pathophysiology of the aging nervous system. In this investigation, relations between the expression of antioxidant-related genes in the auditory portion of the inner ear - cochlea, and age-related hearing loss was explored for CBA/CaJ mice. Forty mice were classified into four groups according to age and degree of hearing loss. Cochlear mRNA samples were collected and cDNA generated. Using Affymetrix (R) GeneChip, the expressions of 56 antioxidant-related gene probes were analyzed to estimate the differences in gene expression between the four subject groups. The expression of Glutathione peroxidase 6, Gpx6; Thioredoxin reductase 1, Txnrd1; Isocitrate dehydrogenase 1, Idh1; and Heat shock protein 1, Hspb1; were significantly different, or showed large fold-change differences between subject groups. The Gpx6, Txnrd1 and Hspb1 gene expression changes were validated using qPCR. The Gpx6 gene was upregulated while the Txnrd1 gene was downregulated with age/hearing loss. The Hspb1 gene was found to be downregulated in middle-aged animals as well as those with mild presbycusis, whereas it was upregulated in those with severe presbycusis. These results facilitate development of future interventions to predict, prevent or slow down the progression of presbycusis.	[Tadros, Sherif F.; D'Souza, Mary; Zhu, Xiaoxia; Frisina, Robert D.] Rochester Inst Technol, Natl Tech Inst Deaf, Int Ctr Hearing & Speech Res, Rochester, NY 14623 USA; [Tadros, Sherif F.; D'Souza, Mary; Zhu, Xiaoxia; Frisina, Robert D.] Univ Rochester, Sch Med, Dept Otolaryngol, Rochester, NY USA; [Zhu, Xiaoxia; Frisina, Robert D.] Univ S Florida, Dept Chem & Biomed Engn, Tampa, FL USA; [Zhu, Xiaoxia; Frisina, Robert D.] Univ S Florida, Dept Commun Sci & Disorders, Tampa, FL USA; [Zhu, Xiaoxia; Frisina, Robert D.] Univ S Florida, Global Ctr Hearing & Speech Res, Tampa, FL USA	Rochester Institute of Technology; University of Rochester; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Frisina, RD (corresponding author), Rochester Inst Technol, Natl Tech Inst Deaf, Int Ctr Hearing & Speech Res, Rochester, NY 14623 USA.	Rfrisina@usf.edu	Frisina, Robert D./AAG-8050-2019	Frisina, Robert D./0000-0002-7423-6257	National Institutes of Health from the National Institute on Aging [P01 AG009524]; National Institutes of Health from the National Institute on Deafness & Communication Disorders, USA [P30 DC005409]; NATIONAL INSTITUTE ON AGING [P01AG009524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005409] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute on Aging; National Institutes of Health from the National Institute on Deafness & Communication Disorders, USA; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research was supported by National Institutes of Health Grants P01 AG009524 from the National Institute on Aging, P30 DC005409 from the National Institute on Deafness & Communication Disorders, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baik SY, 2005, NEUROSCI LETT, V374, P53, DOI 10.1016/j.neulet.2004.10.047; Barrenas ML, 1996, EAR HEARING, V17, P63, DOI 10.1097/00003446-199602000-00008; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; Christensen N, 2009, BRAIN RES, V1253, P27, DOI 10.1016/j.brainres.2008.11.070; CLERICI WJ, 1995, HEARING RES, V84, P30, DOI 10.1016/0378-5955(95)00010-2; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Drew JE, 2005, FEBS LETT, V579, P6135, DOI 10.1016/j.febslet.2005.09.085; Frisina R.D., 2010, OXFORD HDB AUDITORY, P415; Frisina RD, 2007, J ACOUST SOC AM, V121, pEL29, DOI 10.1121/1.2401226; Frisina RD, 2011, NEUROBIOL AGING, V32, P1716, DOI 10.1016/j.neurobiolaging.2009.09.009; Fukuhara R, 2005, COMP BIOCHEM PHYS B, V141, P428, DOI 10.1016/j.cbpc.2005.05.002; Gan L, 2005, J CELL BIOCHEM, V96, P653, DOI 10.1002/jcb.20585; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Guimaraes P, 2004, HEARING RES, V192, P83, DOI 10.1016/j.heares.2004.01.013; Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202; IKEDA K, 1993, ACTA OTO-LARYNGOL, V113, P137, DOI 10.3109/00016489309135781; Jacobson M, 2003, LARYNGOSCOPE, V113, P1707, DOI 10.1097/00005537-200310000-00009; Joseph JA, 2005, NEUROCHEM RES, V30, P927, DOI 10.1007/s11064-005-6967-4; Joseph JA, 1998, NEUROL CLIN, V16, P747, DOI 10.1016/S0733-8619(05)70092-X; Joseph JA, 1998, ANN NY ACAD SCI, V854, P268, DOI 10.1111/j.1749-6632.1998.tb09908.x; Kawamoto K, 2004, MOL THER, V9, P173, DOI 10.1016/j.ymthe.2003.11.020; Klemens James J, 2003, J Am Acad Audiol, V14, P134; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lanaz G, 1988, BIOCHIM BIOPHYS ACTA, V1366, P63; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; Leonova EV, 2002, HEARING RES, V163, P61, DOI 10.1016/S0378-5955(01)00379-3; Linford NJ, 2006, CANCER RES, V66, P2497, DOI 10.1158/0008-5472.CAN-05-3163; Lopez-Diazguerrero NE, 2005, LIFE SCI, V77, P2840, DOI 10.1016/j.lfs.2005.05.034; Lynch ED, 2005, HEARING RES, V201, P81, DOI 10.1016/j.heares.2004.08.002; Madeja Z, 2005, BIOCHEM PHARMACOL, V69, P1765, DOI 10.1016/j.bcp.2005.02.023; Maher P, 2005, AGEING RES REV, V4, P288, DOI 10.1016/j.arr.2005.02.005; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; Meseguer M, 2004, J ANDROL, V25, P773; Mikuriya T, 2005, BRAIN RES, V1065, P107, DOI 10.1016/j.brainres.2005.10.045; Miranda-Vizuete A, 1999, EUR J BIOCHEM, V261, P405, DOI 10.1046/j.1432-1327.1999.00286.x; Ohlemiller KK, 2000, JARO-J ASSOC RES OTO, V1, P243, DOI 10.1007/s101620010043; Patenaude A, 2005, CELL MOL LIFE SCI, V62, P1063, DOI 10.1007/s00018-005-4541-5; Pourbakht A, 2003, HEARING RES, V181, P100, DOI 10.1016/S0378-5955(03)00178-3; Quiles JL, 2006, J GERONTOL A-BIOL, V61, P107, DOI 10.1093/gerona/61.2.107; Rabinowitz PM, 2002, HEARING RES, V173, P164, DOI 10.1016/S0378-5955(02)00350-7; RAVI R, 1995, PHARMACOL TOXICOL, V76, P386, DOI 10.1111/j.1600-0773.1995.tb00167.x; Rybak LP, 1997, PHARMACOL TOXICOL, V81, P173, DOI 10.1111/j.1600-0773.1997.tb02065.x; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Seemann S, 2005, ONCOGENE, V24, P3853, DOI 10.1038/sj.onc.1208549; Seidman MD, 2000, LARYNGOSCOPE, V110, P727, DOI 10.1097/00005537-200005000-00003; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Staecker H, 2001, ACTA OTO-LARYNGOL, V121, P666, DOI 10.1080/00016480152583593; Sun QA, 1999, J BIOL CHEM, V274, P24522, DOI 10.1074/jbc.274.35.24522; Sun QA, 2005, BIOCHEMISTRY-US, V44, P14528, DOI 10.1021/bi051321w; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Tadros SF, 2007, NEUROBIOL AGING, V28, P1112, DOI 10.1016/j.neurobiolaging.2006.05.021; Tadros SF, 2007, BRAIN RES, V1127, P1, DOI 10.1016/j.brainres.2006.09.081; Tanaka C, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.027; Van Remmen H, 2001, EXP GERONTOL, V36, P957; Varghese GI, 2005, HEARING RES, V209, P60, DOI 10.1016/j.heares.2005.06.006; Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003; Witte AB, 2005, FREE RADICAL BIO MED, V39, P696, DOI 10.1016/j.freeradbiomed.2005.04.025; Yamawaki H, 2005, CURR OPIN NEPHROL HY, V14, P149, DOI 10.1097/00041552-200503000-00010; Zhu XX, 2007, J COMP NEUROL, V503, P593, DOI 10.1002/cne.21402	62	34	40	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90279	10.1371/journal.pone.0090279	http://dx.doi.org/10.1371/journal.pone.0090279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587312	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200160
J	Xu, JX; Huang, YQ; Cai, HB; Qi, Y; Jia, N; Shen, WF; Lin, JX; Peng, F; Niu, WQ				Xu, Junxia; Huang, Yingqun; Cai, Hongbin; Qi, Yue; Jia, Nan; Shen, Weifeng; Lin, Jinxiu; Peng, Feng; Niu, Wenquan			Is Cryoballoon Ablation Preferable to Radiofrequency Ablation for Treatment of Atrial Fibrillation by Pulmonary Vein Isolation? A Meta-Analysis	PLOS ONE			English	Article							EXPERT CONSENSUS STATEMENT; PROCEDURAL TECHNIQUES; PATIENT-MANAGEMENT; CATHETER ABLATION; SURGICAL ABLATION; END-POINTS; FOLLOW-UP; RECOMMENDATIONS; CRYOABLATION; DEFINITIONS	Objective: Currently radiofrequency and cryoballoon ablations are the two standard ablation systems used for catheter ablation of atrial fibrillation; however, there is no universal consensus on which ablation is the optimal choice. We therefore sought to undertake a meta-analysis with special emphases on comparing the efficacy and safety between cryoballoon and radiofrequency ablations by synthesizing published clinical trials. Methods and Results: Articles were identified by searching the MEDLINE and EMBASE databases before September 2013, by reviewing the bibliographies of eligible reports, and by consulting with experts in this field. Data were extracted independently and in duplicate. There were respectively 469 and 635 patients referred for cryoballoon and radiofrequency ablations from 14 qualified clinical trials. Overall analyses indicated that cryoballoon ablation significantly reduced fluoroscopic time and total procedure time by a weighted mean of 14.13 (95% confidence interval [95% CI]: 2.82 to 25.45; P = 0.014) minutes and 29.65 (95% CI: 8.54 to 50.77; P = 0.006) minutes compared with radiofrequency ablation, respectively, whereas ablation time in cryoballoon ablation was nonsignificantly elongated by a weighted mean of 11.66 (95% CI: -10.71 to 34.04; P = 0.307) minutes. Patients referred for cryoballoon ablation had a high yet nonsignificant success rate of catheter ablation compared with cryoballoon ablation (odds ratio; 95% CI; P: 1.34; 0.53 to 3.36; 0.538), and cryoballoon ablation was also found to be associated with the relatively low risk of having recurrent atrial fibrillation (0.75; 0.3 to 1.88; 0.538) and major complications (0.46; 0.11 to 1.83; 0.269). There was strong evidence of heterogeneity and low probability of publication bias. Conclusion: Our findings demonstrate greater improvement in fluoroscopic time and total procedure duration for atrial fibrillation patients referred for cryoballoon ablation than those for radiofrequency ablation.	[Xu, Junxia] PLA, Fuzhou Gen Hosp Nanjing Command, Dept Geratol, Fuzhou, Fujian, Peoples R China; [Xu, Junxia] Fujian Med Univ, Fozhou Gen Hosp, Dept Geratol, Fuzhou, Fujian, Peoples R China; [Huang, Yingqun; Cai, Hongbin; Lin, Jinxiu; Peng, Feng] Fujian Med Univ, Affiliated Hosp 1, Dept Cardiol, Fuzhou, Fujian, Peoples R China; [Qi, Yue] Capital Med Univ, Affiliated Beijing An Zhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Epidemiol, Beijing, Peoples R China; [Jia, Nan] Fourth Peoples Hosp Shenzhen, Dept Cardiol, Shenzhen, Guangdong, Peoples R China; [Shen, Weifeng] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Niu, Wenquan] Dalian Med Univ, Inst Cardiovasc Dis, Dept Human Genet & Biostat, Dalian, Liaoning, Peoples R China; [Niu, Wenquan] Dalian Med Univ, Inst Cardiovasc Dis, Ctr Evidence Based Med, Dalian, Liaoning, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China	Fujian Medical University; Fujian Medical University; Capital Medical University; Shanghai Jiao Tong University; Dalian Medical University; Dalian Medical University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Xu, JX (corresponding author), PLA, Fuzhou Gen Hosp Nanjing Command, Dept Geratol, Fuzhou, Fujian, Peoples R China.	xujunxia1970@aliyun.com; fengpengfuzhou@yeah.net; niuwenquan_shcn@163.com						Betts TR, 2013, J CARDIOVASC ELECTR, V24, P775, DOI 10.1111/jce.12129; Bowden J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-41; Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027; Calkins H, 2012, J INTERV CARD ELECTR, V33, P171, DOI 10.1007/s10840-012-9672-7; Chierchia GB, 2010, EUROPACE, V12, P337, DOI 10.1093/europace/eup422; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Gaita F, 2011, J CARDIOVASC ELECTR, V22, P961, DOI 10.1111/j.1540-8167.2011.02050.x; Klein G, 2008, Minerva Cardioangiol, V56, P623; Knecht S, 2013, J CARDIOVASC ELECTR, V24, P132, DOI 10.1111/jce.12003; Kojodjojo P, 2010, HEART, V96, P1379, DOI 10.1136/hrt.2009.192419; Kuhne M, 2010, HEART RHYTHM, V7, P1770, DOI 10.1016/j.hrthm.2010.08.028; Li XP, 2013, CHINESE MED J-PEKING, V126, P2747, DOI 10.3760/cma.j.issn.0366-6999.20131089; Linhart M, 2009, J CARDIOVASC ELECTR, V20, P1343, DOI 10.1111/j.1540-8167.2009.01560.x; Maagh P, 2013, INT J MED SCI, V10, P24, DOI 10.7150/ijms.4771; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Neumann T, 2011, EUROPACE, V13, P37, DOI 10.1093/europace/euq303; Packer DL, 2013, J AM COLL CARDIOL, V61, P1713, DOI 10.1016/j.jacc.2012.11.064; Piccini JP, 2009, EUR HEART J, V30, P1245, DOI 10.1093/eurheartj/ehp100; Pokushalov E, 2013, J CARDIOVASC ELECTR, V24, P274, DOI 10.1111/jce.12038; Sauren LD, 2009, J CARDIOVASC ELECTR, V20, P1102, DOI 10.1111/j.1540-8167.2009.01509.x; Schmidt B, 2013, J CARDIOVASC ELECTRO; Schmidt M, 2012, INT J CARDIOL, V158, P33, DOI 10.1016/j.ijcard.2010.12.084; Siklody CH, 2012, HEART RHYTHM, V9, P189, DOI 10.1016/j.hrthm.2011.09.017; Siklody CH, 2011, J AM COLL CARDIOL, V58, P681, DOI 10.1016/j.jacc.2011.04.010; Sorgente Antonio, 2010, Indian Pacing Electrophysiol J, V10, P486; Tse HF, 2003, J AM COLL CARDIOL, V42, P752, DOI 10.1016/S0735-1097(03)00788-5	26	18	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90323	10.1371/journal.pone.0090323	http://dx.doi.org/10.1371/journal.pone.0090323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587324	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200170
J	Zhang, ZN; Lv, JR; Lei, XM; Li, SY; Zhang, Y; Meng, LH; Xue, RL; Li, ZF				Zhang, Zhenni; Lv, Jianrui; Lei, Xiaoming; Li, Siyuan; Zhang, Yong; Meng, Lihua; Xue, Rongliang; Li, Zongfang			RETRACTED: Baicalein Reduces the Invasion of Glioma Cells via Reducing the Activity of p38 Signaling Pathway (Retracted article. See vol. 11, e0160194, 2016)	PLOS ONE			English	Article; Retracted Publication							RANDOMIZED PHASE-III; MATRIX METALLOPROTEINASES; ADJUVANT TEMOZOLOMIDE; ORAL-CANCER; MAPK; GLIOBLASTOMA; RADIOTHERAPY; PROGRESSION; CONCOMITANT; INHIBITION	Baicalein, one of the major flavonids in Scutellaria baicalensis, has historically been used in anti-inflammatory and anticancer therapies. However, the anti-metastatic effect and related mechanism(s) in glioma are still unclear. In this study, we thus utilized glioma cell lines U87MG and U251MG to explore the effect of baicalein. We found that administration of baicalein significantly inhibited migration and invasion of glioma cells. In addition, after treating with baicalein for 24 h, there was a decrease in the levels of matrix metalloproteinase-2 (MMP-2) and MMP-9 expression as well as proteinase activity in glioma cells. Conversely, the expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 was increased in a dose-dependent manner. Moreover, baicalein treatment significantly decreased the phosphorylated level of p38, but not ERK1/2, JNK1/2 and PI3K/Akt. Combined treatment with a p38 inhibitor (SB203580) and baicalein resulted in the synergistic reduction of MMP-2 and MMP-9 expression and then increase of TIMP-1 and TIMP-2 expression; and the invasive capabilities of U87MG cells were also inhibited. However, p38 chemical activator (anisomycin) could block these effects produced by baicalein, suggesting baicalein directly downregulate the p38 signaling pathway. In conclusion, baicalein inhibits glioma cells invasion and metastasis by reducing cell motility and migration via suppression of p38 signaling pathway, suggesting that baicalein is a potential therapeutic agent for glioma.	[Zhang, Zhenni; Lv, Jianrui; Lei, Xiaoming; Li, Siyuan; Zhang, Yong; Meng, Lihua; Xue, Rongliang] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Anesthesia, Xian 710049, Peoples R China; [Li, Zongfang] Xi An Jiao Tong Univ, Natl Local Joint Engn Res Ctr Biodiagnost & Bioth, Xian 710049, Peoples R China; [Li, Zongfang] Xi An Jiao Tong Univ, Sch Med, Educ Minist, Key Lab Environm & Genes Related Dis, Xian 710049, Peoples R China; [Li, Zongfang] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Gen Surgeon Dept Cadres Ward, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Li, ZF (corresponding author), Xi An Jiao Tong Univ, Natl Local Joint Engn Res Ctr Biodiagnost & Bioth, Xian 710049, Peoples R China.	lzf2568@gmail.com			Program for Changjiang Scholars and Innovative Research Team in University [PCSIRT: 1171]; Fundamental Research Funds for the Central Universities [XJJ2008020]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT: 1171) and by the Fundamental Research Funds for the Central Universities (XJJ2008020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha O, 2003, REV CLIN ESP, V203, P189, DOI 10.1157/13045539; Ahmed AU, 2013, EXPERT REV NEUROTHER, V13, P545, DOI [10.1586/ern.13.42, 10.1586/ERN.13.42]; Ahn HC, 2001, MOL CELLS, V12, P127; Bradham C, 2006, CELL CYCLE, V5, P824, DOI 10.4161/cc.5.8.2685; Chandrashekar N, 2012, TOXICOL APPL PHARM, V261, P10, DOI 10.1016/j.taap.2012.02.004; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072927; Cohen M, 2006, MOL HUM REPROD, V12, P225, DOI 10.1093/molehr/gal023; Demuth T, 2007, MOL CANCER THER, V6, P1212, DOI 10.1158/1535-7163.MCT-06-0711; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Huang WH, 2005, J PHARM PHARMACOL, V57, P219, DOI 10.1211/0022357055371; Hwang JM, 2005, J BIOMED SCI, V12, P389, DOI 10.1007/s11373-005-1572-8; Iguchi K, 2012, YAKUGAKU ZASSHI, V132, P1025, DOI 10.1248/yakushi.132.1025; Itoh Y, 2002, ESSAYS BIOCHEM, V38, P21, DOI 10.1042/bse0380021; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim SM, 2008, NEUROSCI LETT, V440, P289, DOI 10.1016/j.neulet.2008.05.064; Kumar A, 2010, INVEST OPHTH VIS SCI, V51, P2664, DOI 10.1167/iovs.09-4195; Liu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021416; Ma YY, 2010, CANCER-AM CANCER SOC, V116, P3294, DOI 10.1002/cncr.25059; Mondal S, 2012, ANTI-CANCER AGENT ME, V12, P49, DOI 10.2174/187152012798764697; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; Okada A, 1999, Gan To Kagaku Ryoho, V26, P2247; Posser T, 2007, ARCH TOXICOL, V81, P407, DOI 10.1007/s00204-007-0177-6; Ricard D, 2012, LANCET, V379, P1984, DOI 10.1016/S0140-6736(11)61346-9; Rock K, 2012, BRIT J RADIOL, V85, pE729, DOI 10.1259/bjr/83796755; ROTA R, 2012, PLOS ONE, V7; Rubaci AH, 2012, J ORAL PATHOL MED, V41, P689, DOI 10.1111/j.1600-0714.2012.01160.x; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun CY, 2013, NEUROSCI BULL, V29, P83, DOI 10.1007/s12264-012-1296-5; Wang ZD, 2010, ONCOL REP, V23, P413, DOI 10.3892/or_00000650; WANG ZS, 2013, CELLULAR MOL NEUROBI; Wei J, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/285246; Weng CJ, 2008, CARCINOGENESIS, V29, P147, DOI 10.1093/carcin/bgm261; Wisniewski P, 2010, CELL SIGNAL, V22, P212, DOI 10.1016/j.cellsig.2009.09.016; Woo JS, 2013, BIOCHEM BIOPH RES CO, V431, P354, DOI 10.1016/j.bbrc.2012.11.134; Wu B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-527; WU Y, 2013, J CELLULAR PHYSL; Yang SF, 2008, ARCH ORAL BIOL, V53, P287, DOI 10.1016/j.archoralbio.2007.09.001; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yoshino Y, 2006, INT J ONCOL, V29, P981	41	38	42	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90318	10.1371/journal.pone.0090318	http://dx.doi.org/10.1371/journal.pone.0090318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587321	Green Published, gold			2022-12-27	WOS:000332396200167
J	Ferrando, S; Castellano, L; Gallus, L; Ghigliotti, L; Masini, MA; Pisano, E; Vacchi, M				Ferrando, Sara; Castellano, Laura; Gallus, Lorenzo; Ghigliotti, Laura; Masini, Maria Angela; Pisano, Eva; Vacchi, Marino			A Demonstration of Nesting in Two Antarctic Icefish (Genus Chionodraco) Using a Fin Dimorphism Analysis and Ex Situ Videos	PLOS ONE			English	Article							PARENTAL CARE; EGG-MIMICRY; ROSS SEA; BEHAVIOR; EVOLUTION; FISH; REPRODUCTION; BIOLOGY; CHANNICHTHYIDAE; FERTILIZATION	Visual observations and videos of Chionodraco hamatus icefish at the "Acquario di Genova" and histological analyses of congeneric species C. hamatus and C. rastrospinosus adults sampled in the field provided new anatomical and behavioral information on the reproductive biology of these white blooded species that are endemic to the High-Antarctic region. During the reproductive season, mature males of both species, which are different from females and immature males, display fleshy, club-like knob modifications of their anal fin that consisted of a much thicker epithelium. Histology indicated that the knobs were without any specialized glandular or sensorial organization, thus suggesting a mechanical and/or ornamental role of the modified anal fin. In addition, the occurrence of necrotic regions at the base of the thickened epithelium and the detachment of the knobs in post-spawning C. hamatus males indicated the temporary nature of the knobs. The role of these structures was confirmed as mechanical and was clarified using visual observations and videos of the behavior of two C. hamatus during a reproductive event that occurred in an exhibit tank at the "Acquario di Genova". The reproductive process included pre-spawning activity, preparation of the nest, egg guarding and successfully ended with egg hatching. When the spawning event approached, the male prepared the nest. The nest was constructed on an accurately selected bottom surface, which was flattened and maintained free from sand or debris by a combination of radial body movements and continuous anal fin sweeping, thus demonstrating the important mechanical/abrasive function of the anal fin knobs. The present data are the first records of active nesting in icefish and clarify the meaning of dimorphic temporary structures, whose function would have been difficult to obtain in the field.	[Ferrando, Sara; Gallus, Lorenzo; Ghigliotti, Laura; Masini, Maria Angela; Pisano, Eva] Univ Genoa, Dept Earth Environm & Life Sci DiSTAV, Genoa, Italy; [Castellano, Laura] Acquario Genova, Costa Edutainment Spa, Genoa, Italy; [Vacchi, Marino] CNR, Inst Marine Sci ISMAR, Inst Environm Protect & Res ISPRA, Genoa, Italy	University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Italian Institute for Environmental Protection & Research (ISPRA)	Vacchi, M (corresponding author), CNR, Inst Marine Sci ISMAR, Inst Environm Protect & Res ISPRA, Genoa, Italy.	marino.vacchi@isprambiente.it	Ghigliotti, Laura/AAN-6843-2021; Ghigliotti, Laura/J-3076-2012; Ferrando, Sara/AAC-9934-2022; CNR, Ismar/P-1247-2014	Ghigliotti, Laura/0000-0003-2139-1381; Ferrando, Sara/0000-0002-5781-9709; CNR, Ismar/0000-0001-5351-1486	PNRA (Italian National Antarctic Research Programme) (PNRA Project) [2010_A1.11]	PNRA (Italian National Antarctic Research Programme) (PNRA Project)	The paper was finantially and logistically supported by PNRA (Italian National Antarctic Research Programme) (PNRA Project n. 2010_A1.11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balshine-Earn S, 1998, P ROY SOC B-BIOL SCI, V265, P2217, DOI 10.1098/rspb.1998.0562; Barrera-Oro ER, 2010, POLAR BIOL, V33, P1585, DOI 10.1007/s00300-010-0847-3; BART HL, 1991, COPEIA, P80, DOI 10.2307/1446250; Cheng CHC, 2007, PHILOS T R SOC B, V362, P2215, DOI 10.1098/rstb.2006.1946; COLLETTE BRUCE B., 1965, PROC U S NAT MUS, V117, P567; DANIELS RA, 1978, J FISH BIOL, V12, P465, DOI 10.1111/j.1095-8649.1978.tb04190.x; Detrich HW, 2005, POLAR BIOL, V28, P828, DOI 10.1007/s00300-005-0010-8; DEWITT H H, 1979, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V1, P775; Eastman JT, 2005, POLAR BIOL, V28, P93, DOI 10.1007/s00300-004-0667-4; Evans CW, 2005, ANTARCT SCI, V17, P319, DOI 10.1017/S0954102005002749; Fischer W., 1985, SO OCEAN FISHING ARE, V2, P233; GHERASIMCHOOK VV, 1989, ZOOL ZH, V68, P142; Giacomello E, 2006, BIOL LETTERS, V2, P330, DOI 10.1098/rsbl.2006.0492; Goodwin NB, 1998, P ROY SOC B-BIOL SCI, V265, P2265, DOI 10.1098/rspb.1998.0569; Gross MR, 2005, Q REV BIOL, V80, P37, DOI 10.1086/431023; GROSS MR, 1981, EVOLUTION, V35, P775, DOI 10.1111/j.1558-5646.1981.tb04937.x; GROSS MR, 1985, AM ZOOL, V25, P807; Helfman GS, 2009, DIVERSITY FISHES BIO; Henning F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043695; HOURIGAN TF, 1989, MAR BIOL, V100, P277, DOI 10.1007/BF00391969; HUREAU JC, 1994, POLAR BIOL, V14, P307; Iwami T., 1990, P381; Jones CD, 2012, J FISH BIOL, V80, P2629, DOI 10.1111/j.1095-8649.2012.03282.x; KNAPP RA, 1989, BEHAV ECOL SOCIOBIOL, V25, P321, DOI 10.1007/BF00302989; Kock KH, 2006, ANTARCT SCI, V18, P223, DOI 10.1017/S0954102006000265; Kock K-H., 1992, ANTARCTIC FISH FISHE; Kock KH, 2008, POLAR BIOL, V31, P381, DOI 10.1007/s00300-007-0366-z; Kock KH, 2005, POLAR BIOL, V28, P897, DOI [10.1007/s00300-005-0019-z, 10.1007/s00300-005-0020-6]; KOCK KH, 1991, ANTARCT SCI, V3, P125, DOI 10.1017/S0954102091000172; Kuwamura T, 1997, ETHOLOGY, V103, P1015, DOI 10.1111/j.1439-0310.1997.tb00143.x; La Mesa M, 2003, POLAR BIOL, V26, P621, DOI 10.1007/s00300-003-0519-7; Lindstrom K, 2000, EVOLUTION, V54, P617, DOI 10.1111/j.0014-3820.2000.tb00063.x; LINQUIST DG, 1981, ENVIRON BIOL FISH, V6, P177; MORENO CA, 1980, COPEIA, P171; Moyle P. B., 1996, FISHES INTRO ICHTHYO; Near TJ, 2003, MOL PHYLOGENET EVOL, V28, P87, DOI 10.1016/S1055-7903(03)00029-0; Newman HH, 1909, BIOL BULL-US, V17, P170, DOI 10.2307/1536035; Noble GK, 1939, AM NAT, V73, P113, DOI 10.1086/280821; OLSEN STEINAR, 1955, NYTT MAG ZOOL OSLO, V3, P79; Pisano E., 2010, FISH ICE DVD; Porter BA, 2002, BEHAV ECOL SOCIOBIOL, V51, P350, DOI 10.1007/s00265-002-0456-4; ROBILLIARD GA, 1969, ANTARCT J U S, V4, P304; RUUD JT, 1954, NATURE, V173, P848, DOI 10.1038/173848a0; SMITH RL, 1974, B MAR SCI, V24, P595; St Mary CM, 2001, ETHOLOGY, V107, P1035, DOI 10.1046/j.1439-0310.2001.00747.x; Theis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029878; Vacchi M, 1996, ANTARCT SCI, V8, P185, DOI 10.1017/S0954102096000259; Weitzman Stanley H., 2005, Neotrop. ichthyol., V3, P329, DOI 10.1590/S1679-62252005000300002; WILEY M L, 1970, Bulletin of the American Museum of Natural History, V143, P147; WINN HE, 1958, ECOL MONOGR, V28, P156, DOI 10.2307/1942207; YAO ZX, 1995, AQUACULTURE, V130, P361, DOI 10.1016/0044-8486(94)00337-N; Zander C.D., 1975, Pubblicazioni Staz zool Napoli, V39, P717	52	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90512	10.1371/journal.pone.0090512	http://dx.doi.org/10.1371/journal.pone.0090512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598889	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400086
J	Ceseracciu, E; Sawacha, Z; Cobelli, C				Ceseracciu, Elena; Sawacha, Zimi; Cobelli, Claudio			Comparison of Markerless and Marker-Based Motion Capture Technologies through Simultaneous Data Collection during Gait: Proof of Concept	PLOS ONE			English	Article							JOINT COORDINATE SYSTEM; MOVEMENT; STEREOPHOTOGRAMMETRY; SHAPE; HIP	During the last decade markerless motion capture techniques have gained an increasing interest in the biomechanics community. In the clinical field, however, the application of markerless techniques is still debated. This is mainly due to a limited number of papers dedicated to the comparison with the state of the art of marker based motion capture, in term of repeatability of the three dimensional joints' kinematics. In the present work the application of markerless technique to data acquired with a marker-based system was investigated. All videos and external data were recorded with the same motion capture system and included the possibility to use markerless and marker-based methods simultaneously. Three dimensional markerless joint kinematics was estimated and compared with the one determined with traditional marker based systems, through the evaluation of root mean square distance between joint rotations. In order to compare the performance of markerless and marker-based systems in terms of clinically relevant joint angles estimation, the same anatomical frames of reference were defined for both systems. Differences in calibration and synchronization of the cameras were excluded by applying the same wand calibration and lens distortion correction to both techniques. Best results were achieved for knee flexion-extension angle, with an average root mean square distance of 11.75 deg, corresponding to 18.35% of the range of motion. Sagittal plane kinematics was estimated better than on the other planes also for hip and ankle (root mean square distance of 17.62 deg e. g. 44.66%, and 7.17 deg e. g. 33.12%), meanwhile estimates for hip joint were the most incorrect. This technique enables users of markerless technology to compare differences with marker-based in order to define the degree of applicability of markerless technique.	[Ceseracciu, Elena; Sawacha, Zimi; Cobelli, Claudio] Univ Padua, Dept Informat Engn, Padua, Italy	University of Padua	Cobelli, C (corresponding author), Univ Padua, Dept Informat Engn, Padua, Italy.	cobelli@dei.unipd.it	sawacha, zimi/AAC-2185-2022	sawacha, zimi/0000-0002-2624-5415				Bray J., 2001, MARKERLESS BASED HUM; Cappozzo A, 1997, IEEE T BIO-MED ENG, V44, P1165, DOI 10.1109/10.649988; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Ceseracciu E, 2011, J BIOMECH, V44, P2236, DOI 10.1016/j.jbiomech.2011.06.003; Chiari L, 2005, GAIT POSTURE, V21, P197, DOI 10.1016/j.gaitpost.2004.04.004; Corazza S, 2006, ANN BIOMED ENG, V34, P1019, DOI 10.1007/s10439-006-9122-8; Corazza S, 2005, P SUMM BIOENG C ASME; Corazza S, 2007, J BIOMECH, V40, P3510, DOI 10.1016/j.jbiomech.2007.05.029; Corazza S, 2010, IEEE T BIO-MED ENG, V57, P806, DOI 10.1109/TBME.2008.2002103; Del Din S, 2011, MED BIOL ENG COMPUT, V49, P801, DOI 10.1007/s11517-010-0731-x; Della Croce U, 2005, GAIT POSTURE, V21, P226, DOI 10.1016/j.gaitpost.2004.05.003; Ferrari A, 2008, GAIT POSTURE, V28, P207, DOI 10.1016/j.gaitpost.2007.11.009; GAGE JR, 1995, J BONE JOINT SURG AM, V77, P1607, DOI 10.2106/00004623-199510000-00017; Gorton GE, 2009, GAIT POSTURE, V29, P398, DOI 10.1016/j.gaitpost.2008.10.060; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; Guan P, 2009, IEEE I CONF COMP VIS, P1381, DOI 10.1109/iccv.2009.5459300; Leardini A, 2007, GAIT POSTURE, V26, P560, DOI 10.1016/j.gaitpost.2006.12.018; Mundermann L, 2005, PROC SPIE, V5665, P278, DOI 10.1117/12.587970; Mundermann L, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-6; Rosenhahn B, 2008, 2008 IEEE C COMP VIS, P1; Sawacha Z, 2009, CLIN BIOMECH, V24, P722, DOI 10.1016/j.clinbiomech.2009.07.007; Surer E, 2011, GAIT POSTURE, V33, P532, DOI 10.1016/j.gaitpost.2011.01.003; Wang LA, 2003, PATTERN RECOGN, V36, P585, DOI 10.1016/S0031-3203(02)00100-0; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6	26	91	93	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e87640	10.1371/journal.pone.0087640	http://dx.doi.org/10.1371/journal.pone.0087640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595273	gold, Green Published, Green Submitted			2022-12-27	WOS:000332475500003
J	Moskwa, J; Borawska, MH; Markiewicz-Zukowska, R; Puscion-Jakubik, A; Naliwajko, SK; Socha, K; Soroczynska, J				Moskwa, Justyna; Borawska, Maria H.; Markiewicz-Zukowska, Renata; Puscion-Jakubik, Anna; Naliwajko, Sylwia K.; Socha, Katarzyna; Soroczynska, Jolanta			Polish Natural Bee Honeys Are Anti-Proliferative and Anti-Metastatic Agents in Human Glioblastoma multiforme U87MG Cell Line	PLOS ONE			English	Article							ANTINEOPLASTIC ACTIVITY; ANTIBACTERIAL ACTIVITY; PHENOLIC-COMPOUNDS; KAPPA-B; TEMOZOLOMIDE; PROPOLIS; ANTIOXIDANT; FLAVONOIDS; APOPTOSIS; GROWTH	Honey has been used as food and a traditional medicament since ancient times. However, recently many scientists have been concentrating on the anti-oxidant, anti-proliferative, anti-inflammatory and other properties of honey. In this study, we investigated for the first time an anticancer effect of different honeys from Poland on tumor cell line - glioblastoma multiforme U87MG. Anti-proliferative activity of honeys and its interferences with temozolomide were determined by a cytotoxicity test and DNA binding by [H-3]-thymidine incorporation. A gelatin zymography was used to conduct an evaluation of metalloproteinases (MMP-2 and MMP-9) expression in U87MG treatment with honey samples. The honeys were previously tested qualitatively (diastase activity, total phenolic content, lead and cadmium content). The data demonstrated that the examined honeys have a potent anti-proliferative effect on U87MG cell line in a time-and dose-dependent manner, being effective at concentrations as low as 0.5% (multifloral light honey - viability 53% after 72 h of incubation). We observed that after 48 h, combining honey with temozolomide showed a significantly higher inhibitory effect than the samples of honey alone. We observed a strong inhibition of MMP-2 and MMP-9 for the tested honeys (from 20 to 56% and from 5 to 58% compared to control, respectively). Our results suggest that Polish honeys have an anti-proliferative and anti-metastatic effect on U87MG cell line. Therefore, natural bee honey can be considered as a promising adjuvant treatment for brain tumors.	[Moskwa, Justyna; Borawska, Maria H.; Markiewicz-Zukowska, Renata; Puscion-Jakubik, Anna; Naliwajko, Sylwia K.; Socha, Katarzyna; Soroczynska, Jolanta] Med Univ Bialystok, Dept Bromatol, Bialystok, Poland	Medical University of Bialystok	Borawska, MH (corresponding author), Med Univ Bialystok, Dept Bromatol, Bialystok, Poland.	bromatos@umb.edu.pl	Naliwajko, Sylwia/AAR-8452-2021	Naliwajko, Sylwia/0000-0003-3340-6739; Markiewicz Zukowska, Renata/0000-0003-0716-9573; Moskwa, Justyna/0000-0003-2925-9916; Puscion-Jakubik, Anna/0000-0002-8526-8107; Borawska, Maria/0000-0003-0999-9650; Soroczynska, Jolanta/0000-0002-6262-8456; Socha, Katarzyna/0000-0002-5949-7061	Polish Ministry of Science and Higher Education of the Medical University in Bialystok [N 405 625438]; Medical University of Bialystok [POPW.01.03.00-20-022/09]	Polish Ministry of Science and Higher Education of the Medical University in Bialystok; Medical University of Bialystok	The presented work was supported financially by the Polish Ministry of Science and Higher Education (Grant project No N 405 625438 of the Medical University in Bialystok). This study was conducted with the use of the equipment purchased by the Medical University of Bialystok as part of the OP DEP 2007-2013, Priority Axis I.3, contract No. POPW.01.03.00-20-022/09. Founder's website: http://www.nauka.gov.pl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar MB, 2012, INT J MOL SCI, V13, P15054, DOI 10.3390/ijms131115054; [Anonymous], 2010, RD M JOINT FAO WHO E; Aso K, 2004, BIOL PHARM BULL, V27, P727, DOI 10.1248/bpb.27.727; Borges KS, 2011, GENET MOL BIOL, V34, P310, DOI 10.1590/S1415-47572011000200024; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Boukraa L, 2008, J MED FOOD, V11, P195, DOI 10.1089/jmf.2007.502; Codex Alimentarius Commission, 2001, 121981 FAO WHO COD A; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Estevinho L, 2008, FOOD CHEM TOXICOL, V46, P3774, DOI 10.1016/j.fct.2008.09.062; Fauzi AN, 2011, FOOD CHEM TOXICOL, V49, P871, DOI 10.1016/j.fct.2010.12.010; Fernandez-Cabezudo MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055993; Forsyth PA, 1999, BRIT J CANCER, V79, P1828, DOI 10.1038/sj.bjc.6690291; Frankfurt OS, 2003, ANTI-CANCER DRUG, V14, P555, DOI 10.1097/00001813-200308000-00008; Freitas M, 2011, METALLOMICS, V3, P1238, DOI 10.1039/c1mt00050k; Fukushima T, 2012, NEURO-ONCOLOGY, V14, P19, DOI 10.1093/neuonc/nor168; Galijatovic A, 2001, PHARMACEUT RES, V18, P374, DOI 10.1023/A:1011019417236; Ghashm AA, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-49; Gheldof N, 2002, J AGR FOOD CHEM, V50, P3050, DOI 10.1021/jf0114637; Guckenberger M, 2011, STRAHLENTHER ONKOL, V187, P548, DOI 10.1007/s00066-011-2242-6; Irish J, 2008, INT J ANTIMICROB AG, V32, P89, DOI 10.1016/j.ijantimicag.2008.02.012; Ishihara M, 2009, ONCOL REP, V22, P349, DOI 10.3892/or_00000444; Iurlina MO, 2009, FOOD CHEM, V115, P1141, DOI 10.1016/j.foodchem.2009.01.003; Jacinto FV, 2007, DNA REPAIR, V6, P1155, DOI 10.1016/j.dnarep.2007.03.013; Jaganathan SK, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/830616; Jo C, 2013, TOXICOL LETT, V222, P117, DOI 10.1016/j.toxlet.2013.07.015; Karali Y, 2012, PEDIATR HEMAT ONCOL, V29, P335, DOI 10.3109/08880018.2012.670368; Kim JT, 2006, ONCOL REP, V16, P33; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Markiewicz-Zukowska R, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-50; Nieder C, 2005, ANTICANCER RES, V25, P4605; Orsolic N, 2005, J SCI FOOD AGR, V85, P363, DOI 10.1002/jsfa.2041; Park MH, 2011, BIOCHEM BIOPH RES CO, V412, P710, DOI 10.1016/j.bbrc.2011.08.037; Pichichero E, 2009, J SCI FOOD AGR, V89, P609, DOI 10.1002/jsfa.3484; Posser T, 2007, ARCH TOXICOL, V81, P407, DOI 10.1007/s00204-007-0177-6; Pyrzynska K, 2009, TRAC-TREND ANAL CHEM, V28, P893, DOI 10.1016/j.trac.2009.03.015; Roomi MW, 2013, ONCOL REP, V29, P29, DOI 10.3892/or.2012.2110; Samarghandian S, 2011, PHARMACOGN MAG, V7, P46, DOI 10.4103/0973-1296.75901; Scrideli CA, 2008, J NEURO-ONCOL, V88, P281, DOI 10.1007/s11060-008-9579-4; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Swellam T, 2003, INT J UROL, V10, P213, DOI 10.1046/j.0919-8172.2003.00602.x; Van Nifterik KA, 2007, INT J RADIAT ONCOL, V69, P1246, DOI 10.1016/j.ijrobp.2007.07.2366; Wang MD, 2005, J NEURO-ONCOL, V72, P1, DOI 10.1007/s11060-004-1392-0; Wang XH, 2002, J AGR FOOD CHEM, V50, P6923, DOI 10.1021/jf025641n; Wang YB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060834, DOI 10.1371/J0URNAL.P0NE.0060834]; Yao LH, 2003, FOOD CHEM, V81, P159, DOI 10.1016/S0308-8146(02)00388-6; Zhang R, 2007, NEUROCHEM RES, V32, P2194, DOI 10.1007/s11064-007-9417-7; Zhao JX, 2007, EUR J NEUROL, V14, P510, DOI 10.1111/j.1468-1331.2006.01705.x; Zhu YA, 2002, NAT REV CANCER, V2, P616, DOI 10.1038/nrc866	48	24	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90533	10.1371/journal.pone.0090533	http://dx.doi.org/10.1371/journal.pone.0090533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594866	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500061
J	Neumann, JT; Havulinna, AS; Zeller, T; Appelbaum, S; Kunnas, T; Nikkari, S; Jousilahti, P; Blankenberg, S; Sydow, K; Salomaa, V				Neumann, Johannes Tobias; Havulinna, Aki S.; Zeller, Tanja; Appelbaum, Sebastian; Kunnas, Tarja; Nikkari, Seppo; Jousilahti, Pekka; Blankenberg, Stefan; Sydow, Karsten; Salomaa, Veikko			Comparison of Three Troponins as Predictors of Future Cardiovascular Events - Prospective Results from the FINRISK and BiomaCaRE Studies	PLOS ONE			English	Article							SENSITIVITY CARDIAC TROPONIN; EARLY-DIAGNOSIS; I ASSAY; T ASSAY; RISK; ASSOCIATION; BIOMARKERS; MORTALITY; CURVE; DEATH	Importance and Objective: Besides their role in diagnosis of acute myocardial infarction (MI), troponins may be powerful biomarkers for risk stratification in the general population. The objective of our study was to compare the performance of three troponin assays in cardiovascular disease (CVD) risk prediction in a population-based cohort without a history of CVD events. Design, Setting and Participants: Troponin I concentrations were measured using a contemporary-sensitivity, high-sensitivity, and super-sensitivity assay in 7,899 participants of the general-population based FINRISK 1997 cohort. We used Cox proportional hazards regression to determine relative risks, followed by measures of discrimination and reclassification using 10-fold cross-validation to control for over-optimism. Main Outcome: As outcome measures we used CVD, MI, ischemic stroke, heart failure (HF), and major adverse cardiac events (MACE). During the follow-up of 14 years 1,074 incident MACE were observed. Results: Values above the lower limit of detection were observed in 26.4%, 81.5% and 93.9% for the contemporary-sensitivity, high-sensitivity and super-sensitivity assay, respectively. We observed significant associations of troponin concentrations with the risk of future CVD events and the results tended to become stronger with increasing assay sensitivity. For the super-sensitivity assay the multivariate adjusted hazard ratios (per one standard deviation increase) for different outcomes were: MI 1.24 [95% CI 1.11-1.39], stroke 1.14 [1.01-1.28], CVD 1.15 [1.07-1.24], HF 1.28 [1.18-1.39], and MACE 1.18 [1.11-1.25]. In subjects with intermediate risk, we found an improvement of net reclassification for HF (10.2%, p<0.001), and MACE (5.1%, p<0.001). Conclusion: Using a super-sensitivity assay, cardiac troponin was detectable in almost all healthy individuals. Its concentration improved risk prediction and reclassification for cardiovascular endpoints.	[Neumann, Johannes Tobias; Zeller, Tanja; Appelbaum, Sebastian; Blankenberg, Stefan; Sydow, Karsten] Univ Hamburg, Ctr Heart, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Havulinna, Aki S.; Jousilahti, Pekka; Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Kunnas, Tarja; Nikkari, Seppo] Univ Tampere, Sch Med, Dept Med Biochem, FIN-33101 Tampere, Finland; [Zeller, Tanja; Blankenberg, Stefan] Partner Site Hamburg Lubeck Kiel, German Ctr Cardiovasc Res DZHK, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Finland National Institute for Health & Welfare; Tampere University; German Centre for Cardiovascular Research	Salomaa, V (corresponding author), Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland.	veikko.salomaa@thl.fi	Neumann, Johannes/AAW-6131-2020; Havulinna, Aki/AAM-4769-2021	Neumann, Johannes/0000-0002-9478-2757; Zeller, Tanja/0000-0003-3379-2641; Kunnas, Tarja/0000-0002-9647-642X	European Community; Academy of Finland [129 494, 139 635]; Finnish Foundation for Cardiovascular Research; Boehringer Ingelheim; Bayer; Abbott Diagnostics; SIEMENS; Thermo Fisher; Roche Diagnostics	European Community(European Commission); Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Boehringer Ingelheim(Boehringer Ingelheim); Bayer(Bayer AG); Abbott Diagnostics(Abbott Laboratories); SIEMENS(Siemens AG); Thermo Fisher; Roche Diagnostics	This work has been sustained by the MORGAM Project's current funding: European Community FP 7 projects ENGAGE CHANCES and BiomarCaRE. This has supported central coordination, workshops and part of the activities of the MORGAM Data Centre, at THL in Helsinki, Finland. MORGAM Participating Centers are funded by regional and national governments, research councils, charities, and other local sources. VS has been supported by the Academy of Finland (grant numbers 129 494 and 139 635) and the Finnish Foundation for Cardiovascular Research. SB has received research funding from Boehringer Ingelheim, Bayer, Abbott Diagnostics, SIEMENS, Thermo Fisher and Roche Diagnostics and received honoraria for lectures or consulting from Boehringer Ingelheim, Bayer, Roche, Astra Zeneca, SIEMENS, Thermo Fisher, and Abbott Diagnostics. VS has received a speaker honorarium from Roche Diagnostics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apple FS, 2012, CLIN CHEM, V58, P1574, DOI 10.1373/clinchem.2012.192716; Apple FS, 2012, CLIN CHEM, V58, P930, DOI 10.1373/clinchem.2011.179176; Blankenberg S, 2010, CIRCULATION, V121, P2388, DOI 10.1161/CIRCULATIONAHA.109.901413; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; deFilippi CR, 2010, JAMA-J AM MED ASSOC, V304, P2494, DOI 10.1001/jama.2010.1708; Graham I, 2007, ATHEROSCLEROSIS, V194, P1, DOI 10.1016/j.atherosclerosis.2007.08.024; Haaf P, 2012, CIRCULATION, V126, P31, DOI 10.1161/CIRCULATIONAHA.112.100867; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kavsak PA, 2011, CLIN CHEM, V57, P1146, DOI 10.1373/clinchem.2011.164574; Keller T, 2011, JAMA-J AM MED ASSOC, V306, P2684, DOI 10.1001/jama.2011.1896; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; MAHONEN M, 2012, EUR J PREV CARDIOL; OLULEYE OW, 2012, ANN EPIDEMIOL; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Saunders JT, 2011, CIRCULATION, V123, P1367, DOI 10.1161/CIRCULATIONAHA.110.005264; Thygesen K, 2011, EUR HEART J; Todd J, 2007, CLIN CHEM, V53, P1990, DOI 10.1373/clinchem.2007.091181; vansBuuren S., 2011, J STAT SOFTWARE, V45; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Venge P, 2009, J AM COLL CARDIOL, V54, P1165, DOI 10.1016/j.jacc.2009.05.051; Venge P, 2009, CLIN CHEM, V55, P109, DOI 10.1373/clinchem.2008.106500; Wang TJ, 2012, CIRCULATION, V126, P1596, DOI 10.1161/CIRCULATIONAHA.112.129437; ZELLER T, 2013, EUR HEART J	27	47	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90063	10.1371/journal.pone.0090063	http://dx.doi.org/10.1371/journal.pone.0090063			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594734	Green Submitted, Green Published, gold			2022-12-27	WOS:000332475500032
J	Chen, JJ; Zhou, H; Xu, PF; Zhang, P; Ma, SN; Zhou, JY				Chen, Junjun; Zhou, Hua; Xu, Panfeng; Zhang, Pei; Ma, Shanni; Zhou, Jianying			Clinical and Radiographic Characteristics of Pulmonary Nocardiosis: Clues to Earlier Diagnosis	PLOS ONE			English	Article							TERTIARY MEDICAL-CENTER; UNITED-STATES; EXPERIENCE; FEATURES; INFECTIONS; SPECTRUM	Background and objectives: Pulmonary nocardiosis (PN) is a rare but life-threatening disease that is caused by Nocardia spp. The aim of this study was to characterize the common risk factors, clinical features, imaging findings, treatment and outcomes of PN, which are useful for an early diagnosis and patient management. Methods: From January 2009 to June 2013, a retrospective study was performed on all PN cases that were diagnosed at our hospital. Results: The study included 17 patients who were diagnosed with PN. Of these patients, 4 developed concomitant disseminated disease. A male predominance was observed among the patients with PN (76.47%). The most common risk factors were corticosteroid therapy (64.71%), diabetes mellitus (29.41) and chronic lung disease (23.53%). Cough and fever were the most common symptoms (94% and 71%, respectively). One or more nodules or masses (82.35%) and consolidations (58.82%) were the most frequent radiologic abnormalities, and cavitation mostly occurred within two weeks. The median time to diagnosis was 25 days. Overall, the mortality rate was 18.75% for PN, and death was most frequent among patients who received immunosuppressive drugs. For the patients with central nervous system involvement, the mortality rate was 50%. Conclusion: PN remains a rare opportunistic infection that mainly affects immunocompromised patients. A high clinical index of suspicion is necessary for an early diagnosis and timely treatment in immunocompromised patients who present with new nodules or masses evolving into cavitation in a short amount of time.	[Chen, Junjun; Zhou, Hua; Xu, Panfeng; Zhang, Pei; Ma, Shanni; Zhou, Jianying] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Resp Dis, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Zhou, JY (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Resp Dis, Hangzhou 310003, Zhejiang, Peoples R China.	zjyhz@zju.edu.cn		Zhou, Hua/0000-0001-6397-3203	National Natural Science Foundation of China [81170038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is funded by grants from the National Natural Science Foundation of China (grant number: 81170038) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosioni J, 2010, INFECTION, V38, P89, DOI 10.1007/s15010-009-9193-9; Bargehr J, 2013, CLIN RADIOL, V68, pE266, DOI 10.1016/j.crad.2012.11.021; BEAMAN BL, 1976, J INFECT DIS, V134, P286, DOI 10.1093/infdis/134.3.286; Blackmon KN, 2011, J THORAC IMAG, V26, P224, DOI 10.1097/RTI.0b013e3181f45dd5; Brown-Elliott BA, 2006, CLIN MICROBIOL REV, V19, P259, DOI 10.1128/CMR.19.2.259-282.2006; BUCKLEY JA, 1995, J COMPUT ASSIST TOMO, V19, P726, DOI 10.1097/00004728-199509000-00007; FEIGIN DS, 1986, RADIOLOGY, V159, P9, DOI 10.1148/radiology.159.1.3952335; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hardak E, 2012, AM J MED SCI, V343, P286, DOI 10.1097/MAJ.0b013e31822cb5dc; Kontoyiannis DP, 1998, MEDICINE, V77, P255, DOI 10.1097/00005792-199807000-00004; Lerner PI, 1996, CLIN INFECT DIS, V22, P891, DOI 10.1093/clinids/22.6.891; Tomas RM, 2007, RESPIROLOGY, V12, P394, DOI [10.1111/j.1440-1843.2007.01078.x, 10.1111/j.1400-1843.2007.01078.x]; Nocard ME, 1988, ANN I PASTEUR PARIS, P293; Riviere F, 2011, EUR RESPIR REV, V20, P210, DOI 10.1183/09059180.00002211; Rosman Y, 2013, EUR J INTERN MED, V24, P552, DOI 10.1016/j.ejim.2013.05.004; Saubolle MA, 2003, J CLIN MICROBIOL, V41, P4497, DOI 10.1128/JCM.41.10.4497-4501.2003; Uhde KB, 2010, CLIN INFECT DIS, V51, P1445, DOI 10.1086/657399; UTTAMCHANDANI RB, 1994, CLIN INFECT DIS, V18, P348, DOI 10.1093/clinids/18.3.348; Wilson JW, 2012, MAYO CLIN PROC, V87, P403, DOI 10.1016/j.mayocp.2011.11.016; Yildiz O, 2006, CURR OPIN PULM MED, V12, P228, DOI 10.1097/01.mcp.0000219273.57933.48	20	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90724	10.1371/journal.pone.0090724	http://dx.doi.org/10.1371/journal.pone.0090724			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594890	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900138
J	Strand, TA; Lale, R; Degnes, KF; Lando, M; Valla, S				Strand, Trine Aakvik; Lale, Rahmi; Degnes, Kristin Flogstad; Lando, Malin; Valla, Svein			A New and Improved Host-Independent Plasmid System for RK2-Based Conjugal Transfer	PLOS ONE			English	Article							RANGE; CLONING; VECTORS; CONSTRUCTION; EXPRESSION; GENES; RP4	Bacterial conjugation is a process that is mediated either by a direct cell-to-cell junction or by formation of a bridge between the cells. It is often used to transfer DNA constructs designed in Escherichia coli to recipient bacteria, yeast, plants and mammalian cells. Plasmids bearing the RK2/RP4 origin of transfer (oriT) are mostly mobilized using the E. coli S17-1/SM10 donor strains, in which transfer helper functions are provided from a chromosomally integrated RP4::Mu. We have observed that large plasmids were occasionally modified after conjugal transfer when using E. coli S17-1 as a donor. All modified plasmids had increased in size, which most probably was a result of co-transfer of DNA from the chromosomally located oriT. It has earlier also been demonstrated that the bacteriophage Mu is silently transferred to recipient cells by these donor strains, and both occurrences are very likely to lead to mutations within the recipient DNA. Here we report the construction of a new biological system addressing both the above mentioned problems in which the transfer helper functions are provided by a plasmid lacking a functional oriT. This system is compatible with all other replicons commonly used in conjugation experiments and further enables the use of diverse bacterial strains as donors. Plasmids containing large inserts were successfully conjugated and the plasmid modifications observed when E. coli S17-1 was used as donor were eliminated by the use of the new host-independent vector system.	[Strand, Trine Aakvik; Lale, Rahmi; Lando, Malin; Valla, Svein] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway; [Degnes, Kristin Flogstad] SINTEF Mat & Chem, Dept Biotechnol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); SINTEF	Lale, R (corresponding author), Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway.	rahmi.lale@ntnu.no		Lale, Rahmi/0000-0001-5460-3163	Research Council of Norway [192123, 157319]	Research Council of Norway(Research Council of Norway)	This work was supported by the Research Council of Norway, grant numbers 192123 and 157319. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakvik T, 2009, FEMS MICROBIOL LETT, V296, P149, DOI 10.1111/j.1574-6968.2009.01639.x; Babic A, 2008, RES MICROBIOL, V159, P545, DOI 10.1016/j.resmic.2008.06.004; Brautaset T, 2009, MICROB BIOTECHNOL, V2, P15, DOI 10.1111/j.1751-7915.2008.00048.x; BURKARDT HJ, 1979, J GEN MICROBIOL, V114, P341, DOI 10.1099/00221287-114-2-341; DELORENZO V, 1993, J BACTERIOL, V175, P6902, DOI 10.1128/jb.175.21.6902-6907.1993; Ferrieres L, 2010, J BACTERIOL, V192, P6418, DOI 10.1128/JB.00621-10; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HOTTE B, 1990, J BACTERIOL, V172, P2804; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; Lio P., 2012, NANO COMMUN NETW, V3, P36, DOI DOI 10.1016/J.NANC0M.2011.10.003; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; PANSEGRAU W, 1994, J MOL BIOL, V239, P623, DOI 10.1006/jmbi.1994.1404; PRIEFER UB, 1985, J BACTERIOL, V163, P324, DOI 10.1128/JB.163.1.324-330.1985; Sambrook J., 2001, MOL CLONING LAB MANU; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; VALLA S, 1992, APPL ENVIRON MICROB, V58, P1980, DOI 10.1128/AEM.58.6.1980-1985.1992; Wexler M, 2005, ENVIRON MICROBIOL, V7, P1917, DOI 10.1111/j.1462-2920.2005.00854.x; WIATER LA, 1994, PLASMID, V32, P280, DOI 10.1006/plas.1994.1067	21	34	36	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90372	10.1371/journal.pone.0090372	http://dx.doi.org/10.1371/journal.pone.0090372			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595202	Green Submitted, gold, Green Published			2022-12-27	WOS:000332468900100
J	Xia, ZF; Yang, TB; Wang, ZS; Dong, JP; Liang, CY				Xia, Zhenfang; Yang, Tubao; Wang, Zhuansuo; Dong, Jianping; Liang, Chunyan			GRK5 Intronic (CA)(n) Polymorphisms Associated with Type 2 Diabetes in Chinese Hainan Island	PLOS ONE			English	Article							RECEPTOR; GENE; DESENSITIZATION; EXPRESSION; REPEATS; BINDING	A genome-wide association study had showed G-protein-coupled receptor kinase 5 (GRK5) rs10886471 was related to the risk of type 2 diabetes mellitus (T2DM) through upregulated GRK5 mRNA expression. Rs10886471 is located in the intron region of GRK5. However, the mechanism by which intronic SNP affects gene expression remains unclear, whether the effect on gene expression depends on the intronic short tandem repeat (STR) (CA)(n) splicing regulator or not. Here we investigated the STR (CA)(n) polymorphism in rs10886471 and further discussed its role in the T2DM risk of Chinese Hainan Island individuals. A total of 1164 subjects were recruited and classified into a normal fasting glucose (NFG) group, an impaired fasting glucose (IFG) group, an impaired glucose tolerance (IGT) group, and a T2DM group. STR (CA)(n) polymorphisms were detected through polymerase chain reaction and sequencing. Five intronic (CA)(n) alleles, (CA)(15) to (CA)(19), were identified in GRK5 rs10886471. Only the (CA)(16) allele was significantly associated with increased prediabetes and T2DM risk [odds ratio (OR) > 1, P < 0.05]. Conversely, multiple alleles without any (CA)(16) protected against prediabetes and T2DM (0 < OR < 1, P < 0.05). In summary, rs10886471 acts as both an SNP and an STR. The rs10886471 intronic SNP causes GRK5 overexpression the subsequent risk of T2DM may be due to the rs10886471 intronic STR (CA)(n) splicing enhancer. Further studies should focus on verifying these finding using a large sample size and analyzing the splicing mechanism of intronic (CA)(n) in rs10886471.	[Xia, Zhenfang; Yang, Tubao] Cent S Univ, Sch Publ Hlth, Div Hlth Stat, Changsha, Hunan, Peoples R China; [Wang, Zhuansuo] Hainan Med Coll, Affiliated Hosp, Dept Endocrinol, City Of Haikou, Province Hainan, Peoples R China; [Dong, Jianping] Hainan Med Coll, Transgen Lab, City Of Haikou, Province Hainan, Peoples R China; [Liang, Chunyan] Community Hlth Serv Ctr Xiuying, Outpatients Dept, City Of Haikou, Province Hainan, Peoples R China	Central South University; Hainan Medical University; Hainan Medical University	Yang, TB (corresponding author), Cent S Univ, Sch Publ Hlth, Div Hlth Stat, Changsha, Hunan, Peoples R China.	1064960669@qq.com						Agrafioti I, 2007, NUCLEIC ACIDS RES, V35, pD71, DOI 10.1093/nar/gkl806; Chen HY, 2013, HUM MUTAT, V34, P1289, DOI 10.1002/humu.22363; Couvineau A, 2012, CURR DRUG TARGETS, V13, P103, DOI 10.2174/138945012798868434; Dou HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059495; Freedman NJ, 1997, J BIOL CHEM, V272, P17734, DOI 10.1074/jbc.272.28.17734; Ginter E, 2013, ADV EXP MED BIOL, V771, P42; Hamilton BJ, 2008, J BIOL CHEM, V283, P25606, DOI 10.1074/jbc.M802492200; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Hui JY, 2003, NAT STRUCT BIOL, V10, P33, DOI 10.1038/nsb875; KUNAPULI P, 1993, P NATL ACAD SCI USA, V90, P5588, DOI 10.1073/pnas.90.12.5588; Li HX, 2013, DIABETES, V62, P291, DOI 10.2337/db12-0454; Lin Y, 2010, J ENDOCRINOL, V204, P1, DOI 10.1677/JOE-09-0260; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Millar David S., 2010, Human Genomics, V4, P289; So CH, 2012, J BIOL CHEM, V287, P17088, DOI 10.1074/jbc.M112.353854; Tariq K, 2013, MOL VIS, V19, P710; TAUTZ D, 1994, CURR OPIN GENET DEV, V4, P832, DOI 10.1016/0959-437X(94)90067-1; Varela MA, 2010, GENOMICS, V95, P151, DOI 10.1016/j.ygeno.2009.12.003; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wang L, 2012, BIOCHEM BIOPH RES CO, V429, P99, DOI 10.1016/j.bbrc.2012.10.077; Wang WCH, 2008, PHARMACOGENET GENOM, V18, P729, DOI 10.1097/FPC.0b013e32830967e9; Wang Y, 2012, NAT STRUCT MOL BIOL, V19, P1044, DOI 10.1038/nsmb.2377; World Health Organization, 2006, DEF DIAGN DIAB MELL; Yilmaz-Aydogan H, 2013, GENE, V523, P20, DOI 10.1016/j.gene.2013.03.136; Yin YW, 2013, CYTOKINE, V62, P226, DOI 10.1016/j.cyto.2013.02.025; Zhang Wei, 2009, Human Genomics, V3, P236; Zhang WJ, 2013, J BIOL CHEM, V288, P22636, DOI 10.1074/jbc.M113.463901	27	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90597	10.1371/journal.pone.0090597	http://dx.doi.org/10.1371/journal.pone.0090597			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594703	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900122
J	Chiricozzi, A; Nograles, KE; Johnson-Huang, LM; Fuentes-Duculan, J; Cardinale, I; Bonifacio, KM; Gulati, N; Mitsui, H; Guttman-Yassky, E; Suarez-Farinas, M; Krueger, JG				Chiricozzi, Andrea; Nograles, Kristine E.; Johnson-Huang, Leanne M.; Fuentes-Duculan, Judilyn; Cardinale, Irma; Bonifacio, Kathleen M.; Gulati, Nicholas; Mitsui, Hiroshi; Guttman-Yassky, Emma; Suarez-Farinas, Mayte; Krueger, James G.			IL-17 Induces an Expanded Range of Downstream Genes in Reconstituted Human Epidermis Model	PLOS ONE			English	Article							INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; DENDRITIC CELLS; T-CELLS; IFN-GAMMA; HUMAN KERATINOCYTES; PSORIASIS LESIONS; DOUBLE-BLIND; SERUM-LEVELS; PIVOTAL ROLE; TNF-ALPHA	Background: IL-17 is the defining cytokine of the Th17, Tc17, and gamma delta T cell populations that plays a critical role in mediating inflammation and autoimmunity. Psoriasis vulgaris is an inflammatory skin disease mediated by Th1 and Th17 cytokines with relevant contributions of IFN-gamma, TNF-alpha, and IL-17. Despite the pivotal role IL-17 plays in psoriasis, and in contrast to the other key mediators involved in the psoriasis cytokine cascade that are capable of inducing broad effects on keratinocytes, IL-17 was demonstrated to regulate the expression of a limited number of genes in monolayer keratinocytes cultured in vitro. Methodology/Principal Findings: Given the clinical efficacy of anti-IL-17 agents is associated with an impressive reduction in a large set of inflammatory genes, we sought a full-thickness skin model that more closely resemble in vivo epidermal architecture. Using a reconstructed human epidermis (RHE), IL-17 was able to upregulate 419 gene probes and downregulate 216 gene probes. As possible explanation for the increased gene induction in the RHE model is that C/CAAT-enhancer-binding proteins (C/EBP) -beta, the transcription factor regulating IL-17-responsive genes, is expressed preferentially in differentiated keratinocytes. Conclusions/Significance: The genes identified in IL-17-treated RHE are likely relevant to the IL-17 effects in psoriasis, since ixekizumab (anti-IL-17A agent) strongly suppressed the "RHE" genes in psoriasis patients treated in vivo with this IL-17 antagonist.	[Chiricozzi, Andrea; Nograles, Kristine E.; Johnson-Huang, Leanne M.; Fuentes-Duculan, Judilyn; Cardinale, Irma; Bonifacio, Kathleen M.; Gulati, Nicholas; Mitsui, Hiroshi; Guttman-Yassky, Emma; Suarez-Farinas, Mayte; Krueger, James G.] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA; [Chiricozzi, Andrea; Nograles, Kristine E.; Guttman-Yassky, Emma; Suarez-Farinas, Mayte; Krueger, James G.] Rockefeller Univ, Ctr Clin & Translat Sci, New York, NY 10021 USA; [Chiricozzi, Andrea] Univ Roma Tor Vergata, Dept Dermatol, Rome, Italy; [Guttman-Yassky, Emma] Mt Sinai Sch Med, Dept Dermatol, New York, NY USA	Rockefeller University; Rockefeller University; University of Rome Tor Vergata; Icahn School of Medicine at Mount Sinai	Chiricozzi, A (corresponding author), Rockefeller Univ, Invest Dermatol Lab, 1230 York Ave, New York, NY 10021 USA.	chiricozziandrea@gmail.com	Suarez-Farinas, Mayte/I-3558-2012; Nograles, Kristine/V-3648-2019	Suarez-Farinas, Mayte/0000-0001-8712-3553; 	Leo-Pharma Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Leo-Pharma Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Artemis Khatcherian and Inna Cueto for the precious support in immunohistochemical procedures. Andrea Chiricozzi is supported by Leo-Pharma Research Foundation Silver Award 2012.	Albanesi C, 1999, J IMMUNOL, V162, P494; Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Caproni M, 2009, J CLIN IMMUNOL, V29, P210, DOI 10.1007/s10875-008-9233-0; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chamian F, 2005, P NATL ACAD SCI USA, V102, P2075, DOI 10.1073/pnas.0409569102; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Gulati N, 2013, J INVEST DERMATOL, V133, P2640, DOI 10.1038/jid.2013.190; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Johnson-Huang LM, 2010, J INVEST DERMATOL, V130, P2654, DOI 10.1038/jid.2010.166; Johnston A, 2011, J IMMUNOL, V186, P2613, DOI 10.4049/jimmunol.1003162; Krueger JG, 2012, J ALLERGY CLIN IMMUN, V130, P145, DOI 10.1016/j.jaci.2012.04.024; Laan M, 2001, BRIT J PHARMACOL, V133, P200, DOI 10.1038/sj.bjp.0704063; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Morizane S, 2012, J DERMATOL, V39, P225, DOI 10.1111/j.1346-8138.2011.01483.x; Muhr P, 2011, BRIT J DERMATOL, V165, P189, DOI 10.1111/j.1365-2133.2011.10302.x; Nair RP, 2008, J INVEST DERMATOL, V128, P1653, DOI 10.1038/sj.jid.5701255; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Nograles KE, 2010, J ALLERGY CLIN IMMUN, V125, P744, DOI 10.1016/j.jaci.2009.12.934; Ortega C, 2009, J LEUKOCYTE BIOL, V86, P435, DOI [10.1189/jlb.0109046, 10.1189/JLB.0109046]; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pickens SR, 2010, J IMMUNOL, V184, P3233, DOI 10.4049/jimmunol.0903271; Piskin G, 2004, EXP DERMATOL, V13, P764, DOI 10.1111/j.0906-6705.2004.00246.x; Rizzo HL, 2011, J IMMUNOL, V186, P1495, DOI 10.4049/jimmunol.1001001; Roussel L, 2010, J IMMUNOL, V184, P4531, DOI 10.4049/jimmunol.0903162; Ruddy MJ, 2004, J LEUKOCYTE BIOL, V76, P135, DOI 10.1189/jlb.0204065; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; SCHEYNIUS A, 1992, J INVEST DERMATOL, V98, P255, DOI 10.1111/1523-1747.ep12556086; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Suarez-Farinas M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-294; Suarez-Farinas M, 2013, J ALLERGY CLIN IMMUN, V132, P361, DOI 10.1016/j.jaci.2013.04.046; Suarez-Farinas M, 2011, J INVEST DERMATOL, V131, P391, DOI 10.1038/jid.2010.280; Suarez-Farinas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010247; Tian SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044274; Tohyama M, 2009, EUR J IMMUNOL, V39, P2779, DOI 10.1002/eji.200939473; TREFZER U, 1991, J INVEST DERMATOL, V97, P911, DOI 10.1111/1523-1747.ep12491668; Trepicchio WL, 1999, J CLIN INVEST, V104, P1527, DOI 10.1172/JCI6910; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zaba LC, 2007, J CLIN INVEST, V117, P2517, DOI 10.1172/JCI32282; Zaba LC, 2009, J ALLERGY CLIN IMMUN, V124, P1022, DOI 10.1016/j.jaci.2009.08.046; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	56	120	122	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90284	10.1371/journal.pone.0090284	http://dx.doi.org/10.1371/journal.pone.0090284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587313	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200161
J	Rani, A; Greenlaw, R; Runglall, M; Jurcevic, S; John, S				Rani, Aradhana; Greenlaw, Roseanna; Runglall, Manohursingh; Jurcevic, Stipo; John, Susan			FRA2 Is a STAT5 Target Gene Regulated by IL-2 in Human CD4 T Cells	PLOS ONE			English	Article							DNASE HYPERSENSITIVE SITES; BINDING-SITES; SOMATIC MUTATIONS; CHROMATIN IMMUNOPRECIPITATION; BREAST-CANCER; HUMAN GENOME; TRANSCRIPTION; EXPRESSION; RECEPTOR; IDENTIFICATION	Signal transducers and activators of transcription 5(STAT5) are cytokine induced signaling proteins, which regulate key immunological processes, such as tolerance induction, maintenance of homeostasis, and CD4 T-effector cell differentiation. In this study, transcriptional targets of STAT5 in CD4 T cells were studied by Chromatin Immunoprecipitation (ChIP). Genomic mapping of the sites cloned and identified in this study revealed the striking observation that the majority of STAT5-binding sites mapped to intergenic (>50 kb upstream) or intronic, rather than promoter proximal regions. Of the 105 STAT5 responsive binding sites identified, 94% contained the canonical (IFN-gamma activation site) GAS motifs. A number of putative target genes identified here are associated with tumor biology. Here, we identified Fos-related antigen 2 (FRA2) as a transcriptional target of IL-2 regulated STAT5. FRA2 is a basic -leucine zipper (bZIP) motif 'Fos' family transcription factor that is part of the AP-1 transcription factor complex and is also known to play a critical role in the progression of human tumours and more recently as a determinant of T cell plasticity. The binding site mapped to an internal intron within the FRA2 gene. The epigenetic architecture of FRA2, characterizes a transcriptionally active promoter as indicated by enrichment for histone methylation marks H3K4me1, H3K4me2, H3K4me3, and transcription/elongation associated marks H2BK5me1 and H4K20me1. FRA2 is regulated by IL-2 in activated CD4 T cells. Consistently, STAT5 bound to GAS sequence in the internal intron of FRA2 and reporter gene assays confirmed IL-2 induced STAT5 binding and transcriptional activation. Furthermore, addition of JAK3 inhibitor (R333) or Daclizumab inhibited the induction in TCR stimulated cells. Taken together, our data suggest that FRA2 is a novel STAT5 target gene, regulated by IL-2 in activated CD4 T cells.	[Rani, Aradhana; Greenlaw, Roseanna; Runglall, Manohursingh; Jurcevic, Stipo] Kings Coll London, Div Transplantat Immunol & Mucosal Biol, London WC2R 2LS, England; [John, Susan] Kings Coll London, Dept Immunobiol, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Jurcevic, S (corresponding author), Kings Coll London, Div Transplantat Immunol & Mucosal Biol, London WC2R 2LS, England.	stipo.jurcevic@kcl.ac.uk; susan.john@kcl.ac.uk		Runglall, Manohursingh/0000-0002-0549-9029; Rani, Aradhana/0000-0003-4273-9826; , Aradhana/0000-0001-5334-2723	MRC Centre for Transplantation; Wellcome Trust UK [074656/Z/04/Z]; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; National Institute for Health Research (NIHR) Biomedical Research Centre based at King's College London; British Heart Foundation [PG/09/080/28014] Funding Source: researchfish; Medical Research Council [MR/J006742/1] Funding Source: researchfish; MRC [G0400197] Funding Source: UKRI	MRC Centre for Transplantation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust UK(Wellcome Trust); National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; National Institute for Health Research (NIHR) Biomedical Research Centre based at King's College London(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to acknowledge the support of the MRC Centre for Transplantation. This work was supported by Wellcome Trust UK Grant 074656/Z/04/Z (to S.John.). The research was funded/supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Barash I, 2012, CARCINOGENESIS, V33, P2320, DOI 10.1093/carcin/bgs362; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell BD, 2013, NAT IMMUNOL, V14, P364, DOI 10.1038/ni.2541; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Crawford GE, 2004, P NATL ACAD SCI USA, V101, P992, DOI 10.1073/pnas.0307540100; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Ferbeyre G, 2011, BBA-REV CANCER, V1815, P104, DOI 10.1016/j.bbcan.2010.10.004; Foletta VC, 1996, IMMUNOL CELL BIOL, V74, P121, DOI 10.1038/icb.1996.17; Fung MM, 2005, ONCOGENE, V24, P4624, DOI 10.1038/sj.onc.1208507; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gatzka M, 2006, CYTOKINE, V34, P143, DOI 10.1016/j.cyto.2006.04.003; Greif PA, 2011, LEUKEMIA, V25, P821, DOI 10.1038/leu.2011.19; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; John S, 1999, MOL CELL BIOL, V19, P1910; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; LeBaron MJ, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-6; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Lund RJ, 2007, J IMMUNOL, V178, P3648, DOI 10.4049/jimmunol.178.6.3648; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; McDyer JF, 2002, J IMMUNOL, V169, P2736, DOI 10.4049/jimmunol.169.5.2736; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Nagy ZS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057326; Nagy ZS, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-67; Nakayama T, 2012, ANTICANCER RES, V32, P1367; Nelson EA, 2004, J BIOL CHEM, V279, P54724, DOI 10.1074/jbc.M408464200; NISHINA H, 1990, P NATL ACAD SCI USA, V87, P3619, DOI 10.1073/pnas.87.9.3619; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Rani A, 2011, J IMMUNOL, V187, P3721, DOI 10.4049/jimmunol.1002354; Rascle A, 2003, MOL CELL BIOL, V23, P4162, DOI 10.1128/MCB.23.12.4162-4173.2003; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Soldaini E, 2000, MOL CELL BIOL, V20, P389, DOI 10.1128/MCB.20.1.389-401.2000; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Velotta JB, 2009, TRANSPLANTATION, V87, P653, DOI 10.1097/TP.0b013e318196110f; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	54	11	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90370	10.1371/journal.pone.0090370	http://dx.doi.org/10.1371/journal.pone.0090370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587342	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200181
J	Beltran, WA; Cideciyan, AV; Guziewicz, KE; Iwabe, S; Swider, M; Scott, EM; Savina, SV; Ruthel, G; Stefano, F; Zhang, LL; Zorger, R; Sumaroka, A; Jacobson, SG; Aguirre, GD				Beltran, William A.; Cideciyan, Artur V.; Guziewicz, Karina E.; Iwabe, Simone; Swider, Malgorzata; Scott, Erin M.; Savina, Svetlana V.; Ruthel, Gordon; Stefano, Frank; Zhang, Lingli; Zorger, Richard; Sumaroka, Alexander; Jacobson, Samuel G.; Aguirre, Gustavo D.			Canine Retina Has a Primate Fovea-Like Bouquet of Cone Photoreceptors Which Is Affected by Inherited Macular Degenerations	PLOS ONE			English	Article							GANGLION-CELLS; AREA CENTRALIS; VISUAL-ACUITY; GENE-THERAPY; DENSITY; MODEL; EYE; PIT; RESOLUTION; MONKEYS	Retinal areas of specialization confer vertebrates with the ability to scrutinize corresponding regions of their visual field with greater resolution. A highly specialized area found in haplorhine primates (including humans) is the fovea centralis which is defined by a high density of cone photoreceptors connected individually to interneurons, and retinal ganglion cells (RGCs) that are offset to form a pit lacking retinal capillaries and inner retinal neurons at its center. In dogs, a local increase in RGC density is found in a topographically comparable retinal area defined as the area centralis. While the canine retina is devoid of a foveal pit, no detailed examination of the photoreceptors within the area centralis has been reported. Using both in vivo and ex vivo imaging, we identified a retinal region with a primate fovea-like cone photoreceptor density but without the excavation of the inner retina. Similar anatomical structure observed in rare human subjects has been named fovea-plana. In addition, dogs with mutations in two different genes, that cause macular degeneration in humans, developed earliest disease at the newly-identified canine fovea-like area. Our results challenge the dogma that within the phylogenetic tree of mammals, haplorhine primates with a fovea are the sole lineage in which the retina has a central bouquet of cones. Furthermore, a predilection for naturally-occurring retinal degenerations to alter this cone-enriched area fills the void for a clinically-relevant animal model of human macular degenerations.	[Beltran, William A.; Guziewicz, Karina E.; Iwabe, Simone; Scott, Erin M.; Savina, Svetlana V.; Aguirre, Gustavo D.] Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA; [Cideciyan, Artur V.; Swider, Malgorzata; Sumaroka, Alexander; Jacobson, Samuel G.] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ruthel, Gordon] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Stefano, Frank] Univ Penn, Sch Dent Med, Dept Biochem, Philadelphia, PA 19104 USA; [Zhang, Lingli; Zorger, Richard] Univ Penn, Dept Neurosci, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Beltran, WA (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA.	wbeltran@vet.upenn.edu; cideciya@mail.med.upenn.edu	Cideciyan, Artur V/A-1075-2007; Ruthel, Gordon/GYU-9133-2022	Cideciyan, Artur V/0000-0002-2018-0905; Ruthel, Gordon/0000-0001-9193-5589; Aguirre, Gustavo/0000-0002-5228-256X; Jacobson, Samuel/0000-0003-2122-169X; Scott, Erin/0000-0002-9702-7298	NIH [R24EY-022012, 2PNEY-018241, RO1EY-017549, RO1EY-06855, RO1EY-013203, P30EY-001583, P40-OD010939]; Foundation Fighting Blindness; Macula Vision Research Foundation; Hope for Vision; NATIONAL EYE INSTITUTE [R01EY013203, R01EY006855, R24EY022012, P30EY001583, R01EY017549] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010939] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Macula Vision Research Foundation; Hope for Vision; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants R24EY-022012, 2PNEY-018241, RO1EY-017549, -06855, -013203, P30EY-001583, P40-OD010939. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Eye Institute or the National Institutes of Health. Work was also funded by the Foundation Fighting Blindness, the Macula Vision Research Foundation, and Hope for Vision. AVC is a RPB Senior Scientific Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnelt PK, 2000, PROG RETIN EYE RES, V19, P711, DOI 10.1016/S1350-9462(00)00012-4; Ahnelt PK, 1998, EYE, V12, P531, DOI 10.1038/eye.1998.142; [Anonymous], 1977, VISUAL SYSTEM VERTEB, DOI [DOI 10.1007/978-3-642-66468-7, 10.1007/978-3-642-66468-7_11, DOI 10.1007/978-3-642-66468-7_11]; Beltran WA, 2006, INVEST OPHTH VIS SCI, V47, P1669, DOI 10.1167/iovs.05-0845; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; Beltran WA, 2009, VET OPHTHALMOL, V12, P192, DOI 10.1111/j.1463-5224.2009.00694.x; BISHOP PO, 1962, J PHYSIOL-LONDON, V163, P466, DOI 10.1113/jphysiol.1962.sp006990; Boon CJF, 2009, PROG RETIN EYE RES, V28, P187, DOI 10.1016/j.preteyeres.2009.04.002; Bramall AN, 2010, ANNU REV NEUROSCI, V33, P441, DOI 10.1146/annurev-neuro-060909-153227; CALKINS DJ, 1994, NATURE, V371, P70, DOI 10.1038/371070a0; Carroll J, 2004, P NATL ACAD SCI USA, V101, P8461, DOI 10.1073/pnas.0401440101; Chievitz JH, 1889, ARCH ANAT PHYSL AN S, P139; Chui TYP, 2012, OPTOMETRY VISION SCI, V89, P602, DOI 10.1097/OPX.0b013e3182504227; Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, pE517, DOI 10.1073/pnas.1218933110; Cideciyan AV, 2005, P NATL ACAD SCI USA, V102, P5233, DOI 10.1073/pnas.0408892102; Clark DL, 2013, EXP EYE RES, V116, P75, DOI 10.1016/j.exer.2013.08.004; COILE DC, 1988, OPHTHAL PHYSL OPT, V8, P215, DOI 10.1111/j.1475-1313.1988.tb01040.x; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Dawson W.W., 1989, Puerto Rico Health Sciences Journal, V8, P111; Dawson WW, 2008, VISION RES, V48, P360, DOI 10.1016/j.visres.2007.08.006; DOW BM, 1981, EXP BRAIN RES, V44, P213; Ezeh P. I., 1990, Progress in Veterinary Neurology, V1, P427; FISHMAN GA, 1988, ARCH OPHTHALMOL-CHIC, V106, P369; Francis PJ, 2008, HUM MOL GENET, V17, P2673, DOI 10.1093/hmg/ddn167; Franco ECS, 2000, BRAIN BEHAV EVOLUT, V56, P276, DOI 10.1159/000047211; Guziewicz KE, 2007, INVEST OPHTH VIS SCI, V48, P1959, DOI 10.1167/iovs.06-1374; HOGAN D, 1995, J COMP NEUROL, V352, P367, DOI 10.1002/cne.903520305; HOLLANDER H, 1972, BRAIN RES, V42, P497, DOI 10.1016/0006-8993(72)90549-5; HUGHES A, 1975, J COMP NEUROL, V163, P107, DOI 10.1002/cne.901630107; Lamb TD, 2007, NAT REV NEUROSCI, V8, P960, DOI 10.1038/nrn2283; Li KY, 2010, INVEST OPHTH VIS SCI, V51, P6858, DOI 10.1167/iovs.10-5499; Marmor MF, 2008, ARCH OPHTHALMOL-CHIC, V126, P907, DOI 10.1001/archopht.126.7.907; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; McAllister JT, 2010, VISION RES, V50, P810, DOI 10.1016/j.visres.2010.02.003; McGreevy P, 2004, BRAIN BEHAV EVOLUT, V63, P13, DOI 10.1159/000073756; MILLERET C, 1988, INVEST OPHTH VIS SCI, V29, P1299; Miyadera K, 2012, MAMM GENOME, V23, P40, DOI 10.1007/s00335-011-9361-3; Molday LL, 2000, NAT GENET, V25, P257, DOI 10.1038/77004; Moore AT, 2009, CURR OPIN OPHTHALMOL, V20, P363, DOI 10.1097/ICU.0b013e32832f8002; Mowat FM, 2008, MOL VIS, V14, P2518; Muller H, 1861, WURZBURGER NATURWISS, V2, P139; Murphy CJ, 1997, AM J VET RES, V58, P414; NEUHAUS W, 1967, Z VERGL PHYSIOL, V57, P137, DOI 10.1007/BF00303069; ODOM JV, 1983, AM J PHYSIOL, V245, pR637, DOI 10.1152/ajpregu.1983.245.5.R637; Oesterberg G, 1935, ACTA OPHTHALMOL    S, V6, P1; Ofri R., 1993, Progress in Veterinary & Comparative Ophthalmology, V3, P111; PEICHL L, 1992, J COMP NEUROL, V324, P603, DOI 10.1002/cne.903240412; PETTIGREW JD, 1988, BRAIN BEHAV EVOLUT, V32, P39, DOI 10.1159/000116531; Provis JM, 2013, PROG RETIN EYE RES, V35, P63, DOI 10.1016/j.preteyeres.2013.01.005; Putnam NM, 2005, J VISION, V5, P632, DOI 10.1167/5.7.3; RAPAPORT DH, 1984, NEUROSCIENCE, V11, P289, DOI 10.1016/0306-4522(84)90024-1; ROCHONDUVIGNEAU.A, 1907, ARCH ANAT MICROSC, V9, P315; Rossi EA, 2010, NAT NEUROSCI, V13, P156, DOI 10.1038/nn.2465; ROWE MH, 1982, BRAIN BEHAV EVOLUT, V21, P1, DOI 10.1159/000121611; Soemmerring DM, 1818, OCULORUM HOMINIS ANI; Springer AD, 2005, VISUAL NEUROSCI, V22, P171, DOI 10.1017/S095252380522206X; Springer AD, 2011, VISUAL NEUROSCI, V28, P473, DOI 10.1017/S0952523811000332; STEINBERG RH, 1973, J COMP NEUROL, V148, P229, DOI 10.1002/cne.901480209; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; VAKKUR GJ, 1963, VISION RES, V3, P357, DOI 10.1016/0042-6989(63)90009-9; Wagner-Schuman M, 2011, INVEST OPHTH VIS SCI, V52, P625, DOI 10.1167/iovs.10-5886; WIKLER KC, 1990, J COMP NEUROL, V297, P499, DOI 10.1002/cne.902970404; WIKLER KC, 1990, J NEUROSCI, V10, P3390; Zangerl B, 2010, MOL VIS, V16, P2791; Zhang Q, 2002, HUM MOL GENET, V11, P993, DOI 10.1093/hmg/11.9.993; Zurn J., 1902, Arch Anat Suppl, P99	70	80	81	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90390	10.1371/journal.pone.0090390	http://dx.doi.org/10.1371/journal.pone.0090390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599007	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400069
J	Han, HM; Bai, L; Su, JJ; Zhang, JP; Song, LQ; Gao, AN; Yang, XM; Li, XQ; Liu, WH; Li, LH				Han, Haiming; Bai, Li; Su, Junji; Zhang, Jinpeng; Song, Liqiang; Gao, Ainong; Yang, Xinming; Li, Xiuquan; Liu, Weihua; Li, Lihui			Genetic Rearrangements of Six Wheat-Agropyron cristatum 6P Addition Lines Revealed by Molecular Markers	PLOS ONE			English	Article							TRITICUM-AESTIVUM L; CHROMOSOME BIN MAP; DISOMIC ADDITION; ASSISTED SELECTION; CONFERRING RESISTANCE; CRESTED WHEATGRASSES; BREAD WHEAT; IDENTIFICATION; HYBRIDS; HYBRIDIZATION	Agropyron cristatum (L.) Gaertn. (2n = 4x = 28, PPPP) not only is cultivated as pasture fodder but also could provide many desirable genes for wheat improvement. It is critical to obtain common wheat-A. cristatum alien disomic addition lines to locate the desired genes on the P genome chromosomes. Comparative analysis of the homoeologous relationships between the P genome chromosome and wheat genome chromosomes is a key step in transferring different desirable genes into common wheat and producing the desired alien translocation line while compensating for the loss of wheat chromatin. In this study, six common wheat-A. cristatum disomic addition lines were produced and analyzed by phenotypic examination, genomic in situ hybridization (GISH), SSR markers from the ABD genomes and STS markers from the P genome. Comparative maps, six in total, were generated and demonstrated that all six addition lines belonged to homoeologous group 6. However, chromosome 6P had undergone obvious rearrangements in different addition lines compared with the wheat chromosome, indicating that to obtain a genetic compensating alien translocation line, one should recombine alien chromosomal regions with homoeologous wheat chromosomes. Indeed, these addition lines were classified into four types based on the comparative mapping: 6P(I), 6P(II), 6P(III), and 6P(IV). The different types of chromosome 6P possessed different desirable genes. For example, the 6PI type, containing three addition lines, carried genes conferring high numbers of kernels per spike and resistance to powdery mildew, important traits for wheat improvement. These results may prove valuable for promoting the development of conventional chromosome engineering techniques toward molecular chromosome engineering.	[Han, Haiming; Bai, Li; Su, Junji; Zhang, Jinpeng; Song, Liqiang; Gao, Ainong; Yang, Xinming; Li, Xiuquan; Liu, Weihua; Li, Lihui] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Liu, WH (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China.	liuweihua@caas.cn; lilihui@caas.cn			National Basic Research Program of China [2011CB100104]; National High Technology Research and Development Program of China [2011AA100102]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The financial support was provided by the National Basic Research Program of China (Grant No. 2011CB100104; URL: http://www.973.gov.cn/AreaAppl.aspx) and the National High Technology Research and Development Program of China (Grant No. 2011AA100102; URL: http://www.863.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD F, 1991, PLANT BREEDING, V106, P275, DOI 10.1111/j.1439-0523.1991.tb00512.x; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Alkhimova AG, 1999, CHROMOSOME RES, V7, P205, DOI 10.1023/A:1009299300018; Bento M, 2010, THEOR APPL GENET, V121, P489, DOI 10.1007/s00122-010-1325-6; CHAPMAN V, 1955, NATURE, V175, P1091, DOI 10.1038/1751091a0; Chen HM, 2005, CHINESE SCI BULL, V50, P2328, DOI 10.1360/982005-379; CHEN Q, 1989, CR ACAD SCI III-VIE, V308, P425; CHEN Q, 1990, GENOME, V33, P663, DOI 10.1139/g90-098; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Conley EJ, 2004, GENETICS, V168, P625, DOI 10.1534/genetics.104.034801; Cuadrado A, 2000, THEOR APPL GENET, V101, P711, DOI 10.1007/s001220051535; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; Devos KM, 1997, PLANT MOL BIOL, V35, P3, DOI 10.1023/A:1005820229043; Dewey D.R., 1984, GENE MANIPULATION PL, P209, DOI DOI 10.1007/978-1-4613-2429-4_9; DONG YS, 1992, HEREDITAS, V116, P175, DOI 10.1111/j.1601-5223.1992.tb00224.x; Du WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053921; Fischer RA, 1998, CROP SCI, V38, P1467, DOI 10.2135/cropsci1998.0011183X003800060011x; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; Fu SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070483; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Gill BS, 2006, ADV AGRON, V89, P73, DOI 10.1016/S0065-2113(05)89002-9; HSIAO C, 1989, GENOME, V32, P1079, DOI 10.1139/g89-557; Hu LJ, 2012, GENES GENOM, P1; ISLAM AKMR, 1981, HEREDITY, V46, P161, DOI 10.1038/hdy.1981.24; Jahier J, 2001, PLANT BREEDING, V120, P125, DOI 10.1046/j.1439-0523.2001.00585.x; JAUHAR PP, 1992, HEREDITAS, V116, P107, DOI 10.1111/j.1601-5223.1992.tb00212.x; JOHNSON DA, 1986, CRESTED WHEATGRASS I, P65; Kishii M, 2004, THEOR APPL GENET, V109, P255, DOI 10.1007/s00122-004-1631-y; La Rota Mauricio, 2004, Functional & Integrative Genomics, V4, P34, DOI 10.1007/s10142-003-0098-2; LANDE R, 1990, GENETICS, V124, P743; Li L, 1990, SCI CHINA SER B, V34, P45; Li L.H., 1993, ACTA GENET SIN, V15, P45; Li L.H., 1997, ACTA GENET SIN, V24, P154; LI LH, 1991, THEOR APPL GENET, V81, P312, DOI 10.1007/BF00228669; Li LH, 2006, DESCRIPTORS DATA STA; Li Li-hui, 1998, Acta Genetica Sinica, V25, P538; Li Lihui, 1995, Acta Genetica Sinica, V22, P109; LIMIN AE, 1990, GENOME, V33, P581, DOI 10.1139/g90-085; Lin F, 2009, CAN J PLANT SCI, V89, P569, DOI 10.4141/CJPS08139; LIU CJ, 1992, THEOR APPL GENET, V83, P305, DOI 10.1007/BF00224276; Liu WH, 2010, GENOME, V53, P472, DOI [10.1139/G10-023, 10.1139/g10-023]; Liu WX, 2010, AGR SCI CHINA, V9, P463, DOI 10.1016/S1671-2927(09)60118-8; Luan Y, 2010, PLANTA, V232, P501, DOI 10.1007/s00425-010-1187-9; McArthur RI, 2012, CHROMOSOME RES, P1; McFADDEN EDGAR S., 1930, JOUR AMER SOC AGRON, V22, P1020; Mujeeb-Kazi A, 2013, ADV AGRON, V122, P179, DOI 10.1016/B978-0-12-417187-9.00004-8; Munkvold JD, 2004, GENETICS, V168, P639, DOI 10.1534/genetics.104.034819; Niu ZX, 2011, GENETICS, V187, P1011, DOI 10.1534/genetics.110.123588; Pestsova E, 2000, GENOME, V43, P689, DOI 10.1139/gen-43-4-689; POTVIN C, 1990, ECOLOGY, V71, P1389, DOI 10.2307/1938276; Qi LiLi, 2003, Functional & Integrative Genomics, V3, P39; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Qi ZJ, 2010, THEOR APPL GENET, V121, P589, DOI 10.1007/s00122-010-1332-7; Randhawa HS, 2004, GENETICS, V168, P677, DOI 10.1534/genetics.104.034843; Roder MS, 1998, GENETICS, V149, P2007; Schneider A, 2005, GENOME, V48, P1070, DOI 10.1139/G05-062; SHARP PJ, 1989, THEOR APPL GENET, V78, P342, DOI 10.1007/BF00265294; Smith DC, 1942, J AGRIC RES, V64, P0033; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Song LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069501; Sorrells ME, 2003, GENOME RES, V13, P1818, DOI 10.1101/gr.1113003; STEBBINS GL, 1947, ADV GENET, V1, P403, DOI 10.1016/S0065-2660(08)60490-3; Stuber CW, 1999, CROP SCI, V39, P1571, DOI 10.2135/cropsci1999.3961571x; Szakacs E, 2010, J APPL GENET, V51, P149, DOI 10.1007/BF03195723; Tomas D, 2012, INT J MOL SCI, V13, P8549, DOI 10.3390/ijms13078549; Uslu E, 1999, HEREDITAS, V131, P129, DOI 10.1111/j.1601-5223.1999.00129.x; Wang J, 2011, EUPHYTICA, P1; Wang QX, 2010, GENOME, V53, P241, DOI [10.1139/G09-098, 10.1139/g09-098]; Wang RRC, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P77, DOI 10.1007/978-3-642-14228-4_2; WHITE W. J., 1940, SCI AGRIC [OTTAWA], V21, P198; Wu J, 2006, THEOR APPL GENET, V114, P13, DOI 10.1007/s00122-006-0405-0; Yu JK, 2004, GENOME, V47, P805, DOI [10.1139/g04-057, 10.1139/G04-057]; Zhao RH, 2013, THEOR APPL GENET, V126, P2921, DOI 10.1007/s00122-013-2181-y	73	49	51	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e91066	10.1371/journal.pone.0091066	http://dx.doi.org/10.1371/journal.pone.0091066			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595330	Green Submitted, Green Published, gold			2022-12-27	WOS:000332475500113
J	Kang, M; Kim, JH; Cho, WH; Park, EC				Kang, Minsun; Kim, Jae-Hyun; Cho, Woo-Hyun; Park, Eun-Cheol			The Gender-Specific Association between Age at First Drink and Later Alcohol Drinking Patterns in Korea	PLOS ONE			English	Article							EARLY ADOLESCENT; USE DISORDERS; ONSET; DEPENDENCE; CONSUMPTION; PREDICTORS; EXPERIENCES; POPULATION; ADULTHOOD; CHILDHOOD	This study investigated the association between the age at first drink and later alcohol drinking patterns, and analyzed whether differences in the association exist among Korean adults according to gender. The subjects included 10,649 adults (5,405 men and 5,244 women) from the fourth Korean National Health and Nutrition Examination Survey between 2007 and 2009, which extracted the standard survey household by using the proportional systematic sampling method. Baseline individual characteristics, the age at first drink, and individual alcohol drinking patterns were obtained by specially trained interviewers or examiners. The association between the age at first drink and the adult alcohol drinking patterns was summarized with odds ratios and their confidence intervals obtained from multiple logistic regression analysis with sampling weights of KNHANES complex sample survey design. The results of this study show that age, co-habitation, occupation, smoking, and self-rated stress level were significantly related to the drinking patterns for men, whereas education, co-habitation, smoking, and self-rated stress level were significant factors for the drinking patterns of women. The association between the age at first drink and the adult alcohol consumption was significant for both genders and, interestingly, the alcohol drinking patterns were significantly differed by gender even after controlling for the individual characteristics. These results imply a need for gender-specific strategies to prevent hazardous alcohol consumption at a later time for Korean.	[Kang, Minsun; Kim, Jae-Hyun] Yonsei Univ, Dept Publ Hlth, Grad Sch, Seoul 120749, South Korea; [Kang, Minsun; Kim, Jae-Hyun; Cho, Woo-Hyun; Park, Eun-Cheol] Yonsei Univ, Inst Hlth Serv Res, Seoul 120749, South Korea; [Cho, Woo-Hyun] Eulji Univ, Taejon, South Korea; [Park, Eun-Cheol] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Yonsei University; Yonsei University; Eulji University; Yonsei University; Yonsei University Health System	Park, EC (corresponding author), Yonsei Univ, Inst Hlth Serv Res, Seoul 120749, South Korea.	ecpark@yuhs.ac	Kim, Jae Hyun/AAY-8167-2020; Park, Eun-Cheol/O-5644-2019	Kim, Jae Hyun/0000-0003-2824-0113; Park, Eun-Cheol/0000-0002-2306-5398				Bonomo YA, 2004, ADDICTION, V99, P1520, DOI 10.1111/j.1360-0443.2004.00846.x; Dawson DA, 2008, ALCOHOL CLIN EXP RES, V32, P2149, DOI 10.1111/j.1530-0277.2008.00806.x; DeWit DJ, 2000, AM J PSYCHIAT, V157, P745, DOI 10.1176/appi.ajp.157.5.745; Donovan JE, 2004, J ADOLESCENT HEALTH, V35, pe7, DOI [10.1016/j, DOI 10.1016/J.JADOHEALTH.2004.02.003]; Dubow EF, 2008, ADDICTION, V103, P36, DOI 10.1111/j.1360-0443.2008.02175.x; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Flory K, 2004, DEV PSYCHOPATHOL, V16, P193, DOI 10.1017/S0954579404044475; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Grant BF, 2001, J SUBST ABUSE, V13, P493, DOI 10.1016/S0899-3289(01)00096-7; Hingson RW, 2006, ARCH PEDIAT ADOL MED, V160, P739, DOI 10.1001/archpedi.160.7.739; Hingson RW, 2009, PEDIATRICS, V123, P1477, DOI 10.1542/peds.2008-2176; Hingson RW, 2000, JAMA-J AM MED ASSOC, V284, P1527, DOI 10.1001/jama.284.12.1527; Huerta MC, 2010, SOC SCI MED, V71, P143, DOI 10.1016/j.socscimed.2010.03.022; Jefferis BJMH, 2005, ADDICTION, V100, P543, DOI 10.1111/j.1360-0443.2005.01034.x; Korea S, 2010, ANN REPORT CAUSE DEA; Labouvie E, 1997, J STUD ALCOHOL, V58, P638, DOI 10.15288/jsa.1997.58.638; McGue M, 2005, AM J PSYCHIAT, V162, P1118, DOI 10.1176/appi.ajp.162.6.1118; Min S, 2008, J KOREAN MED SCI, V23, P1, DOI 10.3346/jkms.2008.23.1.1; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Monti PM, 2005, ALCOHOL CLIN EXP RES, V29, P207, DOI 10.1097/01.ALC.0000153551.11000.F3; Pedersen W, 1998, J STUD ALCOHOL, V59, P32, DOI 10.15288/jsa.1998.59.32; Pitkanen T, 2005, ADDICTION, V100, P652, DOI 10.1111/j.1360-0443.2005.01053.x; Prescott CA, 1999, ALCOHOL CLIN EXP RES, V23, P101, DOI 10.1097/00000374-199901000-00014; Rothman EF, 2008, PEDIATRICS, V122, pE298, DOI 10.1542/peds.2007-3412; SAMSON HH, 1989, J STUD ALCOHOL, V50, P254, DOI 10.15288/jsa.1989.50.254; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Smyth BP, 2011, ALCOHOL ALCOHOLISM, V46, P478, DOI 10.1093/alcalc/agr047; Ward B, 2010, DRUG-EDUC PREV POLIC, V17, P270, DOI 10.3109/09687630802590526; WERNER MJ, 1994, ARCH PEDIAT ADOL MED, V148, P1331, DOI 10.1001/archpedi.1994.02170120093018; York JL, 2004, ALCOHOL CLIN EXP RES, V28, P1379, DOI 10.1097/01.ALC.0000139812.98173.A4	30	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90713	10.1371/journal.pone.0090713	http://dx.doi.org/10.1371/journal.pone.0090713			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4FD	24595268	gold, Green Published, Green Submitted			2022-12-27	WOS:000332475500090
J	Ariza, A; Collado, D; Vida, Y; Montanez, MI; Perez-Inestrosa, E; Blanca, M; Torres, MJ; Canada, FJ; Perez-Sala, D				Ariza, Adriana; Collado, Daniel; Vida, Yolanda; Montanez, Maria I.; Perez-Inestrosa, Ezequiel; Blanca, Miguel; Jose Torres, Maria; Javier Canada, F.; Perez-Sala, Dolores			Study of Protein Haptenation by Amoxicillin Through the Use of a Biotinylated Antibiotic	PLOS ONE			English	Article							BETA-LACTAM ANTIBIOTICS; NF-KAPPA-B; IGE ANTIBODIES; ALLERGIC REACTIONS; CYSTIC-FIBROSIS; HYPERSENSITIVITY REACTIONS; BENZYL PENICILLOYL; SERUM-ALBUMIN; DRUG; IDENTIFICATION	Allergic reactions towards beta-lactam antibiotics pose an important clinical problem. The ability of small molecules, such as a beta-lactams, to bind covalently to proteins, in a process known as haptenation, is considered necessary for induction of a specific immunological response. Identification of the proteins modified by beta-lactams and elucidation of the relevance of this process in allergic reactions requires sensitive tools. Here we describe the preparation and characterization of a biotinylated amoxicillin analog (AX-B) as a tool for the study of protein haptenation by amoxicillin (AX). AX-B, obtained by the inclusion of a biotin moiety at the lateral chain of AX, showed a chemical reactivity identical to AX. Covalent modification of proteins by AX-B was reduced by excess AX and vice versa, suggesting competition for binding to the same targets. From an immunological point of view, AX and AX-B behaved similarly in RAST inhibition studies with sera of patients with non-selective allergy towards beta-lactams, whereas, as expected, competition by AX-B was poorer with sera of AX-selective patients, which recognize AX lateral chain. Use of AX-B followed by biotin detection allowed the observation of human serum albumin (HSA) modification by concentrations 100-fold lower that when using AX followed by immunological detection. Incubation of human serum with AX-B led to the haptenation of all of the previously identified major AX targets. In addition, some new targets could be detected. Interestingly, AX-B allowed the detection of intracellular protein adducts, which showed a cell type-specific pattern. This opens the possibility of following the formation and fate of AX-B adducts in cells. Thus, AX-B may constitute a valuable tool for the identification of AX targets with high sensitivity as well as for the elucidation of the mechanisms involved in allergy towards beta-lactams.	[Ariza, Adriana; Javier Canada, F.; Perez-Sala, Dolores] CSIC, Dept Chem & Phys Biol, Ctr Invest Biol, Madrid, Spain; [Ariza, Adriana; Montanez, Maria I.; Jose Torres, Maria] Carlos Haya Hosp IBIMA, Res Lab, Malaga, Spain; [Collado, Daniel; Vida, Yolanda; Perez-Inestrosa, Ezequiel] Univ Malaga, Dept Organ Chem, E-29071 Malaga, Spain; [Collado, Daniel; Vida, Yolanda; Montanez, Maria I.; Perez-Inestrosa, Ezequiel] BIONAND Andalusian Ctr Nanomed & Biotechnol, Malaga, Spain; [Blanca, Miguel] Hosp Carlos Haya, Allergy Serv, Malaga, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Universidad de Malaga; Universidad de Malaga; Hospital Carlos Haya	Perez-Sala, D (corresponding author), CSIC, Dept Chem & Phys Biol, Ctr Invest Biol, Madrid, Spain.	dperezsala@cib.csic.es	Torres, María José/T-3518-2017; Vida, Yolanda/M-5662-2014; Montanez, Maria I/B-7194-2014; Cañada, Francisco J./D-5837-2014; Torres, Maria/GVU-3391-2022; Veguillas, Adriana Ariza/X-3696-2018; Perez-Sala, Dolores/L-5969-2014; Perez-Inestrosa, Ezequiel/H-9801-2015	Torres, María José/0000-0001-5228-471X; Montanez, Maria I/0000-0001-6641-5979; Cañada, Francisco J./0000-0003-4462-1469; Veguillas, Adriana Ariza/0000-0003-1524-9602; Perez-Sala, Dolores/0000-0003-0600-665X; Perez-Inestrosa, Ezequiel/0000-0001-7546-5273; Vida Pol, Yolanda/0000-0002-7004-4629	MINECO [SAF2012-36519]; RETIC [RD07/0064/0007, RD12/0013/0008]; Junta de Andalucia [CTS-6603]; ISCIII [PS09/01768, PI12/02529]; European Union under REA grant [300230]	MINECO(Spanish Government); RETIC; Junta de Andalucia(Junta de Andalucia); ISCIII(Instituto de Salud Carlos III); European Union under REA grant	This work was supported by grants SAF2012-36519 from MINECO and RETIC RD07/0064/0007 and RD12/0013/0008 to DPS, Junta de Andalucia CTS-6603 and ISCIII PS09/01768 and PI12/02529 to MJT, funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement no 300230, to MIM. The stay of A. A. at CIB-CSIC was funded in part by a fellowship from ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariza A, 2012, J PROTEOMICS, V77, P504, DOI 10.1016/j.jprot.2012.09.030; Ariza A, 2011, CURR OPIN ALLERGY CL, V11, P305, DOI 10.1097/ACI.0b013e3283489ae5; BATCHELOR FR, 1966, IMMUNOLOGY, V10, P21; Gomez MB, 2004, CURR OPIN ALLERGY CL, V4, P261, DOI 10.1097/01.all.0000136764.74065.15; BLANCA M, 1995, ALLERGY, V50, P777; BLANCA M, 1992, J IMMUNOL METHODS, V153, P99, DOI 10.1016/0022-1759(92)90311-G; Blanca M, 2009, ALLERGY, V64, P183, DOI [10.1111/j.1398-9995.2008.01924.x, 10.1111/j.1398-9995.2008.01916.x]; BLANCA M, 1994, J CLIN IMMUNOASSAY, V17, P166; BLANCA M, 1991, ALLERGY, V46, P632, DOI 10.1111/j.1398-9995.1991.tb00635.x; BLANCA M, 1988, ALLERGY, V43, P508, DOI 10.1111/j.1398-9995.1988.tb01628.x; BRANDER C, 1995, J IMMUNOL, V155, P2670; Brockow K, 2002, ALLERGY, V57, P45; Brooks BM, 2003, CLIN EXP IMMUNOL, V131, P268, DOI 10.1046/j.1365-2249.2003.02069.x; Carey MA, 2005, TOXICOLOGY, V216, P41, DOI 10.1016/j.tox.2005.07.015; Cernuda-Morollon E, 2002, J AM SOC NEPHROL, V13, P2223, DOI 10.1097/01.ASN.0000025786.87646.B1; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; DIAMANDIS EP, 1991, CLIN CHEM, V37, P625; EDWARDS RG, 1982, INT ARCH ALLER A IMM, V68, P352, DOI 10.1159/000233125; El-Ghaiesh S, 2012, J PHARMACOL EXP THER, V341, P597, DOI 10.1124/jpet.111.190900; ERLE DJ, 1994, J IMMUNOL, V153, P517; Fujiwara K, 2011, ANTIMICROB AGENTS CH, V55, P62, DOI 10.1128/AAC.01031-10; Garcia JJ, 1997, J CLIN LAB ANAL, V11, P251, DOI 10.1002/(SICI)1098-2825(1997)11:5<251::AID-JCLA3>3.0.CO;2-A; Garzon B, 2011, J PROTEOMICS, V74, P2243, DOI 10.1016/j.jprot.2011.03.028; Garzon B, 2010, CHEM-BIOL INTERACT, V183, P212, DOI 10.1016/j.cbi.2009.09.019; Jenkins RE, 2013, CHEM RES TOXICOL, V26, P963, DOI 10.1021/tx400124m; Jenkins RE, 2009, PROTEOM CLIN APPL, V3, P720, DOI 10.1002/prca.200800222; Torres MJ, 2010, J ALLERGY CLIN IMMUN, V125, P502, DOI 10.1016/j.jaci.2009.11.032; MAGI B, 1995, ELECTROPHORESIS, V16, P1190, DOI 10.1002/elps.11501601198; MAYORGA C, 1995, TOXICOLOGY, V97, P225, DOI 10.1016/0300-483X(94)02983-2; Morel E, 2007, ALLERGY, V62, P190, DOI 10.1111/j.1398-9995.2006.01285.x; MORENO F, 1995, INT ARCH ALLERGY IMM, V108, P74, DOI 10.1159/000237121; Pichler Werner J, 2006, Allergol Int, V55, P17, DOI 10.2332/allergolint.55.17; Praul CA, 1998, BIOCHEM BIOPH RES CO, V247, P312, DOI 10.1006/bbrc.1998.8757; Sala-Rabanal M, 2008, AM J PHYSIOL-RENAL, V294, pF1422, DOI 10.1152/ajprenal.00030.2008; Stamatakis K, 2006, ANN NY ACAD SCI, V1091, P548, DOI 10.1196/annals.1378.096; TAMAI I, 1985, J ANTIBIOT, V38, P1774, DOI 10.7164/antibiotics.38.1774; Torres MJ, 2010, MED CLIN N AM, V94, P805, DOI 10.1016/j.mcna.2010.04.006; Torres MJ, 2003, ALLERGY, V58, P961, DOI 10.1034/j.1398-9995.2003.00280.x; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Whitaker P, 2011, J IMMUNOL, V187, P200, DOI 10.4049/jimmunol.1100647; WIDE L, 1969, ACTA ENDOCRINOL-COP, VS 63, P207; YVON M, 1990, FEBS LETT, V263, P237, DOI 10.1016/0014-5793(90)81382-X; Zorrilla S, 2010, ANAL BIOCHEM, V399, P84, DOI 10.1016/j.ab.2009.12.021	43	38	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90891	10.1371/journal.pone.0090891	http://dx.doi.org/10.1371/journal.pone.0090891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595455	gold, Green Published			2022-12-27	WOS:000332468900156
J	Duivenvoorden, WCM; Paschos, A; Hopmans, SN; Austin, RC; Pinthus, JH				Duivenvoorden, Wilhelmina C. M.; Paschos, Athanasios; Hopmans, Sarah N.; Austin, Richard C.; Pinthus, Jehonathan H.			Endoplasmic Reticulum Protein ERp46 in Renal Cell Carcinoma	PLOS ONE			English	Article							BACTERIAL 2-HYBRID SYSTEM; SERUM ADIPONECTIN LEVELS; DISULFIDE-ISOMERASE; PROTEOMIC ANALYSIS; CANCER; EXPRESSION; THERAPY; PATHWAY; FAMILY	An established inverse clinical correlation between serum adiponectin levels and renal cell carcinoma (RCC) aggressiveness exists. We have recently demonstrated that adiponectin suppresses clear cell RCC (ccRCC) progression through interaction with its receptor, adiponectin receptor 1 (AdipoR1). ERp46 has been shown to inhibit adiponectin signaling via interaction with AdipoR1 in HeLa cells. However, the expression of ERp46 in RCC has not been described thus far. The objectives of this study were to investigate ERp46 in RCC, its expression, its effects on RCC growth in a mouse model and whether it interacts with AdipoR1. We demonstrated a higher ERp46/AdipoR1 expression ratio in metastatic compared to non-metastatic ccRCC, as determined by immunohistochemistry of tissue microarrays and subsequent image analysis. When ERp46 was stably knocked down using shRNA or overexpressed in murine RCC RAG cells, RCC growth after subcutaneous injection in BALB/c nude mice was inhibited and accelerated, respectively. In vitro analysis to determine the molecular interaction between AdipoR1 and ERp46 included co-immunoprecipitation using human ccRCC 786-O cells and a bacterial adenylate cyclase-based two hybrid system and demonstrated no sustained AdipoR1-ERp46 interaction. This is the first report to suggest a role for ERp46 as a potential therapeutic target in RCC given its expression profile in human RCC samples and its effect on in vivo RCC growth. Since a stable interaction with AdipoR1 could not be established, we suggest that the tumorigenic properties of ERp46 in RCC cells are not related to an inhibitory modulation of AdipoR1.	[Duivenvoorden, Wilhelmina C. M.] McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada; St Josephs Healthcare Hamilton, Hamilton, ON, Canada	McMaster University; McMaster University	Duivenvoorden, WCM (corresponding author), McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada.	duiven@mcmaster.ca	Duivenvoorden, Wilhelmina/F-1512-2016; Pinthus, Jehonathan/AAQ-1667-2021		Prostate Cancer Canada; McMaster Surgical Associates	Prostate Cancer Canada; McMaster Surgical Associates	This work was supported by Prostate Cancer Canada through a pilot grant and by McMaster Surgical Associates (to JHP and WCMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; [Anonymous], [No title captured]; Bastien L, 2009, BJU INT, V103, P1334, DOI 10.1111/j.1464-410X.2009.08454.x; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Benham AM, 2012, ANTIOXID REDOX SIGN, V16, P781, DOI 10.1089/ars.2011.4439; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Charlton HK, 2010, BIOCHEM BIOPH RES CO, V392, P234, DOI 10.1016/j.bbrc.2010.01.029; Chung H, 2013, BIOMARKERS, V18, P573, DOI 10.3109/1354750X.2013.827742; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Duivenvoorden WC, 2013, BRIT J CANCER, V108, P327, DOI 10.1038/bjc.2012.574; Funkner A, 2013, J MOL BIOL, V425, P1340, DOI 10.1016/j.jmb.2013.01.029; Gavrila A, 2003, J CLIN ENDOCR METAB, V88, P4823, DOI 10.1210/jc.2003-030214; Gu MX, 2012, J PROTEOME RES, V11, P2365, DOI 10.1021/pr300098f; Hannig G, 1998, TRENDS BIOTECHNOL, V16, P54, DOI 10.1016/S0167-7799(97)01155-4; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Horiguchi A, 2008, JPN J CLIN ONCOL, V38, P106, DOI 10.1093/jjco/hym158; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Karimova G, 2000, METHOD ENZYMOL, V328, P59, DOI 10.1016/S0076-6879(00)28390-0; Kleinmann N, 2014, CLIN EXP METASTAS, V31, P169, DOI 10.1007/s10585-013-9618-1; Klinghoffer Z, 2009, EXPERT REV ANTICANC, V9, P975, DOI [10.1586/era.09.51, 10.1586/ERA.09.51]; Knoblach B, 2003, MOL CELL PROTEOMICS, V2, P1104, DOI 10.1074/mcp.M300053-MCP200; Komatsubara AT, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-74; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Leys CM, 2007, SURGERY, V141, P41, DOI 10.1016/j.surg.2006.05.009; Lindquist JA, 2001, FASEB J, V15, P1448, DOI 10.1096/fj.00-0720fje; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Pace PE, 2013, BIOCHEM J, V453, P475, DOI 10.1042/BJ20130030; Paschos A, 2011, INFECT IMMUN, V79, P1033, DOI 10.1128/IAI.00993-10; Pinthus JH, 2008, EUR UROL, V54, P866, DOI 10.1016/j.eururo.2008.02.044; Rao DD, 2009, CANCER GENE THER, V16, P807, DOI 10.1038/cgt.2009.53; Rini BI, 2005, J CLIN ONCOL, V23, P1028, DOI 10.1200/JCO.2005.01.186; Rockstroh M MS, 2011, J INTEGR OMICS, V1, P135, DOI DOI 10.5584/JI0MICS; Sullivan DC, 2003, J BIOL CHEM, V278, P47079, DOI 10.1074/jbc.M308124200; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x; Vincent EE, 2011, ANTICANCER RES, V31, P1577; Wang YH, 2007, EXP BIOL MED, V232, P1152, DOI 10.3181/0701-RM-8; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; Yakovlev AA, 2009, NEUROCHEM J+, V3, P139, DOI 10.1134/S181971240902010X; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Zhang HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065277, 10.1371/journal.pone.0054510, 10.1371/journal.pone.0068634, 10.1371/journal.pone.0079454]; Zhang L, 2010, J CANCER RES CLIN, V136, P1497, DOI 10.1007/s00432-010-0807-x	44	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90389	10.1371/journal.pone.0090389	http://dx.doi.org/10.1371/journal.pone.0090389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594673	Green Submitted, gold, Green Published			2022-12-27	WOS:000332468900105
J	Leitman, J; Barak, B; Benyair, R; Shenkman, M; Ashery, U; Hartl, FU; Lederkremer, GZ				Leitman, Julia; Barak, Boaz; Benyair, Ron; Shenkman, Marina; Ashery, Uri; Hartl, F. Ulrich; Lederkremer, Gerardo Z.			ER Stress-Induced eIF2-alpha Phosphorylation Underlies Sensitivity of Striatal Neurons to Pathogenic Huntingtin	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; MUTANT-HUNTINGTIN; CELL-DEATH; DISEASE; INHIBITION; AGGREGATION; UBIQUITIN; TOXICITY; REPRESSION	A hallmark of Huntington's disease is the pronounced sensitivity of striatal neurons to polyglutamine-expanded huntingtin expression. Here we show that cultured striatal cells and murine brain striatum have remarkably low levels of phosphorylation of translation initiation factor eIF2 alpha, a stress-induced process that interferes with general protein synthesis and also induces differential translation of pro-apoptotic factors. EIF2 alpha phosphorylation was elevated in a striatal cell line stably expressing pathogenic huntingtin, as well as in brain sections of Huntington's disease model mice. Pathogenic huntingtin caused endoplasmic reticulum (ER) stress and increased eIF2 alpha phosphorylation by increasing the activity of PKR-like ER-localized eIF2 alpha kinase (PERK). Importantly, striatal neurons exhibited special sensitivity to ER stress-inducing agents, which was potentiated by pathogenic huntingtin. We could strongly reduce huntingtin toxicity by inhibiting PERK. Therefore, alteration of protein homeostasis and eIF2 alpha phosphorylation status by pathogenic huntingtin appears to be an important cause of striatal cell death. A dephosphorylated state of eIF2 alpha has been linked to cognition, which suggests that the effect of pathogenic huntingtin might also be a source of the early cognitive impairment seen in patients.	[Leitman, Julia; Benyair, Ron; Shenkman, Marina; Lederkremer, Gerardo Z.] Tel Aviv Univ, George Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Leitman, Julia; Barak, Boaz; Benyair, Ron; Shenkman, Marina; Ashery, Uri; Lederkremer, Gerardo Z.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Barak, Boaz; Ashery, Uri] Tel Aviv Univ, George Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Tel Aviv University; Tel Aviv University; Tel Aviv University; Max Planck Society	Lederkremer, GZ (corresponding author), Tel Aviv Univ, George Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	gerardo@post.tau.ac.il	Hartl, F. Ulrich/Y-8206-2019	Lederkremer, Gerardo/0000-0002-9857-7152; Benyair, Ron/0000-0003-0420-2649; Barak, Boaz/0000-0001-9724-4578; Ashery, Uri/0000-0001-6338-7888	Israel Science Foundation [1070/10]; German - Israeli Project Cooperation (Deutsch-Israelische Projektkooperation) [K 5-1]	Israel Science Foundation(Israel Science Foundation); German - Israeli Project Cooperation (Deutsch-Israelische Projektkooperation)	The work was supported by grants from the Israel Science Foundation (1070/10) and German - Israeli Project Cooperation (Deutsch-Israelische Projektkooperation K 5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Benyair R, 2011, INT REV CEL MOL BIO, V292, P197, DOI 10.1016/B978-0-12-386033-0.00005-0; Carnemolla A, 2009, J BIOL CHEM, V284, P18167, DOI 10.1074/jbc.M109.018325; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Gupta S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.74; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; Ill-Raga G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021456; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Kondratyev M, 2007, EXP CELL RES, V313, P3395, DOI 10.1016/j.yexcr.2007.07.006; Lajoie P, 2011, J CELL SCI, V124, P3332, DOI 10.1242/jcs.087510; Lee H, 2012, HUM MOL GENET, V21, P101, DOI 10.1093/hmg/ddr445; Leitman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3753; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Mitra S, 2008, THESCIENTIFICWORLDJO, V8, P421, DOI 10.1100/tsw.2008.60; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Reijonen S, 2008, EXP CELL RES, V314, P950, DOI 10.1016/j.yexcr.2007.12.025; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; Ron E, 2011, MOL BIOL CELL, V22, P3945, DOI 10.1091/mbc.E10-12-0944; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Roze E, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00055; Sakahira H, 2002, P NATL ACAD SCI USA, V99, P16412, DOI 10.1073/pnas.182426899; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Stout JC, 2011, NEUROPSYCHOLOGY, V25, P1, DOI 10.1037/a0020937; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Vidal R, 2011, CURR MOL MED, V11, P1, DOI 10.2174/156652411794474419; Vidal RL, 2012, HUM MOL GENET, V21, P2245, DOI 10.1093/hmg/dds040; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang H, 2010, CHEM BIOL DRUG DES, V76, P480, DOI 10.1111/j.1747-0285.2010.01048.x; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905	36	58	60	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90803	10.1371/journal.pone.0090803	http://dx.doi.org/10.1371/journal.pone.0090803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594939	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900147
J	van den Broek, NR; Jean-Baptiste, R; Neilson, JP				van den Broek, Nynke R.; Jean-Baptiste, Rachel; Neilson, James P.			Factors Associated with Preterm, Early Preterm and Late Preterm Birth in Malawi	PLOS ONE			English	Article							RURAL MALAWI; SYSTEMATIC ANALYSIS; TIME TRENDS; PREGNANCY; RISK; EPIDEMIOLOGY; COUNTRIES; MORTALITY; DELIVERY; WOMEN	Background: Assessment of risk factors for preterm birth in a population with high incidence of preterm birth and HIV infection. Methods: Secondary analysis of data for 2,149 women included in a community based randomized placebo controlled trial for the prevention of preterm birth (APPLe trial (ISRCTN84023116) with gestational age at birth determined through ultrasound measurement in early pregnancy. Multivariate Logistic Regression analyses to obtain models for three outcome variables: all preterm, early preterm, and late preterm birth. Findings: No statistical differences were noted for the prevalence of HIV infection (p = 0.30) or syphilis (p = 0.12) between women who delivered preterm versus term. BMI (Adjusted OR 0.91 (0.85-0.97); p = 0.005) and weight gain (Adjusted OR 0.89 (0.82-0.97); p = 0.006) had an independent, protective effect. Previous preterm birth doubled the odds of preterm birth (Adjusted OR 2.13 (1.198-3.80); p = 0.01). Persistent malaria (despite malaria prophylaxis) increased the risk of late preterm birth (Adjusted OR 1.99 (1.05-3.79); p = 0.04). Age <20 (Adjusted OR 1.73 (1.03-2.90); p = 0.04) and anemia (Adjusted OR 1.95 (1.08-3.52); p = 0.03) were associated with early preterm birth (<34 weeks). Conclusions: Despite claims that HIV infection is an important cause of preterm birth in Africa, we found no evidence of an association in this population (unexposed to anti-retroviral treatment). Persistent malaria was associated with late preterm birth. Maternal undernourishment and anemia were independently associated with early preterm birth. The study did not assess whether the link was direct or whether a common precursor such as chronic infection was responsible for both maternal effects and early labour.	[van den Broek, Nynke R.; Jean-Baptiste, Rachel] Univ Liverpool, Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Liverpool L3 5QA, Merseyside, England; [Neilson, James P.] Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool	van den Broek, NR (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	vdbroek@liv.ac.uk		van den Broek, Nynke/0000-0001-8523-2684	The Wellcome Trust, UK [065810/Z/01/Z]	The Wellcome Trust, UK(Wellcome Trust)	This study was funded by The Wellcome Trust, UK (project grant 065810/Z/01/Z) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Chang HH, 2013, LANCET, V381, P223, DOI 10.1016/S0140-6736(12)61856-X; Gladstone M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001121; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goldenberg RL, 2012, AM J OBSTET GYNECOL, V206, P113, DOI 10.1016/j.ajog.2011.10.865; Han Z, 2011, INT J EPIDEMIOL, V40, P65, DOI 10.1093/ije/dyq195; Huybregts L, 2009, AM J CLIN NUTR, V90, P1593, DOI 10.3945/ajcn.2009.28253; Kourtis AP, 2011, J INFECT DIS, V204, P493, DOI 10.1093/infdis/jir318; Kramer MS, 2012, AM J OBSTET GYNECOL, V206, P108, DOI 10.1016/j.ajog.2011.10.864; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; McGready R, 2011, BJOG-INT J OBSTET GY, V118, P123, DOI 10.1111/j.1471-0528.2010.02810.x; Ndirangu J, 2012, HUM REPROD, V27, P1846, DOI 10.1093/humrep/des090; Ota E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000032.pub2; Powis KM, 2011, J INFECT DIS, V204, P506, DOI 10.1093/infdis/jir307; Steer P, 2006, BJOG-INT J OBSTET GY, V113, P1, DOI [10.1111/j.1471-0528.2006.01116.x, 10.1111/j.1471-0528.2005.00837.x]; Steer P, 2005, J PERINAT MED, V33, P273, DOI 10.1515/JPM.2005.053; Taylor-Robinson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023163; van den Akker T, 2012, BJOG-INT J OBSTET GY, V119, P431, DOI 10.1111/j.1471-0528.2011.03229.x; van den Broek N, 2005, HUM REPROD, V20, P3235, DOI 10.1093/humrep/dei208; van den Broek NR, 2006, BJOG-INT J OBSTET GY, V113, P569, DOI 10.1111/j.1471-0528.2006.00891.x; van den Broek NR, 2000, AM J CLIN NUTR, V72, p247S, DOI 10.1093/ajcn/72.1.247S; van den Broek NR, 2003, BJOG-INT J OBSTET GY, V110, P902, DOI 10.1111/j.1471-0528.2003.02402.x; van den Broek NR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000191	25	52	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90128	10.1371/journal.pone.0090128	http://dx.doi.org/10.1371/journal.pone.0090128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595186	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900072
J	Xu, J; Lin, Y; Si, LJ; Jin, GF; Dai, JC; Wang, C; Chen, JP; Da, M; Hu, YL; Yi, CL; Hu, ZB; Shen, HB; Mo, XM; Chen, YJ; Wang, XW				Xu, Jing; Lin, Yuan; Si, Linjie; Jin, Guangfu; Dai, Juncheng; Wang, Cheng; Chen, Jiaping; Da, Min; Hu, Yuanli; Yi, Chenlong; Hu, Zhibin; Shen, Hongbing; Mo, Xuming; Chen, Yijiang; Wang, Xiaowei			Genetic Variants at 10p11 Confer Risk of Tetralogy of Fallot in Chinese of Nanjing	PLOS ONE			English	Article							CONGENITAL HEART-DEFECTS; GENOME-WIDE ASSOCIATION; NON-SYNDROMIC TETRALOGY; JAG1 MUTATIONS; SEPTAL-DEFECT; DISEASE; LOCI; TBX1	A recent genome-wide association study (GWAS) has identified a new subset of susceptibility loci of Tetralogy of Fallot (TOF), one form of cyanotic congenital heart disease (CHD), on chromosomes 10p11, 10p14, 12q24, 13q31, 15q13 and 16q12 in Europeans. In the current study, we conducted a case-control study in a Chinese population including 1,010 CHD cases [atrial septal defect (ASD), ventricular septal defect (VSD) and TOF] and 1,962 controls to evaluate the associations of these loci with risk of CHD. We found that rs2228638 in NRP1 on 10p11 was significantly increased the risk of TOF (OR = 1.52, 95% CI = 1.13-2.04, P = 0.006), but not in other subgroups including ASD and VSD. In addition, no significant associations were observed between the other loci and the risk of ASD, VSD or TOF. Our results suggested that the genetic variants on 10p11 may serve as candidate markers for TOF susceptibility in Chinese population.	[Xu, Jing; Si, Linjie; Yi, Chenlong; Chen, Yijiang; Wang, Xiaowei] Nanjing Med Univ, Affiliated Hosp 1, Dept Thorac & Cardiovasc Surg, Nanjing, Jiangsu, Peoples R China; [Lin, Yuan; Jin, Guangfu; Dai, Juncheng; Wang, Cheng; Chen, Jiaping; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Lin, Yuan; Jin, Guangfu; Dai, Juncheng; Wang, Cheng; Chen, Jiaping; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Lin, Yuan; Jin, Guangfu; Dai, Juncheng; Wang, Cheng; Chen, Jiaping; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Key Lab Modern Toxicol, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Da, Min; Hu, Yuanli; Mo, Xuming] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Mo, XM (corresponding author), Nanjing Med Univ, Nanjing Childrens Hosp, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China.	mohsuming15@sina.com; YJChen@njmu.edu.cn; wangxiaowei@njmu.edu.cn	Yi, Chenlong/HGU-3846-2022		National Natural Science Foundation of China [81300128, 81170158]; Ph.D. Programs Foundation of Ministry of Education of China [20123234120015]; Jiangsu Natural Science Foundation [BK20131025]; Natural Science Foundation of Jiangsu Higher Education Institutions [12KJB320003]; Science and Technology Supporting Project in Xinjiang Province [2013911121]; Scientific Research Foundation for Returned Overseas Chinese Scholars, State Education Ministry; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of Jiangsu Higher Education Institutions; Science and Technology Supporting Project in Xinjiang Province; Scientific Research Foundation for Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported in part by National Natural Science Foundation of China (Grant numbers: 81300128, 81170158); Ph.D. Programs Foundation of Ministry of Education of China (Grant numbers: 20123234120015); Jiangsu Natural Science Foundation (Grant number: BK20131025); Natural Science Foundation of Jiangsu Higher Education Institutions (Grant numbers: 12KJB320003); Science and Technology Supporting Project in Xinjiang Province (Grant numbers: 2013911121); The Project Sponsored by Scientific Research Foundation for Returned Overseas Chinese Scholars, State Education Ministry; The Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apitz C, 2009, LANCET, V374, P1462, DOI 10.1016/S0140-6736(09)60657-7; Bauer RC, 2010, HUM MUTAT, V31, P594, DOI 10.1002/humu.21231; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Cordell HJ, 2013, HUM MOL GENET, V22, P1473, DOI 10.1093/hmg/dds552; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Griffin HR, 2010, HEART, V96, P1651, DOI 10.1136/hrt.2010.200121; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Guida V, 2011, CLIN GENET, V80, P591, DOI 10.1111/j.1399-0004.2011.01710.x; Herzog B, 2011, MOL BIOL CELL, V22, P2766, DOI 10.1091/mbc.E09-12-1061; Hu ZB, 2013, NAT GENET, V45, P818, DOI 10.1038/ng.2636; Jubb AM, 2012, J PATHOL, V226, P50, DOI 10.1002/path.2989; Kola S, 2011, CLIN CHIM ACTA, V412, P2232, DOI 10.1016/j.cca.2011.08.017; Lin XP, 2010, J HUM GENET, V55, P662, DOI 10.1038/jhg.2010.84; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Osoegawa K, 2013, AM J MED GENET A; Oyen N, 2010, CIRC-CARDIOVASC GENE, V3, P122, DOI 10.1161/CIRCGENETICS.109.890103; Parisot P, 2011, BIRTH DEFECTS RES A, V91, P477, DOI 10.1002/bdra.20803; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Raimondi C, 2013, SEMIN CELL DEV BIOL, V24, P172, DOI 10.1016/j.semcdb.2013.01.001; Schwarz Q, 2009, P NATL ACAD SCI USA, V106, P6164, DOI 10.1073/pnas.0811521106; Tennant PWG, 2010, LANCET, V375, P649, DOI 10.1016/S0140-6736(09)61922-X; Villafane J, 2013, J AM COLL CARDIOL S, VS0735-1097, P05379; Wang J, 2011, INT J CARDIOL, V147, P444, DOI 10.1016/j.ijcard.2010.04.029; Wang J, 2012, DNA CELL BIOL, V31, P1610, DOI 10.1089/dna.2012.1814; Ware SM, 2012, J CLIN EXP CARDIOL S, pS8; Yang YQ, 2013, HUM MUTAT, V2; Zhou JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032429	28	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89636	10.1371/journal.pone.0089636	http://dx.doi.org/10.1371/journal.pone.0089636			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594544	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900029
J	Zhou, ZQ; Kecman, M; Chen, TT; Liu, TY; Jin, L; Chen, SJ; Chen, QY; He, MG; Silver, J; Moore, B; Congdon, N				Zhou, Zhongqiang; Kecman, Maja; Chen, Tingting; Liu, Tianyu; Jin, Ling; Chen, Shangji; Chen, Qianyun; He, Mingguang; Silver, Josh; Moore, Bruce; Congdon, Nathan			Spectacle Design Preferences among Chinese Primary and Secondary Students and Their Parents: A Qualitative and Quantitative Study	PLOS ONE			English	Article							PEDIATRIC-REFRACTIVE-ERROR; VISUAL IMPAIRMENT; SCHOOL-CHILDREN; RURAL CHINA; MYOPIA	Purpose: To identify the specific characteristics making glasses designs, particularly those compatible with adjustable glasses, more or less appealing to Chinese children and their parents. Patients and Methods: Primary and secondary school children from urban and rural China with <= -1.00 diopters of bilateral myopia and their parents ranked four conventional-style frames identified by local optical shops as popular versus four child-specific frames compatible with adjustable spectacles. Scores based on the proportion of maximum possible ranking were computed for each style. Selected children and their parents also participated in Focus Groups (FGs) discussing spectacle design preference. Recordings were transcribed and coded by two independents reviewers using NVivo software. Results: Among 136 urban primary school children (age range 9-11 years), 290 rural secondary school children (11-17 years) and 16 parents, all adjustable-style frames (scores on 0-100 scale 25.7-62.4) were ranked behind all conventional frames (63.0-87.5). For eight FGs including 12 primary children, 26 secondary children and 16 parents, average kappa values for NVivo coding were 0.81 (students) and 0.70 (parents). All groups agreed that the key changes to make adjustable designs more attractive were altering the round lenses to rectangular or oval shapes and adding curved earpieces for more stable wear. The thick frames of the adjustable designs were considered stylish, and children indicated they would wear them if the lens shape were modified. Conclusions: Current adjustable lens designs are unattractive to Chinese children and their parents, though this study identified specific modifications which would make them more appealing.	[Zhou, Zhongqiang; Chen, Tingting; Liu, Tianyu; Jin, Ling; Chen, Qianyun; He, Mingguang; Congdon, Nathan] Sun Yat Sen Univ, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Zhongqiang; Chen, Tingting; Liu, Tianyu; Jin, Ling; Chen, Qianyun; He, Mingguang; Congdon, Nathan] Sun Yat Sen Univ, Div Prevent Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Kecman, Maja; Silver, Josh] Univ Oxford St Catherines Coll, Ctr Vis Developing World, Oxford OX1 3UJ, England; [Chen, Shangji] Guangming Eye Hosp, Yangjiang, Guangdong, Peoples R China; [Moore, Bruce] New England Coll Optometry, Boston, MA USA; [Congdon, Nathan] ORBIS Int, New York, NY USA	Sun Yat Sen University; Sun Yat Sen University; University of Oxford	Congdon, N (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	ncongdon1@gmail.com	He, Mingguang/AAY-5239-2020	He, Mingguang/0000-0002-6912-2810	Chinese government; Thousand Man Plan program	Chinese government; Thousand Man Plan program	This work was supported by a grant from the Chinese government under the Thousand Man Plan program; Dr Congdon is also supported by the Thousand Man Plan program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CACERES C, 1993, AIDS HLTH PROMOT EXC, V4, P11; Congdon N, 2008, ARCH OPHTHALMOL-CHIC, V126, P1717, DOI 10.1001/archopht.126.12.1717; Congdon N, 2008, INVEST OPHTH VIS SCI, V49, P2888, DOI 10.1167/iovs.07-1160; Dandona L, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-6; Davey Janet, 2012, Health Mark Q, V29, P346, DOI 10.1080/07359683.2012.732874; Esteso P, 2007, INVEST OPHTH VIS SCI, V48, P4949, DOI 10.1167/iovs.07-0052; FitzPatrick Mary, 2013, Health Mark Q, V30, P281, DOI 10.1080/07359683.2013.814509; Fotedar R, 2007, AM J OPHTHALMOL, V144, P307, DOI 10.1016/j.ajo.2007.03.041; Fylan F, 2005, HEALTH EXPECT, V8, P18, DOI 10.1111/j.1369-7625.2004.00309.x; He MG, 2007, OPHTHALMOLOGY, V114, P374, DOI 10.1016/j.ophtha.2006.08.020; He MG, 2011, OPHTHALMOLOGY, V118, P1162, DOI 10.1016/j.ophtha.2010.10.003; Holguin AMC, 2006, INVEST OPHTH VIS SCI, V47, P925, DOI 10.1167/iovs.05-0895; Keay L, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4793; Odedra N, 2008, OPHTHAL EPIDEMIOL, V15, P410, DOI 10.1080/09286580802399094; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Turner AW, 2011, CLIN EXP OPHTHALMOL, V39, P598, DOI 10.1111/j.1442-9071.2011.02529.x; Zhang MZ, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4767; Zhang MZ, 2009, INVEST OPHTH VIS SCI, V50, P2011, DOI 10.1167/iovs.08-2849; Zhao JL, 2004, OPTOMETRY VISION SCI, V81, P49, DOI 10.1097/00006324-200401000-00010	19	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e88857	10.1371/journal.pone.0088857	http://dx.doi.org/10.1371/journal.pone.0088857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594799	Green Published, gold			2022-12-27	WOS:000332468900009
J	Glaubitz, JC; Casstevens, TM; Lu, F; Harriman, J; Elshire, RJ; Sun, Q; Buckler, ES				Glaubitz, Jeffrey C.; Casstevens, Terry M.; Lu, Fei; Harriman, James; Elshire, Robert J.; Sun, Qi; Buckler, Edward S.			TASSEL-GBS: A High Capacity Genotyping by Sequencing Analysis Pipeline	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MAPPING POPULATION; ASCERTAINMENT BIAS; GENETIC-VARIATION; CROP IMPROVEMENT; SNP DISCOVERY; MAIZE; IMPUTATION; MARKERS; HISTORY	Genotyping by sequencing (GBS) is a next generation sequencing based method that takes advantage of reduced representation to enable high throughput genotyping of large numbers of individuals at a large number of SNP markers. The relatively straightforward, robust, and cost-effective GBS protocol is currently being applied in numerous species by a large number of researchers. Herein we describe a bioinformatics pipeline, TASSEL-GBS, designed for the efficient processing of raw GBS sequence data into SNP genotypes. The TASSEL-GBS pipeline successfully fulfills the following key design criteria: (1) Ability to run on the modest computing resources that are typically available to small breeding or ecological research programs, including desktop or laptop machines with only 8-16 GB of RAM, (2) Scalability from small to extremely large studies, where hundreds of thousands or even millions of SNPs can be scored in up to 100,000 individuals (e. g., for large breeding programs or genetic surveys), and (3) Applicability in an accelerated breeding context, requiring rapid turnover from tissue collection to genotypes. Although a reference genome is required, the pipeline can also be run with an unfinished "pseudo-reference" consisting of numerous contigs. We describe the TASSEL-GBS pipeline in detail and benchmark it based upon a large scale, species wide analysis in maize (Zea mays), where the average error rate was reduced to 0.0042 through application of population genetic-based SNP filters. Overall, the GBS assay and the TASSEL-GBS pipeline provide robust tools for studying genomic diversity.	[Glaubitz, Jeffrey C.; Casstevens, Terry M.; Lu, Fei; Harriman, James; Elshire, Robert J.; Buckler, Edward S.] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Sun, Qi] Cornell Univ, Biotechnol Resource Ctr, Bioinformat Facil, Ithaca, NY USA; [Buckler, Edward S.] USDA ARS, Ithaca, NY 14853 USA	Cornell University; Cornell University; United States Department of Agriculture (USDA)	Glaubitz, JC (corresponding author), Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA.	jcg233@cornell.edu	Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019	Buckler, Edward/0000-0002-3100-371X; Elshire, Robert/0000-0003-1753-6920	National Science Foundation [DBI-0820619, IOS-1238014, IOS-0965342]; USDA-ARS; Division Of Integrative Organismal Systems [0820619, 0965342, 1238014] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (www.nsf.gov) under the Plant Genome Research Program (PGRP) (grant numbers DBI-0820619 and IOS-1238014) and the Basic Research to Enable Agricultural Development (BREAD) project (ID:IOS-0965342), as well as by the USDA-ARS (www.usda.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; Allhoff M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S1; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Arnold B, 2013, MOL ECOL, V22, P3179, DOI 10.1111/mec.12276; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buerkle CA, 2013, MOL ECOL, V22, P3028, DOI 10.1111/mec.12105; Catchen J, 2013, MOL ECOL, V22, P2864, DOI 10.1111/mec.12330; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067500; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Cowling WA, 2013, PLANT BREEDING, V132, P1, DOI 10.1111/pbr.12026; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; De Donato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062137; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Edwards D, 2013, THEOR APPL GENET, V126, P1, DOI 10.1007/s00122-012-1964-x; Eller E, 2001, HUM BIOL, V73, P411, DOI 10.1353/hub.2001.0034; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Eren AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066643; Gautier M, 2013, MOL ECOL, V22, P3165, DOI 10.1111/mec.12089; Harter AV, 2004, NATURE, V430, P201, DOI 10.1038/nature02710; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Kilpinen H, 2013, TRENDS GENET, V29, P23, DOI 10.1016/j.tig.2012.10.001; Kim SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060176; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Ly D, 2013, CROP SCI, V53, P1312, DOI 10.2135/cropsci2012.11.0653; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Maron LG, 2013, P NATL ACAD SCI USA, V110, P5241, DOI 10.1073/pnas.1220766110; Mascher M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076925; McElroy KE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-74; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Monson-Miller J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-72; Morishige DT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-448; Morris GP, 2013, P NATL ACAD SCI USA, V110, P453, DOI 10.1073/pnas.1215985110; Narum SR, 2013, MOL ECOL, V22, P2841, DOI 10.1111/mec.12350; Ofori A, 2008, J APPL GENET, V49, P207, DOI 10.1007/BF03195615; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Prlic A, 2012, BIOINFORMATICS, V28, P2693, DOI 10.1093/bioinformatics/bts494; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; Rutkoski JE, 2013, G3-GENES GENOM GENET, V3, P427, DOI 10.1534/g3.112.005363; Saintenac C, 2013, G3-GENES GENOM GENET, V3, P1105, DOI 10.1534/g3.113.005819; Shendure J, 2012, NAT BIOTECHNOL, V30, P1084, DOI 10.1038/nbt.2421; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Stolle E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063960; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Truong HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037565; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/nmeth.2023, 10.1038/NMETH.2023]; White TA, 2013, MOL ECOL, V22, P2971, DOI 10.1111/mec.12343; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107	65	983	997	3	211	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90346	10.1371/journal.pone.0090346	http://dx.doi.org/10.1371/journal.pone.0090346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587335	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200176
J	Guo, WL; Zhang, SF; Li, JE; Wang, J				Guo, Wan-liang; Zhang, Shu-feng; Li, Jin-en; Wang, Jian			Association of Meteorological Factors with Pediatric Intussusception in Subtropical China: A 5-Year Analysis	PLOS ONE			English	Article							CHILDREN; AGE; EPIDEMIOLOGY; SURVEILLANCE; CHILDHOOD; TAIWAN	Purpose: The aim of this study was to determine whether climate factors correlate with variations in the rate of pediatric intussusception cases presenting to the Children's Hospital in Suzhou, China. Material and Methods: The hospital records of 5,994 pediatric cases of intussusception who had presented between Aug 2006 and Dec 2011 were retrospectively analyzed. Demographic data and air enema reduction data were collected for each case. Results: The monthly rate of new intussusception cases fluctuated throughout the year generally rising from April to September with a peak from May to July. This annual cycling of intussusception incidence was highly significant over the 5 year observation period. Poisson regression analysis showed that the monthly number of intussusception cases was associated with an increase in mean temperature per month (P = 0.0001), sum of sunshine per month (P, 0.0001), precipitation per month (P < 0.0001), and was marginally associated with increased mean wind speed per month (P = 0.0709). Conclusion: The incidence of intussusception in Suzhou was seasonally variable with a peak in cases presenting during hotter, sunnier, and wetter months demonstrating a positive association with certain climatic factors.	[Guo, Wan-liang; Li, Jin-en] Soochow Univ, Childrens Hosp, Dept Radiol, Suzhou, Peoples R China; [Zhang, Shu-feng] Tradit Chinese Med Hosp Yulin, Dept Orthopaed, Yulin, Peoples R China; [Wang, Jian] Soochow Univ, Childrens Hosp, Dept Gen Surg, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Wang, J (corresponding author), Soochow Univ, Childrens Hosp, Dept Gen Surg, Suzhou, Peoples R China.	wangjiansuzhou@163.com			Jiangsu province 333 talents	Jiangsu province 333 talents	This study was funded by Jiangsu province 333 talents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YZ, 2006, AM J SURG, V192, P273, DOI 10.1016/j.amjsurg.2006.04.013; Bines JE, 2004, VACCINE, V22, P569, DOI 10.1016/j.vaccine.2003.09.016; Bines JE, 2002, VACCINES BIOL; Buettcher M, 2007, PEDIATRICS, V120, P473, DOI 10.1542/peds.2007-0035; Chen SCC, 2010, PEDIATR NEONATOL, V51, P285, DOI 10.1016/S1875-9572(10)60055-1; Enweronu-Laryea CC, 2012, J INFECT DEV COUNTR, V6, P148, DOI 10.3855/jidc.1667; Guo WL, 2011, ARCH MED SCI, V7, P877, DOI 10.5114/aoms.2011.25565; Ho WL, 2005, J FORMOS MED ASSOC, V104, P398; Hsiao CC, 2013, PEDIATR NEONATOL, V54, P188, DOI 10.1016/j.pedneo.2013.01.004; Justice F, 2005, J PAEDIATR CHILD H, V41, P475, DOI 10.1111/j.1440-1754.2005.00686.x; Khumjui C, 2009, VACCINE, V27, pF116, DOI 10.1016/j.vaccine.2009.09.003; Nelson E. A. S., 2007, Hong Kong Medical Journal, V13, P279; Nelson EAS, 2002, PEDIATR INFECT DIS J, V21, P701, DOI 10.1097/00006454-200207000-00019; Saez-Llorens X, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-95; Takeuchi M, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-36; Tareen F, 2011, PEDIATR SURG INT, V27, P587, DOI 10.1007/s00383-010-2836-6	16	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90521	10.1371/journal.pone.0090521	http://dx.doi.org/10.1371/journal.pone.0090521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587386	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200220
J	Maiguma, M; Suzuki, Y; Suzuki, H; Okazaki, K; Aizawa, M; Muto, M; Tomino, Y				Maiguma, Masayuki; Suzuki, Yusuke; Suzuki, Hitoshi; Okazaki, Keiko; Aizawa, Masashi; Muto, Masahiro; Tomino, Yasuhiko			Dietary Zinc Is a Key Environmental Modifier in the Progression of IgA Nephropathy	PLOS ONE			English	Article							MODEL; GLOMERULONEPHRITIS; DEFICIENCY; EXPRESSION; NUTRITION; TH1	IgA nephropathy (IgAN) shows diverse epidemiological characteristics, resulting from both genetic and acquired (e. g., environmental) causes. Environmental factors, such as diet or exposure to exogenous antigens, may prescribe the progression or prognosis of IgAN. It remains unclear as to how diet and infection influence susceptibility to IgAN. A relationship, such as Toll-like receptors (TLRs), especially TLR9 and TLR4, was demonstrated between IgAN and pathogen-recognition molecules. Recently, zinc (Zn) was discovered to be involved in various immune-related diseases, affecting B, T, and dendritic cells (DCs). This study investigates the relationship between dietary Zn and IgAN development in IgAN-prone mice. Seven-week-old IgAN-prone mice were divided into low, normal, and high Zn diet groups. To assess exogenous pathogen-mediated immune responses, lipopolysaccharide (LPS) was nasally administered. The activity of IgAN was biochemically and pathologically evaluated during the disease course. We also examined in vitro IgA production in spleen cells or in combinations of cocultured B, T, and DCs under various Zn conditions with or without LPS. Dietary conditioning with Zn affected serum immunoglobulins and urinary albumin levels, and mesangial deposition of IgA and IgG. Zn deficiency is associated with IgAN progression through the activation of the TLR4/TIR-domain-containing adapter-inducing interferon-beta (TRIF), but not the TLR9, in DCs. Zn supplementation prevented disease aggravation. Our findings indicate that immune conditioning with dietary Zn alters nephritogenic IgA production after mucosal infection.	[Maiguma, Masayuki; Suzuki, Yusuke; Suzuki, Hitoshi; Okazaki, Keiko; Aizawa, Masashi; Muto, Masahiro; Tomino, Yasuhiko] Juntendo Univ, Div Nephrol, Dept Internal Med, Fac Med, Tokyo, Japan	Juntendo University	Tomino, Y (corresponding author), Juntendo Univ, Div Nephrol, Dept Internal Med, Fac Med, Tokyo, Japan.	yasu@juntendo.ac.jp			Ministry of Health, Labour and Welfare of Japan; JSPS KAKENHI [23790957]; Strategic International Research Cooperative Program, Japan Science and Technology Agency (JST); Study Group on IgAN in Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Strategic International Research Cooperative Program, Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Study Group on IgAN in Japan	This study was supported in part by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Intractable Disease, from the Ministry of Health, Labour and Welfare of Japan, by JSPS KAKENHI Grant Number 23790957, by Strategic International Research Cooperative Program, Japan Science and Technology Agency (JST), and by a research grant from the Study Group on IgAN in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Biltagi M, 2009, ACTA PAEDIATR, V98, P737, DOI 10.1111/j.1651-2227.2008.01213.x; Berger J, 1968, J Urol Nephrol (Paris), V74, P694; COPPO R, 1988, AM J KIDNEY DIS, V12, P420, DOI 10.1016/S0272-6386(88)80038-6; Coppo R, 2010, CLIN EXP IMMUNOL, V159, P73, DOI 10.1111/j.1365-2249.2009.04045.x; COPPO R, 1986, NEW ENGL J MED, V315, P1167; DAMICO G, 1987, Q J MED, V64, P709; Donadio JV, 1999, J AM SOC NEPHROL, V10, P1772; ENDO Y, 1994, PATHOL INT, V44, P1, DOI 10.1111/j.1440-1827.1994.tb02579.x; Fraker PJ, 2004, ANNU REV NUTR, V24, P277, DOI 10.1146/annurev.nutr.24.012003.132454; Ganss B, 2004, CRIT REV ORAL BIOL M, V15, P282, DOI 10.1177/154411130401500504; Hensel P, 2010, CLIN DERMATOL, V28, P686, DOI 10.1016/j.clindermatol.2010.03.031; Hosea HJ, 2003, J NUTR, V133, P4239, DOI 10.1093/jn/133.12.4239; Ibs KH, 2003, J NUTR, V133, p1452S, DOI 10.1093/jn/133.5.1452S; Johnson RJ, 2003, AM J KIDNEY DIS, V42, P575, DOI 10.1016/S0272-6386(03)00801-1; Kajiyama T, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/819646; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Mohommad MK, 2012, NUTR CLIN PRACT, V27, P8, DOI 10.1177/0884533611433534; Okazaki K, 2012, J AM SOC NEPHROL, V23, P1364, DOI 10.1681/ASN.2011121160; Prasad AS, 1998, MOL CELL BIOCHEM, V188, P63, DOI 10.1023/A:1006868305749; PRASAD AS, 1995, NUTRITION, V11, P93; Prasad AS, 2000, J INFECT DIS, V182, pS62, DOI 10.1086/315916; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Sato D, 2012, NEPHROL DIAL TRANSPL, V27, P1090, DOI 10.1093/ndt/gfr403; Schena FP, 2001, KIDNEY INT, V60, P732, DOI 10.1046/j.1523-1755.2001.060002732.x; Siklar Z, 2003, J TROP PEDIATRICS, V49, P187, DOI 10.1093/tropej/49.3.187; Suzuki H, 2007, KIDNEY INT, V72, P319, DOI 10.1038/sj.ki.5002300; Suzuki H, 2005, J AM SOC NEPHROL, V16, P1289, DOI 10.1681/ASN.2004030219; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TOMINO Y, 1993, AM J KIDNEY DIS, V21, P427, DOI 10.1016/S0272-6386(12)80272-1; Walker CF, 2004, ANNU REV NUTR, V24, P255, DOI 10.1146/annurev.nutr.23.011702.073054	32	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90558	10.1371/journal.pone.0090558	http://dx.doi.org/10.1371/journal.pone.0090558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587392	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200226
J	Zosky, GR; Iosifidis, T; Perks, K; Ditcham, WGF; Devadason, SG; Siah, WS; Devine, B; Maley, F; Cook, A				Zosky, Graeme R.; Iosifidis, Thomas; Perks, Kara; Ditcham, Will G. F.; Devadason, Sunalene G.; Siah, W. Shan; Devine, Brian; Maley, Fiona; Cook, Angus			The Concentration of Iron in Real-World Geogenic PM10 Is Associated with Increased Inflammation and Deficits in Lung Function in Mice	PLOS ONE			English	Article							PARTICLE-SIZE; SILICA; EXPOSURE; DUST; RESPONSES; SUSCEPTIBILITY; MODEL	Background: There are many communities around the world that are exposed to high levels of particulate matter,10 mm (PM10) of geogenic (earth derived) origin. Mineral dusts in the occupational setting are associated with poor lung health, however very little is known about the impact of heterogeneous community derived particles. We have preliminary evidence to suggest that the concentration of iron (Fe) may be associated with the lung inflammatory response to geogenic PM10. We aimed to determine which physico-chemical characteristics of community sampled geogenic PM10 are associated with adverse lung responses. Methods: We collected geogenic PM10 from four towns in the arid regions of Western Australia. Adult female BALB/c mice were exposed to 100 mg of particles and assessed for inflammatory and lung function responses 6 hours, 24 hours and 7 days post-exposure. We assessed the physico-chemical characteristics of the particles and correlated these with lung outcomes in the mice using principal components analysis and multivariate linear regression. Results: Geogenic particles induced an acute inflammatory response that peaked 6 hours post-exposure and a deficit in lung mechanics 7 days post-exposure. This deficit in lung mechanics was positively associated with the concentration of Fe and particle size variability and inversely associated with the concentration of Si. Conclusions: The lung response to geogenic PM10 is complex and highly dependent on the physico-chemical characteristics of the particles. In particular, the concentration of Fe in the particles may be a key indicator of the potential population health consequences for inhaling geogenic PM10.	[Zosky, Graeme R.] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Zosky, Graeme R.; Siah, W. Shan; Devine, Brian; Maley, Fiona; Cook, Angus] Cooperat Res Ctr Asthma & Airways, Sydney, NSW, Australia; [Iosifidis, Thomas; Perks, Kara] Telethon Inst Child Hlth Res, Subiaco, WA, Australia; [Ditcham, Will G. F.; Devadason, Sunalene G.] Univ Western Australia, Sch Paediat & Child Hlth, Subiaco, WA, Australia; [Siah, W. Shan; Devine, Brian; Maley, Fiona; Cook, Angus] Univ Western Australia, Sch Populat Hlth, Crawley, WA, Australia	University of Tasmania; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia	Zosky, GR (corresponding author), Univ Tasmania, Sch Med, Hobart, Tas, Australia.	Graeme.Zosky@utas.edu.au	Iosifidis, Thomas/AAN-2441-2020; Zosky, Graeme/B-2048-2014; Perks, Kara/O-8701-2014; Reid, David W/B-3263-2011; Iosifidis, Thomas/J-6310-2016	Iosifidis, Thomas/0000-0001-8462-5865; Iosifidis, Thomas/0000-0001-8462-5865; Zosky, Graeme/0000-0001-9039-0302; Perks, Kara/0000-0001-5511-3844; Cook, Angus/0000-0002-1758-6496	Co-operative Research Centre for Asthma and Airways (Sydney, Australia); Thoracic Society of Australia; Thoracic Society of New Zealand	Co-operative Research Centre for Asthma and Airways (Sydney, Australia)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Thoracic Society of Australia; Thoracic Society of New Zealand	This study was funded by the Co-operative Research Centre for Asthma and Airways (Sydney, Australia) and the Thoracic Society of Australia and New Zealand (Maurice Blackburn Grant-in-Aid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON IYR, 1994, EXP LUNG RES, V20, P223, DOI 10.3109/01902149409064384; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Aust Ann E, 2002, Res Rep Health Eff Inst, P1; Boylen CE, 2011, INHAL TOXICOL, V23, P906, DOI 10.3109/08958378.2011.625454; Carter JD, 1997, TOXICOL APPL PHARM, V146, P180, DOI 10.1006/taap.1997.8254; CHOW JC, 1993, AEROSOL SCI TECH, V18, P105, DOI 10.1080/02786829308959588; Cowie RL, 1998, CHEST, V113, P340, DOI 10.1378/chest.113.2.340; Department of Environment and Conservation, 2011, W AUSTR AIR MON REP; DOELMAN CJA, 1990, EXP LUNG RES, V16, P41, DOI 10.3109/01902149009064698; FREDBERG JJ, 1989, J APPL PHYSIOL, V67, P2408, DOI 10.1152/jappl.1989.67.6.2408; GHIO AJ, 1992, AM J PHYSIOL, V263, pL511, DOI 10.1152/ajplung.1992.263.5.L511; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; HEDENBORG M, 1989, LUNG, V167, P23, DOI 10.1007/BF02714927; Hnizdo E, 2003, OCCUP ENVIRON MED, V60, P237, DOI 10.1136/oem.60.4.237; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Janosi TZ, 2006, J APPL PHYSIOL, V101, P454, DOI 10.1152/japplphysiol.00011.2006; Kajiwara T, 2007, J OCCUP HEALTH, V49, P88, DOI 10.1539/joh.49.88; KUMAR RK, 1989, AM J PATHOL, V135, P605; Lakatos HF, 2006, EXP LUNG RES, V32, P181, DOI 10.1080/01902140600817465; Larcombe AN, 2013, INFLUENZA OTHER RESP, V7, P701, DOI 10.1111/irv.12012; Ljung K, 2011, SCI TOTAL ENVIRON, V410, P269, DOI 10.1016/j.scitotenv.2011.07.061; Miller MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031359; Moraes TJ, 2006, CURR OPIN HEMATOL, V13, P21, DOI 10.1097/01.moh.0000190113.31027.d5; Mossman Brooke T, 2007, Part Fibre Toxicol, V4, P4, DOI 10.1186/1743-8977-4-4; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; Mullan N, 2006, RESP HOSP PORT HEDLA; OHTSUKA Y, 1995, AM J RESP CRIT CARE, V152, P2144, DOI 10.1164/ajrccm.152.6.8520788; Park MVDZ, 2011, BIOMATERIALS, V32, P9810, DOI 10.1016/j.biomaterials.2011.08.085; Pasula R, 2009, J IMMUNOL, V182, P7102, DOI 10.4049/jimmunol.0803642; Quality of urban air review group, 1996, AIRB PART MATT UK; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; South Australian Department of Health, 2007, WHYALL HLTH IMP STUD; VELAN GM, 1993, PATHOLOGY, V25, P282, DOI 10.3109/00313029309066590; Venaille TJ, 1998, RESP MED, V92, P233, DOI 10.1016/S0954-6111(98)90101-9; Veranth JM, 2006, ENVIRON HEALTH PERSP, V114, P341, DOI 10.1289/ehp.8360; Zhou YM, 2003, TOXICOL APPL PHARM, V190, P157, DOI 10.1016/S0041-008X(03)00157-1; Zosky GR, 2008, J APPL PHYSIOL, V105, P685, DOI 10.1152/japplphysiol.90328.2008; Zosky GR, 2014, RESPIROLOGY, V19, P58, DOI 10.1111/resp.12150; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	40	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90609	10.1371/journal.pone.0090609	http://dx.doi.org/10.1371/journal.pone.0090609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587402	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200236
J	Djukic, M; Brzuszkiewicz, E; Funfhaus, A; Voss, J; Gollnow, K; Poppinga, L; Liesegang, H; Garcia-Gonzalez, E; Genersch, E; Daniel, R				Djukic, Marvin; Brzuszkiewicz, Elzbieta; Fuenfhaus, Anne; Voss, Joern; Gollnow, Kathleen; Poppinga, Lena; Liesegang, Heiko; Garcia-Gonzalez, Eva; Genersch, Elke; Daniel, Rolf			How to Kill the Honey Bee Larva: Genomic Potential and Virulence Mechanisms of Paenibacillus larvae	PLOS ONE			English	Article							AMERICAN FOULBROOD DISEASE; BACTERIAL PATHOGEN; SUBSP LARVAE; CLOSTRIDIUM-BOTULINUM; DIFFERENT GENOTYPES; SECRETED PROTEASES; SYNERGISTIC FACTOR; GRANULOSIS-VIRUS; ETIOLOGIC AGENT; APIS-MELLIFERA	Paenibacillus larvae, a Gram positive bacterial pathogen, causes American Foulbrood (AFB), which is the most serious infectious disease of honey bees. In order to investigate the genomic potential of P. larvae, two strains belonging to two different genotypes were sequenced and used for comparative genome analysis. The complete genome sequence of P. larvae strain DSM 25430 (genotype ERIC II) consisted of 4,056,006 bp and harbored 3,928 predicted protein-encoding genes. The draft genome sequence of P. larvae strain DSM 25719 (genotype ERIC I) comprised 4,579,589 bp and contained 4,868 protein-encoding genes. Both strains harbored a 9.7 kb plasmid and encoded a large number of virulence-associated proteins such as toxins and collagenases. In addition, genes encoding large multimodular enzymes producing nonribosomally peptides or polyketides were identified. In the genome of strain DSM 25719 seven toxin associated loci were identified and analyzed. Five of them encoded putatively functional toxins. The genome of strain DSM 25430 harbored several toxin loci that showed similarity to corresponding loci in the genome of strain DSM 25719, but were non-functional due to point mutations or disruption by transposases. Although both strains cause AFB, significant differences between the genomes were observed including genome size, number and composition of transposases, insertion elements, predicted phage regions, and strain-specific island-like regions. Transposases, integrases and recombinases are important drivers for genome plasticity. A total of 390 and 273 mobile elements were found in strain DSM 25430 and strain DSM 25719, respectively. Comparative genomics of both strains revealed acquisition of virulence factors by horizontal gene transfer and provided insights into evolution and pathogenicity.	[Djukic, Marvin; Brzuszkiewicz, Elzbieta; Voss, Joern; Gollnow, Kathleen; Liesegang, Heiko; Daniel, Rolf] Univ Gottingen, Dept Genom & Appl Microbiol, Inst Microbiol & Genet, D-37073 Gottingen, Germany; [Djukic, Marvin; Brzuszkiewicz, Elzbieta; Voss, Joern; Gollnow, Kathleen; Liesegang, Heiko; Daniel, Rolf] Univ Gottingen, Gottingen Genom Lab, Inst Microbiol & Genet, D-37073 Gottingen, Germany; [Fuenfhaus, Anne; Poppinga, Lena; Garcia-Gonzalez, Eva; Genersch, Elke] Inst Bee Res, Dept Mol Microbiol & Bee Dis, Hohen Neuendorf, Germany	University of Gottingen; University of Gottingen	Genersch, E (corresponding author), Inst Bee Res, Dept Mol Microbiol & Bee Dis, Hohen Neuendorf, Germany.	elke.genersch@rz.hu-berlin.de; rdaniel@gwdg.de	Daniel, Rolf/AAQ-5933-2021; Fünfhaus, Anne/AAD-4642-2022	Daniel, Rolf/0000-0002-8646-7925; Funfhaus, Anne/0000-0003-0990-5853; Liesegang, Heiko/0000-0003-1792-2047; Genersch, Elke/0000-0001-7906-4530	Ministry for Agriculture from Brandenburg, Germany; Ministry for Agriculture from Sachsen-Anhalt, Germany; German Research Foundation (DFG) [GE 1365/1-1, 1121]; Niedersachsisches Ministerium fur Wissenschaft und Kultur; Bundesministerium fur Bildung und Forschung	Ministry for Agriculture from Brandenburg, Germany; Ministry for Agriculture from Sachsen-Anhalt, Germany; German Research Foundation (DFG)(German Research Foundation (DFG)); Niedersachsisches Ministerium fur Wissenschaft und Kultur; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	EG was supported by grants from the Ministries for Agriculture from Brandenburg and Sachsen-Anhalt, Germany. AF and LP were supported by the German Research Foundation (DFG, grant GE 1365/1-1). EG-G was supported by the German Research Foundation (DFG, Graduate School 1121). The Gottingen group was supported by grants from the Niedersachsisches Ministerium fur Wissenschaft und Kultur and the Bundesministerium fur Bildung und Forschung. The funders had no role in study design, data collection, data analysis, data interpretation, writing of the report; and the decision to submit the article for publication.	Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Alippi AM, 2004, J APICULT RES, V43, P135, DOI 10.1080/00218839.2004.11101124; Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Antunez K, 2009, J INVERTEBR PATHOL, V102, P129, DOI 10.1016/j.jip.2009.07.010; Arrebola E, 2010, J APPL MICROBIOL, V108, P386, DOI 10.1111/j.1365-2672.2009.04438.x; BAIDA GE, 1995, BBA-GENE STRUCT EXPR, V1264, P151, DOI 10.1016/0167-4781(95)00150-F; Bailey L., 1991, HONEY BEE PATHOLOGY; Barrett AJ, 2004, CURR OPIN DRUG DISC, V7, P334; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Brodsgaard CJ, 1998, APIDOLOGIE, V29, P569, DOI 10.1051/apido:19980609; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chan QWT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-450; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Dancer BN, 1997, J INVERTEBR PATHOL, V70, P79, DOI 10.1006/jipa.1997.4672; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Du LC, 2010, NAT PROD REP, V27, P255, DOI 10.1039/b912037h; Duitman EH, 1999, P NATL ACAD SCI USA, V96, P13294, DOI 10.1073/pnas.96.23.13294; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2004, J INVERTEBR PATHOL, V85, P105, DOI 10.1016/j.jip.2004.02.004; Fethiere J, 1999, J MOL BIOL, V288, P635, DOI 10.1006/jmbi.1999.2698; Forsgren E, 2008, VET MICROBIOL, V129, P342, DOI 10.1016/j.vetmic.2007.12.001; Funfhaus A, 2013, ENVIRON MICROBIOL, V15, P2951, DOI 10.1111/1462-2920.12229; Funfhaus A, 2009, ENV MICROBIOL REP, V1, P240, DOI 10.1111/j.1758-2229.2009.00039.x; Garcia-Gonzalez E, 2013, ENVIRON MICROBIOL, V15, P2894, DOI 10.1111/1462-2920.12167; Genersch E, 2006, INT J SYST EVOL MICR, V56, P501, DOI 10.1099/ijs.0.63928-0; Genersch E, 2005, APPL ENVIRON MICROB, V71, P7551, DOI 10.1128/AEM.71.11.7551-7555.2005; Genersch E, 2003, APIDOLOGIE, V34, P195, DOI 10.1051/apido:2003025; Genersch E, 2007, BERL MUNCH TIERARZTL, V120, P26, DOI 10.2376/0005-9366-120-26; Genersch E, 2010, APPL MICROBIOL BIOT, V87, P87, DOI 10.1007/s00253-010-2573-8; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; GILLIAM M, 1970, EXPERIENTIA, V26, P1006, DOI 10.1007/BF02114161; Graham J.M., 1999, HIVE HONEY BEE; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Holst EC, 1940, J BACTERIOL, V40, P723, DOI 10.1128/JB.40.5.723-731.1940; Hrabak J, 2007, J APICULT RES, V46, P160, DOI 10.1080/00218839.2007.11101388; JAROSZ J, 1990, J INVERTEBR PATHOL, V56, P143, DOI 10.1016/0022-2011(90)90096-O; Jung CM, 1999, J BACTERIOL, V181, P2816, DOI 10.1128/JB.181.9.2816-2822.1999; Keil B, 1992, Matrix Suppl, V1, P127; Khosla C, 1999, ANNU REV BIOCHEM, V68, P219, DOI 10.1146/annurev.biochem.68.1.219; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; Lindsay AM, 2009, MICROBIOL-SGM, V155, P443, DOI 10.1099/mic.0.020826-0; Loncaric I, 2009, J INVERTEBR PATHOL, V100, P44, DOI 10.1016/j.jip.2008.09.003; LOVGREN A, 1990, MOL MICROBIOL, V4, P2137, DOI 10.1111/j.1365-2958.1990.tb00575.x; Luquez C, 2009, APPL ENVIRON MICROB, V75, P6094, DOI 10.1128/AEM.01009-09; MAGETDANA R, 1994, TOXICOLOGY, V87, P151, DOI 10.1016/0300-483X(94)90159-7; Mahillon J, 1999, RES MICROBIOL, V150, P675, DOI 10.1016/S0923-2508(99)00124-2; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Matsushita O, 2001, J BIOL CHEM, V276, P8761, DOI 10.1074/jbc.M003450200; May JJ, 2001, J BIOL CHEM, V276, P7209, DOI 10.1074/jbc.M009140200; NAKANO H, 1990, JPN J MED SCI BIOL, V43, P183, DOI 10.7883/yoken1952.43.183; Neuendorf S, 2004, MICROBIOL-SGM, V150, P2381, DOI 10.1099/mic.0.27125-0; Peters M, 2006, J VET MED B, V53, P100, DOI 10.1111/j.1439-0450.2006.00920.x; Petit L, 2001, J BIOL CHEM, V276, P15736, DOI 10.1074/jbc.M010412200; Poppinga L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002716; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Qin X, 2006, INSECT MOL BIOL, V15, P715, DOI 10.1111/j.1365-2583.2006.00694.x; QUENTIN MJ, 1982, BIOCHIM BIOPHYS ACTA, V684, P207, DOI 10.1016/0005-2736(82)90007-4; Rauch S, 2009, APPL ENVIRON MICROB, V75, P3344, DOI 10.1128/AEM.02839-08; Rawlings ND, 2008, BIOCHIMIE, V90, P243, DOI 10.1016/j.biochi.2007.09.014; RAYMOND KN, 1979, ACCOUNTS CHEM RES, V12, P183, DOI 10.1021/ar50137a004; Schirmer J, 2002, J BIOL CHEM, V277, P11941, DOI 10.1074/jbc.M108463200; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Shah SA, 2011, RES MICROBIOL, V162, P27, DOI 10.1016/j.resmic.2010.09.001; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; Snowdon JA, 1996, INT J FOOD MICROBIOL, V31, P1, DOI 10.1016/0168-1605(96)00970-1; Staden R, 2000, Methods Mol Biol, V132, P115; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; STJULIAN G, 1971, J BACTERIOL, V108, P828, DOI 10.1128/JB.108.2.828-834.1971; Tamaki M, 2005, J ANTIBIOT, V58, P293, DOI 10.1038/ja.2005.37; THIMON L, 1995, FEMS MICROBIOL LETT, V128, P101, DOI 10.1111/j.1574-6968.1995.tb07507.x; Watanabe M, 2004, J BIOCHEM, V135, P471, DOI 10.1093/jb/mvh062; Wen YP, 2011, ENVIRON MICROBIOL, V13, P2726, DOI 10.1111/j.1462-2920.2011.02542.x; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Winkelmann G, 2002, BIOCHEM SOC T, V30, P691, DOI 10.1042/BST0300691; WOODRING J, 1993, J INSECT PHYSIOL, V39, P89, DOI 10.1016/0022-1910(93)90022-J; YAMAMOTO T, 1978, J INVERTEBR PATHOL, V31, P48, DOI 10.1016/0022-2011(78)90108-8; Yue D, 2008, ENVIRON MICROBIOL, V10, P1612, DOI 10.1111/j.1462-2920.2008.01579.x; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485; ZHU Y, 1989, J INVERTEBR PATHOL, V54, P49, DOI 10.1016/0022-2011(89)90139-0	88	71	71	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90914	10.1371/journal.pone.0090914	http://dx.doi.org/10.1371/journal.pone.0090914			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599066	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400144
J	Du, XR; Dong, YL; Shi, H; Li, J; Kong, SS; Shi, DH; Sun, LV; Xu, T; Deng, KJ; Tao, WF				Du, Xingrong; Dong, Yongli; Shi, Hao; Li, Jiang; Kong, Shanshan; Shi, Donghua; Sun, Ling V.; Xu, Tian; Deng, Kejing; Tao, Wufan			Mst1 and Mst2 Are Essential Regulators of Trophoblast Differentiation and Placenta Morphogenesis	PLOS ONE			English	Article							ORGAN SIZE CONTROL; CARDIOMYOCYTE PROLIFERATION; BRANCHING MORPHOGENESIS; HIPPO PATHWAY; MICE; RECEPTOR; PROTEIN; EXPRESSION; CLONING; GROWTH	The placenta is essential for survival and growth of the fetus because it promotes the delivery of nutrients and oxygen from the maternal circulation as well as fetal waste disposal. Mst1 and Mst2 (Mst1/2), key components of the mammalian hpo/Mst signaling pathway, encode two highly conserved Ser/Thr kinases and play important roles in the prevention of tumorigenesis and autoimmunity, control of T cell development and trafficking, and embryonic development. However, their functions in placental development are not fully understood, and the underlying cellular and molecular mechanisms remain elusive. Here, we investigated the functions of Mst1/2 in mouse placental development using both conventional and conditional (endothelial) Mst1/2 double knockout mice. We found that the number of trophoblast giant cells dramatically increased while spongiotrophoblast cells almost completely disappeared in Mst1/2 deficient placentas. We showed that Mst1/2 deficiency down regulated the expression of Mash2, which is required for suppressing the differentiation of trophoblast giant cells. Furthermore, we demonstrated that endothelial-specific deletion of Mst1/2 led to impaired placental labyrinthine vasculature and embryonic lethality at E11.5, but neither affected vasculature in yolk sac and embryo proper nor endocardium development. Collectively, our findings suggest that Mst1/2 regulate placental development by control of trophoblast cell differentiation and labyrinthine vasculature at midgestation and Mst1/2 control labyrinth morphogenesis in trophoblast-and fetal endothelial-dependent manners. Thus, our studies have defined novel roles of Mst1/2 in mouse placental development.	[Du, Xingrong; Dong, Yongli; Shi, Hao; Li, Jiang; Kong, Shanshan; Shi, Donghua; Sun, Ling V.; Xu, Tian; Deng, Kejing; Tao, Wufan] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Du, Xingrong; Dong, Yongli; Shi, Hao; Li, Jiang; Kong, Shanshan; Shi, Donghua; Sun, Ling V.; Xu, Tian; Deng, Kejing; Tao, Wufan] Fudan Univ, Sch Life Sci, Natl Ctr Int Res Dev & Dis, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China; [Xu, Tian] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA	Fudan University; Fudan University; Howard Hughes Medical Institute; Yale University	Deng, KJ (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	dengkj@fudan.edu.cn; wufan_tao@fudan.edu.cn	Du, Xinrong/GWU-9803-2022; SHI, HAO/ABE-4662-2020	SHI, HAO/0000-0002-2796-629X; Du, Xingrong/0000-0001-6427-9600	National Basic Research Program of China [2013CB945300, 2011CB510100, 2006CB806700]; National Natural Science Foundation of China [31171406, 30971666, 30630043]; Hi-tech Research and Development Program of China [2007AA022101]; Science and Technology Committee of Shanghai Municipality [12JC1400600]; Ministry of Education of China; NATIONAL CANCER INSTITUTE [R01CA069408] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-tech Research and Development Program of China(National High Technology Research and Development Program of China); Science and Technology Committee of Shanghai Municipality(Shanghai Science & Technology Committee); Ministry of Education of China(Ministry of Education, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Basic Research Program of China (2013CB945300, 2011CB510100, 2006CB806700); National Natural Science Foundation of China (31171406, 30971666, 30630043); Hi-tech Research and Development Program of China (2007AA022101); Key Projects Grant for Basic Research (12JC1400600) from the Science and Technology Committee of Shanghai Municipality and 985 projects of Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Chen JX, 2001, AM J PHYSIOL-CELL PH, V280, pC1475, DOI 10.1152/ajpcell.2001.280.6.C1475; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Creasy CL, 1995, GENE, V167, P303, DOI 10.1016/0378-1119(95)00653-2; Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015; Dong YL, 2009, J IMMUNOL, V183, P3865, DOI 10.4049/jimmunol.0900678; Du Xingrong, 2014, J Immunol, V192, P1525, DOI 10.4049/jimmunol.1301060; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Harlow E., 1999, USING ANTIBODIES LAB; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hemberger M, 2001, TRENDS ENDOCRIN MET, V12, P162, DOI 10.1016/S1043-2760(01)00375-7; Hughes M, 2004, DEV BIOL, V271, P26, DOI 10.1016/j.ydbio.2004.03.029; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Katsanou V, 2009, MOL CELL BIOL, V29, P2762, DOI 10.1128/MCB.01393-08; Kong SS, 2013, CELL RES, V23, P835, DOI 10.1038/cr.2013.59; Lan Y, 2007, MOL CELL BIOL, V27, P7683, DOI 10.1128/MCB.00577-07; LESCISIN KR, 1988, GENE DEV, V2, P1639, DOI 10.1101/gad.2.12a.1639; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Mou F, 2012, J EXP MED, V209, P741, DOI 10.1084/jem.20111692; Navankasattusas S, 2008, DEVELOPMENT, V135, P659, DOI 10.1242/dev.013623; Oh S, 2009, MOL CELL BIOL, V29, P6309, DOI 10.1128/MCB.00551-09; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Schreiber J, 2000, MOL CELL BIOL, V20, P2466, DOI 10.1128/MCB.20.7.2466-2474.2000; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Takahashi T, 2003, MOL CELL BIOL, V23, P1817, DOI 10.1128/MCB.23.5.1817-1831.2003; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Tanaka M, 1997, DEV BIOL, V190, P55, DOI 10.1006/dbio.1997.8685; Ueda Y, 2012, PROC IUTAM, V5, P3, DOI 10.1016/j.piutam.2012.06.002; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; Yang JH, 2000, NAT GENET, V24, P309, DOI 10.1038/73550; Yi J, 2010, DEV DYNAM, V239, P2005, DOI 10.1002/dvdy.22343; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhang C, 2010, DEV DYNAM, V239, P2594, DOI 10.1002/dvdy.22391; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zheng-Fischhofer Q, 2007, DEV BIOL, V312, P258, DOI 10.1016/j.ydbio.2007.09.025; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	44	19	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90701	10.1371/journal.pone.0090701	http://dx.doi.org/10.1371/journal.pone.0090701			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595170	Green Submitted, gold, Green Published			2022-12-27	WOS:000332475500088
J	Sasidharan, R; Keuskamp, DH; Kooke, R; Voesenek, LACJ; Pierik, R				Sasidharan, Rashmi; Keuskamp, Diederik H.; Kooke, Rik; Voesenek, Laurentius A. C. J.; Pierik, Ronald			Interactions between Auxin, Microtubules and XTHs Mediate Green Shade- Induced Petiole Elongation in Arabidopsis	PLOS ONE			English	Article							OUTER EPIDERMAL WALL; CORTICAL MICROTUBULES; PLASMA-MEMBRANE; CELL-WALL; MAIZE COLEOPTILES; DIFFERENTIAL GROWTH; AVOIDANCE RESPONSES; ABIOTIC STRESSES; PLANT-CELLS; CELLULOSE	Plants are highly attuned to translating environmental changes to appropriate modifications in growth. Such phenotypic plasticity is observed in dense vegetations, where shading by neighboring plants, triggers rapid unidirectional shoot growth (shade avoidance), such as petiole elongation, which is partly under the control of auxin. This growth is fuelled by cellular expansion requiring cell-wall modification by proteins such as xyloglucan endotransglucosylase/hydrolases (XTHs). Cortical microtubules (cMTs) are highly dynamic cytoskeletal structures that are also implicated in growth regulation. The objective of this study was to investigate the tripartite interaction between auxin, cMTs and XTHs in shade avoidance. Our results indicate a role for cMTs to control rapid petiole elongation in Arabidopsis during shade avoidance. Genetic and pharmacological perturbation of cMTs obliterated shade-induced growth and led to a reduction in XTH activity as well. Furthermore, the cMT disruption repressed the shade-induced expression of a specific set of XTHs. These XTHs were also regulated by the hormone auxin, an important regulator of plant developmental plasticity and also of several shade avoidance responses. Accordingly, the effect of cMT disruption on the shade enhanced XTH expression could be rescued by auxin application. Based on the results we hypothesize that cMTs can mediate petiole elongation during shade avoidance by regulating the expression of cell wall modifying proteins via control of auxin distribution.	[Sasidharan, Rashmi; Keuskamp, Diederik H.; Kooke, Rik; Voesenek, Laurentius A. C. J.; Pierik, Ronald] Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands; [Keuskamp, Diederik H.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Kooke, Rik] Wageningen Univ, Lab Plant Physiol, NL-6700 AP Wageningen, Netherlands	Utrecht University; Wageningen University & Research; Wageningen University & Research	Sasidharan, R (corresponding author), Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands.	r.sasidharan@uu.nl	Pierik, Ronald/B-9591-2011; Voesenek, Laurentius A.C.J./B-9661-2011; Sasidharan, Rashmi/C-2088-2011	Pierik, Ronald/0000-0002-5320-6817; Sasidharan, Rashmi/0000-0002-6940-0657; Voesenek, Laurentius/0000-0002-3361-3837	Netherlands Organisation for Scientific Research (VENI) [86306001, 86312013]	Netherlands Organisation for Scientific Research (VENI)(Netherlands Organization for Scientific Research (NWO))	This work was supported with funds from the Netherlands Organisation for Scientific Research (www.nwo.nl; VENI grant no. 86306001 to R Pierik; VENI grant no. 86312013 to R Sasidharan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arioli T, 1998, SCIENCE, V279, P717, DOI 10.1126/science.279.5351.717; Baskin TI, 2001, PROTOPLASMA, V215, P150, DOI 10.1007/BF01280311; Bichet A, 2001, PLANT J, V25, P137, DOI 10.1046/j.1365-313x.2001.00946.x; Boutte Y, 2006, J CELL SCI, V119, P1255, DOI 10.1242/jcs.02847; Boutte Y, 2007, CELL BIOL INT, V31, P649, DOI 10.1016/j.cellbi.2007.01.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camilleri C, 2002, PLANT CELL, V14, P833, DOI 10.1105/tpc.010402; Casal JJ, 2012, ANONYMOUS ARABIDOPSI, pe0157; Catterou M, 2001, PLANTA, V212, P673, DOI 10.1007/s004250000467; Chuong SDX, 2004, MOL CELL PROTEOMICS, V3, P970, DOI 10.1074/mcp.M400053-MCP200; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Dixit R, 2004, PLANT CELL, V16, P2546, DOI 10.1105/tpc.104.161030; Djakovic-Petrovic T, 2007, PLANT J, V51, P117, DOI 10.1111/j.1365-313X.2007.03122.x; Feraru E, 2011, CURR BIOL, V21, P338, DOI 10.1016/j.cub.2011.01.036; Fischer K, 1997, PROTOPLASMA, V196, P108, DOI 10.1007/BF01281064; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Himmelspach R, 2003, PLANT J, V36, P565, DOI 10.1046/j.1365-313X.2003.01906.x; Himmelspach R, 2001, PLANTA, V212, P184, DOI 10.1007/s004250000378; Hornitschek P, 2012, PLANT J, V71, P699, DOI 10.1111/j.1365-313X.2012.05033.x; Hush JM, 1996, J MICROSC-OXFORD, V181, P129, DOI 10.1046/j.1365-2818.1996.106386.x; ISHIDA K, 1992, INT J PLANT SCI, V153, P155, DOI 10.1086/297017; Kakar K, 2013, NATURE, V495, P529, DOI 10.1038/nature11980; Keller MM, 2011, PLANT J, V67, P195, DOI 10.1111/j.1365-313X.2011.04598.x; Keuskamp DH, 2011, PLANT J, V67, P208, DOI 10.1111/j.1365-313X.2011.04597.x; Keuskamp DH, 2010, P NATL ACAD SCI USA, V107, P22740, DOI 10.1073/pnas.1013457108; Keuskamp DH, 2010, PLANT SIGNAL BEHAV, V5, P655, DOI 10.4161/psb.5.6.11401; Kozuka T, 2010, PLANT PHYSIOL, V153, P1608, DOI 10.1104/pp.110.156802; Lane DR, 2001, PLANT PHYSIOL, V126, P278, DOI 10.1104/pp.126.1.278; Li L, 2012, GENE DEV, V26, P785, DOI 10.1101/gad.187849.112; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd C, 2006, SCIENCE, V312, P1482, DOI 10.1126/science.1128903; Martinez-Garcia JF, 2010, ADV BOT RES, V53, P65, DOI 10.1016/S0065-2296(10)53003-9; Millenaar FF, 2005, PLANT PHYSIOL, V137, P998, DOI 10.1104/pp.104.053967; Morelli G, 2000, PLANT PHYSIOL, V122, P621, DOI 10.1104/pp.122.3.621; Mustroph A, 2006, CELL TYPE SPECIFIC A; Mustroph A, 2009, P NATL ACAD SCI USA, V106, P18843, DOI 10.1073/pnas.0906131106; NICK P, 1990, PLANTA, V181, P162, DOI 10.1007/BF02411533; NICK P, 1992, PLANT PHYSIOL, V99, P1302, DOI 10.1104/pp.99.4.1302; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Pagant S, 2002, PLANT CELL, V14, P2001, DOI 10.1105/tpc.002873; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Pierik R, 2009, PLANT PHYSIOL, V149, P1701, DOI 10.1104/pp.108.133496; Polko JK, 2012, NEW PHYTOL, V193, P339, DOI 10.1111/j.1469-8137.2011.03920.x; ROBERTS IN, 1985, PLANTA, V164, P439, DOI 10.1007/BF00395959; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; Sasidharan R, 2008, PLANT PHYSIOL, V148, P1557, DOI 10.1104/pp.108.125518; Sasidharan R, 2011, CRIT REV PLANT SCI, V30, P548, DOI 10.1080/07352689.2011.615706; Sasidharan R, 2010, PLANT PHYSIOL, V154, P978, DOI 10.1104/pp.110.162057; SHIBAOKA H, 1994, ANNU REV PLANT PHYS, V45, P527, DOI 10.1146/annurev.pp.45.060194.002523; Soga K, 2006, PLANTA, V224, P1485, DOI 10.1007/s00425-006-0319-8; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Sugimoto K, 2003, PLANT CELL, V15, P1414, DOI 10.1105/tpc.011593; SULOVA Z, 1995, ANAL BIOCHEM, V229, P80, DOI 10.1006/abio.1995.1381; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Tatematsu K, 2004, PLANT CELL, V16, P379, DOI 10.1105/tpc.018630; Ueda K, 1999, PROTOPLASMA, V206, P201, DOI 10.1007/BF01279267; Vandenbussche F, 2005, CURR OPIN PLANT BIOL, V8, P462, DOI 10.1016/j.pbi.2005.07.007; Vissenberg K, 2005, J EXP BOT, V56, P673, DOI 10.1093/jxb/eri048; Wang C, 2011, BIOCHEMISTRY-MOSCOW+, V76, P320, DOI 10.1134/S0006297911030047; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128; Williamson RE, 2001, PROTOPLASMA, V215, P116, DOI 10.1007/BF01280308; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Zadnikova P, 2010, DEVELOPMENT, V137, P607, DOI 10.1242/dev.041277; ZANDOMENI K, 1993, PROTOPLASMA, V173, P103, DOI 10.1007/BF01378999	66	27	30	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90587	10.1371/journal.pone.0090587	http://dx.doi.org/10.1371/journal.pone.0090587			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594664	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500071
J	Tu, QC; He, ZL; Li, Y; Chen, YF; Deng, Y; Lin, L; Hemme, CL; Yuan, T; Van Nostrand, JD; Wu, LY; Zhou, XD; Shi, WY; Li, LJ; Xu, J; Zhou, JZ				Tu, Qichao; He, Zhili; Li, Yan; Chen, Yanfei; Deng, Ye; Lin, Lu; Hemme, Christopher L.; Yuan, Tong; Van Nostrand, Joy D.; Wu, Liyou; Zhou, Xuedong; Shi, Wenyuan; Li, Lanjuan; Xu, Jian; Zhou, Jizhong			Development of HuMiChip for Functional Profiling of Human Microbiomes	PLOS ONE			English	Article							CORE GUT MICROBIOME; PROBE DESIGN; COMMUNITY COMPOSITION; GENE MICROARRAYS; AMINO-ACIDS; PERIODONTITIS; METABOLISM; APOPTOSIS; HEALTH; METAGENOME	Understanding the diversity, composition, structure, function, and dynamics of human microbiomes in individual human hosts is crucial to reveal human-microbial interactions, especially for patients with microbially mediated disorders, but challenging due to the high diversity of the human microbiome. Here we have developed a functional gene-based microarray for profiling human microbiomes (HuMiChip) with 36,802 probes targeting 50,007 protein coding sequences for 139 key functional gene families. Computational evaluation suggested all probes included are highly specific to their target sequences. HuMiChip was used to analyze human oral and gut microbiomes, showing significantly different functional gene profiles between oral and gut microbiome. Obvious shifts of microbial functional structure and composition were observed for both patients with dental caries and periodontitis from moderate to advanced stages, suggesting a progressive change of microbial communities in response to the diseases. Consistent gene family profiles were observed by both HuMiChip and next generation sequencing technologies. Additionally, HuMiChip was able to detect gene families at as low as 0.001% relative abundance. The results indicate that the developed HuMiChip is a useful and effective tool for functional profiling of human microbiomes.	[Tu, Qichao; He, Zhili; Deng, Ye; Hemme, Christopher L.; Yuan, Tong; Van Nostrand, Joy D.; Wu, Liyou; Zhou, Jizhong] Univ Oklahoma, Dept Microbiol & Plant Biol, Inst Environm Genom, Norman, OK 73019 USA; [Li, Yan; Zhou, Xuedong] Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Peoples R China; [Chen, Yanfei; Li, Lanjuan] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Lu; Xu, Jian] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Shandong, Peoples R China; [Shi, Wenyuan] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Zhou, Jizhong] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Zhou, Jizhong] Tsinghua Univ, State Key Joint Lab Environm Simulat & Pollut Con, Sch Environm, Beijing 100084, Peoples R China	University of Oklahoma System; University of Oklahoma - Norman; Sichuan University; Zhejiang University; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; University of California System; University of California Los Angeles; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Tsinghua University	He, ZL (corresponding author), Univ Oklahoma, Dept Microbiol & Plant Biol, Inst Environm Genom, Norman, OK 73019 USA.	zhili.he@ou.edu; jzhou@ou.edu	吴, 昊/AAB-1620-2020; ZHOU, XUE/F-6129-2013; He, Zhili/C-2879-2012; SHI, wen/GPW-9531-2022; Van Nostrand, Joy D/F-1740-2016; Deng, Ye/X-4358-2019; Xu, Jian/G-8430-2012	He, Zhili/0000-0001-8225-7333; Van Nostrand, Joy D/0000-0001-9548-6450; Deng, Ye/0000-0002-7584-0632; Xu, Jian/0000-0002-0548-8477; Tu, Qichao/0000-0002-3245-7545; Zhou, Xuedong/0000-0002-9319-7302	Oklahoma Center for the Advancement of Science and Technology (OCAST) through the Oklahoma Applied Research Support (OARS) [AR11-035]; ENIGMA-Ecosystems and Networks Integrated with Genes and Molecular Assemblies [DE-AC02-05CH11231]; International Science and Technology Cooperation Program of China [2011DFA30940]; National Basic Research Program of China "973 Pilot Research Program" [2011CB512108]; National Key Technologies R&D Program of the Twelfth Five-Year Plan, the Ministry of Science and Technology of China [2012BAI07B03]; National Natural Science Foundation of China [81170959, 30901689, 81172579]; Sichuan Provincial Department of science and technology project [2013SZ0039]	Oklahoma Center for the Advancement of Science and Technology (OCAST) through the Oklahoma Applied Research Support (OARS); ENIGMA-Ecosystems and Networks Integrated with Genes and Molecular Assemblies; International Science and Technology Cooperation Program of China; National Basic Research Program of China "973 Pilot Research Program"(National Basic Research Program of China); National Key Technologies R&D Program of the Twelfth Five-Year Plan, the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Provincial Department of science and technology project	This work was supported by the Oklahoma Center for the Advancement of Science and Technology (OCAST) through the Oklahoma Applied Research Support (OARS) Project AR11-035, ENIGMA-Ecosystems and Networks Integrated with Genes and Molecular Assemblies under Contract No. DE-AC02-05CH11231, the International Science and Technology Cooperation Program of China (grant number: 2011DFA30940), the National Basic Research Program of China ("973 Pilot Research Program", Grant Number: 2011CB512108), National Key Technologies R&D Program of the Twelfth Five-Year Plan, the Ministry of Science and Technology of China (grand 2012BAI07B03), the National Natural Science Foundation of China (81170959, 30901689 and 81172579), and the Sichuan Provincial Department of science and technology project(2013SZ0039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2012, J ORAL SCI, V54, P7, DOI 10.2334/josnusd.54.7; Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Cantarel BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028742; Comstock LE, 2006, CELL, V126, P847, DOI 10.1016/j.cell.2006.08.021; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Delzenne NM, 2011, ANNU REV NUTR, V31, P15, DOI 10.1146/annurev-nutr-072610-145146; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Hardie J M, 1982, Dent Update, V9, P199; He Z, 2012, CURRENT OPINION BIOT; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; He ZL, 2012, CURR OPIN BIOTECH, V23, P49, DOI 10.1016/j.copbio.2011.11.001; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; He ZL, 2005, APPL ENVIRON MICROB, V71, P3753, DOI 10.1128/AEM.71.7.3753-3760.2005; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Klaenhammer TR, 2008, J CLIN GASTROENTEROL, V42, pS160, DOI 10.1097/MCG.0b013e31817da140; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Lee Y-J, 2013, ISME J; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Li XY, 2005, NUCLEIC ACIDS RES, V33, P6114, DOI 10.1093/nar/gki914; Liang YT, 2010, APPL ENVIRON MICROB, V76, P1088, DOI 10.1128/AEM.02749-09; Liebich J, 2006, APPL ENVIRON MICROB, V72, P1688, DOI 10.1128/AEM.72.2.1688-1691.2006; Loscalzo J, 2011, CIRC RES, V109, P127, DOI 10.1161/RES.0b013e3182290620; Lu Rui-fang, 2008, Zhonghua Kou Qiang Yi Xue Za Zhi, V43, P664; Meng H, 2008, PERIODONTOLOGY, P156; Metges CC, 2000, J NUTR, V130, p1857S, DOI 10.1093/jn/130.7.1857S; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Ochiai K, 2011, J ORAL BIOSCI, V53, P213, DOI 10.2330/joralbiosci.53.213; Otte S, 1999, APPL ENVIRON MICROB, V65, P3148; Paliy O, 2009, APPL ENVIRON MICROB, V75, P3572, DOI 10.1128/AEM.02764-08; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Qiqiang L, 2012, J PERIODONTAL RES; Quirynen M, 2001, J CLIN PERIODONTOL, V28, P499, DOI 10.1034/j.1600-051x.2001.028006499.x; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Reeds PJ, 2000, J NUTR, V130, p1835S; Rhee SK, 2004, APPL ENVIRON MICROB, V70, P4303, DOI 10.1128/AEM.70.7.4303-4317.2004; Roh SW, 2010, TRENDS BIOTECHNOL, V28, P291, DOI 10.1016/j.tibtech.2010.03.001; Salminen A, 2008, CELL MOL LIFE SCI, V65, P2979, DOI 10.1007/s00018-008-8103-5; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Sboner A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-125; Scholz MB, 2012, CURR OPIN BIOTECH, V23, P9, DOI 10.1016/j.copbio.2011.11.013; Siqueira JF, 2009, ORAL SURG ORAL MED O, V107, P870, DOI 10.1016/j.tripleo.2009.01.044; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Stehle HW, 2001, J PERIODONTOL, V72, P1059, DOI 10.1902/jop.2001.72.8.1059; Stralis-Pavese N, 2011, NAT PROTOC, V6, P609, DOI 10.1038/nprot.2010.191; Tanner ACR, 2007, J CLIN PERIODONTOL, V34, P917, DOI 10.1111/j.1600-051X.2007.01126.x; Tatakis Dimitris N, 2005, Dent Clin North Am, V49, P491, DOI 10.1016/j.cden.2005.03.001; Tatakis DN, 2005, DENT CLIN N AM, V49, pv; Tiquia SM, 2004, BIOTECHNIQUES, V36, P664, DOI 10.2144/04364RR02; Tottey W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062544; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Tsuda H, 2010, J PERIODONTAL RES, V45, P626, DOI 10.1111/j.1600-0765.2010.01277.x; Tu Q, 2013, GEOCHIP 4 0 HIGH DEN; Tu QC, 2013, APPL ENVIRON MICROB, V79, P5085, DOI 10.1128/AEM.01124-13; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; VERMEER C, 1990, BIOCHEM J, V266, P625, DOI 10.1042/bj2660625; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wu LY, 2006, APPL ENVIRON MICROB, V72, P4931, DOI 10.1128/AEM.02738-05; Wu LY, 2001, APPL ENVIRON MICROB, V67, P5780, DOI 10.1128/AEM.67.12.5780-5790.2001; XIE G, 2011, ORALGEN COMPREHENSIV; Zhou A, 2013, ENVIRON SCI TECHNOL, V13, P13; Zhou JZ, 2012, NAT CLIM CHANGE, V2, P106, DOI 10.1038/NCLIMATE1331	79	11	11	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90546	10.1371/journal.pone.0090546	http://dx.doi.org/10.1371/journal.pone.0090546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595026	gold, Green Submitted, Green Published			2022-12-27	WOS:000332475500065
J	Westermann, FL; Suckling, DM; Lester, PJ				Westermann, Fabian Ludwig; Suckling, David Maxwell; Lester, Philip John			Disruption of Foraging by a Dominant Invasive Species to Decrease Its Competitive Ability	PLOS ONE			English	Article							TRAIL PHEROMONE DISRUPTION; LINEPITHEMA-HUMILE MAYR; ARGENTINE ANT; NATIVE ANTS; NICHE DIFFERENTIATION; ECONOMIC COSTS; INTERFERENCE; CONSEQUENCES; EXPLOITATION; COMMUNITIES	Invasive species are a major threat to biodiversity when dominant within their newly established habitat. The globally distributed Argentine ant Linepithema humile has been reported to break the trade-off between interference and exploitative competition, achieve high population densities, and overpower nests of many endemic ant species. We have used the sensitivity of the Argentine ant to the synthetic trail pheromone (Z)-9-hexadecanal to investigate species interactions for the first time. We predicted that disrupting Argentine ant trail following behaviour would reduce their competitive ability and create an opportunity for three other resident species to increase their foraging success. Argentine ant success in the control was reduced with increasing pheromone concentration, as predicted, but interactions varied among competing resident species. These behavioural variations provide an explanation for observed differences in foraging success of the competing resident species and how much each of these individual competitors can increase their foraging if the competitive ability of the dominant invader is decreased. The mechanism for the observed increase in resource acquisition of resident species appears to be a decrease in aggressive behaviour displayed by the Argentine ant, which may create an opportunity for other resident species to forage more successfully. Our demonstration of species interactions with trail pheromone disruption is the first known case of reduced dominance under a pheromone treatment in ants.	[Westermann, Fabian Ludwig; Lester, Philip John] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Suckling, David Maxwell] New Zealand Inst Plant & Food Res, Christchurch, New Zealand	Victoria University Wellington; New Zealand Institute for Plant & Food Research Ltd	Westermann, FL (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	fabian.westermann@vuw.ac.nz	Suckling, David M/F-7005-2010; Suckling, David Maxwell/M-7730-2019; Lester, Phil/A-1296-2008; Westermann, Fabian Ludwig/N-2848-2013	Suckling, David M/0000-0001-7216-9348; Suckling, David Maxwell/0000-0001-7216-9348; Lester, Phil/0000-0002-1801-5687; Westermann, Fabian Ludwig/0000-0002-4709-6973	Victoria University of Wellington doctoral scholarship	Victoria University of Wellington doctoral scholarship	This research was funded by a Victoria University of Wellington doctoral scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI MF, 1990, BIOL REV, V65, P227, DOI 10.1111/j.1469-185X.1990.tb01425.x; Alowe S, 2000, ALIENS, V12, P2; ANDERSEN AN, 1994, OECOLOGIA, V98, P15, DOI 10.1007/BF00326085; ANDERSEN AN, 1992, AM NAT, V140, P401, DOI 10.1086/285419; Barbieri RF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2157; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Blancafort X, 2005, ACTA OECOL, V28, P49, DOI 10.1016/j.actao.2005.02.004; Buczkowski G, 2008, BIOL INVASIONS, V10, P1001, DOI 10.1007/s10530-007-9179-9; Cerda X, 1998, OIKOS, V82, P99, DOI 10.2307/3546920; DENEUBOURG JL, 1990, J INSECT BEHAV, V3, P159, DOI 10.1007/BF01417909; FELLERS JH, 1987, ECOLOGY, V68, P1466, DOI 10.2307/1939230; Gibb H, 2005, AUSTRAL ECOL, V30, P856, DOI 10.1111/j.1442-9993.2005.01528.x; Gomez C, 2003, ACTA OECOL, V24, P47, DOI 10.1016/S1146-609X(03)00042-0; Harris RJ, 2002, SURVEY CURRENT DISTR; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; HOLLDOBLER B, 1983, BIOTROPICA, V15, P241, DOI 10.2307/2387648; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; Human KG, 1996, OECOLOGIA, V105, P405, DOI 10.1007/BF00328744; KENWARD RE, 1993, P ROY SOC B-BIOL SCI, V251, P187; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McGrannachan CM, 2013, J APPL ENTOMOL, V137, P550, DOI 10.1111/jen.12032; McNatty A, 2009, OECOLOGIA, V160, P187, DOI 10.1007/s00442-009-1279-z; Morrison LW, 1996, OECOLOGIA, V107, P243, DOI 10.1007/BF00327909; Nishisue K, 2010, J ECON ENTOMOL, V103, P1784, DOI 10.1603/EC10008; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Pintor LM, 2009, ECOLOGY, V90, P581, DOI 10.1890/08-0552.1; RACE MS, 1982, OECOLOGIA, V54, P337, DOI 10.1007/BF00380002; Roura-Pascual N, 2006, ECOL APPL, V16, P1832, DOI 10.1890/1051-0761(2006)016[1832:NDAFPF]2.0.CO;2; Rowles AD, 2007, BIOL INVASIONS, V9, P73, DOI 10.1007/s10530-006-9009-5; Rowles AD, 2009, AUSTRAL ECOL, V34, P239, DOI 10.1111/j.1442-9993.2008.01922.x; Ruther J, 2002, NATURWISSENSCHAFTEN, V89, P111, DOI 10.1007/s00114-001-0292-9; Sagata K, 2009, J APPL ECOL, V46, P19, DOI 10.1111/j.1365-2664.2008.01523.x; Sanders NJ, 2003, P NATL ACAD SCI USA, V100, P2474, DOI 10.1073/pnas.0437913100; Sanders NJ, 2001, OECOLOGIA, V127, P123, DOI 10.1007/s004420000572; SAVOLAINEN R, 1991, BEHAV ECOL SOCIOBIOL, V28, P1, DOI 10.1007/BF00172132; SAVOLAINEN R, 1989, OIKOS, V56, P3, DOI 10.2307/3566082; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih A, 2012, ECOL LETT, V15, P278, DOI 10.1111/j.1461-0248.2011.01731.x; Smith AA, 2009, CURR BIOL, V19, P78, DOI 10.1016/j.cub.2008.11.059; Sorrells TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018717; Stringer LD, 2007, ECOL ENTOMOL, V32, P732, DOI 10.1111/j.1365-2311.2007.00924.x; Suarez AV, 2001, P NATL ACAD SCI USA, V98, P1095, DOI 10.1073/pnas.98.3.1095; Suckling DM, 2008, J CHEM ECOL, V34, P1602, DOI 10.1007/s10886-008-9566-4; Suckling DM, 2011, J CHEM ECOL, V37, P1143, DOI 10.1007/s10886-011-0019-0; Suckling DM, 2010, J CHEM ECOL, V36, P122, DOI 10.1007/s10886-009-9734-1; Tsutsui ND, 2003, CONSERV BIOL, V17, P48, DOI 10.1046/j.1523-1739.2003.02018.x; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Vander Meer RK, 2002, BEHAV ECOL SOCIOBIOL, V51, P122, DOI 10.1007/s002650100417; VEPSALAINEN K, 1982, ANN ZOOL FENN, V19, P327; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Wild AL, 2004, ANN ENTOMOL SOC AM, V97, P1204, DOI 10.1603/0013-8746(2004)097[1204:TADOTA]2.0.CO;2; Wilson E, 2013, P I CIVIL ENG-CIV EN, V166, P2, DOI 10.1680/cien.2013.166.6.2; Zavaleta ES, 2001, TRENDS ECOL EVOL, V16, P454, DOI 10.1016/S0169-5347(01)02194-2	57	13	13	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90173	10.1371/journal.pone.0090173	http://dx.doi.org/10.1371/journal.pone.0090173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594633	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500035
J	Banerjee, J; Das Ghatak, P; Roy, S; Khanna, S; Sequin, EK; Bellman, K; Dickinson, BC; Suri, P; Subramaniam, VV; Chang, CJ; Sen, CK				Banerjee, Jaideep; Das Ghatak, Piya; Roy, Sashwati; Khanna, Savita; Sequin, Emily K.; Bellman, Karen; Dickinson, Bryan C.; Suri, Prerna; Subramaniam, Vish V.; Chang, Christopher J.; Sen, Chandan K.			Improvement of Human Keratinocyte Migration by a Redox Active Bioelectric Dressing	PLOS ONE			English	Article							EXTERNAL ELECTRIC-FIELD; HYDROGEN-PEROXIDE; OXIDATIVE-PHOSPHORYLATION; DIRECTIONAL MIGRATION; HUMAN-FIBROBLASTS; LIVING SYSTEMS; CELL-MIGRATION; IN-VIVO; STIMULATION; INTEGRIN	Exogenous application of an electric field can direct cell migration and improve wound healing; however clinical application of the therapy remains elusive due to lack of a suitable device and hence, limitations in understanding the molecular mechanisms. Here we report on a novel FDA approved redox-active Ag/Zn bioelectric dressing (BED) which generates electric fields. To develop a mechanistic understanding of how the BED may potentially influence wound reepithelialization, we direct emphasis on understanding the influence of BED on human keratinocyte cell migration. Mapping of the electrical field generated by BED led to the observation that BED increases keratinocyte migration by three mechanisms: (i) generating hydrogen peroxide, known to be a potent driver of redox signaling, (ii) phosphorylation of redox-sensitive IGF1R directly implicated in cell migration, and (iii) reduction of protein thiols and increase in integrin(alpha v) expression, both of which are known to be drivers of cell migration. BED also increased keratinocyte mitochondrial membrane potential consistent with its ability to fuel an energy demanding migration process. Electric fields generated by a Ag/Zn BED can cross-talk with keratinocytes via redox-dependent processes improving keratinocyte migration, a critical event in wound re-epithelialization.	[Banerjee, Jaideep; Das Ghatak, Piya; Roy, Sashwati; Khanna, Savita; Suri, Prerna; Sen, Chandan K.] Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA; [Sequin, Emily K.; Bellman, Karen; Subramaniam, Vish V.] Ohio State Univ, Dept Mech & Aerosp Engn, Columbus, OH 43210 USA; [Dickinson, Bryan C.; Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem & Mol & Cell Biol, Berkeley, CA 94720 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Sen, CK (corresponding author), Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA.	Chandan.sen@osumc.edu	Subramaniam, Vish/D-7013-2016; Roy, sashwati/E-3990-2011	Banerjee, Jaideep/0000-0002-8688-7137	Procellera(R), Vomaris Innovations; National Institutes of Health [GM077185, GM069589, DK076566, GM 79465]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069589, T32GM066698, R01GM079465, R01GM077185] Funding Source: NIH RePORTER	Procellera(R), Vomaris Innovations; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partly supported by the manufacturer of Procellera (R), Vomaris Innovations, by means of an unrestricted gift to The Ohio State University. The work was also supported by National Institutes of Health awards GM077185, GM069589 to CKS, DK076566 to SR and GM 79465 to CJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO Y, 1993, J CELL PHYSIOL, V156, P487, DOI 10.1002/jcp.1041560308; Borba GC, 2011, J SURG RES, V166, P324, DOI 10.1016/j.jss.2009.08.018; BORGENS RB, 1977, J EXP ZOOL, V200, P403, DOI 10.1002/jez.1402000310; BORGENS RB, 1977, P NATL ACAD SCI USA, V74, P4528, DOI 10.1073/pnas.74.10.4528; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BOURGUIGNON GJ, 1989, J CELL PHYSIOL, V140, P379, DOI 10.1002/jcp.1041400224; BOURGUIGNON GJ, 1987, FASEB J, V1, P398, DOI 10.1096/fasebj.1.5.3678699; Brooks PC, 1997, J CLIN INVEST, V99, P1390, DOI 10.1172/JCI119298; David E, 1983, Indian J Physiol Pharmacol, V27, P289; Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; EBERHARDT A, 1986, Acta Physiologica Polonica, V37, P41; ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296; Fang KS, 1999, J CELL SCI, V112, P1967; Fang KS, 1998, J INVEST DERMATOL, V111, P751, DOI 10.1046/j.1523-1747.1998.00366.x; FOULDS IS, 1983, BRIT J DERMATOL, V109, P515, DOI 10.1111/j.1365-2133.1983.tb07673.x; Fu D, 2013, P NATL ACAD SCI USA, V110, P7288, DOI 10.1073/pnas.1304285110; Gest C, 2012, CANCER LETT, V317, P207, DOI 10.1016/j.canlet.2011.11.026; Haase I, 2003, J CELL SCI, V116, P3227, DOI 10.1242/jcs.00610; HAMAMOTO T, 1982, J BIOCHEM-TOKYO, V91, P1759, DOI 10.1093/oxfordjournals.jbchem.a133868; Hussain SRA, 2008, BLOOD, V111, P3190, DOI 10.1182/blood-2007-10-115733; JAFFE LF, 1977, ANNU REV BIOPHYS BIO, V6, P445, DOI 10.1146/annurev.bb.06.060177.002305; Junger M, 2008, WOUND REPAIR REGEN, V16, P480, DOI 10.1111/j.1524-475X.2008.00393.x; Khanna S, 2006, J NEUROCHEM, V98, P1474, DOI 10.1111/j.1471-4159.2006.04000.x; KIM JP, 1994, J BIOL CHEM, V269, P26926; Kim LT, 1998, J SURG RES, V76, P185, DOI 10.1006/jsre.1998.5331; Kloth Luther C, 2005, Int J Low Extrem Wounds, V4, P23; Kopidakis N, 2000, J PHYS CHEM B, V104, P3930, DOI 10.1021/jp9936603; Lampe K E, 1998, J Hand Ther, V11, P131; Lin VS, 2013, METHOD ENZYMOL, V526, P19, DOI 10.1016/B978-0-12-405883-5.00002-8; Lippert AR, 2011, ACCOUNTS CHEM RES, V44, P793, DOI 10.1021/ar200126t; Liu WK, 1997, J ANTIMICROB CHEMOTH, V39, P687, DOI 10.1093/jac/39.6.687; Liu XP, 2001, FREE RADICAL BIO MED, V31, P894, DOI 10.1016/S0891-5849(01)00665-7; MAILER K, 1990, BIOCHEM BIOPH RES CO, V170, P59, DOI 10.1016/0006-291X(90)91240-S; Manickam N, 2011, J THROMB HAEMOST, V9, P1207, DOI 10.1111/j.1538-7836.2011.04266.x; McCaig CD, 1997, BIOESSAYS, V19, P819, DOI 10.1002/bies.950190912; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Miller EW, 2010, J AM CHEM SOC, V132, P17071, DOI 10.1021/ja107783j; MOHR T, 1987, PHYS THER, V67, P526, DOI 10.1093/ptj/67.4.526; National Pressure Ulcer Advisory Panel European Pressure Ulcer Advisory Panel, 2009, PREV TREATM PRESS UL, P51; Nie YH, 2009, J CELL MOL MED, V13, P3051, DOI 10.1111/j.1582-4934.2008.00382.x; Nishimura KY, 1996, J CELL SCI, V109, P199; Nuccitelli R, 2003, CURR TOP DEV BIOL, V58, P1, DOI 10.1016/S0070-2153(03)58001-2; O'Toole EA, 2001, CLIN EXP DERMATOL, V26, P525, DOI 10.1046/j.1365-2230.2001.00891.x; Ohsaki Y, 2012, AM J PHYSIOL-RENAL, V302, pF95, DOI 10.1152/ajprenal.00469.2011; ORIDA N, 1982, CELL MOTIL CYTOSKEL, V2, P243, DOI 10.1002/cm.970020305; Pullar CE, 2006, MOL BIOL CELL, V17, P4925, DOI 10.1091/mbc.E06-05-0433; Rajnicek AM, 2006, J CELL SCI, V119, P1723, DOI 10.1242/jcs.02896; Reger SI, 1999, ARTIF ORGANS, V23, P460, DOI 10.1046/j.1525-1594.1999.06365.x; Reid AB, 2005, J PHARMACOL EXP THER, V312, P509, DOI 10.1124/jpet.104.075945; Reid B, 2005, FASEB J, V19, P379, DOI 10.1096/fj.04-2325com; RICE GC, 1986, CANCER RES, V46, P6105; Robinson KR, 2003, BIOESSAYS, V25, P759, DOI 10.1002/bies.10307; ROBINSON KR, 1985, J CELL BIOL, V101, P2023, DOI 10.1083/jcb.101.6.2023; Roy S, 2006, MOL THER, V13, P211, DOI 10.1016/j.ymthe.2005.07.684; Sato MJ, 2009, P NATL ACAD SCI USA, V106, P6667, DOI 10.1073/pnas.0809974106; Sen CK, 2002, J BIOL CHEM, V277, P33284, DOI 10.1074/jbc.M203391200; Sen CK, 1997, FREE RADICAL BIO MED, V22, P1241, DOI 10.1016/S0891-5849(96)00552-7; Shen MR, 2006, CARCINOGENESIS, V27, P962, DOI 10.1093/carcin/bgi336; Song B, 2002, P NATL ACAD SCI USA, V99, P13577, DOI 10.1073/pnas.202235299; Sta Iglesia Drina D., 1998, Wound Repair and Regeneration, V6, P531; Sutton G.W., 1965, ENG MAGNETOHYDRODYNA; Tirosh O, 2001, ANTIOXID REDOX SIGN, V3, P711, DOI 10.1089/15230860152543041; Torabi F, 2012, J ELECTROCHEM SOC, V159, pA1986, DOI 10.1149/2.038212jes; VINKLER C, 1982, P NATL ACAD SCI-BIOL, V79, P3183, DOI 10.1073/pnas.79.10.3183; WEISS DS, 1990, ARCH DERMATOL, V126, P222, DOI 10.1001/archderm.126.2.222; Yang HY, 2013, J CELL SCI, V126, P1942, DOI 10.1242/jcs.113225; YANG WP, 1984, EXP CELL RES, V155, P92, DOI 10.1016/0014-4827(84)90770-5; Yurko MA, 2001, J CELL PHYSIOL, V188, P24, DOI 10.1002/jcp.1093; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009	71	58	59	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89239	10.1371/journal.pone.0089239	http://dx.doi.org/10.1371/journal.pone.0089239			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595050	Green Published, gold			2022-12-27	WOS:000332468900012
J	Liu, XX; Chen, M; Collins, HL; Onstad, DW; Roush, RT; Zhang, QW; Earle, ED; Shelton, AM				Liu, Xiaoxia; Chen, Mao; Collins, Hilda L.; Onstad, David W.; Roush, Richard T.; Zhang, Qingwen; Earle, Elizabeth D.; Shelton, Anthony M.			Natural Enemies Delay Insect Resistance to Bt Crops	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; TRANSGENIC PLANTS; PINK-BOLLWORM; FIELD-RESISTANCE; POTENTIAL IMPACT; TOXIN CRY1AC; MANAGEMENT; LEPIDOPTERA; ADAPTATION; SUPPRESSION	We investigated whether development of resistance to a Bt crop in the presence of a natural enemy would be slower than without the natural enemy and whether biological control, in conjunction with a Bt crop, could effectively suppress the pest population. Additionally, we investigated whether insecticide-sprayed refuges of non-Bt crops would delay or accelerate resistance to the Bt crop. We used a system of Bt broccoli expressing Cry1Ac, a population of the pest Plutella xylostella with a low frequency of individuals resistant to Cry1Ac and the insecticide spinosad, and a natural enemy, Coleomegilla maculata, to conduct experiments over multiple generations. The results demonstrated that after 6 generations P. xylostella populations were very low in the treatment containing C. maculata and unsprayed non-Bt refuge plants. Furthermore, resistance to Bt plants evolved significantly slower in this treatment. In contrast, Bt plants with no refuge were completely defoliated in treatments without C. maculata after 4-5 generations. In the treatment containing sprayed non-Bt refuge plants and C. maculata, the P. xylostella population was low, although the speed of resistance selection to Cry1Ac was significantly increased. These data demonstrate that natural enemies can delay resistance to Bt plants and have significant implications for integrated pest management (IPM) with Bt crops.	[Liu, Xiaoxia; Zhang, Qingwen] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Liu, Xiaoxia; Chen, Mao; Collins, Hilda L.; Shelton, Anthony M.] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Onstad, David W.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Roush, Richard T.] Univ Melbourne, Melbourne Sch Land & Environm, Melbourne, Vic 3010, Australia; [Earle, Elizabeth D.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA	China Agricultural University; Cornell University; University of Illinois System; University of Illinois Urbana-Champaign; University of Melbourne; Cornell University	Shelton, AM (corresponding author), Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA.	ams5@cornell.edu			USDA National Institute of Food and Agriculture [2008-33120-19536]; Special Research Projects for Developing Transgenic Plants in China [2011zx08011-002]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Special Research Projects for Developing Transgenic Plants in China	This project was supported by the Biotechnology Risk Assessment Program Competitive Grant no. 2008-33120-19536 from the USDA National Institute of Food and Agriculture and the Special Research Projects for Developing Transgenic Plants (2011zx08011-002) in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia S, 1997, ENTOMOL EXP APPL, V82, P91, DOI 10.1023/A:1002935706990; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Chen M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002284; Chilcutt CF, 1999, ENVIRON ENTOMOL, V28, P505, DOI 10.1093/ee/28.3.505; Desneux N, 2010, ECOTOXICOLOGY, V19, P1642, DOI 10.1007/s10646-010-0550-8; Desneux N, 2010, ECOTOXICOLOGY, V19, P1183, DOI 10.1007/s10646-010-0502-3; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Gassmann AJ, 2006, J ECON ENTOMOL, V99, P920, DOI 10.1603/0022-0493-99.3.920; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; GOULD F, 1991, ENTOMOL EXP APPL, V58, P1, DOI 10.1007/BF00163307; Heimpel GE, 2005, ENVIRON ENTOMOL, V34, P512, DOI 10.1603/0046-225X-34.3.512; Huang F, 2012, ENTOMOL EXP APPL, V140, P1; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Johnson MT, 1997, ENTOMOL EXP APPL, V83, P121, DOI 10.1023/A:1002961813014; Johnson MT, 1997, ENTOMOL EXP APPL, V82, P219, DOI 10.1023/A:1002900803649; Kathage J, 2012, P NATL ACAD SCI USA, V109, P11652, DOI 10.1073/pnas.1203647109; Liu XX, 2012, J ECON ENTOMOL, V105, P354, DOI 10.1603/EC11299; Liu XX, 2011, TRANSGENIC RES, V20, P887, DOI 10.1007/s11248-010-9471-9; Lovei GL, 2009, ENVIRON ENTOMOL, V38, P293, DOI 10.1603/022.038.0201; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Lundgren JG, 2009, CROP PROT, V28, P1017, DOI 10.1016/j.cropro.2009.06.001; Mallampalli N, 2005, ENTOMOL EXP APPL, V114, P47, DOI 10.1111/j.0013-8703.2005.00232.x; METZ TD, 1995, MOL BREEDING, V1, P309, DOI 10.1007/BF01248408; Naranjo S. E., 2009, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V4, P1, DOI 10.1079/PAVSNNR20094011; Onstad DW, 2008, INSECT RESISTANCE MA, P289; Qaim Matin, 2008, V5, P329, DOI 10.1007/978-1-4020-8373-0_12; Romeis J., 2008, INTEGRATION INSECT R; Romeis J, 2013, NAT BIOTECHNOL, V31, P386, DOI 10.1038/nbt.2578; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Shelton AM, 2000, NAT BIOTECHNOL, V18, P339, DOI 10.1038/73804; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Shelton AM, 2009, TRANSGENIC RES, V18, P317, DOI 10.1007/s11248-009-9260-5; SPSS, 1998, SPSS US GUID; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Tang JD, 2001, J ECON ENTOMOL, V94, P240, DOI 10.1603/0022-0493-94.1.240; Tian JC, 2012, TRANSGENIC RES, V21, P1303, DOI 10.1007/s11248-012-9604-4; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Zhao JZ, 2010, PEST MANAG SCI, V66, P1101, DOI 10.1002/ps.1985; Zhao JZ, 2005, P NATL ACAD SCI USA, V102, P8426, DOI 10.1073/pnas.0409324102	45	45	48	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90366	10.1371/journal.pone.0090366	http://dx.doi.org/10.1371/journal.pone.0090366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595158	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900099
J	Stoeva, MK; Aris-Brosou, S; Chetelat, J; Hintelmann, H; Pelletier, P; Poulain, AJ				Stoeva, Magdalena K.; Aris-Brosou, Stephane; Chetelat, John; Hintelmann, Holger; Pelletier, Philip; Poulain, Alexandre J.			Microbial Community Structure in Lake and Wetland Sediments from a High Arctic Polar Desert Revealed by Targeted Transcriptomics	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; CORNWALLIS-ISLAND; CHAR LAKE; PHYLOGENETIC ANALYSIS; ORGANIC-CARBON; SWISS-MODEL; METHANE; DIVERSITY; BACTERIAL; MERCURY	While microbial communities play a key role in the geochemical cycling of nutrients and contaminants in anaerobic freshwater sediments, their structure and activity in polar desert ecosystems are still poorly understood, both across heterogeneous freshwater environments such as lakes and wetlands, and across sediment depths. To address this question, we performed targeted environmental transcriptomics analyses and characterized microbial diversity across three depths from sediment cores collected in a lake and a wetland, located on Cornwallis Island, NU, Canada. Microbial communities were characterized based on 16S rRNA and two functional gene transcripts: mcrA, involved in archaeal methane cycling and glnA, a bacterial housekeeping gene implicated in nitrogen metabolism. We show that methane cycling and overall bacterial metabolic activity are the highest at the surface of lake sediments but deeper within wetland sediments. Bacterial communities are highly diverse and structured as a function of both environment and depth, being more diverse in the wetland and near the surface. Archaea are mostly methanogens, structured by environment and more diverse in the wetland. McrA transcript analyses show that active methane cycling in the lake and wetland corresponds to distinct communities with a higher potential for methane cycling in the wetland. Methanosarcina spp., Methanosaeta spp. and a group of uncultured Archaea are the dominant methanogens in the wetland while Methanoregula spp. predominate in the lake.	[Stoeva, Magdalena K.; Aris-Brosou, Stephane; Pelletier, Philip; Poulain, Alexandre J.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Aris-Brosou, Stephane] Univ Ottawa, Dept Math & Stat, Ottawa, ON, Canada; [Chetelat, John] Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada; [Hintelmann, Holger] Trent Univ, Dept Chem, Peterborough, ON K9J 7B8, Canada	University of Ottawa; University of Ottawa; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; Trent University	Poulain, AJ (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	apoulain@uottawa.ca	Hintelmann, Holger/AEV-0466-2022; Chételat, John/AAE-4711-2020	Hintelmann, Holger/0000-0002-5287-483X; Chételat, John/0000-0002-9380-7203; Stoeva, Magdalena/0000-0002-6974-6009; Aris-Brosou, Stephane/0000-0003-4987-0296; Poulain, Alexandre/0000-0002-0488-3993	NSERC; Northern Contaminants Program (Aboriginal Affairs and Northern Development Canada)	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Northern Contaminants Program (Aboriginal Affairs and Northern Development Canada)	This project was supported by Discovery Grants from NSERC and infrastructure support from CFI to AJP and SAB, as well as funding from the Northern Contaminants Program (Aboriginal Affairs and Northern Development Canada) awarded to JC and AJP. The Polar Shelf Continental Project provided logistical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Biddle JF, 2012, ISME J, V6, P1018, DOI 10.1038/ismej.2011.164; Borrel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043346; Castro H, 2004, APPL ENVIRON MICROB, V70, P6559, DOI 10.1128/AEM.70.11.6559-6568.2004; Cavicchioli R, 2006, NAT REV MICROBIOL, V4, P331, DOI 10.1038/nrmicro1390; Deison R, 2012, ENVIRON SCI TECHNOL, V46, P8748, DOI 10.1021/es300798w; DEMARCH L, 1978, J FISH RES BOARD CAN, V35, P1089, DOI 10.1139/f78-172; Drevnick PE, 2010, ENVIRON SCI TECHNOL, V44, P8415, DOI 10.1021/es101991p; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Freitag TE, 2010, FEMS MICROBIOL ECOL, V73, P157, DOI 10.1111/j.1574-6941.2010.00871.x; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gallon C, 2008, J N AM BENTHOL SOC, V27, P570, DOI 10.1899/07-132.1; Gentzel T, 2012, INLAND WATERS, V2, P77, DOI 10.5268/IW-2.2.416; Gilmour CC, 2013, ENVIRON SCI TECHNOL, V47, P11810, DOI 10.1021/es403075t; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Hales BA, 1996, APPL ENVIRON MICROB, V62, P668, DOI 10.1128/AEM.62.2.668-675.1996; Hallam SJ, 2003, APPL ENVIRON MICROB, V69, P5483, DOI 10.1128/AEM.69.9.5483-5491.2003; Hamelin S, 2011, ENVIRON SCI TECHNOL, V45, P7693, DOI 10.1021/es2010072; Hansen AA, 2007, ENVIRON MICROBIOL, V9, P2870, DOI 10.1111/j.1462-2920.2007.01403.x; Hirsch PR, 2010, SOIL BIOL BIOCHEM, V42, P878, DOI 10.1016/j.soilbio.2010.02.019; Hoj L, 2005, FEMS MICROBIOL ECOL, V53, P89, DOI 10.1016/j.femsec.2005.01.004; Hsu-Kim H, 2013, ENVIRON SCI TECHNOL, V47, P2441, DOI 10.1021/es304370g; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hurt RA, 2001, APPL ENVIRON MICROB, V67, P4495, DOI 10.1128/AEM.67.10.4495-4503.2001; Jorgenson MT, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024960; KALFF J, 1974, J FISH RES BOARD CAN, V31, P621, DOI 10.1139/f74-094; Kirk JL, 2011, ENVIRON SCI TECHNOL, V45, P964, DOI 10.1021/es102840u; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Kotsyurbenko OR, 2004, ENVIRON MICROBIOL, V6, P1159, DOI 10.1111/j.1462-2920.2004.00634.x; Labrenz M, 2004, APPL ENVIRON MICROB, V70, P4971, DOI 10.1128/AEM.70.8.4971-4979.2004; Lauro FM, 2011, ISME J, V5, P879, DOI 10.1038/ismej.2010.185; Lehours AC, 2007, APPL ENVIRON MICROB, V73, P2016, DOI 10.1128/AEM.01490-06; Liebner S, 2008, INT MICROBIOL, V11, P195, DOI 10.2436/20.1501.01.60; Loseto LL, 2004, ENVIRON TOXICOL CHEM, V23, P17, DOI 10.1897/02-644; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Luton PE, 2002, MICROBIOL-SGM, V148, P3521, DOI 10.1099/00221287-148-11-3521; Macdonald RW, 2005, SCI TOTAL ENVIRON, V342, P5, DOI 10.1016/j.scitotenv.2004.12.059; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; Michelutti N, 2003, GLOBAL PLANET CHANGE, V38, P257, DOI 10.1016/S0921-8181(02)00260-6; Nakagawa F, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2000GB001384; OREMLAND RS, 1991, APPL ENVIRON MICROB, V57, P130, DOI 10.1128/AEM.57.1.130-137.1991; Parks JM, 2013, SCIENCE, V339, P1332, DOI 10.1126/science.1230667; Pfaffl MW, 2001, BIOTECHNOL LETT, V23, P275, DOI 10.1023/A:1005658330108; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Purdy KJ, 2003, APPL ENVIRON MICROB, V69, P3181, DOI 10.1128/AEM.69.6.3181-3191.2003; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; SCHINDLE.DW, 1974, J FISH RES BOARD CAN, V31, P585, DOI 10.1139/f74-092; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Smith SL, 2012, CAN J EARTH SCI, V49, P914, DOI 10.1139/E2012-019; Smol JP, 2005, P NATL ACAD SCI USA, V102, P4397, DOI 10.1073/pnas.0500245102; Stibal M, 2012, GLOBAL CHANGE BIOL, V18, P3332, DOI 10.1111/j.1365-2486.2012.02763.x; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Wilhelm RC, 2011, CAN J MICROBIOL, V57, P303, DOI [10.1139/w11-004, 10.1139/W11-004]; Woo MK, 2003, WETLANDS, V23, P291, DOI 10.1672/8-20; Yavitt JB, 2012, BIOGEOCHEMISTRY, V109, P117, DOI 10.1007/s10533-011-9644-5; Young KL, 2011, WETLANDS, V31, P535, DOI 10.1007/s13157-011-0172-9; Young KL, 2003, PERMAFROST, VOLS 1 AND 2, P1265; Zemanick ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015101; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	69	21	26	6	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89531	10.1371/journal.pone.0089531	http://dx.doi.org/10.1371/journal.pone.0089531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594936	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900022
J	Ulak, M; Chandyo, RK; Adhikari, RK; Sharma, PR; Sommerfelt, H; Refsum, H; Strand, TA				Ulak, Manjeswori; Chandyo, Ram K.; Adhikari, Ramesh K.; Sharma, Pushpa R.; Sommerfelt, Halvor; Refsum, Helga; Strand, Tor A.			Cobalamin and Folate Status in 6 to 35 Months Old Children Presenting with Acute Diarrhea in Bhaktapur, Nepal	PLOS ONE			English	Article							METHYLMALONIC ACID LEVELS; TOTAL HOMOCYSTEINE; MICROBIOLOGICAL ASSAY; FOLIC-ACID; YOUNG-CHILDREN; SERUM; VITAMIN-B-12; DEFICIENCY; INFANTS; PLASMA	Background: Cobalamin and folate are essential micronutrients and are important in DNA and RNA synthesis, cell proliferation, growth, hematopoiesis, and cognitive function. However, data on cobalamin and folate status are lacking particularly from young children residing in low and middle income countries. Objective: To measure cobalamin and folate status and identifies their predictors among 6 to 35 months old children presenting with acute diarrhea. Design: This was a cross-sectional study in 823 children presenting with acute diarrhea. We measured plasma cobalamin, folate, methylmalonic acid and total homocysteine who sought treatment for acute diarrhea between June 1998 and August 2000. Results: The mean (SD) plasma concentrations of cobalamin, folate, total homocysteine and methylmalonic acid were 206 (124) pmol/L, 55 (32) nmol/L, 11.4 (5.6) mu mol/L and 0.79 (1.2) mmol/L, respectively. The prevalence of low plasma cobalamin (<150 pmol/L) was 41% but less than 2% (15) children had low folate concentration (<10 mu mol/L). Plasma homocysteine and methylmalonic acid concentrations were negatively associated with cobalamin concentration but not associated with folate status. The prevalence of cobalamin deficiency was higher in breastfed than non-breastfed children (44% vs 24%; p =<0.001). The prevalence of hyperhomocysteinemia (> 10 mu mol/L) and elevated methylmalonic acid (>0.28 mu mol/L) were 73% and 52%, respectively. In the regression analyses, the plasma cobalamin concentration was positively associated with age, and introduction of animal or formula milk. Conclusions: Our study indicated that poor cobalamin status was common particularly among breastfed children. Folate deficiency was virtually none existent. Possible consequences of cobalamin deficiency in young children need to be explored.	[Ulak, Manjeswori; Chandyo, Ram K.; Sommerfelt, Halvor; Strand, Tor A.] Univ Bergen, Ctr Int Hlth, N-5020 Bergen, Norway; [Ulak, Manjeswori] Inst Med, Dept Child Hlth, Kathmandu, Nepal; [Adhikari, Ramesh K.; Sharma, Pushpa R.] Kathmandu Med Coll, Dept Pediat, Kathmandu, Nepal; [Chandyo, Ram K.] Kathmandu Med Coll, Community Med, Kathmandu, Nepal; [Refsum, Helga] Univ Oslo, Inst Basic Med Sci, Dept Nutr, N-0316 Oslo, Norway; [Strand, Tor A.] Innlandet Hosp Trust, Lillehammer, Norway	University of Bergen; University of Oslo; Innlandet Hospital Trust	Ulak, M (corresponding author), Univ Bergen, Ctr Int Hlth, N-5020 Bergen, Norway.	manjeswori@gmail.com	Refsum, Helga/A-4073-2010; Strand, Tor/D-9836-2016; Sommerfelt, Halvor/ABD-3552-2020	Strand, Tor/0000-0002-4038-151X; Sommerfelt, Halvor/0000-0002-5670-9786	EU-INCO-DC [IC18-CT96-0045]; NUFU [PRO 52-53/96]	EU-INCO-DC; NUFU	The study was funded by EU-INCO-DC (contract number IC18-CT96-0045: "Effect of zinc and vitamin A supplementation on diarrhoea and physical growth in children" and NUFU (project number PRO 52-53/96: "Institutional capacity and competence building in research and education for promotion of child health and nutrition in South Asia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LH, 2005, AM J CLIN NUTR, V81, p1206S; ALLEN LH, 1994, CLIN OBSTET GYNECOL, V37, P587, DOI 10.1097/00003081-199409000-00011; Allen LH, 2008, FOOD NUTR BULL, V29, pS20, DOI 10.1177/15648265080292S105; [Anonymous], 2012, SERUM RED BLOOD CELL; BAKER H, 1981, AM J OBSTET GYNECOL, V141, P792, DOI 10.1016/0002-9378(81)90706-7; Bjorke-Monsen AL, 2011, J INHERIT METAB DIS, V34, P111, DOI 10.1007/s10545-010-9119-1; Bondevik GT, 2001, EUR J CLIN NUTR, V55, P856, DOI 10.1038/sj.ejcn.1601236; Bostom AG, 1999, J AM SOC NEPHROL, V10, P164; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Chandra J, 2010, INDIAN J PEDIATR, V77, P795, DOI 10.1007/s12098-010-0121-2; Chandyo RK, 2002, COBALAMIN FOLATE STA; Clarke R, 2004, AGE AGEING, V33, P34, DOI 10.1093/ageing/afg109; dataset] National Institute of Statistics (NIS), 2011, POPULATION HOUSING C; DAVIS RE, 1986, ACTA PAEDIATR SCAND, V75, P402, DOI 10.1111/j.1651-2227.1986.tb10221.x; De Onis M, 2006, WHO CHILD GROWTH STA; Hannisdal R, 2010, J NUTR, V140, P522, DOI 10.3945/jn.109.116418; Hay G, 2008, AM J CLIN NUTR, V88, P105, DOI 10.1093/ajcn/88.1.105; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; HUSEK P, 1995, J CHROMATOGR B, V669, P352; IOM, 1998, DIET REF INT THIAM R; Jiang TN, 2005, J NUTR, V135, P1106, DOI 10.1093/jn/135.5.1106; Karademir F, 2007, J INT MED RES, V35, P384, DOI 10.1177/147323000703500313; KELLEHER BP, 1987, CLIN CHEM, V33, P52; Klee GG, 2000, CLIN CHEM, V46, P1277; LINDENBAUM J, 1990, AM J HEMATOL, V34, P99, DOI 10.1002/ajh.2830340205; Mackey AD, 1999, AM J CLIN NUTR, V69, P285; Ministry of Health and Population (MOHP) [Nepali] New ERA ICF International Inc., 2012, NEP DEM HLTH SURV 20; Molloy AM, 1997, METHOD ENZYMOL, V281, P43; Monsen ALB, 2003, AM J CLIN NUTR, V78, P7, DOI 10.1093/ajcn/78.1.7; Murphy SP, 2003, J NUTR, V133, p3932S, DOI 10.1093/jn/133.11.3932S; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Olivares JL, 2002, J AM COLL NUTR, V21, P109, DOI 10.1080/07315724.2002.10719202; Rimestad A. H., 2001, STORE MATVARETABELLE; SCOTT JM, 1981, LANCET, V2, P337; SHIPCHANDLER MT, 1995, CLIN CHEM, V41, P991; Snow CF, 1999, ARCH INTERN MED, V159, P1289, DOI 10.1001/archinte.159.12.1289; SPECKER BL, 1990, AM J CLIN NUTR, V52, P1073, DOI 10.1093/ajcn/52.6.1073; Strand TA, 2002, PEDIATRICS, V109, P898, DOI 10.1542/peds.109.5.898; TaneJa S, 2007, AM J CLIN NUTR, V86, P1302, DOI 10.1093/ajcn/86.5.1302; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; UELAND PM, 1993, CLIN CHEM, V39, P1764; Ulak M, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-1; USAID/INACG, 2002, ADJ HEM VAL PROGR SU; Vollset SE, 2000, AM J CLIN NUTR, V71, P962; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Yajnik CS, 2005, ASIA PAC J CLIN NUTR, V14, P179	46	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90079	10.1371/journal.pone.0090079	http://dx.doi.org/10.1371/journal.pone.0090079			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594935	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900066
J	Vendramin, E; Pea, G; Dondini, L; Pacheco, I; Dettori, MT; Gazza, L; Scalabrin, S; Strozzi, F; Tartarini, S; Bassi, D; Verde, I; Rossini, L				Vendramin, Elisa; Pea, Giorgio; Dondini, Luca; Pacheco, Igor; Dettori, Maria Teresa; Gazza, Laura; Scalabrin, Simone; Strozzi, Francesco; Tartarini, Stefano; Bassi, Daniele; Verde, Ignazio; Rossini, Laura			A Unique Mutation in a MYB Gene Cosegregates with the Nectarine Phenotype in Peach	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; MOLECULAR CHARACTERIZATION; TRANSPOSON INSERTION; TRICHOME DEVELOPMENT; IDENTIFIES GENES; READ ALIGNMENT; CANDIDATE GENE; CELL-TYPES; ARABIDOPSIS; EXPRESSION	Nectarines play a key role in peach industry; the fuzzless skin has implications for consumer acceptance. The peach/nectarine (G/g) trait was described as monogenic and previously mapped on chromosome 5. Here, the position of the G locus was delimited within a 1.1 cM interval (635 kb) based on linkage analysis of an F-2 progeny from the cross 'Contender' (C, peach) x 'Ambra' (A, nectarine). Careful inspection of the genes annotated in the corresponding genomic sequence (Peach v1.0), coupled with variant discovery, led to the identification of MYB gene PpeMYB25 as a candidate for trichome formation on fruit skin. Analysis of genomic re-sequencing data from five peach/nectarine accessions pointed to the insertion of a LTR retroelement in exon 3 of the PpeMYB25 gene as the cause of the recessive glabrous phenotype. A functional marker (indelG) developed on the LTR insertion cosegregated with the trait in the CxA F-2 progeny and was validated on a broad panel of genotypes, including all known putative donors of the nectarine trait. This marker was shown to efficiently discriminate between peach and nectarine plants, indicating that a unique mutational event gave rise to the nectarine trait and providing a useful diagnostic tool for early seedling selection in peach breeding programs.	[Vendramin, Elisa; Dettori, Maria Teresa; Gazza, Laura; Verde, Ignazio] Ctr Ric Frutticoltura CRA FRU, Consiglio Ric Sperimentaz Agr, Rome, Italy; [Pea, Giorgio; Strozzi, Francesco; Rossini, Laura] Parco Tecnol Padano, Lodi, Italy; [Dondini, Luca; Tartarini, Stefano] Univ Bologna, DipSA, Bologna, Italy; [Pacheco, Igor; Bassi, Daniele; Rossini, Laura] Univ Milan, DiSAA, Milan, Italy; [Scalabrin, Simone] IGA Technol Serv, Udine, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Bologna; University of Milan	Verde, I (corresponding author), Ctr Ric Frutticoltura CRA FRU, Consiglio Ric Sperimentaz Agr, Rome, Italy.	ignazio.verde@entecra.it; laura.rossini@unimi.it	gazza, laura/K-3927-2019; Rossini, Laura/J-7873-2012; Cruz, Igor Pacheco/J-1193-2019; Verde, Ignazio/K-6348-2019; Cruz, Igor Pacheco/A-8507-2015; Dondini, Luca/N-8797-2015; Bassi, Daniele/C-2952-2012; Vendramin, Elisa/AAI-8762-2020; Gazza, Laura/X-3266-2019	gazza, laura/0000-0003-2772-3199; Rossini, Laura/0000-0001-6509-9177; Cruz, Igor Pacheco/0000-0001-5057-0464; Cruz, Igor Pacheco/0000-0001-5057-0464; Dondini, Luca/0000-0002-3547-9731; Gazza, Laura/0000-0003-2772-3199; TARTARINI, STEFANO/0000-0002-3920-5658; Strozzi, Francesco/0000-0002-6845-6982; Vendramin, Elisa/0000-0002-7324-7237; Verde, Ignazio/0000-0002-9139-955X; Dettori, Maria Teresa/0000-0003-0528-2855; Bassi, Daniele/0000-0002-8966-3534	Ministero delle Politiche Agricole Alimentari e Forestali-Italy (MiPAAF) [DM14999/7303/08]; private and public agencies "MAS.PES: apricot and peach breeding by molecular-assisted selection"	Ministero delle Politiche Agricole Alimentari e Forestali-Italy (MiPAAF); private and public agencies "MAS.PES: apricot and peach breeding by molecular-assisted selection"	This work was supported by the Ministero delle Politiche Agricole Alimentari e Forestali-Italy (MiPAAF www.politicheagricole.it) through the project 'DRUPOMICS' (grant DM14999/7303/08) and by an Italian grant to DB funded by private and public agencies "MAS.PES: apricot and peach breeding by molecular-assisted selection". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami M, 2013, PLANT MOL BIOL REP, V31, P1166, DOI 10.1007/s11105-013-0628-6; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BHATTACHARYYA MK, 1990, CELL, V60, P115, DOI 10.1016/0092-8674(90)90721-P; BLAKE M. A., 1932, Proceedings. American Society for Horticultural Science, V29, P131; Botton A, 2006, PLANT SCI, V171, P106, DOI 10.1016/j.plantsci.2006.02.016; Cadle-Davidson MM, 2008, THEOR APPL GENET, V116, P1079, DOI 10.1007/s00122-008-0737-z; Creller MA, 1996, J AM SOC HORTIC SCI, V121, P198, DOI 10.21273/JASHS.121.2.198; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dirlewanger E, 2007, TREE GENET GENOMES, V3, P1, DOI 10.1007/s11295-006-0053-1; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Eduardo I, 2011, TREE GENET GENOMES, V7, P323, DOI 10.1007/s11295-010-0334-6; Esau K., 1977, Anatomy of seed plants.; Falchi R, 2013, PLANT J, V76, P175, DOI 10.1111/tpj.12283; Faust M, 1995, HORTTICULTURAL REV, V17; Fernandez V, 2011, PLANT PHYSIOL, V156, P2098, DOI 10.1104/pp.111.176305; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Glover BJ, 1998, DEVELOPMENT, V125, P3497; Harada E, 2010, PLANT CELL PHYSIOL, V51, P1627, DOI 10.1093/pcp/pcq118; Hauser MT, 2001, MOL BIOL EVOL, V18, P1754, DOI 10.1093/oxfordjournals.molbev.a003963; Hesse CO, 1975, ADV FRUIT BREEDING; Hulskamp M, 2004, NAT REV MOL CELL BIO, V5, P471, DOI 10.1038/nrm1404; Iijima Y, 2004, PLANT PHYSIOL, V136, P3724, DOI 10.1104/pp.104.051318; Jaffe FW, 2007, J EXP BOT, V58, P1515, DOI 10.1093/jxb/erm020; Jakoby MJ, 2008, PLANT PHYSIOL, V148, P1583, DOI 10.1104/pp.108.126979; Jeffree CE, 2006, ANNU PLANT REV, V23, P11; Jia L, 2004, PLANT PHYSIOL, V134, P575, DOI 10.1104/pp.103.027201; Aranzana MJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-69; Jurinke C, 2002, USE MASSARRAY TECHNO; Kawase M, 2005, MOL GENET GENOMICS, V274, P131, DOI 10.1007/s00438-005-0013-8; Kirik V, 2004, PLANT MOL BIOL, V55, P389, DOI 10.1007/s11103-004-0893-8; Kivimaki M, 2007, MOL ECOL, V16, P453, DOI 10.1111/j.1365-294X.2007.03109.x; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kumar A, 1996, TRENDS GENET, V12, P41, DOI 10.1016/0168-9525(96)81393-X; Lange BM, 2000, P NATL ACAD SCI USA, V97, P2934, DOI 10.1073/pnas.97.6.2934; Le Dantec L, 2010, TREE GENET GENOMES, V6, P995, DOI 10.1007/s11295-010-0308-8; Lee JJ, 2006, PLANTA, V223, P418, DOI 10.1007/s00425-005-0098-7; Li F, 2013, THEOR APPL GENET, V126, P1227, DOI 10.1007/s00122-013-2049-1; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Lopez-Molina L, 2003, GENE DEV, V17, P410, DOI 10.1101/gad.1055803; Machado A, 2009, PLANT J, V59, P52, DOI 10.1111/j.1365-313X.2009.03847.x; Marchese A, 2005, J HORTIC SCI BIOTECH, V80, P121, DOI 10.1080/14620316.2005.11511902; Martin C, 2002, PHILOS T ROY SOC B, V357, P809, DOI 10.1098/rstb.2002.1089; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer RS, 2013, NAT REV GENET, V14, P840, DOI 10.1038/nrg3605; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; NODA K, 1994, NATURE, V369, P661, DOI 10.1038/369661a0; Okie W.R., 1998, HDB PEACH NECTARINE; Okie WR, 2008, FRESH MARKET CULTIVA; OPPENHEIMER DG, 1991, CELL, V67, P483, DOI 10.1016/0092-8674(91)90523-2; Pastorello EA, 2011, INT ARCH ALLERGY IMM, V156, P362, DOI 10.1159/000324440; Payne CT, 2000, GENETICS, V156, P1349; Perez-Rodriguez M, 2005, DEVELOPMENT, V132, P359, DOI 10.1242/dev.01584; Pirona R, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-166; Rosinski JA, 1998, J MOL EVOL, V46, P74, DOI 10.1007/PL00006285; Schellmann S, 2002, EMBO J, V21, P5036, DOI 10.1093/emboj/cdf524; Shimazaki M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021308; Stavrianakou S, 2010, PLANT STRESS, V4, P25; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Studer A, 2011, NAT GENET, V43, P1160, DOI 10.1038/ng.942; Tian JB, 2012, ACTA HORTIC, V962, P97, DOI 10.17660/ActaHortic.2012.962.12; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Uphof J.C.T., 1962, ENCYCL PLANT ANAT, V5, P1; Van Ooijen JW, 2002, JOINMAP 3 0 SOFTWARE; Venuto A, 1516, AGR OPUSCULUM; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Wang GD, 2008, PLANT PHYSIOL, V148, P1254, DOI 10.1104/pp.108.125187; Wang SC, 2008, PLANT CELL PHYSIOL, V49, P1792, DOI 10.1093/pcp/pcn159; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Wilkins TA, 2000, CRIT REV PLANT SCI, V19, P511, DOI 10.1016/S0735-2689(01)80007-1; Wu YR, 2006, PLANT CELL PHYSIOL, V47, P107, DOI 10.1093/pcp/pci228; Xia Y, 2010, PLANT PHYSIOL, V154, P833, DOI 10.1104/pp.110.161646; Yao JL, 2001, P NATL ACAD SCI USA, V98, P1306, DOI 10.1073/pnas.031502498; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yoon JH, 2006, J AM SOC HORTIC SCI, V131, P513, DOI 10.21273/JASHS.131.4.513; Yoshida M, 1994, PEACH, P32; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zhang LC, 2012, J EXP BOT, V63, P203, DOI 10.1093/jxb/err264	86	62	68	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90574	10.1371/journal.pone.0090574	http://dx.doi.org/10.1371/journal.pone.0090574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595269	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900118
J	Zeng, Q; Dong, SY; Wang, ML; Xiang, H; Zhao, XL				Zeng, Qiang; Dong, Sheng-Yong; Wang, Man-Liu; Xiang, Hang; Zhao, Xiao-Lan			Association of EZSCAN Values with Arterial Stiffness in Individuals without Diabetes or Cardiovascular Disease	PLOS ONE			English	Article							ANKLE-BRACHIAL INDEX; SYMPATHETIC-NERVOUS-SYSTEM; CHRONIC KIDNEY-DISEASE; PULSE-WAVE VELOCITY; ALL-CAUSE MORTALITY; METABOLIC SYNDROME; AORTIC STIFFNESS; HEART-FAILURE; HYPERTENSION; EVENTS	Background: The EZSCAN test was recently developed to screen for early dysglycemia through an assessment of sudomotor function. Given the associations of dysglycemia and autonomic dysfunction with the development of arterial stiffness, EZSCAN may also detect early arterial stiffness. The aim of this study was to investigate the association of EZSCAN with arterial stiffness across blood glucose levels. Methodology and Principal Findings: A total of 5532 participants without diabetes or established cardiovascular disease were evaluated with EZSCAN. Their central systolic blood pressure (cSBP), brachial-ankle pulse wave velocity (baPWV), and ankle-brachial index (ABI) were also measured. Multivariate linear regression analyses were used to assess the association between the EZSCAN value and the cSBP, baPWV, and ABI measurements in all of the participants, with additional subgroup analysis that separated participants into a normal glucose tolerance (NGT) group and an impaired glucose regulation (IGR) group. The frequency of the IGRs increased with quartiles of the EZSCAN value (P for trend <0.0001). The levels of cSBP and baPWV increased while the levels of ABI decreased across quartiles of EZSCAN value in both NGT and IGR individuals (P for trend <0.0001 for all). In multivariable analyses, the EZSCAN value was positively associated with cSBP (log-transformed beta = 8.20, P<0.0001) and baPWV (log-transformed beta = 1.82, P<0.0001) but inversely associated with ABI (log-transformed beta = -0.043, P<0.0001) and was independent of conventional factors. Further adjustment for fasting and postprandial glucoses did not attenuate the associations. The results were also unchanged when stratified by IGR. Conclusions and Significance: The EZSCAN results were associated with arterial stiffness independent of conventional factors, blood glucose levels, and glucose tolerance status, suggesting a probable link between the EZSCAN value and arterial stiffness through autonomic dysfunction. The EZSCAN test may help us detect the development of arterial stiffness in high risk individuals to prevent unfavorable cardiovascular events.	[Zeng, Qiang; Dong, Sheng-Yong; Xiang, Hang] Chinese Peoples Liberat Army Gen Hosp, Int Med Ctr, Beijing, Peoples R China; [Wang, Man-Liu] Tsinghua Univ, Ctr Biomed Anal, Beijing 100084, Peoples R China; [Zhao, Xiao-Lan] Third Mil Med Univ, Southwest Hosp, Chongqing, Peoples R China	Chinese People's Liberation Army General Hospital; Tsinghua University; Army Medical University	Zeng, Q (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Int Med Ctr, Beijing, Peoples R China.	zq301@hotmail.com; 1021211982@qq.com	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Dong, Sheng-Yong/0000-0002-8395-4269	State Science and Technology Support Program [2012BAI37B04]; Military Eleventh Five Year Health Promotion Program [10BIZ18]	State Science and Technology Support Program; Military Eleventh Five Year Health Promotion Program	This study was supported by the State Science and Technology Support Program (No. 2012BAI37B04) and the Military Eleventh Five Year Health Promotion Program (No. 10BIZ18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bruno RM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00284; Bruno RM, 2011, HYPERTENSION, V57, P79, DOI 10.1161/HYPERTENSIONAHA.110.163584; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; Chen LZ, 2013, DIABETES RES CLIN PR, V100, P210, DOI 10.1016/j.diabres.2013.03.001; Fink GD, 2009, HYPERTENSION, V53, P307, DOI 10.1161/HYPERTENSIONAHA.108.119990; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Gamboa A, 2012, AM J PHYSIOL-HEART C, V302, pH1438, DOI 10.1152/ajpheart.01020.2011; Ix JH, 2010, J AM COLL CARDIOL, V55, P342, DOI 10.1016/j.jacc.2009.11.010; Kaess BM, 2012, JAMA-J AM MED ASSOC, V308, P875, DOI 10.1001/2012.jama.10503; Kang S, 2010, EUR HEART J, V31, P2799, DOI 10.1093/eurheartj/ehq296; Korosoglou G, 2012, J AM COLL CARDIOL, V60, P167, DOI 10.1016/j.jacc.2012.02.056; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Licht CMM, 2013, J CLIN ENDOCR METAB, V98, P2484, DOI 10.1210/jc.2012-3104; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Mayaudon H, 2010, DIABETES METAB, V36, P450, DOI 10.1016/j.diabet.2010.05.004; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Napoli C, 2012, CIRCULATION, V125, P2363, DOI 10.1161/CIRCULATIONAHA.111.085787; Neumann J, 2004, KIDNEY INT, V65, P1568, DOI 10.1111/j.1523-1755.2004.00552.x; Nilsson PM, 2014, BLOOD PRESSURE, V23, P17, DOI 10.3109/08037051.2013.796142; O'Rourke MF, 2005, CURR OPIN CARDIOL, V20, P275, DOI 10.1097/01.hco.0000166595.44711.6f; Okada Y, 2012, HYPERTENSION, V59, P98, DOI 10.1161/HYPERTENSIONAHA.111.176560; Parati G, 2012, EUR HEART J, V33, P1058, DOI 10.1093/eurheartj/ehs041; Ramachandran A, 2010, DIABETES RES CLIN PR, V88, P302, DOI 10.1016/j.diabres.2010.01.023; Sheng CS, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-36; Sun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043449; Swierblewska E, 2010, J HYPERTENS, V28, P979, DOI 10.1097/HJH.0b013e328336ed9a; Tentolouris N, 2008, NEUROMOL MED, V10, P169, DOI 10.1007/s12017-008-8022-5; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Theilade S, 2013, DIABETES CARE, V36, P715, DOI 10.2337/dc12-0850; Tomiyama H, 2010, J AM COLL CARDIOL, V55, P1979, DOI 10.1016/j.jacc.2009.12.042; Vlachopoulos C, 2012, HYPERTENSION, V60, P556, DOI 10.1161/HYPERTENSIONAHA.112.194779; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Webb DR, 2010, DIABETOLOGIA, V53, P1190, DOI 10.1007/s00125-010-1689-9; Yang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056480; Zeng Q, 2008, CLIN EXP PHARMACOL P, V35, P78, DOI 10.1111/j.1440-1681.2007.04749.x; Zeng Q, 2013, INT J CARDIOL, V167, P2311, DOI 10.1016/j.ijcard.2012.06.022; Zeng Q, 2012, BRAZ J MED BIOL RES, V45, P591, DOI 10.1590/S0100-879X2012007500059	39	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90854	10.1371/journal.pone.0090854	http://dx.doi.org/10.1371/journal.pone.0090854			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595279	Green Submitted, gold, Green Published			2022-12-27	WOS:000332468900152
J	Lankinen, M; Kolehmainen, M; Jaaskelainen, T; Paananen, J; Joukamo, L; Kangas, AJ; Soininen, P; Poutanen, K; Mykkanen, H; Gylling, H; Oresic, M; Jauhiainen, M; Ala-Korpela, M; Uusitupa, M; Schwab, U				Lankinen, Maria; Kolehmainen, Marjukka; Jaaskelainen, Tiina; Paananen, Jussi; Joukamo, Laura; Kangas, Antti J.; Soininen, Pasi; Poutanen, Kaisa; Mykkanen, Hannu; Gylling, Helena; Oresic, Matej; Jauhiainen, Matti; Ala-Korpela, Mika; Uusitupa, Matti; Schwab, Ursula			Effects of Whole Grain, Fish and Bilberries on Serum Metabolic Profile and Lipid Transfer Protein Activities: A Randomized Trial (Sysdimet)	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CHOLESTEROL EFFLUX CAPACITY; PHOSPHOLIPID TRANSFER PROTEIN; POLYUNSATURATED FATTY-ACID; GENOME-WIDE ASSOCIATION; HEALTHY NORDIC DIET; CARDIOVASCULAR-DISEASE; LIPOPROTEIN SUBFRACTIONS; MEDITERRANEAN DIET; HDL-CHOLESTEROL	Objective: We studied the combined effects of wholegrain, fish and bilberries on serum metabolic profile and lipid transfer protein activities in subjects with the metabolic syndrome. Methods: Altogether 131 subjects (40-70 y, BMI 26-39 kg/m(2)) with impaired glucose metabolism and features of the 2 metabolic syndrome were randomized into three groups with 12-week periods according to a parallel study design. They consumed either: a) wholegrain and low postprandial insulin response grain products, fatty fish 3 times a week, and bilberries 3 portions per day (HealthyDiet), b) wholegrain and low postprandial insulin response grain products (WGED), or c) refined wheat breads as cereal products (Control). Altogether 106 subjects completed the study. Serum metabolic profile was studied using an NMR-based platform providing information on lipoprotein subclasses and lipids as well as low-molecular-weight metabolites. Results: There were no significant differences in clinical characteristics between the groups at baseline or at the end of the intervention. Mixed model analyses revealed significant changes in lipid metabolites in the HealthyDiet group during the intervention compared to the Control group. All changes reflected increased polyunsaturation in plasma fatty acids, especially in n-3 PUFAs, while n-6 and n-7 fatty acids decreased. According to tertiles of changes in fish intake, a greater increase of fish intake was associated with increased concentration of large HDL particles, larger average diameter of HDL particles, and increased concentrations of large HDL lipid components, even though total levels of HDL cholesterol remained stable. Conclusions: The results suggest that consumption of diet rich in whole grain, bilberries and especially fatty fish causes changes in HDL particles shifting their subclass distribution toward larger particles. These changes may be related to known protective functions of HDL such as reverse cholesterol transport and could partly explain the known protective effects of fish consumption against atherosclerosis.	[Lankinen, Maria; Kolehmainen, Marjukka; Jaaskelainen, Tiina; Paananen, Jussi; Joukamo, Laura; Poutanen, Kaisa; Mykkanen, Hannu; Gylling, Helena; Uusitupa, Matti; Schwab, Ursula] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Dept Clin Nutr, Kuopio, Finland; [Kolehmainen, Marjukka] Tech Res Ctr Finland, VTT, Kuopio, Finland; [Kangas, Antti J.; Soininen, Pasi; Ala-Korpela, Mika] Univ Oulu, Fac Med, Inst Hlth Sci, Oulu, Finland; [Soininen, Pasi; Ala-Korpela, Mika] Univ Eastern Finland, Sch Pharm, NMR Metab Lab, Kuopio, Finland; [Poutanen, Kaisa; Oresic, Matej] Tech Res Ctr Finland, VTT, FIN-02150 Espoo, Finland; [Gylling, Helena] Univ Helsinki, Dept Med, Div Internal Med, Helsinki, Finland; [Jauhiainen, Matti] Natl Inst Hlth & Welf, Biomedicum, Publ Hlth Genom Res Unit, Helsinki, Finland; [Ala-Korpela, Mika] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Ala-Korpela, Mika] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [Ala-Korpela, Mika] Oulu Univ Hosp, Oulu, Finland; [Uusitupa, Matti] Kuopio Univ Hosp, Res Unit, SF-70210 Kuopio, Finland; [Schwab, Ursula] Kuopio Univ Hosp, Inst Clin Med, SF-70210 Kuopio, Finland	University of Eastern Finland; VTT Technical Research Center Finland; University of Oulu; University of Eastern Finland; VTT Technical Research Center Finland; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; University of Bristol; University of Bristol; University of Oulu; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Lankinen, M (corresponding author), Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Dept Clin Nutr, Kuopio Campus, Kuopio, Finland.	maria.lankinen@uef.fi	Uusitupa, Matti Ilmari Julius/AAX-4929-2020; Oresic, Matej/AAV-3978-2020; Oresic, Matej/K-7673-2016	Oresic, Matej/0000-0002-2856-9165; Kangas, Antti/0000-0001-7492-1732; Ala-Korpela, Mika/0000-0001-5905-1206; /0000-0002-9158-283X; Jaaskelainen, Tiina/0000-0002-1202-0936; Paananen, Jussi/0000-0001-5100-4907	Academy of Finland [117844, 118590, 117996, 131460, 137870, 257545]; European Commission [FOOD-CT-2005-514008]; Kuopio University Hospital [5106, 5168, 5254]; Sigrid Juselius Foundation; TEKES - the Finnish Funding Agency for Technology and Innovation; University of Oulu; Finnish Diabetes Research Foundation; Nordic Centre of Excellence on Systems Biology in Controlled Dietary Intervention and Cohort Studies (SYSDIET) [070014]; Fazer bakeries Oy; Vaasan Vaasan Oy; KE Leipa Oy; Leipomo Ruistahka; Leipomo Koskelonseutu; Raisio Oyj; Pakkasmarja Oy; Joswola Oy; Medical Research Council [MC_UU_12013/1] Funding Source: researchfish; MRC [MC_UU_12013/1] Funding Source: UKRI	Academy of Finland(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre); Kuopio University Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); TEKES - the Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); University of Oulu; Finnish Diabetes Research Foundation; Nordic Centre of Excellence on Systems Biology in Controlled Dietary Intervention and Cohort Studies (SYSDIET); Fazer bakeries Oy; Vaasan Vaasan Oy; KE Leipa Oy; Leipomo Ruistahka; Leipomo Koskelonseutu; Raisio Oyj; Pakkasmarja Oy; Joswola Oy; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by: the Academy of Finland (grant numbers 117844 and 118590 to MU, 117996 for MO, 131460 to KP, 137870 to PS, and 257545 to MJ), European Commission in the Communities 6th Framework Programme Project HEALTHGRAIN (FOOD-CT-2005-514008 to HM and KP), The Kuopio University Hospital (grant numbers 5106, 5168 and 5254 to MU), Sigrid Juselius Foundation (MAK), TEKES - the Finnish Funding Agency for Technology and Innovation (MAK), the Strategic Research Funding from the University of Oulu (MAK). The Finnish Diabetes Research Foundation, Nordic Centre of Excellence on Systems Biology in Controlled Dietary Intervention and Cohort Studies (SYSDIET, 070014), Fazer bakeries Oy, Vaasan & Vaasan Oy, KE Leipa Oy, Leipomo Ruistahka, Leipomo Koskelonseutu, Raisio Oyj, Pakkasmarja Oy and Joswola Oy. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ABBEY M, 1990, ARTERIOSCLEROSIS, V10, P85, DOI 10.1161/01.ATV.10.1.85; Adamsson V, 2011, J INTERN MED, V269, P150, DOI 10.1111/j.1365-2796.2010.02290.x; Akinkuolie AO, 2011, CLIN NUTR, V30, P702, DOI 10.1016/j.clnu.2011.08.013; Annuzzi G, 2012, AM J CLIN NUTR, V95, P1315, DOI 10.3945/ajcn.111.023887; [Anonymous], 2010, R LANG ENV STAT COMP; Arsenault BJ, 2009, ATHEROSCLEROSIS, V206, P276, DOI 10.1016/j.atherosclerosis.2009.01.044; Aviram M, 2013, CURR OPIN LIPIDOL; Balk EM, 2006, ATHEROSCLEROSIS, V189, P19, DOI 10.1016/j.atherosclerosis.2006.02.012; Barter PJ, 2012, J LIPID RES, V53, P1755, DOI 10.1194/jlr.R024075; Basu A, 2010, NUTR REV, V68, P168, DOI 10.1111/j.1753-4887.2010.00273.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop BM, 2013, AM J THER; Bogl LH, 2013, NUTR METAB CARDIOVAS, V23, P1071, DOI 10.1016/j.numecd.2012.11.007; Bogl LH, 2011, ATHEROSCLEROSIS, V219, P880, DOI 10.1016/j.atherosclerosis.2011.09.010; Brennan L, 2013, BIOCHEM SOC T, V41, P670, DOI 10.1042/BST20120350; Burillo E, 2012, CURR VASC PHARMACOL, V10, P432, DOI 10.2174/157016112800812845; Chadli FK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061109; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; DAVIDSON WS, 1995, J BIOL CHEM, V270, P17106, DOI 10.1074/jbc.270.29.17106; de Grooth GJ, 2004, J LIPID RES, V45, P1967, DOI 10.1194/jlr.R400007-JLR200; de Mello VDF, 2011, DIABETOLOGIA, V54, P2755, DOI 10.1007/s00125-011-2285-3; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Erkkila A, 2013, J CLIN LIPI IN PRESS; Fournier N, 1997, ARTERIOSCL THROM VAS, V17, P2685, DOI 10.1161/01.ATV.17.11.2685; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; Gordon SM, 2013, DIABETES, V62, P2958, DOI 10.2337/db12-1753; Graham I, 2012, CURR CARDIOL REP, V14, P709, DOI 10.1007/s11886-012-0313-7; GROENER JEM, 1986, CLIN CHEM, V32, P283; Haase CL, 2012, J CLIN ENDOCR METAB, V97, pE248, DOI 10.1210/jc.2011-1846; Harris WS, 2008, CURR ATHEROSCLER REP, V10, P503, DOI 10.1007/s11883-008-0078-z; Harris WS, 1997, AM J CLIN NUTR, V65, P1645, DOI 10.1093/ajcn/65.5.1645S; He K, 2004, CIRCULATION, V109, P2705, DOI 10.1161/01.CIR.0000132503.19410.6B; HOMMA Y, 1991, ATHEROSCLEROSIS, V91, P145, DOI 10.1016/0021-9150(91)90196-A; Inouye M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.93; Jauhiainen M, 2005, METHODS, V36, P97, DOI 10.1016/j.ymeth.2004.11.006; Karlstrom BE, 2011, AM J CLIN NUTR, V94, P26, DOI 10.3945/ajcn.110.006221; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Kleemola P, 2002, ATHEROSCLEROSIS, V160, P425, DOI 10.1016/S0021-9150(01)00594-9; Kwak SM, 2012, ARCH INTERN MED, V172, P686, DOI 10.1001/archinternmed.2012.262; Lankinen M, 2010, NUTR METAB CARDIOVAS, V20, P249, DOI 10.1016/j.numecd.2009.04.009; Lankinen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022646; Matsuura F, 2006, J CLIN INVEST, V116, P1435, DOI 10.1172/JCI27602; Mukamal KJ, 2007, J CLIN ENDOCR METAB, V92, P2559, DOI 10.1210/jc.2006-2422; Musa-Veloso K, 2011, BRIT J NUTR, V106, P1129, DOI 10.1017/S0007114511001644; Nakanishi S, 2009, J LIPID RES, V50, P183, DOI 10.1194/jlr.M800196-JLR200; Olsen A, 2011, J NUTR, V141, P639, DOI 10.3945/jn.110.131375; Parra ES, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-87; Paturi M, 2008, PUBLICATIONS NATL B, V23; PINHEIRO J PINHEIRO J PINHEIRO J PINHEIRO J PINHEIRO J PINHEIRO J PINHEIRO J, 2009, NLME LINEAR NONLINEA NLME LINEAR NONLINEA NLME LINEAR NONLINEA NLME LINEAR NONLINEA NLME LINEAR NONLINEA NLME LINEAR NONLINEA NLME LINEAR NONLINEA; Pirillo A, 2013, CARDIOLOGY, V124, P116, DOI 10.1159/000346463; Rye KA, 2009, J LIPID RES, V50, pS195, DOI 10.1194/jlr.R800034-JLR200; Salas-Salvado J, 2011, DIABETES CARE, V34, P14, DOI 10.2337/dc10-1288; Soderlund S, 2010, METABOLISM, V59, P1502, DOI 10.1016/j.metabol.2010.01.015; Sofi F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1344; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Sonestedt E, 2012, BRIT J NUTR, V107, P1062, DOI 10.1017/S0007114511003783; Uusitupa M, 2013, J INTERN MED, V274, P52, DOI 10.1111/joim.12044; Vikstedt R, 2007, BIOCHEMISTRY-US, V46, P11979, DOI 10.1021/bi700833h; Villard EF, 2013, ARTERIOSCL THROM VAS, V33, P822, DOI 10.1161/ATVBAHA.112.300979; Villard EF, 2012, ARTERIOSCL THROM VAS, V32, P2341, DOI 10.1161/ATVBAHA.112.252841; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wurtz P, 2012, DIABETES, V61, P1372, DOI 10.2337/db11-1355; Ye EQ, 2012, J NUTR, V142, P1304, DOI 10.3945/jn.111.155325	67	49	50	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90352	10.1371/journal.pone.0090352	http://dx.doi.org/10.1371/journal.pone.0090352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587337	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200178
J	Li, L; Tian, JH; Tian, HL; Sun, R; Wang, Q; Yang, KH				Li, Lun; Tian, Jinhui; Tian, Hongliang; Sun, Rao; Wang, Quan; Yang, Kehu			The Efficacy and Safety of Different Kinds of Laparoscopic Cholecystectomy: A Network Meta Analysis of 43 Randomized Controlled Trials	PLOS ONE			English	Article							LAPAROENDOSCOPIC SINGLE-SITE; CLINICAL-TRIAL; POSTOPERATIVE PAIN; BLINDED TRIAL; INCISION; PORT; METAANALYSIS; 3-PORT; LESS; OUTCOMES	Background and Objective: We conducted a network meta analysis (NMA) to compare different kinds of laparoscopic cholecystectomy [LC] (single port [SPLC], two ports [2PLC], three ports [3PLC], and four ports laparoscopic cholecystectomy [4PLC], and four ports mini-laparoscopic cholecystectomy [mini-4PLC]). Methods: PubMed, the Cochrane library, EMBASE, and ISI Web of Knowledge were searched to find randomized controlled trials [RCTs]. Direct pair-wise meta analysis (DMA), indirect treatment comparison meta analysis (ITC) and NMA were conducted to compare different kinds of LC. Results: We included 43 RCTs. The risk of bias of included studies was high. DMA showed that SPLC was associated with more postoperative complications, longer operative time, and higher cosmetic score than 4PLC, longer operative time and higher cosmetic score than 3PLC, more postoperative complications than mini-4PLC. Mini-4PLC was associated with longer operative time than 4PLC. ITC showed that 3PLC was associated with shorter operative time than mini-4PLC, and lower postoperative pain level than 2PLC. 2PLC was associated with fewer postoperative complications and longer hospital stay than SPLC. NMA showed that SPLC was associated with more postoperative complications than mini-4PLC, and longer operative time than 4PLC. Conclusion: The rank probability plot suggested 4PLC might be the worst due to the highest level of postoperative pain, longest hospital stay, and lowest level of cosmetic score. The best one might be mini-4PLC because of highest level of cosmetic score, and fewest postoperative complications, or SPLC because of lowest level of postoperative pain and shortest hospital stay. But more studies are needed to determine which will be better between mini-4PLC and SPLC.	[Li, Lun; Tian, Hongliang; Wang, Quan; Yang, Kehu] Lanzhou Univ, Clin Coll 1, Lanzhou 730000, Peoples R China; [Li, Lun; Tian, Jinhui; Tian, Hongliang; Sun, Rao; Wang, Quan; Yang, Kehu] Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University	Yang, KH (corresponding author), Lanzhou Univ, Clin Coll 1, Lanzhou 730000, Peoples R China.	yangkehuebm2006@163.com	Li, LILUNlilun871116@/R-8202-2019					Ainslie WG, 2003, SURG ENDOSC, V17, P766, DOI 10.1007/s00464-002-8568-5; Alponat A, 2002, WORLD J SURG, V26, P1437, DOI 10.1007/s00268-002-6351-3; Antoniou SA, 2011, SURG ENDOSC, V25, P367, DOI 10.1007/s00464-010-1217-5; Aprea G, 2011, J SURG RES, V166, pE109, DOI 10.1016/j.jss.2010.11.885; Arezzo A, 2013, SURG ENDOSC, V27, P2293, DOI 10.1007/s00464-012-2763-9; Asakuma M, 2011, BRIT J SURG, V98, P991, DOI 10.1002/bjs.7486; Bignell M, 2012, GASTROENTEROLOGY, V142, pS1034; Bisgaard T, 2000, SURG ENDOSC-ULTRAS, V14, P340, DOI 10.1007/s004640020014; Bisgaard T, 2002, SURG ENDOSC, V16, P458, DOI 10.1007/s00464-001-9026-5; Bresadola F, 1999, EUR J SURG, V165, P29, DOI 10.1080/110241599750007478; Brown KM, 2013, SURG ENDOSC, V27, P3108, DOI 10.1007/s00464-013-2914-7; Bucher P, 2011, BRIT J SURG, V98, P1695, DOI 10.1002/bjs.7689; Cao ZG, 2011, SURG LAPARO ENDO PER, V21, P311, DOI 10.1097/SLE.0b013e31822cfacd; Cerci C, 2007, HEPATO-GASTROENTEROL, V54, P15; Chang SKY, 2013, ASIAN J ENDOSC SURG, V6, P14, DOI 10.1111/j.1758-5910.2012.00154.x; Cheah WK, 2001, BRIT J SURG, V88, P45, DOI 10.1046/j.1365-2168.2001.01636.x; de Carvalho LFA, 2013, J LAPAROENDOSC ADV S, V23, P109, DOI 10.1089/lap.2012.0349; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Elwan AM, 2013, COMP STUDY 2 PORT 4; Garg P, 2012, J GASTROINTEST SURG, V16, P1618, DOI 10.1007/s11605-012-1906-6; Geng L, 2013, PLOS ONE, V8; Gurusamy KS, 2013, COCHRANE DATABASE SY; Gurusamy Kurinchi S, 2008, COCHRANE DATABASE SY; Henneman D, 2013, SURG ENDOSC, V27, P351, DOI 10.1007/s00464-012-2458-2; Hoaglin DC, 2011, VALUE HEALTH, V14, P429, DOI 10.1016/j.jval.2011.01.011; Hsieh CH, 2003, AM J SURG, V185, P344, DOI 10.1016/S0002-9610(02)01417-4; Huang MT, 2003, ARCH SURG-CHICAGO, V138, P1017, DOI 10.1001/archsurg.138.9.1017; Jimenez DF, 2012, CHILD NERV SYST, V28, P1429, DOI 10.1007/s00381-012-1777-x; Khorgami Z, 2013, J INVEST SURG; Kumar Manoj, 2007, JSLS, V11, P358; Lai ECH, 2011, AM J SURG, V202, P254, DOI 10.1016/j.amjsurg.2010.12.009; Lirici MM, 2011, AM J SURG, V202, P45, DOI 10.1016/j.amjsurg.2010.06.019; Look M, 2001, J ROY COLL SURG EDIN, V46, P138; Luna RA, 2013, SURG ENDOSC, V27, P1254, DOI 10.1007/s00464-012-2589-5; Ma J, 2011, ANN SURG, V254, P22, DOI 10.1097/SLA.0b013e3182192f89; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mehmood Z, 2010, J SURG PAK INT, V15, P122; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Novitsky YW, 2005, ARCH SURG-CHICAGO, V140, P1178, DOI 10.1001/archsurg.140.12.1178; Ostlie DJ, 2013, J PEDIATR SURG, V48, P209, DOI 10.1016/j.jpedsurg.2012.10.039; Pan MX, 2013, WORLD J GASTROENTERO, V19, P394, DOI 10.3748/wjg.v19.i3.394; Poon CM, 2003, SURG ENDOSC, V17, P1624, DOI 10.1007/s00464-002-8718-9; Pucher PH, 2013, SURG ENDOSC, V27, P1478, DOI 10.1007/s00464-012-2632-6; Puzziello A, 2012, SURG INNOV, V19, P364, DOI 10.1177/1553350611436282; Qiu JG, 2013, J LAPAROENDOSC ADV S, V23, P815, DOI 10.1089/lap.2013.0040; Rasic Z, 2010, COLLEGIUM ANTROPOL, V34, P595; Saad S, 2013, BRIT J SURG, V100, P339, DOI 10.1002/bjs.9003; Sarli L, 2003, BRIT J SURG, V90, P1345, DOI 10.1002/bjs.4315; Sasaki A, 2012, SURG LAPARO ENDO PER, V22, P396, DOI 10.1097/SLE.0b013e3182631a9a; Schmidt J, 2002, SURG ENDOSC, V16, P476, DOI 10.1007/s00464-001-9057-y; Schwenk W, 2000, SURG ENDOSC, V14, P345, DOI 10.1007/s004640020063; Sharma A, 2012, INDIAN J SURG, V74, P13, DOI 10.1007/s12262-011-0372-9; Sinan H, 2012, SURG LAPARO ENDO PER, V22, P12, DOI 10.1097/SLE.0b013e3182402448; Song Fujian, 2011, BMJ, V343, pd4909, DOI 10.1136/bmj.d4909; Sun SL, 2009, WORLD J SURG, V33, P1904, DOI 10.1007/s00268-009-0108-1; Trastulli S, 2013, BRIT J SURG, V100, P191, DOI 10.1002/bjs.8937; Trichak S, 2003, SURG ENDOSC, V17, P1434, DOI 10.1007/s00464-002-8713-1; Tsimoyiannis EC, 2010, SURG ENDOSC, V24, P1842, DOI 10.1007/s00464-010-0887-3; Madureira FAV, 2013, SURG ENDOSC, V27, P1009, DOI 10.1007/s00464-012-2556-1; Vilallonga R, 2012, J MINIM ACCESS SURG, V8, P74, DOI 10.4103/0972-9941.97586; Wu XS, 2013, J LAPAROENDOSC ADV S, V23, P183, DOI 10.1089/lap.2012.0189; Yilmaz H, 2013, J KOREAN SURG SOC, V85, P149, DOI 10.4174/jkss.2013.85.4.149; Zapf M, 2013, SURGERY, V154, P662, DOI 10.1016/j.surg.2013.04.043; Zehetner J, 2013, SURG LAPARO ENDO PER, V23, P235, DOI 10.1097/SLE.0b013e31828b8b4e; Zheng MW, 2012, MINIM INVASIV THER, V21, P113, DOI 10.3109/13645706.2011.577787	65	19	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90313	10.1371/journal.pone.0090313	http://dx.doi.org/10.1371/journal.pone.0090313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587319	gold, Green Submitted, Green Published			2022-12-27	WOS:000332396200165
J	Zhang, Y; Wang, Y; Wan, Z; Liu, SP; Cao, Y; Zeng, Z				Zhang, Yun; Wang, Yan; Wan, Zhi; Liu, Shiping; Cao, Yu; Zeng, Zhi			Sphingosine Kinase 1 and Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							BREAST-CANCER; PROSTATE-CANCER; SPHINGOLIPID METABOLISM; HIGH EXPRESSION; POOR SURVIVAL; MESSENGER-RNA; PROGRESSION; RESISTANCE; SPHK1; OVEREXPRESSION	Background: Sphingosine kinase 1 (SK1) is a key regulator of the dynamic ceramide/sphingosine 1-phosphate rheostat balance and important in the pathological cancer genesis, progression, and metastasis processes. Many studies have demonstrated SK1 overexpressed in various cancers, but no meta-analysis has evaluated the relationship between SK1 and various cancers. Methods: We retrieved relevant articles from the PubMed, EBSCO, ISI, and OVID databases. A pooled odds ratio (OR) was used to assess the associations between SK1 expression and cancer; hazard ratios (HR) were used for 5-year and overall survival. Review Manager 5.0 was used for the meta-analysis, and publication bias was evaluated with STATA 12.0 (Egger's test). Results: Thirty-four eligible studies (n = 4,673 patients) were identified. SK1 positivity and high expression were significantly different between cancer, non-cancer, and benign tissues. SK1 mRNA and protein expression levels were elevated in the cancer tissues, compared with the normal tissues. SK1 positivity rates differed between various cancer types (lowest [27.3%] in estrogen receptor-positive breast cancer and highest [82.2%] in tongue squamous cell carcinoma). SK1 positivity and high expression were associated with 5-year survival; the HR was 1.86 (95% confidence interval [CI], 1.18-2.94) for breast cancer, .58 (1.08-2.31) for gastric cancer, and 2.68 (2.10-3.44) for other cancers; the total cancer HR was 2.21 (95% CI, 1.83-2.67; P<0.00001). The overall survival HRs were 2.09 (95% CI, 1.35-3.22), 1.56 (1.08-2.25), and 2.62 (2.05-3.35) in breast, gastric, and other cancers, respectively. The total effect HR was 2.21 (95% CI, 1.83-2.66; P<0.00001). Conclusions: SK1 positivity and high expression were significantly associated with cancer and a shorter 5-year and overall survival. SK1 positivity rates vary tremendously among the cancer types. It is necessary to further explore whether SK1 might be a predictive biomarker of outcomes in cancer patients.	[Zhang, Yun; Wan, Zhi; Liu, Shiping; Cao, Yu; Zeng, Zhi] Sichuan Univ, West China Sch Med, West China Hosp, Dept Emergency, Chengdu 610064, Peoples R China; [Wang, Yan] Jilin Med Coll, Sch Publ Hlth, Dept Epidemiol, Jilin, Peoples R China	Sichuan University; Jilin Medical University	Zeng, Z (corresponding author), Sichuan Univ, West China Sch Med, West China Hosp, Dept Emergency, Chengdu 610064, Peoples R China.	zengzhi@cd120.com		Wan, Zhi/0000-0002-3124-0125				Akao Y, 2006, BIOCHEM BIOPH RES CO, V342, P1284, DOI 10.1016/j.bbrc.2006.02.070; Bao MY, 2012, LIVER INT, V32, P331, DOI 10.1111/j.1478-3231.2011.02666.x; Bayerl MG, 2008, LEUKEMIA LYMPHOMA, V49, P948, DOI 10.1080/10428190801911654; Blondeau N, 2007, J NEUROCHEM, V103, P509, DOI 10.1111/j.1471-4159.2007.04755.x; Brizuela L, 2012, MOL CANCER THER, V11, P1841, DOI 10.1158/1535-7163.MCT-12-0227; Cuvillier O, 2002, BBA-MOL CELL BIOL L, V1585, P153, DOI 10.1016/S1388-1981(02)00336-0; Erez-Roman R, 2010, BIOCHEM BIOPH RES CO, V391, P219, DOI 10.1016/j.bbrc.2009.11.035; Fukuda Y, 2003, BIOCHEM BIOPH RES CO, V309, P155, DOI 10.1016/S0006-291X(03)01551-1; Georgiou GK, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-213; Guan HY, 2011, MOL ENDOCRINOL, V25, P1858, DOI 10.1210/me.2011-1048; Guan HY, 2010, MICROBIOLOGY, P68; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Harris BN, 2013, J CANC THERAPY, V4, P704; Ipatova OM, 2006, BIOCHEMISTRY-MOSCOW+, V71, P713, DOI 10.1134/S0006297906070030; Jing H, 2010, DIGESTIVE MED, P54; Johnson KR, 2005, J HISTOCHEM CYTOCHEM, V53, P1159, DOI 10.1369/jhc.4A6606.2005; Kalari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045330; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Knapp P, 2010, PROSTAG OTH LIPID M, V92, P62, DOI 10.1016/j.prostaglandins.2010.03.002; Li J, 2008, CLIN CANCER RES, V14, P6996, DOI 10.1158/1078-0432.CCR-08-0754; Li W, 2009, CLIN CANCER RES, V15, P1393, DOI 10.1158/1078-0432.CCR-08-1158; Liu GL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-495; Liu SQ, 2013, INT J ONCOL, V42, P617, DOI 10.3892/ijo.2012.1733; Liu Y, 2012, J SHANDONG U HLTH SC, V50, p[21, 28]; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Malavaud B, 2010, EUR J CANCER, V46, P3417, DOI 10.1016/j.ejca.2010.07.053; Murate T, 2001, J HISTOCHEM CYTOCHEM, V49, P845, DOI 10.1177/002215540104900705; Nunes J, 2012, BRIT J CANCER, V106, P909, DOI 10.1038/bjc.2012.14; Ohotski J, 2012, BRIT J CANCER, V106, P1453, DOI 10.1038/bjc.2012.98; OHOTSKI J, 2013, J INT CANC, V132, P605, DOI DOI 10.1002/IJC.27692; Pan J, 2011, J TRANSL MED, V9, P157; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pyne S, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00168; Ricci C, 2006, BBA-BIOMEMBRANES, V1758, P2121, DOI 10.1016/j.bbamem.2006.06.016; Rosa R, 2013, CLIN CANCER RES, V19, P138, DOI 10.1158/1078-0432.CCR-12-1050; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Ruckhaberle E, 2013, J CANCER RES CLIN, V139, P1681, DOI 10.1007/s00432-013-1490-5; Selvam Shanmugam Panneer, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-7091-1511-4_1; Shan HX, 2012, CHINESE CLIN ONCOLOG, V17, P1076; Shida D, 2008, CURR DRUG TARGETS, V9, P662, DOI 10.2174/138945008785132402; Shirai K, 2011, CANCER PREV RES, V4, P454, DOI 10.1158/1940-6207.CAPR-10-0299; Sinha UK, 2011, HEAD NECK-J SCI SPEC, V33, P178, DOI 10.1002/hed.21418; Su Ying-jie, 2012, Zhonghua Nei Ke Za Zhi, V51, P220; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Vadas M, 2008, BBA-MOL CELL BIOL L, V1781, P442, DOI 10.1016/j.bbalip.2008.06.007; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Watson C, 2010, AM J PATHOL, V177, P2205, DOI 10.2353/ajpath.2010.100220; [徐哲 Xu Zhe], 2010, [中华实验外科杂志, Chinese Journal of Experimental Surgery], V27, P1413; Yi Z, 2010, CHIN J BREAST DIS, V4, P200; [岳增文 Yue Zengwen], 2012, [实用口腔医学杂志, Journal of Practical Stomatology], V28, P735; [张娈景 Zhang Luanjing], 2013, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V34, P321; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009; Zhuge Yong-hua, 2011, Zhonghua Yi Xue Za Zhi, V91, P2765	53	41	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e90362	10.1371/journal.pone.0090362	http://dx.doi.org/10.1371/journal.pone.0090362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24587339	Green Submitted, Green Published, gold			2022-12-27	WOS:000332390800104
J	Apollonio, M; De Cena, F; Bongi, P; Ciuti, S				Apollonio, Marco; De Cena, Fabio; Bongi, Paolo; Ciuti, Simone			Female Preference and Predation Risk Models Can Explain the Maintenance of a Fallow Deer (Dama dama) Lek and Its 'Handy' Location	PLOS ONE			English	Article							SPATIAL SEXUAL SEGREGATION; MATE RETENTION; MATING SUCCESS; LEKKING; EVOLUTION; HARASSMENT; HOTSPOTS; CHOICE; MALES; SIZE	We tested the predictions of three models (female preference; hotspot; predator avoidance) on lek formation in the fallow deer population of San Rossore, Tuscany. We collected behavioural observations in two leks and radiotracking data on 67 deer over 7 years. Two deer sub-populations were present in the northern and southern sides of the area, respectively, the two sectors being delimited by a river and including one lek each. Predictions were tested for one lek (SG), located in the south-side where we set up our 7-year radiotracking program. Data from a second lek (FO, north-side) were used to test those predictions which imply the occurrence of multiple leks in the same population. We showed that the majority of females made one single visit to one lek, only during the rut. The lek was located outside areas of higher female traffic and home range overlap, and females increased home range sizes during the rut to reach it. Twilight routes of females never crossed the lek; instead, females walked atypical routes and at a faster pace to reach the lek and mate. The distance between the two leks was higher than the average diameter of female home ranges, and only one lek was present within female home ranges. Males reached the lek one month before the arrival of females, corroborating that lekking is a female-initiated process (females moving towards large clumped male aggregations) rather than a male-initiated process (males moving towards female hotspots). Our results supported the female preference model, and rejected the predictions of the hotspot model. Also, leks were located far from areas with higher predation risk, supporting the predator avoidance model. The position of lek SG resulted 'handy' at the sub-population level because of the optimal trade-off between travel costs for females to reach it and avoidance of human predators.	[Apollonio, Marco; De Cena, Fabio; Bongi, Paolo] Univ Sassari, Dept Sci Nat & Environm Resources, I-07100 Sassari, Italy; [Ciuti, Simone] Univ Freiburg, Dept Biometry & Environm Syst Anal, D-79106 Freiburg, Germany	University of Sassari; University of Freiburg	Ciuti, S (corresponding author), Univ Freiburg, Dept Biometry & Environm Syst Anal, Hugstetter Str 55, D-79106 Freiburg, Germany.	simone.ciuti@biom.uni-freiburg.de	Ciuti, Simone/D-7283-2013	Ciuti, Simone/0000-0003-1052-9509	EEC HUMAN CAPITAL AND MOBILITY [ERBCHRXCT940674]; Italian Ministry of Education PRIN [9705242520_010, 9905101114_002]	EEC HUMAN CAPITAL AND MOBILITY; Italian Ministry of Education PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This study was funded by EEC HUMAN CAPITAL AND MOBILITY (ERBCHRXCT940674; coordinator Dr. Rauno V. Alatalo University of Jyvaskyla, Finland); Italian Ministry of Education PRIN 1997 9705242520_010; Italian Ministry of Education PRIN 1999 9905101114_002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1992, BEHAV ECOL, V3, P53, DOI 10.1093/beheco/3.1.53; Alexander R.D., 1975, P35; APOLLONIO M, 1992, BEHAV ECOL, V3, P25, DOI 10.1093/beheco/3.1.25; Apollonio M, 2005, J MAMMAL, V86, P937, DOI 10.1644/1545-1542(2005)86[937:LIOHPO]2.0.CO;2; Apollonio M, 1998, ETHOLOGY, V104, P603, DOI 10.1111/j.1439-0310.1998.tb00095.x; APOLLONIO M, 1989, BEHAV ECOL SOCIOBIOL, V25, P89, DOI 10.1007/BF00302925; ARAK A, 1988, BEHAV ECOL SOCIOBIOL, V22, P317; BALMFORD A, 1992, BEHAV ECOL, V3, P112, DOI 10.1093/beheco/3.2.112; BALMFORD A, 1993, BEHAV ECOL SOCIOBIOL, V33, P57, DOI 10.1007/BF00164347; Bartos L, 2003, FOLIA ZOOL, V52, P1; BEEHLER BM, 1988, AM NAT, V131, P203, DOI 10.1086/284786; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; BRADBURY J, 1986, ANIM BEHAV, V34, P1694, DOI 10.1016/S0003-3472(86)80257-3; Bradbury J.W., 1981, P138; Bradbury J.W., 1983, P109; Bro-Jorgensen J, 2003, BEHAV ECOL SOCIOBIOL, V53, P324, DOI 10.1007/s00265-002-0573-0; Bro-Jorgensen J, 2002, P NATL ACAD SCI USA, V99, P9290, DOI 10.1073/pnas.142125899; Bro-Jorgensen J, 2008, ANIM BEHAV, V75, P1229, DOI 10.1016/j.anbehav.2007.06.010; Buzzard PJ, 2008, J ZOOL, V276, P330, DOI 10.1111/j.1469-7998.2008.00493.x; Carbone C, 1996, BEHAV ECOL, V7, P370, DOI 10.1093/beheco/7.3.370; Chapman D., 1997, FALLOW DEER THEIR HI; Ciuti S, 2006, J ZOOL, V268, P97, DOI 10.1111/j.1469-7998.2005.00003.x; Ciuti S, 2004, BEHAV ECOL SOCIOBIOL, V56, P552, DOI 10.1007/s00265-004-0819-0; Ciuti S, 2008, BEHAV ECOL SOCIOBIOL, V62, P1747, DOI 10.1007/s00265-008-0603-7; Ciuti S, 2011, BEHAVIOUR, V148, P435, DOI 10.1163/000579511X563981; CluttonBrock TH, 1996, BEHAV ECOL, V7, P373, DOI 10.1093/beheco/7.3.373; CLUTTONBROCK TH, 1992, BEHAV ECOL, V3, P234, DOI 10.1093/beheco/3.3.234; CLUTTONBROCK TH, 1993, ANIM BEHAV, V46, P1121, DOI 10.1006/anbe.1993.1302; Davini S, 2004, ACTA THERIOL, V49, P393, DOI 10.1007/BF03192537; DEUTSCH JC, 1992, BEHAV ECOL, V3, P223, DOI 10.1093/beheco/3.3.223; GOSLING LM, 1990, ANIM BEHAV, V40, P272, DOI 10.1016/S0003-3472(05)80922-4; HOGLUND J, 1990, BEHAV ECOL SOCIOBIOL, V26, P173; HOGLUND J, 1990, ANIM BEHAV, V40, P15, DOI 10.1016/S0003-3472(05)80661-X; HOGLUND J, 1993, BEHAV ECOL SOCIOBIOL, V32, P31; Hoglund J., 1995, LEKS, DOI DOI 10.1515/9781400864157; Hooge PN, 1999, ANIMAL MOVEMENT PROG; Isvaran K, 2005, BEHAV ECOL SOCIOBIOL, V57, P283, DOI 10.1007/s00265-004-0844-z; Jones TM, 2002, ANIM BEHAV, V63, P605, DOI 10.1006/anbe.2001.1946; MACHLIS L, 1985, Z TIERPSYCHOL, V68, P201; McElligott AG, 1999, ANIM BEHAV, V57, P1159, DOI 10.1006/anbe.1999.1076; NEFDT RJC, 1995, ANIM BEHAV, V49, P419, DOI 10.1006/anbe.1995.0055; Oring LW., 1982, AVIAN BIOL, P1; Pinheiro J, 2001, MIXED EFFECTS MODELS; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ryder TB, 2006, AUK, V123, P247, DOI 10.1642/0004-8038(2006)123[0247:ATOTEH]2.0.CO;2; SCHAAL A, 1987, BIOL BEHAV, V12, P28; Stenstrom D, 2000, WILDLIFE BIOL, V6, P23, DOI 10.2981/wlb.2000.034; Stillman RA, 1996, ANIM BEHAV, V52, P891, DOI 10.1006/anbe.1996.0237; STILLMAN RA, 1993, BEHAV ECOL, V4, P1, DOI 10.1093/beheco/4.1.1; Westcott DA, 1997, ANIM BEHAV, V53, P235, DOI 10.1006/anbe.1996.0294; Wikelski M, 1996, ANIM BEHAV, V52, P581, DOI 10.1006/anbe.1996.0199; Wiley RH, 1973, TERRITORIALITY NONRA; Wiley RH, 1991, ADV STUD BEHAV, V20, P201; WITTENBERGER JF, 1978, CONDOR, V80, P126, DOI 10.2307/1367912; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Young KA, 2009, BEHAV ECOL, V20, P609, DOI 10.1093/beheco/arp038; [No title captured]	57	7	7	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89852	10.1371/journal.pone.0089852	http://dx.doi.org/10.1371/journal.pone.0089852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599036	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400032
J	Lashley, MA; Chitwood, MC; Biggerstaff, MT; Morina, DL; Moorman, CE; DePerno, CS				Lashley, Marcus A.; Chitwood, M. Colter; Biggerstaff, Michael T.; Morina, Daniel L.; Moorman, Christopher E.; DePerno, Christopher S.			White-Tailed Deer Vigilance: The Influence of Social and Environmental Factors	PLOS ONE			English	Article							PREDATION RISK; SEXUAL SEGREGATION; GROUP-SIZE; TEMPORAL VARIATION; ANTIPREDATOR BEHAVIOR; HABITAT SELECTION; RESPONSES; PREY; RUMINANTS; COSTS	Vigilance behavior may directly affect fitness of prey animals, and understanding factors influencing vigilance may provide important insight into predator-prey interactions. We used 40,540 pictures taken withcamera traps in August 2011 and 2012to evaluate factors influencing individual vigilance behavior of white-tailed deer (Odocoileus virginianus) while foraging at baited sites. We used binary logistic regression to determine if individual vigilance was affected by age, sex, and group size. Additionally, we evaluated whether the time of the day, moon phase, and presence of other non-predatorwildlife species impacted individual vigilance. Juveniles were 11% less vigilant at baited sites than adults. Females were 46% more vigilant when fawns were present. Males and females spent more time feeding as group size increased, but with each addition of 1 individual to a group, males increased feeding time by nearly double that of females. Individual vigilance fluctuated with time of day andwith moon phase but generally was least during diurnal and moonlit nocturnal hours, indicating deer have the ability to adjust vigilance behavior to changing predation risk associated with varyinglight intensity. White-tailed deer increased individual vigilance when other non-predator wildlife were present. Our data indicate that differential effects of environmental and social constraints on vigilance behavior between sexes may encourage sexual segregation in white-tailed deer.	[Lashley, Marcus A.; Chitwood, M. Colter; Biggerstaff, Michael T.; Morina, Daniel L.; Moorman, Christopher E.; DePerno, Christopher S.] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Lashley, MA (corresponding author), N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA.	marcus_lashley@ncsu.edu		Chitwood, Colter/0000-0001-7240-7430; Morina, Daniel/0000-0002-0743-0041	Fort Bragg Wildlife Branch; United States Department of Defense	Fort Bragg Wildlife Branch; United States Department of Defense(United States Department of Defense)	Funding was provided by Fort Bragg Wildlife Branch and the United States Department of Defense. The funders designed the sampling scheme and camera trap positions based on proper techniques for white-tailed deer population surveys as indicated by previous literature; however, the funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsky Z, 2002, ECOLOGY, V83, P1330, DOI 10.2307/3071947; Beier P., 1990, WILDLIFE MONOGRAPHS, V109, P3; Benoist S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082960; BERGERUD AT, 1983, J WILDLIFE MANAGE, V47, P977, DOI 10.2307/3808156; BERTRAM BCR, 1980, ANIM BEHAV, V28, P278, DOI 10.1016/S0003-3472(80)80030-3; Bleich VC, 1997, WILDLIFE MONOGR, P1; Blumstein DT, 2005, P ROY SOC B-BIOL SCI, V272, P1663, DOI 10.1098/rspb.2005.3147; Bowyer RT, 2004, J MAMMAL, V85, P1039, DOI 10.1644/BBL-002.1; Bro-Jorgensen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045769; Brown CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040505; Brown JS, 1999, EVOL ECOL RES, V1, P49; Cantrell M.A., 1995, RED COCKADED WOODPEC; Ciuti S, 2004, BEHAV ECOL SOCIOBIOL, V56, P552, DOI 10.1007/s00265-004-0819-0; Ciuti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050611; Creel S, 2005, ANIM BEHAV, V69, P1181, DOI 10.1016/j.anbehav.2004.07.022; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; FORMANOWICZ DR, 1989, AM MIDL NAT, V121, P379, DOI 10.2307/2426042; Fortin D, 2004, OIKOS, V107, P172, DOI 10.1111/j.0030-1299.2004.12976.x; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Hewitt D. G., 2011, NUTRITION, P75; Hewitt DG, 2011, ANATOMY PHYSL, P43; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; HUGHES JJ, 1993, ANIM BEHAV, V46, P1243, DOI 10.1006/anbe.1993.1320; Hunter LTB, 1998, BEHAVIOUR, V135, P195, DOI 10.1163/156853998793066320; Hwang S, 2013, PLOS ONE, V8; Jacobson HA, 1997, WILDLIFE SOC B, V25, P547; Kie JG, 1999, J MAMMAL, V80, P1004, DOI 10.2307/1383271; Kie JG, 1999, J MAMMAL, V80, P1114, DOI 10.2307/1383163; Kilgo JC, 2012, J WILDLIFE MANAGE, V76, P1420, DOI 10.1002/jwmg.393; Kuijper DPJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084607; Lark AM, 2008, AM MIDL NAT, V159, P67, DOI 10.1674/0003-0031(2008)159[67:VIVIWD]2.0.CO;2; Li CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032607; Li Z, 2009, J ZOOL, V277, P302, DOI 10.1111/j.1469-7998.2008.00541.x; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima SL, 1999, BEHAV ECOL SOCIOBIOL, V46, P110, DOI 10.1007/s002650050599; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Main MB, 1996, J MAMMAL, V77, P449, DOI 10.2307/1382821; METCALFE NB, 1984, ANIM BEHAV, V32, P986, DOI 10.1016/S0003-3472(84)80211-0; Nelson EH, 2004, ECOLOGY, V85, P1853, DOI 10.1890/03-3109; Pays O, 2012, OECOLOGIA, V169, P419, DOI 10.1007/s00442-011-2218-3; Prugh LR, 2014, J ANIM ECOL, V83, P504, DOI 10.1111/1365-2656.12148; Rhind SM, 2002, NUTR RES REV, V15, P43, DOI 10.1079/NRR200236; Ridley AR, 2014, FUNCT ECOL, V28, P197, DOI 10.1111/1365-2435.12153; Rieucau G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044801; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; Rockhill AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069213; Seiler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067397; Sih A, 2002, ANIM BEHAV, V63, P437, DOI 10.1006/anbe.2001.1921; Sonnichsen L, 2013, ETHOLOGY, V119, P233, DOI 10.1111/eth.12057; Stewart KM, 2011, BIOLOGY AND MANAGEMENT OF WHITE-TAILED DEER, P181; Tettamanti F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086004; Toigo C, 1999, CAN J ZOOL, V77, P1060, DOI 10.1139/cjz-77-7-1060; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; Vander Wal E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053777; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Winnie J, 2006, BEHAV ECOL SOCIOBIOL, V61, P277, DOI 10.1007/s00265-006-0258-1	56	45	48	2	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90652	10.1371/journal.pone.0090652	http://dx.doi.org/10.1371/journal.pone.0090652			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599090	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400108
J	Lim, U; Kocarnik, JM; Bush, WS; Matise, TC; Caberto, C; Park, SL; Carlson, CS; Deelman, E; Duggan, D; Fesinmeyer, M; Haiman, CA; Henderson, BE; Hindorff, LA; Kolonel, LN; Peters, U; Stram, DO; Tiirikainen, M; Wilkens, LR; Wu, CY; Kooperberg, C; Le Marchand, L				Lim, Unhee; Kocarnik, Jonathan M.; Bush, William S.; Matise, Tara C.; Caberto, Christian; Park, Sungshim Lani; Carlson, Christopher S.; Deelman, Ewa; Duggan, David; Fesinmeyer, Megan; Haiman, Christopher A.; Henderson, Brian E.; Hindorff, Lucia A.; Kolonel, Laurence N.; Peters, Ulrike; Stram, Daniel O.; Tiirikainen, Maarit; Wilkens, Lynne R.; Wu, Chunyuan; Kooperberg, Charles; Le Marchand, Loic			Pleiotropy of Cancer Susceptibility Variants on the Risk of Non-Hodgkin Lymphoma: The PAGE Consortium	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CHRONIC LYMPHOCYTIC-LEUKEMIA; MANTLE CELL LYMPHOMA; 2ND PRIMARY CANCERS; MULTIETHNIC COHORT; FOLLICULAR LYMPHOMA; INFLAMMATION GENES; COMPLEX DISEASES; COMMON VARIANTS; LOCI	Background: Risk of non-Hodgkin lymphoma (NHL) is higher among individuals with a family history or a prior diagnosis of other cancers. Genome-wide association studies (GWAS) have suggested that some genetic susceptibility variants are associated with multiple complex traits (pleiotropy). Objective: We investigated whether common risk variants identified in cancer GWAS may also increase the risk of developing NHL as the first primary cancer. Methods: As part of the Population Architecture using Genomics and Epidemiology (PAGE) consortium, 113 cancer risk variants were analyzed in 1,441 NHL cases and 24,183 controls from three studies (BioVU, Multiethnic Cohort Study, Women's Health Initiative) for their association with the risk of overall NHL and common subtypes [diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL)] using an additive genetic model adjusted for age, sex and ethnicity. Study-specific results for each variant were meta-analyzed across studies. Results: The analysis of NHL subtype-specific GWAS SNPs and overall NHL suggested a shared genetic susceptibility between FL and DLBCL, particularly involving variants in the major histocompatibility complex region (rs6457327 in 6p21.33: FL OR = 1.29, p = 0.013; DLBCL OR = 1.23, p = 0.013; NHL OR = 1.22, p = 5.9 x E-05). In the pleiotropy analysis, six risk variants for other cancers were associated with NHL risk, including variants for lung (rs401681 in TERT: OR per C allele = 0.89, p = 3.7 x E-03; rs4975616 in TERT: OR per A allele = 0.90, p = 0.01; rs3131379 in MSH5: OR per T allele = 1.16, p = 0.03), prostate (rs7679673 in TET2: OR per C allele = 0.89, p = 5.7 x E-03; rs10993994 in MSMB: OR per T allele = 1.09, p = 0.04), and breast (rs3817198 in LSP1: OR per C allele = 1.12, p = 0.01) cancers, but none of these associations remained significant after multiple test correction. Conclusion: This study does not support strong pleiotropic effects of non-NHL cancer risk variants in NHL etiology; however, larger studies are warranted.	[Lim, Unhee; Caberto, Christian; Kolonel, Laurence N.; Tiirikainen, Maarit; Wilkens, Lynne R.; Le Marchand, Loic] Univ Hawaii, Program Epidemiol, Ctr Canc, Honolulu, HI 96822 USA; [Kocarnik, Jonathan M.; Carlson, Christopher S.; Peters, Ulrike; Wu, Chunyuan; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Bush, William S.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [Matise, Tara C.; Deelman, Ewa] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Park, Sungshim Lani; Haiman, Christopher A.; Henderson, Brian E.; Stram, Daniel O.] Univ So Calif, Dept Prevent Med, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Los Angeles, CA 90089 USA; [Duggan, David] Translat Genom Res Inst, Phoenix, AZ USA; [Fesinmeyer, Megan] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Hindorff, Lucia A.] NHGRI, Div Genom Med, NIH, Bethesda, MD 20892 USA	Cancer Research Center of Hawaii; University of Hawaii System; Fred Hutchinson Cancer Center; Vanderbilt University; Rutgers State University New Brunswick; University of Southern California; Translational Genomics Research Institute; Seattle Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Lim, U (corresponding author), Univ Hawaii, Program Epidemiol, Ctr Canc, Honolulu, HI 96822 USA.	ulim@cc.hawaii.edu	Lim, Unhee/AEA-8591-2022; Bush, William/N-1369-2019; Tirikainen, M/B-6954-2012	Lim, Unhee/0000-0001-6221-7190; Bush, William/0000-0002-9729-6519; Tirikainen, M/0000-0002-8124-3818; Fesinmeyer, Megan/0000-0003-2003-4251	National Human Genome Research Institute (NHGRI); NHGRI PAGE program [U01HG004802, U01HG004790, U01HG004798-01]; Johns Hopkins University from NHLBI [N01-HV-48195]; Centers for Disease Control and Prevention; Vanderbilt CTSA from NCATS/NIH [UL1 TR000445]; NHGRI; National Cancer Institute [R37CA54281, R01 CA63, P01CA33619, U01CA136792, U01CA98758]; National Heart, Lung, and Blood Institute; NIH; U.S. Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 4210726, 42129-32, 44221]; NCI [R25CA94880]; PAGE Coordinating Center [U01HG004801-01];  [U01HG004803];  [U01HG004798];  [U01HG004801]; NATIONAL CANCER INSTITUTE [U01CA098758, P30CA071789, R37CA054281, R25CA094880, U01CA136792, T32CA009168, P01CA033619] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004798, U01HG007376, U01HG004801, U01HG004790, U01HG004803, U01HG004802] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH042129, N01WH032115, N01WH042107, N01WH022110, N01WH032108, N01WH032119, N01WH032122, N01WH032118, N01WH032111, N01WH032100, N01WH032105] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI PAGE program; Johns Hopkins University from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Vanderbilt CTSA from NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. Department of Health and Human Services; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PAGE Coordinating Center; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Population Architecture Using Genomics and Epidemiology (PAGE) program is funded by the National Human Genome Research Institute (NHGRI), supported by U01HG004803 (CALiCo), U01HG004798 (EAGLE), U01HG004802 (MEC), U01HG004790 (WHI), and U01HG004801 (Coordinating Center), and their respective NHGRI ARRA supplements. The complete list of PAGE members can be found at http://www.pagestudy.org. The data and materials included in this report result from collaboration between the following studies: The "Epidemiologic Architecture for Genes Linked to Environment (EAGLE)'' is funded through the NHGRI PAGE program (U01HG004798-01 and its NHGRI ARRA supplement). Genotyping services for select NHANES III SNPs presented here were also provided by the Johns Hopkins University under federal contract number (N01-HV-48195) from NHLBI. The study participants derive from the National Health and Nutrition Examination Surveys (NHANES), and these studies are supported by the Centers for Disease Control and Prevention. The dataset used for the analyses described were obtained from Vanderbilt University Medical Center's BioVU which is supported by institutional funding and by the Vanderbilt CTSA grant UL1 TR000445 from NCATS/NIH. The Multiethnic Cohort study (MEC) characterization of epidemiological architecture is funded through the NHGRI PAGE program (U01HG004802 and its NHGRI ARRA supplement). The MEC study is funded through the National Cancer Institute (R37CA54281, R01 CA63, P01CA33619, U01CA136792, and U01CA98758). Funding support for the "Epidemiology of putative genetic variants: The Women's Health Initiative'' study is provided through the NHGRI PAGE program (U01HG004790 and its NHGRI ARRA supplement). The WHI program is funded by the National Heart, Lung, and Blood Institute; NIH; and U.S. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 4210726, 42129-32, and 44221. A full listing of WHI investigators can be found at: http://www.whiscience.org/publications/WHI_investigators_shortlist. pdf. Additional support for Dr. Kocarnik was provided by R25CA94880 from NCI. Assistance with phenotype harmonization, SNP selection and annotation, data cleaning, data management, integration and dissemination, and general study coordination was provided by the PAGE Coordinating Center (U01HG004801-01 and its NHGRI ARRA supplement). The National Institutes of Mental Health also contributes to the support for the Coordinating Center. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Au WY, 2000, HAEMATOLOGICA, V85, P1225; Bush William S, 2013, Pac Symp Biocomput, P373; Cerhan JR, 2007, BLOOD, V110, P4455, DOI 10.1182/blood-2007-05-088682; Cerhan JR, 2012, CANCER EPIDEM BIOMAR, V21, P1799, DOI 10.1158/1055-9965.EPI-12-0696; Chakraborty S, 2013, AM J CLIN ONCOL-CANC, V36, P132, DOI 10.1097/COC.0b013e3182438ddf; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; Curb JD, 2003, ANN EPIDEMIOL, V13, pS122, DOI 10.1016/S1047-2797(03)00048-6; De Roos AJ, 2013, CANCER EPIDEM BIOMAR, V22, P1747, DOI 10.1158/1055-9965.EPI-13-0240; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Enciso-Mora V, 2010, NAT GENET, V42, P1126, DOI 10.1038/ng.696; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Harris N L, 2000, Hematol J, V1, P53, DOI 10.1038/sj.thj.6200013; Hindorff LA, CATALOG PUBLISHED GE; Hindorff LA, 2011, CARCINOGENESIS, V32, P945, DOI 10.1093/carcin/bgr056; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; Kazma R, 2012, CARCINOGENESIS, V33, P1059, DOI 10.1093/carcin/bgs116; Kolonel LN, 2004, NAT REV CANCER, V4, P519, DOI 10.1038/nrc1389; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Lim U, 2012, INT J CANCER, V131, pE1038, DOI 10.1002/ijc.27592; Matise TC, 2011, AM J EPIDEMIOL, V174, P849, DOI 10.1093/aje/kwr160; Mocellin S, 2012, JNCI-J NATL CANCER I, V104, P840, DOI 10.1093/jnci/djs222; Morton LM, 2007, BLOOD, V110, P695, DOI 10.1182/blood-2006-11-051672; Nielsen SF, 2012, CAN MED ASSOC J, V184, pE57, DOI 10.1503/cmaj.110167; Nielsen SF, 2011, BLOOD, V118, P4062, DOI 10.1182/blood-2011-02-337170; Okhowat R, 2003, CANCER GENET CYTOGEN, V142, P60, DOI 10.1016/S0165-4608(02)00801-4; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Skibola CF, 2009, NAT GENET, V41, P873, DOI 10.1038/ng.419; Slager SL, 2012, BRIT J HAEMATOL, V159, P572, DOI 10.1111/bjh.12070; Smedby KE, 2011, SEMIN CANCER BIOL, V21, P293, DOI 10.1016/j.semcancer.2011.09.010; Smedby KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001378; Wang SS, 2007, BLOOD, V109, P3479, DOI 10.1182/blood-2006-06-031948; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	41	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89791	10.1371/journal.pone.0089791	http://dx.doi.org/10.1371/journal.pone.0089791			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598796	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400028
J	Neuille, M; El Shamieh, S; Orhan, E; Michiels, C; Antonio, A; Lancelot, ME; Condroyer, C; Bujakowska, K; Poch, O; Sahel, JA; Audo, I; Zeitz, C				Neuille, Marion; El Shamieh, Said; Orhan, Elise; Michiels, Christelle; Antonio, Aline; Lancelot, Marie-Elise; Condroyer, Christel; Bujakowska, Kinga; Poch, Olivier; Sahel, Jose-Alain; Audo, Isabelle; Zeitz, Christina			Lrit3 Deficient Mouse (nob6): A Novel Model of Complete Congenital Stationary Night Blindness (cCSNB)	PLOS ONE			English	Article							RICH REPEAT PROTEIN; METABOTROPIC GLUTAMATE-RECEPTOR; OPTICAL COHERENCE TOMOGRAPHY; ROD BIPOLAR CELLS; CGMP PHOSPHODIESTERASE; SYNAPTIC-TRANSMISSION; RETINAL DEGENERATION; MAMMALIAN RETINA; LIGHT RESPONSE; BETA-SUBUNIT	Mutations in LRIT3, coding for a Leucine-Rich Repeat, immunoglobulin-like and transmembrane domains 3 protein lead to autosomal recessive complete congenital stationary night blindness (cCSNB). The role of the corresponding protein in the ON-bipolar cell signaling cascade remains to be elucidated. Here we genetically and functionally characterize a commercially available Lrit3 knock-out mouse, a model to study the function and the pathogenic mechanism of LRIT3. We confirm that the insertion of a Bgeo/Puro cassette in the knock-out allele introduces a premature stop codon, which presumably codes for a non-functional protein. The mouse line does not harbor other mutations present in common laboratory mouse strains or in other known cCSNB genes. Lrit3 mutant mice exhibit a so-called no b-wave (nob) phenotype with lacking or severely reduced b-wave amplitudes in the scotopic and photopic electroretinogram (ERG), respectively. Optomotor tests reveal strongly decreased optomotor responses in scotopic conditions. No obvious fundus auto-fluorescence or histological retinal structure abnormalities are observed. However, spectral domain optical coherence tomography (SD-OCT) reveals thinned inner nuclear layer and part of the retina containing inner plexiform layer, ganglion cell layer and nerve fiber layer in these mice. To our knowledge, this is the first time that SD-OCT technology is used to characterize an animal model for CSNB. This phenotype is noted at 6 weeks and at 6 months. The stationary nob phenotype of mice lacking Lrit3, which we named nob6, confirms the findings previously reported in patients carrying LRIT3 mutations and is similar to other cCSNB mouse models. This novel mouse model will be useful for investigating the pathogenic mechanism(s) associated with LRIT3 mutations and clarifying the role of LRIT3 in the ON-bipolar cell signaling cascade.	[Neuille, Marion; El Shamieh, Said; Orhan, Elise; Michiels, Christelle; Antonio, Aline; Lancelot, Marie-Elise; Condroyer, Christel; Bujakowska, Kinga; Sahel, Jose-Alain; Audo, Isabelle; Zeitz, Christina] INSERM, U968, Paris, France; [Neuille, Marion; El Shamieh, Said; Orhan, Elise; Michiels, Christelle; Antonio, Aline; Lancelot, Marie-Elise; Condroyer, Christel; Bujakowska, Kinga; Sahel, Jose-Alain; Audo, Isabelle; Zeitz, Christina] CNRS, UMR 7210, Paris, France; [Neuille, Marion; El Shamieh, Said; Orhan, Elise; Michiels, Christelle; Antonio, Aline; Lancelot, Marie-Elise; Condroyer, Christel; Bujakowska, Kinga; Sahel, Jose-Alain; Audo, Isabelle; Zeitz, Christina] Univ Paris 06, Univ Sorbonne, UMR S 968, Inst Vis, Paris, France; [Antonio, Aline; Sahel, Jose-Alain; Audo, Isabelle] Ctr Hosp Natl Ophtalmol Quinze Vingts, INSERM DHOS CIC 503, Paris, France; [Bujakowska, Kinga] Massachusetts Eye & Ear Infirm, Ocular Genom Inst, Boston, MA 02114 USA; [Poch, Olivier] CNRS, UMR 7357, ICube, Lab Bioinformat Integrat & Genom, Strasbourg, France; [Sahel, Jose-Alain; Audo, Isabelle] UCL, Inst Ophthalmol, London, England; [Sahel, Jose-Alain] Fdn Ophtalmol Adolphe Rothschild, Paris, France; [Sahel, Jose-Alain] Acad Sci Inst France, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Harvard University; Massachusetts Eye & Ear Infirmary; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of London; University College London; Fondation Adolphe de Rothschild	Zeitz, C (corresponding author), INSERM, U968, Paris, France.	christina.zeitz@inserm.fr	Zeitz, Christina/F-2757-2017; Bujakowska, Kinga Maria/AGL-1293-2022; Shamieh, Said El/J-6343-2019; Sahel, Jose-Alain/F-3172-2017	Zeitz, Christina/0000-0002-3510-1712; Shamieh, Said El/0000-0002-8522-0445; Sahel, Jose-Alain/0000-0002-4831-1153; Bujakowska, Kinga/0000-0001-6809-9818; Orhan, Elise/0000-0002-8306-5250; Audo, Isabelle/0000-0003-0698-5309	Agence Nationale de la Recherche [ANR-12-BSVS1-0012-01_GPR179]; Foundation Voir et Entendre; Prix Dalloz for "la recherche en ophtalmologie''; Fondation pour la Recherche Medicale (FRM); Fondation Roland Bailly; Ville de Paris; Region Ile de France; Agence Nationale de la Recherche within the Investissements d'Avenir programme [ANR-11-IDEX-0004-0]; Foundation Fighting Blindness center grant [C-CMM-0907-0428-INSERM04]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Foundation Voir et Entendre; Prix Dalloz for "la recherche en ophtalmologie''; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation Roland Bailly; Ville de Paris; Region Ile de France(Region Ile-de-France); Agence Nationale de la Recherche within the Investissements d'Avenir programme(French National Research Agency (ANR)); Foundation Fighting Blindness center grant	The project was supported by Agence Nationale de la Recherche [ANR-12-BSVS1-0012-01_GPR179] (CZ), Foundation Voir et Entendre (CZ), Prix Dalloz for "la recherche en ophtalmologie'' (CZ), The Fondation pour la Recherche Medicale (FRM) in partnership with the Fondation Roland Bailly (CZ), Ville de Paris and Region Ile de France, LABEX LIFESENSES [reference ANR-10-LABX-65] supported by French state funds managed by the Agence Nationale de la Recherche within the Investissements d'Avenir programme [ANR-11-IDEX-0004-0], Foundation Fighting Blindness center grant [C-CMM-0907-0428-INSERM04]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Audo I, 2008, SURV OPHTHALMOL, V53, P16, DOI 10.1016/j.survophthal.2007.10.010; Audo I, 2012, AM J HUM GENET, V90, P321, DOI 10.1016/j.ajhg.2011.12.007; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Bahadori R, 2006, EUR J NEUROSCI, V24, P1664, DOI 10.1111/j.1460-9568.2006.05053.x; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807; BOWES C, 1993, P NATL ACAD SCI USA, V90, P2955, DOI 10.1073/pnas.90.7.2955; Cao Y, 2011, J NEUROSCI, V31, P11521, DOI 10.1523/JNEUROSCI.1682-11.2011; Chang B, 2006, INVEST OPHTH VIS SCI, V47, P5017, DOI 10.1167/iovs.05-1468; Delori FC, 2001, INVEST OPHTH VIS SCI, V42, P1855; Dhingra A, 2000, J NEUROSCI, V20, P9053; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Godara P, 2012, AM J OPHTHALMOL, V154, P987, DOI 10.1016/j.ajo.2012.06.003; Gregg RG, 2003, INVEST OPHTH VIS SCI, V44, P378, DOI 10.1167/iovs.02-0501; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Iwakabe H, 1997, NEUROPHARMACOLOGY, V36, P135, DOI 10.1016/S0028-3908(96)00167-0; Kim KH, 2008, J VISION, V8, DOI 10.1167/8.1.17; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; LeFur N, 1996, GENOMICS, V37, P245; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Maddox DM, 2008, J PHYSIOL-LONDON, V586, P4409, DOI 10.1113/jphysiol.2008.157289; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Morgans CW, 2006, EUR J NEUROSCI, V23, P1163, DOI 10.1111/j.1460-9568.2006.04647.x; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; Nawy S, 1999, J NEUROSCI, V19, P2938; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; O'Connor E, 2005, HUM MOL GENET, V14, P1877, DOI 10.1093/hmg/ddi194; Orhan E, 2013, INVEST OPHTH VIS SCI, V54, P8041, DOI 10.1167/iovs.13-12610; Orlandi C, 2013, INVEST OPHTHALMOL VI; Orlandi C, 2012, J CELL BIOL, V197, P711, DOI 10.1083/jcb.201202123; Pardue MT, 1998, INVEST OPHTH VIS SCI, V39, P2443; Peachey NS, 2012, J NEUROPHYSIOL, V108, P2442, DOI 10.1152/jn.00137.2012; Peachey NS, 2012, AM J HUM GENET, V90, P331, DOI 10.1016/j.ajhg.2011.12.006; Pearring JN, 2011, J NEUROSCI, V31, P10060, DOI 10.1523/JNEUROSCI.1014-11.2011; Pinto LH, 2007, VISUAL NEUROSCI, V24, P111, DOI 10.1017/S0952523807070149; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Ruether K, 2000, INVEST OPHTH VIS SCI, V41, P4039; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; Slotnick S, 2012, OPTOMETRY VISION SCI, V89, pE575, DOI 10.1097/OPX.0b013e318250835d; Terry RB, 2004, ANIM GENET, V35, P134, DOI 10.1111/j.1365-2052.2004.01113.x; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; Wycisk KA, 2006, INVEST OPHTH VIS SCI, V47, P3523, DOI 10.1167/iovs.06-0271; Xu Y, 2012, J NEUROPHYSIOL, V107, P948, DOI 10.1152/jn.00933.2011; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28; Zeitz C, 2005, INVEST OPHTH VIS SCI, V46, P4328, DOI 10.1167/iovs.05-0526; Zeitz C, 2003, INVEST OPHTH VIS SCI, V44, P4184, DOI 10.1167/iovs.03-0251; Zeitz C, 2007, EXPERT REV OPHTHALMO, V2, P467, DOI 10.1586/17469899.2.3.467; Zeitz C, 2013, AM J HUM GENET, V92, P67, DOI 10.1016/j.ajhg.2012.10.023	56	38	40	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90342	10.1371/journal.pone.0090342	http://dx.doi.org/10.1371/journal.pone.0090342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598786	gold, Green Published, Green Submitted			2022-12-27	WOS:000332479400065
J	Shi, SH; Cai, YP; Cai, XJ; Zheng, XY; Cao, DS; Ye, FQ; Xiang, Z				Shi, Shao-hua; Cai, Yue-piao; Cai, Xiao-jun; Zheng, Xiao-yong; Cao, Dong-sheng; Ye, Fa-qing; Xiang, Zheng			A Network Pharmacology Approach to Understanding the Mechanisms of Action of Traditional Medicine: Bushenhuoxue Formula for Treatment of Chronic Kidney Disease	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; UNILATERAL URETERAL OBSTRUCTION; ANGIOTENSIN-ALDOSTERONE SYSTEM; SALVIAE-MILTIORRHIZAE RADIX; INSULIN SIGNALING PATHWAY; TANSHINONE IIA; DIABETIC-NEPHROPATHY; MASS-SPECTROMETRY; TGF-BETA; GENE-EXPRESSION	Traditional Chinese medicine (TCM) has unique therapeutic effects for complex chronic diseases. However, for the lack of an effective systematic approach, the research progress on the effective substances and pharmacological mechanism of action has been very slow. In this paper, by incorporating network biology, bioinformatics and chemoinformatics methods, an integrated approach was proposed to systematically investigate and explain the pharmacological mechanism of action and effective substances of TCM. This approach includes the following main steps: First, based on the known drug targets, network biology was used to screen out putative drug targets; Second, the molecular docking method was used to calculate whether the molecules from TCM and drug targets related to chronic kidney diseases (CKD) interact or not; Third, according to the result of molecular docking, natural product-target network, main component-target network and compound-target network were constructed; Finally, through analysis of network characteristics and literature mining, potential effective multi-components and their synergistic mechanism were putatively identified and uncovered. Bu-shen-Huo-xue formula (BSHX) which was frequently used for treating CKD, was used as the case to demonstrate reliability of our proposed approach. The results show that BSHX has the therapeutic effect by using multi-channel network regulation, such as regulating the coagulation and fibrinolytic balance, and the expression of inflammatory factors, inhibiting abnormal ECM accumulation. Tanshinone IIA, rhein, curcumin, calycosin and quercetin may be potential effective ingredients of BSHX. This research shows that the integration approach can be an effective means for discovering active substances and revealing their pharmacological mechanisms of TCM.	[Shi, Shao-hua; Cai, Yue-piao; Cai, Xiao-jun; Zheng, Xiao-yong; Ye, Fa-qing; Xiang, Zheng] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou, Peoples R China; [Cao, Dong-sheng] Cent S Univ, Sch Pharmaceut Sci, Changsha, Hunan, Peoples R China	Wenzhou Medical University; Central South University	Ye, FQ (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou, Peoples R China.	yfq664340@163.com; XZH0077@126.com			National Natural Science Foundation of China [81001614]; Nature Foundation Committee of Zhejiang Province, China [Y2100317, LQ13H280001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Foundation Committee of Zhejiang Province, China	The authors acknowledge financial support from the National Natural Science Foundation of China (No. 81001614) and the Nature Foundation Committee of Zhejiang Province, China (Y2100317 and LQ13H280001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasian N, 2012, NEPHROL DIAL TRANSPL, V27, P241; Abdel-Rahman E, 2009, SEMIN DIALYSIS, V22, P532, DOI 10.1111/j.1525-139X.2009.00634.x; Agarwal SK, 2001, J SCI IND RES INDIA, V60, P1; Ahn YM, 2010, PHYTOTHER RES, V24, P1886, DOI 10.1002/ptr.3347; Akgul T, 2011, KAOHSIUNG J MED SCI, V27, P15, DOI 10.1016/j.kjms.2010.03.001; Alasbahi RH, 2012, PHARMAZIE, V67, P5, DOI 10.1691/ph.2012.1642; [Anonymous], KIDNEY INT, V73, P269; Azuaje FJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00052; Bailey JL, 2002, J AM SOC NEPHROL, V13, p522A; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Biggar PH, 2011, PEDIATR NEPHROL, V26, P7, DOI 10.1007/s00467-010-1526-x; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brophy D, 2009, AM J KIDNEY DIS, V53, pA30; Cao J, 2008, BIOMED CHROMATOGR, V22, P164, DOI 10.1002/bmc.911; Chea E, 2007, BMC BIOINFORMATICS, V8; Chen XH, 2012, J CHROMATOGR A, V1263, P34, DOI 10.1016/j.chroma.2012.09.074; Chen XM, 2011, J CHROMATOGR B, V879, P2339, DOI 10.1016/j.jchromb.2011.06.019; [陈修平 CHEN Xiu-ping], 2010, [中草药, Chinese Traditional and Herbal Drugs], V41, P1; Chevalier RL, 1999, J UROLOGY, V161, P309, DOI 10.1016/S0022-5347(01)62137-2; Cho DY, 2012, PLOS COMPUTATIONAL B, V8; Choi ME, 2012, SEMIN NEPHROL, V32, P244, DOI 10.1016/j.semnephrol.2012.04.003; Chuang CC, 2010, AM J CLIN NUTR, V92, P1511, DOI 10.3945/ajcn.2010.29807; Chuang PY, 2010, KIDNEY INT, V78, P231, DOI 10.1038/ki.2010.158; CHUNG HY, 1988, CHEM PHARM BULL, V36, P274; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Dubey RK, 1999, HYPERTENSION, V33, P177, DOI 10.1161/01.HYP.33.1.177; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eybl V, 2008, HUM EXP TOXICOL, V27, P347, DOI 10.1177/0960327108094508; Fernand VE, 2011, CHEM-BIOL INTERACT, V192, P220, DOI 10.1016/j.cbi.2011.03.013; Fujimoto H, 1998, CHEM PHARM BULL, V46, P1506; Gaedeke J, 2004, KIDNEY INT, V66, P112, DOI 10.1111/j.1523-1755.2004.00713.x; Gao S, 2012, ATHEROSCLEROSIS, V220, P3, DOI 10.1016/j.atherosclerosis.2011.06.041; Gao ZhiQing, 2010, China Journal of Traditional Chinese Medicine and Pharmacy, V25, P296; Garcia-Mediavilla V, 2007, EUR J PHARMACOL, V557, P221, DOI 10.1016/j.ejphar.2006.11.014; Gold MR, 2000, IMMUNOL REV, V176, P47; Gong ZW, 2009, ENDOCRINOLOGY, V150, P104, DOI 10.1210/en.2008-0322; Gonzalez-Salazar A, 2011, CARDIOVASC TOXICOL, V11, P357, DOI 10.1007/s12012-011-9128-9; Greenbaum D, 2003, GENOME BIOL, V4; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Guan XH, 2009, TRANSPL INT, V22, P232, DOI 10.1111/j.1432-2277.2008.00770.x; Ha MK, 2011, BIOL PHARM BULL, V34, P1432, DOI 10.1248/bpb.34.1432; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; He DY, 2011, BIOL PHARM BULL, V34, P1219, DOI 10.1248/bpb.34.1219; Heyman SN, 2008, AM J NEPHROL, V28, P998, DOI 10.1159/000146075; Hong JY, 2006, J FOOD SCI, V71, pS626, DOI 10.1111/j.1750-3841.2006.00194.x; Hsieh CL, 2013, J AGR FOOD CHEM, V61, P7258, DOI 10.1021/jf304595p; Hu YB, 2012, ACTA PHYS-CHIM SIN, V28, P1257, DOI 10.3866/PKU.WHXB201202212; Hu Y, 2010, AM J NEPHROL, V31, P332, DOI 10.1159/000287230; Huang LM, 2006, ACTA PHARMACOL SIN, V27, P321; Huang XZ, 2008, CANCER BIOL THER, V7, P468, DOI 10.4161/cbt.7.3.5457; Hwang JS, 2005, ARCH PHARM RES, V28, P190, DOI 10.1007/BF02977714; Hwang WC, 2008, CLIN PHARMACOL THER, V84, P563, DOI 10.1038/clpt.2008.129; Hwang W, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-24; Iqbal M, 2009, MOL CELL BIOCHEM, V324, P157, DOI 10.1007/s11010-008-9994-z; Jariyawat S, 2009, J NAT MED-TOKYO, V63, P430, DOI 10.1007/s11418-009-0345-5; Jha V, 2010, NEPHROLOGY, V15, P10, DOI 10.1111/j.1440-1797.2010.01305.x; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Jin RF, 2011, INT J QUANTUM CHEM, V111, P1064, DOI 10.1002/qua.22466; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Kang DG, 2002, AM J CHINESE MED, V30, P87, DOI 10.1142/S0192415X02000107; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Khan SS, 2012, AM J KIDNEY DIS, V59, pA47; Khorsandi L, 2008, DARU, V16, P155; Kim SK, 2009, BIOL PHARM BULL, V32, P220, DOI 10.1248/bpb.32.220; Kim W, 2006, NY TIMES BK REV, P1; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Ko JC, 2011, BIOCHEM PHARMACOL, V81, P680, DOI 10.1016/j.bcp.2010.12.008; Kong LD, 2004, J ETHNOPHARMACOL, V91, P351, DOI 10.1016/j.jep.2004.01.013; Koyama J, 2007, J CHROMATOGR A, V1145, P183, DOI 10.1016/j.chroma.2007.01.076; KUPPUSAMY UR, 1994, BIOCHEM PHARMACOL, V47, P521, DOI 10.1016/0006-2952(94)90184-8; Lai PB, 2012, RENAL FAILURE, V34, P83, DOI 10.3109/0886022X.2011.623564; Lee KJ, 2012, PHARM BIOL, V50, P591; Lee S, 2009, EXPERT OPIN DRUG DIS, V4, P1177, DOI 10.1517/17460440903322234; Lee W, 2012, BMB REP, V45, P141, DOI 10.5483/BMBRep.2012.45.3.141; Letavernier E, 2005, J AM SOC NEPHROL, V16, P2395, DOI 10.1681/ASN.2004090802; Li BH, 2012, INT J MOL SCI, V13, P13501, DOI 10.3390/ijms131013501; Li FM, 2010, HYPERTENSION, V56, pE123; Li JH, 2002, J AM SOC NEPHROL, V13, p287A; Li JX, 2005, CHINESE J PHYSIOL, V48, P101; Li LS, 1996, NEPHROLOGY, V2, pS146, DOI 10.1111/j.1440-1797.1996.tb00160.x; Li M, 2013, J ETHNOPHARMACOL, V146, P614, DOI 10.1016/j.jep.2013.01.038; Li R, 2011, FOOD CHEM, V126, P1890, DOI 10.1016/j.foodchem.2010.12.014; Li S, 2006, J ASIAN NAT PROD RES, V8, P281, DOI 10.1080/10286020412331286434; Li Shao, 2011, Zhongguo Zhong Yao Za Zhi, V36, P2017; Li SG, 2009, CARBOHYD POLYM, V78, P343, DOI 10.1016/j.carbpol.2009.04.013; Li XM, 2005, ADV CHRONIC KIDNEY D, V12, P276, DOI 10.1016/j.ackd.2005.03.007; Li YG, 2009, J CHROMATOGR A, V1216, P1941, DOI 10.1016/j.chroma.2008.12.032; Li YS, 2009, J HUAZHONG U SCI-MED, V29, P476, DOI 10.1007/s11596-009-0417-5; Lin SL, 2011, AM J PATHOL, V178, P911, DOI 10.1016/j.ajpath.2010.10.012; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu F, 2012, KIDNEY BLOOD PRESS R, V35, P182, DOI 10.1159/000331054; Liu Y, 2010, J PHARMACEUT BIOMED, V53, P698, DOI 10.1016/j.jpba.2010.03.041; Luyckx VA, 2012, ADV CHRONIC KIDNEY D, V19, P129, DOI 10.1053/j.ackd.2012.04.005; Lv ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022806; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Martin A, 2010, BMC BIOINFORMATICS, V11; Matsuura S, 2011, J HISTOCHEM CYTOCHEM, V59, P864, DOI 10.1369/0022155411413929; Mencher Simon K, 2005, BMC Clin Pharmacol, V5, P3, DOI 10.1186/1472-6904-5-3; Morphy R, 2007, DRUG DISCOV TODAY, V12, P156, DOI 10.1016/j.drudis.2006.12.006; Nabavi SM, 2012, RENAL FAILURE, V34, P901, DOI 10.3109/0886022X.2012.687347; Nagao S, 2008, KIDNEY INT, V73, P269, DOI 10.1038/sj.ki.5002629; Nagler EV, 2012, NEPHROL DIAL TRANSPL, V27, P3736, DOI 10.1093/ndt/gfs295; Navab KD, 2011, CURR PHARM DESIGN, V17, P17; Navaneethan SD, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-3; Ozturk M, 2007, FOOD CHEM, V103, P623, DOI 10.1016/j.foodchem.2006.09.005; PALYA A, 2008, AM J KIDNEY DIS, V51, pA77; Pan HJ, 2005, J ETHNOPHARMACOL, V99, P99, DOI 10.1016/j.jep.2005.02.007; Pei LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057414; Qi LW, 2009, J CHROMATOGR A, V1216, P2087, DOI 10.1016/j.chroma.2008.02.095; Qin Y, 2011, AM J PATHOL, V179, P2766, DOI 10.1016/j.ajpath.2011.08.025; Remuzzi G, 2005, KIDNEY INT, V68, P57; Sheng BW, 2005, CHINESE MED J-PEKING, V118, P43; Shi CS, 2007, THROMB RES, V119, P769, DOI 10.1016/j.thromres.2006.06.008; Siragy HM, 2010, AM J NEPHROL, V31, P541, DOI 10.1159/000313363; Skupien J, 2009, DIABETES, V58, pA219; Soetikno V, 2011, NUTR METAB, V8; Stinghen AEM, 2010, BLOOD PURIFICAT, V29, P114, DOI 10.1159/000245636; Stone R, 2008, SCIENCE, V319, P709, DOI 10.1126/science.319.5864.709; Tang FT, 2011, EUR J PHARMACOL, V650, P275, DOI 10.1016/j.ejphar.2010.07.038; Tang JL, 2008, LANCET, V372, P1938, DOI 10.1016/S0140-6736(08)61354-9; Tang JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011822; Tang JH, 2008, J HUAZHONG U SCI-MED, V28, P539, DOI 10.1007/s11596-008-0511-0; Tang SCW, 2006, J AM SOC NEPHROL, V17, P1633, DOI 10.1681/ASN.2005101113; Tapmeier TT, 2008, KIDNEY INT, V73, P885, DOI 10.1038/sj.ki.5002797; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsukiyama F, 2006, BIOCHEM BIOPH RES CO, V351, P234, DOI 10.1016/j.bbrc.2006.10.025; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang D, 2006, J SEP SCI, V29, P2012, DOI 10.1002/jssc.200500486; Wang H, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008000.pub2; Wang JX, 2012, IEEE ACM T COMPUT BI, V9, P1070, DOI 10.1109/TCBB.2011.147; Wang JP, 2006, EUR J PHARMACOL, V553, P297, DOI 10.1016/j.ejphar.2006.08.087; Wang R, 2007, LIFE SCI, V80, P2481, DOI 10.1016/j.lfs.2007.04.010; Wang SP, 2010, RAPID COMMUN MASS SP, V24, P1641, DOI 10.1002/rcm.4561; Wang YJ, 2012, J ETHNOPHARMACOL, V139, P757, DOI 10.1016/j.jep.2011.12.009; Wasserman RL, 2012, J CLIN IMMUNOL, V32, P1153, DOI 10.1007/s10875-012-9740-x; Wichitnithad W, 2009, PHYTOCHEM ANALYSIS, V20, P314, DOI 10.1002/pca.1129; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wu LC, 2012, ACTA PHARMACOL SIN, V33, P1254, DOI 10.1038/aps.2012.84; Wu XL, 2012, PLANTA MED, V78, P866, DOI 10.1055/s-0031-1298487; Xavier S, 2012, EUR J PHARMACOL, V687, P14, DOI 10.1016/j.ejphar.2012.02.050; Xiang Z, 2011, PHYTOCHEM ANALYSIS, V22, P411, DOI 10.1002/pca.1296; Xiao HB, 2004, J CHROMATOGR A, V1032, P117, DOI 10.1016/j.chroma.2003.09.032; Xiao-hong D, 2011, CHIN J INTEGR TRAD W, V31, P765; Yang FQ, 2006, J CHROMATOGR A, V1134, P226, DOI 10.1016/j.chroma.2006.09.048; Yang JX, 2008, J ETHNOPHARMACOL, V119, P166, DOI 10.1016/j.jep.2008.06.027; Yang KY, 2007, J CHROMATOGR B, V853, P183, DOI 10.1016/j.jchromb.2007.03.010; Ye M, 2005, RAPID COMMUN MASS SP, V19, P1469, DOI 10.1002/rcm.1944; Yon JM, 2011, REPROD TOXICOL, V31, P513, DOI 10.1016/j.reprotox.2011.02.011; Yongzheng H., 2011, COMPREHENSIVE NATURA; Zhang G, 1996, NEPHROL DIAL TRANSPL, V11, P186, DOI 10.1093/oxfordjournals.ndt.a027039; Zhang HX, 2004, J CHROMATOGR B, V812, P175, DOI 10.1016/j.jchromb.2004.08.010; ZHANG JH, 1992, KIDNEY INT, V42, P498; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang P, 2008, PHYSICA A, V387, P6869, DOI 10.1016/j.physa.2008.09.006; Zhang Q, 2012, EXP BIOL MED, V237, P903, DOI 10.1258/ebm.2012.012032; Zhang X, 2007, ANAL CHIM ACTA, V602, P252, DOI 10.1016/j.aca.2007.09.033; Zhao YL, 2011, FOOD CHEM TOXICOL, V49, P1705, DOI 10.1016/j.fct.2011.04.011; Zhong F, 2011, BIOL PHARM BULL, V34, P226, DOI 10.1248/bpb.34.226; Zhu B, 2011, MOL MED REP, V4, P505, DOI 10.3892/mmr.2011.444; Zhu M, 2009, J DRUG TARGET, V17, P524, DOI 10.1080/10611860903046610; Zuo C, 2009, J ZHEJIANG UNIV-SC B, V10, P380, DOI 10.1631/jzus.B0820230	166	70	73	4	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89123	10.1371/journal.pone.0089123	http://dx.doi.org/10.1371/journal.pone.0089123			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598793	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400008
J	Beltran, LM; Hernandez, RM; Bernal, RSD; Morillo, JSG; Egido, J; Noval, ML; Ferrando-Martinez, S; Blanco-Colio, LM; Genebat, M; Villar, JR; Moreno-Luna, R; Moreno, JA				Beltran, Luis M.; Munoz Hernandez, Rocio; de Pablo Bernal, Rebeca S.; Garcia Morillo, Jose S.; Egido, Jesus; Leal Noval, Manuel; Ferrando-Martinez, Sara; Blanco-Colio, Luis M.; Genebat, Miguel; Villar, Jose R.; Moreno-Luna, Rafael; Antonio Moreno, Juan			Reduced sTWEAK and Increased sCD163 Levels in HIV-Infected Patients: Modulation by Antiretroviral Treatment, HIV Replication and HCV Co-Infection	PLOS ONE			English	Article							SOLUBLE CD163; ASYMMETRIC DIMETHYLARGININE; MYOCARDIAL-INFARCTION; WEAK INDUCER; TWEAK; INFLAMMATION; MARKERS; RISK; ACTIVATION; THERAPY	Background: Patients infected with the human immunodeficiency virus (HIV) have an increased risk of cardiovascular disease due to increased inflammation and persistent immune activation. CD163 is a macrophage scavenger receptor that is involved in monocyte-macrophage activation in HIV-infected patients. CD163 interacts with TWEAK, a member of the TNF superfamily. Circulating levels of sTWEAK and sCD163 have been previously associated with cardiovascular disease, but no previous studies have fully analyzed their association with HIV. Objective: The aim of this study was to analyze circulating levels of sTWEAK and sCD163 as well as other known markers of inflammation (hsCRP, IL-6 and sTNFRII) and endothelial dysfunction (sVCAM-1 and ADMA) in 26 patients with HIV before and after 48 weeks of antiretroviral treatment (ART) and 23 healthy subjects. Results: Patients with HIV had reduced sTWEAK levels and increased sCD163, sVCAM-1, ADMA, hsCRP, IL-6 and sTNFRII plasma concentrations, as well as increased sCD163/sTWEAK ratio, compared with healthy subjects. Antiretroviral treatment significantly reduced the concentrations of sCD163, sVCAM-1, hsCRP and sTNFRII, although they remained elevated when compared with healthy subjects. Antiretroviral treatment had no effect on the concentrations of ADMA and sTWEAK, biomarkers associated with endothelial function. The use of protease inhibitors as part of antiretroviral therapy and the presence of HCV-HIV co-infection and/or active HIV replication attenuated the ART-mediated decrease in sCD163 plasma concentrations. Conclusion: HIV-infected patients showed a proatherogenic profile characterized by increased inflammatory, immune-activation and endothelial-dysfunction biomarkers that partially improved after ART. HCV-HIV co-infection and/or active HIV replication enhanced immune activation despite ART.	[Beltran, Luis M.; Munoz Hernandez, Rocio; Garcia Morillo, Jose S.; Villar, Jose R.; Moreno-Luna, Rafael] Univ Seville, Inst Biomed Sevilla, Hosp Univ Virgen del Rocio, Ctr Super Invest Cient,Unidad Clin Expt Riesgo Va, Seville, Spain; [Beltran, Luis M.] Hosp Univ La Paz, Unidad Metab Vasc, Fdn Invest, IdiPAZ, Madrid, Spain; [de Pablo Bernal, Rebeca S.; Leal Noval, Manuel; Ferrando-Martinez, Sara; Genebat, Miguel] Univ Seville, Lab Inmunovirol, Unidad Clin Enfermedades Infecciosas Microbiol &, Inst Biomed Sevilla,Hosp Univ Virgen del Rocio,Ct, Seville, Spain; [Egido, Jesus; Blanco-Colio, Luis M.; Antonio Moreno, Juan] Fdn Jimenez Diaz, Lab Patol Vasc, Inst Invest Sanitaria, E-28040 Madrid, Spain; [Egido, Jesus] Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain; [Ferrando-Martinez, Sara] Hosp Gen Univ Gregorio Maranon, Lab Inmunobiol Mol, Madrid, Spain; [Ferrando-Martinez, Sara] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Ferrando-Martinez, Sara] Networking Res Ctr Bioengn Biomat & Nanomed, Madrid, Spain; [Moreno-Luna, Rafael] Hosp Nacl Paraplejicos, Dept Vasc Physiopathol, Serv Salud Castilla La Mancha, Toledo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Universitario La Paz; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Fundacion Jimenez Diaz; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Hospital Nacional de Paraplejicos	Moreno-Luna, R (corresponding author), Univ Seville, Inst Biomed Sevilla, Hosp Univ Virgen del Rocio, Ctr Super Invest Cient,Unidad Clin Expt Riesgo Va, Seville, Spain.	rmluna@sescam.jccm.es; jamoreno@fjd.es	MORENO-LUNA, RAFAEL/AFP-3358-2022; Blanco-Colio, Luis M./Z-2390-2019; Garcia Morillo, Salvador/C-9364-2015; Beltrán-Romero, Luis M./H-5479-2017; Genebat, Miguel/F-3072-2015; García-Morillo, José-Salvador/L-8365-2018; Moreno, Juan Antonio/B-3487-2018; IBIS, HIPERCOLESTERO/P-3953-2015; de Pablo-Bernal, Rebeca S/E-9923-2015	MORENO-LUNA, RAFAEL/0000-0002-9840-5078; Garcia Morillo, Salvador/0000-0001-9969-1881; Beltrán-Romero, Luis M./0000-0001-8048-9106; García-Morillo, José-Salvador/0000-0003-1311-5483; Moreno, Juan Antonio/0000-0002-7468-2871; Blanco-Colio, Luis Miguel/0000-0002-1560-6609; de Pablo-Bernal, Rebeca S/0000-0002-8026-2857	Unidad Clinico-Experimental de Riesgo Vascular [RIMON_ L_01031]; Redes Tematicas de Investigacion en SIDA [ISCIII RETIC RD12/0017/0029, RD12/0017/0037]; Junta de Andalucia, Incentivos a proyectos de investigacion de excelencia [CTS-6313]; Consejeria de Salud [PI-0278]; FIS [PI10/00234]; Programa Miguel Servet [CP10/00479, PI13/00802]; Fundacion Lilly; FRIAT; ISCIII fund [PI10/00072]; Incentivos a proyectos de investigacion de excelencia [CTS-6313]	Unidad Clinico-Experimental de Riesgo Vascular; Redes Tematicas de Investigacion en SIDA; Junta de Andalucia, Incentivos a proyectos de investigacion de excelencia(Junta de Andalucia); Consejeria de Salud; FIS(Instituto de Salud Carlos III); Programa Miguel Servet; Fundacion Lilly; FRIAT; ISCIII fund; Incentivos a proyectos de investigacion de excelencia	This study was supported by grants from the Unidad Clinico-Experimental de Riesgo Vascular (RIMON_ L_01031, to Jose Villar), Redes Tematicas de Investigacion en SIDA (ISCIII RETIC RD12/0017/0029 and RD12/0017/0037), Junta de Andalucia, Incentivos a proyectos de investigacion de excelencia (CTS-6313, to Manolo Leal), Consejeria de Salud (PI-0278), FIS PI10/00234 to LMBC and Programa Miguel Servet: CP10/00479 and PI13/00802 to JAM. Fundacion Lilly, FRIAT and ISCIII fund PI10/00072 to JE. RSPB is supported by Incentivos a proyectos de investigacion de excelencia (CTS-6313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristoteli LP, 2006, ATHEROSCLEROSIS, V184, P342, DOI 10.1016/j.atherosclerosis.2005.05.004; Baker JV, 2012, JAIDS-J ACQ IMM DEF, V60, P128, DOI 10.1097/QAI.0b013e318252f99f; Baker JV, 2011, EUR HEART J, V32, P945, DOI 10.1093/eurheartj/ehq483; Blanco-Colio LM, 2007, FRONT BIOSCI-LANDMRK, V12, P3648, DOI 10.2741/2341; Blanco-Colio LM, 2007, ARTERIOSCL THROM VAS, V27, P916, DOI 10.1161/01.ATV.0000258972.10109.ff; Bover LC, 2007, J IMMUNOL, V178, P8183, DOI 10.4049/jimmunol.178.12.8183; Burdo TH, 2011, J INFECT DIS, V204, P1227, DOI 10.1093/infdis/jir520; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; Calza L, 2009, JAIDS-J ACQ IMM DEF, V50, P430, DOI 10.1097/QAI.0b013e31819a292c; Carrero JJ, 2009, CLIN J AM SOC NEPHRO, V4, P110, DOI 10.2215/CJN.02790608; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Chorianopoulos E, 2010, ATHEROSCLEROSIS, V211, P322, DOI 10.1016/j.atherosclerosis.2010.02.016; Chorianopoulos E, 2009, EUR J HEART FAIL, V11, P1050, DOI 10.1093/eurjhf/hfp139; Currier Judith S, 2008, Circulation, V118, pe29, DOI 10.1161/CIRCULATIONAHA.107.189624; Davis BH, 2005, CYTOM PART B-CLIN CY, V63B, P16, DOI 10.1002/cyto.b.20031; Dube Michael P, 2008, Circulation, V118, pe36, DOI 10.1161/CIRCULATIONAHA.107.189625; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fick A, 2012, J BIOL CHEM, V287, P484, DOI 10.1074/jbc.M111.287656; Funderburg NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083514; Hearps AC, 2012, AIDS, V26, P843, DOI 10.1097/QAD.0b013e328351f756; Hsue PY, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000422; Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x; Jang JJ, 2011, ATHEROSCLEROSIS, V217, P514, DOI 10.1016/j.atherosclerosis.2011.03.035; Jelic-Ivanovic Z, 2009, CLIN BIOCHEM, V42, P1381, DOI 10.1016/j.clinbiochem.2009.06.001; Jong E, 2010, THROMB HAEMOSTASIS, V104, P1228, DOI 10.1160/TH10-04-0233; Kalayjian RC, 2010, J INFECT DIS, V201, P1796, DOI 10.1086/652750; Kim SH, 2004, CIRC J, V68, P396, DOI 10.1253/circj.68.396; Kralisch S, 2008, ATHEROSCLEROSIS, V199, P440, DOI 10.1016/j.atherosclerosis.2007.10.022; Kristoffersen US, 2009, HIV MED, V10, P79, DOI 10.1111/j.1468-1293.2008.00661.x; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Kurz K, 2009, PHARMACOL RES, V60, P508, DOI 10.1016/j.phrs.2009.07.009; Law MG, 2006, HIV MED, V7, P218, DOI 10.1111/j.1468-1293.2006.00362.x; Levy AP, 2007, CIRC RES, V101, P106, DOI 10.1161/CIRCRESAHA.107.149435; Martin GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055279; Martin-Ventura JL, 2011, ATHEROSCLEROSIS, V214, P486, DOI 10.1016/j.atherosclerosis.2010.11.009; McComsey GA, 2012, AIDS, V26, P1371, DOI 10.1097/QAD.0b013e328354f4fb; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Moller HJ, 2002, BLOOD, V99, P378, DOI 10.1182/blood.V99.1.378; Moreno JA, 2010, ARTERIOSCL THROM VAS, V30, P1253, DOI 10.1161/ATVBAHA.110.203364; Moreno JA, 2009, ATHEROSCLEROSIS, V207, P103, DOI 10.1016/j.atherosclerosis.2009.04.033; Moreno JA, 2012, EUR HEART J, V33, P252, DOI 10.1093/eurheartj/ehr123; Munoz-Garcia B, 2006, STROKE, V37, P2044, DOI 10.1161/01.STR.0000230648.00027.00; Munoz-Garcia B, 2009, ARTERIOSCL THROM VAS, V29, P2061, DOI 10.1161/ATVBAHA.109.194852; Nakayama M, 2003, BIOCHEM BIOPH RES CO, V306, P819, DOI 10.1016/S0006-291X(03)01051-9; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Panel de expertos de Gesida y Plan Nacional sobre el Sida, 2012, Enferm Infecc Microbiol Clin, V30, pe1, DOI 10.1016/j.eimc.2012.03.006; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Sandler NG, 2014, CURR OPIN HIV AIDS, V9, P72, DOI 10.1097/COH.0000000000000020; Sosner P, 2012, ATHEROSCLEROSIS, V222, P274, DOI 10.1016/j.atherosclerosis.2012.02.027; Stein JH, 2001, CIRCULATION, V104, P257, DOI 10.1161/01.CIR.104.3.257; Subramanian S, 2012, JAMA-J AM MED ASSOC, V308, P379, DOI 10.1001/jama.2012.6698; Tippett E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019968; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Triant VA, 2009, JAIDS-J ACQ IMM DEF, V51, P268, DOI 10.1097/QAI.0b013e3181a9992c; Urbonaviciene G, 2011, ATHEROSCLEROSIS, V219, P892, DOI 10.1016/j.atherosclerosis.2011.09.016; Valdivielso JM, 2013, J NEPHROL, V26, P1105, DOI 10.5301/jn.5000245; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Yilmaz MI, 2011, CLIN J AM SOC NEPHRO, V6, P785, DOI 10.2215/CJN.09231010	58	44	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90541	10.1371/journal.pone.0090541	http://dx.doi.org/10.1371/journal.pone.0090541			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594990	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500064
J	Caruso, R; Botta, L; Verde, A; Milazzo, F; Vecchi, I; Trivella, MG; Martinelli, L; Paino, R; Frigerio, M; Parodi, O				Caruso, Raffaele; Botta, Luca; Verde, Alessandro; Milazzo, Filippo; Vecchi, Irene; Trivella, Maria Giovanna; Martinelli, Luigi; Paino, Roberto; Frigerio, Maria; Parodi, Oberdan			Relationship between Pre-Implant Interleukin-6 Levels, Inflammatory Response, and Early Outcome in Patients Supported by Left Ventricular Assist Device: A Prospective Study	PLOS ONE			English	Article							HEART-FAILURE; INTENSIVE-CARE; TASK-FORCE; ASSOCIATION; GUIDELINES; DIAGNOSIS; PEROXYNITRITE; MORTALITY; NEOPTERIN; SOCIETY	Purpose: The immune response is crucial in the development of multi-organ failure (MOF) and complications in end-stage heart failure patients supported by left ventricular assist device (LVAD). However, at pre-implant, the association between inflammatory state and post-LVAD outcome is not yet clarified. Aim of the study was to assess the relationship among pre-implant levels of immune-related cytokines, postoperative inflammatory response and 3-month outcome in LVAD-patients. Methods: In 41 patients undergoing LVAD implantation, plasma levels of interleukin (IL)-6, IL-8, crucial for monocyte modulation, and urine neopterin/creatinine ratio (Neo/Cr), marker of monocyte activation, were assessed preoperatively, at 3 days, 1 and 4 weeks post-LVAD. MOF was evaluated by total sequential organ failure assessment (tSOFA) score. Intensive care unit (ICU)-death and/or post-LVAD tSOFA >= 11 was considered as main adverse outcome. Length of ICU-stay, 1 week-tSOFA score, hospitalisation and 3-month survival were considered additional end-points. Results: During ICU-stay, 8 patients died of MOF, while 8 of the survivors experienced severe MOF with postoperative tSOFA score >= 11. Pre-implant level of IL-6 >= 8.3 pg/mL was identified as significant marker of discrimination between patients with or without adverse outcome (OR 6.642, 95% Cl 1.201-36.509, p = 0.030). Patients were divided according to pre-implant IL-6 cutoff of 8.3 pg/ml in A [3.5 (1.2-6.1) pg/mL] and B [24.6 (16.4-38.0) pg/mL] groups. Among pre-implant variables, only white blood cells count was independently associated with pre-implant IL-6 levels higher than 8.3 pg/ml (OR 1.491, 95% CI 1.004-2.217, p = 0.048). The ICU-stay and hospitalisation resulted longer in B-group (p = 0.001 and p = 0.030, respectively). Postoperatively, 1 week-tSOFA score, IL-8 and Neo/Cr levels were higher in B-group. Conclusions: LVAD-candidates with elevated pre-implant levels of IL-6 are associated, after intervention, to higher release of monocyte activation related-markers, a clue for the development of MOF, longer clinical course and poor outcome.	[Caruso, Raffaele; Parodi, Oberdan] Osped Niguarda Ca Granda, CNR Inst Clin Physiol, CardioThorac & Vasc Dept, Milan, Italy; [Botta, Luca; Verde, Alessandro; Milazzo, Filippo; Vecchi, Irene; Martinelli, Luigi; Paino, Roberto; Frigerio, Maria] Osped Niguarda Ca Granda, CardioThorac & Vasc Dept, Milan, Italy; [Trivella, Maria Giovanna] CNR Inst Clin Physiol, Pisa, Italy; [Trivella, Maria Giovanna] Univ Pisa, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Pisa	Caruso, R (corresponding author), Osped Niguarda Ca Granda, CNR Inst Clin Physiol, CardioThorac & Vasc Dept, Milan, Italy.	raffaele.caruso@ospedaleniguarda.it	Vecchi, Irene/Y-5084-2019; Botta, Luca/A-1090-2015	Vecchi, Irene/0000-0002-7836-7430; Botta, Luca/0000-0002-5674-3861; Verde, Alessandro/0000-0003-3917-2355; Trivella, Maria Giovanna/0000-0001-8702-2859	 [24863]		This study was partially supported by FP7-ICT-2009 project grant agreement 24863 (SensorART - A Remote Controlled Sensorized ARTificial Heart Enabling Patients Empowerment and New Therapy Approaches). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Caruso R, 2012, J HEART LUNG TRANSPL, V31, P625, DOI 10.1016/j.healun.2012.02.006; Caruso R, 2010, ASAIO J, V56, P313, DOI 10.1097/MAT.0b013e3181de3049; Castellani ML, 2012, J BIOL REGUL HOMEOST, V24, P1; De Rosa S, 2011, CURR VASC PHARMACOL, V9, P188, DOI 10.2174/157016111794519372; Deng MC, 2005, J HEART LUNG TRANSPL, V24, P1182, DOI 10.1016/j.healun.2005.07.002; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Ferdinandy P, 2000, CIRC RES, V87, P241, DOI 10.1161/01.RES.87.3.241; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Herpfer I, 2002, FREE RADICAL RES, V36, P509, DOI 10.1080/10715760290025898; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Kirsch M, 2012, INT J ARTIF ORGANS, V35, P169, DOI 10.5301/ijao.5000053; Kobold ACM, 2000, INTENS CARE MED, V26, P883, DOI 10.1007/s001340051277; Levey AS, 2000, J AM SOC NEPHROL, V11, pA0828; Lund LH, 2010, EUR J HEART FAIL, V12, P434, DOI 10.1093/eurjhf/hfq006; Masai T, 2002, ANN THORAC SURG, V73, P549, DOI 10.1016/S0003-4975(01)03510-X; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Nieminen MS, 2005, EUR HEART J, V26, P384; Palardy M, 2010, J CARD FAIL, V16, P218, DOI 10.1016/j.cardfail.2009.11.002; Ploder M, 2006, SHOCK, V25, P129, DOI 10.1097/01.shk.0000191379.62897.1d; Shiga T, 2011, CIRC J, V75, P121, DOI 10.1253/circj.CJ-10-0770; Walsh DS, 2005, J SURG RES, V129, P221, DOI 10.1016/j.jss.2005.05.003; Wiel E, 2005, CRIT CARE CLIN, V21, P403, DOI 10.1016/j.ccc.2005.03.001; Wilson SR, 2009, CIRCULATION, V119, P2225, DOI 10.1161/CIRCULATIONAHA.109.850610	24	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90802	10.1371/journal.pone.0090802	http://dx.doi.org/10.1371/journal.pone.0090802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594915	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500102
J	de Oliveira, DN; Ferreira, MS; Catharino, RR				de Oliveira, Diogo N.; Ferreira, Monica S.; Catharino, Rodrigo R.			Rapid and Simultaneous In Situ Assessment of Aflatoxins and Stilbenes Using Silica Plate Imprinting Mass Spectrometry Imaging	PLOS ONE			English	Article							SOLID-PHASE EXTRACTION; LIQUID-CHROMATOGRAPHY; SMALL MOLECULES; FOOD SAFETY; RESVERATROL; MYCOTOXIN; MALDI; URINE; HPLC; OCHRATOXIN	A fast and direct combination of techniques for simultaneous mycotoxin and phytoalexin identification in peanut skin and kernel is described. Silica Plate Imprinting Laser Desorption/Ionization Mass Spectrometry Imaging (SPILDI-MSI) is a powerful technique that exhibits great advantages, such as solvent-free and matrix-free characteristics, as well as no sample preparation or separation steps. It also permits accurate identification of mycotoxins and phytoalexins with unique fingerprint profiles in just a few seconds. Results are expressed as chemical images of the 4 identified types of aflatoxins (B1, B2, G1 and G2) and a stilbenoid (resveratrol). Also, SPILDI-MSI allows the comparison between the spatial distribution of aflatoxins and resveratrol found in kernel and skin. This novel application has proven to be useful for instantaneous qualitative assessment of aflatoxins and stilbenoids both in the peanut skin and kernel and offers precise tracking of fungal contamination in nuts and other foodstuffs.	[de Oliveira, Diogo N.; Ferreira, Monica S.; Catharino, Rodrigo R.] Univ Estadual Campinas, UNICAMP, Sch Med Sci, INNOVARE Biomarkers Lab, Campinas, SP, Brazil	Universidade Estadual de Campinas	Catharino, RR (corresponding author), Univ Estadual Campinas, UNICAMP, Sch Med Sci, INNOVARE Biomarkers Lab, Campinas, SP, Brazil.	rrc@fcm.unicamp.br	de Oliveira, Diogo Noin/C-3939-2013; Siqueira Ferreira, Mônica/B-8718-2014; Catharino, Rodrigo/G-1487-2013; Catharino, Rodrigo/AAH-4333-2021	de Oliveira, Diogo Noin/0000-0002-2725-476X; Catharino, Rodrigo/0000-0001-7219-2644; Catharino, Rodrigo/0000-0001-7219-2644	CAPES, FAPESP [2011/50400-0]; INCT	CAPES, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); INCT	The authors would like to thanks CAPES, FAPESP (process number 2011/50400-0) and INCT for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali WH, 2010, J CHROMATOGR A, V1217, P6668, DOI 10.1016/j.chroma.2010.04.071; Ayed-Boussema I, 2008, TOXICOL IN VITRO, V22, P1671, DOI 10.1016/j.tiv.2008.06.016; Belli P, 2010, FOOD CHEM TOXICOL, V48, P2818, DOI 10.1016/j.fct.2010.07.012; Bicchi C, 2007, J CHROMATOGR A, V1148, P137, DOI 10.1016/j.chroma.2007.03.007; Bouhet S, 2005, VET IMMUNOL IMMUNOP, V108, P199, DOI 10.1016/j.vetimm.2005.08.010; Bryden WL, 2012, ANIM FEED SCI TECH, V173, P134, DOI 10.1016/j.anifeedsci.2011.12.014; Catharino RR, 2005, ANAL CHEM, V77, P8155, DOI 10.1021/ac051111p; Cavaliere C, 2006, J CHROMATOGR A, V1135, P135, DOI 10.1016/j.chroma.2006.07.048; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; de Melo FT, 2012, FOOD CHEM TOXICOL, V50, P3548, DOI 10.1016/j.fct.2011.12.022; de Oliveira D, 2013, INT J COSMETIC SCI; Drexler Dieter M., 2007, Journal of Pharmacological and Toxicological Methods, V55, P279, DOI 10.1016/j.vascn.2006.11.004; Fabiani A, 2010, TALANTA, V83, P281, DOI 10.1016/j.talanta.2010.08.027; Ferreira MS, 2014, ANAL CHIM ACTA, V807, P96, DOI 10.1016/j.aca.2013.11.033; Galezowska A, 2013, RAPID COMMUN MASS SP, V27, P964, DOI 10.1002/rcm.6536; Garrett TJ, 2007, INT J MASS SPECTROM, V260, P166, DOI 10.1016/j.ijms.2006.09.019; Grove KJ, 2011, J AM SOC MASS SPECTR, V22, P192, DOI 10.1007/s13361-010-0013-8; Holcomb M, 1996, J SUPERCRIT FLUID, V9, P118, DOI 10.1016/S0896-8446(96)90007-8; Jeannot E, 2012, INT J CANCER, V130, P1347, DOI 10.1002/ijc.26140; KUSSAK A, 1993, J CHROMATOGR-BIOMED, V616, P235, DOI 10.1016/0378-4347(93)80391-G; Lee SS, 2004, FOOD RES INT, V37, P247, DOI 10.1016/j.foodres.2003.11.007; Moss MO, 1996, MYCOL RES, V100, P513, DOI 10.1016/S0953-7562(96)80001-3; Norris JL, 2013, CHEM REV, V113, P2309, DOI 10.1021/cr3004295; Pascual-Marti MC, 2001, TALANTA, V54, P735, DOI 10.1016/S0039-9140(01)00319-8; Pitt JI, 2013, FOOD CONTROL, V32, P205, DOI 10.1016/j.foodcont.2012.11.023; Reiter E, 2009, MOL NUTR FOOD RES, V53, P508, DOI 10.1002/mnfr.200800145; Rodriguez-Carrasco Y, 2012, J CHROMATOGR A, V1270, P28, DOI 10.1016/j.chroma.2012.10.061; Scott E, 2012, MOL NUTR FOOD RES, V56, P7, DOI 10.1002/mnfr.201100400; Sherma J, 2000, J CHROMATOGR A, V880, P129, DOI 10.1016/S0021-9673(99)01132-2; Shindler KS, 2010, J NEURO-OPHTHALMOL, V30, P328, DOI 10.1097/WNO.0b013e3181f7f833; Sobolev VS, 2007, J AGR FOOD CHEM, V55, P2195, DOI 10.1021/jf063478g; Sobolev VS, 2011, J AGR FOOD CHEM, V59, P1673, DOI 10.1021/jf104742n; Sobolev VS, 2009, J AGR FOOD CHEM, V57, P62, DOI 10.1021/jf802891v; Somogyi A, 2007, MACROMOLECULES, V40, P5311, DOI 10.1021/ma062200m; Tokusoglu O, 2005, J AGR FOOD CHEM, V53, P5003, DOI 10.1021/jf050496+; Ungvari Z, 2007, AM J PHYSIOL-HEART C, V292, pH2417, DOI 10.1152/ajpheart.01258.2006; Urayama S, 2010, RAPID COMMUN MASS SP, V24, P613, DOI 10.1002/rcm.4420; Vatinno R, 2008, J CHROMATOGR A, V1201, P215, DOI 10.1016/j.chroma.2008.05.079; Wagacha JM, 2008, INT J FOOD MICROBIOL, V124, P1, DOI 10.1016/j.ijfoodmicro.2008.01.008; Wang SH, 2010, RECENT ADVANCES IN FOOD AND FLAVOR CHEMISTRY: FOOD FLAVORS AND ENCAPSULATION, HEALTH BENEFITS, ANALYTICAL METHODS, AND MOLECULAR BIOLOGY OF FUNCTIONAL FOODS, P322; Wang Y, 2002, J AGR FOOD CHEM, V50, P431, DOI 10.1021/jf010812u; Xu H, 2007, J CHROMATOGR B, V852, P529, DOI 10.1016/j.jchromb.2007.02.057; Youssef M, 2013, THER DRUG MONIT, V35, P698	43	23	23	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90901	10.1371/journal.pone.0090901	http://dx.doi.org/10.1371/journal.pone.0090901			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595464	gold, Green Published, Green Submitted			2022-12-27	WOS:000332475500110
J	Gavilan, HS; Kulikauskas, RM; Gutmann, DH; Fehon, RG				Gavilan, Heather S.; Kulikauskas, Rima M.; Gutmann, David H.; Fehon, Richard G.			In Vivo Functional Analysis of the Human NF2 Tumor Suppressor Gene in Drosophila	PLOS ONE			English	Article							REGULATE CELL-PROLIFERATION; EXPANDED FUNCTION; EPITHELIAL-CELLS; ERM PROTEINS; MERLIN; HIPPO; MOESIN; TUMORIGENESIS; NF2/MERLIN; GROWTH	The proper control of tissue growth is essential during normal development and an important problem in human disease. Merlin, the product of the Neurofibromatosis 2 tumor suppressor gene, has been extensively studied to understand its functions in growth control. Here we describe experiments in which we used Drosophila as an in vivo system to test the functions of the normal human NF2 gene products and patient-derived mutant alleles. Although the predominant NF2 gene isoform, isoform 1, could functionally replace the Drosophila Merlin gene, a second isoform with a distinct C-terminal tail could not. Immunofluorescence studies show that the two isoforms have distinct subcellular localizations when expressed in the polarized imaginal epithelium, and function in genetic rescue assays correlates with apical localization of the NF2 protein. Interestingly, we found that a patient-derived missense allele, NF2(L64P), appears to be temperature sensitive. These studies highlight the utility of Drosophila for in vivo functional analysis of highly conserved human disease genes.	[Fehon, Richard G.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Gavilan, Heather S.; Kulikauskas, Rima M.] Duke Univ, Dept Biol, Durham, NC USA; [Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	University of Chicago; Duke University; Washington University (WUSTL)	Fehon, RG (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA.	rfehon@uchicago.edu		Gutmann, David/0000-0002-3127-5045	National Institutes of Health [NS034783]; U.S. Army Neurofibromatosis Research Program [DAMD17-97-1-7345]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Neurofibromatosis Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (NS034783) and the U.S. Army Neurofibromatosis Research Program (DAMD17-97-1-7345) to RGF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cockburn K, 2013, CURR BIOL, V23, P1195, DOI 10.1016/j.cub.2013.05.044; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Denholm B, 2005, DEVELOPMENT, V132, P2389, DOI 10.1242/dev.01829; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Giovannini M, 1999, GENE DEV, V13, P978, DOI 10.1101/gad.13.8.978; Goutebroze L, 2000, MOL CELL BIOL, V20, P1699, DOI 10.1128/MCB.20.5.1699-1712.2000; Gronholm M, 1999, J CELL SCI, V112, P895; Guilgur LG, 2012, DEVELOPMENT, V139, P503, DOI 10.1242/dev.071027; Gutmann DH, 1999, HUM MOL GENET, V8, P267, DOI 10.1093/hmg/8.2.267; Gutmann DH, 1998, HUM MOL GENET, V7, P335, DOI 10.1093/hmg/7.3.335; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; HARA T, 1994, CANCER RES, V54, P330; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; Hughes SC, 2006, J CELL BIOL, V175, P305, DOI 10.1083/jcb.200608009; LaJeunesse DR, 1998, J CELL BIOL, V141, P1589, DOI 10.1083/jcb.141.7.1589; LaJeunesse DR, 2001, GENETICS, V158, P667; Li W, 2012, EMBO REP, V13, P204, DOI 10.1038/embor.2012.11; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; McCartney BM, 2000, DEVELOPMENT, V127, P1315; McCartney BM, 1996, J CELL BIOL, V133, P843, DOI 10.1083/jcb.133.4.843; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; MCCLATCHEY AI, 1992, CELL, V68, P769, DOI 10.1016/0092-8674(92)90151-2; McClatchey AI, 2009, TRENDS CELL BIOL, V19, P198, DOI 10.1016/j.tcb.2009.02.006; Neisch AL, 2013, MOL BIOL CELL, V24, P1420, DOI 10.1091/mbc.E12-11-0800; Nguyen R, 2001, J BIOL CHEM, V276, P7621, DOI 10.1074/jbc.M006708200; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Schulz A, 2013, NAT NEUROSCI, V16, P426, DOI 10.1038/nn.3348; Scoles DR, 1998, NAT GENET, V18, P354, DOI 10.1038/ng0498-354; Sher I, 2012, DEV CELL, V22, P703, DOI 10.1016/j.devcel.2012.03.008; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; WILDER EL, 1995, DEVELOPMENT, V121, P477; Yang K, 2005, FEBS LETT, V579, P4113, DOI 10.1016/j.febslet.2005.06.039; Yi CL, 2010, GENE DEV, V24, P1673, DOI 10.1101/gad.1964810; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015	39	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90853	10.1371/journal.pone.0090853	http://dx.doi.org/10.1371/journal.pone.0090853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595234	Green Published, gold			2022-12-27	WOS:000332475500105
J	Li, JJ; Dolios, G; Wang, R; Liao, FF				Li, Jing Jing; Dolios, Georgia; Wang, Rong; Liao, Francesca-Fang			Soluble Beta-Amyloid Peptides, but Not Insoluble Fibrils, Have Specific Effect on Neuronal MicroRNA Expression	PLOS ONE			English	Article							LONG-TERM POTENTIATION; IMPAIR SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; A-BETA; POSTSYNAPTIC DENSITY-95; SECRETED OLIGOMERS; OXIDATIVE STRESS; SMALL RNAS; IN-VIVO; PROTEIN	Recent studies indicate that soluble beta-amyloid (sA beta) oligomers, rather than their fibrillar aggregates, contribute to the pathogenesis of Alzheimer's disease (AD), though the mechanisms of their neurotoxicity are still elusive. Here, we demonstrate that sA beta derived from 7PA2 cells exert a much stronger effect on the regulation of a set of functionally validated microRNAs (miRNAs) in primary cultured neurons than the synthetic insoluble A beta fibrils (fA beta). Synthetic sA beta peptides at a higher concentration present comparable effect on these miRNAs in our neuronal model. Further, the sA beta-induced miR-134, miR-145 and miR-210 expressions are fully reversed by two selective N-methyl-d-aspartate (NMDA) receptor inhibitors, but are neither reversed by insulin nor by forskolin, suggesting an NMDA receptor-dependent, rather than PI3K/AKT or PKA/CREB signaling dependent regulatory mechanism. In addition, the repression of miR-107 expression by the sA beta containing 7PA2 CM is likely involved multiple mechanisms and multiple players including NMDA receptor, N-terminally truncated A beta and reactive oxygen species (ROS).	[Li, Jing Jing; Liao, Francesca-Fang] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; [Dolios, Georgia; Wang, Rong] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA	University of Tennessee System; University of Tennessee Health Science Center; Icahn School of Medicine at Mount Sinai	Li, JJ (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA.	jli43@uthsc.edu; fliao@uthsc.edu	Wang, Rong/A-8721-2009		NIH [R01AG031893, R21AG041934, R21NS083908]; Alzheimer's Association [IIRG-11-204030]; NIH/NINDS [P30 NS061777]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061777, R21NS083908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031893, R21AG041934] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by research grants from NIH (R01AG031893, R21AG041934, R21NS083908); Alzheimer's Association (IIRG-11-204030 for F. F. L.); and NIH/NINDS P30 NS061777 for W. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschrafi A, 2008, J NEUROSCI, V28, P12581, DOI 10.1523/JNEUROSCI.3338-08.2008; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Boissonneault V, 2009, J BIOL CHEM, V284, P1971, DOI 10.1074/jbc.M807530200; Brouillette J, 2012, J NEUROSCI, V32, P7852, DOI 10.1523/JNEUROSCI.5901-11.2012; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Cui JG, 2010, J BIOL CHEM, V285, P38951, DOI 10.1074/jbc.M110.178848; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; delaMonte SM, 1997, J NEUROL SCI, V152, P73, DOI 10.1016/S0022-510X(97)00131-7; Eacker SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025068; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2013, J ALZHEIMERS DIS, V35, P335, DOI 10.3233/JAD-122350; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Irizarry MC, 1997, J NEUROSCI, V17, P7053; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kitamura Y, 1997, BIOCHEM BIOPH RES CO, V232, P418, DOI 10.1006/bbrc.1997.6301; Klein WL, 2013, J ALZHEIMERS DIS, V33, pS49, DOI 10.3233/JAD-2012-129039; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Kwak YD, 2012, J NEUROSCI, V32, P10971, DOI 10.1523/JNEUROSCI.1836-12.2012; Kye MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024682; Lambert TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015182; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lau P, 2013, EMBO MOL MED, V5, P1613, DOI 10.1002/emmm.201201974; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Li YY, 2011, NEUROSCI LETT, V487, P94, DOI 10.1016/j.neulet.2010.09.079; Lin Q, 2011, NAT NEUROSCI, V14, P1115, DOI 10.1038/nn.2891; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Lukiw Walter J, 2012, Int J Biochem Mol Biol, V3, P105; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Mok YF, 2006, METHOD ENZYMOL, V413, P199, DOI 10.1016/S0076-6879(06)13011-6; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Muller M, 2014, NEUROBIOL AGING, V35, P152, DOI 10.1016/j.neurobiolaging.2013.07.005; Nakanishi N, 2013, J NEUROSCI, V33, P14170, DOI 10.1523/JNEUROSCI.4646-10.2013; Portelius E, 2013, J ALZHEIMERS DIS, V33, P85, DOI 10.3233/JAD-2012-120994; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Schonrock N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011070; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shao NY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-409; Shrestha BR, 2006, MOL CELL NEUROSCI, V33, P274, DOI 10.1016/j.mcn.2006.07.011; Su D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054505; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Uljon SN, 2000, METH MOL B, V146, P439, DOI 10.1385/1-59259-045-4:439; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HL, 2010, BRAIN RES, V1357, P166, DOI 10.1016/j.brainres.2010.08.023; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202; Wang XY, 2009, BRAIN RES BULL, V80, P268, DOI 10.1016/j.brainresbull.2009.08.006; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Wong HKA, 2013, HUM MOL GENET, V22, P3077, DOI 10.1093/hmg/ddt164; Xie L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0001.2002; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yoon SO, 2012, NEURON, V75, P824, DOI 10.1016/j.neuron.2012.06.024	75	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90770	10.1371/journal.pone.0090770	http://dx.doi.org/10.1371/journal.pone.0090770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595404	gold, Green Submitted, Green Published			2022-12-27	WOS:000332475500100
J	Schmer, MR; Vogel, KP; Varvel, GE; Follett, RF; Mitchell, RB; Jin, VL				Schmer, Marty R.; Vogel, Kenneth P.; Varvel, Gary E.; Follett, Ronald F.; Mitchell, Robert B.; Jin, Virginia L.			Energy Potential and Greenhouse Gas Emissions from Bioenergy Cropping Systems on Marginally Productive Cropland	PLOS ONE			English	Article							LAND-USE CHANGE; CELLULOSIC ETHANOL; CARBON DEBT; CORN STOVER; NET ENERGY; SWITCHGRASS; BIOMASS; BIOFUELS; US; GRASSLANDS	Low-carbon biofuel sources are being developed and evaluated in the United States and Europe to partially offset petroleum transport fuels. Current and potential biofuel production systems were evaluated from a long-term continuous no-tillage corn (Zea mays L.) and switchgrass (Panicum virgatum L.) field trial under differing harvest strategies and nitrogen (N) fertilizer intensities to determine overall environmental sustainability. Corn and switchgrass grown for bioenergy resulted in near-term net greenhouse gas (GHG) reductions of -29 to -396 grams of CO2 equivalent emissions per megajoule of ethanol per year as a result of direct soil carbon sequestration and from the adoption of integrated biofuel conversion pathways. Management practices in switchgrass and corn resulted in large variation in petroleum offset potential. Switchgrass, using best management practices produced 3919 +/- 117 liters of ethanol per hectare and had 74 +/- 2.2 gigajoules of petroleum offsets per hectare which was similar to intensified corn systems (grain and 50% residue harvest under optimal N rates). Co-locating and integrating cellulosic biorefineries with existing dry mill corn grain ethanol facilities improved net energy yields (GJ ha(-1)) of corn grain ethanol by >70%. A multi-feedstock, landscape approach coupled with an integrated biorefinery would be a viable option to meet growing renewable transportation fuel demands while improving the energy efficiency of first generation biofuels.	[Schmer, Marty R.; Varvel, Gary E.; Jin, Virginia L.] Univ Nebraska, USDA ARS, Agroecosyst Management Res Unit, Lincoln, NE 68583 USA; [Vogel, Kenneth P.; Mitchell, Robert B.] Univ Nebraska, USDA ARS, Grain Forage & Bioenergy Res Unit, Lincoln, NE 68583 USA; [Follett, Ronald F.] USDA ARS, Soil Plant Nutrient Res Unit, Ft Collins, CO 80522 USA	United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA)	Schmer, MR (corresponding author), Univ Nebraska, USDA ARS, Agroecosyst Management Res Unit, Lincoln, NE 68583 USA.	marty.schmer@ars.usda.gov			U.S. Department of Agriculture (USDA), Agricultural Research Service (ARS); USDA-ARS GRACEnet effort; USDA Natural Resources Conservation Service	U.S. Department of Agriculture (USDA), Agricultural Research Service (ARS)(United States Department of Agriculture (USDA)); USDA-ARS GRACEnet effort; USDA Natural Resources Conservation Service(United States Department of Agriculture (USDA))	This research was funded by the U.S. Department of Agriculture (USDA), Agricultural Research Service (ARS) including funds from the USDA-ARS GRACEnet effort, and partly by the USDA Natural Resources Conservation Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PR, 2007, ECOL APPL, V17, P675, DOI 10.1890/05-2018; California Air Resources Board, 2013, LOW CARB FUEL STAND, P13; Claassen R., 2011, ERR120; Davis SC, 2012, FRONT ECOL ENVIRON, V10, P69, DOI 10.1890/110003; DOE US, 2011, ORNLTM2011224 DOE US; Donner SD, 2008, P NATL ACAD SCI USA, V105, P4513, DOI 10.1073/pnas.0708300105; Dunn JB, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-51; Energy Information Agency, 2013, DOEEIA0383; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Follett RF, 2013, SOIL SCI SOC AM J, V77, P951, DOI 10.2136/sssaj2012.0413; Follett RF, 2012, BIOENERG RES, V5, P866, DOI 10.1007/s12155-012-9198-y; Frank AB, 2004, CROP SCI, V44, P1391, DOI 10.2135/cropsci2004.1391; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Gelfand I, 2011, P NATL ACAD SCI USA, V108, P13864, DOI 10.1073/pnas.1017277108; GRABOSKI MS, 2002, FOSSIL ENERGY USE MA; Humbird D, 2011, NRELTP510047764 USDO, P136; Jin VL, 2011, ASA CSSA SSSA INT AN; Liebig MA, 2008, BIOENERG RES, V1, P215, DOI 10.1007/s12155-008-9019-5; Liska A. J., 2008, BESS BIOFUEL ENERGY; Liska AJ, 2008, J BIOBASED MATER BIO, V2, P187, DOI 10.1166/jbmb.2008.402; Liska AJ, 2009, J IND ECOL, V13, P58, DOI 10.1111/j.1530-9290.2008.00105.x; MacLean HL, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014001; Mitchell R, 2012, BIOFUELS-UK, V3, P47, DOI 10.4155/BFS.11.153; Plevin RJ, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/2/024003; Renewable and Applicable Energy Laboratory, 2007, EN RES GROUP BIOF AN; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Sheehan John, 2003, Journal of Industrial Ecology, V7, P117; Spatari S, 2010, BIORESOURCE TECHNOL, V101, P654, DOI 10.1016/j.biortech.2009.08.067; Templeton DW, 2009, CELLULOSE, V16, P621, DOI 10.1007/s10570-009-9325-x; Uden DR, 2013, BIOENERG RES, V6, P930, DOI 10.1007/s12155-013-9311-x; Unger N, 2010, P NATL ACAD SCI USA, V107, P3382, DOI 10.1073/pnas.0906548107; USDA-NASS, 2013, US CORN YIELDS; Varvel GE, 2008, BIOMASS BIOENERG, V32, P18, DOI 10.1016/j.biombioe.2007.07.003; Vogel KP, 2011, BIOENERG RES, V4, P96, DOI 10.1007/s12155-010-9104-4; Vogel KP, 2008, CROP SCI, V48, P2159, DOI 10.2135/cropsci2008.02.0117; Vogel KP, 2002, AGRON J, V94, P413, DOI 10.2134/agronj2002.0413; Wallace R, 2005, NREPTP51037092 USDOE; Wallander S., 2011, USDA ERS EC INFORM B, V79; Wang M, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045905; Wang M, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/2/024001; Wiens J, 2011, ECOL APPL, V21, P1085, DOI 10.1890/09-0673.1; Wilhelm WW, 2007, AGRON J, V99, P1665, DOI 10.2134/agronj2007.0150; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110	45	44	45	3	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89501	10.1371/journal.pone.0089501	http://dx.doi.org/10.1371/journal.pone.0089501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594783	Green Submitted, Green Published, gold			2022-12-27	WOS:000332475500015
J	Breitbach, S; Tug, S; Helmig, S; Zahn, D; Kubiak, T; Michal, M; Gori, T; Ehlert, T; Beiter, T; Simon, P				Breitbach, Sarah; Tug, Suzan; Helmig, Susanne; Zahn, Daniela; Kubiak, Thomas; Michal, Matthias; Gori, Tommaso; Ehlert, Tobias; Beiter, Thomas; Simon, Perikles			Direct Quantification of Cell-Free, Circulating DNA from Unpurified Plasma	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROME; MATERNAL PLASMA; CANCER-PATIENTS; PROGNOSTIC MARKER; QUANTITATIVE PCR; NUCLEIC-ACIDS; BREAST-CANCER; HUMAN GENOME; HUMAN-BLOOD	Cell-free DNA (cfDNA) in body tissues or fluids is extensively investigated in clinical medicine and other research fields. In this article we provide a direct quantitative real-time PCR (qPCR) as a sensitive tool for the measurement of cfDNA from plasma without previous DNA extraction, which is known to be accompanied by a reduction of DNA yield. The primer sets were designed to amplify a 90 and 222 bp multi-locus L1PA2 sequence. In the first module, cfDNA concentrations in unpurified plasma were compared to cfDNA concentrations in the eluate and the flow-through of the QIAamp DNA Blood Mini Kit and in the eluate of a phenol-chloroform isoamyl (PCI) based DNA extraction, to elucidate the DNA losses during extraction. The analyses revealed 2.79-fold higher cfDNA concentrations in unpurified plasma compared to the eluate of the QIAamp DNA Blood Mini Kit, while 36.7% of the total cfDNA were found in the flow-through. The PCI procedure only performed well on samples with high cfDNA concentrations, showing 87.4% of the concentrations measured in plasma. The DNA integrity strongly depended on the sample treatment. Further qualitative analyses indicated differing fractions of cfDNA fragment lengths in the eluate of both extraction methods. In the second module, cfDNA concentrations in the plasma of 74 coronary heart disease patients were compared to cfDNA concentrations of 74 healthy controls, using the direct L1PA2 qPCR for cfDNA quantification. The patient collective showed significantly higher cfDNA levels (mean (SD) 20.1 (23.8) ng/ml; range 5.1-183.0 ng/ml) compared to the healthy controls (9.7 (4.2) ng/ml; range 1.6-23.7 ng/ml). With our direct qPCR, we recommend a simple, economic and sensitive procedure for the quantification of cfDNA concentrations from plasma that might find broad applicability, if cfDNA became an established marker in the assessment of pathophysiological conditions.	[Breitbach, Sarah; Tug, Suzan; Helmig, Susanne; Ehlert, Tobias; Simon, Perikles] Johannes Gutenberg Univ Mainz, Dept Sports Med Rehabil & Prevent, D-55122 Mainz, Germany; [Zahn, Daniela; Kubiak, Thomas] Johannes Gutenberg Univ Mainz, Dept Hlth Psychol, D-55122 Mainz, Germany; [Michal, Matthias] Johannes Gutenberg Univ Mainz, Dept Psychosomat Med & Psychotherapy, D-55122 Mainz, Germany; [Gori, Tommaso] Johannes Gutenberg Univ Mainz, Dept Cardiol Angiol & Internal Med, D-55122 Mainz, Germany; [Beiter, Thomas] Univ Tubingen, Dept Sports Med, Med Clin, Tubingen, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Eberhard Karls University of Tubingen	Simon, P (corresponding author), Johannes Gutenberg Univ Mainz, Dept Sports Med Rehabil & Prevent, D-55122 Mainz, Germany.	simonpe@uni-mainz.de	Gori, Tommaso/F-1575-2012; Kubiak, Thomas/D-4655-2009; Simon, Perikles D/B-2293-2013	Kubiak, Thomas/0000-0003-0095-9265; Simon, Perikles D/0000-0002-7996-4034; Zahn, Daniela/0000-0002-0477-1369; Beiter, Thomas/0000-0001-7299-7303	Johannes Gutenberg University of Mainz	Johannes Gutenberg University of Mainz	This work was supported by the internal research funding of the Johannes Gutenberg University of Mainz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKER P, 1975, CANCER RES, V35, P2375; Antonatos D, 2006, ANN NY ACAD SCI, V1075, P278, DOI 10.1196/annals.1368.037; Atamaniuk J, 2004, CLIN CHEM, V50, P1668, DOI 10.1373/clinchem.2004.034553; Atamaniuk J, 2008, EUR J APPL PHYSIOL, V104, P711, DOI 10.1007/s00421-008-0827-2; Atamaniuk J, 2010, EUR J APPL PHYSIOL, V110, P695, DOI 10.1007/s00421-010-1532-5; Balta S, 2013, CARDIOLOGY, V126, P122, DOI 10.1159/000353266; Beck J, 2009, CLIN CHEM, V55, P730, DOI 10.1373/clinchem.2008.113597; Beiter T, 2011, CLIN CHEM, V57, P633, DOI 10.1373/clinchem.2010.158030; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Breitbach S, 2012, SPORTS MED, V42, P565, DOI 10.2165/11631380-000000000-00000; Brojer E, 2005, TRANSFUSION, V45, P1473, DOI 10.1111/j.1537-2995.2005.00559.x; Buzdin A, 2003, HUM GENET, V112, P527, DOI 10.1007/s00439-002-0904-2; Chan KCA, 2008, CLIN CANCER RES, V14, P4141, DOI 10.1158/1078-0432.CCR-08-0182; Chang CPY, 2003, CLIN CHIM ACTA, V327, P95, DOI 10.1016/S0009-8981(02)00337-6; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Clausen FB, 2007, PRENATAL DIAG, V27, P6, DOI 10.1002/pd.1605; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cui M, 2013, CARDIOLOGY, V126, P124, DOI 10.1159/000353665; Deligezer U, 2008, CLIN CHEM LAB MED, V46, P311, DOI 10.1515/CCLM.2008.080; Destouni A, 2009, ACTA CARDIOL, V64, P51, DOI 10.2143/AC.64.1.2034362; Esser KH, 2006, NAT METHODS, V3, pI, DOI 10.1038/NMETH853; Fatouros IG, 2006, CLIN CHEM, V52, P1820, DOI 10.1373/clinchem.2006.070417; Fatouros IG, 2010, CLIN BIOCHEM, V43, P1368, DOI 10.1016/j.clinbiochem.2010.08.020; Fleischhacker M, 2011, CLIN CHIM ACTA, V412, P2085, DOI 10.1016/j.cca.2011.07.011; Fong SL, 2009, CLIN CHEM, V55, P587, DOI 10.1373/clinchem.2008.110122; Heitzer E, 2013, INT J CANCER, V133, P346, DOI 10.1002/ijc.28030; Herrera LJ, 2005, CLIN CHEM, V51, P113, DOI 10.1373/clinchem.2004.039263; Huang DJ, 2005, CLIN CHEM, V51, P2419, DOI 10.1373/clinchem.2005.056010; Huggett Jim F, 2008, BMC Res Notes, V1, P70, DOI 10.1186/1756-0500-1-70; Jahr S, 2001, CANCER RES, V61, P1659; Jensen MK, 2013, J AM HEART ASS, V2, P1; Jiang F, 2013, INT UROL NEPHROL, V45, P1023, DOI 10.1007/s11255-013-0491-2; Lee YJ, 2011, CLIN CANCER RES, V17, P5179, DOI 10.1158/1078-0432.CCR-11-0400; Lehner J, 2013, INT J CLIN PHARM TH, V51, P59, DOI 10.5414/CPP51059; LOPAREV VN, 1991, J VIROL METHODS, V34, P105, DOI 10.1016/0166-0934(91)90126-K; Macher H, 2012, CLIN CHIM ACTA, V414, P12, DOI 10.1016/j.cca.2012.08.001; Mamon H, 2008, CLIN CHEM, V54, P1582, DOI 10.1373/clinchem.2008.104612; Mygind T, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-17; Parida SK, 2006, ADV COLLOID INTERFAC, V121, P77, DOI 10.1016/j.cis.2006.05.028; Pavlicek A, 2001, GENE, V276, P39, DOI 10.1016/S0378-1119(01)00645-X; Puszyk WM, 2009, CLIN BIOCHEM, V42, P736, DOI 10.1016/j.clinbiochem.2008.11.006; Rozen S, 2000, Methods Mol Biol, V132, P365; Sai S, 2007, ANTICANCER RES, V27, P2747; Salvianti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049843; Schmidt B, 2005, CLIN CHEM, V51, P1561, DOI 10.1373/clinchem.2005.051003; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Stroun M, 2001, CLIN CHIM ACTA, V313, P139, DOI 10.1016/S0009-8981(01)00665-9; Tamkovich SN, 2006, ANN NY ACAD SCI, V1075, P191, DOI 10.1196/annals.1368.026; Tangkijvanich P, 2007, CLIN CHIM ACTA, V379, P127, DOI 10.1016/j.cca.2006.12.029; Umetani N, 2006, J CLIN ONCOL, V24, P4270, DOI 10.1200/JCO.2006.05.9493; Umetani N, 2006, CLIN CHEM, V52, P1062, DOI 10.1373/clinchem.2006.068577; Umetani N, 2006, ANN NY ACAD SCI, V1075, P299, DOI 10.1196/annals.1368.040; van der Vaart M, 2008, ANN NY ACAD SCI, V1137, P18, DOI 10.1196/annals.1448.022; Yun DD, 1997, CARDIOLOGY, V88, P223, DOI 10.1159/000177335	55	96	101	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e87838	10.1371/journal.pone.0087838	http://dx.doi.org/10.1371/journal.pone.0087838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595313	Green Published, gold			2022-12-27	WOS:000332468900003
J	Hira, ZM; Trigeorgis, G; Gillies, DF				Hira, Zena M.; Trigeorgis, George; Gillies, Duncan F.			An Algorithm for Finding Biologically Significant Features in Microarray Data Based on A Priori Manifold Learning	PLOS ONE			English	Article							CLASSIFICATION; DISCOVERY; SELECTION; CANCER; ISOMAP	Microarray databases are a large source of genetic data, which, upon proper analysis, could enhance our understanding of biology and medicine. Many microarray experiments have been designed to investigate the genetic mechanisms of cancer, and analytical approaches have been applied in order to classify different types of cancer or distinguish between cancerous and non-cancerous tissue. However, microarrays are high-dimensional datasets with high levels of noise and this causes problems when using machine learning methods. A popular approach to this problem is to search for a set of features that will simplify the structure and to some degree remove the noise from the data. The most widely used approach to feature extraction is principal component analysis (PCA) which assumes a multivariate Gaussian model of the data. More recently, non-linear methods have been investigated. Among these, manifold learning algorithms, for example Isomap, aim to project the data from a higher dimensional space onto a lower dimension one. We have proposed a priori manifold learning for finding a manifold in which a representative set of microarray data is fused with relevant data taken from the KEGG pathway database. Once the manifold has been constructed the raw microarray data is projected onto it and clustering and classification can take place. In contrast to earlier fusion based methods, the prior knowledge from the KEGG databases is not used in, and does not bias the classification process-it merely acts as an aid to find the best space in which to search the data. In our experiments we have found that using our new manifold method gives better classification results than using either PCA or conventional Isomap.	[Hira, Zena M.; Trigeorgis, George; Gillies, Duncan F.] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England	Imperial College London	Hira, ZM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England.	zena.hira09@imperial.ac.uk	Trigeorgis, George/Y-8208-2019		Imperial College, Department of Computing	Imperial College, Department of Computing	George Trigeorgis and Zena Hira have been receiving PhD student funding from Imperial College, Department of Computing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian M, 2002, SCIENCE, V295; BELLMAN R, 1966, SCIENCE, V153, P34, DOI 10.1126/science.153.3731.34; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Cayton L., 2005, 12 U CAL, P1; Cayton L, 2005, CS20080923 U CAL; Chen X, 2008, BIOINFORMATICS; Chen X, 2009, J COMPUT BIOL, V16, P265, DOI 10.1089/cmb.2008.12TT; Chen Y, 2004, NUCLEIC ACIDS RES, V32, P6414, DOI 10.1093/nar/gkh978; Cheng Jill, 2004, J Biopharm Stat, V14, P687, DOI 10.1081/BIP-200025659; Choudhary A, 2006, BIOINFORMATICS, V22, P837, DOI 10.1093/bioinformatics/btl008; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Cobaleda C, 2009, BIOESSAYS, V31, P600, DOI 10.1002/bies.200800234; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dawson K, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-195; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Evangelista PF, 2005, P EUR S ART NEUR NET; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Jaccard P, 1901, B SOC VAUD SCI NAT, V37, P547, DOI [10.5169/seals.266450, DOI 10.5169/SEALS.266450, DOI 10.5169/SEALS-266450]; Jonnalagadda S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-267; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Kung S, 2009, MACHINE LEARNING BIO; Kustra R, 2010, IEEE ACM T COMPUT BI, V7, P50, DOI 10.1109/TCBB.2007.70267; Landgrebe J, 2002, GENOME BIOL, V3; Li C, 2008, BIOINFORMATICS; Liu H, 2008, CH CRC DATA MIN KNOW, P3; Liu QZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008250; McLachlan G, 2005, WILEY SERIES PROBABI; Misra J, 2002, GENOME RES, V12, P1112, DOI 10.1101/gr.225302; Nikulin Vladimir, 2009, Computational Intelligence Methods for Bioinformatics and Biostatistics. 6th International Meeting, CIBB 2009. Revised Selected Papers, P82; Orsenigo C, 2012, PATTERN RECOGN LETT, V33, P9, DOI 10.1016/j.patrec.2011.09.016; Osareh A, 2010, 2010 5 INT S HLTH IN, P114, DOI 10.1109/HIBIT.2010.5478895; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; Tai F, 2007, BIOINFORMATICS, V23, P1775, DOI 10.1093/bioinformatics/btm234; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319	38	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90562	10.1371/journal.pone.0090562	http://dx.doi.org/10.1371/journal.pone.0090562			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595155	gold, Green Published, Green Submitted			2022-12-27	WOS:000332468900117
J	Leuner, B; Fredericks, PJ; Nealer, C; Albin-Brooks, C				Leuner, Benedetta; Fredericks, Peter J.; Nealer, Connor; Albin-Brooks, Christopher			Chronic Gestational Stress Leads to Depressive-Like Behavior and Compromises Medial Prefrontal Cortex Structure and Function during the Postpartum Period	PLOS ONE			English	Article							AFFECTS MATERNAL-CARE; DENDRITIC SPINES; QUANTITATIVE-ANALYSIS; MUSHROOM SPINES; ANXIETY; PLASTICITY; GLUCOCORTICOIDS; CORTICOSTERONE; EXPERIENCE; PREGNANCY	Postpartum depression, which affects approximately 15% of new mothers, is associated with impaired mother-infant interactions and deficits in cognitive function. Exposure to stress during pregnancy is a major risk factor for postpartum depression. However, little is known about the neural consequences of gestational stress. The medial prefrontal cortex (mPFC) is a brain region that has been linked to stress, cognition, maternal care, and mood disorders including postpartum depression. Here we examined the effects of chronic gestational stress on mPFC function and whether these effects might be linked to structural modifications in the mPFC. We found that in postpartum rats, chronic gestational stress resulted in maternal care deficits, increased depressive-like behavior, and impaired performance on an attentional set shifting task that relies on the mPFC. Furthermore, exposure to chronic stress during pregnancy reduced dendritic spine density on mPFC pyramidal neurons and altered spine morphology. Taken together, these findings suggest that pregnancy stress may contribute to postpartum mental illness and its associated symptoms by compromising structural plasticity in the mPFC.	[Leuner, Benedetta] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Leuner, B (corresponding author), Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA.	leuner.1@osu.edu			United States National Institutes of Health [R00 MH084148]; National Alliance for Research on Schizophrenia and Depression; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH084148] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding was provided by the United States National Institutes of Health R00 MH084148 and the National Alliance for Research on Schizophrenia and Depression to BL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso VM, 2007, BEHAV NEUROSCI, V121, P515, DOI 10.1037/0735-7044.121.3.515; Atkinson L, 2009, DEV PSYCHOPATHOL, V21, P99, DOI 10.1017/S0954579409000078; Austin MP, 2001, BRIT J PSYCHIAT, V178, P200, DOI 10.1192/bjp.178.3.200; Avishai-Eliner S, 2002, TRENDS NEUROSCI, V25, P518, DOI 10.1016/S0166-2236(02)02241-5; Barbazanges A, 1996, J NEUROSCI, V16, P3943; Barrett J, 2011, J CHILD PSYCHOL PSYC, V52, P368, DOI 10.1111/j.1469-7610.2010.02306.x; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bloss EB, 2011, J NEUROSCI, V31, P7831, DOI 10.1523/JNEUROSCI.0839-11.2011; Boccia ML, 2007, PSYCHONEUROENDOCRINO, V32, P65, DOI 10.1016/j.psyneuen.2006.10.004; Bondi CO, 2008, NEUROPSYCHOPHARMACOL, V33, P320, DOI 10.1038/sj.npp.1301410; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Brand SR, 2009, CLIN OBSTET GYNECOL, V52, P441, DOI 10.1097/GRF.0b013e3181b52930; Brummelte S, 2010, PROG NEURO-PSYCHOPH, V34, P766, DOI 10.1016/j.pnpbp.2009.09.006; Brummelte S, 2012, NEUROPHARMACOLOGY, V62, P406, DOI 10.1016/j.neuropharm.2011.08.017; Brummelte S, 2010, HORM BEHAV, V58, P769, DOI 10.1016/j.yhbeh.2010.07.012; Champagne FA, 2006, BIOL PSYCHIAT, V59, P1227, DOI 10.1016/j.biopsych.2005.10.016; Christoffel DJ, 2011, REV NEUROSCIENCE, V22, P535, DOI 10.1515/RNS.2011.044; Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009; Darnaudery M, 2004, BEHAV BRAIN RES, V153, P211, DOI 10.1016/j.bbr.2003.12.001; DIORIO D, 1993, J NEUROSCI, V13, P3839; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duman RS, 2012, SCIENCE, V338, P68, DOI 10.1126/science.1222939; Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010; Febo M, 2010, BRAIN RES, V1325, P77, DOI 10.1016/j.brainres.2010.02.027; Fleming AS, 1999, NEUROSCI BIOBEHAV R, V23, P673, DOI 10.1016/S0149-7634(99)00011-1; Floresco SB, 2011, NEUROPSYCHOPHARMACOL, V36, P227, DOI 10.1038/npp.2010.158; Forlano PM, 2010, J COMP NEUROL, V518, P1330, DOI 10.1002/cne.22279; Gazal M, 2012, NEUROCHEM RES, V37, P583, DOI 10.1007/s11064-011-0647-3; Gonzalez A, 2012, J AM ACAD CHILD PSY, V51, P673, DOI 10.1016/j.jaac.2012.04.003; Gorman JM, 2010, J NEUROPSYCH CLIN N, V22, P256, DOI 10.1176/appi.neuropsych.22.3.256; Gourley SL, 2013, J NEUROSCI, V33, P3107, DOI 10.1523/JNEUROSCI.2138-12.2013; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Hillerer KM, 2011, ENDOCRINOLOGY, V152, P3930, DOI 10.1210/en.2011-1091; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kolb B, 2012, P NATL ACAD SCI USA, V109, P17186, DOI 10.1073/pnas.1121251109; Kurata A, 2009, HORM BEHAV, V56, P112, DOI 10.1016/j.yhbeh.2009.03.016; Lapiz-Bluhm MDS, 2008, J NEUROENDOCRINOL, V20, P1115, DOI 10.1111/j.1365-2826.2008.01772.x; Lemaire V, 2006, EUR J NEUROSCI, V23, P3368, DOI 10.1111/j.1460-9568.2006.04870.x; Leuner B, 2013, NEUROSCIENCE, V251, P108, DOI 10.1016/j.neuroscience.2012.04.021; Leuner B, 2010, TRENDS NEUROSCI, V33, P465, DOI 10.1016/j.tins.2010.07.003; Leuner B, 2010, J NEUROSCI, V30, P13499, DOI 10.1523/JNEUROSCI.3388-10.2010; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Logsdon MC, 2006, JOGNN-J OBST GYN NEO, V35, P652, DOI 10.1111/J.1552-6909.2006.00087.x; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Lovic V, 2004, BEHAV BRAIN RES, V148, P209, DOI 10.1016/S0166-4328(03)00206-7; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; McEwen AM, 2012, NEUROPSYCHOPHARMACOL, V37, P2428, DOI 10.1038/npp.2012.101; McEwen BS, 2013, NEURON, V79, P16, DOI 10.1016/j.neuron.2013.06.028; McLaughlin KJ, 2009, MOL NEUROBIOL, V40, P166, DOI 10.1007/s12035-009-8079-7; Moghaddam B, 2002, BIOL PSYCHIAT, V51, P775, DOI 10.1016/S0006-3223(01)01362-2; Moses-Kolko EL, 2010, AM J PSYCHIAT, V167, P1373, DOI 10.1176/appi.ajp.2010.09081235; Musazzi L, 2011, NEUROCHEM INT, V59, P138, DOI 10.1016/j.neuint.2011.05.002; O'Brien JA, 2006, NAT PROTOC, V1, P1517, DOI 10.1038/nprot.2006.258; O'Brien LM, 2004, PEDIATRICS, V113, P1242, DOI 10.1542/peds.113.5.1242; O'Mahony SM, 2006, NEUROIMMUNOMODULAT, V13, P82, DOI 10.1159/000096090; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Olazabal DE, 2013, NEUROSCI BIOBEHAV R, V37, P1875, DOI 10.1016/j.neubiorev.2013.04.004; Pereira M, 2011, J NEUROENDOCRINOL, V23, P1020, DOI 10.1111/j.1365-2826.2011.02200.x; de Almeida LSP, 2012, J AFFECT DISORDERS, V136, P1238, DOI 10.1016/j.jad.2011.09.031; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Radley JJ, 2008, J COMP NEUROL, V507, P1141, DOI 10.1002/cne.21588; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Smith JW, 2004, PSYCHONEUROENDOCRINO, V29, P227, DOI 10.1016/S0306-4530(03)00025-8; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; Staffend NA, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00014; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Walker CD, 2004, J PSYCHIATR NEUROSCI, V29, P364; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Workman JL, 2013, J NEUROENDOCRINOL, V25, P119, DOI 10.1111/j.1365-2826.2012.02380.x	74	66	69	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89912	10.1371/journal.pone.0089912	http://dx.doi.org/10.1371/journal.pone.0089912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594708	gold, Green Submitted, Green Published			2022-12-27	WOS:000332468900046
J	Miltz, A; Price, H; Shahmanesh, M; Copas, A; Gilson, R				Miltz, Ada; Price, Huw; Shahmanesh, Maryam; Copas, Andrew; Gilson, Richard			Systematic Review and Meta-Analysis of L1-VLP-Based Human Papillomavirus Vaccine Efficacy against Anogenital Pre-Cancer in Women with Evidence of Prior HPV Exposure	PLOS ONE			English	Review							CERVICAL INTRAEPITHELIAL NEOPLASIA; 18 RECOMBINANT VACCINE; PARTICLE VACCINE; YOUNG-WOMEN; DOUBLE-BLIND; QUADRIVALENT VACCINE; INFECTION; TYPE-18; DISEASE; CANCER	Background: It is unclear whether L1-VLP-based human papillomavirus (HPV) vaccines are efficacious in reducing the likelihood of anogenital pre-cancer in women with evidence of prior vaccine-type HPV exposure. This study aims to determine whether the combined results of the vaccine trials published to date provide evidence of efficacy compared with control (hepatitis A vaccine/placebo). Methods: A systematic review and meta-analysis was conducted. Randomized-controlled trials (RCTs) were identified from MEDLINE, Embase, Web of Science, PubMed, Cochrane Central Register of Controlled Trials and references of identified studies. The bivalent vaccine containing HPV-16 and 18 VLPs from GlaxoSmithKline Biologicals (Rixenstart, Belgium), the quadrivalent vaccine containing HPV-6, 11, 16, and 18 VLPs from Merck & Co., Inc., (Whitehouse Station, NJ USA), and the HPV-16 monovalent vaccine from Merck Research Laboratories (West Point, PA USA) were evaluated. Findings: Three RCT reports and two post-trial cohort studies were eligible, comprising data from 13,482 women who were included in the vaccine studies but had evidence of HPV infection at study entry. Data on efficacy was synthesized using the Mantel-Haenszel weighted fixed-effect approach, or where there was heterogeneity between studies, the DerSimonian and Laird weighted random-effect approach. The mean odds ratio (OR) and 95% confidence interval (CI) for the association between Cervarix, Gardasil and HPV-16 monovalent vaccine and HPV-associated cervical intraepithelial neoplasia grade 3 or worse was 0.90 (95% CI: 0.56, 1.44). For the association between Gardasil and HPV-associated vulval/vaginal intraepithelial neoplasia grades 2-3, the overall OR and 95% CI was 2.25 (95% CI: 0.78, 6.50). Sample size and follow-up were limited. Conclusions: There was no evidence that HPV vaccines are effective in preventing vaccine-type HPV associated pre-cancer in women with evidence of prior HPV exposure. Small effects of vaccination however cannot be excluded and a longer-term benefit in preventing re-infection remains possible.	[Miltz, Ada; Price, Huw; Shahmanesh, Maryam; Copas, Andrew; Gilson, Richard] UCL, Mortimer Market Ctr, Res Dept Infect & Populat Hlth, Ctr Sexual Hlth & HIV Res, London, England	University of London; University College London	Miltz, A (corresponding author), UCL, Mortimer Market Ctr, Res Dept Infect & Populat Hlth, Ctr Sexual Hlth & HIV Res, London, England.	Ada.Miltz.11@ucl.ac.uk		Copas, Andrew/0000-0001-8968-5963; Shahmanesh, Maryam/0000-0001-7129-8535				Castellsague X, 2011, BRIT J CANCER, V105, P28, DOI 10.1038/bjc.2011.185; Einstein MH, 2009, HUM VACCINES, V5, P705, DOI 10.4161/hv.5.10.9518; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Harbord R. M., 2009, METAANALYSIS STATA U, P138; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Harris RJ, 2009, METAANALYSIS STATA U, P29; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hildesheim A, 2007, JAMA-J AM MED ASSOC, V298, P743, DOI 10.1001/jama.298.7.743; Howell-Jones R, 2012, VACCINE, V30, P3867, DOI 10.1016/j.vaccine.2012.04.006; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Joura EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1401; Kang WD, 2013, GYNECOL ONCOL, V130, P264, DOI 10.1016/j.ygyno.2013.04.050; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Lu BB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-13; Mao C, 2006, OBSTET GYNECOL, V107, P18, DOI 10.1097/01.AOG.0000192397.41191.fb; McCormack PL, 2011, BIODRUGS, V25, P339, DOI 10.2165/11205060-000000000-00000; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Molano M, 2003, AM J EPIDEMIOL, V158, P486, DOI 10.1093/aje/kwg171; Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981; Munoz N, 2009, LANCET, V373, P1949, DOI 10.1016/S0140-6736(09)60691-7; Olsson SE, 2006, EUR RES ORG GEN INF; Olsson SE, 2007, VACCINE, V25, P4931, DOI 10.1016/j.vaccine.2007.03.049; Olsson SE, 2009, HUM VACCINES, V5, P696, DOI 10.4161/hv.5.10.9515; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; PRISMA, 2009, PRISMA CHECKL; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Schiller JT, 2008, VACCINE, V26, pK53, DOI 10.1016/j.vaccine.2008.06.002; Shin HR, 2003, INT J CANCER, V103, P413, DOI 10.1002/ijc.10825; StataCorp, 2009, STATA STAT SOFTW; Szarewski A, 2012, INT J CANCER, V131, P106, DOI 10.1002/ijc.26362; Villa L, 2007, LANCET, V369, P1861, DOI 10.1016/S0140-6736(07)60852-6; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Villa LL, 2006, VACCINE, V24, P5571, DOI 10.1016/j.vaccine.2006.04.068; Wheeler CM, 2009, J INFECT DIS, V199, P936, DOI 10.1086/597309	37	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90348	10.1371/journal.pone.0090348	http://dx.doi.org/10.1371/journal.pone.0090348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595046	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900097
J	Raza, FA; Rehman, SU; Khalid, R; Ahmad, J; Ashraf, S; Iqbal, M; Hasnain, S				Raza, Faiz Ahmed; Rehman, Shafiq Ur; Khalid, Ruqyya; Ahmad, Jameel; Ashraf, Sajjad; Iqbal, Mazhar; Hasnain, Shahida			Demographic and Clinico-Epidemiological Features of Dengue Fever in Faisalabad, Pakistan	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; RISK-FACTORS; VIRUS; SEVERITY; CHILDREN; KARACHI; ADULTS	This cross-sectional study was carried out to explore the epidemiological and clinical features of dengue fever in Faisalabad, Pakistan during 2011 and 2012. During the study period, anti-dengue IgM positive cases were reported in the post-monsoon period during the months of August-December. Certain hotspots for the dengue infection were identified in the city that coincide with the clusters of densely populated urban regions of the city. Out of total 299 IgM positive patients (male 218 and female 81); there were 239 dengue fever (DF) and 60 dengue hemorrhagic fever (DHF) patients. There was decrease in the median age of dengue patients from 31 years in 2011 to 21.5 years in 2012 (p<0.001). Abdominal pain was seen in 35% DHF patients followed by nausea in 28.3%, epistaxis in 25% and rash in 20% patients (p<0.05). Patients reported to be suffering from high-grade fever for an average of 8.83 days in DHF as compared to 5.82 days in DF before being hospitalized. Co-morbidities were found to be risk factor for the development of DHF in dengue patients. Clinical and laboratory features of dengue cases studied could be used for the early identification of patients at risk of severe dengue fever.	[Raza, Faiz Ahmed; Iqbal, Mazhar] Punjab Med Coll, Res Ctr, Pakistan Med Res Council, Faisalabad, Pakistan; [Raza, Faiz Ahmed; Rehman, Shafiq Ur; Hasnain, Shahida] Univ Punjab, Dept Microbiol & Mol Genet, Lahore, Pakistan; [Khalid, Ruqyya] Univ Punjab, Sch Biol Sci, Lahore, Pakistan; [Ahmad, Jameel] Allied Hosp, Dept Pathol, Faisalabad, Pakistan; [Ashraf, Sajjad] Chung Ang Univ, Nano Bio Energy Engn Sch Integrat Engn, Seoul 156756, South Korea	Punjab Medical College; University of Punjab; University of Punjab; Chung Ang University	Raza, FA (corresponding author), Punjab Med Coll, Res Ctr, Pakistan Med Res Council, Faisalabad, Pakistan.	faiz.raza@gmail.com	Ashraf, Sajjad/A-7479-2019; Rehman, shafiq ur/AAE-9102-2019; Hasnain, Shahida/I-6924-2015; Raza, Faiz Ahmed/N-5177-2014	Rehman, shafiq ur/0000-0002-1265-3442; Raza, Faiz Ahmed/0000-0002-8748-7741; Hasnain, Shahida/0000-0002-5916-7759; Ashraf, Sajjad/0000-0001-7987-4816; Khalid, Ruqyya/0000-0001-5658-3506	Pakistan Medical Research Council [4-23-4/11/Dengue/RDC/PMC/3495]	Pakistan Medical Research Council	This work was supported by Pakistan Medical Research Council (www.pmrc.org.pk) via Grant No. 4-23-4/11/Dengue/RDC/PMC/3495. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram Dure Samin, 1998, Indian Journal of Pediatrics, V65, P735, DOI 10.1007/BF02731055; Anker M, 2011, WEST PAC SURVEILL RE, V2, P17, DOI [10.5365/WPSAR.2011.2.1.002, 10.5365/wpsar.2011.2.1.002]; [Anonymous], 2003, INT WORKSH DEV REG S, p21e23; Barraud PJ., 1934, FAUNA BRIT INDIA INC, P420; Bhatty Shaheen, 2009, JPMA Journal of the Pakistan Medical Association, V59, P519; Carlos CC, 2005, AM J TROP MED HYG, V73, P435, DOI 10.4269/ajtmh.2005.73.435; da Rosa APAT, 2000, EMERG INFECT DIS, V6, P298; de Souza LJ, 2007, BRAZ J INFECT DIS, V11, P407, DOI 10.1590/S1413-86702007000400007; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Figueiredo MAA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000699; García-Rivera Enid J., 2003, Rev Panam Salud Publica, V13, P362, DOI 10.1590/S1020-49892003000500004; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Gulati S, 2007, TROP MED INT HEALTH, V12, P1087, DOI 10.1111/j.1365-3156.2007.01891.x; Gunther J, 2009, J CLIN VIROL, V45, P218, DOI 10.1016/j.jcv.2009.05.007; Guzman Maria G., 2002, International Journal of Infectious Diseases, V6, P118, DOI 10.1016/S1201-9712(02)90072-X; Hammond SN, 2005, AM J TROP MED HYG, V73, P1063; Jamil B, 2007, EMERG INFECT DIS, V13, P182, DOI 10.3201/eid1301.060376; Khan E, 2008, J CLIN VIROL, V43, P176, DOI 10.1016/j.jcv.2008.06.003; Khan E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012505; Laughlin CA, 2012, J INFECT DIS, V206, P1121, DOI 10.1093/infdis/jis351; Murgue B, 1999, TROP MED INT HEALTH, V4, P765, DOI 10.1046/j.1365-3156.1999.00478.x; Nishtar S, 2013, LANCET, V381, P2193, DOI 10.1016/S0140-6736(13)60019-7; Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/eid1206.051210; Pang JX, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001641; Rasheed SB, 2013, PUBLIC HEALTH, V127, P11, DOI 10.1016/j.puhe.2012.09.006; Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007; Shekhar K C, 1992, Asia Pac J Public Health, V6, P126; Thein TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081060; WHO, 2009, WHO TECH REP SER, V958, P1; World-Gazetteer, WORLD GAZETTEER; Yew YW, 2009, ANN ACAD MED SINGAP, V38, P667	31	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89868	10.1371/journal.pone.0089868	http://dx.doi.org/10.1371/journal.pone.0089868			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595236	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900041
J	Siawaya, JFD				Siawaya, Joel Fleury Djoba			Chlamydia trachomatis, Human Immunodeficiency Virus (HIV) Distribution and Sexual Behaviors across Gender and Age Group in an African Setting	PLOS ONE			English	Article							DRINKING INCARCERATED WOMEN; ADOLESCENT HEALTH; RISK-TAKING; PREVALENCE; PREVENTION; INFECTION; POPULATION; COUNTRIES; PATTERNS; STUDENTS	Objective: The purpose of this study was to (1) describe the distribution of Chlamydia trachomatis (CT) and Human Immunodeficiency Virus (HIV) cases across gender and age groups in Libreville (Gabon); (2) examine Gabonese Sexually Transmitted Infections (STIs)-related risk behaviour. Methods: The sampled population was people attending the "Laboratoire National de Sante Plublique''. Between 2007 and 2011, 14 667 and 9 542 people respectively, were tested for CT and HIV infections. 1 854 of them were tested for both infections. We calculated CT and HIV rates across gender and age groups. Also analysed was the groups' contribution to the general CT and HIV epidemiology. STIs-related risk behaviours were assessed in 224 men and 795 women (between July 2011 and March 2013) who agreed and answered a questionnaire including questions on their marital status, number of sex partners, sexual practices, history of STIs, sex frequency and condom use. Results: Data showed a 24% dropped in the CT infection rate between 2007 and 2010, followed by a 14% increase in 2011. The HIV infection rates for the same period were between 15% and 16%. The risk of a CT-positive subject getting HIV is about 0.71 times the risk of a CT-negative subject. Young adult aged between 18 and 35 years old represented 65.2% of people who had STIs. 80% of women and 66% of men confessed to an inconsistent use of condoms. 11.6% of women and 48% of men declared having multiple sex partners. 61% of questioned women and 67% of men declared knowing their HIV status. Conclusions: In this Gabonese setting, the population-aged from 18 to 35 years is the most affected by STIs. Other matters of concern are the inconsistent use of protection and sex with non-spousal or non-life partners.	LNSP, Unite Rech & Diagnost Specialise, Libreville, Gabon		Siawaya, JFD (corresponding author), LNSP, Unite Rech & Diagnost Specialise, BP 10736, Libreville, Gabon.	joelfleury@yahoo.com	Siawaya, Joel Fleury Djoba/N-3156-2019	Siawaya, Joel Fleury Djoba/0000-0002-0369-0153				Adams EJ, 2004, SEX TRANSM INFECT, V80, P354, DOI 10.1136/sti.2003.005454; Agency HP, 2008, SEX TRANSM INF YOUNG; Annang L, 2010, PUBLIC HEALTH REP, V125, P110, DOI 10.1177/00333549101250S415; [Anonymous], 2011, UNAIDS WORLD AIDS DA; [Anonymous], 2011, B RES SURV INF SEX T; Awusabo-Asare K, 2008, APPL HEALTH ECON HEA, V6, P27, DOI 10.2165/00148365-200806010-00003; Banandur P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S13; BERHAN A, 2012, WORLD J AIDS, V2, P78, DOI DOI 10.4236/WJA.2012.22011; Berhan Y, 2013, AIDS CARE, V25, P151, DOI 10.1080/09540121.2012.689812; Bertozzi SM, 2008, LANCET, V372, P831, DOI 10.1016/S0140-6736(08)60889-2; Bingenheimer JB, 2010, STUD FAMILY PLANN, V41, P1, DOI 10.1111/j.1728-4465.2010.00220.x; Blum RW, 2012, LANCET, V379, P1567, DOI 10.1016/S0140-6736(12)60407-3; Blum RW, 2009, LANCET, V374, P853, DOI 10.1016/S0140-6736(09)61607-X; Carael MaG J.R, 2007, HIV INFECT YOUNG ADU, P123; Catalano RF, 2012, LANCET, V379, P1653, DOI 10.1016/S0140-6736(12)60238-4; Caviness CM, 2012, WOMEN HEALTH, V52, P119, DOI 10.1080/03630242.2011.649396; CDC, 2011, HIV YOUTH; Direction Generale de la Statistique (DGS) International eI, 2013, ENQ DEM SANT GAB 201; Doyle AM, 2012, TROP MED INT HEALTH, V17, P796, DOI 10.1111/j.1365-3156.2012.03005.x; Eaton D., 2011, MORB MORTAL, V59, P1; Goulet V, 2010, SEX TRANSM INFECT, V86, P263, DOI 10.1136/sti.2009.038752; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Johnson WD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001230.pub2; Jonason PK, 2007, J SOC PSYCHOL, V147, P5, DOI 10.3200/SOCP.147.1.5-14; Jonason P, 2009, SEX ROLES, V60, P151, DOI 10.1007/s11199-008-9506-3; Kohli Ruchika, 2013, BMC Res Notes, V6, P44, DOI 10.1186/1756-0500-6-44; Le Marchand C, 2013, DRUG ALCOHOL DEPEND; Marangoni A, 2012, NEW MICROBIOL, V35, P215; McCoy SI, 2010, AIDS BEHAV, V14, P469, DOI 10.1007/s10461-009-9644-9; Mengistu TS, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-38; Neema S, 2006, ADOLESCENT SEXUAL RE; Ngandjio A, 2003, J CLIN MICROBIOL, V41, P4404, DOI 10.1128/JCM.41.9.4404-4407.2003; Nys S, 2004, J ANTIMICROB CHEMOTH, V54, P952, DOI 10.1093/jac/dkh448; Opio A, 2008, JAIDS-J ACQ IMM DEF, V49, P320, DOI 10.1097/QAI.0b013e3181893eb0; Pettifor A, LANCET, V379, P1280; Stein MD, 2009, J STUD ALCOHOL DRUGS, V70, P508, DOI 10.15288/jsad.2009.70.508; UNIAIDS WHO, 2009, GAB EP FACT SHEET HI; van der Helm JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068698; Wand H, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000005	40	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90174	10.1371/journal.pone.0090174	http://dx.doi.org/10.1371/journal.pone.0090174			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4CT	24594663	gold, Green Published			2022-12-27	WOS:000332468900075
J	Tong, H; Mrazek, J				Tong, Hao; Mrazek, Jan			Investigating the Interplay between Nucleoid-Associated Proteins, DNA Curvature, and CRISPR Elements Using Comparative Genomics	PLOS ONE			English	Article							SEQUENCE PERIODICITY; H-NS; GENE-EXPRESSION; IMMUNE-SYSTEM; CURVED DNA; 10-11 BP; BINDING; PROKARYOTES; PROMOTERS; BACTERIA	Many prokaryotic and eukaryotic genomes feature a characteristic periodic signal in distribution of short runs of A or T (A-tracts) phased with the DNA helical period of similar to 10-11 bp. Such periodic spacing of A-tracts has been associated with intrinsic DNA curvature. In eukaryotes, this periodicity is a major component of the nucleosome positioning signal but its physiological role in prokaryotes is not clear. One hypothesis centers on possible role of intrinsic DNA bends in nucleoid compaction. We use comparative genomics to investigate possible relationship between the A-tract periodicity and nucleoid-associated proteins in prokaryotes. We found that genomes with DNA-bridging proteins tend to exhibit stronger A-tract periodicity, presumably indicative of more prevalent intrinsic DNA curvature. A weaker relationship was detected for nucleoid-associated proteins that do not form DNA bridges. We consider these results an indication that intrinsic DNA curvature acts collaboratively with DNA-bridging proteins in maintaining the compact structure of the nucleoid, and that previously observed differences among prokaryotic genomes in terms DNA curvature-related sequence periodicity may reflect differences in nucleoid organization. We subsequently investigated the relationship between A-tract periodicity and presence of CRISPR elements and we found that genomes with CRISPR tend to have stronger A-tract periodicity. This result is consistent with our earlier hypothesis that extensive A-tract periodicity could help protect the chromosome against integration of prophages, possibly due to its role in compaction of the nucleoid.	[Tong, Hao] Univ Georgia, Dept Stat, Athens, GA 30602 USA; [Mrazek, Jan] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Mrazek, Jan] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Mrazek, J (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	mrazek@uga.edu			National Science Foundation [DBI-0950266]; Div Of Biological Infrastructure [0950266] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by the National Science Foundation grant no. DBI-0950266. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-188; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolshoy A, 2000, GENOME RES, V10, P1185, DOI 10.1101/gr.10.8.1185; Browning DF, 2010, CURR OPIN MICROBIOL, V13, P773, DOI 10.1016/j.mib.2010.09.013; Cho BK, 2008, GENOME RES, V18, P900, DOI 10.1101/gr.070276.107; Dame RT, 2001, BIOCHIMIE, V83, P231; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Herzel H, 1999, BIOINFORMATICS, V15, P187, DOI 10.1093/bioinformatics/15.3.187; Herzel H, 1998, J BIOMOL STRUCT DYN, V16, P341, DOI 10.1080/07391102.1998.10508251; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; KOO HS, 1986, NATURE, V320, P501, DOI 10.1038/320501a0; Kozobay-Avraham L, 2006, NUCLEIC ACIDS RES, V34, P2316, DOI 10.1093/nar/gkl230; Medina-Aparicio L, 2011, J BACTERIOL, V193, P2396, DOI 10.1128/JB.01480-10; Mrazek Jan, 2011, Microb Inform Exp, V1, P13, DOI 10.1186/2042-5783-1-13; Mrazek J, 2010, J BACTERIOL, V192, P3763, DOI 10.1128/JB.00149-10; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Robison K, 1998, J MOL BIOL, V284, P241, DOI 10.1006/jmbi.1998.2160; Schieg P, 2004, J MOL BIOL, V343, P891, DOI 10.1016/j.jmb.2004.08.068; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; Tolstorukov MY, 2005, NUCLEIC ACIDS RES, V33, P3907, DOI 10.1093/nar/gki699; TRIFONOV EN, 1980, P NATL ACAD SCI-BIOL, V77, P3816, DOI 10.1073/pnas.77.7.3816; ULANOVSKY LE, 1987, NATURE, V326, P720, DOI 10.1038/326720a0; Waterhouse RM, 2013, NUCLEIC ACIDS RES, V41, pD358, DOI 10.1093/nar/gks1116	26	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90940	10.1371/journal.pone.0090940	http://dx.doi.org/10.1371/journal.pone.0090940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595272	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900159
J	Bradford, AL; Forney, KA; Oleson, EM; Barlow, J				Bradford, Amanda L.; Forney, Karin A.; Oleson, Erin M.; Barlow, Jay			Accounting for Subgroup Structure in Line-Transect Abundance Estimates of False Killer Whales (Pseudorca crassidens) in Hawaiian Waters	PLOS ONE			English	Article							RESPONSIVE MOVEMENT; SOCIAL UNITS; POPULATION; PACIFIC; CETACEANS; PATTERNS; ISLANDS; DESIGN	For biological populations that form aggregations (or clusters) of individuals, cluster size is an important parameter in line-transect abundance estimation and should be accurately measured. Cluster size in cetaceans has traditionally been represented as the total number of individuals in a group, but group size may be underestimated if group members are spatially diffuse. Groups of false killer whales (Pseudorca crassidens) can comprise numerous subgroups that are dispersed over tens of kilometers, leading to a spatial mismatch between a detected group and the theoretical framework of line-transect analysis. Three stocks of false killer whales are found within the U. S. Exclusive Economic Zone of the Hawaiian Islands (Hawaiian EEZ): an insular main Hawaiian Islands stock, a pelagic stock, and a Northwestern Hawaiian Islands (NWHI) stock. A ship-based line-transect survey of the Hawaiian EEZ was conducted in the summer and fall of 2010, resulting in six systematic-effort visual sightings of pelagic (n = 5) and NWHI (n = 1) false killer whale groups. The maximum number and spatial extent of subgroups per sighting was 18 subgroups and 35 km, respectively. These sightings were combined with data from similar previous surveys and analyzed within the conventional line-transect estimation framework. The detection function, mean cluster size, and encounter rate were estimated separately to appropriately incorporate data collected using different methods. Unlike previous line-transect analyses of cetaceans, subgroups were treated as the analytical cluster instead of groups because subgroups better conform to the specifications of line-transect theory. Bootstrap values (n = 5,000) of the line-transect parameters were randomly combined to estimate the variance of stock-specific abundance estimates. Hawai'i pelagic and NWHI false killer whales were estimated to number 1,552 (CV = 0.66; 95% CI = 479-5,030) and 552 (CV = 1.09; 95% CI = 97-3,123) individuals, respectively. Subgroup structure is an important factor to consider in line-transect analyses of false killer whales and other species with complex grouping patterns.	[Bradford, Amanda L.; Oleson, Erin M.] Natl Ocean & Atmospher Adm, Protected Species Div, Pacific Isl Fisheries Sci Ctr, Natl Marine Fisheries Serv, Honolulu, HI 96813 USA; [Forney, Karin A.] Natl Ocean & Atmospher Adm, Marine Mammal & Turtle Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Santa Cruz, CA USA; [Barlow, Jay] Natl Ocean & Atmospher Adm, Marine Mammal & Turtle Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA	National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Bradford, AL (corresponding author), Natl Ocean & Atmospher Adm, Protected Species Div, Pacific Isl Fisheries Sci Ctr, Natl Marine Fisheries Serv, Honolulu, HI 96813 USA.	amanda.bradford@noaa.gov	Oleson, Erin/AAA-9681-2019; Barlow, Jay/D-3565-2019	Oleson, Erin/0000-0002-4889-6059; Barlow, Jay/0000-0001-7862-855X	National Marine Fisheries Service of the National Oceanic and Atmospheric Administration	National Marine Fisheries Service of the National Oceanic and Atmospheric Administration	This study was supported by the National Marine Fisheries Service of the National Oceanic and Atmospheric Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AcevedoGutierrez A, 1997, MAR MAMMAL SCI, V13, P307, DOI 10.1111/j.1748-7692.1997.tb00634.x; Baird RW, 2008, MAR MAMMAL SCI, V24, P591, DOI 10.1111/j.1748-7692.2008.00200.x; Baird RW, 2013, PAC SCI, V67, P513, DOI 10.2984/67.4.2; Baird Robin W., 2012, Endangered Species Research, V18, P47, DOI 10.3354/esr00435; Baird Robin W., 2010, Endangered Species Research, V10, P107, DOI 10.3354/esr00258; Baird RW, 2000, CAN J ZOOL, V73, P1300; BARLOW J, 1995, FISH B-NOAA, V93, P1; Barlow J, 2006, MAR MAMMAL SCI, V22, P446, DOI 10.1111/j.1748-7692.2006.00032.x; Barlow J, 2005, MAR MAMMAL SCI, V21, P429, DOI 10.1111/j.1748-7692.2005.tb01242.x; Barlow J., 2007, LJ0702 SW FISH SCI C; Barlow J, 2007, FISH B-NOAA, V105, P509; Barlow Jay, 2001, Journal of Cetacean Research and Management, V3, P201; Becker EA, 2012, SPECIES RES, V16, P97; Borchers DL, 1998, BIOMETRICS, V54, P1221, DOI 10.2307/2533652; Buckland S.T., 2001, pi; Buckland ST, 2010, INT J PRIMATOL, V31, P833, DOI 10.1007/s10764-010-9431-5; Burnham K.P., 1987, American Fisheries Society Monograph, P1; Caretta JV, 2009, NMFSSWFSC434 NOAA US; Chivers SJ, 2010, NMFSSWFSC458 NOAA US; Chivers SJ, 2007, CAN J ZOOL, V85, P783, DOI 10.1139/Z07-059; Christal J, 1998, CAN J ZOOL, V76, P1431, DOI 10.1139/cjz-76-8-1431; Dawson S, 2004, FISH B-NOAA, V102, P441; Ferrari SF, 2010, AM J PRIMATOL, V72, P1100, DOI 10.1002/ajp.20873; Forney KA, 1998, MAR MAMMAL SCI, V14, P460, DOI 10.1111/j.1748-7692.1998.tb00737.x; Forney KA, 2011, MAR ECOL-EVOL PERSP, V32, P380, DOI 10.1111/j.1439-0485.2011.00454.x; Gerrodette T, 2005, MAR ECOL PROG SER, V291, P1, DOI 10.3354/meps291001; GILMARTIN M, 1974, J EXP MAR BIOL ECOL, V16, P181, DOI 10.1016/0022-0981(74)90019-7; Hammond P.S., 1984, REPORT INT WHALING C, V34, P543; LO NCH, 1994, CAL COOP OCEAN FISH, V35, P246; Marques FFC, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P31; Martien KK, 2011, PSRG201114; NMFS, 2005, REV GUID ASS MAR MAM; Oleson EM, 2010, NMFSPIFSC22 NOAA US; Ottensmeyer CA, 2003, CAN J ZOOL, V81, P1327, DOI 10.1139/Z03-127; Palka DL, 2001, CAN J FISH AQUAT SCI, V58, P777, DOI 10.1139/cjfas-58-4-777; Schwarz Lisa K., 2010, Journal of Cetacean Research and Management, V11, P253; TEC Inc, 2009, REP PREP NOAA NMFS P; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; TURNOCK BJ, 1991, BIOMETRICS, V47, P701, DOI 10.2307/2532156; Zerbini AN, 2007, MAR BIOL, V150, P1033, DOI 10.1007/s00227-006-0347-8	40	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90464	10.1371/journal.pone.0090464	http://dx.doi.org/10.1371/journal.pone.0090464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587372	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200206
J	Dai, L; Trillo-Tinoco, J; Bai, LH; Kang, BL; Xu, ZG; Wen, XF; Del Valle, L; Qin, ZQ				Dai, Lu; Trillo-Tinoco, Jimena; Bai, Lihua; Kang, Baoli; Xu, Zengguang; Wen, Xiaofei; Del Valle, Luis; Qin, Zhiqiang			Systematic Analysis of a Xenograft Mice Model for KSHV+ Primary Effusion Lymphoma (PEL)	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; PROTEIN-COUPLED RECEPTOR; NF-KAPPA-B; KAPOSIS-SARCOMA; SOLID LYMPHOMAS; CELL-LINES; ANTIRETROVIRAL THERAPY; INFLAMMATORY CYTOKINES; ENDOTHELIAL-CELLS; DUAL INHIBITION	Kaposi's sarcoma-associated herpesvirus is the causative agent of primary effusion lymphoma (PEL), which arises preferentially in the setting of infection with human immunodeficiency virus (HIV). Even with standard cytotoxic chemotherapy, PEL continues to cause high mortality rates, requiring the development of novel therapeutic strategies. PEL xenograft models employing immunodeficient mice have been used to study the in vivo effects of a variety of therapeutic approaches. However, it remains unclear whether these xenograft models entirely reflect clinical presentations of KSHV+ PEL, especially given the recent description of extracavitary solid tumor variants arising in patients. In addition, effusion and solid tumor cells propagated in vivo exhibit unique biology, differing from one another or from their parental cell lines propagated through in vitro culture. Therefore, we used a KSHV+ PEL/BCBL-1 xenograft model involving non-obese diabetic/severe-combined immunodeficient (NOD/SCID) mice, and compared characteristics of effusion and solid tumors with their parent cell culture-derived counterparts. Our results indicate that although this xenograft model can be used for study of effusion and solid lymphoma observed in patients, tumor cells in vivo display unique features to those passed in vitro, including viral lytic gene expression profile, rate of solid tumor development, the host proteins and the complex of tumor microenvironment. These items should be carefully considered when the xenograft model is used for testing novel therapeutic strategies against KSHV-related lymphoma.	[Dai, Lu; Qin, Zhiqiang] Tongji Univ, Sch Med, Res Ctr Translat Med, Shanghai 200092, Peoples R China; [Dai, Lu; Qin, Zhiqiang] Tongji Univ, Sch Med, East Hosp, Key Lab Arrhythmias,Minist Educ China, Shanghai 200092, Peoples R China; [Qin, Zhiqiang] Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Microbiol, New Orleans, LA USA; [Qin, Zhiqiang] Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Immunol, New Orleans, LA USA; [Qin, Zhiqiang] Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Parasitol, New Orleans, LA USA; [Dai, Lu] Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Med, New Orleans, LA USA; [Trillo-Tinoco, Jimena; Del Valle, Luis] Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Pathol, New Orleans, LA USA; [Bai, Lihua; Kang, Baoli; Xu, Zengguang] Tongji Univ, Sch Med, East Hosp, Cent Lab, Shanghai 200092, Peoples R China; [Wen, Xiaofei] Tongji Univ, Sch Med, East Hosp, Dept Urol, Shanghai 200092, Peoples R China	Tongji University; Ministry of Education, China; Tongji University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tongji University; Tongji University	Qin, ZQ (corresponding author), Tongji Univ, Sch Med, Res Ctr Translat Med, Shanghai 200092, Peoples R China.	zqin@lsuhsc.edu	Del Valle, Luis/J-4085-2015	Del Valle, Luis/0000-0003-3894-9206; Trillo-Tinoco, Jimena/0000-0002-1240-9650	Center for Biomedical Research Excellence Award [P20-RR021970]; SOM Research Enhancement Funding [5497400038]; National Natural Science Foundation [81272191]; NNSF for Young Scientists of China [81101791]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103501] Funding Source: NIH RePORTER	Center for Biomedical Research Excellence Award; SOM Research Enhancement Funding; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NNSF for Young Scientists of China; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from a Center for Biomedical Research Excellence Award (P20-RR021970 to ZQ and LDV), the SOM Research Enhancement Funding (5497400038 to ZQ), the National Natural Science Foundation (81272191 to ZQ) and the NNSF for Young Scientists of China (81101791 to ZQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 2004, LEUKEMIA, V18, P1699, DOI 10.1038/sj.leu.2403460; Aoki Y, 2000, BLOOD, V96, P1599, DOI 10.1182/blood.V96.4.1599.h8001599_1599_1601; Bais C, 2003, CANCER CELL, V3, P131, DOI 10.1016/S1535-6108(03)00024-2; Bala K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002927; Bellare P, 2009, CELL HOST MICROBE, V6, P570, DOI 10.1016/j.chom.2009.11.008; Bhatt AP, 2010, BLOOD, V115, P4455, DOI 10.1182/blood-2009-10-251082; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Cannon M, 2003, J VIROL, V77, P57, DOI 10.1128/JVI.77.1.57-67.2003; Capello D, 2000, LEUKEMIA, V14, P285, DOI 10.1038/sj.leu.2401666; Carbone A, 2005, J MOL DIAGN, V7, P17, DOI 10.1016/S1525-1578(10)60004-9; Carbone A, 2008, BRIT J HAEMATOL, V140, P13, DOI 10.1111/j.1365-2141.2007.06879.x; Carbone A, 2010, AIDS, V24, P479, DOI 10.1097/QAD.0b013e3283365395; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Chadburn A, 2004, AM J SURG PATHOL, V28, P1401, DOI 10.1097/01.pas.0000138177.10829.5c; Chaisuparat R, 2008, CANCER RES, V68, P8361, DOI 10.1158/0008-5472.CAN-08-0878; Chang J, 2000, VIROLOGY, V266, P17, DOI 10.1006/viro.1999.0077; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen DM, 2009, J VIROL, V83, P722, DOI 10.1128/JVI.01517-08; Chen YB, 2007, ONCOLOGIST, V12, P569, DOI 10.1634/theoncologist.12-5-569; Cirone M, 2008, IMMUNOL LETT, V120, P37, DOI 10.1016/j.imlet.2008.06.011; Cohen A, 2006, J GEN VIROL, V87, P795, DOI 10.1099/vir.0.81619-0; Cousins E, 2013, J VIROL, V87, P10816, DOI 10.1128/JVI.02047-13; Gopalakrishnan R, 2013, CLIN CANCER RES, V19, P5016, DOI 10.1158/1078-0432.CCR-12-3510; Haque M, 2006, J VIROL, V80, P7037, DOI 10.1128/JVI.00553-06; Hocqueloux L, 2001, AIDS, V15, P280, DOI 10.1097/00002030-200101260-00023; Jones KD, 1999, BLOOD, V94, P2871; Katano H, 2000, MODERN PATHOL, V13, P77, DOI 10.1038/modpathol.3880012; Lefort S, 2009, J VIROL, V83, P5869, DOI 10.1128/JVI.01821-08; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Li XD, 2011, J VIROL, V85, P715, DOI 10.1128/JVI.01742-10; Liang DG, 2011, CELL RES, V21, P793, DOI 10.1038/cr.2011.5; Lim ST, 2005, ANN HEMATOL, V84, P551, DOI 10.1007/s00277-005-1040-6; Lin XZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016224; Lu CC, 2010, EMBO REP, V11, P784, DOI 10.1038/embor.2010.132; Mercader M, 2000, AM J PATHOL, V156, P1961, DOI 10.1016/S0002-9440(10)65069-9; Oksenhendler E, 2000, BLOOD, V96, P2069, DOI 10.1182/blood.V96.6.2069.h8002069_2069_2073; Oksenhendler E, 1998, AM J HEMATOL, V57, P266, DOI 10.1002/(SICI)1096-8652(199803)57:3<266::AID-AJH25>3.0.CO;2-7; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Qin ZQ, 2010, J LEUKOCYTE BIOL, V87, P25, DOI 10.1189/jlb.0409251; Samols MA, 2005, J VIROL, V79, P9301, DOI 10.1128/JVI.79.14.9301-9305.2005; Sarosiek KA, 2010, P NATL ACAD SCI USA, V107, P13069, DOI 10.1073/pnas.1002985107; Sin SH, 2007, BLOOD, V109, P2165, DOI 10.1182/blood-2006-06-028092; Towata T, 2010, LEUKEMIA RES, V34, P906, DOI 10.1016/j.leukres.2009.12.010; Uddin S, 2005, CLIN CANCER RES, V11, P3102, DOI 10.1158/1078-0432.CCR-04-1857; Vart RJ, 2007, CANCER RES, V67, P4042, DOI 10.1158/0008-5472.CAN-06-3321; Yanagisawa Y, 2006, J PATHOL, V209, P464, DOI 10.1002/path.2012; Ye FC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002054; Zhang YJ, 2011, ANTIVIR THER, V16, P657, DOI 10.3851/IMP1810	48	14	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90349	10.1371/journal.pone.0090349	http://dx.doi.org/10.1371/journal.pone.0090349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587336	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200177
J	Shiell, MM; Champoux, F; Zatorre, RJ				Shiell, Martha M.; Champoux, Francois; Zatorre, Robert J.			Enhancement of Visual Motion Detection Thresholds in Early Deaf People	PLOS ONE			English	Article							CROSS-MODAL PLASTICITY; AUDITORY DEPRIVATION; EARLY-BLIND; SIGN-LANGUAGE; HEARING; PERCEPTION; ATTENTION; ORGANIZATION; MOVEMENT; CORTEX	In deaf people, the auditory cortex can reorganize to support visual motion processing. Although this cross-modal reorganization has long been thought to subserve enhanced visual abilities, previous research has been unsuccessful at identifying behavioural enhancements specific to motion processing. Recently, research with congenitally deaf cats has uncovered an enhancement for visual motion detection. Our goal was to test for a similar difference between deaf and hearing people. We tested 16 early and profoundly deaf participants and 20 hearing controls. Participants completed a visual motion detection task, in which they were asked to determine which of two sinusoidal gratings was moving. The speed of the moving grating varied according to an adaptive staircase procedure, allowing us to determine the lowest speed necessary for participants to detect motion. Consistent with previous research in deaf cats, the deaf group had lower motion detection thresholds than the hearing. This finding supports the proposal that cross-modal reorganization after sensory deprivation will occur for supramodal sensory features and preserve the output functions.	[Shiell, Martha M.; Zatorre, Robert J.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Shiell, Martha M.; Champoux, Francois; Zatorre, Robert J.] BRAMS Int Lab Brain Mus & Sound Res, Montreal, PQ, Canada; [Shiell, Martha M.; Champoux, Francois; Zatorre, Robert J.] CRBLM Ctr Res Brain Language & Mus, Montreal, PQ, Canada; [Champoux, Francois] Univ Montreal, Ecole Orthophonie & Audiol, Montreal, PQ, Canada; [Champoux, Francois] Montreal Metropolitain Inst Raymond Dewar, Ctr Rech Interdisciplinaire Readaptat, Montreal, PQ, Canada	McGill University; Universite de Montreal; Universite de Montreal	Shiell, MM (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	martha.shiell@mail.mcgill.ca			Canadian Institutes of Health Research; Canada Fund for Innovation; Natural Sciences and Engineering Research Council; Centre for Research on Brain, Language, and Music; Centre of Excellence for Commercialization and Research; Natural Sciences and Engineering Research Council of Canada; Fonds de Recherche Sante Quebec; Vanier Canada Graduate fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Fund for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre for Research on Brain, Language, and Music; Centre of Excellence for Commercialization and Research; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de Recherche Sante Quebec; Vanier Canada Graduate fellowship	This work was supported by grants from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) to RJZ; the Canada Fund for Innovation (innovation.ca) to RJZ; the Natural Sciences and Engineering Research Council to RJZ (www.nserc-crsng.gc.ca); an Interdisciplinary Graduate Student Award from the Centre for Research on Brain, Language, and Music to MMS, RJZ, and FC (www.crblm.ca); and by a Centre of Excellence for Commercialization and Research award to the Montreal Neurological Institute (www.nce-rce.gc.ca). FC was supported by grants from the Natural Sciences and Engineering Research Council of Canada; and Fonds de Recherche Sante Quebec (www.frsq.gouv.qc.ca). MMS was supported by a Vanier Canada Graduate fellowship (www.vanier.gc.ca). The funder's had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong BA, 2002, COGNITIVE BRAIN RES, V14, P422, DOI 10.1016/S0926-6410(02)00211-2; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bavelier D, 2001, J NEUROSCI, V21, P8931, DOI 10.1523/JNEUROSCI.21-22-08931.2001; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Bavelier D, 2010, NAT NEUROSCI, V13, P1309, DOI 10.1038/nn1110-1309; Bosworth RG, 2013, BRAIN COGNITION, V82, P117, DOI 10.1016/j.bandc.2013.01.006; Bosworth RG, 2002, BRAIN COGNITION, V49, P170, DOI 10.1006/brcg.2001.1498; Bosworth RG, 2002, BRAIN COGNITION, V49, P152, DOI 10.1006/brcg.2001.1497; Bosworth RG, 1999, PSYCHOL SCI, V10, P256, DOI 10.1111/1467-9280.00146; Bottari D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025607; Brozinsky CJ, 2004, COGNITIVE BRAIN RES, V21, P1, DOI 10.1016/j.cogbrainres.2004.05.002; Codina C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020417; Collignon O, 2009, EXP BRAIN RES, V192, P343, DOI 10.1007/s00221-008-1553-z; Dye MWG, 2010, RESTOR NEUROL NEUROS, V28, P181, DOI 10.3233/RNN-2010-0501; Fine I, 2005, J COGNITIVE NEUROSCI, V17, P1621, DOI 10.1162/089892905774597173; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; Finney EM, 2001, COGNITIVE BRAIN RES, V11, P171, DOI 10.1016/S0926-6410(00)00082-3; Giraud AL, 2001, NEURON, V30, P657, DOI 10.1016/S0896-6273(01)00318-X; Gougoux F, 2005, PLOS BIOL, V3, P324, DOI 10.1371/journal.pbio.0030027; Harrell RW., 2002, HDB CLIN AUDIOLOGY, V5, P71; Hauthal N, 2013, ADV COGN PSYCHOL, V9, P53, DOI [10.2478/v10053-008-0131-z, 10.5709/acp-0131-z]; KAERNBACH C, 1991, PERCEPT PSYCHOPHYS, V49, P227, DOI 10.3758/BF03214307; Karns CM, 2012, J NEUROSCI, V32, P9626, DOI 10.1523/JNEUROSCI.6488-11.2012; Krumbholz K, 2005, EUR J NEUROSCI, V21, P230, DOI 10.1111/j.1460-9568.2004.03836.x; Kupers R, 2014, NEUROSCI BIOBEHAV R, V41, P36, DOI 10.1016/j.neubiorev.2013.08.001; Lee HJ, 2005, HEARING RES, V203, P2, DOI 10.1016/j.heares.2004.11.005; Lee HJ, 2007, BRAIN, V130, P2929, DOI 10.1093/brain/awm230; LOKE WH, 1991, B PSYCHONOMIC SOC, V29, P437; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; Meredith MA, 2011, P NATL ACAD SCI USA, V108, P8856, DOI 10.1073/pnas.1018519108; MERIGAN WH, 1991, J NEUROSCI, V11, P3422; NEVILLE HJ, 1987, BRAIN RES, V405, P268, DOI 10.1016/0006-8993(87)90296-4; Pascual-Leone A, 2001, PROG BRAIN RES, V134, P427; Pavani F, 2002, CURR BIOL, V12, P1584, DOI 10.1016/S0960-9822(02)01143-0; Petitto LA, 2000, P NATL ACAD SCI USA, V97, P13961, DOI 10.1073/pnas.97.25.13961; Poirier C, 2006, NEUROIMAGE, V31, P279, DOI 10.1016/j.neuroimage.2005.11.036; Port Michael, 2010, DEVELOPMENTAL SCI, V14, P725; Proksch J, 2002, J COGNITIVE NEUROSCI, V14, P687, DOI 10.1162/08989290260138591; Renier LA, 2010, NEURON, V68, P138, DOI 10.1016/j.neuron.2010.09.021; Sadato N, 2005, CEREB CORTEX, V15, P1113, DOI 10.1093/cercor/bhh210; Shiell MM, 2013, REORGANIZATION UNPUB; Stevens C, 2006, J COGNITIVE NEUROSCI, V18, P701, DOI 10.1162/jocn.2006.18.5.701; Strelnikov K, 2013, BRAIN, V136, P3682, DOI 10.1093/brain/awt274; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P263; Voss P, 2008, NEUROIMAGE, V40, P746, DOI 10.1016/j.neuroimage.2007.12.020; Voss P, 2012, CURR BIOL, V22, pR168, DOI 10.1016/j.cub.2012.01.030; Voss P, 2010, WIRES COGN SCI, V1, P308, DOI 10.1002/wcs.13; Warren JD, 2002, NEURON, V34, P139, DOI 10.1016/S0896-6273(02)00637-2	48	42	45	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90498	10.1371/journal.pone.0090498	http://dx.doi.org/10.1371/journal.pone.0090498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587381	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200215
J	Vasudeva, K; Andersen, K; Zeyzus-Johns, B; Hitchens, TK; Patel, SK; Balducci, A; Janjic, JM; Pollock, JA				Vasudeva, Kiran; Andersen, Karl; Zeyzus-Johns, Bree; Hitchens, T. Kevin; Patel, Sravan Kumar; Balducci, Anthony; Janjic, Jelena M.; Pollock, John A.			Imaging Neuroinflammation In Vivo in a Neuropathic Pain Rat Model with Near-Infrared Fluorescence and F-19 Magnetic Resonance	PLOS ONE			English	Article							DORSAL-ROOT GANGLIA; CHRONIC CONSTRICTION INJURY; PRIMARY SENSORY NEURONS; UP-REGULATION; MECHANICAL ALLODYNIA; NEUROPEPTIDE-Y; SCIATIC-NERVE; INFLAMMATION; RECEPTOR; HYPERALGESIA	Chronic neuropathic pain following surgery represents a serious worldwide health problem leading to life-long treatment and the possibility of significant disability. In this study, neuropathic pain was modeled using the chronic constriction injury (CCI). The CCI rats exhibit mechanical hypersensitivity (typical neuropathic pain symptom) to mechanical stimulation of the affected paw 11 days post surgery, at a time when sham surgery animals do not exhibit hypersensitivity. Following a similar time course, TRPV1 gene expression appears to rise with the hypersensitivity to mechanical stimulation. Recent studies have shown that immune cells play a role in the development of neuropathic pain. To further explore the relationship between neuropathic pain and immune cells, we hypothesize that the infiltration of immune cells into the affected sciatic nerve can be monitored in vivo by molecular imaging. To test this hypothesis, an intravenous injection of a novel perfluorocarbon (PFC) nanoemulsion, which is phagocytosed by inflammatory cells (e.g. monocytes and macrophages), was used in a rat CCI model. The nanoemulsion carries two distinct imaging agents, a near-infrared (NIR) lipophilic fluorescence reporter (DiR) and a F-19 MRI (magnetic resonance imaging) tracer, PFC. We demonstrate that in live rats, NIR fluorescence is concentrated in the area of the affected sciatic nerve. Furthermore, the F-19 MRI signal was observed on the sciatic nerve. Histological examination of the CCI sciatic nerve reveals significant infiltration of CD68 positive macrophages. These results demonstrate that the infiltration of immune cells into the sciatic nerve can be visualized in live animals using these methods.	[Vasudeva, Kiran; Andersen, Karl; Zeyzus-Johns, Bree; Pollock, John A.] Duquesne Univ, Bayer Sch Nat & Environm Sci, Pittsburgh, PA 15219 USA; [Vasudeva, Kiran; Andersen, Karl; Zeyzus-Johns, Bree; Patel, Sravan Kumar; Janjic, Jelena M.; Pollock, John A.] Duquesne Univ, Chron Pain Res Consortium, Pittsburgh, PA 15219 USA; [Hitchens, T. Kevin] Carnegie Mellon Univ, NMR Ctr Biomed Res, Pittsburgh, PA 15213 USA; [Patel, Sravan Kumar; Janjic, Jelena M.] Duquesne Univ, Grad Sch Pharmaceut Sci, Mylan Sch Pharm, Pittsburgh, PA 15219 USA; [Balducci, Anthony] Celsense Inc, Dept Res & Dev, Pittsburgh, PA USA	Duquesne University; Duquesne University; Carnegie Mellon University; Duquesne University	Pollock, JA (corresponding author), Duquesne Univ, Bayer Sch Nat & Environm Sci, Pittsburgh, PA 15219 USA.	pollock@duq.edu	Patel, Sravan Kumar/H-2713-2017	Patel, Sravan Kumar/0000-0002-1235-3458; Janjic, Jelena/0000-0002-0539-8359; Pollock, John/0000-0001-6602-3676	Hunkele Dreaded Disease Award; Samuel and Emma Winters Foundation Award; Pennsylvania's Commonwealth Universal Research Enhancement (CURE) Award; Pittsburgh Tissue Engineering Initiative Interface Seed Grant	Hunkele Dreaded Disease Award; Samuel and Emma Winters Foundation Award; Pennsylvania's Commonwealth Universal Research Enhancement (CURE) Award; Pittsburgh Tissue Engineering Initiative Interface Seed Grant	Funding for this work was provided by a Hunkele Dreaded Disease Award to JAP, a Samuel and Emma Winters Foundation Award to JAP, a Pennsylvania's Commonwealth Universal Research Enhancement (CURE) Award to JMJ and a Pittsburgh Tissue Engineering Initiative Interface Seed Grant to JMJ & JAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ET, 2011, BIOTECHNIQUES, V50, P229, DOI 10.2144/000113652; Andersen LB, 1999, EXP NEUROL, V155, P157, DOI 10.1006/exnr.1998.6903; Balducci A, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23034; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Baron R, 2001, Curr Pain Headache Rep, V5, P114, DOI 10.1007/s11916-001-0079-x; Bedoui S, 2007, PEPTIDES, V28, P373, DOI 10.1016/j.peptides.2006.07.029; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Boehm-Sturm P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029040; Chen JJ, 2010, WIRES NANOMED NANOBI, V2, P431, DOI 10.1002/wnan.87; CLATWORTHY AL, 1995, NEUROSCI LETT, V184, P5, DOI 10.1016/0304-3940(94)11154-B; Cortright DN, 2009, CURR PHARM DESIGN, V15, P1736, DOI 10.2174/138161209788186308; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Eisenblatter M, 2009, J NUCL MED, V50, P1676, DOI 10.2967/jnumed.108.060707; Field MJ, 1999, PAIN, V83, P303, DOI 10.1016/S0304-3959(99)00111-6; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Hong SS, 2008, J NEUROCHEM, V105, P1212, DOI 10.1111/j.1471-4159.2008.05220.x; Hu P, 2002, NEUROSCIENCE, V112, P23, DOI 10.1016/S0306-4522(02)00065-9; Janjic JM, 2009, WIRES NANOMED NANOBI, V1, P492, DOI 10.1002/wnan.35; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Jones RCW, 2005, J NEUROSCI, V25, P10981, DOI 10.1523/JNEUROSCI.0703-05.2005; Kadayakkara DK, 2012, LAB INVEST, V92, P636, DOI 10.1038/labinvest.2012.7; Kanai Y, 2005, NEUROPHARMACOLOGY, V49, P977, DOI 10.1016/j.neuropharm.2005.05.003; Lari R, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2616; LESLIE TA, 1995, NEUROSCIENCE, V67, P753, DOI 10.1016/0306-4522(95)00101-N; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma WY, 2005, J NEUROCHEM, V93, P664, DOI 10.1111/j.1471-4159.2005.03050.x; Mannelli LD, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/328797; Mayer-Kuckuk P, 2006, BONE, V39, P965, DOI 10.1016/j.bone.2006.05.009; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Moran TD, 2004, J NEUROPHYSIOL, V92, P3266, DOI 10.1152/jn.00096.2004; Morin N, 2007, J NEUROIMMUNOL, V184, P164, DOI 10.1016/j.jneuroim.2006.12.009; Moriwaki K, 1997, PAIN, V72, P277, DOI 10.1016/S0304-3959(97)00029-8; Myers RR, 1996, EXP NEUROL, V141, P94, DOI 10.1006/exnr.1996.0142; National Research Council, 2011, REL PAIN AM BLUEPR T; Patel SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055802; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Smith PA, 2007, PEPTIDES, V28, P464, DOI 10.1016/j.peptides.2006.09.029; Somers DL, 2003, ARCH PHYS MED REHAB, V84, P1575, DOI 10.1053/S0003-9993(03)00290-9; Srinivas M, 2007, MAGN RESON MED, V58, P725, DOI 10.1002/mrm.21352; Srinivas M, 2010, TRENDS BIOTECHNOL, V28, P363, DOI 10.1016/j.tibtech.2010.04.002; Srinivas M, 2009, MAGN RESON MED, V62, P747, DOI 10.1002/mrm.22063; Staaf S, 2009, PAIN, V144, P187, DOI 10.1016/j.pain.2009.04.013; STANTONHICKS M, 1995, PAIN, V63, P127, DOI 10.1016/0304-3959(95)00110-E; Stucky CL, 2009, BRAIN RES REV, V60, P2, DOI 10.1016/j.brainresrev.2008.12.018; Suyama H, 2002, J BONE MINER METAB, V20, P91, DOI 10.1007/s007740200012; SWETT JE, 1991, EXP NEUROL, V114, P82, DOI 10.1016/0014-4886(91)90087-S; SWETT JE, 1985, J COMP NEUROL, V231, P66, DOI 10.1002/cne.902310106; Szabo A, 2005, J PHARMACOL EXP THER, V314, P111, DOI 10.1124/jpet.104.082487; Tal, 1999, Curr Rev Pain, V3, P440; Temme S, 2012, WIRES NANOMED NANOBI, V4, P329, DOI 10.1002/wnan.1163; Thacker MA, 2007, ANESTH ANALG, V105, P838, DOI 10.1213/01.ane.0000275190.42912.37; VANDERZEE CEEM, 1989, J NEUROSCI, V9, P3505; Voets T, 2005, NAT CHEM BIOL, V1, P85, DOI 10.1038/nchembio0705-85; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Wang LLX, 2003, ADV DRUG DELIVER REV, V55, P949, DOI 10.1016/S0169-409X(03)00098-X; Weise G, 2011, EXP NEUROL, V229, P494, DOI 10.1016/j.expneurol.2011.03.020; Wheway J, 2007, PEPTIDES, V28, P453, DOI 10.1016/j.peptides.2006.09.030; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Xu GY, 2007, GASTROENTEROLOGY, V133, P1282, DOI 10.1053/j.gastro.2007.06.015	60	32	32	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90589	10.1371/journal.pone.0090589	http://dx.doi.org/10.1371/journal.pone.0090589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587398	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200232
J	Yoshimoto, S; Imai, H; Kashino, M; Takeuchi, T				Yoshimoto, Sanae; Imai, Hisato; Kashino, Makio; Takeuchi, Tatsuto			Pupil Response and the Subliminal Mere Exposure Effect	PLOS ONE			English	Article							AFFECTIVE DISCRIMINATION; PROCESSING FLUENCY; VISUAL-STIMULI; DILATION; ATTENTION; DIAMETER; MEMORY; LOAD	The subliminal mere exposure effect (SMEE) is the phenomenon wherein people tend to prefer patterns they have repeatedly observed without consciously identifying them. One popular explanation for the SMEE is that perceptual fluency within exposed patterns is misattributed to a feeling of preference for those patterns. Assuming that perceptual fluency is negatively correlated with the amount of mental effort needed to analyze perceptual aspects of incoming stimuli, pupil diameter should associate with SMEE strength since the former is known to reflect mental effort. To examine this hypothesis, we measured participants' pupil diameter during exposure to subthreshold stimuli. Following exposure, a preference test was administered. Average pupil diameter throughout exposure was smaller when the SMEE was induced than when the SMEE was not induced. This supports the hypothesis that increasing perceptual fluency during mere exposure modulates autonomic nervous responses, such as pupil diameter, and eventually leads to preference.	[Yoshimoto, Sanae; Takeuchi, Tatsuto] Japan Womens Univ, Dept Psychol, Kawasaki, Kanagawa, Japan; [Yoshimoto, Sanae; Kashino, Makio; Takeuchi, Tatsuto] NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan; [Yoshimoto, Sanae; Kashino, Makio; Takeuchi, Tatsuto] Japan Sci & Technol Agcy, CREST, Atsugi, Kanagawa, Japan; [Imai, Hisato] Gakushuin Univ, Dept Psychol, Toshima Ku, Tokyo 171, Japan	Japan Womens University; Nippon Telegraph & Telephone Corporation; Japan Science & Technology Agency (JST); Gakushuin University	Yoshimoto, S (corresponding author), Japan Womens Univ, Dept Psychol, Kawasaki, Kanagawa, Japan.	n1384003ys@gr.jwu.ac.jp			JSPS KAKENHI [22330206]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant Number 22330206 (http://www.jsps.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyoun DC, 1998, SOC BEHAV PERSONAL, V26, P415, DOI 10.2224/sbp.1998.26.4.415; Alter AL, 2006, P NATL ACAD SCI USA, V103, P9369, DOI 10.1073/pnas.0601071103; Barbur J.L., 2004, VISUAL NEUROSCIENCES, P641; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Bonnano GA, 1986, AM J PSYCHOL, V99, P403; BORNSTEIN RF, 1992, J PERS SOC PSYCHOL, V63, P545, DOI 10.1037//0022-3514.63.4.545; BORNSTEIN RF, 1994, SOC COGNITION, V12, P103, DOI 10.1521/soco.1994.12.2.103; BORNSTEIN RF, 1987, J PERS SOC PSYCHOL, V53, P1070, DOI 10.1037/0022-3514.53.6.1070; BORNSTEIN RF, 1989, PSYCHOL BULL, V106, P265, DOI 10.1037/0033-2909.106.2.265; Boucsein W., 1992, ELECTRODERMAL ACTIVI; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carle CF, 2013, INVEST OPHTH VIS SCI, V54, P467, DOI 10.1167/iovs.12-10829; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; HESS EH, 1960, SCIENCE, V132, P349, DOI 10.1126/science.132.3423.349; JACOBY LL, 1989, J EXP PSYCHOL GEN, V118, P115, DOI 10.1037/0096-3445.118.2.115; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; KUNSTWILSON WR, 1980, SCIENCE, V207, P557, DOI 10.1126/science.7352271; Laeng B, 2012, P NATL ACAD SCI USA, V109, P2162, DOI 10.1073/pnas.1118298109; Lee AY, 2001, PERS SOC PSYCHOL B, V27, P1255, DOI 10.1177/01461672012710002; LIBBY WL, 1973, PSYCHOPHYSIOLOGY, V10, P270, DOI 10.1111/j.1469-8986.1973.tb00526.x; Link B, 2006, INVEST OPHTH VIS SCI, V47, P4947, DOI 10.1167/iovs.06-0021; Loewenfeld I. E., 1999, PUPIL ANATOMY PHYSL; Monahan JL, 2000, PSYCHOL SCI, V11, P462, DOI 10.1111/1467-9280.00289; Oppenheimer DM, 2008, TRENDS COGN SCI, V12, P237, DOI 10.1016/j.tics.2008.02.014; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Porter G, 2007, Q J EXP PSYCHOL, V60, P211, DOI 10.1080/17470210600673818; Privitera CM, 2010, J VISION, V10, DOI 10.1167/10.10.3; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; SEAMON JG, 1984, J EXP PSYCHOL LEARN, V10, P465, DOI 10.1037/0278-7393.10.3.465; SEAMON JG, 1983, J EXP PSYCHOL LEARN, V9, P544, DOI 10.1037/0278-7393.9.3.544; STEINHAUER SR, 1983, PSYCHOPHYSIOLOGY, V20, P472; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; Takeuchi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021973; Van Orden KF, 2000, BIOL PSYCHOL, V52, P221, DOI 10.1016/S0301-0511(99)00043-5; Winkielman P, 2006, PSYCHOL SCI, V17, P799, DOI 10.1111/j.1467-9280.2006.01785.x; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; Zajonc RB, 2001, CURR DIR PSYCHOL SCI, V10, P224, DOI 10.1111/1467-8721.00154; Zylberberg A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00316	40	8	8	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90670	10.1371/journal.pone.0090670	http://dx.doi.org/10.1371/journal.pone.0090670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24587408	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200243
J	Barboza, P; Vaillant, L; Le Strat, Y; Hartley, DM; Nelson, NP; Mawudeku, A; Madoff, LC; Linge, JP; Collier, N; Brownstein, JS; Astagneau, P				Barboza, Philippe; Vaillant, Laetitia; Le Strat, Yann; Hartley, David M.; Nelson, Noele P.; Mawudeku, Abla; Madoff, Lawrence C.; Linge, Jens P.; Collier, Nigel; Brownstein, John S.; Astagneau, Pascal			Factors Influencing Performance of Internet-Based Biosurveillance Systems Used in Epidemic Intelligence for Early Detection of Infectious Diseases Outbreaks	PLOS ONE			English	Article							EARLY WARNING SYSTEM; PROMED-MAIL; SURVEILLANCE; IMPORTATION; BIOCASTER	Background: Internet-based biosurveillance systems have been developed to detect health threats using information available on the Internet, but system performance has not been assessed relative to end-user needs and perspectives. Method and Findings: Infectious disease events from the French Institute for Public Health Surveillance (InVS) weekly international epidemiological bulletin published in 2010 were used to construct the gold-standard official dataset. Data from six biosurveillance systems were used to detect raw signals (infectious disease events from informal Internet sources): Argus, BioCaster, GPHIN, HealthMap, MedISys and ProMED-mail. Crude detection rates (C-DR), crude sensitivity rates (C-Se) and intrinsic sensitivity rates (I-Se) were calculated from multivariable regressions to evaluate the systems' performance (events detected compared to the gold-standard) 472 raw signals (Internet disease reports) related to the 86 events included in the gold-standard data set were retrieved from the six systems. 84 events were detected before their publication in the gold-standard. The type of sources utilised by the systems varied significantly (p < 0001). I-Se varied significantly from 43% to 71% (p = 0001) whereas other indicators were similar (C-DR: p = 020; C-Se, p = 013). I-Se was significantly associated with individual systems, types of system, languages, regions of occurrence, and types of infectious disease. Conversely, no statistical difference of C-DR was observed after adjustment for other variables. Conclusion: Although differences could result from a biosurveillance system's conceptual design, findings suggest that the combined expertise amongst systems enhances early detection performance for detection of infectious diseases. While all systems showed similar early detection performance, systems including human moderation were found to have a 53% higher I-Se (p = 00001) after adjustment for other variables. Overall, the use of moderation, sources, languages, regions of occurrence, and types of cases were found to influence system performance.	[Barboza, Philippe; Vaillant, Laetitia] Inst Veille Sanit, French Inst Publ Hlth Surveillance, Int Dept, St Maurice, France; [Le Strat, Yann] Inst Veille Sanit, French Inst Publ Hlth Surveillance, Infect Dept, St Maurice, France; [Hartley, David M.] Georgetown Univ, Dept Microbiol & Immunol, Med Ctr, Washington, DC USA; [Hartley, David M.] Georgetown Univ, Sch Med, Imaging Sci & Informat Syst Ctr, Washington, DC USA; [Nelson, Noele P.] Georgetown Univ, Med Ctr, Dept Pediat, Washington, DC 20007 USA; [Mawudeku, Abla] Publ Hlth Agcy Canada, Ctr Emergency Preparedness & Response, Ottawa, ON, Canada; [Madoff, Lawrence C.] Int Soc Infect Dis, ProMED Mail, Boston, MA USA; [Linge, Jens P.] Commiss European Communities, Joint Res Ctr, I-21020 Ispra, Italy; [Collier, Nigel] Natl Inst Informat, Tokyo, Japan; [Collier, Nigel] European Bioinformat Inst, Cambridge, England; [Brownstein, John S.] Harvard Univ, Sch Med, Boston Childrens Hosp, Boston, MA USA; [Astagneau, Pascal] PRES Sorbonne Cite, Univ Sch Publ Hlth, EHESP, Paris, France	Institute of Public Health Surveillance; Institute of Public Health Surveillance; Georgetown University; Georgetown University; Georgetown University; Public Health Agency of Canada; European Commission Joint Research Centre; EC JRC ISPRA Site; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; European Molecular Biology Laboratory (EMBL); Harvard University; Boston Children's Hospital; Harvard Medical School; Ecole des Hautes Etudes en Sante Publique (EHESP)	Barboza, P (corresponding author), Inst Veille Sanit, French Inst Publ Hlth Surveillance, Int Dept, St Maurice, France.	barbozap@who.int	Le Strat, Yann/C-9848-2013; Astagneau, Pascal/AAF-3473-2020	Le Strat, Yann/0000-0002-6180-4200; Hartley, David/0000-0003-2589-2538; Collier, Nigel/0000-0002-7230-4164				[Anonymous], 2010, W NIL VIR CIRC EPISO; Barboza P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057252; Barboza Philippe, 2007, Rev Prat, V57, P867; Bitar D, 2009, B ACAD NAT MED PARIS, V193, P1847, DOI 10.1016/S0001-4079(19)32418-5; Brownstein J., 2007, EUROSURVEILLANCE, V12, DOI DOI 10.2807/ESW.12.48.03322-EN5; Collier N, 2008, BIOINFORMATICS, V24, P2940, DOI 10.1093/bioinformatics/btn534; Cowen P, 2006, JAVMA-J AM VET MED A, V229, P1090, DOI 10.2460/javma.229.7.1090; Formenty P, 2006, MED MALADIES INFECT, V36, P9, DOI 10.1016/j.medmal.2005.06.009; Hartley DM, 2013, CLIN MICROBIOL INFEC, V19, P1006, DOI 10.1111/1469-0691.12273; Hartley Dm, 2010, Emerg Health Threats J, V3, pe3, DOI 10.3134/ehtj.10.003; Heymann D L, 2001, Lancet Infect Dis, V1, P345, DOI 10.1016/S1473-3099(01)00148-7; Institut de Veille Sanitaire website, EP INT I VEILL SAN I; Institut de Veille Sanitaire website, B HEBD INT; Josseran L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011984; Ledrans M, 2007, EUROSURVEILLANCE, V12; Linge JP, 2009, EUROSURVEILLANCE, V14; Lyon A, 2012, TRANSBOUND EMERG DIS, V59, P223, DOI 10.1111/j.1865-1682.2011.01258.x; Madoff LC, 2004, CLIN INFECT DIS, V39, P227, DOI 10.1086/422003; Mawudeku A, 2008, P 7 C ASS MACH TRANS; Morse SS, 2012, BIOSECUR BIOTERROR, V10, P6, DOI 10.1089/bsp.2011.0088; Nelson NP, 2010, EUROSURVEILLANCE, V15, P7; Paquet C, 2012, EUROSURVEILLANCE, V12, P212; Rotureau B, 2007, EMERG INFECT DIS, V13, P1590, DOI 10.3201/eid1310.070522; Woodall J P, 2001, Cad Saude Publica, V17 Suppl, P147, DOI 10.1590/S0102-311X2001000700024; Zhang ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015314; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	26	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90536	10.1371/journal.pone.0090536	http://dx.doi.org/10.1371/journal.pone.0090536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599062	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400090
J	Kim, YW; Jeong, YJ; Kim, AY; Son, HH; Lee, JA; Jung, CH; Kim, CH; Kim, J				Kim, Young-Wook; Jeong, Young-Ju; Kim, Ah-Young; Son, Hyun-Hee; Lee, Jong-Am; Jung, Cheong-Hwan; Kim, Chae-Hyun; Kim, Jaeman			Lactobacillus brevis Strains from Fermented Aloe vera Survive Gastroduodenal Environment and Suppress Common Food Borne Enteropathogens	PLOS ONE			English	Article							GLUTAMATE-DECARBOXYLASE; ACID; MICROENCAPSULATION; BACTERIA; BARBADENSIS; CLONING; SAFETY; GENE	Five novel Lactobacillus brevis strains were isolated from naturally fermented Aloe vera leaf flesh. Each strain was identified by Random Amplified Polymorphic DNA (RAPD) analysis and 16S rRNA sequence comparison. These strains were highly tolerant to acid, surviving in pH2.5 for up to 4 hours, and resistant to 5% bile salts at 37 degrees C for 18 hours. Due to its tolerance to acid and bile salts, one strain passed through the gastric barrier and colonised the intestine after oral administration. All five strains inhibited the growth of many harmful enteropathogens without restraining most of normal commensals in the gut and hence named POAL (Probiotics Originating from Aloe Leaf) strains. Additionally, each strain exhibited discriminative resistance to a wide range of antibiotics. The L. brevis POAL strains, moreover, expressed high levels of the glutamate decarboxylase (GAD) gene which produces a beneficial neurotransmitter, gamma-aminobutyric acid (GABA). These characteristics in all suggest that the novel L. brevis strains should be considered as potential food additives and resources for pharmaceutical research.	[Kim, Young-Wook; Jeong, Young-Ju; Son, Hyun-Hee; Lee, Jong-Am; Jung, Cheong-Hwan; Kim, Chae-Hyun] KBNP Inc, KBNP Technol Inst, Yesan, South Korea; [Kim, Ah-Young] Chonnam Natl Univ, Sch Biol Sci & Technol, Kwangju, South Korea; [Kim, Jaeman] Mokpo Natl Univ, Dept Biol, Muan, South Korea	Chonnam National University; Mokpo National University	Kim, J (corresponding author), Mokpo Natl Univ, Dept Biol, Muan, South Korea.	jkim@mokpo.ac.kr			KBNP Inc.	KBNP Inc.	This study was supported by KBNP Inc., a manufacturing company specialising in animal health products for providing funding in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcroft M, 2003, ALOE VERA NATURES SE; Betoret N, 2003, J FOOD ENG, V56, P273, DOI 10.1016/S0260-8774(02)00268-6; Chandramouli V, 2004, J MICROBIOL METH, V56, P27, DOI 10.1016/j.mimet.2003.09.002; Cho JK, 2007, KOREAN J FOOD SCI AN, V27, P363, DOI 10.5851/kosfa.2007.27.3.363; Chou LS, 1999, J DAIRY SCI, V82, P23, DOI 10.3168/jds.S0022-0302(99)75204-5; Collado MC, 2007, LETT APPL MICROBIOL, V45, P454, DOI 10.1111/j.1472-765X.2007.02212.x; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Deng Xinhua, 1999, Journal of Plant Resources and Environment, V8, P26; Ding WK, 2009, J FOOD SCI, V74, pM53, DOI 10.1111/j.1750-3841.2008.01030.x; ERLANDER MG, 1991, NEUROCHEM RES, V16, P215, DOI 10.1007/BF00966084; Esteban-Carrasco A, 2001, PLANT PHYSIOL BIOCH, V39, P521, DOI 10.1016/S0981-9428(01)01270-0; Ezendam J, 2006, NUTR REV, V64, P1, DOI [10.1301/nr.2006.jan.1-14, 10.1111/j.1753-4887.2006.tb00168.x]; Farnell MB, 2005, J APPL MICROBIOL, V99, P1043, DOI 10.1111/j.1365-2672.2005.02712.x; Favaro-Trindade CS, 2002, J MICROENCAPSUL, V19, P485, DOI 10.1080/02652040210140715; Ferro VA, 2003, ANTIMICROB AGENTS CH, V47, P1137, DOI 10.1128/AAC.47.3.1137-1139.2003; Ge SY, 2007, TRENDS NEUROSCI, V30, P1, DOI 10.1016/j.tins.2006.11.001; Kang TK, 2010, KOREAN J FOOD SCI AN, V30, P795, DOI 10.5851/kosfa.2010.30.5.795; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kim TW, 2009, INT J FOOD MICROBIOL, V131, P265, DOI 10.1016/j.ijfoodmicro.2009.03.001; Makras L, 2006, INT DAIRY J, V16, P1049, DOI 10.1016/j.idairyj.2005.09.006; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Morelli L, 2000, Curr Issues Intest Microbiol, V1, P59; National Committee for Clinical Laboratory Standards, 2004, M11A6 NCCLS CLIN LAB; Park KB, 2007, BIORESOURCE TECHNOL, V98, P312, DOI 10.1016/j.biortech.2006.01.004; Park Ki-Bum, 2004, Preventive Nutrition and Food Science, V9, P324; Park S. Y., 1996, KOR J APPL MICROBIOL, V24, P304; 강효진, 2004, [Korean Journal of Microbiology, 미생물학회지], V40, P1; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Salminen S, 1993, LACTIC ACID BACTERIA; Saxelin M, 2005, CURR OPIN BIOTECH, V16, P204, DOI 10.1016/j.copbio.2005.02.003; Shahzad K., 2009, PHARMACOLOGYONLINE, V1, P416; Shamim S, 2004, PHARM BIOL, V42, P491, DOI 10.3109/13880200490891845; 이윤미, 2004, [Korean Journal of Food Science and Technology, 한국식품과학회지], V36, P129; Takahashi N, 2004, J DAIRY RES, V71, P340, DOI 10.1017/S0022029904000251; Ueno H, 2000, J MOL CATAL B-ENZYM, V10, P67, DOI 10.1016/S1381-1177(00)00114-4; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; Vernazza CL, 2006, J APPL MICROBIOL, V100, P846, DOI 10.1111/j.1365-2672.2006.02832.x; Vesterlund S, 2007, INT J FOOD MICROBIOL, V116, P325, DOI 10.1016/j.ijfoodmicro.2007.02.002; VIDGREN G, 1992, J BACTERIOL, V174, P7419, DOI 10.1128/jb.174.22.7419-7427.1992; YAMADA K, 1977, BIOTECHNOL BIOENG, V19, P1563, DOI 10.1002/bit.260191102	40	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90866	10.1371/journal.pone.0090866	http://dx.doi.org/10.1371/journal.pone.0090866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598940	Green Submitted, Green Published, gold			2022-12-27	WOS:000332479400141
J	Okuda, DT; Siva, A; Kantarci, O; Inglese, M; Katz, I; Tutuncu, M; Keegan, BM; Donlon, S; Hua, LH; Vidal-Jordana, A; Montalban, X; Rovira, A; Tintore, M; Amato, MP; Brochet, B; de Seze, J; Brassat, D; Vermersch, P; De Stefano, N; Sormani, MP; Pelletier, D; Lebrun, C				Okuda, Darin T.; Siva, Aksel; Kantarci, Orhun; Inglese, Matilde; Katz, Ilana; Tutuncu, Melih; Keegan, B. Mark; Donlon, Stacy; Hua, Le H.; Vidal-Jordana, Angela; Montalban, Xavier; Rovira, Alex; Tintore, Mar; Amato, Maria Pia; Brochet, Bruno; de Seze, Jerome; Brassat, David; Vermersch, Patrick; De Stefano, Nicola; Sormani, Maria Pia; Pelletier, Daniel; Lebrun, Christine		RISC; CFSEP	Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; CONVERSION; LESIONS; DISABILITY; MRI; AGE	Objective: To report the 5-year risk and to identify risk factors for the development of a seminal acute or progressive clinical event in a multi-national cohort of asymptomatic subjects meeting 2009 RIS Criteria. Methods: Retrospectively identified RIS subjects from 22 databases within 5 countries were evaluated. Time to the first clinical event related to demyelination (acute or 12-month progression of neurological deficits) was compared across different groups by univariate and multivariate analyses utilizing a Cox regression model. Results: Data were available in 451 RIS subjects (F: 354 (78.5%)). The mean age at from the time of the first brain MRI revealing anomalies suggestive of MS was 37.2 years (y) (median: 37.1 y, range: 11-74 y) with mean clinical follow-up time of 4.4 y (median: 2.8 y, range: 0.01-21.1 y). Clinical events were identified in 34% (standard error = 3%) of individuals within a 5-year period from the first brain MRI study. Of those who developed symptoms, 9.6% fulfilled criteria for primary progressive MS. In the multivariate model, age [hazard ratio (HR): 0.98 (95% CI: 0.96-0.99); p = 0.03], sex (male) [HR: 1.93 (1.24-2.99); p = 0.004], and lesions within the cervical or thoracic spinal cord [HR: 3.08 (2.06-4.62); p =< 0.001] were identified as significant predictors for the development of a first clinical event. Interpretation: These data provide supportive evidence that a meaningful number of RIS subjects evolve to a first clinical symptom. An age <37 y, male sex, and spinal cord involvement appear to be the most important independent predictors of symptom onset.	[Okuda, Darin T.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Clin Ctr Multiple Sclerosis, Dallas, TX 75390 USA; [Siva, Aksel; Tutuncu, Melih] Istanbul Univ, Dept Neurol, Cerrahpasa Med Sch, Istanbul, Turkey; [Kantarci, Orhun; Keegan, B. Mark] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN USA; [Inglese, Matilde; Katz, Ilana] Mt Sinai Sch Med, Dept Neurol Radiol & Neurosci, New York, NY USA; [Donlon, Stacy] Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA; [Hua, Le H.] Cleveland Clin, Dept Neurol, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA; [Vidal-Jordana, Angela; Montalban, Xavier; Rovira, Alex; Tintore, Mar] Vall dHebron Hosp, MS Ctr Catalunya Cemcat, Barcelona, Spain; [Vidal-Jordana, Angela; Montalban, Xavier; Rovira, Alex; Tintore, Mar] Vall dHebron Hosp, Magnet Resonance Unit, Barcelona, Spain; [Amato, Maria Pia] Univ Florence, Dept Neurol, Florence, Italy; [Brochet, Bruno] Ctr Hosp Univ Bordeaux, Bordeaux, France; [de Seze, Jerome] Ctr Hosp Univ Strasbourg, Strasbourg, France; [Brassat, David] Ctr Hosp Univ Purpan, Toulouse, France; [Vermersch, Patrick] Ctr Hosp Univ Salengro, Lille, France; [De Stefano, Nicola] Univ Siena, Dept Med Surg & Neurosci, I-53100 Siena, Italy; [Sormani, Maria Pia] Univ Genoa, Dept Hlth Sci DISSAL, Genoa, Italy; [Pelletier, Daniel] Yale Univ, Dept Neurol, New Haven, CT USA; [Pelletier, Daniel] Yale Univ, Dept Diagnost Radiol, New Haven, CT 06510 USA; [Lebrun, Christine] Hop Louis Pasteur, Serv Neurol, F-06002 Nice, France	University of Texas System; University of Texas Southwestern Medical Center Dallas; Istanbul University; Istanbul University - Cerrahpasa; Mayo Clinic; Icahn School of Medicine at Mount Sinai; Barrow Neurological Institute; Cleveland Clinic Foundation; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; University of Florence; CHU Bordeaux; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Toulouse; Universite de Lille - ISITE; CHU Lille; University of Siena; University of Genoa; Yale University; Yale University; CHU Nice	Okuda, DT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Clin Ctr Multiple Sclerosis, Dallas, TX 75390 USA.	darin.okuda@utsouthwestern.edu	De Seze, Jerome/M-8316-2016; Brassat, David/L-2173-2014; Siva, Aksel/A-5132-2016; lebrun-frenay, christine/AAP-9539-2021; Sormani, Maria Pia/ABH-8756-2020; Rovira, Alex/AAX-3973-2020; De Stefano, Nicola/AHE-3052-2022; Amato, Maria Pia/AAC-5940-2022; amato, Maria Pia/AAL-5998-2020; Hua, Le/S-4930-2019; Inglese, Matilde/AAH-3189-2020; Donlon, Stacy/AAL-9460-2020; Montalban, Xavier/J-5938-2016; Tütüncü, Melih/AAF-1702-2021	De Seze, Jerome/0000-0002-7197-7578; Siva, Aksel/0000-0002-8340-6641; lebrun-frenay, christine/0000-0002-3713-2416; De Stefano, Nicola/0000-0003-4930-7639; amato, Maria Pia/0000-0003-3325-3760; Inglese, Matilde/0000-0002-9610-0297; Montalban, Xavier/0000-0002-0098-9918; Tütüncü, Melih/0000-0002-9851-7002; Hua, Le/0000-0002-0535-3978; SORMANI, MARIA PIA/0000-0001-6892-104X; Vidal-Jordana, Angela/0000-0002-7270-5507; Okuda, Darin/0000-0002-6499-1523; Tintore, Mar/0000-0001-9999-5359	Acorda Therapeutics; Biogen IDEC; Genzyme; Ipsen Pharmaceuticals; Teva Neuroscience; Bayer-Schering AG; Novartis; Allergan; Merck-Serono; Gen Ilac; Celgene; Vaccinex; National MS Society; eMedicine; Bristol Meyers Squibb; Bionest; Terumo BCT; EMD Serono; Almirall; Bayer; Merck; Genentech; GeNeuro; Neurotec; Sanofi-Aventis; AdvanceCell Bayer-Schering Pharma; OLEA Medical; Siemens AG; Merck Serono; Bayer-Schering; Caridian; GSK; Novartis Pharma AG; Actelion; Synthon; Allozyne; Roche	Acorda Therapeutics; Biogen IDEC(Biogen); Genzyme(Sanofi-AventisGenzyme Corporation); Ipsen Pharmaceuticals(Ipsen); Teva Neuroscience(Teva Pharmaceutical Industries); Bayer-Schering AG; Novartis(Novartis); Allergan(AbbVieAllergan); Merck-Serono(Merck & Company); Gen Ilac; Celgene(Bristol-Myers SquibbCelgene Corporation); Vaccinex; National MS Society(National Multiple Sclerosis Society); eMedicine; Bristol Meyers Squibb(Bristol-Myers Squibb); Bionest; Terumo BCT; EMD Serono; Almirall(Almirall); Bayer(Bayer AG); Merck(Merck & Company); Genentech(Roche HoldingGenentech); GeNeuro; Neurotec; Sanofi-Aventis(Sanofi-Aventis); AdvanceCell Bayer-Schering Pharma; OLEA Medical; Siemens AG(Siemens AG); Merck Serono(Merck & Company); Bayer-Schering(Bayer AG); Caridian; GSK(GlaxoSmithKline); Novartis Pharma AG; Actelion; Synthon; Allozyne; Roche(Roche Holding)	Dr. Okuda reports personal fees for consulting, advisory board, and speaking activities from Acorda Therapeutics, Biogen IDEC, Genzyme, Ipsen Pharmaceuticals, and Teva Neuroscience, outside the submitted work. Professor Siva reports personal fees for consulting and serving on a scientific advisory board from Bayer-Schering AG, Novartis, Biogen IDEC and Allergan within the last year, and travel and registration coverage for congresses or symposia from Bayer-Schering AG, Merck-Serono, Gen Ilac, and Allergan. Professor Siva received research support from Bayer-Schering AG, outside the submitted work. Dr. Kantarci has nothing to disclose. Dr. Inglese reports personal fees from Celgene, and Vaccinex. Dr. Katz reports grants from Acorda Therapeutics and from the National MS Society, outside the submitted work. Dr. Tutuncu has nothing to disclose. Dr. Keegan reports personal fees from eMedicine, Bristol Meyers Squibb, Novartis, Bionest, and grants from Terumo BCT, outside the submitted work. Dr. Donlon has nothing to disclose. Dr. Hua has nothing to disclose. Dr. Vidal-Jordana reports personal fees from EMD Serono, outside the submitted work. Dr. Montalban reports personal fees from Almirall, Bayer, Biogen IDEC, EMD Serono, Merck, Genentech, GeNeuro, Genzyme, Neurotec, Novartis, Sanofi-Aventis, and Teva Neuroscience, outside the submitted work. Dr. Rovira reports personal fees from AdvanceCell Bayer-Schering Pharma, Novartis, OLEA Medical, Sanofi-Aventis, Teva Neuroscience, Biogen IDEC, grants from Siemens AG, outside the submitted work. Dr. Tintore reports personal fees from Genzyme, Biogen IDEC, Teva Neuroscience, Novartis, Sanofi-Aventis, Bayer, and Merck Serono, outside the submitted work. Dr. Amato reports grants and personal fees from Biogen IDEC, Merck Serono, Bayer-Schering, Teva Neuroscience, Sanofi-Aventis, and Novartis, outside the submitted work. Dr. Brochet reports personal fees from Novartis, Genzyme, and Bayer, grants from Bayer and Teva Neuroscience, Merck-Serono, and Caridian, outside the submitted work. Dr. de Seze has nothing to disclose. Dr. Brassat reports personal fees from Bayer-Schering, Biogen IDEC, Merck-Serono, Novartis, Sanofi-Aventis, and Teva Neuroscience, outside the submitted work. Dr. Vermersch reports grants and personal fees from Biogen IDEC, Sanofi-Aventis, Bayer, Merck-Serono, personal fees from Novartis, GSK, and Almirall, outside the submitted work. Dr. De Stefano reports personal fees from Merck-Serono, Novartis Pharma AG, Teva Neuroscience, Sanofi-Aventis, Bayer-Schering AG, and Biogen IDEC, outside the submitted work. Dr. Sormani reports personal fees from Biogen IDEC, Merck-Serono, Actelion, Synthon, and Allozyne, outside the submitted work. Dr. Pelletier reports personal fees from Teva Neuroscience, Biogen IDEC, and Roche, grants from Biogen IDEC, outside the submitted work. Dr. Lebrun has nothing to disclose. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bot JCJ, 2002, RADIOLOGY, V223, P46, DOI 10.1148/radiol.2231010707; Cohen AB, 2012, J NEUROIMAGING, V22, P122, DOI 10.1111/j.1552-6569.2011.00589.x; Comi G, 2009, LANCET, V374, P1503, DOI 10.1016/S0140-6736(09)61259-9; Confavreux C, 2003, BRAIN, V126, P770, DOI 10.1093/brain/awg081; De Stefano N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019452; Gabelic T, 2012, ACTA NEUROL BELG; Gabelic T, 2013, AJNR AM J NEURORADIO; Giorgio A, 2011, NEUROLOGY, V77, P1896, DOI 10.1212/WNL.0b013e318238ee9b; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Kappos L, 2006, NEUROLOGY, V67, P1242, DOI 10.1212/01.wnl.0000237641.33768.8d; Koch-Henriksen N, 2010, LANCET NEUROL, V9, P520, DOI 10.1016/S1474-4422(10)70064-8; Kruit MC, 2010, CEPHALALGIA, V30, P129, DOI 10.1111/j.1468-2982.2009.01904.x; Lebrun C, 2008, J NEUROL NEUROSUR PS, V79, P195, DOI 10.1136/jnnp.2006.108274; Lebrun C, 2012, MULT SCLER J, V18, P1297, DOI 10.1177/1352458511435931; Lebrun C, 2010, MULT SCLER J, V16, P919, DOI 10.1177/1352458510375707; Lebrun C, 2009, ARCH NEUROL-CHICAGO, V66, P841, DOI 10.1001/archneurol.2009.119; Liu S, 2013, MULT SCLER J, V19, P1101, DOI 10.1177/1352458512471874; McDonnell GV, 2003, MULT SCLER J, V9, P204, DOI 10.1191/1352458503ms890cr; Oh J, 2013, NEUROLOGY; Okuda DT, 2011, NEUROLOGY, V76, P686, DOI 10.1212/WNL.0b013e31820d8b1d; Okuda DT, 2009, NEUROLOGY, V72, P800, DOI 10.1212/01.wnl.0000335764.14513.1a; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Scalfari A, 2011, NEUROLOGY, V77, P1246, DOI 10.1212/WNL.0b013e318230a17d; Siva A, 2009, MULT SCLER J, V15, P918, DOI 10.1177/1352458509106214; Sombekke MH, 2013, NEUROLOGY, V80, P69, DOI 10.1212/WNL.0b013e31827b1a67; Stromillo ML, 2013, NEUROLOGY; Tintore M, 2010, NEUROLOGY, V75, P1933, DOI 10.1212/WNL.0b013e3181feb26f; Tutuncu M, 2013, MULT SCLER J, V19, P188, DOI 10.1177/1352458512451510; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972	29	179	184	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90509	10.1371/journal.pone.0090509	http://dx.doi.org/10.1371/journal.pone.0090509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598783	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400084
J	Carter, H; Drury, J; Amlot, R; Rubin, GJ; Williams, R				Carter, Holly; Drury, John; Amlot, Richard; Rubin, G. James; Williams, Richard			Effective Responder Communication Improves Efficiency and Psychological Outcomes in a Mass Decontamination Field Experiment: Implications for Public Behaviour in the Event of a Chemical Incident	PLOS ONE			English	Article							SOCIAL-IDENTITY; SUPPORT; ORDER	The risk of incidents involving mass decontamination in response to a chemical, biological, radiological, or nuclear release has increased in recent years, due to technological advances, and the willingness of terrorists to use unconventional weapons. Planning for such incidents has focused on the technical issues involved, rather than on psychosocial concerns. This paper presents a novel experimental study, examining the effect of three different responder communication strategies on public experiences and behaviour during a mass decontamination field experiment. Specifically, the research examined the impact of social identity processes on the relationship between effective responder communication, and relevant outcome variables (e. g. public compliance, public anxiety, and co-operative public behaviour). All participants (n = 111) were asked to visualise that they had been involved in an incident involving mass decontamination, before undergoing the decontamination process, and receiving one of three different communication strategies: 1) 'Theory-based communication': Health-focused explanations about decontamination, and sufficient practical information; 2) 'Standard practice communication': No health-focused explanations about decontamination, sufficient practical information; 3) 'Brief communication': No health-focused explanations about decontamination, insufficient practical information. Four types of data were collected: timings of the decontamination process; observational data; and quantitative and qualitative self-report data. The communication strategy which resulted in the most efficient progression of participants through the decontamination process, as well as the fewest observations of non-compliance and confusion, was that which included both health-focused explanations about decontamination and sufficient practical information. Further, this strategy resulted in increased perceptions of responder legitimacy and increased identification with responders, which in turn resulted in higher levels of expected compliance during a real incident, and increased willingness to help other members of the public. This study shows that an understanding of the social identity approach facilitates the development of effective responder communication strategies for incidents involving mass decontamination.	[Carter, Holly; Amlot, Richard] Publ Hlth England, Emergency Response Dept, Salisbury, Wilts, England; [Drury, John] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Rubin, G. James] Kings Coll London, Dept Psychol Med, London WC2R 2LS, England; [Williams, Richard] Univ South Wales, Welsh Inst Hlth & Social Care, Pontypridd, M Glam, Wales; [Williams, Richard] Univ Manchester, Humanitarian & Conflict Response Inst, Manchester, Lancs, England; [Williams, Richard] Publ Hlth England, Extreme Events & Hlth Protect Sect, London, England	Public Health England; University of Sussex; University of London; King's College London; University of South Wales; University of Manchester; Public Health England	Carter, H (corresponding author), Publ Hlth England, Emergency Response Dept, Salisbury, Wilts, England.	holly.carter@hpa.org.uk	Drury, John/AAO-4119-2020; Drury, John/A-6479-2012	Drury, John/0000-0002-7748-5128; Drury, John/0000-0002-7748-5128	Public Health England PhD Studentship	Public Health England PhD Studentship	Holly Carter is funded by a Public Health England PhD Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre BE, 2011, SOC SCI QUART, V92, P100, DOI 10.1111/j.1540-6237.2011.00759.x; Aguirre BE, 1998, SOCIOL FORUM, V13, P301, DOI 10.1023/A:1022145900928; Alexander DA, 2006, J POSTGRAD MED, V52, P126; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Carter H, 2013, THESIS U SUSSEX BRIG; Carter H, BASIC APPL IN PRESS; Carter H, 2013, BPS SOC PSYCH SECT A; Carter H, 2012, LANCET, V380, pS28; Carter H, 2013, INT J EMERG SERV, V2, P29, DOI 10.1108/IJES-06-2012-0026; Drury J, 2000, BRIT J SOC PSYCHOL, V39, P579, DOI 10.1348/014466600164642; Drury J., 2009, INT J MASS EMERGENCI, V27, P66, DOI DOI 10.1007/S13398-014-0173-7.2; Drury J, 2009, BRIT J SOC PSYCHOL, V48, P487, DOI 10.1348/014466608X357893; Edwards Nicholas A, 2006, Emerg Med Australas, V18, P185, DOI 10.1111/j.1742-6723.2006.00827.x; Hanley C., 1999, LATINO NEWS     1207; Haslam SA, 2006, J APPL PSYCHOL, V91, P1037, DOI 10.1037/0021-9010.91.5.1037; Haslam SA, 2009, STRESS HEALTH, V25, P21, DOI 10.1002/smi.1221; Haslam SA, 2005, BRIT J SOC PSYCHOL, V44, P355, DOI 10.1348/014466605X37468; Haslam SA, 2004, STRESS HEALTH, V20, P3, DOI 10.1002/smi.995; HM Government, 2010, UK STRAT COUNT CHEM; Holdsworth D, 2012, J R Army Med Corps, V158, P58; Holloway HC, 1997, JAMA-J AM MED ASSOC, V278, P425, DOI 10.1001/jama.278.5.425; Johnson GA, 1999, AM J EMERG MED, V17, P148, DOI 10.1016/S0735-6757(99)90048-7; Johnson N. R., 1988, INT J MASS EMERGENCI, V6, P7; JOHNSON NR, 1987, SOC PROBL, V34, P362, DOI 10.1525/sp.1987.34.4.03a00040; La Piere R.T., 1938, COLLECTIVE BEHAV; Lake, 2009, GUIDELINES MASS CASU, VI; New Dimension Regional Team, 2003, NAT GUID DOC FIR SER; Proulx G., 1991, FIRE SAFETY SCI, V3, P843, DOI [10.3801/IAFSS.FSS.3-843, DOI 10.3801/IAFSS.FSS.3-843]; Rayburn B. B., 2006, CBRN DECONTAMINATION; Reicher S, 2007, POLIC-J POLICY PRACT, V1, P403, DOI 10.1093/police/pam067; Smelser N. J., 1963, THEORY COLLECTIVE BE; Stott C, 2008, PSYCHOL PUBLIC POL L, V14, P115, DOI 10.1037/a0013419; Stott C, 2012, BRIT J CRIMINOL, V52, P381, DOI 10.1093/bjc/azr076; Turner J.C., 1987, REDISCOVERING SOCIAL; United States Fire Administration, 1997, FIR DEP RESP BIOL TH; Vogt B. M., 2002, CLEAN IS SAFE IMPROV	36	26	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89846	10.1371/journal.pone.0089846	http://dx.doi.org/10.1371/journal.pone.0089846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4FD	24595097	Green Published, Green Accepted, gold			2022-12-27	WOS:000332475500024
J	Gong, G; Xiang, L; Yuan, LB; Hu, L; Wu, W; Cai, L; Yin, L; Dong, HL				Gong, Gu; Xiang, Lei; Yuan, Libang; Hu, Ling; Wu, Wei; Cai, Lin; Yin, Liang; Dong, Hailong			Protective Effect of Glycyrrhizin, a Direct HMGB1 Inhibitor, on Focal Cerebral Ischemia/Reperfusion-Induced Inflammation, Oxidative Stress, and Apoptosis in Rats	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; ISCHEMIA-REPERFUSION INJURY; CHROMATIN PROTEIN HMGB1; POSTISCHEMIC BRAIN; LIVER-INJURY; IN-VIVO; MEDIATOR; CELLS; HMG-1; STROKE	Aim: Glycyrrhizin (GL) has been reported to protect against ischemia and reperfusion (I/R)-induced injury by inhibiting the cytokine activity of high mobility group box 1 (HMGB1). In the present study, the protective effects of GL against I/R injury, as well as the related molecular mechanisms, were investigated in rat brains. Methods: Focal cerebral I/R injury was induced by intraluminal filamentous occlusion of the middle cerebral artery (MCA) in Male Sprague-Dawley rats. GL alone or GL and rHMGB1 were administered intravenously at the time of reperfusion. Serum levels of HMGB1 and inflammatory mediators were quantified via enzyme-linked immunosorbent assay (ELISA). Histopathological examination, immunofluorescence, RT-PCR and western blotting analyses were performed to investigate the protective and anti-apoptotic effects and related molecular mechanisms of GL against I/R injury in rat brains. Results: Pre-treatment with GL significantly reduced infarct volume and improved the accompanying neurological deficits in locomotor function. The release of HMGB1 from the cerebral cortex into the serum was inhibited by GL administration. Moreover, pre-treatment with GL alleviated apoptotic injury resulting from cerebral I/R through the inhibition of cytochrome C release and caspase 3 activity. The expression levels of inflammation-and oxidative stress-related molecules including TNF-alpha, iNOS, IL-1 beta, and IL-6, which were over-expressed in I/R, were decreased by GL. P38 and P-JNK signalling were involved in this process. All of the protective effects of GL could be reversed by rHMGB1 administration. Conclusions: GL has a protective effect on ischemia-reperfusion injury in rat brains through the inhibition of inflammation, oxidative stress and apoptotic injury by antagonising the cytokine activity of HMGB1.	[Gong, Gu; Hu, Ling; Wu, Wei; Cai, Lin; Yin, Liang] Peoples Liberat Army, Gen Hosp, Dept Anaesthesiol, Chengdu, Sichuan, Peoples R China; [Xiang, Lei] Tianjin Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China; [Yuan, Libang; Dong, Hailong] Fourth Mil Med Univ, Xijing Hosp, Dept Anaesthesiol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Dong, HL (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Anaesthesiol, Xian 710032, Shaanxi, Peoples R China.	hldong2012_12@163.com		Dong, Hailong/0000-0001-8984-9067	State Key Program of the National Natural Science Foundation of China, Sichuan Province [110469]; Chengdu military area command general hospital [2011YG-A06]	State Key Program of the National Natural Science Foundation of China, Sichuan Province; Chengdu military area command general hospital	This study was supported by the State Key Program of the National Natural Science Foundation of China (Grant NO. 110469), Sichuan Province and Chengdu military area command general hospital Awards Fund (2011YG-A06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Arase Y, 1997, CANCER, V79, P1494, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-B; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Ceulemans AG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-74; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Goldstein RS, 2006, SHOCK, V25, P571, DOI 10.1097/01.shk.0000209540.99176.72; Gong G, 2012, ACTA PHARMACOL SIN, V33, P11, DOI 10.1038/aps.2011.151; Gursoy-Ozdemir Y, 2004, STROKE, V35, P1449, DOI 10.1161/01.STR.0000126044.83777.f4; Gwak GY, 2012, WORLD J GASTROENTERO, V18, P679, DOI 10.3748/wjg.v18.i7.679; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR286, DOI 10.1152/ajpregu.1995.268.1.R286; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kim I, 2012, SPACE, P20; Kim JB, 2008, J NEUROSCI RES, V86, P1125, DOI 10.1002/jnr.21555; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Kim SW, 2011, ANAT CELL BIOL, V44, P304, DOI 10.5115/acb.2011.44.4.304; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; LANDSMAN D, 1993, BIOESSAYS, V15, P539, DOI 10.1002/bies.950150807; Lee ST, 2005, BRAIN RES, V1058, P120, DOI 10.1016/j.brainres.2005.07.076; Li J, 2007, STROKE, V38, P2992, DOI 10.1161/STROKEAHA.107.490904; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Ogiku M, 2011, J PHARMACOL EXP THER, V339, P93, DOI 10.1124/jpet.111.182592; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; Oozawa S, 2008, CIRC J, V72, P1178, DOI 10.1253/circj.72.1178; Piao CS, 2003, J NEUROSCI RES, V73, P537, DOI 10.1002/jnr.10671; Ren D, 2006, INFLAMM RES, V55, P207, DOI 10.1007/s00011-006-0072-2; Sato H, 1996, ANTIVIR RES, V30, P171, DOI 10.1016/0166-3542(96)00942-4; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sitia G, 2007, J LEUKOCYTE BIOL, V81, P100, DOI 10.1189/jlb.0306173; van Rossum TGJ, 2001, AM J GASTROENTEROL, V96, P2432, DOI 10.1111/j.1572-0241.2001.04049.x; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Yang QW, 2010, J CEREBR BLOOD F MET, V30, P243, DOI 10.1038/jcbfm.2009.202; Yoshida T, 2007, EUR J PHARMACOL, V576, P136, DOI 10.1016/j.ejphar.2007.08.012; Zhai C, 2012, ACTA PHARM SIN, V10, P1	43	133	145	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89450	10.1371/journal.pone.0089450	http://dx.doi.org/10.1371/journal.pone.0089450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594628	Green Submitted, Green Published, gold			2022-12-27	WOS:000332475500014
J	Gong, JH; Wang, ZD; Polejaeva, I; Salgia, R; Kao, CM; Chen, CT; Chen, GC; Chen, LH				Gong, Jianhua; Wang, Zhongde; Polejaeva, Irina; Salgia, Ravi; Kao, Chien-Min; Chen, Chin-Tu; Chen, Guangchun; Chen, Liaohai			Activating the Expression of Human K-ras(G12D) Stimulates Oncogenic Transformation in Transgenic Goat Fetal Fibroblast Cells	PLOS ONE			English	Article							K-RAS; CONDITIONAL EXPRESSION; CAPRA-HIRCUS; TUMOR; GENE; MUTATIONS; TUMORIGENESIS; GROWTH; CANCER; KRAS	Humane use of preclinical large animal cancer models plays a critical role in understanding cancer biology and developing therapeutic treatments. Among the large animal candidates, goats have great potentials as sustainable sources for large animal cancer model development. Goats are easier to handle and cheaper to raise. The genome of the goats has been sequenced recently. It has been known that goats develop skin, adrenal cortex, breast and other types of cancers. Technically, goats are subject to somatic cell nuclear transfer more efficiently and exhibit better viability through the cloning process. Towards the development of a goat cancer model, we created a transgenic goat fetal fibroblast (GFF) cell as the donor cell for SCNT. Human mutated K-ras (hK-ras(G12D)) was chosen as the transgene, as it is present in 20% of cancers. Both hK-ras(G12D) and a herpes simplex viral thymidine kinase (HSV1-tk) reporter genes, flanked by a pair of LoxP sites, were knocked in the GFF endogenous K-ras locus through homologous recombination. Following Cre-mediated activation (with a 95% activation efficiency), hK-ras(G12D) and HSV1-tk were expressed in the transgenic GFF cells, evidently through the presence of corresponding mRNAs, and confirmed by HSV1-tk protein function assay. The hK-ras(G12D) expressing GFF cells exhibited enhanced proliferation rates and an anchorage-independent growth behavior. They were able to initiate tumor growth in athymic nude mice. In conclusion, after activating hK-ras(G12D) gene expression, hK-ras(G12D) transgenic GFF cells were transformed into tumorgenesis cells. Transgenic goats via SCNT using the above-motioned cells as the donor cells have been established.	[Gong, Jianhua; Chen, Guangchun; Chen, Liaohai] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Wang, Zhongde; Polejaeva, Irina] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Salgia, Ravi; Kao, Chien-Min; Chen, Chin-Tu] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; University of Chicago	Chen, LH (corresponding author), Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA.	l.chen@usu.edu	Chen, Chin-Tu/K-3393-2014; Kao, Chien-Min/CAI-0648-2022; Gong, Jian-Hua/L-5284-2019; Polejaeva, Irina/G-4881-2012	Kao, Chien-Min/0000-0002-8785-5225; Wang, Zhongde/0000-0003-2441-4729; Polejaeva, Irina/0000-0002-0858-5889	Utah Science Technology and Research Initiative at Utah State University	Utah Science Technology and Research Initiative at Utah State University	This work was supported by Utah Science Technology and Research Initiative at Utah State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr SM, 2001, J CELL BIOCHEM, V81, P621, DOI 10.1002/jcb.1099; BOS JL, 1989, CANCER RES, V49, P4682; Brose MS, 2002, CANCER RES, V62, P6997; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hatada S, 2000, P NATL ACAD SCI USA, V97, P13807, DOI 10.1073/pnas.240462897; Hospers GAP, 2000, CANCER RES, V60, P1488; Hu YM, 2012, CELL RES, V22, P399, DOI 10.1038/cr.2011.145; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Lohr CV, 2013, VET PATHOL, V50, P668, DOI 10.1177/0300985812471544; Lu ZH, 2003, BLOOD, V102, P1531, DOI 10.1182/blood-2003-03-0708; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; Reed SD, 2009, J VET DIAGN INVEST, V21, P262, DOI 10.1177/104063870902100217; Reggio BC, 2001, BIOL REPROD, V65, P1528, DOI 10.1095/biolreprod65.5.1528; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Scocco P, 2001, VET PATHOL, V38, P98, DOI 10.1354/vp.38-1-98; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; SHIH C, 1981, NATURE, V290, P261, DOI 10.1038/290261a0; SINGH B, 1972, VET PATHOL, V9, P441, DOI 10.1177/030098587200900604; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vizan P, 2005, CANCER RES, V65, P5512, DOI 10.1158/0008-5472.CAN-05-0074; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Wang SH, 2013, J BIOTECHNOL, V163, P377, DOI 10.1016/j.jbiotec.2012.10.018; WINTER E, 1986, MOL CELL BIOL, V6, P2562, DOI 10.1128/MCB.6.7.2562; Yaghoubi SS, 2006, NAT PROTOC, V1, P3069, DOI 10.1038/nprot.2006.459; YAMAMOTO F, 1988, ONCOGENE RES, V3, P125	33	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90059	10.1371/journal.pone.0090059	http://dx.doi.org/10.1371/journal.pone.0090059			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594684	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500031
J	Hrvatin, S; Deng, F; O'Donnell, CW; Gifford, DK; Melton, DA				Hrvatin, Sinisa; Deng, Francis; O'Donnell, Charles W.; Gifford, David K.; Melton, Douglas A.			MARIS: Method for Analyzing RNA following Intracellular Sorting	PLOS ONE			English	Article							STEM-CELL LINES; CAPTURE; QUANTIFICATION; EXPRESSION; GENE; FACS	Transcriptional profiling is a key technique in the study of cell biology that is limited by the availability of reagents to uniquely identify specific cell types and isolate high quality RNA from them. We report a Method for Analyzing RNA following Intracellular Sorting (MARIS) that generates high quality RNA for transcriptome profiling following cellular fixation, intracellular immunofluorescent staining and FACS. MARIS can therefore be used to isolate high quality RNA from many otherwise inaccessible cell types simply based on immunofluorescent tagging of unique intracellular proteins. As proof of principle, we isolate RNA from sorted human embryonic stem cell-derived insulin-expressing cells as well as adult human beta cells. MARIS is a basic molecular biology technique that could be used across several biological disciplines.	[Hrvatin, Sinisa; Deng, Francis; O'Donnell, Charles W.; Melton, Douglas A.] Harvard Univ, Harvard Stem Cell Inst, Harvard Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [O'Donnell, Charles W.; Gifford, David K.] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Melton, Douglas A.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Howard Hughes Medical Institute	Melton, DA (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Harvard Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	dmelton@harvard.edu	Young, Richard A/F-6495-2012; Deng, Francis/X-9840-2019	Young, Richard A/0000-0001-8855-8647; Deng, Francis/0000-0003-3117-5076; Hrvatin, Sinisa/0000-0001-7303-4218; O'donnell, Colm/0000-0002-8004-450X	Sternlicht Director's Fund Fellowship; Howard Hughes Medical Institute; Harvard Stem Cell Institute; National Institutes of Health [2U01DK07247307, RL1DK081184, 1U01HL10040804]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RL1DK081184] Funding Source: NIH RePORTER	Sternlicht Director's Fund Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Harvard Stem Cell Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SH is supported by the Sternlicht Director's Fund Fellowship. This project is funded by the Howard Hughes Medical Institute, Harvard Stem Cell Institute and National Institutes of Health grants (2U01DK07247307, RL1DK081184, 1U01HL10040804) and the Harvard Stem Cell Institute. DM Is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS S, 2010, GENOME BIOL, V11; Auer H, 2003, NAT GENET, V35, P292, DOI 10.1038/ng1203-292; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dobson JT, 2009, BRIT J HAEMATOL, V144, P732, DOI 10.1111/j.1365-2141.2008.07527.x; Fend F, 1999, AM J PATHOL, V154, P61, DOI 10.1016/S0002-9440(10)65251-0; Goldsworthy SM, 1999, MOL CARCINOGEN, V25, P86, DOI 10.1002/(SICI)1098-2744(199906)25:2<86::AID-MC2>3.3.CO;2-W; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Jeyapalan JC, 2013, AGING-US, V5, P120, DOI 10.18632/aging.100536; Lindeman N, 2002, DIAGN MOL PATHOL, V11, P187, DOI 10.1097/00019606-200212000-00001; Pan Y, 2011, PLOS ONE, V6; Pechhold S, 2009, NAT BIOTECHNOL, V27, P1038, DOI 10.1038/nbt.1579; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; ROOZEMOND RC, 1976, HISTOCHEM J, V8, P625, DOI 10.1007/BF01003963; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Yamada H, 2010, BIOCHEM BIOPH RES CO, V397, P425, DOI 10.1016/j.bbrc.2010.05.112	19	69	71	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89459	10.1371/journal.pone.0089459	http://dx.doi.org/10.1371/journal.pone.0089459			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594682	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900017
J	Liu, TW; Chen, JA; Wang, WH; Simon, M; Wu, FH; Hu, WJ; Chen, JB; Zheng, HL				Liu, Tingwu; Chen, Juan A.; Wang, Wenhua; Simon, Martin; Wu, Feihua; Hu, Wenjun; Chen, Juan B.; Zheng, Hailei			A Combined Proteomic and Transcriptomic Analysis on Sulfur Metabolism Pathways of Arabidopsis thaliana under Simulated Acid Rain	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; SERINE ACETYLTRANSFERASE; DIFFERENTIAL EXPRESSION; SULFATE TRANSPORTERS; GLUTAMINE-SYNTHETASE; SIGNALING PATHWAY; OXIDATIVE BURST; PLANT-RESPONSES; GENE-EXPRESSION; CELL-DEATH	With rapid economic development, most regions in southern China have suffered acid rain (AR) pollution. In our study, we analyzed the changes in sulfur metabolism in Arabidopsis under simulated AR stress which provide one of the first case studies, in which the systematic responses in sulfur metabolism were characterized by high-throughput methods at different levels including proteomic, genomic and physiological approaches. Generally, we found that all of the processes related to sulfur metabolism responded to AR stress, including sulfur uptake, activation and also synthesis of sulfur-containing amino acid and other secondary metabolites. Finally, we provided a catalogue of the detected sulfur metabolic changes and reconstructed the coordinating network of their mutual influences. This study can help us to understand the mechanisms of plants to adapt to AR stress.	[Liu, Tingwu; Chen, Juan A.; Wang, Wenhua; Simon, Martin; Wu, Feihua; Hu, Wenjun; Chen, Juan B.; Zheng, Hailei] Xiamen Univ, Coll Environm & Ecol, Minist Educ Coastal & Wetland Ecosyst, Key Lab, Xiamen, Fujian, Peoples R China; [Liu, Tingwu] Huaiyin Normal Univ, Dept Biol, Huaian, Jiangsu, Peoples R China; [Wang, Wenhua] Duke Univ, Dept Biol, Durham, NC USA; [Zheng, Hailei] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China	Xiamen University; Huaiyin Normal University; Duke University; Xiamen University	Zheng, HL (corresponding author), Xiamen Univ, Coll Environm & Ecol, Minist Educ Coastal & Wetland Ecosyst, Key Lab, Xiamen, Fujian, Peoples R China.	zhenghl@xmu.edu.cn	Zheng, Hai-Lei/G-3432-2010	Zheng, Hai-Lei/0000-0001-8588-1529; Wu, Feihua/0000-0002-5817-3831	Natural Science Foundation of China (NSFC) [30930076, 31260057, 30770192, 30670317]; Ministry of Education; Foundation of the Chinese Ministry of Education [20070384033, 209084]; Program for New Century Excellent Talents in Xiamen University [NCETXMU X07115]; Changjiang Scholarship [X09111]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Education; Foundation of the Chinese Ministry of Education(Ministry of Education, China); Program for New Century Excellent Talents in Xiamen University(Program for New Century Excellent Talents in University (NCET)); Changjiang Scholarship	This study was financially supported by the Natural Science Foundation of China (NSFC) (30930076, 31260057, 30770192 and 30670317), the Scholarship Award for Excellent Doctoral Student granted by Ministry of Education, the Foundation of the Chinese Ministry of Education (20070384033, 209084), the Program for New Century Excellent Talents in Xiamen University (NCETXMU X07115) and a Changjiang Scholarship (X09111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada K, 2004, PLANT CELL PHYSIOL, V45, pS11; Bandurska H, 2009, ACTA BIOL CRACOV BOT, V51, P37; Bick JA, 1998, CURR OPIN PLANT BIOL, V1, P240, DOI 10.1016/S1369-5266(98)80111-8; Brychkova G, 2007, PLANT J, V50, P696, DOI 10.1111/j.1365-313X.2007.03080.x; Carpentier SC, 2005, PROTEOMICS, V5, P2497, DOI 10.1002/pmic.200401222; Cordwell SJ, 2010, PROTEOMICS, V10, P611, DOI 10.1002/pmic.200900521; Dixon DP, 2010, PHYTOCHEMISTRY, V71, P338, DOI 10.1016/j.phytochem.2009.12.012; Fabio F, 2007, SULFUR METABOLISM CA; Fan HB, 2000, FOREST ECOL MANAG, V132, P285, DOI 10.1016/S0378-1127(00)00392-3; Gallardo K, 2007, MOL CELL PROTEOMICS, V6, P2165, DOI 10.1074/mcp.M700171-MCP200; Ge CM, 2006, CELL RES, V16, P446, DOI 10.1038/sj.cr.7310056; Gorg A, 2009, ELECTROPHORESIS, V30, pS122, DOI 10.1002/elps.200900051; Goto DB, 2002, GENES GENET SYST, V77, P89, DOI 10.1266/ggs.77.89; Harms K, 2000, PLANT J, V22, P335, DOI 10.1046/j.1365-313x.2000.00743.x; Hatzios KK, 1999, ABSTR PAP AM CHEM S, V218, pU117; Hawkesford MJ, 2006, PLANT CELL ENVIRON, V29, P382, DOI 10.1111/j.1365-3040.2005.01470.x; Hawkesford MJ, 2003, PHYSIOL PLANTARUM, V117, P155, DOI 10.1034/j.1399-3054.2003.00034.x; Hell R, 1997, PLANTA, V202, P138, DOI 10.1007/s004250050112; Hesse H, 2001, AMINO ACIDS, V20, P281, DOI 10.1007/s007260170044; Hirai MY, 2005, J BIOL CHEM, V280, P25590, DOI 10.1074/jbc.M502332200; KARNI L, 1984, ARCH MICROBIOL, V140, P215, DOI 10.1007/BF00454930; Karnosky DF, 2001, ENVIRON POLLUT, V115, P317, DOI 10.1016/S0269-7491(01)00224-X; Klikocka H, 2005, J PLANT NUTR, V28, P819, DOI 10.1081/PLN-200055547; Kopriva S, 2004, J EXP BOT, V55, P1831, DOI 10.1093/jxb/erh203; Koralewska A, 2009, J PLANT PHYSIOL, V166, P168, DOI 10.1016/j.jplph.2008.03.005; Langebartels C, 2002, PLANT PHYSIOL BIOCH, V40, P567, DOI 10.1016/S0981-9428(02)01416-X; Larssen T, 2006, ENVIRON SCI TECHNOL, V40, P418, DOI 10.1021/es0626133; Lee Y, 2006, PLANT PHYSIOL BIOCH, V44, P38, DOI 10.1016/j.plaphy.2006.01.003; Li LY, 2007, J PROTEOME RES, V6, P759, DOI 10.1021/pr060383l; Likens GE, 1998, SCIENCE, V282, P1991; Likens GE, 1996, SCIENCE, V272, P244, DOI 10.1126/science.272.5259.244; Liu TW, 2011, J PROTEOME RES, V10, P2579, DOI 10.1021/pr200056a; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loudet O, 2007, NAT GENET, V39, P896, DOI 10.1038/ng2050; Marmagne A, 2010, NEW PHYTOL, V186, P216, DOI 10.1111/j.1469-8137.2009.03139.x; Maruyama-Nakashita A, 2003, PLANT PHYSIOL, V132, P597, DOI 10.1104/pp.102.019802; Mitchell P, 2010, NAT BIOTECHNOL, V28, P665, DOI 10.1038/nbt0710-665; Moons A, 2005, VITAM HORM, V72, P155, DOI 10.1016/S0083-6729(05)72005-7; Nikiforova V, 2003, PLANT J, V33, P633, DOI 10.1046/j.1365-313X.2003.01657.x; Noctor G, 1998, PLANT PHYSIOL, V118, P471, DOI 10.1104/pp.118.2.471; Oliveira IC, 1999, PLANT PHYSIOL, V121, P301, DOI 10.1104/pp.121.1.301; PETERMAN TK, 1991, MOL GEN GENET, V230, P145, DOI 10.1007/BF00290662; Rausch T, 2005, TRENDS PLANT SCI, V10, P503, DOI 10.1016/j.tplants.2005.08.006; Rennenberg H, 2007, PLANT BIOLOGY, V9, P620, DOI 10.1055/s-2007-965248; Resch A, 2006, PROTEOMICS, V6, P1867, DOI 10.1002/pmic.200500531; Rogasik J, 2002, PHYTON-ANN REI BOT A, V42, P171; Saito K, 2004, PLANT PHYSIOL, V136, P2443, DOI 10.1104/pp.104.046755; Shibagaki N, 2002, PLANT J, V29, P475, DOI 10.1046/j.0960-7412.2001.01232.x; Toda K, 2001, J PLANT RES, V114, P291, DOI 10.1007/PL00013990; Tomlinson GH, 2003, BIOGEOCHEMISTRY, V65, P51, DOI 10.1023/A:1026069927380; Walters DR, 2003, PHYTOCHEMISTRY, V64, P97, DOI 10.1016/S0031-9422(03)00329-7; Winfield MO, 2010, PLANT BIOTECHNOL J, V8, P749, DOI 10.1111/j.1467-7652.2010.00536.x; Yano A, 1999, PLANT J, V18, P105, DOI 10.1046/j.1365-313X.1999.00421.x; Yoshimoto N, 2002, PLANT J, V29, P465, DOI 10.1046/j.0960-7412.2001.01231.x; Youssefian S, 2001, PLANT PHYSIOL, V126, P1001, DOI 10.1104/pp.126.3.1001; Zhu GH, 2006, J INTEGR PLANT BIOL, V48, P1177, DOI 10.1111/j.1744-7909.2006.00332.x	56	15	16	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90120	10.1371/journal.pone.0090120	http://dx.doi.org/10.1371/journal.pone.0090120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595051	gold, Green Submitted, Green Published			2022-12-27	WOS:000332468900069
J	Onraedt, T; Koster, EHW				Onraedt, Thomas; Koster, Ernst H. W.			Training Working Memory to Reduce Rumination	PLOS ONE			English	Article							COGNITIVE CONTROL; DEPRESSION; INTERFERENCE; CAPACITY; INFORMATION; DISORDERS; DYSPHORIA; SYMPTOMS; BELIEFS	Cognitive symptoms of depression, such as rumination, have shown to be associated with deficits in working memory functioning. More precisely, the capacity to expel irrelevant negative information from working memory seems to be affected. Even though these associations have repeatedly been demonstrated, the nature and causal direction of this association is still unclear. Therefore, within an experimental design, we tried to manipulate working memory functioning of participants with heightened rumination scores in two similar experiments (n = 72 and n = 45) using a six day working memory training compared to active and passive control groups. Subsequently the effects on the processing of non-emotional and emotional information in working memory were monitored. In both experiments, performance during the training task significantly increased, but this performance gain did not transfer to the outcome working memory tasks or rumination and depression measures. Possible explanations for the failure to find transfer effects are discussed.	[Onraedt, Thomas; Koster, Ernst H. W.] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	Ghent University	Koster, EHW (corresponding author), Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium.	Ernst.Koster@Ugent.be	Koster, Ernst H.W./AFS-7487-2022	Koster, Ernst H.W./0000-0003-0792-476X	Fund of Scientific Research Flanders	Fund of Scientific Research Flanders(FWO)	This work was funded by a grant of the Fund of Scientific Research Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Beck AT., 1996, MANUAL BECK DEPRESSI; Berman MG, 2011, SOC COGN AFFECT NEUR, V6, P548, DOI 10.1093/scan/nsq080; Broadway JM, 2010, BEHAV RES METHODS, V42, P563, DOI 10.3758/BRM.42.2.563; Chambers R, 2008, COGNITIVE THER RES, V32, P303, DOI 10.1007/s10608-007-9119-0; De Lissnyder E, 2012, COGNITIVE THER RES, V36, P348, DOI 10.1007/s10608-011-9352-4; De Lissnyder E, 2012, J BEHAV THER EXP PSY, V43, P519, DOI 10.1016/j.jbtep.2011.07.004; De Raedt R, 2010, COGN AFFECT BEHAV NE, V10, P50, DOI 10.3758/CABN.10.1.50; Demeyer I, 2012, BEHAV RES THER, V50, P292, DOI 10.1016/j.brat.2012.02.012; Draine S, 2011, INQUISIT VERSION 3 0; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Hoskinson P, 2008, BRAIN WORKSH VERS 4; Houben K, 2011, PSYCHOL SCI, V22, P968, DOI 10.1177/0956797611412392; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jaeggi SM, 2010, INTELLIGENCE, V38, P625, DOI 10.1016/j.intell.2010.09.001; Jonides J, 2006, NEUROSCIENCE, V139, P181, DOI 10.1016/j.neuroscience.2005.06.042; Joormann J, 2008, J ABNORM PSYCHOL, V117, P182, DOI 10.1037/0021-843X.117.1.182; Joormann J, 2007, J ABNORM PSYCHOL, V116, P135, DOI 10.1037/0021-843X.116.1.135; Joormann J, 2010, COGNITION EMOTION, V24, P913, DOI 10.1080/02699931003784939; Kessler RC, 2009, HDB DEPRESSION, V2nd, P5; Kessler RC, 2006, AM J PSYCHIAT, V163, P1561, DOI 10.1176/appi.ajp.163.9.1561; Klingberg T, 2007, EUR NEUROPSYCHOPHARM, V17, pS192, DOI 10.1016/S0924-977X(07)70216-X; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Koster EHW, 2009, J ABNORM PSYCHOL, V118, P1, DOI 10.1037/a0014379; Levens SM, 2010, J EXP PSYCHOL GEN, V139, P654, DOI 10.1037/a0020283; Levin RL, 2007, COGNITIVE THER RES, V31, P211, DOI 10.1007/s10608-007-9128-z; Lundqvist D., 1998, KAROLINSKA DIRECTED, DOI 10.1037/t27732-000; Luppa M, 2007, J AFFECT DISORDERS, V98, P29, DOI 10.1016/j.jad.2006.07.017; Millan MJ, 2012, NAT REV DRUG DISCOV, V11, P141, DOI 10.1038/nrd3628; Moors A, 2013, BEHAV RES METHODS, V45, P169, DOI 10.3758/s13428-012-0243-8; Morrison AB, 2011, PSYCHON B REV, V18, P46, DOI 10.3758/s13423-010-0034-0; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Mueller TI, 1999, AM J PSYCHIAT, V156, P1000; Nitz D, 2010, RUNNING MEMORY SPAN; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; NOLENHOEKSEMA S, 1991, J ABNORM PSYCHOL, V100, P569, DOI 10.1037/0021-843X.100.4.569; NOLENHOEKSEMA S, 1991, J PERS SOC PSYCHOL, V61, P115, DOI 10.1037/0022-3514.61.1.115; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Owens M, 2013, PSYCHOPHYSIOLOGY, V50, P297, DOI 10.1111/psyp.12010; Owens M, 2012, SOC COGN AFFECT NEUR, V7, P752, DOI 10.1093/scan/nsr050; Papageorgiou C, 2001, COGN BEHAV PRACT, V8, P160, DOI 10.1016/S1077-7229(01)80021-3; Papageorgiou C, 2001, BEHAV THER, V32, P13, DOI 10.1016/S0005-7894(01)80041-1; Papageorgiou C, 2003, COGNITIVE THER RES, V27, P261, DOI 10.1023/A:1023962332399; Philippot P, 2008, J BEHAV THER EXP PSY, V39, P219, DOI 10.1016/j.jbtep.2007.07.001; Raes F, 2007, REVISED VERSIO UNPUB; Roelofs J, 2010, COGNITIVE THER RES, V34, P196, DOI 10.1007/s10608-009-9244-z; Rose EJ, 2006, J AFFECT DISORDERS, V90, P149, DOI 10.1016/j.jad.2005.11.003; Schneider W, 2007, E PRIME 2 USERS GUID; Schweizer S, 2013, J NEUROSCI, V33, P5301, DOI 10.1523/JNEUROSCI.2593-12.2013; Schweizer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024372; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Shipstead Z, 2010, PSYCHOL BELG, V50, P245, DOI 10.5334/pb-50-3-4-245; Siegle GJ, 2007, COGNITIVE THER RES, V31, P235, DOI 10.1007/s10608-006-9118-6; Szmalec A, 2011, J EXP PSYCHOL HUMAN, V37, P137, DOI 10.1037/a0020365; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561; TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Van der Does A.J.W., 2002, HANDLEIDING BIJ NEDE	62	44	51	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90632	10.1371/journal.pone.0090632	http://dx.doi.org/10.1371/journal.pone.0090632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4CT	24595102	Green Submitted, Green Published, gold			2022-12-27	WOS:000332468900126
J	Patole, S; Keil, AD; Chang, A; Nathan, E; Doherty, D; Simmer, K; Esvaran, M; Conway, P				Patole, Sanjay; Keil, Anthony D.; Chang, Annie; Nathan, Elizabeth; Doherty, Dorota; Simmer, Karen; Esvaran, Meera; Conway, Patricia			Effect of Bifidobacterium breve M-16V Supplementation on Fecal Bifidobacteria in Preterm Neonates - A Randomised Double Blind Placebo Controlled Trial	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; NECROTIZING ENTEROCOLITIS; UPDATED METAANALYSIS; PROBIOTICS; MORTALITY; INFANTS; EXPRESSION; SAFETY; TIME	Background: Probiotic supplementation significantly reduces the risk of necrotising enterocolitis (NEC) and all cause mortality in preterm neonates. Independent quality assessment is important before introducing routine probiotic supplementation in this cohort. Aim: To assess product quality, and confirm that Bifidobacterium breve (B. breve) M-16V supplementation will increase fecal B. breve counts without adverse effects. Methods and Participants: Strain identity (16S rRNA gene sequencing), viability over 2 year shelf-life were confirmed, and microbial contamination of the product was ruled out. In a controlled trial preterm neonates (Gestation,33 weeks) ready to commence or on feeds for,12 hours were randomly allocated to either B. breve M-16V (3x10(9) cfu/day) or placebo (dextrin) supplementation until the corrected age 37 weeks. Stool samples were collected before (S1) and after 3 weeks of supplementation (S2) for studying fecal B. breve levels using quantitative PCR (Primary outcome). Secondary outcomes included total fecal bifidobacteria and NEC >= Stage II. Categorical and continuous outcomes were analysed using Chi-square and Mann-Whitney tests, and McNemar and Wilcoxon signed-rank tests for paired comparisons. Results: A total of 159 neonates (Probiotic: 79, Placebo: 80) were enrolled. Maternal and neonatal demographic characteristics were comparable between the groups. The proportion of neonates with detectable B. breve increased significantly post intervention: Placebo: [S1: 2/66 (3%), S2: 25/66 (38%), p<0.001] Probiotic: [S1: 29/74 (40%), S2: 67/74 (91%), p<0.001]. Median S1 B. breve counts in both groups were below detection (<4.7 log cells. g(-1)), increasing significantly in S2 for the probiotic group (log 8.6) while remaining <4.7 log in the control group (p<0.001). There were no adverse effects including probiotic sepsis and no deaths. NEC >= Stage II occurred in only 1 neonate (placebo group). Conclusion: B. breve M-16V is a suitable probiotic strain for routine use in preterm neonates.	[Patole, Sanjay; Chang, Annie; Simmer, Karen] KEM Hosp Women, Dept Neonatal Paediat, Perth, WA, Australia; [Keil, Anthony D.] KEM Hosp Women, PathWest Lab Med WA, Perth, WA, Australia; [Nathan, Elizabeth; Doherty, Dorota] KEM Hosp Women, Women & Infants Res Fdn, Perth, WA, Australia; [Doherty, Dorota] Univ New S Wales, Sch Womens & Infants Hlth, Sydney, NSW, Australia; [Patole, Sanjay; Simmer, Karen] Univ Western Australia, Ctr Neonatal Res & Educ, Perth, WA 6009, Australia; [Esvaran, Meera; Conway, Patricia] Univ New S Wales, Sydney, NSW, Australia	University of New South Wales Sydney; University of Western Australia; University of New South Wales Sydney	Patole, S (corresponding author), KEM Hosp Women, Dept Neonatal Paediat, Perth, WA, Australia.	sanjay.patole@health.wa.gov.au	Simmer, Karen N/H-5834-2014	Conway, Patricia Lynne/0000-0003-1763-0773; Esvaran, Meera/0000-0002-7886-1834; Simmer, Karen/0000-0003-4777-9069	Telethon Channel 7 Trust, Western Australia	Telethon Channel 7 Trust, Western Australia	This trial was funded by the Telethon Channel 7 Trust, Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F., 2009, Bioscience and Microflora, V28, P7; Abe F, 2010, ANAEROBE, V16, P131, DOI 10.1016/j.anaerobe.2009.07.006; Alfaleh K, 2011, COCHRANE DB SYST REV, V16; Australian Government National Health and Medical Research Council, 1997, JOINT NHMRC AVCC STA; Barrington KJ, 2011, ARCH DIS CHILDHOOD-E, V96, P199, DOI 10.1136/adc.2011.214569; Bermudez-Brito M, 2012, ANN NUTR METAB, V61, P160, DOI 10.1159/000342079; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Claud EC, 2008, J CLIN GASTROENTEROL, V42, pS46, DOI 10.1097/MCG.0b013e31815a57a8; Deshpande G, 2010, PEDIATRICS, V125, P921, DOI 10.1542/peds.2009-1301; Deshpande GC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-92; Fujii T, 2006, J PEDIATR GASTR NUTR, V43, P83, DOI 10.1097/01.mpg.0000228100.04702.f8; Ganguli K, 2012, GASTROENTEROL CLIN N, V41, P733, DOI 10.1016/j.gtc.2012.08.004; Hikaru U., 2010, International Journal of Probiotics and Prebiotics, V5, P33; Hotel ACP., 2001, PREVENTION, V5, P1; Jain L, 2013, CLIN PERINATOL, V40, pXIII, DOI 10.1016/j.clp.2013.01.002; Janvier A, 2012, ACTA PAEDIATR, V102, P116; Kitajima H, 1997, ARCH DIS CHILD-FETAL, V76, pF101, DOI 10.1136/fn.76.2.F101; Layden BT, 2013, TRANSL RES, V161, P131, DOI 10.1016/j.trsl.2012.10.007; Li YD, 2004, PEDIATR INT, V46, P509, DOI 10.1111/j.1442-200x.2004.01953.x; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Locascio M, 2001, CAN J MICROBIOL, V47, P1048, DOI 10.1139/cjm-47-11-1048; Martin CR, 2008, SEMIN PERINATOL, V32, P127, DOI 10.1053/j.semperi.2008.01.006; Martin R, 2009, APPL ENVIRON MICROB, V75, P965, DOI 10.1128/AEM.02063-08; Matsuki T, 1999, APPL ENVIRON MICROB, V65, P4506; Matsuki Takahiro, 2003, Curr Issues Intest Microbiol, V4, P61; Mattoo J, 2007, INT DAIRY J, V17, P1123, DOI 10.1016/j.idairyj.2007.01.008; Mikami K, 2012, PHARMACEUTICALS-BASE, V5, P629, DOI 10.3390/ph5060629; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Namachivayam K, 2013, AM J PHYSIOL-GASTR L, V304, pG167, DOI 10.1152/ajpgi.00141.2012; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Satoh Y, 2007, INT J PROBIOT PREBIO, V2, P149; Schouten B, 2009, J NUTR, V139, P1398, DOI 10.3945/jn.109.108514; Seale JV, 2013, J HOSP INFECT, V84, P1, DOI 10.1016/j.jhin.2013.01.005; Shanahan F, 2012, GASTROENTEROL CLIN N, V41, P869, DOI 10.1016/j.gtc.2012.08.006; Swanson JR, 2013, J PERINATOL, V33, P1, DOI 10.1038/jp.2012.122; Tarnow-Mordi WO, 2010, PEDIATRICS, V125, P1068, DOI 10.1542/peds.2009-2151; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; Wang CX, 2007, J PEDIATR GASTR NUTR, V44, P252, DOI 10.1097/01.mpg.0000252184.89922.5f; Wang QZ, 2012, J PEDIATR SURG, V47, P241, DOI 10.1016/j.jpedsurg.2011.09.064; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WILLIAMS AF, 1997, SEMIN NEONATOL, V2, P263	41	72	77	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89511	10.1371/journal.pone.0089511	http://dx.doi.org/10.1371/journal.pone.0089511			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594833	gold, Green Published, Green Submitted			2022-12-27	WOS:000332468900020
J	Zhuang, JY; Zhang, S; Xu, J; Hu, D				Zhuang, Jin-Ying; Zhang, Sen; Xu, Jing; Hu, Die			Discriminating Males and Unpredictable Females: Males Differentiate Self-Similar Facial Cues More than Females in the Judgment of Opposite-Sex Attractiveness	PLOS ONE			English	Article							MALE MATE CHOICE; MENSTRUAL-CYCLE; MALE FACES; GOOD GENES; WOMENS PREFERENCES; SPERM COMPETITION; MARRIED-COUPLES; APPARENT HEALTH; JAPANESE-QUAIL; IMMUNE-SYSTEM	Attractiveness judgment in the context of mate preferences is thought to reflect an assessment of mate quality in relation to an absolute scale of genetic fitness and a relative scale of self-similarity. In this study, subjects judged the attractiveness and trustworthiness of faces in composite images that were manipulated to produce self-similar (self-resemblance) and dissimilar (other-resemblance) images. Males differentiated between self- and other-resemblance as well as among different degrees of self-resemblance in their attractiveness ratings; females did not. Specifically, in Experiment 1, using a morphing technique, we created previously unseen face images possessing different degrees (0%, 30%, 40%, or 50%) of incorporation of the subject's images (different degrees of self-resemblance) and found that males preferred images that were closer to average (0%) rather than more self-similar, whereas females showed no preference for any degree of self-similarity. In Experiment 2, we added a pro-social question about trustworthiness. We replicated the Experiment 1 attractiveness rating results and further found that males differentiated between self- and other-resemblance for the same degree of composites; women did not. Both males and females showed a similar preference for self-resemblances when judging trustworthiness. In conclusion, only males factored self-resemblance into their attractiveness ratings of opposite-sex individuals in a manner consistent with cues of reproductive fitness, although both sexes favored self-resemblance when judging trustworthiness.	[Zhuang, Jin-Ying] E China Normal Univ, Key Lab Brain Funct Genom, MOE, Shanghai 200062, Peoples R China; E China Normal Univ, STCSM, Sch Psychol & Cognit Sci, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University; Science & Technology Commission of Shanghai Municipality (STCSM)	Zhuang, JY (corresponding author), E China Normal Univ, Key Lab Brain Funct Genom, MOE, Shanghai 200062, Peoples R China.	jinyingzhuang@gmail.com						AHMED SA, 1990, BAILLIERE CLIN RHEUM, V4, P13, DOI 10.1016/S0950-3579(05)80241-9; Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; Amundsen T, 2001, P NATL ACAD SCI USA, V98, P13155, DOI 10.1073/pnas.211439298; Bailenson JN, 2006, POLIT PSYCHOL, V27, P373, DOI 10.1111/j.1467-9221.2006.00505.x; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BATESON P, 1982, NATURE, V295, P236, DOI 10.1038/295236a0; BATESON P, 1980, Z TIERPSYCHOL, V53, P231; Bateson P, 1978, SEXUAL IMPRINTING OP; Bereczkei T, 2002, PERS INDIV DIFFER, V33, P677, DOI 10.1016/S0191-8869(01)00182-9; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Bonilla MM, 2011, ETHOLOGY, V117, P740, DOI 10.1111/j.1439-0310.2011.01928.x; Brooks R, 2011, P ROY SOC B-BIOL SCI, V278, P810, DOI 10.1098/rspb.2010.0964; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; Darwin Charles, 1871, DESCENT MAN; DeBruine LM, 2008, ARCH SEX BEHAV, V37, P64, DOI 10.1007/s10508-007-9266-0; DeBruine LM, 2011, P ROY SOC B-BIOL SCI, V278, P813, DOI 10.1098/rspb.2010.2200; DeBruine LM, 2010, P ROY SOC B-BIOL SCI, V277, P2405, DOI 10.1098/rspb.2009.2184; DeBruine LM, 2002, P ROY SOC B-BIOL SCI, V269, P1307, DOI 10.1098/rspb.2002.2034; DeBruine LM, 2005, P ROY SOC B-BIOL SCI, V272, P919, DOI 10.1098/rspb.2004.3003; DeBruine LM, 2005, HORM BEHAV, V47, P379, DOI 10.1016/j.yhbeh.2004.11.006; DeBruine LM, 2004, P ROY SOC B-BIOL SCI, V271, P2085, DOI 10.1098/rspb.2004.2824; Enlow DH, 1990, FACIAL GROWTH, P240; EPSTEIN E, 1984, SOC BIOL, V31, P243; Espinedo CM, 2010, EVOL ECOL, V24, P865, DOI 10.1007/s10682-009-9343-z; Fink B, 2007, AM J HUM BIOL, V19, P82, DOI 10.1002/ajhb.20583; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; GRIFFITHS RW, 1973, SOC BIOL, V20, P448, DOI 10.1080/19485565.1973.9988075; HINSZ VB, 1989, J SOC PERS RELAT, V6, P223, DOI 10.1177/026540758900600205; Hughes SM, 2004, EVOL HUM BEHAV, V25, P295, DOI 10.1016/j.evolhumbehav.2004.06.001; Johnston VS, 2001, EVOL HUM BEHAV, V22, P251, DOI 10.1016/S1090-5138(01)00066-6; Jones BC, 2005, HORM BEHAV, V48, P283, DOI 10.1016/j.yhbeh.2005.03.010; Jones BC, 2001, EVOL HUM BEHAV, V22, P417, DOI 10.1016/S1090-5138(01)00083-6; Keller MC, 1996, PERS INDIV DIFFER, V21, P217, DOI 10.1016/0191-8869(96)00066-9; Kocsor F, 2011, ARCH SEX BEHAV, V40, P1263, DOI 10.1007/s10508-010-9723-z; Kokko H, 2008, J EVOLUTIONARY BIOL, V21, P259; Krupp DB, 2008, EVOL HUM BEHAV, V29, P49, DOI 10.1016/j.evolhumbehav.2007.08.002; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; Lass-Hennemann J, 2010, P ROY SOC B-BIOL SCI, V277, P2175, DOI 10.1098/rspb.2010.0258; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Lebas NR, 2006, TRENDS ECOL EVOL, V21, P170, DOI 10.1016/j.tree.2006.01.007; Lihoreau M, 2010, ANIM BEHAV, V80, P303, DOI 10.1016/j.anbehav.2010.05.011; Lihoreau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003365; Little AC, 2006, PERS INDIV DIFFER, V40, P973, DOI 10.1016/j.paid.2005.09.016; Little AC, 2001, P ROY SOC B-BIOL SCI, V268, P39, DOI 10.1098/rspb.2000.1327; MITTON JB, 1984, ANNU REV ECOL SYST, V15, P479; Morse DH, 2010, BEHAV ECOL, V21, P250, DOI 10.1093/beheco/arp183; Murphy TG, 2009, BEHAV ECOL, V20, P1000, DOI 10.1093/beheco/arp089; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; Penton-Voak IS, 1999, CURR PSYCHOL, V18, P104; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; Penton-Voak IS, 2003, J COMP PSYCHOL, V117, P264, DOI 10.1037/0735-7036.117.3.264; Penton-Voak IS, 2001, ADV STUD BEHAV, V30, P219, DOI 10.1016/S0065-3454(01)80008-5; Penton-Voak IS, 2000, EVOL HUM BEHAV, V21, P39, DOI 10.1016/S1090-5138(99)00033-1; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Perrett DI, 1999, EVOL HUM BEHAV, V20, P295, DOI 10.1016/S1090-5138(99)00014-8; Pizzari T, 2003, NATURE, V426, P70, DOI 10.1038/nature02004; Provost MP, 2008, EVOL HUM BEHAV, V29, P65, DOI 10.1016/j.evolhumbehav.2007.07.007; Quist MC, 2012, J EXP SOC PSYCHOL, V48, P770, DOI 10.1016/j.jesp.2011.12.018; READ AF, 1988, HUMAN MATING PATTERN, P115; Reading KL, 2007, ANIM BEHAV, V74, P867, DOI 10.1016/j.anbehav.2006.09.025; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; ROWLAND DA, 1995, IEEE COMPUT GRAPH, V15, P70, DOI 10.1109/38.403830; RUSHTON JP, 1988, ETHOL SOCIOBIOL, V9, P329, DOI 10.1016/0162-3095(88)90025-8; Saxton TK, 2009, BEHAV ECOL, V20, P1133, DOI 10.1093/beheco/arp107; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Seli E, 2002, IMMUNOL ALLERGY CLIN, V22, P407, DOI 10.1016/S0889-8561(02)00017-6; THIESSEN D, 1980, ETHOL SOCIOBIOL, V1, P111, DOI 10.1016/0162-3095(80)90003-5; Thiessen D, 1999, SOCIAL INFLUENCES HU, P311; Thomas ML, 2007, AM NAT, V170, P190, DOI 10.1086/519404; Thomas ML, 2009, P R SOC B, V276, P383, DOI 10.1098/rspb.2008.1206; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; THORNHILL R, 1993, HUM NATURE-INT BIOS, V4, P237, DOI 10.1007/BF02692201; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Tobias JA, 2011, J EVOLUTION BIOL, V24, P2118, DOI 10.1111/j.1420-9101.2011.02345.x; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Vukovic J, 2010, BEHAV ECOL, V21, P767, DOI 10.1093/beheco/arq051; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Willians G. C., 1966, ADAPTATION NATURAL S; ZAJONC RB, 1987, MOTIV EMOTION, V11, P335, DOI 10.1007/BF00992848; Zentner M, 2012, PSYCHOL SCI, V23, P1176, DOI 10.1177/0956797612441004	81	1	2	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90493	10.1371/journal.pone.0090493	http://dx.doi.org/10.1371/journal.pone.0090493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4CT	24594644	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900112
J	Foronjy, RF; Dabo, AJ; Taggart, CC; Weldon, S; Geraghty, P				Foronjy, Robert F.; Dabo, Abdoulaye J.; Taggart, Clifford C.; Weldon, Sinead; Geraghty, Patrick			Respiratory Syncytial Virus Infections Enhance Cigarette Smoke Induced COPD in Mice	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY EPITHELIAL-CELLS; SURFACTANT PROTEIN-A; CD8(+) T-CELLS; NF-KAPPA-B; ACUTE EXACERBATIONS; IFN-GAMMA; IN-VIVO; MATRIX METALLOPROTEINASE-1; RSV INFECTION	Respiratory syncytial viral (RSV) infections are a frequent cause of chronic obstructive pulmonary disease (COPD) exacerbations, which are a major factor in disease progression and mortality. RSV is able to evade antiviral defenses to persist in the lungs of COPD patients. Though RSV infection has been identified in COPD, its contribution to cigarette smoke-induced airway inflammation and lung tissue destruction has not been established. Here we examine the long-term effects of cigarette smoke exposure, in combination with monthly RSV infections, on pulmonary inflammation, protease production and remodeling in mice. RSV exposures enhanced the influx of macrophages, neutrophils and lymphocytes to the airways of cigarette smoke exposed C57BL/6J mice. This infiltration of cells was most pronounced around the vasculature and bronchial airways. By itself, RSV caused significant airspace enlargement and fibrosis in mice and these effects were accentuated with concomitant smoke exposure. Combined stimulation with both smoke and RSV synergistically induced cytokine (IL-1 alpha, IL-17, IFN-gamma, KC, IL-13, CXCL9, RANTES, MIF and GM-CSF) and protease (MMP-2, -8, -12, -13, -16 and cathepsins E, S, W and Z) expression. In addition, RSV exposure caused marked apoptosis within the airways of infected mice, which was augmented by cigarette smoke exposure. RSV and smoke exposure also reduced protein phosphatase 2A (PP2A) and protein tyrosine phosphates (PTP1B) expression and activity. This is significant as these phosphatases counter smoke-induced inflammation and protease expression. Together, these findings show for the first time that recurrent RSV infection markedly enhances inflammation, apoptosis and tissue destruction in smoke-exposed mice. Indeed, these results indicate that preventing RSV transmission and infection has the potential to significantly impact on COPD severity and progression.	[Foronjy, Robert F.; Dabo, Abdoulaye J.; Geraghty, Patrick] St Lukes Roosevelt Hosp, Div Pulm & Crit Care Med, Mt Sinai Hlth Syst, New York, NY 10025 USA; [Taggart, Clifford C.; Weldon, Sinead] Queens Univ Belfast, Ctr Infect & Immun, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland	Icahn School of Medicine at Mount Sinai; Mount Sinai St. Luke's; Mount Sinai West; Queens University Belfast	Geraghty, P (corresponding author), St Lukes Roosevelt Hosp, Div Pulm & Crit Care Med, Mt Sinai Hlth Syst, New York, NY 10025 USA.	pgeraghty@chpnet.org	Weldon, Sinead/J-5451-2014; Taggart, Clifford C/G-4492-2014	Weldon, Sinead/0000-0001-5628-6624; Taggart, Clifford/0000-0002-9930-2978; Geraghty, Patrick/0000-0003-1647-5505	Flight Attendant Medical Research Institute [YCSA 113380]; US National Institutes of Health [5R01HL098528-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098528] Funding Source: NIH RePORTER; Public Health Agency [COM/4275/10] Funding Source: researchfish	Flight Attendant Medical Research Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Public Health Agency	This work was supported by grants made available to P.G. ( Flight Attendant Medical Research Institute (YCSA 113380)) (http://www.famri.org/intro/) and to R. F. ( US National Institutes of Health 5R01HL098528-04) (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Bauer CMT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013251; Bem RA, 2010, AM J RESP CELL MOL, V42, P697, DOI 10.1165/rcmb.2009-0100OC; Boukhvalova MS, 2010, CURR PROTOC CELL BIO; Castro SM, 2008, TOXICOL SCI, V106, P509, DOI 10.1093/toxsci/kfn175; Cody SH, 2013, CLIN INFECT DIS, V57, P1135, DOI 10.1093/cid/cit474; Collison A, 2013, NAT MED, V19, P232, DOI 10.1038/nm.3049; D'Armiento JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056352; De Langhe E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043123; DiBonaventura MD, 2012, COPD, V9, P46, DOI 10.3109/15412555.2011.634863; DiFranza JR, 2012, BMC PEDIATR, V12, P81, DOI DOI 10.1186/1471-2431-12-81; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Drannik AG, 2013, J VIROL, V87, P7526, DOI 10.1128/JVI.02243-12; Elliott MB, 2007, J MED VIROL, V79, P447, DOI 10.1002/jmv.20830; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Ford JG, 2001, J IMMUNOL, V167, P1769, DOI 10.4049/jimmunol.167.3.1769; FORONJY R, 2005, TRANSGENIC EXPRESSIO; Foronjy RF, 2006, AM J RESP CRIT CARE, V173, P623, DOI 10.1164/rccm.200506-850OC; Geraghty P, 2008, THORAX, V63, P621, DOI 10.1136/thx.2007.088559; Geraghty P, 2007, J BIOL CHEM, V282, P33389, DOI 10.1074/jbc.M706884200; Geraghty P, 2007, J IMMUNOL, V178, P5871, DOI 10.4049/jimmunol.178.9.5871; Geraghty P, 2013, AM J RESP CELL MOL, V49, P721, DOI 10.1165/rcmb.2013-0026OC; Geraghty P, 2011, J BIOL CHEM, V286, P30211, DOI 10.1074/jbc.M111.238824; Gong DP, 2011, J INFECT DIS, V204, P592, DOI 10.1093/infdis/jir352; Groskreutz DJ, 2007, J IMMUNOL, V179, P2741, DOI 10.4049/jimmunol.179.5.2741; Groskreutz DJ, 2009, AM J RESP CELL MOL, V41, P189, DOI 10.1165/rcmb.2008-0131OC; HIRAKAWA S, 2013, J MED VIROL; Hosakote YM, 2011, AM J RESP CRIT CARE, V183, P1550, DOI 10.1164/rccm.201010-1755OC; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Kotelkin A, 2003, J VIROL, V77, P9156, DOI 10.1128/JVI.77.17.9156-9172.2003; Langsetmo L, 2008, AM J RESP CRIT CARE, V177, P396, DOI 10.1164/rccm.200708-1290OC; Lee N, 2013, CLIN INFECT DIS, V57, P1069, DOI 10.1093/cid/cit471; LeVine AM, 1999, J CLIN INVEST, V103, P1015, DOI 10.1172/JCI5849; Li W, 2007, CHINESE MED J-PEKING, V120, P5, DOI 10.1097/00029330-200701010-00002; Maeno T, 2007, J IMMUNOL, V178, P8090, DOI 10.4049/jimmunol.178.12.8090; MALLIA P, 2005, P AM THORAC SOC, V2; Mallia Patrick, 2005, Proc Am Thorac Soc, V2, P361, DOI 10.1513/pats.200504-025SR; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; Mehra D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052889; Mehta J, 2013, COPD, V10, P293, DOI 10.3109/15412555.2012.744741; Minino Arialdi M, 2010, Natl Vital Stat Rep, V59, P1; Miravitlles M, 2007, RESP MED, V101, P453, DOI 10.1016/j.rmed.2006.07.010; Modestou MA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-64; Monick MM, 2005, J BIOL CHEM, V280, P2147, DOI 10.1074/jbc.M408745200; Morissette MC, 2008, AM J RESP CRIT CARE, V178, P240, DOI 10.1164/rccm.200710-1486OC; Morissette MC, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-105; Murdoch JR, 2010, AM J RESP CRIT CARE, V182, P464, DOI 10.1164/rccm.200911-1775OC; Nadigel J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-149; Niture SK, 2012, J BIOL CHEM, V287, P9873, DOI 10.1074/jbc.M111.312694; O'Donnell DR, 1999, VIROLOGY, V257, P198, DOI 10.1006/viro.1999.9650; Respiratory syncytial virus activity-United States, 2003, MMWR MORB MORTAL WKL, V53, P1159; Robbins CS, 2004, AM J RESP CELL MOL, V30, P202, DOI 10.1165/rcmb.2003-0259OC; Sajjan US, 2013, CURR OPIN PULM MED, V19, P125, DOI 10.1097/MCP.0b013e32835cef10; Schneider D, 2010, AM J RESP CRIT CARE, V182, P332, DOI 10.1164/rccm.200911-1673OC; Schochett P, 1999, EXP LUNG RES, V25, P595; Schuurhof A, 2012, EUR RESPIR J, V39, P1475, DOI 10.1183/09031936.00012311; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Shapiro SD, 2003, EUR RESPIR J, V22, p30S, DOI 10.1183/09031936.03.00000903a; Sikkel MB, 2008, PEDIATR INFECT DIS J, V27, pS63, DOI 10.1097/INF.0b013e3181684d67; Sin DD, 2002, AM J RESP CRIT CARE, V165, P704, DOI 10.1164/ajrccm.165.5.2104055; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Thomas KW, 2002, J BIOL CHEM, V277, P492, DOI 10.1074/jbc.M108107200; van den Berg E, 2011, AM J PHYSIOL-LUNG C, V301, pL451, DOI 10.1152/ajplung.00368.2010; Wallace AM, 2012, TOXICOL SCI, V126, P589, DOI 10.1093/toxsci/kfr351; Wang ZD, 2000, J EXP MED, V192, P1587, DOI 10.1084/jem.192.11.1587; Wedzicha JA, 2001, AM J RESP CRIT CARE, V164, P1757, DOI 10.1164/ajrccm.164.10.2108049a; Wilkinson TMA, 2006, AM J RESP CRIT CARE, V173, P871, DOI 10.1164/rccm.200509-1489OC; YANG H, 2013, MOL CANC RES; Yeo SJ, 2002, ARCH VIROL, V147, P229, DOI 10.1007/s705-002-8316-1; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458; Zheng T, 2005, J IMMUNOL, V174, P8106, DOI 10.4049/jimmunol.174.12.8106; Zhou Y, 2013, J IMMUNOL, V191, P2637, DOI 10.4049/jimmunol.1300082	76	46	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90567	10.1371/journal.pone.0090567	http://dx.doi.org/10.1371/journal.pone.0090567			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587397	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200231
J	Meng, WB; Li, X; Bai, ZT; Li, Y; Yuan, JQ; Liu, T; Yan, J; Zhou, WC; Zhu, KX; Zhang, H; Li, YM				Meng, Wenbo; Li, Xun; Bai, Zhongtian; Li, Yan; Yuan, Jinqiu; Liu, Tao; Yan, Jun; Zhou, Wence; Zhu, Kexiang; Zhang, Hui; Li, Yumin			Silencing Alpha-Fetoprotein Inhibits VEGF and MMP-2/9 Production in Human Hepatocellular Carcinoma Cell	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EXPRESSION; ANGIOGENESIS; CANCER; PROGRESSION; PEPTIDES; RECEPTOR; PATHWAY	Alpha-fetoprotein not only serves as a diagnostic marker for liver cancer, but also posses a variety of biological functions. However, the role of Alpha-fetoprotein on tumor angiogenesis and cell invasion remains incompletely understood. In this study, we aimed to evaluate if Alpha-fetoprotein can regulate the major angiogenic factors and matrix metalloproteinases in human liver cancer cells. Alpha-fetoprotein silencing was achieved by Stealth RNAi. Expression of Alpha-fetoprotein was examined by a full-automatic electrochemistry luminescence immunity analyzer. Expression of VEGF, VEGFR-2, MMP-9, and MMP-2 was examined by Western blot and immunocytochemistry. Apoptosis was detected by TUNEL assay. Angiogenesis was detected by in vitro angiogenesis assay kit. Silencing of Alpha-fetoprotein led to an increased apoptosis, which was associated with a decreased expression of vascular endothelial growth factor, vascular endothelial growth factor receptor 2, matrix metalloproteinases-2/9. These results suggest that Alpha-fetoprotein may play a regulatory role on angiogenesis and cell invasion during liver cancer development.	[Meng, Wenbo; Liu, Tao; Li, Yumin] Lanzhou Univ, Hosp 2, Key Lab Digest Syst Tumors, Lanzhou 730000, Gansu, Peoples R China; [Meng, Wenbo] Lanzhou Univ, Hepatopancreatobiliary Surg Inst Gansu Prov, Hosp 1, Clin Med Coll,Canc Ctr, Lanzhou 730000, Gansu, Peoples R China; [Li, Xun; Bai, Zhongtian; Yan, Jun; Zhou, Wence; Zhu, Kexiang; Zhang, Hui] Lanzhou Univ, Hepatopancreatobiliary Surg Inst Gansu Prov, Dept Gen Surg 2, Clin Med Coll,Canc Ctr,Hosp 1, Lanzhou 730000, Gansu, Peoples R China; [Li, Yan] Cleveland Clin, Dept Immunol, Cleveland, OH 44106 USA; [Yuan, Jinqiu] Chinese Univ Hong Kong, Div Epidemiol, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University; Cleveland Clinic Foundation; Chinese University of Hong Kong	Li, X (corresponding author), Lanzhou Univ, Hepatopancreatobiliary Surg Inst Gansu Prov, Dept Gen Surg 2, Clin Med Coll,Canc Ctr,Hosp 1, Lanzhou 730000, Gansu, Peoples R China.	drlixun@163.com; liym@lzu.edu.cn	li, Yu/HCI-9086-2022; li, yan/B-8629-2015; li, yu/HGL-9518-2022; Yuan, Jinqiu/A-4867-2018; Li, yu/HHZ-5236-2022	Ye, Cheng/0000-0001-9180-6648	Natural Science Foundation of China [31270532, 31270543]; Fundamental Research Funds for the Central Universities [lzujbky-2010-144, lzujbky-2012-167]; West Light Foundation of The Chinese Academy of Science [2009-236]; Health Industry Research Project of Gansu Province [GSWST 2011-04]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); West Light Foundation of The Chinese Academy of Science(Chinese Academy of Sciences); Health Industry Research Project of Gansu Province	This work was supported by the Natural Science Foundation of China (31270532, 31270543), "Fundamental Research Funds for the Central Universities'' (lzujbky-2010-144; lzujbky-2012-167), West Light Foundation of The Chinese Academy of Science (2009-236), and Health Industry Research Project of Gansu Province (GSWST 2011-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid R, 2004, ARTERIOSCL THROM VAS, V24, P294, DOI 10.1161/01.ATV.0000110502.10593.06; Carlomagno F, 2006, JNCI-J NATL CANCER I, V98, P326, DOI 10.1093/jnci/djj069; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; El-Assal ON, 1998, HEPATOLOGY, V27, P1554, DOI 10.1002/hep.510270613; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; Ginanni Corradini S, 2009, LIVER INT, V29, P103, DOI 10.1111/j.1478-3231.2008.01781.x; Guo RP, 2006, J CANCER RES CLIN, V132, P547, DOI 10.1007/s00432-006-0097-5; Iida H, 2005, GUT, V54, P843, DOI 10.1136/gut.2004.049486; Li MS, 2004, WORLD J GASTROENTERO, V10, P819; Li MS, 2011, INT J CANCER, V128, P524, DOI 10.1002/ijc.25373; Li MS, 2009, INT J CANCER, V124, P2845, DOI 10.1002/ijc.24272; Li MS, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-96; Li MS, 2002, WORLD J GASTROENTERO, V8, P469, DOI 10.3748/wjg.v8.i3.469; Li QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033379; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mizejewski GJ, 2003, MOL CANCER THER, V2, P1243; Muehlemann M, 2005, CANCER METAST REV, V24, P441, DOI 10.1007/s10555-005-5135-2; Ng YS, 2006, EXP CELL RES, V312, P527, DOI 10.1016/j.yexcr.2005.11.008; Olin DL, 2004, J CLIN ENDOCR METAB, V89, P1415; Poon RTP, 2004, BRIT J SURG, V91, P1354, DOI 10.1002/bjs.4594; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; Semela D, 2004, J HEPATOL, V41, P864, DOI 10.1016/j.jhep.2004.09.006; Takahashi Y, 2004, ONCOL REP, V11, P809; Vakharia D, 2000, BREAST CANCER RES TR, V63, P41, DOI 10.1023/A:1006484223325; WANG W, 1995, HEPATOLOGY, V22, P921, DOI 10.1002/hep.1840220333; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034406; Yamaguchi R, 1998, HEPATOLOGY, V28, P68, DOI 10.1002/hep.510280111; Zhu AX, 2009, J CLIN ONCOL, V27, P3027, DOI 10.1200/JCO.2008.20.9908	32	25	32	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90660	10.1371/journal.pone.0090660	http://dx.doi.org/10.1371/journal.pone.0090660			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587407	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200241
J	Zhang, WN; Liu, T; Yang, Y; Cao, LJ; Zhang, Y; Ji, RR				Zhang, Wei-Nan; Liu, Ting; Yang, Yang; Cao, Liujuan; Zhang, Yu; Ji, Rongrong			A Topic Clustering Approach to Finding Similar Questions from Large Question and Answer Archives	PLOS ONE			English	Article							WORDNET	With the blooming of Web 2.0, Community Question Answering (CQA) services such as Yahoo! Answers (http://answers.yahoo.com), WikiAnswer (http://wiki.answers.com), and Baidu Zhidao (http://zhidao.baidu.com), etc., have emerged as alternatives for knowledge and information acquisition. Over time, a large number of question and answer (Q&A) pairs with high quality devoted by human intelligence have been accumulated as a comprehensive knowledge base. Unlike the search engines, which return long lists of results, searching in the CQA services can obtain the correct answers to the question queries by automatically finding similar questions that have already been answered by other users. Hence, it greatly improves the efficiency of the online information retrieval. However, given a question query, finding the similar and well-answered questions is a non-trivial task. The main challenge is the word mismatch between question query (query) and candidate question for retrieval (question). To investigate this problem, in this study, we capture the word semantic similarity between query and question by introducing the topic modeling approach. We then propose an unsupervised machine-learning approach to finding similar questions on CQA Q&A archives. The experimental results show that our proposed approach significantly outperforms the state-of-the-art methods.	[Zhang, Wei-Nan; Liu, Ting; Zhang, Yu] Harbin Inst Technol, Res Ctr Social Comp & Informat Retrieval, Harbin 150006, Heilongjiang, Peoples R China; [Yang, Yang] Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore; [Cao, Liujuan] Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Fujian, Peoples R China; [Ji, Rongrong] Xiamen Univ, Dept Cognit Sci, Xiamen, Fujian, Peoples R China	Harbin Institute of Technology; National University of Singapore; Xiamen University; Xiamen University	Cao, LJ (corresponding author), Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Fujian, Peoples R China.	caoliujuan@gmail.com; zhangyu@ir.hit.edu.cn			Natural Science Foundation of China [61133012, 61202277, 61073126]; Fundamental Research Funds for the Central Universities [2013121026, 2011121052]; Xiamen University 985 Project	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Xiamen University 985 Project	This work was supported by the Natural Science Foundation of China (Grant No. 61133012, 61202277, 61073126) and the Fundamental Research Funds for the Central Universities (No. 2013121026 and No. 2011121052) and Xiamen University 985 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan James, 2003, P 26 ANN INT ACM SIG, P314, DOI DOI 10.1145/860435.860493; Banerjee Satanjeev., 2003, P 18 INT JOINT C ART, P805; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Budanitsky A, 2006, COMPUT LINGUIST, V32, P13, DOI 10.1162/coli.2006.32.1.13; Chen TC, 2009, PROC EUR SOLID-STATE, P1; Cheng MM, 2014, VISUAL COMPUT, V30, P443, DOI 10.1007/s00371-013-0867-4; Cheng MM, 2011, TPAMI2011100753; Cui H., 2005, P 28 ANN INT ACM SIG, P400, DOI [DOI 10.1145/1076034.1076103, 10. 1145/1076034.1076103]; Duan H., 2008, ACL, V8, P156; Gao Y, 2013, IEEE T IMAGE PROCESS, V22, P363, DOI 10.1109/TIP.2012.2202676; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P4290, DOI 10.1109/TIP.2012.2199502; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P2269, DOI 10.1109/TIP.2011.2170081; Gehler P, 2009, IEEE I CONF COMP VIS, P221, DOI 10.1109/ICCV.2009.5459169; Hoad TC, 2003, J AM SOC INF SCI TEC, V54, P203, DOI 10.1002/asi.10170; Jeon J., 2005, P 14 ACM INT C INF K, P84, DOI DOI 10.1145/1099554.1099572; Ji RR, 2012, INT J COMPUT VISION, V96, P290, DOI 10.1007/s11263-011-0472-9; Ji RR, 2012, IEEE T IMAGE PROCESS, V21, P2282, DOI 10.1109/TIP.2011.2176950; Ji RR, 2011, ACM T MULTIM COMPUT, V7, DOI 10.1145/2037676.2037688; Jiwoon Jeon, 2005, SIGIR 2005. Proceedings of the Twenty-Eighth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P617, DOI 10.1145/1076034.1076156; Landauer TK, 1997, PROCEEDINGS OF THE NINETEENTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P412; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Lin D, 1998, P INT C MACH LEARN; Mandreoli F., 2002, Proceedings of the Eleventh International Conference on Information and Knowledge Management. CIKM 2002, P635, DOI 10.1145/584792.584904; Metzler Donald, 2005, P 14 ACM INT C INF K, P517; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Min Chen, 2011, IEEE INFOCOM 2011 - IEEE Conference on Computer Communications. Workshops, P409, DOI 10.1109/INFCOMW.2011.5928847; Ming ZY, 2010, P 19 ACM INT C INF K, P1605; Park JH, 2010, SIGIR 2010: PROCEEDINGS OF THE 33RD ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH DEVELOPMENT IN INFORMATION RETRIEVAL, P829; Park JH, 2011, P 20 ACM INT C INF K, P17, DOI DOI 10.1145/2063576.2063585; Ponte J. M., 1998, P 21 ANN INT ACM SIG, P275, DOI DOI 10.1145/290941.291008; Robertson S. E., 1995, Text REtrieval Conference (TREC-3) (NIST SP 500-225), P109; Sparck-Jones K, 2000, INFORM PROCESS MANAG, V36, P779, DOI 10.1016/S0306-4573(00)00015-7; Wang K, 2009, PROCEEDINGS 32ND ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P187, DOI 10.1145/1571941.1571975; Xue X., 2008, P 31 ANN INT ACM SIG, P475, DOI 10.1145/1390334.1390416; Zhang ST, 2010, PROC CVPR IEEE, P3312, DOI 10.1109/CVPR.2010.5540036; Zhang W.N., 2012, COLING, P3105; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064601, 10.1371/journal.pone.0071243, 10.1371/journal.pone.0067564]	37	61	64	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e71511	10.1371/journal.pone.0071511	http://dx.doi.org/10.1371/journal.pone.0071511			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595052	Green Published, Green Submitted, gold			2022-12-27	WOS:000332475500001
J	Li, CH; Yang, YC; Wu, JS; Huang, YH; Lee, CT; Lu, FH; Chang, CJ				Li, Chung-Hao; Yang, Yi-Ching; Wu, Jin-Shang; Huang, Ying-Hsiang; Lee, Chih-Ting; Lu, Feng-Hwa; Chang, Chih-Jen			Increased Tea Consumption Is Associated with Decreased Arterial Stiffness in a Chinese Population	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ALCOHOL-CONSUMPTION; INSULIN-RESISTANCE; AORTIC STIFFNESS; HEART-DISEASE; RISK	Background: Tea has attracted considerable attention for its potential cardioprotective effects. The primary chemical components of tea are thought to have a beneficial effect by reducing arterial stiffness. The objective of this study was to assess the association between tea consumption and brachial-ankle pulse wave velocity (baPWV) in a relatively healthy Chinese population. Methods: We enrolled 3,135 apparently healthy subjects from October 2006 to August 2009. Subjects taking medication for diabetes, hypertension, or hyperlipidemia, or with a history of cardiovascular disease, were excluded from the study. The subjects were categorized into three groups according to their tea-drinking habits: (1) none to low (n = 1615), defined as non-habitual tea drinkers, or drinking for <1 year, or drinking <= 150 mL per day for >= 1 year; (2) moderate tea consumption, defined as drinking for >= 1 year and consumption between 151 and 450 mL per day; and (3) heavy tea consumption, defined as a drinking for >= 1 year and consumption >450 mL per day. Multiple logistic regression was used to determine whether different levels of consumption were independently associated with the highest quartile of baPWV values, defined as >= 1428.5 cm/s. Results: Of the 3,135 subjects, 48.5% had drunk >150 mL of tea per day for at least 1 year. In multivariate regression analysis with adjustment for co-variables, including, age, sex, current smoking, alcohol use, habitual exercise, total cholesterol/high-density lipoprotein cholesterol (TC/HDL-C) ratio >5, obesity, newly diagnosed hypertension and diabetes, subjects with high tea consumption had a decreased risk of highest quartile of baPWV by 22% (odds ratio = 0.78, 95% confidence interval = 0.62-0.98, p = 0.032), while subjects with moderate tea consumption did not (p = 0.742), as compared subjects with none to low tea consumption. Conclusions: High, but not moderate, habitual tea consumption may decrease arterial stiffness.	[Li, Chung-Hao] China Med Univ, Tainan Municipal An Nan Hosp, Dept Family Med, Taichung, Taiwan; [Yang, Yi-Ching; Wu, Jin-Shang; Huang, Ying-Hsiang; Lee, Chih-Ting; Lu, Feng-Hwa; Chang, Chih-Jen] Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan; [Yang, Yi-Ching; Wu, Jin-Shang; Lu, Feng-Hwa; Chang, Chih-Jen] Natl Cheng Kung Univ, Coll Med, Dept Family Med, Tainan 70101, Taiwan	China Medical University Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Chang, CJ (corresponding author), Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan.	smallhear@gmail.com	LI, CHUNG-HAO/W-6529-2019; Yang, Yi-Ching/C-7033-2014	LI, CHUNG-HAO/0000-0001-5062-8128; Yang, Yi-Ching/0000-0003-1391-8040	Department of Family Medicine, National Cheng-Kung University Hospital [NCKUHFM-101-001]; National Science Council, Taiwan, R.O.C.	Department of Family Medicine, National Cheng-Kung University Hospital; National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This study was supported by the grants from the Department of Family Medicine, National Cheng-Kung University Hospital (NCKUHFM-101-001). The authors would like to thank the National Science Council, Taiwan, R.O.C. for financially supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Arsenault Benoit J, 2009, J Am Coll Cardiol, V55, P35, DOI 10.1016/j.jacc.2009.07.057; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; Cecelja M, 2009, HYPERTENSION, V54, P1328, DOI 10.1161/HYPERTENSIONAHA.109.137653; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Deka A, 2011, PHARMACOL RES, V64, P136, DOI 10.1016/j.phrs.2011.03.009; Grassi D, 2009, J HYPERTENS, V27, P774, DOI 10.1097/HJH.0b013e328326066c; Hodgson JM, 2010, MOL ASPECTS MED, V31, P495, DOI 10.1016/j.mam.2010.09.004; Jatoi NA, 2007, HYPERTENSION, V49, P981, DOI 10.1161/HYPERTENSIONAHA.107.087338; Kawai Y, 2011, BIOSCI BIOTECH BIOCH, V75, P609, DOI 10.1271/bbb.100785; Lemieux I, 2001, ARCH INTERN MED, V161, P2685, DOI 10.1001/archinte.161.22.2685; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Mattace-Raso FUS, 2005, J GERONTOL A-BIOL, V60, P1479, DOI 10.1093/gerona/60.11.1479; Miyai N, 2009, J HUM HYPERTENS, V23, P444, DOI 10.1038/jhh.2008.143; Motobe K, 2005, CIRC J, V69, P55, DOI 10.1253/circj.69.55; Nakanishi N, 2001, IND HEALTH, V39, P24, DOI 10.2486/indhealth.39.24; Rahman S, 2008, DIABETES RES CLIN PR, V80, P253, DOI 10.1016/j.diabres.2007.12.010; Ryu OH, 2006, DIABETES RES CLIN PR, V71, P356, DOI 10.1016/j.diabres.2005.08.001; Schmitt CA, 2009, NITRIC OXIDE-BIOL CH, V21, P77, DOI 10.1016/j.niox.2009.05.006; Stangl V, 2006, MOL NUTR FOOD RES, V50, P218, DOI 10.1002/mnfr.200500118; Tanaka H, 2005, AM J HYPERTENS, V18, P137, DOI 10.1016/j.amjhyper.2004.07.008; Todd AS, 2010, AM J CLIN NUTR, V91, P557, DOI 10.3945/ajcn.2009.28645; Tomiyama H, 2010, CIRC J, V74, P24, DOI 10.1253/circj.CJ-09-0534; Urbina EM, 2012, DIABETOLOGIA, V55, P625, DOI 10.1007/s00125-011-2412-1; Whaley MH, 2006, ACSMS GUIDELINES EXE, Vxxi; Wilkinson IB, 2009, HYPERTENSION, V54, P1213, DOI 10.1161/HYPERTENSIONAHA.109.142612; Wilkinson IB, 2002, CIRCULATION, V105, P213, DOI 10.1161/hc0202.101970; Yamashina A, 2003, HYPERTENS RES, V26, P615, DOI 10.1291/hypres.26.615; Yang YC, 2004, ARCH INTERN MED, V164, P1534, DOI 10.1001/archinte.164.14.1534; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	30	64	66	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86022	10.1371/journal.pone.0086022	http://dx.doi.org/10.1371/journal.pone.0086022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465848	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100099
J	Vieira, LD; Faoro, H; Fraga, HPD; Rogalski, M; de Souza, EM; Pedrosa, FD; Nodari, RO; Guerra, MP				Vieira, Leila do Nascimento; Faoro, Helisson; de Freitas Fraga, Hugo Pacheco; Rogalski, Marcelo; de Souza, Emanuel Maltempi; Pedrosa, Fabio de Oliveira; Nodari, Rubens Onofre; Guerra, Miguel Pedro			An Improved Protocol for Intact Chloroplasts and cpDNA Isolation in Conifers	PLOS ONE			English	Article							INVERTED REPEAT COPIES; PLASTID GENOME; DNA EXTRACTION; EVOLUTION; NUCLEAR; GENES; SEQUENCE; PROTEIN; BIOTECHNOLOGY; PINACEAE	Background: Performing chloroplast DNA (cpDNA) isolation is considered a major challenge among different plant groups, especially conifers. Isolating chloroplasts in conifers by such conventional methods as sucrose gradient and high salt has not been successful. So far, plastid genome sequencing protocols for conifer species have been based mainly on long-range PCR, which is known to be time-consuming and difficult to implement. Methodology/Principal Findings: We developed a protocol for cpDNA isolation using three different conifer families: Araucaria angustifolia and Araucaria bidwilli (Araucariaceae), Podocarpus lambertii (Podocarpaceae) and Pinus patula (Pinaceae). The present protocol is based on high salt isolation buffer followed by saline Percoll gradient. Combining these two strategies allowed enhanced chloroplast isolation, along with decreased contamination caused by polysaccharides, polyphenols, proteins, and nuclear DNA in cpDNA. Microscopy images confirmed the presence of intact chloroplasts in high abundance. This method was applied to cpDNA isolation and subsequent sequencing by Illumina MiSeq (2x250 bp), using only 50 ng of cpDNA. Reference-guided chloroplast genome mapping showed that high average coverage was achieved for all evaluated species: 24.63 for A. angustifolia, 135.97 for A. bidwilli, 1196.10 for P. lambertii, and 64.68 for P. patula. Conclusion: Results show that this improved protocol is suitable for enhanced quality and yield of chloroplasts and cpDNA isolation from conifers, providing a useful tool for studies that require isolated chloroplasts and/or whole cpDNA sequences.	[Vieira, Leila do Nascimento; de Freitas Fraga, Hugo Pacheco; Nodari, Rubens Onofre; Guerra, Miguel Pedro] Univ Fed Santa Catarina, Programa Pos Grad Recursos Genet Vegetais, Dept Fitotecnia, Florianopolis, SC, Brazil; [Faoro, Helisson; de Souza, Emanuel Maltempi; Pedrosa, Fabio de Oliveira] Univ Fed Parana, Nucleo Fixacao Biol Nitrogenio, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil; [Rogalski, Marcelo] Univ Fed Vicosa, Dept Biol Vegetal, Vicosa, MG, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal do Parana; Universidade Federal de Vicosa	Guerra, MP (corresponding author), Univ Fed Santa Catarina, Programa Pos Grad Recursos Genet Vegetais, Dept Fitotecnia, Florianopolis, SC, Brazil.	miguel.guerra@ufsc.br	Faoro, Helisson/F-7163-2012; Pedrosa, Fabio 0/C-1938-2013; Vieira, Leila N/F-9934-2012; ROGALSKI, MARCELO/ABA-3940-2020; Rogalski, Marcelo/AAA-5192-2020; Nodari, Rubens O/B-7006-2014; Fraga, Hugo PF/F-9049-2012; Fraga, Hugo/L-7275-2019	Faoro, Helisson/0000-0002-0146-8639; ROGALSKI, MARCELO/0000-0002-1990-5243; Nodari, Rubens O/0000-0002-8884-2426; Fraga, Hugo PF/0000-0002-7363-5213; Guerra, Miguel/0000-0002-5319-3446; do Nascimento Vieira, Leila/0000-0001-8413-2155	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC) [14848/2011-2, 3770/2012, 2780/2012-4]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC)(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de desenvolvimento Cientifico e Tecnologico (CNPq) with fellowships, and by Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC) under project number 14848/2011-2, 3770/2012, and 2780/2012-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkatib S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003076; Arif IA, 2010, INT J MOL SCI, V11, P3149, DOI 10.3390/ijms11093149; Atherton RA, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-22; AYLIFFE MA, 1992, THEOR APPL GENET, V85, P229, DOI 10.1007/BF00222864; Ayliffe MA, 1998, MOL BIOL EVOL, V15, P738, DOI 10.1093/oxfordjournals.molbev.a025977; Bock R, 2013, PLANT MOL BIOL, V83, P21, DOI 10.1007/s11103-013-0045-0; BOOKJANS G, 1984, ANAL BIOCHEM, V141, P244, DOI 10.1016/0003-2697(84)90452-4; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Clarke JL, 2011, PLANT MOL BIOL, V76, P207, DOI 10.1007/s11103-011-9792-y; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Diekmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002813; Gargano D, 2013, PLANT MOL BIOL, V81, P235, DOI 10.1007/s11103-012-9994-y; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Greiner S, 2013, BIOESSAYS, V35, P354, DOI 10.1002/bies.201200137; He ZH, 2013, J PLANT PHYSIOL, V170, P1139, DOI 10.1016/j.jplph.2013.03.016; Hirao T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-70; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kaneko T, 1996, DNA Res, V3, P109; Keeling CI, 2006, PHYTOCHEMISTRY, V67, P2415, DOI 10.1016/j.phytochem.2006.08.019; Kubis Sybille E., 2008, V425, P171, DOI 10.1007/978-1-60327-210-0_16; Lin CP, 2010, GENOME BIOL EVOL, V2, P504, DOI 10.1093/gbe/evq036; Maliga P, 2011, PLANT PHYSIOL, V155, P1501, DOI 10.1104/pp.110.170969; Mastroberti Alexandra A., 2003, Braz. J. Bot., V26, P343, DOI 10.1590/S0100-84042003000300007; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; PALMER JD, 1986, CURR GENET, V10, P823, DOI 10.1007/BF00418529; Rogalski M, 2008, PLANT CELL, V20, P2221, DOI 10.1105/tpc.108.060392; Rogalski M, 2011, PLANT BIOTECHNOL J, V9, P554, DOI 10.1111/j.1467-7652.2011.00621.x; Rousseau-Gueutin M, 2011, PLANT PHYSIOL, V157, P2181, DOI 10.1104/pp.111.185074; Shi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031468; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; WALKER DA, 1987, METHOD ENZYMOL, V148, P145; Werner O, 2009, BRYOLOGIST, V112, P315, DOI 10.1639/0007-2745-112.2.315; Wolf PG, 2010, GENOME, V53, P731, DOI [10.1139/G10-061, 10.1139/g10-061]; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Wu CS, 2007, MOL BIOL EVOL, V24, P1366, DOI 10.1093/molbev/msm059; Wu CS, 2011, GENOME BIOL EVOL, V3, P1284, DOI 10.1093/gbe/evr095; Yamamoto S, 2004, J MASS SPECTROM, V39, P1337, DOI 10.1002/jms.726; Yi X, 2013, GENOME BIOL EVOL, V5, P688, DOI 10.1093/gbe/evt042	41	71	74	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84792	10.1371/journal.pone.0084792	http://dx.doi.org/10.1371/journal.pone.0084792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392157	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460100080
J	Dai, LL; Mao, YY; Luo, XM; Shen, YP				Dai, Lin-Lin; Mao, Yuan-Yuan; Luo, Xiao-Ming; Shen, Yue-Ping			Prenatal Care in Combination with Maternal Educational Level Has a Synergetic Effect on the Risk of Neonatal Low Birth Weight: New Findings in a Retrospective Cohort Study in Kunshan City, China	PLOS ONE			English	Article							PRETERM BIRTH; ASSOCIATION; OUTCOMES; INEQUALITIES; ADEQUACY; INDEXES; VISITS	Objectives: To investigate the dose-response relationship and synergetic effect of the maternal educational level and two measures of prenatal care on neonatal low birth weight (LBW) risk. Methods: Data were derived from the Perinatal Health Care Surveillance System (PHCSS) from January 2001 to September 2009 in Kunshan City, Jiangsu province, eastern China, which included data on 31412 women with a normal birth weight delivery and 640 women with a LBW delivery. Logistic modelling was performed to estimate the association including the joint effects with odds ratio (OR) and 95% confidence interval (CI) between the prenatal care measures and LBW risk after adjusting for the potential confounders. The dose-response relationship between the number of prenatal care visits and the risk of LBW was investigated by modeling the quantitative exposure with restricted cubic splines (RCS). Results: There was a significant synergetic effect on the LBW risk between maternal educational attainment and the number of prenatal care visits (chi(2)=4.98, P=0.0257), whereas no significant maternal educational attainment interaction was found with the week of initiation of prenatal care after adjusting for relevant confounding factors (chi(2)=2.04, P=0.1530), and the LBW risk displayed a 'U-shape' curve tendency among the different number of prenatal care visits (P for nonlinearity=0.0002) using RCS. In particular, the ORs were approaching the curve's bottom when the women had 9 or 10 prenatal care visits. Comparing with 5 prenatal care visits, the ORs and 95% CI of LBW risk for 7, 9, 11 and >= 13 visits were 0.92 (0.82-1.03), 0.50 (0.38-0.66), 0.62 (0.47-0.82), and 0.99 (0.61-1.60), respectively. Conclusions: Our findings suggest that appropriate prenatal care, in combination with a higher maternal educational level, can produce a protective interaction effect on LBW risk. Reasonable health resource assignment for different social statuses should be taken into account by policy-makers in developing countries.	[Dai, Lin-Lin; Shen, Yue-Ping] Soochow Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Coll Med, Suzhou, Jiangsu, Peoples R China; [Mao, Yuan-Yuan] Kunshan First Peoples Hosp, Suzhou, Jiangsu, Peoples R China; [Luo, Xiao-Ming] Kunshan Fourth Peoples Hosp, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Shen, YP (corresponding author), Soochow Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Coll Med, Suzhou, Jiangsu, Peoples R China.	shenyueping@suda.edu.cn	Dai, Yun/AAG-4040-2019	Dai, Yun/0000-0003-2285-0818; Orlowski, Robert/0000-0002-5723-4129; Takabatake, Yukie/0000-0003-0540-3610	Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL CANCER INSTITUTE [R01CA100866, P50CA142509, P30CA016672, R01CA093738] Funding Source: NIH RePORTER	Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to gratefully acknowledge the work and support of the leaders and health care professionals at all levels responsible for the operation of the Perinatal Health Care Surveillance System in Kunshan City, Jiangsu Province, China. This study was supported by a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Alexander GR, 2001, PUBLIC HEALTH REP, V116, P306; Alibekova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084237; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barros H, 1996, J PUBLIC HEALTH MED, V18, P321, DOI 10.1093/oxfordjournals.pubmed.a024513; Blumenshine P, 2010, AM J PREV MED, V39, P263, DOI 10.1016/j.amepre.2010.05.012; Breslow NE, 1980, IARC SCI PUBL, P5; Cano-Serral Gemma, 2006, Gac Sanit, V20, P25, DOI 10.1157/13084124; Collins JW, 1997, J NATL MED ASSOC, V89, P198; Goldani MZ, 2004, AM J PUBLIC HEALTH, V94, P1366, DOI 10.2105/AJPH.94.8.1366; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; Hien NT, 2005, TROP DOCT, V35, P103, DOI 10.1258/0049475054036823; Jefferis BJMH, 2002, BRIT MED J, V325, P305, DOI 10.1136/bmj.325.7359.305; Jewell RT, 2006, HEALTH ECON, V15, P1245, DOI 10.1002/hec.1121; Khan-Neelofur D, 1998, PAEDIATR PERINAT EP, V12, P7, DOI 10.1046/j.1365-3016.12.s2.6.x; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1486, DOI 10.2105/AJPH.84.9.1486; Krans EE, 2012, AM J OBSTET GYNECOL, V206, P398, DOI 10.1016/j.ajog.2011.06.082; Lauderdale Diane S, 2010, Med Care Res Rev, V67, P609, DOI 10.1177/1077558709351530; Li CY, 2008, PUBLIC HEALTH, V122, P243, DOI 10.1016/j.puhe.2007.05.011; Liu Ying-hui, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P1029; Liu YH, 2008, AM J PUBLIC HEALTH, V98, P687, DOI 10.2105/AJPH.2006.088716; Lu M C, 2003, J Matern Fetal Neonatal Med, V13, P362, DOI 10.1080/713605924; Nwaru BI, 2012, EUR J PUBLIC HEALTH, V22, P776, DOI 10.1093/eurpub/ckr182; Orsini N, 2011, STATA J, V11, P1; PANETH NS, 1995, FUTURE CHILD, V5, P19, DOI 10.2307/1602505; Pathak PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013593; Petrou S, 2003, EUR J OBSTET GYN R B, V106, P40, DOI 10.1016/S0301-2115(02)00215-4; RUTTER DR, 1990, SOC SCI MED, V30, P553, DOI 10.1016/0277-9536(90)90154-K; VanderWeele TJ, 2009, J CLIN EPIDEMIOL, V62, P438, DOI 10.1016/j.jclinepi.2008.08.001; Wehby GL, 2009, HEALTH POLICY PLANN, V24, P175, DOI 10.1093/heapol/czp005	29	63	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113377	10.1371/journal.pone.0113377	http://dx.doi.org/10.1371/journal.pone.0113377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CZ	24594907	gold, Green Published, Green Submitted			2022-12-27	WOS:000349145400046
J	Xiao, JQ; Liu, XH; Hou, B; Yao, Y; Deng, K; Feng, M; Xing, B; Lian, W; Wang, RZ; Feng, F				Xiao, Jian-Qi; Liu, Xiao-Hai; Hou, Bo; Yao, Yong; Deng, Kan; Feng, Min; Xing, Bin; Lian, Wei; Wang, Ren-Zhi; Feng, Feng			Correlations of Pituitary Tumor Transforming Gene Expression with Human Pituitary Adenomas: A Meta-Analysis	PLOS ONE			English	Article							PTTG EXPRESSION; CAUSES ANEUPLOIDY; CLONAL ORIGIN; OVEREXPRESSION; HYPOPLASIA; HORMONE	Objective: Pituitary tumor transforming gene (PTTG) is an important paracrine growth factor involved in early lactotrope transformation and early onset of angiogenesis in pituitary hyperplasia. Emerging evidences have shown that PTTG expression may contribute to the etiology of pituitary adenomas; but individually published studies showed inconclusive results. This meta-analysis aimed to derive a more precise estimation of the correlations of PTTG expression with human pituitary adenomas. Methods: A range of electronic databases were searched: MEDLINE (1966 similar to 2013), the Cochrane Library Database (Issue 12, 2013), EMBASE (1980 similar to 2013), CINAHL (1982 similar to 2013), Web of Science (1945 similar to 2013) and the Chinese Biomedical Database (CBM) (1982 similar to 2013) without language restrictions. Meta-analysis was performed using the STATA 12.0 software. Crude odds ratio (OR) or standard mean difference (SMD) with its corresponding 95% confidence interval (95% CI) were calculated. Results: Twenty-four clinical cohort studies were included with a total of 1,464 pituitary adenomas patients. The meta-analysis results revealed that patients with invasive pituitary adenomas had higher positive expression of PTTG than those of non-invasive patients (OR = 6.68, 95% CI = 3.72-11.99, P<0.001). We also found a significant difference in microvessel density between invasive and non-invasive patients (SMD = 1.81, 95% CI = 0.39-3.23, P = 0.013). However, there were no significant difference in PTTG expression between functional and non-functional patients with pituitary adenomas (OR = 1.11, 95% CI = 0.58-2.10, P = 0.753). No publication bias was detected in this meta-analysis (all P>0.05). Conclusion: This present meta-analysis suggests that PTTG expression may be associated with tumor invasiveness and microvessel density of pituitary adenomas, while no correlations with functional status was found.	[Xiao, Jian-Qi; Liu, Xiao-Hai; Yao, Yong; Deng, Kan; Feng, Min; Xing, Bin; Lian, Wei; Wang, Ren-Zhi] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurosurg, Beijing 100730, Peoples R China; [Xiao, Jian-Qi; Liu, Xiao-Hai; Hou, Bo; Yao, Yong; Deng, Kan; Feng, Min; Xing, Bin; Lian, Wei; Wang, Ren-Zhi; Feng, Feng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Hou, Bo; Feng, Feng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Radiol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Wang, RZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurosurg, Beijing 100730, Peoples R China.	wangrz@126.com; cjr.fengfeng@vip.163.com		George, Tipoe/0000-0002-2603-0625; So, Kwok-Fai/0000-0003-4039-4246	National Natural Science Foundation of China [81072084, 81100869]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (Grant No. 81072084 and 81100869). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JM, 1990, J CLIN INVEST, V86, P336, DOI 10.1172/JCI114705; Biggerstaff BJ, 2008, STAT MED, V27, P6093, DOI 10.1002/sim.3428; Chesnokova V, 2005, MOL ENDOCRINOL, V19, P2371, DOI 10.1210/me.2005-0137; Chesnokova V, 2008, P NATL ACAD SCI USA, V105, P17498, DOI 10.1073/pnas.0804810105; Chesnokova V, 2007, CANCER RES, V67, P10564, DOI 10.1158/0008-5472.CAN-07-0974; Chesnokova V, 2013, P NATL ACAD SCI USA, V110, pE3331, DOI 10.1073/pnas.1310589110; Cristina C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-4; Cuny T, 2013, EUR J ENDOCRINOL, V168, P533, DOI 10.1530/EJE-12-0763; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Donangelo I, 2006, ENDOCRINOLOGY, V147, P4781, DOI 10.1210/en.2006-0544; Dworakowska D, 2009, BEST PRACT RES CL EN, V23, P525, DOI 10.1016/j.beem.2009.05.004; Fedele M, 2013, TUM CTR NERV SYST, V10, P161; Filippella M, 2006, CLIN ENDOCRINOL, V65, P536, DOI 10.1111/j.1365-2265.2006.02630.x; Gagliano T, 2013, PITUITARY, V16, P91, DOI 10.1007/s11102-012-0380-1; Gruppetta M, 2013, PITUITARY, V16, P545, DOI 10.1007/s11102-012-0454-0; He XL, 2008, MOD PRACT MED, V20; Heaney AP, 2002, J CLIN INVEST, V109, P277, DOI 10.1172/JCI200214264; HERMAN V, 1990, J CLIN ENDOCR METAB, V71, P1427, DOI 10.1210/jcem-71-6-1427; Hsueh C, 2013, CLIN ENDOCRINOL, V78, P303, DOI 10.1111/cen.12007; [胡静芳 Hu Jingfang], 2006, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University. Medical Science], V26, P193; Hunter JAC, 2003, EUR J ENDOCRINOL, V148, P203, DOI 10.1530/eje.0.1480203; Ishikawa H, 2001, J CLIN ENDOCR METAB, V86, P867, DOI 10.1210/jc.86.2.867; JACOBY LB, 1990, J NEUROSURG, V73, P731, DOI 10.3171/jns.1990.73.5.0731; Jaffrain-Rea M- L, 2013, TUM CTR NERV SYST, V10, P189; Jia W, 2013, TUMOR BIOL, V34, P1559, DOI 10.1007/s13277-013-0686-2; Li AJ, 2007, CHIN J CLIN NEUROSUR, V12, P418; Li J, 2008, CHIN J MINIM INVAS N, V13, P71; Li YY, 2006, PRACTICAL CLIN MED, V7, P10; Tena-Suck ML, 2008, ANN DIAGN PATHOL, V12, P275, DOI 10.1016/j.anndiagpath.2008.02.001; Liu JN, 2004, PRACT CLIN MED, V9, P172; McCabe CJ, 2003, CLIN ENDOCRINOL, V58, P141, DOI 10.1046/j.1365-2265.2003.01598.x; Melmed S, 2003, J CLIN INVEST, V112, P1603, DOI 10.1172/JCI200320401; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; Minematsu T, 2006, ENDOCR PATHOL, V17, P143, DOI 10.1385/EP:17:2:143; Mo K, 2011, J MINIMALLY INVASIVE, V6, P94; Monsalves E, 2014, J CLIN ENDOCR METAB; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Perez-Castro C, 2012, PHYSIOL REV, V92, P1, DOI 10.1152/physrev.00003.2011; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Raverot G, 2010, J CLIN ENDOCR METAB, V95, P1708, DOI 10.1210/jc.2009-1191; Salehi F, 2010, INT J SURG PATHOL, V18, P5, DOI 10.1177/1066896909356105; Sanchez-Tejada L, 2013, ENDOCRINOL NUTR, V60, P358, DOI 10.1016/j.endonu.2012.09.005; Shen YL, 2012, ANAT RES, V34, P202; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tfelt-Hansen J, 2006, CLIN MED RES, V4, P130, DOI 10.3121/cmr.4.2.130; Vlotides G, 2007, ENDOCR REV, V28, P165, DOI 10.1210/er.2006-0042; Wang F, 2005, CHIN J CLIN NEUROSUR, V10; Wang YS, 2008, CHIN J CLIN NEUROSUR, V13, P279; Wierinckx A, 2007, ENDOCR-RELAT CANCER, V14, P887, DOI 10.1677/ERC-07-0062; Wu JS, 2010, ZHEJIANG MED J, V32, P1290; Xiong ZY, 2006, CHIN J CLIN NEUROSUR, V11, P531; Yu R, 2000, J BIOL CHEM, V275, P36502, DOI 10.1074/jbc.C000546200; Yu R, 2003, ENDOCRINOLOGY, V144, P4991, DOI 10.1210/en.2003-0305; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; Zhang X, 1999, J CLIN ENDOCR METAB, V84, P761, DOI 10.1210/jc.84.2.761; Zhang Y, 2012, CHIN J LAB DIAGN, V16, P1671; Zhou C, 2013, ONCOGENE; Zhou CQ, 2008, ENDOCR-RELAT CANCER, V15, P817, DOI 10.1677/ERC-08-0060; Zhou J, 2008, J XIANNING U MED SCI, V22, P102; 孙慧莉, 2013, [中国老年学杂志, Chinese Journal of Gerontology], V33, P176	60	134	137	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90396	10.1371/journal.pone.0090396	http://dx.doi.org/10.1371/journal.pone.0090396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24740309	Green Published, gold, Green Submitted			2022-12-27	WOS:000332475500046
J	Crichton, GE; Elias, MF; Davey, A; Alkerwi, A				Crichton, Georgina E.; Elias, Merrill F.; Davey, Adam; Alkerwi, Ala'a			Cardiovascular Health and Cognitive Function: The Maine-Syracuse Longitudinal Study	PLOS ONE			English	Article							BLOOD-PRESSURE; RISK SCORE; SERUM-CHOLESTEROL; PHYSICAL-ACTIVITY; SEDENTARY TIME; DEMENTIA RISK; HEART-DISEASE; DIET QUALITY; PERFORMANCE; MORTALITY	Background: Smoking, physical inactivity, and poor diet, along with obesity, fasting glucose and blood pressure have been independently associated with poorer cognitive performance. Few studies have related scales representing a combination of these variables to multiple domains of cognitive performance. The aim of this study was to investigate the association between overall cardiovascular health, incorporating seven components, and cognitive function. Methods: A cross-sectional analysis employing 972 participants, from the Maine-Syracuse Longitudinal Study was undertaken. Four health behaviors (body mass index, physical activity, diet, smoking) and three health factors (total cholesterol, blood pressure, and fasting plasma glucose) were measured. Each was categorized according to the American Heart Association definitions for ideal cardiovascular health, except diet, for which two food scores were calculated. A Cardiovascular Health Score was determined by summing the number of cardiovascular metrics at ideal levels. Cognitive function was assessed using a thorough neuropsychological test battery. Results: Cardiovascular Health Score was positively associated with seven out of eight measures of cognitive function, with adjustment for age, education, and gender. With further adjustment for cardiovascular and psychological variables, these associations remained significant for Visual-Spatial Memory, Working Memory, Scanning and Tracking, Executive Function and the Global Composite score (p<0.05 for all). Ideal levels of a number of health factors and behaviors were positively associated with global cognitive performance. Conclusion: Increasing cardiovascular health, indexed by a higher number of metrics at ideal levels, is associated with greater cognitive performance. Smoking, physical activity, and diet are important components of cardiovascular health that impact upon cognition.	[Crichton, Georgina E.] Univ S Australia, Nutr Physiol Res Ctr, Adelaide, SA 5001, Australia; [Crichton, Georgina E.; Alkerwi, Ala'a] Ctr Etud Sante, Ctr Rech Publ Sante, Strassen, Luxembourg; [Elias, Merrill F.] Univ Maine, Dept Psychol, Orono, ME 04469 USA; [Elias, Merrill F.] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME USA; [Davey, Adam] Temple Univ, Dept Publ Hlth, Philadelphia, PA 19122 USA	University of South Australia; Luxembourg Institute of Health; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Crichton, GE (corresponding author), Univ S Australia, Nutr Physiol Res Ctr, Adelaide, SA 5001, Australia.	whige003@mymail.unisa.edu.au		Alkerwi, Ala'a/0000-0002-7448-3936	National Heart, Lung and Blood Institute, National Institutes of Health (USA) [R01HL067358, R01HL081290]; National Institute on Aging, National Institutes of Health (USA) [R01AG03055]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067358, R01HL081290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG003055] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute, National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging, National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Maine Syracuse Longitudinal Study was supported by grants R01HL067358, and R01HL081290 from the National Heart, Lung and Blood Institute, National Institutes of Health (USA), and research grant R01AG03055 from the National Institute on Aging, National Institutes of Health (USA). GC is a National Health and Medical Research Council (NHMRC) Sidney Sax Research Fellow (GNT1054567) (Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Appel LJ, 2012, CIRCULATION, V125, P973, DOI 10.1161/CIRCULATIONAHA.111.088542; Baik I, 2013, EUR J CLIN NUTR, V67, P25, DOI 10.1038/ejcn.2012.175; Bambs C, 2011, CIRCULATION, V123, P850, DOI 10.1161/CIRCULATIONAHA.110.980151; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Crawford AG, 2010, POPUL HEALTH MANAG, V13, P151, DOI 10.1089/pop.2009.0039; D'Agostino RB, 2008, CIRCULATION, V118, pE86, DOI 10.1161/CIRCULATIONAHA.108.190154; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Dore GA, 2008, ANN BEHAV MED, V35, P341, DOI 10.1007/s12160-008-9038-7; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Elias MF, 2007, HYPERTENSION, V49, P439, DOI 10.1161/01.HYP.0000256361.68158.24; Elias Merrill F, 2005, Neurobiol Aging, V26 Suppl 1, P11, DOI 10.1016/j.neurobiolaging.2005.08.019; Elias MF, 2006, PSYCHOSOM MED, V68, P547, DOI 10.1097/01.psy.0000221380.92521.51; Elias MF, 2012, J ALZHEIMERS DIS, V30, pS113, DOI 10.3233/JAD-2011-111175; Elias MF, 2009, HYPERTENSION, V53, P668, DOI 10.1161/HYPERTENSIONAHA.108.126342; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; Elias MF, 2004, STROKE, V35, P404, DOI 10.1161/01.STR.0000103141.82869.77; Elias PK, 2005, PSYCHOSOM MED, V67, P24, DOI 10.1097/01.psy.0000151745.67285.c2; Elias PK, 1997, DIABETES CARE, V20, P1388, DOI 10.2337/diacare.20.9.1388; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ford ES, 2012, CIRCULATION, V125, P1955, DOI 10.1161/CIRCULATIONAHA.112.102327; Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122; Francis H, 2013, APPETITE, V63, P119, DOI 10.1016/j.appet.2012.12.018; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gunstad John, 2005, J Cardiopulm Rehabil, V25, P173, DOI 10.1097/00008483-200505000-00009; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Jaccard J, 2010, THEORY CONSTRUCTION; Kaffashian S, 2013, NEUROLOGY, V80, P1300, DOI 10.1212/WNL.0b013e31828ab370; Kaluza J, 2009, EUR J CLIN NUTR, V63, P451, DOI 10.1038/sj.ejcn.1602968; Kanoski SE, 2011, PHYSIOL BEHAV, V103, P59, DOI 10.1016/j.physbeh.2010.12.003; Kant AK, 2000, JAMA-J AM MED ASSOC, V283, P2109, DOI 10.1001/jama.283.16.2109; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Kroke A, 1999, AM J CLIN NUTR, V70, P439; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Michels KB, 2002, INT J EPIDEMIOL, V31, P847, DOI 10.1093/ije/31.4.847; Middleton LE, 2009, ARCH NEUROL-CHICAGO, V66, P1210, DOI 10.1001/archneurol.2009.201; Muldoon MF, 1997, PSYCHOSOM MED, V59, P382, DOI 10.1097/00006842-199707000-00008; Muldoon MF, 2001, NEUROPSYCHOLOGY OF CARDIOVASCULAR DISEASE, P37; Office of the Surgeon General (US) Office on Smoking and Health (US), 2004, HLTH CONS SMOK REP S; Petretta M, 2012, EUR J NUCL MED MOL I, V39, P1959, DOI 10.1007/s00259-012-2254-1; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reis JP, 2013, ANN NEUROL, V73, P170, DOI 10.1002/ana.23836; Robbins MA, 2005, PSYCHOSOM MED, V67, P707, DOI 10.1097/01.psy.0000171164.50990.80; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Sacco RL, 2011, CIRCULATION, V123, P2653, DOI 10.1161/CIR.0b013e318220dec1; SCHULTZ NR, 1979, J GERONTOL, V34, P246, DOI 10.1093/geronj/34.2.246; Singh-Manoux A, 2012, NEUROLOGY, V79, P755, DOI 10.1212/WNL.0b013e3182661f63; Tangney CC, 2011, AM J CLIN NUTR, V93, P601, DOI 10.3945/ajcn.110.007369; US Department of Agriculture & US Department of Health and Human Services, 2010, DIET GUID AM 2010; Waldstein S.R., 2001, NEUROPSYCHOLOGY CARD; WALDSTEIN SR, 1995, EXP AGING RES, V21, P321, DOI 10.1080/03610739508253989; Weiner H, 1976, PSYCHOL BULL, V2, P213; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; World Health Organization and Alzheimers Disease International, 2012, DEM PUBL HLTH PRIOR; Wright CB, 2008, STROKE, V39, P800, DOI 10.1161/STROKEAHA.107.484147; Yaffe K, 2004, NEUROLOGY, V63, P658, DOI 10.1212/01.WNL.0000134666.64593.BA; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339	67	70	71	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89317	10.1371/journal.pone.0089317	http://dx.doi.org/10.1371/journal.pone.0089317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595096	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000332468900013
J	Wang, Q; Tikhonenko, M; Bozack, SN; Lydic, TA; Yan, L; Panchy, NL; Mcsorley, KM; Faber, MS; Yan, YQ; Boulton, ME; Grant, MB; Busik, JV				Wang, Qi; Tikhonenko, Maria; Bozack, Svetlana N.; Lydic, Todd A.; Yan, Lily; Panchy, Nicholas L.; Mcsorley, Kelly M.; Faber, Matthew S.; Yan, Yuanqing; Boulton, Michael E.; Grant, Maria B.; Busik, Julia V.			Changes in the Daily Rhythm of Lipid Metabolism in the Diabetic Retina	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; CIRCADIAN CLOCK; MOLECULAR CLOCKS; LIVER; MOUSE; TIME; MELATONIN; INSULIN; PROTEIN-1; SYSTEM	Disruption of circadian regulation was recently shown to cause diabetes and metabolic disease. We have previously demonstrated that retinal lipid metabolism contributed to the development of diabetic retinopathy. The goal of this study was to determine the effect of diabetes on circadian regulation of clock genes and lipid metabolism genes in the retina and retinal endothelial cells (REC). Diabetes had a pronounced inhibitory effect on the negative clock arm with lower amplitude of the period (per) 1 in the retina; lower amplitude and a phase shift of per2 in the liver; and a loss of cryptochrome (cry) 2 rhythmic pattern in suprachiasmatic nucleus (SCN). The positive clock arm was increased by diabetes with higher amplitude of circadian locomotor output cycles kaput (CLOCK) and brain and muscle aryl-hydrocarbon receptor nuclear translocator-like 1 (bmal1) and phase shift in bmal1 rhythmic oscillations in the retina; and higher bmal1 amplitude in the SCN. Peroxisome proliferator-activated receptor (PPAR) alpha exhibited rhythmic oscillation in retina and liver; PPAR gamma had lower amplitude in diabetic liver; sterol regulatory element-binding protein (srebp) 1c had higher amplitude in the retina but lower in the liver in STZ-induced diabetic animals. Both of Elongase (Elovl) 2 and Elovl4 had a rhythmic oscillation pattern in the control retina. Diabetic retinas lost Elovl4 rhythmic oscillation and had lower amplitude of Elovl2 oscillations. In line with the in vivo data, circadian expression levels of CLOCK, bmal1 and srebp1c had higher amplitude in rat REC (rREC) isolated from diabetic rats compared with control rats, while PPAR gamma and Elovl2 had lower amplitude in diabetic rREC. In conclusion, diabetes causes dysregulation of circadian expression of clock genes and the genes controlling lipid metabolism in the retina with potential implications for the development of diabetic retinopathy.	[Wang, Qi; Bozack, Svetlana N.; Mcsorley, Kelly M.; Faber, Matthew S.; Busik, Julia V.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Tikhonenko, Maria; Panchy, Nicholas L.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Lydic, Todd A.] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Yan, Lily] Michigan State Univ, Dept Psychol Social Sci, E Lansing, MI 48824 USA; [Yan, Yuanqing; Grant, Maria B.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA; [Boulton, Michael E.] Indiana Univ, Dept Ophthalmol, Indianapolis, IN 46204 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; State University System of Florida; University of Florida; Indiana University System; Indiana University-Purdue University Indianapolis	Busik, JV (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	busik@msu.edu	Busik, Julia V/A-2698-2010; Lydic, Todd A./ADB-0177-2022	Busik, Julia V/0000-0003-3453-7124; Yan, Lily/0000-0002-6261-2542; Faber, Matthew/0000-0002-5583-5115	National Institutes of Health (NIH) [EY016077]; MEAS [MICL02163, EY07739, EY12601, EY021626, DK090730]; NATIONAL EYE INSTITUTE [R01EY016077, R01EY007739, R01EY012601, R21EY021626, R29EY007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090730, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEAS; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) Grants EY016077; and MEAS grant MICL02163 to JVB, EY07739 and EY12601 to MBG, EY021626 to MEB and DK090730 to MBG and JVB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Ando H, 2009, DIABETOLOGIA, V52, P329, DOI 10.1007/s00125-008-1194-6; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bhatwadekar AD, 2013, DIABETES, V62, P273, DOI 10.2337/db12-0172; Botolin D, 2003, J BIOL CHEM, V278, P6959, DOI 10.1074/jbc.M212846200; Brewer M, 2005, J BIOL RHYTHM, V20, P195, DOI 10.1177/0748730405275952; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Busik J, 2009, DIABETES, V58, pA229; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Deng X, 2007, J BIOL CHEM, V282, P17517, DOI 10.1074/jbc.M702228200; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dinet V, 2007, J PINEAL RES, V42, P83, DOI 10.1111/j.1600-079X.2006.00387.x; Grace MS, 1996, BRAIN RES, V735, P93; Herichova I, 2005, MOL CELL BIOCHEM, V270, P223, DOI 10.1007/s11010-005-5323-y; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Hofmann K, 2013, HORM METAB RES, V45, P629, DOI 10.1055/s-0033-1343462; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Kohsaka A, 2007, TRENDS ENDOCRIN MET, V18, P4, DOI 10.1016/j.tem.2006.11.005; Kudo T, 2004, DIABETOLOGIA, V47, P1425, DOI 10.1007/s00125-004-1461-0; Kuriyama K, 2004, FEBS LETT, V572, P206, DOI 10.1016/j.febslet.2004.07.036; Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764; Lowden A, 2010, SCAND J WORK ENV HEA, V36, P150, DOI 10.5271/sjweh.2898; Maeda A, 2006, INVEST OPHTH VIS SCI, V47, P4050, DOI 10.1167/iovs.06-0183; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Mater MK, 1999, J BIOL CHEM, V274, P32725, DOI 10.1074/jbc.274.46.32725; Matsumoto E, 2010, J BIOL CHEM, V285, P33028, DOI 10.1074/jbc.M109.089391; Maywood ES, 2003, J NEUROENDOCRINOL, V15, P329, DOI 10.1046/j.1365-2826.2003.00971.x; Monteleone P, 2008, NEUROSCI LETT, V435, P30, DOI 10.1016/j.neulet.2008.02.003; Mulligan JD, 2008, EXP GERONTOL, V43, P146, DOI 10.1016/j.exger.2007.10.011; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Oishi K, 2006, FEBS LETT, V580, P127, DOI 10.1016/j.febslet.2005.11.063; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Oishi K, 2004, BIOCHEM BIOPH RES CO, V317, P330, DOI 10.1016/j.bbrc.2004.03.055; Organisciak DT, 2000, INVEST OPHTH VIS SCI, V41, P3694; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pavan B, 2006, BIOCHEM BIOPH RES CO, V350, P169, DOI 10.1016/j.bbrc.2006.09.015; Paxinos G, 1999, CHEMOARCHITECTONIC A; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; Peschke E, 2008, J PINEAL RES, V45, P439, DOI 10.1111/j.1600-079X.2008.00612.x; Prasai MJ, 2008, DIABETES VASC DIS RE, V5, P89, DOI 10.3132/dvdr.2008.015; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sakamoto K, 2000, NEUROREPORT, V11, P3995, DOI 10.1097/00001756-200012180-00018; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sookoian S, 2008, AM J CLIN NUTR, V87, P1606, DOI 10.1093/ajcn/87.6.1606; Stamenkovic JA, 2012, METABOLISM, V61, P978, DOI 10.1016/j.metabol.2011.11.013; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Straume M, 2004, METHOD ENZYMOL, V383, P149; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; Xue JF, 2010, FITOTERAPIA, V81, P173, DOI 10.1016/j.fitote.2009.08.020; Yamazaki S, 1999, J BIOL RHYTHM, V14, P197, DOI 10.1177/074873099129000605; Yang GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038117; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	61	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95028	10.1371/journal.pone.0095028	http://dx.doi.org/10.1371/journal.pone.0095028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736612	Green Published, Green Submitted, gold			2022-12-27	WOS:000336922600131
J	Huang, YL; Chen, HW; Han, BC; Liu, CW; Chuang, HC; Lin, LY; Chuang, KJ				Huang, Ya-Li; Chen, Hua-Wei; Han, Bor-Cheng; Liu, Chien-Wei; Chuang, Hsiao-Chi; Lin, Lian-Yu; Chuang, Kai-Jen			Personal Exposure to Household Particulate Matter, Household Activities and Heart Rate Variability among Housewives	PLOS ONE			English	Article							AIR-POLLUTION; ENVIRONMENTAL EXPOSURE; DISEASE; ASSOCIATION; INFLAMMATION; PARTICLES; WORKERS; SMOKE; PM2.5; RISK	Background: The association between indoor air pollution and heart rate variability (HRV) has been well-documented. Little is known about effects of household activities on indoor air quality and HRV alteration. To investigate changes in HRV associated with changes in personal exposure to household particulate matter (PM) and household activities. Methods: We performed 24-h continuous monitoring of electrocardiography and measured household PM exposure among 50 housewives. The outcome variables were log(10)-transformed standard deviation of normal-to-normal (NN) intervals (SDNN) and the square root of the mean of the sum of the squares of differences between adjacent NN intervals (r-MSSD). ,Household PM was measured as the mass concentration of PM with an aerodynamic diameter <2.5 mu m (PM2.5). We used mixed-effects models to examine the association between household PM2.5 exposure and log(10)-transformed HRV indices. Results: After controlling for potential confounders, an interquartile range change in household PM2.5 with 1- to 4-h mean was associated with 1.25-4.31% decreases in SDNN and 0.12-3.71% decreases in r-MSSD. Stir-frying, cleaning with detergent and burning incense may increase household PM2.5 concentrations and modify the effects of household PM2.5 on HRV indices among housewives. Conclusions: Indoor PM2.5 exposures were associated with decreased SDNN and r-MSSD among housewives, especially during stir-frying, cleaning with detergent and burning incense.	[Huang, Ya-Li; Chuang, Kai-Jen] Taipei Med Univ, Coll Med, Sch Med, Dept Publ Hlth, Taipei, Taiwan; [Huang, Ya-Li; Han, Bor-Cheng; Chuang, Kai-Jen] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan; [Chen, Hua-Wei] St Marys Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Yilan, Taiwan; [Liu, Chien-Wei] St Marys Jr Coll Med Nursing & Management, Dept Informat Management, Yilan, Taiwan; [Chuang, Hsiao-Chi] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Chuang, Hsiao-Chi] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan; [Lin, Lian-Yu] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; National Taiwan University; National Taiwan University Hospital	Chuang, KJ (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Publ Hlth, Taipei, Taiwan.	kjc@tmu.edu.tw	Chuang, Hsiao-Chi/E-7912-2010	Chuang, Hsiao-Chi/0000-0003-4651-5192; Han, Bor-Cheng/0000-0002-8493-8199; LIN, LIAN-YU/0000-0001-7505-6429; Huang, Yan-Ping/0000-0002-3301-2847	National Science Council of Taiwan [NSC 101-2314-B-038-053-MY3, TMU101-AE1-B08]; Taipei Medical University	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University	This study was supported by grants (NSC 101-2314-B-038-053-MY3 and TMU101-AE1-B08) from the National Science Council of Taiwan and Taipei Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behera D, 2006, CANCER RES, V66, P4961; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Chan CC, 2004, ENVIRON HEALTH PERSP, V112, P1063, DOI 10.1289/ehp.6897; Chuang KJ, 2007, AM J RESP CRIT CARE, V176, P370, DOI 10.1164/rccm.200611-1627OC; Chuang KJ, 2007, J OCCUP ENVIRON MED, V49, P610, DOI 10.1097/JOM.0b013e318058205b; Chuang KJ, 2005, ENVIRON HEALTH PERSP, V113, P1693, DOI 10.1289/ehp.8145; Gold DR, 2000, CIRCULATION, V101, P1267, DOI 10.1161/01.CIR.101.11.1267; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Lanki T, 2007, J EXPO SCI ENV EPID, V17, P124, DOI 10.1038/sj.jes.7500470; Lee GS, 2010, AUTON NEUROSCI-BASIC, V155, P94, DOI 10.1016/j.autneu.2009.12.008; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lin LY, 2012, SCI TOTAL ENVIRON, V414, P68, DOI 10.1016/j.scitotenv.2011.08.050; Lung SC, 1999, COMMUNITY AIR QUALIT; Magari SR, 2002, EPIDEMIOLOGY, V13, P305, DOI 10.1097/00001648-200205000-00011; Magari SR, 2001, CIRCULATION, V104, P986, DOI 10.1161/hc3401.095038; McCracken J, 2011, ENVIRON HEALTH PERSP, V119, P1562, DOI 10.1289/ehp.1002834; Pan CH, 2008, CANCER EPIDEM BIOMAR, V17, P3351, DOI 10.1158/1055-9965.EPI-08-0075; Polidori A, 2006, J EXPO SCI ENV EPID, V16, P321, DOI 10.1038/sj.jes.7500476; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Svendsen K, 2003, AM J IND MED, V43, P436, DOI 10.1002/ajim.10197; Syazwan AI, 2012, DRUG HEALTHC PATIENT, V4, P107, DOI 10.2147/DHPS.S33400; Tse LA, 2011, ENVIRON HEALTH PERSP, V119, P1641, DOI 10.1289/ehp.1002790; WHO-Europe, 2006, AIR QUAL GUID GLOB U	24	36	37	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89969	10.1371/journal.pone.0089969	http://dx.doi.org/10.1371/journal.pone.0089969			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24667838	Green Published, gold, Green Submitted			2022-12-27	WOS:000332468900050
J	Pei, XY; Dai, Y; Felthousen, J; Chen, S; Takabatake, Y; Zhou, L; Youssefian, LE; Sanderson, MW; Bodie, WW; Kramer, LB; Orlowski, RZ; Grant, S				Pei, Xin-Yan; Dai, Yun; Felthousen, Jessica; Chen, Shuang; Takabatake, Yukie; Zhou, Liang; Youssefian, Leena E.; Sanderson, Michael W.; Bodie, Wesley W.; Kramer, Lora B.; Orlowski, Robert Z.; Grant, Steven			Circumvention of Mcl-1-Dependent Drug Resistance by Simultaneous Chk1 and MEK1/2 Inhibition in Human Multiple Myeloma Cells	PLOS ONE			English	Article							DOWN-REGULATION; BONE-MARROW; INDUCE APOPTOSIS; UP-REGULATION; FACTOR-I; MCL-1; PHOSPHORYLATION; SURVIVAL; PROTEIN; BIM	The anti-apoptotic protein Mcl-1 plays a major role in multiple myeloma (MM) cell survival as well as bortezomib- and microenvironmental forms of drug resistance in this disease. Consequently, there is a critical need for strategies capable of targeting Mcl-1-dependent drug resistance in MM. The present results indicate that a regimen combining Chk1 with MEK1/2 inhibitors effectively kills cells displaying multiple forms of drug resistance stemming from Mcl-1 up-regulation in association with direct transcriptional Mcl-1 down-regulation and indirect disabling of Mcl-1 anti-apoptotic function through Bim up-regulation and increased Bim/Mcl-1 binding. These actions release Bak from Mcl-1, accompanied by Bak/Bax activation. Analogous events were observed in both drug-naive and acquired bortezomib-resistant MM cells displaying increased Mcl-1 but diminished Bim expression, or cells ectopically expressing Mcl-1. Moreover, concomitant Chk1 and MEK1/2 inhibition blocked Mcl-1 up-regulation induced by IL-6/IGF-1 or co-culture with stromal cells, effectively overcoming microenvironment-related drug resistance. Finally, this regimen down-regulated Mcl-1 and robustly killed primary CD138(+) MM cells, but not normal hematopoietic cells. Together, these findings provide novel evidence that this targeted combination strategy could be effective in the setting of multiple forms of Mcl-1-related drug resistance in MM.	[Pei, Xin-Yan; Dai, Yun; Felthousen, Jessica; Chen, Shuang; Takabatake, Yukie; Zhou, Liang; Youssefian, Leena E.; Sanderson, Michael W.; Bodie, Wesley W.; Kramer, Lora B.; Grant, Steven] Virginia Commonwealth Univ, Dept Med, Div Hematol Oncol, Richmond, VA 23298 USA; [Pei, Xin-Yan; Dai, Yun; Felthousen, Jessica; Chen, Shuang; Takabatake, Yukie; Zhou, Liang; Youssefian, Leena E.; Sanderson, Michael W.; Bodie, Wesley W.; Kramer, Lora B.; Grant, Steven] Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Richmond, VA 23298 USA; [Orlowski, Robert Z.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA; [Grant, Steven] Virginia Commonwealth Univ, Dept Biochem, Richmond, VA USA; [Grant, Steven] Inst Mol Med, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; University of Texas System; UTMD Anderson Cancer Center; Virginia Commonwealth University	Grant, S (corresponding author), Virginia Commonwealth Univ, Dept Med, Div Hematol Oncol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	stgrant@vcu.edu	Dai, Yun/AAG-4040-2019	Dai, Yun/0000-0003-2285-0818; Orlowski, Robert/0000-0002-5723-4129; Takabatake, Yukie/0000-0003-0540-3610	National Institutes of Health [CA100866, CA93738, P50 CA142509-01]; MMRF; NATIONAL CANCER INSTITUTE [R01CA100866, P50CA142509, P30CA016672, R01CA093738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MMRF; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by awards CA100866, CA93738, and P50 CA142509-01 from the National Institutes of Health and the MMRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat UG, 2010, LEUKEMIA, V24, P851, DOI 10.1038/leu.2010.3; Bhat UG, 2010, MOL CANCER THER, V9, P1688, DOI 10.1158/1535-7163.MCT-09-0919; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006593; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chen S, 2012, CANCER RES, V72, P4225, DOI 10.1158/0008-5472.CAN-12-1118; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Dai Y, 2002, BLOOD, V100, P3333, DOI 10.1182/blood-2002-03-0940; Dai Y, 2008, BLOOD, V112, P2439, DOI 10.1182/blood-2008-05-159392; Dai Y, 2011, J BIOL CHEM, V286, P34036, DOI 10.1074/jbc.M111.284216; Dai Y, 2011, BLOOD, V117, P1947, DOI 10.1182/blood-2010-06-291146; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; Eichhorn JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.411; Ewings KE, 2007, CELL CYCLE, V6, P2236, DOI 10.4161/cc.6.18.4728; Ewings KE, 2007, EMBO J, V26, P2856, DOI 10.1038/sj.emboj.7601723; Fulda S, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00121; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; Gores GJ, 2012, GENE DEV, V26, P305, DOI 10.1101/gad.186189.111; Han J, 2004, J BIOL CHEM, V279, P22020, DOI 10.1074/jbc.M313234200; Hazlehurst LA, 2003, ONCOGENE, V22, P7396, DOI 10.1038/sj.onc.1206943; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hu JS, 2012, BLOOD, V119, P826, DOI 10.1182/blood-2011-07-366492; Jourdan M, 2003, ONCOGENE, V22, P2950, DOI 10.1038/sj.onc.1206423; Kale AJ, 2012, J MED CHEM, V55, P10317, DOI 10.1021/jm300434z; Kawabata T, 2012, J BIOL CHEM, V287, P10289, DOI 10.1074/jbc.M111.319426; Khoury JD, 2003, J PATHOL, V199, P90, DOI 10.1002/path.1254; Kim KH, 2010, BIOMAT PROP PROD DEV, P149; Konopleva M, 2012, LEUKEMIA, V26, P778, DOI 10.1038/leu.2011.287; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuhn DJ, 2012, BLOOD, V120, P3260, DOI 10.1182/blood-2011-10-386789; Laubach JP, 2011, J NATL COMPR CANC NE, V9, P1209, DOI 10.6004/jnccn.2011.0098; Le Gouill S, 2004, CELL CYCLE, V3, P1259; Le Gouill S, 2004, BLOOD, V104, P2886, DOI 10.1182/blood-2004-05-1760; Ley R, 2004, J BIOL CHEM, V279, P8837, DOI 10.1074/jbc.M311578200; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Mahindra A, 2012, NAT REV CLIN ONCOL, V9, P135, DOI 10.1038/nrclinonc.2012.15; Manier S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/157496; Mazumder S, 2012, CANCER RES, V72, P3069, DOI 10.1158/0008-5472.CAN-11-4106; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Mitsiades CS, 2006, EUR J CANCER, V42, P1564, DOI 10.1016/j.ejca.2005.12.025; MOALLI PA, 1993, CANCER RES, V53, P3877; Morales AA, 2011, BLOOD, V118, P1329, DOI 10.1182/blood-2011-01-327197; Nair RR, 2012, ADV PHARMACOL, V65, P143, DOI 10.1016/B978-0-12-397927-8.00006-3; Nefedova Y, 2003, LEUKEMIA, V17, P1175, DOI 10.1038/sj.leu.2402924; Nencioni A, 2005, BLOOD, V105, P3255, DOI 10.1182/blood-2004-10-3984; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Nifoussi SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047060; Pagnucco G, 2004, ANN NY ACAD SCI, V1028, P390, DOI 10.1196/annals.1322.047; Pei XY, 2007, BLOOD, V110, P2092, DOI 10.1182/blood-2007-04-083204; Pei XY, 2011, BLOOD, V118, P5189, DOI 10.1182/blood-2011-02-339432; Perez-Galan P, 2007, BLOOD, V109, P4441, DOI 10.1182/blood-2006-07-034173; Rahmani M, 2005, J BIOL CHEM, V280, P35217, DOI 10.1074/jbc.M506551200; Schmidmaier R., 2006, Experimental Oncology, V28, P12; Schmidmaier R, 2004, BLOOD, V104, P1825, DOI 10.1182/blood-2003-12-4218; Senderowicz AM, 2000, ONCOGENE, V19, P6600, DOI 10.1038/sj.onc.1204085; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Tai YT, 2007, BLOOD, V110, P1656, DOI 10.1182/blood-2007-03-081240; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; Yang-Yen HF, 2006, J BIOMED SCI, V13, P201, DOI 10.1007/s11373-005-9064-4; Yasui H, 2006, BRIT J HAEMATOL, V132, P385, DOI 10.1111/j.1365-2141.2005.05860.x; Zhang B, 2003, ONCOGENE, V22, P1848, DOI 10.1038/sj.onc.1206358; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885; Zhang J, 2003, ONCOGENE, V22, P6289, DOI 10.1038/sj.onc.1206718	64	63	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89064	10.1371/journal.pone.0089064	http://dx.doi.org/10.1371/journal.pone.0089064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594907	Green Submitted, Green Published, gold			2022-12-27	WOS:000332475500008
J	Graversen, L; Sorensen, TIA; Petersen, L; Sovio, U; Kaakinen, M; Sandbaek, A; Laitinen, J; Taanila, A; Pouta, A; Jarvelin, MR; Obel, C				Graversen, Lise; Sorensen, Thorkild I. A.; Petersen, Liselotte; Sovio, Ulla; Kaakinen, Marika; Sandbaek, Annelli; Laitinen, Jaana; Taanila, Anja; Pouta, Anneli; Jarvelin, Marjo-Riitta; Obel, Carsten			Preschool Weight and Body Mass Index in Relation to Central Obesity and Metabolic Syndrome in Adulthood	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; CORONARY-HEART-DISEASE; FINLAND BIRTH COHORT; AGE 31 YEARS; CHILDHOOD OBESITY; RISK-FACTORS; CARDIOVASCULAR RISK; ABERDEEN CHILDREN; LIFE; INFANCY	Background: If preschool measures of body size routinely collected at preventive health examinations are associated with adult central obesity and metabolic syndrome, a focused use of these data for the identification of high risk children is possible. The aim of this study was to test the associations between preschool weight and body mass index (BMI) and adult BMI, central obesity and metabolic alterations. Methods: The Northern Finland Birth Cohort 1966 (NFBC1966) (N = 4111) is a population-based cohort. Preschool weight (age 5 months and 1 year) and BMI (age 2-5 years) were studied in relation to metabolic syndrome as well as BMI, waist circumference, lipoproteins, blood pressure, and fasting glucose at the age of 31 years. Linear regression models and generalized linear regression models with log link were used. Results: Throughout preschool ages, weight and BMI were significantly linearly associated with adult BMI and waist circumference. Preschool BMI was inversely associated with high-density lipoprotein levels from the age of 3 years. Compared with children in the lower half of the BMI range, the group of children with the 5% highest BMI at the age of 5 years had a relative risk of adult obesity of 6.2(95% CI: 4.2-9.3), of adult central obesity of 2.4(95% CI:2.0-2.9), and of early onset adult metabolic syndrome of 2.5(95% CI:1.7-3.8). Conclusions: High preschool BMI is consistently associated with adult obesity, central obesity and early onset metabolic syndrome. Routinely collected measures of body size in preschool ages can help to identify children in need of focused prevention due to their increased risk of adverse metabolic alterations in adulthood.	[Graversen, Lise; Sandbaek, Annelli; Obel, Carsten] Aarhus Univ, Dept Publ Hlth, Sect Gen Med Practice, Aarhus, Denmark; [Sorensen, Thorkild I. A.] Bispebjerg & Frederiksberg Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Petersen, Liselotte] Aarhus Univ, Natl Ctr Register Based Res, Fac Social Sci, Aarhus, Denmark; [Sovio, Ulla] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England; [Sovio, Ulla; Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Kaakinen, Marika; Taanila, Anja; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Oulu, Finland; [Taanila, Anja; Jarvelin, Marjo-Riitta] Univ Hosp Oulu, Primary Hlth Care Unit, Oulu, Finland; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Oulu, Finland; [Pouta, Anneli] Univ Oulu, Dept Obstet & Gynecol, SF-90220 Oulu, Finland; [Pouta, Anneli] Oulu Univ Hosp, Oulu, Finland	Aarhus University; University of Copenhagen; Bispebjerg Hospital; Novo Nordisk Foundation; University of Copenhagen; Aarhus University; University of Cambridge; Imperial College London; University of Oulu; University of Oulu; Finnish Institute of Occupational Health; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu	Graversen, L (corresponding author), Aarhus Univ, Dept Publ Hlth, Sect Gen Med Practice, Aarhus, Denmark.	lgra@alm.au.dk; m.jarvelin@imperial.ac.uk	Sovio, Ulla/H-8532-2019; Obel, Carsten/H-9605-2016	Sovio, Ulla/0000-0002-0799-1105; Obel, Carsten/0000-0001-5004-1933; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Petersen, Liselotte Vogdrup/0000-0002-0479-5379; Kaakinen, Marika/0000-0002-9228-0462	Nordic Council of Ministers research program 'Longitudinal Epidemiology' [020056]; Academy of Finland; Oulu University Hospital; Biocenter Oulu, University of Oulu, Finland; The Finnish Ministry of Health and Social Affairs; European Commission Quality of Life and Management of Living Resources Programme [QLG1-CT-2000-01643]; Medical Research Council, UK [G0500539, G0600705, PrevMetSyn/SALVE, PS0476]; Danish Tryg Foundation, the Health Foundation, Denmark; Aarhus University, Denmark; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0600705] Funding Source: researchfish	Nordic Council of Ministers research program 'Longitudinal Epidemiology'; Academy of Finland(Academy of Finland); Oulu University Hospital; Biocenter Oulu, University of Oulu, Finland; The Finnish Ministry of Health and Social Affairs; European Commission Quality of Life and Management of Living Resources Programme(European CommissionEuropean Commission Joint Research Centre); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Tryg Foundation, the Health Foundation, Denmark; Aarhus University, Denmark; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was financially supported by the Nordic Council of Ministers research program 'Longitudinal Epidemiology' (020056), the Academy of Finland, Oulu University Hospital, Biocenter Oulu, University of Oulu, Finland, The Finnish Ministry of Health and Social Affairs, the European Commission Quality of Life and Management of Living Resources Programme Contract QLG1-CT-2000-01643, the Medical Research Council, UK (G0500539, G0600705, PrevMetSyn/SALVE, PS0476), the Danish Tryg Foundation, the Health Foundation, Denmark, and Aarhus University, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Carmienke S, 2013, EUR J CLIN NUTR; de Kroon MLA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013966; Fall CHD, 2008, DIABETES CARE, V31, P2349, DOI 10.2337/dc08-0911; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; Gamborg M, 2007, AM J EPIDEMIOL, V166, P634, DOI 10.1093/aje/kwm042; Gamborg M, 2009, AM J EPIDEMIOL, V169, P1167, DOI 10.1093/aje/kwp047; Jarvelin MR, 2004, HYPERTENSION, V44, P838, DOI 10.1161/01.HYP.0000148304.33869.ee; Lawlor DA, 2006, DIABETOLOGIA, V49, P2614, DOI 10.1007/s00125-006-0408-z; Lawlor DA, 2005, CIRCULATION, V112, P1414, DOI 10.1161/CIRCULATIONAHA.104.528356; Lawlor DA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6224; Leitzmann MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018582; Liddle K, 2012, J PAEDIATR CHILD H, V48, P424, DOI 10.1111/j.1440-1754.2011.02247.x; Lloyd LJ, 2012, INT J OBESITY, V36, P1, DOI 10.1038/ijo.2011.186; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Park MH, 2012, OBES REV, V13, P985, DOI 10.1111/j.1467-789X.2012.01015.x; RANTAKALLIO P, 1969, ACTA PAEDIATR SC S, V0193; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Sovio U, 2013, INT J OBES LOND; Sovio U, 2007, J HEALTH PSYCHOL, V12, P371, DOI 10.1177/1359105307074301; Tzoulaki I, 2010, AM J EPIDEMIOL, V171, P989, DOI 10.1093/aje/kwq027; Zimmermann E, 2011, INT J OBESITY, V35, P1193, DOI 10.1038/ijo.2010.274	28	32	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89986	10.1371/journal.pone.0089986	http://dx.doi.org/10.1371/journal.pone.0089986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24748033	Green Published, Green Submitted, gold			2022-12-27	WOS:000332468900052
J	Li, X; Zhang, Y; Xia, M; Gulbins, E; Boini, KM; Li, PL				Li, Xiang; Zhang, Yang; Xia, Min; Gulbins, Erich; Boini, Krishna M.; Li, Pin-Lan			Activation of Nlrp3 Inflammasomes Enhances Macrophage Lipid-Deposition and Migration: Implication of a Novel Role of Inflammasome in Atherogenesis	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; NALP3 INFLAMMASOME; SIGNALING PATHWAY; OXIDATIVE STRESS; CHOLESTEROL; CELLS; ATHEROSCLEROSIS; CONTRIBUTE; CRYSTALS	Although Nlrp3 inflammasome activation in macrophages has been shown to be critical for the development of atherosclerosis upon atherogenic stimuli, it remains unknown whether activated Nlrp3 inflammasomes by other non-atherogenic stimuli induce alterations in macrophages that may contribute in the concert with other factors to atherogenesis. Thus, the present study tested the hypothesis that activation of Nlrp3 inflammasomes by ATP, which is a classical non-lipid danger stimulus, enhances the migration of macrophage and increases lipids deposition in macrophages accelerating foam cell formation. We first demonstrated that extracellular ATP (2.5 mM) markedly increased the formation and activation of Nlrp3 inflammasomes in bone marrow macrophages (BMMs) from wild type (Asc(+/+)) mice resulting in activation of caspase-1 and IL-1 beta production. In these Asc(+/+) macrophages, such stimulation of inflammasomes by non-lipid ATP was similar to those induced by atherogenic stimuli such as cholesterol crystals or 7-ketocholesterol. Both non-lipid and lipid forms of stimuli induced formation and activation of Nlrp3 inflammasomes, which were prevented by Asc gene deletion. Interestingly, Asc(+/+) BMMs had dramatic lipids accumulation after stimulation with ATP. Further, we demonstrated that large amount of cholesterol was accumulated in lysosomes of Asc(+/+) BMMs when inflammasomes were activated by ATP. Such intracellular and lysosomal lipids deposition was not observed in Asc(-/-) BMMs and also prevented by caspase-1 inhibitor WEHD. In addition, in vitro and in vivo experiments revealed that migration of Asc(+/+) BMMs increased due to stimulation of Nlrp3 inflammasomes, which was markedly attenuated in Asc(-/-) BMMs. Together, these results suggest that activation of Nlrp3 inflammasomes remarkably increases the susceptibility of macrophages to lipid deposition and their migration ability. Such novel action of inflammasomes may facilitate entry or retention of macrophages into the arterial wall, where they form foam cells and ultimately induce atherosclerosis.	[Li, Xiang; Zhang, Yang; Xia, Min; Boini, Krishna M.; Li, Pin-Lan] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA; [Gulbins, Erich] Univ Duisburg Essen, Med Sch Essen, Dept Mol Biol, Essen, Germany	Virginia Commonwealth University; University of Duisburg Essen	Li, PL (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	pli@vcu.edu	Xia, Min/C-2084-2012; Gulbins, Erich/L-6989-2014; Han, Zhong Chao/D-7157-2016	Gulbins, Erich/0000-0002-3117-1342; Han, Zhong Chao/0000-0002-2687-7682	National Institutes of Health [HL-57244, HL-075316, HL-091464]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL057244, R01HL075316, R01HL091464, R01HL057244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the National Institutes of Health (HL-57244, HL-075316, and HL-091464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel A, 2005, J BIOL CHEM, V280, P43079, DOI 10.1074/jbc.M509796200; Busso N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2952; CHABRAOUI F, 1993, J IMMUNOL METHODS, V165, P225, DOI 10.1016/0022-1759(93)90348-B; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Dinarello CA, 2010, CURR OPIN ENDOCRINOL, V17, P314, DOI 10.1097/MED.0b013e32833bf6dc; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Fearon WF, 2008, CIRCULATION, V117, P2577, DOI 10.1161/CIRCULATIONAHA.108.772491; HALEY NJ, 1977, LAB INVEST, V37, P287; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Herijgers N, 2000, ARTERIOSCL THROM VAS, V20, P1961, DOI 10.1161/01.ATV.20.8.1961; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Jerome WG, 1998, J LIPID RES, V39, P1362; Johnston TP, 2006, EUR J PHARMACOL, V536, P232, DOI 10.1016/j.ejphar.2006.03.019; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Nour AM, 2009, INFECT IMMUN, V77, P1262, DOI 10.1128/IAI.01032-08; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rodriguez G, 2009, INVEST CLIN, V50, P109; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Rudel LL, 2001, CURR OPIN LIPIDOL, V12, P121, DOI 10.1097/00041433-200104000-00005; Silverstein RL, 2000, CURR OPIN LIPIDOL, V11, P483, DOI 10.1097/00041433-200010000-00006; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Stienstra R, 2012, CELL METAB, V15, P10, DOI 10.1016/j.cmet.2011.10.011; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Wei YM, 2013, CELL PHYSIOL BIOCHEM, V31, P925, DOI 10.1159/000350111; Wei YM, 2013, J PHARMACOL EXP THER, V345, P170, DOI 10.1124/jpet.112.201442; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Xia M, 2011, CARDIOVASC RES, V89, P401, DOI 10.1093/cvr/cvq286; Xu SW, 2010, CYTOTECHNOLOGY, V62, P473, DOI 10.1007/s10616-010-9290-0; Yancey PG, 1998, J LIPID RES, V39, P1349; Zhang AY, 2006, HYPERTENSION, V47, P74, DOI 10.1161/01.HYP.0000196727.53300.62; Zhang F, 2011, AM J PHYSIOL-CELL PH, V301, pC421, DOI 10.1152/ajpcell.00393.2010; Zhang Y, 2011, NAT MED, V17, P341, DOI 10.1038/nm.2296; Zheng Y, 2011, ARTERIOSCL THROM VAS, V31, P2781, DOI 10.1161/ATVBAHA.111.224907; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	39	142	149	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87552	10.1371/journal.pone.0087552	http://dx.doi.org/10.1371/journal.pone.0087552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475307	Green Published, gold			2022-12-27	WOS:000330507300200
J	Wang, H; Liu, B; Liu, X; Li, ZL; Yu, XF; Zhang, WY				Wang, Hong; Liu, Bin; Liu, Xin; Li, Zhaolong; Yu, Xiao-Fang; Zhang, Wenyan			Identification of HIV-1 Vif Regions Required for CBF-beta Interaction and APOBEC3 Suppression	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 VIF; LIGASE COMPLEX; HCCH MOTIF; SOCS-BOX; BINDING; DEGRADATION; INFECTION; DETERMINANTS; RESTRICTION	Human immunodeficiency virus type 1 (HIV-1) Vif requires core binding factor beta (CBF-beta) to degrade the host APOBEC3 restriction factors. Although a minimum domain and certain amino acids of HIV-1 Vif, including hydrophobic residues at the N-terminal, have been identified as critical sites for binding with CBF-beta, other regions that potentially mediate this interaction need to be further investigated. Here, we mapped two new regions of HIV-1 Vif that are required for interaction with CBF-beta by generating a series of single-site or multiple-site Vif mutants and testing their effect on the suppression of APOBEC3G (A3G) and APOBEC3F (A3F). A number of the mutants, including G84A/SIEW86-89AAAA (84/86-89), E88A/W89A (88/89), G84A, W89A, L106S and I107S in the (84)GxSIEW(89) and L(102)ADQLI(107) regions, affected Vif function by disrupting CBF-beta binding. These Vif mutants also had altered interactions with CUL5, since CBF-beta is known to facilitate the binding of Vif to CUL5. We further showed that this effect was not due to misfolding or conformational changes in Vif, as the mutants still maintained their interactions with other factors such as ElonginB, A3G and A3F. Notably, G84D and D104A had stronger effects on the Vif-CUL5 interaction than on the Vif-CBF-beta interaction, indicating that they mainly influenced the CUL5 interaction and implying that the interaction of Vif with CUL5 contributes to the binding of Vif to CBF-beta. These new binding interfaces with CBF-beta in HIV-1 Vif provide novel targets for the development of HIV-1 inhibitors.	[Wang, Hong; Liu, Bin; Liu, Xin; Li, Zhaolong; Yu, Xiao-Fang; Zhang, Wenyan] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun 130023, Jilin Province, Peoples R China; [Liu, Bin] Jilin Univ, Hosp 1, Dept Hand Surg, Changchun 130023, Jilin Province, Peoples R China; [Yu, Xiao-Fang] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Jilin University; Jilin University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhang, WY (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun 130023, Jilin Province, Peoples R China.	zhangwenyan@jlu.edu.cn			National Natural Science Foundation of China [31270202]; Chinese Ministry of Science and Technology [2012CB911102, 2013ZX10001-005]; Chinese Ministry of Education [IRT1016]; Key Laboratory of Molecular Virology, Jilin Province [20102209]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Ministry of Education(Ministry of Education, China); Key Laboratory of Molecular Virology, Jilin Province	This work was supported in part by funding from National Natural Science Foundation of China (No. 31270202), the Chinese Ministry of Science and Technology (2012CB911102 and No. 2013ZX10001-005), the Chinese Ministry of Education (IRT1016), and the Key Laboratory of Molecular Virology, Jilin Province (20102209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chackerian B, 1997, J VIROL, V71, P3932, DOI 10.1128/JVI.71.5.3932-3939.1997; Chen GY, 2009, J VIROL, V83, P8674, DOI 10.1128/JVI.00653-09; Dang Y, 2010, J VIROL, V84, P5741, DOI 10.1128/JVI.00079-10; Dang Y, 2009, J VIROL, V83, P8544, DOI 10.1128/JVI.00651-09; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Du J, 2013, J VIROL, V87, P1906, DOI 10.1128/JVI.02199-12; Fribourgh JL, 2014, J VIROL; Guo YY, 2014, NATURE, V505, P229, DOI 10.1038/nature12884; He ZW, 2008, J MOL BIOL, V381, P1000, DOI 10.1016/j.jmb.2008.06.061; Hultquist JF, 2012, J VIROL, V86, P2874, DOI 10.1128/JVI.06950-11; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kim DY, 2013, MOL CELL, V49, P632, DOI 10.1016/j.molcel.2012.12.012; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Matsui Y, 2014, VIROLOGY, V449, P82, DOI 10.1016/j.virol.2013.11.004; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Paul I, 2006, P NATL ACAD SCI USA, V103, P18475, DOI 10.1073/pnas.0604150103; Pery E, 2009, J VIROL, V83, P2374, DOI 10.1128/JVI.01898-08; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Tian CJ, 2006, J VIROL, V80, P3112, DOI 10.1128/JVI.80.6.3112-3115.2006; Wang XD, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-94; Wissing S, 2011, J BIOL CHEM, V286, P36427, DOI 10.1074/jbc.M111.251058; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Zhang WY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003963; Zhen AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038771; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004; Zhou XH, 2014, J VIROL, V88, P2555, DOI 10.1128/JVI.03604-13; Zhou XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033495	31	50	51	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e95738	10.1371/journal.pone.0095738	http://dx.doi.org/10.1371/journal.pone.0095738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24595218	gold, Green Published, Green Submitted			2022-12-27	WOS:000338213300014
J	Wang, ST; Sun, XL; Hoshino, Y; Yu, Y; Jia, B; Sun, ZW; Sun, MZ; Duan, XB; Zhu, YM				Wang, Sun-ting; Sun, Xiao-li; Hoshino, Yoichiro; Yu, Yang; Jia, Bei; Sun, Zhong-wen; Sun, Ming-zhe; Duan, Xiang-bo; Zhu, Yan-ming			MicroRNA319 Positively Regulates Cold Tolerance by Targeting OsPCF6 and OsTCP21 in Rice (Oryza sativa L.)	PLOS ONE			English	Article							APOPLASTIC OXIDATIVE BURST; PLANT MICRORNAS; TRANSCRIPTION FACTORS; LOW-TEMPERATURE; GENE-REGULATION; SMALL RNAS; STRESS; ARABIDOPSIS; EXPRESSION; LANCEOLATE	The microRNA319 (miR319) family is conserved among diverse plant species. In rice (Oryza sativa L.), the miR319 gene family is comprised of two members, Osa-miR319a and Osa-miR319b. We found that overexpressing Osa-miR319b in rice resulted in wider leaf blades and delayed development. Here, we focused on the biological function and potential molecular mechanism of the Osa-miR319b gene in response to cold stress in rice. The expression of Osa-miR319b was down-regulated by cold stress, and the overexpression of Osa-miR319b led to an enhanced tolerance to cold stress, as evidenced by higher survival rates and proline content. Also, the expression of a handful of cold stress responsive genes, such as DREB1A/B/C, DREB2A, TPP1/2, was increased in Osa-miR319b transgenic lines. Furthermore, we demonstrated the nuclear localization of the transcription factors, OsPCF6 and OsTCP21, which may be Osa-miR319b-targeted genes. We also showed that OsPCF6 and OsTCP21 expression was largely induced by cold stress, and the degree of induction was obviously repressed in plants overexpressing Osa-miR319b. As expected, the down-regulation of OsPCF6 and OsTCP21 resulted in enhanced tolerance to cold stress, partially by modifying active oxygen scavenging. Taken together, our findings suggest that Osa-miR319b plays an important role in plant response to cold stress, maybe by targeting OsPCF6 and OsTCP21.	[Wang, Sun-ting; Sun, Xiao-li; Yu, Yang; Jia, Bei; Sun, Zhong-wen; Sun, Ming-zhe; Duan, Xiang-bo; Zhu, Yan-ming] Northeast Agr Univ, Key Lab Agr Biol Funct Genes, Harbin, Peoples R China; [Hoshino, Yoichiro] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Kita Ku, Sapporo, Hokkaido, Japan	Northeast Agricultural University - China; Hokkaido University	Zhu, YM (corresponding author), Northeast Agr Univ, Key Lab Agr Biol Funct Genes, Harbin, Peoples R China.	ymzhu2001@neau.edu.cn	han, xiao/HDN-9782-2022; Sun, Xiaoli/AAH-2265-2020; Hoshino, Yoichiro/A-5115-2012	Sun, Xiaoli/0000-0003-1134-3976; Hoshino, Yoichiro/0000-0003-3828-0696; Sun, Mingzhe/0000-0001-7557-623X	National Natural Science Foundation of China [31171578]; "863" project [2008AA10Z153]; Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program [2011TD005]; National basic scientific talent training fund projects [J1210069]; Graduate student innovation research project in Heilongjiang province [YJSCX2012-047HLJ]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "863" project(National High Technology Research and Development Program of China); Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program; National basic scientific talent training fund projects; Graduate student innovation research project in Heilongjiang province	This work was supported by the National Natural Science Foundation of China (31171578), the "863" project (2008AA10Z153), Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program (2011TD005), National basic scientific talent training fund projects (J1210069), Graduate student innovation research project in Heilongjiang province (YJSCX2012-047HLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Andaya VC, 2003, THEOR APPL GENET, V106, P1084, DOI 10.1007/s00122-002-1126-7; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Armengaud P, 2004, PHYSIOL PLANTARUM, V120, P442, DOI 10.1111/j.0031-9317.2004.00251.x; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Ben-Gera H, 2012, PLANT SIGNAL BEHAV, V7, P1255, DOI 10.4161/psb.21550; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Chinnusamy V, 2010, METHODS MOL BIOL, V639, P39, DOI 10.1007/978-1-60761-702-0_3; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Efroni I, 2008, PLANT CELL, V20, P2293, DOI 10.1105/tpc.107.057521; Eldem V, 2013, TURK J AGRIC FOR, V37, P1, DOI 10.3906/tar-1206-50; Fattash I, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-13; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; GLASZMANN JC, 1990, EUPHYTICA, V45, P95; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hsieh TH, 2002, PLANT PHYSIOL, V129, P1086, DOI 10.1104/pp.003442; Huang J, 2009, BIOCHEM BIOPH RES CO, V389, P556, DOI 10.1016/j.bbrc.2009.09.032; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Liu Q, 2009, FEBS LETT, V583, P723, DOI 10.1016/j.febslet.2009.01.020; Lou QJ, 2007, EUPHYTICA, V158, P87, DOI 10.1007/s10681-007-9431-5; Lv DK, 2010, GENE, V459, P39, DOI 10.1016/j.gene.2010.03.011; Ma QB, 2009, PLANT PHYSIOL, V150, P244, DOI 10.1104/pp.108.133454; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mao DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047275; Martin-Trillo M, 2010, TRENDS PLANT SCI, V15, P31, DOI 10.1016/j.tplants.2009.11.003; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Nonogaki H, 2010, PLANT CELL PHYSIOL, V51, P1840, DOI 10.1093/pcp/pcq154; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Ozhuner E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059543; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Peyman S, 2010, RICE SCI, V1, P77; Phillips JR, 2007, FEBS LETT, V581, P3592, DOI 10.1016/j.febslet.2007.04.007; Saini A., 2012, MICRORNAS PLANT DEV, P219, DOI [10.1016/j.tplants.2012.01.010, DOI 10.1016/J.TPLANTS.2012.01.010]; Schommer C., 2012, SIGNAL COMMUN PLANTS, V15, P29, DOI [DOI 10.1007/978-3-642-27384-1_2, 10.1007/978-3-642-27384-1_2]; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Sharma R., 2010, J PLANT MOL BIOL BIO, V1, P24; Song SY, 2011, PLANTA, V234, P331, DOI 10.1007/s00425-011-1403-2; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Suzuki N, 2006, PHYSIOL PLANTARUM, V126, P45, DOI 10.1111/j.0031-9317.2005.00582.x; Talmor-Neiman M, 2006, PLANT J, V47, P25, DOI 10.1111/j.1365-313X.2006.02768.x; Thiebaut F, 2012, PLANT CELL ENVIRON, V35, P502, DOI 10.1111/j.1365-3040.2011.02430.x; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Ueno M, 2003, PLANT J, V36, P215, DOI 10.1046/j.1365-313X.2003.01875.x; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Warthmann N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001829; Xin Z, 2000, PLANT CELL ENVIRON, V23, P893, DOI 10.1046/j.1365-3040.2000.00611.x; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yanai O, 2011, PLANT J, V68, P571, DOI 10.1111/j.1365-313X.2011.04716.x; Yang CH, 2013, PLANT CELL ENVIRON, V36, P2207, DOI 10.1111/pce.12130; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zhao K, 2013, PLANT CELL PHYSIOL, V54, P1415, DOI 10.1093/pcp/pct087	61	208	242	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e91357	10.1371/journal.pone.0091357	http://dx.doi.org/10.1371/journal.pone.0091357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667308	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600005
J	Wang, S; Han, XH; Wang, JF; Yao, JR; Shi, YK				Wang, Shuai; Han, Xiaohong; Wang, Jianfei; Yao, Jiarui; Shi, Yuankai			Antitumor Effects of a Novel Chromosome Region Maintenance 1 (CRM1) Inhibitor on Non-Small Cell Lung Cancer Cells In Vitro and in Mouse Tumor Xenografts	PLOS ONE			English	Article							NUCLEAR EXPORT SIGNAL; SELECTIVE INHIBITORS; PROGNOSTIC-FACTOR; TRANSPORT; RECEPTOR; APOPTOSIS; EGFR	Background: Chromosome Region Maintenance 1 (CRM1) is a nuclear exporter and its inhibitor has anti-tumor activity in various cancers. This study assessed the therapeutic efficiency of the novel CRM1 inhibitor KPT-185 on non-small cell lung cancer (NSCLC). Methods: NSCLC cell lines were treated with KPT-185 to assess changes in cell viability, cell cycle, apoptosis, and protein expression. NOD-SCID mice carrying NSCLC cell xenografts were orally treated with KPT-276, a clinical analog of KPT-185, to examine the efficacy and side effects of KPT-276 in vivo. Results: KPT-185 significantly reduced the viability of six NSCLC cell lines in a time-and dose-dependent manner, including epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-resistant H1975 and H1650GR cell lines. In addition, KPT-185 induced these NSCLC cells to arrest at G1 phase of the cell cycle and caused apoptosis in a dose-dependent manner. KPT-185 treatment also reduced CRM1 protein levels in six NSCLC cell lines, and the reduction could be completely abolished by the proteasome inhibitor bortezomib. KPT-185 activated caspase 3, 8, and 9, but inhibited survivin expression in NSCLC cells. In a mouse H1975 cell xenograft model, tumor growth was significantly inhibited by oral KPT-276 administration, and there was no significant mouse body weight loss or other side effects. Conclusions: The current study demonstrated the anti-tumor effects of KPT-185 in NSCLC cells, including EGFR-TKI-resistant NSCLC cell lines. Further studies will assess anti-tumor activity of KPT-185 in a clinical trial for NSCLC patients.	[Shi, Yuankai] Chinese Acad Med Sci, Dept Med Oncol, Canc Inst Hosp, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China; Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Shi, YK (corresponding author), Chinese Acad Med Sci, Dept Med Oncol, Canc Inst Hosp, Beijing 100730, Peoples R China.	syuankai@cicams.ac.cn	han, xiao/HDN-9782-2022; Sun, Xiaoli/AAH-2265-2020; Hoshino, Yoichiro/A-5115-2012	Sun, Xiaoli/0000-0003-1134-3976; Hoshino, Yoichiro/0000-0003-3828-0696; Sun, Mingzhe/0000-0001-7557-623X				Azmi AS, 2013, GASTROENTEROLOGY, V144, P447, DOI 10.1053/j.gastro.2012.10.036; Bartholomeusz G, 2006, MOL CARCINOGEN, V45, P73, DOI 10.1002/mc.20156; Bonazzi S, 2010, J AM CHEM SOC, V132, P1432, DOI 10.1021/ja9097093; Cahir-McFarland ED, 2000, P NATL ACAD SCI USA, V97, P6055, DOI 10.1073/pnas.100119497; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Etchin J, 2013, LEUKEMIA, V27, P66, DOI 10.1038/leu.2012.219; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Keller Shannon A., 2000, Blood, V96, P2537; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Meissner T, 2004, FEBS LETT, V576, P27, DOI 10.1016/j.febslet.2004.08.056; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Murakami N, 2002, BIOORG MED CHEM LETT, V12, P2807, DOI 10.1016/S0960-894X(02)00624-8; Mutka SC, 2009, CANCER RES, V69, P510, DOI 10.1158/0008-5472.CAN-08-0858; Newlands ES, 1996, BRIT J CANCER, V74, P648, DOI 10.1038/bjc.1996.415; Noske A, 2008, CANCER-AM CANCER SOC, V112, P1733, DOI 10.1002/cncr.23354; Noske A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-294; Phelps RM, 1996, J CELL BIOCHEM, P32; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Sakakibara K, 2011, BLOOD, V118, P3922, DOI 10.1182/blood-2011-01-333138; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Turner JG, 2012, BIOCHEM PHARMACOL, V83, P1021, DOI 10.1016/j.bcp.2011.12.016; Van Neck T, 2008, BIOORGAN MED CHEM, V16, P9487, DOI 10.1016/j.bmc.2008.09.051; Wach JY, 2010, BIOORG MED CHEM LETT, V20, P2843, DOI 10.1016/j.bmcl.2010.03.049; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Zhang KJ, 2013, EXP HEMATOL, V41, P67, DOI 10.1016/j.exphem.2012.09.002	31	208	242	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89848	10.1371/journal.pone.0089848	http://dx.doi.org/10.1371/journal.pone.0089848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24667308	gold, Green Published, Green Submitted			2022-12-27	WOS:000332475500025
J	Wang, SL; Yang, H; Yu, LJ; Jin, JL; Qian, L; Zhao, H; Xu, Y; Zhu, XL				Wang, Sulei; Yang, Hui; Yu, Linjie; Jin, Jiali; Qian, Lai; Zhao, Hui; Xu, Yun; Zhu, Xiaolei			Oridonin Attenuates A beta(1-42)-Induced Neuroinflammation and Inhibits NF-kappa B Pathway	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OXIDATIVE STRESS; IN-VITRO; PROINFLAMMATORY CYTOKINES; INFLAMMATION; ACTIVATION; HYPOTHESIS; PROTECTS; NEURONS	Neuroinflammation induced by beta-amyloid (A beta) plays a critical role in the pathogenesis of Alzheimer's disease (AD), and inhibiting A beta-induced neuroinflammation serves as a potential strategy for the treatment of AD. Oridonin (Ori), a compound of Rabdosia rubescens, has been shown to exert anti-inflammatory effects. In this study, we demonstrated that Ori inhibited glial activation and decreased the release of inflammatory cytokines in the hippocampus of A beta(1-42)-induced AD mice. In addition, Ori inhibited the NF-kappa B pathway and A beta(1-42)-induced apoptosis. Furthermore, Ori could attenuate memory deficits in A beta(1-42)-induced AD mice. In conclusion, our study demonstrated that Ori inhibited the neuroinflammation and attenuated memory deficits induced by A beta(1-42), suggesting that Ori might be a promising candidate for AD treatment.	[Wang, Sulei; Yang, Hui; Xu, Yun] Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Yu, Linjie; Jin, Jiali; Qian, Lai; Zhao, Hui; Xu, Yun; Zhu, Xiaolei] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University of Chinese Medicine; Nanjing University	Xu, Y (corresponding author), Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Dept Neurol, Nanjing, Jiangsu, Peoples R China.	xuyun20042001@aliyun.com; zhuquelee@126.com	han, xiao/HDN-9782-2022; Sun, Xiaoli/AAH-2265-2020; Hoshino, Yoichiro/A-5115-2012	Sun, Xiaoli/0000-0003-1134-3976; Hoshino, Yoichiro/0000-0003-3828-0696; Sun, Mingzhe/0000-0001-7557-623X	National Nature Science Foundation of China [81200839, 81230026, 81171085]; Natural Science Foundation [BL2012013]; Bureau of Health of the Jiangsu Province of China [LJ201101]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Bureau of Health of the Jiangsu Province of China	This study was supported by the National Nature Science Foundation of China (81200839, 81230026, and 81171085), the Natural Science Foundation (BL2012013) and the Bureau of Health (LJ201101) of the Jiangsu Province of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae S, 2014, INT J MOL MED, V33, P185, DOI 10.3892/ijmm.2013.1561; Batsch N., 2012, WORLD ALZHEIMER REPO; Boissiere F, 1997, NEUROREPORT, V8, P2849, DOI 10.1097/00001756-199709080-00009; Bu HQ, 2014, ONCOL REP, V31, P975, DOI 10.3892/or.2013.2888; Capiralla H, 2012, J NEUROCHEM, V120, P461, DOI 10.1111/j.1471-4159.2011.07594.x; Couturier J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-72; Fan H, 2013, J BIOMED RES, V27, P296, DOI 10.7555/JBR.27.20120100; Gubandru M, 2013, FOOD CHEM TOXICOL, V61, P209, DOI 10.1016/j.fct.2013.07.013; Han LJ, 2013, NEUROCHEM INT, V62, P913, DOI 10.1016/j.neuint.2013.03.003; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; Huang Y, 2005, NEUROSCI LETT, V373, P115, DOI 10.1016/j.neulet.2004.09.074; Jaturapatporn D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006378.pub2; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim HG, 2014, NEUROTOXICOLOGY, V40, P23, DOI 10.1016/j.neuro.2013.10.004; Ku CM, 2013, FOOD CHEM, V141, P1104, DOI 10.1016/j.foodchem.2013.04.044; Kurt MA, 1997, NEUROSCI LETT, V239, P41, DOI 10.1016/S0304-3940(97)00876-8; Lawrence T, 2010, INT J BIOCHEM CELL B, V42, P519, DOI 10.1016/j.biocel.2009.12.016; Leung CH, 2005, MOL PHARMACOL, V68, P286, DOI 10.1124/mol.105.012765; Llano DA, 2012, ALZ DIS ASSOC DIS, V26, P322, DOI 10.1097/WAD.0b013e31823b2728; Lyman M, 2014, NEUROSCI RES, V79, P1, DOI 10.1016/j.neures.2013.10.004; McGeer PL, 2013, ACTA NEUROPATHOL, V126, P479, DOI 10.1007/s00401-013-1177-7; Meng QH, 2013, PHARMAZIE, V68, P904, DOI 10.1691/ph.2013.3571; Overmyer M, 1999, DEMENT GERIATR COGN, V10, P252, DOI 10.1159/000017128; Paris D, 2007, NEUROSCI LETT, V415, P11, DOI 10.1016/j.neulet.2006.12.029; PRICE DL, 1995, CURR OPIN NEUROL, V8, P268, DOI 10.1097/00019052-199508000-00004; Rozemuller AJM, 2012, NEURODEGENER DIS, V10, P301, DOI 10.1159/000335380; Thangavel R, 2012, NEUROPATH APPL NEURO, V38, P572, DOI 10.1111/j.1365-2990.2011.01232.x; Valerio A, 2006, EUR J NEUROSCI, V23, P1711, DOI 10.1111/j.1460-9568.2006.04722.x; Wang C, 2011, NEUROSCI LETT, V491, P127, DOI 10.1016/j.neulet.2011.01.022; Wu J, 2011, BIOCHEM BIOPH RES CO, V408, P382, DOI 10.1016/j.bbrc.2011.04.013; Xu Y, 2009, INT IMMUNOPHARMACOL, V9, P360, DOI 10.1016/j.intimp.2009.01.002; Zhang J, 2013, BEHAV BRAIN RES, V244, P70, DOI 10.1016/j.bbr.2013.01.037; Zhang YY, 2013, CLIN INTERV AGING, V8, DOI 10.2147/CIA.S40405; Zhao H, 2013, CNS NEUROSCI THER, V19, P117, DOI 10.1111/cns.12043; Zhu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035823	37	208	242	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104745	10.1371/journal.pone.0104745	http://dx.doi.org/10.1371/journal.pone.0104745			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	24667308	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000058
